Citrus Sinensis ID: 038168
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 757 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.944 | 0.859 | 0.340 | 1e-116 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.974 | 0.846 | 0.330 | 1e-106 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.898 | 0.820 | 0.322 | 4e-91 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.915 | 0.836 | 0.308 | 1e-83 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.865 | 0.821 | 0.283 | 1e-78 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.908 | 0.842 | 0.292 | 4e-77 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.935 | 0.849 | 0.284 | 4e-76 | |
| O64770 | 804 | G-type lectin S-receptor- | no | no | 0.922 | 0.868 | 0.287 | 5e-76 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.944 | 0.870 | 0.283 | 1e-75 | |
| O64776 | 792 | G-type lectin S-receptor- | no | no | 0.926 | 0.885 | 0.296 | 6e-74 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 419 bits (1076), Expect = e-116, Method: Compositional matrix adjust.
Identities = 279/820 (34%), Positives = 415/820 (50%), Gaps = 105/820 (12%)
Query: 14 FFILSSGCLTATAKQRRSNISIGSSLSPIGN----SSWRSPSGLYAFGFYPQSNVSGRYY 69
FF+ S R ++ +G SL+ + SSWRSPSG +AFGF G +
Sbjct: 20 FFVFSQNI-------RNGSVPVGESLTASESQQISSSWRSPSGDFAFGFRKIQPNDG-FT 71
Query: 70 VGVFLAGIPEKTVVWTA---NRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQS 126
+ ++ I +KT+VW A N V + + ++G +V+ + + Q+ A S
Sbjct: 72 LSIWFDKISDKTIVWHAQAVNTTTGLVPNGSKVTLTADGGLVI-ADPRGQELWRALSGGS 130
Query: 127 ASSASMLDSGNFVLY----DSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPST 182
S D GNFVL+ + + + LW +FE+PTDTLLPNQ + VG L +ET+
Sbjct: 131 VSRGRFTDDGNFVLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVGRNLSSRRTETSFKK 190
Query: 183 GKFLLIMQGDGNLVQYANINPYGTQHA-----YWASNTYNKGD-NVSLNLDENGHLFLMN 236
G+F L ++ DGNL Q ++N + Y+ SNT + + + L +++G ++++
Sbjct: 191 GRFSLRLEDDGNL-QLHSLNAETASESDIYSQYYESNTNDPNNPGIQLVFNQSGEIYVLQ 249
Query: 237 TTGVNIFNLTGGENPTKGMIYLMKIDSDGIFRLYSYNLRRQNSTWQVVWESTSDRCDP-- 294
+ +P + I + + R+ ++ + C P
Sbjct: 250 RNNSRF--VVKDRDPDFSIAAPFYISTGFLLSTIIPKEARRIVGGCLLGLCRDNMCSPDD 307
Query: 295 -IG--FCGFNSFCVL-NDQIPDCPCLPGFVQISQGNFTSGCERNYTAESC------GNKA 344
+G CG+N+ C L N++ P C C FV N C ++ ++C N
Sbjct: 308 ALGNMACGYNNICSLGNNKRPKCECPERFVLKDPSNEYGDCLPDFEMQTCRPENQTANSD 367
Query: 345 IR-----ELKNTKWEDVSYYVLSETTEEKCKQACLEDCNCEAALF---KEEECKMQRLPL 396
+ L+ T W Y + EE+CK +CL DC C A +F ++ +C ++ PL
Sbjct: 368 VNLYEFITLEKTNWPFGDYESYANYDEERCKASCLSDCLCAAVIFGTNRDLKCWKKKFPL 427
Query: 397 RFGRRNLRDSSIAFVKVDDATSSSPQAPFSVEGNKKELWKDIVIICLFVAVVILISAVTF 456
G R+ R S F+KV + S P + KK W L +A +L+ F
Sbjct: 428 SHGERSPRGDSDTFIKVRN--RSIADVPVTGNRAKKLDW-------LIIACSVLLGTSAF 478
Query: 457 GIF----IYRYHVGS-------YRRIPGNGSARYCEDIAPLSFSYAELEKMTDGFKEEVG 505
IF YR S R I + ++ F+Y EL + T F EE+G
Sbjct: 479 VIFDTSCSYRKTKKSKNMMKNQARDIGRTTATTTANELNLRVFTYGELAEATRDFTEELG 538
Query: 506 RGSSG-----------------------------EREFQTEMKVIGRTHHRNLVRLLGYS 536
RG+ G E+EF+ E+KVIG+ HH+NLVRL+G+
Sbjct: 539 RGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNLVRLIGFC 598
Query: 537 LEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCD 596
E +++VYE++ G+LA+ LF +P+W +R IA IARGILYLH+EC QIIHCD
Sbjct: 599 NEGQSQMIVYEFLPQGTLANFLFR-RPRPSWEDRKNIAVAIARGILYLHEECSEQIIHCD 657
Query: 597 IKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVY 656
IKPQNIL+DE +ISDFGLAKL+ +QT T T IRGT+GYVAPEW RN PIT K DVY
Sbjct: 658 IKPQNILLDEYYTPRISDFGLAKLLLMNQTYTLTNIRGTKGYVAPEWFRNSPITSKVDVY 717
Query: 657 SFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEV---DEKQLERM 713
S+GV+LLEI+C ++ +D +D VIL W Y CF G L L ED+ D + +ER
Sbjct: 718 SYGVMLLEIVCCKKAVD---LEDNVILINWAYDCFRQGRLEDLTEDDSEAMNDMETVERY 774
Query: 714 IKVALWCILDEPSLRPSMKKVLLMLEGTVEIPIPPNPTSF 753
+K+A+WCI +E +RP+M+ V MLEG +++ PPNP+ +
Sbjct: 775 VKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVFDPPNPSPY 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 386 bits (991), Expect = e-106, Method: Compositional matrix adjust.
Identities = 278/840 (33%), Positives = 426/840 (50%), Gaps = 102/840 (12%)
Query: 1 MQRFHFLFKHSIIFFILSSGCLTATAKQRRSNISIGSSL-SPIGNSSWRSPSGLYAFGFY 59
M FHF F +F C + +I +GS L + N +W S +G +A GF
Sbjct: 1 MSSFHFYFPSVGLFSFF---CFFLVSLATEPHIGLGSKLKASEPNRAWVSANGTFAIGF- 56
Query: 60 PQSNVSGRYYVGVFLAGIP-EKTVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDS 118
+ + R+ + ++ A +P + T+VW+ NR+ P V+ A L + G++VL S Q +
Sbjct: 57 TRFKPTDRFLLSIWFAQLPGDPTIVWSPNRNSP-VTKEAVLELEATGNLVL-SDQNTVVW 114
Query: 119 LIADDSQSASSASMLDSGNFVLYDSN---GKTLWQTFEHPTDTLLPNQRLSVGTKLFPGI 175
+ SA M +SGNF+L + G T+WQ+F P+DTLLPNQ L+V +L
Sbjct: 115 TSNTSNHGVESAVMSESGNFLLLGTEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNP 174
Query: 176 SETNPSTGKFLLIMQGDG---NLVQYANINPYGTQHAYWAS-NTYNKGDNVSLNLDENGH 231
S + ++ Q L N++P+ ++YW+ + N +V+ LD+ G
Sbjct: 175 SPSRHGHYSLKMLQQHTSLSLGLTYNINLDPHA-NYSYWSGPDISNVTGDVTAVLDDTGS 233
Query: 232 LFLM------------------NTTGVNIFNLTGGENPTKGMIYLMKIDSDGIFRLYSY- 272
++ N N NL +NP ++ + ++++G RLY +
Sbjct: 234 FKIVYGESSIGAVYVYKNPVDDNRNYNNSSNLGLTKNP---VLRRLVLENNGNLRLYRWD 290
Query: 273 NLRRQNSTWQVVWESTSDRCDPIGFCGFNSFCVLN--DQIPDCPCLPGFVQISQGNFTSG 330
N +S W W + S+ CD G CG N C L+ + DC CLPG V++
Sbjct: 291 NDMNGSSQWVPEWAAVSNPCDIAGICG-NGVCNLDRTKKNADCLCLPGSVKLPDQENAKL 349
Query: 331 CERNYT-AESCGNKAIR--ELKNTKWEDVSYYVLSETTEE---------KCKQACLEDCN 378
C N + + C + R K + ++ +YY + E KC + CL DC
Sbjct: 350 CSDNSSLVQECESNINRNGSFKISTVQETNYYFSERSVIENISDISNVRKCGEMCLSDCK 409
Query: 379 CEAALFKEEE----CKMQRLPLRFGRRNLRD-SSIAFVKVDDATSSSPQAPFSVEGNKKE 433
C A+++ ++ C + + L FG RD S FVK S + + ++K
Sbjct: 410 CVASVYGLDDEKPYCWILK-SLNFG--GFRDPGSTLFVKTRANESYPSNSNNNDSKSRKS 466
Query: 434 --LWKDIVIICLFVAVVILISAVTFGIFIYRYHVGSYRRI--PGNGSARYCEDIAPLSFS 489
L + +++I + V +++L++ + G+ +Y Y++ R + S C+ +P+SF+
Sbjct: 467 HGLRQKVLVIPIVVGMLVLVALL--GMLLY-YNLDRKRTLKRAAKNSLILCD--SPVSFT 521
Query: 490 YAELEKMTDGFKEEVGRG-------------------------SSGEREFQTEMKVIGRT 524
Y +L+ T+ F + +G G S GEREF TE+ IG
Sbjct: 522 YRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNTIGSM 581
Query: 525 HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPN---WVERMGIARDIARGI 581
HH NLVRL GY E S ++LVYEYM NGSL +F+ E+ N W R IA A+GI
Sbjct: 582 HHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGI 641
Query: 582 LYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAP 641
Y H++C +IIHCDIKP+NIL+D+N C K+SDFGLAK+M + + T IRGTRGY+AP
Sbjct: 642 AYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMIRGTRGYLAP 701
Query: 642 EWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVE 701
EW N PITVKADVYS+G++LLEI+ RR LD + + W Y+ NG + V+
Sbjct: 702 EWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYPGWAYKELTNGTSLKAVD 761
Query: 702 DE---EVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV-EIPIPPNPTSFLSAI 757
+E+++ + +KVA WCI DE S+RPSM +V+ +LEGT EI +PP P + L I
Sbjct: 762 KRLQGVAEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMPQTILELI 821
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 336 bits (862), Expect = 4e-91, Method: Compositional matrix adjust.
Identities = 253/784 (32%), Positives = 378/784 (48%), Gaps = 104/784 (13%)
Query: 31 SNISIGSSLSPIG-NSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRD 89
S I +GS + G N +W SP+ ++ F P + + F +P +W+A
Sbjct: 25 STIPLGSVIYASGSNQNWPSPNSTFSVSFVPSPSPNSFLAAVSFAGSVP----IWSAG-- 78
Query: 90 DPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDSGNFVLYDSNGKTLW 149
V + +L ++ GS+ L + + D +S S+ D+G F+L ++ +W
Sbjct: 79 --TVDSRGSLRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVW 136
Query: 150 QTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHA 209
+F++PTDT++ +Q + G L G+ + ++ GNL N T
Sbjct: 137 SSFDNPTDTIVQSQNFTAGKILRSGL---------YSFQLERSGNLTLRWN-----TSAI 182
Query: 210 YWASNTYNKGDNVSLNLDENGHLFLMNTTGV-NIF--NLTGGENPTKGMIY-------LM 259
YW N G N S + + + + T GV +IF NL GG Y +
Sbjct: 183 YW-----NHGLNSSFSSNLSSPRLSLQTNGVVSIFESNLLGGAEIVYSGDYGDSNTFRFL 237
Query: 260 KIDSDGIFRLYSYNLRRQ---NSTWQVVWESTSDRCDPIGFCGFNSFCVLNDQIPDCPCL 316
K+D DG R+YS R N+ W V D+C G+CG C ND P C C
Sbjct: 238 KLDDDGNLRIYSSASRNSGPVNAHWSAV-----DQCLVYGYCGNFGICSYNDTNPICSCP 292
Query: 317 P-GFVQISQGNFTSGCERNYTAESC-GNKAIRELKNTK---WEDVSYYVLSETTEEKCKQ 371
F + + GC+R C GN + +L +T+ +ED C+
Sbjct: 293 SRNFDFVDVNDRRKGCKRKVELSDCSGNTTMLDLVHTRLFTYEDDPNSESFFAGSSPCRA 352
Query: 372 ACLEDCNCEAALFKEEECK--MQRLPLRF--GRRNLRDSSIAFVKVDD--ATSSSPQAPF 425
CL C A++ + Q+ P F G + S ++VKV ++ +A
Sbjct: 353 NCLSSVLCLASVSMSDGSGNCWQKHPGSFFTGYQWPSVPSTSYVKVCGPVVANTLERATK 412
Query: 426 SVEGNKK-ELWKDIVIICLFVAVVILISAVTFGIFIYRYHVGSYRRIP--GNGSARYC-- 480
+ N K LW IV + + ++ L+ AV G++ R+ P G S+ Y
Sbjct: 413 GDDNNSKVHLW--IVAVAVIAGLLGLV-AVEIGLWWC-----CCRKNPRFGTLSSHYTLL 464
Query: 481 --EDIAPLSFSYAELEKMTDGFKEEVGRGS------------------------SGEREF 514
AP+ F+Y EL++ T FKE++G G GE++F
Sbjct: 465 EYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQF 524
Query: 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE--KQPNWVERMG 572
+ E+ I THH NLVRL+G+ + ++LVYE+M NGSL + LF + K W R
Sbjct: 525 RMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFN 584
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTG 631
IA A+GI YLH+EC I+HCDIKP+NIL+D+N AK+SDFGLAKL+ P R +
Sbjct: 585 IALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSS 644
Query: 632 IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCF 691
+RGTRGY+APEW NLPIT K+DVYS+G+VLLE++ +R D + + W Y+ F
Sbjct: 645 VRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEF 704
Query: 692 ENGNL-----SQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPI 746
E GN ++L ED+ VD +Q+ RM+K + WCI ++P RP+M KV+ MLEG EI
Sbjct: 705 EKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKN 764
Query: 747 PPNP 750
P P
Sbjct: 765 PLCP 768
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (797), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 244/792 (30%), Positives = 371/792 (46%), Gaps = 99/792 (12%)
Query: 34 SIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPV 93
+I + G+ + S G Y GF+ + S +Y+G++ + + T++W ANRD
Sbjct: 25 TISGDFTLSGDQTIVSSDGTYEMGFF-KPGSSSNFYIGMWYKQLSQ-TILWVANRDKAVS 82
Query: 94 STNATLLFNSEGSIVLRSSQQS----QDSLIADDSQSASSASMLDSGNFVLYDS----NG 145
N+++ S G+++L L + S SA A + D GN VL +
Sbjct: 83 DKNSSVFKISNGNLILLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRTGGSSLSA 142
Query: 146 KTLWQTFEHPTDTLLP------NQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYA 199
LWQ+F+HP DT LP ++R +L S +PS G F L + Y
Sbjct: 143 NVLWQSFDHPGDTWLPGVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLELD---ESTAYK 199
Query: 200 NINPYGTQHAYWASNTYNKGDNV-------SLNLDENGHLFLMNTTGVNIFNLTGGENPT 252
+ + + YW+S +N + LN N F T +++ N +
Sbjct: 200 IL--WNGSNEYWSSGPWNPQSRIFDSVPEMRLNYIYNFSFFSNTTDSYFTYSIYNQLNVS 257
Query: 253 KGMIYLMKIDSDGIFRLYSYNLRRQNSTWQVVWESTSDRCDPIGFCGFNSFCVLNDQI-P 311
+ ++M + ++ + N W + W +C +CG SF + +D+ P
Sbjct: 258 R---FVMDVSG----QIKQFTWLEGNKAWNLFWSQPRQQCQVYRYCG--SFGICSDKSEP 308
Query: 312 DCPCLPGFVQISQGN-----FTSGCERNYTAESCGNKAIRE---LKNTKWEDVSYYVLSE 363
C C GF +SQ + +++GC R T C I + L N K D S VL+
Sbjct: 309 FCRCPQGFRPMSQKDWDLKDYSAGCVRK-TELQCSRGDINQFFRLPNMKLADNSE-VLTR 366
Query: 364 TTEEKCKQACLEDCNCEAALFKEEECK-----MQRLPLRFGRRNLRDSSIAFVKVDDATS 418
T+ C AC DC+C+A + E K L L+ + +I ++++ A S
Sbjct: 367 TSLSICASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRL--AAS 424
Query: 419 SSPQAPFSVEGNKKELWKDIVIICLFVAVVILISAVTFGIFIYRYHVGSYRRIPGNGSAR 478
P S + N K L +F AV+ + + + + + RR G
Sbjct: 425 DVPNVGASGKSNNKGL--------IFGAVLGSLGVIVLVLLVVILILRYRRRKRMRGEK- 475
Query: 479 YCEDIAPLSFSYAELEKMTDGFKEEVGRG------------------------SSGEREF 514
D +FSY EL+ T F +++G G S GE++F
Sbjct: 476 --GDGTLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQF 533
Query: 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPN----WVER 570
+TE+ IG H NLVRL G+ E SKK+LVY+YM NGSL LF + + W R
Sbjct: 534 RTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLR 593
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
IA ARG+ YLHDEC IIHCDIKP+NIL+D C K++DFGLAKL+ D +R T
Sbjct: 594 FQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLT 653
Query: 631 GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQC 690
+RGTRGY+APEW + IT KADVYS+G++L E++ RR + + + W
Sbjct: 654 TMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATI 713
Query: 691 F-ENGNLSQLV----EDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIP 745
++G++ LV E + VD +++ R KVA WCI DE S RP+M +V+ +LEG +E+
Sbjct: 714 LTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVN 773
Query: 746 IPPNPTSFLSAI 757
PP P S + +
Sbjct: 774 PPPFPRSIQALV 785
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (755), Expect = 1e-78, Method: Compositional matrix adjust.
Identities = 219/773 (28%), Positives = 356/773 (46%), Gaps = 118/773 (15%)
Query: 34 SIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPV 93
S+ S + GN + S ++ GF+ +N S +Y+G+ A +P T VW ANR P
Sbjct: 20 SVQSKVIIKGNQTILSFKAIFRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVS 79
Query: 94 STNA-TLLFNSEGSIVLRSSQQSQDSLI--ADDSQSASSASMLDSGNFVLYDSNGKTLWQ 150
++ TL S G +++ +D ++ D+ Q + ++GN +L + +G +WQ
Sbjct: 80 DPDSSTLELTSTGYLIV---SNLRDGVVWQTDNKQPGTDFRFSETGNLILINDDGSPVWQ 136
Query: 151 TFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAY 210
+F++PTDT LP ++ T + S +PS G + L + N Q Y Y
Sbjct: 137 SFDNPTDTWLPGMNVTGLTAMTSWRSLFDPSPGFYSLRLSPSFNEFQLV----YKGTTPY 192
Query: 211 WASNTYNKGDNVSLNLDENGHLFL----MNTTGVNIFNLTGGENPTKGMIYLMK------ 260
W++ + G F+ M + F+ PT Y++
Sbjct: 193 WSTGNWT------------GEAFVGVPEMTIPYIYRFHFVNPYTPTASFWYIVPPLDSVS 240
Query: 261 --------IDSDGIFRLYSYNLRRQNSTWQVVWESTSDRCDPIGFCGFNSFCVLNDQIPD 312
+ ++G + Y+++ Q +W + W D C CG FC ++ +
Sbjct: 241 EPRLTRFMVGANGQLKQYTWD--PQTQSWNMFWLQPEDPCRVYNLCGQLGFCS-SELLKP 297
Query: 313 CPCLPGF-----VQISQGNFTSGCERNYTAESCGNKAIRELKNTKWEDVSYYVLSETTEE 367
C C+ GF +++ GC R + + + +++ + ++
Sbjct: 298 CACIRGFRPRNDAAWRSDDYSDGCRRENGDSGEKSDTFEAVGDLRYDGDVKMSRLQVSKS 357
Query: 368 KCKQACLEDCNCEAALFKEEECKMQRLPLRFGRRNLRDSSIAFVKVDDATSSSPQAPFSV 427
C + CL + +C + +E+ + ++ L ++P ++
Sbjct: 358 SCAKTCLGNSSC-VGFYHKEKSNLCKILL-------------------------ESPNNL 391
Query: 428 EGNKKELWKDIVIICLFVAVVILISAVTFGIFIYRYHVGSYRRIPGNGSARYCEDIAPLS 487
+ +K + K I+I+C +VV IS + F + + + R+ + + A L+
Sbjct: 392 KNSKGNISKSIIILC---SVVGSISVLGFTLLVPLILLKRSRKR-KKTRKQDEDGFAVLN 447
Query: 488 ---FSYAELEKMTDGFKEEVGRGS-------------------------SGEREFQTEMK 519
FS+ EL+ T+GF ++VG G SGE EF+ E+
Sbjct: 448 LKVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGESEFRAEVC 507
Query: 520 VIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIA 578
IG H NLVRL G+ E ++LVY+YM GSL+ L K +W R IA A
Sbjct: 508 TIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPKLLSWETRFRIALGTA 567
Query: 579 RGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGY 638
+GI YLH+ C IIHCDIKP+NIL+D + AK+SDFGLAKL+ D +R +RGT GY
Sbjct: 568 KGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLATMRGTWGY 627
Query: 639 VAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPN---LPDDQVILEEWVYQCFE--- 692
VAPEW LPIT KADVYSFG+ LLE+I RR + N L + + E+W + +
Sbjct: 628 VAPEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPPWAARE 687
Query: 693 --NGNLSQLVEDE---EVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740
GN+ +V+ E + +++ RM VA+WCI D +RP+M V+ MLEG
Sbjct: 688 IIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 290 bits (741), Expect = 4e-77, Method: Compositional matrix adjust.
Identities = 246/840 (29%), Positives = 374/840 (44%), Gaps = 152/840 (18%)
Query: 16 ILSSGCLTA-------TAKQRRSNISIGSSL--SPIGNSSWRSPSGLYAFGFY---PQSN 63
+LS+ C+ + A R + +GSSL +S+ +S G ++ GFY +
Sbjct: 8 LLSTACILSFFIALFPRAASSRDILPLGSSLVVESYESSTLQSSDGTFSSGFYEVYTHAF 67
Query: 64 VSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADD 123
+Y A KT+VW+AN D P + + L +G++VL + AD
Sbjct: 68 TFSVWYSKTEAAAANNKTIVWSANPDRPVHARRSALTLQKDGNMVL-TDYDGAAVWRADG 126
Query: 124 SQ--SASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPS 181
+ A +LD+GN V+ DS G T+WQ+F+ PTDT LP Q ++ T+L P +P
Sbjct: 127 NNFTGVQRARLLDTGNLVIEDSGGNTVWQSFDSPTDTFLPTQLITAATRLVPTTQSRSPG 186
Query: 182 TGKF----LLIMQGDGNLVQYANINPYGTQHAYWA---SNTYNKGDNVSLNLDENGHLFL 234
F L ++ ++ Q ++I YW N Y G N + L +
Sbjct: 187 NYIFRFSDLSVLSLIYHVPQVSDI--------YWPDPDQNLYQDGRNQY----NSTRLGM 234
Query: 235 MNTTGV-NIFNLTGGE-----NPTKGMIYLMKIDSDGIFRLYSYNLRRQNSTWQVVWEST 288
+ +GV + G+ + G+ + +D DG RLYS N + +W V +
Sbjct: 235 LTDSGVLASSDFADGQALVASDVGPGVKRRLTLDPDGNLRLYSMN--DSDGSWSVSMVAM 292
Query: 289 SDRCDPIGFCGFNSFCVLNDQIPDCPCLPGFVQISQGNFTSGCER--NYTAESCGNKAIR 346
+ C+ G CG N C + P C C PG+ + GN+T GC N T + +++R
Sbjct: 293 TQPCNIHGLCGPNGICHYS-PTPTCSCPPGYATRNPGNWTEGCMAIVNTTCDRYDKRSMR 351
Query: 347 --ELKNTK-WEDVSYYVLSETTEEKCKQACLEDCNCEAALFKEEECKMQRLPLRFGRRNL 403
L NT W ++LS + C+ C+ DC C+ ++E F R
Sbjct: 352 FVRLPNTDFWGSDQQHLLS-VSLRTCRDICISDCTCKGFQYQEGTGSCYPKAYLFSGRTY 410
Query: 404 RDSSI---------------AFVKVDDATSSSPQ------------APF-----SVEGNK 431
S + A + D S P+ PF + G
Sbjct: 411 PTSDVRTIYLKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNKSIREPFPDVHKTGGGES 470
Query: 432 KELWKDIVIICLFVAVVILISAVTFGIFI--------------YRYHVGSYRRIPGNGSA 477
K + I FV V IS F + Y+ ++RR
Sbjct: 471 KWFYFYGFIAAFFVVEVSFISFAWFFVLKRELRPSELWASEKGYKAMTSNFRR------- 523
Query: 478 RYCEDIAPLSFSYAELEKMTDGFKEEVGRGSSG------------------------ERE 513
+SY EL K T FK E+GRG SG +
Sbjct: 524 ----------YSYRELVKATRKFKVELGRGESGTVYKGVLEDDRHVAVKKLENVRQGKEV 573
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP--NWVERM 571
FQ E+ VIGR +H NLVR+ G+ E S ++LV EY+ NGSLA+ILF+ +W R
Sbjct: 574 FQAELSVIGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNILLDWEGRF 633
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM-KPDQTRTFT 630
IA +A+G+ YLH EC +IHCD+KP+NIL+D+ KI+DFGL KL+ + T+ +
Sbjct: 634 NIALGVAKGLAYLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQNVS 693
Query: 631 GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQV--ILEEWVY 688
+RGT GY+APEW +LPIT K DVYS+GVVLLE++ R + D+V +L + V
Sbjct: 694 HVRGTLGYIAPEWVSSLPITAKVDVYSYGVVLLELLTGTRVSELVGGTDEVHSMLRKLVR 753
Query: 689 ----------QCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738
Q + +G L + + V+ Q +IK+A+ C+ ++ S RP+M+ + L
Sbjct: 754 MLSAKLEGEEQSWIDGYLDSKL-NRPVNYVQARTLIKLAVSCLEEDRSKRPTMEHAVQTL 812
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 286 bits (732), Expect = 4e-76, Method: Compositional matrix adjust.
Identities = 232/816 (28%), Positives = 389/816 (47%), Gaps = 108/816 (13%)
Query: 21 CLTATAKQRRSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEK 80
C++ RR ++ G + G +AFGF+ + RY VG++ A I ++
Sbjct: 16 CISVDTIMRRQSLRDGEVILSAGKR--------FAFGFFSLGDSELRY-VGIWYAQISQQ 66
Query: 81 TVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASS------ASMLD 134
T+VW ANRD P T+ + F++ G++ + +S ++ LI + S S A++ D
Sbjct: 67 TIVWVANRDHPINDTSGMVKFSNRGNLSVYAS-DNETELIWSTNVSDSMLEPTLVATLSD 125
Query: 135 SGNFVLYDS-NGKTLWQTFEHPTDTLLPNQRLSVGTK------LFPGISETNPSTGKFLL 187
GN VL+D G++ W++F+HPTDT LP RL K L S +P +G +L
Sbjct: 126 LGNLVLFDPVTGRSFWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLIL 185
Query: 188 IMQGDG--NLVQYANINPYGTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGVNI-FN 244
M+ G L+ Y + P+ + W + ++ + + N F+ N V+ +
Sbjct: 186 RMERRGFPQLILYKGVTPW-WRMGSWTGHRWSGVPEMPIGYIFNNS-FVNNEDEVSFTYG 243
Query: 245 LTGGENPTKGMIYLMKIDSDGIFRLYSYNLRRQNSTWQVVWESTSDRCDPIGFCGFNSFC 304
+T T+ M ++ G +++ R + W W ++CD CG N +C
Sbjct: 244 VTDASVITRTM-----VNETGTMHRFTWIAR--DKRWNDFWSVPKEQCDNYAHCGPNGYC 296
Query: 305 -VLNDQIPDCPCLPGFVQISQGNF-----TSGCERNYTAESCGNK-AIRELKNTKWEDVS 357
+ + +C CLPGF ++ + GC + A C K +LK K D S
Sbjct: 297 DSPSSKTFECTCLPGFEPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTS 356
Query: 358 -YYVLSETTEEKCKQACLEDCNCEAALFKEEECKMQRLP-LRF------GRRNLRDSSIA 409
V T ++CKQ CL++C+C A E K + L++ R L
Sbjct: 357 DASVDMNITLKECKQRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDF 416
Query: 410 FVKVDDATSSSPQAPFSVEGNKKELWKDIVIICLFVAVVILISAVTFGIFIYRYHVGSYR 469
+++VD + + G ++ L +I+ +A V+L++ + F + R +R
Sbjct: 417 YIRVDKEELARWNRN-GLSGKRRVL----LILISLIAAVMLLTVILFCVVRERRKSNRHR 471
Query: 470 RIPGN---------GSARYCEDIA-----PLSFSYAELEKMTDGF--KEEVGRG------ 507
N S R+ +D A PL F + T+ F + ++G G
Sbjct: 472 SSSANFAPVPFDFDESFRFEQDKARNRELPL-FDLNTIVAATNNFSSQNKLGAGGFGPVY 530
Query: 508 -------------------SSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 548
G EF+ E+K+I + HRNLVR+LG +E+ +K+LVYEY
Sbjct: 531 KGVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEY 590
Query: 549 MSNGSLADILFNPEKQP--NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDE 606
+ N SL +F+ E++ +W +RM I R IARGILYLH + +IIH D+K NIL+D
Sbjct: 591 LPNKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDS 650
Query: 607 NRCAKISDFGLAKLMKPDQTRTFTG-IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
KISDFG+A++ +Q T + GT GY+APE+ ++K+DVYSFGV++LEI
Sbjct: 651 EMIPKISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEI 710
Query: 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVED----EEVDEKQLERMIKVALWCI 721
I ++ + ++ L ++ +ENG ++++++ E DE+++ + I++ L C+
Sbjct: 711 ITGKK--NSAFHEESSNLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCV 768
Query: 722 LDEPSLRPSMKKVLLML-EGTVEIPIPPNPTSFLSA 756
+ S R M V++ML +P P +P +F SA
Sbjct: 769 QENASDRVDMSSVVIMLGHNATNLPNPKHP-AFTSA 803
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64770|Y1649_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61490 OS=Arabidopsis thaliana GN=At1g61490 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 286 bits (731), Expect = 5e-76, Method: Compositional matrix adjust.
Identities = 235/817 (28%), Positives = 391/817 (47%), Gaps = 119/817 (14%)
Query: 9 KHSIIFFILSSGCLTATAKQRRSNISIGSSLSPIG-NSSWRSPSGLYAFGFYPQSNVSGR 67
K I+FF CL R + + ++ SP+ + S +G+Y GF+ +N S
Sbjct: 3 KKRIVFF----ACLLLFTVLLRFSYAGITTESPLSVEQTLSSSNGIYELGFFSPNN-SQN 57
Query: 68 YYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADD-SQS 126
YVG++ GI + VVW ANR+ P T+A L +S GS++L + + I ++ + +
Sbjct: 58 LYVGIWFKGIIPRVVVWVANRETPTTDTSANLAISSNGSLLLFNGKHGVVWSIGENFASN 117
Query: 127 ASSASMLDSGNFVLYD-SNGKTLWQTFEHPTDTLLPNQ----RLSVGTK--LFPGISETN 179
S A + D+GN V+ D ++G+TLW++FEH DT+LP L+ G K L ++T+
Sbjct: 118 GSRAELTDNGNLVVIDNASGRTLWESFEHFGDTMLPFSSLMYNLATGEKRVLTSWKTDTD 177
Query: 180 PSTGKFL-----------LIMQGDGNLVQYANINPYGTQHAYWASNTYNKGDNVSLNLDE 228
PS G F+ LIM+G +Y P WA +
Sbjct: 178 PSPGVFVGQITPQVPSQVLIMRGS---TRYYRTGP-------WAKTRFTG---------- 217
Query: 229 NGHLFLMNTTGVNIFNLTGGENPTKGMIYLMK--------IDSDGIFRLYSYNLRRQNST 280
+ LM+ T + F+L N + Y + I S+G + + +N +
Sbjct: 218 ---IPLMDDTYASPFSLQQDANGSGFFTYFDRSFKLSRIIISSEGSMKRFRHN----GTD 270
Query: 281 WQVVWESTSDRCDPIGFCGFNSFCVLNDQIP-DCPCLPGFVQIS-----QGNFTSGCERN 334
W++ + + ++ CD G CG C+++ +P C CL GFV S +GN+T GC R
Sbjct: 271 WELSYMAPANSCDIYGVCGPFGLCIVS--VPLKCKCLKGFVPHSTEEWKRGNWTGGCARL 328
Query: 335 YTAESCGNKAIRELK------NTKWEDVSYYVLSETTEEKCKQACLEDCNCEAALFKEEE 388
GN +++ N K D Y S E+C Q+CL +C+C A +
Sbjct: 329 TELHCQGNSTGKDVNIFHPVTNVKLPDF-YEYESSVDAEECHQSCLHNCSCLAFAY---- 383
Query: 389 CKMQRLPLRFGRRNLRDSSIAFVKVDDATSSSPQAPFSVEGNKKELWKDIVIICLFVAVV 448
+ + +NL D+ + F + S A + GNK+ K IV + +++
Sbjct: 384 --IHGIGCLIWNQNLMDA-VQFSAGGEILSIR-LAHSELGGNKRN--KIIVASTVSLSLF 437
Query: 449 ILISAVTFGIFIYRYHVGSY------------RRIPG------------NGSARYCEDIA 484
+++++ FG + YR +Y + +PG + +
Sbjct: 438 VILTSAAFGFWRYRVKHKAYTLKDAWRNDLKSKEVPGLEFFEMNTIQTATNNFSLSNKLG 497
Query: 485 PLSFSYAELEKMTDGFKEEVGRGSS----GEREFQTEMKVIGRTHHRNLVRLLGYSLEVS 540
F K+ DG + V + SS G+ EF E+ +I + HRNLVR+LG +E
Sbjct: 498 QGGFGSVYKGKLQDGKEIAVKQLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEGE 557
Query: 541 KKILVYEYMSNGSLADILFNPEK--QPNWVERMGIARDIARGILYLHDECETQIIHCDIK 598
+K+L+YE+M N SL +F+ K + +W +R I + IARG+LYLH + ++IH D+K
Sbjct: 558 EKLLIYEFMLNKSLDTFVFDARKKLEVDWPKRFDIVQGIARGLLYLHRDSRLKVIHRDLK 617
Query: 599 PQNILMDENRCAKISDFGLAKLMKPDQTRTFT-GIRGTRGYVAPEWHRNLPITVKADVYS 657
NIL+DE KISDFGLA++ + Q + T + GT GY++PE+ + K+D+YS
Sbjct: 618 VSNILLDEKMNPKISDFGLARMYEGTQCQDKTRRVVGTLGYMSPEYAWTGVFSEKSDIYS 677
Query: 658 FGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDE-KQLE--RMI 714
FGV+LLEII + + ++ L + ++ + L++ + D + LE R +
Sbjct: 678 FGVLLLEIIIGEKISRFSYGEEGKTLLAYAWESWGETKGIDLLDQDLADSCRPLEVGRCV 737
Query: 715 KVALWCILDEPSLRPSMKKVLLMLEGTVEIPIPPNPT 751
++ L C+ +P+ RP+ ++L ML T ++P P PT
Sbjct: 738 QIGLLCVQHQPADRPNTLELLAMLTTTSDLPSPKQPT 774
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (729), Expect = 1e-75, Method: Compositional matrix adjust.
Identities = 229/807 (28%), Positives = 386/807 (47%), Gaps = 92/807 (11%)
Query: 15 FILSSGCLTATAKQRRSNI-SIGSSLSPIGNS--SWRSPSGLY------AFGFYPQSNVS 65
FI+ CL R+ + SIGS G S ++ + G++ AFGF V+
Sbjct: 5 FIVIVTCLVFLPDPLRAGVASIGSITPGFGGSQMNYINNDGIFLESNNSAFGF---GFVT 61
Query: 66 GRYYVGVFLAGIPEKT---VVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIAD 122
+ V +F I K+ ++W+ANR P VS + +F+ G++V+ ++ + + +
Sbjct: 62 TQDSVTLFTLSIIHKSSTKLIWSANRASP-VSNSDKFVFDDNGNVVMEGTEVWR---LDN 117
Query: 123 DSQSASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPST 182
++AS + DSGN V+ +G ++W++F+HPTDTL+ NQ G KL S +N +
Sbjct: 118 SGKNASRIELRDSGNLVVVSVDGTSIWESFDHPTDTLITNQAFKEGMKLTSSPSSSNMTY 177
Query: 183 GKFLLIMQGDGNLVQYANINPYGTQHAYWA-----SNTYNKGDNV--SLNLDENGHLFLM 235
L I GD L ++N T YW+ NK V S +L N F
Sbjct: 178 A--LEIKSGDMVL----SVNSL-TPQVYWSMANARERIINKDGGVVTSSSLLGNSWRFF- 229
Query: 236 NTTGVNIFNLTGGENPTKGMIYLMKIDSDGIFRLYSYNLRRQNSTWQVVWESTSDRCDPI 295
+ V ++ +N ++ + ++G+ NL S + SD C
Sbjct: 230 DQKQVLLWQFVFSDNKDDNTTWIAVLGNNGVISFS--NLGSGASAADSSTKIPSDLCGTP 287
Query: 296 GFCGFNSFCVLNDQIPDCPCLPGFVQIS---QGNFTSGCERNYTAESCGNKAIRELKNTK 352
CG C + C C+ G + + TS C++ N + +
Sbjct: 288 EPCGPYYVCSGSKV---CGCVSGLSRARSDCKTGITSPCKKTKD-----NATLPLQLVSA 339
Query: 353 WEDVSYYVLS-------ETTEEKCKQACLEDCNCEAALFKEEECKMQRLPLRFGRRNLRD 405
+ V Y+ L +T + CK+ C +C+C F+ + +
Sbjct: 340 GDGVDYFALGYAPPFSKKTDLDSCKEFCHNNCSCLGLFFQNSSGNCFLFDYIGSFKTSGN 399
Query: 406 SSIAFVKVDDATSSSPQAPFSVEGNKKELWKDIVIICLFVAVVILISAVTFGIFIYRYHV 465
FV S+ + E + K ++I+ + V ++ ++ V F I + +
Sbjct: 400 GGSGFVSYIKIASTGSGGGDNGEDDGKHFPYVVIIVVVTVFIIAVLIFVAFRIHKRKKMI 459
Query: 466 GSYRRIPGNGSAR--YCEDIA--PLSFSYAELEKMTDGFKEEVGRGS------------- 508
P S + E+++ P+ F+Y +L+ T+ F ++G+G
Sbjct: 460 ---LEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGS 516
Query: 509 -----------SGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADI 557
G++EF+ E+ +IG HH +LVRL G+ E + ++L YE++S GSL
Sbjct: 517 RLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERW 576
Query: 558 LFNPEKQP---NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISD 614
+F + +W R IA A+G+ YLH++C+ +I+HCDIKP+NIL+D+N AK+SD
Sbjct: 577 IFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSD 636
Query: 615 FGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDP 674
FGLAKLM +Q+ FT +RGTRGY+APEW N I+ K+DVYS+G+VLLE+I R+ DP
Sbjct: 637 FGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDP 696
Query: 675 NLPDDQVILEEWVYQCFENGNLSQLVEDE----EVDEKQLERMIKVALWCILDEPSLRPS 730
+ ++ + ++ E G L +V+ + +V +++++R +K ALWCI ++ RPS
Sbjct: 697 SETSEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPS 756
Query: 731 MKKVLLMLEGTVEIPIPPNPTSFLSAI 757
M KV+ MLEG + PP+ ++ S +
Sbjct: 757 MSKVVQMLEGVFPVVQPPSSSTMGSRL 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64776|Y1144_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61440 OS=Arabidopsis thaliana GN=At1g61440 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 279 bits (713), Expect = 6e-74, Method: Compositional matrix adjust.
Identities = 238/802 (29%), Positives = 370/802 (46%), Gaps = 101/802 (12%)
Query: 9 KHSIIFFILSSGCLTATAKQRRSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRY 68
K I+ + S K+ S +SIG +LS S +G+Y GF+ +N S
Sbjct: 3 KKRIVLLLFISFSYAEITKE--SPLSIGQTLS--------SSNGVYELGFFSFNN-SQNQ 51
Query: 69 YVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQS-A 127
YVG++ GI + VVW ANR+ P + A L+ +S GS++L + + + S S
Sbjct: 52 YVGIWFKGIIPRVVVWVANREKPVTDSAANLVISSSGSLLLINGKHDVVWSTGEISASKG 111
Query: 128 SSASMLDSGNFVLYDS-NGKTLWQTFEHPTDTLLP----NQRLSVGTK--LFPGISETNP 180
S A + D GN ++ D+ G+TLW++FEH +TLLP L G K L S T+P
Sbjct: 112 SHAELSDYGNLMVKDNVTGRTLWESFEHLGNTLLPLSTMMYNLVTGEKRGLSSWKSYTDP 171
Query: 181 STGKFLLIM--QGDGNLVQYANINPYGTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTT 238
S G F + + Q PY + WA Y + M+ +
Sbjct: 172 SPGDFWVQITPQVPSQGFVMRGSTPY-YRTGPWAKTRYTG-------------IPQMDES 217
Query: 239 GVNIFNLTGGENPTKGMIYL--------MKIDSDGIFRLYSYNLRRQNSTWQVVWESTSD 290
+ F+L N + Y + + S+G ++ YN W+ +E ++
Sbjct: 218 YTSPFSLHQDVNGSGYFSYFERDYKLSRIMLTSEGSMKVLRYN----GLDWKSSYEGPAN 273
Query: 291 RCDPIGFCGFNSFCVLNDQIPDCPCLPGFVQIS-----QGNFTSGCERNYTAESCGNKAI 345
CD G CG FCV++D P C C GFV S +GN+TSGC R GN
Sbjct: 274 SCDIYGVCGPFGFCVISDP-PKCKCFKGFVPKSIEEWKRGNWTSGCARRTELHCQGNSTG 332
Query: 346 RE------LKNTKWEDVSYYVLSETTEEKCKQACLEDCNCEA-ALFKEEECKMQRLPLRF 398
++ + N K D Y S E C Q+CL +C+C A A C M
Sbjct: 333 KDANVFHTVPNIKPPDFYEYANS-VDAEGCYQSCLHNCSCLAFAYIPGIGCLMWS----- 386
Query: 399 GRRNLRDSSIAFVKVDDATSSSPQAPFSVEGNKKELWKDIVIICLFVAVVILISAVTFGI 458
++L D+ + + + V K + V + LFV ++ TFG
Sbjct: 387 --KDLMDTMQFSAGGEILSIRLAHSELDVHKRKMTIVASTVSLTLFV----ILGFATFGF 440
Query: 459 FIYRY-HVGSYRR------IPG------------NGSARYCEDIAPLSFSYAELEKMTDG 499
+ R H ++R +PG + + F K+ DG
Sbjct: 441 WRNRVKHHDAWRNDLQSQDVPGLEFFEMNTIQTATSNFSLSNKLGHGGFGSVYKGKLQDG 500
Query: 500 FKEEVGRGSS----GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLA 555
+ V R SS G++EF E+ +I + HRNLVR+LG +E +K+L+YE+M N SL
Sbjct: 501 REIAVKRLSSSSEQGKQEFMNEIVLISKLQHRNLVRVLGCCVEGKEKLLIYEFMKNKSLD 560
Query: 556 DILFNPEK--QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKIS 613
+F K + +W +R I + I RG+LYLH + ++IH D+K NIL+DE KIS
Sbjct: 561 TFVFGSRKRLELDWPKRFDIIQGIVRGLLYLHRDSRLRVIHRDLKVSNILLDEKMNPKIS 620
Query: 614 DFGLAKLMKPDQTRTFT-GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCL 672
DFGLA+L + Q + T + GT GY++PE+ + K+D+YSFGV+LLEII +
Sbjct: 621 DFGLARLFQGSQYQDKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIISGEKIS 680
Query: 673 DPNLPDDQVILEEWVYQCF---ENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP 729
+ ++ L +V++C+ NL D+ ++ R +++ L C+ +P+ RP
Sbjct: 681 RFSYGEEGKALLAYVWECWCETRGVNLLDQALDDSSHPAEVGRCVQIGLLCVQHQPADRP 740
Query: 730 SMKKVLLMLEGTVEIPIPPNPT 751
+ ++L ML T ++P+P PT
Sbjct: 741 NTLELLSMLTTTSDLPLPKQPT 762
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 757 | ||||||
| 255582003 | 817 | ATP binding protein, putative [Ricinus c | 0.985 | 0.913 | 0.581 | 0.0 | |
| 255582007 | 783 | ATP binding protein, putative [Ricinus c | 0.984 | 0.951 | 0.585 | 0.0 | |
| 359477044 | 768 | PREDICTED: G-type lectin S-receptor-like | 0.952 | 0.938 | 0.588 | 0.0 | |
| 359477040 | 774 | PREDICTED: G-type lectin S-receptor-like | 0.961 | 0.940 | 0.589 | 0.0 | |
| 225431551 | 768 | PREDICTED: G-type lectin S-receptor-like | 0.953 | 0.940 | 0.586 | 0.0 | |
| 225431549 | 772 | PREDICTED: G-type lectin S-receptor-like | 0.953 | 0.935 | 0.549 | 0.0 | |
| 147857245 | 726 | hypothetical protein VITISV_039751 [Viti | 0.898 | 0.936 | 0.546 | 0.0 | |
| 147838246 | 760 | hypothetical protein VITISV_031648 [Viti | 0.937 | 0.934 | 0.536 | 0.0 | |
| 359493028 | 815 | PREDICTED: G-type lectin S-receptor-like | 0.952 | 0.884 | 0.512 | 0.0 | |
| 255584574 | 1031 | conserved hypothetical protein [Ricinus | 0.955 | 0.701 | 0.497 | 0.0 |
| >gi|255582003|ref|XP_002531799.1| ATP binding protein, putative [Ricinus communis] gi|223528565|gb|EEF30587.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 905 bits (2339), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/787 (58%), Positives = 565/787 (71%), Gaps = 41/787 (5%)
Query: 4 FHFLFKHSIIFFILSSGCLTATAKQRRSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSN 63
+ LF SI FF+ S + A A+QR++NIS+GSSL+P NSSW SPSGLYAFGFY Q N
Sbjct: 5 YQNLFMASISFFLFLSSLIKAAAQQRQTNISLGSSLTPTKNSSWLSPSGLYAFGFYQQGN 64
Query: 64 VSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADD 123
Y VGVFLAG P+KTVVWTANRDDPPVS + TLLF S+ VL+S+ S+
Sbjct: 65 ---GYAVGVFLAGAPQKTVVWTANRDDPPVSKDVTLLFTSDSGFVLQSASGQNSSVFISA 121
Query: 124 SQSASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTG 183
QSASSA++ DSGNFVLY+S +WQ+F++P DTLLP QRL G +L +S T+ STG
Sbjct: 122 DQSASSAALFDSGNFVLYNSERDIIWQSFDNPIDTLLPTQRLEAGNELISSVSATDHSTG 181
Query: 184 KFLLIMQGDGNLVQYANINPYGTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGVNIF 243
F L MQ DGNLVQY AYWAS T GDNV+LNLD +G L+L+N TG NI
Sbjct: 182 IFRLKMQDDGNLVQYPVRTLDTAAFAYWASGTNGAGDNVTLNLDHDGRLYLLNNTGFNIR 241
Query: 244 NLTGGENPTKGMIYLMKIDSDGIFRLYSYNLRRQNSTWQVVWESTSDRCDPIGFCGFNSF 303
N+T G P + IY++++D DGIFRLYSY+L+ +N W V+ ST DRC P G CG NS+
Sbjct: 242 NITEGGFPVQETIYMIRLDFDGIFRLYSYDLK-ENGNWSVLHSSTDDRCAPKGLCGLNSY 300
Query: 304 CVLNDQIPDCPCLPGFVQISQGNFTSGCERNYTAESCG----NKAIRELKNTKWEDVSYY 359
C+LNDQ P+C CLPGF +S+GN+T+GCERN ESC + I+EL NT W D +Y+
Sbjct: 301 CILNDQEPECICLPGFGFVSEGNWTAGCERNSITESCKGDNVSNRIQELTNTVWLDNTYF 360
Query: 360 VLSETTEEKCKQACLEDCNCEAALFKEEECKMQRLPLRFGRRNLRDSSIAFVKVDDATSS 419
VLS +E C++ACLEDCNC+AA + EC+ Q LPLR+GRR+LRDS++A +KV + S+
Sbjct: 361 VLSSYNKEDCEKACLEDCNCDAAFYNSGECRKQGLPLRYGRRDLRDSNLALIKVGRSVSN 420
Query: 420 SPQAPFSVE--GNKKELWKDIVIICLFVAVVILISAVTFGIFIYRYHVGSYRRIPGNGSA 477
P +E KKE K ++I+ V + GI IYRYHV +Y+RI N
Sbjct: 421 ----PNIIEPIKKKKEPGKVLLIVSASVIGFGFLVLTVIGIMIYRYHVKAYKRISSNEHM 476
Query: 478 RYCEDIAPLSFSYAELEKMTDGFKEEVGRGS--------------------------SGE 511
E++APLSF+YAELE++TDGFKEE+GRGS G+
Sbjct: 477 GLSEEVAPLSFTYAELERVTDGFKEEIGRGSFGTVYKGLLSSSQKVVAVKKLERVLADGD 536
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERM 571
REFQTEMKVIG+THHRNLV LLGY E ++LVY++MSNGSL+D+LF+PEK+P + ER+
Sbjct: 537 REFQTEMKVIGKTHHRNLVCLLGYCNEGLNRLLVYDFMSNGSLSDVLFSPEKRPCFTERI 596
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG 631
IAR+IARGILYLH+ECETQIIHCDIKP+NILMD C KISDFGLAKL+KPDQT+T TG
Sbjct: 597 EIARNIARGILYLHEECETQIIHCDIKPENILMDAYMCPKISDFGLAKLLKPDQTKTMTG 656
Query: 632 IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCF 691
IRGTRGYVAPEWHR LP+T KADVYSFG+VLLEI C R+ +D + P+ + IL EWVY CF
Sbjct: 657 IRGTRGYVAPEWHRKLPVTTKADVYSFGIVLLEIACCRKHVDLSAPEHECILVEWVYNCF 716
Query: 692 ENGNLSQLV-EDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPIPPNP 750
ENG L +LV +D+EVD++Q+ RMIKV LWC LDEPSLRPSMKKVLLMLEGTV+IP PP+P
Sbjct: 717 ENGELDELVGDDKEVDKRQMNRMIKVGLWCTLDEPSLRPSMKKVLLMLEGTVDIPTPPSP 776
Query: 751 TSFLSAI 757
TSFLS I
Sbjct: 777 TSFLSCI 783
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255582007|ref|XP_002531801.1| ATP binding protein, putative [Ricinus communis] gi|223528567|gb|EEF30589.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 904 bits (2336), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/782 (58%), Positives = 566/782 (72%), Gaps = 37/782 (4%)
Query: 7 LFKHSIIFFILSSGCLTATAKQRRSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSG 66
LF SI+FF+ S + A A+QR++NIS+GSSL+P NSSW SPSGLYAFGFY Q N
Sbjct: 8 LFMASILFFLFLSSLIKAAAQQRQTNISLGSSLTPTKNSSWLSPSGLYAFGFYQQGN--- 64
Query: 67 RYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQS 126
Y VGVFLAG P+KTV+WTANRDDPPVS + TLLF S+ VL+S++ S+ QS
Sbjct: 65 GYAVGVFLAGAPQKTVIWTANRDDPPVSRDVTLLFTSDSGFVLQSARGQNSSVSISAVQS 124
Query: 127 ASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFL 186
A+SA++ DSGNFVLY+S +WQ+F+ PTDTLLP QRL G +L +S T+ STG F
Sbjct: 125 AASAALFDSGNFVLYNSERDIIWQSFDSPTDTLLPTQRLQAGDELISSVSATDHSTGIFR 184
Query: 187 LIMQGDGNLVQYANINPYGTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGVNIFNLT 246
L MQ DGNLVQY AYWAS T G+NV+LNLD +G L+L+N TG NI N+T
Sbjct: 185 LKMQDDGNLVQYPVRTMDTAAFAYWASGTNGAGNNVTLNLDHDGRLYLLNNTGFNIKNIT 244
Query: 247 GGENPTKGMIYLMKIDSDGIFRLYSYNLRRQNSTWQVVWESTSDRCDPIGFCGFNSFCVL 306
GG P + IY+++ID DGIFRLYSY+L+ +N W V+W S++D+CDP G CG NS CVL
Sbjct: 245 GGGFPMQEAIYIIRIDFDGIFRLYSYDLK-ENGNWSVLWSSSNDKCDPKGLCGLNSCCVL 303
Query: 307 NDQIPDCPCLPGFVQISQGNFTSGCERNYTAESC-GNKA---IRELKNTKWEDVSYYVLS 362
NDQ C CLPGF +S+GN+T+GCERN ESC G+ A IREL NT WE +Y ++S
Sbjct: 304 NDQEAKCVCLPGFAFVSEGNWTAGCERNSVPESCKGDDARNTIRELPNTIWEVNTYSLMS 363
Query: 363 ETTEEKCKQACLEDCNCEAALFKEEECKMQRLPLRFGRRNLRDSSIAFVKVDDATSSSPQ 422
+ +E C++ACLEDCNC+AA F EC QRLPLR+GRR+L + + A +KV A++S P
Sbjct: 364 FSVKEDCEKACLEDCNCDAAFFSSGECAKQRLPLRYGRRDLSNPNSALIKVR-ASTSIPN 422
Query: 423 APFSVEGNKKELWKDIVIICLFVAVVILISAVTFGIFIYRYHVGSYRRIPGNGSARYCED 482
KKE K I+I+ + L++ GI IYRYHV +Y+RI N E+
Sbjct: 423 I-IDPTDKKKEPGKGILIVSASIFGFGLLALTIAGIMIYRYHVRAYKRISSNEHIGLSEE 481
Query: 483 IAPLSFSYAELEKMTDGFKEEVGRGS--------------------------SGEREFQT 516
+APLSF+YAELE++TDGFKEE+GRGS G+REFQT
Sbjct: 482 VAPLSFTYAELERVTDGFKEEIGRGSFGTVYKGLLSRSQKVVAVKKLERVLADGDREFQT 541
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
EMK IG+THH+NLVRLLGY E ++LVYE+MSNGSL+D+LF+PE +P + ER+ IAR+
Sbjct: 542 EMKAIGKTHHKNLVRLLGYCNEGPNRLLVYEFMSNGSLSDVLFSPENRPCFAERIEIARN 601
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
IARGILYLH+ECETQIIHCDIKP+NILMD C KISDFGLAKL+KPDQT+T T IRGTR
Sbjct: 602 IARGILYLHEECETQIIHCDIKPENILMDAYMCPKISDFGLAKLLKPDQTKTMTDIRGTR 661
Query: 637 GYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNL 696
GYVAPEWHR LP+TVKADVYSFG+VLLEI C R+ +D + P+ + IL EWVY CF +G L
Sbjct: 662 GYVAPEWHRKLPVTVKADVYSFGIVLLEITCCRKNVDLSAPERECILVEWVYDCFASGEL 721
Query: 697 SQLV-EDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPIPPNPTSFLS 755
+LV +DEEVD++Q+ RMIKV LWC LDEPSLRPSMKKVLLMLEGTV+IPIPP+PTSFLS
Sbjct: 722 DKLVGDDEEVDKRQMNRMIKVGLWCTLDEPSLRPSMKKVLLMLEGTVDIPIPPSPTSFLS 781
Query: 756 AI 757
I
Sbjct: 782 CI 783
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477044|ref|XP_002275760.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 888 bits (2295), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/770 (58%), Positives = 559/770 (72%), Gaps = 49/770 (6%)
Query: 21 CLTATAKQRRSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEK 80
C+ A A+QR SNIS GSSL+P NS W SP+ YAFGFY Q + YY+G+FL GIP+K
Sbjct: 15 CVAAAAQQRGSNISRGSSLTPTSNSYWLSPNRQYAFGFYNQGD---GYYLGIFLKGIPQK 71
Query: 81 TVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDSGNFVL 140
TVVWTANRDD PV + ATL F SEG + L++ Q ++ +S SA SASML+SGNFVL
Sbjct: 72 TVVWTANRDDLPVPSTATLHFTSEGRLRLQTQGQQKE---IANSASAYSASMLNSGNFVL 128
Query: 141 YDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYAN 200
Y+S+G +WQ+F+ PTDTLLP QRLS G +L +SETNPSTG F L MQ DGNLVQY
Sbjct: 129 YNSDGDIVWQSFDLPTDTLLPGQRLSAGKELLSSMSETNPSTGLFRLKMQNDGNLVQYPV 188
Query: 201 INPYGTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTT-GVNIFNLTGGENPTKGMIYLM 259
P +AY+AS T KGDNV+LNLD+ GHL+L+N T G NI N+T G N +Y +
Sbjct: 189 EAPDTATYAYYASGTDGKGDNVTLNLDDEGHLYLLNNTNGSNIKNITDGYNNEN--LYRL 246
Query: 260 KIDSDGIFRLYSYNLRRQNSTWQVVWESTSDRCDPIGFCGFNSFCVLNDQIPDCPCLPGF 319
+ID DGIF+LYS++L QN +W ++W S++D+C P G CG N FCVL D DC CLPGF
Sbjct: 247 RIDPDGIFKLYSHDLG-QNGSWSILWRSSADKCAPKGLCGVNGFCVLLDDRADCVCLPGF 305
Query: 320 VQISQGNFTSGCERNYTAESCGNK------AIRELKNTKWEDVSYYVLSETTEEKCKQAC 373
+ N++SGC RN+ + C +K + L NT WED SY LS T+E C+QAC
Sbjct: 306 DFVVASNWSSGCIRNFEEDICKSKDGSTKYTMSTLDNTWWEDASYSTLSLPTQEDCEQAC 365
Query: 374 LEDCNCEAALFKEEECKMQRLPLRFGRRNLRDSSIAFVKVDDATSSSPQAPFSVEGNKKE 433
LEDCNCEAALF++ C+ QRLPLRFGRR+L +S+I FVKV S +G KKE
Sbjct: 366 LEDCNCEAALFEDGSCRKQRLPLRFGRRSLSNSNILFVKVGSTEVSQ-------QGTKKE 418
Query: 434 LWKDIVIICLFVAVVILISAVTFGIFIYRYHVGSYRRIPGNGSARYCEDIAPLSFSYAEL 493
+ DI++I + +A LI V G+ I+R ++ +Y++I G+ E +A SF+Y EL
Sbjct: 419 IRTDILVISVSLASFALIILVISGVLIHRKNLWAYKKISETGNVGLTEGVALRSFTYMEL 478
Query: 494 EKMTDGFKEEVGRGSSG--------------------------EREFQTEMKVIGRTHHR 527
EK+T+GFKEE+G+G+SG +REFQ E+KVIGRTHHR
Sbjct: 479 EKVTNGFKEEIGKGASGTVYKGAISNSQRIVAVKKLEKVLAEGQREFQNELKVIGRTHHR 538
Query: 528 NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587
NLVRLLGY LE ++LVYEYMSNGSLAD+LF P KQP W+ERMGIA ++ARG+LYLH+E
Sbjct: 539 NLVRLLGYCLEGPNRLLVYEYMSNGSLADLLFTPGKQPCWIERMGIALNVARGVLYLHEE 598
Query: 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL 647
CETQIIHCDIKPQNILMDE + AKISDFGLAKL+ DQT TFTGIRGTRGYVAPEWHR L
Sbjct: 599 CETQIIHCDIKPQNILMDEYKRAKISDFGLAKLLMHDQTNTFTGIRGTRGYVAPEWHRKL 658
Query: 648 PITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDE 707
P+TVKADVYS+G+VLLE IC R+ +D +LP+++ ILEEWVY CFE G L +LV DEEVD+
Sbjct: 659 PVTVKADVYSYGIVLLETICCRKNVDWSLPEEEAILEEWVYHCFEAGELGKLVGDEEVDK 718
Query: 708 KQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPIPPNPTSFLSAI 757
+QLERM+KV LWCILDEPSLRPSMKKVLLMLEGTV+IP+PP+P SFLSAI
Sbjct: 719 RQLERMVKVGLWCILDEPSLRPSMKKVLLMLEGTVDIPVPPSPVSFLSAI 768
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477040|ref|XP_002275651.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 885 bits (2288), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/769 (58%), Positives = 548/769 (71%), Gaps = 41/769 (5%)
Query: 21 CLTATAKQRRSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEK 80
C+ A A+QR SNIS GSSL+P NS W SP+ LYAFGFY Q + YY+G+FL GIP+K
Sbjct: 15 CVAAAAQQRGSNISRGSSLTPTSNSFWLSPNRLYAFGFYKQGD---GYYLGIFLNGIPQK 71
Query: 81 TVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDSGNFVL 140
TVVWTANRDDPPV + A L F SEG LR Q Q IA+ S SAS ASMLDSGNFVL
Sbjct: 72 TVVWTANRDDPPVPSTAALHFTSEGR--LRLQTQGQQKEIAN-STSASFASMLDSGNFVL 128
Query: 141 YDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYAN 200
Y S+G +WQ+F+ PTDTLL QRL G +LF +SETNPSTG F L MQ DGNLVQY
Sbjct: 129 YSSDGDMVWQSFDLPTDTLLLGQRLLAGKELFSSVSETNPSTGMFRLKMQNDGNLVQYPV 188
Query: 201 INPYGTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGVNIFNLTGGENPTKGMIYLMK 260
P +AY+AS T GDNV+L+LD GHL+L+NT G NI N+T G + + YL++
Sbjct: 189 KTPDAPTYAYYASETGGVGDNVTLHLDGGGHLYLLNTNGSNIKNITDGGYDNENL-YLLR 247
Query: 261 IDSDGIFRLYSYNLRRQNSTWQVVWESTSDRCDPIGFCGFNSFCVLNDQIPDCPCLPGFV 320
ID DGIF+LYS++ QN +W ++W S +D+C P G CG N FCVL D PDC CLPGF
Sbjct: 248 IDPDGIFKLYSHD-SGQNGSWSILWRSLNDKCAPKGLCGVNGFCVLLDDRPDCRCLPGFD 306
Query: 321 QISQGNFTSGCERNYTAESCGNK------AIRELKNTKWEDVSYYVLSETTEEKCKQACL 374
+ N++SGC RN+ E C +K + L+NT WED SY LS T+E C+QACL
Sbjct: 307 FVVASNWSSGCIRNFQQEICKSKDGSTKYTMSTLENTWWEDASYSTLSIPTQEDCEQACL 366
Query: 375 EDCNCEAALFKEEECKMQRLPLRFGRRNLRDSSIAFVKVDDATSSSPQAPFSVEGNKKEL 434
EDCNCEAALFK+ CK QR PLRFGRR+L DS+I FVK+ +T++ P + K
Sbjct: 367 EDCNCEAALFKDGSCKKQRFPLRFGRRSLGDSNILFVKMGSSTAT-PSLQNPQDKRKSPG 425
Query: 435 WKDIVIICLFVAVVILISAVTFGIFIYRYHVGSYRRIPGNGSARYCEDIAPLSFSYAELE 494
KDI++I + +A LI G+ I R ++ +Y++I + ED+A SF+Y ELE
Sbjct: 426 AKDILVISVSLASFALIILAISGVLIRRNNLWAYKKISETVNVELTEDVALRSFTYMELE 485
Query: 495 KMTDGFKEEVGRGSSG--------------------------EREFQTEMKVIGRTHHRN 528
K+T+GF EE+G+G+SG E EFQ E+KVIGRTHHRN
Sbjct: 486 KVTNGFMEEIGKGASGTVYKGATSNGQRIVAVKKLEKVLAEGEIEFQNELKVIGRTHHRN 545
Query: 529 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588
LVRLLGY L+ ++LVYEYMSNGSLAD LF P KQP W ERMGIA ++ARGILYLH+EC
Sbjct: 546 LVRLLGYCLDGPNRLLVYEYMSNGSLADWLFTPGKQPRWSERMGIALNVARGILYLHEEC 605
Query: 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP 648
ET IIHCDIKPQNILMDE RCAKISDFGLAKL+ DQT T TGIRGTRGYVAPEWHR P
Sbjct: 606 ETCIIHCDIKPQNILMDEYRCAKISDFGLAKLLMHDQTNTSTGIRGTRGYVAPEWHRKQP 665
Query: 649 ITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEK 708
++VKADVYS+G+VLLE IC RR +D +LPD++VILEEWVYQCFE G L +LV DEEVD +
Sbjct: 666 VSVKADVYSYGIVLLETICCRRNVDWSLPDEEVILEEWVYQCFEAGELGKLVGDEEVDRR 725
Query: 709 QLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPIPPNPTSFLSAI 757
QL+ M+KV LWCILD+PSLRPSMKKVLLMLEGTV+IP+PP+P SFLS+I
Sbjct: 726 QLDMMVKVGLWCILDDPSLRPSMKKVLLMLEGTVDIPVPPSPVSFLSSI 774
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431551|ref|XP_002275615.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2284), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/769 (58%), Positives = 563/769 (73%), Gaps = 47/769 (6%)
Query: 21 CLTATAKQRRSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEK 80
C+ A A+QR SNIS GSSL+P NS W SP+ LYAFGFY Q + YYVG+FL GIP+K
Sbjct: 15 CVAAEAQQRGSNISRGSSLTPTSNSFWLSPNRLYAFGFYKQGD---GYYVGIFLNGIPQK 71
Query: 81 TVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDSGNFVL 140
TVVWTANRDDPPV +N TL F SEG + L++ Q ++ + +S SASSASMLDSGNFVL
Sbjct: 72 TVVWTANRDDPPVPSNVTLHFTSEGRLRLQTQAQQKEIV---NSASASSASMLDSGNFVL 128
Query: 141 YDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYAN 200
Y+S+G +WQ+F+ PTDTLL QRLS G +LF +SETNPSTG F L MQ DGNLVQY
Sbjct: 129 YNSDGDMVWQSFDLPTDTLLLGQRLSAGKELFSIVSETNPSTGMFRLKMQHDGNLVQYPV 188
Query: 201 INPYGTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGVNIFNLTGGENPTKGMIYLMK 260
P +AY+A+NT GDNV+L+LD GHL+L+NT G NI N+T G + + YL++
Sbjct: 189 KTPDTETYAYYATNTGGVGDNVTLHLDGGGHLYLVNTNGFNIVNITDGGYDNENL-YLLR 247
Query: 261 IDSDGIFRLYSYNLRRQNSTWQVVWESTSDRCDPIGFCGFNSFCVLNDQIPDCPCLPGFV 320
ID DGIF+LYS++L QN +W ++W S++D+C P G CG N FCV+ D C CLPGF
Sbjct: 248 IDPDGIFKLYSHDLG-QNGSWSILWRSSNDKCAPKGLCGVNGFCVVLDDRRGCECLPGFD 306
Query: 321 QISQGNFTSGCERNYTAESCGNK------AIRELKNTKWEDVSYYVLSETTEEKCKQACL 374
+ N++ GC RN+ E C +K + L+NT WED SY LS +T+E C+QACL
Sbjct: 307 FVVASNWSLGCIRNFQEEICKSKDGSTKFTMSTLENTWWEDASYSALSLSTQEDCEQACL 366
Query: 375 EDCNCEAALFKEEECKMQRLPLRFGRRNLRDSSIAFVKVDDATSSSPQAPFSVEGNKKEL 434
EDCNCEAALF++ CK QRLPLRFGRR+L DS+I FVKV SP+ S +G+KKEL
Sbjct: 367 EDCNCEAALFEDGSCKKQRLPLRFGRRSLSDSNILFVKV-----GSPEV--SRQGSKKEL 419
Query: 435 WKDIVIICLFVAVVILISAVTFGIFIYRYHVGSYRRIPGNGSARYCEDIAPLSFSYAELE 494
+I++I + +A LI G+ I+R ++ +Y++I G+ ED+A SF+Y ELE
Sbjct: 420 RTNILVISVSLASFTLIILAISGVLIHRKNLLAYKKISETGNVGLTEDVALRSFTYMELE 479
Query: 495 KMTDGFKEEVGRGSSG--------------------------EREFQTEMKVIGRTHHRN 528
K+T+ FKEE+G+G+SG +REFQ E+KV+GRTHHRN
Sbjct: 480 KVTNCFKEEIGKGASGTVYKGAISNGQRIVAVKKQEKVLAEWQREFQNELKVLGRTHHRN 539
Query: 529 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588
LVRLLGY L+ ++LVYEYMSNGSLAD+LF P KQP WVER+ IA ++A+G+LYLH+EC
Sbjct: 540 LVRLLGYCLDGRNRLLVYEYMSNGSLADLLFTPAKQPCWVERVRIALNVAKGVLYLHEEC 599
Query: 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP 648
ETQIIHCDIKPQNILMDE RCAKISDFGLAKL+ DQT TFTGIRGTRGYVAPEWHR L
Sbjct: 600 ETQIIHCDIKPQNILMDEYRCAKISDFGLAKLLMHDQTNTFTGIRGTRGYVAPEWHRKLA 659
Query: 649 ITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEK 708
+TVKADVYS+G+VLLE IC RR +D +LP+++ ILEEWVY C E G L +LV DEEVD++
Sbjct: 660 VTVKADVYSYGIVLLETICCRRNVDWSLPEEEAILEEWVYHCLEAGELGKLVGDEEVDKR 719
Query: 709 QLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPIPPNPTSFLSAI 757
QLERM+KV LWCILDEPSLRPSM KVLL+LEGTV+IP+PP+P SFLS+I
Sbjct: 720 QLERMVKVGLWCILDEPSLRPSMNKVLLILEGTVDIPVPPSPGSFLSSI 768
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431549|ref|XP_002275592.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2105), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/766 (54%), Positives = 542/766 (70%), Gaps = 44/766 (5%)
Query: 25 TAKQRRSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVW 84
TA+QR SNIS SSL+P +S W SPSG +AFGFY + G + +G+ L G P+ T+VW
Sbjct: 18 TAQQRHSNISKTSSLTPTTDSLWFSPSGFFAFGFY---HAEGGFAIGIILVGNPQNTIVW 74
Query: 85 TANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDSGNFVLYDSN 144
TANRD+PPVS+N +L+F G +VLR+SQ + S+I D Q+ASSASMLDSGNFVLY+S
Sbjct: 75 TANRDEPPVSSNVSLVFTVHG-LVLRTSQGREISII-DPHQNASSASMLDSGNFVLYNSK 132
Query: 145 GKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPY 204
+ +WQ+F+HPTDTLL QRL G +L +SE N STG F L MQ DGNLVQY P
Sbjct: 133 QEIIWQSFDHPTDTLLSGQRLQAGAELVSSVSEKNYSTGMFQLKMQHDGNLVQYPTNVPE 192
Query: 205 GTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGVNIFNLTGGENPTKGMIYLMKIDSD 264
++AYWAS+T+ +GDN +LNLD +G+L+L+N TG NI NLT G P + IYLMKID D
Sbjct: 193 VVEYAYWASDTHGEGDNATLNLDADGYLYLLNATGFNIKNLTDGGGPQEETIYLMKIDVD 252
Query: 265 GIFRLYSYNLRRQNSTWQVVWESTSDRCDPIGFCGFNSFCVLNDQIPDCPCLPGFVQISQ 324
GIFRLYS L Q+S W V W S+ D+CDP G CG NS+C L DQ P C CLPGF + +
Sbjct: 253 GIFRLYSRGLD-QSSEWSVEWSSSIDKCDPKGLCGLNSYCSLMDQEPVCTCLPGFDFVDK 311
Query: 325 GNFTSGCERNYTAESCGNK------AIRELKNTKWEDVSYYVLSETTEEKCKQACLEDCN 378
+ GCERN+ AE+C N +I L++ WED SY V+S TEE C +ACLEDCN
Sbjct: 312 SQKSWGCERNFVAEACKNNDGSIEYSIESLQSVMWEDDSYLVISSRTEENCIEACLEDCN 371
Query: 379 CEAALFKEEECKMQRLPLRFGRRNLRDSSIAFVKVDDATSSSPQAPFSVEGNKKELWKDI 438
CEAALFK EC+ Q+LP RFGRR+L D + AFVKV +T++ +AP + +KKE KDI
Sbjct: 372 CEAALFKNSECRKQKLPSRFGRRSLSDETTAFVKVGTSTATR-RAP---KESKKEWRKDI 427
Query: 439 VII-CLFVAVVILISAVTFGIFIYRYHVGSYRRIPGNGSARYCEDIAPLSFSYAELEKMT 497
+II C +A+ ++ A++ G+ IYR + +++ G+ R E SF+Y EL+K+T
Sbjct: 428 LIISCSLLALACIVLAIS-GLLIYRNRGCTLKKVSKQGNLRLTEGATLQSFTYQELKKVT 486
Query: 498 DGFKEEVGRG------------------------SSGEREFQTEMKVIGRTHHRNLVRLL 533
+GF E +G+G S+GE+EF+TEMK + THHRNLV+LL
Sbjct: 487 NGFTEVLGKGGFGTVYKGAMSNGQRLVAVKKLNVSTGEKEFRTEMKALAGTHHRNLVQLL 546
Query: 534 GYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQII 593
GY LE + LVYEY+SNGSLA++LF P K P W ERMGIA+++ARGILYLH+ECETQI+
Sbjct: 547 GYCLEGPNRFLVYEYISNGSLANLLFTPAKWPRWDERMGIAQNVARGILYLHEECETQIM 606
Query: 594 HCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKA 653
HCDIKPQNILMDE AKIS FGLAK +K QT T IRGT+GY+APEW RN P+TVK
Sbjct: 607 HCDIKPQNILMDEYGGAKISSFGLAKRLKHGQTSTLAEIRGTKGYIAPEWFRNQPVTVKV 666
Query: 654 DVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERM 713
DVYSFG++LL+IIC R+ D +LPD+++ L EWV CFE G L +LV+DEEVD+++LERM
Sbjct: 667 DVYSFGIMLLQIICCRKNFDLSLPDEEIGLNEWVSHCFEAGELGKLVDDEEVDKRELERM 726
Query: 714 IKVALWCILDEPSLRPSMKKVLLMLEGT-VEIPIPPN-PTSFLSAI 757
+KV LWCI DEP RPS+KKVLLMLEG+ ++IP+PP+ T++ SA+
Sbjct: 727 VKVGLWCIQDEPLFRPSIKKVLLMLEGSIIDIPVPPSTSTTYFSAV 772
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147857245|emb|CAN79207.1| hypothetical protein VITISV_039751 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 789 bits (2037), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/769 (54%), Positives = 522/769 (67%), Gaps = 89/769 (11%)
Query: 21 CLTATAKQRRSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEK 80
C+ A A+QR SNIS GSSL+P NS W SP+ LYAFGFY Q N YY+G+FL GIP+K
Sbjct: 15 CVAAVAQQRGSNISRGSSLTPTSNSFWLSPNRLYAFGFYKQGN---GYYLGIFLIGIPQK 71
Query: 81 TVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDSGNFVL 140
TVVWTANRDDPPV + ATL F SEG LR Q Q IA+ S SASSASMLDSGNFVL
Sbjct: 72 TVVWTANRDDPPVPSTATLHFTSEGR--LRLQTQGQQKEIAN-SASASSASMLDSGNFVL 128
Query: 141 YDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYAN 200
Y+S+G +WQ+F+ TDTLLP R + PSTG F L MQ +GNLVQY
Sbjct: 129 YNSDGDIVWQSFDLQTDTLLPVCR------------KLTPSTGMFRLKMQNNGNLVQYPV 176
Query: 201 INPYGTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGVNIFNLTGGENPTKGMIYLMK 260
P +AY+ S T GDNV+L LD GHL+L+NT G NI N+T G + + +L+K
Sbjct: 177 KTPDAPTYAYYTSETGGVGDNVTLLLDGGGHLYLLNTNGSNILNITDGGYDNENL-HLLK 235
Query: 261 IDSDGIFRLYSYNLRRQNSTWQVVWESTSDRCDPIGFCGFNSFCVLNDQIPDCPCLPGFV 320
ID DGIF+LYS++ QN +W ++W S++D+C P G CG N FC+L D+ PDC CLPGF
Sbjct: 236 IDPDGIFKLYSHD-SGQNGSWSILWRSSNDKCAPKGLCGVNGFCILLDERPDCKCLPGFX 294
Query: 321 QISQGNFTSGCERNYTAESCGNKAIRE------LKNTKWEDVSYYVLSETTEEKCKQACL 374
+ + N++SGC RN+ E C + R L+NT+WE+ SY LS T+E C+QACL
Sbjct: 295 FVVESNWSSGCIRNFKEEICKSNDGRTKYTMSTLENTRWEEASYSNLSVPTQEDCEQACL 354
Query: 375 EDCNCEAALFKEEECKMQRLPLRFGRRNLRDSSIAFVKVDDATSSSPQAPFSVEGNKKEL 434
EDCNCEAALF++ CK QRLPLRFGRR+L DS+I FVK+ SP+ S G+KKEL
Sbjct: 355 EDCNCEAALFEDGSCKKQRLPLRFGRRSLGDSNILFVKM-----GSPEV--SPHGSKKEL 407
Query: 435 WKDIVIICLFVAVVILISAVTFGIFIYRYHVGSYRRIPGNGSARYCEDIAPLSFSYAELE 494
DI++I + +A LI G+ I R ++ +Y++I G+ ED+A SF+Y ELE
Sbjct: 408 RTDILVISVSLASFALIILAISGVLIRRKNLWAYKKISETGNVGLTEDVALRSFTYMELE 467
Query: 495 KMTDGFKEEVGRGSSG--------------------------EREFQTEMKVIGRTHHRN 528
K+TDGFKEE+G+G+SG +REFQ E+KVIGRTHHRN
Sbjct: 468 KVTDGFKEEIGKGASGTVYKGAISNGQRIVAVKKLAKELAEGQREFQNELKVIGRTHHRN 527
Query: 529 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588
LVRLLGY L+ K+LVY+YMSNGSLAD+LF P KQP W+ERMGIA ++ARGILYLH+E
Sbjct: 528 LVRLLGYCLDGQNKLLVYQYMSNGSLADLLFTPGKQPRWIERMGIALNVARGILYLHEE- 586
Query: 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP 648
+KL+ DQT T TGIRGTRGYVAPEWHR P
Sbjct: 587 -----------------------------SKLLMHDQTNTSTGIRGTRGYVAPEWHRKQP 617
Query: 649 ITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEK 708
++VKADVYS+G+VLLE IC RR +D +LP+++VILEEWVYQCFE G L +LV DEEVD +
Sbjct: 618 VSVKADVYSYGIVLLETICCRRNVDWSLPEEEVILEEWVYQCFEAGQLGKLVGDEEVDRR 677
Query: 709 QLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPIPPNPTSFLSAI 757
QL+RM+KV LWCILDEPSLRPSMKKVL+ML GTV+IP+PP+P SFLS+I
Sbjct: 678 QLDRMVKVGLWCILDEPSLRPSMKKVLMMLGGTVDIPVPPSPGSFLSSI 726
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147838246|emb|CAN72121.1| hypothetical protein VITISV_031648 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 784 bits (2024), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/766 (53%), Positives = 529/766 (69%), Gaps = 56/766 (7%)
Query: 25 TAKQRRSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVW 84
TA+QR SNIS SSL+P +S W SPSG +AFGFY + G + +G+ L G P+ TVVW
Sbjct: 18 TAQQRHSNISKTSSLTPTTDSLWFSPSGFFAFGFY---HAEGGFAIGIILVGNPQNTVVW 74
Query: 85 TANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDSGNFVLYDSN 144
TANRD+PPVS+N +L+F G +VL +SQ + S+I D Q+ASSASMLDSGNFVLY+S
Sbjct: 75 TANRDEPPVSSNVSLVFTVHG-LVLXTSQGREISII-DPHQNASSASMLDSGNFVLYNSK 132
Query: 145 GKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPY 204
+ +WQ+F+HPTDTLL QRL G +L +SE N STG F L MQ DGNLVQY P
Sbjct: 133 QEIIWQSFDHPTDTLLSGQRLQAGAELVSSVSEKNYSTGMFQLKMQHDGNLVQYPTNVPE 192
Query: 205 GTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGVNIFNLTGGENPTKGMIYLMKIDSD 264
++AYWAS+T+ +GDN +LNLD +G+L+L+N TG NI NLT G P + IYLMKID D
Sbjct: 193 VVEYAYWASDTHGEGDNATLNLDADGYLYLLNATGFNIKNLTDGGGPQEETIYLMKIDVD 252
Query: 265 GIFRLYSYNLRRQNSTWQVVWESTSDRCDPIGFCGFNSFCVLNDQIPDCPCLPGFVQISQ 324
GIFRLYS L Q+S W V W S+ D+CDP G CG NS+C L DQ P C CLPGF + +
Sbjct: 253 GIFRLYSRGLD-QSSEWSVEWSSSIDKCDPKGLCGLNSYCSLMDQEPVCTCLPGFDFVDK 311
Query: 325 GNFTSGCERNYTAESCGNK------AIRELKNTKWEDVSYYVLSETTEEKCKQACLEDCN 378
+ GCERN+ AE+C N +I L++ WED SY V+S TEE C +ACLEDCN
Sbjct: 312 SQKSWGCERNFVAEACKNNDGSIEYSIESLQSVMWEDDSYLVISSRTEENCIEACLEDCN 371
Query: 379 CEAALFKEEECKMQRLPLRFGRRNLRDSSIAFVKVDDATSSSPQAPFSVEGNKKELWKDI 438
CEAALFK EC+ Q+LP RFGRR+L D + AFVKV +T++ +AP + +KKE KDI
Sbjct: 372 CEAALFKNSECRKQKLPSRFGRRSLSDETTAFVKVGTSTATR-RAP---KESKKEWRKDI 427
Query: 439 VII-CLFVAVVILISAVTFGIFIYRYHVGSYRRIPGNGSARYCEDIAPLSFSYAELEKMT 497
+II C +A+ ++ A++ G+ IYR + +++ G+ R E SF+Y EL+K+T
Sbjct: 428 LIISCSLLALACIVLAIS-GLLIYRNRGCTLKKVSKQGNLRLTEGATLQSFTYQELKKVT 486
Query: 498 DGFKEEVGRG------------------------SSGEREFQTEMKVIGRTHHRNLVRLL 533
+GF E +G+G S+GE+EF+TEMK + THHRNLV+LL
Sbjct: 487 NGFTEVLGKGGFGTVYKGAMSNGQRLVAVKKLNVSTGEKEFRTEMKALAGTHHRNLVQLL 546
Query: 534 GYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQII 593
GY LE + LVYEY+SNGSLA++LF P K P W ERMGIA+++ARGILYLH+ECETQI+
Sbjct: 547 GYCLEGPNRFLVYEYISNGSLANLLFTPAKWPRWDERMGIAQNVARGILYLHEECETQIM 606
Query: 594 HCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKA 653
HCDIKPQNILMDE AKIS FGLAK +K QT T IRGT+GY+APEW RN P+TVK
Sbjct: 607 HCDIKPQNILMDEYGGAKISSFGLAKRLKHGQTSTLAEIRGTKGYIAPEWFRNQPVTVK- 665
Query: 654 DVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERM 713
IIC R+ D +JPD+++ L EWV CFE G L +LV+ EEVD+++LERM
Sbjct: 666 -----------IICCRKNFDLSJPDEEIGLNEWVSHCFEAGELGKLVDGEEVDKRELERM 714
Query: 714 IKVALWCILDEPSLRPSMKKVLLMLEGT-VEIPIPPN-PTSFLSAI 757
+KV LWCI DEP RPS+KKVLLMLEG+ ++IP+PP+ T++ SA+
Sbjct: 715 VKVGLWCIQDEPLFRPSIKKVLLMLEGSIIDIPVPPSTSTTYFSAV 760
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493028|ref|XP_002264274.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1945), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/773 (51%), Positives = 512/773 (66%), Gaps = 52/773 (6%)
Query: 12 IIFFILSSGCLTATAKQRRSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVG 71
I+F + S T T + S+I++GSSLSP G S+W S SG +AFGFY + Y VG
Sbjct: 62 ILFLLFISEFSTTTGQLGNSSITLGSSLSPTGPSNWSSHSGQFAFGFYQKGK---GYAVG 118
Query: 72 VFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSAS 131
++ I +TV+WTANRD P+S + L+F S+G ++L+ +Q S++ D ASSAS
Sbjct: 119 IWFNRISRRTVIWTANRDAAPLSRDVQLIFTSDGKLILQQNQGESISIVDRDLPPASSAS 178
Query: 132 MLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQG 191
MLD GNFVL +S+ +WQ+F+ PTDT+LP Q L G KL +SETN S GKF LIMQ
Sbjct: 179 MLDDGNFVLKNSSSSVIWQSFDTPTDTILPGQPLLAGQKLVSSVSETNHSAGKFQLIMQS 238
Query: 192 DGNLVQYANINPYGTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGVNIFNLTGGENP 251
DGNLVQY I+ + AYW ++T+ G VSLNLD NG L+L N TG NI NL G +P
Sbjct: 239 DGNLVQYP-IDVAKPETAYWNTSTFTAGATVSLNLDVNGKLYLRNGTGFNIMNLYEG-SP 296
Query: 252 TKGMIYLMKIDSDGIFRLYSYNLRRQNSTWQVVWESTSDRCDPIGFCGFNSFCVLNDQIP 311
IY + ID+DGI RLYS + QN W V W T++RC P G CG N +C+L +Q P
Sbjct: 297 FSTGIYRLTIDADGILRLYSSS-SDQNGDWTVEWSPTTNRCVPRGLCGLNGYCLLTNQNP 355
Query: 312 DCPCLPGFVQISQGNFTSGCERNYTAESCGNKA--IRELKNTKWEDVSYYVLSETTEEKC 369
C CLPGF G S CERN + G+ I L++ WED Y VLS T + C
Sbjct: 356 QCVCLPGFYLTKPGQNNSDCERNVSMSKNGDIEYNIIALEDITWEDDPYSVLS-MTRQAC 414
Query: 370 KQACLEDCNCEAALFKEEECKMQRLPLRFGRRNLRDSSIAFVKVDDATSSSPQAPFSVEG 429
+ CL D NCEAAL+K ++C+ Q LPLRFG + KV + +S ++
Sbjct: 415 IENCLSDGNCEAALYKNQQCRKQTLPLRFGSQ--EGGVTTLFKVGNFSSVGKES------ 466
Query: 430 NKKELWKDIVIICLFVAVVILISAVTFGIFIYRYHVGSYRRIPGNGSARYCEDIAPLSFS 489
+KEL + IVI+ ++ + IS G+ IYRY +++R+ G+ R+ ED+A F+
Sbjct: 467 -RKEL-RIIVILSTSISFFLAIS----GVVIYRY---AFKRVSNQGNDRWAEDVALRPFT 517
Query: 490 YAELEKMTDGFKEEVGRGS-------------------------SGEREFQTEMKVIGRT 524
Y ELEK T+GF++EVG+G+ GE EFQ EMK IGRT
Sbjct: 518 YHELEKATNGFRDEVGKGAFGTVFKGAISNGKTVAIKRLEKMMAEGEWEFQNEMKSIGRT 577
Query: 525 HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584
HH+NLVRLLGY + S ++LVYEYM+NGSLAD LF E++P W ER+ IA +ARGILYL
Sbjct: 578 HHKNLVRLLGYCHDGSNRLLVYEYMTNGSLADFLFKSERKPIWEERIEIALSVARGILYL 637
Query: 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWH 644
H+ECETQIIHCDIKP+NILMDE CAKI+DFGLAKL+ P+QTRT+TGIRGTRGYVAPEWH
Sbjct: 638 HEECETQIIHCDIKPENILMDEKGCAKIADFGLAKLLMPNQTRTYTGIRGTRGYVAPEWH 697
Query: 645 RNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEE 704
RNLPITVKADVYSFG++L+EIIC RR LD ++ +++V+L ++VY CFE L +LV DEE
Sbjct: 698 RNLPITVKADVYSFGIMLMEIICCRRSLDMDVSENEVVLVDYVYDCFEARELDKLVRDEE 757
Query: 705 VDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPIPPNPTSFLSAI 757
VD +L+RM+KV LWCI DEPS+RP MKKV+LM+EGTV+IP PP SF S++
Sbjct: 758 VDGMKLQRMVKVGLWCIQDEPSVRPLMKKVVLMMEGTVDIPAPPR-ASFASSM 809
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255584574|ref|XP_002533013.1| conserved hypothetical protein [Ricinus communis] gi|223527202|gb|EEF29367.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 740 bits (1911), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/749 (49%), Positives = 499/749 (66%), Gaps = 26/749 (3%)
Query: 2 QRFHFLFKHSIIFFILSSGCLTATAKQRRSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQ 61
Q F +F + LSS ATA+QR SNIS+GS+L+P S W S SG +AFGFYP+
Sbjct: 20 QNFAAMF---LFLLFLSSIFSGATAQQRVSNISLGSALTPTSTSYWSSNSGHFAFGFYPE 76
Query: 62 SNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIA 121
N + VG++ A I ++TV+WTANRDD P+ ++ TL +++G ++L+ +Q Q+ I+
Sbjct: 77 GN---GFAVGIWFANIQQRTVIWTANRDDTPLPSDVTLTLSTDGRLILQFNQ-GQEIPIS 132
Query: 122 DDSQSASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPS 181
D + ASSASMLDS + +WQTF+ PTD ++ QRL G +L IS TN S
Sbjct: 133 DATLYASSASMLDS--------ESRIIWQTFDAPTDAIISGQRLLAGKQLVASISNTNHS 184
Query: 182 TGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGVN 241
+G+F LIMQ DGNLV Y NP AYW + T+ G+NVSLNL NG L+L+N+TG
Sbjct: 185 SGRFELIMQTDGNLVLYPAQNPKAPNSAYWHTETFTAGNNVSLNLKSNGQLYLLNSTGFI 244
Query: 242 IFNLTGGENPTKGMIYLMKIDSDGIFRLYSYNLRRQNSTWQVVWESTSDRCDPIGFCGFN 301
I L + IY ID DGIFRLYS+NL QNS W + W S+ + C+PIG CG N
Sbjct: 245 IKTLKDAGTISGNPIYRATIDVDGIFRLYSHNLD-QNSNWSIEWSSSDNLCNPIGLCGLN 303
Query: 302 SFCVLNDQIPDCPCLPGFVQISQGNFTSGCERNYTAESC-----GNKAIRELKNTKWEDV 356
S+C L P C C PGF I GC++N ++ C N + EL++ WED
Sbjct: 304 SYCTLAGGSPTCVCTPGFDFIDHSQKNLGCKKNSSSVDCTSLAESNFTMHELRDITWEDN 363
Query: 357 SYYVLSETTEEKCKQACLEDCNCEAALFKE-EECKMQRLPLRFGRRNLRDSSIAFVKVDD 415
Y +LS +T C++ CL DCNCEAA++ + +EC+ Q+LPLRFGR S F+K+
Sbjct: 364 PYSILSSSTRAACREECLGDCNCEAAIYNQNQECRKQKLPLRFGRTQKGQIS-TFIKISI 422
Query: 416 ATSSSPQAPFSVEGNKKELWKDIVIICLFVAVVILISAVTFGIFIYRYHVGSYRRIPGNG 475
S + S+E K KD++II + + +I FGI +RY + +Y++I +
Sbjct: 423 GNSRTTGG--SIE-RKNGQGKDVLIIGIVFLTLSIIMLAIFGILFFRYRIWNYKKISSHP 479
Query: 476 SARYCEDIAPLSFSYAELEKMTDGFKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGY 535
+ ED+ SF++ EL+K T+ FK E+GRG+SG EMK+IGRTHH+NLVRL GY
Sbjct: 480 NDELLEDVTLRSFTFDELKKATNNFKNEIGRGASGTVFKGNEMKIIGRTHHKNLVRLFGY 539
Query: 536 SLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHC 595
+ + K+LVYEYMS+GSLAD LF E++P W ER+ IA ++ARGI YLH+EC T IIHC
Sbjct: 540 CQDGTNKLLVYEYMSSGSLADFLFKGEEKPAWEERIQIALNVARGIFYLHEECSTPIIHC 599
Query: 596 DIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADV 655
DIKP+NILMDE AKI+DFGL+KL+ P+Q++T+TG+RGTRGYVAPEWH NLPITVKADV
Sbjct: 600 DIKPENILMDEKEGAKIADFGLSKLLMPNQSKTYTGVRGTRGYVAPEWHTNLPITVKADV 659
Query: 656 YSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIK 715
YS+G++LLEIIC R +D ++PDD+++L WVY CFE L +L++DE V+E + ERM+K
Sbjct: 660 YSYGIMLLEIICCRENVDMSVPDDEIVLANWVYDCFEAKELDKLMQDEVVEEGKFERMVK 719
Query: 716 VALWCILDEPSLRPSMKKVLLMLEGTVEI 744
V LWCI DEPSLRPSMKKVLLMLEGT++I
Sbjct: 720 VGLWCIQDEPSLRPSMKKVLLMLEGTIDI 748
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 757 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.319 | 0.291 | 0.460 | 5.5e-81 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.322 | 0.294 | 0.434 | 6e-72 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.322 | 0.297 | 0.398 | 8.5e-66 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.314 | 0.296 | 0.348 | 9.3e-63 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.311 | 0.291 | 0.349 | 6.3e-62 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.313 | 0.288 | 0.359 | 8.1e-62 | |
| TAIR|locus:2197714 | 792 | AT1G61440 [Arabidopsis thalian | 0.314 | 0.300 | 0.356 | 8.7e-62 | |
| TAIR|locus:2200923 | 802 | AT1G61550 [Arabidopsis thalian | 0.313 | 0.295 | 0.342 | 3.9e-61 | |
| TAIR|locus:2197724 | 806 | AT1G61430 [Arabidopsis thalian | 0.313 | 0.294 | 0.346 | 6.6e-61 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.313 | 0.281 | 0.346 | 1e-60 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 5.5e-81, Sum P(2) = 5.5e-81
Identities = 116/252 (46%), Positives = 157/252 (62%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE--KQPNWVERM 571
F+ E+ I THH NLVRL+G+ + ++LVYE+M NGSL + LF + K W R
Sbjct: 524 FRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRF 583
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP-DQXXXXX 630
IA A+GI YLH+EC I+HCDIKP+NIL+D+N AK+SDFGLAKL+ P D
Sbjct: 584 NIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMS 643
Query: 631 XXXXXXXYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQC 690
Y+APEW NLPIT K+DVYS+G+VLLE++ +R D + + W Y+
Sbjct: 644 SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEE 703
Query: 691 FENGNL-----SQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEI- 744
FE GN ++L ED+ VD +Q+ RM+K + WCI ++P RP+M KV+ MLEG EI
Sbjct: 704 FEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIK 763
Query: 745 -PIPPNPTSFLS 755
P+ P S +S
Sbjct: 764 NPLCPKTISEVS 775
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 504 (182.5 bits), Expect = 6.0e-72, Sum P(2) = 6.0e-72
Identities = 110/253 (43%), Positives = 149/253 (58%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF-NPEKQP---NWVE 569
F+TE+ IG H NLVRL G+ E SKK+LVY+YM NGSL LF N ++ W
Sbjct: 533 FRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKL 592
Query: 570 RMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQXXXX 629
R IA ARG+ YLHDEC IIHCDIKP+NIL+D C K++DFGLAKL+ D
Sbjct: 593 RFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVL 652
Query: 630 XXXXXXXXYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQ 689
Y+APEW + IT KADVYS+G++L E++ RR + + + W
Sbjct: 653 TTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAAT 712
Query: 690 CF-ENGNLSQLV----EDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEI 744
++G++ LV E + VD +++ R KVA WCI DE S RP+M +V+ +LEG +E+
Sbjct: 713 ILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEV 772
Query: 745 PIPPNPTSFLSAI 757
PP P S + +
Sbjct: 773 NPPPFPRSIQALV 785
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 508 (183.9 bits), Expect = 8.5e-66, Sum P(2) = 8.5e-66
Identities = 100/251 (39%), Positives = 156/251 (62%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP---NWVER 570
F+ E+ +IG HH +LVRL G+ E + ++L YE++S GSL +F + +W R
Sbjct: 533 FRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTR 592
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQXXXXX 630
IA A+G+ YLH++C+ +I+HCDIKP+NIL+D+N AK+SDFGLAKLM +Q
Sbjct: 593 FNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFT 652
Query: 631 XXXXXXXYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQC 690
Y+APEW N I+ K+DVYS+G+VLLE+I R+ DP+ ++ + ++
Sbjct: 653 TMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFAFKK 712
Query: 691 FENGNLSQLVEDE----EVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPI 746
E G L +V+ + +V +++++R +K ALWCI ++ RPSM KV+ MLEG +
Sbjct: 713 MEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQ 772
Query: 747 PPNPTSFLSAI 757
PP+ ++ S +
Sbjct: 773 PPSSSTMGSRL 783
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 375 (137.1 bits), Expect = 9.3e-63, Sum P(2) = 9.3e-63
Identities = 85/244 (34%), Positives = 139/244 (56%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEK--QPNWVERM 571
F E+ +I + HRNLVR+LG +E +K+L+YE+M N SL +F+ K + +W +R
Sbjct: 531 FMNEIVLISKLQHRNLVRVLGCCIEGEEKLLIYEFMLNKSLDTFVFDARKKLEVDWPKRF 590
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ-XXXXX 630
I + IARG+LYLH + ++IH D+K NIL+DE KISDFGLA++ + Q
Sbjct: 591 DIVQGIARGLLYLHRDSRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQCQDKTR 650
Query: 631 XXXXXXXYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQC 690
Y++PE+ + K+D+YSFGV+LLEII + + ++ L + ++
Sbjct: 651 RVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSYGEEGKTLLAYAWES 710
Query: 691 FENGNLSQLVEDEEVDE-KQLE--RMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPIP 747
+ L++ + D + LE R +++ L C+ +P+ RP+ ++L ML T ++P P
Sbjct: 711 WGETKGIDLLDQDLADSCRPLEVGRCVQIGLLCVQHQPADRPNTLELLAMLTTTSDLPSP 770
Query: 748 PNPT 751
PT
Sbjct: 771 KQPT 774
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 367 (134.2 bits), Expect = 6.3e-62, Sum P(2) = 6.3e-62
Identities = 86/246 (34%), Positives = 136/246 (55%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEK--QPNWVERM 571
F E+ +I + H+NLVR+LG +E +++LVYE++ N SL LF+ K + +W +R
Sbjct: 537 FMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDSRKRLEIDWPKRF 596
Query: 572 GIARDIARGILYLH-DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK-PDQXXXX 629
I IARG+ YLH D C ++IH D+K NIL+DE KISDFGLA++ + +
Sbjct: 597 NIIEGIARGLHYLHRDSC-LRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNT 655
Query: 630 XXXXXXXXYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRC--LDPNLPDDQVILEEWV 687
Y+APE+ + K+D+YSFGV+LLEII + ++ W
Sbjct: 656 RRVAGTLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEKISRFSYGRQGKTLLAYAWE 715
Query: 688 YQCFENGNLSQLVED--EEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIP 745
C E+G + L +D + ++ER +++ L C+ +P+ RP+ ++L ML T ++
Sbjct: 716 SWC-ESGGIDLLDKDVADSCHPLEVERCVQIGLLCVQHQPADRPNTMELLSMLTTTSDLT 774
Query: 746 IPPNPT 751
P PT
Sbjct: 775 SPKQPT 780
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 391 (142.7 bits), Expect = 8.1e-62, Sum P(2) = 8.1e-62
Identities = 88/245 (35%), Positives = 140/245 (57%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEK--QPNWVERM 571
F E+K+I + HRNL+RLLG ++ +K+LVYEYM N SL +F+ +K + +W R
Sbjct: 539 FMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLDIFIFDLKKKLEIDWATRF 598
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQXXXXXX 631
I + IARG+LYLH + +++H D+K NIL+DE KISDFGLA+L +Q
Sbjct: 599 NIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKISDFGLARLFHGNQHQDSTG 658
Query: 632 XXXXXX-YVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQC 690
Y++PE+ + K+D+YSFGV++LEII + + D L + +
Sbjct: 659 SVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIITGKEISSFSYGKDNKNLLSYAWDS 718
Query: 691 F-ENGNLSQLVED----EEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIP 745
+ ENG ++ L +D + V+ + R + + L C+ + RP++K+V+ ML T ++P
Sbjct: 719 WSENGGVNLLDQDLDDSDSVNSVEAGRCVHIGLLCVQHQAIDRPNIKQVMSMLTSTTDLP 778
Query: 746 IPPNP 750
P P
Sbjct: 779 KPTQP 783
|
|
| TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 390 (142.3 bits), Expect = 8.7e-62, Sum P(2) = 8.7e-62
Identities = 87/244 (35%), Positives = 139/244 (56%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEK--QPNWVERM 571
F E+ +I + HRNLVR+LG +E +K+L+YE+M N SL +F K + +W +R
Sbjct: 519 FMNEIVLISKLQHRNLVRVLGCCVEGKEKLLIYEFMKNKSLDTFVFGSRKRLELDWPKRF 578
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQXXXXXX 631
I + I RG+LYLH + ++IH D+K NIL+DE KISDFGLA+L + Q
Sbjct: 579 DIIQGIVRGLLYLHRDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARLFQGSQYQDKTR 638
Query: 632 XXXXXX-YVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQC 690
Y++PE+ + K+D+YSFGV+LLEII + + ++ L +V++C
Sbjct: 639 RVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIISGEKISRFSYGEEGKALLAYVWEC 698
Query: 691 F--ENG-NLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPIP 747
+ G NL D+ ++ R +++ L C+ +P+ RP+ ++L ML T ++P+P
Sbjct: 699 WCETRGVNLLDQALDDSSHPAEVGRCVQIGLLCVQHQPADRPNTLELLSMLTTTSDLPLP 758
Query: 748 PNPT 751
PT
Sbjct: 759 KQPT 762
|
|
| TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 371 (135.7 bits), Expect = 3.9e-61, Sum P(2) = 3.9e-61
Identities = 84/245 (34%), Positives = 139/245 (56%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP--NWVERM 571
F E+ +I + H NLVR+LG +E +++LVYE+M N SL +F+ K+ +W +R
Sbjct: 530 FMNEILLISKLQHINLVRILGCCIEGEERLLVYEFMVNKSLDTFIFDSRKRVEIDWPKRF 589
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQXXXXXX 631
I + IARG+LYLH + +IIH D+K NIL+D+ KISDFGLA++ + +
Sbjct: 590 SIIQGIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPKISDFGLARMYEGTKYQDNTR 649
Query: 632 XXXXXX-YVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQ--VILEEWVY 688
Y++PE+ + K+D YSFGV+LLE+I + + ++ ++ W
Sbjct: 650 RIVGTLGYMSPEYAWTGVFSEKSDTYSFGVLLLEVISGEKISRFSYDKERKNLLAYAWES 709
Query: 689 QCFENGNLSQLVED--EEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPI 746
C ENG + L +D + ++ R +++ L C+ +P+ RP+ ++L ML T ++P+
Sbjct: 710 WC-ENGGVGFLDKDATDSCHPSEVGRCVQIGLLCVQHQPADRPNTLELLSMLTTTSDLPL 768
Query: 747 PPNPT 751
P PT
Sbjct: 769 PKEPT 773
|
|
| TAIR|locus:2197724 AT1G61430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 380 (138.8 bits), Expect = 6.6e-61, Sum P(2) = 6.6e-61
Identities = 85/245 (34%), Positives = 140/245 (57%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEK--QPNWVERM 571
F E+ +I + HRNLVR+LG +E ++K+L+Y ++ N SL +F+ K + +W +R
Sbjct: 533 FMNEIVLISKLQHRNLVRVLGCCVEGTEKLLIYGFLKNKSLDTFVFDARKKLELDWPKRF 592
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQXXXXXX 631
I IARG+LYLH + ++IH D+K NIL+DE KISDFGLA++ + Q
Sbjct: 593 EIIEGIARGLLYLHRDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMFQGTQYQEKTR 652
Query: 632 XXXXXX-YVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQC 690
Y++PE+ + K+D+YSFGV+LLEII ++ + ++ L + ++C
Sbjct: 653 RVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIISGKKISSFSYGEEGKALLAYAWEC 712
Query: 691 F----ENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPI 746
+ E L Q + D ++ R +++ L C+ EP+ RP+ ++L ML T ++P+
Sbjct: 713 WCETREVNFLDQALADSS-HPSEVGRCVQIGLLCVQHEPADRPNTLELLSMLTTTSDLPL 771
Query: 747 PPNPT 751
P PT
Sbjct: 772 PKKPT 776
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 372 (136.0 bits), Expect = 1.0e-60, Sum P(2) = 1.0e-60
Identities = 86/248 (34%), Positives = 140/248 (56%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPN--WVERM 571
F E+++I + H NLVRLLG ++ +K+L+YEY+ N SL LF+ + N W +R
Sbjct: 560 FMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRF 619
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM-KPDQXXXXX 630
I IARG+LYLH + +IIH D+K N+L+D+N KISDFG+A++ + +
Sbjct: 620 DIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTR 679
Query: 631 XXXXXXXYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQC 690
Y++PE+ + ++K+DV+SFGV+LLEII +R + + L +V++
Sbjct: 680 RVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRH 739
Query: 691 FENGNLSQLVEDEEVDE-------KQLERMIKVALWCILDEPSLRPSMKKVLLMLEG-TV 742
++ GN ++V+ +D ++ R I++ L C+ + RP M V++ML T
Sbjct: 740 WKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETT 799
Query: 743 EIPIPPNP 750
IP P P
Sbjct: 800 AIPQPKRP 807
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q39202 | RLK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3402 | 0.9445 | 0.8593 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00034863001 | SubName- Full=Chromosome chr4 scaffold_73, whole genome shotgun sequence; (775 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 757 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-34 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-28 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 9e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-22 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-20 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-19 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-17 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 4e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-17 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 5e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-14 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-08 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-07 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 5e-07 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 5e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-06 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-05 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 4e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 3e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 5e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.002 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.002 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 9e-44
Identities = 60/174 (34%), Positives = 92/174 (52%), Gaps = 10/174 (5%)
Query: 508 SSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNW 567
SS E E++++ + +H N+V+L G + + LV EY GSL D+L E + +
Sbjct: 32 SSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSE 91
Query: 568 VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDE-NRCAKISDFGLAKLMKPDQT 626
E + I I G+ YLH IIH D+KP+NIL+D N K++DFGL+KL+
Sbjct: 92 DEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLT-SDK 147
Query: 627 RTFTGIRGTRGYVAPE-WHRNLPITVKADVYSFGVVLLEI--ICR--RRCLDPN 675
I GT Y+APE + K+D++S GV+L E+ + R+ L +
Sbjct: 148 SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYELPELKDLIRKMLQKD 201
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 5e-39
Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 24/226 (10%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMG 572
E+K++ + H N+VRL E K+ LV EY G L D+L + R
Sbjct: 44 ILREIKILKKLKHPNIVRLYD-VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF- 101
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGI 632
R I + YLH + I+H D+KP+NIL+DE+ K++DFGLA+ + P + T
Sbjct: 102 YLRQILSALEYLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTF 156
Query: 633 RGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFE 692
GT Y+APE D++S GV+L E++ + P P D +LE +++
Sbjct: 157 VGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK----PPFPGDDQLLE--LFKKIG 210
Query: 693 NGNLSQLVEDEEVDE--KQL-ERMIKVALWCILDEPSLRPSMKKVL 735
+ ++ K L +++ +P R + ++ L
Sbjct: 211 KPKPPFPPPEWDISPEAKDLIRKLLVK-------DPEKRLTAEEAL 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 8e-38
Identities = 73/233 (31%), Positives = 104/233 (44%), Gaps = 13/233 (5%)
Query: 504 VGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEK 563
S ++ + E++++ R H N+VRL+ + LV EY G L D L
Sbjct: 35 RSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GG 93
Query: 564 QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623
+ E IA I RG+ YLH IIH D+KP+NIL+DEN KI+DFGLAK +
Sbjct: 94 PLSEDEAKKIALQILRGLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLK 150
Query: 624 DQTRTFTGIRGTRGYVAPEWHR-NLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
+ T GT Y+APE K DV+S GV+L E++ + DQ
Sbjct: 151 SSSS-LTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQ-- 207
Query: 683 LEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
Q L DE E + C+ +PS RP+ +++L
Sbjct: 208 -----LQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 67/232 (28%), Positives = 110/232 (47%), Gaps = 23/232 (9%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVER 570
EF E +++ + H N+V+LLG E +V EYM G L L + + +
Sbjct: 45 IEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDL 104
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
+ A IARG+ YL + IH D+ +N L+ EN KISDFGL++ + D
Sbjct: 105 LSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR 161
Query: 631 G----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEW 686
G IR ++APE + T K+DV+SFGV+L EI P + +++V+ E+
Sbjct: 162 GGKLPIR----WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL--EY 215
Query: 687 VYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738
+ +NG + + + L C ++P RP+ +++ +L
Sbjct: 216 L----KNGYRLPQPPNCP------PELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 70/233 (30%), Positives = 113/233 (48%), Gaps = 24/233 (10%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL-FNPEKQPNWVE 569
EF E +++ + H N+V+LLG E ++V EYM G L D L N K+ + +
Sbjct: 45 IEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSD 104
Query: 570 RMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
+ A IARG+ YL + IH D+ +N L+ EN KISDFGL++ + D
Sbjct: 105 LLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV 161
Query: 630 TG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEE 685
G IR ++APE + T K+DV+SFGV+L EI P + + +V+ E
Sbjct: 162 KGGKLPIR----WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVL--E 215
Query: 686 WVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738
++ + G + + K+ L C ++P RP+ +++ +L
Sbjct: 216 YL----KKGYRLPKPPNCP------PELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 12/162 (7%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERM 571
EF E ++ + H N+VRLLG + +V EYM G L D L ++ + +
Sbjct: 46 EEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLL 105
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG 631
+A IA+G+ YL + +H D+ +N L+ EN KISDFGL++ + D G
Sbjct: 106 QMALQIAKGMEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG 162
Query: 632 -----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668
I+ ++APE ++ T K+DV+SFGV+L EI
Sbjct: 163 GGKLPIK----WMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 69/243 (28%), Positives = 115/243 (47%), Gaps = 36/243 (14%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL--------FNPEK 563
++F E +V+ + H N+VRLLG E LV EYM G L D L +
Sbjct: 41 KDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKS 100
Query: 564 QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623
+ + + A IA+G+ YL + +H D+ +N L+ E+ KISDFGL++ +
Sbjct: 101 TLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157
Query: 624 DQTRTFTG-----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDP--NL 676
D IR ++APE ++ T K+DV+SFGV+L EI P L
Sbjct: 158 DDYYRKKTGGKLPIR----WMAPESLKDGIFTSKSDVWSFGVLLWEIFT--LGATPYPGL 211
Query: 677 PDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736
+++V+ E++ G +L + E ++ + ++ L C +P RP+ +++
Sbjct: 212 SNEEVL--EYL----RKGY--RLPKPEYCPDE----LYELMLSCWQLDPEDRPTFSELVE 259
Query: 737 MLE 739
LE
Sbjct: 260 RLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 56/172 (32%), Positives = 88/172 (51%), Gaps = 14/172 (8%)
Query: 503 EVGRGSSGE-REFQTEMKVIGRTHHRNLVRLLGYSLEVSKK-ILVY-EYMSNGSLADILF 559
E+ S E + E++++ H N+VR G + K + ++ EY+S GSL+ +L
Sbjct: 34 ELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL- 92
Query: 560 NPEKQPNWVERMGI---ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFG 616
+K E + I R I G+ YLH I+H DIK NIL+D + K++DFG
Sbjct: 93 --KKFGKLPEPV-IRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFG 146
Query: 617 LAKLMKPDQTRTFTG-IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
AK + +T TG +RGT ++APE R AD++S G ++E+
Sbjct: 147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 69/227 (30%), Positives = 113/227 (49%), Gaps = 20/227 (8%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP-NWVERMG 572
F E V+ H NLV+LLG L+ + +V EYM+ GSL D L + + +++G
Sbjct: 47 FLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG 106
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGI 632
A D+ G+ YL E +H D+ +N+L+ E+ AK+SDFGLAK + ++
Sbjct: 107 FALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSG 159
Query: 633 RGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFE 692
+ + APE R + K+DV+SFG++L EI R P +P V+ E
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------PHVE 213
Query: 693 NGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
G +E E ++ +++K W + +P+ RP+ K++ L
Sbjct: 214 KG---YRMEAPEGCPPEVYKVMKDC-WEL--DPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 9e-27
Identities = 44/109 (40%), Positives = 60/109 (55%), Gaps = 6/109 (5%)
Query: 79 EKTVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQD-SLIADDSQSASSASMLDSGN 137
+TVVW ANR +P ++ TL+ S+G++VL S S A + D GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 138 FVLYDSNGKTLWQTFEHPTDTLLPNQRL---SVGTKLFPGI--SETNPS 181
VLYD++GK LWQ+F+HPTDTLLP Q+ +G S T+PS
Sbjct: 61 LVLYDNSGKVLWQSFDHPTDTLLPGQKDGNVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 56/154 (36%), Positives = 85/154 (55%), Gaps = 14/154 (9%)
Query: 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERM--G 572
E+K + +V+ G + +I +V EYM GSLAD+L +K E +
Sbjct: 48 RELKTLRSCESPYVVKCYG-AFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAY 103
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP--DQTRTFT 630
IAR I +G+ YLH + IIH DIKP N+L++ KI+DFG++K+++ DQ TF
Sbjct: 104 IARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV 161
Query: 631 GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664
GT Y++PE + + AD++S G+ LLE
Sbjct: 162 ---GTVTYMSPERIQGESYSYAADIWSLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 59/170 (34%), Positives = 91/170 (53%), Gaps = 4/170 (2%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMG 572
F E +++ + H LV+L E +V EYMS GSL D L + E K+ + +
Sbjct: 48 FLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD 107
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGI 632
+A IA G+ YL IH D+ +NIL+ EN KI+DFGLA+L++ D+ G
Sbjct: 108 MAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164
Query: 633 RGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
+ + APE T+K+DV+SFG++L EI+ R P + + +V+
Sbjct: 165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL 214
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 102 bits (253), Expect = 4e-23
Identities = 60/239 (25%), Positives = 97/239 (40%), Gaps = 18/239 (7%)
Query: 511 EREFQTEMKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVE 569
F E++++ H N+V+L + + LV EY+ GSL D+L ++ E
Sbjct: 41 VERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSE 100
Query: 570 R--MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC-AKISDFGLAKLMKPDQT 626
+ I I + YLH IIH DIKP+NIL+D + K+ DFGLAKL+ +
Sbjct: 101 SEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157
Query: 627 RT-----FTGIRGTRGYVAPEWHRNL---PITVKADVYSFGVVLLEIIC-RRRCLDPNLP 677
+ + GT GY+APE L + +D++S G+ L E++
Sbjct: 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS 217
Query: 678 DDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736
+ + + S L E + + + +P R S L
Sbjct: 218 SATSQTLKIILELPTPSLASPLSPS--NPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 55/162 (33%), Positives = 88/162 (54%), Gaps = 16/162 (9%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERM 571
+F TE ++G+ H N++RL G + +++ EYM NGSL L + + + +
Sbjct: 50 LDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLV 109
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK-LMKPDQTRTFT 630
G+ R IA G+ YL + +H D+ +NIL++ N K+SDFGL++ L + T T
Sbjct: 110 GMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
Query: 631 G----IRGTRGYVAPE--WHRNLPITVKADVYSFGVVLLEII 666
G IR T APE +R T +DV+SFG+V+ E++
Sbjct: 167 GGKIPIRWT----APEAIAYRKF--TSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 19/227 (8%)
Query: 517 EMKVIGRTHHRNLVRLLG-YSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMG-- 572
E+++ +V+ G + E S I + EY GSL I +K+ R+G
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGG---RIGEK 105
Query: 573 ----IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT 628
IA + +G+ YLH +IIH DIKP NIL+ K+ DFG++ + T
Sbjct: 106 VLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT 162
Query: 629 FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVY 688
FT GT Y+APE + P ++ +DV+S G+ LLE+ R P +E Y
Sbjct: 163 FT---GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY 219
Query: 689 QCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
N +L ++ K E C+ +P+ RP+ +L
Sbjct: 220 --IVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDML 264
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 4e-22
Identities = 64/241 (26%), Positives = 112/241 (46%), Gaps = 27/241 (11%)
Query: 504 VGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEK 563
+ G+ E +F E +V+ + H LV+L G E S LV+E+M +G L+D L
Sbjct: 36 IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG 95
Query: 564 QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623
+ + +G+ D+ G+ YL +IH D+ +N L+ EN+ K+SDFG+ + +
Sbjct: 96 KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152
Query: 624 DQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVIL 683
DQ + TG + + +PE + K+DV+SFGV++ E+ + P
Sbjct: 153 DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK-----TP------ 201
Query: 684 EEWVYQCFENGNLSQLVEDEEVDEKQL------ERMIKVALWCILDEPSLRPSMKKVLLM 737
+EN + S++VE + + + ++ C + P RPS +L
Sbjct: 202 -------YENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254
Query: 738 L 738
L
Sbjct: 255 L 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 52/160 (32%), Positives = 76/160 (47%), Gaps = 10/160 (6%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
EMKV+ H NLV+ G + K + EY S G+L ++L + V R+
Sbjct: 49 EMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV-YTLQ 107
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
+ G+ YLH I+H DIKP NI +D N K+ DFG A +K + T ++
Sbjct: 108 LLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA 164
Query: 637 G---YVAPEWHRNLPITVK---ADVYSFGVVLLEIICRRR 670
G Y+APE AD++S G V+LE+ +R
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 50/157 (31%), Positives = 80/157 (50%), Gaps = 23/157 (14%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN-----PEKQPNWVERM 571
E++++ + H N+V+ G L+ + +V E+ S GSL D+L + E Q
Sbjct: 47 EIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ------- 99
Query: 572 GIA---RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR- 627
IA +++ +G+ YLH IIH DIK NIL+ + K+ DFGL+ + + R
Sbjct: 100 -IAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN 155
Query: 628 TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664
T GT ++APE P KAD++S G+ +E
Sbjct: 156 TMV---GTPYWMAPEVINGKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 51/178 (28%), Positives = 90/178 (50%), Gaps = 6/178 (3%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQP 565
G+ ++F E +++ + H L++L +V E M GSL + L +
Sbjct: 41 GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRAL 100
Query: 566 NWVERMGIARDIARGILYLHDECETQ-IIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+ + +A +A G+ YL E Q IH D+ +N+L+ EN K++DFGLA+++K D
Sbjct: 101 KLPQLIDMAAQVASGMAYL----EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156
Query: 625 QTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
G + + APE ++K+DV+SFG++L EI+ R P + + +V+
Sbjct: 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL 214
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 60/178 (33%), Positives = 95/178 (53%), Gaps = 7/178 (3%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPE-KQ 564
GS F E ++ + H LVRL Y++ + I ++ EYM NGSL D L PE +
Sbjct: 41 GSMSPEAFLAEANLMKQLQHPRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPEGIK 98
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+ + +A IA G+ ++ IH D++ NIL+ E C KI+DFGLA+L++ +
Sbjct: 99 LTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155
Query: 625 QTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
+ G + + APE T+K+DV+SFG++L EI+ R P + + +VI
Sbjct: 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 52/159 (32%), Positives = 85/159 (53%), Gaps = 3/159 (1%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPN 566
GS E EF E KV+ + H LV+L G + +V EYMSNG L + L K+
Sbjct: 39 GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQ 98
Query: 567 WVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626
+ + + +D+ G+ YL + Q IH D+ +N L+D+ C K+SDFGL++ + D+
Sbjct: 99 PSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155
Query: 627 RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
+ G + + PE + K+DV++FGV++ E+
Sbjct: 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 54/170 (31%), Positives = 91/170 (53%), Gaps = 13/170 (7%)
Query: 503 EVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE 562
+ G R+F +E ++G+ H N++ L G + ++V EYM NGSL L +
Sbjct: 41 KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD 100
Query: 563 KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK 622
Q ++ +G+ R IA G+ YL D +H D+ +NIL++ N K+SDFGL+++++
Sbjct: 101 GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157
Query: 623 PDQTRTFTGIRGTRG------YVAPEWHRNLPITVKADVYSFGVVLLEII 666
D +T TRG + APE T +DV+S+G+V+ E++
Sbjct: 158 DDPEAAYT----TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 47/153 (30%), Positives = 79/153 (51%), Gaps = 8/153 (5%)
Query: 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGIA 574
E+ ++ H N+V S V ++ +V EYM GSL DI+ + N + +
Sbjct: 64 NEILIMKDCKHPNIVDYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVC 122
Query: 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL-AKLMKPDQTRTFTGIR 633
R++ +G+ YLH +IH DIK NIL+ ++ K++DFG A+L K R +
Sbjct: 123 REVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR--NSVV 177
Query: 634 GTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
GT ++APE + K D++S G++ +E+
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 13/174 (7%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI--LVYEYMSNGSLADILFNPEKQPNWVE 569
+F+ E++++ H N+V+ G + + L+ EY+ +GSL D L Q N
Sbjct: 51 SDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKR 110
Query: 570 RMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
+ + I +G+ YL + + IH D+ +NIL++ KISDFGLAK+ + + +
Sbjct: 111 LLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV--LPEDKDY 165
Query: 630 TGIRGTRG----YVAPEWHRNLPITVKADVYSFGVVLLEII--CRRRCLDPNLP 677
++ + APE R + +DV+SFGV L E+ P
Sbjct: 166 YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 4e-20
Identities = 52/153 (33%), Positives = 79/153 (51%), Gaps = 7/153 (4%)
Query: 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGIA 574
TE ++ R +H +V+L Y+ + +K+ LV EY G L L + R A
Sbjct: 42 TERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA 100
Query: 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRG 634
+I + YLH II+ D+KP+NIL+D + K++DFGLAK + + +RT T G
Sbjct: 101 -EIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCG 155
Query: 635 TRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
T Y+APE D +S GV+L E++
Sbjct: 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 50/162 (30%), Positives = 85/162 (52%), Gaps = 7/162 (4%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERM 571
++FQ E++ + R H++L+ L ++ E M GSL L +PE Q V +
Sbjct: 47 QDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL 106
Query: 572 -GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD-QTRTF 629
+A +A G+ YL ++ IH D+ +NIL+ E+ K++DFGLA+L+K D +
Sbjct: 107 IDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSD 163
Query: 630 TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRC 671
I + APE + + K+DV+SFG++L E+ +
Sbjct: 164 KKI--PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQV 203
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 6e-20
Identities = 72/227 (31%), Positives = 112/227 (49%), Gaps = 21/227 (9%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP-NWVERMG 572
F E V+ + HH+NLVRLLG L I V E MS G+L + L + + ++ +
Sbjct: 46 FLEETAVMTKLHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQ 104
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGI 632
+ D+A G+ YL + +++H D+ +NIL+ E+ AK+SDFGLA++ + +
Sbjct: 105 FSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV 161
Query: 633 RGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFE 692
+ T APE ++ + K+DV+S+GV+L E+ R P + L+E V +C E
Sbjct: 162 KWT----APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----LKE-VKECVE 211
Query: 693 NGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
G + E D L C EP RPS K+ LE
Sbjct: 212 KGYRMEPPEGCPADVYVLMTS------CWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 69/228 (30%), Positives = 103/228 (45%), Gaps = 16/228 (7%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP-NWVERM 571
EF E V+ H NLV+LLG ++ E+M+ G+L D L +Q N V +
Sbjct: 48 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 107
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG 631
+A I+ + YL + IH D+ +N L+ EN K++DFGL++LM D G
Sbjct: 108 YMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 164
Query: 632 IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCF 691
+ + APE ++K+DV++FGV+L EI P + Q VY+
Sbjct: 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELL 218
Query: 692 ENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
E G ++ E K E M W PS RPS ++ E
Sbjct: 219 EKG--YRMERPEGCPPKVYELMRACWQW----NPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 34/202 (16%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMG 572
E+ ++ H N+V+ +G ++ EY NGSL I+ P E +
Sbjct: 45 SIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP---ESL- 100
Query: 573 IARDIA---RGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLA-KLMKPDQTRT 628
+A + +G+ YLH++ +IH DIK NIL ++ K++DFG+A KL D ++
Sbjct: 101 VAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKD 155
Query: 629 FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI------------------ICRRR 670
+ GT ++APE + +D++S G ++E+ I +
Sbjct: 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD 215
Query: 671 CLDPNLPDD-QVILEEWVYQCF 691
P LP+ L++++ QCF
Sbjct: 216 H--PPLPEGISPELKDFLMQCF 235
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 493 LEKMTDGFKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 552
L ++ G + R E+K + H +V+LL S +LV EYM
Sbjct: 35 LRRLEGGIPNQALR----------EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-S 83
Query: 553 SLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKI 612
L+++L + E+ + R + +G+ Y+H I+H D+KP N+L+ + KI
Sbjct: 84 DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKI 140
Query: 613 SDFGLAKLMKPDQTRTFTGIRGTRGYVAPE 642
+DFGLA+L ++ R ++ TR Y APE
Sbjct: 141 ADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 51/189 (26%), Positives = 87/189 (46%), Gaps = 33/189 (17%)
Query: 493 LEKMTDGFKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 552
L M++ +E+ E+K++ + +H N+++ E K +V EY G
Sbjct: 35 LSNMSEKEREDA----------LNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGG 84
Query: 553 SLADIL--FNPEKQP-------NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNIL 603
L+ + E +P +W + + YLH +I+H DIKPQNI
Sbjct: 85 DLSQKIKKQKKEGKPFPEEQILDWF------VQLCLALKYLHSR---KILHRDIKPQNIF 135
Query: 604 MDENRCAKISDFGLAKLM--KPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVV 661
+ N K+ DFG++K++ D +T GT Y++PE +N P K+D++S G V
Sbjct: 136 LTSNGLVKLGDFGISKVLSSTVDLAKTVV---GTPYYLSPELCQNKPYNYKSDIWSLGCV 192
Query: 662 LLEIICRRR 670
L E+ +
Sbjct: 193 LYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 49/159 (30%), Positives = 80/159 (50%), Gaps = 3/159 (1%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPN 566
G+ E +F E KV+ + H NLV+L G + +V EYM+NG L + L + +
Sbjct: 39 GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLG 98
Query: 567 WVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626
+ + D+ + YL IH D+ +N L+ E+ K+SDFGLA+ + DQ
Sbjct: 99 TEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155
Query: 627 RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
+ G + + PE + K+DV+SFGV++ E+
Sbjct: 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 50/156 (32%), Positives = 91/156 (58%), Gaps = 5/156 (3%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMG 572
+F +E ++G+ H N++RL G + +++ EYM NG+L L + + + + + +G
Sbjct: 52 DFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG 111
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK--PDQTRTFT 630
+ R IA G+ YL D +H D+ +NIL++ N K+SDFGL+++++ P+ T T +
Sbjct: 112 MLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTS 168
Query: 631 GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
G + + APE T +DV+SFG+V+ E++
Sbjct: 169 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 55/175 (31%), Positives = 92/175 (52%), Gaps = 21/175 (12%)
Query: 506 RGSSGERE-----FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL-- 558
R +S E+E + E++++ R +H +++R+LG + E S L E+M+ GS++ +L
Sbjct: 37 RNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK 96
Query: 559 FNPEKQPNWVERMGIA--RDIARGILYLHDECETQIIHCDIKPQNILMDEN-RCAKISDF 615
+ K E + I + RG+ YLH+ QIIH D+K N+L+D + +I+DF
Sbjct: 97 YGAFK-----EAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADF 148
Query: 616 GLAKLMKPDQTRT--FTG-IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
G A + T F G + GT ++APE R DV+S G V++E+
Sbjct: 149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-19
Identities = 58/181 (32%), Positives = 98/181 (54%), Gaps = 13/181 (7%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPE--- 562
G+ F E +++ + H LV+L Y++ + I +V EYMS GSL D L + E
Sbjct: 41 GTMSPESFLEEAQIMKKLRHDKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRA 98
Query: 563 -KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM 621
K PN V+ +A +A G+ Y+ IH D++ NIL+ + KI+DFGLA+L+
Sbjct: 99 LKLPNLVD---MAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLI 152
Query: 622 KPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQV 681
+ ++ G + + APE T+K+DV+SFG++L E++ + R P + + +V
Sbjct: 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV 212
Query: 682 I 682
+
Sbjct: 213 L 213
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 49/159 (30%), Positives = 89/159 (55%), Gaps = 7/159 (4%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERM 571
R+F +E ++G+ H N++ L G + +++ E+M NG+L L + Q ++ +
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLV 109
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFT 630
G+ R IA G+ YL E +H D+ +NIL++ N K+SDFGL++ ++ D + T+T
Sbjct: 110 GMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 166
Query: 631 GIRGTR---GYVAPEWHRNLPITVKADVYSFGVVLLEII 666
G + + APE T +DV+S+G+V+ E++
Sbjct: 167 SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 59/239 (24%), Positives = 111/239 (46%), Gaps = 23/239 (9%)
Query: 501 KEEVGRGSSGEREFQ-TEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF 559
+ ++G S ERE E++++ +H N++ L+ +K +V EY G L+ +
Sbjct: 32 EVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAIS 91
Query: 560 NPEKQPNWVERMGIAR---DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFG 616
+K+ + I R + RG+ LH++ +I+H D+K NIL+ N KI D G
Sbjct: 92 KRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLG 148
Query: 617 LAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNL 676
++K++K + +T GT Y+APE + P + K+D++S G +L E+
Sbjct: 149 ISKVLKKNMAKTQI---GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA------P 199
Query: 677 PDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
P + +++ + + G + D + + +P LRP+ K+L
Sbjct: 200 PFEARSMQD-LRYKVQRGKYPPIPPIYSQD------LQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 16/221 (7%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERM--GIA 574
E+ ++ + + +V G + EYM GSL IL + + ER+ IA
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIP--ERILGKIA 106
Query: 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRG 634
+ +G+ YLH++ +IIH D+KP NIL++ K+ DFG++ + +TF G
Sbjct: 107 VAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---G 161
Query: 635 TRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENG 694
T Y+APE + +VK+D++S G+ L+E+ R P I E + Q N
Sbjct: 162 TSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE--LLQYIVNE 219
Query: 695 NLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+L + + + + C++ +P RPS K++L
Sbjct: 220 PPPRLPSGKF--SPDFQDFVNL---CLIKDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 66/233 (28%), Positives = 105/233 (45%), Gaps = 32/233 (13%)
Query: 516 TEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP--EKQPNWVERM- 571
+E+ +I H N+VR LE + +V + + L + FN EK+ + E
Sbjct: 57 SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERI 115
Query: 572 -GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
I + + YLH E +I+H D+ P NI++ E+ I+DFGLAK +P+ T
Sbjct: 116 WNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLT 171
Query: 631 GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDP-----NLPDDQVILEE 685
+ GT Y PE +N P KADV++FG +L ++ L P N+ + E
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMC----TLQPPFYSTNMLSLATKIVE 227
Query: 686 WVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738
VY+ G S+ V D +I C+ + RP + +V M+
Sbjct: 228 AVYEPLPEGMYSEDVTD----------VIT---SCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 7/167 (4%)
Query: 501 KEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN 560
+EE ++ +E E V+ H ++VRLLG L S+ L+ + M G L D + N
Sbjct: 45 REETSPKAN--KEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRN 101
Query: 561 PEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620
+ + IA+G+ YL E +++H D+ +N+L+ + KI+DFGLAKL
Sbjct: 102 HKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158
Query: 621 MKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
+ D+ G + ++A E + T K+DV+S+GV + E++
Sbjct: 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 65/229 (28%), Positives = 112/229 (48%), Gaps = 25/229 (10%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL--FNPEKQPNWVE 569
++ + E+ ++ + H N+V+ LG E + E + GSLA +L + +P V
Sbjct: 47 KQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP--VI 104
Query: 570 RMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK-LMKPDQTRT 628
R+ R I G+ YLHD +H DIK NIL+D N K++DFG+AK +++ ++
Sbjct: 105 RL-YTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160
Query: 629 FTGIRGTRGYVAPE-WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWV 687
F +G+ ++APE + + AD++S G +LE+ P Q+ E V
Sbjct: 161 F---KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMA------TGKPPWSQL---EGV 208
Query: 688 YQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736
F+ G +L + + + I L C+ +PSLRP+ ++L
Sbjct: 209 AAVFKIGRSKELPPIPDHLSDEAKDFI---LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-17
Identities = 86/357 (24%), Positives = 149/357 (41%), Gaps = 46/357 (12%)
Query: 415 DATSSSPQAPFSVEGNKKELWKDIVIICLFVAVVILISAVTFG-IFIYRYHVGSYRRIP- 472
D TS P P W I C A ++L + V FG +FI + +R+
Sbjct: 611 DTTSGLP--PCKRVRKTPSWW--FYITCTLGAFLVL-ALVAFGFVFIRGRNNLELKRVEN 665
Query: 473 --GNGSARYCEDIAPLSF-------SYAELEKMTDGFKEEVGRGSSGEREFQTEMKVI-- 521
G ++ + S S E ++ G K +G S + Q +K I
Sbjct: 666 EDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIND 725
Query: 522 ------------GRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVE 569
G+ H N+V+L+G L++EY+ +L+++L N +W
Sbjct: 726 VNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNL----SWER 781
Query: 570 RMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
R IA IA+ + +LH C ++ ++ P+ I++D + L L+ D
Sbjct: 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI 840
Query: 630 TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQ 689
+ YVAPE IT K+D+Y FG++L+E++ + D I+ EW
Sbjct: 841 SS-----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV-EWARY 894
Query: 690 CFENGNLSQLVE-----DEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741
C+ + +L ++ D V++ ++ ++ +AL C +P+ RP VL LE
Sbjct: 895 CYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 68/261 (26%), Positives = 112/261 (42%), Gaps = 48/261 (18%)
Query: 501 KEEVGRGSSGER-EFQTE---MKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD 556
K S ER EF E MK HH +VRLLG ++V E M+ G L
Sbjct: 42 KTVNENASMRERIEFLNEASVMKEF-NCHH--VVRLLGVVSTGQPTLVVMELMAKGDLKS 98
Query: 557 IL---------FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN 607
L P + + +A +IA G+ YL + +H D+ +N ++ E+
Sbjct: 99 YLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAED 155
Query: 608 RCAKISDFGLAKLM-KPDQTRTFTGIRGTRG-----YVAPEWHRNLPITVKADVYSFGVV 661
KI DFG+ + + + D R +G +G ++APE ++ T K+DV+SFGVV
Sbjct: 156 LTVKIGDFGMTRDIYETDYYR-----KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVV 210
Query: 662 LLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQL---ERMIKVAL 718
L E+ L E YQ N + + V D + ++++++
Sbjct: 211 LWEM---------------ATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMR 255
Query: 719 WCILDEPSLRPSMKKVLLMLE 739
C P +RP+ +++ L+
Sbjct: 256 MCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 55/171 (32%), Positives = 85/171 (49%), Gaps = 9/171 (5%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERM- 571
F E V+ + H NLV+LLG +E + +V EYM+ GSL D L + + + +
Sbjct: 46 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 105
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG 631
+ D+ + YL +H D+ +N+L+ E+ AK+SDFGL K Q
Sbjct: 106 KFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 162
Query: 632 IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
++ T APE R + K+DV+SFG++L EI R P +P V+
Sbjct: 163 VKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 51/239 (21%), Positives = 101/239 (42%), Gaps = 32/239 (13%)
Query: 508 SSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNW 567
R+ E+ ++ H N++ + ++ + ++ EY + G+L D + +K +
Sbjct: 40 EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLF 98
Query: 568 VERMGIAR--DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ 625
E M + I + Y+H + I+H DIK NI + + K+ DFG++K++ +
Sbjct: 99 EEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155
Query: 626 TRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEE 685
+ T + GT Y++PE + + K+D+++ G VL E++ +R
Sbjct: 156 SMAETVV-GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR--------------- 199
Query: 686 WVYQCFENGNLSQLV------EDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738
F+ N LV V +I + + +P RP+ +VL
Sbjct: 200 ----TFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 4e-17
Identities = 36/113 (31%), Positives = 57/113 (50%), Gaps = 5/113 (4%)
Query: 43 GNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFN 102
+ S + L+ GF+ + + Y + +TVVW ANRD+P VS + TL
Sbjct: 6 SGQTLVSGNSLFELGFF--TLIMQNDYNLILYKSSS-RTVVWVANRDNP-VSDSCTLTLQ 61
Query: 103 SEGSIVL-RSSQQSQDSLIADDSQSASSASMLDSGNFVLYDSNGKTLWQTFEH 154
S+G++VL + S + +LD GN V+YDS+G LWQ+F++
Sbjct: 62 SDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 47/151 (31%), Positives = 80/151 (52%), Gaps = 14/151 (9%)
Query: 525 HHRNLVRLLGYSLEVSKKIL--VYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGIL 582
H N+VR ++ S + L V EY G LA ++ +K+ ++E I R + + +L
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 583 YLHDEC------ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ--TRTFTGIRG 634
L+ EC ++H D+KP NI +D N K+ DFGLAK++ D +T+ G
Sbjct: 117 ALY-ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV---G 172
Query: 635 TRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
T Y++PE ++ K+D++S G ++ E+
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 5e-17
Identities = 37/110 (33%), Positives = 58/110 (52%), Gaps = 8/110 (7%)
Query: 49 SPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIV 108
S L+ GF+ R Y + G +TVVW ANRD+P ++ TL S+G++V
Sbjct: 12 SSGSLFELGFFKLIM-QSRDYNLILYKGSS-RTVVWVANRDNP-SGSSCTLTLQSDGNLV 68
Query: 109 LRSSQQSQDSLIADDSQSASS---ASMLDSGNFVLYDSNGKTLWQTFEHP 155
+ S + + ++ + +LD GN VLYDS+G LWQ+F++P
Sbjct: 69 I--YDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 5e-17
Identities = 51/166 (30%), Positives = 90/166 (54%), Gaps = 8/166 (4%)
Query: 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPN-WVERMGI 573
Q E +V+ H N++ LE ++V EY G+LA+ + +K+ N ++ I
Sbjct: 47 QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI---QKRCNSLLDEDTI 103
Query: 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENR-CAKISDFGLAKLMKPDQTRTFTGI 632
+ +L LH I+H D+K QNIL+D+++ KI DFG++K++ +++ +T +
Sbjct: 104 LHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVV 162
Query: 633 RGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLD-PNLP 677
GT Y++PE P K+D+++ G VL E+ +R + NLP
Sbjct: 163 -GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 59/192 (30%), Positives = 90/192 (46%), Gaps = 31/192 (16%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWV-- 568
E +F E ++ + +H+N+VRL+G S E + ++ E M+ G L L E +P
Sbjct: 53 ESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFL--RENRPRPERP 110
Query: 569 ------ERMGIARDIARGILYLHDECETQIIHCDIKPQNILMD---ENRCAKISDFGLAK 619
+ + ARD+A+G YL E IH DI +N L+ R AKI+DFG+A+
Sbjct: 111 SSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
Query: 620 LMKPDQTRTFTGIRGTRGYVAPEWHRNLP--------ITVKADVYSFGVVLLEIICRRRC 671
D R +G R + +W +P T K DV+SFGV+L EI
Sbjct: 168 ----DIYRASYYRKGGRAMLPIKW---MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYM 220
Query: 672 LDPNLPDDQVIL 683
P + +V+
Sbjct: 221 PYPGRTNQEVME 232
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 9e-17
Identities = 56/181 (30%), Positives = 95/181 (52%), Gaps = 13/181 (7%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPE--- 562
G+ F E +++ + H LV L Y++ + I +V E+M GSL D L +
Sbjct: 41 GTMMPEAFLQEAQIMKKLRHDKLVPL--YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKY 98
Query: 563 -KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM 621
K P V+ +A IA G+ Y+ IH D++ NIL+ +N KI+DFGLA+L+
Sbjct: 99 LKLPQLVD---MAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLI 152
Query: 622 KPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQV 681
+ ++ G + + APE T+K+DV+SFG++L E++ + R P + + +V
Sbjct: 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV 212
Query: 682 I 682
+
Sbjct: 213 L 213
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 9e-17
Identities = 57/181 (31%), Positives = 95/181 (52%), Gaps = 13/181 (7%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPE--- 562
G+ F E +V+ + H LV+L Y++ + I +V EYMS GSL D L
Sbjct: 41 GTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKY 98
Query: 563 -KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM 621
+ P V+ +A IA G+ Y+ +H D++ NIL+ EN K++DFGLA+L+
Sbjct: 99 LRLPQLVD---MAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 152
Query: 622 KPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQV 681
+ ++ G + + APE T+K+DV+SFG++L E+ + R P + + +V
Sbjct: 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 212
Query: 682 I 682
+
Sbjct: 213 L 213
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 37/235 (15%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL-------FNPEKQPNWVE 569
E++ + + +H N+V+ + + LV Y+S GSL DI+ E
Sbjct: 49 EVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI----- 103
Query: 570 RMGIA---RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL-AKLMKP-- 623
IA +++ +G+ YLH IH DIK NIL+ E+ KI+DFG+ A L
Sbjct: 104 ---IATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157
Query: 624 DQTRTFTGIRGTRGYVAPE-WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
+ GT ++APE + KAD++SFG+ +E+ P +V+
Sbjct: 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA-TGAAPYSKYPPMKVL 216
Query: 683 LEEWVYQCFENGNLSQLVEDEEVDE--KQLERMIKVALWCILDEPSLRPSMKKVL 735
+ + L + + K +MI + C+ +PS RP+ +++L
Sbjct: 217 MLTL------QNDPPSLETGADYKKYSKSFRKMISL---CLQKDPSKRPTAEELL 262
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 4/177 (2%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPN 566
G+ + F E ++ H LVRL + ++ EYM+ GSL D L + E
Sbjct: 41 GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKV 100
Query: 567 WVERM-GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ 625
+ ++ + IA G+ Y+ IH D++ N+L+ E+ KI+DFGLA++++ ++
Sbjct: 101 LLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157
Query: 626 TRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
G + + APE T+K+DV+SFG++L EI+ + P + + V+
Sbjct: 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM 214
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-16
Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 21/170 (12%)
Query: 510 GERE---FQTEMKVIGRTHHRNLVRLLGYSLEVSKKIL--VYEYMSNGSLADILFNPEKQ 564
E + F+ E + R +H N+V LL S E +L V+EY+ +L ++L
Sbjct: 18 EEHQRARFRRETALCARLYHPNIVALLD-SGEAPPGLLFAVFEYVPGRTLREVLAADGAL 76
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKISDFGLAKLM 621
P E + + + H++ I+H D+KPQNI++ AK+ DFG+ L+
Sbjct: 77 PA-GETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL 132
Query: 622 KPD------QTRTFTG-IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664
P T T T + GT Y APE R P+T +D+Y++G++ LE
Sbjct: 133 -PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 46/173 (26%), Positives = 85/173 (49%), Gaps = 10/173 (5%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERM 571
R+F E +++ + H N+V+L+G ++ +V E + GSL L + + + +
Sbjct: 37 RKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL 96
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG 631
++ D A G+ YL + IH D+ +N L+ EN KISDFG++ + ++ +T
Sbjct: 97 QMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMS---REEEGGIYTV 150
Query: 632 IRGTR----GYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQ 680
G + + APE T ++DV+S+G++L E P + + Q
Sbjct: 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ 203
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 4e-16
Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL--FNPEKQPNWVERMGIA 574
E+ ++ H N+V+LL K LV+EY L L PN ++ I
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IM 104
Query: 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRG 634
+ RG+ Y H +I+H D+KPQNIL++ + K++DFGLA+ RT+T
Sbjct: 105 YQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVV 160
Query: 635 TRGYVAPE-----WHRNLPITVKADVYSFGVVLLEIICRR 669
T Y APE H + + D++S G + E+I +
Sbjct: 161 TLWYRAPEILLGSKHYSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 64/236 (27%), Positives = 116/236 (49%), Gaps = 21/236 (8%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPE--K 563
GS F E V+ H LV+L +++ + I ++ E+M+ GSL D L + E K
Sbjct: 41 GSMSVEAFLAEANVMKTLQHDKLVKL--HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSK 98
Query: 564 QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623
QP + + + IA G+ ++ + IH D++ NIL+ + KI+DFGLA++++
Sbjct: 99 QP-LPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154
Query: 624 DQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVIL 683
++ G + + APE T+K+DV+SFG++L+EI+ R P + + +VI
Sbjct: 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI- 213
Query: 684 EEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
+ E G E+ E + + + C + P RP+ + + +L+
Sbjct: 214 -----RALERGYRMPRPENCP------EELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 52/157 (33%), Positives = 85/157 (54%), Gaps = 9/157 (5%)
Query: 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIA 574
E+ ++ H N+V+ LG SL+ + EY+ GS+A +L N + R
Sbjct: 54 AREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFV 112
Query: 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG--- 631
R I +G+ YLH+ IIH DIK NIL+D KISDFG++K ++ + T T
Sbjct: 113 RQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR 169
Query: 632 --IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
++G+ ++APE + T KAD++S G +++E++
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 23/160 (14%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E+KV+ + H N+V L + LV+EY+ +L ++L E P + +
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELL---EASPGGLPPDAVRSY 105
Query: 577 I---ARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIR 633
I + I Y H IIH DIKP+NIL+ E+ K+ DFG A+ ++ T
Sbjct: 106 IWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV 162
Query: 634 GTRGYVAPEWHRNLPITVK-------ADVYSFGVVLLEII 666
TR Y APE + V DV++ G ++ E++
Sbjct: 163 ATRWYRAPE------LLVGDTNYGKPVDVWAIGCIMAELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 9e-16
Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 29/166 (17%)
Query: 524 THHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMG--IARDIARG 580
H +++L Y+ + + + V EY NG L + K + E+ A +I
Sbjct: 59 NGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLA 114
Query: 581 ILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ--------------- 625
+ YLH + IIH D+KP+NIL+D++ KI+DFG AK++ P+
Sbjct: 115 LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 626 ----TRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
R F GT YV+PE P +D+++ G ++ +++
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 51/183 (27%), Positives = 77/183 (42%), Gaps = 41/183 (22%)
Query: 509 SGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF--------- 559
++F+ E +++ H N+V+ G E I+V+EYM +G L L
Sbjct: 50 DARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFL 109
Query: 560 ----NPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDF 615
+P + + + IA IA G++YL + +H D+ +N L+ + KI DF
Sbjct: 110 KSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDF 166
Query: 616 GLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-------------TVKADVYSFGVVL 662
G M D T Y H LPI T ++DV+SFGVVL
Sbjct: 167 G----MSRDVYTT--------DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVL 214
Query: 663 LEI 665
EI
Sbjct: 215 WEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 53/165 (32%), Positives = 86/165 (52%), Gaps = 21/165 (12%)
Query: 518 MKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL---------------FNPE 562
MK+IG+ H+N++ LLG + +V EY ++G+L D L PE
Sbjct: 69 MKMIGK--HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 563 KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK-LM 621
+ + + A +ARG+ +L + + IH D+ +N+L+ E+ KI+DFGLA+ +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183
Query: 622 KPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
D R T R ++APE + T ++DV+SFGV+L EI
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 70/279 (25%), Positives = 123/279 (44%), Gaps = 46/279 (16%)
Query: 480 CEDIAPLSFSYAELEKMTDGFKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEV 539
C ++ P E +K+ K + ++F E +++ H ++V+ G +E
Sbjct: 26 CYNLCP------EQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79
Query: 540 SKKILVYEYMSNGSLADILF------------NPEKQPNWVERMGIARDIARGILYLHDE 587
I+V+EYM +G L L N + + + IA+ IA G++YL +
Sbjct: 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ 139
Query: 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAK-LMKPDQTR----TFTGIRGTRGYVAPE 642
+H D+ +N L+ EN KI DFG+++ + D R T IR ++ PE
Sbjct: 140 ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR----WMPPE 192
Query: 643 WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVED 702
T ++DV+S GVVL EI + L +++VI +C G + Q
Sbjct: 193 SIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI------ECITQGRVLQRPRT 246
Query: 703 --EEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
+EV + + L C EP +R ++K++ +L+
Sbjct: 247 CPKEVYD--------LMLGCWQREPHMRLNIKEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 50/141 (35%), Positives = 69/141 (48%), Gaps = 12/141 (8%)
Query: 535 YSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQII 593
YS + K + LV EY+ G LA +L N V R+ IA +I + YLH II
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLH---SNGII 115
Query: 594 HCDIKPQNILMDENRCAKISDFGLAK-------LMKPDQTRTFTGIRGTRGYVAPEWHRN 646
H D+KP NIL+D N K++DFGL+K + D + I GT Y+APE
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 647 LPITVKADVYSFGVVLLEIIC 667
+ D +S G +L E +
Sbjct: 176 QGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 52/162 (32%), Positives = 78/162 (48%), Gaps = 9/162 (5%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP---NWVERMGI 573
E +V+ + ++R L+ K +V EY NG L +L +P + V R I
Sbjct: 49 EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI 108
Query: 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIR 633
I G+ +LH + +I+H DIK N+ +D KI D G+AKL+ T I
Sbjct: 109 --QILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIV 162
Query: 634 GTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPN 675
GT Y++PE + P K+DV++ GVVL E + D N
Sbjct: 163 GTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 50/157 (31%), Positives = 83/157 (52%), Gaps = 9/157 (5%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFN-PEKQPNWVERMGI- 573
E +++ + H R +V L Y+ + + LV M+ G L ++N E+ P + E
Sbjct: 43 EKRILAKVHSRFIVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF 101
Query: 574 -ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGI 632
I G+ +LH + +II+ D+KP+N+L+D + +ISD GLA +K Q++T G
Sbjct: 102 YTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT-KGY 157
Query: 633 RGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669
GT G++APE + D ++ GV L E+I R
Sbjct: 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 64/263 (24%), Positives = 117/263 (44%), Gaps = 47/263 (17%)
Query: 505 GRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL---------- 554
SS R+ +E ++ + +H ++++L G + +L+ EY GSL
Sbjct: 41 NASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKV 100
Query: 555 ------------ADILFNPEKQP-NWVERMGIARDIARGILYLHDECETQIIHCDIKPQN 601
+ L NP+++ + + A I+RG+ YL E +++H D+ +N
Sbjct: 101 GPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARN 157
Query: 602 ILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRG-----YVAPEWHRNLPITVKADVY 656
+L+ E R KISDFGL++ + + + ++ ++G ++A E + T ++DV+
Sbjct: 158 VLVAEGRKMKISDFGLSRDVYEEDSY----VKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213
Query: 657 SFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKV 716
SFGV+L EI+ P + +++ NL + E E E M +
Sbjct: 214 SFGVLLWEIVTLGGNPYPGIAPERLF------------NLLKTGYRMERPENCSEEMYNL 261
Query: 717 ALWCILDEPSLRPSMKKVLLMLE 739
L C EP RP+ + LE
Sbjct: 262 MLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 63/234 (26%), Positives = 109/234 (46%), Gaps = 21/234 (8%)
Query: 504 VGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEK 563
+G SS ++ E++++ +V G L + + E+M GSL I +
Sbjct: 40 IGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY--KKG 97
Query: 564 QPNWVERMG-IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK 622
P VE +G IA + G+ YL++ +I+H DIKP NIL++ K+ DFG++ +
Sbjct: 98 GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155
Query: 623 PDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCL-DPNLPDDQV 681
TF G T Y++PE + TVK+DV+S G+ ++E+ + N+ DD
Sbjct: 156 NSIADTFVG---TSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ 212
Query: 682 -----ILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS 730
IL+ + Q +L + + L + C+L +P+ RP+
Sbjct: 213 DDPMGILD--LLQQIVQEPPPRLPSSDF--PEDLRDFVDA---CLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-15
Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 12/156 (7%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMG 572
+ Q E+ V+ + + R G L+ +K ++ EY+ GS D+L +P +E
Sbjct: 48 DIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETY 102
Query: 573 IA---RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
IA R+I +G+ YLH E + IH DIK N+L+ E K++DFG+A + Q +
Sbjct: 103 IATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159
Query: 630 TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
T + GT ++APE + KAD++S G+ +E+
Sbjct: 160 TFV-GTPFWMAPEVIKQSAYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 69/257 (26%), Positives = 119/257 (46%), Gaps = 63/257 (24%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKK----ILVYEYMSNGSLADILFNPEKQPNWVERMG 572
E++++ + H NLV L+ EV ++ LV+E++ + L D+ EK PN ++
Sbjct: 50 EIRMLKQLRHENLVNLI----EVFRRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESR 101
Query: 573 IAR---DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK-LMKPDQTRT 628
+ + I RGI + H IIH DIKP+NIL+ ++ K+ DFG A+ L P + T
Sbjct: 102 VRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158
Query: 629 FTGIRGTRGYVAPEWHRNLPITVK-------ADVYSFGVVLLEIICRRRCLDPNLPDDQV 681
YVA W+R + V D+++ G ++ E++ +P P D
Sbjct: 159 --------DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG----EPLFPGDSD 206
Query: 682 ILEEW-VYQCFENGNLSQ----------------LVEDEEVD--EKQLERMIKVAL---- 718
I + + + +C GNL L E +E++ EK+ ++ + L
Sbjct: 207 IDQLYHIIKCL--GNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAK 264
Query: 719 WCILDEPSLRPSMKKVL 735
C+ +P RPS ++L
Sbjct: 265 QCLRIDPDDRPSSSQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 43/201 (21%)
Query: 508 SSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNW 567
+ +F E+K++ R N+ RLLG ++ EYM NG L L + +
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119
Query: 568 VER----------MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL 617
+ + +A IA G+ YL +H D+ +N L+ +N KI+DFG+
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 618 AK-LMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-------------TVKADVYSFGVVLL 663
++ L D R ++G AP LPI T K+DV++FGV L
Sbjct: 177 SRNLYSSDYYR----VQGR----AP-----LPIRWMAWESVLLGKFTTKSDVWAFGVTLW 223
Query: 664 EI--ICRRRCLDPNLPDDQVI 682
EI +CR + + +L D QVI
Sbjct: 224 EILTLCREQPYE-HLTDQQVI 243
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKI----LVYEYMSNGSLADILFNPEKQPNWVERMG 572
E+K++ + H N+VRL + SK +V+EYM + L +L +PE + +
Sbjct: 48 EIKLLQKLRHPNIVRL--KEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKC 104
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGI 632
+ + G+ YLH I+H DIK NIL++ + K++DFGLA+ + +T
Sbjct: 105 YMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR 161
Query: 633 RGTRGYVAPEWHRNLPI-----TVKADVYSFGVVLLEIICRR 669
T Y PE L + + D++S G +L E+ +
Sbjct: 162 VITLWYRPPE----LLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 9/168 (5%)
Query: 505 GRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI--LVYEYMSNGSLADILFNPE 562
G ++ E+ ++ +H N+V+ G E K L+ EY+ GSL D L P+
Sbjct: 44 ECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PK 101
Query: 563 KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK 622
+ N + + A+ I G+ YLH + IH D+ +N+L+D +R KI DFGLAK +
Sbjct: 102 HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158
Query: 623 PDQTRTFTGIRGTRG--YVAPEWHRNLPITVKADVYSFGVVLLEIICR 668
G + A E + + +DV+SFGV L E++
Sbjct: 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTH 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 7/158 (4%)
Query: 509 SGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWV 568
+G++EF E V+ + H +VRL+G +LV E G L L + P
Sbjct: 38 AGKKEFLREASVMAQLDHPCIVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPV-S 95
Query: 569 ERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-- 626
+ +A +A G+ YL +H D+ +N+L+ AKISDFG+++ +
Sbjct: 96 DLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152
Query: 627 RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664
R T R + APE + K+DV+S+GV L E
Sbjct: 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 37/94 (39%), Positives = 47/94 (50%), Gaps = 5/94 (5%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
I + YLH IIH DIKP NIL+DE I+DF +A + PD T GT
Sbjct: 109 IVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTP 163
Query: 637 GYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670
GY+APE +V D +S GV E + +R
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 44/162 (27%), Positives = 80/162 (49%), Gaps = 3/162 (1%)
Query: 504 VGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEK 563
+ G+ E +F E KV+ + H LV+L G + +V E+M NG L + L +
Sbjct: 36 INEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG 95
Query: 564 QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623
+ + + + +D+ G+ YL IH D+ +N L+ K+SDFG+ + +
Sbjct: 96 KLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152
Query: 624 DQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
D+ + +G + + PE + K+DV+SFGV++ E+
Sbjct: 153 DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 56/182 (30%), Positives = 94/182 (51%), Gaps = 25/182 (13%)
Query: 518 MKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL-----------FNPEKQPN 566
MK+IG+ H+N++ LLG + ++ EY S G+L + L +NP + P
Sbjct: 77 MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP- 133
Query: 567 WVERMGI------ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK- 619
E++ A +ARG+ YL + + IH D+ +N+L+ E+ KI+DFGLA+
Sbjct: 134 -EEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARD 189
Query: 620 LMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDD 679
+ D + T R ++APE + T ++DV+SFGV+L EI P +P +
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249
Query: 680 QV 681
++
Sbjct: 250 EL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 3e-14
Identities = 48/151 (31%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E +++ H LV L G + S LV EY+ G L L + P V R A
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA-Q 109
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
+ + YLH I++ D+KP+N+L+D + KI+DFG AK +K RT+T + GT
Sbjct: 110 VVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK---GRTYT-LCGTP 162
Query: 637 GYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
Y+APE + D ++ G+++ E++
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 43/197 (21%)
Query: 502 EEVGRGSSGE---------------------------REFQTEMKVIGRTHHRNLVRLLG 534
E +G+GS GE + Q E++ + + + + G
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG 66
Query: 535 YSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIA---RDIARGILYLHDECETQ 591
L+ SK ++ EY GS D+L +P ++ IA R++ G+ YLH+E
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEE---G 118
Query: 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR--TFTGIRGTRGYVAPEWHRNLPI 649
IH DIK NIL+ E K++DFG++ + ++ TF GT ++APE +
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV---GTPFWMAPEVIKQSGY 175
Query: 650 TVKADVYSFGVVLLEII 666
KAD++S G+ +E+
Sbjct: 176 DEKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 64/239 (26%), Positives = 107/239 (44%), Gaps = 39/239 (16%)
Query: 493 LEKMTDGFKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSL-EVSKKILVYEYMSN 551
L ++TD EEV +F E ++ H N++ LLG L ++V YM +
Sbjct: 31 LNRITD--LEEV-------EQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81
Query: 552 GSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 611
G L + + + P + +G +A+G+ YL + +H D+ +N ++DE+ K
Sbjct: 82 GDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVK 138
Query: 612 ISDFGLAKLM---KPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668
++DFGLA+ + + TG + ++A E + T K+DV+SFGV+L E++ R
Sbjct: 139 VADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 198
Query: 669 --------------------RRCLDPNL-PDD--QVILEEWVYQCFENGNLSQLVEDEE 704
RR L P PD +V+L W + S+LV E
Sbjct: 199 GAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 54/180 (30%), Positives = 92/180 (51%), Gaps = 21/180 (11%)
Query: 518 MKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLA---------------DILFNPE 562
MK+IG+ H+N++ LLG + ++ EY S G+L DI P+
Sbjct: 74 MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD 131
Query: 563 KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK-LM 621
+Q + + + +ARG+ YL + + IH D+ +N+L+ EN KI+DFGLA+ +
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVN 188
Query: 622 KPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQV 681
D + T R ++APE + T ++DV+SFGV++ EI P +P +++
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 25/177 (14%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLG--YSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVE 569
R+F+ E++++ H N+V+ G YS LV EY+ GSL D L ++ + +
Sbjct: 50 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRK 109
Query: 570 RMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM-------- 621
+ A I +G+ YL + +H D+ +NIL++ KI DFGL K++
Sbjct: 110 LLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYK 166
Query: 622 --KPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII--CRRRCLDP 674
+P ++ F + APE +V +DV+SFGVVL E+ + C P
Sbjct: 167 VREPGESPIF--------WYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPP 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 4/122 (3%)
Query: 544 LVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNIL 603
+V EY GS++DI+ K E I +G+ YLH + IH DIK NIL
Sbjct: 75 IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNIL 131
Query: 604 MDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663
++E AK++DFG++ + + T I GT ++APE + + KAD++S G+ +
Sbjct: 132 LNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNNKADIWSLGITAI 190
Query: 664 EI 665
E+
Sbjct: 191 EM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 10/159 (6%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGY-SLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWV 568
+ +E +++ +H +V+L Y + + K I ++ EY G L IL + +
Sbjct: 37 QEHIFSEKEILEECNHPFIVKL--YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYT 94
Query: 569 ERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT 628
R IA + YLH+ II+ D+KP+N+L+D N K+ DFG AK +K Q +T
Sbjct: 95 ARFYIAC-VVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KT 149
Query: 629 FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
+T GT YVAPE N D +S G++L E++
Sbjct: 150 WTFC-GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLT 187
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 18/159 (11%)
Query: 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-------ILFNPEKQPNW 567
+ E+ ++ + H N+V E + +V EY G L +LF+ ++ +W
Sbjct: 47 KKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW 106
Query: 568 VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN-RCAKISDFGLAKLMKPDQT 626
+ I+ G+ ++HD +I+H DIK QNI + +N AK+ DFG+A+ +
Sbjct: 107 FVQ------ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157
Query: 627 RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
+T + GT Y++PE +N P K D++S G VL E+
Sbjct: 158 LAYTCV-GTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 18/155 (11%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGIAR 575
E+K++ H N++ L + + I V E + L +L + + +++
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYF--LY 115
Query: 576 DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGT 635
I RG+ Y+H ++H D+KP NIL++EN KI DFGLA++ P TG T
Sbjct: 116 QILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----MTGYVST 168
Query: 636 RGYVAPE----WHRNLPITVKADVYSFGVVLLEII 666
R Y APE W + V+ D++S G + E++
Sbjct: 169 RYYRAPEIMLTWQK---YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 14/171 (8%)
Query: 507 GSSGERE-FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP 565
S E E F E+ ++ H N+V L +K ++ E+ G+L I+ E+
Sbjct: 41 ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGL 100
Query: 566 NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL-AKLMKPD 624
+ + R + + +LH ++IH D+K NIL+ + K++DFG+ AK
Sbjct: 101 TEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157
Query: 625 QTR-TFTGIRGTRGYVAP-----EWHRNLPITVKADVYSFGVVLLEIICRR 669
Q R TF GT ++AP E ++ P KAD++S G+ L+E+
Sbjct: 158 QKRDTFI---GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 40/120 (33%), Positives = 70/120 (58%), Gaps = 8/120 (6%)
Query: 547 EYMSNGSLADILFNPEKQP-NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMD 605
E+M GSL +L + P N + ++ IA + RG+ YL ++ +I+H D+KP NIL++
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILGKISIA--VLRGLTYLREK--HKIMHRDVKPSNILVN 134
Query: 606 ENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
K+ DFG++ + +F GTR Y++PE + TV++D++S G+ L+E+
Sbjct: 135 SRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-14
Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 41/234 (17%)
Query: 526 HRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL------FNPEKQPNWVERMGIARDIAR 579
H N+++ LG +E +LV E+ G L + L Q + ++RM A ++A
Sbjct: 54 HPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVAS 111
Query: 580 GILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD-----QTRTFTGIRG 634
G+L+LH + IH D+ +N + + KI D+GLA P+ + +R
Sbjct: 112 GLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRW 168
Query: 635 TRGYVAPEWHRNL---PITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCF 691
+ ++L T K++++S GV + E+ P+L D+QV
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV---------- 218
Query: 692 ENGNLSQLVEDEEV--DEKQL-----ERMIKVALWCILDEPSLRPSMKKVLLML 738
L Q+V ++++ + QL +R +V +C LD P RP+ ++V +L
Sbjct: 219 ----LKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 19/169 (11%)
Query: 511 EREFQTEMKVIGR-THHRNLVRLLGYSLEVSKKI------LVYEYMSNGSLADILFNPEK 563
E E + E ++ + ++H N+ G ++ + LV E GS+ D++ K
Sbjct: 46 EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRK 105
Query: 564 QPNWVERMGIA---RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620
+ ++ IA R+ RG+ YLH+ ++IH DIK QNIL+ +N K+ DFG++
Sbjct: 106 KGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162
Query: 621 MKPDQTRTFTGIRGTRGYVAPE-----WHRNLPITVKADVYSFGVVLLE 664
+ R T I GT ++APE + ++DV+S G+ +E
Sbjct: 163 LDSTLGRRNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 25/179 (13%)
Query: 506 RGSSGE--REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEK 563
+G++ + +EF E ++ +H N+V+LLG L + ++ E M G L L +
Sbjct: 36 KGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARV 95
Query: 564 QPNW------VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDE-----NRCAKI 612
+ E + I D+A+G +YL IH D+ +N L+ E +R KI
Sbjct: 96 ERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKI 152
Query: 613 SDFGLAK-LMKPDQTRTFTGIRGTR----GYVAPEWHRNLPITVKADVYSFGVVLLEII 666
DFGLA+ + K D R G ++APE + T ++DV+SFGV++ EI+
Sbjct: 153 GDFGLARDIYKSDYYR----KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 56/180 (31%), Positives = 95/180 (52%), Gaps = 21/180 (11%)
Query: 518 MKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL-----------FN----PE 562
MK+IG+ H+N++ LLG + ++ EY S G+L + L F+ PE
Sbjct: 71 MKMIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPE 128
Query: 563 KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK-LM 621
+Q + + + A +ARG+ YL + + IH D+ +N+L+ E+ KI+DFGLA+ +
Sbjct: 129 EQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185
Query: 622 KPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQV 681
D + T R ++APE + T ++DV+SFGV+L EI P +P +++
Sbjct: 186 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 71/260 (27%), Positives = 117/260 (45%), Gaps = 57/260 (21%)
Query: 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP---EKQPNW 567
R+F E++V+ + HH N++ LLG L EY +G+L D L E P +
Sbjct: 52 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 111
Query: 568 V------------ERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDF 615
+ + A D+ARG+ YL + Q IH D+ +NIL+ EN AKI+DF
Sbjct: 112 AIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADF 168
Query: 616 GLAKLMKPDQTRTFTGIRGTRGYVAPEWHR----NLPI-TVKADVYSFGVVLLEII---- 666
GL++ + ++ T G + W N + T +DV+S+GV+L EI+
Sbjct: 169 GLSRGQE-------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 221
Query: 667 ---CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILD 723
C C + L E + Q + +L + D++ + M + C +
Sbjct: 222 TPYCGMTCAE---------LYEKLPQGY------RLEKPLNCDDEVYDLMRQ----CWRE 262
Query: 724 EPSLRPSMKKVLLMLEGTVE 743
+P RPS ++L+ L +E
Sbjct: 263 KPYERPSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMG 572
+ Q E+ V+ + + + G L+ +K ++ EY+ GS D+L +P ++
Sbjct: 48 DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQ 102
Query: 573 IA---RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
IA R+I +G+ YLH E + IH DIK N+L+ E+ K++DFG+A + Q +
Sbjct: 103 IATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR- 158
Query: 630 TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQ 689
GT ++APE + KAD++S G+ +E L P + V
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE-------LAKGEPPHSELHPMKVLF 211
Query: 690 CFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
N L E K L+ ++ C+ EPS RP+ K++L
Sbjct: 212 LIPKNNPPTL---EGNYSKPLKEFVEA---CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 50/163 (30%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWV 568
GE+ E K++ + R +V L Y+ E + LV M+ G L ++N +P +
Sbjct: 36 GEQMALNEKKILEKVSSRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYN-VGEPGFP 93
Query: 569 ERMGI--ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626
E I A I G+ +LH +I++ D+KP+N+L+D++ +ISD GLA +
Sbjct: 94 EARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGK 149
Query: 627 RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669
+ G GT GY+APE + D ++ G L E+I R
Sbjct: 150 KI-KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 27/173 (15%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF--NPEKQPNWVER 570
EF+ E +++ H N+V LLG + +++EY+++G L + L +P
Sbjct: 54 EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 571 MG-------------IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL 617
IA IA G+ YL +H D+ +N L+ E KISDFGL
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGL 170
Query: 618 AKLMKPD-----QTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
++ + Q+++ +R ++ PE T ++D++SFGVVL EI
Sbjct: 171 SRDIYSADYYRVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 32/205 (15%)
Query: 480 CEDIAPLSFSYAELEKMTDGFKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEV 539
C ++ P E +KM K S ++FQ E +++ H+++VR G E
Sbjct: 26 CHNLLP------EQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79
Query: 540 SKKILVYEYMSNGSL----------ADILFNPEKQP----NWVERMGIARDIARGILYLH 585
++V+EYM +G L A IL E + + IA IA G++YL
Sbjct: 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL- 138
Query: 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAK-LMKPDQ----TRTFTGIRGTRGYVA 640
+H D+ +N L+ + KI DFG+++ + D RT IR ++
Sbjct: 139 --ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR----WMP 192
Query: 641 PEWHRNLPITVKADVYSFGVVLLEI 665
PE T ++D++SFGVVL EI
Sbjct: 193 PESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 50/164 (30%), Positives = 87/164 (53%), Gaps = 21/164 (12%)
Query: 518 MKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLA---------------DILFNPE 562
MK+IG+ H+N++ LLG + ++ EY + G+L DI PE
Sbjct: 71 MKLIGK--HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 563 KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK-LM 621
+Q ++ + + A +ARG+ YL + IH D+ +N+L+ E+ KI+DFGLA+ +
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185
Query: 622 KPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
D + + R ++APE + T ++DV+SFG+++ EI
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 45/162 (27%), Positives = 79/162 (48%), Gaps = 17/162 (10%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E++ + H N+V+ LG+ + EY+ GS+ L + + R
Sbjct: 58 EIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF-FTEQ 116
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK----LMKPDQTRTFTGI 632
+ G+ YLH + I+H D+K N+L+D + KISDFG++K + DQ +
Sbjct: 117 VLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN---MSM 170
Query: 633 RGTRGYVAPE----WHRNLPITVKADVYSFGVVLLEIICRRR 670
+G+ ++APE + + + K D++S G V+LE+ RR
Sbjct: 171 QGSVFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-13
Identities = 59/174 (33%), Positives = 82/174 (47%), Gaps = 26/174 (14%)
Query: 581 ILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL----MKPDQTRTFTGIRGTR 636
+L +H +IH DIK NIL+ N K+ DFG +K+ + D RTF G T
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG---TP 209
Query: 637 GYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNL 696
YVAPE R P + KAD++S GV+L E++ +R P D +EE +++ G
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR------PFDGENMEEVMHKTLA-GRY 262
Query: 697 SQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL------LMLEGTVEI 744
L E Q I AL +P RPS K+L L + G +EI
Sbjct: 263 DPL-PPSISPEMQ---EIVTALLS--SDPKRRPSSSKLLNMPICKLFISGLLEI 310
|
Length = 496 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 35/182 (19%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL--FNPEKQP--- 565
+ +FQ E ++ H N+V+LLG L++EYM+ G L + L +P Q
Sbjct: 52 QADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLS 111
Query: 566 ----------------NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC 609
+ E++ IA+ +A G+ YL E + +H D+ +N L+ EN
Sbjct: 112 HSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMV 168
Query: 610 AKISDFGLAKLM------KPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663
KI+DFGL++ + K + IR ++ PE T ++DV+++GVVL
Sbjct: 169 VKIADFGLSRNIYSADYYKASEN-DAIPIR----WMPPESIFYNRYTTESDVWAYGVVLW 223
Query: 664 EI 665
EI
Sbjct: 224 EI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 66/248 (26%), Positives = 114/248 (45%), Gaps = 42/248 (16%)
Query: 511 ER-EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL--FNPEKQ--- 564
ER EF E V+ ++VRLLG + ++V E M++G L L PE +
Sbjct: 52 ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 111
Query: 565 ----PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK- 619
P E + +A +IA G+ YL+ + + +H D+ +N ++ + KI DFG+ +
Sbjct: 112 GRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD 168
Query: 620 LMKPDQTRTFTGIRGTRG-----YVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDP 674
+ + D R +G +G ++APE ++ T +D++SFGVVL EI
Sbjct: 169 IYETDYYR-----KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------- 216
Query: 675 NLPDDQVILEEWVYQCFENGNLSQLVEDE---EVDEKQLERMIKVALWCILDEPSLRPSM 731
L E YQ N + + V D + + ER+ + C P +RP+
Sbjct: 217 --------LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTF 268
Query: 732 KKVLLMLE 739
+++ +L+
Sbjct: 269 LEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 53/177 (29%), Positives = 76/177 (42%), Gaps = 29/177 (16%)
Query: 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKI--------LVYEYMSNGSLADILFNPEKQPN 566
E+K++ + H N+V L+ ++E K +V YM + L+ +L NP +
Sbjct: 55 LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLT 113
Query: 567 WVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLA-------- 618
+ + GI YLH E I+H DIK NIL+D KI+DFGLA
Sbjct: 114 ESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 619 KLMKPDQ--TRTFTGIRGTRGYVAPE----WHRNLPITVKADVYSFGVVLLEIICRR 669
TR +T + TR Y PE R T D++ G V E+ RR
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERR---YTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 6e-13
Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 30/174 (17%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL------ADILFNPEKQPNWVER 570
E+K++ H N++ LL S LV+E+M L I+ P +++
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYM-L 109
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
M RG+ YLH I+H D+KP N+L+ + K++DFGLA+ R T
Sbjct: 110 M-----TLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMT 160
Query: 631 GIRGTRGYVAPEWHRNLPI-----TVKADVYSFGVVLLEIICRRRCLDPNLPDD 679
TR Y APE L V D++S G + E++ R P LP D
Sbjct: 161 HQVVTRWYRAPE----LLFGARHYGVGVDMWSVGCIFAELLLRV----PFLPGD 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 70/260 (26%), Positives = 114/260 (43%), Gaps = 57/260 (21%)
Query: 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP---EKQPNW 567
R+F E++V+ + HH N++ LLG L EY +G+L D L E P +
Sbjct: 40 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 99
Query: 568 VERMG------------IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDF 615
A D+ARG+ YL + Q IH D+ +NIL+ EN AKI+DF
Sbjct: 100 AIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADF 156
Query: 616 GLAKLMKPDQTRTFTGIRGTRGYVAPEWHR----NLPI-TVKADVYSFGVVLLEII---- 666
GL++ + ++ T G + W N + T +DV+S+GV+L EI+
Sbjct: 157 GLSRGQE-------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 209
Query: 667 ---CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILD 723
C C + +Y+ G +L + D++ + M + C +
Sbjct: 210 TPYCGMTCAE-------------LYEKLPQG--YRLEKPLNCDDEVYDLMRQ----CWRE 250
Query: 724 EPSLRPSMKKVLLMLEGTVE 743
+P RPS ++L+ L +E
Sbjct: 251 KPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 72/268 (26%), Positives = 112/268 (41%), Gaps = 73/268 (27%)
Query: 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP---EKQPNW 567
R+F E++V+ + HH N++ LLG + EY G+L D L E P +
Sbjct: 47 RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAF 106
Query: 568 VERMGIAR------------DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDF 615
+ G A D+A G+ YL ++ Q IH D+ +N+L+ EN +KI+DF
Sbjct: 107 AKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADF 163
Query: 616 GLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-------------TVKADVYSFGVVL 662
GL+ RG YV R LP+ T K+DV+SFGV+L
Sbjct: 164 GLS--------------RGEEVYVKKTMGR-LPVRWMAIESLNYSVYTTKSDVWSFGVLL 208
Query: 663 LEII-------CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIK 715
EI+ C C + L E + Q + ++ + D++ E M +
Sbjct: 209 WEIVSLGGTPYCGMTCAE---------LYEKLPQGY------RMEKPRNCDDEVYELMRQ 253
Query: 716 VALWCILDEPSLRPSMKKVLLMLEGTVE 743
C D P RP ++ + L +E
Sbjct: 254 ----CWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 9e-13
Identities = 46/156 (29%), Positives = 68/156 (43%), Gaps = 7/156 (4%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERM- 571
+F E ++ H NL+RL G L +V E GSL D L + +
Sbjct: 42 DFLKEAAIMHSLDHENLIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLC 100
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK--PDQTRTF 629
A IA G+ YL + IH D+ +NIL+ + KI DFGL + + D
Sbjct: 101 DYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157
Query: 630 TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
++ + APE R + +DV+ FGV L E+
Sbjct: 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 50/161 (31%), Positives = 75/161 (46%), Gaps = 17/161 (10%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN-----PEKQPN 566
Q E+ ++ H N+V G L K +V EY GSL DI E Q
Sbjct: 45 EIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIA 104
Query: 567 WVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626
+V R+ +G+ YLH ET IH DIK NIL+ E+ K++DFG++ +
Sbjct: 105 YV-----CRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156
Query: 627 RTFTGIRGTRGYVAPEW---HRNLPITVKADVYSFGVVLLE 664
+ + I GT ++APE R K D+++ G+ +E
Sbjct: 157 KRKSFI-GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVY-EYMSNGSLADILFNPEKQPNWVERMGIAR 575
E++++ H +V+ G L + + ++ EYM GS+ D L V R R
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK-YTR 111
Query: 576 DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIR-- 633
I G+ YLH I+H DIK NIL D K+ DFG +K ++ + TG++
Sbjct: 112 QILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG-TGMKSV 167
Query: 634 -GTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
GT +++PE KADV+S G ++E++
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 60/230 (26%), Positives = 93/230 (40%), Gaps = 58/230 (25%)
Query: 472 PGNGSARYCEDIAPLSFSYAELEKMTDGFKEEVGRGSSG--------------------- 510
+ SA A S S ELE++ +G G+ G
Sbjct: 57 SSSSSASGSAPSAAKSLS--ELERV-----NRIGSGAGGTVYKVIHRPTGRLYALKVIYG 109
Query: 511 ------EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQ 564
R+ E++++ +H N+V+ + ++ E+M GSL E+
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF 169
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFG----LAKL 620
+AR I GI YLH I+H DIKP N+L++ + KI+DFG LA+
Sbjct: 170 -----LADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221
Query: 621 MKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKA------DVYSFGVVLLE 664
M P + GT Y++PE N + A D++S GV +LE
Sbjct: 222 MDPCNSSV-----GTIAYMSPE-RINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 61/241 (25%), Positives = 110/241 (45%), Gaps = 31/241 (12%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKK------ILVYEYMSNGSLADILF------N 560
EF +E + H N+++L+G E S +++ +M +G L L
Sbjct: 47 EFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGL 106
Query: 561 PEKQPNWVERM-GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLA- 618
PEK P ++ + DIA G+ YL + IH D+ +N ++ E+ ++DFGL+
Sbjct: 107 PEKLP--LQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSK 161
Query: 619 KLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPD 678
K+ D R + ++A E + T K+DV++FGV + EI R + P + +
Sbjct: 162 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN 221
Query: 679 DQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738
+ +Y +GN +L + E+ ++ + M C +P RP+ K+ +L
Sbjct: 222 HE------IYDYLRHGN--RLKQPEDCLDELYDLMYS----CWRADPKDRPTFTKLREVL 269
Query: 739 E 739
E
Sbjct: 270 E 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 45/167 (26%), Positives = 83/167 (49%), Gaps = 16/167 (9%)
Query: 509 SGEREF---QTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL--FNPEK 563
+ E+E+ Q E+ ++ H N+V+ LG L+ + + E++ GS++ IL F P
Sbjct: 41 AAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLP 100
Query: 564 QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM-- 621
+P + + + I G+ YLH+ C ++H DIK N+++ N K+ DFG A+ +
Sbjct: 101 EPVFCK---YTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154
Query: 622 ---KPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
+ + GT ++APE K+D++S G + E+
Sbjct: 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 44/150 (29%), Positives = 79/150 (52%), Gaps = 6/150 (4%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E+ V+ H N+V L L + +V EY++ GSL D++ E + + + R+
Sbjct: 66 EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRE 123
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
+ + +LH Q+IH DIK NIL+ + K++DFG + P+Q++ T + GT
Sbjct: 124 CLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 179
Query: 637 GYVAPEWHRNLPITVKADVYSFGVVLLEII 666
++APE K D++S G++ +E++
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 9/165 (5%)
Query: 505 GRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQ 564
G R F E +G+ H N+VRL G + ++V EYMSNG+L L E Q
Sbjct: 44 GCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ 103
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+ MG+ +A G+ YL E +H + +L++ + KIS F + K +
Sbjct: 104 LVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160
Query: 625 QTRTFTGIRGTRGYVAPE---WHRNLPITVKADVYSFGVVLLEII 666
T + + APE +H +DV+SFG+V+ E++
Sbjct: 161 AIYTTMSGKSPVLWAAPEAIQYHHFSS---ASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 49/163 (30%), Positives = 86/163 (52%), Gaps = 8/163 (4%)
Query: 509 SGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNW 567
SGE+ E +++ + + +V L Y+ E + LV M+ G L ++N ++
Sbjct: 35 SGEKMALLEKEILEKVNSPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLE 93
Query: 568 VER-MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626
+ER + + I GIL+LH I++ D+KP+N+L+D+ ++SD GLA +K
Sbjct: 94 MERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK--DG 148
Query: 627 RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669
+T T GT GY+APE + P + D ++ G + E++ R
Sbjct: 149 KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 51/156 (32%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E++ + + H N + G L LV EY GS +DIL +K VE I
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHG 123
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
+G+ YLH IH DIK NIL+ E K++DFG A L+ P +F GT
Sbjct: 124 ALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN--SFV---GTP 175
Query: 637 GYVAPEWHRNL---PITVKADVYSFGVVLLEIICRR 669
++APE + K DV+S G+ +E+ R+
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 65/250 (26%), Positives = 114/250 (45%), Gaps = 39/250 (15%)
Query: 509 SGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL--------ADILFN 560
+ ++FQ E +++ H ++V+ G + I+V+EYM +G L D +
Sbjct: 49 AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 108
Query: 561 PEKQP-------NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKIS 613
+ QP + + IA IA G++YL + +H D+ +N L+ N KI
Sbjct: 109 VDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIG 165
Query: 614 DFGLAK-LMKPDQTR----TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668
DFG+++ + D R T IR ++ PE T ++DV+SFGV+L EI
Sbjct: 166 DFGMSRDVYSTDYYRVGGHTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTY 221
Query: 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLR 728
+ L + +VI +C G +++E V K++ + L C EP R
Sbjct: 222 GKQPWFQLSNTEVI------ECITQG---RVLERPRVCPKEV---YDIMLGCWQREPQQR 269
Query: 729 PSMKKVLLML 738
++K++ +L
Sbjct: 270 LNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 43/133 (32%), Positives = 75/133 (56%), Gaps = 10/133 (7%)
Query: 547 EYMSNGSLADILFNPEKQPNWVERMG-IARDIARGILYLHDECETQIIHCDIKPQNILMD 605
E+M GSL +L ++ P E +G ++ + RG+ YL ++ QI+H D+KP NIL++
Sbjct: 83 EHMDGGSLDQVLKEAKRIPE--EILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVN 138
Query: 606 ENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
K+ DFG++ + +F GTR Y++PE + +V++D++S G+ L+E+
Sbjct: 139 SRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
Query: 666 ICRRRCLDPNLPD 678
R + P PD
Sbjct: 196 AIGRYPIPP--PD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 4/94 (4%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
I RG+ YLH I+H DIKP N+L++ N KI DFGLA++ +PD+++ T T+
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 637 GYVAPEWHRNLP-ITVKADVYSFGVVLLEIICRR 669
Y APE T D++S G + E++ RR
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 16/159 (10%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN-----PEKQPNWVERM 571
E+K++ +H N+++LL LV+E+M L ++ + PE
Sbjct: 48 EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESL-----IK 101
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG 631
+ +G+ + H I+H D+KP+N+L++ K++DFGLA+ R +T
Sbjct: 102 SYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH 157
Query: 632 IRGTRGYVAPE-WHRNLPITVKADVYSFGVVLLEIICRR 669
TR Y APE + + D++S G + E++ RR
Sbjct: 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 47/149 (31%), Positives = 77/149 (51%), Gaps = 15/149 (10%)
Query: 545 VYEYMSNGSLADILFNPEKQPNWVERMGI--ARDIARGILYLHDECETQIIHCDIKPQNI 602
V EY++ G D++F+ ++ + E A +I G+ +LH E II+ D+K N+
Sbjct: 74 VMEYVNGG---DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNV 127
Query: 603 LMDENRCAKISDFGLAK--LMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGV 660
L+D KI+DFG+ K ++ T TF GT Y+APE P D ++ GV
Sbjct: 128 LLDSEGHIKIADFGMCKEGILGGVTTSTFC---GTPDYIAPEILSYQPYGPAVDWWALGV 184
Query: 661 VLLEIICRRRCLDPNLPDD--QVILEEWV 687
+L E++ + + + D+ Q ILE+ V
Sbjct: 185 LLYEMLAGQSPFEGDDEDELFQSILEDEV 213
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 41/141 (29%), Positives = 65/141 (46%), Gaps = 21/141 (14%)
Query: 544 LVYEYMSNGSLADIL----FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKP 599
LV EY++ G A ++ PE +W ++ ++ G+ LH IIH DIKP
Sbjct: 74 LVMEYLNGGDCASLIKTLGGLPE---DWAKQY--IAEVVLGVEDLHQR---GIIHRDIKP 125
Query: 600 QNILMDENRCAKISDFGLAK--LMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYS 657
+N+L+D+ K++DFGL++ L GT Y+APE + +D +S
Sbjct: 126 ENLLIDQTGHLKLTDFGLSRNGLENKK-------FVGTPDYLAPETILGVGDDKMSDWWS 178
Query: 658 FGVVLLEIICRRRCLDPNLPD 678
G V+ E + PD
Sbjct: 179 LGCVIFEFLFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 45/153 (29%), Positives = 79/153 (51%), Gaps = 6/153 (3%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMG 572
+ Q E+ V+ + + + G L+ +K ++ EY+ GS D+L + M
Sbjct: 48 DIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATM- 106
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGI 632
++I +G+ YLH E + IH DIK N+L+ E K++DFG+A + Q + T +
Sbjct: 107 -LKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162
Query: 633 RGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
GT ++APE + KAD++S G+ +E+
Sbjct: 163 -GTPFWMAPEVIQQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 20/168 (11%)
Query: 509 SGEREFQT---EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL------F 559
SG + FQ M +G H +VRLLG S + LV + GSL D +
Sbjct: 48 SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSL 106
Query: 560 NPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK 619
+P++ NW + IA+G+ YL + ++H ++ +NIL+ + +I+DFG+A
Sbjct: 107 DPQRLLNWCVQ------IAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD 157
Query: 620 LMKPDQTRTF-TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
L+ PD + F + + ++A E T ++DV+S+GV + E++
Sbjct: 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 6e-12
Identities = 50/170 (29%), Positives = 90/170 (52%), Gaps = 21/170 (12%)
Query: 511 EREFQTEMKVIGR-THHRNLVRLLGYSLEVS------KKILVYEYMSNGSLADILFNPEK 563
E E + E+ ++ + +HHRN+ G ++ + + LV E+ GS+ D++ N +
Sbjct: 46 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG 105
Query: 564 ---QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620
+ W+ I R+I RG+ +LH + ++IH DIK QN+L+ EN K+ DFG++
Sbjct: 106 NTLKEEWIAY--ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160
Query: 621 MKPDQTRTFTGIRGTRGYVAPE-----WHRNLPITVKADVYSFGVVLLEI 665
+ R T I GT ++APE + + K+D++S G+ +E+
Sbjct: 161 LDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 36/197 (18%)
Query: 501 KEEVGRGSSGERE--FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL 558
+E+ G S+ RE EM H N+VRL + LV+EY+ D+
Sbjct: 39 QEDEGVPSTAIREISLLKEM------QHGNIVRLQDVVHSEKRLYLVFEYLD----LDLK 88
Query: 559 FNPEKQPNWVERMGIAR----DIARGILYLHDECETQIIHCDIKPQNILMDENRCA-KIS 613
+ + P++ + + + I RGI Y H +++H D+KPQN+L+D A K++
Sbjct: 89 KHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLA 145
Query: 614 DFGLAKLMK-PDQTRTFTGIRGTRGYVAPEW-----HRNLPITVKADVYSFGVVLLEIIC 667
DFGLA+ P RTFT T Y APE H + P+ D++S G + E++
Sbjct: 146 DFGLARAFGIP--VRTFTHEVVTLWYRAPEILLGSRHYSTPV----DIWSVGCIFAEMVN 199
Query: 668 RRRCLDPNLPDDQVILE 684
++ P P D I E
Sbjct: 200 QK----PLFPGDSEIDE 212
|
Length = 294 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 43/228 (18%)
Query: 487 SFSYAELEKMTDGFKEEV------GRGSSGER-EFQTEMKVIGRTHHRNLVRLLGYSLEV 539
SF A L K + K+ V + S ER E + E+ V+ H N+V+ E
Sbjct: 12 SFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71
Query: 540 SKKILVYEYMSNGSL-------ADILFNPEKQPNWVERMGIARDIARGILYLHDECETQI 592
+V +Y G L +LF ++ +W ++ +A + ++HD +I
Sbjct: 72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHDR---KI 122
Query: 593 IHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVK 652
+H DIK QNI + ++ K+ DFG+A+++ T I GT Y++PE N P K
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENRPYNNK 181
Query: 653 ADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLV 700
+D+++ G VL E+ + FE GN+ LV
Sbjct: 182 SDIWALGCVLYEMCTLK-------------------HAFEAGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 7e-12
Identities = 42/150 (28%), Positives = 79/150 (52%), Gaps = 6/150 (4%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E+ V+ + N+V L L + +V EY++ GSL D++ E + + + R+
Sbjct: 66 EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRE 123
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
+ + +LH Q+IH DIK N+L+ + K++DFG + P+Q++ T + GT
Sbjct: 124 CLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 179
Query: 637 GYVAPEWHRNLPITVKADVYSFGVVLLEII 666
++APE K D++S G++ +E++
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 7e-12
Identities = 51/179 (28%), Positives = 74/179 (41%), Gaps = 49/179 (27%)
Query: 517 EMKVIGRTHHRNLVRLL-----GYSLEVSKKILVYEYM---------SNGSLAD-----I 557
E+K++ H N++ LL + + +V E M S L D
Sbjct: 49 EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYF 108
Query: 558 LFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL 617
L+ I RG+ YLH +IH D+KP NIL++ N KI DFGL
Sbjct: 109 LYQ----------------ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGL 149
Query: 618 AKLMKPDQ--TRTFTGIRGTRGYVAPE----WHR-NLPITVKADVYSFGVVLLEIICRR 669
A+ + PD+ T TR Y APE R I D++S G + E++ R+
Sbjct: 150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 51/160 (31%), Positives = 84/160 (52%), Gaps = 10/160 (6%)
Query: 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWV 568
GE E +++ + + R +V L Y+ E + LV M+ G L +++ + +
Sbjct: 43 GESMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYH-MGEAGFE 100
Query: 569 ERMGI--ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626
E + A +I G+ LH E +I++ D+KP+NIL+D++ +ISD GLA + Q
Sbjct: 101 EGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156
Query: 627 RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
T G GT GY+APE +N T D ++ G +L E+I
Sbjct: 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 62/241 (25%), Positives = 112/241 (46%), Gaps = 41/241 (17%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF--------NPEKQ 564
EF E V+ + ++VRLLG + +++ E M+ G L L NP +
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 565 PNWVERM-GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK-LMK 622
P +++M +A +IA G+ YL+ + +H D+ +N ++ E+ KI DFG+ + + +
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 171
Query: 623 PDQTRTFTGIRGTRG-----YVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLP 677
D R +G +G +++PE ++ T +DV+SFGVVL EI
Sbjct: 172 TDYYR-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI------------ 214
Query: 678 DDQVILEEWVYQCFENGNLSQLVEDEEVDEKQ---LERMIKVALWCILDEPSLRPSMKKV 734
L E YQ N + + V + + +K + + ++ C P +RPS ++
Sbjct: 215 ---ATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 271
Query: 735 L 735
+
Sbjct: 272 I 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 41/126 (32%), Positives = 69/126 (54%), Gaps = 13/126 (10%)
Query: 545 VYEYMSNGSLADILFNPEKQPNWVERMGI--ARDIARGILYLHDECETQIIHCDIKPQNI 602
V EY++ G D++++ ++ + E + A +IA G+ +LH + II+ D+K N+
Sbjct: 79 VMEYVNGG---DLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNV 132
Query: 603 LMDENRCAKISDFGLAK--LMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGV 660
++D KI+DFG+ K + TRTF GT Y+APE P D ++FGV
Sbjct: 133 MLDAEGHIKIADFGMCKENIFGGKTTRTFC---GTPDYIAPEIIAYQPYGKSVDWWAFGV 189
Query: 661 VLLEII 666
+L E++
Sbjct: 190 LLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 30/195 (15%)
Query: 508 SSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNW 567
+ +F E+K++ R + N++RLLG + ++ EYM NG L L E + +
Sbjct: 58 KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTF 117
Query: 568 VERMGI-----------ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFG 616
I A IA G+ YL +H D+ +N L+ + KI+DFG
Sbjct: 118 THANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFG 174
Query: 617 LAK-LMKPD----QTRTFTGIRGTRGYVAPEWHRNL--PITVKADVYSFGVVLLEI--IC 667
+++ L D Q R IR ++A W L T +DV++FGV L E+ +C
Sbjct: 175 MSRNLYSGDYYRIQGRAVLPIR----WMA--WESILLGKFTTASDVWAFGVTLWEMFTLC 228
Query: 668 RRRCLDPNLPDDQVI 682
+ + L D+QVI
Sbjct: 229 KEQPYSL-LSDEQVI 242
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 17/159 (10%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
IA + YLH E I+H D+K QN+ + K+ D G+A++++ +Q + + GT
Sbjct: 111 IAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTP 166
Query: 637 GYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNL 696
Y++PE N P K+DV++ G + E+ + N D + VY+ E G L
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF--NAKD----MNSLVYRIIE-GKL 219
Query: 697 SQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+ +D +L +I L P RPS+K +L
Sbjct: 220 PPMPKDY---SPELGELIATML---SKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 50/170 (29%), Positives = 90/170 (52%), Gaps = 21/170 (12%)
Query: 511 EREFQTEMKVIGR-THHRNLVRLLGYSLEVS------KKILVYEYMSNGSLADILFNPEK 563
E E + E+ ++ + +HHRN+ G ++ S + LV E+ GS+ D++ N +
Sbjct: 56 EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG 115
Query: 564 ---QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620
+ +W+ I R+I RG+ +LH ++IH DIK QN+L+ EN K+ DFG++
Sbjct: 116 NALKEDWIAY--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170
Query: 621 MKPDQTRTFTGIRGTRGYVAPE-----WHRNLPITVKADVYSFGVVLLEI 665
+ R T I GT ++APE + + ++D++S G+ +E+
Sbjct: 171 LDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 54/166 (32%), Positives = 79/166 (47%), Gaps = 33/166 (19%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL---FNPEKQPNWVERMGI 573
E+ + HRN+V+ LG E + E + GSL+ +L + P K N +
Sbjct: 55 EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKD-NEQTIIFY 113
Query: 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDE-NRCAKISDFGLAKLM---KPDQTRTF 629
+ I G+ YLHD QI+H DIK N+L++ + KISDFG +K + P T TF
Sbjct: 114 TKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETF 169
Query: 630 TGI----------RGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
TG +G RGY AP AD++S G ++E+
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAP-----------ADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 36/142 (25%), Positives = 71/142 (50%), Gaps = 6/142 (4%)
Query: 525 HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584
H N+V + L + +V E++ G+L DI+ + + + + + + +L
Sbjct: 74 QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT--VCLAVLKALSFL 131
Query: 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWH 644
H + +IH DIK +IL+ + K+SDFG + + R + GT ++APE
Sbjct: 132 HAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR-KSLVGTPYWMAPEVI 187
Query: 645 RNLPITVKADVYSFGVVLLEII 666
LP + D++S G++++E++
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 22/235 (9%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL------FNPEKQPN 566
EF+ E+ + + H+N+VRLLG E ++ EY G L L K P
Sbjct: 54 EFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113
Query: 567 W--VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+++ + IA G+ +L + + +H D+ +N L+ R K+S L+K +
Sbjct: 114 LSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170
Query: 625 QTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILE 684
+ ++APE + + K+DV+SFGV++ E+ + L D++V+
Sbjct: 171 EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL-- 228
Query: 685 EWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
+ G L +L V E R+ K+ C P RPS +++ L
Sbjct: 229 ----NRLQAGKL-EL----PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 49/163 (30%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 509 SGERE-FQTEMKVIGRTH---HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF-NPEK 563
S ERE +E+K++ +H H N+V LLG +++ EY G L + L E
Sbjct: 79 SSEREALMSELKIM--SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES 136
Query: 564 QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623
+ + + +A+G+ +L + IH D+ +N+L+ + KI DFGLA+ +
Sbjct: 137 FLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193
Query: 624 DQTRTFTG-IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
D G R ++APE N T ++DV+S+G++L EI
Sbjct: 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 35/97 (36%), Positives = 56/97 (57%), Gaps = 7/97 (7%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM--KPDQTRTF-TGIR 633
+ RG+ Y+H +IH D+KP N+L++E+ +I DFG+A+ + P + + F T
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 634 GTRGYVAPEWHRNLP-ITVKADVYSFGVVLLEIICRR 669
TR Y APE +LP T D++S G + E++ RR
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (160), Expect = 2e-11
Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 31/166 (18%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL-------ADILFNPEKQ 564
RE ++ K+ H N+V+L E + V+EYM G+L F+
Sbjct: 46 REVKSLRKL---NEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVI 101
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+ + I +G+ ++H H D+KP+N+L+ KI+DFGLA+ ++
Sbjct: 102 RSII------YQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS- 151
Query: 625 QTRTFTGIRGTRGYVAPEW-----HRNLPITVKADVYSFGVVLLEI 665
+T TR Y APE + P+ D+++ G ++ E+
Sbjct: 152 -RPPYTDYVSTRWYRAPEILLRSTSYSSPV----DIWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 33/195 (16%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL------------------ 554
+F E+K++ R N++RLLG ++ ++ EYM NG L
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 555 ADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISD 614
A + ++ + +A IA G+ YL +H D+ +N L+ EN KI+D
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 615 FGLAK-LMKPD----QTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI--IC 667
FG+++ L D Q R IR ++A E T +DV++FGV L EI +C
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIR----WMAWECILMGKFTTASDVWAFGVTLWEILMLC 237
Query: 668 RRRCLDPNLPDDQVI 682
+ + L D+QVI
Sbjct: 238 KEQPYG-ELTDEQVI 251
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 517 EMKVIGRTHHRNLVRLL----GYSLEVSKKILVYEYMSN--GSLADILFNPEKQPNWVER 570
E+ ++ H N+V L G L+ LV EY SL D + P + +
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLD--SIFLVMEYCEQDLASLLDNMPTPFSES---QV 110
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK-PDQTRTF 629
+ + RG+ YLH+ IIH D+K N+L+ + C KI+DFGLA+ P + T
Sbjct: 111 KCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTP 167
Query: 630 TGIRGTRGYVAPEWHRNLPITVKA-DVYSFGVVLLEII 666
+ T Y APE A D+++ G +L E++
Sbjct: 168 KVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 63/244 (25%), Positives = 108/244 (44%), Gaps = 27/244 (11%)
Query: 508 SSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK------ILVYEYMSNGSLADILFNP 561
SS EF E + H N+++L+G SL K +++ +M +G L L
Sbjct: 42 SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMS 101
Query: 562 E--KQPNWVERMGIAR---DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFG 616
++P + + R DIA G+ YL + IH D+ +N +++EN ++DFG
Sbjct: 102 RIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFG 158
Query: 617 LA-KLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPN 675
L+ K+ D R + ++A E + T +DV++FGV + EI+ R +
Sbjct: 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218
Query: 676 LPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+ + + +Y GN +L + + E E M + C EP RPS + +
Sbjct: 219 VENSE------IYNYLIKGN--RLKQPPDCLEDVYELMCQ----CWSPEPKCRPSFQHLR 266
Query: 736 LMLE 739
LE
Sbjct: 267 DQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 43/150 (28%), Positives = 79/150 (52%), Gaps = 6/150 (4%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E+ V+ + N+V L L + +V EY++ GSL D++ E + + + R+
Sbjct: 66 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRE 123
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
+ + +LH Q+IH DIK NIL+ + K++DFG + P+Q++ T + GT
Sbjct: 124 CLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 179
Query: 637 GYVAPEWHRNLPITVKADVYSFGVVLLEII 666
++APE K D++S G++ +E++
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 50/146 (34%), Positives = 78/146 (53%), Gaps = 15/146 (10%)
Query: 526 HRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMG--IARDIARGIL 582
H LV L YS + ++K+ V +Y++ G L F+ +++ ++E A ++A I
Sbjct: 55 HPFLVGL-HYSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIG 110
Query: 583 YLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL-MKP-DQTRTFTGIRGTRGYVA 640
YLH II+ D+KP+NIL+D ++DFGL K ++P + T TF GT Y+A
Sbjct: 111 YLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC---GTPEYLA 164
Query: 641 PEWHRNLPITVKADVYSFGVVLLEII 666
PE R P D + G VL E++
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 5e-11
Identities = 43/150 (28%), Positives = 79/150 (52%), Gaps = 6/150 (4%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E+ V+ + N+V L L + +V EY++ GSL D++ E + + + R+
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRE 124
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
+ + +LH Q+IH DIK NIL+ + K++DFG + P+Q++ + + GT
Sbjct: 125 CLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTP 180
Query: 637 GYVAPEWHRNLPITVKADVYSFGVVLLEII 666
++APE K D++S G++ +E+I
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 5/161 (3%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPN 566
G EF E ++ H +LVRLLG L + + LV + M +G L D + +
Sbjct: 49 GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIG 107
Query: 567 WVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626
+ IA+G++YL E +++H D+ +N+L+ KI+DFGLA+L++ D+
Sbjct: 108 SQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164
Query: 627 R-TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
G + ++A E T ++DV+S+GV + E++
Sbjct: 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 49/163 (30%), Positives = 74/163 (45%), Gaps = 22/163 (13%)
Query: 518 MKVIGRTHHRNLVRLL----GYSLEVSKKI-LVYEYMSNGSLADILFN------PEKQPN 566
+K + H N+VRLL G + K+ LV+E++ LA L P +
Sbjct: 52 LKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK 110
Query: 567 WVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626
+ R + RG+ +LH I+H D+KPQNIL+ + KI+DFGLA++
Sbjct: 111 D-----LMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY--SFE 160
Query: 627 RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669
T + T Y APE D++S G + E+ RR
Sbjct: 161 MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 44/169 (26%), Positives = 83/169 (49%), Gaps = 5/169 (2%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMG 572
+F +E +++ + H N+V+L+G + +V E + G L + + + +
Sbjct: 38 KFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVK 97
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGI 632
A D A G+ YL + IH D+ +N L+ EN KISDFG+++ + D + +G+
Sbjct: 98 FALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGL 153
Query: 633 RGTR-GYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQ 680
+ + APE + ++DV+S+G++L E C P + + Q
Sbjct: 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ 202
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 56/188 (29%), Positives = 88/188 (46%), Gaps = 27/188 (14%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL--FNPEKQPNWVER 570
+F E+K++ R N++RLL + ++ EYM NG L L P++ +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 571 MGI--------ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK-LM 621
+ I A IA G+ YL +H D+ +N L+ +N KI+DFG+++ L
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 622 KPDQTRTFTGIRGTRGYVAPEWHRNLPI-----TVKADVYSFGVVLLEI--ICRRRCLDP 674
D R I+G R + W I T +DV++FGV L EI +C+ +
Sbjct: 182 SGDYYR----IQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS- 235
Query: 675 NLPDDQVI 682
L D+QVI
Sbjct: 236 QLSDEQVI 243
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 66/246 (26%), Positives = 105/246 (42%), Gaps = 46/246 (18%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF--NP--------- 561
EFQ E ++ HH N+V LLG + +++EY++ G L + L +P
Sbjct: 53 EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112
Query: 562 -----EKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFG 616
+ + + + IA IA G+ YL +H D+ +NIL+ E KISD G
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLG 169
Query: 617 LAK-LMKPD----QTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRC 671
L++ + D Q ++ IR ++ PE + +D++SFGVVL EI
Sbjct: 170 LSREIYSADYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFG-- 223
Query: 672 LDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEV---DEKQLERMIKVALWCILDEPSLR 728
L P Y F N + ++V ++ E RM + C + PS R
Sbjct: 224 LQP-------------YYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRR 270
Query: 729 PSMKKV 734
P K +
Sbjct: 271 PRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 59/242 (24%), Positives = 106/242 (43%), Gaps = 27/242 (11%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKK------ILVYEYMSNGSLADILFNPE--KQ 564
+F +E + H N++RL+G L+ + +++ +M +G L L
Sbjct: 46 DFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC 105
Query: 565 PNWVERMGIAR---DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLA-KL 620
P ++ + + DIA G+ YL + IH D+ +N +++EN ++DFGL+ K+
Sbjct: 106 PQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKI 162
Query: 621 MKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQ 680
D R + ++A E + T K+DV+SFGV + EI R + P + + +
Sbjct: 163 YNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222
Query: 681 VILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740
+Y GN + D L+ + + C L P RPS + + LE
Sbjct: 223 ------IYDYLRQGNRLKQPPD------CLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270
Query: 741 TV 742
+
Sbjct: 271 AL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 43/151 (28%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E+ ++ HH N+V + L + +V E++ G+L DI+ + + + ++
Sbjct: 69 EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-- 126
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL-AKLMKPDQTRTFTGIRGT 635
+ R + YLH++ +IH DIK +IL+ + K+SDFG A++ K R + GT
Sbjct: 127 VLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK--SLVGT 181
Query: 636 RGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
++APE LP + D++S G++++E+I
Sbjct: 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 46/139 (33%), Positives = 71/139 (51%), Gaps = 14/139 (10%)
Query: 533 LGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMG--IARDIARGILYLHDECE 589
L YS + + K+ V +Y++ G L F+ +++ ++ E A +IA + YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLH---S 114
Query: 590 TQIIHCDIKPQNILMDENRCAKISDFGLAK--LMKPDQTRTFTGIRGTRGYVAPEWHRNL 647
II+ D+KP+NIL+D ++DFGL K + T TF GT Y+APE R
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC---GTPEYLAPEVLRKQ 171
Query: 648 PITVKADVYSFGVVLLEII 666
P D + G VL E++
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 38/96 (39%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP--DQTRTFTGIRG 634
I RG+ Y+H ++H D+KP N+L++ N KI DFGLA++ P D T T
Sbjct: 115 ILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 635 TRGYVAPEWHRNLPITVKA-DVYSFGVVLLEIICRR 669
TR Y APE N KA D++S G +L E++ R
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 10/160 (6%)
Query: 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWV 568
GE E +++ + + + +V L Y+ E + LV M+ G L ++N P +
Sbjct: 43 GESMALNEKQILEKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFE 100
Query: 569 ERMGI--ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626
E + A +I G+ LH E ++ D+KP+NIL+D+ +ISD GLA +K +
Sbjct: 101 EERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEG 155
Query: 627 RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
+ G GT GY+APE N T+ D + G ++ E+I
Sbjct: 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 44/153 (28%), Positives = 84/153 (54%), Gaps = 12/153 (7%)
Query: 547 EYMSNGSLADILFNPEKQPNWV-ERMGIARDIARGILYLHDECETQIIHCDIKPQNILMD 605
E+M GSL +L + P + ++ IA + +G+ YL ++ +I+H D+KP NIL++
Sbjct: 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK--HKIMHRDVKPSNILVN 138
Query: 606 ENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
K+ DFG++ + +F GTR Y++PE + +V++D++S G+ L+E+
Sbjct: 139 SRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195
Query: 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQ 698
R + P PD + + E ++ C G+ ++
Sbjct: 196 AIGRYPIPP--PDAKEL--ELMFGCPVEGDPAE 224
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 2e-10
Identities = 44/154 (28%), Positives = 66/154 (42%), Gaps = 40/154 (25%)
Query: 524 THHRNLVRLLG-YSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGIARDI---- 577
H N+V+LL E K I LV+EYM E + V R I D+
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVFEYM------------ETDLHAVIRANILEDVHKRY 111
Query: 578 -----ARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGI 632
+ + Y+H +IH D+KP NIL++ + K++DFGLA R+ + +
Sbjct: 112 IMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLA--------RSLSEL 160
Query: 633 RGTRG------YVAPEWHRNLPITVKADVYSFGV 660
YVA W+R I + + Y+ GV
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGV 194
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 13/154 (8%)
Query: 540 SKKILVYEYMSNGSLADILFNPEKQPNWVERMG--IARDIARGILYLHDECETQIIHCDI 597
S+ LV EY++ G D++F+ ++Q E A +I + +LH E II+ D+
Sbjct: 69 SRLFLVIEYVNGG---DLMFHMQRQRKLPEEHARFYAAEICIALNFLH---ERGIIYRDL 122
Query: 598 KPQNILMDENRCAKISDFGLAK--LMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADV 655
K N+L+D + K++D+G+ K L D T TF G T Y+APE R D
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG---TPNYIAPEILRGEEYGFSVDW 179
Query: 656 YSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQ 689
++ GV++ E++ R D + + E++++Q
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 51/160 (31%), Positives = 82/160 (51%), Gaps = 10/160 (6%)
Query: 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWV 568
GE E +++ + + R +V L Y+ E + LV M+ G L ++N P +
Sbjct: 43 GEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYN-MGNPGFD 100
Query: 569 ERMGI--ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626
E + A +I G+ LH E +I++ D+KP+NIL+D+ +ISD GLA + +
Sbjct: 101 EERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156
Query: 627 RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
T G GT GY+APE +N T D + G ++ E+I
Sbjct: 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 45/156 (28%), Positives = 82/156 (52%), Gaps = 17/156 (10%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSL-----ADILFNPEKQPNWVER 570
E ++ +H +V+L Y+ + K+ L+ +++ G L +++F E ++
Sbjct: 48 ERDILAEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 106
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
+ +A D +LH II+ D+KP+NIL+DE K++DFGL+K + + ++
Sbjct: 107 LALALD------HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157
Query: 631 GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
GT Y+APE T AD +SFGV++ E++
Sbjct: 158 -FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 50/160 (31%), Positives = 82/160 (51%), Gaps = 10/160 (6%)
Query: 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWV 568
GE E +++ + + R +V L Y+ E + LV M+ G L ++N P +
Sbjct: 43 GEAMALNEKRILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFD 100
Query: 569 ERMGI--ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626
E+ I A ++ G+ L E +I++ D+KP+NIL+D+ +ISD GLA ++ +
Sbjct: 101 EQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEG 155
Query: 627 RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
T G GT GY+APE N T D + G ++ E+I
Sbjct: 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 45/160 (28%), Positives = 84/160 (52%), Gaps = 13/160 (8%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMG 572
++ E++++ +H +V+LLG K ++ E+ G++ I+ ++ +
Sbjct: 55 DYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 114
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL-AKLMKPDQTR-TFT 630
I R + + YLH +IIH D+K N+L+ + K++DFG+ AK +K Q R +F
Sbjct: 115 ICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI 171
Query: 631 GIRGTRGYVAP-----EWHRNLPITVKADVYSFGVVLLEI 665
GT ++AP E ++ P KAD++S G+ L+E+
Sbjct: 172 ---GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 56/187 (29%), Positives = 89/187 (47%), Gaps = 25/187 (13%)
Query: 515 QTEMKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMG- 572
QTE V ++H LV L S+ V E++S G D++F+ ++Q E
Sbjct: 43 QTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHAR 99
Query: 573 -IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK--LMKPDQTRTF 629
+ +I+ + +LH E II+ D+K N+L+D K++D+G+ K + D T TF
Sbjct: 100 FYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF 156
Query: 630 TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLD----PNLPDD------ 679
GT Y+APE R D ++ GV++ E++ R D + PD
Sbjct: 157 C---GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213
Query: 680 -QVILEE 685
QVILE+
Sbjct: 214 FQVILEK 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 19/168 (11%)
Query: 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADI------- 557
+ SS + + E ++ + H N+V S E + +V EY G L
Sbjct: 37 KSSSAVEDSRKEAVLLAKMKHPNIVAF-KESFEADGHLYIVMEYCDGGDLMQKIKLQRGK 95
Query: 558 LFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL 617
LF + W +M + G+ ++H++ +++H DIK +NI + +N K+ DFG
Sbjct: 96 LFPEDTILQWFVQMCL------GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGS 146
Query: 618 AKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
A+L+ T + GT YV PE N+P K+D++S G +L E+
Sbjct: 147 ARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 45/157 (28%), Positives = 63/157 (40%), Gaps = 44/157 (28%)
Query: 544 LVYEYMSNGSLADILFNPEKQPNWVERMGIARD------IARGILYLHDECETQIIHCDI 597
LV EYM G L N + R + + IA +L L + IH DI
Sbjct: 78 LVMEYMPGGDLM----------NLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDI 127
Query: 598 KPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIR------------------------ 633
KP NIL+D + K++DFGL K M + R +
Sbjct: 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187
Query: 634 ----GTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
GT Y+APE R P ++ D +S GV+L E++
Sbjct: 188 NSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 48/179 (26%), Positives = 86/179 (48%), Gaps = 28/179 (15%)
Query: 502 EEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP 561
EE G S+ RE + ++ H N+V L ++ S+ L++E++S D+
Sbjct: 38 EEEGVPSTAIRE----ISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS----MDLKKYL 89
Query: 562 EKQP--NWVERMGIAR---DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFG 616
+ P +++ + I +GIL+ H +++H D+KPQN+L+D K++DFG
Sbjct: 90 DSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFG 146
Query: 617 LAKLMK-PDQTRTFTGIRGTRGYVAPE-----WHRNLPITVKADVYSFGVVLLEIICRR 669
LA+ P R +T T Y APE + P+ D++S G + E+ ++
Sbjct: 147 LARAFGIP--VRVYTHEVVTLWYRAPEVLLGSPRYSTPV----DIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 40/151 (26%), Positives = 78/151 (51%), Gaps = 8/151 (5%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E+ ++ H N+V + L + +V E++ G+L DI+ + + + +A
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-- 124
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL-AKLMKPDQTRTFTGIRGT 635
+ + + LH + +IH DIK +IL+ + K+SDFG A++ K R + GT
Sbjct: 125 VLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK--SLVGT 179
Query: 636 RGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
++APE LP + D++S G++++E++
Sbjct: 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 15/155 (9%)
Query: 539 VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGI--ARDIARGILYLHDECETQIIHCD 596
V + V EY++ G D++++ ++ + E + A +I+ G+ +LH II+ D
Sbjct: 73 VDRLYFVMEYVNGG---DLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRD 126
Query: 597 IKPQNILMDENRCAKISDFGLAK--LMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKAD 654
+K N+++D KI+DFG+ K ++ TRTF GT Y+APE P D
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC---GTPDYIAPEIIAYQPYGKSVD 183
Query: 655 VYSFGVVLLEIICRRRCLDPNLPDD--QVILEEWV 687
+++GV+L E++ + D D+ Q I+E V
Sbjct: 184 WWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV 218
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 28/163 (17%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKI----LVYEYMSNGSLADILFNPEKQPNWVER-- 570
E++++ + H NLV L+ EV ++ LV+EY + L ++ EK P V
Sbjct: 50 EIRMLKQLKHPNLVNLI----EVFRRKRKLHLVFEYCDHTVLNEL----EKNPRGVPEHL 101
Query: 571 -MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
I + + + H + IH D+KP+NIL+ + K+ DFG A+++ +
Sbjct: 102 IKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDY 157
Query: 630 TGIRGTRGYVAPEW-----HRNLPITVKADVYSFGVVLLEIIC 667
T TR Y APE P+ DV++ G V E++
Sbjct: 158 TDYVATRWYRAPELLVGDTQYGPPV----DVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 35/172 (20%)
Query: 525 HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD-------- 576
+H N+VRLL +K LV+E++ D+ +K + G+
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFLD----LDL----KKYMDSSPLTGLDPPLIKSYLYQ 107
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK-PDQTRTFTGIRGT 635
+ +GI Y H +++H D+KPQN+L+D K++DFGLA+ P RT+T T
Sbjct: 108 LLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTYTHEVVT 162
Query: 636 RGYVAPEW-----HRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
Y APE + P+ D++S G + E++ RR P P D I
Sbjct: 163 LWYRAPEILLGSRQYSTPV----DIWSIGCIFAEMVNRR----PLFPGDSEI 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 22/226 (9%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMG 572
+F E +++ + H N+VRL+G + +V E + G L + E +
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQ 98
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGI 632
+ + A G+ YL + IH D+ +N L+ E KISDFG+++ + D TG
Sbjct: 99 MVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTG- 153
Query: 633 RGTR----GYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVY 688
G + + APE + ++DV+SFG++L E NL + Q E +
Sbjct: 154 -GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT--REAIE 210
Query: 689 QCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKV 734
Q L E + + ++ C +P RPS V
Sbjct: 211 Q---GVRL-------PCPELCPDAVYRLMERCWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 12/95 (12%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
I + + YL ++ +IH D+KP NIL+D + K+ DFG++ + + +T + G
Sbjct: 123 IVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCA 178
Query: 637 GYVAPEWHRNLPIT------VKADVYSFGVVLLEI 665
Y+APE R P ++ADV+S G+ L+E+
Sbjct: 179 AYMAPE--RIDPPDPNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 44/149 (29%), Positives = 69/149 (46%), Gaps = 4/149 (2%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E+K++ N+V L K LV+EY+ L + E+ PN V +
Sbjct: 50 ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELL----EEMPNGVPPEKVRSY 105
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
I + I +H + I+H DIKP+N+L+ N K+ DFG A+ + +T TR
Sbjct: 106 IYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATR 165
Query: 637 GYVAPEWHRNLPITVKADVYSFGVVLLEI 665
Y +PE P D++S G +L E+
Sbjct: 166 WYRSPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 48/151 (31%), Positives = 78/151 (51%), Gaps = 8/151 (5%)
Query: 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIAR 575
+E K++ +H V L G + S LV E++ G L ++ PN V A
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF-YAA 138
Query: 576 DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGT 635
I YL I++ D+KP+N+L+D++ K++DFG AK++ TRT+T + GT
Sbjct: 139 QIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGT 191
Query: 636 RGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
Y+APE N+ AD ++ G+ + EI+
Sbjct: 192 PEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 46/140 (32%), Positives = 75/140 (53%), Gaps = 16/140 (11%)
Query: 533 LGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVE---RMGIARDIARGILYLHDEC 588
L YS + ++K+ V ++++ G L F+ +++ ++ E R A +IA + YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAA-EIASALGYLH--- 113
Query: 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAK--LMKPDQTRTFTGIRGTRGYVAPEWHRN 646
I++ D+KP+NIL+D ++DFGL K + + D T TF GT Y+APE R
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC---GTPEYLAPEVIRK 170
Query: 647 LPITVKADVYSFGVVLLEII 666
P D + G VL E++
Sbjct: 171 QPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 27/170 (15%)
Query: 517 EMKVIGRTHHRNLVRLLGY------SLEVSKK----ILVYEYMSN---GSLADILFNPEK 563
E+K++ + +HRN+V L +L+ K LV+EYM + G L L + +
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 564 QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623
+ + G+ Y H +H DIK NIL++ K++DFGLA+L
Sbjct: 116 DHI----KSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 624 DQTRTFTGIRGTRGYVAPEW----HRNLPITVKADVYSFGVVLLEIICRR 669
+++R +T T Y PE R P DV+S G +L E+ ++
Sbjct: 169 EESRPYTNKVITLWYRPPELLLGEERYGP---AIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 46/160 (28%), Positives = 82/160 (51%), Gaps = 13/160 (8%)
Query: 513 EFQTEMKVIGRTHHRNLVRLL-GYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERM 571
++ E+ ++ H N+V+LL + E + IL+ E+ + G++ ++ E+ +
Sbjct: 48 DYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIR 106
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL-AKLMKPDQTRTFT 630
+ + + YLH E +IIH D+K NIL + K++DFG+ AK + Q R
Sbjct: 107 VVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--D 161
Query: 631 GIRGTRGYVAP-----EWHRNLPITVKADVYSFGVVLLEI 665
GT ++AP E ++ P KADV+S G+ L+E+
Sbjct: 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 49/222 (22%), Positives = 97/222 (43%), Gaps = 17/222 (7%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIAR- 575
E+ ++ + H N+++ L +E ++ +V E G L+ ++ + +KQ + I +
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 576 --DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIR 633
+ + ++H +I+H DIKP N+ + K+ D GL + T + +
Sbjct: 112 FVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV- 167
Query: 634 GTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFEN 693
GT Y++PE K+D++S G +L E+ + P D + + + E
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ---SPFYGDKMNLYS--LCKKIEK 222
Query: 694 GNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+ L D + +L ++ CI +P RP + VL
Sbjct: 223 CDYPPLPADHYSE--ELRDLVSR---CINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 43/168 (25%), Positives = 83/168 (49%), Gaps = 11/168 (6%)
Query: 505 GRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK--ILVYEYMSNGSLADILFNPE 562
G + + + E++++ +H N+V+ G E L+ E++ +GSL + L +
Sbjct: 44 ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK 103
Query: 563 KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK 622
+ N +++ A I +G+ YL Q +H D+ +N+L++ KI DFGL K ++
Sbjct: 104 NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160
Query: 623 PDQTRTFTGIRGTRG----YVAPEWHRNLPITVKADVYSFGVVLLEII 666
D + + ++ + APE + +DV+SFGV L E++
Sbjct: 161 TD--KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 58/189 (30%), Positives = 91/189 (48%), Gaps = 25/189 (13%)
Query: 515 QTEMKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMG- 572
QTE V + ++H LV L S+ V EY++ G D++F+ ++Q E
Sbjct: 43 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHAR 99
Query: 573 -IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK--LMKPDQTRTF 629
+ +I+ + YLH E II+ D+K N+L+D K++D+G+ K L D T TF
Sbjct: 100 FYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF 156
Query: 630 TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLD----PNLPDD------ 679
GT Y+APE R D ++ GV++ E++ R D + PD
Sbjct: 157 C---GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 213
Query: 680 -QVILEEWV 687
QVILE+ +
Sbjct: 214 FQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGIA 574
TE +V+ T H L L YS + ++ V EY + G L F+ ++ + E A
Sbjct: 44 TESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDR--A 97
Query: 575 R----DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK--LMKPDQTRT 628
R +I + YLH +++ D+K +N+++D++ KI+DFGL K + +T
Sbjct: 98 RFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154
Query: 629 FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669
F GT Y+APE + D + GVV+ E++C R
Sbjct: 155 FC---GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 50/156 (32%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E+K + + H N + G L+ LV EY GS +D+L +K VE I
Sbjct: 71 EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHG 129
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
+G+ YLH +IH DIK NIL+ E K++DFG A P +F GT
Sbjct: 130 ALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--ANSFV---GTP 181
Query: 637 GYVAPEWHRNL---PITVKADVYSFGVVLLEIICRR 669
++APE + K DV+S G+ +E+ R+
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT---FTGIR 633
I G+ Y+H ++H D+KP N+L++ + KI DFGLA+ + T
Sbjct: 114 ILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 634 GTRGYVAPE-WHRNLPITVKADVYSFGVVLLEIICRR 669
TR Y APE T DV+S G +L E++ R+
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 10/127 (7%)
Query: 544 LVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNIL 603
LV +YMS G L L + + IA ++ + +LH + I++ D+KP+NIL
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH---KYDIVYRDLKPENIL 128
Query: 604 MDENRCAKISDFGLAK--LMKPDQTRTFTGIRGTRGYVAPE-WHRNLPITVKADVYSFGV 660
+D + DFGL+K L T TF GT Y+APE T D +S GV
Sbjct: 129 LDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAPEVLLDEKGYTKHVDFWSLGV 185
Query: 661 VLLEIIC 667
++ E+ C
Sbjct: 186 LVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 12/156 (7%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E+K + R H N + G L LV EY GS +D+L +K VE I
Sbjct: 75 EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHG 133
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
+G+ YLH +IH DIK NIL+ E K++DFG A + P + GT
Sbjct: 134 ALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTP 185
Query: 637 GYVAPEWHRNL---PITVKADVYSFGVVLLEIICRR 669
++APE + K DV+S G+ +E+ R+
Sbjct: 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 32/82 (39%), Positives = 46/82 (56%), Gaps = 9/82 (10%)
Query: 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP 648
E +IIH D+KP NIL+D N K+ DFG++ + +T G R Y+APE R P
Sbjct: 126 ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPE--RIDP 181
Query: 649 IT-----VKADVYSFGVVLLEI 665
V++DV+S G+ L E+
Sbjct: 182 SARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 38/98 (38%), Positives = 53/98 (54%), Gaps = 16/98 (16%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
I RG+ Y+H IIH D+KP NI ++E+ KI DFGLA+ + TG TR
Sbjct: 127 ILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATR 179
Query: 637 GYVAPE----W-HRNLPITVKADVYSFGVVLLEIICRR 669
Y APE W H N TV D++S G ++ E++ +
Sbjct: 180 WYRAPEIMLNWMHYNQ--TV--DIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 3e-09
Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 10/161 (6%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILV--YEYMSNGSLADILFNPEKQPNWVERM 571
+ E++++ H +V+ G + ++K L EYM GS+ D L V R
Sbjct: 51 LECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRK 110
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG 631
R I G+ YLH I+H DIK NIL D K+ DFG +K ++ + TG
Sbjct: 111 -YTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ-TICMSGTG 165
Query: 632 IR---GTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669
IR GT +++PE KADV+S G ++E++ +
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 49/177 (27%), Positives = 79/177 (44%), Gaps = 14/177 (7%)
Query: 500 FKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKIL--VYEYMSNGSLADI 557
F E S + E++++ H +V+ G + ++ L E+M GS+ D
Sbjct: 37 FDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQ 96
Query: 558 LFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL 617
L + V R R I G+ YLH I+H DIK NIL D K+ DFG
Sbjct: 97 LKSYGALTENVTRK-YTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGA 152
Query: 618 AKLMKPDQTRTFTG-----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669
+K + QT +G + GT +++PE KAD++S G ++E++ +
Sbjct: 153 SKRL---QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 44/129 (34%), Positives = 68/129 (52%), Gaps = 17/129 (13%)
Query: 547 EYMSNGSLADILF----NPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNI 602
EYM GSL D L+ E P V R I + +G+ +L +E IIH D+KP N+
Sbjct: 79 EYMDAGSL-DKLYAGGVATEGIPEDVLRR-ITYAVVKGLKFLKEE--HNIIHRDVKPTNV 134
Query: 603 LMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR------NLPITVKADVY 656
L++ N K+ DFG++ + +T G + Y+APE + N TV++DV+
Sbjct: 135 LVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMAPERIKSGGPNQNPTYTVQSDVW 191
Query: 657 SFGVVLLEI 665
S G+ +LE+
Sbjct: 192 SLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 45/173 (26%), Positives = 85/173 (49%), Gaps = 14/173 (8%)
Query: 495 KMTDGFKEEVGRGSSGEREFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGS 553
KM D K++ RE VI R + H+N+V + L + ++ E++ G+
Sbjct: 52 KMMDLRKQQ-------RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 554 LADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKIS 613
L DI+ + + N + + + + + YLH + +IH DIK +IL+ + K+S
Sbjct: 105 LTDIV--SQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLS 159
Query: 614 DFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
DFG + D + + GT ++APE P + D++S G++++E++
Sbjct: 160 DFGFCAQISKDVPKR-KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 12/156 (7%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E++ + + H N ++ G L LV EY GS +D+L +K VE +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHG 123
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
+G+ YLH +IH D+K NIL+ E K+ DFG A +M P GT
Sbjct: 124 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTP 175
Query: 637 GYVAPEWHRNL---PITVKADVYSFGVVLLEIICRR 669
++APE + K DV+S G+ +E+ R+
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVER 570
E+ E +V+ H ++RL + ++ EY+ G L L N + N
Sbjct: 45 EQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL 104
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
A +I + YLH + +I++ D+KP+NIL+D+ K++DFG AK ++ RT+T
Sbjct: 105 F-YASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR---DRTWT 157
Query: 631 GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
+ GT Y+APE ++ D ++ G+++ E++
Sbjct: 158 -LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 70/255 (27%), Positives = 119/255 (46%), Gaps = 53/255 (20%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEK------Q 564
+ +F E + H NL++ LG EV+ +LV E+ G L L + K
Sbjct: 39 QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPD 98
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL---- 620
P ++RM A +IA G+L+LH + IH D+ +N L+ + KI D+GL+
Sbjct: 99 PTTLQRM--ACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153
Query: 621 ---MKPDQTRTFTGIRGTRGYVAPEW----HRNLPI---TVKADVYSFGVVLLEIICRRR 670
+ PDQ + +R ++APE H NL + T +++V+S GV + E+
Sbjct: 154 DYYVTPDQ--LWVPLR----WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGS 207
Query: 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVD--EKQL-----ERMIKVALWCILD 723
+L D+QV L+ V ++++ + +L +R +V +C L
Sbjct: 208 QPYRHLSDEQV--------------LTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWL- 252
Query: 724 EPSLRPSMKKVLLML 738
+P RPS ++V L+L
Sbjct: 253 QPEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 12/99 (12%)
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGI 632
IA I + + YLH + +IH D+KP N+L++ N K+ DFG++ + +T
Sbjct: 108 IAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA- 164
Query: 633 RGTRGYVAPEWHRNLPIT------VKADVYSFGVVLLEI 665
G + Y+APE R P VK+DV+S G+ ++E+
Sbjct: 165 -GCKPYMAPE--RINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 36/113 (31%), Positives = 56/113 (49%), Gaps = 8/113 (7%)
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGI 632
I + I G+ YLH + +IIH D+K +NI +++ I D G A+ P F G+
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGL 216
Query: 633 RGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCL---DPNLPDDQVI 682
GT APE KAD++S G+VL E++ + P+ P++ V
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK 269
|
Length = 357 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 47/187 (25%), Positives = 88/187 (47%), Gaps = 22/187 (11%)
Query: 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKIL-VYEYMSNGSLADILFNPEKQPNWVERMG-- 572
TE +++ + + L + ++ V E+++ G D++F+ +K + E
Sbjct: 44 TEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARF 100
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK--LMKPDQTRTFT 630
A +I +++LHD+ II+ D+K N+L+D K++DFG+ K + T TF
Sbjct: 101 YAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157
Query: 631 GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPD--------DQVI 682
GT Y+APE + + D ++ GV+L E++C + D D+V+
Sbjct: 158 ---GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV 214
Query: 683 LEEWVYQ 689
W+ Q
Sbjct: 215 YPTWLSQ 221
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 7e-09
Identities = 43/123 (34%), Positives = 65/123 (52%), Gaps = 8/123 (6%)
Query: 544 LVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNIL 603
+ E++ G L L + PN V + A ++ YLH II+ D+KP+N+L
Sbjct: 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHA-ELVLAFEYLH---SKDIIYRDLKPENLL 150
Query: 604 MDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663
+D K++DFG AK + PD RTFT + GT Y+APE ++ D ++ GV+L
Sbjct: 151 LDNKGHVKVTDFGFAKKV-PD--RTFT-LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLY 206
Query: 664 EII 666
E I
Sbjct: 207 EFI 209
|
Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 15/159 (9%)
Query: 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMG-- 572
TE +V+ T H L L Y+ + ++ V EY + G L F+ ++ + E
Sbjct: 44 TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARF 99
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT--RTFT 630
+I + YLH +++ DIK +N+++D++ KI+DFGL K D +TF
Sbjct: 100 YGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156
Query: 631 GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669
GT Y+APE + D + GVV+ E++C R
Sbjct: 157 ---GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 7/154 (4%)
Query: 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGIA 574
TE +V+ + L Y+ + K+ L+ +Y++ G L L+ E R+ IA
Sbjct: 53 TERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA 112
Query: 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRG 634
+I + +LH + II+ DIK +NIL+D ++DFGL+K ++ G
Sbjct: 113 -EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCG 168
Query: 635 TRGYVAPEWHRNLPI--TVKADVYSFGVVLLEII 666
T Y+APE R D +S GV+ E++
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 38/164 (23%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVS----KKILVYEYMSNGSLADILFNPEKQPNW 567
+ E+K + R N++++ G+ +++ + L+ EY + G L ++L EK ++
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK-EKDLSF 121
Query: 568 VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR 627
++ +A D +G+ L+ + ++ + L+ EN KI GL K++ +
Sbjct: 122 KTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKIL---SSP 176
Query: 628 TFTGIRGTRGYVAPEWHRNL--PITVKADVYSFGVVLLEIICRR 669
F + Y + + ++ T+K D+YS GVVL EI +
Sbjct: 177 PFKNV-NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 42/157 (26%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQ---PNWVE 569
E E +++ + + +VR++G E +LV E S G L L + + N VE
Sbjct: 41 EMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVE 99
Query: 570 RMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT--R 627
M ++ G+ YL +H D+ +N+L+ AKISDFGL+K + D + +
Sbjct: 100 LM---HQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153
Query: 628 TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664
+ + + APE + ++DV+S+G+ + E
Sbjct: 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 15/159 (9%)
Query: 517 EMKVIGRTHHRNLVRLL-----GYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERM 571
E++++ H N++ LL SLE + + ++ L +I+ + + V+ +
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG 631
I RG+ Y+H IIH D+KP N+ ++E+ KI DFGLA+ + TG
Sbjct: 126 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTG 176
Query: 632 IRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICRR 669
TR Y APE N + D++S G ++ E++ R
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 41/127 (32%), Positives = 68/127 (53%), Gaps = 13/127 (10%)
Query: 544 LVYEYMSNGSLADILFNPEKQPNWVERMGI--ARDIARGILYLHDECETQIIHCDIKPQN 601
V EY++ G D+++ ++ + E + A +IA G+ +LH + II+ D+K N
Sbjct: 78 FVMEYVNGG---DLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDN 131
Query: 602 ILMDENRCAKISDFGLAKLMKPD--QTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFG 659
+++D KI+DFG+ K D T+TF GT Y+APE P D ++FG
Sbjct: 132 VMLDSEGHIKIADFGMCKENMWDGVTTKTFC---GTPDYIAPEIIAYQPYGKSVDWWAFG 188
Query: 660 VVLLEII 666
V+L E++
Sbjct: 189 VLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-08
Identities = 36/136 (26%), Positives = 54/136 (39%), Gaps = 27/136 (19%)
Query: 156 TDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNT 215
++TL Q L G LF G F LIMQ D NL+ Y + + W +N
Sbjct: 1 SNTLSSGQTLVSGNSLF--------ELGFFTLIMQNDYNLILYKSSSRT----VVWVANR 48
Query: 216 YNKGDNVS-LNLDENGHLFLMNTTGVNIF--NLTGGENPTKGMIYLMKIDSDGIFRLYSY 272
N + L L +G+L L + G ++ N TG Y++ + DG +Y
Sbjct: 49 DNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTTGANGN-----YVLVLLDDGNLVIYD- 102
Query: 273 NLRRQNSTWQVVWEST 288
S +W+S
Sbjct: 103 ------SDGNFLWQSF 112
|
Length = 114 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 11/157 (7%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG--SLADILFNPEKQPNWVERMGIA 574
E+ ++ +H N+V+LL +K LV+E++ D ++
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK--SYL 106
Query: 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK-PDQTRTFTGIR 633
+ +G+ + H +++H D+KPQN+L++ K++DFGLA+ P RT+T
Sbjct: 107 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEV 161
Query: 634 GTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEIICRR 669
T Y APE + D++S G + E++ RR
Sbjct: 162 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 11/156 (7%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVER-- 570
E E V+ + + +VR++G E +LV E G L L +K + E+
Sbjct: 42 ELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNI 97
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT--RT 628
+ ++ G+ YL ET +H D+ +N+L+ AKISDFGL+K + D+ +
Sbjct: 98 TELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154
Query: 629 FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664
T + + APE + K+DV+SFGV++ E
Sbjct: 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 11/157 (7%)
Query: 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMG-- 572
TE +V+ T H L L YS + ++ V EY++ G L F+ ++ + E
Sbjct: 44 TESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRF 99
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGI 632
+I + YLH +I++ D+K +N+++D++ KI+DFGL K D T
Sbjct: 100 YGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKTF 155
Query: 633 RGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669
GT Y+APE + D + GVV+ E++C R
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 37/91 (40%), Positives = 53/91 (58%), Gaps = 6/91 (6%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK-LMK-PDQTRTFTGIRG 634
+ARG+ +L + IH D+ +NIL+ EN KI DFGLA+ + K PD R R
Sbjct: 182 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA-RL 237
Query: 635 TRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
++APE + T ++DV+SFGV+L EI
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 36/91 (39%), Positives = 52/91 (57%), Gaps = 6/91 (6%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK--LMKPDQTRTFTGIRG 634
+ARG+ +L + IH D+ +NIL+ EN KI DFGLA+ PD R + R
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA-RL 238
Query: 635 TRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
++APE + T ++DV+SFGV+L EI
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 48/161 (29%), Positives = 75/161 (46%), Gaps = 17/161 (10%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK--LMKPDQTRTFTGIRG 634
+A+G+ +L + IH D+ +NIL+ EN KI DFGLA+ PD R R
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA-RL 243
Query: 635 TRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENG 694
++APE + T+++DV+SFGV+L EI P + D EE+ + E
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCRRLKEGT 299
Query: 695 NLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+ + M + L C EPS RP+ +++
Sbjct: 300 RM-------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 20/162 (12%)
Query: 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSL-----ADILFNPEKQPNWVE 569
TE +V+ + H L L YS + ++ V EY + G L + +F+ ++ +
Sbjct: 44 TENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY-- 100
Query: 570 RMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD--QTR 627
+I + YLH E +++ D+K +N+++D++ KI+DFGL K D +
Sbjct: 101 ----GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154
Query: 628 TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669
TF GT Y+APE + D + GVV+ E++C R
Sbjct: 155 TFC---GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 43/144 (29%), Positives = 66/144 (45%), Gaps = 10/144 (6%)
Query: 533 LGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591
L Y+ + + LV EY G L +L E Q + E M +A +L +H +
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFD--EDM-AQFYLAELVLAIHSVHQMG 122
Query: 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITV 651
+H DIKP+N+L+D K++DFG A + ++ GT Y+APE +
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 652 KA------DVYSFGVVLLEIICRR 669
K D +S GV+ E+I R
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 17/162 (10%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERM 571
+E E V+ + ++ RLLG L S L+ + M G L D + + +
Sbjct: 54 KEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLL 112
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG 631
IA+G+ YL E +++H D+ +N+L+ + KI+DFGLAKL+ D+
Sbjct: 113 NWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE---- 165
Query: 632 IRGTRGYVAPEW-------HRNLPITVKADVYSFGVVLLEII 666
G V +W HR T ++DV+S+GV + E++
Sbjct: 166 YHAEGGKVPIKWMALESILHRIY--THQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 12/105 (11%)
Query: 525 HHRNLVRLLGYSLE-VSKKI-LVYEYMSNGSLADILFNPEKQPNWV-ERM--GIARDIAR 579
H N+V L+ LE K + L+++Y + I F+ + + + M + I
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 580 GILYLHDECETQIIHCDIKPQNILM----DENRCAKISDFGLAKL 620
G+ YLH ++H D+KP NIL+ E KI D GLA+L
Sbjct: 120 GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 8/154 (5%)
Query: 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIA 574
Q E+ ++ H N+V G L K + EY GSL DI ++ + ++ +
Sbjct: 54 QQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDI-YHVTGPLSELQIAYVC 112
Query: 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRG 634
R+ +G+ YLH + + +H DIK NIL+ +N K++DFG+A + + + I G
Sbjct: 113 RETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-G 168
Query: 635 TRGYVAPE---WHRNLPITVKADVYSFGVVLLEI 665
T ++APE +N D+++ G+ +E+
Sbjct: 169 TPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 45/161 (27%), Positives = 80/161 (49%), Gaps = 14/161 (8%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVE 569
E+ +E V+ + + L +S + + K+ V +Y++ G L ++ +++ ++E
Sbjct: 39 EKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLE 95
Query: 570 RMG--IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL-MKPD-Q 625
A +IA + YLH I++ D+KP+NIL+D ++DFGL K ++ +
Sbjct: 96 PRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT 152
Query: 626 TRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
T TF GT Y+APE P D + G VL E++
Sbjct: 153 TSTFC---GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG-IRGT 635
+A+G+ +L + IH D+ +NIL+ R KI DFGLA+ ++ D G R
Sbjct: 223 VAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 636 RGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGN 695
++APE N T ++DV+S+G++L EI P +P D Y+ + G
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF-----YKMIKEG- 333
Query: 696 LSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
+ E ++ ++K C +P RP+ K+++ ++E
Sbjct: 334 --YRMLSPECAPSEMYDIMKS---CWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 40/156 (25%), Positives = 79/156 (50%), Gaps = 13/156 (8%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVER 570
+++ +E++++ + ++ G ++ + E+M GSL D+ K P V
Sbjct: 43 QKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL-DVY---RKIPEHV-- 96
Query: 571 MG-IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
+G IA + +G+ YL +I+H D+KP N+L++ K+ DFG++ + +T+
Sbjct: 97 LGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY 153
Query: 630 TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
GT Y+APE + +DV+S G+ +E+
Sbjct: 154 V---GTNAYMAPERISGEQYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 48/163 (29%), Positives = 77/163 (47%), Gaps = 14/163 (8%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLE-VSKKILVY-EYMSNGSLADILFNPEKQPNWVERM 571
+ E++++ H +V+ G + KK+ ++ EYM GS+ D L V R
Sbjct: 51 LECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR 110
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG 631
R I +G+ YLH I+H DIK NIL D K+ DFG +K + QT +G
Sbjct: 111 -YTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI---QTICMSG 163
Query: 632 -----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669
+ GT +++PE KADV+S ++E++ +
Sbjct: 164 TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 17/162 (10%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERM 571
+E E V+ + RLLG L S LV + M G L D + + + + +
Sbjct: 54 KEILDEAYVMAGVGSPYVCRLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLL 112
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG 631
IA+G+ YL E +++H D+ +N+L+ KI+DFGLA+L+ D+T
Sbjct: 113 NWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE---- 165
Query: 632 IRGTRGYVAPEW-------HRNLPITVKADVYSFGVVLLEII 666
G V +W HR T ++DV+S+GV + E++
Sbjct: 166 YHADGGKVPIKWMALESILHRRF--THQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADI--LFNP--EKQPNWVER 570
Q E+ ++ H N+V G L K + E+ GSL DI + P E Q +V
Sbjct: 54 QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYV-- 111
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
+R+ +G+ YLH + + +H DIK NIL+ +N K++DFG++ + + +
Sbjct: 112 ---SRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS 165
Query: 631 GIRGTRGYVAPE---WHRNLPITVKADVYSFGVVLLEI 665
I GT ++APE R D+++ G+ +E+
Sbjct: 166 FI-GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 38/137 (27%), Positives = 65/137 (47%), Gaps = 15/137 (10%)
Query: 517 EMKVIGRTHHRNLVRLL--------GYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWV 568
E+K++ H N+V L+ Y+ LV+E+ + LA +L N +
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS 119
Query: 569 ERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK---LMKPDQ 625
E + + + G+ Y+H +I+H D+K NIL+ ++ K++DFGLA+ L K +
Sbjct: 120 EIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176
Query: 626 TRTFTGIRGTRGYVAPE 642
+T T Y PE
Sbjct: 177 PNRYTNRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 36/126 (28%), Positives = 65/126 (51%), Gaps = 13/126 (10%)
Query: 545 VYEYMSNGSLADILFNPEKQPNWVERMG--IARDIARGILYLHDECETQIIHCDIKPQNI 602
V EY++ G D++F ++ + E A ++ +++LH +I+ D+K NI
Sbjct: 74 VMEYVNGG---DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNI 127
Query: 603 LMDENRCAKISDFGLAK--LMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGV 660
L+D K++DFG+ K ++ T TF GT Y+APE + L D ++ GV
Sbjct: 128 LLDAEGHCKLADFGMCKEGILNGVTTTTFC---GTPDYIAPEILQELEYGPSVDWWALGV 184
Query: 661 VLLEII 666
++ E++
Sbjct: 185 LMYEMM 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 580 GILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM--KPDQTRTFTGIRGTRG 637
G+ Y+H + +I+H D+K +NI + N KI DFG+++L+ D TFTG T
Sbjct: 118 GVHYMH---QRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTG---TPY 170
Query: 638 YVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
Y++PE ++ K+D++S G +L E+ C
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 8/95 (8%)
Query: 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK--LMKPDQTRTFTG 631
A +I G+ +LH + II+ D+K N+++D + KI+DFG+ K + ++ TF G
Sbjct: 102 AAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG 158
Query: 632 IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
T Y+APE + L T D +SFGV+L E++
Sbjct: 159 ---TPDYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 40/126 (31%), Positives = 67/126 (53%), Gaps = 13/126 (10%)
Query: 545 VYEYMSNGSLADILFNPEKQPNWVERMG--IARDIARGILYLHDECETQIIHCDIKPQNI 602
V EY++ G D++F+ + + E A +I G+ +LH + II+ D+K N+
Sbjct: 74 VMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNV 127
Query: 603 LMDENRCAKISDFGLAK--LMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGV 660
L+D++ KI+DFG+ K + + TF GT Y+APE + D +SFGV
Sbjct: 128 LLDKDGHIKIADFGMCKENMNGEGKASTFC---GTPDYIAPEILKGQKYNESVDWWSFGV 184
Query: 661 VLLEII 666
+L E++
Sbjct: 185 LLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 39/116 (33%), Positives = 53/116 (45%), Gaps = 13/116 (11%)
Query: 567 WVERMG---------IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL 617
+V+R G I R + + YLH IIH D+K +NI +DE A + DFG
Sbjct: 175 YVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGA 231
Query: 618 A-KLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCL 672
A KL T G GT +PE P K D++S G+VL E+ + L
Sbjct: 232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL--MKPDQTRTFTGIRG 634
A + L + + +I+ D+KP+NIL+D + DFGL KL D+T TF G
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---G 155
Query: 635 TRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
T Y+APE T D ++ GV+L E++
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 22/166 (13%)
Query: 512 REFQTEMKVIGRTHHRNLVRL----LGYSLEVSKKI-LVYEYMSNG--SLADILFNPEKQ 564
RE +K+ H N+V + +G +L+ KI +V EY+ + SL + + P Q
Sbjct: 53 REINILLKL----QHPNIVTVKEVVVGSNLD---KIYMVMEYVEHDLKSLMETMKQPFLQ 105
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
E + + G+ +LHD I+H D+K N+L++ KI DFGLA+
Sbjct: 106 S---EVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY-GS 158
Query: 625 QTRTFTGIRGTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEIICRR 669
+ +T + T Y APE + D++S G + E++ ++
Sbjct: 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
+ RG+ Y+H ++H D+KP N+L++ N KI DFGLA+ ++ T TR
Sbjct: 117 LLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTR 172
Query: 637 GYVAPEWHRNLP-ITVKADVYSFGVVLLEIICRR 669
Y APE N T DV+S G + E++ R+
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 39/182 (21%), Positives = 80/182 (43%), Gaps = 19/182 (10%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E+ ++ + +H N+++ +E ++ +V E G L+ ++ + +KQ + + +
Sbjct: 52 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY 111
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
+ L +++H DIKP N+ + K+ D GL + T + + GT
Sbjct: 112 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTP 170
Query: 637 GYVAPEWHRNLPITVKADVYSFGVVLLEI----------------ICRR--RCLDPNLPD 678
Y++PE K+D++S G +L E+ +C++ +C P LP
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS 230
Query: 679 DQ 680
D
Sbjct: 231 DH 232
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 34/152 (22%), Positives = 73/152 (48%), Gaps = 7/152 (4%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIAR- 575
E+ ++ + +H N+++ L +E ++ +V E G L+ ++ +KQ + + +
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 576 --DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIR 633
+ + ++H +++H DIKP N+ + K+ D GL + T + +
Sbjct: 112 FVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LV 167
Query: 634 GTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
GT Y++PE K+D++S G +L E+
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 5e-07
Identities = 29/110 (26%), Positives = 47/110 (42%), Gaps = 17/110 (15%)
Query: 181 STGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGV 240
+ + LI+Q DGNLV Y G W+SNT KG L ++G+L L + +G
Sbjct: 15 TDSSYTLILQSDGNLVLYD-----GNGRVVWSSNTSGKGSGCVAVLQDDGNLVLYDNSGK 69
Query: 241 NIFNLTGGENPTKGMIYLMKIDSDGIFRLYSYNLRRQNSTWQVVWESTSD 290
++ ++PT ++ K N+ S W+S +D
Sbjct: 70 VLWQ--SFDHPTDTLLPGQKDG----------NVVIGGSRRLTSWKSNTD 107
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 5e-07
Identities = 19/62 (30%), Positives = 32/62 (51%), Gaps = 3/62 (4%)
Query: 259 MKIDSDGIFRLYSYNLRRQNSTWQVVWESTSDRCDPIGFCGFNSFCVLNDQIPDCPCLPG 318
+ + S+G +++ Q+ W + W + D+CD G CG +C +N P C C+ G
Sbjct: 49 LTLSSEGSLERFTWIPNSQD--WNLFWSAPKDQCDVYGRCGPYGYCDVNTS-PKCNCIKG 105
Query: 319 FV 320
FV
Sbjct: 106 FV 107
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 45/177 (25%), Positives = 84/177 (47%), Gaps = 42/177 (23%)
Query: 517 EMKVIGRTHHRNLVRL--------------LGYSLEVSKKILVYEYMSNGSLADILFNPE 562
E+K+I R H N+V++ +G E++ +V EYM LA++L E
Sbjct: 52 EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL---E 107
Query: 563 KQPNWVERMGI-ARDIARGILYLHDECETQIIHCDIKPQNILMD-ENRCAKISDFGLAKL 620
+ P E + + RG+ Y+H ++H D+KP N+ ++ E+ KI DFGLA++
Sbjct: 108 QGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164
Query: 621 MKPDQTRTFTGIRGTRGY----VAPEWHRNLPI-------TVKADVYSFGVVLLEII 666
+ P + +GY + +W+R+ + T D+++ G + E++
Sbjct: 165 VDPHYSH--------KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 46/167 (27%), Positives = 82/167 (49%), Gaps = 22/167 (13%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVE-RM 571
F ++ + H++LV+L G + + I+V EY+ G L D+ + EK + ++
Sbjct: 47 AFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPL-DVFLHREKNNVSLHWKL 104
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILM---DENR----CAKISDFGLAKLMKPD 624
+A+ +A + YL D+ +++H ++ +NIL+ N K+SD G+ +
Sbjct: 105 DVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR 161
Query: 625 QTRTFTGIRGTRG-YVAPEWHRNLP--ITVKADVYSFGVVLLEIICR 668
+ R R ++APE RN +T+ AD +SFG LLEI
Sbjct: 162 E------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 13/97 (13%)
Query: 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLA---KLMKPDQTRTFT 630
A +I G+ ++H+ +++ D+KP NIL+DE+ +ISD GLA KP +
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 155
Query: 631 GIRGTRGYVAPE-WHRNLPITVKADVYSFGVVLLEII 666
GT GY+APE + + AD +S G +L +++
Sbjct: 156 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 16/157 (10%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG--SLADILFNPEK-QPNWVERMGI 573
E+ ++ H N+VRL +K +LV+EYM D PN V+
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVK--SF 105
Query: 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK-PDQTRTFTGI 632
+ +GI + H E +++H D+KPQN+L+++ K++DFGLA+ P TF+
Sbjct: 106 TYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VNTFSNE 160
Query: 633 RGTRGYVAPE---WHRNLPITVKADVYSFGVVLLEII 666
T Y AP+ R ++ D++S G ++ E+I
Sbjct: 161 VVTLWYRAPDVLLGSRTYSTSI--DIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 32/94 (34%), Positives = 45/94 (47%), Gaps = 17/94 (18%)
Query: 580 GILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK------LMKPDQTRTFTGIR 633
GI +LH IIH D+KP NI++ + KI DFGLA+ +M P
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV------- 179
Query: 634 GTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
TR Y APE + D++S G ++ E+I
Sbjct: 180 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 16/98 (16%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-FTGIRGT 635
+ +G+ Y+H IIH D+KP N+ ++E+ KI DFGLA+ QT + TG T
Sbjct: 127 MLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVT 178
Query: 636 RGYVAPE----WHRNLPITVKADVYSFGVVLLEIICRR 669
R Y APE W T D++S G ++ E++ +
Sbjct: 179 RWYRAPEVILNWMH---YTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 8/95 (8%)
Query: 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK--LMKPDQTRTFTG 631
A +I G+ +LH + I++ D+K NIL+D + KI+DFG+ K ++ +T TF
Sbjct: 102 AAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC- 157
Query: 632 IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
GT Y+APE D +SFGV+L E++
Sbjct: 158 --GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 29/74 (39%), Positives = 45/74 (60%), Gaps = 1/74 (1%)
Query: 593 IHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG-IRGTRGYVAPEWHRNLPITV 651
IH D+ +N+L+ + R AKI DFGLA+ + D G R ++APE + TV
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293
Query: 652 KADVYSFGVVLLEI 665
++DV+S+G++L EI
Sbjct: 294 QSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 14/163 (8%)
Query: 526 HRNLVRL-----LGYSLEVSKKILVYEYMSNG--SLADILFNPEKQPNWVERMGIARDIA 578
H N+VRL + + +K LV+E++ + D + P ++ M +
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF--QLL 120
Query: 579 RGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGY 638
RG+ +LH +++H D+KPQNIL+ + K++DFGLA++ T + T Y
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWY 175
Query: 639 VAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQV 681
APE D++S G + E+ R+ + DQ+
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 47/193 (24%), Positives = 89/193 (46%), Gaps = 23/193 (11%)
Query: 552 GSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 611
+ D L N ++++ +G + +A G+ +L + +H D+ +N+L+ E + K
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVK 279
Query: 612 ISDFGLAKLMKPDQT-----RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
I DFGLA+ + D TF ++ ++APE N T +DV+SFG++L EI
Sbjct: 280 ICDFGLARDIMRDSNYISKGSTFLPLK----WMAPESIFNNLYTTLSDVWSFGILLWEIF 335
Query: 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPS 726
P LP + E Y + G ++ + ++ E M K C ++
Sbjct: 336 TLGGTPYPELP-----MNEQFYNAIKRG--YRMAKPAHASDEIYEIMQK----CWEEKFE 384
Query: 727 LRPSMKKVLLMLE 739
+RP +++ ++
Sbjct: 385 IRPDFSQLVHLVG 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 13/97 (13%)
Query: 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLA---KLMKPDQTRTFT 630
A +I G+ ++H+ +++ D+KP NIL+DE+ +ISD GLA KP +
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 155
Query: 631 GIRGTRGYVAPE-WHRNLPITVKADVYSFGVVLLEII 666
GT GY+APE + AD +S G +L +++
Sbjct: 156 --VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 19/164 (11%)
Query: 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKILV-YEYMSNGSLADILFNPEKQPNWVER--- 570
Q + G H+N++ +L +E + V Y YM+ G+L L +
Sbjct: 57 QESCLLYG-LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115
Query: 571 ------MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
M I IA G+ YLH + +IH DI +N ++DE KI+D L++ + P
Sbjct: 116 TQQLVHMAI--QIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPM 170
Query: 625 QTRTFTGIRGTR--GYVAPEWHRNLPITVKADVYSFGVVLLEII 666
G R ++A E N + +DV+SFGV+L E++
Sbjct: 171 DYHCL-GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 57/200 (28%), Positives = 83/200 (41%), Gaps = 31/200 (15%)
Query: 501 KEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL-----A 555
++EV +R F+T H LV L V EY + G L
Sbjct: 40 RDEVESLMCEKRIFET----ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT 95
Query: 556 DILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDF 615
D+ E + + A + G+ YLH E +I++ D+K N+L+D KI+DF
Sbjct: 96 DVF--SEPRAVFY-----AACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADF 145
Query: 616 GLAKL-MKP-DQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLD 673
GL K M D+T TF GT ++APE T D + GV++ E++
Sbjct: 146 GLCKEGMGFGDRTSTFC---GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLV---GES 199
Query: 674 PNLPDDQVILEEWVYQCFEN 693
P DD EE V+ N
Sbjct: 200 PFPGDD----EEEVFDSIVN 215
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 44/218 (20%)
Query: 468 YRRIPGNGSARY---CEDIAPLSFSYAELEKMTDGFKEEVGRGSSGEREFQTEMKVIGRT 524
Y + GS Y C I + ++K++ F+ E+ +R ++ E+ ++
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI----FAKRAYR-ELTLLKHM 71
Query: 525 HHRNLVRLLGYSLEVSKKI--------LVYEYMSNGSLADIL---FNPEKQPNWVERMGI 573
H N++ LL + S LV YM L I+ + +K V +M
Sbjct: 72 QHENVIGLL--DVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQM-- 126
Query: 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIR 633
G+ Y+H IIH D+KP N+ ++E+ KI DFGLA+ + TG
Sbjct: 127 ----LCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYV 175
Query: 634 GTRGYVAPE----W-HRNLPITVKADVYSFGVVLLEII 666
TR Y APE W H N + D++S G ++ E++
Sbjct: 176 VTRWYRAPEVILNWMHYNQTV----DIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 40/130 (30%), Positives = 65/130 (50%), Gaps = 15/130 (11%)
Query: 544 LVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNIL 603
+V EYM G L +++ N + W + A +L L +IH D+KP N+L
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNML 174
Query: 604 MDENRCAKISDFGLAKLMKPDQT---RTFTGIRGTRGYVAPEWHRNLP----ITVKADVY 656
+D++ K++DFG MK D+T R T + GT Y++PE ++ + D +
Sbjct: 175 LDKHGHLKLADFGTC--MKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 657 SFGVVLLEII 666
S GV L E++
Sbjct: 232 SVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 50/169 (29%), Positives = 76/169 (44%), Gaps = 27/169 (15%)
Query: 525 HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL--FNPEKQPNWVERMGIARDIARGIL 582
H+N+VRL K LV+EY + L N + P V+ + +G+
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMF--QLLKGLA 113
Query: 583 YLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGI--RGTRGYVA 640
+ H ++H D+KPQN+L+++N K++DFGLA R F GI R V
Sbjct: 114 FCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA--------RAF-GIPVRCYSAEVV 161
Query: 641 PEWHRNLPITVKA-------DVYSFGVVLLEIICRRRCLDP-NLPDDQV 681
W+R + A D++S G + E+ R L P N DDQ+
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 47/165 (28%), Positives = 74/165 (44%), Gaps = 18/165 (10%)
Query: 526 HRNLVRLLGYSLEV-----SKKILVYEYMSNGSLADILFNPEKQPNW---VERM-GIARD 576
H N+VRL+ +K LV+E++ D+ +K P E + + R
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQ----DLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
RG+ +LH C I+H D+KP+NIL+ K++DFGLA++ T + T
Sbjct: 117 FLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQM--ALTPVVVTL 171
Query: 637 GYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQV 681
Y APE D++S G + E+ R+ N DQ+
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVER 570
R TE ++ T LV+LL Y+ + + + L EY+ G +L N R
Sbjct: 46 RHVLTERDILTTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHAR 104
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
+A + LH E IH D+KP+N L+D + K++DFGL+K T+
Sbjct: 105 FYMAEMFE-AVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYA 155
Query: 631 -GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
+ G+ Y+APE R D +S G +L E +C
Sbjct: 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 16/93 (17%)
Query: 579 RGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGY 638
RG+ Y+H IIH D+KP N+ ++E+ +I DFGLA+ + TG TR Y
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWY 181
Query: 639 VAPE----W-HRNLPITVKADVYSFGVVLLEII 666
APE W H N + D++S G ++ E++
Sbjct: 182 RAPEIMLNWMHYNQTV----DIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 45/161 (27%), Positives = 68/161 (42%), Gaps = 27/161 (16%)
Query: 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKILV--------YEYMS---NGSLADILFNPEKQ 564
TE ++ +H ++++L G L+ Y Y++ N ++ DIL
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDIL------ 185
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
I R + R I YLH E +IIH DIK +NI ++ + DFG A
Sbjct: 186 -------AIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235
Query: 625 QTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
+ G GT APE P D++S G+VL E+
Sbjct: 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 43/155 (27%), Positives = 76/155 (49%), Gaps = 8/155 (5%)
Query: 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGI 573
+TE V+ + L Y+ + K+ L+ +Y+S G + L+ Q + +
Sbjct: 52 RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEV 107
Query: 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK-LMKPDQTRTFTGI 632
IL L + I++ DIK +NIL+D ++DFGL+K + ++ RT++
Sbjct: 108 RFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-F 166
Query: 633 RGTRGYVAPEWHRNLPITVKA-DVYSFGVVLLEII 666
GT Y+APE R KA D +S G+++ E++
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 44/146 (30%), Positives = 67/146 (45%), Gaps = 19/146 (13%)
Query: 536 SLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIH 594
S E + + +V EY+ G A +L N P + RM A + + YLH+ I+H
Sbjct: 69 SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL-ALEYLHN---YGIVH 124
Query: 595 CDIKPQNILMDENRCAKISDFGLAK--LMK----------PDQTRTFTG--IRGTRGYVA 640
D+KP N+L+ K++DFGL+K LM TR F + GT Y+A
Sbjct: 125 RDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIA 184
Query: 641 PEWHRNLPITVKADVYSFGVVLLEII 666
PE D ++ G++L E +
Sbjct: 185 PEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 41/122 (33%), Positives = 60/122 (49%), Gaps = 28/122 (22%)
Query: 533 LGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGI---------ARDIARGIL 582
L Y+ + K+ L+ EY+S G L L ER GI +I+ +
Sbjct: 65 LIYAFQTGGKLYLILEYLSGGELFMHL----------EREGIFMEDTACFYLSEISLALE 114
Query: 583 YLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK--LMKPDQTRTFTGIRGTRGYVA 640
+LH + II+ D+KP+NIL+D K++DFGL K + + T TF GT Y+A
Sbjct: 115 HLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMA 168
Query: 641 PE 642
PE
Sbjct: 169 PE 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 46/176 (26%), Positives = 83/176 (47%), Gaps = 27/176 (15%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-----RTFTG 631
+ARG+ +L + +H D+ +N+L+ + + KI DFGLA+ + D TF
Sbjct: 246 VARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 632 IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCF 691
++ ++APE + T +DV+S+G++L EI P + I++ Y
Sbjct: 303 VK----WMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM-----IVDSTFYNKI 353
Query: 692 ENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPIP 747
++G ++ + + ++ + M+K C EP RPS L L VE +P
Sbjct: 354 KSG--YRMAKPDHATQEVYDIMVK----CWNSEPEKRPS----FLHLSDIVESLLP 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 12/166 (7%)
Query: 511 EREFQTEMKVI-GRTHHRNLVRLLGYSLEVSKKI-----LVYEYMSNGSLADILFNPEKQ 564
+ E + E ++ + H N+V+ G + K LV E + GS+ D++ K+
Sbjct: 58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR 117
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+E IA + ++ L + IH D+K NIL+ K+ DFG++ +
Sbjct: 118 GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177
Query: 625 QTRTFTGIRGTRGYVAPE---WHRNLPITVKA--DVYSFGVVLLEI 665
+ R T + GT ++APE + L T A DV+S G+ +E+
Sbjct: 178 RLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 7/155 (4%)
Query: 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGI 573
+TE +V+ + L Y+ + K+ L+ +Y++ G L L E+ ++
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS 111
Query: 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIR 633
+I + +LH + II+ DIK +NIL+D N ++DFGL+K D+
Sbjct: 112 G-EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC 167
Query: 634 GTRGYVAPEWHR--NLPITVKADVYSFGVVLLEII 666
GT Y+AP+ R + D +S GV++ E++
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 19/102 (18%)
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR--TFT 630
I R++ + Y+H + +IH DIK NIL+ K+ DFG+A L+ + ++ TF
Sbjct: 106 IIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV 162
Query: 631 GIRGTRGYVAPEWHRNLPIT------VKADVYSFGVVLLEII 666
GT ++APE IT KAD++S G+ + E+
Sbjct: 163 ---GTPYWMAPE-----VITEGKYYDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 35/95 (36%), Positives = 50/95 (52%), Gaps = 8/95 (8%)
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMD--ENRCAKISDFGLAKLMKPDQTRTFT 630
+AR + I Y+H E IIH DIK +N+L++ E+ C + DFG A + + F
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSWSTPFH 319
Query: 631 -GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664
GI GT APE P T D++S G+V+ E
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 4e-06
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 15/94 (15%)
Query: 533 LGYSLEVSKKI-LVYEYMSNGSLADIL-----FNPEKQPNWVERMGIARDIARGILYLHD 586
L YSL+ + + LV EY+ G + +L F+ E ++ + +A D YLH
Sbjct: 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD------YLH- 121
Query: 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620
IIH D+KP N+L+ K++DFGL+K+
Sbjct: 122 --RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 47/187 (25%), Positives = 87/187 (46%), Gaps = 32/187 (17%)
Query: 493 LEKMTDGFKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGY-----SLEVSKKILVYE 547
++K++ F+ + + +R ++ E+ ++ +H+N++ LL SLE + + +
Sbjct: 54 IKKLSRPFQNQ----THAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 108
Query: 548 YMSNGSLADILFNPEKQPNWVERMG-IARDIARGILYLHDECETQIIHCDIKPQNILMDE 606
+ + +L ++ ERM + + GI +LH IIH D+KP NI++
Sbjct: 109 ELMDANLCQVIQMELDH----ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 161
Query: 607 NRCAKISDFGLAK------LMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGV 660
+ KI DFGLA+ +M P TR Y APE + D++S G
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVV--------TRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 661 VLLEIIC 667
++ E+I
Sbjct: 214 IMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 7/92 (7%)
Query: 579 RGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ-TRTF-TGIRGTR 636
R + Y+H + H D+KP+NIL + + KI DFGLA++ D T F T TR
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 637 GYVAPEWHRNL--PITVKADVYSFGVVLLEII 666
Y APE + T D++S G + E++
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 202
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-06
Identities = 36/128 (28%), Positives = 56/128 (43%), Gaps = 24/128 (18%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ----------- 625
I I Y+H + ++H D+KP NIL+ I D+G A K ++
Sbjct: 122 ICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 626 -----TRTFTG-IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC----RRRCLDPN 675
+ T G I GT Y+APE +P + D+Y+ GV+L +++ RR
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238
Query: 676 LPDDQVIL 683
+ VIL
Sbjct: 239 ISYRDVIL 246
|
Length = 932 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 5e-06
Identities = 40/145 (27%), Positives = 67/145 (46%), Gaps = 12/145 (8%)
Query: 525 HHRNLVRLLGYSLEVSKK-ILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILY 583
+ N ++L YS+ K +L+ +Y+ +G L D+L K E I R + +
Sbjct: 67 DNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSE-AEVKKIIRQLVEALND 124
Query: 584 LHDECETQIIHCDIKPQNILMDENRC-AKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPE 642
LH + IIH DIK +N+L D + + D+GL K++ GT Y +PE
Sbjct: 125 LH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPE 176
Query: 643 WHRNLPITVKADVYSFGVVLLEIIC 667
+ V D ++ GV+ E++
Sbjct: 177 KIKGHNYDVSFDWWAVGVLTYELLT 201
|
Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 33/144 (22%), Positives = 67/144 (46%), Gaps = 10/144 (6%)
Query: 526 HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGI---ARDIARGIL 582
H ++V+L+G + + +V E G L L + ++ + + ++ +
Sbjct: 66 HPHIVKLIGV-ITENPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALA 121
Query: 583 YLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPE 642
YL + +H DI +N+L+ C K+ DFGL++ ++ + + + ++APE
Sbjct: 122 YLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 643 WHRNLPITVKADVYSFGVVLLEII 666
T +DV+ FGV + EI+
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 49/217 (22%)
Query: 491 AELEKMTDGFKEEVGRGSSGEREFQTEMKVIGRTH------------------HRNLVRL 532
E ++M D ++ + G++ RE + +KV+ +H H +L +
Sbjct: 24 PEEDEMED--EDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81
Query: 533 LGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVE-RMGIARDIARGILYLHDECETQ 591
G + S+ I+V E++ +G L D+ EK V ++ +A+ +A + YL D+
Sbjct: 82 HGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---N 137
Query: 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKP-----DQTRTFTGI-RGTR----GYVAP 641
++H ++ +NIL+ + GLA+ P D +FT + R R ++AP
Sbjct: 138 LVHGNVCAKNILL--------ARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAP 189
Query: 642 EWHRNL-PITVKADVYSFGVVLLEIICRRRCLDPNLP 677
E ++ AD +SFG LLEI C D +P
Sbjct: 190 ECVPGGNSLSTAADKWSFGTTLLEI-----CFDGEVP 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 37/128 (28%), Positives = 63/128 (49%), Gaps = 11/128 (8%)
Query: 544 LVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNIL 603
+V EYM G L +++ N + W R A ++ + +H IH D+KP N+L
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPEKWA-RFYTA-EVVLALDAIH---SMGFIHRDVKPDNML 174
Query: 604 MDENRCAKISDFGLAKLMKPD-QTRTFTGIRGTRGYVAPEWHRNLPITV----KADVYSF 658
+D++ K++DFG M + R T + GT Y++PE ++ + D +S
Sbjct: 175 LDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 659 GVVLLEII 666
GV L E++
Sbjct: 234 GVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 30/197 (15%)
Query: 495 KMTDGFKEEVGRGSSGEREFQTE--MKVIGRTH------------------HRNLVRLLG 534
K+ G + EVG +TE +KV+ ++H H++LV G
Sbjct: 10 KIFKGIRREVG---DYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYG 66
Query: 535 YSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIH 594
+ + I+V EY+ GSL L + N ++ +A+ +A + +L D+ + H
Sbjct: 67 VCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTH 123
Query: 595 CDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG--IRGTR-GYVAPEWHRN-LPIT 650
++ +N+L+ K + KL P + T I R +V PE N ++
Sbjct: 124 GNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENPQNLS 183
Query: 651 VKADVYSFGVVLLEIIC 667
+ AD +SFG L EI
Sbjct: 184 LAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 517 EMKVIGRTHHRNLVRLLGY-----SLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVER 570
E+ ++ +H+N++ LL SLE + + LV E M + +L ++ ER
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDH----ER 124
Query: 571 MG-IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
M + + GI +LH IIH D+KP NI++ + KI DFGLA+ + T
Sbjct: 125 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP 181
Query: 630 TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
+ TR Y APE + D++S G ++ E++
Sbjct: 182 YVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 53/226 (23%)
Query: 544 LVYEYMSNGSLADILFNPEKQPNWVERMGIAR---DIARGILYLHDECETQIIHCDIKPQ 600
LV+EY+ + + N + I + +G+ + H ++H D+KPQ
Sbjct: 83 LVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQ 139
Query: 601 NILMDENR-CAKISDFGLAKLMK-PDQTRTFTGIRGTRGYVAPE-----WHRNLPITVKA 653
N+L+D+ + KI+D GL + P ++ T + T Y APE H + P+
Sbjct: 140 NLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWYRAPEVLLGSTHYSTPV---- 193
Query: 654 DVYSFGVVLLEIICRRRCLDP---------------NLPDDQVI-----LEEW-VYQCFE 692
D++S G + E+ R++ L P P +QV L +W + ++
Sbjct: 194 DIWSVGCIFAEMS-RKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWK 252
Query: 693 NGNLSQLVED---EEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+LS+ V D E +D L++M++ +P+ R S K L
Sbjct: 253 PQDLSRAVPDLSPEGLD--LLQKMLRY-------DPAKRISAKAAL 289
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 544 LVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNI 602
LV +Y G L +L E + P + R IA +L +H + +H DIKP N+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAE----MVLAIHSIHQLHYVHRDIKPDNV 133
Query: 603 LMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITV-----KADVYS 657
L+D N +++DFG M D T + GT Y++PE + + + + D +S
Sbjct: 134 LLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS 193
Query: 658 FGVVLLEII 666
GV + E++
Sbjct: 194 LGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 38/128 (29%), Positives = 61/128 (47%), Gaps = 11/128 (8%)
Query: 544 LVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNIL 603
+V EYM G L +++ N + W A +L L IH D+KP N+L
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNML 174
Query: 604 MDENRCAKISDFGLA-KLMKPDQTRTFTGIRGTRGYVAPEWHRNLP----ITVKADVYSF 658
+D++ K++DFG K+ K R T + GT Y++PE ++ + D +S
Sbjct: 175 LDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 659 GVVLLEII 666
GV L E++
Sbjct: 234 GVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 51/180 (28%), Positives = 70/180 (38%), Gaps = 55/180 (30%)
Query: 544 LVYEYMSNGSLAD--------------ILFNPEKQPNWVERMG-IARDIARGILY----L 584
LV+ Y +LAD +L + P +ER I + I R IL+ L
Sbjct: 212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGL 271
Query: 585 HDECETQIIHCDIKPQNILMDE-NRCAKISDFGLAK-------------LMKPDQTRTFT 630
H T I+H D+KPQNI+ E + KI D G A L+ P
Sbjct: 272 HS---TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQ 328
Query: 631 GIRGTRGYVAPE-----------WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDD 679
I T+ AP W NLP + D+YS G++ L++ PNL D
Sbjct: 329 YIMSTQTPSAPSAPVATALSPVLWQLNLPD--RFDIYSAGLIFLQM-----AF-PNLRSD 380
|
Length = 566 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 35/108 (32%), Positives = 55/108 (50%), Gaps = 17/108 (15%)
Query: 579 RGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGY 638
RG+ Y H + +I+H D+KPQN+L++E K++DFGLA+ K T+T++ T Y
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWY 169
Query: 639 VAPE-----WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQV 681
P+ + PI D++ G +L E+ R P P V
Sbjct: 170 RPPDVLLGSTEYSTPI----DMWGVGCILYEMATGR----PMFPGSTV 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-05
Identities = 14/69 (20%), Positives = 31/69 (44%), Gaps = 3/69 (4%)
Query: 347 ELKNTKWEDVSYYVLSETTEEKCKQACLEDCNCEAALFKEEE--CKMQRLPLRFGRRNLR 404
+L + K D + ++ + E+C++ACL +C+C A + C + L R
Sbjct: 16 KLPDVKLPD-NASAITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSS 74
Query: 405 DSSIAFVKV 413
++++
Sbjct: 75 GGGTLYLRL 83
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 23/159 (14%)
Query: 541 KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLH-----DECETQ-IIH 594
K +L+ EY S G L N + + E + ++ G+L+ DE ++ ++H
Sbjct: 139 KLLLIMEYGSGGDL-----NKQIKQRLKEHLPF-QEYEVGLLFYQIVLALDEVHSRKMMH 192
Query: 595 CDIKPQNILMDENRCAKISDFGLAKL----MKPDQTRTFTGIRGTRGYVAPE-WHRNLPI 649
D+K NI + K+ DFG +K + D +F G T Y+APE W R
Sbjct: 193 RDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG---TPYYLAPELWERK-RY 248
Query: 650 TVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVY 688
+ KAD++S GV+L E++ R P + I+++ +Y
Sbjct: 249 SKKADMWSLGVILYELLTLHRPFKG--PSQREIMQQVLY 285
|
Length = 478 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 39/166 (23%), Positives = 75/166 (45%), Gaps = 12/166 (7%)
Query: 511 EREFQTEMKVI-GRTHHRNLVRLLGYSLEVSKKI-----LVYEYMSNGSLADILFNPEKQ 564
+ E + E ++ +H N+V+ G + K + LV E + GS+ +++
Sbjct: 62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC 121
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
++ I+ + +L L +IIH D+K NIL+ K+ DFG++ +
Sbjct: 122 GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181
Query: 625 QTRTFTGIRGTRGYVAP-----EWHRNLPITVKADVYSFGVVLLEI 665
+ R T + GT ++AP E + + DV+S G+ +E+
Sbjct: 182 RLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 5e-05
Identities = 39/169 (23%), Positives = 80/169 (47%), Gaps = 35/169 (20%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLG--YSLEVSKKILVYEYMSNGSLADIL------FNPEK 563
RE Q ++ + + H N++RL+ + + + LV+E M + +L +++ ++
Sbjct: 46 REIQA-LRRL--SPHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKR 101
Query: 564 QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623
+++ + + + ++H I H DIKP+NIL+ ++ K++DFG + +
Sbjct: 102 VKSYM------YQLLKSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGI-- 149
Query: 624 DQTRTFTGIRGTRGYVAPE------WHRNLPITVKADVYSFGVVLLEII 666
+T TR Y APE ++ K D+++ G V EI+
Sbjct: 150 YSKPPYTEYISTRWYRAPECLLTDGYY-----GPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 39/164 (23%), Positives = 66/164 (40%), Gaps = 24/164 (14%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E+K++ H N++ L+ +E LV + M+ L + + + + + I
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKV-VDRKIRLTESQVKCILLQ 127
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLA-------------KLMKP 623
I G+ LH + +H D+ P NI ++ KI+DFGLA K
Sbjct: 128 ILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 624 DQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
+ T T Y APE + + A+ Y F V + + C
Sbjct: 185 QRREEMTSKVVTLWYRAPE------LLMGAEKYHFAVDMWSVGC 222
|
Length = 335 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 31/108 (28%), Positives = 57/108 (52%), Gaps = 5/108 (4%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
I RG+ Y H +++H D+KPQN+L++E K++DFGLA+ K T+T++ T
Sbjct: 113 ILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTL 168
Query: 637 GYVAPE-WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVIL 683
Y P+ + + + D++ G + E+ R + +D++ L
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 7e-05
Identities = 48/188 (25%), Positives = 90/188 (47%), Gaps = 21/188 (11%)
Query: 493 LEKMTDGFKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGY-----SLEVSKKILVYE 547
++K++ F+ + + +R ++ E+ ++ +H+N++ LL SLE + + +
Sbjct: 47 IKKLSRPFQNQ----THAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 101
Query: 548 YMSNGSLADILFNPEKQPNWVERMG-IARDIARGILYLHDECETQIIHCDIKPQNILMDE 606
+ + +L ++ ERM + + GI +LH IIH D+KP NI++
Sbjct: 102 ELMDANLCQVIQMELDH----ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 154
Query: 607 NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
+ KI DFGLA+ + T TR Y APE + D++S G ++ E++
Sbjct: 155 DCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
Query: 667 CRRRCLDP 674
R + L P
Sbjct: 213 -RHKILFP 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 7e-05
Identities = 47/185 (25%), Positives = 75/185 (40%), Gaps = 40/185 (21%)
Query: 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGI 573
TE +++ H L L S + + LV +Y G L +L ++QP +
Sbjct: 49 LTEQEILATLDHPFLPTLYA-SFQTETYLCLVMDYCPGGELFRLL---QRQPGKCLSEEV 104
Query: 574 ARDIARGIL----YLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL--------- 620
AR A +L YLH I++ D+KP+NIL+ E+ +SDF L+K
Sbjct: 105 ARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161
Query: 621 -----------MKPDQTRTF---TGIR-----GTRGYVAPEWHRNLPITVKADVYSFGVV 661
+ + TF R GT Y+APE D ++ G++
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGIL 221
Query: 662 LLEII 666
L E++
Sbjct: 222 LYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 33/176 (18%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF--NPE-------- 562
EF+ E + R H N+V LLG + +++ Y S+ L + L +P
Sbjct: 54 EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113
Query: 563 --------KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISD 614
+ ++V I IA G+ +L ++H D+ +N+L+ + KISD
Sbjct: 114 DKTVKSTLEPADFVH---IVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISD 167
Query: 615 FGLAKLMKPDQTRTFTG-----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
GL + + G IR +++PE ++ +D++S+GVVL E+
Sbjct: 168 LGLFREVYAADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 28/92 (30%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 579 RGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGY 638
RG+ Y H +++H D+KPQN+L++E K++DFGLA+ K T+T++ T Y
Sbjct: 115 RGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWY 170
Query: 639 VAPE-WHRNLPITVKADVYSFGVVLLEIICRR 669
P+ + + + D++ G + E+ R
Sbjct: 171 RPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 4/52 (7%)
Query: 579 RGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
RG+ Y H +++H D+KPQN+L+ E K++DFGLA+ K ++T++
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYS 161
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 544 LVYEYMSNGSLADILFNPEKQ-PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNI 602
LV +Y G L +L E + P + R +A ++ I +H + +H DIKP NI
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVIAIDSVH---QLHYVHRDIKPDNI 133
Query: 603 LMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP-----ITVKADVYS 657
LMD N +++DFG + D T + GT Y++PE + + + D +S
Sbjct: 134 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWS 193
Query: 658 FGVVLLEII 666
GV + E++
Sbjct: 194 LGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 21/53 (39%), Positives = 27/53 (50%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
IA IL + + IH DIKP N+L+D K+SDFGL +K F
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 31/201 (15%)
Query: 489 SYAELEKMTDGFKEEVGRGSSGEREFQTEMKVIGRTH-------------------HRNL 529
SY +LEK+ +G V +G S +KVI H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 530 VRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIAR---DIARGILYLHD 586
V L LV+EY+ D+ +K P + + + RG+ Y+H
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH- 120
Query: 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPE-WHR 645
+ I+H D+KPQN+L+ + K++DFGLA+ K + T++ T Y P+
Sbjct: 121 --QRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLG 177
Query: 646 NLPITVKADVYSFGVVLLEII 666
+ + D++ G + +E+I
Sbjct: 178 STEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 41/177 (23%), Positives = 82/177 (46%), Gaps = 18/177 (10%)
Query: 504 VGRGSSGEREFQTEMKVIGRTHHRNLV------RLLGYSLEVSKKIL--VYEYMSNGSLA 555
V GS + + E+ +GR +H N++ R + +++K +Y +M + +
Sbjct: 200 VKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEA-- 257
Query: 556 DILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDF 615
F+ + +P + I + + + Y+HD+ ++IH DIK +NI ++ + + DF
Sbjct: 258 ---FDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDF 311
Query: 616 GLA-KLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRC 671
G A K + + G GT +PE D++S G++LL+++ C
Sbjct: 312 GTAMPFEKEREAFDY-GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367
|
Length = 501 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 2e-04
Identities = 12/35 (34%), Positives = 18/35 (51%), Gaps = 1/35 (2%)
Query: 348 LKNTKWEDVSYY-VLSETTEEKCKQACLEDCNCEA 381
L N K D + V ++C+Q CL +C+C A
Sbjct: 10 LPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTA 44
|
Length = 66 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 7/101 (6%)
Query: 544 LVYEYMSNGSLADIL--FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQN 601
LV +Y G L +L F ++ P + R +A ++ I +H + +H DIKP N
Sbjct: 78 LVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLA-EMVLAIDSVH---QLGYVHRDIKPDN 132
Query: 602 ILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPE 642
+L+D+N +++DFG + D T GT Y++PE
Sbjct: 133 VLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 32/108 (29%), Positives = 44/108 (40%), Gaps = 19/108 (17%)
Query: 139 VLYDSNGKTLWQTFEHPTD----TLLPNQRLSVGTKLFPGISET--------NPSTGKFL 186
S+G+TL + + L+ R L+ G S T NPS
Sbjct: 1 SNPLSSGQTLV-SSGSLFELGFFKLIMQSRDYNLI-LYKGSSRTVVWVANRDNPSGSSCT 58
Query: 187 LIMQGDGNLVQYANINPYGTQHAYWASNTYNKGDNVSLNLDENGHLFL 234
L +Q DGNLV Y G+ W+SNT N L L ++G+L L
Sbjct: 59 LTLQSDGNLVIY-----DGSGTVVWSSNTTRVNGNYVLVLLDDGNLVL 101
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 5e-04
Identities = 26/85 (30%), Positives = 42/85 (49%), Gaps = 13/85 (15%)
Query: 535 YSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIH 594
Y ++ +K +V EY+ L D+L E P V ++G +A+ LH I+H
Sbjct: 404 YDVDPEEKTIVMEYIGGKDLKDVL---EGNPELVRKVG--EIVAK----LHK---AGIVH 451
Query: 595 CDIKPQNILMDENRCAKISDFGLAK 619
D+ N ++ ++R I DFGL K
Sbjct: 452 GDLTTSNFIVRDDRLYLI-DFGLGK 475
|
Length = 535 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 24/73 (32%), Positives = 37/73 (50%), Gaps = 4/73 (5%)
Query: 545 VYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILM 604
V +Y+ G + +L + R IA ++ I +H + IH DIKP NIL+
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVH---KMGFIHRDIKPDNILI 134
Query: 605 DENRCAKISDFGL 617
D + K++DFGL
Sbjct: 135 DRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDEN-RCAKISDFGLAKLMKPDQTRTFTGIRGT 635
+ R + Y+H + I H D+KPQN+L+D N K+ DFG AK + Q R+ + I +
Sbjct: 179 LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ-RSVSYI-CS 233
Query: 636 RGYVAPEWHRNLP-ITVKADVYSFGVVLLEII 666
R Y APE T D++S G ++ E+I
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 36/161 (22%), Positives = 67/161 (41%), Gaps = 14/161 (8%)
Query: 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN--PEKQPNWVERMG 572
Q E+ + H N++ + + S+ +V M+ GS D+L PE P
Sbjct: 47 QQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF- 105
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM-KPDQTRTF-- 629
I +D+ + Y+H + IH +K +IL+ + +S + M K + +
Sbjct: 106 ILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162
Query: 630 ---TGIRGTRGYVAPE-WHRNLP-ITVKADVYSFGVVLLEI 665
+++PE +NL K+D+YS G+ E+
Sbjct: 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 9e-04
Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 19/96 (19%)
Query: 579 RGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK-PDQTRTFTGIRGTRG 637
RG+ Y+H + I+H D+KPQN+L+ K++DFGLA+ P QT +
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS--------S 162
Query: 638 YVAPEWHRNLPITVKA-------DVYSFGVVLLEII 666
V W+R + + A D++ G + +E++
Sbjct: 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 25/75 (33%), Positives = 37/75 (49%), Gaps = 4/75 (5%)
Query: 544 LVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNIL 603
L+ E++ G L +L + V R +A +L + + IH DIKP NIL
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAE----CVLAIEAVHKLGFIHRDIKPDNIL 133
Query: 604 MDENRCAKISDFGLA 618
+D K+SDFGL+
Sbjct: 134 IDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 51/222 (22%), Positives = 96/222 (43%), Gaps = 51/222 (22%)
Query: 501 KEEVGRGSSGEREFQTEMKVIGRTH------------------HRNLVRLLGYSLEVSKK 542
++ G S E+E + +KV+ +H H+++V L G + +
Sbjct: 20 DDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79
Query: 543 ILVYEYMSNGSLADILFNPEKQP---NWVERMGIARDIARGILYLHDECETQIIHCDIKP 599
I+V E++ G L D+ + + W + +A+ +A + YL D+ ++H ++
Sbjct: 80 IMVEEFVEFGPL-DLFMHRKSDVLTTPW--KFKVAKQLASALSYLEDK---DLVHGNVCT 133
Query: 600 QNILMD----ENRCA---KISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEW---HRNLPI 649
+NIL+ + C K+SD G+ + Q ++APE +NL
Sbjct: 134 KNILLAREGIDGECGPFIKLSDPGIPITVLSRQECV-----ERIPWIAPECVEDSKNL-- 186
Query: 650 TVKADVYSFGVVLLEIICRRRCLDPNLP--DDQVILEEWVYQ 689
++ AD +SFG L EI C + +P D + +E Y+
Sbjct: 187 SIAADKWSFGTTLWEI-----CYNGEIPLKDKTLAEKERFYE 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.001
Identities = 14/47 (29%), Positives = 22/47 (46%), Gaps = 3/47 (6%)
Query: 346 RELKNTKWEDVSYYVLSETTEEKCKQACLE-DCNCEAALF--KEEEC 389
L NTK S V+S + E+C CL +C+C + + + C
Sbjct: 7 VRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGC 53
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 6/104 (5%)
Query: 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGI 573
+ E ++ + +V+L YS + + V +Y+ G + +L E P + R I
Sbjct: 49 KAERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYI 107
Query: 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL 617
A ++ I +H + IH DIKP NIL+D + K++DFGL
Sbjct: 108 A-ELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.002
Identities = 25/85 (29%), Positives = 43/85 (50%), Gaps = 9/85 (10%)
Query: 535 YSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIH 594
Y ++ I+V EY+ L D++ N +E + ++R+I R + LH IIH
Sbjct: 67 YFVDPENFIIVMEYIEGEPLKDLI-----NSNGMEELELSREIGRLVGKLH---SAGIIH 118
Query: 595 CDIKPQNILMDENRCAKISDFGLAK 619
D+ N+++ + I DFGLA+
Sbjct: 119 GDLTTSNMILSGGKIYLI-DFGLAE 142
|
Length = 211 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.002
Identities = 23/85 (27%), Positives = 41/85 (48%), Gaps = 12/85 (14%)
Query: 535 YSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIH 594
Y ++ K +V EY+ L D++ E + +G R + + LH + I+H
Sbjct: 65 YDVDPDNKTIVMEYIEGKPLKDVIE--EGNDELLREIG--RLVGK----LH---KAGIVH 113
Query: 595 CDIKPQNILMDENRCAKISDFGLAK 619
D+ NI++ +++ I DFGL K
Sbjct: 114 GDLTTSNIIVRDDKLYLI-DFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.004
Identities = 47/187 (25%), Positives = 78/187 (41%), Gaps = 35/187 (18%)
Query: 511 ERE---FQTEMKVIGRTHHRNLVRLLGYSLEVS--KKILVYEYMSNGSLADILFNPEKQP 565
ERE E+ V+ H+N+VR + L + K ++ E+ G L+ + K
Sbjct: 53 EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF 112
Query: 566 NWVERMGIARDIARGILYLHDECET--------QIIHCDIKPQNIL-------------- 603
+E I DI R +L+ C +++H D+KPQNI
Sbjct: 113 GKIEEHAIV-DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171
Query: 604 ---MDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPE--WHRNLPITVKADVYSF 658
++ AKI DFGL+K + + GT Y +PE H K+D+++
Sbjct: 172 ANNLNGRPIAKIGDFGLSKNIGIESMA--HSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229
Query: 659 GVVLLEI 665
G ++ E+
Sbjct: 230 GCIIYEL 236
|
Length = 1021 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 757 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.98 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.98 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.98 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.98 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.96 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.96 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.96 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.96 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.95 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.95 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.94 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.94 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.94 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.94 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.94 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.93 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.93 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.93 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.92 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.92 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.91 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.91 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.9 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.9 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.89 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.89 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.89 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.87 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.85 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.85 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.84 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.82 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.8 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.77 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.73 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.71 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.67 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.66 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.61 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.59 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.59 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.56 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.54 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.48 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.45 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.43 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.42 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.33 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.32 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.3 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.3 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.29 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.27 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.26 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.21 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.2 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.19 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.16 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.14 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.12 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.86 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.85 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.74 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.67 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.63 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.6 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.48 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.44 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.42 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.38 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.38 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.38 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.35 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.32 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.27 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.17 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.13 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.12 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.09 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.93 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.59 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.54 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.53 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.23 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.12 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.08 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.83 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 96.81 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.74 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.68 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.68 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.55 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.15 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.07 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 95.6 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.58 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.25 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 95.18 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.09 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.88 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.66 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.47 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.37 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 92.94 | |
| PLN02236 | 344 | choline kinase | 92.88 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 92.75 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 90.5 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 90.01 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 89.49 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 89.3 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 89.18 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 89.14 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 88.63 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 88.33 | |
| smart00223 | 79 | APPLE APPLE domain. Four-fold repeat in plasma kal | 87.54 | |
| PF14295 | 51 | PAN_4: PAN domain; PDB: 2YIL_E 2YIP_C 2YIO_A. | 86.78 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-51 Score=437.69 Aligned_cols=260 Identities=45% Similarity=0.755 Sum_probs=233.5
Q ss_pred CCccccHHHHHHhhcccc--ccccCCCch-------------------------HHHHHHHHHHHhhcCCCceeeeeeEE
Q 038168 484 APLSFSYAELEKMTDGFK--EEVGRGSSG-------------------------EREFQTEMKVIGRTHHRNLVRLLGYS 536 (757)
Q Consensus 484 ~~~~~~~~~l~~~t~~f~--~~lg~g~~~-------------------------~~~~~~E~~~l~~l~h~niv~l~g~~ 536 (757)
....|+|.||.+||++|+ ..+|+|+|| .++|.+|+.++++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 566799999999999999 489999882 47899999999999999999999999
Q ss_pred Eece-eeeEEEEeccCCChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEee
Q 038168 537 LEVS-KKILVYEYMSNGSLADILFNPEK-QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISD 614 (757)
Q Consensus 537 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~D 614 (757)
.+.+ +++||||||++|+|.++|+.... .++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9999 59999999999999999998766 889999999999999999999999999999999999999999999999999
Q ss_pred cCCccccCC-CCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhc
Q 038168 615 FGLAKLMKP-DQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFEN 693 (757)
Q Consensus 615 fGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 693 (757)
||||+..+. ........ .||.+|+|||++..+..++|+|||||||+|+||+||+++.+...+..+..+.+|++..+.+
T Consensus 221 FGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999977654 22211111 7999999999999999999999999999999999999999877666666799999999999
Q ss_pred CCccccccccc----cCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcCC
Q 038168 694 GNLSQLVEDEE----VDE-KQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEI 744 (757)
Q Consensus 694 ~~~~~~~d~~~----~~~-~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~~ 744 (757)
+++.+++|+.. ... +++.++.+++.+|++.+|++||+|.||+++|+.+...
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99999999873 233 6899999999999999999999999999999765543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.00 Aligned_cols=216 Identities=33% Similarity=0.511 Sum_probs=184.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEece-eeeEEEEeccCCChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVS-KKILVYEYMSNGSLADILFN-PEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.++|.+|+.+|++++|||||+++|+|.+.. ...+||||+++|+|.+++++ ....+++..+++|+.+||+|+.|||++
T Consensus 83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~- 161 (362)
T KOG0192|consen 83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE- 161 (362)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-
Confidence 568999999999999999999999999988 79999999999999999988 478899999999999999999999998
Q ss_pred CCC-eeeCCCCcceEEECCCC-cEEEeecCCccccCCCCcceecccccCccccCccccc--CCCCCccccchhhHHHHHH
Q 038168 589 ETQ-IIHCDIKPQNILMDENR-CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR--NLPITVKADVYSFGVVLLE 664 (757)
Q Consensus 589 ~~~-iiH~Dik~~Nill~~~~-~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~Dv~S~G~~l~e 664 (757)
. ||||||||+|||++.+. ++||+|||+++...... ...+...||..|||||++. ...++.|+|||||||++||
T Consensus 162 --~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWE 238 (362)
T KOG0192|consen 162 --GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWE 238 (362)
T ss_pred --CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHH
Confidence 6 99999999999999997 99999999999765432 3334478999999999999 5699999999999999999
Q ss_pred HHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 665 IICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
|+||+.||....+ . +.+......+.-.. .+......+..++.+||+.||+.||++.+|+.+|+.+.
T Consensus 239 l~t~~~Pf~~~~~-~-----~~~~~v~~~~~Rp~------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 239 LLTGEIPFEDLAP-V-----QVASAVVVGGLRPP------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred HHHCCCCCCCCCH-H-----HHHHHHHhcCCCCC------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 9999999986544 1 11222222222221 22336678899999999999999999999999999654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=346.15 Aligned_cols=218 Identities=32% Similarity=0.459 Sum_probs=186.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN-PEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.|.+|+++|++|+|+|||+++|+|..++..+||||||+.|+|.+||.. .+..+...+.+.++.|||+|++||+++
T Consensus 245 ~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~-- 322 (468)
T KOG0197|consen 245 PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK-- 322 (468)
T ss_pred hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC--
Confidence 48899999999999999999999999998999999999999999999987 567889999999999999999999999
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
.+|||||.++|||++++..+||+|||||+...++......+..-+..|.|||.+....++.|||||||||+|+||+|-.
T Consensus 323 -~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G 401 (468)
T KOG0197|consen 323 -NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYG 401 (468)
T ss_pred -CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccC
Confidence 9999999999999999999999999999977776666666777788999999999999999999999999999999954
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcC-CccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcCC
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENG-NLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEI 744 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~~ 744 (757)
+...+ .+...+ +.+.+++| ++. .+...+.++.+|+..||+.+|++|||++.+...|+.+...
T Consensus 402 ~~py~-----~msn~e-v~~~le~GyRlp-------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 402 RVPYP-----GMSNEE-VLELLERGYRLP-------RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCC-----CCCHHH-HHHHHhccCcCC-------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 43322 222233 33344444 232 2344567899999999999999999999999999876543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=323.54 Aligned_cols=213 Identities=29% Similarity=0.431 Sum_probs=178.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEece-eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVS-KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+++.+|++++++.+||+||+++|.|.... +..++||||++|||++++... +.++....-+|+.++++||.|||+.
T Consensus 121 ~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~-- 197 (364)
T KOG0581|consen 121 QKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEE-- 197 (364)
T ss_pred HHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhc--
Confidence 478899999999999999999999999888 599999999999999998653 6688888899999999999999963
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
.+||||||||+|||++..+.+||+|||.++.+... ....++||..|||||.+.+..|+.++||||||++++|+.+|+
T Consensus 198 ~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~Gr 274 (364)
T KOG0581|consen 198 RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGR 274 (364)
T ss_pred cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCC
Confidence 39999999999999999999999999999987654 234578999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDE-KQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
.|+....+ ......+.+... -.+..+ ..+. ....++..++..||+.||.+||+..|++++
T Consensus 275 fP~~~~~~-~~~~~~~Ll~~I-v~~ppP------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 275 FPYPPPNP-PYLDIFELLCAI-VDEPPP------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCcCC-CCCCHHHHHHHH-hcCCCC------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 99987522 122222222222 222211 1222 366789999999999999999999998863
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=351.86 Aligned_cols=237 Identities=30% Similarity=0.449 Sum_probs=198.8
Q ss_pred HHHhhccccccccCCCch--------------------------------HHHHHHHHHHHhhcCCCceeeeeeEEEece
Q 038168 493 LEKMTDGFKEEVGRGSSG--------------------------------EREFQTEMKVIGRTHHRNLVRLLGYSLEVS 540 (757)
Q Consensus 493 l~~~t~~f~~~lg~g~~~--------------------------------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 540 (757)
+..--..|.+++|+|.|| .++|++|+++++.++|||||+|+|.|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 333344567889999985 378999999999999999999999999999
Q ss_pred eeeEEEEeccCCChhhhhcCCC---------C----CCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCC
Q 038168 541 KKILVYEYMSNGSLADILFNPE---------K----QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN 607 (757)
Q Consensus 541 ~~~lV~e~~~~gsL~~~l~~~~---------~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~ 607 (757)
..++|+|||..|+|.+||.... . .++..+.++||.|||.|++||-++ .+|||||..+|+|+.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence 9999999999999999996321 1 278889999999999999999998 99999999999999999
Q ss_pred CcEEEeecCCccccCCCCcceec-ccccCccccCcccccCCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCccccHHH
Q 038168 608 RCAKISDFGLAKLMKPDQTRTFT-GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEE 685 (757)
Q Consensus 608 ~~~ki~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~ 685 (757)
..|||+||||+|..-..+.+... +..-.++||+||.++.++||.+||||||||+|||+++ |+.|+.+...++
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------ 713 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------ 713 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH------
Confidence 99999999999966444433322 3344779999999999999999999999999999998 667776654432
Q ss_pred HHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcCCC
Q 038168 686 WVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIP 745 (757)
Q Consensus 686 ~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~~~ 745 (757)
+.+.++.|++. - .+...+.++.+|+..||+.+|++||+++||-..|+...+..
T Consensus 714 -VIe~i~~g~lL--~----~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 -VIECIRAGQLL--S----CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred -HHHHHHcCCcc--c----CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 56677777763 2 24456678999999999999999999999999999755443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=325.15 Aligned_cols=209 Identities=27% Similarity=0.401 Sum_probs=175.3
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 038168 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQI 592 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 592 (757)
...+|+++|++|+|||||++++++.+.+..||||||+++|+|.+++-. .+.+....-.-+++|++.|+.|||+. +|
T Consensus 222 ~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~---GI 297 (475)
T KOG0615|consen 222 DVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQ---GI 297 (475)
T ss_pred hhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHc---Cc
Confidence 456999999999999999999999999999999999999999999865 34455566678999999999999999 99
Q ss_pred eeCCCCcceEEECCC---CcEEEeecCCccccCCCCcceecccccCccccCcccccCCC---CCccccchhhHHHHHHHH
Q 038168 593 IHCDIKPQNILMDEN---RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP---ITVKADVYSFGVVLLEII 666 (757)
Q Consensus 593 iH~Dik~~Nill~~~---~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~S~G~~l~ell 666 (757)
+||||||+||||..+ ..+||+|||||+..+. ...+...+||+.|.|||++.... +..|+|+||+||+||-++
T Consensus 298 ~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcL 375 (475)
T KOG0615|consen 298 IHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCL 375 (475)
T ss_pred ccccCCcceEEeccCCcceEEEecccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEe
Confidence 999999999999766 7799999999998763 34556789999999999998654 335889999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+|.+||.....+.. +.+.+..|++... .....+..++..+++.+||+.||++|||++|+++
T Consensus 376 sG~pPFS~~~~~~s------l~eQI~~G~y~f~---p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 376 SGYPPFSEEYTDPS------LKEQILKGRYAFG---PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ccCCCcccccCCcc------HHHHHhcCccccc---ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 99999986554321 2344556655432 1233566788999999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=335.26 Aligned_cols=208 Identities=27% Similarity=0.399 Sum_probs=180.8
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+...+||++.++|+|||||++++++++.+..|||.|+|++++|.++++ ..+.++..++..+.+||+.||.|||+.
T Consensus 61 ~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~-- 137 (592)
T KOG0575|consen 61 QREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSL-- 137 (592)
T ss_pred hHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhc--
Confidence 45788999999999999999999999999999999999999999999986 578889999999999999999999999
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+|||||..|+||+++.++||+|||||..+..+..+. ..++||+.|+|||++....++..+||||+||++|-|+.|+
T Consensus 138 -~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk-~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~ 215 (592)
T KOG0575|consen 138 -GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK-KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGR 215 (592)
T ss_pred -CceecccchhheeecCcCcEEecccceeeeecCccccc-ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCC
Confidence 99999999999999999999999999999887665443 3479999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+||+...- .+ ....++..+.. ++.....+..+|+..+|++||.+|||+++|+.
T Consensus 216 PPFetk~v------ke-ty~~Ik~~~Y~-------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 216 PPFETKTV------KE-TYNKIKLNEYS-------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred CCcccchH------HH-HHHHHHhcCcc-------cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 99985421 11 23333333222 22344566788999999999999999999997
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=306.26 Aligned_cols=215 Identities=22% Similarity=0.367 Sum_probs=180.4
Q ss_pred HHHHHHHHHHhhcCCCceeeeee-EEEecee-eeEEEEeccCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLG-YSLEVSK-KILVYEYMSNGSLADILFN---PEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g-~~~~~~~-~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
+....|+.+|++|+|||||+.++ -+.+.++ .+|||||+..|+|...++. .++.++..++.+++.|+++||.++|.
T Consensus 63 q~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~ 142 (375)
T KOG0591|consen 63 QDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHS 142 (375)
T ss_pred HHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhc
Confidence 67889999999999999999998 4455555 8999999999999998853 35678999999999999999999999
Q ss_pred CCCCC--eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHH
Q 038168 587 ECETQ--IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664 (757)
Q Consensus 587 ~~~~~--iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~e 664 (757)
+. ++ |+||||||.||+|+.++.+||+||||++.+..... ..+..+||+.||+||.+++.+|+.||||||+||++||
T Consensus 143 ~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyE 220 (375)
T KOG0591|consen 143 KI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYE 220 (375)
T ss_pred cc-cccceeeccCcchheEEcCCCceeeccchhHhHhcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHH
Confidence 42 24 99999999999999999999999999999876544 3456899999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 665 IICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
|..-.+||.+. .+.+ +.+.++.|+++.+ .+......+.+|+..|+..||+.||+...+++.+..
T Consensus 221 McaL~~PF~g~------n~~~-L~~KI~qgd~~~~-----p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 221 MCALQSPFYGD------NLLS-LCKKIEQGDYPPL-----PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHhcCCCcccc------cHHH-HHHHHHcCCCCCC-----cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 99999999865 2222 3455666755433 225677889999999999999999986666555543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.68 Aligned_cols=215 Identities=28% Similarity=0.486 Sum_probs=185.7
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
.+|+.|+.||.++.||||++|.|+.......++|+|||+||+|+.||+++..++.+.+...++++||.|++||.+. +
T Consensus 675 rdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~ 751 (996)
T KOG0196|consen 675 RDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---N 751 (996)
T ss_pred hhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---C
Confidence 6899999999999999999999999999999999999999999999999999999999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCccee--cccccCccccCcccccCCCCCccccchhhHHHHHHHHh-C
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF--TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-R 668 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G 668 (757)
+|||||.++|||++.+..+|++||||+|.+.++..... .+-+-..+|.|||.+...+++..||||||||+|||+++ |
T Consensus 752 YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyG 831 (996)
T KOG0196|consen 752 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 831 (996)
T ss_pred chhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccC
Confidence 99999999999999999999999999998876654333 33444678999999999999999999999999999876 6
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcC-CccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcC
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENG-NLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~ 743 (757)
.+|+-....++ +.+.+++| +++ .+++.+..|.+|++.|||+|-.+||.+.||+.+|++++.
T Consensus 832 ERPYWdmSNQd-------VIkaIe~gyRLP-------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 832 ERPYWDMSNQD-------VIKAIEQGYRLP-------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred CCcccccchHH-------HHHHHHhccCCC-------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 67765433322 22222322 232 245667889999999999999999999999999998653
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=306.53 Aligned_cols=160 Identities=30% Similarity=0.501 Sum_probs=145.7
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+..|+.+|+.++|||||++++++...+..|||||||.+|+|.+|++. .+.++..+...++.|+|.||++||++ +
T Consensus 54 e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~---~ 129 (429)
T KOG0595|consen 54 ELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHEN---N 129 (429)
T ss_pred HHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 5577899999999999999999999999999999999999999999976 44788899999999999999999999 9
Q ss_pred eeeCCCCcceEEECCC------CcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 592 IIHCDIKPQNILMDEN------RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 592 iiH~Dik~~Nill~~~------~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
||||||||+||||+.. -.+||+|||+||.+..... ....+|++-|||||+++..+|+.|+|+||.|+++||+
T Consensus 130 IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~--a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~ 207 (429)
T KOG0595|consen 130 IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSM--AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQC 207 (429)
T ss_pred eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhH--HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHH
Confidence 9999999999999765 5689999999998874432 3357899999999999999999999999999999999
Q ss_pred HhCCCCCCCCCC
Q 038168 666 ICRRRCLDPNLP 677 (757)
Q Consensus 666 ltG~~p~~~~~~ 677 (757)
++|+.||+....
T Consensus 208 l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 208 LTGKPPFDAETP 219 (429)
T ss_pred HhCCCCccccCH
Confidence 999999986544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.75 Aligned_cols=238 Identities=23% Similarity=0.315 Sum_probs=190.3
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
....+||.||++|.||||++|.+...+. ...|||+|||+. +|..++....-.++..++..+++|++.||+|+|.+
T Consensus 161 ~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~-- 237 (560)
T KOG0600|consen 161 ITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR-- 237 (560)
T ss_pred HHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc--
Confidence 4557899999999999999999998876 689999999987 89999988778899999999999999999999999
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG 668 (757)
+|+|||||.+|||||.++.+||+|||||+++........++.+-|..|.|||.+.+. .|+...|+||.||||.||+.|
T Consensus 238 -gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~g 316 (560)
T KOG0600|consen 238 -GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLG 316 (560)
T ss_pred -CeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcC
Confidence 999999999999999999999999999999988887778888999999999999875 799999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHH-----HHHhcCCcc--ccccccc-c-------CHHHHHHHHHHHHHccccCCCCCCCHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVY-----QCFENGNLS--QLVEDEE-V-------DEKQLERMIKVALWCILDEPSLRPSMKK 733 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~-----~~~~~~~~~--~~~d~~~-~-------~~~~~~~l~~l~~~cl~~~p~~RPsm~e 733 (757)
++.+.+..+-++....-.+. ..|...+++ ..+.+.. + ........++|+..+|..||.+|.|+.+
T Consensus 317 kPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~ 396 (560)
T KOG0600|consen 317 KPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASS 396 (560)
T ss_pred CCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHH
Confidence 99998776554433221110 112212222 1111111 1 1112355788899999999999999999
Q ss_pred HHHHhhcCcCCCCCCCCCCcc
Q 038168 734 VLLMLEGTVEIPIPPNPTSFL 754 (757)
Q Consensus 734 Vl~~Le~~~~~~~p~~p~~~~ 754 (757)
+++.= -....|.|+.|++++
T Consensus 397 aL~se-yF~t~p~~~~p~~Lp 416 (560)
T KOG0600|consen 397 ALQSE-YFTTEPLPCDPSSLP 416 (560)
T ss_pred HhcCc-ccccCCCCCCcccCC
Confidence 88742 235556666665543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=335.41 Aligned_cols=217 Identities=28% Similarity=0.450 Sum_probs=181.3
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC------CCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP------EKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.+|.+|..+|++++|||||+++|+|.+....++++|||++|+|..||++. ...+.....+.++.|||+|..|||
T Consensus 740 ~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe 819 (1025)
T KOG1095|consen 740 SDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE 819 (1025)
T ss_pred HHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH
Confidence 78999999999999999999999999999999999999999999999887 567888999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecc-cccCccccCcccccCCCCCccccchhhHHHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG-IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~e 664 (757)
++ ++|||||.++|+||+....+||+||||||.+-..+...... ..-...|||||.++.+.++.|+|||||||++||
T Consensus 820 ~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWE 896 (1025)
T KOG1095|consen 820 SK---HFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWE 896 (1025)
T ss_pred hC---CCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHH
Confidence 99 99999999999999999999999999999554443333332 244679999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcC
Q 038168 665 IICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~ 743 (757)
++|...+.++..... +......+.|++. + +...++.+.+|+..||+.+|++||++..|++.++.+..
T Consensus 897 ifslG~~PY~~~~n~-----~v~~~~~~ggRL~----~---P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 897 IFSLGATPYPSRSNF-----EVLLDVLEGGRLD----P---PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred HHhCCCCCCCCcchH-----HHHHHHHhCCccC----C---CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 999665444333222 2122234455332 2 34456778899999999999999999999998887543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=350.13 Aligned_cols=244 Identities=25% Similarity=0.499 Sum_probs=195.3
Q ss_pred ccHHHHHHhhccccccccCCCchH----------------------HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEE
Q 038168 488 FSYAELEKMTDGFKEEVGRGSSGE----------------------REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILV 545 (757)
Q Consensus 488 ~~~~~l~~~t~~f~~~lg~g~~~~----------------------~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 545 (757)
++++++..... ..+.+|+|++|. .....|++++++++|||||+++|+|.+.+..++|
T Consensus 683 ~~~~~~~~~~~-~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 683 ITINDILSSLK-EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred hhHHHHHhhCC-cccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 45555544322 235789998842 1234679999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCC
Q 038168 546 YEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ 625 (757)
Q Consensus 546 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~ 625 (757)
|||+++|+|.++++ .++|.++.+|+.|+|+||+|||..+.++|+||||||+||+++.++.+++. ||........
T Consensus 762 ~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 762 HEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred EeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 99999999999995 38999999999999999999998777899999999999999999988876 6665543221
Q ss_pred cceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCcccccccc--
Q 038168 626 TRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDE-- 703 (757)
Q Consensus 626 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~-- 703 (757)
....++..|+|||++.+..++.|+|||||||++|||++|+.|++..... .....+|+............+|+.
T Consensus 836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCcccc
Confidence 1235789999999999999999999999999999999999998654332 334556665555444444444432
Q ss_pred ---ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcC
Q 038168 704 ---EVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 704 ---~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~ 743 (757)
....++..++.+++.+|++.+|++||+|.||+++|+.+..
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 2355677889999999999999999999999999998654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=294.85 Aligned_cols=200 Identities=26% Similarity=0.311 Sum_probs=167.7
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+..++|..+|.+++||.||+++-.+++.+..|||+||+.||.|..+|.+ +..++.....-++.+|+.||.|||++ +
T Consensus 70 ~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~---g 145 (357)
T KOG0598|consen 70 RHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSK---G 145 (357)
T ss_pred HHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhC---C
Confidence 5678899999999999999999999999999999999999999999965 45677777777999999999999999 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRC 671 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p 671 (757)
||||||||+|||||.+|.++|+||||++..-.... .+..++||+.|||||++.+..++..+|.||+|+++|||++|.+|
T Consensus 146 IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pP 224 (357)
T KOG0598|consen 146 IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPP 224 (357)
T ss_pred eeeccCCHHHeeecCCCcEEEeccccchhcccCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCC
Confidence 99999999999999999999999999996544433 33448999999999999999999999999999999999999999
Q ss_pred CCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC
Q 038168 672 LDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP 729 (757)
Q Consensus 672 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP 729 (757)
|...... + ..+.+..++... .+.-...+..+++...++.+|++|.
T Consensus 225 F~~~~~~------~-~~~~I~~~k~~~------~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 225 FYAEDVK------K-MYDKILKGKLPL------PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CcCccHH------H-HHHHHhcCcCCC------CCccCCHHHHHHHHHHhccCHHHhc
Confidence 9865321 2 223333343211 1112345678889999999999995
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=317.60 Aligned_cols=220 Identities=30% Similarity=0.380 Sum_probs=181.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.++|.+|++++++++|||||+++|++......++|||+++||+|.++|.+....++..+++.++.++|+||+|||++
T Consensus 205 ~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k--- 281 (474)
T KOG0194|consen 205 IKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK--- 281 (474)
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---
Confidence 47899999999999999999999999999999999999999999999998877899999999999999999999999
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-CC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-RR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G~ 669 (757)
.+|||||.++|+|++.+..+||+||||++.-....... ..-.-+..|+|||.+....+++++|||||||++||+++ |.
T Consensus 282 ~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~ 360 (474)
T KOG0194|consen 282 NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGA 360 (474)
T ss_pred CCcchhHhHHHheecCCCeEEeCccccccCCcceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCC
Confidence 99999999999999999999999999988654111111 01235689999999999999999999999999999998 67
Q ss_pred CCCCCCCCCccccHHHHHHHHH-hcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcCCCCC
Q 038168 670 RCLDPNLPDDQVILEEWVYQCF-ENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPIP 747 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~~~~p 747 (757)
.|+.+.... + +...+ ..+.... .+...+..+..++..|+..+|++||+|.+|.+.|+.+.....+
T Consensus 361 ~Py~g~~~~------~-v~~kI~~~~~r~~------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 361 EPYPGMKNY------E-VKAKIVKNGYRMP------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCCCCCHH------H-HHHHHHhcCccCC------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 776644322 2 22222 2222111 1224456778888899999999999999999999986655443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.48 Aligned_cols=215 Identities=27% Similarity=0.428 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEece--eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVS--KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.+.+.+|+.+|++++|||||+.+|.....+ .+++.|||+++|+|.+++.+.+..++...+..+++||++||+|||++
T Consensus 58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~- 136 (313)
T KOG0198|consen 58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK- 136 (313)
T ss_pred HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 466899999999999999999999855444 68999999999999999987665789999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECC-CCcEEEeecCCccccCC--CCcceecccccCccccCcccccCC-CCCccccchhhHHHHHH
Q 038168 589 ETQIIHCDIKPQNILMDE-NRCAKISDFGLAKLMKP--DQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLE 664 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~-~~~~ki~DfGla~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~e 664 (757)
+|+||||||+|||++. ++.+||+|||+++.... ..........||+.|||||++.++ ....++||||+||+++|
T Consensus 137 --g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvE 214 (313)
T KOG0198|consen 137 --GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVE 214 (313)
T ss_pred --CEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEe
Confidence 9999999999999999 79999999999987764 222334457899999999999964 34469999999999999
Q ss_pred HHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 665 IICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
|+||++||... ....+++.........+ .++.....+..+++.+|++.+|++|||++++++..-
T Consensus 215 M~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 215 MLTGKPPWSEF-----FEEAEALLLIGREDSLP------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ccCCCCcchhh-----cchHHHHHHHhccCCCC------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 99999999864 11112222222222222 233445677889999999999999999999998653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=308.70 Aligned_cols=230 Identities=28% Similarity=0.442 Sum_probs=189.1
Q ss_pred cccccCCCch-------------------------HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChh
Q 038168 501 KEEVGRGSSG-------------------------EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLA 555 (757)
Q Consensus 501 ~~~lg~g~~~-------------------------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 555 (757)
.+.||+|.|| .+.|++||..+++-+|.||+=+.|+|.+... .+|+.++++.+|.
T Consensus 397 ~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY 475 (678)
T KOG0193|consen 397 GERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLY 475 (678)
T ss_pred cceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhh
Confidence 4679999995 2789999999999999999999999998877 9999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCC-Ccceeccccc
Q 038168 556 DILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD-QTRTFTGIRG 634 (757)
Q Consensus 556 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~-~~~~~~~~~g 634 (757)
.+|+-.+..++..+.+.||.|||+|+.|||.+ .|||||||..||+|.+++.|||+||||+..-..- .........|
T Consensus 476 ~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~g 552 (678)
T KOG0193|consen 476 THLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHG 552 (678)
T ss_pred hhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCcc
Confidence 99998889999999999999999999999999 9999999999999999999999999999754321 1122223457
Q ss_pred CccccCcccccCC---CCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHH
Q 038168 635 TRGYVAPEWHRNL---PITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLE 711 (757)
Q Consensus 635 t~~y~aPE~~~~~---~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 711 (757)
...|||||+++.. +|++.+||||||+++|||++|..|+... ..+++.+ +...|.+ ..|..........
T Consensus 553 silwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dqIif------mVGrG~l--~pd~s~~~s~~pk 623 (678)
T KOG0193|consen 553 SLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQIIF------MVGRGYL--MPDLSKIRSNCPK 623 (678)
T ss_pred chhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-ChhheEE------Eeccccc--CccchhhhccCHH
Confidence 8899999998753 7999999999999999999999999833 3222221 1112211 1222233445567
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHhhcCcC
Q 038168 712 RMIKVALWCILDEPSLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 712 ~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~ 743 (757)
++.+|+..||..++++||.+.+|+.+|+.+..
T Consensus 624 ~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 624 AMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred HHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 88899999999999999999999998887654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=303.34 Aligned_cols=234 Identities=26% Similarity=0.396 Sum_probs=188.6
Q ss_pred cccccccCCCch--------------------------HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCC
Q 038168 499 GFKEEVGRGSSG--------------------------EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 552 (757)
Q Consensus 499 ~f~~~lg~g~~~--------------------------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 552 (757)
.|.++||+|.|| .++|.+|+++|.+++|||||+|+|.|...+..++|+|||++|
T Consensus 541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 477899999985 378999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceec-
Q 038168 553 SLADILFNPEKQ-PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT- 630 (757)
Q Consensus 553 sL~~~l~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~- 630 (757)
+|.+|+.++.-. ..-..-++|+.|||.|++||.+. .+|||||.++|+|+|.++++||+|||++|-+-..+.....
T Consensus 621 DLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqg 697 (807)
T KOG1094|consen 621 DLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQG 697 (807)
T ss_pred cHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeec
Confidence 999999876433 35566678999999999999998 9999999999999999999999999999966555544433
Q ss_pred ccccCccccCcccccCCCCCccccchhhHHHHHHHHh--CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHH
Q 038168 631 GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC--RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEK 708 (757)
Q Consensus 631 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 708 (757)
..+-.++|||+|.+..++++.++|||+||+++||+++ ...|+.....+ ...+.....+..+....... .+.-
T Consensus 698 r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~l~---~P~~ 771 (807)
T KOG1094|consen 698 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVVLS---RPPA 771 (807)
T ss_pred ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCcceecc---CCCc
Confidence 3566889999999999999999999999999999854 55666543322 12222222333222222211 2334
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 709 QLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 709 ~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
.+..+.+++++||..+-++||+++++...|...
T Consensus 772 cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 772 CPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 456788999999999999999999999998754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=307.36 Aligned_cols=218 Identities=25% Similarity=0.392 Sum_probs=174.5
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEece-eeeEEEEeccCCChhhhhcCCC-------------------------
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLEVS-KKILVYEYMSNGSLADILFNPE------------------------- 562 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~------------------------- 562 (757)
..+.+.+|+.+++++ +||||+++++++...+ ..++||||+++|+|.+++....
T Consensus 53 ~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (338)
T cd05102 53 EHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132 (338)
T ss_pred HHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhc
Confidence 346789999999999 8999999999887654 5789999999999999986431
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECC
Q 038168 563 ------------------------------------KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDE 606 (757)
Q Consensus 563 ------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~ 606 (757)
..+++.+.+.++.||++||+|||+. +|+||||||+|||++.
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~ 209 (338)
T cd05102 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSE 209 (338)
T ss_pred cccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcC
Confidence 2367888899999999999999998 9999999999999999
Q ss_pred CCcEEEeecCCccccCCCCcce-ecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCccccHH
Q 038168 607 NRCAKISDFGLAKLMKPDQTRT-FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-RRRCLDPNLPDDQVILE 684 (757)
Q Consensus 607 ~~~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~ 684 (757)
++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 210 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----- 284 (338)
T cd05102 210 NNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----- 284 (338)
T ss_pred CCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----
Confidence 9999999999998764332221 222446778999999999999999999999999999997 999887543221
Q ss_pred HHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 685 EWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 685 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
........+..... +......+.+++.+||+.||++|||+.||+++|+.+.
T Consensus 285 -~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 285 -EFCQRLKDGTRMRA------PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred -HHHHHHhcCCCCCC------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11222333322111 1233457889999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.62 Aligned_cols=216 Identities=25% Similarity=0.382 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+++++|++.++.++||||++.+..|..+.+.|+||.||.+||+.++++.. ...++...+..|.+++++||.|||.+
T Consensus 68 ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~-- 145 (516)
T KOG0582|consen 68 LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN-- 145 (516)
T ss_pred HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc--
Confidence 478999999999999999999999999999999999999999999999653 34578888999999999999999999
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc---eecccccCccccCcccccCC--CCCccccchhhHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR---TFTGIRGTRGYVAPEWHRNL--PITVKADVYSFGVVLLE 664 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~G~~l~e 664 (757)
|.||||||+.||||+++|.+||+|||.+..+.....+ ....++||+.|||||++++. .|+.|+|||||||+.+|
T Consensus 146 -G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~E 224 (516)
T KOG0582|consen 146 -GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACE 224 (516)
T ss_pred -CceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHH
Confidence 9999999999999999999999999998766543322 22557899999999996543 59999999999999999
Q ss_pred HHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccc---cccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 665 IICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLV---EDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|.+|..||....+-.- +... ..+..+.+. .+.+........+.+++..||+.||++|||++++++
T Consensus 225 LA~G~aPf~k~pPmkv------Ll~t-Lqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 225 LAHGHAPFSKYPPMKV------LLLT-LQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HhcCCCCcccCChHHH------HHHH-hcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 9999999986544211 1111 122222111 111122334457889999999999999999999986
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=282.18 Aligned_cols=220 Identities=24% Similarity=0.320 Sum_probs=174.7
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+-.++|+++|++|+|+|+|.|+++|......+||+||++.--|.+ |.......+.....+++.|+++|+.|+|++ .
T Consensus 46 KIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~e-Le~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n 121 (396)
T KOG0593|consen 46 KIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHE-LERYPNGVPSELVKKYLYQLLKAIHFCHKN---N 121 (396)
T ss_pred HHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHH-HHhccCCCCHHHHHHHHHHHHHHhhhhhhc---C
Confidence 556799999999999999999999999999999999998855554 445556677788889999999999999999 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHHHhCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|||||||+||||+.++.+||+|||.||.+.. .....+..+.|..|.|||.+.+ .+|...+|||+.||++.||++|.+
T Consensus 122 ~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~p 200 (396)
T KOG0593|consen 122 CIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEP 200 (396)
T ss_pred eecccCChhheEEecCCcEEeccchhhHhhcC-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCc
Confidence 99999999999999999999999999998874 2334566788999999999988 789999999999999999999999
Q ss_pred CCCCCCCCccccHHHHH--------HHHHhcC------Ccccccccccc---CHHHHHHHHHHHHHccccCCCCCCCHHH
Q 038168 671 CLDPNLPDDQVILEEWV--------YQCFENG------NLSQLVEDEEV---DEKQLERMIKVALWCILDEPSLRPSMKK 733 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~--------~~~~~~~------~~~~~~d~~~~---~~~~~~~l~~l~~~cl~~~p~~RPsm~e 733 (757)
.|.+..+-++..+.... .+.+... .+++..+++.. -+....-+++++..|++.||++|++-+|
T Consensus 201 L~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~q 280 (396)
T KOG0593|consen 201 LWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQ 280 (396)
T ss_pred CCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHH
Confidence 88776655443322111 1111111 12222222111 1122346899999999999999999999
Q ss_pred HHH
Q 038168 734 VLL 736 (757)
Q Consensus 734 Vl~ 736 (757)
++.
T Consensus 281 ll~ 283 (396)
T KOG0593|consen 281 LLH 283 (396)
T ss_pred Hhc
Confidence 875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=303.04 Aligned_cols=210 Identities=27% Similarity=0.398 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
++-+.+|+.+|+..+|+|||++++.+..+++.++|||||++|+|.+.+.+ ..++..++..|+++++.||+|||.+
T Consensus 314 keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~--- 388 (550)
T KOG0578|consen 314 KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHAR--- 388 (550)
T ss_pred hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhc---
Confidence 35678999999999999999999999999999999999999999999854 4588999999999999999999999
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+|||||.+||||+.++.+||+|||++..+...+.. ....+||+.|||||+.....|.+|.||||||++++||+-|.+
T Consensus 389 gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K-R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEP 467 (550)
T KOG0578|consen 389 GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK-RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEP 467 (550)
T ss_pred ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCC
Confidence 9999999999999999999999999999988776653 345789999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|+-...+-. +..++......++-.+ ......+.++..+||+.|+++||++.|+++.
T Consensus 468 PYlnE~Plr-------AlyLIa~ng~P~lk~~----~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 468 PYLNENPLR-------ALYLIATNGTPKLKNP----EKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CccCCChHH-------HHHHHhhcCCCCcCCc----cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 987533211 1222222223333333 3445678999999999999999999999873
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=293.88 Aligned_cols=215 Identities=26% Similarity=0.347 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.|.+|+.++++++||||+++++++...+..++||||+++|+|.+++......+++.+++.++.|++.||+|||+.
T Consensus 50 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~--- 126 (266)
T cd05064 50 RRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM--- 126 (266)
T ss_pred HHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 45789999999999999999999999999999999999999999999977666789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-CC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-RR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G~ 669 (757)
+++||||||+|||++.++.+|++|||.+...............++..|+|||.+.+..++.++||||||++++|+++ |+
T Consensus 127 ~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~ 206 (266)
T cd05064 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGE 206 (266)
T ss_pred CEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999999876543322222222345678999999999999999999999999999875 99
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
.||......+ ..+....+... ..+...+..+.+++..||+.+|++||++.+|++.|++.
T Consensus 207 ~p~~~~~~~~-------~~~~~~~~~~~------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 207 RPYWDMSGQD-------VIKAVEDGFRL------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCcCcCCHHH-------HHHHHHCCCCC------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 9886543211 11222322211 11223456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=297.08 Aligned_cols=209 Identities=25% Similarity=0.365 Sum_probs=173.7
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+-...|-.+|.+| .||.|++|+-.+++...+|+|+||+++|+|.++|.+. ..++......++.+|+.||+|||++
T Consensus 118 kYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~--- 193 (604)
T KOG0592|consen 118 KYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSN--- 193 (604)
T ss_pred chhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhc---
Confidence 3455788889999 8999999999999999999999999999999999764 5677788888999999999999999
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc----------ee--cccccCccccCcccccCCCCCccccchhh
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR----------TF--TGIRGTRGYVAPEWHRNLPITVKADVYSF 658 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~ 658 (757)
+||||||||+|||||+|+.+||+|||-|+.+...... .. ..++||..|.+||.+.....+..+|+|+|
T Consensus 194 GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAl 273 (604)
T KOG0592|consen 194 GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWAL 273 (604)
T ss_pred CceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHH
Confidence 9999999999999999999999999999988643221 11 34899999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 038168 659 GVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 659 G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~L 738 (757)
||+||+|+.|.+||....+. ..+ +.+..-.+ .+++..++.+.+|+.+.|..||.+|+|.+||.+..
T Consensus 274 GCilyQmlaG~PPFra~Ney--liF-----qkI~~l~y-------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 274 GCILYQMLAGQPPFRAANEY--LIF-----QKIQALDY-------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHHHHhcCCCCCccccHH--HHH-----HHHHHhcc-------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 99999999999999865332 111 11111111 12333346788899999999999999999998753
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=293.92 Aligned_cols=212 Identities=22% Similarity=0.288 Sum_probs=172.5
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEe----ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLE----VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
+.|.+|+.++++++|||||+++|++.+ ....++||||+++|+|.+++.+ ...+++.++.+++.+++.||.|||+.
T Consensus 63 ~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~ 141 (283)
T PHA02988 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKY 141 (283)
T ss_pred HHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhc
Confidence 668899999999999999999999877 3467899999999999999965 45788999999999999999999973
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC--CCCCccccchhhHHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN--LPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~G~~l~el 665 (757)
.+++||||||+|||+++++.+||+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||
T Consensus 142 --~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el 215 (283)
T PHA02988 142 --TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEI 215 (283)
T ss_pred --CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHH
Confidence 277899999999999999999999999998654322 22457899999999976 6899999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
++|+.||...... +........+.-. . .+......+.+++.+||+.||++|||+.||++.|+...
T Consensus 216 ~~g~~Pf~~~~~~------~~~~~i~~~~~~~-~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 216 FTGKIPFENLTTK------EIYDLIINKNNSL-K-----LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHCCCCCCCCCHH------HHHHHHHhcCCCC-C-----CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 9999999754221 1111221221111 1 11234567889999999999999999999999998654
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=286.74 Aligned_cols=218 Identities=25% Similarity=0.403 Sum_probs=177.9
Q ss_pred CCCchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 506 ~g~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.+....++|.+|+.++++++|+||+++++++.+.+..++||||+++|+|.+++......+++..+..++.|++.||+|||
T Consensus 38 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 117 (256)
T cd05114 38 EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117 (256)
T ss_pred cCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH
Confidence 33445678999999999999999999999999999999999999999999999765567899999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+. +++|+||||+||++++++.+||+|||+++..............++..|+|||.+.+..++.++||||||++++||
T Consensus 118 ~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el 194 (256)
T cd05114 118 RN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEV 194 (256)
T ss_pred HC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHH
Confidence 98 999999999999999999999999999987644333333334456789999999988999999999999999999
Q ss_pred Hh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 666 IC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 666 lt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
++ |+.|+...... +.+ .....+.. ...+ ......+.+++.+||+.+|++||+|.+++++|.
T Consensus 195 ~~~g~~p~~~~~~~------~~~-~~i~~~~~--~~~~----~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 195 FTEGKMPFEKKSNY------EVV-EMISRGFR--LYRP----KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HcCCCCCCCCCCHH------HHH-HHHHCCCC--CCCC----CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 99 88887643221 111 11222211 1111 122357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=287.53 Aligned_cols=242 Identities=27% Similarity=0.403 Sum_probs=184.5
Q ss_pred ccccccCCCch---------------------HHHHHHHHHHHhh--cCCCceeeeeeEEEece----eeeEEEEeccCC
Q 038168 500 FKEEVGRGSSG---------------------EREFQTEMKVIGR--THHRNLVRLLGYSLEVS----KKILVYEYMSNG 552 (757)
Q Consensus 500 f~~~lg~g~~~---------------------~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~----~~~lV~e~~~~g 552 (757)
+.+.+|+|.|| .+.|.+|-.|.+. ++|+||+++++.-..+. +++||+||.++|
T Consensus 214 l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kG 293 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKG 293 (534)
T ss_pred hHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCC
Confidence 34677888885 3678888887765 48999999999877665 899999999999
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC------CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc
Q 038168 553 SLADILFNPEKQPNWVERMGIARDIARGILYLHDEC------ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626 (757)
Q Consensus 553 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~ 626 (757)
+|.+||. ...++|....+|+..|++||+|||++. +++|+|||||.+|||+.+|++..|+|||||..+.....
T Consensus 294 sL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~ 371 (534)
T KOG3653|consen 294 SLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKP 371 (534)
T ss_pred cHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCC
Confidence 9999995 467899999999999999999999864 57899999999999999999999999999998876554
Q ss_pred c-eecccccCccccCcccccCC-CC-----CccccchhhHHHHHHHHhCCCCCC-CCCCCccccHHHH---------HHH
Q 038168 627 R-TFTGIRGTRGYVAPEWHRNL-PI-----TVKADVYSFGVVLLEIICRRRCLD-PNLPDDQVILEEW---------VYQ 689 (757)
Q Consensus 627 ~-~~~~~~gt~~y~aPE~~~~~-~~-----~~k~Dv~S~G~~l~elltG~~p~~-~~~~~~~~~l~~~---------~~~ 689 (757)
. ...+.+||.+|||||++.+. .+ -.+.||||+|.+||||+++..-.+ ...++-+..+... ++.
T Consensus 372 ~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~ 451 (534)
T KOG3653|consen 372 QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQE 451 (534)
T ss_pred CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHH
Confidence 3 33458899999999999764 22 257999999999999999876664 2222223322211 122
Q ss_pred HHhcCCcc-ccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcCC
Q 038168 690 CFENGNLS-QLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEI 744 (757)
Q Consensus 690 ~~~~~~~~-~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~~ 744 (757)
.....+.. .+-+.- .....+..+.+.+..||.+||+.|.|+.-|.+++..+.-+
T Consensus 452 ~VV~kK~RP~~p~~W-~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 452 LVVRKKQRPKIPDAW-RKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred HHHhhccCCCChhhh-hcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 22111111 111110 1124567789999999999999999999998888765543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=294.69 Aligned_cols=207 Identities=29% Similarity=0.406 Sum_probs=172.5
Q ss_pred HHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeC
Q 038168 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHC 595 (757)
Q Consensus 516 ~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~ 595 (757)
.+|+-|++|+|+||+.+.|+|....-++||||||+.|-|...|+. +..+.-.....+..+||.|+.|||.+ .||||
T Consensus 161 TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHR 236 (904)
T KOG4721|consen 161 TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHR 236 (904)
T ss_pred hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhh
Confidence 478889999999999999999999999999999999999999965 44555566778999999999999998 99999
Q ss_pred CCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 038168 596 DIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPN 675 (757)
Q Consensus 596 Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~ 675 (757)
|||.-||||..+..+||+|||-++..... ...-.+.||..|||||++.+.+.++|+||||||||||||+||..|+..-
T Consensus 237 DLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 237 DLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred ccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 99999999999999999999999876543 2233578999999999999999999999999999999999999988643
Q ss_pred CCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 676 LPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 676 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
..... .|.-|.-. .....+...++-+.-|++.||+..|.+||++.+|+..|+-
T Consensus 315 dssAI---------IwGVGsNs---L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 315 DSSAI---------IWGVGSNS---LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred chhee---------EEeccCCc---ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 22110 01111100 0112355667778889999999999999999999999974
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=290.44 Aligned_cols=221 Identities=24% Similarity=0.349 Sum_probs=173.1
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC------------------CCCCHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE------------------KQPNWVERM 571 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------~~l~~~~~~ 571 (757)
..++|.+|++++++++|+||+++++++.+.+..++||||+++|+|.+++.... ..++|.++.
T Consensus 62 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (304)
T cd05096 62 ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLL 141 (304)
T ss_pred HHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHH
Confidence 35679999999999999999999999999999999999999999999885421 246888999
Q ss_pred HHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCccee-cccccCccccCcccccCCCCC
Q 038168 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF-TGIRGTRGYVAPEWHRNLPIT 650 (757)
Q Consensus 572 ~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~ 650 (757)
+++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......... ....++..|+|||++.+..++
T Consensus 142 ~i~~~i~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 218 (304)
T cd05096 142 HVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT 218 (304)
T ss_pred HHHHHHHHHHHHHHHC---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC
Confidence 9999999999999998 999999999999999999999999999986644332222 224457889999999988999
Q ss_pred ccccchhhHHHHHHHHhC--CCCCCCCCCCccccHHHHHHHHHhcCCcc-ccccccccCHHHHHHHHHHHHHccccCCCC
Q 038168 651 VKADVYSFGVVLLEIICR--RRCLDPNLPDDQVILEEWVYQCFENGNLS-QLVEDEEVDEKQLERMIKVALWCILDEPSL 727 (757)
Q Consensus 651 ~k~Dv~S~G~~l~elltG--~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~ 727 (757)
.++||||||++++||+++ ..|+...... ...+.+.......... ....+ ...+..+.+++.+||+.+|++
T Consensus 219 ~~~Dv~slG~~l~el~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 219 TASDVWAFGVTLWEILMLCKEQPYGELTDE---QVIENAGEFFRDQGRQVYLFRP----PPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred chhhhHHHHHHHHHHHHccCCCCCCcCCHH---HHHHHHHHHhhhccccccccCC----CCCCHHHHHHHHHHccCCchh
Confidence 999999999999999874 4555533221 1112222222221111 11111 223467899999999999999
Q ss_pred CCCHHHHHHHhhc
Q 038168 728 RPSMKKVLLMLEG 740 (757)
Q Consensus 728 RPsm~eVl~~Le~ 740 (757)
||||.||++.|+.
T Consensus 292 RPs~~~i~~~l~~ 304 (304)
T cd05096 292 RPSFSDIHAFLTE 304 (304)
T ss_pred CcCHHHHHHHHhC
Confidence 9999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=301.99 Aligned_cols=217 Identities=26% Similarity=0.402 Sum_probs=174.0
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC--------------------------
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-------------------------- 562 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-------------------------- 562 (757)
..+.+.+|+.+++.+ +||||+++++++.+.+..++||||+++|+|.+++....
T Consensus 81 ~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (375)
T cd05104 81 EREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREM 160 (375)
T ss_pred HHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcc
Confidence 346788999999999 89999999999999999999999999999999885421
Q ss_pred ------------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeee
Q 038168 563 ------------------------------------------------KQPNWVERMGIARDIARGILYLHDECETQIIH 594 (757)
Q Consensus 563 ------------------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 594 (757)
..+++..+++++.||++||+|||+. +|+|
T Consensus 161 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH 237 (375)
T cd05104 161 SCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIH 237 (375)
T ss_pred cchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---Ceec
Confidence 1467888999999999999999998 9999
Q ss_pred CCCCcceEEECCCCcEEEeecCCccccCCCCccee-cccccCccccCcccccCCCCCccccchhhHHHHHHHHh-CCCCC
Q 038168 595 CDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF-TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-RRRCL 672 (757)
Q Consensus 595 ~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G~~p~ 672 (757)
|||||+|||++.++.+||+|||+++.......... ....++..|+|||.+.+..++.++||||||++++||++ |..|+
T Consensus 238 ~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~ 317 (375)
T cd05104 238 RDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317 (375)
T ss_pred cCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 99999999999999999999999987654332221 12345678999999999999999999999999999998 77777
Q ss_pred CCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 673 DPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 673 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
....... . ..+.+..+.... .+ .....++.+++.+|++.||++||+|.||+++|+..
T Consensus 318 ~~~~~~~--~----~~~~~~~~~~~~--~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 318 PGMPVDS--K----FYKMIKEGYRML--SP----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCchH--H----HHHHHHhCccCC--CC----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 5432211 1 122223222111 11 11235788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=293.48 Aligned_cols=207 Identities=28% Similarity=0.441 Sum_probs=174.5
Q ss_pred HHHHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|+.++++++ ||||++++.++......++||||+.+|+|.+++.+ ...+...+..+++.|++.|++|+|+.
T Consensus 63 ~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~-- 139 (370)
T KOG0583|consen 63 DELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSR-- 139 (370)
T ss_pred chhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC--
Confidence 455668999999998 99999999999999999999999999999999987 66777799999999999999999998
Q ss_pred CCeeeCCCCcceEEECCC-CcEEEeecCCccccCCCCcceecccccCccccCcccccCCC-CC-ccccchhhHHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDEN-RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP-IT-VKADVYSFGVVLLEII 666 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~-~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~k~Dv~S~G~~l~ell 666 (757)
+|+||||||+|||||.+ +++||+|||++.... .........+||+.|+|||++.+.. |. .++||||+||+||.|+
T Consensus 140 -gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml 217 (370)
T KOG0583|consen 140 -GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLL 217 (370)
T ss_pred -CEeeCCCCHHHEEecCCCCCEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHH
Confidence 99999999999999999 999999999999875 2233445678999999999999977 75 8899999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl 735 (757)
+|+.||+... ... +...+..+.+.-. .... ..++..++.+|++.||.+|+++.+|+
T Consensus 218 ~G~~PF~d~~------~~~-l~~ki~~~~~~~p---~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 218 CGRLPFDDSN------VPN-LYRKIRKGEFKIP---SYLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred hCCCCCCCcc------HHH-HHHHHhcCCccCC---CCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 9999998621 111 1222344432211 1111 57789999999999999999999999
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=286.12 Aligned_cols=218 Identities=29% Similarity=0.401 Sum_probs=177.8
Q ss_pred CchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 508 SSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 508 ~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
..+.+++.+|++++++++|+||+++++++...+..++||||+++++|.+++... ...+++..++.++.|+++||+|||+
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~ 122 (263)
T cd05052 43 TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 122 (263)
T ss_pred chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 335678999999999999999999999999999999999999999999998654 3468999999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
. +++||||||+||++++++.+||+|||+++..............++..|+|||++.+..++.++||||||++++||+
T Consensus 123 ~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 199 (263)
T cd05052 123 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 199 (263)
T ss_pred C---CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 8 9999999999999999999999999999876543322222233467899999999999999999999999999999
Q ss_pred h-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 667 C-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 667 t-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
+ |..|+.....+ + .......+... ..+...+..+.+++.+|++.+|++||++.+++++|+.+
T Consensus 200 t~g~~p~~~~~~~------~-~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 200 TYGMSPYPGIDLS------Q-VYELLEKGYRM------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred cCCCCCCCCCCHH------H-HHHHHHCCCCC------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 8 88887643221 1 12222222111 11222346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=297.10 Aligned_cols=215 Identities=27% Similarity=0.394 Sum_probs=180.3
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 038168 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQI 592 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 592 (757)
.+.+|+.+|+.+.|||+++|++.+++..++|||.||+++|.|.+++-.+ +.+...+..+++.||+.|+.|+|.. +|
T Consensus 58 ~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~---~i 133 (786)
T KOG0588|consen 58 GIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAF---NI 133 (786)
T ss_pred chhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhh---cc
Confidence 4668999999999999999999999999999999999999999999664 4566678889999999999999998 99
Q ss_pred eeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCC-CccccchhhHHHHHHHHhCCCC
Q 038168 593 IHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEIICRRRC 671 (757)
Q Consensus 593 iH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~G~~l~elltG~~p 671 (757)
+|||+||+|+|||..+++||+|||+|.+...+. ....-+|++.|.|||++++.+| ..++||||.|||||.|++|+.|
T Consensus 134 cHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LP 211 (786)
T KOG0588|consen 134 CHRDLKPENLLLDVKNNIKIADFGMASLEVPGK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLP 211 (786)
T ss_pred eeccCCchhhhhhcccCEeeeccceeecccCCc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCC
Confidence 999999999999999999999999998755443 2344689999999999999998 5789999999999999999999
Q ss_pred CCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcCcCCCCC
Q 038168 672 LDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM--LEGTVEIPIP 747 (757)
Q Consensus 672 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~--Le~~~~~~~p 747 (757)
|+. +.... +......|.+. ++.....++.+|+.+|+..||+.|.|++||++. |.+-..++.+
T Consensus 212 FdD---dNir~----LLlKV~~G~f~-------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 212 FDD---DNIRV----LLLKVQRGVFE-------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred CCC---ccHHH----HHHHHHcCccc-------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 982 22111 23444555543 234456778999999999999999999999994 5565554443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=287.98 Aligned_cols=215 Identities=21% Similarity=0.316 Sum_probs=174.3
Q ss_pred HHHHHHHHhhcC-CCceeeeeeEEEece-eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 514 FQTEMKVIGRTH-HRNLVRLLGYSLEVS-KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 514 ~~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
=.+|++.|++|+ |||||+|.+.+.+.+ ..++|||||+. +|.++++.+.+.++...+..|+.||++||+|+|++ |
T Consensus 55 nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---G 130 (538)
T KOG0661|consen 55 NLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---G 130 (538)
T ss_pred HHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---C
Confidence 358999999998 999999999999888 99999999965 99999988888999999999999999999999999 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc-CCCCCccccchhhHHHHHHHHhCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR-NLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+.|||+||+|||+..+..+||+||||||.+.... ..+..+.|+.|.|||++. ..-|+.+.|||++|||++||.+-++
T Consensus 131 fFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrP 208 (538)
T KOG0661|consen 131 FFHRDLKPENILISGNDVIKIADFGLAREVRSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRP 208 (538)
T ss_pred cccccCChhheEecccceeEecccccccccccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcc
Confidence 9999999999999999999999999999876544 345678899999999875 5678999999999999999999998
Q ss_pred CCCCCCCCccccHHHHHHHHHhc-----------------CCcccccccc--ccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFEN-----------------GNLSQLVEDE--EVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~-----------------~~~~~~~d~~--~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
.|-+..+-++..- +.+.+.. -++++..-.. ..-.....++++++..|+.-||++|||+
T Consensus 209 LFPG~sE~Dqi~K---Ic~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA 285 (538)
T KOG0661|consen 209 LFPGASEIDQIYK---ICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTA 285 (538)
T ss_pred cCCCCcHHHHHHH---HHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccH
Confidence 8776544332211 1111100 0111110000 0112266889999999999999999999
Q ss_pred HHHHHH
Q 038168 732 KKVLLM 737 (757)
Q Consensus 732 ~eVl~~ 737 (757)
.|.+++
T Consensus 286 ~~al~~ 291 (538)
T KOG0661|consen 286 SQALQH 291 (538)
T ss_pred HHHhcC
Confidence 999985
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=284.05 Aligned_cols=218 Identities=27% Similarity=0.421 Sum_probs=178.2
Q ss_pred CCchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhh
Q 038168 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 507 g~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
+....+++.+|+.++++++|+||+++++++...+..++||||+++++|.+++.... ..+++.++..++.|++.||.|||
T Consensus 41 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 120 (261)
T cd05068 41 GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120 (261)
T ss_pred CcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 33456789999999999999999999999999999999999999999999996543 56899999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+. +++|+||||+||++++++.+||+|||+++...........+...+..|+|||++.+..++.++||||||++++||
T Consensus 121 ~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 197 (261)
T cd05068 121 AQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEI 197 (261)
T ss_pred hC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHH
Confidence 98 999999999999999999999999999987764332222233345689999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 666 IC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 666 lt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
++ |+.|+...... . +.......... ..+......+.+++.+|++.+|++||+|.++++.||.
T Consensus 198 ~t~g~~p~~~~~~~------~-~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 198 VTYGRMPYPGMTNA------E-VLQQVDQGYRM------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HhcCCCCCCCCCHH------H-HHHHHHcCCCC------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 99 88887643211 1 11222222110 1112334678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=287.76 Aligned_cols=214 Identities=26% Similarity=0.401 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------------CCCCHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------------KQPNWVERMGIAR 575 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~ 575 (757)
.++|.+|++++++++|+||+++++++...+..+++|||+++++|.+++.... ..+++.+.+.++.
T Consensus 52 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 131 (283)
T cd05048 52 QQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131 (283)
T ss_pred HHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHH
Confidence 4678999999999999999999999999999999999999999999986431 4578889999999
Q ss_pred HHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCcccc
Q 038168 576 DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKAD 654 (757)
Q Consensus 576 ~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~D 654 (757)
|++.||+|||+. +++|+||||+||++++++.+||+|||+++....... .......++..|+|||.+.+..++.++|
T Consensus 132 ~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sD 208 (283)
T cd05048 132 QIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESD 208 (283)
T ss_pred HHHHHHHHHHhC---CeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhh
Confidence 999999999998 999999999999999999999999999986543322 1222345678899999999899999999
Q ss_pred chhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 038168 655 VYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKK 733 (757)
Q Consensus 655 v~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~e 733 (757)
|||||++++||++ |..|+......+ ....+..+.... .+...+.++.+++.+||+.+|++||++.|
T Consensus 209 v~slG~il~el~~~g~~p~~~~~~~~-------~~~~i~~~~~~~------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~ 275 (283)
T cd05048 209 IWSFGVVLWEIFSYGLQPYYGFSNQE-------VIEMIRSRQLLP------CPEDCPARVYALMIECWNEIPARRPRFKD 275 (283)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCCcCC------CcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999998 999887543321 222233333221 12344578999999999999999999999
Q ss_pred HHHHhhc
Q 038168 734 VLLMLEG 740 (757)
Q Consensus 734 Vl~~Le~ 740 (757)
|+++|+.
T Consensus 276 i~~~l~~ 282 (283)
T cd05048 276 IHTRLRS 282 (283)
T ss_pred HHHHHhc
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=268.12 Aligned_cols=236 Identities=20% Similarity=0.264 Sum_probs=183.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.....+|++.|+.++|+||+.|++.+-..+...||+|||+. +|...++.....+.-.+...++.++++||+|||.+
T Consensus 45 ~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~--- 120 (318)
T KOG0659|consen 45 NRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK--- 120 (318)
T ss_pred cHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---
Confidence 35678999999999999999999999999999999999987 99999988888899999999999999999999999
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG~ 669 (757)
.|+||||||.|+|+++++.+||+|||+|+.+......... .+-|..|.|||.+.+. .|+...||||.||++.||+-|.
T Consensus 121 ~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~ 199 (318)
T KOG0659|consen 121 WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV 199 (318)
T ss_pred hhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC
Confidence 9999999999999999999999999999998765443332 3679999999998875 6999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCcc---ccccc---c--------ccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLS---QLVED---E--------EVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~~~d~---~--------~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl 735 (757)
+-+.+..+-++....--+.-.-.....+ .+-|- . ..-.......++++..++..||.+|+++.|++
T Consensus 200 P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL 279 (318)
T KOG0659|consen 200 PFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQAL 279 (318)
T ss_pred CCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHh
Confidence 8776655443332211111000111111 11110 0 01122345669999999999999999999999
Q ss_pred HHhhcCcCCCCCCCCCC
Q 038168 736 LMLEGTVEIPIPPNPTS 752 (757)
Q Consensus 736 ~~Le~~~~~~~p~~p~~ 752 (757)
++= -....|.|..|..
T Consensus 280 ~~~-yf~~~P~pt~~~~ 295 (318)
T KOG0659|consen 280 KHP-YFKSLPLPTPPSK 295 (318)
T ss_pred cch-hhhcCCCCCChhh
Confidence 874 2444555555543
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=288.71 Aligned_cols=218 Identities=24% Similarity=0.395 Sum_probs=179.4
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------------CCCCHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------------KQPNWVERMGIA 574 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~ 574 (757)
..+.+.+|++++++++|+||+++++++.+.+..++||||+++++|.+++.... ..+++.++++++
T Consensus 50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 129 (291)
T cd05094 50 ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129 (291)
T ss_pred HHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHH
Confidence 34679999999999999999999999999999999999999999999986432 347899999999
Q ss_pred HHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccc
Q 038168 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKA 653 (757)
Q Consensus 575 ~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~ 653 (757)
.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++
T Consensus 130 ~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 206 (291)
T cd05094 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 206 (291)
T ss_pred HHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchh
Confidence 9999999999998 9999999999999999999999999999866443321 12234567889999999999999999
Q ss_pred cchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 654 DVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 654 Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
||||||++++||++ |+.|+......+ +.+....+..... ....+..+.+++.+||+.+|++||++.
T Consensus 207 Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~P~~Rpt~~ 273 (291)
T cd05094 207 DVWSFGVILWEIFTYGKQPWFQLSNTE-------VIECITQGRVLER------PRVCPKEVYDIMLGCWQREPQQRLNIK 273 (291)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhCCCCCCC------CccCCHHHHHHHHHHcccChhhCcCHH
Confidence 99999999999999 898876433211 2222333333221 122346788999999999999999999
Q ss_pred HHHHHhhcCcC
Q 038168 733 KVLLMLEGTVE 743 (757)
Q Consensus 733 eVl~~Le~~~~ 743 (757)
+|+++|+.+..
T Consensus 274 ~v~~~l~~~~~ 284 (291)
T cd05094 274 EIYKILHALGK 284 (291)
T ss_pred HHHHHHHHHHh
Confidence 99999998744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=282.64 Aligned_cols=218 Identities=28% Similarity=0.431 Sum_probs=178.4
Q ss_pred CCCchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 506 ~g~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.+....++|.+|+.++++++||||+++++++.+.+..++||||+++++|.+++......+++.+++.++.|++.||+|||
T Consensus 38 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH 117 (256)
T cd05113 38 EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE 117 (256)
T ss_pred CCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 33445678999999999999999999999999988999999999999999999765567899999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+. +++|+||||+||++++++.+||+|||+++..............++..|+|||...+..++.++||||||++++||
T Consensus 118 ~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l 194 (256)
T cd05113 118 SK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEV 194 (256)
T ss_pred hC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHH
Confidence 98 999999999999999999999999999987654433322334466789999999988899999999999999999
Q ss_pred Hh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 666 IC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 666 lt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
++ |+.|+...... + .......+..... .......+.+++.+||+.+|++||++.+|++.|+
T Consensus 195 ~~~g~~p~~~~~~~------~-~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 195 YSLGKMPYERFNNS------E-TVEKVSQGLRLYR------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred hcCCCCCcCcCCHH------H-HHHHHhcCCCCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 98 88887643321 1 1112222211110 1123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=301.30 Aligned_cols=217 Identities=24% Similarity=0.418 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------------------------
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE--------------------------- 562 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------- 562 (757)
.+.+.+|+++++++ +|+|||+++++|.+....++||||+++|+|.+++++..
T Consensus 85 ~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (374)
T cd05106 85 REALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEK 164 (374)
T ss_pred HHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhc
Confidence 35688999999999 89999999999999999999999999999999885421
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcc
Q 038168 563 ------------------------------------------KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQ 600 (757)
Q Consensus 563 ------------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~ 600 (757)
..+++.+..+++.||++||+|||+. +|+||||||+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~ 241 (374)
T cd05106 165 KYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAAR 241 (374)
T ss_pred ccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchh
Confidence 2367888999999999999999998 9999999999
Q ss_pred eEEECCCCcEEEeecCCccccCCCCccee-cccccCccccCcccccCCCCCccccchhhHHHHHHHHh-CCCCCCCCCCC
Q 038168 601 NILMDENRCAKISDFGLAKLMKPDQTRTF-TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-RRRCLDPNLPD 678 (757)
Q Consensus 601 Nill~~~~~~ki~DfGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G~~p~~~~~~~ 678 (757)
|||+++++.+||+|||+++.......... ....++..|+|||++.+..++.++||||||++++||++ |+.||......
T Consensus 242 Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~ 321 (374)
T cd05106 242 NVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN 321 (374)
T ss_pred eEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc
Confidence 99999999999999999987644332221 12345678999999999999999999999999999997 99998654322
Q ss_pred ccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 679 DQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 679 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
. . .......+.- ...+ .....++.+++.+||+.+|++||++.+|+++|+++.
T Consensus 322 ~--~----~~~~~~~~~~--~~~~----~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 322 S--K----FYKMVKRGYQ--MSRP----DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred H--H----HHHHHHcccC--ccCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1 1 1122222210 1111 112357889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=277.55 Aligned_cols=208 Identities=22% Similarity=0.377 Sum_probs=180.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
....+++|++||+.|+||||+.++.+|++.+...|||||..+|.|.+|+.. ...++..+..++++||..|+.|+|++
T Consensus 96 DlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHkn-- 172 (668)
T KOG0611|consen 96 DLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKN-- 172 (668)
T ss_pred HHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhc--
Confidence 345688999999999999999999999999999999999999999999954 56788889999999999999999999
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCC-CccccchhhHHHHHHHHhC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~G~~l~elltG 668 (757)
+++|||||.+|||||+|+++||+||||+.++... ...+.++|++-|.+||++.+.+| .+..|-|||||+||-|+.|
T Consensus 173 -rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyG 249 (668)
T KOG0611|consen 173 -RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYG 249 (668)
T ss_pred -cceecccchhheeecCCCCeeeeccchhhhhccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhc
Confidence 9999999999999999999999999999988654 34566899999999999999988 5889999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~L 738 (757)
..||++.... . +.+.+..|.+.+...+ ....-|+.|||-.||++|-|+.+|....
T Consensus 250 tMPFDG~Dhk------~-lvrQIs~GaYrEP~~P--------SdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 250 TMPFDGRDHK------R-LVRQISRGAYREPETP--------SDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ccccCCchHH------H-HHHHhhcccccCCCCC--------chHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 9999875321 1 2344566666554333 3466789999999999999999998754
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=282.17 Aligned_cols=216 Identities=27% Similarity=0.425 Sum_probs=177.9
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..++|.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++......+++.++++++.|++.||+|||+.
T Consensus 48 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~-- 125 (266)
T cd05033 48 QRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM-- 125 (266)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 356789999999999999999999999999999999999999999999977666889999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+|+|+||||+||++++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||++++||++
T Consensus 126 -~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~ 204 (266)
T cd05033 126 -NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSY 204 (266)
T ss_pred -CcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHcc
Confidence 999999999999999999999999999998752222 22222345678999999999999999999999999999998
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
|..|+...... + .......+.... .+......+.+++.+|++.+|++||++.||+++|+.+
T Consensus 205 g~~p~~~~~~~------~-~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 205 GERPYWDMSNQ------D-VIKAVEDGYRLP------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCHH------H-HHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 88887543211 1 122222221110 1123346789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=268.65 Aligned_cols=195 Identities=25% Similarity=0.320 Sum_probs=166.0
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+...+|-.+|+.+.||.+++|++.+.+.+..+|||||.++|.|.++|++ ..+++.....-+|.||+.||+|||+. .
T Consensus 89 eH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~---~ 164 (355)
T KOG0616|consen 89 EHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSL---D 164 (355)
T ss_pred HHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhc---C
Confidence 4567899999999999999999999999999999999999999999976 45677778888999999999999999 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRC 671 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p 671 (757)
|++||+||+|||||.+|.+||.|||.|+..... +-.++||+.|+|||++....++..+|.|+|||++|||+.|.+|
T Consensus 165 iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pP 240 (355)
T KOG0616|consen 165 IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPP 240 (355)
T ss_pred eeeccCChHHeeeccCCcEEEEeccceEEecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999999976543 3457899999999999999999999999999999999999999
Q ss_pred CCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCC
Q 038168 672 LDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLR 728 (757)
Q Consensus 672 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~R 728 (757)
|....+. ...+.+-++++. ++.-....+.+|+...++.|-.+|
T Consensus 241 F~~~~~~-------~iY~KI~~~~v~-------fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 241 FYDDNPI-------QIYEKILEGKVK-------FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CcCCChH-------HHHHHHHhCccc-------CCcccCHHHHHHHHHHHhhhhHhh
Confidence 9865541 133444455433 122333457777888888888888
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=281.01 Aligned_cols=215 Identities=25% Similarity=0.398 Sum_probs=177.0
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+.+.+|+.++++++|+||+++++.+.+.+..++||||+++++|.+++... ...+++.+++.++.|++.||+|||+.
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~- 122 (261)
T cd05072 44 SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK- 122 (261)
T ss_pred hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4678999999999999999999999999999999999999999999999653 45688999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+++|+||||+||++++++.+||+|||+++..............++..|+|||++.+..++.++||||||++++||++
T Consensus 123 --~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~ 200 (261)
T cd05072 123 --NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTY 200 (261)
T ss_pred --CeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHcc
Confidence 99999999999999999999999999998765443333333456778999999998899999999999999999998
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
|+.|+....... ....+..+.... ........+.+++.+|++.+|++||+++++.++|+.
T Consensus 201 g~~p~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 201 GKIPYPGMSNSD-------VMSALQRGYRMP------RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCCCHHH-------HHHHHHcCCCCC------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 888886432211 111122221110 111234578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-33 Score=293.37 Aligned_cols=238 Identities=29% Similarity=0.408 Sum_probs=197.9
Q ss_pred cHHHHHHhhccccccccCCCch-------------------------HHHHHHHHHHHhhcCCCceeeeeeEEEeceeee
Q 038168 489 SYAELEKMTDGFKEEVGRGSSG-------------------------EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI 543 (757)
Q Consensus 489 ~~~~l~~~t~~f~~~lg~g~~~-------------------------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 543 (757)
.-.|+++-....+.+||.|.+| .++|++|+.+|+.++|||+|+|+|+|..+...|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 3445665555667788888774 379999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccC
Q 038168 544 LVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK 622 (757)
Q Consensus 544 lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~ 622 (757)
||+|||.+|+|.+||+... ..++-...+.++.||+.|++||..+ .+|||||.++|+|+.++..+||+||||+|++.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 9999999999999998754 4456667788999999999999998 99999999999999999999999999999998
Q ss_pred CCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC-CCCCCCCCCccccHHHHHHHHHhcCCcccccc
Q 038168 623 PDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR-RCLDPNLPDDQVILEEWVYQCFENGNLSQLVE 701 (757)
Q Consensus 623 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 701 (757)
.+......+..-.+.|.|||.+....++.|+|||+|||+||||.|-. .|+.+ ..+. .+..+++.|-- ++
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG------idlS-qVY~LLEkgyR---M~ 486 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLS-QVYGLLEKGYR---MD 486 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC------ccHH-HHHHHHhcccc---cc
Confidence 87766666667788999999999999999999999999999998844 33322 2222 24555555421 12
Q ss_pred ccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 702 DEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 702 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
. ++.+++.+.+|++.||+-+|.+||++.|+-+.+|.+.
T Consensus 487 ~---PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 487 G---PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred C---CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 1 3345678999999999999999999999999998643
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=284.96 Aligned_cols=212 Identities=25% Similarity=0.292 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
...+.+|+.++++++|+|++++++.+.+.+..++||||+++|+|.+++... ...+++.++..++.|++.||+|||+.
T Consensus 44 ~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-- 121 (285)
T cd05631 44 EAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121 (285)
T ss_pred HHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 356789999999999999999999999999999999999999999888643 34688999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||+++++.+||+|||++....... ......|+..|+|||++.+..++.++|||||||+++||++|+
T Consensus 122 -~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~ 198 (285)
T cd05631 122 -RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198 (285)
T ss_pred -CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCC
Confidence 99999999999999999999999999998764332 223457899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS-----MKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----m~eVl~~ 737 (757)
.||......... +.+........ ...+.+....+.+++.+||+.||++||+ ++++++.
T Consensus 199 ~pf~~~~~~~~~---~~~~~~~~~~~-------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 199 SPFRKRKERVKR---EEVDRRVKEDQ-------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CCCCCCCcchhH---HHHHHHhhccc-------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 999864432211 11111111111 1122234467889999999999999997 7888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=279.72 Aligned_cols=215 Identities=27% Similarity=0.416 Sum_probs=175.5
Q ss_pred chHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 509 SGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 509 ~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
....+|.+|++++++++|+||+++++++.+.+..++|+||+++++|.+++......+++..++.++.|++.||+|||+.
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~- 119 (256)
T cd05059 41 MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN- 119 (256)
T ss_pred CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3456789999999999999999999999999999999999999999999976666789999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+++||||||+||++++++.+||+|||+++..............++..|+|||.+.+..++.++||||||++++||++
T Consensus 120 --~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~ 197 (256)
T cd05059 120 --GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197 (256)
T ss_pred --CcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhcc
Confidence 99999999999999999999999999998765433222222334568999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
|+.|+......+ .......+.. .. .+.....++.+++.+|++.+|++||||.||+++|.
T Consensus 198 g~~p~~~~~~~~-------~~~~~~~~~~--~~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 198 GKMPYERFSNSE-------VVESVSAGYR--LY----RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCCCCHHH-------HHHHHHcCCc--CC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 788886433211 1111222211 11 11224567999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=286.37 Aligned_cols=213 Identities=31% Similarity=0.507 Sum_probs=168.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..++|.+|++.+++++|+||++++|++.+.+..++|+||+++|+|.++|... ...+++.++..|+.|+++||+|||++
T Consensus 44 ~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~- 122 (259)
T PF07714_consen 44 EEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN- 122 (259)
T ss_dssp HHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT-
T ss_pred cceeeeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 3578999999999999999999999999888899999999999999999876 57789999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||+++||++++++.+||+|||+++....... ...........|+|||.+....++.++||||||++++||++
T Consensus 123 --~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~ 200 (259)
T PF07714_consen 123 --NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILT 200 (259)
T ss_dssp --TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHT
T ss_pred --cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999988733222 22233456789999999999999999999999999999999
Q ss_pred -CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 038168 668 -RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 668 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~L 738 (757)
|+.|+.... ..+. ...+.++..... +......+.+++..||+.+|++||+|.+|++.|
T Consensus 201 ~~~~p~~~~~------~~~~-~~~~~~~~~~~~------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 201 LGKFPFSDYD------NEEI-IEKLKQGQRLPI------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSSGTTTTSC------HHHH-HHHHHTTEETTS------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccccccc------cccc-ccccccccccee------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 667764331 1121 222233332211 122346688999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=282.74 Aligned_cols=216 Identities=24% Similarity=0.320 Sum_probs=172.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.+..++||.+|++++|+|||+|+++..+. +..|||+||+..|.+...=- ....++..+..+++++++.||+|||.+
T Consensus 152 ~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~Q- 229 (576)
T KOG0585|consen 152 IEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHYQ- 229 (576)
T ss_pred HHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHhc-
Confidence 46889999999999999999999998764 57899999999988865431 122388999999999999999999999
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCC----cceecccccCccccCcccccCCC----CCccccchhhHH
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ----TRTFTGIRGTRGYVAPEWHRNLP----ITVKADVYSFGV 660 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~k~Dv~S~G~ 660 (757)
+||||||||+|+||++++++||+|||.+....... .......+||+.|+|||...++. .+.+.||||+||
T Consensus 230 --giiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGV 307 (576)
T KOG0585|consen 230 --GIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGV 307 (576)
T ss_pred --CeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhh
Confidence 99999999999999999999999999998763321 12233478999999999887743 467899999999
Q ss_pred HHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 661 VLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 661 ~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
+||.|+.|+.||...... + ..+.+....+.... ..++.+++.+|++++|+.||++|.++.+|....--
T Consensus 308 TLYCllfG~~PF~~~~~~------~-l~~KIvn~pL~fP~-----~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 308 TLYCLLFGQLPFFDDFEL------E-LFDKIVNDPLEFPE-----NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred hHHHhhhccCCcccchHH------H-HHHHHhcCcccCCC-----cccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 999999999999754321 1 22333333332221 23567889999999999999999999999987754
Q ss_pred Cc
Q 038168 741 TV 742 (757)
Q Consensus 741 ~~ 742 (757)
..
T Consensus 376 t~ 377 (576)
T KOG0585|consen 376 TR 377 (576)
T ss_pred cc
Confidence 33
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=278.83 Aligned_cols=214 Identities=23% Similarity=0.312 Sum_probs=172.8
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
....+.+|++++++++|+||+++++++...+..++||||+++++|.+++......+++.++..++.|++.||+|||+.
T Consensus 36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-- 113 (252)
T cd05084 36 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK-- 113 (252)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 356799999999999999999999999999999999999999999999976666789999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCccee-cccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF-TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+++|+||||+||+++.++.+||+|||+++.......... .....+..|+|||.+.+..++.++||||||++++||++
T Consensus 114 -~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~ 192 (252)
T cd05084 114 -HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSL 192 (252)
T ss_pred -CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999999986543211111 11123457999999999999999999999999999998
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
|..|+....... ........... ..+......+.+++.+|++.+|++||++.+|.++|+
T Consensus 193 ~~~p~~~~~~~~-------~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 193 GAVPYANLSNQQ-------TREAIEQGVRL------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCCccccCHHH-------HHHHHHcCCCC------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 777775432211 11111111111 112233567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=293.93 Aligned_cols=219 Identities=21% Similarity=0.215 Sum_probs=168.3
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|++++++++|||||++++++......++|+|++. ++|.+++.. ...+++.+++.++.|++.||+|||++ +
T Consensus 128 ~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~---~ 202 (391)
T PHA03212 128 GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHEN---R 202 (391)
T ss_pred hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 457899999999999999999999999999999999995 688888754 35678999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRC 671 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p 671 (757)
|+||||||+|||++.++.+||+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 203 IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p 282 (391)
T PHA03212 203 IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282 (391)
T ss_pred cccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999999976443333333456799999999999999999999999999999999999988
Q ss_pred CCCCCCCc-----cccHHHHHHHHH----------------------hcCCccccccccc--cCHHHHHHHHHHHHHccc
Q 038168 672 LDPNLPDD-----QVILEEWVYQCF----------------------ENGNLSQLVEDEE--VDEKQLERMIKVALWCIL 722 (757)
Q Consensus 672 ~~~~~~~~-----~~~l~~~~~~~~----------------------~~~~~~~~~d~~~--~~~~~~~~l~~l~~~cl~ 722 (757)
+....... ...+.. +.... ............. ........+.+++.+||+
T Consensus 283 ~~~~~~~~~~~~~~~~l~~-i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~ 361 (391)
T PHA03212 283 LFEKDGLDGDCDSDRQIKL-IIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLA 361 (391)
T ss_pred cCCcccccccCchhHHHHH-HHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhc
Confidence 75432211 000000 00000 0000000000000 011234578899999999
Q ss_pred cCCCCCCCHHHHHH
Q 038168 723 DEPSLRPSMKKVLL 736 (757)
Q Consensus 723 ~~p~~RPsm~eVl~ 736 (757)
.||++|||++|+++
T Consensus 362 ~dP~~Rpta~elL~ 375 (391)
T PHA03212 362 FDAHHRPSAEALLD 375 (391)
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999986
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=304.16 Aligned_cols=210 Identities=22% Similarity=0.280 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP---EKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
...+++|+.++++++|||||++++++...+..+|||||+++|+|.+++... ...+++.+...++.|++.||+|||+.
T Consensus 109 ~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~ 188 (478)
T PTZ00267 109 AAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR 188 (478)
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 356788999999999999999999999999999999999999999988542 34578889999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+|+||||||+|||++.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||+++||+
T Consensus 189 ---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 265 (478)
T PTZ00267 189 ---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265 (478)
T ss_pred ---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHH
Confidence 999999999999999999999999999987654322 2233467899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+|+.||..... .+. ......+.... .+......+.+++.+||+.+|++||++.+++.
T Consensus 266 tg~~Pf~~~~~------~~~-~~~~~~~~~~~------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 266 TLHRPFKGPSQ------REI-MQQVLYGKYDP------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred hCCCCCCCCCH------HHH-HHHHHhCCCCC------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 99999864321 111 12222222211 11223457899999999999999999999864
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=284.06 Aligned_cols=219 Identities=25% Similarity=0.418 Sum_probs=178.1
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC------------CCCCHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE------------KQPNWVERMGIARDI 577 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~i 577 (757)
..+.+.+|++++++++|+||+++++++...+..++||||+++++|.+++.... ..+++.+++.++.|+
T Consensus 50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql 129 (288)
T cd05093 50 ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHH
Confidence 45679999999999999999999999999999999999999999999986432 348999999999999
Q ss_pred HHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccccch
Q 038168 578 ARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKADVY 656 (757)
Q Consensus 578 a~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~ 656 (757)
+.||+|||++ +++||||||+|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||
T Consensus 130 ~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiw 206 (288)
T cd05093 130 AAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 206 (288)
T ss_pred HHHHHHHHhC---CeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHH
Confidence 9999999998 9999999999999999999999999999866433221 12223457789999999999999999999
Q ss_pred hhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 038168 657 SFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735 (757)
Q Consensus 657 S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl 735 (757)
|||++++||++ |..|+....... .......+..... + ......+.+++.+|++.+|.+|||+.||+
T Consensus 207 slG~il~~l~t~g~~p~~~~~~~~-------~~~~i~~~~~~~~--~----~~~~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 207 SLGVVLWEIFTYGKQPWYQLSNNE-------VIECITQGRVLQR--P----RTCPKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCcCCC--C----CCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 99999999998 888876433211 1222333332211 1 12335689999999999999999999999
Q ss_pred HHhhcCcCC
Q 038168 736 LMLEGTVEI 744 (757)
Q Consensus 736 ~~Le~~~~~ 744 (757)
+.|+.+...
T Consensus 274 ~~l~~~~~~ 282 (288)
T cd05093 274 SLLQNLAKA 282 (288)
T ss_pred HHHHHHHHh
Confidence 999886543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=292.46 Aligned_cols=208 Identities=24% Similarity=0.386 Sum_probs=176.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEecee--eeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSK--KILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.+.|..|+.+|+.|+|+|||+++.++.+... ..+|+|.+..|+|..|+.+ .+..+.+...++++||++||.|||++
T Consensus 85 leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~- 162 (632)
T KOG0584|consen 85 LERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQ- 162 (632)
T ss_pred HHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcC-
Confidence 3789999999999999999999999987665 6799999999999999965 45677888899999999999999997
Q ss_pred CCCeeeCCCCcceEEECCC-CcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 589 ETQIIHCDIKPQNILMDEN-RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~-~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
.|+|||||||..||+|+.+ |.|||+|+|||.+...... ..++||+.|||||... ..|++..||||||+.++||+|
T Consensus 163 ~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT 238 (632)
T KOG0584|consen 163 DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVT 238 (632)
T ss_pred CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHh
Confidence 7899999999999999877 8999999999998765433 3378999999999888 689999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+..|+..-... ..+++....|..+..+..- .-.++.+++.+|+.. .++|||+.|+++
T Consensus 239 ~eYPYsEC~n~------AQIYKKV~SGiKP~sl~kV-----~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 239 SEYPYSECTNP------AQIYKKVTSGIKPAALSKV-----KDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ccCChhhhCCH------HHHHHHHHcCCCHHHhhcc-----CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 99998754432 2245555666555443332 134688999999999 999999999997
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=289.52 Aligned_cols=209 Identities=21% Similarity=0.219 Sum_probs=169.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.
T Consensus 36 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-- 112 (312)
T cd05585 36 EVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKF-- 112 (312)
T ss_pred HHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 346788999999999999999999999999999999999999999999965 44688899999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||+++||++|+
T Consensus 113 -~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~ 190 (312)
T cd05585 113 -NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGL 190 (312)
T ss_pred -CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCC
Confidence 999999999999999999999999999986433222 223457899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
.||..... .+.... ...+.. ..+......+.+++.+||+.||++||+...+.+.
T Consensus 191 ~pf~~~~~------~~~~~~-~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~ 244 (312)
T cd05585 191 PPFYDENV------NEMYRK-ILQEPL-------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEI 244 (312)
T ss_pred CCcCCCCH------HHHHHH-HHcCCC-------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence 99874321 111111 122211 1222334668899999999999999865433333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=279.91 Aligned_cols=215 Identities=27% Similarity=0.459 Sum_probs=176.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+++.+|++++++++|+|++++++++...+..++||||+++++|.+++.+....+++.++..++.|++.||+|||+.
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~--- 126 (268)
T cd05063 50 RQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM--- 126 (268)
T ss_pred HHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46789999999999999999999999999999999999999999999977667789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceec--ccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT--GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+++|+||||+||++++++.+||+|||++............ ....+..|+|||++.+..++.++||||||++++||++
T Consensus 127 ~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~ 206 (268)
T cd05063 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSF 206 (268)
T ss_pred CeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999876543322211 2223557999999998899999999999999999997
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
|+.|+...... + .......+... .........+.+++.+|++.+|++||+|.+|++.|+++
T Consensus 207 g~~p~~~~~~~------~-~~~~i~~~~~~------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 207 GERPYWDMSNH------E-VMKAINDGFRL------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCcCCHH------H-HHHHHhcCCCC------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99998643321 1 12222222111 11122346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=288.71 Aligned_cols=209 Identities=23% Similarity=0.369 Sum_probs=179.3
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEecee-eeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSK-KILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
+...+|+.++++++|||||.+.+.+.+++. .+|||+|++||+|.+.+.+.. ..++..+..+++.|++.|+.|||++
T Consensus 48 ~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~-- 125 (426)
T KOG0589|consen 48 RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN-- 125 (426)
T ss_pred HHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh--
Confidence 467899999999999999999999999888 899999999999999997665 6678899999999999999999988
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
.|+|||||+.||+++.+..+||.|||+|+.+..+... ....+||+.||.||.+.+.+|..|+|||||||++|||++-+
T Consensus 126 -~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk 203 (426)
T KOG0589|consen 126 -RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLK 203 (426)
T ss_pred -hhhcccchhhhhhccccCceeecchhhhhhcCCchhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcc
Confidence 9999999999999999999999999999998876532 23478999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++|...... ..+.+... +. +. ..+..+..++..++..|++.+|+.||++.+++.+
T Consensus 204 ~aF~a~~m~------~Li~ki~~-~~----~~--Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 204 PAFKASNMS------ELILKINR-GL----YS--PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cccCccchH------HHHHHHhh-cc----CC--CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 998764322 22222221 11 11 2345566789999999999999999999999875
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=262.46 Aligned_cols=223 Identities=22% Similarity=0.307 Sum_probs=176.5
Q ss_pred chHHHHHHHHHHHhhcCCCceeeeeeEEEece-----eeeEEEEeccCCChhhhhcCC---CCCCCHHHHHHHHHHHHHH
Q 038168 509 SGEREFQTEMKVIGRTHHRNLVRLLGYSLEVS-----KKILVYEYMSNGSLADILFNP---EKQPNWVERMGIARDIARG 580 (757)
Q Consensus 509 ~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~g 580 (757)
.+.+..++|++.-++++|||+++++++...+. +.||+++|...|+|.+.+... +..++..+.++|+.++++|
T Consensus 60 ~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~g 139 (302)
T KOG2345|consen 60 EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRG 139 (302)
T ss_pred HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHH
Confidence 35678899999999999999999999876443 589999999999999998643 3567999999999999999
Q ss_pred HHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc--------ceecccccCccccCccccc---CCCC
Q 038168 581 ILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT--------RTFTGIRGTRGYVAPEWHR---NLPI 649 (757)
Q Consensus 581 L~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~--------~~~~~~~gt~~y~aPE~~~---~~~~ 649 (757)
|++||+. .++++||||||.|||+.+++.++|.|||.+....-.-. +....-..|+.|.|||.+. +..+
T Consensus 140 L~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti 218 (302)
T KOG2345|consen 140 LEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTI 218 (302)
T ss_pred HHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCccc
Confidence 9999997 45699999999999999999999999999986542111 1223356899999999874 4568
Q ss_pred CccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC
Q 038168 650 TVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP 729 (757)
Q Consensus 650 ~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP 729 (757)
++++|||||||+||+|+.|..||+........... ....+.+.... .....+.+.+++.+|++.||.+||
T Consensus 219 ~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL-----Av~n~q~s~P~-----~~~yse~l~~lik~mlqvdP~qRP 288 (302)
T KOG2345|consen 219 TERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL-----AVQNAQISIPN-----SSRYSEALHQLIKSMLQVDPNQRP 288 (302)
T ss_pred ccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE-----eeeccccccCC-----CCCccHHHHHHHHHHhcCCcccCC
Confidence 99999999999999999999999864432211000 00111111111 123678899999999999999999
Q ss_pred CHHHHHHHhhcCc
Q 038168 730 SMKKVLLMLEGTV 742 (757)
Q Consensus 730 sm~eVl~~Le~~~ 742 (757)
++.+++..++.++
T Consensus 289 ~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 289 TIPELLSKLDDLI 301 (302)
T ss_pred CHHHHHHHHHhhc
Confidence 9999999998754
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=290.66 Aligned_cols=207 Identities=23% Similarity=0.276 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
...+.+|+.++++++|+||+++++++.+.+..++||||+++|+|.+++.+ ...+++.+...++.||+.||+|||+.
T Consensus 39 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~--- 114 (323)
T cd05571 39 VAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSC--- 114 (323)
T ss_pred HHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 35678899999999999999999999999999999999999999999865 45678999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||+++||++|+.
T Consensus 115 ~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 193 (323)
T cd05571 115 DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193 (323)
T ss_pred CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCC
Confidence 99999999999999999999999999997532221 12234578999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~ 736 (757)
||.....+ . .......+.. ..+.....++.+++.+||+.||++|| ++.++++
T Consensus 194 Pf~~~~~~------~-~~~~~~~~~~-------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 194 PFYNQDHE------K-LFELILMEEI-------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCHH------H-HHHHHHcCCC-------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 98653221 1 1111222211 11223446788999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=295.00 Aligned_cols=217 Identities=23% Similarity=0.377 Sum_probs=175.0
Q ss_pred HHHHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------------------------
Q 038168 511 EREFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE--------------------------- 562 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------- 562 (757)
.+.|.+|+++++++. ||||+++++++.+.+..+|||||+++|+|.+++.+..
T Consensus 84 ~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (400)
T cd05105 84 KQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADEST 163 (400)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccc
Confidence 467999999999995 9999999999999999999999999999999885421
Q ss_pred --------------------------------------------------------------------CCCCHHHHHHHH
Q 038168 563 --------------------------------------------------------------------KQPNWVERMGIA 574 (757)
Q Consensus 563 --------------------------------------------------------------------~~l~~~~~~~i~ 574 (757)
..+++.++..++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~ 243 (400)
T cd05105 164 RSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFT 243 (400)
T ss_pred cchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHH
Confidence 236788889999
Q ss_pred HHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccc
Q 038168 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKA 653 (757)
Q Consensus 575 ~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~ 653 (757)
.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++
T Consensus 244 ~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 320 (400)
T cd05105 244 YQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLS 320 (400)
T ss_pred HHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchh
Confidence 9999999999998 9999999999999999999999999999876443222 12224467889999999999999999
Q ss_pred cchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 654 DVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 654 Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
||||||++++||++ |..|+........ .......+.... .+......+.+++.+||+.+|++||++.
T Consensus 321 DiwSlGvil~ellt~g~~P~~~~~~~~~------~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~ 388 (400)
T cd05105 321 DVWSYGILLWEIFSLGGTPYPGMIVDST------FYNKIKSGYRMA------KPDHATQEVYDIMVKCWNSEPEKRPSFL 388 (400)
T ss_pred hHHHHHHHHHHHHHCCCCCCcccchhHH------HHHHHhcCCCCC------CCccCCHHHHHHHHHHCccCHhHCcCHH
Confidence 99999999999997 8888764322211 122222221111 1123356789999999999999999999
Q ss_pred HHHHHhhcCc
Q 038168 733 KVLLMLEGTV 742 (757)
Q Consensus 733 eVl~~Le~~~ 742 (757)
+|+++|+.+.
T Consensus 389 ~l~~~l~~l~ 398 (400)
T cd05105 389 HLSDIVESLL 398 (400)
T ss_pred HHHHHHHHHc
Confidence 9999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=288.27 Aligned_cols=213 Identities=22% Similarity=0.231 Sum_probs=172.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++++.+.+..++||||+++|+|.+++.. ...+++.+...++.|++.||.|||+.
T Consensus 45 ~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~--- 120 (333)
T cd05600 45 VRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHEL--- 120 (333)
T ss_pred HHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 45688999999999999999999999999999999999999999999964 34678889999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++.... ......||..|+|||++.+..++.++|||||||+++||++|+.
T Consensus 121 ~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~ 196 (333)
T cd05600 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196 (333)
T ss_pred CccccCCCHHHEEECCCCCEEEEeCcCCccccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCC
Confidence 999999999999999999999999999986543 2234568999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
||......+. .........................++.+++.+|++.+|++||++.++++.
T Consensus 197 pf~~~~~~~~------~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 197 PFSGSTPNET------WENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCCHHHH------HHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 9875432211 111111110000000000012335678899999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=281.02 Aligned_cols=215 Identities=26% Similarity=0.407 Sum_probs=176.2
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-------------CCCCHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-------------KQPNWVERMGIARD 576 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~ 576 (757)
..+.|.+|++++++++|+|++++++++...+..++||||+++++|.+++.... ..+++.+...++.|
T Consensus 51 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 130 (280)
T cd05049 51 ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130 (280)
T ss_pred HHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHH
Confidence 45789999999999999999999999999999999999999999999996432 34688899999999
Q ss_pred HHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccccc
Q 038168 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKADV 655 (757)
Q Consensus 577 ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv 655 (757)
++.||+|||+. +++||||||+||+++.++.+||+|||+++........ ......++..|+|||++.+..++.++||
T Consensus 131 i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 207 (280)
T cd05049 131 IASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 207 (280)
T ss_pred HHHHHHHHhhC---CeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhH
Confidence 99999999998 9999999999999999999999999999865433221 1223345788999999999999999999
Q ss_pred hhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 038168 656 YSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKV 734 (757)
Q Consensus 656 ~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eV 734 (757)
||||++++||++ |+.|+......+ .......+..... +......+.+++.+||+.+|++||++.||
T Consensus 208 ~slG~il~e~~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 274 (280)
T cd05049 208 WSFGVVLWEIFTYGKQPWYGLSNEE-------VIECITQGRLLQR------PRTCPSEVYDIMLGCWKRDPQQRINIKDI 274 (280)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCcCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 999999999998 999886443211 1122233332221 12344678999999999999999999999
Q ss_pred HHHhhc
Q 038168 735 LLMLEG 740 (757)
Q Consensus 735 l~~Le~ 740 (757)
++.|+.
T Consensus 275 l~~l~~ 280 (280)
T cd05049 275 HERLQK 280 (280)
T ss_pred HHHhhC
Confidence 999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=284.40 Aligned_cols=220 Identities=27% Similarity=0.377 Sum_probs=174.7
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------------CCCCHHHHHHH
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------------KQPNWVERMGI 573 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i 573 (757)
..+.|.+|+++++++ +||||+++++++.+.+..++|+||+++++|.+++.+.. ..+++.+++.+
T Consensus 45 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 124 (297)
T cd05089 45 DHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124 (297)
T ss_pred HHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHH
Confidence 346789999999999 79999999999999999999999999999999996432 24788999999
Q ss_pred HHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccc
Q 038168 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKA 653 (757)
Q Consensus 574 ~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~ 653 (757)
+.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... .......+..|+|||++....++.++
T Consensus 125 ~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~ 199 (297)
T cd05089 125 ASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKS 199 (297)
T ss_pred HHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchh
Confidence 99999999999998 99999999999999999999999999987432111 11112235679999999988999999
Q ss_pred cchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 654 DVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 654 Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
||||||++++||++ |..||......+ +......+.... .+......+.+++.+|++.+|.+||+++
T Consensus 200 DvwSlG~il~el~t~g~~pf~~~~~~~-------~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 266 (297)
T cd05089 200 DVWSFGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQGYRME------KPRNCDDEVYELMRQCWRDRPYERPPFA 266 (297)
T ss_pred hHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhcCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 99999999999997 988886443211 111222221110 1122345688999999999999999999
Q ss_pred HHHHHhhcCcCCCCC
Q 038168 733 KVLLMLEGTVEIPIP 747 (757)
Q Consensus 733 eVl~~Le~~~~~~~p 747 (757)
+|++.|+.+.....+
T Consensus 267 ~i~~~l~~~~~~~~~ 281 (297)
T cd05089 267 QISVQLSRMLEARKA 281 (297)
T ss_pred HHHHHHHHHHHhhcc
Confidence 999999886654443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=281.05 Aligned_cols=214 Identities=28% Similarity=0.372 Sum_probs=173.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC----------------CCCCCHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP----------------EKQPNWVERMGIA 574 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~----------------~~~l~~~~~~~i~ 574 (757)
.++|.+|+.++++++|+||+++++++..++..++||||+++++|.+++... ...+++.+.+.++
T Consensus 51 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 130 (283)
T cd05090 51 WGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130 (283)
T ss_pred HHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHH
Confidence 467899999999999999999999999999999999999999999998522 1346888999999
Q ss_pred HHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccc
Q 038168 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKA 653 (757)
Q Consensus 575 ~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~ 653 (757)
.|++.||+|||++ +++|+||||+|||+++++.+||+|||+++....... .......++..|+|||++.+..++.++
T Consensus 131 ~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 207 (283)
T cd05090 131 IQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDS 207 (283)
T ss_pred HHHHHHHHHHHhc---CeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchh
Confidence 9999999999998 999999999999999999999999999987644332 122234457789999999988999999
Q ss_pred cchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 654 DVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 654 Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
||||||++++||++ |..|+...... .+.+......... .+.....++.+++.+|++.+|++||++.
T Consensus 208 Dv~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 274 (283)
T cd05090 208 DIWSFGVVLWEIFSFGLQPYYGFSNQ-------EVIEMVRKRQLLP------CSEDCPPRMYSLMTECWQEGPSRRPRFK 274 (283)
T ss_pred hhHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcCCcCC------CCCCCCHHHHHHHHHHcccCcccCcCHH
Confidence 99999999999998 88887643221 1122222222211 1122346788999999999999999999
Q ss_pred HHHHHhhc
Q 038168 733 KVLLMLEG 740 (757)
Q Consensus 733 eVl~~Le~ 740 (757)
+|.++|..
T Consensus 275 ~i~~~l~~ 282 (283)
T cd05090 275 DIHTRLRS 282 (283)
T ss_pred HHHHHhhc
Confidence 99999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=274.59 Aligned_cols=213 Identities=23% Similarity=0.315 Sum_probs=174.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
...|.+|++++++++|+||+++++++...+..++||||+++++|.+++......+++.++..++.|++.+|.|||+.
T Consensus 36 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--- 112 (250)
T cd05085 36 KIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK--- 112 (250)
T ss_pred HHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 35688999999999999999999999999999999999999999999976666789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-CC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-RR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G~ 669 (757)
+++|+||||+||++++++.+||+|||+++..............++..|+|||+..+..++.++||||||++++|+++ |.
T Consensus 113 ~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~ 192 (250)
T cd05085 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGV 192 (250)
T ss_pred CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999999997654332222222334678999999998899999999999999999998 88
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
.||...... . .......+... ..+......+.+++.+|++.+|++||++.|+++.|.
T Consensus 193 ~p~~~~~~~------~-~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 193 CPYPGMTNQ------Q-AREQVEKGYRM------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCHH------H-HHHHHHcCCCC------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 888643221 1 11122222111 111234567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=284.41 Aligned_cols=222 Identities=21% Similarity=0.239 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++++.+.+..++||||++++.|..+. .....+++..+..++.|++.||+|||+.
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~--- 119 (287)
T cd07848 44 KETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKN--- 119 (287)
T ss_pred hhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 467889999999999999999999999999999999999998776554 3345688899999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+||+++.++.+||+|||+++..............|+..|+|||++.+..++.++|||||||+++||++|+.
T Consensus 120 ~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~ 199 (287)
T cd07848 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQP 199 (287)
T ss_pred CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCC
Confidence 99999999999999999999999999998765443333344568999999999999899999999999999999999999
Q ss_pred CCCCCCCCccccHHHH---------HHHHHhcCCccccccccc---------cCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 671 CLDPNLPDDQVILEEW---------VYQCFENGNLSQLVEDEE---------VDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~---------~~~~~~~~~~~~~~d~~~---------~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
||......+....... ...............+.. ........+.+++.+||+.||++|||++
T Consensus 200 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~ 279 (287)
T cd07848 200 LFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTE 279 (287)
T ss_pred CCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHH
Confidence 9875432211100000 000000000000000000 0112345689999999999999999999
Q ss_pred HHHH
Q 038168 733 KVLL 736 (757)
Q Consensus 733 eVl~ 736 (757)
|+++
T Consensus 280 ~~l~ 283 (287)
T cd07848 280 QCLN 283 (287)
T ss_pred HHhc
Confidence 9885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=287.99 Aligned_cols=219 Identities=23% Similarity=0.363 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. .
T Consensus 47 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--~ 123 (331)
T cd06649 47 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREK--H 123 (331)
T ss_pred HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhc--C
Confidence 46789999999999999999999999999999999999999999999865 34578889999999999999999975 2
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++...... .....|+..|+|||.+.+..++.++||||||++++||++|+.
T Consensus 124 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 200 (331)
T cd06649 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRY 200 (331)
T ss_pred CEEcCCCChhhEEEcCCCcEEEccCcccccccccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 69999999999999999999999999998654322 223568999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCC---cc---------------------------c----cc---cccccCHHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGN---LS---------------------------Q----LV---EDEEVDEKQLERM 713 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~---~~---------------------------~----~~---d~~~~~~~~~~~l 713 (757)
||......+ +..........+. .. + +. .+.........++
T Consensus 201 p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (331)
T cd06649 201 PIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDF 277 (331)
T ss_pred CCCCCCHHH---HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHH
Confidence 986433211 0000000000000 00 0 00 0000011234678
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHh
Q 038168 714 IKVALWCILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 714 ~~l~~~cl~~~p~~RPsm~eVl~~L 738 (757)
.+++.+||+.||++|||+.|+++..
T Consensus 278 ~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 278 QEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred HHHHHHHccCCcccCCCHHHHhcCh
Confidence 9999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=287.29 Aligned_cols=218 Identities=27% Similarity=0.406 Sum_probs=174.4
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEec-eeeeEEEEeccCCChhhhhcCCC--------------------------
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEV-SKKILVYEYMSNGSLADILFNPE-------------------------- 562 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~~~lV~e~~~~gsL~~~l~~~~-------------------------- 562 (757)
.+.+.+|+.++.++ +|+||++++++|... ...++|+||+++++|.+++....
T Consensus 54 ~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (337)
T cd05054 54 YKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133 (337)
T ss_pred HHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhcccccccccccccccccccccccccccc
Confidence 45678899999999 899999999988654 56789999999999999885321
Q ss_pred ----------------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCC
Q 038168 563 ----------------------------------KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR 608 (757)
Q Consensus 563 ----------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~ 608 (757)
..++|..+.+++.||+.||+|||+. +|+||||||+|||+++++
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~ 210 (337)
T cd05054 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENN 210 (337)
T ss_pred ccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCC
Confidence 2578999999999999999999998 999999999999999999
Q ss_pred cEEEeecCCccccCCCCcce-ecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCccccHHHH
Q 038168 609 CAKISDFGLAKLMKPDQTRT-FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEW 686 (757)
Q Consensus 609 ~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~ 686 (757)
.+||+|||+++.+....... .....++..|+|||++.+..++.++|||||||+++||++ |..|+......+.
T Consensus 211 ~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------ 284 (337)
T cd05054 211 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------ 284 (337)
T ss_pred cEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------
Confidence 99999999998764433221 223456778999999999999999999999999999998 9888865332211
Q ss_pred HHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcC
Q 038168 687 VYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 687 ~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~ 743 (757)
.......+.... .+.....++.+++.+||+.+|++||++.||+++|+.+.+
T Consensus 285 ~~~~~~~~~~~~------~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 285 FCRRLKEGTRMR------APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHhccCCCC------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 122222222111 112334678999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=272.46 Aligned_cols=211 Identities=25% Similarity=0.351 Sum_probs=175.9
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+++.+|++++++++|+|++++++++.+.+..++||||+++++|.+++... ...+++.++..++.|++.||.|||+.
T Consensus 42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~- 120 (256)
T cd08529 42 EREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK- 120 (256)
T ss_pred HHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4578899999999999999999999999999999999999999999999764 46788999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
+++|+||||+||+++.++.+||+|||+++........ .....++..|+|||+..+..++.++||||||++++||++|
T Consensus 121 --~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 197 (256)
T cd08529 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG 197 (256)
T ss_pred --CcccCCCCcceEEEeCCCCEEEcccccceeccCccch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhC
Confidence 9999999999999999999999999999876543222 2234678899999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+.|+..... .........+....+ .......+.+++.+|++.+|++||++.++++.
T Consensus 198 ~~p~~~~~~-------~~~~~~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 198 KHPFDANNQ-------GALILKIIRGVFPPV------SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCCCCCH-------HHHHHHHHcCCCCCC------ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 999865431 111122222222211 22345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=278.60 Aligned_cols=216 Identities=23% Similarity=0.349 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+++..|+.++++++|+||+++++++.. ...++|+||+++|+|.+++......+++..+..++.|++.||+|||+.
T Consensus 53 ~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--- 128 (279)
T cd05111 53 FQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128 (279)
T ss_pred HHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 3567889999999999999999998754 457889999999999999987667789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-C
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-R 668 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G 668 (757)
+++||||||+|||+++++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |
T Consensus 129 ~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g 208 (279)
T cd05111 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYG 208 (279)
T ss_pred CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999987644332 22233557789999999999999999999999999999998 9
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcC
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~ 743 (757)
+.|+....... ..+.+..+.... .+.. ....+.+++.+|+..+|++|||+.|+++.|+.+..
T Consensus 209 ~~p~~~~~~~~-------~~~~~~~~~~~~--~~~~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 209 AEPYAGMRPHE-------VPDLLEKGERLA--QPQI----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCCCCCCHHH-------HHHHHHCCCcCC--CCCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 88886543211 122233332211 1111 23457888999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=275.02 Aligned_cols=241 Identities=27% Similarity=0.366 Sum_probs=185.8
Q ss_pred ccccccCCCch---------------------HHHHHHHHHHHhhc--CCCceeeeeeEEEece----eeeEEEEeccCC
Q 038168 500 FKEEVGRGSSG---------------------EREFQTEMKVIGRT--HHRNLVRLLGYSLEVS----KKILVYEYMSNG 552 (757)
Q Consensus 500 f~~~lg~g~~~---------------------~~~~~~E~~~l~~l--~h~niv~l~g~~~~~~----~~~lV~e~~~~g 552 (757)
..+.+|+|.|| ++.+.+|.+|.+.+ +|+||+.+++.-..++ +.+||+||.+.|
T Consensus 215 L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~G 294 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHG 294 (513)
T ss_pred EEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCC
Confidence 34679999985 47788888887765 9999999998765433 789999999999
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-----CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-
Q 038168 553 SLADILFNPEKQPNWVERMGIARDIARGILYLHDEC-----ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT- 626 (757)
Q Consensus 553 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~- 626 (757)
||.|||.. ..++-...++++..+|.||+|||.+. +|.|.|||||.+|||+..+++..|+|+|||.....+..
T Consensus 295 SL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~ 372 (513)
T KOG2052|consen 295 SLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDT 372 (513)
T ss_pred cHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCc
Confidence 99999954 67888999999999999999999753 78999999999999999999999999999987765532
Q ss_pred --ceecccccCccccCcccccCC------CCCccccchhhHHHHHHHHhC----------CCCCCCCCCCccccHHHHHH
Q 038168 627 --RTFTGIRGTRGYVAPEWHRNL------PITVKADVYSFGVVLLEIICR----------RRCLDPNLPDDQVILEEWVY 688 (757)
Q Consensus 627 --~~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~S~G~~l~elltG----------~~p~~~~~~~~~~~l~~~~~ 688 (757)
......+||.+|||||++... +.-..+||||||.++||+..+ ..||....+.+.. +.+ +.
T Consensus 373 idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs-~ee-Mr 450 (513)
T KOG2052|consen 373 IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS-FEE-MR 450 (513)
T ss_pred ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC-HHH-Hh
Confidence 223347899999999998653 123579999999999999763 2444444333321 111 12
Q ss_pred HHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcCC
Q 038168 689 QCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEI 744 (757)
Q Consensus 689 ~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~~ 744 (757)
+..=..++...+...-.+.+.+..+.+++..||..||..|-|+-.|.+.|.++.+.
T Consensus 451 kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 451 KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 22222233333333334667889999999999999999999999999999876654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=284.66 Aligned_cols=205 Identities=22% Similarity=0.316 Sum_probs=170.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.. ...+++.....++.|++.||+|||++
T Consensus 45 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--- 120 (291)
T cd05612 45 EQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSK--- 120 (291)
T ss_pred HHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 45688999999999999999999999999999999999999999999865 34678889999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++...... ....|++.|+|||.+.+..++.++||||||++++||++|+.
T Consensus 121 ~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~ 196 (291)
T cd05612 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196 (291)
T ss_pred CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999998764321 23468999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS-----MKKVLLM 737 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----m~eVl~~ 737 (757)
||...... + ..+....+... .+......+.+++.+||+.||.+||+ ++|+++.
T Consensus 197 pf~~~~~~------~-~~~~i~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 197 PFFDDNPF------G-IYEKILAGKLE-------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCCCCHH------H-HHHHHHhCCcC-------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 98754321 1 11222222221 11222456889999999999999995 8887765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=286.53 Aligned_cols=216 Identities=23% Similarity=0.353 Sum_probs=175.3
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+++.+|+.++++++|+||++++|+|... ..++|+||+++|+|.+++......+++...+.++.||+.||+|||+.
T Consensus 52 ~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-- 128 (316)
T cd05108 52 ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER-- 128 (316)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc--
Confidence 457899999999999999999999999764 56799999999999999987667789999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-ecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+|+||||||+|||+++++.+||+|||+++.+....... .....++..|+|||.+.+..++.++||||||+++|||++
T Consensus 129 -~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~ 207 (316)
T cd05108 129 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 207 (316)
T ss_pred -CeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcC
Confidence 99999999999999999999999999999775443321 222334678999999999999999999999999999998
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
|+.|+...... + .......+... ..+ ......+.+++.+||+.+|++||++.+++..|..+.
T Consensus 208 g~~p~~~~~~~------~-~~~~~~~~~~~--~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 208 GSKPYDGIPAS------E-ISSILEKGERL--PQP----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CCCCCCCCCHH------H-HHHHHhCCCCC--CCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 88888643211 1 11222222111 111 122356889999999999999999999999988644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=288.24 Aligned_cols=209 Identities=23% Similarity=0.289 Sum_probs=171.0
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++|+||+++++++...+..++||||+++|+|.+++.. ...+++.++..++.||+.||+|||++
T Consensus 38 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~-- 114 (328)
T cd05593 38 EVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSG-- 114 (328)
T ss_pred HHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 346788999999999999999999999999999999999999999988854 45688999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||+++||++|+
T Consensus 115 -~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~ 192 (328)
T cd05593 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192 (328)
T ss_pred -CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCC
Confidence 99999999999999999999999999987543221 1223457899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~~ 737 (757)
.||...... +. ......+.. ..+.....++.+++.+||+.||++|| ++.|+++.
T Consensus 193 ~Pf~~~~~~------~~-~~~~~~~~~-------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 193 LPFYNQDHE------KL-FELILMEDI-------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCCHH------HH-HHHhccCCc-------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 998653221 11 111111111 11223345688999999999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=257.18 Aligned_cols=211 Identities=22% Similarity=0.358 Sum_probs=172.3
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
+-+++.+|+.|-+.|+|||||+|+..+.+....|||+|+|++++|..-+-.. ...+....-+.++||+++|.|+|.+
T Consensus 53 ~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n-- 129 (355)
T KOG0033|consen 53 DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSN-- 129 (355)
T ss_pred cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhc--
Confidence 4578889999999999999999999999999999999999999997654321 3345566678999999999999999
Q ss_pred CCeeeCCCCcceEEECC---CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDE---NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~---~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+|||||+||+|+||.. ..-+||+|||+|..+. ......+..||++|||||++...+++..+|||+.||+||-|+
T Consensus 130 -~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL 206 (355)
T KOG0033|consen 130 -GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 206 (355)
T ss_pred -CceeccCChhheeeeeccCCCceeecccceEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHH
Confidence 9999999999999953 3568999999999887 344566789999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
.|+.||.... +.. +.+.+..|.+. ++++. -....++..+++.+||..||.+|.|..|.+.
T Consensus 207 ~G~~PF~~~~---~~r----lye~I~~g~yd--~~~~~-w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 207 VGYPPFWDED---QHR----LYEQIKAGAYD--YPSPE-WDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred hCCCCCCCcc---HHH----HHHHHhccccC--CCCcc-cCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 9999997532 222 33445555443 12211 1233466788999999999999999998764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=283.04 Aligned_cols=218 Identities=22% Similarity=0.276 Sum_probs=168.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
...+.+|+.++++++|+||+++++++...+..++||||+++ +|.+++......+++.....++.||+.||+|||+.
T Consensus 47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--- 122 (288)
T cd07871 47 PCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR--- 122 (288)
T ss_pred chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 35678999999999999999999999999999999999985 89998876666788999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+ ..++.++||||+|++++||++|+
T Consensus 123 ~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~ 201 (288)
T cd07871 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201 (288)
T ss_pred CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999986543221 2233567899999998865 56899999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhc------------CCccccccccc-------cCHHHHHHHHHHHHHccccCCCCCCC
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFEN------------GNLSQLVEDEE-------VDEKQLERMIKVALWCILDEPSLRPS 730 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~------------~~~~~~~d~~~-------~~~~~~~~l~~l~~~cl~~~p~~RPs 730 (757)
.||......+.... ..+.... ..+.....+.. .......++.+++.+|++.||.+|||
T Consensus 202 ~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t 278 (288)
T cd07871 202 PMFPGSTVKEELHL---IFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS 278 (288)
T ss_pred CCCCCCCHHHHHHH---HHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC
Confidence 99875433221110 1110000 00000000000 00112356789999999999999999
Q ss_pred HHHHHH
Q 038168 731 MKKVLL 736 (757)
Q Consensus 731 m~eVl~ 736 (757)
++|+++
T Consensus 279 ~~~~l~ 284 (288)
T cd07871 279 AEAALR 284 (288)
T ss_pred HHHHhc
Confidence 999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=277.06 Aligned_cols=215 Identities=29% Similarity=0.394 Sum_probs=171.3
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------------CCCCHHHHHHH
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------------KQPNWVERMGI 573 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i 573 (757)
..+.+.+|+++++++ +||||+++++++...+..++||||+++|+|.+++.+.. ..+++.++..+
T Consensus 38 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 117 (270)
T cd05047 38 DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117 (270)
T ss_pred HHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHH
Confidence 346788999999999 89999999999999999999999999999999986432 24789999999
Q ss_pred HHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccc
Q 038168 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKA 653 (757)
Q Consensus 574 ~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~ 653 (757)
+.|++.||+|||+. +++|+||||+||++++++.+||+|||+++...... .......+..|+|||++....++.++
T Consensus 118 ~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~ 192 (270)
T cd05047 118 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNS 192 (270)
T ss_pred HHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCCccccchhh--hccCCCCccccCChHHHccCCCCchh
Confidence 99999999999998 99999999999999999999999999986322111 11112235679999999888999999
Q ss_pred cchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 654 DVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 654 Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
||||||++++||++ |..||...... + ..+....+.... ........+.+++.+|++.+|.+|||+.
T Consensus 193 Di~slG~il~el~~~g~~pf~~~~~~------~-~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~ 259 (270)
T cd05047 193 DVWSYGVLLWEIVSLGGTPYCGMTCA------E-LYEKLPQGYRLE------KPLNCDDEVYDLMRQCWREKPYERPSFA 259 (270)
T ss_pred hHHHHHHHHHHHHcCCCCCccccCHH------H-HHHHHhCCCCCC------CCCcCCHHHHHHHHHHcccChhhCCCHH
Confidence 99999999999997 88888543211 1 111122221111 1112335688999999999999999999
Q ss_pred HHHHHhhcCc
Q 038168 733 KVLLMLEGTV 742 (757)
Q Consensus 733 eVl~~Le~~~ 742 (757)
++++.|+.+.
T Consensus 260 ~il~~l~~~~ 269 (270)
T cd05047 260 QILVSLNRML 269 (270)
T ss_pred HHHHHHHHhh
Confidence 9999998754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=279.59 Aligned_cols=215 Identities=24% Similarity=0.371 Sum_probs=173.6
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC--------------CCCCHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE--------------KQPNWVERMGIAR 575 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~ 575 (757)
..+.|.+|++++++++|+||+++++++.+.+..++|+||+++++|.+++.... ..+++.+++.++.
T Consensus 50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 129 (280)
T cd05092 50 ARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129 (280)
T ss_pred HHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHH
Confidence 45689999999999999999999999999999999999999999999986532 3478999999999
Q ss_pred HHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-ecccccCccccCcccccCCCCCcccc
Q 038168 576 DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-FTGIRGTRGYVAPEWHRNLPITVKAD 654 (757)
Q Consensus 576 ~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~D 654 (757)
|++.||+|||+. +++|+||||+|||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++|
T Consensus 130 qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 206 (280)
T cd05092 130 QIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESD 206 (280)
T ss_pred HHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhh
Confidence 999999999998 99999999999999999999999999998664332211 12234567899999999999999999
Q ss_pred chhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 038168 655 VYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKK 733 (757)
Q Consensus 655 v~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~e 733 (757)
|||||++++||++ |+.|+......+ .......+... ..+ ......+.+++.+||+.+|++||++.|
T Consensus 207 i~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~--~~~----~~~~~~~~~li~~cl~~~P~~Rp~~~~ 273 (280)
T cd05092 207 IWSFGVVLWEIFTYGKQPWYQLSNTE-------AIECITQGREL--ERP----RTCPPEVYAIMQGCWQREPQQRMVIKD 273 (280)
T ss_pred HHHHHHHHHHHHcCCCCCCccCCHHH-------HHHHHHcCccC--CCC----CCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9999999999998 888875432211 11111222111 111 123456889999999999999999999
Q ss_pred HHHHhhc
Q 038168 734 VLLMLEG 740 (757)
Q Consensus 734 Vl~~Le~ 740 (757)
|++.|+.
T Consensus 274 l~~~l~~ 280 (280)
T cd05092 274 IHSRLQA 280 (280)
T ss_pred HHHHHhC
Confidence 9999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=274.34 Aligned_cols=213 Identities=25% Similarity=0.355 Sum_probs=173.1
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+++.+|+.++++++|+||+++++++. .+..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.
T Consensus 39 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~-- 114 (257)
T cd05116 39 LKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEET-- 114 (257)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 3578999999999999999999999885 4567899999999999999864 34688999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce--ecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT--FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+||+++.++.+||+|||+++......... .....++..|+|||.+....++.++||||||++++||++
T Consensus 115 -~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t 193 (257)
T cd05116 115 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193 (257)
T ss_pred -CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHh
Confidence 99999999999999999999999999998775443321 122334678999999988889999999999999999998
Q ss_pred -CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 668 -RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 668 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
|+.||...... + ..+....+.... .+.....++.+++.+|++.+|++||+|.+|+++|++
T Consensus 194 ~g~~p~~~~~~~------~-~~~~i~~~~~~~------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 194 YGQKPYKGMKGN------E-VTQMIESGERME------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCCCHH------H-HHHHHHCCCCCC------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 88888643221 1 122233332211 112334678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=288.04 Aligned_cols=205 Identities=21% Similarity=0.261 Sum_probs=169.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++.+ ...++......++.|++.||+|||+.
T Consensus 62 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--- 137 (329)
T PTZ00263 62 VQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSK--- 137 (329)
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 35688999999999999999999999999999999999999999999865 34577888889999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++...... ....|++.|+|||.+.+..++.++|||||||+++||++|+.
T Consensus 138 ~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 213 (329)
T PTZ00263 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYP 213 (329)
T ss_pred CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCC
Confidence 99999999999999999999999999998764322 23568999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS-----MKKVLLM 737 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----m~eVl~~ 737 (757)
||...... + ..+....+... .+.....++.+++.+||+.||++||+ +++++..
T Consensus 214 pf~~~~~~------~-~~~~i~~~~~~-------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 214 PFFDDTPF------R-IYEKILAGRLK-------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCCCHH------H-HHHHHhcCCcC-------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 98643221 1 12223333221 11112356789999999999999996 6777643
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=278.57 Aligned_cols=214 Identities=24% Similarity=0.372 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------CCCCHHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------KQPNWVERMGIARDIARGI 581 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL 581 (757)
..+|.+|+.++++++|+||+++++++.+....++||||+++++|.+++.+.. ..+++.+++.++.|+++||
T Consensus 53 ~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 132 (277)
T cd05062 53 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132 (277)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHH
Confidence 4568899999999999999999999999999999999999999999986432 2357889999999999999
Q ss_pred HHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-ecccccCccccCcccccCCCCCccccchhhHH
Q 038168 582 LYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-FTGIRGTRGYVAPEWHRNLPITVKADVYSFGV 660 (757)
Q Consensus 582 ~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~ 660 (757)
+|||+. +++|+||||+||++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+
T Consensus 133 ~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 209 (277)
T cd05062 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 209 (277)
T ss_pred HHHHHC---CcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHH
Confidence 999998 99999999999999999999999999998654432221 11234577899999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 661 VLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 661 ~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
+++||++ |..|+...... + .......+..... +......+.+++.+|++.+|++|||+.|++++|+
T Consensus 210 ~l~el~~~~~~p~~~~~~~------~-~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 210 VLWEIATLAEQPYQGMSNE------Q-VLRFVMEGGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHcCCCCCCCCCCHH------H-HHHHHHcCCcCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 9999999 67777543221 1 1122222222211 1223457899999999999999999999999987
Q ss_pred c
Q 038168 740 G 740 (757)
Q Consensus 740 ~ 740 (757)
+
T Consensus 277 ~ 277 (277)
T cd05062 277 E 277 (277)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=286.64 Aligned_cols=215 Identities=23% Similarity=0.365 Sum_probs=186.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.|++|..+|++++|||||+|+|.|.+ ...++|||.++.|.|.+||+.++..++..+...++.||..+|+|||++
T Consensus 435 tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk--- 510 (974)
T KOG4257|consen 435 TEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK--- 510 (974)
T ss_pred HHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---
Confidence 4789999999999999999999999975 577999999999999999998888999999999999999999999999
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-CC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-RR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G~ 669 (757)
..|||||.++|||+.....+||+||||+|.+..+.........-.+.|||||.+.-.+++..+|||-|||.+||+++ |.
T Consensus 511 rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGv 590 (974)
T KOG4257|consen 511 RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGV 590 (974)
T ss_pred chhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcC
Confidence 99999999999999999999999999999998877766666667889999999999999999999999999999876 88
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
.||.+-...+-.. .++.| ++...++.++..+..++.+||..+|.+||+..|+...|+.+.
T Consensus 591 kPfqgvkNsDVI~-------~iEnG------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 591 KPFQGVKNSDVIG-------HIENG------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred CccccccccceEE-------EecCC------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 8988654433211 11222 122345677788999999999999999999999988887643
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=286.87 Aligned_cols=207 Identities=24% Similarity=0.283 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
...+.+|++++++++||||+++++.+...+..++||||+++|+|..++.. ...+++..+..++.||+.||+|||++
T Consensus 39 ~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--- 114 (323)
T cd05595 39 VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR--- 114 (323)
T ss_pred HHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 35677899999999999999999999999999999999999999988854 34678999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++...... .......|+..|+|||++.+..++.++|||||||+++||++|+.
T Consensus 115 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~ 193 (323)
T cd05595 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193 (323)
T ss_pred CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCC
Confidence 99999999999999999999999999987532221 12234568999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~ 736 (757)
||....... .......+... .+......+.+++.+||+.||++|| ++.++++
T Consensus 194 Pf~~~~~~~-------~~~~~~~~~~~-------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 194 PFYNQDHER-------LFELILMEEIR-------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCHHH-------HHHHHhcCCCC-------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 987543211 11111111111 1223345688999999999999998 7888775
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=259.17 Aligned_cols=208 Identities=24% Similarity=0.357 Sum_probs=174.8
Q ss_pred HHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 513 EFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 513 ~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
.-++|+.||+++ .||+|+++.++++.....++|+|.|+.|.|.|+|.. .-.++.+...+|++|+.+|++|||.. .
T Consensus 68 aT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~---~ 143 (411)
T KOG0599|consen 68 ATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHAR---N 143 (411)
T ss_pred HHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHh---h
Confidence 345899999999 699999999999999999999999999999999954 45578888899999999999999999 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC------CCCCccccchhhHHHHHHH
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN------LPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~S~G~~l~el 665 (757)
||||||||+|||+|++.++||+|||.+..+.... .....+||++|+|||.+.- ..|+...|+|+.||++|-|
T Consensus 144 IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTL 221 (411)
T KOG0599|consen 144 IVHRDLKPENILLDDNMNIKISDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTL 221 (411)
T ss_pred hhhcccChhheeeccccceEEeccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHH
Confidence 9999999999999999999999999999876644 3456889999999998753 3588999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+.|.+||.... .-.+.+++.+|++..- .+.-.+......+++.+||+.||.+|.|.+|++.
T Consensus 222 LaGcpPFwHRk-------QmlMLR~ImeGkyqF~---speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 222 LAGCPPFWHRK-------QMLMLRMIMEGKYQFR---SPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HcCCCchhHHH-------HHHHHHHHHhcccccC---CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 99999986321 1223456666765432 1112344567889999999999999999999876
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=273.34 Aligned_cols=214 Identities=28% Similarity=0.411 Sum_probs=175.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..++.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++.+. ...+++.++..++.|++.||+|||+.
T Consensus 46 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-- 123 (261)
T cd05148 46 QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ-- 123 (261)
T ss_pred HHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 467889999999999999999999999999999999999999999999764 35689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-C
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-R 668 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G 668 (757)
+++|+||||+||++++++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++++|++ |
T Consensus 124 -~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g 201 (261)
T cd05148 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYG 201 (261)
T ss_pred -CeeccccCcceEEEcCCceEEEccccchhhcCCccc-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999987654322 1223446778999999998899999999999999999998 7
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
+.|+...... +.. .....+... ..+......+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 202 ~~p~~~~~~~------~~~-~~~~~~~~~------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 202 QVPYPGMNNH------EVY-DQITAGYRM------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCcCCHH------HHH-HHHHhCCcC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 8888643311 111 111111111 11123346788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=275.44 Aligned_cols=207 Identities=23% Similarity=0.359 Sum_probs=167.0
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+++.+|+.++++++|+|++++++++..++..++||||+++|+|.+++......+++..++.++.||+.||+|||++
T Consensus 42 ~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-- 119 (258)
T cd05078 42 YSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK-- 119 (258)
T ss_pred HHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 346788999999999999999999999999999999999999999999987667789999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCc--------EEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHH
Q 038168 590 TQIIHCDIKPQNILMDENRC--------AKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGV 660 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~--------~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~ 660 (757)
+|+||||||+||+++.++. +|++|||++...... ....++..|+|||++.+. .++.++||||||+
T Consensus 120 -~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 193 (258)
T cd05078 120 -GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGT 193 (258)
T ss_pred -CeecCCCccceEEEecccccccCCCceEEecccccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHH
Confidence 9999999999999987765 699999998755332 224578899999999874 5799999999999
Q ss_pred HHHHHHhCCC-CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 661 VLLEIICRRR-CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 661 ~l~elltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
+++||++|.. |+....... . ...... . ...+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 194 ~l~~l~~g~~~~~~~~~~~~------~-~~~~~~-~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 194 TLWEIFSGGDKPLSALDSQK------K-LQFYED-R-------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHHHcCCCCChhhccHHH------H-HHHHHc-c-------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 9999999964 433221111 0 011111 0 0111122356889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=273.46 Aligned_cols=216 Identities=27% Similarity=0.414 Sum_probs=174.4
Q ss_pred CchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 508 SSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 508 ~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
....+.+.+|+.++++++|+|++++++++. .+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+
T Consensus 42 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~ 120 (260)
T cd05069 42 TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120 (260)
T ss_pred CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 335578999999999999999999999875 456789999999999999997543 457999999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
. +++|+||||+||++++++.+||+|||+++..............++..|+|||+..+..++.++||||||++++||+
T Consensus 121 ~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~ 197 (260)
T cd05069 121 M---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELV 197 (260)
T ss_pred C---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHH
Confidence 8 9999999999999999999999999999876543332223345677899999999889999999999999999999
Q ss_pred h-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 667 C-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 667 t-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
+ |+.|+......+ .......+... ..+......+.+++.+|++.+|++||++++|++.|+.
T Consensus 198 t~g~~p~~~~~~~~-------~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 198 TKGRVPYPGMVNRE-------VLEQVERGYRM------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred hCCCCCCCCCCHHH-------HHHHHHcCCCC------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 9 888876432211 11112222111 1122345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=293.09 Aligned_cols=222 Identities=22% Similarity=0.240 Sum_probs=170.5
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
..+.+|+++|++++|+|||++++++..++..++|||++. ++|.+++......++|.+++.|+.|+++||+|||++ +
T Consensus 205 ~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---g 280 (461)
T PHA03211 205 ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---G 280 (461)
T ss_pred cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 346789999999999999999999999999999999995 789988876566799999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
|+||||||+||||+.++.+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|||++|..
T Consensus 281 IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~ 360 (461)
T PHA03211 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTA 360 (461)
T ss_pred EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999876443221 2234679999999999999999999999999999999999887
Q ss_pred CCCCCCCC-ccccHHHHHHHHHhcCCcc-----cccc----------------c----ccc--CHHHHHHHHHHHHHccc
Q 038168 671 CLDPNLPD-DQVILEEWVYQCFENGNLS-----QLVE----------------D----EEV--DEKQLERMIKVALWCIL 722 (757)
Q Consensus 671 p~~~~~~~-~~~~l~~~~~~~~~~~~~~-----~~~d----------------~----~~~--~~~~~~~l~~l~~~cl~ 722 (757)
++...... ........+.+.+...... .... + ... .......+.+++.+||+
T Consensus 361 ~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 440 (461)
T PHA03211 361 SLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALT 440 (461)
T ss_pred CcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcc
Confidence 65432211 1111111122222221110 0000 0 000 00112367889999999
Q ss_pred cCCCCCCCHHHHHHH
Q 038168 723 DEPSLRPSMKKVLLM 737 (757)
Q Consensus 723 ~~p~~RPsm~eVl~~ 737 (757)
.||++|||+.|+++.
T Consensus 441 ~DP~~RPsa~elL~h 455 (461)
T PHA03211 441 FDGARRPSAAELLRL 455 (461)
T ss_pred cChhhCcCHHHHhhC
Confidence 999999999999874
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=277.14 Aligned_cols=213 Identities=24% Similarity=0.290 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN---PEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
.+.+..|+.++++++|+||+++.+++......++||||+++|+|.+++.. ....+++..+..++.||+.||+|||+.
T Consensus 37 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 116 (280)
T cd05608 37 YEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116 (280)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 35678899999999999999999999999999999999999999988743 235688999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+||+++.++.+||+|||++..+..... ......|+..|+|||.+.+..++.++||||||++++||++
T Consensus 117 ---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~ 192 (280)
T cd05608 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIA 192 (280)
T ss_pred ---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHh
Confidence 999999999999999999999999999986654332 2234578999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLLM 737 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~~ 737 (757)
|+.||........ ... .......+ +...+......+.+++..||+.||++|| +++++++.
T Consensus 193 g~~pf~~~~~~~~--~~~-~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 193 ARGPFRARGEKVE--NKE-LKQRILND-------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCCCCCCCCcchh--HHH-HHHhhccc-------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 9999875432211 111 11111111 1122234456788999999999999999 77888863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=273.17 Aligned_cols=214 Identities=22% Similarity=0.326 Sum_probs=174.1
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..++|.+|+.++++++|+||+++++++. .+..++||||+++++|.+++......+++.++.+++.|++.||+|||++
T Consensus 38 ~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-- 114 (257)
T cd05115 38 VRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK-- 114 (257)
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc--
Confidence 3467999999999999999999999885 4578999999999999999976667789999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce--ecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT--FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||||+|||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++|+++
T Consensus 115 -~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 193 (257)
T cd05115 115 -NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193 (257)
T ss_pred -CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhc
Confidence 99999999999999999999999999998664433211 122234578999999988889999999999999999996
Q ss_pred -CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 668 -RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 668 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
|..|+...... + +......+.... .+....+.+.+++..||+.+|++||++.+|.+.|+.
T Consensus 194 ~g~~p~~~~~~~------~-~~~~~~~~~~~~------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 194 YGQKPYKKMKGP------E-VMSFIEQGKRLD------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCcCcCCHH------H-HHHHHHCCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 88888654321 1 122223332111 122345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=273.38 Aligned_cols=215 Identities=29% Similarity=0.421 Sum_probs=174.0
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..++|.+|++++++++|+||+++++++.+ +..++||||+++|+|.+++.+. ...+++.++..++.|++.||+|||+.
T Consensus 44 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~- 121 (262)
T cd05071 44 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM- 121 (262)
T ss_pred CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 45689999999999999999999998754 5678999999999999999753 34578999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+++|+||||+||++++++.+||+|||+++.+............++..|+|||+..+..++.++||||||++++||++
T Consensus 122 --~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~ 199 (262)
T cd05071 122 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 199 (262)
T ss_pred --CccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999998765443332233456778999999998899999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
|..|+....... .......+... ....+....+.+++.+|++.+|++||++.+++++|+..
T Consensus 200 g~~p~~~~~~~~-------~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 200 GRVPYPGMVNRE-------VLDQVERGYRM------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCCCCCChHH-------HHHHHhcCCCC------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 777775432211 11112211100 11234456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=273.49 Aligned_cols=215 Identities=27% Similarity=0.404 Sum_probs=173.9
Q ss_pred chHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 509 SGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 509 ~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
...+.|.+|+.++++++|+|++++++++. .+..++||||+++++|.+++.+. ...+++.++..++.+++.||+|||+.
T Consensus 43 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~ 121 (260)
T cd05070 43 MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121 (260)
T ss_pred CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34678999999999999999999999875 45678999999999999999754 34589999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||||+||++++++.+||+|||++..+............++..|+|||...+..++.++||||||++++||++
T Consensus 122 ---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 198 (260)
T cd05070 122 ---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198 (260)
T ss_pred ---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHh
Confidence 99999999999999999999999999998765443322233445678999999988899999999999999999999
Q ss_pred -CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 668 -RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 668 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
|+.|+...... +.. ..+..+... ..+......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 199 ~g~~p~~~~~~~------~~~-~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 199 KGRVPYPGMNNR------EVL-EQVERGYRM------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred cCCCCCCCCCHH------HHH-HHHHcCCCC------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 78887543211 111 112221111 1122334679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=274.01 Aligned_cols=218 Identities=20% Similarity=0.330 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN---PEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
.+.+.+|++++++++|+|++++++++.+.+..++|+||+++++|.+++.. ....++..+...++.|+++||.|||+.
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 125 (267)
T cd08228 46 RQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR 125 (267)
T ss_pred HHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 45788999999999999999999999999999999999999999988743 234578889999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||++++||++
T Consensus 126 ---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~ 201 (267)
T cd08228 126 ---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201 (267)
T ss_pred ---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhc
Confidence 999999999999999999999999999987654322 1223567889999999998889999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
|+.|+...... .... ......... +..........+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 202 g~~p~~~~~~~----~~~~-~~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 202 LQSPFYGDKMN----LFSL-CQKIEQCDY-----PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCCCcccccc----HHHH-HHHHhcCCC-----CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 99998643221 1111 122222211 11122344577899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=281.95 Aligned_cols=231 Identities=24% Similarity=0.403 Sum_probs=189.5
Q ss_pred cccccCCCchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038168 501 KEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARG 580 (757)
Q Consensus 501 ~~~lg~g~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~g 580 (757)
..+.|+.....+.+++|++|+++++|||||.+++.++...+.++|+||+.+ +|..+|.. ...++......|+.+++.|
T Consensus 35 i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsa 112 (808)
T KOG0597|consen 35 IDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSA 112 (808)
T ss_pred ehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHH
Confidence 345555555667899999999999999999999999999999999999987 99999965 4567788899999999999
Q ss_pred HHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHH
Q 038168 581 ILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGV 660 (757)
Q Consensus 581 L~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~ 660 (757)
|.|||+. +|+|||+||.||||+.++.+|++|||+|+.+.... ...+.++||+-|||||...+.+|+..+|+||+||
T Consensus 113 L~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~vltsikGtPlYmAPElv~e~pyd~~sDlWslGc 188 (808)
T KOG0597|consen 113 LYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGC 188 (808)
T ss_pred HHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc-eeeeeccCcccccCHHHHcCCCccchhhHHHHHH
Confidence 9999999 99999999999999999999999999999887643 3445689999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hh
Q 038168 661 VLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL--ML 738 (757)
Q Consensus 661 ~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~--~L 738 (757)
++||+++|++||... .+.+.+..... |+...+.+....+..++.-.++.||.+|.+-.+++. ..
T Consensus 189 ilYE~~~G~PPF~a~------si~~Lv~~I~~--------d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~ 254 (808)
T KOG0597|consen 189 ILYELYVGQPPFYAR------SITQLVKSILK--------DPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFW 254 (808)
T ss_pred HHHHHhcCCCCchHH------HHHHHHHHHhc--------CCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHH
Confidence 999999999998743 22222222222 222234456677889999999999999999999886 33
Q ss_pred hc-CcCCCCCCCCC
Q 038168 739 EG-TVEIPIPPNPT 751 (757)
Q Consensus 739 e~-~~~~~~p~~p~ 751 (757)
++ +..+..|.+|+
T Consensus 255 k~~~~~~~~~~~~a 268 (808)
T KOG0597|consen 255 KGKINIAELPAQVA 268 (808)
T ss_pred hhhhhhhccccccc
Confidence 44 33344454444
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=283.98 Aligned_cols=214 Identities=23% Similarity=0.298 Sum_probs=170.4
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|+.++.++ +||||+++++++...+..++||||+++|+|..++.. ...+++..+..++.|++.||+|||++
T Consensus 39 ~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~-- 115 (329)
T cd05618 39 IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHER-- 115 (329)
T ss_pred HHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 45678899988877 899999999999999999999999999999988854 35688899999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++||||||++++||++|+
T Consensus 116 -~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 193 (329)
T cd05618 116 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193 (329)
T ss_pred -CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCC
Confidence 99999999999999999999999999997543221 1223457899999999999999999999999999999999999
Q ss_pred CCCCCCCCCc--cccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 038168 670 RCLDPNLPDD--QVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS------MKKVLL 736 (757)
Q Consensus 670 ~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs------m~eVl~ 736 (757)
.||....... ......++.+........ .+......+.+++.+||+.||++||+ +.++++
T Consensus 194 ~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-------~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 194 SPFDIVGSSDNPDQNTEDYLFQVILEKQIR-------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCCccCCCcCCcccccHHHHHHHHhcCCCC-------CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 9996422111 112223333333332221 12233456889999999999999998 566644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=274.92 Aligned_cols=215 Identities=25% Similarity=0.358 Sum_probs=170.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec------eeeeEEEEeccCCChhhhhcC-----CCCCCCHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV------SKKILVYEYMSNGSLADILFN-----PEKQPNWVERMGIARDIAR 579 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lV~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~ 579 (757)
.+.+.+|++++++++|+||+++++++... ...++|+||+++|+|.+++.. ....+++.+...++.|++.
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 123 (272)
T cd05075 44 MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123 (272)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHH
Confidence 46788999999999999999999988542 246899999999999988742 2245789999999999999
Q ss_pred HHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-ecccccCccccCcccccCCCCCccccchhh
Q 038168 580 GILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-FTGIRGTRGYVAPEWHRNLPITVKADVYSF 658 (757)
Q Consensus 580 gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~ 658 (757)
||+|||+. +|+||||||+|||+++++.+||+|||+++.+....... .....++..|+|||+..+..++.++|||||
T Consensus 124 ~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl 200 (272)
T cd05075 124 GMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSF 200 (272)
T ss_pred HHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHH
Confidence 99999998 99999999999999999999999999998765433211 112335678999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 659 GVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 659 G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|++++||++ |+.|+..... . + .......+..... .......+.+++.+||+.+|++|||+.+|++.
T Consensus 201 G~il~el~~~g~~p~~~~~~---~---~-~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 201 GVTMWEIATRGQTPYPGVEN---S---E-IYDYLRQGNRLKQ------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHHcCCCCCCCCCCH---H---H-HHHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999 7777754221 1 1 2222333322111 11234568899999999999999999999999
Q ss_pred hhcC
Q 038168 738 LEGT 741 (757)
Q Consensus 738 Le~~ 741 (757)
|+.+
T Consensus 268 l~~~ 271 (272)
T cd05075 268 LEKA 271 (272)
T ss_pred HHhh
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=283.80 Aligned_cols=216 Identities=21% Similarity=0.373 Sum_probs=168.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++++.+.+..++||||+++++|.+++.. ...+++.....++.+++.||.|||+. .
T Consensus 47 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~--~ 123 (333)
T cd06650 47 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREK--H 123 (333)
T ss_pred HHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhc--C
Confidence 46789999999999999999999999999999999999999999999965 34578888899999999999999974 2
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+|+||||+|||++.++.+||+|||++....... .....|+..|+|||.+.+..++.++|||||||+++||++|+.
T Consensus 124 ~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~ 200 (333)
T cd06650 124 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRY 200 (333)
T ss_pred CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 69999999999999999999999999997653321 223568999999999999899999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCcccc---------------------------------cc---ccccCHHHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQL---------------------------------VE---DEEVDEKQLERMI 714 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~---------------------------------~d---~~~~~~~~~~~l~ 714 (757)
|+......... . .......+..... .. +.........++.
T Consensus 201 p~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (333)
T cd06650 201 PIPPPDAKELE---L-MFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQ 276 (333)
T ss_pred CCCCcchhHHH---H-HhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHH
Confidence 98754321100 0 0000000000000 00 0000011235688
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 038168 715 KVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 715 ~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+++.+||+.||++|||+.|+++
T Consensus 277 ~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 277 DFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred HHHHHhccCCcccCcCHHHHhh
Confidence 9999999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=285.61 Aligned_cols=205 Identities=24% Similarity=0.267 Sum_probs=170.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.
T Consensus 75 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--- 150 (340)
T PTZ00426 75 VDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSL--- 150 (340)
T ss_pred HHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 45688999999999999999999999999999999999999999999965 34678899999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+++||++|+.
T Consensus 151 ~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~ 226 (340)
T PTZ00426 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCP 226 (340)
T ss_pred CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCC
Confidence 9999999999999999999999999999876432 223568999999999999899999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLLM 737 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~~ 737 (757)
||...... ...+....+... .+......+.+++.+|++.+|++|+ +++++++.
T Consensus 227 Pf~~~~~~-------~~~~~i~~~~~~-------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 227 PFYANEPL-------LIYQKILEGIIY-------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCHH-------HHHHHHhcCCCC-------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 99753221 112222222211 1112234578999999999999995 89988775
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=274.49 Aligned_cols=218 Identities=25% Similarity=0.344 Sum_probs=167.7
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC----CCCCHHHHHHHHHHHHHHHHHhh
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE----KQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
....+.+|+.++++++|+||+++++++.+....++||||+++|+|.+++.... ..+++..+..++.|+++||+|||
T Consensus 38 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 117 (269)
T cd05087 38 EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117 (269)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 34678999999999999999999999999999999999999999999986432 34677888899999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-ecccccCccccCcccccCC-------CCCccccchh
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-FTGIRGTRGYVAPEWHRNL-------PITVKADVYS 657 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-------~~~~k~Dv~S 657 (757)
+. +++|+||||+||+++.++.+||+|||+++......... .....++..|+|||++.+. .++.++||||
T Consensus 118 ~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 194 (269)
T cd05087 118 KN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWS 194 (269)
T ss_pred HC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHH
Confidence 98 99999999999999999999999999997654433221 2234567889999988642 3588999999
Q ss_pred hHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 658 FGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 658 ~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||++++||++ |+.||......+. . ....... .....++. ......+.+.+++..|+ .+|++|||++||++
T Consensus 195 lG~~l~el~~~g~~p~~~~~~~~~--~----~~~~~~~-~~~~~~~~-~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 195 LGVTIWELFELGSQPYRHLSDEQV--L----TYTVREQ-QLKLPKPR-LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred HHHHHHHHHhCCCCCCCCCChHHH--H----HHHhhcc-cCCCCCCc-cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 9999999996 9988865432211 1 1111111 11111111 11122345777888898 58999999999999
Q ss_pred Hhh
Q 038168 737 MLE 739 (757)
Q Consensus 737 ~Le 739 (757)
.|+
T Consensus 266 ~l~ 268 (269)
T cd05087 266 LLS 268 (269)
T ss_pred Hhc
Confidence 986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=281.70 Aligned_cols=215 Identities=29% Similarity=0.394 Sum_probs=171.1
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------------CCCCHHHHHHH
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------------KQPNWVERMGI 573 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i 573 (757)
..+.+.+|++++.++ +|+||+++++++.+.+..++|+||+++++|.+++.+.. ..+++.+++.+
T Consensus 50 ~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 129 (303)
T cd05088 50 DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129 (303)
T ss_pred HHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHH
Confidence 456789999999999 89999999999999999999999999999999996432 25788999999
Q ss_pred HHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccc
Q 038168 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKA 653 (757)
Q Consensus 574 ~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~ 653 (757)
+.|++.||+|||+. +++||||||+|||++.++.+||+|||+++...... ......++..|+|||++.+..++.++
T Consensus 130 ~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~ 204 (303)
T cd05088 130 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNS 204 (303)
T ss_pred HHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccc
Confidence 99999999999998 99999999999999999999999999986432111 11112235679999999888899999
Q ss_pred cchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 654 DVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 654 Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
||||||++++||++ |..||...... + .......+.... .+......+.+++.+|++.+|++||++.
T Consensus 205 Di~slG~il~ellt~g~~p~~~~~~~------~-~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 271 (303)
T cd05088 205 DVWSYGVLLWEIVSLGGTPYCGMTCA------E-LYEKLPQGYRLE------KPLNCDDEVYDLMRQCWREKPYERPSFA 271 (303)
T ss_pred cchhhhhHHHHHHhcCCCCcccCChH------H-HHHHHhcCCcCC------CCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 99999999999998 99888643221 1 111112111100 1112345688999999999999999999
Q ss_pred HHHHHhhcCc
Q 038168 733 KVLLMLEGTV 742 (757)
Q Consensus 733 eVl~~Le~~~ 742 (757)
+++++|+.+.
T Consensus 272 ~il~~l~~~~ 281 (303)
T cd05088 272 QILVSLNRML 281 (303)
T ss_pred HHHHHHHHHH
Confidence 9999987643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=273.58 Aligned_cols=217 Identities=18% Similarity=0.304 Sum_probs=177.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN---PEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
.+++.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++.. ....+++.++..++.|+++||.|||+.
T Consensus 46 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 125 (267)
T cd08229 46 RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR 125 (267)
T ss_pred HHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 46788999999999999999999999999999999999999999998853 235679999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||||+||+++.++.+||+|||++........ ......++..|+|||++.+..++.++||||||++++||++
T Consensus 126 ---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~ 201 (267)
T cd08229 126 ---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201 (267)
T ss_pred ---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999987654322 1233568889999999999899999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
|..|+.....+. ... .+....... +........+.+.+++.+|++.+|++||||.+|.++++++
T Consensus 202 g~~p~~~~~~~~----~~~-~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 202 LQSPFYGDKMNL----YSL-CKKIEQCDY-----PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCcccccchH----HHH-hhhhhcCCC-----CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 999986432211 111 111111111 1111223456789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=277.39 Aligned_cols=227 Identities=24% Similarity=0.347 Sum_probs=173.4
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..+.|.+|++++++++|+||+++++++... ...++||||+++++|.+++.. ..+++.++..++.|++.||+|||+.
T Consensus 49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~ 126 (283)
T cd05080 49 NTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQ 126 (283)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 456788999999999999999999988754 357899999999999999854 3589999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc--eecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR--TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+|+|+||||+|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||
T Consensus 127 ---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el 203 (283)
T cd05080 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203 (283)
T ss_pred ---CeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHH
Confidence 9999999999999999999999999999876543221 11223356679999999988999999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccc---cccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVED---EEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~---~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
++|+.|+..........+ ...........+.+..+. ...+.....++.+++..|++.+|++|||+++|+++|+.+.
T Consensus 204 ~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 204 LTHCDSKQSPPKKFEEMI-GPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred HhCCCCCCCCcchhhhhh-cccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 999998764332110000 000000000000001110 0112234567999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=272.00 Aligned_cols=217 Identities=29% Similarity=0.465 Sum_probs=176.5
Q ss_pred CCchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 507 g~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
+.....+|.+|++++++++|+|++++++++......++|+||+++++|.+++......+++..+..++.+++.||+|||+
T Consensus 39 ~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 118 (256)
T cd05112 39 GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES 118 (256)
T ss_pred CCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 33456789999999999999999999999999999999999999999999997666678899999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
. +++|+||||+||+++.++.+||+|||+++..............++.+|+|||.+.+..++.++||||||++++||+
T Consensus 119 ~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~ 195 (256)
T cd05112 119 S---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C---CccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHH
Confidence 8 9999999999999999999999999999866443322222334567899999999889999999999999999999
Q ss_pred h-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 667 C-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 667 t-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
+ |+.|+..... .+.. +....+. ....+.. ....+.+++.+||+.+|++||++.||+++|.
T Consensus 196 ~~g~~p~~~~~~------~~~~-~~~~~~~--~~~~~~~----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 196 SEGKTPYENRSN------SEVV-ETINAGF--RLYKPRL----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred cCCCCCCCcCCH------HHHH-HHHhCCC--CCCCCCC----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 8 8888764321 1111 1122221 1111111 2467999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=274.60 Aligned_cols=216 Identities=25% Similarity=0.420 Sum_probs=174.8
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..++|..|+.++++++||||+++++++.+++..++||||+++++|.+++......+++.+++.++.|++.||+|||+.
T Consensus 48 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~-- 125 (269)
T cd05065 48 QRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM-- 125 (269)
T ss_pred HHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 346899999999999999999999999999999999999999999999977667789999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-ecc---cccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-FTG---IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-~~~---~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+++|+||||+||+++.++.+||+|||+++......... ... ...+..|+|||++.+..++.++||||||++++|+
T Consensus 126 -g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~ 204 (269)
T cd05065 126 -NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 204 (269)
T ss_pred -CEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHH
Confidence 99999999999999999999999999998664432211 111 1124579999999999999999999999999998
Q ss_pred Hh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 666 IC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 666 lt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
++ |..|+...... .. ....... .. ...+.+.+..+.+++..|++.+|++||+|.+|+.+|+.+
T Consensus 205 l~~g~~p~~~~~~~---~~----~~~i~~~-~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 205 MSYGERPYWDMSNQ---DV----INAIEQD-YR-----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred hcCCCCCCCCCCHH---HH----HHHHHcC-Cc-----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 86 98888643321 11 1111111 00 011123345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=275.86 Aligned_cols=220 Identities=24% Similarity=0.326 Sum_probs=171.4
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-----------CCCCHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-----------KQPNWVERMGIARDIA 578 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~ia 578 (757)
....|.+|++++++++|+|++++++++...+..++||||+++++|.+++.... ..+++.+++.++.|++
T Consensus 60 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~ 139 (295)
T cd05097 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIA 139 (295)
T ss_pred HHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHH
Confidence 34678999999999999999999999999999999999999999999985432 2368899999999999
Q ss_pred HHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-ecccccCccccCcccccCCCCCccccchh
Q 038168 579 RGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-FTGIRGTRGYVAPEWHRNLPITVKADVYS 657 (757)
Q Consensus 579 ~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S 657 (757)
.||+|||+. +++|+||||+||++++++.+||+|||+++......... .....++..|+|||+..+..++.++||||
T Consensus 140 ~al~~lH~~---~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS 216 (295)
T cd05097 140 SGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216 (295)
T ss_pred HHHHHHHhc---CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHH
Confidence 999999998 99999999999999999999999999998654332221 12234577899999999999999999999
Q ss_pred hHHHHHHHHhC--CCCCCCCCCCccccHHHHHHHHHhcC-CccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 038168 658 FGVVLLEIICR--RRCLDPNLPDDQVILEEWVYQCFENG-NLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKV 734 (757)
Q Consensus 658 ~G~~l~elltG--~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eV 734 (757)
||++++||+++ ..|+....... ......+..... .......+ ...+..+.+++.+|++.+|++||+|.+|
T Consensus 217 lG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~RPs~~~i 289 (295)
T cd05097 217 FGVTLWEMFTLCKEQPYSLLSDEQ---VIENTGEFFRNQGRQIYLSQT----PLCPSPVFKLMMRCWSRDIKDRPTFNKI 289 (295)
T ss_pred HHHHHHHHHHcCCCCCCcccChHH---HHHHHHHhhhhccccccCCCC----CCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 99999999984 45554332211 111111111111 11111111 1234679999999999999999999999
Q ss_pred HHHhh
Q 038168 735 LLMLE 739 (757)
Q Consensus 735 l~~Le 739 (757)
++.|+
T Consensus 290 ~~~l~ 294 (295)
T cd05097 290 HHFLR 294 (295)
T ss_pred HHHHh
Confidence 99986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=282.96 Aligned_cols=214 Identities=22% Similarity=0.289 Sum_probs=171.7
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+..|..++.++ +||||+++++++.+.+..++||||+++|+|.+++.+ ...+++..+..++.|++.||+|||++
T Consensus 39 ~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~-- 115 (329)
T cd05588 39 IDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHER-- 115 (329)
T ss_pred HHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 45678899999998 799999999999999999999999999999988854 35689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++||||||++++||++|+
T Consensus 116 -~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~ 193 (329)
T cd05588 116 -GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193 (329)
T ss_pred -CeEecCCCHHHeEECCCCCEEECcCccccccccCC-CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCC
Confidence 99999999999999999999999999987532211 1223457899999999999999999999999999999999999
Q ss_pred CCCCCCCCCc--cccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 038168 670 RCLDPNLPDD--QVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS------MKKVLL 736 (757)
Q Consensus 670 ~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs------m~eVl~ 736 (757)
.||+.....+ .....++..+....+... .+.....++.+++.+||+.||.+||+ ++++++
T Consensus 194 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 194 SPFDIVGMSDNPDQNTEDYLFQVILEKQIR-------IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCcccccccccccccchHHHHHHHHcCCCC-------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 9997432211 122223333333333221 11223456889999999999999997 677764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=274.31 Aligned_cols=223 Identities=26% Similarity=0.372 Sum_probs=172.1
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEe--ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLE--VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..+.|.+|++++++++|+||+++++++.. ....++|+||+++++|.+++.+....+++..+..++.|++.||+|||+.
T Consensus 48 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~ 127 (284)
T cd05081 48 HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127 (284)
T ss_pred HHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 35678999999999999999999998754 3467899999999999999976666789999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCccee--cccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF--TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+++||||||+||++++++.+||+|||+++.......... ....++..|+|||.+.+..++.++||||||++++||
T Consensus 128 ---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 204 (284)
T cd05081 128 ---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204 (284)
T ss_pred ---CceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHH
Confidence 999999999999999999999999999997654332211 112234569999999988999999999999999999
Q ss_pred HhCCCCCCCCCCCc--------c-ccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 666 ICRRRCLDPNLPDD--------Q-VILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 666 ltG~~p~~~~~~~~--------~-~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
++|..++......- . ........+....+... .........+.+++.+||+.+|++|||+.||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 205 FTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRL------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcC------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99877654321100 0 00001111111111110 011223457899999999999999999999999
Q ss_pred HhhcC
Q 038168 737 MLEGT 741 (757)
Q Consensus 737 ~Le~~ 741 (757)
+|+.+
T Consensus 279 ~l~~~ 283 (284)
T cd05081 279 QVEAI 283 (284)
T ss_pred HHHhc
Confidence 99865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=271.36 Aligned_cols=218 Identities=30% Similarity=0.471 Sum_probs=175.9
Q ss_pred CCCchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHh
Q 038168 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 506 ~g~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
......+.|.+|+.++++++|+|++++++++. .+..++||||+++++|.+++... ...+++.++..++.|++.||+||
T Consensus 40 ~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~L 118 (260)
T cd05067 40 QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118 (260)
T ss_pred CCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 33445678999999999999999999999864 45789999999999999998653 35689999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~e 664 (757)
|+. +++|+||||+||++++++.++|+|||++...............++..|+|||++....++.++||||||++++|
T Consensus 119 H~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~e 195 (260)
T cd05067 119 ERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTE 195 (260)
T ss_pred hcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHH
Confidence 998 99999999999999999999999999998765433333333456788999999998899999999999999999
Q ss_pred HHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 665 IIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 665 llt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
|++ |+.||...... + ....+..+.... .......++.+++.+|++.+|++||++++++..|+.
T Consensus 196 l~~~g~~p~~~~~~~------~-~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 196 IVTYGRIPYPGMTNP------E-VIQNLERGYRMP------RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHhCCCCCCCCCChH------H-HHHHHHcCCCCC------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 999 99888643221 1 111222221111 112234579999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=278.53 Aligned_cols=216 Identities=27% Similarity=0.420 Sum_probs=175.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-----------------------CCCCCH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-----------------------EKQPNW 567 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-----------------------~~~l~~ 567 (757)
.+.+.+|+.++++++||||+++++.+.+.+..++|+||+++++|.+++... ...+++
T Consensus 47 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 126 (290)
T cd05045 47 LRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126 (290)
T ss_pred HHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCH
Confidence 467889999999999999999999999999999999999999999987532 134788
Q ss_pred HHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccC
Q 038168 568 VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRN 646 (757)
Q Consensus 568 ~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~ 646 (757)
.+++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++........ ......++..|+|||.+.+
T Consensus 127 ~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 203 (290)
T cd05045 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD 203 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc
Confidence 99999999999999999998 9999999999999999999999999999865433221 1122345678999999988
Q ss_pred CCCCccccchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCC
Q 038168 647 LPITVKADVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEP 725 (757)
Q Consensus 647 ~~~~~k~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p 725 (757)
..++.++||||||++++||++ |+.|+....++ .+++....+.... .+.....++.+++.+|++.+|
T Consensus 204 ~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~~~~~~i~~cl~~~P 270 (290)
T cd05045 204 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-------RLFNLLKTGYRME------RPENCSEEMYNLMLTCWKQEP 270 (290)
T ss_pred CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhCCCCCC------CCCCCCHHHHHHHHHHccCCc
Confidence 899999999999999999998 88888643321 1222233221111 112234578899999999999
Q ss_pred CCCCCHHHHHHHhhcCc
Q 038168 726 SLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 726 ~~RPsm~eVl~~Le~~~ 742 (757)
++||++.|+++.|+.+.
T Consensus 271 ~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 271 DKRPTFADISKELEKMM 287 (290)
T ss_pred ccCCCHHHHHHHHHHHH
Confidence 99999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=273.64 Aligned_cols=218 Identities=23% Similarity=0.343 Sum_probs=166.6
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC----CCCCHHHHHHHHHHHHHHHHHhh
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE----KQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
..+.|.+|+.++++++|+||+++++.+.+....++||||+++|+|.+++.... ...++.....++.||+.||+|||
T Consensus 38 ~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 117 (269)
T cd05042 38 EQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117 (269)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 34678999999999999999999999999999999999999999999996543 23467788899999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-ecccccCccccCcccccC-------CCCCccccchh
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-FTGIRGTRGYVAPEWHRN-------LPITVKADVYS 657 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~S 657 (757)
+. +|+||||||+|||+++++.+||+|||+++......... .....++..|+|||+... ..++.++||||
T Consensus 118 ~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 194 (269)
T cd05042 118 QA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWS 194 (269)
T ss_pred hc---CEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHH
Confidence 98 99999999999999999999999999987644332211 122345678999998643 45788999999
Q ss_pred hHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 658 FGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 658 ~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||++++||++ |..|+....+. +........+... +..+ .........+.+++..|+ .+|++||++++|++
T Consensus 195 lG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 195 LGVTMWELFTAADQPYPDLSDE------QVLKQVVREQDIK-LPKP-QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhccCcc-CCCC-cccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 9999999999 66776543221 1112222222211 1111 122334456677888888 59999999999999
Q ss_pred Hhh
Q 038168 737 MLE 739 (757)
Q Consensus 737 ~Le 739 (757)
+|.
T Consensus 266 ~l~ 268 (269)
T cd05042 266 LLT 268 (269)
T ss_pred Hhc
Confidence 874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=277.32 Aligned_cols=216 Identities=27% Similarity=0.411 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcC---------------CCCCCCHHHHHHHH
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN---------------PEKQPNWVERMGIA 574 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~---------------~~~~l~~~~~~~i~ 574 (757)
..++.+|+++++++ +|+||+++++++.+.+..++||||+++|+|.+++.. ....+++..+++++
T Consensus 59 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 138 (293)
T cd05053 59 LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138 (293)
T ss_pred HHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHH
Confidence 35688999999999 899999999999999999999999999999999853 23567899999999
Q ss_pred HHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-ecccccCccccCcccccCCCCCccc
Q 038168 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-FTGIRGTRGYVAPEWHRNLPITVKA 653 (757)
Q Consensus 575 ~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~ 653 (757)
.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.+....... .....++..|+|||.+.+..++.++
T Consensus 139 ~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 215 (293)
T cd05053 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQS 215 (293)
T ss_pred HHHHHHHHHHHHC---CccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCccc
Confidence 9999999999998 99999999999999999999999999998765433221 2223456789999999988999999
Q ss_pred cchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 654 DVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 654 Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
||||||+++|||++ |..|+...... + +.+....+.... .+......+.+++.+|++.+|++|||+.
T Consensus 216 Di~slG~il~el~~~g~~p~~~~~~~------~-~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~ 282 (293)
T cd05053 216 DVWSFGVLLWEIFTLGGSPYPGIPVE------E-LFKLLKEGYRME------KPQNCTQELYHLMRDCWHEVPSQRPTFK 282 (293)
T ss_pred ceeehhhHHHHHhcCCCCCCCCCCHH------H-HHHHHHcCCcCC------CCCCCCHHHHHHHHHHcccCcccCcCHH
Confidence 99999999999998 88877543221 1 122222222111 1223346788999999999999999999
Q ss_pred HHHHHhhcCc
Q 038168 733 KVLLMLEGTV 742 (757)
Q Consensus 733 eVl~~Le~~~ 742 (757)
|+++.|+.++
T Consensus 283 eil~~l~~~~ 292 (293)
T cd05053 283 QLVEDLDRML 292 (293)
T ss_pred HHHHHHHHhh
Confidence 9999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=283.58 Aligned_cols=207 Identities=23% Similarity=0.233 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
...+.+|+.++++++||||+++++.+..++..++||||+++++|.+++.. ...+.......++.|++.||+|||+.
T Consensus 44 ~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--- 119 (323)
T cd05584 44 TAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQ--- 119 (323)
T ss_pred HHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 35678899999999999999999999999999999999999999999865 34567788888999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++....... ......|+..|+|||++.+..++.++||||||++++||++|+.
T Consensus 120 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 198 (323)
T cd05584 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAP 198 (323)
T ss_pred CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCC
Confidence 999999999999999999999999999875432221 2233568999999999999899999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~ 736 (757)
||...... . .......+... .+......+.+++.+|++.+|++|| ++.++++
T Consensus 199 pf~~~~~~------~-~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 199 PFTAENRK------K-TIDKILKGKLN-------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCHH------H-HHHHHHcCCCC-------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 98753321 1 11222222211 1122345688999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=281.42 Aligned_cols=209 Identities=23% Similarity=0.291 Sum_probs=169.8
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|+.++.++ +|+||+++++++.+.+..++||||+++|+|..++.. ...+++..+..++.|++.||+|||++
T Consensus 39 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~-- 115 (327)
T cd05617 39 IDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHER-- 115 (327)
T ss_pred HHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 45688999999888 699999999999999999999999999999988854 34688999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||++++||++|+
T Consensus 116 -~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~ 193 (327)
T cd05617 116 -GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193 (327)
T ss_pred -CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCC
Confidence 99999999999999999999999999997532221 1223457899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
.||............+...+........ .+......+.+++.+||+.||++||++
T Consensus 194 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 194 SPFDIITDNPDMNTEDYLFQVILEKPIR-------IPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCccCCCcccccHHHHHHHHHhCCCC-------CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 9997654433333333344433333221 112233567899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=284.63 Aligned_cols=212 Identities=21% Similarity=0.236 Sum_probs=172.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+||+++++++.+.+..++||||+++|+|.+++.+....+++.....++.|++.||+|||+.
T Consensus 45 ~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~--- 121 (330)
T cd05601 45 VSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM--- 121 (330)
T ss_pred HHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 45688999999999999999999999999999999999999999999977667789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc------CCCCCccccchhhHHHHHH
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR------NLPITVKADVYSFGVVLLE 664 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~Dv~S~G~~l~e 664 (757)
+|+||||||+|||++.++.+||+|||++..+............||..|+|||.+. ...++.++|||||||+++|
T Consensus 122 ~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~e 201 (330)
T cd05601 122 GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYE 201 (330)
T ss_pred CeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeee
Confidence 9999999999999999999999999999877654443334457899999999986 4567899999999999999
Q ss_pred HHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 665 IICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|++|+.||...... ................+. ......+.+++..|++ +|++||++.++++
T Consensus 202 l~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~~~~----~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 202 MIYGRSPFHEGTSA------KTYNNIMNFQRFLKFPED----PKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred eccCCCCCCCCCHH------HHHHHHHcCCCccCCCCC----CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 99999998754321 111222221111111111 1234567788888997 9999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=272.22 Aligned_cols=215 Identities=25% Similarity=0.393 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEecee------eeEEEEeccCCChhhhhcCC-----CCCCCHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSK------KILVYEYMSNGSLADILFNP-----EKQPNWVERMGIARDIAR 579 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~lV~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~ 579 (757)
.+.+.+|++.+++++|+|++++++++.+.+. .++|+||+++|+|.+++... ...+++.....++.|++.
T Consensus 45 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~ 124 (273)
T cd05035 45 IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124 (273)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHH
Confidence 4678999999999999999999999876554 78999999999999988542 246789999999999999
Q ss_pred HHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCccee-cccccCccccCcccccCCCCCccccchhh
Q 038168 580 GILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF-TGIRGTRGYVAPEWHRNLPITVKADVYSF 658 (757)
Q Consensus 580 gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~ 658 (757)
||+|||+. +++||||||+||++++++.+||+|||+++.+........ ....++..|+|||++.+..++.++|||||
T Consensus 125 aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~Sl 201 (273)
T cd05035 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF 201 (273)
T ss_pred HHHHHHhC---CeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHH
Confidence 99999998 999999999999999999999999999987654332211 11234678999999998899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 659 GVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 659 G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|++++||++ |..|+...... + ..+....+.... .+.....++.+++.+|++.||++||++.||++.
T Consensus 202 G~il~el~~~g~~p~~~~~~~------~-~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 202 GVTMWEIATRGQTPYPGVENH------E-IYDYLRHGNRLK------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCCC------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999 77877543221 1 112222222111 122345678999999999999999999999999
Q ss_pred hhcC
Q 038168 738 LEGT 741 (757)
Q Consensus 738 Le~~ 741 (757)
|+.+
T Consensus 269 l~~~ 272 (273)
T cd05035 269 LENI 272 (273)
T ss_pred HHhh
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=272.04 Aligned_cols=216 Identities=25% Similarity=0.425 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe-ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE-VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|+.++++++|+|++++++++.. +...++|+||+++++|.+++.+....+.+..++.++.|+++||+|||+.
T Consensus 40 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-- 117 (262)
T cd05058 40 VEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK-- 117 (262)
T ss_pred HHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 4678899999999999999999998764 4567899999999999999976666678888899999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc---eecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR---TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+++||||||+|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||+
T Consensus 118 -~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 196 (262)
T cd05058 118 -KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 196 (262)
T ss_pred -CccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999865432211 112334577899999999889999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
+|..|...... . .+.... ...+... ..+...+..+.+++..||+.+|++||++.||++.|+.+
T Consensus 197 ~~~~~~~~~~~--~---~~~~~~-~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 197 TRGAPPYPDVD--S---FDITVY-LLQGRRL------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred cCCCCCCCCCC--H---HHHHHH-HhcCCCC------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 96554332211 1 111111 1222111 01112245788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=284.72 Aligned_cols=208 Identities=25% Similarity=0.364 Sum_probs=164.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++++.+.+..++||||+++++|.+.. .........++.||++||+|||+.
T Consensus 116 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~--- 187 (353)
T PLN00034 116 RRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRR--- 187 (353)
T ss_pred HHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 467899999999999999999999999999999999999999997542 345677788999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-----CCCCccccchhhHHHHHHH
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-----LPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|||+++++.+||+|||+++.+..... ......||..|+|||.+.. ...+.++|||||||++|||
T Consensus 188 ~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el 266 (353)
T PLN00034 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEF 266 (353)
T ss_pred CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHH
Confidence 999999999999999999999999999987653322 1233578999999998743 2345689999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++|+.||......+ ........ .... ..........++.+++.+||+.||++||++.||++.
T Consensus 267 ~~g~~pf~~~~~~~---~~~~~~~~-~~~~------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 267 YLGRFPFGVGRQGD---WASLMCAI-CMSQ------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HhCCCCCCCCCCcc---HHHHHHHH-hccC------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999987332221 11111111 1110 111122344678999999999999999999999985
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=270.88 Aligned_cols=218 Identities=26% Similarity=0.424 Sum_probs=176.1
Q ss_pred CCCchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHh
Q 038168 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 506 ~g~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+....+.|.+|++++++++|+|++++++++.+ ...++||||+++++|.+++.+. ...+++.+++.++.|++.||+||
T Consensus 40 ~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~l 118 (260)
T cd05073 40 PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118 (260)
T ss_pred CChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHH
Confidence 334456789999999999999999999999887 7789999999999999999753 35678999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~e 664 (757)
|+. +++|+||||+||+++.++.+||+|||++...............++..|+|||++....++.++||||||++++|
T Consensus 119 H~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~ 195 (260)
T cd05073 119 EQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLME 195 (260)
T ss_pred HhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHH
Confidence 998 99999999999999999999999999998765433222233445678999999998899999999999999999
Q ss_pred HHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 665 IIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 665 llt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
+++ |+.|+...... . .......+.... ........+.+++.+|++.+|++||++.++.++|+.
T Consensus 196 l~t~g~~p~~~~~~~---~----~~~~~~~~~~~~------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 196 IVTYGRIPYPGMSNP---E----VIRALERGYRMP------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHhcCCCCCCCCCHH---H----HHHHHhCCCCCC------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 999 88887643211 1 112222221111 112344678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=271.62 Aligned_cols=218 Identities=21% Similarity=0.311 Sum_probs=165.9
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---KQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
..+.|.+|+.+++.++||||+++++.+.+....++||||+++|+|.+++.+.. ...+......++.|+++||+|||+
T Consensus 38 ~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~ 117 (268)
T cd05086 38 EQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK 117 (268)
T ss_pred HHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH
Confidence 45789999999999999999999999999999999999999999999996532 345667778999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCC-cceecccccCccccCcccccC-------CCCCccccchhh
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ-TRTFTGIRGTRGYVAPEWHRN-------LPITVKADVYSF 658 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~S~ 658 (757)
. +++||||||+|||++.++.+||+|||++....... ........++..|+|||++.. ..++.++|||||
T Consensus 118 ~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 194 (268)
T cd05086 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWAL 194 (268)
T ss_pred C---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHH
Confidence 8 99999999999999999999999999986432221 112234567889999998753 245789999999
Q ss_pred HHHHHHHHhC-CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 659 GVVLLEIICR-RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 659 G~~l~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|++++||+++ ..|+..... .+........+ ...+.++.. ......++.+++..|+ .+|++||++++|++.
T Consensus 195 G~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~ 265 (268)
T cd05086 195 GVTLWELFENAAQPYSHLSD------REVLNHVIKDQ-QVKLFKPQL-ELPYSERWYEVLQFCW-LSPEKRATAEEVHRL 265 (268)
T ss_pred HHHHHHHHhCCCCCCCCCCH------HHHHHHHHhhc-ccccCCCcc-CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHH
Confidence 9999999975 455543221 11122222222 222222221 1123456777888899 579999999999998
Q ss_pred hh
Q 038168 738 LE 739 (757)
Q Consensus 738 Le 739 (757)
|.
T Consensus 266 l~ 267 (268)
T cd05086 266 LT 267 (268)
T ss_pred hc
Confidence 84
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=285.77 Aligned_cols=208 Identities=22% Similarity=0.275 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD-ECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~ 589 (757)
...+.+|++++++++|+||+++++++.+.+..++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+ .
T Consensus 39 ~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~-- 115 (325)
T cd05594 39 VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEK-- 115 (325)
T ss_pred HHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcC--
Confidence 45678899999999999999999999999999999999999999998854 3568899999999999999999997 5
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++....... ......||..|+|||.+.+..++.++||||||++++||++|+
T Consensus 116 -~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~ 193 (325)
T cd05594 116 -NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193 (325)
T ss_pred -CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCC
Confidence 999999999999999999999999999875432221 223456899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~~ 737 (757)
.||.....+. .......+... .+.....++.+++.+||+.||++|+ ++.++++.
T Consensus 194 ~Pf~~~~~~~-------~~~~i~~~~~~-------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 194 LPFYNQDHEK-------LFELILMEEIR-------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCHHH-------HHHHHhcCCCC-------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 9996543211 11111111111 1122345688999999999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=275.03 Aligned_cols=221 Identities=24% Similarity=0.351 Sum_probs=174.6
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC----------CCCCHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE----------KQPNWVERMGIARDIAR 579 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~ 579 (757)
..+++.+|++++++++|+|++++++++..++..++|+||+++++|.+++.... ..+++..++.++.|++.
T Consensus 62 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 141 (296)
T cd05051 62 AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIAS 141 (296)
T ss_pred HHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHH
Confidence 45788999999999999999999999999999999999999999999986543 26789999999999999
Q ss_pred HHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccccchhh
Q 038168 580 GILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKADVYSF 658 (757)
Q Consensus 580 gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~ 658 (757)
||+|||+. +++|+||||+||++++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||
T Consensus 142 al~~LH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (296)
T cd05051 142 GMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAF 218 (296)
T ss_pred HHHHHHHc---CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhh
Confidence 99999998 9999999999999999999999999999865443322 2223456788999999998899999999999
Q ss_pred HHHHHHHHh--CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 659 GVVLLEIIC--RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 659 G~~l~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|++++||++ |..|+...... .....+...++......... .+...+.++.+++.+|++.+|++|||+.||++
T Consensus 219 G~~l~el~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 219 GVTLWEILTLCREQPYEHLTDQ---QVIENAGHFFRDDGRQIYLP---RPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhcCCCCCCCCcChH---HHHHHHHhccccccccccCC---CccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 999999998 55665432211 11111222222111111111 11223467999999999999999999999999
Q ss_pred Hhh
Q 038168 737 MLE 739 (757)
Q Consensus 737 ~Le 739 (757)
.|+
T Consensus 293 ~L~ 295 (296)
T cd05051 293 FLQ 295 (296)
T ss_pred Hhc
Confidence 986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=274.23 Aligned_cols=206 Identities=24% Similarity=0.375 Sum_probs=165.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
..+|.+|+.++++++|+||+++++++.+....++||||+++|+|..++.+....+++..++.++.|+++||+|||++
T Consensus 60 ~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--- 136 (274)
T cd05076 60 ALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK--- 136 (274)
T ss_pred HHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---
Confidence 35688899999999999999999999999999999999999999999977667789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCC-------cEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHH
Q 038168 591 QIIHCDIKPQNILMDENR-------CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVL 662 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~-------~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l 662 (757)
+|+||||||+|||++..+ .+|++|||++....... ...++..|+|||.+.+ ..++.++||||||+++
T Consensus 137 ~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l 211 (274)
T cd05076 137 NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTL 211 (274)
T ss_pred CccCCCCCcccEEEeccCcccCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHH
Confidence 999999999999997643 48999999986543221 2346788999998875 5689999999999999
Q ss_pred HHHH-hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 663 LEII-CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 663 ~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
|||+ +|+.|+........ . ....... . .+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 212 ~el~~~g~~p~~~~~~~~~---~----~~~~~~~-~-------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 212 LEICFDGEVPLKERTPSEK---E----RFYEKKH-R-------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHhCCCCCccccChHHH---H----HHHHhcc-C-------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 9994 68888765433221 1 1111110 0 01111246889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=274.27 Aligned_cols=216 Identities=21% Similarity=0.335 Sum_probs=175.7
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++|+||+++++++.+ +..++||||+++++|.+++......+++.++..++.+++.||+|||+.
T Consensus 50 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-- 126 (270)
T cd05056 50 VREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK-- 126 (270)
T ss_pred HHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 35679999999999999999999998875 557899999999999999976666789999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-C
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-R 668 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G 668 (757)
+++|+||||+||+++.++.+||+|||+++..............++..|+|||.+....++.++||||||++++||++ |
T Consensus 127 -~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 205 (270)
T cd05056 127 -RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLG 205 (270)
T ss_pred -CeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999998765443322223344568999999988889999999999999999986 9
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
..||......+ .. .....+.... .+......+.+++.+|+..+|++|||+.++++.|+++.
T Consensus 206 ~~pf~~~~~~~------~~-~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 206 VKPFQGVKNND------VI-GRIENGERLP------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred CCCCCCCCHHH------HH-HHHHcCCcCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 99886543221 11 1122222111 11233467889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=282.82 Aligned_cols=213 Identities=21% Similarity=0.209 Sum_probs=170.6
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|+.+++++ +|+||+++++++.+.+..++||||+++|+|.+++.. ...+++.+...++.||+.||+|||+.
T Consensus 48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-- 124 (332)
T cd05614 48 VEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKL-- 124 (332)
T ss_pred HHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 45678899999999 599999999999999999999999999999999865 34578899999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+|||++.++.+||+|||+++.+............||..|+|||.+.+. .++.++||||||++++||++|
T Consensus 125 -~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg 203 (332)
T cd05614 125 -GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203 (332)
T ss_pred -CcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcC
Confidence 999999999999999999999999999987654443334456799999999998865 478999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLLM 737 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~~ 737 (757)
+.||........ ... +......... ..+......+.+++.+||+.||++|| +++++++.
T Consensus 204 ~~pf~~~~~~~~--~~~-~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 204 ASPFTLEGERNT--QSE-VSRRILKCDP-------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCCCCCCC--HHH-HHHHHhcCCC-------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 999975432221 111 1111111111 11222345678999999999999999 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=272.03 Aligned_cols=215 Identities=28% Similarity=0.473 Sum_probs=176.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.|.+|+.++++++||||+++++++.+.+..++||||+++++|.+++......+++.+++.++.|++.||+|||+.
T Consensus 49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--- 125 (267)
T cd05066 49 RRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM--- 125 (267)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46789999999999999999999999999999999999999999999977666789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCccee--cccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF--TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+++||||||+|||++.++.+||+|||+++.+........ ....++..|+|||++.+..++.++||||||++++|+++
T Consensus 126 ~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~ 205 (267)
T cd05066 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 205 (267)
T ss_pred CEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcC
Confidence 999999999999999999999999999987754432221 22234568999999999899999999999999999887
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
|..|+......+ ......++.- . ......+..+.+++.+|++.+|++||+|.++++.|+.+
T Consensus 206 g~~p~~~~~~~~-------~~~~~~~~~~--~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 206 GERPYWEMSNQD-------VIKAIEEGYR--L----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCcccCCHHH-------HHHHHhCCCc--C----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 998886543211 1111222210 0 11122346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=269.62 Aligned_cols=212 Identities=29% Similarity=0.385 Sum_probs=171.1
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEE-eceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSL-EVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..+.|.+|+.++++++|+|++++++++. +.+..++|+||+++++|.+++.+.. ..+++..++.++.|++.||+|||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 121 (256)
T cd05082 42 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121 (256)
T ss_pred hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3567999999999999999999999765 4567899999999999999997644 3578999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+++||||||+||++++++.+||+|||+++....... ...++..|+|||++.+..++.++||||||++++||++
T Consensus 122 ---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~ 194 (256)
T cd05082 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194 (256)
T ss_pred ---CEeccccchheEEEcCCCcEEecCCccceeccccCC----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHh
Confidence 999999999999999999999999999886543221 2234668999999999899999999999999999998
Q ss_pred -CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 668 -RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 668 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
|+.|+.... ..+.. .....+... .........+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 195 ~g~~p~~~~~------~~~~~-~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 195 FGRVPYPRIP------LKDVV-PRVEKGYKM------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCCC------HHHHH-HHHhcCCCC------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 888775321 11111 112222111 11223356788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=280.54 Aligned_cols=208 Identities=27% Similarity=0.401 Sum_probs=175.1
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+++.+|+.+|++++|+||.+.+|.+..+...+++|||+.+|++.+.|.. ...++.....-|++++..||.|||.+ +
T Consensus 56 ediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~---~ 131 (467)
T KOG0201|consen 56 EDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSE---K 131 (467)
T ss_pred HHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhc---c
Confidence 6778999999999999999999999999999999999999999999854 33446666677889999999999999 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRC 671 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p 671 (757)
.+|||||+.|||+..++.+|++|||++..+....... ..++||+-|||||++.+..|+.|+||||||++.+||.+|.+|
T Consensus 132 kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP 210 (467)
T KOG0201|consen 132 KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPP 210 (467)
T ss_pred eecccccccceeEeccCcEEEEecceeeeeechhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCC
Confidence 9999999999999999999999999999887665554 668999999999999999999999999999999999999999
Q ss_pred CCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 672 LDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 672 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+....+..-..+. .+.. |+.........+.+++..||+.||+.||++.++++.
T Consensus 211 ~s~~hPmrvlflI-------pk~~------PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 211 HSKLHPMRVLFLI-------PKSA------PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CcccCcceEEEec-------cCCC------CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 8866553222110 1111 111222445568889999999999999999999873
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=269.65 Aligned_cols=215 Identities=25% Similarity=0.349 Sum_probs=174.0
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+++.+|+++++++.|+|++++++++. .+..++||||+++++|.+++.+.. .+++..+..++.|++.||+|||..
T Consensus 39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~-- 114 (257)
T cd05060 39 GKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESK-- 114 (257)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhc--
Confidence 4567899999999999999999999876 456899999999999999997644 689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce--ecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT--FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||||+|||++.++.+||+|||+++......... .....++..|+|||...+..++.++||||||++++||++
T Consensus 115 -~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~ 193 (257)
T cd05060 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193 (257)
T ss_pred -CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHc
Confidence 99999999999999999999999999998765433221 122334568999999999999999999999999999998
Q ss_pred -CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 668 -RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 668 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
|..|+..... ..+ ......+... ..+......+.+++.+|++.+|++||++.+|++.|++..
T Consensus 194 ~g~~p~~~~~~---~~~----~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 194 YGAKPYGEMKG---AEV----IAMLESGERL------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCcccCCH---HHH----HHHHHcCCcC------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 8988864322 111 1222222111 112233467889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=284.54 Aligned_cols=212 Identities=22% Similarity=0.307 Sum_probs=162.7
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
..+.+|+.++.+++|+||+++++.+.+....++||||+++|+|.+++.+ ...+++.+...++.|++.||+|||++ +
T Consensus 46 ~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---g 121 (363)
T cd05628 46 GHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQL---G 121 (363)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 5678899999999999999999999999999999999999999999965 35688899999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCc----------------------------------ceecccccCcc
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT----------------------------------RTFTGIRGTRG 637 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~----------------------------------~~~~~~~gt~~ 637 (757)
|+||||||+|||++.++.+||+|||+++.+..... .......||+.
T Consensus 122 ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~ 201 (363)
T cd05628 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPD 201 (363)
T ss_pred eEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCcc
Confidence 99999999999999999999999999976532110 00123579999
Q ss_pred ccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHH
Q 038168 638 YVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVA 717 (757)
Q Consensus 638 y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~ 717 (757)
|+|||++.+..++.++|||||||+++||++|+.||......+ ........... +..+... ....++.+++
T Consensus 202 Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~-------~~~~i~~~~~~-~~~p~~~--~~s~~~~~li 271 (363)
T cd05628 202 YIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE-------TYKKVMNWKET-LIFPPEV--PISEKAKDLI 271 (363)
T ss_pred ccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCcCc-ccCCCcC--CCCHHHHHHH
Confidence 999999999999999999999999999999999997543211 11111111111 1111111 1123344444
Q ss_pred HH--ccccCCCCCCCHHHHHHH
Q 038168 718 LW--CILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 718 ~~--cl~~~p~~RPsm~eVl~~ 737 (757)
.+ |...++..||+++||++.
T Consensus 272 ~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 272 LRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHcCChhhcCCCCCHHHHhCC
Confidence 44 333455567999999885
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=285.90 Aligned_cols=204 Identities=23% Similarity=0.244 Sum_probs=167.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
...+.+|++++++++|+||+++++++.+.+..++||||+++|+|.+++.+ ...+++.++..++.|+++||+|||+.
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~--- 117 (318)
T cd05582 42 RVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSL--- 117 (318)
T ss_pred HHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 34577899999999999999999999999999999999999999999854 34688999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++....... ......|+..|+|||.+.+..++.++||||||++++||++|+.
T Consensus 118 ~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 196 (318)
T cd05582 118 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSL 196 (318)
T ss_pred CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCC
Confidence 999999999999999999999999999986543322 2234678999999999999889999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKK 733 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~e 733 (757)
||...... +.. ......... .+......+.+++.+||+.||++||++.+
T Consensus 197 p~~~~~~~------~~~-~~i~~~~~~-------~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 197 PFQGKDRK------ETM-TMILKAKLG-------MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHH------HHH-HHHHcCCCC-------CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 98754221 111 111122111 11223456789999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=272.09 Aligned_cols=213 Identities=23% Similarity=0.304 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
++.+..|++++++++||||+++++++......++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.
T Consensus 37 ~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-- 114 (277)
T cd05607 37 EKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM-- 114 (277)
T ss_pred hHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4456679999999999999999999999999999999999999998886543 4588999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+||+++.++.+||+|||++....... ......|+..|+|||++.+..++.++||||+||+++||++|+
T Consensus 115 -~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~ 191 (277)
T cd05607 115 -DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191 (277)
T ss_pred -CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999998765432 223356899999999999989999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
.|+........ ..+ +........... .......++.+++..||+.||++||++.|+++.
T Consensus 192 ~p~~~~~~~~~--~~~-~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 192 TPFKDHKEKVA--KEE-LKRRTLEDEVKF------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CCCCCCcchhh--HHH-HHHHhhcccccc------ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 99875432211 111 111111111110 011234568899999999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=255.24 Aligned_cols=207 Identities=23% Similarity=0.346 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
++++++|+++.+.|+||||+++++++.+....||++||.+.|+|...|+.. ..+++......++.|+|.||.|+|.+
T Consensus 66 ~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k-- 143 (281)
T KOG0580|consen 66 EHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK-- 143 (281)
T ss_pred hhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC--
Confidence 478999999999999999999999999999999999999999999999744 35677778888999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
.||||||||+|+|++.++..||+|||-+...+.. .....+||..|++||...+..++...|+|++|++.+|++.|.
T Consensus 144 -~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~---kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ 219 (281)
T KOG0580|consen 144 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN---KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGL 219 (281)
T ss_pred -CcccCCCCHHHhccCCCCCeeccCCCceeecCCC---CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcC
Confidence 9999999999999999999999999998765422 234467999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+||+....++ ..+.+..- ++.+| ......+.+++..|+..+|.+|.+..||+..
T Consensus 220 ppFes~~~~e-------tYkrI~k~---~~~~p----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 220 PPFESQSHSE-------TYKRIRKV---DLKFP----STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred CchhhhhhHH-------HHHHHHHc---cccCC----cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 9998654211 12222222 22222 3344678899999999999999999999864
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=287.04 Aligned_cols=221 Identities=21% Similarity=0.260 Sum_probs=170.6
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|++++++++|+|||++++++......++|||++. ++|.+++. ....+++.+++.++.||+.||+|||+. +
T Consensus 131 ~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~---g 205 (392)
T PHA03207 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGR---G 205 (392)
T ss_pred ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 456789999999999999999999999999999999986 68888883 356789999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
|+||||||+|||++.++.+||+|||+++....... .......||..|+|||++.+..++.++|||||||++|||++|+.
T Consensus 206 ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~ 285 (392)
T PHA03207 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285 (392)
T ss_pred ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999986654332 22234679999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccc-----------------cccccc-c-----CHHHHHHHHHHHHHccccCCCC
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQ-----------------LVEDEE-V-----DEKQLERMIKVALWCILDEPSL 727 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~-----------------~~d~~~-~-----~~~~~~~l~~l~~~cl~~~p~~ 727 (757)
||..............+.+.+....... ...+.. . .......+.+++.+|++.+|++
T Consensus 286 pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~ 365 (392)
T PHA03207 286 TLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEF 365 (392)
T ss_pred CCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhh
Confidence 9976543321111111111111000000 000000 0 0112346778999999999999
Q ss_pred CCCHHHHHHH
Q 038168 728 RPSMKKVLLM 737 (757)
Q Consensus 728 RPsm~eVl~~ 737 (757)
||++.|++..
T Consensus 366 Rpsa~e~l~~ 375 (392)
T PHA03207 366 RPSAQDILSL 375 (392)
T ss_pred CCCHHHHhhC
Confidence 9999999886
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=272.68 Aligned_cols=212 Identities=26% Similarity=0.318 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
...+.+|+.++++++|+||+++++.+.+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-- 121 (285)
T cd05605 44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE-- 121 (285)
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4567889999999999999999999999999999999999999999886543 4689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++||||||+||++++++.++|+|||+++....... .....|+..|+|||.+.+..++.++||||+|++++||++|+
T Consensus 122 -~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~ 198 (285)
T cd05605 122 -RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198 (285)
T ss_pred -CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCC
Confidence 999999999999999999999999999987643322 23356899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~~ 737 (757)
.||........ .+.+......+. ...+......+.+++..|++.||++|| +++++++.
T Consensus 199 ~pf~~~~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 199 SPFRQRKEKVK---REEVERRVKEDQ-------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred CCCCCCchhhH---HHHHHHHhhhcc-------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 99975432211 111111111111 112234456788999999999999999 88888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=271.05 Aligned_cols=212 Identities=20% Similarity=0.340 Sum_probs=169.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+++.+|++++++++|+||+++++++...+..++||||+++++|..+. .+++.....++.|++.||.|||+.
T Consensus 42 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~-- 114 (279)
T cd06619 42 LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSL-- 114 (279)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 3567999999999999999999999999999999999999999997653 457788889999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+|+||||+|||++.++.+||+|||++....... .....++..|+|||++.+..++.++||||||++++||++|+
T Consensus 115 -~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~ 190 (279)
T cd06619 115 -KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190 (279)
T ss_pred -CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999998654322 22356899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
.||................+.......... .......++.+++.+|++.+|++||+++|+++.
T Consensus 191 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 191 FPYPQIQKNQGSLMPLQLLQCIVDEDPPVL-----PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCchhhcccccccchHHHHHHHhccCCCCC-----CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 998754332211111111111111111111 112234568899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=271.02 Aligned_cols=206 Identities=20% Similarity=0.336 Sum_probs=165.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.|.+|+.++++++||||+++++++......++||||+++++|..++......+++..+++++.||++||+|||+.
T Consensus 48 ~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--- 124 (262)
T cd05077 48 SLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK--- 124 (262)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---
Confidence 34688899999999999999999999999999999999999999999876666789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCc-------EEEeecCCccccCCCCcceecccccCccccCccccc-CCCCCccccchhhHHHH
Q 038168 591 QIIHCDIKPQNILMDENRC-------AKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR-NLPITVKADVYSFGVVL 662 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~-------~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~S~G~~l 662 (757)
+|+||||||+|||++.++. +|++|||++...... ....++..|+|||.+. +..++.++||||||+++
T Consensus 125 ~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l 199 (262)
T cd05077 125 DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTL 199 (262)
T ss_pred CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHH
Confidence 9999999999999987654 899999998765322 1235688999999887 46789999999999999
Q ss_pred HHHH-hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 663 LEII-CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 663 ~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
|||+ .|+.|+......+. ... ..+... . .......+.+++.+||+.||++||++.+|++.|+
T Consensus 200 ~el~~~~~~p~~~~~~~~~-------~~~-~~~~~~-~------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 200 WEICYNGEIPLKDKTLAEK-------ERF-YEGQCM-L------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHHhCCCCCCCCcchhHH-------HHH-HhcCcc-C------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 9998 57776653321110 111 111111 1 1112356889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=278.22 Aligned_cols=222 Identities=26% Similarity=0.385 Sum_probs=178.3
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------------CCCCHHHHHHH
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------------KQPNWVERMGI 573 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i 573 (757)
..+++.+|+.+++++ +|+||+++++++......++||||+++|+|.+++.... ..+++.+++.+
T Consensus 63 ~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (304)
T cd05101 63 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142 (304)
T ss_pred HHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHH
Confidence 346788999999999 89999999999999999999999999999999986532 34788899999
Q ss_pred HHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCcc
Q 038168 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVK 652 (757)
Q Consensus 574 ~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k 652 (757)
+.||++||+|||+. +++||||||+||++++++.+||+|||+++........ ......++..|+|||.+.+..++.+
T Consensus 143 ~~qi~~al~~LH~~---givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 219 (304)
T cd05101 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 219 (304)
T ss_pred HHHHHHHHHHHHHC---CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch
Confidence 99999999999998 9999999999999999999999999999876543322 1222345678999999998899999
Q ss_pred ccchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 653 ADVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 653 ~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
+||||||++++||++ |..|+.... ..+ .......+.... .+......+.+++.+||+.+|++||+|
T Consensus 220 ~Di~slG~~l~el~~~g~~p~~~~~------~~~-~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rps~ 286 (304)
T cd05101 220 SDVWSFGVLMWEIFTLGGSPYPGIP------VEE-LFKLLKEGHRMD------KPANCTNELYMMMRDCWHAIPSHRPTF 286 (304)
T ss_pred hhHHHHHHHHHHHHcCCCCCcccCC------HHH-HHHHHHcCCcCC------CCCCCCHHHHHHHHHHcccChhhCCCH
Confidence 999999999999998 667664322 112 122222222111 112334678889999999999999999
Q ss_pred HHHHHHhhcCcCCCCC
Q 038168 732 KKVLLMLEGTVEIPIP 747 (757)
Q Consensus 732 ~eVl~~Le~~~~~~~p 747 (757)
.||++.|+++..+..+
T Consensus 287 ~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 287 KQLVEDLDRILTLTTN 302 (304)
T ss_pred HHHHHHHHHHHHhhhc
Confidence 9999999987765443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=271.29 Aligned_cols=214 Identities=26% Similarity=0.399 Sum_probs=174.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------CCCCHHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------KQPNWVERMGIARDIARGI 581 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL 581 (757)
...+.+|+.++++++|+||+++++++......++||||+++|+|.+++.... ..+++..++.++.|++.||
T Consensus 53 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 132 (277)
T cd05032 53 RIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132 (277)
T ss_pred HHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHH
Confidence 4578899999999999999999999999999999999999999999986422 2468899999999999999
Q ss_pred HHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccchhhHH
Q 038168 582 LYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGV 660 (757)
Q Consensus 582 ~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~ 660 (757)
.|||+. +++||||||+||+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+
T Consensus 133 ~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 209 (277)
T cd05032 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGV 209 (277)
T ss_pred HHHHhC---CccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHH
Confidence 999998 999999999999999999999999999986654332 1122344678999999999889999999999999
Q ss_pred HHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 661 VLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 661 ~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
+++||++ |..|+....... ..+....+..... +......+.+++.+|++.+|++|||+.++++.|+
T Consensus 210 il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 210 VLWEMATLAEQPYQGLSNEE-------VLKFVIDGGHLDL------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHhhccCCCCCccCCHHH-------HHHHHhcCCCCCC------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 9999998 888875432211 1122222222111 1223567899999999999999999999999986
Q ss_pred c
Q 038168 740 G 740 (757)
Q Consensus 740 ~ 740 (757)
.
T Consensus 277 ~ 277 (277)
T cd05032 277 D 277 (277)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=282.93 Aligned_cols=228 Identities=21% Similarity=0.296 Sum_probs=167.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec-----eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV-----SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
...+.+|+.++++++||||+++++++... ...++||||+. ++|.+++.. ...+++..+..++.||++||.|||
T Consensus 43 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH 120 (338)
T cd07859 43 ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIH 120 (338)
T ss_pred HHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHH
Confidence 45688999999999999999999988643 25799999996 689888854 346889999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc--ceecccccCccccCcccccC--CCCCccccchhhHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT--RTFTGIRGTRGYVAPEWHRN--LPITVKADVYSFGVV 661 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~G~~ 661 (757)
+. +|+||||||+|||++.++.+||+|||+++....... .......|+..|+|||++.+ ..++.++|||||||+
T Consensus 121 ~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvv 197 (338)
T cd07859 121 TA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 197 (338)
T ss_pred HC---CeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHH
Confidence 98 999999999999999999999999999986533221 12234678999999999876 678999999999999
Q ss_pred HHHHHhCCCCCCCCCCCccccHHH--------HHHHHHhcCCccc----cccccccC-----HHHHHHHHHHHHHccccC
Q 038168 662 LLEIICRRRCLDPNLPDDQVILEE--------WVYQCFENGNLSQ----LVEDEEVD-----EKQLERMIKVALWCILDE 724 (757)
Q Consensus 662 l~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~~~~~~~----~~d~~~~~-----~~~~~~l~~l~~~cl~~~ 724 (757)
++||++|+.||............. .....+....... +....... ......+.+++.+||+.+
T Consensus 198 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 277 (338)
T cd07859 198 FAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFD 277 (338)
T ss_pred HHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcC
Confidence 999999999986543211100000 0000000000000 00000000 112356789999999999
Q ss_pred CCCCCCHHHHHHH--hhcCcC
Q 038168 725 PSLRPSMKKVLLM--LEGTVE 743 (757)
Q Consensus 725 p~~RPsm~eVl~~--Le~~~~ 743 (757)
|++|||++|+++. +++...
T Consensus 278 P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 278 PKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred cccCCCHHHHhcCchhhhcCc
Confidence 9999999999974 444433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=273.47 Aligned_cols=213 Identities=26% Similarity=0.368 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE------KQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yL 584 (757)
+..|.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++.... ..+++.++++++.||+.||+||
T Consensus 53 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L 132 (277)
T cd05036 53 ESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132 (277)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 4578999999999999999999999999999999999999999999986543 2579999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCC---cEEEeecCCccccCCCCcce-ecccccCccccCcccccCCCCCccccchhhHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENR---CAKISDFGLAKLMKPDQTRT-FTGIRGTRGYVAPEWHRNLPITVKADVYSFGV 660 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~---~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~ 660 (757)
|+. +++|+||||+||+++.++ .+||+|||+++......... ......+..|+|||++.+..++.++|||||||
T Consensus 133 H~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 209 (277)
T cd05036 133 EEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGV 209 (277)
T ss_pred HHC---CEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHH
Confidence 998 999999999999998654 69999999998764322211 11223356899999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 661 VLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 661 ~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
+++||++ |+.||.....+. .........+.. .+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 210 il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~-------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 210 LLWEIFSLGYMPYPGRTNQE------VMEFVTGGGRLD-------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHHcCCCCCCCCCCHHH------HHHHHHcCCcCC-------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 9999997 888876433221 111111111111 12233467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=276.58 Aligned_cols=216 Identities=25% Similarity=0.309 Sum_probs=163.6
Q ss_pred HHHHHHHHHHhhc---CCCceeeeeeEEEe-----ceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHH
Q 038168 512 REFQTEMKVIGRT---HHRNLVRLLGYSLE-----VSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGIL 582 (757)
Q Consensus 512 ~~~~~E~~~l~~l---~h~niv~l~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~ 582 (757)
..+.+|+.+++++ +||||+++++++.. ....++||||++ ++|.+++... ...+++.++..++.|++.||+
T Consensus 46 ~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 124 (290)
T cd07862 46 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124 (290)
T ss_pred HHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHH
Confidence 4566777777666 69999999999852 346899999997 5899888654 345889999999999999999
Q ss_pred HhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHH
Q 038168 583 YLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662 (757)
Q Consensus 583 yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l 662 (757)
|||+. +|+||||||+|||++.++.+||+|||+++..... .......|+..|+|||.+.+..++.++||||||+++
T Consensus 125 ~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 199 (290)
T cd07862 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIF 199 (290)
T ss_pred HHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHH
Confidence 99998 9999999999999999999999999999876543 222345689999999999988999999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHHHHHhc---CCcc-------cccccc------ccCHHHHHHHHHHHHHccccCCC
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVYQCFEN---GNLS-------QLVEDE------EVDEKQLERMIKVALWCILDEPS 726 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~-------~~~d~~------~~~~~~~~~l~~l~~~cl~~~p~ 726 (757)
+||++|+.||......+.. .. +...... .... ....+. .........+.+++.+|++.+|+
T Consensus 200 ~el~~g~~~f~~~~~~~~~--~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 276 (290)
T cd07862 200 AEMFRRKPLFRGSSDVDQL--GK-ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 276 (290)
T ss_pred HHHHcCCCCcCCCCHHHHH--HH-HHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCch
Confidence 9999999998765432211 11 1111000 0000 000000 00112345678999999999999
Q ss_pred CCCCHHHHHH
Q 038168 727 LRPSMKKVLL 736 (757)
Q Consensus 727 ~RPsm~eVl~ 736 (757)
+|||+.|+++
T Consensus 277 ~R~s~~~~l~ 286 (290)
T cd07862 277 KRISAYSALS 286 (290)
T ss_pred hcCCHHHHhc
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=280.52 Aligned_cols=218 Identities=27% Similarity=0.397 Sum_probs=175.5
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC---------------CCCCCHHHHHHH
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP---------------EKQPNWVERMGI 573 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i 573 (757)
..+++.+|+++++++ +|+||+++++++.+.+..++|+||+++|+|.+++... ...+++.+++++
T Consensus 60 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 139 (334)
T cd05100 60 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139 (334)
T ss_pred HHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHH
Confidence 356889999999999 8999999999999999999999999999999998642 235789999999
Q ss_pred HHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCcc
Q 038168 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVK 652 (757)
Q Consensus 574 ~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k 652 (757)
+.|++.||+|||+. +++||||||+|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.+
T Consensus 140 ~~qi~~al~~LH~~---givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 216 (334)
T cd05100 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 216 (334)
T ss_pred HHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch
Confidence 99999999999998 9999999999999999999999999999876443221 1222334568999999999999999
Q ss_pred ccchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 653 ADVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 653 ~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
+||||||++++||++ |..|+.... ..+. ......+.... .+.....++.+++.+|++.+|++||+|
T Consensus 217 ~Di~slG~il~el~~~g~~p~~~~~------~~~~-~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~ 283 (334)
T cd05100 217 SDVWSFGVLLWEIFTLGGSPYPGIP------VEEL-FKLLKEGHRMD------KPANCTHELYMIMRECWHAVPSQRPTF 283 (334)
T ss_pred hhhHHHHHHHHHHHhcCCCCCCCCC------HHHH-HHHHHcCCCCC------CCCCCCHHHHHHHHHHcccChhhCcCH
Confidence 999999999999998 777775432 1121 22222221111 112234578899999999999999999
Q ss_pred HHHHHHhhcCcC
Q 038168 732 KKVLLMLEGTVE 743 (757)
Q Consensus 732 ~eVl~~Le~~~~ 743 (757)
.|+++.|+.+..
T Consensus 284 ~ell~~l~~~~~ 295 (334)
T cd05100 284 KQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHHHhh
Confidence 999999997663
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=275.53 Aligned_cols=216 Identities=24% Similarity=0.385 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.+.+.+|+++++++ +|+||+++++++...+..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+.
T Consensus 82 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~- 160 (302)
T cd05055 82 REALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK- 160 (302)
T ss_pred HHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 46789999999999 79999999999999999999999999999999996543 3489999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-ecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+|+||||+|||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++
T Consensus 161 --~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t 238 (302)
T cd05055 161 --NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238 (302)
T ss_pred --CeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHh
Confidence 99999999999999999999999999998665433211 122345778999999999999999999999999999998
Q ss_pred -CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 668 -RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 668 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
|+.|+....... ........+.... .+.....++.+++.+|++.+|++||++.||++.|+..
T Consensus 239 ~g~~p~~~~~~~~------~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 239 LGSNPYPGMPVDS------KFYKLIKEGYRMA------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCcCCCCchH------HHHHHHHcCCcCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 888876432211 1112222221110 1112245789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=267.04 Aligned_cols=212 Identities=22% Similarity=0.383 Sum_probs=176.0
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+++.+|++++++++|+||+++++++.+.+..++||||+++++|.+++... ...+++.++..++.|+++||+|||+.
T Consensus 42 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~- 120 (256)
T cd08221 42 ERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA- 120 (256)
T ss_pred HHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 4567899999999999999999999999999999999999999999999764 45689999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
+++|+||||+||++++++.+||+|||++........ ......++..|+|||...+...+.++||||||++++||++|
T Consensus 121 --~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g 197 (256)
T cd08221 121 --GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTL 197 (256)
T ss_pred --CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHC
Confidence 999999999999999999999999999987654432 22345688999999999988899999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~L 738 (757)
+.|+...... +.... ...+..... ......++.+++.+|++.+|++||++.++++.+
T Consensus 198 ~~~~~~~~~~------~~~~~-~~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 198 KRTFDATNPL------NLVVK-IVQGNYTPV------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCCCCCCHH------HHHHH-HHcCCCCCC------ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 9998643221 11122 122322221 123346788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=278.11 Aligned_cols=218 Identities=21% Similarity=0.237 Sum_probs=165.8
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
..+.+|+.++++++|+||+++++++.+.+..++||||++ ++|.+++......++...+..++.|++.||+|||+. +
T Consensus 48 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ 123 (303)
T cd07869 48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---Y 123 (303)
T ss_pred hhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 467889999999999999999999999999999999996 688888876666788889999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHHHhCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
|+||||||+|||++.++.+||+|||+++...... .......++..|+|||.+.+ ..++.++||||+||+++||++|+.
T Consensus 124 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 202 (303)
T cd07869 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVA 202 (303)
T ss_pred eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999997543322 22233567899999998865 457899999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCC---cc-----cccccc--------cc-----CHHHHHHHHHHHHHccccCCCCCC
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGN---LS-----QLVEDE--------EV-----DEKQLERMIKVALWCILDEPSLRP 729 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~---~~-----~~~d~~--------~~-----~~~~~~~l~~l~~~cl~~~p~~RP 729 (757)
||....... ..+ ..+........ .. ...++. .. .......+.+++.+|++.||++||
T Consensus 203 pf~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~ 280 (303)
T cd07869 203 AFPGMKDIQ-DQL-ERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRL 280 (303)
T ss_pred CCCCCccHH-HHH-HHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhcc
Confidence 997542211 111 10111000000 00 000000 00 001124577899999999999999
Q ss_pred CHHHHHH
Q 038168 730 SMKKVLL 736 (757)
Q Consensus 730 sm~eVl~ 736 (757)
|+.|+++
T Consensus 281 s~~~~l~ 287 (303)
T cd07869 281 SAQAALS 287 (303)
T ss_pred CHHHHhc
Confidence 9999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=293.03 Aligned_cols=225 Identities=23% Similarity=0.298 Sum_probs=178.5
Q ss_pred ccCCCchHHHHHHHHHHHhhcC-CCceeeeee-EEEe------ceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHH
Q 038168 504 VGRGSSGEREFQTEMKVIGRTH-HRNLVRLLG-YSLE------VSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIA 574 (757)
Q Consensus 504 lg~g~~~~~~~~~E~~~l~~l~-h~niv~l~g-~~~~------~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~ 574 (757)
+.....+.+..++||++|++|+ |+|||.+++ .... .-+.+|.||||++|+|-+++... ...|+..++++|+
T Consensus 71 ~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf 150 (738)
T KOG1989|consen 71 YVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIF 150 (738)
T ss_pred ecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHH
Confidence 3344446688999999999996 999999999 3322 23789999999999999999654 3459999999999
Q ss_pred HHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc--------eecccccCccccCcccc--
Q 038168 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR--------TFTGIRGTRGYVAPEWH-- 644 (757)
Q Consensus 575 ~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~--------~~~~~~gt~~y~aPE~~-- 644 (757)
.++++|+++||.. .++|||||||.+||||+.++..||||||.|...-..... .....--|+.|+|||.+
T Consensus 151 ~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDl 229 (738)
T KOG1989|consen 151 YDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDL 229 (738)
T ss_pred HHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhh
Confidence 9999999999984 889999999999999999999999999999754322210 01112358999999965
Q ss_pred -cCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHcccc
Q 038168 645 -RNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILD 723 (757)
Q Consensus 645 -~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~ 723 (757)
.+.++++|+|||+|||+||-|+....||+..-.-. +..+++... ....+..++..||..||++
T Consensus 230 ysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-----------Ilng~Y~~P-----~~p~ys~~l~~LI~~mL~~ 293 (738)
T KOG1989|consen 230 YSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-----------ILNGNYSFP-----PFPNYSDRLKDLIRTMLQP 293 (738)
T ss_pred hcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-----------EEeccccCC-----CCccHHHHHHHHHHHHhcc
Confidence 67899999999999999999999999998542211 111222111 1257789999999999999
Q ss_pred CCCCCCCHHHHHHHhhcCcCCC
Q 038168 724 EPSLRPSMKKVLLMLEGTVEIP 745 (757)
Q Consensus 724 ~p~~RPsm~eVl~~Le~~~~~~ 745 (757)
||++||++-||+..+-.+...+
T Consensus 294 nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 294 NPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred CcccCCCHHHHHHHHHHHhcCC
Confidence 9999999999999998765443
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=284.06 Aligned_cols=211 Identities=23% Similarity=0.296 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+++++.++|+||+++++++.+.+..++||||+++++|.+++.+. ..++...+..++.|++.||+|||+.
T Consensus 45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~--- 120 (350)
T cd05573 45 IAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKL--- 120 (350)
T ss_pred HHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 467889999999999999999999999999999999999999999999764 6788899999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCC----------------------------cceecccccCccccCcc
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ----------------------------TRTFTGIRGTRGYVAPE 642 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~----------------------------~~~~~~~~gt~~y~aPE 642 (757)
+|+||||||+|||++.++.+||+|||+++...... ........||..|+|||
T Consensus 121 giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 200 (350)
T cd05573 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE 200 (350)
T ss_pred CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHH
Confidence 99999999999999999999999999998765433 11223356899999999
Q ss_pred cccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhc-CCccccccccccCHHHHHHHHHHHHHcc
Q 038168 643 WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFEN-GNLSQLVEDEEVDEKQLERMIKVALWCI 721 (757)
Q Consensus 643 ~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~d~~~~~~~~~~~l~~l~~~cl 721 (757)
.+.+..++.++|||||||+++||++|+.||....... ........ ..... +. .......+.+++.+|+
T Consensus 201 ~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~~---p~--~~~~~~~~~~li~~ll 269 (350)
T cd05573 201 VLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE------TYNKIINWKESLRF---PP--DPPVSPEAIDLICRLL 269 (350)
T ss_pred HHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH------HHHHHhccCCcccC---CC--CCCCCHHHHHHHHHHc
Confidence 9999999999999999999999999999987543211 11111110 11110 00 0113467888999999
Q ss_pred ccCCCCCCC-HHHHHHH
Q 038168 722 LDEPSLRPS-MKKVLLM 737 (757)
Q Consensus 722 ~~~p~~RPs-m~eVl~~ 737 (757)
+ +|++||+ ++|+++.
T Consensus 270 ~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 270 C-DPEDRLGSFEEIKSH 285 (350)
T ss_pred c-ChhhcCCCHHHHhcC
Confidence 7 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=282.63 Aligned_cols=211 Identities=19% Similarity=0.217 Sum_probs=168.2
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|+.++++++|+||+++++++.+.+..++||||+++|+|.+++.. ..++......++.|++.||+|||+. +
T Consensus 88 ~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ 162 (370)
T cd05596 88 AFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSM---G 162 (370)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 4578899999999999999999999999999999999999999999854 3467778888999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC----CCCccccchhhHHHHHHHHh
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL----PITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~S~G~~l~ellt 667 (757)
|+||||||+|||++.++.+||+|||+++..............||+.|+|||.+.+. .++.++|||||||+++||++
T Consensus 163 ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyellt 242 (370)
T cd05596 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242 (370)
T ss_pred eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHh
Confidence 99999999999999999999999999987654433333346789999999998653 47899999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSL--RPSMKKVLLM 737 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~--RPsm~eVl~~ 737 (757)
|+.||...... ..... ...+... +..+. .......+.+++.+||+.+|++ ||+++|+++.
T Consensus 243 G~~Pf~~~~~~------~~~~~-i~~~~~~-~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 243 GDTPFYADSLV------GTYSK-IMDHKNS-LTFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCcCCCCHH------HHHHH-HHcCCCc-CCCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 99999754321 11111 1111110 00011 1123467888999999999987 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=273.73 Aligned_cols=214 Identities=22% Similarity=0.323 Sum_probs=173.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC---------------CCCCCHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP---------------EKQPNWVERMGIAR 575 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~ 575 (757)
.+.|.+|+.++++++|+||+++++++.+.+..++++||+++++|.+++... ...+++..+..++.
T Consensus 52 ~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 131 (283)
T cd05091 52 REEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131 (283)
T ss_pred HHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHH
Confidence 456889999999999999999999999999999999999999999998421 13478888999999
Q ss_pred HHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCcccc
Q 038168 576 DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKAD 654 (757)
Q Consensus 576 ~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~D 654 (757)
|++.||+|||+. +|+||||||+||++++++.+||+|||+++........ ......+++.|+|||.+.+..++.++|
T Consensus 132 ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 208 (283)
T cd05091 132 QIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSD 208 (283)
T ss_pred HHHHHHHHHHHc---CccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchh
Confidence 999999999998 9999999999999999999999999999876443322 122344578999999999889999999
Q ss_pred chhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 038168 655 VYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKK 733 (757)
Q Consensus 655 v~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~e 733 (757)
|||||++++||++ |..|+...... + ..+....+.... .+...+..+.+++..|++.+|++||++.+
T Consensus 209 v~slG~~l~el~~~g~~p~~~~~~~------~-~~~~i~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~RP~~~~ 275 (283)
T cd05091 209 IWSYGVVLWEVFSYGLQPYCGYSNQ------D-VIEMIRNRQVLP------CPDDCPAWVYTLMLECWNEFPSRRPRFKD 275 (283)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHHcCCcCC------CCCCCCHHHHHHHHHHhCCCcccCCCHHH
Confidence 9999999999998 77777543221 1 222233333221 12234566889999999999999999999
Q ss_pred HHHHhhc
Q 038168 734 VLLMLEG 740 (757)
Q Consensus 734 Vl~~Le~ 740 (757)
|++.|+.
T Consensus 276 i~~~l~~ 282 (283)
T cd05091 276 IHSRLRT 282 (283)
T ss_pred HHHHhhC
Confidence 9999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=270.82 Aligned_cols=213 Identities=26% Similarity=0.320 Sum_probs=168.6
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHhhhC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP--NWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.+++......+ ++..+..++.|++.||+|||+.
T Consensus 48 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 127 (268)
T cd06624 48 YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127 (268)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC
Confidence 34678999999999999999999999999999999999999999999997654444 7888889999999999999998
Q ss_pred CCCCeeeCCCCcceEEECC-CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCC--CCccccchhhHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMDE-NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP--ITVKADVYSFGVVLLE 664 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~-~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~G~~l~e 664 (757)
+|+||||||+||+++. ++.+||+|||++........ ......++..|+|||++.+.. ++.++||||||++++|
T Consensus 128 ---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~ 203 (268)
T cd06624 128 ---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVE 203 (268)
T ss_pred ---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHH
Confidence 9999999999999986 67999999999976543222 122345789999999986643 7899999999999999
Q ss_pred HHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 665 IICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|++|+.|+......... . ....... .....+....+++.+++.+||+.+|++|||+.|++..
T Consensus 204 l~~g~~p~~~~~~~~~~---~--~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 204 MATGKPPFIELGEPQAA---M--FKVGMFK------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHhCCCCCccccChhhh---H--hhhhhhc------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 99999998643221110 0 0000000 0111223345678899999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=268.85 Aligned_cols=214 Identities=26% Similarity=0.355 Sum_probs=175.2
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+.+.+|+.++++++|+||+++++++.+ ...++|+||+++++|.+++.+.. ..+++.....++.|++.||+|||+.
T Consensus 39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~- 116 (257)
T cd05040 39 IMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK- 116 (257)
T ss_pred HHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC-
Confidence 45678999999999999999999999988 88999999999999999997655 5789999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc--eecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR--TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+++|+||||+||+++.++.+||+|||+++.+...... ......++..|+|||++.+..++.++||||||++++||+
T Consensus 117 --~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~ 194 (257)
T cd05040 117 --RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMF 194 (257)
T ss_pred --CccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHH
Confidence 9999999999999999999999999999877543221 111245678999999999999999999999999999999
Q ss_pred h-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 667 C-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 667 t-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
+ |+.|+...... +........+.. . ..+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus 195 t~g~~p~~~~~~~------~~~~~~~~~~~~--~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 195 TYGEEPWAGLSGS------QILKKIDKEGER--L----ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred hCCCCCCCCCCHH------HHHHHHHhcCCc--C----CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 9 99988643221 111111111111 1 111233567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=267.84 Aligned_cols=218 Identities=32% Similarity=0.473 Sum_probs=177.4
Q ss_pred CCchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhh
Q 038168 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 507 g~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.....+++.+|+.++++++|+|++++++++......++||||+++++|.+++.... ..+++.++..++.+++.||.|||
T Consensus 41 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh 120 (261)
T cd05034 41 GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120 (261)
T ss_pred CccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 33456789999999999999999999999998889999999999999999997644 56899999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+. +++|+||||+||++++++.+||+|||++................+..|+|||.+.+..++.++||||||++++||
T Consensus 121 ~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l 197 (261)
T cd05034 121 SR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEI 197 (261)
T ss_pred hC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHH
Confidence 98 999999999999999999999999999987654322222233456789999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 666 IC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 666 lt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
++ |+.|+...... . .......+. . ... +...+.++.+++.+|++.+|++||+++++++.|+.
T Consensus 198 ~t~g~~p~~~~~~~------~-~~~~~~~~~-~-~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 198 VTYGRVPYPGMTNR------E-VLEQVERGY-R-MPR----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HhCCCCCCCCCCHH------H-HHHHHHcCC-C-CCC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 99 88887543221 1 111112111 0 011 11224678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=267.53 Aligned_cols=212 Identities=32% Similarity=0.430 Sum_probs=174.9
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+++.+|+.++++++|+|++++++++.+.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.
T Consensus 43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~- 121 (256)
T cd05039 43 AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK- 121 (256)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 46789999999999999999999999999899999999999999999996544 3689999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+++|+||||+||++++++.+||+|||+++....... ....+..|+|||++....++.++||||||++++||++
T Consensus 122 --~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~ 195 (256)
T cd05039 122 --NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 195 (256)
T ss_pred --CccchhcccceEEEeCCCCEEEcccccccccccccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhc
Confidence 999999999999999999999999999987633222 2334678999999998899999999999999999997
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
|+.|+...... . +......+... ..+...+..+.+++.+|+..+|++||+++|++++|+.+
T Consensus 196 g~~p~~~~~~~---~----~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 196 GRVPYPRIPLK---D----VVPHVEKGYRM------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCCCCCCCHH---H----HHHHHhcCCCC------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 88887643211 1 12222222111 11122346788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=278.83 Aligned_cols=206 Identities=22% Similarity=0.276 Sum_probs=164.4
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+..|..++..+ +|+||+++++++...+..++||||+++|+|.+++.. ...++..+...++.|++.||+|||+.
T Consensus 39 ~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~-- 115 (316)
T cd05592 39 VECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKK-- 115 (316)
T ss_pred HHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 34556677777654 899999999999999999999999999999998865 34678888899999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++...... .......||..|+|||.+.+..++.++|||||||+++||++|+
T Consensus 116 -~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~ 193 (316)
T cd05592 116 -GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193 (316)
T ss_pred -CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCC
Confidence 99999999999999999999999999998643322 2223457899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK-KVL 735 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~-eVl 735 (757)
.||...... +.. ........ ..+.....++.+++.+||+.+|++||++. +++
T Consensus 194 ~Pf~~~~~~------~~~-~~i~~~~~-------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 194 SPFHGEDED------ELF-DSILNDRP-------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCCHH------HHH-HHHHcCCC-------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 998754321 111 11111111 11222345678899999999999999876 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=269.38 Aligned_cols=213 Identities=20% Similarity=0.300 Sum_probs=171.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+|++++++++.+.+..++|+||+++++|..++.+....+++..+..++.|+++||+|||+.
T Consensus 46 ~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~--- 122 (282)
T cd06643 46 LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN--- 122 (282)
T ss_pred HHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46788999999999999999999999999999999999999999998876566789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc-----CCCCCccccchhhHHHHHHH
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR-----NLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~G~~l~el 665 (757)
+++|+||||+||+++.++.+||+|||++........ ......++..|+|||++. +..++.++|||||||+++||
T Consensus 123 ~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el 201 (282)
T cd06643 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201 (282)
T ss_pred CeeecCCCcccEEEccCCCEEEcccccccccccccc-ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHH
Confidence 999999999999999999999999999976543221 222356889999999874 44578899999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~L 738 (757)
++|+.|+...... +.+.... .........+ ......+.+++.+||+.+|++||++.++++.-
T Consensus 202 ~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 202 AQIEPPHHELNPM------RVLLKIA-KSEPPTLAQP----SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred ccCCCCccccCHH------HHHHHHh-hcCCCCCCCc----cccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 9999988643221 1111111 1111111111 22346788999999999999999999988643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=270.69 Aligned_cols=222 Identities=23% Similarity=0.327 Sum_probs=172.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC----------CCCCHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE----------KQPNWVERMGIARDIAR 579 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~ 579 (757)
..+.|.+|+.++++++|+||+++++++...+..++||||+++++|.+++.+.. ..+++.+...++.|++.
T Consensus 62 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 141 (296)
T cd05095 62 ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIAS 141 (296)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHH
Confidence 45689999999999999999999999999999999999999999999986532 24678899999999999
Q ss_pred HHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCccee-cccccCccccCcccccCCCCCccccchhh
Q 038168 580 GILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF-TGIRGTRGYVAPEWHRNLPITVKADVYSF 658 (757)
Q Consensus 580 gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~ 658 (757)
||+|||+. +++|+||||+|||+++++.+||+|||+++.+........ ....++..|++||...+..++.++|||||
T Consensus 142 al~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSl 218 (296)
T cd05095 142 GMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAF 218 (296)
T ss_pred HHHHHHHC---CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHH
Confidence 99999998 999999999999999999999999999986644332221 12334678999999888899999999999
Q ss_pred HHHHHHHHh--CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 659 GVVLLEIIC--RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 659 G~~l~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|++++||++ |..|+......+. ................. + .+......+.+++.+||+.+|++||+|.||++
T Consensus 219 G~~l~el~~~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 219 GVTLWEILTLCKEQPYSQLSDEQV---IENTGEFFRDQGRQVYL-P--KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHhCCCCCccccChHHH---HHHHHHHHhhccccccC-C--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 999999998 5666654322211 11111111111111111 0 11223467889999999999999999999999
Q ss_pred Hhhc
Q 038168 737 MLEG 740 (757)
Q Consensus 737 ~Le~ 740 (757)
.|+.
T Consensus 293 ~l~~ 296 (296)
T cd05095 293 TLLE 296 (296)
T ss_pred HHhC
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=270.51 Aligned_cols=221 Identities=23% Similarity=0.374 Sum_probs=174.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.+.+.+|++++++++|+|++++++++.+. ...++||||+++++|.+++.+....+++.++..++.|++.||+|||+.
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~- 128 (284)
T cd05079 50 IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR- 128 (284)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 45788999999999999999999998875 567899999999999999976556789999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc--eecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR--TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+++||||||+||+++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||++++||+
T Consensus 129 --gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ell 206 (284)
T cd05079 129 --QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206 (284)
T ss_pred --CeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhh
Confidence 9999999999999999999999999999876543321 122345677899999999889999999999999999999
Q ss_pred hCCCCCCCCCCC---------ccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 667 CRRRCLDPNLPD---------DQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 667 tG~~p~~~~~~~---------~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+++.|....... .+..... .......+.... ........+.+++.+|++.+|++||++.+|++.
T Consensus 207 t~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 207 TYCDSESSPMTLFLKMIGPTHGQMTVTR-LVRVLEEGKRLP------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cCCCCCccccchhhhhcccccccccHHH-HHHHHHcCccCC------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 987654322110 0111111 111222222111 112245679999999999999999999999999
Q ss_pred hhcC
Q 038168 738 LEGT 741 (757)
Q Consensus 738 Le~~ 741 (757)
|+.+
T Consensus 280 l~~~ 283 (284)
T cd05079 280 FEAI 283 (284)
T ss_pred HHhh
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=284.53 Aligned_cols=218 Identities=20% Similarity=0.256 Sum_probs=164.8
Q ss_pred HHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCee
Q 038168 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQII 593 (757)
Q Consensus 514 ~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii 593 (757)
...|+.++++++|+||+++++++.+.+..++|+|++. ++|.+++......+++.++..|+.||+.||+|||+. +|+
T Consensus 104 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~iv 179 (357)
T PHA03209 104 TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RII 179 (357)
T ss_pred cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---Cee
Confidence 4579999999999999999999999999999999995 689998877677899999999999999999999998 999
Q ss_pred eCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCC
Q 038168 594 HCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLD 673 (757)
Q Consensus 594 H~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~ 673 (757)
||||||+|||++.++.+||+|||+++..... .......||..|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 180 HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 180 HRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cCCCCHHHEEECCCCCEEEecCccccccccC--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 9999999999999999999999999754322 12234568999999999999999999999999999999999776653
Q ss_pred CCCCCccccH----HHHHHHHHhc-CCccccc--cccc-----------------------cCHHHHHHHHHHHHHcccc
Q 038168 674 PNLPDDQVIL----EEWVYQCFEN-GNLSQLV--EDEE-----------------------VDEKQLERMIKVALWCILD 723 (757)
Q Consensus 674 ~~~~~~~~~l----~~~~~~~~~~-~~~~~~~--d~~~-----------------------~~~~~~~~l~~l~~~cl~~ 723 (757)
...+...... ...+...... +...... ++.. ........+..++.+||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~ 337 (357)
T PHA03209 258 EDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTF 337 (357)
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcC
Confidence 3322211000 0111111110 0000000 0000 0001123455689999999
Q ss_pred CCCCCCCHHHHHHH
Q 038168 724 EPSLRPSMKKVLLM 737 (757)
Q Consensus 724 ~p~~RPsm~eVl~~ 737 (757)
||++|||+.||++.
T Consensus 338 dP~~Rpta~e~l~h 351 (357)
T PHA03209 338 DAAMRPSAEEILNY 351 (357)
T ss_pred CcccCcCHHHHhcC
Confidence 99999999999863
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=279.86 Aligned_cols=209 Identities=20% Similarity=0.281 Sum_probs=169.0
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+.+..|.+++..+ +|+||+++++++...+..++||||+++|+|..++.+ ...+++..+..++.|++.||+|||+.
T Consensus 38 ~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~- 115 (321)
T cd05591 38 DVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRH- 115 (321)
T ss_pred HHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 345677899998876 899999999999999999999999999999998864 35678889999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+|||++.++.+||+|||+++...... .......|+..|+|||++.+..++.++||||||++++||++|
T Consensus 116 --~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg 192 (321)
T cd05591 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG 192 (321)
T ss_pred --CeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcC
Confidence 99999999999999999999999999997543222 122345689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-------SMKKVLLM 737 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-------sm~eVl~~ 737 (757)
+.||...... + .......+... .+.....++.+++..||+.+|++|| ++.++++.
T Consensus 193 ~~Pf~~~~~~------~-~~~~i~~~~~~-------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 193 QPPFEADNED------D-LFESILHDDVL-------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCCHH------H-HHHHHHcCCCC-------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 9999754321 1 11112222111 1112235688999999999999999 77888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=268.75 Aligned_cols=205 Identities=24% Similarity=0.403 Sum_probs=167.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.|.+|+.++++++|+||+++++++.. ...++|+||+++|+|.+++......+++..++.++.|++.||+|||+.
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--- 120 (259)
T cd05037 45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK--- 120 (259)
T ss_pred HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---
Confidence 5788999999999999999999999988 778999999999999999977655789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCC-------cEEEeecCCccccCCCCcceecccccCccccCcccccCC--CCCccccchhhHHH
Q 038168 591 QIIHCDIKPQNILMDENR-------CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL--PITVKADVYSFGVV 661 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~-------~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~G~~ 661 (757)
+|+||||||+|||++.++ .+||+|||++...... ....++..|+|||++.+. .++.++||||||++
T Consensus 121 ~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~ 195 (259)
T cd05037 121 KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTT 195 (259)
T ss_pred CeecccCccceEEEecCccccCCceeEEeCCCCcccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHH
Confidence 999999999999999887 7999999999865431 123456789999998876 78999999999999
Q ss_pred HHHHHhC-CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 662 LLEIICR-RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 662 l~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
++||++| ..|+........ ...+..... .+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 196 ~~~l~~~~~~p~~~~~~~~~-------~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 196 LLEICSNGEEPLSTLSSSEK-------ERFYQDQHR--------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HHHHHhCCCCCcccCCchhH-------HHHHhcCCC--------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 9999995 565554322111 011111110 01111267889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=265.81 Aligned_cols=219 Identities=20% Similarity=0.333 Sum_probs=178.2
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN---PEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
..+.+.+|++++++++|+|++++++++.+.+..++||||+++++|.+++.. ....+++.++..++.++++||.|||+
T Consensus 45 ~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~ 124 (267)
T cd08224 45 ARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS 124 (267)
T ss_pred hHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh
Confidence 356789999999999999999999999999999999999999999998853 23557899999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
. +++|+||||+||+++.++.+||+|||+++........ .....++..|+|||.+.+..++.++||||||++++||+
T Consensus 125 ~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~ 200 (267)
T cd08224 125 K---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred C---CEecCCcChhhEEECCCCcEEEeccceeeeccCCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHH
Confidence 8 9999999999999999999999999999866433221 22345788999999999889999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
+|+.|+..... ...+. .+....+..... ........+.+++.+|++.+|++||++.+|+++|+.+.
T Consensus 201 ~g~~p~~~~~~----~~~~~-~~~~~~~~~~~~-----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 201 ALQSPFYGDKM----NLYSL-CKKIEKCDYPPL-----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HCCCCcccCCc----cHHHH-HhhhhcCCCCCC-----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 99999864321 11111 122222222111 11244567889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=284.04 Aligned_cols=217 Identities=23% Similarity=0.383 Sum_probs=173.5
Q ss_pred HHHHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------------------------
Q 038168 511 EREFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE--------------------------- 562 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------- 562 (757)
.+.+.+|++++.++. |+|||++++++...+..++|+||+++|+|.++++...
T Consensus 84 ~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (401)
T cd05107 84 KQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQ 163 (401)
T ss_pred HHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccc
Confidence 457899999999997 9999999999999999999999999999999986431
Q ss_pred ----------------------------------------------------------------------CCCCHHHHHH
Q 038168 563 ----------------------------------------------------------------------KQPNWVERMG 572 (757)
Q Consensus 563 ----------------------------------------------------------------------~~l~~~~~~~ 572 (757)
..+++...++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 243 (401)
T cd05107 164 RKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVG 243 (401)
T ss_pred cccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHH
Confidence 2357778889
Q ss_pred HHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCc
Q 038168 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITV 651 (757)
Q Consensus 573 i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 651 (757)
++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.
T Consensus 244 ~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 320 (401)
T cd05107 244 FSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320 (401)
T ss_pred HHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCc
Confidence 999999999999998 999999999999999999999999999986543322 1122245678899999999888999
Q ss_pred cccchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC
Q 038168 652 KADVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS 730 (757)
Q Consensus 652 k~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 730 (757)
++||||||++++||++ |+.|+...... +........+... ..+ .....++.+++..||+.+|++||+
T Consensus 321 ~~DvwslGvil~e~l~~g~~P~~~~~~~------~~~~~~~~~~~~~--~~p----~~~~~~l~~li~~cl~~~P~~RPs 388 (401)
T cd05107 321 LSDVWSFGILLWEIFTLGGTPYPELPMN------EQFYNAIKRGYRM--AKP----AHASDEIYEIMQKCWEEKFEIRPD 388 (401)
T ss_pred HhHHHHHHHHHHHHHHcCCCCCCCCCch------HHHHHHHHcCCCC--CCC----CCCCHHHHHHHHHHcCCChhHCcC
Confidence 9999999999999998 88887543221 1112222222111 111 123467899999999999999999
Q ss_pred HHHHHHHhhcCc
Q 038168 731 MKKVLLMLEGTV 742 (757)
Q Consensus 731 m~eVl~~Le~~~ 742 (757)
++||++.|+.+.
T Consensus 389 ~~ell~~L~~~~ 400 (401)
T cd05107 389 FSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHHHHHh
Confidence 999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=283.40 Aligned_cols=200 Identities=21% Similarity=0.292 Sum_probs=168.3
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+..+.|-.|+... +||-|++|+..++..++.|+||||..+|++..+. +...++.....-++..++.||+|||++
T Consensus 413 e~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~--- 487 (694)
T KOG0694|consen 413 ESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHEN--- 487 (694)
T ss_pred HHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhc---
Confidence 5677888888777 5999999999999999999999999999965544 346788888888999999999999999
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+||+||||.+|||||.+|.+||+||||++..-.... .+..++||+.|||||++.+..|+..+|.|||||+||||+.|..
T Consensus 488 ~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~ 566 (694)
T KOG0694|consen 488 GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGES 566 (694)
T ss_pred CceeeecchhheEEcccCcEEecccccccccCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999999986543333 4556899999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
||.+..+++- .+.+. .|...++.-...+.+.++.+++..+|++|.-+
T Consensus 567 PF~gddEee~-------FdsI~-------~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 567 PFPGDDEEEV-------FDSIV-------NDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCHHHH-------HHHHh-------cCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 9986544321 11111 22233455556788999999999999999876
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=279.85 Aligned_cols=212 Identities=19% Similarity=0.227 Sum_probs=166.2
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|+.+++.++||||+++++.+.+.+..++||||+++|+|.+++.. ..++...+..++.||+.||+|||+. +
T Consensus 88 ~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ 162 (371)
T cd05622 88 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSM---G 162 (371)
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 4577899999999999999999999999999999999999999999854 3477788888999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC----CCCccccchhhHHHHHHHHh
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL----PITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~S~G~~l~ellt 667 (757)
|+||||||+|||++.++.+||+|||+++..............||+.|+|||.+.+. .++.++|||||||++|||++
T Consensus 163 ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~ 242 (371)
T cd05622 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242 (371)
T ss_pred EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHh
Confidence 99999999999999999999999999987654433333456799999999998754 37899999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHh
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSL--RPSMKKVLLML 738 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~--RPsm~eVl~~L 738 (757)
|+.||...... ................+ .......+.+++..|+..++.+ ||+++|+++..
T Consensus 243 G~~Pf~~~~~~------~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 243 GDTPFYADSLV------GTYSKIMNHKNSLTFPD----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCCCCCCCHH------HHHHHHHcCCCcccCCC----cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 99999753221 11122222111111111 1233456778888899844433 78999988853
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=259.49 Aligned_cols=235 Identities=21% Similarity=0.252 Sum_probs=182.9
Q ss_pred HHHHHHHHhhcCCCceeeeeeEEEe--ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 514 FQTEMKVIGRTHHRNLVRLLGYSLE--VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 514 ~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
-.+||.+|.+.+|||||.+-.+... -+..||||||++. +|.+++..-...+...+...+..|+++||+|||+. .
T Consensus 122 sLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---w 197 (419)
T KOG0663|consen 122 SLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---W 197 (419)
T ss_pred hHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---e
Confidence 4689999999999999999987764 4579999999987 89999988778889999999999999999999999 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
|+|||||++|+|+...|.+||+||||||.++.. ....+..+-|..|.|||.+.+. .|+...|+||+|||+.||+++++
T Consensus 198 ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kP 276 (419)
T KOG0663|consen 198 ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKP 276 (419)
T ss_pred eEecccchhheeeccCCcEEecccchhhhhcCC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCC
Confidence 999999999999999999999999999998765 3456677889999999998876 58999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccc--------c---------ccCHH-HHHHHHHHHHHccccCCCCCCCHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVED--------E---------EVDEK-QLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~--------~---------~~~~~-~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
.|.+...-++....-.....-.+...+.+.+. . .+... ..+.-+++....+..||.+|.|++
T Consensus 277 lf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~ 356 (419)
T KOG0663|consen 277 LFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAE 356 (419)
T ss_pred CCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHH
Confidence 88876654443222111000000001111000 0 01111 235667888889999999999999
Q ss_pred HHHHHhhcCcCCCCCCCCCCcc
Q 038168 733 KVLLMLEGTVEIPIPPNPTSFL 754 (757)
Q Consensus 733 eVl~~Le~~~~~~~p~~p~~~~ 754 (757)
|.++.= -..+.|.|..|..|+
T Consensus 357 ~~L~h~-~F~e~P~p~~P~~~P 377 (419)
T KOG0663|consen 357 DGLKHE-YFRETPLPIDPSMFP 377 (419)
T ss_pred Hhhccc-ccccCCCCCChhhcC
Confidence 987651 367777777776654
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=268.45 Aligned_cols=214 Identities=26% Similarity=0.393 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC------CCCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP------EKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
..++.+|+.++++++|+||+++++++...+..++||||+++++|.+++... ...+++.+++.++.|++.||+||
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 122 (269)
T cd05044 43 KKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122 (269)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHH
Confidence 457889999999999999999999999999999999999999999999642 23478899999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCC-----cEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccccchhh
Q 038168 585 HDECETQIIHCDIKPQNILMDENR-----CAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKADVYSF 658 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~-----~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~ 658 (757)
|+. +++|+||||+||+++.+. .+||+|||+++........ ......++..|+|||++.+..++.++|||||
T Consensus 123 H~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 199 (269)
T cd05044 123 EQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSF 199 (269)
T ss_pred HhC---CcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHH
Confidence 998 999999999999999877 8999999999866433221 1122345678999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 659 GVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 659 G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|++++||++ |+.|+..... ... ......+... ..+...+..+.+++.+||+.+|++||++.+|+++
T Consensus 200 G~il~ellt~g~~p~~~~~~---~~~----~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 266 (269)
T cd05044 200 GVLMWEILTLGQQPYPALNN---QEV----LQHVTAGGRL------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEI 266 (269)
T ss_pred HHHHHHHHHcCCCCCcccCH---HHH----HHHHhcCCcc------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 999999998 8888753321 111 1111111111 1122345678899999999999999999999999
Q ss_pred hhc
Q 038168 738 LEG 740 (757)
Q Consensus 738 Le~ 740 (757)
|++
T Consensus 267 l~~ 269 (269)
T cd05044 267 LQN 269 (269)
T ss_pred HhC
Confidence 863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=276.57 Aligned_cols=216 Identities=18% Similarity=0.206 Sum_probs=166.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|+++++.++||||+++++++...+..++|+||+++|+|.+++... ...+++..+..++.|++.||+|||+.
T Consensus 43 ~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-- 120 (327)
T cd08227 43 VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM-- 120 (327)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 356778999999999999999999999999999999999999999998654 34588999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-c-----eecccccCccccCcccccC--CCCCccccchhhHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-R-----TFTGIRGTRGYVAPEWHRN--LPITVKADVYSFGVV 661 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~-----~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~G~~ 661 (757)
+|+||||||+|||++.++.++++||+.......... . ......++..|+|||++.+ ..++.++|||||||+
T Consensus 121 -~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~i 199 (327)
T cd08227 121 -GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT 199 (327)
T ss_pred -CEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHH
Confidence 999999999999999999999999987654322111 0 0112346778999999876 468999999999999
Q ss_pred HHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccc---------------------------------------
Q 038168 662 LLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVED--------------------------------------- 702 (757)
Q Consensus 662 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~--------------------------------------- 702 (757)
++||++|+.||....... . . ... ..+......+.
T Consensus 200 l~el~~g~~pf~~~~~~~-~-~----~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (327)
T cd08227 200 ACELANGHVPFKDMPATQ-M-L----LEK-LNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSS 272 (327)
T ss_pred HHHHHHCCCCCCCcchhH-H-H----HHH-hcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcc
Confidence 999999999986432211 0 0 000 00111110000
Q ss_pred cccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 703 EEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 703 ~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
..........+.+++.+||+.||++|||++|+++
T Consensus 273 ~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 273 HPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0011223457889999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=265.45 Aligned_cols=214 Identities=31% Similarity=0.448 Sum_probs=178.1
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC--------CCCCCHHHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP--------EKQPNWVERMGIARDIARGI 581 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~gL 581 (757)
..+.+.+|++++++++|+|++++++++......++||||+++++|.+++... ...+++.++..++.|+++||
T Consensus 39 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al 118 (262)
T cd00192 39 ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118 (262)
T ss_pred HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHH
Confidence 3567899999999999999999999999999999999999999999999775 46789999999999999999
Q ss_pred HHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccchhhHH
Q 038168 582 LYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGV 660 (757)
Q Consensus 582 ~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~ 660 (757)
+|||++ +++|+||||+||++++++.+||+|||.++....... .......++..|+|||.+....++.++||||+|+
T Consensus 119 ~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 195 (262)
T cd00192 119 EYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGV 195 (262)
T ss_pred HHHHcC---CcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHH
Confidence 999998 999999999999999999999999999998765432 2223355788999999999889999999999999
Q ss_pred HHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 661 VLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 661 ~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
+++||++ |..|+...... + ..+....+... . .+.....++.+++.+|++.+|++|||+.|+++.|+
T Consensus 196 il~~l~~~g~~p~~~~~~~------~-~~~~~~~~~~~--~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 196 LLWEIFTLGATPYPGLSNE------E-VLEYLRKGYRL--P----KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCCC--C----CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 9999999 58888654221 1 22222222111 1 12233567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=282.17 Aligned_cols=213 Identities=21% Similarity=0.267 Sum_probs=164.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++++.+.+..++||||+++|+|.+++... ..+++.....++.||+.||+|||+.
T Consensus 45 ~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~--- 120 (381)
T cd05626 45 VAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKM--- 120 (381)
T ss_pred HHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 356889999999999999999999999999999999999999999998653 4577888888999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc--------------------------------------------
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-------------------------------------------- 626 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-------------------------------------------- 626 (757)
+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 121 givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (381)
T cd05626 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQH 200 (381)
T ss_pred CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccc
Confidence 999999999999999999999999999864321100
Q ss_pred --ceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccc
Q 038168 627 --RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEE 704 (757)
Q Consensus 627 --~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 704 (757)
.......||..|+|||.+.+..++.++|||||||+++||++|+.||........ ................
T Consensus 201 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~~~~-- 272 (381)
T cd05626 201 QRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTET------QLKVINWENTLHIPPQ-- 272 (381)
T ss_pred cccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHH------HHHHHccccccCCCCC--
Confidence 001235699999999999999999999999999999999999999976433211 1111111111111111
Q ss_pred cCHHHHHHHHHHHHH--ccccCCCCCCCHHHHHHH
Q 038168 705 VDEKQLERMIKVALW--CILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 705 ~~~~~~~~l~~l~~~--cl~~~p~~RPsm~eVl~~ 737 (757)
.....++.+++.+ |+.++|..||++.|++..
T Consensus 273 --~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 273 --VKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred --CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1122445566655 566777789999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=270.08 Aligned_cols=219 Identities=23% Similarity=0.334 Sum_probs=176.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+++.+|+.+++.++|+||+++++++.. ...++++||+++|+|.+++......+++.+++.++.|++.||+|||+.
T Consensus 53 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--- 128 (279)
T cd05109 53 NKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV--- 128 (279)
T ss_pred HHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 5678899999999999999999999875 456799999999999999977667789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-C
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-R 668 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G 668 (757)
+|+||||||+|||+++++.+||+|||+++........ ......++..|+|||...+..++.++||||||++++||++ |
T Consensus 129 ~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g 208 (279)
T cd05109 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFG 208 (279)
T ss_pred CeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999999877543321 1222345678999999999999999999999999999998 8
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcCCCC
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPI 746 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~~~~ 746 (757)
..|+..... ..+ ...+..+..... .......+.+++..||+.||++||++.++++.|+.+...|.
T Consensus 209 ~~p~~~~~~---~~~----~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 209 AKPYDGIPA---REI----PDLLEKGERLPQ------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred CCCCCCCCH---HHH----HHHHHCCCcCCC------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 888764322 111 122222221111 12234568899999999999999999999999988765553
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=278.92 Aligned_cols=203 Identities=21% Similarity=0.347 Sum_probs=165.5
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+.+..|+.++.++ +|+||+++++++...+..++||||+++|+|.+++.+. ..++...+..++.|++.||+|||+.
T Consensus 38 ~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~- 115 (320)
T cd05590 38 DVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDK- 115 (320)
T ss_pred HHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 345677888888877 6999999999999999999999999999999988653 5688899999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||++++||++|
T Consensus 116 --~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 192 (320)
T cd05590 116 --GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192 (320)
T ss_pred --CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhC
Confidence 99999999999999999999999999987543221 122345789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
+.||...... + +.+.+..+... .+......+.+++.+||+.||++||++
T Consensus 193 ~~Pf~~~~~~------~-~~~~i~~~~~~-------~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 193 HAPFEAENED------D-LFEAILNDEVV-------YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCCCHH------H-HHHHHhcCCCC-------CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 9999754321 1 11222222211 112234568899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=277.15 Aligned_cols=214 Identities=20% Similarity=0.179 Sum_probs=166.7
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|+.++..++|+||+++++.+.+.+..++||||+++|+|.+++.+....+++..+..++.|++.||+|||+. +
T Consensus 46 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ 122 (332)
T cd05623 46 ACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---H 122 (332)
T ss_pred HHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 4588899999999999999999999999999999999999999999977666789999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc-----CCCCCccccchhhHHHHHHHH
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR-----NLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~G~~l~ell 666 (757)
|+||||||+|||++.++.+||+|||++...............||+.|+|||++. ...++.++|||||||+++||+
T Consensus 123 iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell 202 (332)
T cd05623 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202 (332)
T ss_pred eEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHh
Confidence 999999999999999999999999999765444333333457899999999986 346889999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILD--EPSLRPSMKKVLLM 737 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~--~p~~RPsm~eVl~~ 737 (757)
+|+.||..... .+.............. + .........+.+++.+|+.. ++..|++++|+++.
T Consensus 203 ~g~~Pf~~~~~------~~~~~~i~~~~~~~~~--p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 203 YGETPFYAESL------VETYGKIMNHKERFQF--P-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCCCCCCCCH------HHHHHHHhCCCccccC--C-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 99999874322 1111222111110000 0 00112245567777777754 44447899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=279.73 Aligned_cols=212 Identities=19% Similarity=0.232 Sum_probs=166.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++.. ..++......++.||+.||+|||+.
T Consensus 87 ~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~--- 161 (370)
T cd05621 87 SAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSM--- 161 (370)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 34578899999999999999999999999999999999999999999854 3578888899999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC----CCCccccchhhHHHHHHHH
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL----PITVKADVYSFGVVLLEII 666 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~S~G~~l~ell 666 (757)
+|+||||||+|||+++++.+||+|||++...............||+.|+|||.+.+. .++.++||||+||+++||+
T Consensus 162 ~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell 241 (370)
T cd05621 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241 (370)
T ss_pred CeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHH
Confidence 999999999999999999999999999987654333233346799999999998764 3789999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSL--RPSMKKVLLM 737 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~--RPsm~eVl~~ 737 (757)
+|+.||...... ............... +. .......+.+++..|++.++.+ ||++.|+++.
T Consensus 242 ~G~~Pf~~~~~~------~~~~~i~~~~~~~~~--p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 242 VGDTPFYADSLV------GTYSKIMDHKNSLNF--PE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred hCCCCCCCCCHH------HHHHHHHhCCcccCC--CC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 999999754321 111222211111111 10 1123455677888888755543 8899999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=269.20 Aligned_cols=223 Identities=25% Similarity=0.382 Sum_probs=177.7
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEe--ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLE--VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..++|.+|++++++++|+||+++++++.. ....++||||+++++|.+++......+++.++..++.|++.||+|||+.
T Consensus 49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~ 128 (284)
T cd05038 49 HRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128 (284)
T ss_pred HHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 45789999999999999999999999887 5578999999999999999977666799999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce--ecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT--FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+++|+||||+||+++.++.+||+|||++.......... .....++..|++||...+..++.++||||||++++||
T Consensus 129 ---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el 205 (284)
T cd05038 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205 (284)
T ss_pred ---CeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhhee
Confidence 99999999999999999999999999999876332211 1123445679999999988999999999999999999
Q ss_pred HhCCCCCCCCCCCccc--------cHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQV--------ILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~--------~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++|+.|+......... ............+... ..+.....++.+++.+|++.+|++||+|.||+++
T Consensus 206 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05038 206 FTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERL------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI 279 (284)
T ss_pred eccCCCcccccchhccccccccccccHHHHHHHHHcCCcC------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 9999887653322110 0011111222221110 0112234678999999999999999999999999
Q ss_pred hhcC
Q 038168 738 LEGT 741 (757)
Q Consensus 738 Le~~ 741 (757)
|+.+
T Consensus 280 l~~i 283 (284)
T cd05038 280 VDRL 283 (284)
T ss_pred Hhhc
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=277.69 Aligned_cols=215 Identities=20% Similarity=0.179 Sum_probs=168.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++.+++|+||+++++++.+.+..++||||+++|+|.+++.+....+++..+..++.|++.||+|||+.
T Consensus 45 ~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~--- 121 (331)
T cd05624 45 TACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL--- 121 (331)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 34578899999999999999999999999999999999999999999977566788899999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-----CCCCccccchhhHHHHHHH
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-----LPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|||++.++.+||+|||+++..............|++.|+|||++.+ ..++.++||||||+++|||
T Consensus 122 ~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~el 201 (331)
T cd05624 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEM 201 (331)
T ss_pred CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhh
Confidence 99999999999999999999999999998765544333334578999999999875 4678999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSL--RPSMKKVLLM 737 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~--RPsm~eVl~~ 737 (757)
++|+.||...... +............. + +. ......+++.+++.+|+..++++ |++++++++.
T Consensus 202 l~g~~Pf~~~~~~------~~~~~i~~~~~~~~-~-p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 202 LYGETPFYAESLV------ETYGKIMNHEERFQ-F-PS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred hhCCCCccCCCHH------HHHHHHHcCCCccc-C-CC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 9999998743221 11111111111000 0 00 11123466778888888765543 4688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=275.94 Aligned_cols=217 Identities=27% Similarity=0.391 Sum_probs=174.5
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------------CCCCHHHHHHH
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------------KQPNWVERMGI 573 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i 573 (757)
..+++.+|+.+++++ +|+||+++++++.+.+..++||||+++|+|.+++.... ..+++.+++++
T Consensus 66 ~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 145 (307)
T cd05098 66 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145 (307)
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHH
Confidence 456788999999999 79999999999999999999999999999999996532 34789999999
Q ss_pred HHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCcc
Q 038168 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVK 652 (757)
Q Consensus 574 ~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k 652 (757)
+.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.+
T Consensus 146 ~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 222 (307)
T cd05098 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ 222 (307)
T ss_pred HHHHHHHHHHHHHC---CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH
Confidence 99999999999998 9999999999999999999999999999866432211 1122234568999999999899999
Q ss_pred ccchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 653 ADVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 653 ~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
+||||||++++||++ |+.|+..... .+ +......+.... .+......+.+++.+|++.+|++||+|
T Consensus 223 ~DvwslG~~l~el~~~g~~p~~~~~~------~~-~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~ 289 (307)
T cd05098 223 SDVWSFGVLLWEIFTLGGSPYPGVPV------EE-LFKLLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTF 289 (307)
T ss_pred HHHHHHHHHHHHHHcCCCCCCCcCCH------HH-HHHHHHcCCCCC------CCCcCCHHHHHHHHHHcccChhhCcCH
Confidence 999999999999998 7777753221 11 122222222111 122334678889999999999999999
Q ss_pred HHHHHHhhcCc
Q 038168 732 KKVLLMLEGTV 742 (757)
Q Consensus 732 ~eVl~~Le~~~ 742 (757)
.+|++.|+.+.
T Consensus 290 ~evl~~l~~~~ 300 (307)
T cd05098 290 KQLVEDLDRIL 300 (307)
T ss_pred HHHHHHHHHHH
Confidence 99999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=271.92 Aligned_cols=215 Identities=27% Similarity=0.399 Sum_probs=173.4
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------------------CCCCHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------------------KQPNWV 568 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------------~~l~~~ 568 (757)
..++|.+|+.++++++|+||+++++++.+++..++|+||+++|+|.+++.... ..+++.
T Consensus 51 ~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 130 (288)
T cd05050 51 MQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130 (288)
T ss_pred HHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHH
Confidence 35679999999999999999999999999999999999999999999996321 246788
Q ss_pred HHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCC
Q 038168 569 ERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNL 647 (757)
Q Consensus 569 ~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 647 (757)
+++.++.|++.||+|||.. +++||||||+||++++++.+||+|||+++....... ........+..|+|||.+.+.
T Consensus 131 ~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 207 (288)
T cd05050 131 EQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN 207 (288)
T ss_pred HHHHHHHHHHHHHHHHHhC---CeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC
Confidence 8999999999999999998 999999999999999999999999999986543322 111223346789999999988
Q ss_pred CCCccccchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCC
Q 038168 648 PITVKADVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPS 726 (757)
Q Consensus 648 ~~~~k~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~ 726 (757)
.++.++||||||++++||++ |..|+.....+ + .......+.... .+.....++.+++.+|++.+|+
T Consensus 208 ~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~------~-~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~ 274 (288)
T cd05050 208 RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE------E-VIYYVRDGNVLS------CPDNCPLELYNLMRLCWSKLPS 274 (288)
T ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHhcCCCCC------CCCCCCHHHHHHHHHHcccCcc
Confidence 99999999999999999998 77777543221 1 122233333221 1122346789999999999999
Q ss_pred CCCCHHHHHHHhhc
Q 038168 727 LRPSMKKVLLMLEG 740 (757)
Q Consensus 727 ~RPsm~eVl~~Le~ 740 (757)
+|||+.|+++.|++
T Consensus 275 ~Rpt~~el~~~l~~ 288 (288)
T cd05050 275 DRPSFASINRILQR 288 (288)
T ss_pred cCCCHHHHHHHhhC
Confidence 99999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=275.13 Aligned_cols=208 Identities=23% Similarity=0.285 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|..++..+ +|+||+++++++...+..++||||+++|+|..++.+ ...+++.++..++.|++.||.|||+.
T Consensus 39 ~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~-- 115 (318)
T cd05570 39 VECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHER-- 115 (318)
T ss_pred HHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 45677899999888 799999999999999999999999999999998864 34688999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||+++++.+||+|||+++....... ......|+..|+|||++.+..++.++|||||||+++||++|+
T Consensus 116 -~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~ 193 (318)
T cd05570 116 -GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193 (318)
T ss_pred -CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCC
Confidence 999999999999999999999999999875322221 223356899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM-----KKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm-----~eVl~~ 737 (757)
.||...... . ........... .+......+.+++.+||+.||++||++ .++++.
T Consensus 194 ~pf~~~~~~------~-~~~~i~~~~~~-------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 194 SPFEGDDED------E-LFQSILEDEVR-------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCCCCHH------H-HHHHHHcCCCC-------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 998643211 1 11222222111 112234678899999999999999999 887653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=274.08 Aligned_cols=218 Identities=23% Similarity=0.355 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+++.+|++++++++|+||+++++++.+.+..++||||+++++|.+++.+. ..+++..+..++.|+++||.|||+. .
T Consensus 43 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~ 119 (308)
T cd06615 43 RNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREK--H 119 (308)
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh--C
Confidence 356889999999999999999999999999999999999999999999654 5678889999999999999999973 2
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+++|+||||+|||++.++.+||+|||++....... .....++..|+|||.+.+..++.++||||||++++||++|+.
T Consensus 120 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 196 (308)
T cd06615 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRY 196 (308)
T ss_pred CEEECCCChHHEEEecCCcEEEccCCCcccccccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCC
Confidence 89999999999999999999999999987653321 223567899999999988889999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCcc------------------------ccc---cccccCHHHHHHHHHHHHHcccc
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLS------------------------QLV---EDEEVDEKQLERMIKVALWCILD 723 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~------------------------~~~---d~~~~~~~~~~~l~~l~~~cl~~ 723 (757)
|+....... ............... ... .+..........+.+++.+||+.
T Consensus 197 p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 273 (308)
T cd06615 197 PIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKK 273 (308)
T ss_pred CCCCcchhh---HHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccC
Confidence 986432211 000000000000000 000 00000111345688999999999
Q ss_pred CCCCCCCHHHHHHH
Q 038168 724 EPSLRPSMKKVLLM 737 (757)
Q Consensus 724 ~p~~RPsm~eVl~~ 737 (757)
+|++||++.||++.
T Consensus 274 ~P~~Rpt~~~ll~~ 287 (308)
T cd06615 274 NPKERADLKELTKH 287 (308)
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=276.08 Aligned_cols=207 Identities=23% Similarity=0.287 Sum_probs=166.2
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+..|..+++.+ +||||+++++++.+.+..++||||+++|+|.+++.. ...+++.+...++.|++.||+|||+.
T Consensus 39 ~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~-- 115 (316)
T cd05619 39 VECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSK-- 115 (316)
T ss_pred HHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 34566788888765 999999999999999999999999999999999864 35678899999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||+++||++|+
T Consensus 116 -~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~ 193 (316)
T cd05619 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193 (316)
T ss_pred -CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCC
Confidence 99999999999999999999999999987532221 1223456899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK-KVLL 736 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~-eVl~ 736 (757)
.||...... + ..+....+.. ..+......+.+++.+||+.+|++||++. ++.+
T Consensus 194 ~pf~~~~~~------~-~~~~i~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 194 SPFHGHDEE------E-LFQSIRMDNP-------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCCCCCHH------H-HHHHHHhCCC-------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 998753221 1 1111221111 11122345678999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=277.27 Aligned_cols=205 Identities=22% Similarity=0.290 Sum_probs=163.6
Q ss_pred HHHHHHHHHH---hhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 512 REFQTEMKVI---GRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 512 ~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
+.+.+|+.++ ++++|+||+++++++...+..++||||+++++|..++.. ..+++.++..++.|++.||+|||+.
T Consensus 44 ~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~- 120 (324)
T cd05589 44 ESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHEN- 120 (324)
T ss_pred HHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 4566666554 567899999999999999999999999999999988853 5689999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+|||++.++.+||+|||+++...... .......|+..|+|||.+.+..++.++||||||++++||++|
T Consensus 121 --~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G 197 (324)
T cd05589 121 --KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197 (324)
T ss_pred --CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhC
Confidence 99999999999999999999999999987543222 122345789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLL 736 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~ 736 (757)
+.||...... + .......+... .+......+.+++.+||+.||++|| ++.++++
T Consensus 198 ~~pf~~~~~~------~-~~~~i~~~~~~-------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 198 ESPFPGDDEE------E-VFDSIVNDEVR-------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCCCCHH------H-HHHHHHhCCCC-------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 9998754321 1 11112222111 1122345678999999999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=283.62 Aligned_cols=222 Identities=25% Similarity=0.312 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEece-----eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVS-----KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.+.+.+|+.+++.++|+||+++++++...+ ..++|+||+. ++|.+++.. ...+++..+..++.||+.||+|||
T Consensus 43 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH 120 (372)
T cd07853 43 CKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLH 120 (372)
T ss_pred HHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999999999998776 7899999997 578777754 456889999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLE 664 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~e 664 (757)
+. +|+||||||+|||++.++.+||+|||+++..............++..|+|||.+.+. .++.++|||||||+++|
T Consensus 121 ~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~e 197 (372)
T cd07853 121 SA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAE 197 (372)
T ss_pred hC---CeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHH
Confidence 98 999999999999999999999999999987654433333445678999999998874 47999999999999999
Q ss_pred HHhCCCCCCCCCCCccccHH----------H------HHHHHHhcCCccc-cc-cccccCHHHHHHHHHHHHHccccCCC
Q 038168 665 IICRRRCLDPNLPDDQVILE----------E------WVYQCFENGNLSQ-LV-EDEEVDEKQLERMIKVALWCILDEPS 726 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~----------~------~~~~~~~~~~~~~-~~-d~~~~~~~~~~~l~~l~~~cl~~~p~ 726 (757)
|++|+.||............ + .....+....... .. ..........+++.+++.+||+.||+
T Consensus 198 l~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 277 (372)
T cd07853 198 LLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPD 277 (372)
T ss_pred HHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChh
Confidence 99999999765432211100 0 0000010000000 00 00001122246788999999999999
Q ss_pred CCCCHHHHHHH
Q 038168 727 LRPSMKKVLLM 737 (757)
Q Consensus 727 ~RPsm~eVl~~ 737 (757)
+|||+.|+++.
T Consensus 278 ~R~t~~e~l~h 288 (372)
T cd07853 278 KRISAADALAH 288 (372)
T ss_pred hCcCHHHHhcC
Confidence 99999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=268.82 Aligned_cols=217 Identities=24% Similarity=0.332 Sum_probs=174.3
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|++++++++|+||+++++++...+..++||||+++++|.+++.+ ...+++.....++.+++.||.|||+.
T Consensus 46 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~-- 122 (284)
T cd06620 46 VRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNV-- 122 (284)
T ss_pred HHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHh--
Confidence 357899999999999999999999999999999999999999999998865 34678999999999999999999973
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
.+++|+||||+||++++++.++|+|||++....... .....|+..|+|||.+.+..++.++||||||++++||++|+
T Consensus 123 ~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~ 199 (284)
T cd06620 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199 (284)
T ss_pred cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCC
Confidence 289999999999999999999999999987543221 12356899999999998889999999999999999999999
Q ss_pred CCCCCCCCCc-----cccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 038168 670 RCLDPNLPDD-----QVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 670 ~p~~~~~~~~-----~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~L 738 (757)
.||....... ...+.+........ .... ....+....+.+++.+|++.||++||++.||+++.
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 200 FPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPR-----LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCcccchhhhhhhhhhHHHHHHHHHhhc-cCCC-----CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 9998544321 11112222222111 1111 11122446788999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=276.38 Aligned_cols=206 Identities=21% Similarity=0.287 Sum_probs=165.5
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+..|..++.++ +|+||+++++++.+.+..++||||+++|+|.+++.. ...+++.+...++.|+++||+|||+.
T Consensus 39 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-- 115 (316)
T cd05620 39 VECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSK-- 115 (316)
T ss_pred HHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 35567788888765 899999999999999999999999999999998865 35678889999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++||||||++++||++|+
T Consensus 116 -~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~ 193 (316)
T cd05620 116 -GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193 (316)
T ss_pred -CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCC
Confidence 99999999999999999999999999987532211 2233467899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK-KVL 735 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~-eVl 735 (757)
.||...... + ..+....+.. ..+.....++.+++.+||+.||++||++. +++
T Consensus 194 ~Pf~~~~~~------~-~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 194 SPFHGDDED------E-LFESIRVDTP-------HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCHH------H-HHHHHHhCCC-------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 999643221 1 1122221111 11112335678899999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=266.36 Aligned_cols=210 Identities=22% Similarity=0.298 Sum_probs=170.5
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|++++++++|+||+++++++.+.+..++|+||+++++|.+++... ..++......++.|++.||.|||+. +
T Consensus 49 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~ 124 (263)
T cd06625 49 NALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSN---M 124 (263)
T ss_pred HHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 56889999999999999999999999999999999999999999988643 4578888899999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCccee--cccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF--TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
++|+||||+||++++++.+||+|||+++.......... ....++..|+|||.+.+..++.++||||||++++||++|+
T Consensus 125 i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 204 (263)
T cd06625 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204 (263)
T ss_pred eecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986543222111 2345788999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
.|+...... ............ ...+......+.+++.+|++.+|++|||+.|+++.
T Consensus 205 ~p~~~~~~~------~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 205 PPWAEFEAM------AAIFKIATQPTN------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCccccchH------HHHHHHhccCCC------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 998643211 111111111111 11223345678899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=290.94 Aligned_cols=211 Identities=26% Similarity=0.318 Sum_probs=169.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEece--------eeeEEEEeccCCChhhhhcCC---CCCCCHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVS--------KKILVYEYMSNGSLADILFNP---EKQPNWVERMGIARDIAR 579 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--------~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~ 579 (757)
...+.+|+.++..++|+|++++++.+...+ ..++||||+++|+|.+++... ...++......++.|++.
T Consensus 75 ~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~ 154 (496)
T PTZ00283 75 KNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154 (496)
T ss_pred HHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHH
Confidence 356788999999999999999988765432 367999999999999998643 346788899999999999
Q ss_pred HHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccchhh
Q 038168 580 GILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYSF 658 (757)
Q Consensus 580 gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~ 658 (757)
||+|||+. +|+||||||+|||++.++.+||+|||+++.+..... .......||+.|+|||.+.+..++.++|||||
T Consensus 155 aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSl 231 (496)
T PTZ00283 155 AVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSL 231 (496)
T ss_pred HHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHH
Confidence 99999998 999999999999999999999999999987654322 22234678999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 659 GVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 659 G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|+++|||++|+.||..... .+.+ .....+.... .+.....++.+++.+||+.+|++||++.+++.+
T Consensus 232 GvilyeLltG~~Pf~~~~~------~~~~-~~~~~~~~~~------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 232 GVLLYELLTLKRPFDGENM------EEVM-HKTLAGRYDP------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHHHHCCCCCCCCCH------HHHH-HHHhcCCCCC------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 9999999999999864321 1111 2222222211 122344678899999999999999999999864
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=269.19 Aligned_cols=211 Identities=26% Similarity=0.381 Sum_probs=166.9
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEec------eeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLEV------SKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGI 581 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~------~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL 581 (757)
...++.+|+.+++++ +|+|++++++++... ...++||||+++++|.+++.... ..+++..+..++.|++.||
T Consensus 45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l 124 (272)
T cd06637 45 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124 (272)
T ss_pred cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence 356789999999999 799999999998753 45789999999999999987643 5688999999999999999
Q ss_pred HHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc-----CCCCCccccch
Q 038168 582 LYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR-----NLPITVKADVY 656 (757)
Q Consensus 582 ~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~ 656 (757)
+|||+. +|+|+||||+||++++++.+||+|||+++....... ......|+..|+|||++. +..++.++|||
T Consensus 125 ~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~ 200 (272)
T cd06637 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW 200 (272)
T ss_pred HHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHH
Confidence 999998 999999999999999999999999999986543221 223356889999999986 34578899999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 657 SFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 657 S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|||++++||++|+.|+........ ............ ........+.+++.+||+.+|++|||+.||++
T Consensus 201 slGv~l~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 201 SLGITAIEMAEGAPPLCDMHPMRA-------LFLIPRNPAPRL-----KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHHHHHHHhCCCCccccCHHHH-------HHHHhcCCCCCC-----CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 999999999999999864322111 011111111111 11223456889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=273.28 Aligned_cols=216 Identities=25% Similarity=0.397 Sum_probs=173.2
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC---------------CCCCCHHHHHHHH
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP---------------EKQPNWVERMGIA 574 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~ 574 (757)
.+++.+|+.+++++ +|+||+++++++.+.+..++|+||+++|+|.+++... ...+++.++++++
T Consensus 61 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (314)
T cd05099 61 LADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCA 140 (314)
T ss_pred HHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHH
Confidence 45688999999999 6999999999999988999999999999999999643 2357899999999
Q ss_pred HHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccc
Q 038168 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKA 653 (757)
Q Consensus 575 ~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~ 653 (757)
.|++.||.|||++ +++||||||+|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++
T Consensus 141 ~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 217 (314)
T cd05099 141 YQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS 217 (314)
T ss_pred HHHHHHHHHHHHC---CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccc
Confidence 9999999999998 9999999999999999999999999999876532221 11122345679999999998999999
Q ss_pred cchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 654 DVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 654 Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
||||||++++||++ |..|+...... + +......+.... .+......+.+++.+|++.+|++||++.
T Consensus 218 DiwslG~~l~el~~~g~~p~~~~~~~------~-~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~ 284 (314)
T cd05099 218 DVWSFGILMWEIFTLGGSPYPGIPVE------E-LFKLLREGHRMD------KPSNCTHELYMLMRECWHAVPTQRPTFK 284 (314)
T ss_pred hhhHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence 99999999999999 78777543211 1 122222222111 1122345688999999999999999999
Q ss_pred HHHHHhhcCc
Q 038168 733 KVLLMLEGTV 742 (757)
Q Consensus 733 eVl~~Le~~~ 742 (757)
|+++.|+.+.
T Consensus 285 ~ll~~l~~~~ 294 (314)
T cd05099 285 QLVEALDKVL 294 (314)
T ss_pred HHHHHHHHHH
Confidence 9999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=264.81 Aligned_cols=211 Identities=26% Similarity=0.371 Sum_probs=174.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+++.+|++++++++|+|++++++++.+....++++||+++++|.+++......+++..+..++.|++.||.|||+.
T Consensus 42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~--- 118 (256)
T cd06612 42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN--- 118 (256)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 56789999999999999999999999999999999999999999999977677889999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+++|+||+|+||++++++.+||+|||++........ ......++..|+|||.+.+..++.++||||||++++||++|+.
T Consensus 119 ~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~ 197 (256)
T cd06612 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKP 197 (256)
T ss_pred CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999987654321 1223457889999999999899999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|+....+.... ........... ..+......+.+++.+|++.+|++|||+.||++
T Consensus 198 p~~~~~~~~~~-------~~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 198 PYSDIHPMRAI-------FMIPNKPPPTL----SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCCcchhhhh-------hhhccCCCCCC----CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 98754332111 00011111111 112233467889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=272.57 Aligned_cols=209 Identities=21% Similarity=0.267 Sum_probs=166.4
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+..+.|-.+|....++.||+|+-.+++.+.+||||||++||++..+|.+ ...|+......++.+++.||+-||+. +
T Consensus 186 ~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~---g 261 (550)
T KOG0605|consen 186 EHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQL---G 261 (550)
T ss_pred HHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHc---C
Confidence 5677899999999999999999999999999999999999999999976 44566667777899999999999999 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCC-----------------------CCcc---------------------
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKP-----------------------DQTR--------------------- 627 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~-----------------------~~~~--------------------- 627 (757)
+|||||||+|+|||..|.+||+||||+..+.. +...
T Consensus 262 yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nr 341 (550)
T KOG0605|consen 262 YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNR 341 (550)
T ss_pred cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhh
Confidence 99999999999999999999999999963311 0000
Q ss_pred --eecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCC--cccccccc
Q 038168 628 --TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGN--LSQLVEDE 703 (757)
Q Consensus 628 --~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~d~~ 703 (757)
.....+||+.|||||++.+..++..+|.||+|||+||||.|.+||....+.+. ++.+...+ +....+
T Consensus 342 r~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T-------~rkI~nwr~~l~fP~~-- 412 (550)
T KOG0605|consen 342 RQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQET-------YRKIVNWRETLKFPEE-- 412 (550)
T ss_pred hhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHhhhccCCCc--
Confidence 00125699999999999999999999999999999999999999987766442 22221111 111111
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 038168 704 EVDEKQLERMIKVALWCILDEPSLRPS---MKKVLLM 737 (757)
Q Consensus 704 ~~~~~~~~~l~~l~~~cl~~~p~~RPs---m~eVl~~ 737 (757)
.+...+..+++.+|+. ||++|.- .+||.++
T Consensus 413 ---~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 413 ---VDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred ---CcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 1222678889999998 9999974 6666653
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=275.37 Aligned_cols=221 Identities=20% Similarity=0.263 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
...+.+|+.++++++|+||+++++++...+..++||||+++ +|.+++......+++..+..++.|++.||+|||+.
T Consensus 48 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--- 123 (309)
T cd07872 48 PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR--- 123 (309)
T ss_pred chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 35678899999999999999999999999999999999985 88888876666788999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+ ..++.++||||||++++||++|+
T Consensus 124 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~ 202 (309)
T cd07872 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202 (309)
T ss_pred CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999976543222 1223457889999998865 46899999999999999999999
Q ss_pred CCCCCCCCCccccHHHH--------HHHHHhc------CCcccccccc--ccCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 038168 670 RCLDPNLPDDQVILEEW--------VYQCFEN------GNLSQLVEDE--EVDEKQLERMIKVALWCILDEPSLRPSMKK 733 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~--------~~~~~~~------~~~~~~~d~~--~~~~~~~~~l~~l~~~cl~~~p~~RPsm~e 733 (757)
.||......+....... .+..+.. .......... .........+.+++.+|++.||++|||+.|
T Consensus 203 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 282 (309)
T cd07872 203 PLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEE 282 (309)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHH
Confidence 99875443221111000 0000000 0000000000 001122456789999999999999999999
Q ss_pred HHH
Q 038168 734 VLL 736 (757)
Q Consensus 734 Vl~ 736 (757)
+++
T Consensus 283 ~l~ 285 (309)
T cd07872 283 AMK 285 (309)
T ss_pred Hhc
Confidence 988
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=263.92 Aligned_cols=214 Identities=25% Similarity=0.347 Sum_probs=173.6
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|++++++++|+||+++++++.+.+..+++|||+++++|.+++......++..++..++.|++.||+|||+.
T Consensus 43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~-- 120 (262)
T cd06613 43 DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET-- 120 (262)
T ss_pred hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 357889999999999999999999999999999999999999999999876556788999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC---CCCccccchhhHHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL---PITVKADVYSFGVVLLEII 666 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~S~G~~l~ell 666 (757)
+++|+||||+||++++++.+||+|||++....... .......++..|+|||.+.+. .++.++||||||++++||+
T Consensus 121 -~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~ 198 (262)
T cd06613 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA 198 (262)
T ss_pred -CceecCCChhhEEECCCCCEEECccccchhhhhhh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHH
Confidence 99999999999999999999999999998654322 122335678899999999877 8899999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+|+.|+........ ... .....+.... ..........+.+++.+|++.+|.+|||+.+|+.
T Consensus 199 tg~~p~~~~~~~~~------~~~-~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 199 ELQPPMFDLHPMRA------LFL-ISKSNFPPPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hCCCCCCCCCHHHH------HHH-HHhccCCCcc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999875432111 111 1111111000 0112344567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=277.36 Aligned_cols=206 Identities=24% Similarity=0.259 Sum_probs=164.1
Q ss_pred HHHHHHHHH-HHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMK-VIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+++..|.. +++.++|+||+++++.+...+..++||||+++|+|..++.+ ...+++.+...++.||+.||+|||+.
T Consensus 39 ~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~-- 115 (325)
T cd05604 39 QKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSI-- 115 (325)
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 345566655 46778999999999999999999999999999999988864 45678899999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||+++++.+||+|||+++...... .......|+..|+|||.+.+..++.++|||||||+++||++|+
T Consensus 116 -givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~ 193 (325)
T cd05604 116 -NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGL 193 (325)
T ss_pred -CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCC
Confidence 99999999999999999999999999987532221 2223467899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl 735 (757)
.||...... +. .+....+... ........+.+++.+|++.+|++||++.+.+
T Consensus 194 ~pf~~~~~~------~~-~~~~~~~~~~-------~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 194 PPFYCRDVA------EM-YDNILHKPLV-------LRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCCCHH------HH-HHHHHcCCcc-------CCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 998753221 11 1112222111 1112345678899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=262.78 Aligned_cols=215 Identities=24% Similarity=0.344 Sum_probs=173.7
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|++++++++|+||+++++++.+.+..++||||+++++|.+++.+....+++..+..++.+++.+|+|||+.
T Consensus 35 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~-- 112 (251)
T cd05041 35 LKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK-- 112 (251)
T ss_pred HHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 356789999999999999999999999999999999999999999999976666788999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCccee-cccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF-TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+++||||||+||+++.++.+||+|||+++.......... .....+..|+|||.+.+..++.++||||||++++||++
T Consensus 113 -~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~ 191 (251)
T cd05041 113 -NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191 (251)
T ss_pred -CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhc
Confidence 999999999999999999999999999986543221111 11233567999999998899999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
|..|+....... .......+. .. ..+......+.+++.+|++.+|++||++.||++.|+.
T Consensus 192 ~~~p~~~~~~~~-------~~~~~~~~~--~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 192 GDTPYPGMSNQQ-------TRERIESGY--RM----PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCCCccCCHHH-------HHHHHhcCC--CC----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 777775433211 111122111 01 1122334679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=270.30 Aligned_cols=210 Identities=26% Similarity=0.370 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+|++++++.+......++||||+++++|.+++.. ..+++.++..++.|++.||+|||+.
T Consensus 61 ~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~--- 135 (296)
T cd06654 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN--- 135 (296)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46788999999999999999999999999999999999999999999853 4578899999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+|+||||+||+++.++.+||+|||++......... .....++..|+|||.+.+..++.++||||||++++||++|+.
T Consensus 136 gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~ 214 (296)
T cd06654 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (296)
T ss_pred CcccCCCCHHHEEEcCCCCEEECccccchhccccccc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999998865433221 223467889999999998889999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
||....+... .......+ ..... .+......+.+++.+|++.+|++||++.+|++.
T Consensus 215 pf~~~~~~~~------~~~~~~~~-~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 215 PYLNENPLRA------LYLIATNG-TPELQ----NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCCCHHHh------HHHHhcCC-CCCCC----CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 9865432111 11111111 11111 122344668899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=277.45 Aligned_cols=202 Identities=25% Similarity=0.273 Sum_probs=162.3
Q ss_pred HHHHHHHH-HHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMK-VIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+++.+|.. +++.++||||+++++.+.+.+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++
T Consensus 40 ~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--- 115 (323)
T cd05575 40 KHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSL--- 115 (323)
T ss_pred HHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 34555554 56789999999999999999999999999999999998865 45678888899999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||+++||++|+.
T Consensus 116 givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~ 194 (323)
T cd05575 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLP 194 (323)
T ss_pred CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCC
Confidence 99999999999999999999999999987542221 22334578999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
||..... .+.... ...+... ........+.+++.+|++.+|++||++.
T Consensus 195 pf~~~~~------~~~~~~-i~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 195 PFYSRDT------AEMYDN-ILNKPLR-------LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCH------HHHHHH-HHcCCCC-------CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 9875321 111111 1222111 1122356788999999999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=263.68 Aligned_cols=210 Identities=31% Similarity=0.461 Sum_probs=170.3
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+.+.+|+.++++++|+|++++++++... ..++||||+++++|.+++.... ..+++.++..++.|++.||.|||+.
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~- 119 (254)
T cd05083 42 TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK- 119 (254)
T ss_pred hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 446789999999999999999999998754 4799999999999999997543 4578999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+++||||||+||+++.++.+||+|||+++...... .....+..|+|||.+.+..++.++||||||++++||++
T Consensus 120 --~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~ 193 (254)
T cd05083 120 --KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSY 193 (254)
T ss_pred --CeeccccCcceEEEcCCCcEEECCCccceeccccC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999997643221 12234578999999998899999999999999999998
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
|+.|+...... + .......+..... ....+..+.+++.+|++.+|++||++.+|++.|++
T Consensus 194 g~~p~~~~~~~------~-~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 194 GRAPYPKMSLK------E-VKECVEKGYRMEP------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCccCCHH------H-HHHHHhCCCCCCC------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 88887643221 1 1222222211111 12334678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=264.39 Aligned_cols=211 Identities=22% Similarity=0.310 Sum_probs=173.0
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+.+.+|+.++++++|+|++++++.+...+..++||||+++++|.+++... ...++......++.|++.||.|||+.
T Consensus 41 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~- 119 (255)
T cd08219 41 AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK- 119 (255)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC-
Confidence 4567889999999999999999999999999999999999999999988543 34578889999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
+++|+||||+||++++++.++|+|||+++....... ......++..|+|||.+.+..++.++||||||+++++|++|
T Consensus 120 --~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g 196 (255)
T cd08219 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTL 196 (255)
T ss_pred --CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhc
Confidence 999999999999999999999999999987644322 12235688899999999998999999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+.||..... .... .....+....+ +......+.+++.+||+.+|++||++.+|+..
T Consensus 197 ~~p~~~~~~------~~~~-~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 197 KHPFQANSW------KNLI-LKVCQGSYKPL------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cCCCCCCCH------HHHH-HHHhcCCCCCC------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 999874321 1111 11222222211 12234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=269.31 Aligned_cols=216 Identities=25% Similarity=0.375 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------CCCCHHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------KQPNWVERMGIARDIARGI 581 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL 581 (757)
...+.+|+.++++++|+||+++++++.+.+..++||||+++|+|.+++.+.. ..+.+..+..++.|++.||
T Consensus 53 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 132 (288)
T cd05061 53 RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132 (288)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHH
Confidence 3468899999999999999999999999999999999999999999996421 2346778899999999999
Q ss_pred HHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-ecccccCccccCcccccCCCCCccccchhhHH
Q 038168 582 LYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-FTGIRGTRGYVAPEWHRNLPITVKADVYSFGV 660 (757)
Q Consensus 582 ~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~ 660 (757)
.|||+. +|+||||||+||++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+
T Consensus 133 ~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~ 209 (288)
T cd05061 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 209 (288)
T ss_pred HHHHhC---CCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHH
Confidence 999998 99999999999999999999999999998654332211 12234567899999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 661 VLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 661 ~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
+++||++ |..|+.....+ + +......+..... +......+.+++.+|++.+|++|||+.++++.|+
T Consensus 210 ~l~el~~~~~~p~~~~~~~------~-~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~ 276 (288)
T cd05061 210 VLWEITSLAEQPYQGLSNE------Q-VLKFVMDGGYLDQ------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276 (288)
T ss_pred HHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 9999999 67777543221 1 1111222221111 1223468999999999999999999999999998
Q ss_pred cCc
Q 038168 740 GTV 742 (757)
Q Consensus 740 ~~~ 742 (757)
+..
T Consensus 277 ~~~ 279 (288)
T cd05061 277 DDL 279 (288)
T ss_pred hhc
Confidence 754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=281.07 Aligned_cols=212 Identities=19% Similarity=0.193 Sum_probs=164.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++++.+.+..++||||+++|+|.+++.. ...++......++.|++.||+|||+.
T Consensus 45 ~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~--- 120 (377)
T cd05629 45 LAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKL--- 120 (377)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 35688899999999999999999999999999999999999999999865 35678888889999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-------------------------------------------
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR------------------------------------------- 627 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~------------------------------------------- 627 (757)
+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 121 givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (377)
T cd05629 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKN 200 (377)
T ss_pred CeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhc
Confidence 9999999999999999999999999999643211000
Q ss_pred ---eecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccc
Q 038168 628 ---TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEE 704 (757)
Q Consensus 628 ---~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 704 (757)
......||+.|+|||++.+..++.++|||||||+++||++|+.||......+ .............+-+.
T Consensus 201 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~p~~-- 272 (377)
T cd05629 201 RRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHE------TYRKIINWRETLYFPDD-- 272 (377)
T ss_pred ccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHH------HHHHHHccCCccCCCCC--
Confidence 0012468999999999999999999999999999999999999997543211 11111111111111111
Q ss_pred cCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 038168 705 VDEKQLERMIKVALWCILDEPSLR---PSMKKVLLM 737 (757)
Q Consensus 705 ~~~~~~~~l~~l~~~cl~~~p~~R---Psm~eVl~~ 737 (757)
.....++.+++.+|++ +|.+| +++.|+++.
T Consensus 273 --~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 273 --IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred --CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 1123457788888887 66665 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=277.77 Aligned_cols=219 Identities=27% Similarity=0.402 Sum_probs=170.7
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEec-eeeeEEEEeccCCChhhhhcCCC-------------------------
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLEV-SKKILVYEYMSNGSLADILFNPE------------------------- 562 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~~~lV~e~~~~gsL~~~l~~~~------------------------- 562 (757)
..+.+.+|+.++.++ +|+||+++++++... ...++||||+++|+|.+++....
T Consensus 53 ~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (343)
T cd05103 53 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISE 132 (343)
T ss_pred HHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhh
Confidence 345788999999999 789999999988654 46789999999999999885421
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcce
Q 038168 563 -----------------------------------------KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQN 601 (757)
Q Consensus 563 -----------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~N 601 (757)
..+++.++.+++.|+++||+|||++ +|+||||||+|
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~N 209 (343)
T cd05103 133 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARN 209 (343)
T ss_pred hhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCe
Confidence 2367888899999999999999998 99999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCc
Q 038168 602 ILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-RRRCLDPNLPDD 679 (757)
Q Consensus 602 ill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G~~p~~~~~~~~ 679 (757)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |..|+.......
T Consensus 210 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 289 (343)
T cd05103 210 ILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 289 (343)
T ss_pred EEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH
Confidence 99999999999999999875433221 1122345678999999998899999999999999999997 888875432211
Q ss_pred cccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcC
Q 038168 680 QVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 680 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~ 743 (757)
. .......+..... +. ....++.+++..||+.+|++||++.||++.|+.+.+
T Consensus 290 ~------~~~~~~~~~~~~~--~~----~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 290 E------FCRRLKEGTRMRA--PD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred H------HHHHHhccCCCCC--CC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1 1222222221111 11 123468899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=261.51 Aligned_cols=237 Identities=23% Similarity=0.316 Sum_probs=177.0
Q ss_pred HHHHHhhccccccccCCCchHHHHHHHHHHHhhcCCCceeeeeeEEEe-----ceeeeEEEEeccCCChhhhhcCCCCCC
Q 038168 491 AELEKMTDGFKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLE-----VSKKILVYEYMSNGSLADILFNPEKQP 565 (757)
Q Consensus 491 ~~l~~~t~~f~~~lg~g~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~l 565 (757)
..+++..+-|...+ ..+.-.+|+++|+.++|+||+.+.+...- .+..|+|+|+|+ -+|...++. +..+
T Consensus 50 VAIKKi~~~F~~~~-----~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-tDL~~iik~-~~~L 122 (359)
T KOG0660|consen 50 VAIKKILNPFENQI-----DAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME-TDLHQIIKS-QQDL 122 (359)
T ss_pred eehhhhhhhhhchH-----HHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHh-hHHHHHHHc-Cccc
Confidence 34444444444432 45778899999999999999999998764 457899999994 489888854 4447
Q ss_pred CHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCC-cceecccccCccccCcccc
Q 038168 566 NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ-TRTFTGIRGTRGYVAPEWH 644 (757)
Q Consensus 566 ~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~ 644 (757)
+.....-++.|+++||+|+|+. +|+|||+||+|+|++.+...||+||||||...... ....+..+-|..|.|||.+
T Consensus 123 ~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPEll 199 (359)
T KOG0660|consen 123 TDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELL 199 (359)
T ss_pred cHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHH
Confidence 7788888999999999999998 99999999999999999999999999999886432 2334667889999999987
Q ss_pred cC-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHH--------HHHHhcCCcccccc------cc---ccC
Q 038168 645 RN-LPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWV--------YQCFENGNLSQLVE------DE---EVD 706 (757)
Q Consensus 645 ~~-~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~~~~~~d------~~---~~~ 706 (757)
.. ..|+...||||.||++.||++|++.|.+...-++..+.-.+ ...+...+....+. +. ..-
T Consensus 200 l~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~f 279 (359)
T KOG0660|consen 200 LNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIF 279 (359)
T ss_pred hccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHc
Confidence 54 57999999999999999999999988776544333221110 11111111111110 00 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 707 EKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 707 ~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+......+++..+||..||.+|+|.+|.++.
T Consensus 280 p~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 280 PNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1223567899999999999999999999873
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=277.07 Aligned_cols=202 Identities=25% Similarity=0.272 Sum_probs=161.4
Q ss_pred HHHHHHHH-HHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMK-VIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+.+.+|.. +++.++|+||+++++.+.+.+..++||||+++++|..++.. ...+...+...++.||+.||+|||+.
T Consensus 40 ~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~--- 115 (321)
T cd05603 40 NHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSL--- 115 (321)
T ss_pred HHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 44555554 67889999999999999999999999999999999988854 45567788888999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++...... .......|++.|+|||.+.+..++.++|||||||+++||++|+.
T Consensus 116 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 194 (321)
T cd05603 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLP 194 (321)
T ss_pred CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCC
Confidence 99999999999999999999999999987532221 12234568999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
||..... ... ......+.. ..+......+.+++.+||+.+|++||+..
T Consensus 195 pf~~~~~------~~~-~~~i~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 195 PFYSRDV------SQM-YDNILHKPL-------QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCH------HHH-HHHHhcCCC-------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 9875321 111 111122211 11223345788999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=266.38 Aligned_cols=215 Identities=25% Similarity=0.376 Sum_probs=174.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC--------CCCCHHHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE--------KQPNWVERMGIARDIARGIL 582 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~ia~gL~ 582 (757)
.+++.+|++++++++|+||+++++++.+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||+
T Consensus 52 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~ 131 (275)
T cd05046 52 QSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131 (275)
T ss_pred HHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 4678999999999999999999999999999999999999999999996543 15899999999999999999
Q ss_pred HhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHH
Q 038168 583 YLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662 (757)
Q Consensus 583 yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l 662 (757)
|||+. +|+||||||+||+++.++.+||+|||+++..............++..|+|||.+.+...+.++||||||+++
T Consensus 132 ~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l 208 (275)
T cd05046 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLM 208 (275)
T ss_pred Hhhhc---CcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHH
Confidence 99998 999999999999999999999999999875543333333344567789999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 663 LEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 663 ~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
+||++ |..|+...... . .......+...... .......+.+++.+|++.+|++||++.|++++|++
T Consensus 209 ~~l~~~~~~p~~~~~~~------~-~~~~~~~~~~~~~~-----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 209 WEVFTQGELPFYGLSDE------E-VLNRLQAGKLELPV-----PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred HHHHhCCCCCccccchH------H-HHHHHHcCCcCCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 99999 67777532211 1 12222223222111 11234678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=280.81 Aligned_cols=212 Identities=20% Similarity=0.249 Sum_probs=166.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++++.+.+..++||||+++|+|.+++.. ...++..++..++.|++.||+|||+.
T Consensus 45 ~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~--- 120 (364)
T cd05599 45 VAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKL--- 120 (364)
T ss_pred HHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 35678899999999999999999999999999999999999999999865 34688899999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-------------------------------------eecccc
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-------------------------------------TFTGIR 633 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-------------------------------------~~~~~~ 633 (757)
+|+||||||+|||++.++.+||+|||++..+...... .....+
T Consensus 121 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (364)
T cd05599 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV 200 (364)
T ss_pred CeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccc
Confidence 9999999999999999999999999999765322110 011246
Q ss_pred cCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHH
Q 038168 634 GTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERM 713 (757)
Q Consensus 634 gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l 713 (757)
||+.|+|||++.+..++.++|||||||+++||++|+.||....... .............. +.. ....+.+
T Consensus 201 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~------~~~~i~~~~~~~~~--~~~--~~~s~~~ 270 (364)
T cd05599 201 GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQE------TYRKIINWKETLQF--PDE--VPLSPEA 270 (364)
T ss_pred cCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHH------HHHHHHcCCCccCC--CCC--CCCCHHH
Confidence 8999999999999999999999999999999999999997543211 11111111111011 111 1123456
Q ss_pred HHHHHHccccCCCCCCC---HHHHHHH
Q 038168 714 IKVALWCILDEPSLRPS---MKKVLLM 737 (757)
Q Consensus 714 ~~l~~~cl~~~p~~RPs---m~eVl~~ 737 (757)
.+++.+|+. +|.+|++ +.|+++.
T Consensus 271 ~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 271 KDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred HHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 778888886 9999998 8888773
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=277.31 Aligned_cols=205 Identities=24% Similarity=0.259 Sum_probs=162.3
Q ss_pred HHHHHHHH-HHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMK-VIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+.+..|.. +++.++|+||+++++.+.+.+..++||||+++|+|.+++.. ...+.......++.||++||+|||+.
T Consensus 40 ~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~--- 115 (325)
T cd05602 40 KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSL--- 115 (325)
T ss_pred HHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 34444444 56788999999999999999999999999999999999865 34566777788999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||+++||++|+.
T Consensus 116 giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 194 (325)
T cd05602 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 194 (325)
T ss_pred CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCC
Confidence 99999999999999999999999999997543221 12234578999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl 735 (757)
||...... +.... ....... ........+.+++.+|++.+|.+||++.+.+
T Consensus 195 pf~~~~~~------~~~~~-i~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 195 PFYSRNTA------EMYDN-ILNKPLQ-------LKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCCHH------HHHHH-HHhCCcC-------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 98743221 11111 1111111 1123345688999999999999999887544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=280.14 Aligned_cols=224 Identities=27% Similarity=0.349 Sum_probs=180.4
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP--NWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
+-+..|+.+-++|+|+|||+.+|.+.+++..-+.||..|+|+|.++|...=..+ +..+.--+.+||++||.|||+.
T Consensus 617 QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen-- 694 (1226)
T KOG4279|consen 617 QPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN-- 694 (1226)
T ss_pred ccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc--
Confidence 447789999999999999999999999999999999999999999997654444 5666677889999999999999
Q ss_pred CCeeeCCCCcceEEEC-CCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC--CCCccccchhhHHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMD-ENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL--PITVKADVYSFGVVLLEII 666 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~-~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~G~~l~ell 666 (757)
.|||||||-.|||++ -.|.+||+|||-++.+..- ...+..+.||..|||||++..+ .|...+|||||||++.||.
T Consensus 695 -~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMA 772 (1226)
T KOG4279|consen 695 -KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMA 772 (1226)
T ss_pred -ceeeccccCCcEEEeeccceEEecccccchhhccC-CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeec
Confidence 999999999999996 4699999999999876532 2233457799999999999876 4899999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcCcCC
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL--MLEGTVEI 744 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~--~Le~~~~~ 744 (757)
||++||....... ..+++-|-+. -.+.++.+...+...++++|..++|.+||++.++++ .|+.-...
T Consensus 773 TGrPPF~Elgspq--------AAMFkVGmyK---vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 773 TGRPPFVELGSPQ--------AAMFKVGMYK---VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred cCCCCeeecCChh--------Hhhhhhccee---cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCC
Confidence 9999997533221 1223333221 224567888899999999999999999999999986 45443334
Q ss_pred CCCCCC
Q 038168 745 PIPPNP 750 (757)
Q Consensus 745 ~~p~~p 750 (757)
+.|+.+
T Consensus 842 ~r~~ls 847 (1226)
T KOG4279|consen 842 PRPKLS 847 (1226)
T ss_pred CCCCCC
Confidence 444443
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=267.85 Aligned_cols=211 Identities=30% Similarity=0.467 Sum_probs=168.9
Q ss_pred HHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCee
Q 038168 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQII 593 (757)
Q Consensus 514 ~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii 593 (757)
..+|+.++++++|+||+++++++.+.+..++||||+++++|.+++. ....+++.++..++.|+++||+|||+. +++
T Consensus 45 ~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~ 120 (260)
T PF00069_consen 45 NIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSK---GIV 120 (260)
T ss_dssp HHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred hhhhhhcccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccc---ccc
Confidence 4559999999999999999999999999999999999999999997 356779999999999999999999998 999
Q ss_pred eCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc-CCCCCccccchhhHHHHHHHHhCCCCC
Q 038168 594 HCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR-NLPITVKADVYSFGVVLLEIICRRRCL 672 (757)
Q Consensus 594 H~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~S~G~~l~elltG~~p~ 672 (757)
|+||||+||++++++.++|+|||.+.... ..........++..|+|||++. +...+.++||||+|+++++|++|+.|+
T Consensus 121 H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~ 199 (260)
T PF00069_consen 121 HRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPF 199 (260)
T ss_dssp ESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSS
T ss_pred ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999998652 2223334567899999999998 888999999999999999999999998
Q ss_pred CCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 673 DPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 673 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
......+.. ....+... ....... .........+.+++..||+.||++||++.++++
T Consensus 200 ~~~~~~~~~---~~~~~~~~-~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 200 EESNSDDQL---EIIEKILK-RPLPSSS---QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TTSSHHHHH---HHHHHHHH-THHHHHT---TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccchhhh---hhhhhccc-ccccccc---cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 855111111 11111111 0000000 000011278999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=265.55 Aligned_cols=214 Identities=23% Similarity=0.320 Sum_probs=168.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+||+++++.+...+..++|+||+++++|.+++.. ...+++.++..++.|++.||+|||+.
T Consensus 50 ~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--- 125 (267)
T cd06646 50 FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSK--- 125 (267)
T ss_pred HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 35688999999999999999999999999999999999999999998864 34678899999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc---CCCCCccccchhhHHHHHHHHh
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR---NLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+|+||||+||+++.++.+||+|||+++....... ......++..|+|||.+. ...++.++||||||++++||++
T Consensus 126 ~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~ 204 (267)
T cd06646 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAE 204 (267)
T ss_pred CccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999987643221 122346788999999874 3457889999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~L 738 (757)
|+.|+....+..... .......... . ..........+.+++.+||+.+|++||++++|++.|
T Consensus 205 g~~p~~~~~~~~~~~-------~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 205 LQPPMFDLHPMRALF-------LMSKSNFQPP-K-LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCccccchhhhhe-------eeecCCCCCC-C-CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 999886433211100 0011111100 0 001112346788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-30 Score=274.96 Aligned_cols=203 Identities=24% Similarity=0.322 Sum_probs=163.3
Q ss_pred hHHHHHHHHHHHhhcCC-CceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHH-RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+.+..|+.++..++| ++|+++++++.+.+..++||||+++|+|.+++.. ...+++.++..++.||+.||+|||++
T Consensus 43 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~- 120 (324)
T cd05587 43 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSK- 120 (324)
T ss_pred HHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34567889999999965 5688899999999999999999999999998864 34678899999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||+++||++|
T Consensus 121 --~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG 197 (324)
T cd05587 121 --GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197 (324)
T ss_pred --CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhC
Confidence 99999999999999999999999999987532221 122345689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
+.||......+ ........... .+.....++.+++.+||+.+|++||+.
T Consensus 198 ~~pf~~~~~~~-------~~~~i~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 198 QPPFDGEDEDE-------LFQSIMEHNVS-------YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCHHH-------HHHHHHcCCCC-------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 99987543211 11112222111 112234568899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=274.05 Aligned_cols=202 Identities=24% Similarity=0.326 Sum_probs=164.1
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+..|..++..+ +|++|+++++++.+.+..++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+.
T Consensus 44 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~-- 120 (323)
T cd05616 44 VECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSK-- 120 (323)
T ss_pred HHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 34567788888877 689999999999999999999999999999998864 34578899999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||+++++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||+++||++|+
T Consensus 121 -~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~ 198 (323)
T cd05616 121 -GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198 (323)
T ss_pred -CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCC
Confidence 999999999999999999999999999975432221 223456899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
.||...... . ..+.+..+... .+.....++.+++.+|++.+|++|++.
T Consensus 199 ~Pf~~~~~~------~-~~~~i~~~~~~-------~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 199 APFEGEDED------E-LFQSIMEHNVA-------YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCCCHH------H-HHHHHHhCCCC-------CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 999754321 1 11222222211 122334678899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=265.29 Aligned_cols=207 Identities=22% Similarity=0.349 Sum_probs=181.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
...+.+|+.-|+.++|||||+|+++.......|||+|+=++|+|.+|+.+++..+......+++.||+.|+.|+|+.
T Consensus 61 t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL--- 137 (864)
T KOG4717|consen 61 TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL--- 137 (864)
T ss_pred hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---
Confidence 46788999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred CeeeCCCCcceEEECC-CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCC-ccccchhhHHHHHHHHhC
Q 038168 591 QIIHCDIKPQNILMDE-NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPIT-VKADVYSFGVVLLEIICR 668 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~-~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~Dv~S~G~~l~elltG 668 (757)
.+|||||||+||.+-+ -|-+||.|||++..+.+.+. .+..+|+..|-|||++.+..|. +..||||||||||-|++|
T Consensus 138 HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCG 215 (864)
T KOG4717|consen 138 HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCG 215 (864)
T ss_pred hhhcccCCcceeEEeeecCceEeeeccccccCCCcch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhC
Confidence 9999999999998855 58999999999987766543 3456899999999999999885 679999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccc-cccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVED-EEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~-~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+.||+...+.+.. ..++|= -..+.....++.+|+..||+.||++|-+.+||+..
T Consensus 216 q~PFqeANDSETL---------------TmImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 216 QPPFQEANDSETL---------------TMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred CCccccccchhhh---------------hhhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 9999865543322 122332 23567778999999999999999999999999863
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=261.72 Aligned_cols=211 Identities=22% Similarity=0.343 Sum_probs=171.9
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEe-ceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLE-VSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..+.+.+|++++++++|+|++++++.+.. ....++||||+++++|.+++... ...+++.++..++.+++.||+|||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~ 121 (257)
T cd08223 42 ERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121 (257)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34678899999999999999999998764 44678999999999999998753 34589999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||||+||+++.++.+||+|||++..+..... ......++..|+|||.+.+..++.++||||||++++||++
T Consensus 122 ---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08223 122 ---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197 (257)
T ss_pred ---CeeccCCCchhEEEecCCcEEEecccceEEecccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHc
Confidence 999999999999999999999999999987643322 2233567889999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|+.|+..... ..... ....+.... .+......+.+++.+|++.+|++||++.++++.
T Consensus 198 g~~~~~~~~~------~~~~~-~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 198 LKHAFNAKDM------NSLVY-RIIEGKLPP------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCCCCCCCH------HHHHH-HHHhcCCCC------CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 9998864321 11111 222233221 123445678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=279.72 Aligned_cols=212 Identities=19% Similarity=0.242 Sum_probs=163.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++.+.+++..++||||+++|+|.+++.+. ..++......++.||+.||+|||+.
T Consensus 45 ~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~--- 120 (376)
T cd05598 45 AAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKM--- 120 (376)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 456889999999999999999999999999999999999999999999653 4577788888999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCC------------------------------------------cce
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ------------------------------------------TRT 628 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~------------------------------------------~~~ 628 (757)
+|+||||||+|||++.++.+||+|||++..+.... ...
T Consensus 121 ~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (376)
T cd05598 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCL 200 (376)
T ss_pred CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhccccc
Confidence 99999999999999999999999999985332100 000
Q ss_pred ecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHH
Q 038168 629 FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEK 708 (757)
Q Consensus 629 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 708 (757)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ................ ..
T Consensus 201 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~~~~~~~~~----~~ 270 (376)
T cd05598 201 AHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAET------QLKVINWETTLHIPSQ----AK 270 (376)
T ss_pred ccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHH------HHHHhccCccccCCCC----CC
Confidence 1235799999999999999999999999999999999999999976433211 1111111110011111 11
Q ss_pred HHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 038168 709 QLERMIKVALWCILDEPSLRP---SMKKVLLM 737 (757)
Q Consensus 709 ~~~~l~~l~~~cl~~~p~~RP---sm~eVl~~ 737 (757)
....+.+++.+|+ .+|++|+ ++.|+++.
T Consensus 271 ~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 271 LSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 2344566666665 5999999 88888865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=267.12 Aligned_cols=216 Identities=24% Similarity=0.301 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe-ceeeeEEEEeccCCChhhhhcCCC-------CCCCHHHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE-VSKKILVYEYMSNGSLADILFNPE-------KQPNWVERMGIARDIARGIL 582 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~ia~gL~ 582 (757)
.+.+.+|+.++++++|+|++++++++.+ ....++++||+++++|.+++.... ..+++.++..++.|++.||+
T Consensus 52 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~ 131 (280)
T cd05043 52 VTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131 (280)
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 4668899999999999999999999876 467899999999999999986432 45789999999999999999
Q ss_pred HhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-ecccccCccccCcccccCCCCCccccchhhHHH
Q 038168 583 YLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVV 661 (757)
Q Consensus 583 yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~ 661 (757)
|||+. +++|+||||+||++++++.+||+|||+++.+....... .....++..|+|||++.+..++.++||||||++
T Consensus 132 ~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~ 208 (280)
T cd05043 132 YLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVL 208 (280)
T ss_pred HHHHC---CEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHH
Confidence 99998 99999999999999999999999999998764433221 222345778999999998899999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 662 LLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 662 l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
++|+++ |+.|+....+ ..+ ......+.. ... .......+.+++.+|++.+|++|||+.+|++.|+.
T Consensus 209 l~el~~~g~~p~~~~~~---~~~----~~~~~~~~~--~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 209 LWELMTLGQTPYVEIDP---FEM----AAYLKDGYR--LAQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred HHHHhcCCCCCcCcCCH---HHH----HHHHHcCCC--CCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 999999 9988864322 111 112222211 011 11234578999999999999999999999999987
Q ss_pred Cc
Q 038168 741 TV 742 (757)
Q Consensus 741 ~~ 742 (757)
+.
T Consensus 276 ~~ 277 (280)
T cd05043 276 FH 277 (280)
T ss_pred HH
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=265.87 Aligned_cols=216 Identities=25% Similarity=0.365 Sum_probs=176.0
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
...++.+|+.++++++|+|++++++++.. ...++|+||+++|+|.+++......+++.....++.|++.||+|||+.
T Consensus 52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-- 128 (279)
T cd05057 52 ANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK-- 128 (279)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 45678899999999999999999999987 788999999999999999987666789999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-ecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+++|+||||+||++++++.+||+|||+++......... .....++..|+|||.+....++.++||||||++++|+++
T Consensus 129 -~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~ 207 (279)
T cd05057 129 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTF 207 (279)
T ss_pred -CEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcC
Confidence 99999999999999999999999999998765433211 112234568999999988899999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
|+.|+.....+ + ..+....+... -. +......+.+++.+||..+|++||++.++++.|+.+.
T Consensus 208 g~~p~~~~~~~------~-~~~~~~~~~~~--~~----~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 208 GAKPYEGIPAV------E-IPDLLEKGERL--PQ----PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred CCCCCCCCCHH------H-HHHHHhCCCCC--CC----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 99988754321 1 12222222111 11 1122356889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=263.79 Aligned_cols=210 Identities=27% Similarity=0.362 Sum_probs=172.8
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
....+.+|++++++++|+|++++++++.++...++|+||+++++|.+++... .+++.++..++.|++.||.|||+.
T Consensus 42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~-- 117 (274)
T cd06609 42 EIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE-- 117 (274)
T ss_pred HHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 3467889999999999999999999999999999999999999999998653 789999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++|+||+|+||++++++.++|+|||+++....... ......++..|+|||++.+..++.++||||||++++||++|+
T Consensus 118 -~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~ 195 (274)
T cd06609 118 -GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195 (274)
T ss_pred -CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999987754322 222346788999999999989999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
.|+....+.. .......+....+.+ ......+.+++.+|++.+|++||+++++++.
T Consensus 196 ~p~~~~~~~~-------~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 196 PPLSDLHPMR-------VLFLIPKNNPPSLEG-----NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CCcccCchHH-------HHHHhhhcCCCCCcc-----cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 9986543211 111112221111111 1144568899999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=264.72 Aligned_cols=212 Identities=22% Similarity=0.324 Sum_probs=169.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+|++++++.+......++||||+++++|..++.+....+++.++..++.|++.+|+|||+.
T Consensus 53 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~--- 129 (292)
T cd06644 53 LEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM--- 129 (292)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---
Confidence 46788999999999999999999999999999999999999999998876667789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc-----CCCCCccccchhhHHHHHHH
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR-----NLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~G~~l~el 665 (757)
+++||||||+||+++.++.+||+|||++........ ......++..|+|||++. ...++.++||||||+++|||
T Consensus 130 ~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el 208 (292)
T cd06644 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208 (292)
T ss_pred CeeecCCCcceEEEcCCCCEEEccCccceecccccc-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHH
Confidence 999999999999999999999999999875433211 122345788999999884 34578899999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++|+.|+...... ..... ........... +.....++.+++.+||+.+|++||++++|++.
T Consensus 209 ~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 209 AQIEPPHHELNPM------RVLLK-IAKSEPPTLSQ----PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred hcCCCCCccccHH------HHHHH-HhcCCCccCCC----CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 9999988643221 11111 11121111111 12334568899999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-30 Score=280.82 Aligned_cols=211 Identities=19% Similarity=0.234 Sum_probs=161.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++.+.+.+..++||||+++|+|.+++.+. ..++......++.||+.||+|||+.
T Consensus 45 ~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~--- 120 (382)
T cd05625 45 VAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKM--- 120 (382)
T ss_pred HHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 356889999999999999999999999999999999999999999998653 4577788888999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc--------------------------------------------
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-------------------------------------------- 626 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-------------------------------------------- 626 (757)
+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 121 ~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (382)
T cd05625 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQH 200 (382)
T ss_pred CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccc
Confidence 999999999999999999999999999864321000
Q ss_pred --ceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccc
Q 038168 627 --RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEE 704 (757)
Q Consensus 627 --~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 704 (757)
.......||+.|+|||++.+..++.++|||||||+++||++|+.||....+.+ .................
T Consensus 201 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~p~~-- 272 (382)
T cd05625 201 QRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLE------TQMKVINWQTSLHIPPQ-- 272 (382)
T ss_pred ccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHH------HHHHHHccCCCcCCCCc--
Confidence 00123468999999999999999999999999999999999999997543211 11111111111111001
Q ss_pred cCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 038168 705 VDEKQLERMIKVALWCILDEPSLRPS---MKKVLL 736 (757)
Q Consensus 705 ~~~~~~~~l~~l~~~cl~~~p~~RPs---m~eVl~ 736 (757)
.....++.+++.+++ .+|++|++ +.|+++
T Consensus 273 --~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 273 --AKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred --ccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 112334555555554 49999997 777765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=271.96 Aligned_cols=162 Identities=25% Similarity=0.331 Sum_probs=134.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe--ceeeeEEEEeccCCChhhhhcCC--------CCCCCHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE--VSKKILVYEYMSNGSLADILFNP--------EKQPNWVERMGIARDIARG 580 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~g 580 (757)
...+.+|+.++++++||||+++++++.. ....++|+||+.+ +|.+++... ...++......++.||+.|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 120 (317)
T cd07868 42 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120 (317)
T ss_pred cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHH
Confidence 3567899999999999999999998864 4467899999865 787776421 1247888899999999999
Q ss_pred HHHhhhCCCCCeeeCCCCcceEEE----CCCCcEEEeecCCccccCCCCc--ceecccccCccccCcccccCC-CCCccc
Q 038168 581 ILYLHDECETQIIHCDIKPQNILM----DENRCAKISDFGLAKLMKPDQT--RTFTGIRGTRGYVAPEWHRNL-PITVKA 653 (757)
Q Consensus 581 L~yLH~~~~~~iiH~Dik~~Nill----~~~~~~ki~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~ 653 (757)
|+|||++ +|+||||||+|||+ +.++.+||+|||+++....... .......+|+.|+|||++.+. .++.++
T Consensus 121 l~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 197 (317)
T cd07868 121 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI 197 (317)
T ss_pred HHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchh
Confidence 9999998 99999999999999 4567899999999987654322 222346789999999998774 589999
Q ss_pred cchhhHHHHHHHHhCCCCCCCCC
Q 038168 654 DVYSFGVVLLEIICRRRCLDPNL 676 (757)
Q Consensus 654 Dv~S~G~~l~elltG~~p~~~~~ 676 (757)
||||+||+++||++|+.||....
T Consensus 198 DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 198 DIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred hHHHHHHHHHHHHhCCCCccCCc
Confidence 99999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=264.15 Aligned_cols=219 Identities=26% Similarity=0.347 Sum_probs=171.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFN---PEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
..+++.+|++++++++|+||+++++++.+. +..++||||+++++|.+++.. ....++......++.|++.||.||
T Consensus 42 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l 121 (287)
T cd06621 42 LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121 (287)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 457799999999999999999999988654 468999999999999988643 345578889999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~e 664 (757)
|+. +++|+||+|+||+++.++.+||+|||++........ ....++..|+|||.+.+..++.++||||||++++|
T Consensus 122 H~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~ 195 (287)
T cd06621 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195 (287)
T ss_pred HHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHH
Confidence 998 999999999999999999999999999876543221 12456889999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 665 IICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|++|+.|+......... ..+. ...........+.+.........+.+.+++.+||+.+|++|||+.||++
T Consensus 196 l~~g~~p~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 196 VAQNRFPFPPEGEPPLG-PIEL-LSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHhCCCCCCcccCCCCC-hHHH-HHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 99999998765331111 1111 1111221222222111111234567899999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=258.83 Aligned_cols=218 Identities=24% Similarity=0.343 Sum_probs=170.4
Q ss_pred HHHHHHHHHHhhcCCCc-eeeeeeEEEece------eeeEEEEeccCCChhhhhcCCC---CCCCHHHHHHHHHHHHHHH
Q 038168 512 REFQTEMKVIGRTHHRN-LVRLLGYSLEVS------KKILVYEYMSNGSLADILFNPE---KQPNWVERMGIARDIARGI 581 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~------~~~lV~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL 581 (757)
....+|+.+|++|+|+| ||+|++++...+ ..++|+||++. +|..++.... ..++-..+..++.||++||
T Consensus 55 ~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl 133 (323)
T KOG0594|consen 55 STAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGL 133 (323)
T ss_pred chhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHH
Confidence 45679999999999999 999999998877 78899999966 8999987654 3566688899999999999
Q ss_pred HHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHH
Q 038168 582 LYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGV 660 (757)
Q Consensus 582 ~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~ 660 (757)
+|||++ +|+||||||+||||++++.+||+|||+|+.+.-.. ...+..++|..|.|||++.+. .|+...||||+||
T Consensus 134 ~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~Gc 209 (323)
T KOG0594|consen 134 AFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGC 209 (323)
T ss_pred HHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHH
Confidence 999999 99999999999999999999999999999765332 234556789999999999887 7999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccccHHHHHHHHHhc---CCccccc---c----------ccccCHHH---HHHHHHHHHHcc
Q 038168 661 VLLEIICRRRCLDPNLPDDQVILEEWVYQCFEN---GNLSQLV---E----------DEEVDEKQ---LERMIKVALWCI 721 (757)
Q Consensus 661 ~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~---d----------~~~~~~~~---~~~l~~l~~~cl 721 (757)
++.||++++..|.+..+.++... +.+.+.. ...+... + +....... .....+++.+|+
T Consensus 210 IfaEm~~~~~LFpG~se~~ql~~---If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L 286 (323)
T KOG0594|consen 210 IFAEMFTRRPLFPGDSEIDQLFR---IFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLL 286 (323)
T ss_pred HHHHHHhCCCCCCCCcHHHHHHH---HHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHh
Confidence 99999998887776554332211 1111111 0111100 0 11111111 147889999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 038168 722 LDEPSLRPSMKKVLLM 737 (757)
Q Consensus 722 ~~~p~~RPsm~eVl~~ 737 (757)
+.+|++|.|++.++.+
T Consensus 287 ~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 287 QYDPAKRISAKGALTH 302 (323)
T ss_pred ccCcccCcCHHHHhcC
Confidence 9999999999999986
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=271.08 Aligned_cols=215 Identities=20% Similarity=0.179 Sum_probs=166.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++.+++|+||+++++++.+.+..++||||+++|+|.+++.+....++..++..++.||+.||+|||++
T Consensus 45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--- 121 (331)
T cd05597 45 TACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL--- 121 (331)
T ss_pred HHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 35688999999999999999999999999999999999999999999976566788899999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-----CCCCccccchhhHHHHHHH
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-----LPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|||++.++.+||+|||++..+............||+.|+|||++.. ..++.++|||||||+++||
T Consensus 122 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el 201 (331)
T cd05597 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEM 201 (331)
T ss_pred CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHH
Confidence 99999999999999999999999999997665433333333568999999999863 4578899999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccc--cCCCCCCCHHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCIL--DEPSLRPSMKKVLLM 737 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~--~~p~~RPsm~eVl~~ 737 (757)
++|+.||..... .+.............+.. ........+.+++.+|+. .++..||++.++++.
T Consensus 202 ~~g~~Pf~~~~~------~~~~~~i~~~~~~~~~~~---~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 202 LYGETPFYAESL------VETYGKIMNHKEHFQFPP---DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred hhCCCCCCCCCH------HHHHHHHHcCCCcccCCC---ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999864322 111112211111111100 011133456666666654 444458899998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=270.52 Aligned_cols=210 Identities=26% Similarity=0.354 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|+++|+++. |||||.+.+.++.....++|||++.+|.|.+.+.+. .++......++.|++.+++|||+.
T Consensus 79 ~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~-- 154 (382)
T KOG0032|consen 79 REDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSL-- 154 (382)
T ss_pred HHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 368899999999998 999999999999999999999999999999999765 388889999999999999999998
Q ss_pred CCeeeCCCCcceEEECCC----CcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDEN----RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~----~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|+|+... +.+|++|||++..... .......+||+.|+|||++.+..++..+||||+|+++|.|
T Consensus 155 -gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiL 231 (382)
T KOG0032|consen 155 -GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYIL 231 (382)
T ss_pred -CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHH
Confidence 99999999999999643 4799999999998877 4456678999999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++|.+||......... .....+++. ++. ..-....+.+.+++..|+..||.+|+|+.++++.
T Consensus 232 L~G~~PF~~~~~~~~~-------~~i~~~~~~--f~~-~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 232 LSGVPPFWGETEFEIF-------LAILRGDFD--FTS-EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred hhCCCCCcCCChhHHH-------HHHHcCCCC--CCC-CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 9999999876543321 133444442 111 2223446778889999999999999999999995
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=271.69 Aligned_cols=162 Identities=25% Similarity=0.336 Sum_probs=134.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe--ceeeeEEEEeccCCChhhhhcCC--------CCCCCHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE--VSKKILVYEYMSNGSLADILFNP--------EKQPNWVERMGIARDIARG 580 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~g 580 (757)
...+.+|++++++++|+||+++++++.. ....++|+||+++ +|.+++... ...+++..+..++.|++.|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 120 (317)
T cd07867 42 SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120 (317)
T ss_pred cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHH
Confidence 3568899999999999999999998854 4577899999875 677766321 2347888999999999999
Q ss_pred HHHhhhCCCCCeeeCCCCcceEEE----CCCCcEEEeecCCccccCCCCc--ceecccccCccccCcccccCC-CCCccc
Q 038168 581 ILYLHDECETQIIHCDIKPQNILM----DENRCAKISDFGLAKLMKPDQT--RTFTGIRGTRGYVAPEWHRNL-PITVKA 653 (757)
Q Consensus 581 L~yLH~~~~~~iiH~Dik~~Nill----~~~~~~ki~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~ 653 (757)
|+|||+. +|+||||||+|||+ +.++.+||+|||+++....... .......+|..|+|||.+.+. .++.++
T Consensus 121 L~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 197 (317)
T cd07867 121 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI 197 (317)
T ss_pred HHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHH
Confidence 9999998 99999999999999 5667999999999987654322 122345689999999998764 589999
Q ss_pred cchhhHHHHHHHHhCCCCCCCCC
Q 038168 654 DVYSFGVVLLEIICRRRCLDPNL 676 (757)
Q Consensus 654 Dv~S~G~~l~elltG~~p~~~~~ 676 (757)
||||||++++||++|+.||....
T Consensus 198 DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 198 DIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred HHHhHHHHHHHHHhCCCCccccc
Confidence 99999999999999999987543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=265.59 Aligned_cols=212 Identities=23% Similarity=0.329 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEec-----eeeeEEEEeccCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEV-----SKKILVYEYMSNGSLADILFN---PEKQPNWVERMGIARDIARGI 581 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL 581 (757)
..++.+|+.++.++ +|+|++++++++.+. +..++|+||+++++|.+++.. ....+++..+..++.|++.||
T Consensus 62 ~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 141 (291)
T cd06639 62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141 (291)
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Confidence 36778899999999 899999999998754 358999999999999998853 345689999999999999999
Q ss_pred HHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-----CCCccccch
Q 038168 582 LYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-----PITVKADVY 656 (757)
Q Consensus 582 ~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~Dv~ 656 (757)
+|||+. +++|+||||+||++++++.+||+|||+++........ .....++..|+|||.+... .++.++|||
T Consensus 142 ~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~ 217 (291)
T cd06639 142 QHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVW 217 (291)
T ss_pred HHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchH
Confidence 999998 9999999999999999999999999999865432221 1224578899999987643 368999999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 657 SFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 657 S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|||++++||++|+.|+........ +.. ...+....+.++ .+....+.+++.+|++.+|++||++.|+++
T Consensus 218 slGvi~~el~~g~~p~~~~~~~~~------~~~-~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 218 SLGITAIELGDGDPPLFDMHPVKT------LFK-IPRNPPPTLLHP----EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHHHHHhhCCCCCCCCcHHHH------HHH-HhcCCCCCCCcc----cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 999999999999999864322111 111 122222222222 223456899999999999999999999986
Q ss_pred H
Q 038168 737 M 737 (757)
Q Consensus 737 ~ 737 (757)
.
T Consensus 287 ~ 287 (291)
T cd06639 287 H 287 (291)
T ss_pred C
Confidence 3
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=294.66 Aligned_cols=216 Identities=21% Similarity=0.301 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC----------CCCCCHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP----------EKQPNWVERMGIARDIARG 580 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~ia~g 580 (757)
.+.|.+|++++++++||||+++++++.+.+..++||||+++|+|.+++... ....++..+++++.||++|
T Consensus 46 ~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~A 125 (932)
T PRK13184 46 KKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125 (932)
T ss_pred HHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHH
Confidence 467999999999999999999999999999999999999999999988531 1335677889999999999
Q ss_pred HHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-----------------ceecccccCccccCccc
Q 038168 581 ILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-----------------RTFTGIRGTRGYVAPEW 643 (757)
Q Consensus 581 L~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-----------------~~~~~~~gt~~y~aPE~ 643 (757)
|+|||+. +|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||.
T Consensus 126 L~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~ 202 (932)
T PRK13184 126 IEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPER 202 (932)
T ss_pred HHHHHHC---CccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHH
Confidence 9999998 999999999999999999999999999987622110 01112568999999999
Q ss_pred ccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccc--cCHHHHHHHHHHHHHcc
Q 038168 644 HRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEE--VDEKQLERMIKVALWCI 721 (757)
Q Consensus 644 ~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~--~~~~~~~~l~~l~~~cl 721 (757)
+.+..++.++|||||||+++||++|+.||........ . .. ... .++.. ...+.+..+.+++.+|+
T Consensus 203 l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki-~-----~~----~~i---~~P~~~~p~~~iP~~L~~LI~rcL 269 (932)
T PRK13184 203 LLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI-S-----YR----DVI---LSPIEVAPYREIPPFLSQIAMKAL 269 (932)
T ss_pred hcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh-h-----hh----hhc---cChhhccccccCCHHHHHHHHHHc
Confidence 9999999999999999999999999999875322111 0 00 000 11110 01233456889999999
Q ss_pred ccCCCCCC-CHHHHHHHhhcCc
Q 038168 722 LDEPSLRP-SMKKVLLMLEGTV 742 (757)
Q Consensus 722 ~~~p~~RP-sm~eVl~~Le~~~ 742 (757)
+.||++|| +++++++.|+...
T Consensus 270 ~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 270 AVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred cCChhhCcCHHHHHHHHHHHHH
Confidence 99999996 7788888887643
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=265.49 Aligned_cols=211 Identities=27% Similarity=0.307 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|+.++++++|+|++++++.+.+.+..++||||+++++|.+++.... ..++..++..++.|++.||.|||+.
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-- 121 (285)
T cd05630 44 ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE-- 121 (285)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 4567889999999999999999999999999999999999999999885433 4588999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+||++++++.++|+|||++........ .....|+..|+|||.+.+..++.++||||||++++||++|+
T Consensus 122 -~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 198 (285)
T cd05630 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198 (285)
T ss_pred -CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCC
Confidence 999999999999999999999999999976543322 22346899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS-----MKKVLL 736 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----m~eVl~ 736 (757)
.||......... +.......... ..........+.+++..||+.||++||| ++|+++
T Consensus 199 ~Pf~~~~~~~~~---~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 199 SPFQQRKKKIKR---EEVERLVKEVQ-------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CCCCCCCccchH---HHHHhhhhhhh-------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 999754322110 11111111100 0111223456889999999999999999 788887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=265.18 Aligned_cols=213 Identities=21% Similarity=0.296 Sum_probs=165.9
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEE-----eceeeeEEEEeccCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSL-----EVSKKILVYEYMSNGSLADILFN---PEKQPNWVERMGIARDIARGI 581 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL 581 (757)
..++.+|+.+++++ +|+|++++++++. .++..++||||+++++|.+++.. ....+++..+..++.|+++||
T Consensus 58 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l 137 (286)
T cd06638 58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137 (286)
T ss_pred HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHH
Confidence 35788999999999 6999999999884 34568999999999999998753 235678889999999999999
Q ss_pred HHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-----CCCCccccch
Q 038168 582 LYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-----LPITVKADVY 656 (757)
Q Consensus 582 ~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~ 656 (757)
.|||+. +++||||||+||++++++.+||+|||+++....... ......|+..|+|||++.. ..++.++|||
T Consensus 138 ~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~ 213 (286)
T cd06638 138 QHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVW 213 (286)
T ss_pred HHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhh
Confidence 999998 999999999999999999999999999987643322 1223468999999998753 4578999999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 657 SFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 657 S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|||++++||++|+.|+........ ... ..........++. .....+.+++.+|++.+|++|||+.||++
T Consensus 214 slGvi~~el~~g~~p~~~~~~~~~------~~~-~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 214 SLGITAIELGDGDPPLADLHPMRA------LFK-IPRNPPPTLHQPE----LWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred hHHHHHHHHhcCCCCCCCCchhHH------Hhh-ccccCCCcccCCC----CcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 999999999999999865422111 011 1111111111111 12356889999999999999999999987
Q ss_pred Hh
Q 038168 737 ML 738 (757)
Q Consensus 737 ~L 738 (757)
.+
T Consensus 283 ~~ 284 (286)
T cd06638 283 HV 284 (286)
T ss_pred cc
Confidence 53
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=262.95 Aligned_cols=212 Identities=22% Similarity=0.316 Sum_probs=167.5
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
..+.+|+.+++.++|+||+++++.+...+..++|+||+++++|.+++.. ...++..+...++.|++.||+|||+. +
T Consensus 51 ~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~ 126 (267)
T cd06645 51 AVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSK---G 126 (267)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 4678899999999999999999999999999999999999999998854 34688999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc---CCCCCccccchhhHHHHHHHHhC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR---NLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~G~~l~elltG 668 (757)
++|+||||+||+++.++.+||+|||++....... .......|+..|+|||++. ...++.++|||||||+++||++|
T Consensus 127 i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~ 205 (267)
T cd06645 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAEL 205 (267)
T ss_pred eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcC
Confidence 9999999999999999999999999997654322 1223356889999999874 45688999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+.|+....+... ... ............ ........+.+++.+|++.+|++||++++|++.
T Consensus 206 ~~p~~~~~~~~~------~~~-~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 206 QPPMFDLHPMRA------LFL-MTKSNFQPPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCcccccchhh------HHh-hhccCCCCCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 998864332111 111 111111100000 001223568899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=263.76 Aligned_cols=212 Identities=23% Similarity=0.339 Sum_probs=171.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.|.+|++++++++|+|++++++.+.+....++||||+++++|.+++.+....+++.+...++.|++.||+|||+.
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~--- 122 (280)
T cd06611 46 LEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH--- 122 (280)
T ss_pred HHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 45788999999999999999999999999999999999999999999977667789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc-----CCCCCccccchhhHHHHHHH
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR-----NLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~G~~l~el 665 (757)
+|+|+||||+||+++.++.+||+|||++........ ......++..|+|||.+. ...++.++||||||+++|||
T Consensus 123 ~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l 201 (280)
T cd06611 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201 (280)
T ss_pred CcccCCCChhhEEECCCCCEEEccCccchhhccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHH
Confidence 999999999999999999999999999876543221 222346788999999875 34578899999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++|+.|+....... .. .....+....+.. +......+.+++..||+.+|++||++.+|++.
T Consensus 202 ~~g~~p~~~~~~~~------~~-~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 202 AQMEPPHHELNPMR------VL-LKILKSEPPTLDQ----PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HhCCCCcccCCHHH------HH-HHHhcCCCCCcCC----cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 99999986532211 11 1112222111111 12234567889999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=271.45 Aligned_cols=215 Identities=25% Similarity=0.381 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
..++.+|+.++++++|+||+++++++... ..++|+||+++|+|.+++......+++..+..++.|++.||+|||+.
T Consensus 53 ~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--- 128 (303)
T cd05110 53 NVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--- 128 (303)
T ss_pred HHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---
Confidence 35688999999999999999999998754 46799999999999999977666789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-C
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-R 668 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G 668 (757)
+|+|+||||+||++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |
T Consensus 129 ~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g 208 (303)
T cd05110 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG 208 (303)
T ss_pred CeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999999876543321 1222345778999999999999999999999999999997 8
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
+.|+...... . .......+.... .+ ......+.+++..|+..+|++||+|.++++.|+.+.
T Consensus 209 ~~p~~~~~~~---~----~~~~~~~~~~~~--~~----~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 209 GKPYDGIPTR---E----IPDLLEKGERLP--QP----PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CCCCCCCCHH---H----HHHHHHCCCCCC--CC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 8887643211 1 112222221111 11 122356889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=262.21 Aligned_cols=208 Identities=26% Similarity=0.395 Sum_probs=170.1
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|+.++++++|+||+++++++.+.+..++|+||+++++|.+++... ..+++..+..++.|++.||+|||+. +
T Consensus 51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~---~ 126 (267)
T cd06628 51 DALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNR---G 126 (267)
T ss_pred HHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhc---C
Confidence 56889999999999999999999999999999999999999999999653 5578888999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-----ceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-----RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
++|+||||+||++++++.+||+|||+++....... .......|+..|+|||.+.+..++.++||||||++++||+
T Consensus 127 ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~ 206 (267)
T cd06628 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206 (267)
T ss_pred cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHh
Confidence 99999999999999999999999999987753221 1112345788999999999989999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+|+.||....... .+... ...... ..+......+.+++.+||+.+|++||++.||++
T Consensus 207 ~g~~p~~~~~~~~------~~~~~-~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 207 TGKHPFPDCTQLQ------AIFKI-GENASP------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred hCCCCCCCccHHH------HHHHH-hccCCC------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 9999987532211 01111 111111 112234567889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=286.64 Aligned_cols=223 Identities=17% Similarity=0.280 Sum_probs=164.8
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC----CCCCHHHHHHHHHHHHHHHHHhh
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE----KQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
....+.+|+.+|++++|+|||++++++...+..++|+|++. ++|.+++.... ......+...|+.||+.||+|||
T Consensus 206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999999999999999999985 56777664322 22345567789999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
++ +|+||||||+|||++.++.+||+|||+++.+............||..|+|||.+.+..++.++|||||||+++||
T Consensus 285 ~~---gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 361 (501)
T PHA03210 285 DK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361 (501)
T ss_pred hC---CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHH
Confidence 98 999999999999999999999999999987765444344456799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCC-CccccHHHHHHHHHh--cCCccc-------cccc------c-cc-----CHHHHHHHHHHHHHcccc
Q 038168 666 ICRRRCLDPNLP-DDQVILEEWVYQCFE--NGNLSQ-------LVED------E-EV-----DEKQLERMIKVALWCILD 723 (757)
Q Consensus 666 ltG~~p~~~~~~-~~~~~l~~~~~~~~~--~~~~~~-------~~d~------~-~~-----~~~~~~~l~~l~~~cl~~ 723 (757)
++|..++..... .....+.+.+. .+. ...+.+ .++. . .. .......+.+++.+||+.
T Consensus 362 l~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~ 440 (501)
T PHA03210 362 LSHDFCPIGDGGGKPGKQLLKIID-SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTF 440 (501)
T ss_pred HHCCCCCccCCCCCHHHHHHHHHH-hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhcc
Confidence 999864432221 11111111100 000 000000 0000 0 00 001123467778899999
Q ss_pred CCCCCCCHHHHHHH
Q 038168 724 EPSLRPSMKKVLLM 737 (757)
Q Consensus 724 ~p~~RPsm~eVl~~ 737 (757)
||++|||+.|++++
T Consensus 441 DP~~Rpsa~elL~h 454 (501)
T PHA03210 441 DWHLRPGAAELLAL 454 (501)
T ss_pred CcccCcCHHHHhhC
Confidence 99999999999874
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=270.80 Aligned_cols=218 Identities=20% Similarity=0.269 Sum_probs=167.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
...+.+|+.++++++|+||+++++++...+..++|+||++ ++|.+++......+++.....++.|+++||+|||+.
T Consensus 48 ~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--- 123 (301)
T cd07873 48 PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR--- 123 (301)
T ss_pred hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 3567889999999999999999999999999999999997 589998877666788999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+|+||||+||++++++.+||+|||++........ ......++..|+|||.+.+. .++.++||||||++++||++|+
T Consensus 124 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~ 202 (301)
T cd07873 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202 (301)
T ss_pred CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999976543221 12234568899999988654 5789999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHH------------hcCCcccccccc-------ccCHHHHHHHHHHHHHccccCCCCCCC
Q 038168 670 RCLDPNLPDDQVILEEWVYQCF------------ENGNLSQLVEDE-------EVDEKQLERMIKVALWCILDEPSLRPS 730 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~------------~~~~~~~~~d~~-------~~~~~~~~~l~~l~~~cl~~~p~~RPs 730 (757)
.||......+.. ..+...+ ..........+. .........+.+++.+|++.||.+|||
T Consensus 203 ~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t 279 (301)
T cd07873 203 PLFPGSTVEEQL---HFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS 279 (301)
T ss_pred CCCCCCCHHHHH---HHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC
Confidence 998754332111 0000100 000000000000 001122456789999999999999999
Q ss_pred HHHHHH
Q 038168 731 MKKVLL 736 (757)
Q Consensus 731 m~eVl~ 736 (757)
++||++
T Consensus 280 ~~eil~ 285 (301)
T cd07873 280 AEEAMK 285 (301)
T ss_pred HHHHhc
Confidence 999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=264.38 Aligned_cols=212 Identities=24% Similarity=0.257 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|++++++++|+|++++.+.+..++..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-- 121 (285)
T cd05632 44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE-- 121 (285)
T ss_pred HHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 3557889999999999999999999999999999999999999998886533 4689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+||++++++.+||+|||++....... ......|+..|+|||.+.+..++.++||||||++++||++|+
T Consensus 122 -~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 198 (285)
T cd05632 122 -NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198 (285)
T ss_pred -CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCC
Confidence 99999999999999999999999999997654322 123456899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS-----MKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----m~eVl~~ 737 (757)
.||........ . +.+......... .........+.+++..|++.+|++||+ +.+++..
T Consensus 199 ~P~~~~~~~~~--~-~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 199 SPFRGRKEKVK--R-EEVDRRVLETEE-------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CCCCCCCHHHH--H-HHHHHhhhcccc-------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 99875432111 1 111111111111 112233456788999999999999999 6676663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=259.39 Aligned_cols=213 Identities=31% Similarity=0.466 Sum_probs=174.2
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQ-PNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+.+.+|+.++.+++|+||+++++++.+.+..++||||+++++|.+++...... +++.++..++.|++.||+|||+.
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~- 122 (258)
T smart00219 44 QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK- 122 (258)
T ss_pred HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC-
Confidence 4568899999999999999999999999999999999999999999999765444 89999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+++|+||||+||++++++.+||+|||+++..............++..|+|||.+.+..++.++||||+|++++||++
T Consensus 123 --~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~ 200 (258)
T smart00219 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200 (258)
T ss_pred --CeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999998776543322222346789999999988889999999999999999998
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~L 738 (757)
|+.|+..... .. ..+....+..... ......++.+++.+|+..+|++|||+.|++++|
T Consensus 201 g~~p~~~~~~------~~-~~~~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 201 GESPYPGMSN------EE-VLEYLKKGYRLPK------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCCCCH------HH-HHHHHhcCCCCCC------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 6777654211 11 1122222222111 112456788999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=271.17 Aligned_cols=202 Identities=25% Similarity=0.334 Sum_probs=163.2
Q ss_pred HHHHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+..|+.+++.+. |++|+++++++.+.+..++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+.
T Consensus 44 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~-- 120 (323)
T cd05615 44 VECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRR-- 120 (323)
T ss_pred HHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 456788999998885 57788899999999999999999999999999854 34688999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++....... ......||..|+|||++.+..++.++||||||++++||++|+
T Consensus 121 -~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~ 198 (323)
T cd05615 121 -GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198 (323)
T ss_pred -CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCC
Confidence 999999999999999999999999999985433221 223356899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
.||...... . ..+........ .+.....++.+++.+|++.+|++|++.
T Consensus 199 ~pf~~~~~~------~-~~~~i~~~~~~-------~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 199 PPFDGEDED------E-LFQSIMEHNVS-------YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCCCCHH------H-HHHHHHhCCCC-------CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 998754321 1 11112222211 112234567889999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=261.59 Aligned_cols=215 Identities=26% Similarity=0.390 Sum_probs=174.1
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-CC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD-EC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~ 588 (757)
..+++.+|++++++++|+||+++++.+...+..++|+||+++++|.+++......++......++.|++.||+|||+ .
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~- 120 (265)
T cd06605 42 IQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH- 120 (265)
T ss_pred HHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC-
Confidence 45678999999999999999999999999999999999999999999997655778889999999999999999999 7
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
+++|+||||+||++++++.+||+|||.+......... ...++..|+|||.+.+..++.++||||||+++++|++|
T Consensus 121 --~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 195 (265)
T cd06605 121 --KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG 195 (265)
T ss_pred --CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998765432221 15678899999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+.|+........ ...+.+... ..+..... ........+.+++.+|++.+|++|||+.+++..
T Consensus 196 ~~p~~~~~~~~~-~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 196 RFPYPPENDPPD-GIFELLQYI-VNEPPPRL-----PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCCCccccccc-cHHHHHHHH-hcCCCCCC-----ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 999865432111 111222221 11111111 111145678899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=266.01 Aligned_cols=218 Identities=24% Similarity=0.350 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+|++++++++...+..++||||+++++|.+++.+ ..+++.++..++.|++.||.|||+.
T Consensus 60 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~--- 134 (297)
T cd06656 60 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSN--- 134 (297)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46788999999999999999999999999999999999999999999853 4578889999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+++|+||||+|||++.++.+||+|||++......... .....++..|+|||...+..++.++||||||+++++|++|+.
T Consensus 135 ~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~ 213 (297)
T cd06656 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213 (297)
T ss_pred CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999999865443221 123457889999999999899999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcCcCCC
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL--MLEGTVEIP 745 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~--~Le~~~~~~ 745 (757)
||....+..... .....+ ..... .+......+.+++.+|++.+|++||++.+|++ .++...+.+
T Consensus 214 pf~~~~~~~~~~------~~~~~~-~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 279 (297)
T cd06656 214 PYLNENPLRALY------LIATNG-TPELQ----NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS 279 (297)
T ss_pred CCCCCCcchhee------eeccCC-CCCCC----CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence 996543322110 001111 11111 12233456788999999999999999999998 444444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=261.70 Aligned_cols=215 Identities=25% Similarity=0.375 Sum_probs=172.8
Q ss_pred hHHHHHHHHHHHhh-cCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 510 GEREFQTEMKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN---PEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 510 ~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
..+++.+|+.++.+ ++|+||+++++++.+.+..++||||+++++|.+++.. ....+++..+.+++.|++.||.|||
T Consensus 51 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 130 (269)
T cd08528 51 SIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH 130 (269)
T ss_pred HHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc
Confidence 34567789998875 7999999999999999999999999999999988743 3456888999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+. .+++|+||||+||+++.++.+||+|||++....... ......++..|+|||...+..++.++||||||++++||
T Consensus 131 ~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l 206 (269)
T cd08528 131 KE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206 (269)
T ss_pred cC--CceeecCCCHHHEEECCCCcEEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHH
Confidence 63 289999999999999999999999999998765443 23345688999999999998899999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
++|+.|+...... .. ......+...... .......+.+++.+|++.||++||++.||..+|+.
T Consensus 207 ~~g~~p~~~~~~~------~~-~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 207 CTLQPPFYSTNML------SL-ATKIVEAVYEPLP-----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HhCCCcccccCHH------HH-HHHHhhccCCcCC-----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 9999998643211 11 1111222221111 11234678899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=263.08 Aligned_cols=208 Identities=22% Similarity=0.367 Sum_probs=166.7
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
...|.+|+.+|.+| .|.+||+|++|-..++..||||||= ..+|..+|.+....+....+..+..||+.++.++|.+
T Consensus 403 l~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~-- 479 (677)
T KOG0596|consen 403 LDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH-- 479 (677)
T ss_pred HHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh--
Confidence 46799999999999 5999999999999999999999985 4599999987665554236778999999999999999
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceec-ccccCccccCcccccCC-----------CCCccccchh
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT-GIRGTRGYVAPEWHRNL-----------PITVKADVYS 657 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~-----------~~~~k~Dv~S 657 (757)
+|||.||||.|+|+-. |.+||+|||.|..+..+...... ..+||+.||+||.+... +++.++||||
T Consensus 480 -gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWS 557 (677)
T KOG0596|consen 480 -GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWS 557 (677)
T ss_pred -ceeecCCCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhh
Confidence 9999999999999964 68999999999988877654433 47899999999988543 3678999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccc---cC-HHHHHHHHHHHHHccccCCCCCCCHHH
Q 038168 658 FGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEE---VD-EKQLERMIKVALWCILDEPSLRPSMKK 733 (757)
Q Consensus 658 ~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~---~~-~~~~~~l~~l~~~cl~~~p~~RPsm~e 733 (757)
+|||||+|+.|+.||..... . + .++..+.||.. ++ .....+++++++.||+.||++||++.|
T Consensus 558 LGCILYqMvYgktPf~~~~n-------~--~-----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~e 623 (677)
T KOG0596|consen 558 LGCILYQMVYGKTPFGQIIN-------Q--I-----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPE 623 (677)
T ss_pred hhhHHHHHHhcCCchHHHHH-------H--H-----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHH
Confidence 99999999999999874211 1 1 12233444421 11 111123999999999999999999999
Q ss_pred HHHH
Q 038168 734 VLLM 737 (757)
Q Consensus 734 Vl~~ 737 (757)
+++.
T Consensus 624 LLqh 627 (677)
T KOG0596|consen 624 LLQH 627 (677)
T ss_pred HhcC
Confidence 9875
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=258.53 Aligned_cols=210 Identities=23% Similarity=0.329 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+++.+|+.++++++|+||+++++++.+.+..++|+||+++++|.+++.... ..+++.+++.++.|++.||.|||+.
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-- 120 (256)
T cd08218 43 REESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR-- 120 (256)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 4678999999999999999999999999999999999999999999986543 4578999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++|+||+|+||+++.++.++|+|||++......... .....|+..|+|||+..+...+.++||||||++++||++|+
T Consensus 121 -~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~ 198 (256)
T cd08218 121 -KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198 (256)
T ss_pred -CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCC
Confidence 9999999999999999999999999999876443221 12245788999999999989999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
.|+..... .+.+... ..+.... .+......+.+++.+|++.+|++||+|.+|++.
T Consensus 199 ~~~~~~~~------~~~~~~~-~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 199 HAFEAGNM------KNLVLKI-IRGSYPP------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCccCCCH------HHHHHHH-hcCCCCC------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 98864321 1222222 2222211 122345678999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=266.94 Aligned_cols=210 Identities=23% Similarity=0.368 Sum_probs=169.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+||+++++.+...+..++||||+++++|.+++.. ..+++.++..++.|++.||+|||+.
T Consensus 63 ~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~--- 137 (292)
T cd06658 63 RELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQ--- 137 (292)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 45788999999999999999999999999999999999999999998843 4578999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+||++++++.+||+|||++........ ......++..|+|||...+..++.++||||||++++||++|+.
T Consensus 138 ~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~ 216 (292)
T cd06658 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216 (292)
T ss_pred CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999976543322 1223467899999999988899999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|+........ . ............+ .......+..++.+|++.+|++|||++|+++.
T Consensus 217 p~~~~~~~~~------~-~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 217 PYFNEPPLQA------M-RRIRDNLPPRVKD----SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCCCCCHHHH------H-HHHHhcCCCcccc----ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 9864322110 1 1111111111111 11234567888999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=265.78 Aligned_cols=216 Identities=25% Similarity=0.318 Sum_probs=162.6
Q ss_pred HHHHHHHHHHhhc---CCCceeeeeeEEEe-----ceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHH
Q 038168 512 REFQTEMKVIGRT---HHRNLVRLLGYSLE-----VSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGIL 582 (757)
Q Consensus 512 ~~~~~E~~~l~~l---~h~niv~l~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~ 582 (757)
..+.+|+.+++++ +|+||+++++++.. ....++||||+++ +|.+++.... ..+++.++..++.|++.||.
T Consensus 44 ~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~ 122 (288)
T cd07863 44 LSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122 (288)
T ss_pred hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 3556777777666 69999999998864 3457899999985 8888886543 45899999999999999999
Q ss_pred HhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHH
Q 038168 583 YLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662 (757)
Q Consensus 583 yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l 662 (757)
|||+. +|+||||||+|||++.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||+||++
T Consensus 123 ~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l 197 (288)
T cd07863 123 FLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 197 (288)
T ss_pred HHHhC---CeecCCCCHHHEEECCCCCEEECccCccccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHH
Confidence 99998 999999999999999999999999999987653321 2335678999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHHHHHhc---CCccc-------ccccc------ccCHHHHHHHHHHHHHccccCCC
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVYQCFEN---GNLSQ-------LVEDE------EVDEKQLERMIKVALWCILDEPS 726 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~-------~~d~~------~~~~~~~~~l~~l~~~cl~~~p~ 726 (757)
+||++|++||......+. +.. ....... ..... ...+. ....+..+.+.+++.+|++.||+
T Consensus 198 ~~l~~g~~~f~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 274 (288)
T cd07863 198 AEMFRRKPLFCGNSEADQ--LGK-IFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPH 274 (288)
T ss_pred HHHHhCCcCcCCCCHHHH--HHH-HHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcc
Confidence 999999999865432211 111 1111000 00000 00000 01123346688999999999999
Q ss_pred CCCCHHHHHH
Q 038168 727 LRPSMKKVLL 736 (757)
Q Consensus 727 ~RPsm~eVl~ 736 (757)
+|||+.|++.
T Consensus 275 ~R~t~~~~l~ 284 (288)
T cd07863 275 KRISAFRALQ 284 (288)
T ss_pred cCCCHHHHhc
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=264.56 Aligned_cols=215 Identities=19% Similarity=0.211 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+||+++++.+..++..++||||+++++|.+++... ..+++..+..++.|++.||+|||+.
T Consensus 45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--- 120 (305)
T cd05609 45 IQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNY--- 120 (305)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 457889999999999999999999999999999999999999999999654 4578889999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCC--------------cceecccccCccccCcccccCCCCCccccch
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ--------------TRTFTGIRGTRGYVAPEWHRNLPITVKADVY 656 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~ 656 (757)
+++|+||||+||+++.++.+||+|||+++...... ........++..|+|||.+.+..++.++|||
T Consensus 121 ~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 200 (305)
T cd05609 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWW 200 (305)
T ss_pred CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHH
Confidence 99999999999999999999999999987421110 0111224578899999999988999999999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 657 SFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 657 S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|||++++||++|+.|+.....+ + +......+........ ......+.+++.+|++.+|++||++.++.+
T Consensus 201 slG~vl~el~~g~~pf~~~~~~------~-~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ 269 (305)
T cd05609 201 AMGIILYEFLVGCVPFFGDTPE------E-LFGQVISDDIEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFE 269 (305)
T ss_pred HHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhcccCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHH
Confidence 9999999999999998643221 1 1122222221111111 123456889999999999999999877777
Q ss_pred Hhhc
Q 038168 737 MLEG 740 (757)
Q Consensus 737 ~Le~ 740 (757)
.|+.
T Consensus 270 ll~~ 273 (305)
T cd05609 270 VKQH 273 (305)
T ss_pred HHhC
Confidence 7765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=263.42 Aligned_cols=208 Identities=25% Similarity=0.375 Sum_probs=171.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|+++||.|||+.
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--- 120 (277)
T cd06642 46 IEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSE--- 120 (277)
T ss_pred HHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---
Confidence 35788999999999999999999999999999999999999999998853 4678899999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+++|+||+|+||++++++.+||+|||++........ ......++..|+|||++.+..++.++||||||++++||++|+.
T Consensus 121 ~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~ 199 (277)
T cd06642 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEP 199 (277)
T ss_pred CeeccCCChheEEEeCCCCEEEccccccccccCcch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999987654321 1122457889999999999899999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|+....+... ......+... .........+.+++.+|++.+|++||+|.+|+++
T Consensus 200 p~~~~~~~~~-------~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 200 PNSDLHPMRV-------LFLIPKNSPP------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccchhhH-------HhhhhcCCCC------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 8764332211 1111111111 1122345678899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=264.70 Aligned_cols=210 Identities=21% Similarity=0.343 Sum_probs=171.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+|++++++++..++..++|+||+++++|.+++.. ..+++.++..++.|++.||+|||+.
T Consensus 62 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~--- 136 (297)
T cd06659 62 RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQ--- 136 (297)
T ss_pred HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 46788999999999999999999999999999999999999999998743 4678999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+++|+||||+||+++.++.+||+|||++........ ......++..|+|||++.+..++.++||||||++++||++|+.
T Consensus 137 ~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~ 215 (297)
T cd06659 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215 (297)
T ss_pred CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999976544322 1223568899999999998899999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|+........ . ..+.......... .......+.+++.+|++.+|++||+++++++.
T Consensus 216 p~~~~~~~~~------~-~~~~~~~~~~~~~----~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 216 PYFSDSPVQA------M-KRLRDSPPPKLKN----AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCCCHHHH------H-HHHhccCCCCccc----cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 9874332111 1 1111111111111 11234568899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=270.85 Aligned_cols=219 Identities=24% Similarity=0.279 Sum_probs=163.4
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEec------eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEV------SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y 583 (757)
..+.+.+|+.++++++|+||+++++++... ...++||||+++ +|.+.+. ..++...+..++.|++.||+|
T Consensus 63 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~ 138 (359)
T cd07876 63 HAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKH 138 (359)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHH
Confidence 346788999999999999999999988643 357999999976 5666553 347788888999999999999
Q ss_pred hhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHH
Q 038168 584 LHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663 (757)
Q Consensus 584 LH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ 663 (757)
||++ +|+||||||+|||++.++.+||+|||+++...... ......||..|+|||.+.+..++.++||||||++++
T Consensus 139 LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 213 (359)
T cd07876 139 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 213 (359)
T ss_pred HHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHH
Confidence 9998 99999999999999999999999999997643322 223456899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCcccc------------H----HHHHHHHHhcC-Ccc-----ccc----cc--cccCHHHHHHHHH
Q 038168 664 EIICRRRCLDPNLPDDQVI------------L----EEWVYQCFENG-NLS-----QLV----ED--EEVDEKQLERMIK 715 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~------------l----~~~~~~~~~~~-~~~-----~~~----d~--~~~~~~~~~~l~~ 715 (757)
||++|+.||......+... + ...+....... ... +.. .+ ..........+.+
T Consensus 214 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (359)
T cd07876 214 ELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARD 293 (359)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHH
Confidence 9999999997543211000 0 00000000000 000 000 00 0011122356889
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 038168 716 VALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 716 l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++.+||+.||++|||+.|+++.
T Consensus 294 li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 294 LLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHhccCcccCCCHHHHhcC
Confidence 9999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=273.46 Aligned_cols=218 Identities=24% Similarity=0.276 Sum_probs=163.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec------eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV------SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.+.+|+.+++.++|+||+++++++... ...++||||+++ +|.+.+. ..+++..+..++.|+++||+||
T Consensus 60 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~L 135 (355)
T cd07874 60 AKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHL 135 (355)
T ss_pred HHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999999999988643 357999999975 5666663 3478888899999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~e 664 (757)
|+. +|+||||||+|||++.++.+||+|||+++...... ......||..|+|||.+.+..++.++||||||++++|
T Consensus 136 H~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~e 210 (355)
T cd07874 136 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210 (355)
T ss_pred HhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHH
Confidence 998 99999999999999999999999999998654322 2233568999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCcccc----------------HHHHHHHHHhc-CCccccccc-----------cccCHHHHHHHHHH
Q 038168 665 IICRRRCLDPNLPDDQVI----------------LEEWVYQCFEN-GNLSQLVED-----------EEVDEKQLERMIKV 716 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~----------------l~~~~~~~~~~-~~~~~~~d~-----------~~~~~~~~~~l~~l 716 (757)
|++|+.||......+... +...+...... ........+ ..........+.++
T Consensus 211 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 290 (355)
T cd07874 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290 (355)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHH
Confidence 999999987543211100 00000000000 000000000 00112234578899
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 038168 717 ALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 717 ~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+.+|++.||++|||+.|+++.
T Consensus 291 i~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 291 LSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhcCCchhcCCHHHHhcC
Confidence 999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=282.20 Aligned_cols=216 Identities=22% Similarity=0.264 Sum_probs=159.8
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEEec--------eeeeEEEEeccCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHH
Q 038168 513 EFQTEMKVIGRTHHRNLVRLLGYSLEV--------SKKILVYEYMSNGSLADILFN---PEKQPNWVERMGIARDIARGI 581 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~g~~~~~--------~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL 581 (757)
...+|+.++++++|+|||++++++... ...++||||+++ +|.+++.. ....+++.....++.||+.||
T Consensus 105 ~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL 183 (440)
T PTZ00036 105 YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183 (440)
T ss_pred hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence 345799999999999999999876432 246789999985 67666532 345688999999999999999
Q ss_pred HHhhhCCCCCeeeCCCCcceEEECCCC-cEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhH
Q 038168 582 LYLHDECETQIIHCDIKPQNILMDENR-CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFG 659 (757)
Q Consensus 582 ~yLH~~~~~~iiH~Dik~~Nill~~~~-~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G 659 (757)
+|||+. +|+||||||+|||++.++ .+||+|||+++.+..... .....||+.|+|||++.+. .++.++||||||
T Consensus 184 ~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG 258 (440)
T PTZ00036 184 AYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLG 258 (440)
T ss_pred HHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHH
Confidence 999998 999999999999999664 799999999987654322 2235679999999998764 689999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhc----------CCcccccccc--------ccCHHHHHHHHHHHHHcc
Q 038168 660 VVLLEIICRRRCLDPNLPDDQVILEEWVYQCFEN----------GNLSQLVEDE--------EVDEKQLERMIKVALWCI 721 (757)
Q Consensus 660 ~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----------~~~~~~~d~~--------~~~~~~~~~l~~l~~~cl 721 (757)
|+++||++|..||......+.. .. ..+.+.. ..+..+.-+. .++.....++.+++.+||
T Consensus 259 vil~elltG~~pf~~~~~~~~~--~~-i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L 335 (440)
T PTZ00036 259 CIIAEMILGYPIFSGQSSVDQL--VR-IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFL 335 (440)
T ss_pred HHHHHHHhCCCCCCCCChHHHH--HH-HHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHC
Confidence 9999999999998764332211 11 0110000 0000000000 011223467899999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 038168 722 LDEPSLRPSMKKVLLM 737 (757)
Q Consensus 722 ~~~p~~RPsm~eVl~~ 737 (757)
+.+|++|||+.|+++.
T Consensus 336 ~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 336 KYEPLKRLNPIEALAD 351 (440)
T ss_pred CCChhHCcCHHHHhCC
Confidence 9999999999999853
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=281.13 Aligned_cols=213 Identities=26% Similarity=0.391 Sum_probs=181.3
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+++..|+-+|++|+|+||+||+|+|.... ..||++||+.|+|.+|++.++..+.-...+.+..|||+|+.|||++ +
T Consensus 743 ~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---r 818 (1177)
T KOG1025|consen 743 IELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---R 818 (1177)
T ss_pred HHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---c
Confidence 78999999999999999999999998766 7899999999999999998888899999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-CC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-RR 669 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G~ 669 (757)
++||||.++|||+..-..+||.|||+++....+... ......-.+.|||-|.+....++.++|||||||++||++| |.
T Consensus 819 lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa 898 (1177)
T KOG1025|consen 819 LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGA 898 (1177)
T ss_pred hhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCC
Confidence 999999999999999999999999999998876653 3334555778999999999999999999999999999998 66
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
.|.+....++ +.+.++.|.- +-. ++.....+..++.+||..|++.||+++++...+.+.
T Consensus 899 ~Py~gi~~~e-------I~dlle~geR--Lsq----PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 899 KPYDGIPAEE-------IPDLLEKGER--LSQ----PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred CccCCCCHHH-------hhHHHhcccc--CCC----CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 7766543322 3344444432 222 334456788999999999999999999998887653
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=273.67 Aligned_cols=209 Identities=22% Similarity=0.348 Sum_probs=172.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN-PEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+|++|+.+|.+|+|+|++||+|...+ ....||+|+++.|+|.+.|++ ....+-......++.|||.|+.||..+
T Consensus 155 mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk-- 231 (1039)
T KOG0199|consen 155 MDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK-- 231 (1039)
T ss_pred HHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh--
Confidence 4789999999999999999999999987 778899999999999999988 344566677788999999999999999
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecc-cccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTG-IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~-~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+.|||||.++|+||.....+||+||||.|-++..+. +.+.. ..-...|.|||.+....++.++|||+|||++|||+|
T Consensus 232 -rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFt 310 (1039)
T KOG0199|consen 232 -RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFT 310 (1039)
T ss_pred -hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhc
Confidence 999999999999999999999999999998876544 33332 445678999999999999999999999999999998
Q ss_pred CC-CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 668 RR-RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 668 G~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+. .||-+..... +.+.+.++.. + .-+..+.+++.++++.||.++|++|||+..|.+
T Consensus 311 yGEePW~G~~g~q-------IL~~iD~~er--L----pRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 311 YGEEPWVGCRGIQ-------ILKNIDAGER--L----PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cCCCCCCCCCHHH-------HHHhcccccc--C----CCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 54 6665543321 1122221111 1 124556789999999999999999999999973
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=256.13 Aligned_cols=210 Identities=24% Similarity=0.391 Sum_probs=171.2
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+.+.+|++++++++|+|++++++.+...+..++|+||+++++|.+++.... ..+++..+.+++.++++||+|||+.
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~- 120 (256)
T cd08220 42 ERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK- 120 (256)
T ss_pred HHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 35678999999999999999999999999999999999999999999997643 4578999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCC-CcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 589 ETQIIHCDIKPQNILMDEN-RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~-~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||||+||+++++ ..+||+|||++........ .....++..|+|||.+.+..++.++||||||+++++|++
T Consensus 121 --~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~ 196 (256)
T cd08220 121 --LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS 196 (256)
T ss_pred --CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHh
Confidence 99999999999999865 5689999999987654322 123457889999999998889999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|+.|+...... ..+... ..+....+ .......+.+++.+||+.+|++|||+.|+++.
T Consensus 197 ~~~~~~~~~~~------~~~~~~-~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 197 LKRAFEAANLP------ALVLKI-MSGTFAPI------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCcccCchH------HHHHHH-HhcCCCCC------CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 99998653221 111111 11211111 11234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=264.71 Aligned_cols=218 Identities=23% Similarity=0.308 Sum_probs=165.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE--KQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.+.+.+|+.++++++|+|++++++++.+++..++|+||++ ++|.+++.... ..+++.++..++.|+++||+|||+.
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~- 120 (285)
T cd07861 43 PSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR- 120 (285)
T ss_pred hHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3567889999999999999999999999999999999997 68888875432 5688999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHh
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||||+||+++.++.+||+|||++....... .......++..|+|||.+.+. .++.++||||||++++||++
T Consensus 121 --~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t 197 (285)
T cd07861 121 --RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197 (285)
T ss_pred --CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999998654332 112233568899999988654 57899999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhc------------C----Cccccccc--cccCHHHHHHHHHHHHHccccCCCCCC
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFEN------------G----NLSQLVED--EEVDEKQLERMIKVALWCILDEPSLRP 729 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~------------~----~~~~~~d~--~~~~~~~~~~l~~l~~~cl~~~p~~RP 729 (757)
|+.|+......... .... +.+.. . ........ .........++.+++.+||+.||++||
T Consensus 198 g~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 274 (285)
T cd07861 198 KKPLFHGDSEIDQL--FRIF-RILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRI 274 (285)
T ss_pred CCCCCCCCCHHHHH--HHHH-HHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCC
Confidence 99998754321110 0000 00000 0 00000000 000111245678999999999999999
Q ss_pred CHHHHHH
Q 038168 730 SMKKVLL 736 (757)
Q Consensus 730 sm~eVl~ 736 (757)
|+.+|+.
T Consensus 275 t~~~ll~ 281 (285)
T cd07861 275 SAKKALN 281 (285)
T ss_pred CHHHHhc
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=257.34 Aligned_cols=213 Identities=22% Similarity=0.374 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe--ceeeeEEEEeccCCChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE--VSKKILVYEYMSNGSLADILFNP---EKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.+.+.+|++++++++|+|++++++++.. +...+++|||+++++|.+++... ...+++...+.++.|++.||.|||
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH 122 (265)
T cd08217 43 KQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122 (265)
T ss_pred HHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh
Confidence 4678899999999999999999998764 44678999999999999998643 456899999999999999999999
Q ss_pred hCC--CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHH
Q 038168 586 DEC--ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663 (757)
Q Consensus 586 ~~~--~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ 663 (757)
..+ ..+++|+||||+||++++++.+||+|||++......... .....++..|+|||.+.+..++.++||||||++++
T Consensus 123 ~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~ 201 (265)
T cd08217 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIY 201 (265)
T ss_pred cCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHH
Confidence 322 239999999999999999999999999999877654321 22346889999999999988999999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+|++|+.|+..... . . ..+....+.... .+......+.+++.+|++.+|++||++.+|+++
T Consensus 202 ~l~~g~~p~~~~~~---~---~-~~~~~~~~~~~~------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 202 ELCALSPPFTARNQ---L---Q-LASKIKEGKFRR------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHCCCcccCcCH---H---H-HHHHHhcCCCCC------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 99999999875431 1 1 222233332221 223455788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=264.45 Aligned_cols=221 Identities=23% Similarity=0.349 Sum_probs=176.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+|++++++++.+.+..++|+||+++++|.+++.+ ..+++.++..++.|++.||+|||+.
T Consensus 60 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~--- 134 (296)
T cd06655 60 KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHAN--- 134 (296)
T ss_pred HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46788999999999999999999999999999999999999999998854 3589999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+++|+||||+||+++.++.+||+|||++......... .....++..|+|||.+.+..++.++||||||+++++|++|+.
T Consensus 135 ~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~ 213 (296)
T cd06655 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213 (296)
T ss_pred CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999998865443221 223457889999999999889999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcCcCCCCCC
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL--MLEGTVEIPIPP 748 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~--~Le~~~~~~~p~ 748 (757)
||....+... ...... .....+..+ ......+.+++.+||+.+|++||++.+|++ .++...++..++
T Consensus 214 pf~~~~~~~~------~~~~~~-~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~~~~ 282 (296)
T cd06655 214 PYLNENPLRA------LYLIAT-NGTPELQNP----EKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLT 282 (296)
T ss_pred CCCCCCHHHH------HHHHHh-cCCcccCCc----ccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccccccCC
Confidence 9875433211 111111 111111111 223456888999999999999999999987 344444444333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=259.63 Aligned_cols=208 Identities=25% Similarity=0.373 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++++.+....++||||+++++|.+++.. ..+++.+...++.|++.||+|||+.
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~--- 120 (277)
T cd06640 46 IEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSE--- 120 (277)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 46788999999999999999999999999999999999999999999854 4578888999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++||||||++++||++|..
T Consensus 121 ~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~ 199 (277)
T cd06640 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEP 199 (277)
T ss_pred CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCC
Confidence 999999999999999999999999999987654322 1223457889999999998899999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|+....+.... .....+. +..........+.+++.+||+.+|++||++.++++.
T Consensus 200 p~~~~~~~~~~-------~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 200 PNSDMHPMRVL-------FLIPKNN------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCcChHhHh-------hhhhcCC------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 98654322110 1111111 122334566788999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=263.65 Aligned_cols=216 Identities=26% Similarity=0.333 Sum_probs=165.1
Q ss_pred HHHHHHhhcCCCceeeeeeEEEece---e--eeEEEEeccCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 516 TEMKVIGRTHHRNLVRLLGYSLEVS---K--KILVYEYMSNGSLADILFN---PEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 516 ~E~~~l~~l~h~niv~l~g~~~~~~---~--~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
+|+++|+++.|||||+|+-++.... + ..|||||||. +|.++++. .+..++...+.-+..||.+||.|||+.
T Consensus 66 rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~ 144 (364)
T KOG0658|consen 66 RELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH 144 (364)
T ss_pred HHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc
Confidence 6999999999999999999886432 2 3489999987 88888863 245566666777999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCC-CcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMDEN-RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEI 665 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~-~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|+|+|.+ +.+||+|||.|+.+...+.. .....|.-|.|||.+.+. .|+.+.||||.||++.||
T Consensus 145 ---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aEL 219 (364)
T KOG0658|consen 145 ---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAEL 219 (364)
T ss_pred ---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHH
Confidence 99999999999999987 99999999999988776554 334578999999998875 799999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHH-----HHHh-------cCCcccccccc---ccCHHHHHHHHHHHHHccccCCCCCCC
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVY-----QCFE-------NGNLSQLVEDE---EVDEKQLERMIKVALWCILDEPSLRPS 730 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~-----~~~~-------~~~~~~~~d~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs 730 (757)
+-|++.|.+....++....--+. +.+. +-+.+++.... ........+.++++.++++.+|.+|.+
T Consensus 220 l~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~ 299 (364)
T KOG0658|consen 220 LKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS 299 (364)
T ss_pred hcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC
Confidence 99999988765544332211110 0000 11111111111 123344577899999999999999999
Q ss_pred HHHHHHH
Q 038168 731 MKKVLLM 737 (757)
Q Consensus 731 m~eVl~~ 737 (757)
..|++.+
T Consensus 300 ~~~~l~h 306 (364)
T KOG0658|consen 300 ALEALAH 306 (364)
T ss_pred HHHHhcc
Confidence 9998863
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=274.09 Aligned_cols=212 Identities=20% Similarity=0.267 Sum_probs=163.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++.+++|+||+++++.+.+.+..++||||+++|+|.+++.+ ...++......++.|++.||+|||+.
T Consensus 45 ~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~--- 120 (360)
T cd05627 45 VAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQL--- 120 (360)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 35678899999999999999999999999999999999999999999865 35678888999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc----------------------------------ceecccccCc
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT----------------------------------RTFTGIRGTR 636 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~----------------------------------~~~~~~~gt~ 636 (757)
+|+||||||+|||++.++.+||+|||+++....... .......||+
T Consensus 121 givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 200 (360)
T cd05627 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTP 200 (360)
T ss_pred CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCc
Confidence 999999999999999999999999999875432110 0012356999
Q ss_pred cccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHH
Q 038168 637 GYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKV 716 (757)
Q Consensus 637 ~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l 716 (757)
.|+|||++.+..++.++|||||||+++||++|+.||....+.. ...... ........ +... ....++.++
T Consensus 201 ~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~------~~~~i~-~~~~~~~~-p~~~--~~s~~~~~l 270 (360)
T cd05627 201 DYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE------TYRKVM-NWKETLVF-PPEV--PISEKAKDL 270 (360)
T ss_pred cccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHH------HHHHHH-cCCCceec-CCCC--CCCHHHHHH
Confidence 9999999999999999999999999999999999997543321 111111 11100001 1110 123456666
Q ss_pred HHHccccCCCCCCC---HHHHHHH
Q 038168 717 ALWCILDEPSLRPS---MKKVLLM 737 (757)
Q Consensus 717 ~~~cl~~~p~~RPs---m~eVl~~ 737 (757)
+.+++. +|++|++ +.|+++.
T Consensus 271 i~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 271 ILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred HHHhcc-ChhhcCCCCCHHHHhcC
Confidence 666654 9999985 5666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=251.17 Aligned_cols=209 Identities=25% Similarity=0.375 Sum_probs=177.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+++.+|+.++++.+.+++|+++|.+.....+++|||||..|+..++++...+.+...++-.+++..++||+|||..
T Consensus 72 LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~--- 148 (502)
T KOG0574|consen 72 LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL--- 148 (502)
T ss_pred HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---
Confidence 37899999999999999999999999999999999999999999999998889999999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
.-||||||+.||||+.++.+||+|||.|-.+...-. ....+.||+-|||||++..-.|..++||||+|++..||.-|++
T Consensus 149 ~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~P 227 (502)
T KOG0574|consen 149 KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRP 227 (502)
T ss_pred HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCC
Confidence 899999999999999999999999999976643222 2234789999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccc-cc--cCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVED-EE--VDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~-~~--~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|+..-.+-..... -.-.| .. .+++-..++-++++.||..+|++|-|+.++++.
T Consensus 228 PYsDIHPMRAIFM--------------IPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 228 PYSDIHPMRAIFM--------------IPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CcccccccceeEe--------------ccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 9864333211100 00111 11 144556789999999999999999999888764
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=261.06 Aligned_cols=212 Identities=22% Similarity=0.347 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP--EKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.+.+.+|++++++++|+||+++++.+...+..++||||+++++|.+++... ...+++..+..++.+++.||.|||+.
T Consensus 43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~- 121 (286)
T cd06622 43 FNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE- 121 (286)
T ss_pred HHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc-
Confidence 467889999999999999999999999999999999999999999998654 24689999999999999999999963
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC------CCCccccchhhHHHH
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL------PITVKADVYSFGVVL 662 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~S~G~~l 662 (757)
.+|+|+||||+||+++.++.+||+|||++..+.... .....++..|+|||.+.+. .++.++||||||+++
T Consensus 122 -~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 197 (286)
T cd06622 122 -HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSI 197 (286)
T ss_pred -CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHH
Confidence 289999999999999999999999999997654322 1224578899999988554 358899999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+||++|+.||....... ... .......+... ..+......+.+++.+|++.+|++||++.+++..
T Consensus 198 ~~l~~g~~pf~~~~~~~---~~~-~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 198 LEMALGRYPYPPETYAN---IFA-QLSAIVDGDPP------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHhCCCCCCCcchhh---HHH-HHHHHhhcCCC------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 99999999986532211 111 01111112111 1223456778899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=270.53 Aligned_cols=219 Identities=24% Similarity=0.265 Sum_probs=164.0
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEec------eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEV------SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y 583 (757)
..+.+.+|+.+++.++|+||+++++++... ...++||||+++ +|.+++. ..+++.++..++.|++.||+|
T Consensus 66 ~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~ 141 (364)
T cd07875 66 HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKH 141 (364)
T ss_pred hHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHH
Confidence 346788999999999999999999987543 357999999975 6777663 347888899999999999999
Q ss_pred hhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHH
Q 038168 584 LHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663 (757)
Q Consensus 584 LH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ 663 (757)
||++ +|+||||||+|||++.++.+||+|||+++...... ......+|..|+|||++.+..++.++|||||||+++
T Consensus 142 LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 216 (364)
T cd07875 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216 (364)
T ss_pred HhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHH
Confidence 9998 99999999999999999999999999998654322 223456899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCccccH---------HHH-------HHHHHhc-CCccc-----ccc----c--cccCHHHHHHHHH
Q 038168 664 EIICRRRCLDPNLPDDQVIL---------EEW-------VYQCFEN-GNLSQ-----LVE----D--EEVDEKQLERMIK 715 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l---------~~~-------~~~~~~~-~~~~~-----~~d----~--~~~~~~~~~~l~~ 715 (757)
||++|+.||......+.... .+. +...... ..... ... + ..........+.+
T Consensus 217 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 296 (364)
T cd07875 217 EMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296 (364)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHH
Confidence 99999999975432111000 000 0000000 00000 000 0 0011112356889
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 038168 716 VALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 716 l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++.+|++.||++|||+.|+++.
T Consensus 297 ll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 297 LLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhcCcCcccCCCHHHHhcC
Confidence 9999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=263.33 Aligned_cols=220 Identities=24% Similarity=0.355 Sum_probs=172.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+||+++++++......++|+||+ +++|.+++......+++.++..++.|+++||+|||+.
T Consensus 43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--- 118 (286)
T cd07832 43 PNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN--- 118 (286)
T ss_pred hHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 457889999999999999999999999999999999999 9999999976667789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++|+||||+||+++.++.++|+|||++...............++..|+|||.+.+. .++.++||||+|++++||++|.
T Consensus 119 ~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~ 198 (286)
T cd07832 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198 (286)
T ss_pred CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999987765443333345688999999988654 4689999999999999999997
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcC------------Ccccccccc-------ccCHHHHHHHHHHHHHccccCCCCCCC
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENG------------NLSQLVEDE-------EVDEKQLERMIKVALWCILDEPSLRPS 730 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~------------~~~~~~d~~-------~~~~~~~~~l~~l~~~cl~~~p~~RPs 730 (757)
+++....... ....+....... .......+. ....+....+.+++.+|++.+|++||+
T Consensus 199 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 275 (286)
T cd07832 199 PLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS 275 (286)
T ss_pred cCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC
Confidence 7765432211 111111110000 000000000 011123478899999999999999999
Q ss_pred HHHHHHH
Q 038168 731 MKKVLLM 737 (757)
Q Consensus 731 m~eVl~~ 737 (757)
++++++.
T Consensus 276 ~~~~l~h 282 (286)
T cd07832 276 AAEALRH 282 (286)
T ss_pred HHHHhhC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=263.31 Aligned_cols=223 Identities=24% Similarity=0.308 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++++...+..++||||++++.|..+..+ ...+++.++..++.|++.||+|||+.
T Consensus 44 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~--- 119 (288)
T cd07833 44 KKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSH--- 119 (288)
T ss_pred hhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46788999999999999999999999999999999999998777766543 45588999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++|+||+|+||++++++.+||+|||++...............++..|+|||++.+. .++.++||||||++++||++|+
T Consensus 120 ~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~ 199 (288)
T cd07833 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199 (288)
T ss_pred CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999987765443233345678899999999888 8899999999999999999999
Q ss_pred CCCCCCCCCccccHHHHH--------HHHH-hcC-----Ccccccccc----ccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 670 RCLDPNLPDDQVILEEWV--------YQCF-ENG-----NLSQLVEDE----EVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~--------~~~~-~~~-----~~~~~~d~~----~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
.|+......+........ ...+ ... .+....++. ..+.....++.+++.+||+.+|++||++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 279 (288)
T cd07833 200 PLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC 279 (288)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccH
Confidence 988643221110000000 0000 000 000111110 0112236789999999999999999999
Q ss_pred HHHHHH
Q 038168 732 KKVLLM 737 (757)
Q Consensus 732 ~eVl~~ 737 (757)
++|+++
T Consensus 280 ~~il~~ 285 (288)
T cd07833 280 DELLQH 285 (288)
T ss_pred HHHhcC
Confidence 999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=264.06 Aligned_cols=230 Identities=23% Similarity=0.303 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++++.+.+..++||||+ +++|.+++......+++..+..++.|+++||+|||++
T Consensus 46 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~--- 121 (298)
T cd07841 46 NFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN--- 121 (298)
T ss_pred hHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 456778999999999999999999999999999999999 9999999976555789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++|+||||+||+++.++.+||+|||+++....... ......++..|+|||.+.+ ..++.++||||||++++||++|.
T Consensus 122 ~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~ 200 (298)
T cd07841 122 WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200 (298)
T ss_pred CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999987654322 1222345788999998865 46789999999999999999997
Q ss_pred CCCCCCCCCccccHHHHHHHHHhc---------CCccccc---cccc-----cCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFEN---------GNLSQLV---EDEE-----VDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~---------~~~~~~~---d~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
.++....+.+. + ......... ....... .... ........+.+++.+||+.+|++|||+.
T Consensus 201 ~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~ 277 (298)
T cd07841 201 PFLPGDSDIDQ--L-GKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITAR 277 (298)
T ss_pred ccccCCccHHH--H-HHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHH
Confidence 77654332111 1 111110000 0000000 0000 1123356789999999999999999999
Q ss_pred HHHHH--hhcCcCCCCCC
Q 038168 733 KVLLM--LEGTVEIPIPP 748 (757)
Q Consensus 733 eVl~~--Le~~~~~~~p~ 748 (757)
||+++ +++......|+
T Consensus 278 e~l~~~~~~~~~~~~~~~ 295 (298)
T cd07841 278 QALEHPYFSNDPAPTPPS 295 (298)
T ss_pred HHhhCccccCCCCCCCCC
Confidence 99995 54433333333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=258.82 Aligned_cols=216 Identities=25% Similarity=0.345 Sum_probs=169.2
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEece------eeeEEEEeccCCChhhhhcCC-----CCCCCHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVS------KKILVYEYMSNGSLADILFNP-----EKQPNWVERMGIARDIA 578 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lV~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia 578 (757)
..+++.+|++++++++||||+++++++...+ ..++++||+++|+|.+++... ...+++....+++.|++
T Consensus 44 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~ 123 (273)
T cd05074 44 DIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123 (273)
T ss_pred HHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Confidence 4567899999999999999999999886543 247899999999999887422 23578889999999999
Q ss_pred HHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccccchh
Q 038168 579 RGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKADVYS 657 (757)
Q Consensus 579 ~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S 657 (757)
.||+|||++ +|+||||||+||+++.++.+||+|||+++........ ......++..|++||.+....++.++||||
T Consensus 124 ~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~s 200 (273)
T cd05074 124 SGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWA 200 (273)
T ss_pred HHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHH
Confidence 999999998 9999999999999999999999999999876433221 112234567899999999889999999999
Q ss_pred hHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 658 FGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 658 ~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||++++||++ |+.|+..... ..+ ......+.... .+......+.+++.+|++.+|++||++.++++
T Consensus 201 lG~il~el~~~g~~p~~~~~~---~~~----~~~~~~~~~~~------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 201 FGVTMWEIMTRGQTPYAGVEN---SEI----YNYLIKGNRLK------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred HHHHHHHHhhCCCCCCCCCCH---HHH----HHHHHcCCcCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999 7777653321 111 11111221110 11233467999999999999999999999999
Q ss_pred HhhcC
Q 038168 737 MLEGT 741 (757)
Q Consensus 737 ~Le~~ 741 (757)
.|+++
T Consensus 268 ~l~~~ 272 (273)
T cd05074 268 QLELI 272 (273)
T ss_pred HHHhh
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=261.32 Aligned_cols=222 Identities=23% Similarity=0.300 Sum_probs=169.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+|++++++++...+..++||||++++.|..++.. ...+++.++..++.|++.||+|||+.
T Consensus 44 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~--- 119 (286)
T cd07847 44 KKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKH--- 119 (286)
T ss_pred cHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 35678999999999999999999999999999999999999988887644 44689999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++|+||||+||+++.++.+||+|||++........ ......++..|+|||.+.+ ..++.++||||||++++||++|+
T Consensus 120 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~ 198 (286)
T cd07847 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198 (286)
T ss_pred CceecCCChhhEEEcCCCcEEECccccceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCC
Confidence 999999999999999999999999999987654332 1223456789999999876 45789999999999999999999
Q ss_pred CCCCCCCCCccccHHHH-H-------HHHHhcCCc-cccccccc---c-----CHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 670 RCLDPNLPDDQVILEEW-V-------YQCFENGNL-SQLVEDEE---V-----DEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~-~-------~~~~~~~~~-~~~~d~~~---~-----~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
.||......+....... . ...+..... .....+.. . .......+.+++.+|++.+|++||++.
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 278 (286)
T cd07847 199 PLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCE 278 (286)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHH
Confidence 99875443221110000 0 000000000 00000000 0 112246788999999999999999999
Q ss_pred HHHHH
Q 038168 733 KVLLM 737 (757)
Q Consensus 733 eVl~~ 737 (757)
|++..
T Consensus 279 eil~~ 283 (286)
T cd07847 279 ELLEH 283 (286)
T ss_pred HHhcC
Confidence 98753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=290.11 Aligned_cols=211 Identities=21% Similarity=0.301 Sum_probs=164.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNP---EKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
...|..|+.++++|+|||||++++++.+. ...+|||||+++|+|.++|... ...+++..++.|+.||+.||+|||
T Consensus 56 ~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLH 135 (1021)
T PTZ00266 56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135 (1021)
T ss_pred HHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 46788999999999999999999988543 5689999999999999998642 356899999999999999999999
Q ss_pred hCCC----CCeeeCCCCcceEEECC-----------------CCcEEEeecCCccccCCCCcceecccccCccccCcccc
Q 038168 586 DECE----TQIIHCDIKPQNILMDE-----------------NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWH 644 (757)
Q Consensus 586 ~~~~----~~iiH~Dik~~Nill~~-----------------~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 644 (757)
.... .+||||||||+||||+. ...+||+|||++..+..... .....||+.|+|||++
T Consensus 136 s~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL 213 (1021)
T PTZ00266 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELL 213 (1021)
T ss_pred hcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHH
Confidence 8521 35999999999999964 34589999999987643322 2335689999999998
Q ss_pred cC--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccc
Q 038168 645 RN--LPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCIL 722 (757)
Q Consensus 645 ~~--~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~ 722 (757)
.+ ..++.++|||||||++|||++|+.||..... ... +...+..+.... .......+.+|+..||+
T Consensus 214 ~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~-----~~q-li~~lk~~p~lp-------i~~~S~eL~dLI~~~L~ 280 (1021)
T PTZ00266 214 LHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN-----FSQ-LISELKRGPDLP-------IKGKSKELNILIKNLLN 280 (1021)
T ss_pred hccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-----HHH-HHHHHhcCCCCC-------cCCCCHHHHHHHHHHhc
Confidence 64 4589999999999999999999999864322 111 122222221110 11224568899999999
Q ss_pred cCCCCCCCHHHHHH
Q 038168 723 DEPSLRPSMKKVLL 736 (757)
Q Consensus 723 ~~p~~RPsm~eVl~ 736 (757)
.+|++||++.|++.
T Consensus 281 ~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 281 LSAKERPSALQCLG 294 (1021)
T ss_pred CChhHCcCHHHHhc
Confidence 99999999999984
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=264.40 Aligned_cols=213 Identities=28% Similarity=0.364 Sum_probs=171.0
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|++++++++|+|++++++++.+.+..++||||++ |+|.+++......+++.++..++.|++.||.|||+. +
T Consensus 70 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ 145 (317)
T cd06635 70 QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---N 145 (317)
T ss_pred HHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 578899999999999999999999999999999999997 588887766566789999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc---CCCCCccccchhhHHHHHHHHhC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR---NLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~G~~l~elltG 668 (757)
++|+||+|+||+++.++.+||+|||++...... ....++..|+|||++. ...++.++||||||++++||++|
T Consensus 146 i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g 220 (317)
T cd06635 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 220 (317)
T ss_pred cccCCCCcccEEECCCCCEEEecCCCccccCCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999998765432 2245788999999874 45689999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcCCC
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIP 745 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~~~ 745 (757)
+.|+...... .........+. .. .........+.+++.+|++.+|.+||++.+|++.+--....+
T Consensus 221 ~~p~~~~~~~------~~~~~~~~~~~-~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 221 KPPLFNMNAM------SALYHIAQNES-PT-----LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred CCCCCCccHH------HHHHHHHhccC-CC-----CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 9998643211 11111111111 11 111233456889999999999999999999998765544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=270.59 Aligned_cols=206 Identities=24% Similarity=0.247 Sum_probs=161.9
Q ss_pred HHHHHHHHHhhc---CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 513 EFQTEMKVIGRT---HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 513 ~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+..|..++.++ +||||+++++.+.+.+..++||||+++|+|.+++.+ ...++...+..++.||++||+|||++
T Consensus 39 ~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~-- 115 (330)
T cd05586 39 HTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKY-- 115 (330)
T ss_pred HHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 345566676665 699999999999999999999999999999998864 45678899999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+|||++.++.+||+|||+++....... ......||..|+|||.+.+. .++.++|||||||+++||++|
T Consensus 116 -~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG 193 (330)
T cd05586 116 -DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193 (330)
T ss_pred -CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccC
Confidence 999999999999999999999999999975432221 22345789999999998765 489999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP----SMKKVLL 736 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP----sm~eVl~ 736 (757)
+.||...... + .......+.... + .......+.+++.+||+.+|++|| ++.++++
T Consensus 194 ~~Pf~~~~~~------~-~~~~i~~~~~~~---~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 194 WSPFYAEDTQ------Q-MYRNIAFGKVRF---P---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCCCCCCHH------H-HHHHHHcCCCCC---C---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 9998753221 1 122222222211 0 112345678899999999999998 4555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=258.82 Aligned_cols=212 Identities=25% Similarity=0.364 Sum_probs=167.6
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEece------eeeEEEEeccCCChhhhhcCC---CCCCCHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLEVS------KKILVYEYMSNGSLADILFNP---EKQPNWVERMGIARDIAR 579 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~------~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~ 579 (757)
..+++.+|+.+++++ +|+||+++++++.+.. ..++||||+++++|.+++... ...+++..+..++.|++.
T Consensus 45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~ 124 (275)
T cd06608 45 EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR 124 (275)
T ss_pred hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHH
Confidence 457799999999999 7999999999997644 489999999999999988643 356889999999999999
Q ss_pred HHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-----CCCCcccc
Q 038168 580 GILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-----LPITVKAD 654 (757)
Q Consensus 580 gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~D 654 (757)
||+|||+. +++|+||+|+||++++++.+||+|||++........ ......++..|+|||.+.. ..++.++|
T Consensus 125 al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D 200 (275)
T cd06608 125 GLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSD 200 (275)
T ss_pred HHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecccchh-hhcCccccccccCHhHhcccccccCCcccccc
Confidence 99999998 999999999999999999999999999976543222 1223457889999998753 34678999
Q ss_pred chhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 038168 655 VYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKV 734 (757)
Q Consensus 655 v~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eV 734 (757)
|||||++++||++|+.||....... ...+ ...+...... ........+.+++.+||..||++|||+.||
T Consensus 201 v~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~l 269 (275)
T cd06608 201 VWSLGITAIELADGKPPLCDMHPMR------ALFK-IPRNPPPTLK----SPENWSKKFNDFISECLIKNYEQRPFMEEL 269 (275)
T ss_pred HHHhHHHHHHHHhCCCCccccchHH------HHHH-hhccCCCCCC----chhhcCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 9999999999999999986432111 1111 1122111111 122345678899999999999999999999
Q ss_pred HH
Q 038168 735 LL 736 (757)
Q Consensus 735 l~ 736 (757)
++
T Consensus 270 l~ 271 (275)
T cd06608 270 LE 271 (275)
T ss_pred hc
Confidence 86
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=256.75 Aligned_cols=209 Identities=24% Similarity=0.333 Sum_probs=163.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.+.+.+|+.++++++|+||+++++++.+. ...++++||+++++|.+++.+. ..+++.....++.|++.||+|||+.
T Consensus 48 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~- 125 (266)
T cd06651 48 VSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSN- 125 (266)
T ss_pred HHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 35688999999999999999999988753 5678999999999999998653 3578888999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc--ceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT--RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+|+|+||||+||+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||++++||+
T Consensus 126 --~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~ 203 (266)
T cd06651 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEML 203 (266)
T ss_pred --CeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHH
Confidence 999999999999999999999999999986543211 1122345788999999999989999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+|+.||...... +........... ...+....+.+..++ +|+..+|++||+++||++
T Consensus 204 ~g~~pf~~~~~~------~~~~~~~~~~~~------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 204 TEKPPWAEYEAM------AAIFKIATQPTN------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HCCCCccccchH------HHHHHHhcCCCC------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 999998643211 111111111111 111222234445554 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=261.13 Aligned_cols=219 Identities=21% Similarity=0.247 Sum_probs=164.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
...+.+|+.++++++|+||+++++++..++..++|+||+. ++|.+++......+.+.++..++.|++.||+|||+.
T Consensus 47 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--- 122 (291)
T cd07870 47 PFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ--- 122 (291)
T ss_pred cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 3467899999999999999999999999999999999996 677777765555678888889999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+|+||||+||+++.++.+||+|||+++....... ......++..|+|||++.+. .++.++||||||++++||++|+
T Consensus 123 ~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~ 201 (291)
T cd07870 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201 (291)
T ss_pred CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999976433221 12234568899999998764 5788999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHh------------cCCcccccc----cccc-----CHHHHHHHHHHHHHccccCCCCC
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFE------------NGNLSQLVE----DEEV-----DEKQLERMIKVALWCILDEPSLR 728 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~------------~~~~~~~~d----~~~~-----~~~~~~~l~~l~~~cl~~~p~~R 728 (757)
.||+....... .+.+ .+.... ......... +... .......+.+++.+|++.||++|
T Consensus 202 ~~f~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R 279 (291)
T cd07870 202 PAFPGVSDVFE-QLEK-IWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDR 279 (291)
T ss_pred CCCCCchhHHH-HHHH-HHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccC
Confidence 99875432111 0000 111000 000000000 0000 01124567889999999999999
Q ss_pred CCHHHHHH
Q 038168 729 PSMKKVLL 736 (757)
Q Consensus 729 Psm~eVl~ 736 (757)
||+.|++.
T Consensus 280 ~t~~~~l~ 287 (291)
T cd07870 280 ISAQDALL 287 (291)
T ss_pred cCHHHHhc
Confidence 99999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=257.76 Aligned_cols=209 Identities=22% Similarity=0.338 Sum_probs=169.4
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|++++++++|+||+++++++.+.+..++|+||+++++|.+++.+. ..+++..+..++.|++.||+|||+. +
T Consensus 47 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ 122 (265)
T cd06631 47 EKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNN---C 122 (265)
T ss_pred HHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 56889999999999999999999999999999999999999999999653 4578888899999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCC-----cceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ-----TRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
|+|+||||+||++++++.+||+|||++....... ........++..|+|||++.+..++.++||||||++++||+
T Consensus 123 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~ 202 (265)
T cd06631 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMA 202 (265)
T ss_pred cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999998653211 11122356889999999999989999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhc-CCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFEN-GNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+|+.||....... . ....... +.... .+......+.+++.+||+.+|++||++.|+++
T Consensus 203 ~g~~p~~~~~~~~-----~-~~~~~~~~~~~~~------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 203 TGKPPLASMDRLA-----A-MFYIGAHRGLMPR------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hCCCccccCChHH-----H-HHHhhhccCCCCC------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 9999986432111 0 0111111 11111 12234567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=259.86 Aligned_cols=210 Identities=26% Similarity=0.373 Sum_probs=164.6
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEe------ceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLE------VSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGIL 582 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~ 582 (757)
..++..|+.+++++ +|+|++++++++.. .+..++||||+++|+|.+++.... ..+++..+..++.|++.||.
T Consensus 56 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~ 135 (282)
T cd06636 56 EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135 (282)
T ss_pred HHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHH
Confidence 35788899999999 79999999999853 457899999999999999986533 45788888999999999999
Q ss_pred HhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc-----CCCCCccccchh
Q 038168 583 YLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR-----NLPITVKADVYS 657 (757)
Q Consensus 583 yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S 657 (757)
|||+. +|+|+||||+||++++++.+||+|||++........ ......|+..|+|||.+. +..++.++||||
T Consensus 136 ~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvws 211 (282)
T cd06636 136 HLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWS 211 (282)
T ss_pred HHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhH
Confidence 99998 999999999999999999999999999886543211 122356889999999875 346788999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 658 FGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 658 ~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||++++||++|+.||....+.... ... ..... +..........+.+++.+||+.+|.+||++.|+++
T Consensus 212 lG~~l~el~~g~~p~~~~~~~~~~------~~~-~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 212 LGITAIEMAEGAPPLCDMHPMRAL------FLI-PRNPP-----PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HHHHHHHHHhCCCCccccCHHhhh------hhH-hhCCC-----CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 999999999999998643321110 111 11111 11111233467899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=254.43 Aligned_cols=216 Identities=26% Similarity=0.414 Sum_probs=173.7
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP--EKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..+.+.+|++++++++|+|++++++.+...+..++|+|++++++|.+++... ...+++.....++.|++.||+|||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~ 121 (267)
T cd06610 42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121 (267)
T ss_pred HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4578999999999999999999999999999999999999999999999654 24688999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc---eecccccCccccCcccccCC-CCCccccchhhHHHHH
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR---TFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLL 663 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~ 663 (757)
+++|+||||+||++++++.+||+|||++..+...... ......++..|+|||.+... .++.++||||||++++
T Consensus 122 ---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~ 198 (267)
T cd06610 122 ---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAI 198 (267)
T ss_pred ---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHH
Confidence 9999999999999999999999999999876543322 22335688999999998877 7899999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||++|+.|+....... . ....... .... .............+.+++.+|++.+|++||++.+|++
T Consensus 199 ~l~~g~~p~~~~~~~~--~----~~~~~~~-~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 199 ELATGAAPYSKYPPMK--V----LMLTLQN-DPPS-LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHhCCCCccccChhh--h----HHHHhcC-CCCC-cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 9999999987543221 1 1111111 1111 1111111234567889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=256.28 Aligned_cols=215 Identities=22% Similarity=0.349 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+|++++++++...+..++|+||+++++|.+++.+. ..+++..+..++.|++.||.|||+.
T Consensus 52 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~--- 127 (272)
T cd06629 52 VKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSK--- 127 (272)
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC---
Confidence 356889999999999999999999999999999999999999999999764 5678889999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCC--CCccccchhhHHHHHHHHh
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLP--ITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||||+||+++.++.+||+|||+++....... .......++..|+|||.+.... ++.++||||||++++|+++
T Consensus 128 ~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~ 207 (272)
T cd06629 128 GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA 207 (272)
T ss_pred CeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHh
Confidence 999999999999999999999999999986543221 1223356889999999987654 8899999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|..|+...... +......... ..... +..........+.+++.+|++.+|++||++.+|++.
T Consensus 208 g~~p~~~~~~~------~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 208 GRRPWSDEEAI------AAMFKLGNKR-SAPPI-PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCCCCcCcchH------HHHHHhhccc-cCCcC-CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 99998532111 1111111111 11111 111222345788999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=243.85 Aligned_cols=253 Identities=22% Similarity=0.309 Sum_probs=194.2
Q ss_pred ccHHHHHHhhccccccccCCCch--------------------------HHHHHHHHHHHhhc-CCCceeeeeeEEEece
Q 038168 488 FSYAELEKMTDGFKEEVGRGSSG--------------------------EREFQTEMKVIGRT-HHRNLVRLLGYSLEVS 540 (757)
Q Consensus 488 ~~~~~l~~~t~~f~~~lg~g~~~--------------------------~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 540 (757)
-.|+++.+.|. +.+|+|.++ .....+|++++.+. .|+||+.|++|++++.
T Consensus 73 g~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 73 GKFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred chHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 45788888875 678888762 46788999999999 5999999999999999
Q ss_pred eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCC---CcEEEeecCC
Q 038168 541 KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN---RCAKISDFGL 617 (757)
Q Consensus 541 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~---~~~ki~DfGl 617 (757)
..|||||-|.+|.|.+++.+ ++.++..+..++.++||.||.+||.+ +|.|||+||+|||-.+. --+||+||.|
T Consensus 150 ~FYLVfEKm~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred eEEEEEecccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccc
Confidence 99999999999999999975 45678888999999999999999999 99999999999999654 3589999998
Q ss_pred ccccCCC------CcceecccccCccccCccccc-----CCCCCccccchhhHHHHHHHHhCCCCCCCCCCCc-------
Q 038168 618 AKLMKPD------QTRTFTGIRGTRGYVAPEWHR-----NLPITVKADVYSFGVVLLEIICRRRCLDPNLPDD------- 679 (757)
Q Consensus 618 a~~~~~~------~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~------- 679 (757)
..-+.-. ........+|+..|||||+.. ...|..+.|.||||||+|-|++|..||.+...++
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 8754322 122334467899999999763 3468899999999999999999999998876643
Q ss_pred -cccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH-----HhhcCcCCCCCCCC
Q 038168 680 -QVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL-----MLEGTVEIPIPPNP 750 (757)
Q Consensus 680 -~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~-----~Le~~~~~~~p~~p 750 (757)
-..=.+.+.+.+.+|++...-.. -.....+..+++...+..++.+|.+..+|+. +......+|.|++-
T Consensus 306 ~Cr~CQ~~LFesIQEGkYeFPdkd---WahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~v~ 379 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGKYEFPDKD---WAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQVL 379 (463)
T ss_pred ccHHHHHHHHHHHhccCCcCChhh---hHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCCccc
Confidence 11122334455566666533211 1223445566677778899999999999987 33334556666554
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=258.15 Aligned_cols=204 Identities=23% Similarity=0.275 Sum_probs=169.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++++.+++..++||||+++++|.+++... ..++...+..++.|++.||.|||+.
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~--- 120 (290)
T cd05580 45 VEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSL--- 120 (290)
T ss_pred HHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 456889999999999999999999999999999999999999999998654 5678899999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+++|+||+|+||++++++.+||+|||+++..... .....++..|+|||.+.+...+.++||||||+++++|++|+.
T Consensus 121 ~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 196 (290)
T cd05580 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYP 196 (290)
T ss_pred CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999999876544 223467899999999988889999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~ 736 (757)
|+..... ....+....+... .+......+.+++.+||+.+|++|| +++|+++
T Consensus 197 p~~~~~~-------~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 197 PFFDDNP-------IQIYEKILEGKVR-------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CCCCCCH-------HHHHHHHhcCCcc-------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 9865431 1111222222211 1222346788999999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=257.45 Aligned_cols=209 Identities=21% Similarity=0.343 Sum_probs=171.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+|++++++++...+..++|+||+++++|.+++.. ..+++.++..++.|++.||+|||+.
T Consensus 60 ~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~--- 134 (285)
T cd06648 60 RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQ--- 134 (285)
T ss_pred HHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 45688999999999999999999999999999999999999999999865 5688999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+++||||||+||+++.++.+||+|||++........ ......|+..|+|||...+..++.++||||||++++||++|+.
T Consensus 135 ~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~ 213 (285)
T cd06648 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213 (285)
T ss_pred CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999876543322 1223457899999999998889999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|+....+. ... .....+....... .......+.+++.+|++.+|++||++.++++
T Consensus 214 p~~~~~~~------~~~-~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 214 PYFNEPPL------QAM-KRIRDNLPPKLKN----LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCcCCCHH------HHH-HHHHhcCCCCCcc----cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 98643221 111 1122221111111 1123467999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=255.53 Aligned_cols=208 Identities=26% Similarity=0.382 Sum_probs=170.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+|++++++++.+....++|+||+++++|.+++.+. ..+++..+..++.|++.||+|||+.
T Consensus 46 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--- 121 (258)
T cd06632 46 VKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDR--- 121 (258)
T ss_pred HHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 467889999999999999999999999999999999999999999998653 4578999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCC-CCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP-ITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++|+||+|+||+++.++.+||+|||++....... ......++..|++||.+.... ++.++|+||||+++++|++|+
T Consensus 122 ~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~ 199 (258)
T cd06632 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199 (258)
T ss_pred CcccCCCCHHHEEECCCCCEEEccCccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCC
Confidence 99999999999999999999999999998764433 223356788999999987776 899999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
.|+...... ............. ..+......+.+++.+|++.+|++||++.++++
T Consensus 200 ~pf~~~~~~------~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 200 PPWSQLEGV------AAVFKIGRSKELP------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCcccCcHH------HHHHHHHhcccCC------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 998654311 1111111111111 112233467888999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=255.96 Aligned_cols=208 Identities=21% Similarity=0.212 Sum_probs=163.5
Q ss_pred HHHHHHHHHHh---hcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 512 REFQTEMKVIG---RTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 512 ~~~~~E~~~l~---~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
+.+.+|..++. ..+|+|++++++.+...+..++||||+++++|.+++.. ...+++.+...++.|++.||+|||+.
T Consensus 39 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~- 116 (279)
T cd05633 39 TLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNR- 116 (279)
T ss_pred HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34445554443 34799999999999999999999999999999998864 34689999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc-CCCCCccccchhhHHHHHHHHh
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR-NLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+|+||||+|||+++++.+||+|||++........ ....|+..|+|||... +..++.++||||||++++||++
T Consensus 117 --~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 191 (279)
T cd05633 117 --FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191 (279)
T ss_pred --CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHh
Confidence 999999999999999999999999999976543221 2346899999999886 4568999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLLM 737 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~~ 737 (757)
|+.||..........+ ...... .+...+.....++.+++.+|++.||++|| ++.|++++
T Consensus 192 g~~pf~~~~~~~~~~~----~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 192 GHSPFRQHKTKDKHEI----DRMTLT-------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCCCcCCCCCcCHHHH----HHHhhc-------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 9999975443222111 111100 01112233456788999999999999999 69999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=254.91 Aligned_cols=213 Identities=27% Similarity=0.397 Sum_probs=170.9
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|++++++++|+||+++++++.+.+..++|+||+++++|.+++.+. ..+++..+..++.++++||+|||+.
T Consensus 42 ~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~-- 118 (264)
T cd06626 42 TIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSH-- 118 (264)
T ss_pred HHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHC--
Confidence 4577899999999999999999999999999999999999999999998653 4578899999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCccee---cccccCccccCcccccCCC---CCccccchhhHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF---TGIRGTRGYVAPEWHRNLP---ITVKADVYSFGVVLL 663 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~---~~~k~Dv~S~G~~l~ 663 (757)
+++|+||+|+||++++++.+||+|||++........... ....++..|+|||++.+.. .+.++||||||++++
T Consensus 119 -~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~ 197 (264)
T cd06626 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVL 197 (264)
T ss_pred -CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHH
Confidence 999999999999999999999999999987754433221 1356788999999998766 899999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|+++|+.||....... ..... ...+....+.. .......+.+++.+|++.+|++||++.|++.
T Consensus 198 ~l~~g~~pf~~~~~~~-----~~~~~-~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 198 EMATGKRPWSELDNEF-----QIMFH-VGAGHKPPIPD----SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHhCCCCccCCcchH-----HHHHH-HhcCCCCCCCc----ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 9999999986432111 11111 11111111111 1122456789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=262.83 Aligned_cols=218 Identities=21% Similarity=0.256 Sum_probs=166.1
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|++++++++|+|++++++++.+.+..++|+||++ ++|.+++......+++.....++.||++||.|||+. +
T Consensus 44 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ 119 (284)
T cd07839 44 SSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---N 119 (284)
T ss_pred cchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 457789999999999999999999999999999999997 578888766566789999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
++|+||||+||+++.++.+||+|||+++....... ......++..|+|||.+.+. .++.++||||||++++||++|+.
T Consensus 120 i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~ 198 (284)
T cd07839 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198 (284)
T ss_pred EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999986543321 12234568899999988765 47899999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHH-----------hc-CCcccccccc------ccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCF-----------EN-GNLSQLVEDE------EVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~-----------~~-~~~~~~~d~~------~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
|+....... ..+. ...... .. .......... ........++.+++.+||+.||.+|||++
T Consensus 199 p~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ 276 (284)
T cd07839 199 PLFPGNDVD-DQLK-RIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAE 276 (284)
T ss_pred CCcCCCCHH-HHHH-HHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHH
Confidence 865432211 1110 000000 00 0000000000 00112346788999999999999999999
Q ss_pred HHHH
Q 038168 733 KVLL 736 (757)
Q Consensus 733 eVl~ 736 (757)
|+++
T Consensus 277 ~il~ 280 (284)
T cd07839 277 EALQ 280 (284)
T ss_pred HHhc
Confidence 9976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=267.83 Aligned_cols=206 Identities=27% Similarity=0.353 Sum_probs=172.4
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
.++.+||..|.+++|||+|.+-|++..+...|||||||- |+-.|++.-..+.+...++..|..|.+.||+|||+. .
T Consensus 71 qDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~ 146 (948)
T KOG0577|consen 71 QDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---N 146 (948)
T ss_pred HHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---h
Confidence 678999999999999999999999999999999999995 577788876778888999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc---CCCCCccccchhhHHHHHHHHhC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR---NLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~G~~l~elltG 668 (757)
.||||||+.||||.+.+.|||+|||.|.++.+. ..++||+.|||||++. .+.|+-|+||||+||+..||.-.
T Consensus 147 ~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAER 221 (948)
T KOG0577|consen 147 RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 221 (948)
T ss_pred HHhhhccccceEecCCCeeeeccccchhhcCch-----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhc
Confidence 999999999999999999999999999886543 3478999999999875 56899999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~L 738 (757)
++|...... +. +...+....- |.....+-...+..++..||+.-|.+|||.+++++.-
T Consensus 222 kPPlFnMNA---MS----ALYHIAQNes-----PtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 222 KPPLFNMNA---MS----ALYHIAQNES-----PTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred CCCccCchH---HH----HHHHHHhcCC-----CCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 988753211 11 1111121111 1122456678899999999999999999999988753
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=262.33 Aligned_cols=221 Identities=25% Similarity=0.361 Sum_probs=167.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++++...+..++|+||+++++|.++... ...+++.++..++.|++.||+|||+.
T Consensus 44 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~--- 119 (286)
T cd07846 44 KKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSH--- 119 (286)
T ss_pred hHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 45688999999999999999999999999999999999999999887644 34589999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++|+||+|+||++++++.+||+|||++....... .......++..|+|||+..+ ..++.++||||||++++||++|+
T Consensus 120 ~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~ 198 (286)
T cd07846 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198 (286)
T ss_pred CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999998764433 22233557889999999875 45788999999999999999999
Q ss_pred CCCCCCCCCcccc-HHH-------HHHHHHhcCC------cccccccc---ccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 670 RCLDPNLPDDQVI-LEE-------WVYQCFENGN------LSQLVEDE---EVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 670 ~p~~~~~~~~~~~-l~~-------~~~~~~~~~~------~~~~~d~~---~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
+|+......+... ... .....+.... ........ .........+.+++.+||+.+|++||++.
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~ 278 (286)
T cd07846 199 PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS 278 (286)
T ss_pred CCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHH
Confidence 8886432211000 000 0000000000 00000000 00112356789999999999999999999
Q ss_pred HHHH
Q 038168 733 KVLL 736 (757)
Q Consensus 733 eVl~ 736 (757)
+|++
T Consensus 279 ~il~ 282 (286)
T cd07846 279 QLLH 282 (286)
T ss_pred HHhc
Confidence 9886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=256.84 Aligned_cols=210 Identities=22% Similarity=0.314 Sum_probs=169.4
Q ss_pred hHHHHHHHHHHHhhcC---CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 510 GEREFQTEMKVIGRTH---HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
..+++.+|+.++++++ |+|++++++++.++...++||||+++++|.+++.. ..+++.....++.|++.||.|||+
T Consensus 42 ~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~ 119 (277)
T cd06917 42 DVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHK 119 (277)
T ss_pred hHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3467889999999997 99999999999999999999999999999999854 368899999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHH
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEI 665 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~el 665 (757)
. +++|+||+|+||++++++.++|+|||++........ ......|+..|+|||.+.+. .++.++||||||+++++|
T Consensus 120 ~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l 195 (277)
T cd06917 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEM 195 (277)
T ss_pred C---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHH
Confidence 8 999999999999999999999999999987654432 22334688899999988654 578999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++|+.|+........ .. .........+ ........+.+++.+|++.+|++||++.|+++.
T Consensus 196 l~g~~p~~~~~~~~~------~~-~~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 196 ATGNPPYSDVDAFRA------MM-LIPKSKPPRL-----EDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HhCCCCCCCCChhhh------hh-ccccCCCCCC-----CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 999999875322111 10 0111111111 111244678899999999999999999999873
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=254.77 Aligned_cols=213 Identities=25% Similarity=0.419 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++++.+.+..++|+||+++++|.+++.+ ...+++..+..++.|++.||+|||+.
T Consensus 47 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~--- 122 (268)
T cd06630 47 VEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHEN--- 122 (268)
T ss_pred HHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 46789999999999999999999999999999999999999999999864 34678899999999999999999998
Q ss_pred CeeeCCCCcceEEECCCC-cEEEeecCCccccCCCCcc---eecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 591 QIIHCDIKPQNILMDENR-CAKISDFGLAKLMKPDQTR---TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~-~~ki~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+++|+||||+||+++.++ .+||+|||++..+...... ......++..|+|||.+.+..++.++||||+|+++++|+
T Consensus 123 ~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 202 (268)
T cd06630 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMA 202 (268)
T ss_pred CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHH
Confidence 999999999999998775 6999999999876543211 112346788999999998888999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+|+.|+......... ....+..... .....+......+.+++.+|++.+|++||++.|+++
T Consensus 203 ~g~~p~~~~~~~~~~---~~~~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 203 TAKPPWNAEKHSNHL---ALIFKIASAT------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred hCCCCCCCCCCcchH---HHHHHHhccC------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 999998643322111 1111111111 112233445677899999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=268.55 Aligned_cols=214 Identities=23% Similarity=0.335 Sum_probs=161.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec------eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV------SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.+.+|+.++++++|+||+++++++... ...++++|++ +++|.+++. ...+++..+..++.||+.||+||
T Consensus 58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~L 134 (343)
T cd07878 58 ARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYI 134 (343)
T ss_pred HHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999987543 3568999987 778988874 34688999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLL 663 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~ 663 (757)
|+. +|+||||||+|||+++++.+||+|||+++..... .....||..|+|||.+.+ ..++.++||||||++++
T Consensus 135 H~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 207 (343)
T cd07878 135 HSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 207 (343)
T ss_pred HHC---CeecccCChhhEEECCCCCEEEcCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHH
Confidence 998 9999999999999999999999999999865432 234568999999999877 56899999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHh-----------cCCccccccc-cccC--------HHHHHHHHHHHHHcccc
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFE-----------NGNLSQLVED-EEVD--------EKQLERMIKVALWCILD 723 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~-----------~~~~~~~~d~-~~~~--------~~~~~~l~~l~~~cl~~ 723 (757)
||++|+.||......+. +.. ...... .......... ...+ ......+.+++.+|++.
T Consensus 208 el~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~ 284 (343)
T cd07878 208 ELLKGKALFPGNDYIDQ--LKR-IMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVL 284 (343)
T ss_pred HHHHCCCCCCCCCHHHH--HHH-HHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCC
Confidence 99999999865322110 000 000000 0000000000 0000 01123478999999999
Q ss_pred CCCCCCCHHHHHHH
Q 038168 724 EPSLRPSMKKVLLM 737 (757)
Q Consensus 724 ~p~~RPsm~eVl~~ 737 (757)
||++|||+.|+++.
T Consensus 285 dp~~R~s~~ell~h 298 (343)
T cd07878 285 DSDKRISASEALAH 298 (343)
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=278.15 Aligned_cols=217 Identities=19% Similarity=0.284 Sum_probs=158.6
Q ss_pred HHHHHHHHHHhhcCCC------ceeeeeeEEEec-eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 512 REFQTEMKVIGRTHHR------NLVRLLGYSLEV-SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~------niv~l~g~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
+++..|++++++++|. +++++++++... ...++|||++ +++|.+++.+. ..+++.++..|+.||+.||+||
T Consensus 170 ~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yL 247 (467)
T PTZ00284 170 RDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYF 247 (467)
T ss_pred HHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH
Confidence 3566788888887654 588999988764 4788999988 67888888653 5688999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCC----------------cEEEeecCCccccCCCCcceecccccCccccCcccccCCC
Q 038168 585 HDECETQIIHCDIKPQNILMDENR----------------CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP 648 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~----------------~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 648 (757)
|++ .+|+||||||+|||++.++ .+||+|||++..... ......||..|+|||++.+..
T Consensus 248 H~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~ 321 (467)
T PTZ00284 248 HTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLG 321 (467)
T ss_pred Hhc--CCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCC
Confidence 973 2899999999999998765 499999998864322 223467899999999999999
Q ss_pred CCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHH---------HHH--------HHHhc-CCccccccccc------
Q 038168 649 ITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEE---------WVY--------QCFEN-GNLSQLVEDEE------ 704 (757)
Q Consensus 649 ~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~---------~~~--------~~~~~-~~~~~~~d~~~------ 704 (757)
++.++|||||||++|||++|+.||......+...+.. |.. ..+.. +.+....++..
T Consensus 322 ~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (467)
T PTZ00284 322 WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIAR 401 (467)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhc
Confidence 9999999999999999999999997644322111110 000 00000 00000001000
Q ss_pred ----cCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 705 ----VDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 705 ----~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
........+.+++.+||+.||++|||++|+++
T Consensus 402 ~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 402 ARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred ccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 00112345789999999999999999999997
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=257.22 Aligned_cols=213 Identities=25% Similarity=0.391 Sum_probs=173.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|++++++++|+|++++++.+...+..++|+||+++++|.+++......+++..+..++.|++.||+|||+.
T Consensus 58 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-- 135 (286)
T cd06614 58 NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ-- 135 (286)
T ss_pred hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 456788999999999999999999999999999999999999999999976555789999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++|+||||+||+++.++.+||+|||++........ ......++..|++||.+.+..++.++||||||+++++|++|+
T Consensus 136 -gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~ 213 (286)
T cd06614 136 -NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE 213 (286)
T ss_pred -CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCC
Confidence 999999999999999999999999999876543321 112345788999999999888999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
.|+....+.. ..... .......... .......+.+++.+|++.+|.+||++.+|++.
T Consensus 214 ~p~~~~~~~~------~~~~~-~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 214 PPYLREPPLR------ALFLI-TTKGIPPLKN----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CCCCCCCHHH------HHHHH-HhcCCCCCcc----hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 9986432211 11111 1111211111 11234678899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=255.49 Aligned_cols=208 Identities=27% Similarity=0.401 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+||+++++++.+++..++||||+++++|.+++.. ..+++.....++.|++.+|.|||+.
T Consensus 46 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~--- 120 (277)
T cd06641 46 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSE--- 120 (277)
T ss_pred HHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccC---
Confidence 46788999999999999999999999999999999999999999999854 4578999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+++|+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||++++||++|..
T Consensus 121 ~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 199 (277)
T cd06641 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEP 199 (277)
T ss_pred CeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999999986643321 1222457889999999998889999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|+...... . .......+... .........+.+++.+|++.+|++||++.++++.
T Consensus 200 p~~~~~~~------~-~~~~~~~~~~~------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 200 PHSELHPM------K-VLFLIPKNNPP------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCccchH------H-HHHHHhcCCCC------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 88643221 1 11111111111 1122345668899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=259.79 Aligned_cols=218 Identities=23% Similarity=0.316 Sum_probs=169.7
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
+.+.+|++++++++|+|++++++++.+. +..++|+||+++ +|.+++......+++.++..++.|+++||+|||+.
T Consensus 43 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-- 119 (287)
T cd07840 43 ITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN-- 119 (287)
T ss_pred HHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 5688999999999999999999999988 789999999985 89998876556789999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHHHhC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~elltG 668 (757)
+++|+||||+||++++++.+||+|||++...............++..|+|||.+.+ ..++.++||||||++++||++|
T Consensus 120 -~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~ 198 (287)
T cd07840 120 -GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198 (287)
T ss_pred -CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999998776554333344556888999998765 4678999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhc---CCcccccc--------cc---------ccCHHHHHHHHHHHHHccccCCCCC
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFEN---GNLSQLVE--------DE---------EVDEKQLERMIKVALWCILDEPSLR 728 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~d--------~~---------~~~~~~~~~l~~l~~~cl~~~p~~R 728 (757)
+.|+......... ..+...... .......+ +. .....+...+.+++.+|++.+|++|
T Consensus 199 ~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 275 (287)
T cd07840 199 KPIFQGSTELEQL---EKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKR 275 (287)
T ss_pred CCCCCCCChHHHH---HHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhC
Confidence 9998754432111 001110000 00000000 00 0011125678999999999999999
Q ss_pred CCHHHHHH
Q 038168 729 PSMKKVLL 736 (757)
Q Consensus 729 Psm~eVl~ 736 (757)
|+++++++
T Consensus 276 p~~~~~l~ 283 (287)
T cd07840 276 ISADQALQ 283 (287)
T ss_pred cCHHHHhh
Confidence 99999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=258.67 Aligned_cols=211 Identities=25% Similarity=0.360 Sum_probs=172.1
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++|||++++++.+...+..++|+||+++++|.+++.+ ..+++.++..++.|++.||.|||+.
T Consensus 59 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~-- 134 (293)
T cd06647 59 KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN-- 134 (293)
T ss_pred HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 346789999999999999999999999999999999999999999999854 3578899999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++|+||||+||+++.++.+||+|||++........ ......++..|+|||.+.+..++.++||||||++++|+++|+
T Consensus 135 -gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~ 212 (293)
T cd06647 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (293)
T ss_pred -CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999876554332 122345788999999998888999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
.||.......... .....+. .... ........+.+++.+||+.+|++||++.+++.+
T Consensus 213 ~pf~~~~~~~~~~------~~~~~~~-~~~~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 213 PPYLNENPLRALY------LIATNGT-PELQ----NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCCChhhhee------ehhcCCC-CCCC----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9997543322111 1111111 1110 112234568899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=259.63 Aligned_cols=207 Identities=28% Similarity=0.358 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+++.+|++++++++|+|++++++++.+.+..++|+||++ |+|.+++......+++.++..++.|++.||.|||+.
T Consensus 59 ~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~--- 134 (307)
T cd06607 59 WQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH--- 134 (307)
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 3578899999999999999999999999999999999997 577777755556789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc---CCCCCccccchhhHHHHHHHHh
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR---NLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||+|+||++++++.+||+|||++....... ...++..|+|||.+. ...++.++||||||+++|||++
T Consensus 135 ~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~t 209 (307)
T cd06607 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209 (307)
T ss_pred CceecCCCcccEEECCCCCEEEeecCcceecCCCC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHc
Confidence 99999999999999999999999999997654322 245788999999874 4568899999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~L 738 (757)
|+.|+...... ...... ...... ..........+.+++.+||+.+|++||+|.+|+...
T Consensus 210 g~~p~~~~~~~------~~~~~~-~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 210 RKPPLFNMNAM------SALYHI-AQNDSP-----TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CCCCCCCccHH------HHHHHH-hcCCCC-----CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 99988643211 111111 111111 111223456789999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=260.40 Aligned_cols=212 Identities=20% Similarity=0.230 Sum_probs=170.4
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+.+.+|++++++++|+||+++++.+.+.+..++||||+.+++|.+++... ...+++..+..++.|++.||+|||+.
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~- 122 (316)
T cd05574 44 KVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL- 122 (316)
T ss_pred HHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3467889999999999999999999999999999999999999999998653 35688999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc----------------------------eecccccCccccC
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR----------------------------TFTGIRGTRGYVA 640 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~----------------------------~~~~~~gt~~y~a 640 (757)
+++|+||||+||+++.++.++|+|||++......... ......|+..|+|
T Consensus 123 --~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~a 200 (316)
T cd05574 123 --GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIA 200 (316)
T ss_pred --CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcC
Confidence 9999999999999999999999999998765322110 1112467889999
Q ss_pred cccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHc
Q 038168 641 PEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWC 720 (757)
Q Consensus 641 PE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~c 720 (757)
||++.+..++.++||||||+++++|++|+.|+....... .+ .... ....... ........+.+++.+|
T Consensus 201 PE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~----~~~~-~~~~~~~-----~~~~~~~~~~~li~~~ 268 (316)
T cd05574 201 PEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE--TF----SNIL-KKEVTFP-----GSPPVSSSARDLIRKL 268 (316)
T ss_pred HHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH--HH----HHHh-cCCccCC-----CccccCHHHHHHHHHH
Confidence 999999899999999999999999999999987543221 11 1111 1111100 0112457899999999
Q ss_pred cccCCCCCCC----HHHHHH
Q 038168 721 ILDEPSLRPS----MKKVLL 736 (757)
Q Consensus 721 l~~~p~~RPs----m~eVl~ 736 (757)
++.+|++||+ ++|++.
T Consensus 269 l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 269 LVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ccCCHhHCCCchhhHHHHHc
Confidence 9999999999 666666
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=253.44 Aligned_cols=211 Identities=25% Similarity=0.299 Sum_probs=170.9
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|++++++++|+||+++++.+.+++..++|+||+++++|.+++.+. ..+++..+..++.|++.||+|||+.
T Consensus 36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~-- 112 (262)
T cd05572 36 QQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNR-- 112 (262)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC--
Confidence 3467899999999999999999999999999999999999999999999653 4578899999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++|+||||+||+++.++.+||+|||++....... ......++..|++||.+.+..++.++|+||||++++||++|.
T Consensus 113 -~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~ 189 (262)
T cd05572 113 -GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189 (262)
T ss_pred -CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCC
Confidence 99999999999999999999999999998765432 122345788999999998888999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS-----MKKVLL 736 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----m~eVl~ 736 (757)
.|+.....+.. +....... +. +....+......+.+++.+||+.+|++||+ +.|+++
T Consensus 190 ~p~~~~~~~~~----~~~~~~~~-~~-----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 190 PPFGEDDEDPM----EIYNDILK-GN-----GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCcCCCCCCHH----HHHHHHhc-cC-----CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 99876543211 11111111 11 011112223568999999999999999999 555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=253.38 Aligned_cols=211 Identities=24% Similarity=0.359 Sum_probs=171.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+.+.+|++++++++|+|++++++.+.+.+..++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.
T Consensus 42 ~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~- 120 (257)
T cd08225 42 EKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR- 120 (257)
T ss_pred hhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 35678899999999999999999999999999999999999999999986543 4579999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCC-cEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 589 ETQIIHCDIKPQNILMDENR-CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~-~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||||+||++++++ .+||+|||.+........ ......|+..|+|||+..+..++.++||||||++++||++
T Consensus 121 --~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08225 121 --KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197 (257)
T ss_pred --CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999999885 579999999987654322 1222457889999999988889999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|..|+..... .+.+.+.. .+..... .......+.+++.+|++.+|++|||+.||++.
T Consensus 198 g~~p~~~~~~------~~~~~~~~-~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 198 LKHPFEGNNL------HQLVLKIC-QGYFAPI------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCccH------HHHHHHHh-cccCCCC------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 9999864321 12222222 1221111 12234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=253.89 Aligned_cols=209 Identities=26% Similarity=0.279 Sum_probs=172.1
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|++++++++||||+++++++.+++..++|+||+++++|.+++... ..++..+...++.|+++||.|||+.
T Consensus 43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~-- 119 (258)
T cd05578 43 SVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSK-- 119 (258)
T ss_pred HHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhC--
Confidence 4578999999999999999999999999999999999999999999998654 5678899999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++|+||||+||++++++.++|+|||++....... ......++..|+|||.+.+...+.++||||||+++++|++|+
T Consensus 120 -~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~ 196 (258)
T cd05578 120 -GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK 196 (258)
T ss_pred -CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCC
Confidence 99999999999999999999999999998765432 123356788999999999888999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM--KKVL 735 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm--~eVl 735 (757)
.|+........ +........ .....+......+.+++.+|++.+|.+||+. +|++
T Consensus 197 ~p~~~~~~~~~----~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 197 RPYRGHSRTIR----DQIRAKQET-------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CCCCCCCccHH----HHHHHHhcc-------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 99876544311 111121111 1111222344788899999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=259.70 Aligned_cols=217 Identities=19% Similarity=0.258 Sum_probs=164.4
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 038168 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQI 592 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 592 (757)
.+.+|++++++++|+||+++++++.+.+..++||||+++ +|.+++......+++.....++.|++.||.|||+. +|
T Consensus 49 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i 124 (291)
T cd07844 49 TAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RV 124 (291)
T ss_pred hHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 467899999999999999999999999999999999985 99998876666788999999999999999999998 99
Q ss_pred eeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHHHhCCCC
Q 038168 593 IHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICRRRC 671 (757)
Q Consensus 593 iH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~elltG~~p 671 (757)
+||||||+||+++.++.+||+|||+++....... ......++..|+|||.+.+ ..++.++||||+|++++||++|+.|
T Consensus 125 ~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~ 203 (291)
T cd07844 125 LHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPL 203 (291)
T ss_pred ecccCCHHHEEEcCCCCEEECccccccccCCCCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999875432211 1122346788999998875 4588999999999999999999999
Q ss_pred CCCCCCCccccHHHHHHHHHhcC---Cc---------cc----cccccc-----cCHHHHHHHHHHHHHccccCCCCCCC
Q 038168 672 LDPNLPDDQVILEEWVYQCFENG---NL---------SQ----LVEDEE-----VDEKQLERMIKVALWCILDEPSLRPS 730 (757)
Q Consensus 672 ~~~~~~~~~~~l~~~~~~~~~~~---~~---------~~----~~d~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs 730 (757)
|....... .........+... .. .. ...+.. ........+.+++.+|++.+|++||+
T Consensus 204 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps 281 (291)
T cd07844 204 FPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS 281 (291)
T ss_pred CCCCccHH--HHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC
Confidence 86443111 0001011111000 00 00 000000 00111256789999999999999999
Q ss_pred HHHHHH
Q 038168 731 MKKVLL 736 (757)
Q Consensus 731 m~eVl~ 736 (757)
+.|+++
T Consensus 282 ~~e~l~ 287 (291)
T cd07844 282 AAEAMK 287 (291)
T ss_pred HHHHhc
Confidence 999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-28 Score=250.65 Aligned_cols=213 Identities=27% Similarity=0.391 Sum_probs=175.4
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-CC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD-EC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~ 588 (757)
..+.+.+|+..+.+++|+|++++++++...+..++|+||+++++|.+++... ..++...+..++.|+++||+|||+ .
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~- 119 (264)
T cd06623 42 FRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKR- 119 (264)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccC-
Confidence 3577899999999999999999999999999999999999999999999653 567899999999999999999999 8
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
+++|+||+|+||+++.++.++|+|||++.......... ....++..|+|||.+.+..++.++||||||++++||++|
T Consensus 120 --~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg 196 (264)
T cd06623 120 --HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALG 196 (264)
T ss_pred --CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999998765433221 234578899999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEK-QLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~-~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+.|+....... ..+..... ....... .+.. ....+.+++..|++++|++||++.|+++.
T Consensus 197 ~~p~~~~~~~~---~~~~~~~~-~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 197 KFPFLPPGQPS---FFELMQAI-CDGPPPS------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCccccccC---HHHHHHHH-hcCCCCC------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 99987654311 11111111 1111111 1222 45789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=248.54 Aligned_cols=212 Identities=25% Similarity=0.419 Sum_probs=174.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|++++++++|+|++++++++...+..++++||+++++|.+++......+++..+..++.|++.+|+|||..
T Consensus 40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-- 117 (253)
T cd05122 40 KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN-- 117 (253)
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC--
Confidence 456789999999999999999999999999999999999999999999976556789999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++|+||+|+||++++++.+||+|||.+........ .....++..|++||.+.+...+.++||||||+++++|++|+
T Consensus 118 -~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~ 194 (253)
T cd05122 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194 (253)
T ss_pred -CEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999987655432 23356788999999999888999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
.|+........ .. ............. ......+.+++.+|++.+|++|||+.|+++.
T Consensus 195 ~p~~~~~~~~~------~~-~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 195 PPYSELPPMKA------LF-KIATNGPPGLRNP----EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CCCCCCchHHH------HH-HHHhcCCCCcCcc----cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 98875432111 11 1111111111111 1124678999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-29 Score=266.89 Aligned_cols=206 Identities=24% Similarity=0.343 Sum_probs=173.3
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|+++|+.|+|||||+++.+.......|+||||+.+|.+.+|+.+++...+ .....+..|+.++++|||++ .
T Consensus 100 ~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYcH~k---~ 175 (596)
T KOG0586|consen 100 QKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYCHSK---N 175 (596)
T ss_pred HHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHHhhc---c
Confidence 4588999999999999999999999999999999999999999999988766655 88888999999999999999 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCC-CccccchhhHHHHHHHHhCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~G~~l~elltG~~ 670 (757)
|+|||||++||||+.+.++||+|||++..+... ......+|++.|.|||.+.+.++ ++++|+||+|+++|-|++|..
T Consensus 176 ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsL 253 (596)
T KOG0586|consen 176 IVHRDLKAENILLDENMNIKIADFGFSTFFDYG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSL 253 (596)
T ss_pred eeccccchhhcccccccceeeeccccceeeccc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeeccc
Confidence 999999999999999999999999999887632 33455789999999999999876 689999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
||++..-.+- .+....+++. ++.-...++-+++.++|..+|.+|++++++.+.
T Consensus 254 PFDG~~lk~L-------r~rvl~gk~r-------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 254 PFDGQNLKEL-------RPRVLRGKYR-------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccCCcccccc-------cchheeeeec-------ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 9986543220 1111112111 222334568899999999999999999999763
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=259.13 Aligned_cols=223 Identities=19% Similarity=0.221 Sum_probs=170.1
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+.+.+|++++++++|+||+++++++.+.+..+++|||+++++|.+++... ...++......++.|++.||+|||+.
T Consensus 42 ~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~- 120 (314)
T cd08216 42 DLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK- 120 (314)
T ss_pred HHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3467899999999999999999999999999999999999999999999754 34578888899999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc------ceecccccCccccCcccccC--CCCCccccchhhHH
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT------RTFTGIRGTRGYVAPEWHRN--LPITVKADVYSFGV 660 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~G~ 660 (757)
+|+||||||+||+++.++.+||+|||.+........ .......++..|+|||++.. ..++.++||||||+
T Consensus 121 --~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~ 198 (314)
T cd08216 121 --GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGI 198 (314)
T ss_pred --CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHH
Confidence 999999999999999999999999999875532211 11123456788999999876 35889999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccccHHHHHHHH----Hh-------cCCccc----cccc-------cccCHHHHHHHHHHHH
Q 038168 661 VLLEIICRRRCLDPNLPDDQVILEEWVYQC----FE-------NGNLSQ----LVED-------EEVDEKQLERMIKVAL 718 (757)
Q Consensus 661 ~l~elltG~~p~~~~~~~~~~~l~~~~~~~----~~-------~~~~~~----~~d~-------~~~~~~~~~~l~~l~~ 718 (757)
+++||++|+.||....... .+.+..... +. ...... ..++ .........++.+++.
T Consensus 199 il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 276 (314)
T cd08216 199 TACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVE 276 (314)
T ss_pred HHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHH
Confidence 9999999999987533211 111100000 00 000000 0000 0112233467889999
Q ss_pred HccccCCCCCCCHHHHHHH
Q 038168 719 WCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 719 ~cl~~~p~~RPsm~eVl~~ 737 (757)
+||+.||++|||++|+++.
T Consensus 277 ~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 277 LCLQRDPESRPSASQLLNH 295 (314)
T ss_pred HHhhcCCCcCcCHHHHhcC
Confidence 9999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=253.35 Aligned_cols=215 Identities=26% Similarity=0.329 Sum_probs=174.2
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|++++++++|+||+++++.+..+...++|+||+++++|.+++.+.. .+++..+..++.|++.||+|||+.
T Consensus 36 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~-- 112 (265)
T cd05579 36 QVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSN-- 112 (265)
T ss_pred HHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHc--
Confidence 35678899999999999999999999999999999999999999999996543 689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-------ceecccccCccccCcccccCCCCCccccchhhHHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-------RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l 662 (757)
+++|+||+|+||++++++.+||+|||++........ .......++..|++||.......+.++||||||+++
T Consensus 113 -~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~ 191 (265)
T cd05579 113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCIL 191 (265)
T ss_pred -CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHH
Confidence 999999999999999999999999999886543321 122335678899999999888899999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
+||++|+.|+...... +.. .....+...... .......+.+++.+|++.+|++|||+.+|.+.|+.
T Consensus 192 ~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~~~-----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 192 YEFLVGIPPFHGETPE------EIF-QNILNGKIEWPE-----DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred HHHHhCCCCCCCCCHH------HHH-HHHhcCCcCCCc-----cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 9999999998654321 111 112222221110 01125678999999999999999999777777753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=254.48 Aligned_cols=216 Identities=20% Similarity=0.242 Sum_probs=165.3
Q ss_pred HHHHHHHHHHhhcC-CCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 512 REFQTEMKVIGRTH-HRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 512 ~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
....+|+.++.++. |+|++++++++.+. +..++|+||++ ++|.+++......+++.++..++.|++.||+|||+.
T Consensus 42 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~- 119 (282)
T cd07831 42 VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN- 119 (282)
T ss_pred hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34567999999995 99999999999987 88999999997 588888876556789999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc-CCCCCccccchhhHHHHHHHHh
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR-NLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||||+||+++. +.+||+|||+++........ ....++..|+|||.+. +..++.++|||||||+++||++
T Consensus 120 --~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~ 194 (282)
T cd07831 120 --GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194 (282)
T ss_pred --CceecccCHHHEEEcC-CCeEEEecccccccccCCCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc
Confidence 9999999999999999 99999999999876433221 2245788999999764 4567899999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHH-----------HHHhcCCccccccccc-------cCHHHHHHHHHHHHHccccCCCCCC
Q 038168 668 RRRCLDPNLPDDQVILEEWVY-----------QCFENGNLSQLVEDEE-------VDEKQLERMIKVALWCILDEPSLRP 729 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~-----------~~~~~~~~~~~~d~~~-------~~~~~~~~l~~l~~~cl~~~p~~RP 729 (757)
|..||......+ ...... .............+.. ........+.+++.+||+.+|++||
T Consensus 195 ~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 271 (282)
T cd07831 195 LFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI 271 (282)
T ss_pred CCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCccccc
Confidence 999986543211 111111 1111111111111110 1123467899999999999999999
Q ss_pred CHHHHHHH
Q 038168 730 SMKKVLLM 737 (757)
Q Consensus 730 sm~eVl~~ 737 (757)
+++++++.
T Consensus 272 ~~~~~l~~ 279 (282)
T cd07831 272 TAKQALRH 279 (282)
T ss_pred CHHHHhhC
Confidence 99999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=253.92 Aligned_cols=205 Identities=26% Similarity=0.297 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
+...++|-++|.+++.+-||.|--.++..+..+||+..|.+|+|.-+|.+.+ ..++....+-++.+|+.||++||.+
T Consensus 229 e~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~-- 306 (591)
T KOG0986|consen 229 ETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR-- 306 (591)
T ss_pred hHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc--
Confidence 3456789999999999999999999999999999999999999999998765 4678888889999999999999999
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+||.||+||+|||||+.|.++|+|.|||..+...+. ..+.+||.||||||++.+..|+...|.||+||++|||+.|+
T Consensus 307 -~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~ 383 (591)
T KOG0986|consen 307 -RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGH 383 (591)
T ss_pred -ceeeccCChhheeeccCCCeEeeccceEEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHccc
Confidence 999999999999999999999999999998876554 34458999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS 730 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 730 (757)
.||...-..... +.+.+. -+.++..++....++...+....|+.||++|.-
T Consensus 384 sPFr~~KeKvk~---eEvdrr-------~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 384 SPFRQRKEKVKR---EEVDRR-------TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred CchhhhhhhhhH---HHHHHH-------HhcchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 999754322111 011111 122344455666677888888899999999964
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=252.05 Aligned_cols=210 Identities=22% Similarity=0.290 Sum_probs=166.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.+.+.+|++++++++|+||+++++++.+. ...++||||+++++|.+++... ..+++....+++.|++.||+|||+.
T Consensus 48 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~- 125 (265)
T cd06652 48 VNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSN- 125 (265)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 35788999999999999999999988764 4678999999999999998643 4578888899999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc--ceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT--RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+++|+||||+||+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||++++||+
T Consensus 126 --~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 203 (265)
T cd06652 126 --MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEML 203 (265)
T ss_pred --CEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHh
Confidence 999999999999999999999999999986543211 1122345889999999999888999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+|+.|+...... ....+...... ....+......+.+++.+|+. +|++||+++||++.
T Consensus 204 ~g~~p~~~~~~~------~~~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 204 TEKPPWAEFEAM------AAIFKIATQPT------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred hCCCCCCccchH------HHHHHHhcCCC------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 999998643111 11111111111 111234455677888888885 89999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=261.79 Aligned_cols=221 Identities=24% Similarity=0.302 Sum_probs=165.5
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
...+.+|+.+++++ +|+||+++++++... ...++||||++ ++|.+++... .+++..+..++.|++.||+|||+.
T Consensus 50 ~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~ 126 (337)
T cd07852 50 AQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSG 126 (337)
T ss_pred hhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 35677899999999 999999999988653 36899999997 5999988653 778999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc----ceecccccCccccCcccccC-CCCCccccchhhHHHH
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT----RTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVL 662 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l 662 (757)
+|+|+||||+||+++.++.+||+|||+++....... .......++..|+|||.+.+ ..++.++||||||+++
T Consensus 127 ---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l 203 (337)
T cd07852 127 ---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCIL 203 (337)
T ss_pred ---CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHH
Confidence 999999999999999999999999999987654332 22334568899999998765 4578999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHH--------HHHHh----cCCcccccccc-----ccCHHHHHHHHHHHHHccccCC
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWV--------YQCFE----NGNLSQLVEDE-----EVDEKQLERMIKVALWCILDEP 725 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~----~~~~~~~~d~~-----~~~~~~~~~l~~l~~~cl~~~p 725 (757)
+||++|+.||......+........ ...+. ...+....... ....+....+.+++.+|++.+|
T Consensus 204 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 283 (337)
T cd07852 204 GEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNP 283 (337)
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCc
Confidence 9999999998644322110000000 00000 00000000000 0111135678999999999999
Q ss_pred CCCCCHHHHHHH
Q 038168 726 SLRPSMKKVLLM 737 (757)
Q Consensus 726 ~~RPsm~eVl~~ 737 (757)
++|||+.++++.
T Consensus 284 ~~Rps~~~il~~ 295 (337)
T cd07852 284 NKRLTAEEALEH 295 (337)
T ss_pred ccccCHHHHhhC
Confidence 999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-29 Score=290.53 Aligned_cols=210 Identities=29% Similarity=0.403 Sum_probs=171.3
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+...+|+.++..|+|||+|+.+|+-.+.+..+|-||||++|+|.+.+.. ++..+.....-+..|++.|+.|||+. +
T Consensus 1279 ~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~---g 1354 (1509)
T KOG4645|consen 1279 KLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEH---G 1354 (1509)
T ss_pred cchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhc---C
Confidence 5677999999999999999999999999999999999999999999854 33444445556789999999999999 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCC---cceecccccCccccCcccccCCC---CCccccchhhHHHHHHH
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ---TRTFTGIRGTRGYVAPEWHRNLP---ITVKADVYSFGVVLLEI 665 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~S~G~~l~el 665 (757)
||||||||.||+|+.++.+|++|||.|..+.... ........||+.|||||++.+.. ..-+.||||+|||++||
T Consensus 1355 IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM 1434 (1509)
T KOG4645|consen 1355 IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEM 1434 (1509)
T ss_pred ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEe
Confidence 9999999999999999999999999999876542 12334578999999999998654 56789999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+||++||.....+=++ ......|..+++ +.....+-.+++.+|++.||++|-++.|+++.
T Consensus 1435 ~tGkrPW~~~dne~aI------My~V~~gh~Pq~------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1435 ATGKRPWAELDNEWAI------MYHVAAGHKPQI------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ecCCCchhhccchhHH------HhHHhccCCCCC------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 9999999865443221 122333443333 34456667889999999999999888877764
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=255.64 Aligned_cols=215 Identities=24% Similarity=0.352 Sum_probs=164.8
Q ss_pred hHHHHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhh---hcC-CCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 510 GEREFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADI---LFN-PEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~---l~~-~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
....+.+|+.++.++. |+||+++++++..++..+++|||+.. +|.++ +.. ....+++.....++.+++.||+||
T Consensus 45 ~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l 123 (288)
T cd06616 45 EQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL 123 (288)
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3467889999999996 99999999999998899999999864 54443 222 235688999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC---CCCccccchhhHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL---PITVKADVYSFGVV 661 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~S~G~~ 661 (757)
|+. .+++||||||+||+++.++.+||+|||+++........ ....++..|+|||.+.+. .++.++||||||++
T Consensus 124 h~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~i 199 (288)
T cd06616 124 KEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGIT 199 (288)
T ss_pred hhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc--ccccCccCccCHHHhccccccCCcchhhhhHHHHH
Confidence 973 38999999999999999999999999999765432221 223578899999998776 68999999999999
Q ss_pred HHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 662 LLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 662 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++||++|+.||.... ...+...+.. .+....+. ..........+.+++.+|++.+|++|||+.+|++.
T Consensus 200 l~el~~g~~p~~~~~-----~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 200 LYEVATGKFPYPKWN-----SVFDQLTQVV-KGDPPILS--NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HHHHHhCCCCchhcc-----hHHHHHhhhc-CCCCCcCC--CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999986432 1111111111 11111111 11112345678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=261.53 Aligned_cols=211 Identities=21% Similarity=0.340 Sum_probs=173.4
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
++|.-||+||+...||+||+|++.|..++.++++.|||.||..+.++-.-++.+...++.-+++|++.||.|||++ .
T Consensus 74 EDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~ 150 (1187)
T KOG0579|consen 74 EDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---N 150 (1187)
T ss_pred hhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---c
Confidence 6788999999999999999999999999999999999999999999877788899999999999999999999999 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc-----CCCCCccccchhhHHHHHHHH
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR-----NLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~G~~l~ell 666 (757)
|||||||+.|||++-+|.++|+|||.+...... ......+.||+.|||||+.+ ..+|.-++|||||||+|.||.
T Consensus 151 iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMA 229 (1187)
T KOG0579|consen 151 IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMA 229 (1187)
T ss_pred hhhhhccccceEEEecCcEeeecccccccchhH-HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHh
Confidence 999999999999999999999999998643221 12223478999999999875 468999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
-+.+|.....+- . +.-.+.....+-++.| ..-...+.++..+||..||..||+..++++.
T Consensus 230 qiEPPHhelnpM------R-VllKiaKSePPTLlqP----S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 230 QIEPPHHELNPM------R-VLLKIAKSEPPTLLQP----SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ccCCCccccchH------H-HHHHHhhcCCCcccCc----chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 998876532221 1 1111222223333333 3445678899999999999999999999864
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=255.61 Aligned_cols=210 Identities=20% Similarity=0.322 Sum_probs=169.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++|+|++++++++...+..++||||+++++|.+++.. ..+++.....++.|++.||+|||+.
T Consensus 60 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~-- 135 (292)
T cd06657 60 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQ-- 135 (292)
T ss_pred HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 346688999999999999999999999999999999999999999998743 3578999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++|+||||+||+++.++.++|+|||++........ ......++..|+|||...+..++.++||||||++++||++|.
T Consensus 136 -givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~ 213 (292)
T cd06657 136 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213 (292)
T ss_pred -CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999876644321 122346789999999998888999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
.|+........ ......+...... ........+.+++.+||+.+|.+||++.+|++
T Consensus 214 ~p~~~~~~~~~-------~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 214 PPYFNEPPLKA-------MKMIRDNLPPKLK----NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCCCCCCHHHH-------HHHHHhhCCcccC----CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 99864322111 1111111111110 01123456788999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=252.81 Aligned_cols=211 Identities=26% Similarity=0.311 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|++++++++|+|++++++.+...+..++||||+++++|.+++.+.. ..+++.++..++.|++.||.|||+.
T Consensus 37 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-- 114 (277)
T cd05577 37 EQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR-- 114 (277)
T ss_pred hHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 4567789999999999999999999999999999999999999999987644 3688999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++|+||+|+||++++++.+||+|||++....... ......++..|+|||++.+..++.++||||||+++++|++|+
T Consensus 115 -~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~ 191 (277)
T cd05577 115 -RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191 (277)
T ss_pred -CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCC
Confidence 99999999999999999999999999998664322 122345788999999998888999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLL 736 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~ 736 (757)
.||........ ... + ...... .+...+......+.+++.+||+.+|++|| +..+++.
T Consensus 192 ~p~~~~~~~~~--~~~-~----~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 192 SPFRQRKEKVE--KEE-L----KRRTLE---MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCCCCCccccc--HHH-H----Hhcccc---ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 99875443211 101 1 111110 11112223356788999999999999999 6666754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=246.29 Aligned_cols=212 Identities=27% Similarity=0.383 Sum_probs=174.9
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..+.+.+|++++++++|+||+++++.+.+. +..++|+||+++++|.+++.... .+++.++..++.|+++||+|||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~ 120 (260)
T cd06606 42 ELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSN 120 (260)
T ss_pred HHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 457789999999999999999999999988 88999999999999999987544 789999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+++|+||+|+||+++.++.+||+|||.+......... ......++..|+|||...+...+.++||||||+++++|+
T Consensus 121 ---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~ 197 (260)
T cd06606 121 ---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMA 197 (260)
T ss_pred ---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999999877654321 122356788999999999888999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+|+.|+..... ............... ..+......+.+++.+|++.+|++||++.|+++
T Consensus 198 ~g~~p~~~~~~-----~~~~~~~~~~~~~~~------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 198 TGKPPWSELGN-----PMAALYKIGSSGEPP------EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred hCCCCCCCCCc-----hHHHHHhccccCCCc------CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 99999875441 111111111111111 122333578999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=254.61 Aligned_cols=218 Identities=22% Similarity=0.295 Sum_probs=165.4
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+.+.+|++++++++|+||+++++++.+.+..++||||+. ++|.+++... ...+++..+..++.|++.||+|||+.
T Consensus 44 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~--- 119 (284)
T cd07860 44 STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH--- 119 (284)
T ss_pred hHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 568899999999999999999999999999999999996 6888888653 35679999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCC-CCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP-ITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++|+||+|+||++++++.+||+|||+++....... ......++..|+|||.+.+.. ++.++||||||++++||++|+
T Consensus 120 ~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~ 198 (284)
T cd07860 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198 (284)
T ss_pred CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 999999999999999999999999999986643321 122234678999999887654 688999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhc----------------CCcccccccc--ccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFEN----------------GNLSQLVEDE--EVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~----------------~~~~~~~d~~--~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
.|+......+ .+.... +.... ..+....... ........++.+++.+|++.||++||++
T Consensus 199 ~p~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 275 (284)
T cd07860 199 ALFPGDSEID--QLFRIF-RTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA 275 (284)
T ss_pred CCCCCCCHHH--HHHHHH-HHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCH
Confidence 9986543211 111100 00000 0000000000 0011223567889999999999999999
Q ss_pred HHHHHH
Q 038168 732 KKVLLM 737 (757)
Q Consensus 732 ~eVl~~ 737 (757)
+++++.
T Consensus 276 ~~~l~~ 281 (284)
T cd07860 276 KAALAH 281 (284)
T ss_pred HHHhcC
Confidence 999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=278.71 Aligned_cols=217 Identities=26% Similarity=0.410 Sum_probs=179.6
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------------CCCCHHHHHHH
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------------KQPNWVERMGI 573 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i 573 (757)
..+.+..|+++|+.+ +|+|++.++|.|.+.+..++|.||+..|+|.++|++.+ ..+.....+.+
T Consensus 344 ~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsf 423 (609)
T KOG0200|consen 344 EKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSF 423 (609)
T ss_pred HHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHH
Confidence 457899999999999 79999999999999999999999999999999998765 34788899999
Q ss_pred HHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccc--cCccccCcccccCCCCCc
Q 038168 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIR--GTRGYVAPEWHRNLPITV 651 (757)
Q Consensus 574 ~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~ 651 (757)
+.|||.|++||++. ++|||||.++|||+.++..+||+|||+|+............-. -...|||||.+....++.
T Consensus 424 a~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~ 500 (609)
T KOG0200|consen 424 AYQIANGMEYLASV---PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTS 500 (609)
T ss_pred HHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccc
Confidence 99999999999999 9999999999999999999999999999976665555433323 345699999999999999
Q ss_pred cccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 652 KADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 652 k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
|+|||||||+||||+|...+..+.... ..+ +.+.+++|.-.+. +.....++.++++.||+.+|++||+.
T Consensus 501 kSDVWSfGI~L~EifsLG~~PYp~~~~----~~~-l~~~l~~G~r~~~------P~~c~~eiY~iM~~CW~~~p~~RP~F 569 (609)
T KOG0200|consen 501 KSDVWSFGILLWEIFTLGGTPYPGIPP----TEE-LLEFLKEGNRMEQ------PEHCSDEIYDLMKSCWNADPEDRPTF 569 (609)
T ss_pred cchhhHHHHHHHHHhhCCCCCCCCCCc----HHH-HHHHHhcCCCCCC------CCCCCHHHHHHHHHHhCCCcccCCCH
Confidence 999999999999999965443332211 112 2445565543221 22335678899999999999999999
Q ss_pred HHHHHHhhc
Q 038168 732 KKVLLMLEG 740 (757)
Q Consensus 732 ~eVl~~Le~ 740 (757)
.++++.++.
T Consensus 570 ~~~~~~~~~ 578 (609)
T KOG0200|consen 570 SECVEFFEK 578 (609)
T ss_pred HHHHHHHHH
Confidence 999999987
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=255.23 Aligned_cols=220 Identities=24% Similarity=0.298 Sum_probs=166.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|++++++++|+|++++++++.+.+..++||||++ ++|.+++.... ..+++.++..++.|+++||+|||+.
T Consensus 42 ~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-- 118 (283)
T cd07835 42 PSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH-- 118 (283)
T ss_pred hhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 3567889999999999999999999999999999999995 68999886543 4689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG 668 (757)
+++|+||+|+||+++.++.+||+|||+++....... ......++..|+|||++.+. .++.++||||||++++||++|
T Consensus 119 -~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 196 (283)
T cd07835 119 -RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR 196 (283)
T ss_pred -CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999999986543321 11223468899999988664 578999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcC---------------Cccccc--cccccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENG---------------NLSQLV--EDEEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~---------------~~~~~~--d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
+.||........ +........... ...... ............+.+++.+|++.+|++||++
T Consensus 197 ~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 274 (283)
T cd07835 197 RPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA 274 (283)
T ss_pred CCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 999865432111 111000000000 000000 0000112233678899999999999999999
Q ss_pred HHHHHH
Q 038168 732 KKVLLM 737 (757)
Q Consensus 732 ~eVl~~ 737 (757)
+||++.
T Consensus 275 ~~il~~ 280 (283)
T cd07835 275 KAALQH 280 (283)
T ss_pred HHHhcC
Confidence 999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=261.66 Aligned_cols=225 Identities=22% Similarity=0.299 Sum_probs=165.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec------eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV------SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.+.+|++++++++|+||+++++++... ...++|+||+.. +|.+++ ...+++..+..++.|++.||+||
T Consensus 58 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~L 133 (342)
T cd07879 58 AKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYI 133 (342)
T ss_pred hhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHH
Confidence 35678999999999999999999998654 356899999974 777665 23578899999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLL 663 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~ 663 (757)
|+. +++||||||+||+++.++.+||+|||+++..... .....++..|+|||.+.+ ..++.++||||||++++
T Consensus 134 H~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~ 206 (342)
T cd07879 134 HSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMA 206 (342)
T ss_pred HHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHH
Confidence 998 9999999999999999999999999999865322 223456889999999876 46899999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHH----------HHHhcCCccccc------cccc---cCHHHHHHHHHHHHHccccC
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVY----------QCFENGNLSQLV------EDEE---VDEKQLERMIKVALWCILDE 724 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~----------~~~~~~~~~~~~------d~~~---~~~~~~~~l~~l~~~cl~~~ 724 (757)
||++|+.||........ +..... +.+......... .+.. ........+.+++.+||+.|
T Consensus 207 el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 284 (342)
T cd07879 207 EMLTGKTLFKGKDYLDQ--LTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELD 284 (342)
T ss_pred HHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCC
Confidence 99999999975432111 000000 000000000000 0000 00112356889999999999
Q ss_pred CCCCCCHHHHHHH--hhcCcCCCCCC
Q 038168 725 PSLRPSMKKVLLM--LEGTVEIPIPP 748 (757)
Q Consensus 725 p~~RPsm~eVl~~--Le~~~~~~~p~ 748 (757)
|++||+++|++.. ++...+.+..+
T Consensus 285 P~~R~~~~e~l~h~~f~~~~~~~~~~ 310 (342)
T cd07879 285 VDKRLTATEALEHPYFDSFRDADEET 310 (342)
T ss_pred hhhCcCHHHHhcCcchhhcccccccC
Confidence 9999999999954 77766544333
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=263.09 Aligned_cols=218 Identities=25% Similarity=0.364 Sum_probs=167.1
Q ss_pred HHHHHHHHHHhhcC-CC-----ceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHh
Q 038168 512 REFQTEMKVIGRTH-HR-----NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 512 ~~~~~E~~~l~~l~-h~-----niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+-..|+.+|.+|+ |. |+|++++++...++.+||+|.+.. +|.++|+.++ ..++......|+.||+.||.+|
T Consensus 227 ~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L 305 (586)
T KOG0667|consen 227 RQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFL 305 (586)
T ss_pred HHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 45567999999996 43 899999999999999999999965 9999998765 5689999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCC--CcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDEN--RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~--~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l 662 (757)
|+. +|||+||||+||||.+- ..+||+|||.+......-. ...-++-|.|||++.+.+|+.+.||||||||+
T Consensus 306 ~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIl 378 (586)
T KOG0667|consen 306 HEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCIL 378 (586)
T ss_pred HhC---CeeeccCChhheeeccCCcCceeEEecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhH
Confidence 998 99999999999999654 4799999999987654322 33457899999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHH-----HHHhcC-Cccccc--------------------------------c---
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVY-----QCFENG-NLSQLV--------------------------------E--- 701 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~~-~~~~~~--------------------------------d--- 701 (757)
.||++|.+.|.+..+.++......+. .++..+ +....+ +
T Consensus 379 AEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~ 458 (586)
T KOG0667|consen 379 AELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERR 458 (586)
T ss_pred HhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhccccc
Confidence 99999987776655444332211110 000000 000000 0
Q ss_pred -c---cc----cCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 702 -D---EE----VDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 702 -~---~~----~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+ .. .....-..+++++++|++-||.+|+|..|.++.
T Consensus 459 ~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 459 GPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred CCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 00 011334568999999999999999999999873
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=255.25 Aligned_cols=220 Identities=20% Similarity=0.274 Sum_probs=166.5
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+|+.++++++|+||+++++++... +..++||||+++ +|.+++......+++.+...++.|++.||+|||+.
T Consensus 49 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 125 (293)
T cd07843 49 ITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN-- 125 (293)
T ss_pred hhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4577899999999999999999998877 789999999984 99998876566789999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG 668 (757)
+++|+||||+||+++.++.+||+|||+++....... ......++..|+|||.+.+. .++.++||||||++++||++|
T Consensus 126 -~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 203 (293)
T cd07843 126 -WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203 (293)
T ss_pred -CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999987654321 12234568899999998765 468999999999999999999
Q ss_pred CCCCCCCCCCccccH-HHH-------HHHHHhc------CCcccccc---ccccCHH-HHHHHHHHHHHccccCCCCCCC
Q 038168 669 RRCLDPNLPDDQVIL-EEW-------VYQCFEN------GNLSQLVE---DEEVDEK-QLERMIKVALWCILDEPSLRPS 730 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l-~~~-------~~~~~~~------~~~~~~~d---~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs 730 (757)
+.|+........... ... .+..+.. ........ ...++.. ....+.+++..|++.+|++|||
T Consensus 204 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t 283 (293)
T cd07843 204 KPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS 283 (293)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCC
Confidence 999875432211000 000 0000000 00000000 0001111 3566889999999999999999
Q ss_pred HHHHHH
Q 038168 731 MKKVLL 736 (757)
Q Consensus 731 m~eVl~ 736 (757)
+.|+++
T Consensus 284 ~~ell~ 289 (293)
T cd07843 284 AEDALK 289 (293)
T ss_pred HHHHhc
Confidence 999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=253.97 Aligned_cols=219 Identities=21% Similarity=0.332 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++++..++..++|+||+++ +|.+++......+++.++..++.|++.||.|||+.
T Consensus 42 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--- 117 (283)
T cd05118 42 PKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH--- 117 (283)
T ss_pred HHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46788899999999999999999999999999999999975 88888876566789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+|+||||+||+++.++.+||+|||.+....... .......++..|+|||.+.+. .++.++||||||+++++|++|+
T Consensus 118 ~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~ 196 (283)
T cd05118 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196 (283)
T ss_pred CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999998776543 122234578889999998876 7899999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcC---Cccccc-----------cc-----cccCHHHHHHHHHHHHHccccCCCCCCC
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENG---NLSQLV-----------ED-----EEVDEKQLERMIKVALWCILDEPSLRPS 730 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~-----------d~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs 730 (757)
.||......+.. ......+... ...... +. .........++.+++..||+.+|.+||+
T Consensus 197 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~ 273 (283)
T cd05118 197 PLFPGKSEIDQL---FKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT 273 (283)
T ss_pred CCCCCCCHHHHH---HHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcC
Confidence 888654321111 0000100000 000000 00 0112234578999999999999999999
Q ss_pred HHHHHHH
Q 038168 731 MKKVLLM 737 (757)
Q Consensus 731 m~eVl~~ 737 (757)
+.+++..
T Consensus 274 ~~~ll~~ 280 (283)
T cd05118 274 AEQALAH 280 (283)
T ss_pred HHHHhhC
Confidence 9999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=257.47 Aligned_cols=219 Identities=21% Similarity=0.295 Sum_probs=163.8
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEece--------eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVS--------KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~--------~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y 583 (757)
..+.+|++++++++|+||+++++++...+ ..++||||+.+ +|.+++......+++.+...++.|++.||+|
T Consensus 56 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~ 134 (310)
T cd07865 56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134 (310)
T ss_pred hHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHH
Confidence 34568999999999999999999987654 35999999975 8888886655678999999999999999999
Q ss_pred hhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc---ceecccccCccccCcccccCC-CCCccccchhhH
Q 038168 584 LHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT---RTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFG 659 (757)
Q Consensus 584 LH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G 659 (757)
||+. +++|+||||+||+++.++.+||+|||++........ .......++..|+|||.+.+. .++.++||||||
T Consensus 135 lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 211 (310)
T cd07865 135 IHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211 (310)
T ss_pred HHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHH
Confidence 9998 999999999999999999999999999987643322 122334578899999988765 478999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhc---CCccc-----ccc----ccc---------cCHHHHHHHHHHHH
Q 038168 660 VVLLEIICRRRCLDPNLPDDQVILEEWVYQCFEN---GNLSQ-----LVE----DEE---------VDEKQLERMIKVAL 718 (757)
Q Consensus 660 ~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~-----~~d----~~~---------~~~~~~~~l~~l~~ 718 (757)
++++||++|+.|+........... +...... ..... ..+ +.. ........+.+++.
T Consensus 212 ~~l~el~t~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~ 288 (310)
T cd07865 212 CIMAEMWTRSPIMQGNTEQHQLTL---ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLID 288 (310)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHH
Confidence 999999999998875433221111 1111100 00000 000 000 01112345678999
Q ss_pred HccccCCCCCCCHHHHHHH
Q 038168 719 WCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 719 ~cl~~~p~~RPsm~eVl~~ 737 (757)
+||+.||++|||++|+++.
T Consensus 289 ~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 289 KLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHhcCChhhccCHHHHhcC
Confidence 9999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=251.75 Aligned_cols=210 Identities=23% Similarity=0.306 Sum_probs=161.8
Q ss_pred HHHHHHHHHH-HhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 511 EREFQTEMKV-IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN---PEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 511 ~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
+.++..|+.+ ++.++|+|++++++++...+..++||||++ |+|.+++.. ....+++.++..++.|++.||+|||+
T Consensus 43 ~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 121 (283)
T cd06617 43 QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121 (283)
T ss_pred HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 4556667765 566689999999999999999999999997 688777643 23568999999999999999999997
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC----CCCCccccchhhHHHH
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN----LPITVKADVYSFGVVL 662 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~Dv~S~G~~l 662 (757)
+ .+++||||||+||+++.++.+||+|||+++.+.... ......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 122 ~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l 197 (283)
T cd06617 122 K--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITM 197 (283)
T ss_pred c--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHH
Confidence 4 389999999999999999999999999998664322 1122457889999998865 4568999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+||++|+.|+...... . +....... +....+ ........+.+++.+||+.+|++||++.+|++
T Consensus 198 ~~l~~g~~p~~~~~~~----~-~~~~~~~~-~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 198 IELATGRFPYDSWKTP----F-QQLKQVVE-EPSPQL-----PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHhCCCCCCccccC----H-HHHHHHHh-cCCCCC-----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999998642211 1 11111111 111111 11123467889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=256.43 Aligned_cols=219 Identities=23% Similarity=0.297 Sum_probs=165.7
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEece----------eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVS----------KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGI 581 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~----------~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL 581 (757)
..+.+|++++++++|||++++++++.+.. ..++|+||+++ +|.+++......+++.++..++.|++.||
T Consensus 51 ~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL 129 (302)
T cd07864 51 ITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGL 129 (302)
T ss_pred HHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence 46778999999999999999999987655 78999999986 77777766556789999999999999999
Q ss_pred HHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHH
Q 038168 582 LYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGV 660 (757)
Q Consensus 582 ~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~ 660 (757)
+|||+. +|+|+||||+||++++++.+||+|||++...............++..|+|||.+.+ ..++.++||||||+
T Consensus 130 ~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ 206 (302)
T cd07864 130 NYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 206 (302)
T ss_pred HHHHhC---CeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHH
Confidence 999998 99999999999999999999999999998765443322233446788999998765 45789999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCC---ccccc--------ccc--------ccCHHHHHHHHHHHHHcc
Q 038168 661 VLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGN---LSQLV--------EDE--------EVDEKQLERMIKVALWCI 721 (757)
Q Consensus 661 ~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~--------d~~--------~~~~~~~~~l~~l~~~cl 721 (757)
+++||++|+.|+....... .+ ..+.+...... ...+. +.. ......+..+.+++..||
T Consensus 207 ~~~el~~g~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 283 (302)
T cd07864 207 ILGELFTKKPIFQANQELA--QL-ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHML 283 (302)
T ss_pred HHHHHHhCCCCCCCCChHH--HH-HHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHc
Confidence 9999999999887432211 11 11111111100 00000 000 000112467899999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 038168 722 LDEPSLRPSMKKVLLM 737 (757)
Q Consensus 722 ~~~p~~RPsm~eVl~~ 737 (757)
+.+|++||++.+|++.
T Consensus 284 ~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 284 TLDPSKRCTAEEALNS 299 (302)
T ss_pred cCChhhCCCHHHHhcC
Confidence 9999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=248.41 Aligned_cols=208 Identities=25% Similarity=0.377 Sum_probs=173.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP---EKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..++.+|++++++++|+||+++++++.+....++|+||+++++|.+++.+. ...+++..+..++.|++.||+|||+.
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~ 122 (256)
T cd08530 43 REDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122 (256)
T ss_pred HHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 456788999999999999999999999999999999999999999988542 35678999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||+|+||++++++.+||+|||+++...... .....++..|++||...+..++.++|+||||++++||++
T Consensus 123 ---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~ 196 (256)
T cd08530 123 ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196 (256)
T ss_pred ---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999998775542 122457889999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|+.|+...... + .......+..... .......+.+++.+|++.+|++||++.|+++.
T Consensus 197 g~~p~~~~~~~------~-~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 197 FAPPFEARSMQ------D-LRYKVQRGKYPPI------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCCCCCHH------H-HHHHHhcCCCCCC------chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 99998654321 1 1122222322221 23455779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=252.78 Aligned_cols=221 Identities=22% Similarity=0.312 Sum_probs=166.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE--KQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.+.+.+|+.++++++|+||+++++++.+.+..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+.
T Consensus 42 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~- 119 (284)
T cd07836 42 PSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN- 119 (284)
T ss_pred hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC-
Confidence 35677899999999999999999999999999999999985 8888876543 4589999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHh
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||||+||++++++.+||+|||+++....... ......++..|++||.+.+. .++.++||||||++++||++
T Consensus 120 --~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~ 196 (284)
T cd07836 120 --RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196 (284)
T ss_pred --CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999986543221 12234568899999988664 57899999999999999999
Q ss_pred CCCCCCCCCCCccccHH-HH-------HHHHHhcC-----Cccccccc--cccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 668 RRRCLDPNLPDDQVILE-EW-------VYQCFENG-----NLSQLVED--EEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~-~~-------~~~~~~~~-----~~~~~~d~--~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
|+.|+......+..... +. .++.+... ......+. ..........+.+++.+|++.+|++||++.
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 276 (284)
T cd07836 197 GRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAH 276 (284)
T ss_pred CCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHH
Confidence 99998755432211000 00 00000000 00000000 001122346788999999999999999999
Q ss_pred HHHH
Q 038168 733 KVLL 736 (757)
Q Consensus 733 eVl~ 736 (757)
||++
T Consensus 277 ~~l~ 280 (284)
T cd07836 277 DALQ 280 (284)
T ss_pred HHhc
Confidence 9985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=253.94 Aligned_cols=212 Identities=22% Similarity=0.352 Sum_probs=164.0
Q ss_pred HHHHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+++..|+.++.+.. |+||+++++++.+....++||||++ ++|.+++......+++.++..++.|++.||+|||+.
T Consensus 57 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-- 133 (296)
T cd06618 57 NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK-- 133 (296)
T ss_pred HHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--
Confidence 356677888777775 9999999999999999999999985 477777765556789999999999999999999973
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCC----CCccccchhhHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP----ITVKADVYSFGVVLLEI 665 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~Dv~S~G~~l~el 665 (757)
.+|+||||+|+||++++++.+||+|||++..+...... ....++..|+|||.+.+.. ++.++||||||++++||
T Consensus 134 ~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el 211 (296)
T cd06618 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVEL 211 (296)
T ss_pred CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHH
Confidence 28999999999999999999999999999866433222 2234678999999987654 78999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++|+.|+....... +........ ....... .....+++.+++.+||+.+|++||++.+++++
T Consensus 212 ~~g~~p~~~~~~~~-----~~~~~~~~~-~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 212 ATGQFPYKNCKTEF-----EVLTKILQE-EPPSLPP----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HhCCCCCCcchhHH-----HHHHHHhcC-CCCCCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 99999986432211 111121111 1111111 11234678999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=262.05 Aligned_cols=200 Identities=22% Similarity=0.249 Sum_probs=165.3
Q ss_pred HHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 038168 514 FQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQI 592 (757)
Q Consensus 514 ~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 592 (757)
-.+|+.++.+. +|+|++++.+.+.+..+.|+|||.+.++-|.+.+..... .. .++..|+.+|+.++.|||.+ ++
T Consensus 362 ~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~---gv 436 (612)
T KOG0603|consen 362 NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQ---GV 436 (612)
T ss_pred cccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhc---Ce
Confidence 45677666666 799999999999999999999999999988877754332 22 77788999999999999998 99
Q ss_pred eeCCCCcceEEE-CCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCC
Q 038168 593 IHCDIKPQNILM-DENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRC 671 (757)
Q Consensus 593 iH~Dik~~Nill-~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p 671 (757)
||||+||+|||+ ++.++++|+|||.++....+ ....+-|..|.|||+.....+++.+|+||||++||+|++|+.|
T Consensus 437 vhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp 512 (612)
T KOG0603|consen 437 VHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTL 512 (612)
T ss_pred eecCCChhheeecCCCCcEEEEEechhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCc
Confidence 999999999999 58899999999999987665 1223457899999999999999999999999999999999999
Q ss_pred CCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 672 LDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 672 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+.....+ ..+...+..++.. ....+...+|+.+||+.||++||+|.++...
T Consensus 513 ~~~~P~~------~ei~~~i~~~~~s---------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 513 FAAHPAG------IEIHTRIQMPKFS---------ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred cccCCch------HHHHHhhcCCccc---------cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 9876554 1123333333332 3445678889999999999999999998763
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=254.43 Aligned_cols=218 Identities=24% Similarity=0.314 Sum_probs=163.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|++++++++|+||+++++++.+.+..++||||++ ++|.+++.... ...++.....++.||+.||+|||+.
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-- 121 (294)
T PLN00009 45 PSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-- 121 (294)
T ss_pred hHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC--
Confidence 3568899999999999999999999999999999999996 47877775433 3467888889999999999999998
Q ss_pred CCeeeCCCCcceEEECC-CCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHh
Q 038168 590 TQIIHCDIKPQNILMDE-NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~-~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||||+||+++. +..+||+|||++....... .......++..|+|||++.+. .++.++||||||+++++|++
T Consensus 122 -~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~t 199 (294)
T PLN00009 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199 (294)
T ss_pred -CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 9999999999999985 5679999999998654322 112234568899999988664 57899999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCC----------------cccc--ccccccCHHHHHHHHHHHHHccccCCCCCC
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGN----------------LSQL--VEDEEVDEKQLERMIKVALWCILDEPSLRP 729 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~----------------~~~~--~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP 729 (757)
|+.|+......+. +.. ......... .... .+..........++.+++.+|++.+|++||
T Consensus 200 g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 276 (294)
T PLN00009 200 QKPLFPGDSEIDE--LFK-IFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRI 276 (294)
T ss_pred CCCCCCCCCHHHH--HHH-HHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCc
Confidence 9999875432111 000 001000000 0000 000001122346688999999999999999
Q ss_pred CHHHHHH
Q 038168 730 SMKKVLL 736 (757)
Q Consensus 730 sm~eVl~ 736 (757)
++.++++
T Consensus 277 s~~~~l~ 283 (294)
T PLN00009 277 TARAALE 283 (294)
T ss_pred CHHHHhc
Confidence 9999987
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=247.55 Aligned_cols=193 Identities=21% Similarity=0.324 Sum_probs=157.6
Q ss_pred CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEE
Q 038168 525 HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILM 604 (757)
Q Consensus 525 ~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill 604 (757)
+|+|++++++.+...+..++||||+++++|.+++... ..+++.++..++.|+++||.|||+. +++||||||+||++
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~ 142 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLY 142 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEE
Confidence 6999999999999999999999999999999999654 3789999999999999999999998 99999999999999
Q ss_pred CCCC-cEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccH
Q 038168 605 DENR-CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVIL 683 (757)
Q Consensus 605 ~~~~-~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l 683 (757)
+.++ .++|+|||+++...... ...++..|+|||++.+..++.++||||||++++||++|+.|+.....+ ....
T Consensus 143 ~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~ 216 (267)
T PHA03390 143 DRAKDRIYLCDYGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDL 216 (267)
T ss_pred eCCCCeEEEecCccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhH
Confidence 9998 99999999998664332 235788999999999989999999999999999999999999744322 1122
Q ss_pred HHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 038168 684 EEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS-MKKVLL 736 (757)
Q Consensus 684 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-m~eVl~ 736 (757)
..+.... .... .........+.+++.+||+.+|++||+ ++|+++
T Consensus 217 ~~~~~~~--~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 217 ESLLKRQ--QKKL-------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHhh--cccC-------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 2211111 1111 111234567899999999999999995 688874
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=253.49 Aligned_cols=208 Identities=27% Similarity=0.357 Sum_probs=167.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+++.+|++++++++|+|++++++++......++|+||+. |+|.+++......+++.++..++.|++.||.|||+.
T Consensus 59 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~--- 134 (308)
T cd06634 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH--- 134 (308)
T ss_pred HHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 3567889999999999999999999999999999999997 688887765556688999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc---CCCCCccccchhhHHHHHHHHh
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR---NLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||||+||+++.++.+||+|||++...... ....++..|+|||.+. ....+.++||||||++++||++
T Consensus 135 ~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~ 209 (308)
T cd06634 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209 (308)
T ss_pred CcccCCCCHHhEEECCCCcEEECCcccceeecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHc
Confidence 9999999999999999999999999999765432 2245788999999874 3567899999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
|+.|+....... .... ...+..... ........+.+++.+||+.+|++||++.+|++..-
T Consensus 210 g~~p~~~~~~~~------~~~~-~~~~~~~~~-----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 210 RKPPLFNMNAMS------ALYH-IAQNESPAL-----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred CCCCCccccHHH------HHHH-HhhcCCCCc-----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 999876432111 1111 111211111 12234466889999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=256.56 Aligned_cols=218 Identities=24% Similarity=0.270 Sum_probs=164.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec------eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV------SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.+.+|+.++++++|+||+++++++... ...++||||+.+ +|.+.+... ++..+...++.|++.||+||
T Consensus 59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~L 134 (353)
T cd07850 59 AKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHL 134 (353)
T ss_pred HHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999987643 357999999964 888877432 78888999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~e 664 (757)
|+. +|+||||||+||+++.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++++
T Consensus 135 H~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~ 209 (353)
T cd07850 135 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 209 (353)
T ss_pred HhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHH
Confidence 998 999999999999999999999999999987644322 223457889999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCccc------------cHHHH----HHHHHhcCC------cccccccc-------ccCHHHHHHHHH
Q 038168 665 IICRRRCLDPNLPDDQV------------ILEEW----VYQCFENGN------LSQLVEDE-------EVDEKQLERMIK 715 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~------------~l~~~----~~~~~~~~~------~~~~~d~~-------~~~~~~~~~l~~ 715 (757)
|++|+.||......... .+... ......... +.+..... .........+.+
T Consensus 210 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
T cd07850 210 MIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARD 289 (353)
T ss_pred HHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHH
Confidence 99999998643211100 00000 000000000 00000000 001234567889
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 038168 716 VALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 716 l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++.+||+.||++|||+.|+++.
T Consensus 290 li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 290 LLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHcCCChhhCcCHHHHhcC
Confidence 9999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=250.53 Aligned_cols=216 Identities=21% Similarity=0.208 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|++++.++ +|+||+++++.+......++||||+++++|.+++.. ...+++.....++.|+++||.|||+.
T Consensus 48 ~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~-- 124 (288)
T cd05583 48 AEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQL-- 124 (288)
T ss_pred HHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHC--
Confidence 45678999999999 699999999999999999999999999999999865 34578888999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCC--CCccccchhhHHHHHHHHh
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP--ITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||||+||+++.++.+||+|||+++..............++..|+|||...+.. .+.++||||||++++||++
T Consensus 125 -~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~t 203 (288)
T cd05583 125 -GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203 (288)
T ss_pred -CeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHh
Confidence 9999999999999999999999999999876544333333456889999999987765 7899999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
|..|+....... ...+......... ...+......+.+++.+||+.+|++|||+.+|.+.|+.
T Consensus 204 g~~p~~~~~~~~--~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 204 GASPFTVDGEQN--SQSEISRRILKSK--------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCCCcccCcccc--hHHHHHHHHHccC--------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 999986432211 1112111111111 01112233567889999999999999999999888865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=234.64 Aligned_cols=221 Identities=20% Similarity=0.312 Sum_probs=171.9
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEEec--------eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 513 EFQTEMKVIGRTHHRNLVRLLGYSLEV--------SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~g~~~~~--------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
...+|+++|..|+|+|++.+++.|... ...|||+++++. +|..+|.+...+++..++.+++.++..||.|+
T Consensus 62 talreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~i 140 (376)
T KOG0669|consen 62 TALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYI 140 (376)
T ss_pred HHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHH
Confidence 346899999999999999999988532 347999999987 89999977778899999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCC---cceecccccCccccCcccccCC-CCCccccchhhHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ---TRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGV 660 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~ 660 (757)
|.. .|+|||+||.|+||+.++.+||+|||++|.+.... ....++.+-|..|++||.+.+. .++++.|||..||
T Consensus 141 Hr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgC 217 (376)
T KOG0669|consen 141 HRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGC 217 (376)
T ss_pred HHh---hHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHH
Confidence 998 99999999999999999999999999998775433 2345667789999999988764 7999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccc--------ccc-------CHHHH------HHHHHHHHH
Q 038168 661 VLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVED--------EEV-------DEKQL------ERMIKVALW 719 (757)
Q Consensus 661 ~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~--------~~~-------~~~~~------~~l~~l~~~ 719 (757)
++.||.+|.+.+.+.....+..+...+...+...-.+...+- +.. -.+.. .+.++++..
T Consensus 218 imaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ 297 (376)
T KOG0669|consen 218 IMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEK 297 (376)
T ss_pred HHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHH
Confidence 999999999988877665554443322111111111111000 000 01111 256788889
Q ss_pred ccccCCCCCCCHHHHHHH
Q 038168 720 CILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 720 cl~~~p~~RPsm~eVl~~ 737 (757)
++..||.+|++.++++..
T Consensus 298 ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 298 LLKLDPTKRIDADQALNH 315 (376)
T ss_pred HhccCcccCcchHhhhch
Confidence 999999999999998764
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=244.47 Aligned_cols=211 Identities=24% Similarity=0.388 Sum_probs=174.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP---EKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
..+++.+|++++++++|+|++++++.+...+..++|+||+++++|.+++... ...+++.++..++.+++.||.|||+
T Consensus 42 ~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 121 (258)
T cd08215 42 EREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121 (258)
T ss_pred HHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh
Confidence 3466889999999999999999999999999999999999999999999764 3678999999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
. +++|+||+|+||++++++.+||+|||++....... .......++..|+|||...+..++.++||||+|+++++|+
T Consensus 122 ~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~ 197 (258)
T cd08215 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELC 197 (258)
T ss_pred C---CEecccCChHHeEEcCCCcEEECCccceeecccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHH
Confidence 8 99999999999999999999999999998765543 1222346788999999999889999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+|+.|+..... .+ +...........+ +......+.+++.+|+..+|++||++.|+++.
T Consensus 198 ~g~~p~~~~~~------~~-~~~~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 198 TLKHPFEGENL------LE-LALKILKGQYPPI------PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred cCCCCCCCCcH------HH-HHHHHhcCCCCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 99999864331 11 1122222222211 12334678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=255.08 Aligned_cols=221 Identities=20% Similarity=0.257 Sum_probs=164.5
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNP----EKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
+.+.+|+.++++++||||+++++++.+. +..++||||+++ +|.+++... ...++......++.|++.||+|||
T Consensus 47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH 125 (316)
T cd07842 47 QSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH 125 (316)
T ss_pred HHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999988 789999999985 666655322 235788889999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECC----CCcEEEeecCCccccCCCCc--ceecccccCccccCcccccCC-CCCccccchhh
Q 038168 586 DECETQIIHCDIKPQNILMDE----NRCAKISDFGLAKLMKPDQT--RTFTGIRGTRGYVAPEWHRNL-PITVKADVYSF 658 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~----~~~~ki~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~ 658 (757)
+. +|+||||||+||+++. ++.+||+|||+++....... .......++..|+|||.+.+. .++.++|||||
T Consensus 126 ~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 202 (316)
T cd07842 126 SN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAI 202 (316)
T ss_pred hC---CEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHH
Confidence 98 9999999999999999 89999999999987654322 122335678899999988764 57899999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCccc-------cHHHHHHHHHh------------cCCccc---cccccccC---------H
Q 038168 659 GVVLLEIICRRRCLDPNLPDDQV-------ILEEWVYQCFE------------NGNLSQ---LVEDEEVD---------E 707 (757)
Q Consensus 659 G~~l~elltG~~p~~~~~~~~~~-------~l~~~~~~~~~------------~~~~~~---~~d~~~~~---------~ 707 (757)
|++++||++|+.|+.....+... .+...+ ..+. ...... ........ .
T Consensus 203 G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (316)
T cd07842 203 GCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEK 281 (316)
T ss_pred HHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHh
Confidence 99999999999999765433210 010000 0000 000000 00000000 0
Q ss_pred --HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 708 --KQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 708 --~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
....++.+++.+|++.||++|||+.|+++.
T Consensus 282 ~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 282 HKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred ccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 234568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=246.97 Aligned_cols=209 Identities=23% Similarity=0.358 Sum_probs=168.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN---PEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..++..|+.++++++|||++++++++.+.+..++||||+++++|.+++.. ....+++.++..++.|++.||.|||+.
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 125 (260)
T cd08222 46 TVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125 (260)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc
Confidence 34577899999999999999999999999999999999999999998853 345689999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||||+||++++ +.+||+|||+++....... ......++..|+|||...+..++.++|+||||+++++|++
T Consensus 126 ---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~ 200 (260)
T cd08222 126 ---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC 200 (260)
T ss_pred ---CccccCCChhheEeec-CCEeecccCceeecCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999999976 5699999999987643322 1223457889999999988889999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|..|+.... ....... ...+.... .+......+.+++.+|++.+|++||++.|+++.
T Consensus 201 ~~~~~~~~~------~~~~~~~-~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 201 LAHAFEGQN------FLSVVLR-IVEGPTPS------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCCCCCcc------HHHHHHH-HHcCCCCC------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 999885321 1111111 11222111 223445678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=246.40 Aligned_cols=207 Identities=22% Similarity=0.268 Sum_probs=163.7
Q ss_pred HHHHHHH-HhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 038168 514 FQTEMKV-IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQI 592 (757)
Q Consensus 514 ~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 592 (757)
+..|..+ ....+|+|++++++++.+.+..++|+||+++++|.+++... ..++...+..++.|++.||.|||+. ++
T Consensus 43 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~i 118 (260)
T cd05611 43 VKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQR---GI 118 (260)
T ss_pred HHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 4445444 44558999999999999999999999999999999998643 4578888999999999999999998 99
Q ss_pred eeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCC
Q 038168 593 IHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCL 672 (757)
Q Consensus 593 iH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~ 672 (757)
+|+||+|+||++++++.+||+|||+++.... .....++..|+|||...+..++.++||||||++++||++|..|+
T Consensus 119 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 193 (260)
T cd05611 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPF 193 (260)
T ss_pred ecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999999999876443 12345788999999998888999999999999999999999998
Q ss_pred CCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 673 DPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 673 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
...... . .......+.... +..........+.+++.+||+.+|++||++.++.+.|+
T Consensus 194 ~~~~~~------~-~~~~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 194 HAETPD------A-VFDNILSRRINW---PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred CCCCHH------H-HHHHHHhcccCC---CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 643321 1 112222222111 11111233567899999999999999998877766664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=233.47 Aligned_cols=215 Identities=22% Similarity=0.245 Sum_probs=172.0
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEe----ceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhh
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLE----VSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
...++|+++--.. .|+|||.+++++++ ...+++|||.|++|.|.+.+..++ ..+...+.-.|++||+.|+.|||
T Consensus 99 ~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH 178 (400)
T KOG0604|consen 99 PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH 178 (400)
T ss_pred HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH
Confidence 3457888876555 69999999998864 345679999999999999997665 45788999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECC---CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDE---NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~---~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l 662 (757)
+. .|.||||||+|+|... |-.+||+|||.|+.-.. .......+-|+.|.|||++-..++....|+||+||++
T Consensus 179 ~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVim 253 (400)
T KOG0604|consen 179 SM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253 (400)
T ss_pred hc---chhhccCChhheeeecCCCCcceEecccccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHH
Confidence 98 9999999999999964 56799999999986543 2334446779999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|-|++|.+||....... +..-+...++.|.+... .+.-....+...++++.+|..+|++|.|+.+++..
T Consensus 254 YIlLCGyPPFYS~hg~a---ispgMk~rI~~gqy~FP---~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 254 YILLCGYPPFYSNHGLA---ISPGMKRRIRTGQYEFP---EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HHhhcCCCcccccCCcc---CChhHHhHhhccCccCC---ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 99999999998765422 11123445555554422 22223456677888889999999999999999864
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=241.21 Aligned_cols=210 Identities=21% Similarity=0.239 Sum_probs=171.1
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.....|-+||+.+.||-++.|++.++..+..+||||||+||+|...+++. ++.++...+.-++.+++-||+|||-.
T Consensus 122 ~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml--- 198 (459)
T KOG0610|consen 122 KRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML--- 198 (459)
T ss_pred HHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---
Confidence 34567889999999999999999999999999999999999999999765 46788888888999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCC---------------------------------C-Cc----------
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKP---------------------------------D-QT---------- 626 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~---------------------------------~-~~---------- 626 (757)
|||.|||||+||||.++|.+-|+||.|+..... . ..
T Consensus 199 GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~ 278 (459)
T KOG0610|consen 199 GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASR 278 (459)
T ss_pred ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccc
Confidence 999999999999999999999999998753210 0 00
Q ss_pred -----------ceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCC
Q 038168 627 -----------RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGN 695 (757)
Q Consensus 627 -----------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 695 (757)
.....++||-.|+|||++.+...+..+|.|+|||++|||+.|..||.+....+.. ...+.+ .
T Consensus 279 ~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl------~NIv~~-~ 351 (459)
T KOG0610|consen 279 SLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL------RNIVGQ-P 351 (459)
T ss_pred cchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH------HHHhcC-C
Confidence 0112367999999999999999999999999999999999999999986554321 111111 1
Q ss_pred ccccccccccCHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 038168 696 LSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS----MKKVLL 736 (757)
Q Consensus 696 ~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs----m~eVl~ 736 (757)
+...- ..+....+.+|+...|..||.+|.- +.||.+
T Consensus 352 l~Fp~-----~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 352 LKFPE-----EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred CcCCC-----CCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 11110 1245577899999999999999998 777765
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=244.43 Aligned_cols=208 Identities=23% Similarity=0.363 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+|++++++++.+.+..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~--- 118 (254)
T cd06627 43 LKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQ--- 118 (254)
T ss_pred HHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhC---
Confidence 467899999999999999999999999999999999999999999998654 5789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+++|+||||+||+++.++.+||+|||++......... .....++..|+|||...+..++.++||||+|+++++|++|+.
T Consensus 119 ~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~ 197 (254)
T cd06627 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNP 197 (254)
T ss_pred CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999999876543321 223457889999999988889999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|+...... ...+.. ...... ..+......+.+++.+|++.+|++||++.+++.
T Consensus 198 p~~~~~~~------~~~~~~-~~~~~~------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 198 PYYDLNPM------AALFRI-VQDDHP------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCccHH------HHHHHH-hccCCC------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 88643211 111111 111111 112233567889999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=258.24 Aligned_cols=222 Identities=23% Similarity=0.301 Sum_probs=167.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec-----eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV-----SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.+.+.+|+.++++++|+||+++++++... ...++|+||+. ++|.+++.. ...++......++.|++.||.|||
T Consensus 48 ~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH 125 (337)
T cd07858 48 AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIH 125 (337)
T ss_pred hHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45677899999999999999999988654 34799999996 688888864 356889999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLE 664 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~e 664 (757)
+. +++|+||||+||+++.++.+||+|||+++...... .......++..|+|||.+.+ ..++.++||||||+++++
T Consensus 126 ~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 201 (337)
T cd07858 126 SA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAE 201 (337)
T ss_pred hC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHH
Confidence 98 99999999999999999999999999998764432 12223457889999998765 468999999999999999
Q ss_pred HHhCCCCCCCCCCCccccHHHHHHHHHh-----------cCCcc-------ccccc--cccCHHHHHHHHHHHHHccccC
Q 038168 665 IICRRRCLDPNLPDDQVILEEWVYQCFE-----------NGNLS-------QLVED--EEVDEKQLERMIKVALWCILDE 724 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~~~~~~~~~-----------~~~~~-------~~~d~--~~~~~~~~~~l~~l~~~cl~~~ 724 (757)
|++|+.||......... ....+... .+... ...+. .........++.+++.+||+.+
T Consensus 202 l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 278 (337)
T cd07858 202 LLGRKPLFPGKDYVHQL---KLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFD 278 (337)
T ss_pred HHcCCCCCCCCChHHHH---HHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCC
Confidence 99999998654221100 00000000 00000 00000 0011233567899999999999
Q ss_pred CCCCCCHHHHHHH--hhcC
Q 038168 725 PSLRPSMKKVLLM--LEGT 741 (757)
Q Consensus 725 p~~RPsm~eVl~~--Le~~ 741 (757)
|++|||++|+++. ++..
T Consensus 279 P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 279 PSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhccCHHHHHcCcchhhh
Confidence 9999999999986 6553
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=255.60 Aligned_cols=217 Identities=19% Similarity=0.221 Sum_probs=165.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|+.+++.++|+||+++++++..++..++|+||+++++|.+++.... ..+++..+..++.|++.||+|||+.
T Consensus 43 ~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-- 120 (328)
T cd08226 43 LKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN-- 120 (328)
T ss_pred HHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 3678899999999999999999999999999999999999999999986543 4578889999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce------ecccccCccccCcccccCC--CCCccccchhhHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT------FTGIRGTRGYVAPEWHRNL--PITVKADVYSFGVV 661 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~G~~ 661 (757)
+++||||||+|||++.++.+|++||+.+.......... .....++..|+|||++.+. .++.++||||||++
T Consensus 121 -~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~ 199 (328)
T cd08226 121 -GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGIT 199 (328)
T ss_pred -CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHH
Confidence 99999999999999999999999998665432211110 0012345679999998764 47899999999999
Q ss_pred HHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCc------------------------------------cccccc---
Q 038168 662 LLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNL------------------------------------SQLVED--- 702 (757)
Q Consensus 662 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------------------------------------~~~~d~--- 702 (757)
++||++|+.|+........ .......... ....+.
T Consensus 200 l~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (328)
T cd08226 200 ACELATGRVPFQDMLRTQM------LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR 273 (328)
T ss_pred HHHHHhCCCCCCCcChHHH------HHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhcccccccccccccc
Confidence 9999999999875432110 0000000000 000000
Q ss_pred cccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 703 EEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 703 ~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
..........+.+++.+||+.||++|||+.|+++
T Consensus 274 ~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 274 TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0112345577899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=257.31 Aligned_cols=222 Identities=21% Similarity=0.309 Sum_probs=165.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe----ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE----VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
.+.+.+|+.++++++|+||+++++++.. ....++|+||+. ++|.+++... ..+++.....++.|++.||+|||+
T Consensus 48 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~ 125 (334)
T cd07855 48 AKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHS 125 (334)
T ss_pred hHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4567789999999999999999998753 346899999996 6899988653 458999999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc---eecccccCccccCcccccC-CCCCccccchhhHHHH
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR---TFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVL 662 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l 662 (757)
. +|+||||||+||++++++.+||+|||++......... ......++..|+|||.+.+ ..++.++||||||+++
T Consensus 126 ~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l 202 (334)
T cd07855 126 A---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIF 202 (334)
T ss_pred C---CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHH
Confidence 8 9999999999999999999999999999866433221 1223568899999998765 4689999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHH--------HHHHHhcCCccccc----cccc-----cCHHHHHHHHHHHHHccccCC
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEW--------VYQCFENGNLSQLV----EDEE-----VDEKQLERMIKVALWCILDEP 725 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~~~~~~~----d~~~-----~~~~~~~~l~~l~~~cl~~~p 725 (757)
+||++|+.||.............. .............. .... ........+.+++.+|++.+|
T Consensus 203 ~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 282 (334)
T cd07855 203 AEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDP 282 (334)
T ss_pred HHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCCh
Confidence 999999999965432211100000 00000000000000 0000 112335779999999999999
Q ss_pred CCCCCHHHHHHH
Q 038168 726 SLRPSMKKVLLM 737 (757)
Q Consensus 726 ~~RPsm~eVl~~ 737 (757)
++||++++++..
T Consensus 283 ~~Rpt~~~~l~~ 294 (334)
T cd07855 283 EERITVEQALQH 294 (334)
T ss_pred hhCcCHHHHHhC
Confidence 999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=252.53 Aligned_cols=217 Identities=24% Similarity=0.322 Sum_probs=164.2
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 513 EFQTEMKVIGRTHHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+|+.++++++|+|++++++++.+. +..++||||+.+ +|.+++......+++.++..++.|+++||+|||+.
T Consensus 52 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--- 127 (309)
T cd07845 52 SSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN--- 127 (309)
T ss_pred hhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 456799999999999999999998755 468999999975 88888876567789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++||||||+||++++++.+||+|||+++....... ......++..|+|||.+.+ ..++.++||||||++++||++|+
T Consensus 128 ~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 206 (309)
T cd07845 128 FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206 (309)
T ss_pred CeecCCCCHHHEEECCCCCEEECccceeeecCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999987654321 1222345788999999865 45799999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhc-----------CCc-cccc-ccccc------CHHHHHHHHHHHHHccccCCCCCCC
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFEN-----------GNL-SQLV-EDEEV------DEKQLERMIKVALWCILDEPSLRPS 730 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~-----------~~~-~~~~-d~~~~------~~~~~~~l~~l~~~cl~~~p~~RPs 730 (757)
.|+....+.+.. ..+.+.... ... .... ..... .......+.+++.+|++.||++|||
T Consensus 207 ~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t 283 (309)
T cd07845 207 PLLPGKSEIEQL---DLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT 283 (309)
T ss_pred CCCCCCCHHHHH---HHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC
Confidence 998754322111 101111000 000 0000 00000 0112456788999999999999999
Q ss_pred HHHHHHH
Q 038168 731 MKKVLLM 737 (757)
Q Consensus 731 m~eVl~~ 737 (757)
+.|++..
T Consensus 284 ~~~il~h 290 (309)
T cd07845 284 AEEALES 290 (309)
T ss_pred HHHHhcC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=251.21 Aligned_cols=206 Identities=28% Similarity=0.368 Sum_probs=165.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+|++++++++.+.+..++||||+. ++|.+++......+++.++..++.|++.+|+|||+.
T Consensus 65 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~--- 140 (313)
T cd06633 65 WQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH--- 140 (313)
T ss_pred HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 3568889999999999999999999999999999999996 578888766566789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc---CCCCCccccchhhHHHHHHHHh
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR---NLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||||+||++++++.+||+|||++..... .....|+..|+|||++. ...++.++||||||++++||++
T Consensus 141 gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~ 215 (313)
T cd06633 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 215 (313)
T ss_pred CeecCCCChhhEEECCCCCEEEeecCCCcccCC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999864322 12346788999999974 4568899999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|..|+....... ....... ...... ........+.+++.+|++.+|++||++.+++..
T Consensus 216 g~~p~~~~~~~~------~~~~~~~-~~~~~~-----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 216 RKPPLFNMNAMS------ALYHIAQ-NDSPTL-----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCCCCCChHH------HHHHHHh-cCCCCC-----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999886542211 1111111 111111 112233568889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=258.80 Aligned_cols=211 Identities=25% Similarity=0.363 Sum_probs=163.9
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEec------eeeeEEEEeccCCChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHH
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEV------SKKILVYEYMSNGSLADILFNPE--KQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~y 583 (757)
+...+|+++|++++|+|||++++.-++. ....+|||||.+|||...|.+.+ ..++..+.+.+..+++.||.|
T Consensus 56 e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~ 135 (732)
T KOG4250|consen 56 ERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRH 135 (732)
T ss_pred HHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHH
Confidence 5667899999999999999999976543 36789999999999999998754 678999999999999999999
Q ss_pred hhhCCCCCeeeCCCCcceEEEC----CCCcEEEeecCCccccCCCCcceecccccCccccCccccc-CCCCCccccchhh
Q 038168 584 LHDECETQIIHCDIKPQNILMD----ENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR-NLPITVKADVYSF 658 (757)
Q Consensus 584 LH~~~~~~iiH~Dik~~Nill~----~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~S~ 658 (757)
||++ +|+||||||.||++- ..-..||+|||.|+.+..+. ..+.+.||..|++||.+. ...++..+|.|||
T Consensus 136 LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~ 210 (732)
T KOG4250|consen 136 LREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSF 210 (732)
T ss_pred HHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhh
Confidence 9998 999999999999993 33457999999999887655 566789999999999998 4889999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCC--------------cccccc---ccccCHHHHHHHHHHHHHcc
Q 038168 659 GVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGN--------------LSQLVE---DEEVDEKQLERMIKVALWCI 721 (757)
Q Consensus 659 G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--------------~~~~~d---~~~~~~~~~~~l~~l~~~cl 721 (757)
||++||.+||..||.+...... ..+.++....+.. +..-.. +-........++-+....++
T Consensus 211 GvtlY~caTG~lPF~p~~~pk~--~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L 288 (732)
T KOG4250|consen 211 GVTLYECATGELPFIPFGGPKN--NKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASML 288 (732)
T ss_pred hhHHHHHhccCCCCCcCCCccc--cchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHH
Confidence 9999999999999987654422 1122222222211 100000 01123444566677777777
Q ss_pred ccCCCCCC
Q 038168 722 LDEPSLRP 729 (757)
Q Consensus 722 ~~~p~~RP 729 (757)
.-+|++|-
T Consensus 289 ~~~~~~~~ 296 (732)
T KOG4250|consen 289 EWNPRKRG 296 (732)
T ss_pred hhhHHHhC
Confidence 77888886
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=256.73 Aligned_cols=222 Identities=23% Similarity=0.317 Sum_probs=165.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec-----eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV-----SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
...+.+|+.++++++|+||+++++++... ...++|+||+++ +|.+++. ...+++..+..++.|++.||+|||
T Consensus 47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH 123 (336)
T cd07849 47 CQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILRGLKYIH 123 (336)
T ss_pred HHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 35577899999999999999999987654 357999999975 8887774 346889999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc--eecccccCccccCcccccC-CCCCccccchhhHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR--TFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVL 662 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l 662 (757)
+. +|+||||||+||+++.++.+||+|||+++........ ......|+..|+|||.+.+ ..++.++||||||+++
T Consensus 124 ~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil 200 (336)
T cd07849 124 SA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCIL 200 (336)
T ss_pred hC---CeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHH
Confidence 98 9999999999999999999999999999876433221 1223567899999998754 5689999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHHHHHhcC-----------C----ccccccccc-----cCHHHHHHHHHHHHHccc
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVYQCFENG-----------N----LSQLVEDEE-----VDEKQLERMIKVALWCIL 722 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-----------~----~~~~~d~~~-----~~~~~~~~l~~l~~~cl~ 722 (757)
+||++|+.||........ .......+... . ......... .......++.+++.+||+
T Consensus 201 ~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 277 (336)
T cd07849 201 AEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLT 277 (336)
T ss_pred HHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcC
Confidence 999999999864321110 00000000000 0 000000000 011234678999999999
Q ss_pred cCCCCCCCHHHHHHH--hhcC
Q 038168 723 DEPSLRPSMKKVLLM--LEGT 741 (757)
Q Consensus 723 ~~p~~RPsm~eVl~~--Le~~ 741 (757)
.+|++|||+.|+++. ++..
T Consensus 278 ~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 278 FNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred CChhhCcCHHHHhcCcccccc
Confidence 999999999999986 6543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-27 Score=246.77 Aligned_cols=221 Identities=24% Similarity=0.336 Sum_probs=167.0
Q ss_pred HHHHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.....+|+..+++++ |+|++++++++.+.+..++||||+ +|+|.+++.... ..+++.++..++.|++++|.|||+.
T Consensus 41 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~- 118 (283)
T cd07830 41 ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH- 118 (283)
T ss_pred HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 345567999999998 999999999999999999999999 889999886654 5789999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHHHh
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~ellt 667 (757)
+++|+||||+||++++++.++|+|||++........ .....++..|+|||.+.. ..++.++||||||++++||++
T Consensus 119 --~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~ 194 (283)
T cd07830 119 --GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT 194 (283)
T ss_pred --CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHh
Confidence 999999999999999999999999999986643222 123457889999998754 467999999999999999999
Q ss_pred CCCCCCCCCCCccccH----------HHHHHHHHhcCCccccccc------cccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 668 RRRCLDPNLPDDQVIL----------EEWVYQCFENGNLSQLVED------EEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l----------~~~~~~~~~~~~~~~~~d~------~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
|+.|+......+...- ..|.............+.. ..........+.+++.+|++.+|++||++
T Consensus 195 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~ 274 (283)
T cd07830 195 LRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA 274 (283)
T ss_pred CCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCH
Confidence 9988865432211000 0000000000000000000 00011124678999999999999999999
Q ss_pred HHHHHH
Q 038168 732 KKVLLM 737 (757)
Q Consensus 732 ~eVl~~ 737 (757)
+|++..
T Consensus 275 ~ei~~~ 280 (283)
T cd07830 275 SQALQH 280 (283)
T ss_pred HHHhhC
Confidence 999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=254.33 Aligned_cols=217 Identities=26% Similarity=0.343 Sum_probs=162.3
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEEece--------eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVS--------KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~g~~~~~~--------~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.+|++++++++|+||+++++++.+.. ..++|+||+.. +|.+.+......+++.++..++.|+++||.||
T Consensus 53 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~l 131 (311)
T cd07866 53 TALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYL 131 (311)
T ss_pred hHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 4678999999999999999999875433 46999999875 67777766666789999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc----------ceecccccCccccCcccccCC-CCCccc
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT----------RTFTGIRGTRGYVAPEWHRNL-PITVKA 653 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~-~~~~k~ 653 (757)
|+. +|+|+||||+||++++++.+||+|||+++....... ...+...++..|+|||.+.+. .++.++
T Consensus 132 H~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 208 (311)
T cd07866 132 HEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV 208 (311)
T ss_pred HhC---CeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchh
Confidence 998 999999999999999999999999999986643221 112234678889999987654 589999
Q ss_pred cchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhc---------CCccccc----cccc-c-----CHHHHHHHH
Q 038168 654 DVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFEN---------GNLSQLV----EDEE-V-----DEKQLERMI 714 (757)
Q Consensus 654 Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---------~~~~~~~----d~~~-~-----~~~~~~~l~ 714 (757)
||||||++++||++|+.|+......... ......... ..+.... .... . .......+.
T Consensus 209 Dv~slG~il~el~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (311)
T cd07866 209 DIWGIGCVFAEMFTRRPILQGKSDIDQL---HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGL 285 (311)
T ss_pred HhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHH
Confidence 9999999999999999998754332111 111111000 0000000 0000 0 011235688
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 038168 715 KVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 715 ~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+++.+|++.+|++|||+.|++.
T Consensus 286 ~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 286 DLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHcccCcccCcCHHHHhc
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-27 Score=245.62 Aligned_cols=201 Identities=20% Similarity=0.223 Sum_probs=160.8
Q ss_pred HHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCC
Q 038168 519 KVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIK 598 (757)
Q Consensus 519 ~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik 598 (757)
++++...|+|++++++++.+.+..++||||+++++|.+++.. ...+++..+..++.|+++||+|||+. +++|||||
T Consensus 49 ~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~ 124 (278)
T cd05606 49 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLK 124 (278)
T ss_pred HHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCC
Confidence 344556899999999999999999999999999999998864 45689999999999999999999998 99999999
Q ss_pred cceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 038168 599 PQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICRRRCLDPNLP 677 (757)
Q Consensus 599 ~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG~~p~~~~~~ 677 (757)
|+||+++.++.+||+|||++..+..... ....|+..|+|||.+.+. .++.++||||+|++++||++|+.||.....
T Consensus 125 p~nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~ 201 (278)
T cd05606 125 PANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (278)
T ss_pred HHHEEECCCCCEEEccCcCccccCccCC---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999999999999976543221 234689999999998754 689999999999999999999999976533
Q ss_pred CccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 038168 678 DDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLLM 737 (757)
Q Consensus 678 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~~ 737 (757)
...... ......... ..+......+.+++.+|++.+|.+|| ++.++++.
T Consensus 202 ~~~~~~----~~~~~~~~~-------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 202 KDKHEI----DRMTLTMAV-------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred cchHHH----HHHhhccCC-------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 221111 111111110 11122356788999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=249.84 Aligned_cols=212 Identities=18% Similarity=0.213 Sum_probs=158.1
Q ss_pred HHHHHHHHhhcCCCceeeeeeEEEece----eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 514 FQTEMKVIGRTHHRNLVRLLGYSLEVS----KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 514 ~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
...+...+..+.|+|++++++++.... ..++++|++.. ++.+.+.. ....++.....|+.|+++||+|||+.
T Consensus 70 ~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-- 145 (294)
T PHA02882 70 KIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEH-- 145 (294)
T ss_pred HHHHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 345556677789999999999766543 34677777643 55555533 23356788889999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc------ceecccccCccccCcccccCCCCCccccchhhHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT------RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ 663 (757)
+|+||||||+|||++.++.+||+|||+++.+..... .......||+.|+|||.+.+..++.++|||||||+++
T Consensus 146 -~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~ 224 (294)
T PHA02882 146 -GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCML 224 (294)
T ss_pred -CeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHH
Confidence 999999999999999999999999999987643221 1112246999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCccccH---HHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 664 EIICRRRCLDPNLPDDQVIL---EEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l---~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
||++|+.||........... .++ ...+..++.. .......+.+++..|++.+|++||++.++++.|+
T Consensus 225 el~~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 225 KWAGIKLPWKGFGHNGNLIHAAKCDF-IKRLHEGKIK--------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhCCCCCCccccchHHHHHhHHHH-HHHhhhhhhc--------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 99999999986533221111 011 1111222111 1122466889999999999999999999999874
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=251.28 Aligned_cols=217 Identities=20% Similarity=0.250 Sum_probs=161.7
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEecee-----eeEEEEeccCCChhhhhcCC----CCCCCHHHHHHHHHHHHHHH
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSK-----KILVYEYMSNGSLADILFNP----EKQPNWVERMGIARDIARGI 581 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~-----~~lV~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~gL 581 (757)
+.+.+|+.+++++ +|+||+++++++...+. .++||||+++ +|.+++... ...+++..+..++.||+.||
T Consensus 45 ~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L 123 (295)
T cd07837 45 PTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123 (295)
T ss_pred hHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHH
Confidence 5678899999999 56999999999887665 7999999986 788887543 24579999999999999999
Q ss_pred HHhhhCCCCCeeeCCCCcceEEECC-CCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhH
Q 038168 582 LYLHDECETQIIHCDIKPQNILMDE-NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFG 659 (757)
Q Consensus 582 ~yLH~~~~~~iiH~Dik~~Nill~~-~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G 659 (757)
+|||+. +|+||||||+||+++. ++.+||+|||+++.+...... .....+++.|+|||++.+ ..++.++||||||
T Consensus 124 ~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG 199 (295)
T cd07837 124 AHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVG 199 (295)
T ss_pred HHHHHC---CeeecCCChHHEEEecCCCeEEEeecccceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHH
Confidence 999998 9999999999999998 899999999999865432211 122346788999998865 4579999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCc---------------cccc--cccccCHHHHHHHHHHHHHccc
Q 038168 660 VVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNL---------------SQLV--EDEEVDEKQLERMIKVALWCIL 722 (757)
Q Consensus 660 ~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---------------~~~~--d~~~~~~~~~~~l~~l~~~cl~ 722 (757)
++++||++|..||........ +.. +......... .... +..........++.+++.+||+
T Consensus 200 ~~l~~l~~g~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 276 (295)
T cd07837 200 CIFAEMSRKQPLFPGDSELQQ--LLH-IFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLR 276 (295)
T ss_pred HHHHHHHcCCCCCCCCCHHHH--HHH-HHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHcc
Confidence 999999999998865322110 000 0010000000 0000 0000011235678899999999
Q ss_pred cCCCCCCCHHHHHH
Q 038168 723 DEPSLRPSMKKVLL 736 (757)
Q Consensus 723 ~~p~~RPsm~eVl~ 736 (757)
.+|++||++.|++.
T Consensus 277 ~~P~~R~~~~eil~ 290 (295)
T cd07837 277 YDPAKRISAKAALT 290 (295)
T ss_pred CChhhcCCHHHHhc
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=246.38 Aligned_cols=214 Identities=21% Similarity=0.230 Sum_probs=168.7
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+.+.+|+++++++ +|+||+++++.+..+...++|+||+++++|.+++.. ...+++.+...++.|+++||.|||+.
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~- 124 (290)
T cd05613 47 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKL- 124 (290)
T ss_pred HHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 346678899999999 699999999999998899999999999999999865 34577888888999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC--CCCccccchhhHHHHHHHH
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL--PITVKADVYSFGVVLLEII 666 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~G~~l~ell 666 (757)
+++||||||+|||+++++.+||+|||+++..............|+..|+|||.+... .++.++||||||+++++|+
T Consensus 125 --~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll 202 (290)
T cd05613 125 --GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELL 202 (290)
T ss_pred --CeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHh
Confidence 999999999999999999999999999987654433333345688999999998753 4688999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLLM 737 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~~ 737 (757)
+|+.|+...... ....+.......... ..+......+.+++.+|++.+|++|| +..+++..
T Consensus 203 ~g~~p~~~~~~~--~~~~~~~~~~~~~~~--------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 203 TGASPFTVDGEK--NSQAEISRRILKSEP--------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred cCCCCCCcCCcc--ccHHHHHHHhhccCC--------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 999998643221 122222222211111 11222345788999999999999997 66666653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=242.43 Aligned_cols=209 Identities=22% Similarity=0.285 Sum_probs=166.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.+.+.+|++++++++|+||+++++++.+. ...++|+||+++++|.+++... ..+++.....++.|++.||.|||+.
T Consensus 48 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~- 125 (264)
T cd06653 48 VNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSN- 125 (264)
T ss_pred HHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 45788999999999999999999998764 4578999999999999998653 3478888999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCC--cceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ--TRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+++|+||||+||+++.++.+||+|||+++...... ........++..|+|||.+.+...+.++||||||++++||+
T Consensus 126 --~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 203 (264)
T cd06653 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEML 203 (264)
T ss_pred --CEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHH
Confidence 99999999999999999999999999998654321 11122356889999999999888999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+|+.||...... ..+.+....... ...+....+.+.+++.+|++ +|..||+..+++.
T Consensus 204 ~g~~p~~~~~~~------~~~~~~~~~~~~------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 204 TEKPPWAEYEAM------AAIFKIATQPTK------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred hCCCCCCccCHH------HHHHHHHcCCCC------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 999998643211 111111111111 11233455778999999999 5799999998775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=249.45 Aligned_cols=218 Identities=25% Similarity=0.313 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+|++++++++.+.+..++|+||++ ++|.+++......+++.++..++.++++||+|||+.
T Consensus 42 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--- 117 (282)
T cd07829 42 PSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH--- 117 (282)
T ss_pred cHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 3567789999999999999999999999999999999998 589999976556789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+|+||+|+||++++++.+||+|||+++....... ......++..|+|||.+.+. .++.++||||||++++||++|+
T Consensus 118 ~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~ 196 (282)
T cd07829 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196 (282)
T ss_pred CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999987654322 12223457789999998776 7899999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHh----------------cCCcccccccc--ccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFE----------------NGNLSQLVEDE--EVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~----------------~~~~~~~~d~~--~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
.|+......+.. ..+..... ........... .........+.+++..|++.+|++||++
T Consensus 197 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 273 (282)
T cd07829 197 PLFPGDSEIDQL---FKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA 273 (282)
T ss_pred CCCCCccHHHHH---HHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCH
Confidence 888654321110 00000000 00000000000 0011124679999999999999999999
Q ss_pred HHHHH
Q 038168 732 KKVLL 736 (757)
Q Consensus 732 ~eVl~ 736 (757)
++|+.
T Consensus 274 ~~~l~ 278 (282)
T cd07829 274 KEALK 278 (282)
T ss_pred HHHhh
Confidence 99986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=244.41 Aligned_cols=216 Identities=25% Similarity=0.329 Sum_probs=164.0
Q ss_pred HHHHHHHHHHhhc---CCCceeeeeeEEEecee-----eeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHH
Q 038168 512 REFQTEMKVIGRT---HHRNLVRLLGYSLEVSK-----KILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGIL 582 (757)
Q Consensus 512 ~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~-----~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~ 582 (757)
..+.+|+.+++++ +|+|++++++++...+. .+++|||+++ +|.+++.... ..+++..+..++.|++.||+
T Consensus 43 ~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~ 121 (287)
T cd07838 43 LSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121 (287)
T ss_pred hhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHH
Confidence 3456677777666 59999999999988776 8999999975 8988886543 46899999999999999999
Q ss_pred HhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHH
Q 038168 583 YLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662 (757)
Q Consensus 583 yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l 662 (757)
|||+. +++|+||||+||++++++.+||+|||++........ .....++..|+|||++.+..++.++||||||+++
T Consensus 122 ~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l 196 (287)
T cd07838 122 FLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIF 196 (287)
T ss_pred HHHHC---CeeeccCChhhEEEccCCCEEEeccCcceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHH
Confidence 99998 999999999999999999999999999987654322 1223468899999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHHHHHhc-CC-------------cccccc--ccccCHHHHHHHHHHHHHccccCCC
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVYQCFEN-GN-------------LSQLVE--DEEVDEKQLERMIKVALWCILDEPS 726 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~-------------~~~~~d--~~~~~~~~~~~l~~l~~~cl~~~p~ 726 (757)
+||++|+.|+......+. +.. +.+.... +. ...... ......+....+.+++.+||+.+|+
T Consensus 197 ~~l~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 273 (287)
T cd07838 197 AELFRRRPLFRGTSEADQ--LDK-IFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPH 273 (287)
T ss_pred HHHHhCCCcccCCChHHH--HHH-HHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCc
Confidence 999999988875432211 111 1110000 00 000000 0011123456788999999999999
Q ss_pred CCCCHHHHHH
Q 038168 727 LRPSMKKVLL 736 (757)
Q Consensus 727 ~RPsm~eVl~ 736 (757)
+||++.|++.
T Consensus 274 ~Rp~~~~il~ 283 (287)
T cd07838 274 KRISAFEALQ 283 (287)
T ss_pred cCCCHHHHhc
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=253.89 Aligned_cols=224 Identities=25% Similarity=0.328 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEece-----eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVS-----KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.+.+.+|+.++++++|+||+++++++...+ ..++||||++ ++|.+++... ..+++..+..++.|++.||+|||
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH 120 (330)
T cd07834 43 AKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLH 120 (330)
T ss_pred hhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH
Confidence 466889999999999999999999988765 7899999998 4898888653 47899999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc--ceecccccCccccCcccccCC-CCCccccchhhHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT--RTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVL 662 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l 662 (757)
+. +|+|+||||+|||++.++.+||+|||++........ .......++..|+|||.+.+. .++.++||||||+++
T Consensus 121 ~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il 197 (330)
T cd07834 121 SA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIF 197 (330)
T ss_pred hC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHH
Confidence 98 999999999999999999999999999997755431 122334578899999999888 899999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHHHHHhc-----------CCcccccc---------ccccCHHHHHHHHHHHHHccc
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVYQCFEN-----------GNLSQLVE---------DEEVDEKQLERMIKVALWCIL 722 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-----------~~~~~~~d---------~~~~~~~~~~~l~~l~~~cl~ 722 (757)
++|++|+.||......+.. ..+...... ......+. ...........+.+++.+||+
T Consensus 198 ~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 274 (330)
T cd07834 198 AELLTRKPLFPGRDYIDQL---NLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLV 274 (330)
T ss_pred HHHHcCCCCcCCCCHHHHH---HHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHcc
Confidence 9999999998755432110 000000000 00000000 000111234678899999999
Q ss_pred cCCCCCCCHHHHHHH--hhcCc
Q 038168 723 DEPSLRPSMKKVLLM--LEGTV 742 (757)
Q Consensus 723 ~~p~~RPsm~eVl~~--Le~~~ 742 (757)
.+|++||+++++++. +++..
T Consensus 275 ~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 275 FDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred CChhhCCCHHHHHhCccHHhhc
Confidence 999999999999984 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-27 Score=244.74 Aligned_cols=208 Identities=23% Similarity=0.335 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|++++++++ |+||+++++++...+..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.
T Consensus 45 ~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~-- 121 (280)
T cd05581 45 VKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSK-- 121 (280)
T ss_pred HHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 467889999999998 999999999999999999999999999999999653 4689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-------------------ceecccccCccccCcccccCCCCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-------------------RTFTGIRGTRGYVAPEWHRNLPIT 650 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~ 650 (757)
+++|+||||+||+++.++.++|+|||++........ .......++..|+|||......++
T Consensus 122 -~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~ 200 (280)
T cd05581 122 -GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAG 200 (280)
T ss_pred -CeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCC
Confidence 999999999999999999999999999987654321 112235578899999999988899
Q ss_pred ccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC
Q 038168 651 VKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS 730 (757)
Q Consensus 651 ~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 730 (757)
.++||||||++++++++|+.|+....... . ... ...... ..+....+.+.+++.+||+.+|++||+
T Consensus 201 ~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~----~~~-~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~ 266 (280)
T cd05581 201 KSSDLWALGCIIYQMLTGKPPFRGSNEYL--T----FQK-ILKLEY-------SFPPNFPPDAKDLIEKLLVLDPQDRLG 266 (280)
T ss_pred hhhhHHHHHHHHHHHHhCCCCCCCccHHH--H----HHH-HHhcCC-------CCCCccCHHHHHHHHHHhcCCHhhCCC
Confidence 99999999999999999999987543111 0 111 111111 112233567899999999999999999
Q ss_pred H----HHHHH
Q 038168 731 M----KKVLL 736 (757)
Q Consensus 731 m----~eVl~ 736 (757)
+ +++++
T Consensus 267 ~~~~~~~ll~ 276 (280)
T cd05581 267 VNEGYDELKA 276 (280)
T ss_pred cccCHHHHhc
Confidence 9 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=235.68 Aligned_cols=235 Identities=24% Similarity=0.301 Sum_probs=174.0
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEe-ceeeeEEEEeccCCChhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLE-VSKKILVYEYMSNGSLADILFNP----EKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
....+|+.+++.++|+|++.|..++.+ +...+|++||.+. +|.++++.+ .+.++-.....|+.||+.|+.|||+
T Consensus 72 ~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~ 150 (438)
T KOG0666|consen 72 MSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS 150 (438)
T ss_pred HHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh
Confidence 445689999999999999999998887 6688999999987 788887533 2567888999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCC----CcEEEeecCCccccCCCCcc--eecccccCccccCcccccCC-CCCccccchhhH
Q 038168 587 ECETQIIHCDIKPQNILMDEN----RCAKISDFGLAKLMKPDQTR--TFTGIRGTRGYVAPEWHRNL-PITVKADVYSFG 659 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~----~~~ki~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G 659 (757)
+ -|+||||||.|||+..+ |.+||+|||++|++...-.. ....++-|..|.|||.+.+. .||+..|||+.|
T Consensus 151 N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiG 227 (438)
T KOG0666|consen 151 N---WVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIG 227 (438)
T ss_pred h---heeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHH
Confidence 9 99999999999999877 89999999999998754332 33457789999999998876 689999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCccc---cHHHHHHHHHhc------CCcccccccccc------------CHH----------
Q 038168 660 VVLLEIICRRRCLDPNLPDDQV---ILEEWVYQCFEN------GNLSQLVEDEEV------------DEK---------- 708 (757)
Q Consensus 660 ~~l~elltG~~p~~~~~~~~~~---~l~~~~~~~~~~------~~~~~~~d~~~~------------~~~---------- 708 (757)
|++.||++-.+.|......-.. .-.+.+.+.++- .+.+.+..-.+. +..
T Consensus 228 CIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k 307 (438)
T KOG0666|consen 228 CIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHK 307 (438)
T ss_pred HHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhc
Confidence 9999999998887654322110 001111111110 111111110000 000
Q ss_pred -HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcCCCCCCCCC
Q 038168 709 -QLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPIPPNPT 751 (757)
Q Consensus 709 -~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~~~~p~~p~ 751 (757)
......++..++|+.||.+|.|.++.++.. -..+-+.||.|.
T Consensus 308 ~k~~~a~~LL~klL~yDP~kRIta~qAleh~-yF~~d~lpp~pt 350 (438)
T KOG0666|consen 308 VKDPSALDLLQKLLTYDPIKRITAEQALEHP-YFTEDPLPPLPT 350 (438)
T ss_pred CCCchHHHHHHHHhccCchhhccHHHHhccc-ccccCCCCCCcc
Confidence 012267788999999999999999887754 255666777764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=267.37 Aligned_cols=180 Identities=29% Similarity=0.488 Sum_probs=138.6
Q ss_pred eeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCcccc
Q 038168 542 KILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM 621 (757)
Q Consensus 542 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~ 621 (757)
.||=||||+.-.|.+++..+...-.-....+++++|+.||+|+|+. +||||||||.||+||++..|||+|||+|...
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~ 747 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDL 747 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhh
Confidence 4677999998888888865443224556678999999999999999 9999999999999999999999999999872
Q ss_pred C-----------------CCCcceecccccCccccCcccccCC---CCCccccchhhHHHHHHHHhCCCCCCCCCCCccc
Q 038168 622 K-----------------PDQTRTFTGIRGTRGYVAPEWHRNL---PITVKADVYSFGVVLLEIICRRRCLDPNLPDDQV 681 (757)
Q Consensus 622 ~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~ 681 (757)
. .......+..+||.-|+|||.+.+. +|+.|+|+||+|||++||+. ||...++
T Consensus 748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME---- 820 (1351)
T KOG1035|consen 748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME---- 820 (1351)
T ss_pred hhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH----
Confidence 1 0011234568899999999998765 49999999999999999984 3433221
Q ss_pred cHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 682 ILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 682 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
...+...++.+.++.. ..+..++...=.+++.|++++||.+|||+.|++.
T Consensus 821 --Ra~iL~~LR~g~iP~~---~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 821 --RASILTNLRKGSIPEP---ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred --HHHHHHhcccCCCCCC---cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 1123445566766654 3334455566678999999999999999999986
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=253.02 Aligned_cols=232 Identities=22% Similarity=0.289 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEece------eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVS------KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.+.+|+.++++++|+||+++++++.... ..++||||+ +++|.+++.. ..+++..+..++.|+++||+||
T Consensus 58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~L 134 (343)
T cd07880 58 AKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYI 134 (343)
T ss_pred HHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Confidence 456889999999999999999999887543 458999998 6789888753 4688999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLL 663 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~ 663 (757)
|+. +|+||||||+||+++.++.+||+|||+++..... .....++..|+|||.+.+ ..++.++||||||++++
T Consensus 135 H~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~ 207 (343)
T cd07880 135 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMA 207 (343)
T ss_pred HhC---CeecCCCCHHHEEEcCCCCEEEeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHH
Confidence 998 9999999999999999999999999999865432 223456889999998876 45889999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHH----------HHHHHhcCC-------ccccccc--cccCHHHHHHHHHHHHHccccC
Q 038168 664 EIICRRRCLDPNLPDDQVILEEW----------VYQCFENGN-------LSQLVED--EEVDEKQLERMIKVALWCILDE 724 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~----------~~~~~~~~~-------~~~~~d~--~~~~~~~~~~l~~l~~~cl~~~ 724 (757)
+|++|+.||....... .+... ....+.... +...... ..........+.+++.+|++.|
T Consensus 208 ~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 285 (343)
T cd07880 208 EMLTGKPLFKGHDHLD--QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLD 285 (343)
T ss_pred HHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCC
Confidence 9999999987543211 00000 000000000 0000000 0011123346889999999999
Q ss_pred CCCCCCHHHHHH--HhhcCcCCCCCCCCCCcc
Q 038168 725 PSLRPSMKKVLL--MLEGTVEIPIPPNPTSFL 754 (757)
Q Consensus 725 p~~RPsm~eVl~--~Le~~~~~~~p~~p~~~~ 754 (757)
|++|||+.+++. .++...+.+..+.+..|.
T Consensus 286 P~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~~ 317 (343)
T cd07880 286 AESRITAAEALAHPYFEEFHDPEDETEAPPYD 317 (343)
T ss_pred hhhCCCHHHHhcCccHhhhcCcccccCCCCcc
Confidence 999999999993 555544444333333343
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-27 Score=251.64 Aligned_cols=218 Identities=25% Similarity=0.350 Sum_probs=162.6
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEe-ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLE-VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+.+.+|++++++++||||+++++++.. .+..++|+||+ +++|.+++.. ..++......++.|+++||+|||+.
T Consensus 52 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~- 127 (328)
T cd07856 52 LAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSA- 127 (328)
T ss_pred hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 34678899999999999999999998865 55788999998 5689888753 3567788888999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHHHh
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+|+||||+||++++++.+||+|||+++..... .....++..|+|||.+.+ ..++.++||||||++++||++
T Consensus 128 --~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t 201 (328)
T cd07856 128 --GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLE 201 (328)
T ss_pred --CcccCCCCHHHEeECCCCCEEeCccccccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999754322 123456889999998766 568999999999999999999
Q ss_pred CCCCCCCCCCCccccH---------HHHHHHHHhcCCcc---ccccccccC-----HHHHHHHHHHHHHccccCCCCCCC
Q 038168 668 RRRCLDPNLPDDQVIL---------EEWVYQCFENGNLS---QLVEDEEVD-----EKQLERMIKVALWCILDEPSLRPS 730 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l---------~~~~~~~~~~~~~~---~~~d~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs 730 (757)
|+.||........... .++........... ........+ ......+.+++.+|++.+|++||+
T Consensus 202 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t 281 (328)
T cd07856 202 GKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS 281 (328)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC
Confidence 9998865432111000 00000000000000 000000011 122467899999999999999999
Q ss_pred HHHHHHH
Q 038168 731 MKKVLLM 737 (757)
Q Consensus 731 m~eVl~~ 737 (757)
+++++..
T Consensus 282 ~~ell~~ 288 (328)
T cd07856 282 AAEALAH 288 (328)
T ss_pred HHHHhcC
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=252.66 Aligned_cols=219 Identities=21% Similarity=0.243 Sum_probs=167.4
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
..+.+|++++++++|+||+++++++..++..++||||++ |+|.+++.. ...++......++.|++.||+|||+. +
T Consensus 65 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~---~ 139 (335)
T PTZ00024 65 FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKW---Y 139 (335)
T ss_pred hhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 467899999999999999999999999999999999997 689988854 45688899999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCC-------------cceecccccCccccCcccccCC-CCCccccchh
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ-------------TRTFTGIRGTRGYVAPEWHRNL-PITVKADVYS 657 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S 657 (757)
++|+||||+||+++.++.+||+|||+++...... ........++..|+|||.+.+. .++.++||||
T Consensus 140 i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 219 (335)
T PTZ00024 140 FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWS 219 (335)
T ss_pred eecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHH
Confidence 9999999999999999999999999998765111 1111223467889999998764 4689999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCC---cccc--------ccc---c---ccCHHHHHHHHHHHHHc
Q 038168 658 FGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGN---LSQL--------VED---E---EVDEKQLERMIKVALWC 720 (757)
Q Consensus 658 ~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~--------~d~---~---~~~~~~~~~l~~l~~~c 720 (757)
||++++||++|+.|+......+. ...+........ +... ... . ........++.+++.+|
T Consensus 220 lG~~l~el~tg~~p~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 296 (335)
T PTZ00024 220 VGCIFAELLTGKPLFPGENEIDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSL 296 (335)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHH
Confidence 99999999999999875433211 111111111110 0000 000 0 00112246788999999
Q ss_pred cccCCCCCCCHHHHHHHh
Q 038168 721 ILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 721 l~~~p~~RPsm~eVl~~L 738 (757)
++.+|++||+++|++..-
T Consensus 297 l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 297 LKLNPLERISAKEALKHE 314 (335)
T ss_pred cCCCchhccCHHHHhcCc
Confidence 999999999999999843
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-27 Score=240.01 Aligned_cols=192 Identities=20% Similarity=0.170 Sum_probs=154.3
Q ss_pred HHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeee
Q 038168 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIH 594 (757)
Q Consensus 515 ~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 594 (757)
.+|...+....|||++++++++.+.+..++||||+++|+|.+++.+. ..+++.....++.|+++||+|||+. +++|
T Consensus 33 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H 108 (237)
T cd05576 33 SRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDALHRE---GIVC 108 (237)
T ss_pred hhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 34555556667999999999999999999999999999999998653 4588999999999999999999998 9999
Q ss_pred CCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCC
Q 038168 595 CDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDP 674 (757)
Q Consensus 595 ~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~ 674 (757)
|||||+||+++.++.++++|||++....... ....++..|+|||...+..++.++||||+|++++||++|+.|+..
T Consensus 109 ~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 109 RDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred cCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 9999999999999999999999887654321 223456789999999888899999999999999999999987653
Q ss_pred CCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 675 NLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 675 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
...... . ...+ ..+......+.+++.+|++.||++||++.
T Consensus 185 ~~~~~~------------~--~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 185 HPSGIN------------T--HTTL----NIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred Cchhcc------------c--cccc----CCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 211100 0 0000 01122345688999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=248.87 Aligned_cols=215 Identities=24% Similarity=0.308 Sum_probs=159.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec------eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV------SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.+.+|+.++++++|+||+++++++... ...+++++++ +++|.+++.. ..+++..+..++.|+++||+||
T Consensus 60 ~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~L 136 (345)
T cd07877 60 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYI 136 (345)
T ss_pred HHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Confidence 35678899999999999999999987643 3467788876 7899888753 3588999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLL 663 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~ 663 (757)
|+. +|+||||||+||++++++.+||+|||+++..... .....++..|+|||.+.+ ..++.++||||||++++
T Consensus 137 H~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~ 209 (345)
T cd07877 137 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 209 (345)
T ss_pred HHC---CeeecCCChHHEEEcCCCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHH
Confidence 998 9999999999999999999999999999865332 223467889999998876 56889999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHH----------HHhcCC-------cccccccc--ccCHHHHHHHHHHHHHccccC
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQ----------CFENGN-------LSQLVEDE--EVDEKQLERMIKVALWCILDE 724 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~----------~~~~~~-------~~~~~d~~--~~~~~~~~~l~~l~~~cl~~~ 724 (757)
||++|+.|+....... .+...... .+.... +....... ........++.+++.+|++.+
T Consensus 210 el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 287 (345)
T cd07877 210 ELLTGRTLFPGTDHID--QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 287 (345)
T ss_pred HHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCC
Confidence 9999999986432211 11000000 000000 00000000 000012356889999999999
Q ss_pred CCCCCCHHHHHHH
Q 038168 725 PSLRPSMKKVLLM 737 (757)
Q Consensus 725 p~~RPsm~eVl~~ 737 (757)
|++||++.+++..
T Consensus 288 p~~R~t~~e~l~h 300 (345)
T cd07877 288 SDKRITAAQALAH 300 (345)
T ss_pred hhhcCCHHHHhcC
Confidence 9999999998874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=238.06 Aligned_cols=205 Identities=25% Similarity=0.269 Sum_probs=168.4
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+..|++++++++|+||+++++.+..++..++||||+++++|.+++... ..+++.....++.|++.||.|||+.
T Consensus 36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~-- 112 (250)
T cd05123 36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSL-- 112 (250)
T ss_pred HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4567889999999999999999999999999999999999999999999653 3578999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+++|+||||+||+++.++.++|+|||++....... .......++..|++||...+...+.++|+||||++++||++|+
T Consensus 113 -~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~ 190 (250)
T cd05123 113 -GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190 (250)
T ss_pred -CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999998765432 1223356788999999999888999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKK 733 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~e 733 (757)
.|+..... .... +....+.. ..+......+.+++.+|+..+|++||++.+
T Consensus 191 ~p~~~~~~------~~~~-~~~~~~~~-------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 191 PPFYAEDR------KEIY-EKILKDPL-------RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCCH------HHHH-HHHhcCCC-------CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 99864422 1111 11111111 112222567889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=233.35 Aligned_cols=210 Identities=28% Similarity=0.374 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++.+++++|+|++++++++......++|+||+++++|.+++..... +++..+..++.+++++|.|||+.
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~--- 106 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR-LSEDEARFYARQILSALEYLHSN--- 106 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHHc---
Confidence 57899999999999999999999999999999999999999999999865333 88999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+++|+||+|+||++++++.++|+|||.+....... ......++..|++||...+..++.++||||||+++++|++|..
T Consensus 107 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~ 184 (244)
T smart00220 107 GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKP 184 (244)
T ss_pred CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999998775542 2233557889999999998889999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|+...... ....+....+....... ......++.+++.+|+..+|++||++.++++
T Consensus 185 p~~~~~~~------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 185 PFPGDDQL------LELFKKIGKPKPPFPPP----EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCCCCcH------HHHHHHHhccCCCCccc----cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 88653111 11122222222221110 0014467899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=213.84 Aligned_cols=102 Identities=45% Similarity=0.731 Sum_probs=72.6
Q ss_pred CCeEEEEecCCCCCCCC--CceeEeccCCCEEEecCCCCceeEEe-cC-CCc--ceeEEEecCCCEEEEecCCceeeecc
Q 038168 79 EKTVVWTANRDDPPVST--NATLLFNSEGSIVLRSSQQSQDSLIA-DD-SQS--ASSASMLDSGNFVLYDSNGKTLWQTF 152 (757)
Q Consensus 79 ~~tvVWvANr~~P~~~~--~~~l~~~~~G~Lvl~~~~~~~~~~~~-~~-~~~--~~~a~LldsGNlVl~~~~~~~lWQSF 152 (757)
++||||+|||+.|+.+. ..+|.+..||+|+|.+.++.. .|++ .+ ... ...|+|+|+|||||+|..+.+|||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~-iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf 79 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSV-IWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSF 79 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEE-EEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEEST
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCE-EEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeec
Confidence 47999999999999653 489999999999999988444 6665 33 333 68999999999999999999999999
Q ss_pred CCCccccCCCCcccCC------CcccccCCCCCCC
Q 038168 153 EHPTDTLLPNQRLSVG------TKLFPGISETNPS 181 (757)
Q Consensus 153 D~PTDTlLpg~kl~~~------~~L~S~~s~~dps 181 (757)
||||||+||||+|+.+ ..|+||++.+|||
T Consensus 80 ~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 80 DYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp TSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 9999999999999862 3599999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=228.94 Aligned_cols=211 Identities=23% Similarity=0.334 Sum_probs=171.3
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEEec-eeeeEEEEeccCCChhhhhc-----CC--CCCCCHHHHHHHHHHHHHHHHHh
Q 038168 513 EFQTEMKVIGRTHHRNLVRLLGYSLEV-SKKILVYEYMSNGSLADILF-----NP--EKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~e~~~~gsL~~~l~-----~~--~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+..|--++..+.|||+..+.+.+.+. +..+++|.++.-|+|..||. +. .+.+...+...++.|++.|++||
T Consensus 333 ~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl 412 (563)
T KOG1024|consen 333 LLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL 412 (563)
T ss_pred HHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH
Confidence 456777777788899999999998764 56789999999999999997 22 24456778889999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceec-ccccCccccCcccccCCCCCccccchhhHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT-GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ 663 (757)
|.+ ++||.||.++|++||+...+||+|-.|+|-+-+.+..... +--.+..||+||.+.+..++..+||||||+++|
T Consensus 413 h~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllW 489 (563)
T KOG1024|consen 413 HNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLW 489 (563)
T ss_pred Hhc---CcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHH
Confidence 999 9999999999999999999999999999966544333222 233577899999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCccccHHHHHHHHHhcCC-ccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 664 EIIC-RRRCLDPNLPDDQVILEEWVYQCFENGN-LSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 664 ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
||+| |+.|...-.+. .+...+++|. +.+ +.+.+.++..++.-||...|++||+.+|++.-|.+
T Consensus 490 ELmtlg~~PyaeIDPf-------Em~~ylkdGyRlaQ-------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 490 ELMTLGKLPYAEIDPF-------EMEHYLKDGYRLAQ-------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHHhcCCCCccccCHH-------HHHHHHhccceecC-------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 9987 66665543332 2445555553 222 34567889999999999999999999999999875
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=249.28 Aligned_cols=220 Identities=20% Similarity=0.291 Sum_probs=159.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEec--------------eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEV--------------SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIAR 575 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~ 575 (757)
..+.+.+|++++++++|+||+++++++... ...++|+||++ ++|.+++.. ..+++.....++.
T Consensus 45 ~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~ 121 (342)
T cd07854 45 SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMY 121 (342)
T ss_pred hHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHH
Confidence 356788999999999999999999876543 35789999997 589888743 4578899999999
Q ss_pred HHHHHHHHhhhCCCCCeeeCCCCcceEEECC-CCcEEEeecCCccccCCCCcce--ecccccCccccCcccccC-CCCCc
Q 038168 576 DIARGILYLHDECETQIIHCDIKPQNILMDE-NRCAKISDFGLAKLMKPDQTRT--FTGIRGTRGYVAPEWHRN-LPITV 651 (757)
Q Consensus 576 ~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~-~~~~ki~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~ 651 (757)
|++.||.|||+. +++||||||+||+++. +..+||+|||+++......... .....++..|+|||.+.. ..++.
T Consensus 122 qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 198 (342)
T cd07854 122 QLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTK 198 (342)
T ss_pred HHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCc
Confidence 999999999998 9999999999999974 5678999999998654322111 122357889999997654 56889
Q ss_pred cccchhhHHHHHHHHhCCCCCCCCCCCccccHH-------------HH---HHHHHhcCCccccccc-cccCHHHHHHHH
Q 038168 652 KADVYSFGVVLLEIICRRRCLDPNLPDDQVILE-------------EW---VYQCFENGNLSQLVED-EEVDEKQLERMI 714 (757)
Q Consensus 652 k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~-------------~~---~~~~~~~~~~~~~~d~-~~~~~~~~~~l~ 714 (757)
++||||||++++||++|+.||....+....... .. ........ ......+ .........++.
T Consensus 199 ~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 277 (342)
T cd07854 199 AIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRND-GGEPRRPLRDLLPGVNPEAL 277 (342)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhc-ccccCCCHHHHccCCCHHHH
Confidence 999999999999999999999754321110000 00 00000000 0000000 000112345688
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 038168 715 KVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 715 ~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+++.+|++.||++|||++|+++
T Consensus 278 ~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 278 DFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHHhCCCchhccCHHHHhC
Confidence 9999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=246.79 Aligned_cols=221 Identities=23% Similarity=0.270 Sum_probs=161.3
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEec----eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEV----SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.+.+.+|+.+++++ +|+||+++++++... ...++++||+. ++|.+++.. ...+++..+..++.|++.||+|||
T Consensus 45 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH 122 (332)
T cd07857 45 AKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIH 122 (332)
T ss_pred HHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999 599999999976433 35678888886 689888854 456889999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc---eecccccCccccCcccccC-CCCCccccchhhHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR---TFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVV 661 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~ 661 (757)
+. +++||||||+|||+++++.+||+|||+++........ ......|+..|+|||++.+ ..++.++||||+|++
T Consensus 123 ~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~ 199 (332)
T cd07857 123 SA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCI 199 (332)
T ss_pred hC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHH
Confidence 98 9999999999999999999999999999866432221 1233568999999998766 468999999999999
Q ss_pred HHHHHhCCCCCCCCCCCccccH---------HHHHHHH--------HhcCCccccccccccCHHHHHHHHHHHHHccccC
Q 038168 662 LLEIICRRRCLDPNLPDDQVIL---------EEWVYQC--------FENGNLSQLVEDEEVDEKQLERMIKVALWCILDE 724 (757)
Q Consensus 662 l~elltG~~p~~~~~~~~~~~l---------~~~~~~~--------~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~ 724 (757)
+++|++|+.|+........... .+..... ......................+.+++.+|++.+
T Consensus 200 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 279 (332)
T cd07857 200 LAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFD 279 (332)
T ss_pred HHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCC
Confidence 9999999998865332110000 0000000 0000000000000001112457889999999999
Q ss_pred CCCCCCHHHHHH
Q 038168 725 PSLRPSMKKVLL 736 (757)
Q Consensus 725 p~~RPsm~eVl~ 736 (757)
|++|||+.|+++
T Consensus 280 P~~R~t~~~ll~ 291 (332)
T cd07857 280 PTKRISVEEALE 291 (332)
T ss_pred cccCCCHHHHhc
Confidence 999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=224.52 Aligned_cols=211 Identities=22% Similarity=0.347 Sum_probs=162.2
Q ss_pred HHHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+.++..++++.+-+ .|.||+.+|++......++.||.|.. .++.++..-.+.++....-++...+++||.||.++ +
T Consensus 135 kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H 211 (391)
T KOG0983|consen 135 KRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--H 211 (391)
T ss_pred HHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--c
Confidence 56677777776664 89999999999999999999999854 56666655555667666778999999999999887 6
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC---CCCCccccchhhHHHHHHHHh
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN---LPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+|||+||+|||+|+.|++|++|||.+-.+-... ..+...|-+.|||||.+.- ..|..++||||||++++||.|
T Consensus 212 ~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaT 289 (391)
T KOG0983|consen 212 GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELAT 289 (391)
T ss_pred ceeecccCccceEEccCCCEEeecccccceeeccc--ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhc
Confidence 99999999999999999999999999997664432 2233457889999998864 468999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|..|+.....+-+. +-..+.+. . ..++.. ......+++++..||+.|+.+||...++++.
T Consensus 290 g~yPy~~c~tdFe~-----ltkvln~e-P-P~L~~~---~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 290 GQYPYKGCKTDFEV-----LTKVLNEE-P-PLLPGH---MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ccCCCCCCCccHHH-----HHHHHhcC-C-CCCCcc---cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 99999864332211 11222211 1 122211 1245678899999999999999999988763
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=248.47 Aligned_cols=213 Identities=25% Similarity=0.351 Sum_probs=162.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEecee------eeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSK------KILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.+.+|+.++++++|+|++++++++...+. .++|+||+ +++|.+++.. ..+++..+..++.|+++||+||
T Consensus 58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~L 134 (343)
T cd07851 58 AKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYI 134 (343)
T ss_pred HHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Confidence 3557789999999999999999998766554 89999998 5699998854 4689999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLL 663 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~ 663 (757)
|+. +|+|+||||+||++++++.+||+|||++...... .....++..|+|||.+.+ ..++.++||||||++++
T Consensus 135 H~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ 207 (343)
T cd07851 135 HSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 207 (343)
T ss_pred HHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHH
Confidence 998 9999999999999999999999999999866432 233457889999998865 46789999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHH-----------hcCCcccccc------ccc---cCHHHHHHHHHHHHHcccc
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCF-----------ENGNLSQLVE------DEE---VDEKQLERMIKVALWCILD 723 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~-----------~~~~~~~~~d------~~~---~~~~~~~~l~~l~~~cl~~ 723 (757)
||++|+.||........ +.. ..+.. ........+. ... .......++.+++.+|++.
T Consensus 208 elltg~~pf~~~~~~~~--~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~ 284 (343)
T cd07851 208 ELLTGKTLFPGSDHIDQ--LKR-IMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVL 284 (343)
T ss_pred HHHhCCCCCCCCChHHH--HHH-HHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCC
Confidence 99999999864432110 000 00000 0000000000 000 0011256789999999999
Q ss_pred CCCCCCCHHHHHH
Q 038168 724 EPSLRPSMKKVLL 736 (757)
Q Consensus 724 ~p~~RPsm~eVl~ 736 (757)
+|++|||+.||++
T Consensus 285 ~P~~Rpt~~ell~ 297 (343)
T cd07851 285 DPDKRITAAEALA 297 (343)
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999987
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-26 Score=257.71 Aligned_cols=224 Identities=21% Similarity=0.228 Sum_probs=176.5
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
..|+.|-++|.--+.+=|++|+-.|++.+..|+|||||+||+|-.++.+.. .++.....-++..|+-||.-||+. |
T Consensus 120 A~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~m---g 195 (1317)
T KOG0612|consen 120 ACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSM---G 195 (1317)
T ss_pred HHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhc---c
Confidence 467888888888888889999999999999999999999999999997766 677777788999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc----C-CCCCccccchhhHHHHHHHH
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR----N-LPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~k~Dv~S~G~~l~ell 666 (757)
+|||||||.|||||..|.+||+|||.+..+..+..-.....+||+.|++||++. + +.|++.+|.||+||++|||+
T Consensus 196 yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMl 275 (1317)
T KOG0612|consen 196 YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEML 275 (1317)
T ss_pred ceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHH
Confidence 999999999999999999999999999998888777777789999999999885 2 57899999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcC-CccccccccccCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHh----
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENG-NLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS---MKKVLLML---- 738 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---m~eVl~~L---- 738 (757)
.|..||+.. .+++.....+.-. .+... +. .+..++..+++...+. +|+.|.. ++++...-
T Consensus 276 yG~TPFYad------slveTY~KIm~hk~~l~FP-~~----~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 276 YGETPFYAD------SLVETYGKIMNHKESLSFP-DE----TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred cCCCcchHH------HHHHHHHHHhchhhhcCCC-cc----cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence 999999842 2333222222211 11111 11 2244556666666554 7788887 88887642
Q ss_pred ---hcCcCCCCCCCCC
Q 038168 739 ---EGTVEIPIPPNPT 751 (757)
Q Consensus 739 ---e~~~~~~~p~~p~ 751 (757)
+++.+...|=+|.
T Consensus 344 ~~W~~iR~~~pP~vPe 359 (1317)
T KOG0612|consen 344 IDWDNIRESVPPVVPE 359 (1317)
T ss_pred CChhhhhhcCCCCCCc
Confidence 2355555555553
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=229.04 Aligned_cols=196 Identities=24% Similarity=0.260 Sum_probs=157.8
Q ss_pred HHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeee
Q 038168 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIH 594 (757)
Q Consensus 515 ~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 594 (757)
..|-.+|+..+||-+..|--.++..++.++||||..+|.|.-+|.. .+.++.....-+..+|+.||.|||++ .||.
T Consensus 216 lTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~---~ivY 291 (516)
T KOG0690|consen 216 LTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSR---NIVY 291 (516)
T ss_pred hhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhC---Ceee
Confidence 3577788889999999999899999999999999999999998854 45566665666889999999999998 9999
Q ss_pred CCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCC
Q 038168 595 CDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDP 674 (757)
Q Consensus 595 ~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~ 674 (757)
||||.+|.|||.+|.+||+||||++.--.. ......++||+.|+|||++....|....|.|.+||++|||++|+.||..
T Consensus 292 RDlKLENLlLDkDGHIKitDFGLCKE~I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 292 RDLKLENLLLDKDGHIKITDFGLCKEEIKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred eechhhhheeccCCceEeeecccchhcccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 999999999999999999999999854322 2345568999999999999999999999999999999999999999986
Q ss_pred CCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC
Q 038168 675 NLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP 729 (757)
Q Consensus 675 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP 729 (757)
...+. +. +++..+.+ .++.....+...+..-.|..||.+|.
T Consensus 371 ~dh~k---LF----eLIl~ed~-------kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 371 KDHEK---LF----ELILMEDL-------KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred cchhH---HH----HHHHhhhc-------cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 54432 11 11111111 12223334556667778889999995
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-26 Score=233.06 Aligned_cols=215 Identities=24% Similarity=0.314 Sum_probs=167.3
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEE-eceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSL-EVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+...+|..|-+.|.||.||++++++. +.+..+-|+||+++.+|+-||+. .+.++..+...|+.||+.||.||.+. ++
T Consensus 512 KHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEi-kp 589 (775)
T KOG1151|consen 512 KHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEI-KP 589 (775)
T ss_pred HHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhcc-CC
Confidence 34568999999999999999999886 55678899999999999999954 56788899999999999999999986 78
Q ss_pred CeeeCCCCcceEEECC---CCcEEEeecCCccccCCCCcc------eecccccCccccCcccccCC----CCCccccchh
Q 038168 591 QIIHCDIKPQNILMDE---NRCAKISDFGLAKLMKPDQTR------TFTGIRGTRGYVAPEWHRNL----PITVKADVYS 657 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~---~~~~ki~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~S 657 (757)
+|||-||||.||||-+ -|.+||.||||++++..+... .+....||..|++||.+.-+ +++.|+||||
T Consensus 590 PIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWS 669 (775)
T KOG1151|consen 590 PIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWS 669 (775)
T ss_pred CeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEe
Confidence 9999999999999954 378999999999999765443 23346799999999977543 5789999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 658 FGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 658 ~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
.||++|+.+.|+.||.......++ +.+ ...++...+..... +....+...++.+||+..-++|....++..
T Consensus 670 vGVIFyQClYGrKPFGhnqsQQdI-Lqe--NTIlkAtEVqFP~K-----PvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 670 VGVIFYQCLYGRKPFGHNQSQQDI-LQE--NTILKATEVQFPPK-----PVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred eehhhhhhhccCCCCCCchhHHHH-Hhh--hchhcceeccCCCC-----CccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 999999999999999876543322 111 01111111211111 122345677889999999999988777653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=231.49 Aligned_cols=243 Identities=20% Similarity=0.290 Sum_probs=181.1
Q ss_pred cccHHHHHHhhccccccccCCCchH-------------------------HHHHHHHHHHhhcC-CC-----ceeeeeeE
Q 038168 487 SFSYAELEKMTDGFKEEVGRGSSGE-------------------------REFQTEMKVIGRTH-HR-----NLVRLLGY 535 (757)
Q Consensus 487 ~~~~~~l~~~t~~f~~~lg~g~~~~-------------------------~~~~~E~~~l~~l~-h~-----niv~l~g~ 535 (757)
.|...+...........+|+|.||. +.-+-|+++|.++. +. -+|.+.++
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 3444444333333346788888852 44567999999993 22 37788888
Q ss_pred EEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECC--------
Q 038168 536 SLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDE-------- 606 (757)
Q Consensus 536 ~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~-------- 606 (757)
+.-.++.++|+|.+ +-|+.++|.+++ ..++..++..|+.|+++++++||+. +++|.||||+|||+.+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEec
Confidence 99999999999998 458999998755 5678899999999999999999998 9999999999999931
Q ss_pred ------------CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCC
Q 038168 607 ------------NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDP 674 (757)
Q Consensus 607 ------------~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~ 674 (757)
+..+||+|||.|....... ..++.|..|.|||++.+...+.++||||+||||+|+.+|...|+.
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 3458999999998754433 346779999999999999999999999999999999999998887
Q ss_pred CCCCccccHHHH--------------HHHHHhcCCcc-----------cccccc-------ccCHHHHHHHHHHHHHccc
Q 038168 675 NLPDDQVILEEW--------------VYQCFENGNLS-----------QLVEDE-------EVDEKQLERMIKVALWCIL 722 (757)
Q Consensus 675 ~~~~~~~~l~~~--------------~~~~~~~~~~~-----------~~~d~~-------~~~~~~~~~l~~l~~~cl~ 722 (757)
...-+...+-+. ..+....+++. ...++. ....++..++++|+..||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 653332111111 11111122111 011110 1245667889999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 038168 723 DEPSLRPSMKKVLLM 737 (757)
Q Consensus 723 ~~p~~RPsm~eVl~~ 737 (757)
.||.+|+|+.|+++.
T Consensus 392 fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 392 FDPARRITLREALSH 406 (415)
T ss_pred cCccccccHHHHhcC
Confidence 999999999999863
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-26 Score=232.27 Aligned_cols=220 Identities=26% Similarity=0.365 Sum_probs=170.6
Q ss_pred HHHHHhhc-cccccccCCCchH---------HHH--------------------HHHHHHHhhc-CCCceeeeeeEEEec
Q 038168 491 AELEKMTD-GFKEEVGRGSSGE---------REF--------------------QTEMKVIGRT-HHRNLVRLLGYSLEV 539 (757)
Q Consensus 491 ~~l~~~t~-~f~~~lg~g~~~~---------~~~--------------------~~E~~~l~~l-~h~niv~l~g~~~~~ 539 (757)
.+..++++ +|..++|+|+||. +++ +.|-++|+.. +-|-++.|+.+++.-
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 33444444 7889999999963 111 2344444444 467788888899999
Q ss_pred eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCcc
Q 038168 540 SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK 619 (757)
Q Consensus 540 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~ 619 (757)
+.+|+||||+.+|+|--+++.- ..+......-+|.+||-||-+||++ +||.||||..|||||.++.+||+|||+++
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred hheeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccc
Confidence 9999999999999998888643 3455567778999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCcccc
Q 038168 620 LMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQL 699 (757)
Q Consensus 620 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 699 (757)
.---+ ...+..++||+.|+|||++...+|+..+|.|||||+||||+.|..||++..+++ +.+.+.+...
T Consensus 499 Eni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-------lF~aI~ehnv--- 567 (683)
T KOG0696|consen 499 ENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQAIMEHNV--- 567 (683)
T ss_pred ccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHHccC---
Confidence 53322 234456899999999999999999999999999999999999999998754422 1222222211
Q ss_pred ccccccCHHHHHHHHHHHHHccccCCCCCC
Q 038168 700 VEDEEVDEKQLERMIKVALWCILDEPSLRP 729 (757)
Q Consensus 700 ~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP 729 (757)
.++.....+...+....+...|.+|.
T Consensus 568 ----syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 568 ----SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----cCcccccHHHHHHHHHHhhcCCcccc
Confidence 23455566777788888888998885
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-25 Score=258.61 Aligned_cols=105 Identities=27% Similarity=0.386 Sum_probs=97.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.+++.++|+||+++++.+...+..+|||||+++++|.+++.. ...+++...+.|+.||+.||+|||..
T Consensus 48 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~--- 123 (669)
T cd05610 48 VHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRH--- 123 (669)
T ss_pred HHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 36788999999999999999999999999999999999999999999864 34578888999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCcc
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAK 619 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~ 619 (757)
+|+||||||+||||+.++.+||+|||+++
T Consensus 124 gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-26 Score=225.46 Aligned_cols=215 Identities=22% Similarity=0.276 Sum_probs=164.7
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN----PEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.++|+.|.++..+- +.||||+++|.+..++..++.||.|+- ||+.+-+. ....++....-+|..-.++||.||.
T Consensus 106 q~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK 184 (361)
T KOG1006|consen 106 QKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLK 184 (361)
T ss_pred HHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHH
Confidence 46788898876665 799999999999999999999999965 66554321 2345666667788888999999998
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC--CCCccccchhhHHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL--PITVKADVYSFGVVLL 663 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~G~~l~ 663 (757)
++ ..|||||+||+|||||..|.+||+|||.+-.+...- ..+.-.|-..|||||.+... .+..+|||||||++|+
T Consensus 185 ~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~ 260 (361)
T KOG1006|consen 185 EE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLY 260 (361)
T ss_pred HH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEe
Confidence 86 589999999999999999999999999987654321 22234577899999988643 4899999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|+.||+.|...... ..+.+ .....|..+.+..+. ...+....+..++..|+..|..+||...++.++
T Consensus 261 EvAtG~fPyr~w~s-----vfeql-~~Vv~gdpp~l~~~~-~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 261 EVATGNFPYRKWDS-----VFEQL-CQVVIGDPPILLFDK-ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eeecCCCCcchHHH-----HHHHH-HHHHcCCCCeecCcc-cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 99999999876543 22222 223345444443322 223455678888999999999999999988753
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-26 Score=238.78 Aligned_cols=208 Identities=23% Similarity=0.309 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+.++++|+.||.+++||.||.+-..|+..+..++|||-+.+.=|.-+|.....+++...-.-++.||+.||.|||.+
T Consensus 607 esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k--- 683 (888)
T KOG4236|consen 607 ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK--- 683 (888)
T ss_pred HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---
Confidence 57899999999999999999999999999999999999977666666665567777777777899999999999999
Q ss_pred CeeeCCCCcceEEECCC---CcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 591 QIIHCDIKPQNILMDEN---RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~---~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+|+||||+||||.+. ..+||+|||.||+++...-+ ..++||+.|+|||++....|+..-|+||.||++|--++
T Consensus 684 nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR--rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLS 761 (888)
T KOG4236|consen 684 NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR--RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLS 761 (888)
T ss_pred ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh--hhhcCCccccCHHHHhhccccccccceeeeEEEEEEec
Confidence 99999999999999654 57999999999998765432 35789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl 735 (757)
|..||....+-. +.+... .++=|...-.+.....++++...||..-.+|.+..+-+
T Consensus 762 GTFPFNEdEdIn---------dQIQNA---aFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 762 GTFPFNEDEDIN---------DQIQNA---AFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ccccCCCccchh---------HHhhcc---ccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 999987432211 111111 22223333345566778888888888888888877654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=245.38 Aligned_cols=206 Identities=27% Similarity=0.383 Sum_probs=159.6
Q ss_pred HHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCC---CCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 513 EFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQ---PNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 513 ~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~---l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
-..+||+.|..- +||||||.++.-.+....|+..|.|.. +|.+++..+... ..-...+.+..|+++||+|||+.
T Consensus 548 ~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl- 625 (903)
T KOG1027|consen 548 FAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL- 625 (903)
T ss_pred HHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc-
Confidence 345899999888 799999999988888999999999965 999999774111 11133467889999999999997
Q ss_pred CCCeeeCCCCcceEEECC---C--CcEEEeecCCccccCCCCc--ceecccccCccccCcccccCCCCCccccchhhHHH
Q 038168 589 ETQIIHCDIKPQNILMDE---N--RCAKISDFGLAKLMKPDQT--RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVV 661 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~---~--~~~ki~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~ 661 (757)
+||||||||.||||+. + ..++|+|||+++.+..++. ....+..||.||+|||.+....-+..+||||+||+
T Consensus 626 --~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCv 703 (903)
T KOG1027|consen 626 --KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCV 703 (903)
T ss_pred --ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCce
Confidence 9999999999999976 2 5799999999998876654 23446789999999999999988999999999999
Q ss_pred HHHHHhC-CCCCCCCCCCccccHHHHHHHHHhcC-CccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 662 LLEIICR-RRCLDPNLPDDQVILEEWVYQCFENG-NLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 662 l~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+|+.++| .+||......+.- .+... .+..+. + ..+. +..+|+.+|++++|..||++.+|+.
T Consensus 704 fyYvltgG~HpFGd~~~R~~N--------Il~~~~~L~~L~-~---~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 704 FYYVLTGGSHPFGDSLERQAN--------ILTGNYTLVHLE-P---LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred EEEEecCCccCCCchHHhhhh--------hhcCccceeeec-c---CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 9999998 7888754332111 11111 111111 1 1111 7788999999999999999999973
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=193.43 Aligned_cols=109 Identities=34% Similarity=0.635 Sum_probs=93.2
Q ss_pred CCCeeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCEEEecCCCCceeEEec
Q 038168 43 GNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIAD 122 (757)
Q Consensus 43 ~~~~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~Lvl~~~~~~~~~~~~~ 122 (757)
.+++|+|++|.|++|||++.... +++.+|||.+++ +++||.||++.| ....+.|.|+.||+|+|.+.++ ..+|+++
T Consensus 6 ~~~~l~s~~~~f~~G~~~~~~q~-~dgnlv~~~~~~-~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g-~~vW~S~ 81 (116)
T cd00028 6 SGQTLVSSGSLFELGFFKLIMQS-RDYNLILYKGSS-RTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSG-TVVWSSN 81 (116)
T ss_pred CCCEEEeCCCcEEEecccCCCCC-CeEEEEEEeCCC-CeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCC-cEEEEec
Confidence 35688999999999999987622 489999999887 899999999998 5677899999999999998774 4455555
Q ss_pred CC--CcceeEEEecCCCEEEEecCCceeeeccCCC
Q 038168 123 DS--QSASSASMLDSGNFVLYDSNGKTLWQTFEHP 155 (757)
Q Consensus 123 ~~--~~~~~a~LldsGNlVl~~~~~~~lWQSFD~P 155 (757)
+. ....+|+|+|+|||||++.++.+||||||||
T Consensus 82 ~~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 82 TTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred ccCCCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 44 3457899999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-25 Score=266.75 Aligned_cols=197 Identities=21% Similarity=0.296 Sum_probs=143.0
Q ss_pred hhcCC-CceeeeeeEE-------EeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCee
Q 038168 522 GRTHH-RNLVRLLGYS-------LEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQII 593 (757)
Q Consensus 522 ~~l~h-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii 593 (757)
+.++| +||+++++++ .+.+..++++|++ .++|.++|......+++.+++.++.||++||.|||++ +|+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 45667 6888888877 2334567888987 5599999976666789999999999999999999998 999
Q ss_pred eCCCCcceEEECC-------------------CCcEEEeecCCccccCCCCc---------------ceecccccCcccc
Q 038168 594 HCDIKPQNILMDE-------------------NRCAKISDFGLAKLMKPDQT---------------RTFTGIRGTRGYV 639 (757)
Q Consensus 594 H~Dik~~Nill~~-------------------~~~~ki~DfGla~~~~~~~~---------------~~~~~~~gt~~y~ 639 (757)
||||||+||||+. ++.+||+|||+++....... .......||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 45567777777764321000 0011135788899
Q ss_pred CcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHH
Q 038168 640 APEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALW 719 (757)
Q Consensus 640 aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~ 719 (757)
|||++.+..++.++|||||||+||||++|..|+.... ... ..+....+ .+. ......+...++.+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~-----~~~~~~~~----~~~--~~~~~~~~~~~~~~ 247 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTM-----SSLRHRVL----PPQ--ILLNWPKEASFCLW 247 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHH-----HHHHHhhc----Chh--hhhcCHHHHHHHHH
Confidence 9999999999999999999999999999887654211 011 11111111 010 01123445678889
Q ss_pred ccccCCCCCCCHHHHHHH
Q 038168 720 CILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 720 cl~~~p~~RPsm~eVl~~ 737 (757)
||+++|.+||+|.||++.
T Consensus 248 ~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 248 LLHPEPSCRPSMSELLQS 265 (793)
T ss_pred hCCCChhhCcChHHHhhc
Confidence 999999999999999863
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=239.40 Aligned_cols=211 Identities=26% Similarity=0.353 Sum_probs=172.5
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEe-----ceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLE-----VSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGIL 582 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~ 582 (757)
..+++..|..+|+.. +|||++.++|++.. +++++||||||.+|+..|++++. +..+.|..+.-|++++++||+
T Consensus 58 ~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~ 137 (953)
T KOG0587|consen 58 EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLA 137 (953)
T ss_pred ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHH
Confidence 357889999999998 79999999999863 56899999999999999999764 467889999999999999999
Q ss_pred HhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-----CCCccccchh
Q 038168 583 YLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-----PITVKADVYS 657 (757)
Q Consensus 583 yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~Dv~S 657 (757)
|||.. .++|||||=.||||+.++.+||.|||++..+.....+.. ..+||+.|||||++... .|+.++|+||
T Consensus 138 HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRn-T~iGtP~WMAPEViac~e~~d~tyd~R~D~Ws 213 (953)
T KOG0587|consen 138 HLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRN-TFIGTPYWMAPEVIACDESPDATYDYRSDLWS 213 (953)
T ss_pred HHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeeccccccc-CcCCCcccccceeeecccCCCCCcccccchhh
Confidence 99998 999999999999999999999999999987655433332 35799999999998643 4788999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcC--CccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 038168 658 FGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENG--NLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735 (757)
Q Consensus 658 ~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl 735 (757)
||++..||--|.+|+....+-. .++... ..+.+. -+..-.+++.+++..||..|-++||++.+++
T Consensus 214 LGITaIEladG~PPl~DmHPmr---------aLF~IpRNPPPkLk----rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 214 LGITAIEMAEGAPPLCDMHPMR---------ALFLIPRNPPPKLK----RPKKWSKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred ccceeehhcCCCCCccCcchhh---------hhccCCCCCCcccc----chhhHHHHHHHHHHHHHhhccccCcchhhhc
Confidence 9999999999999886543321 111111 111111 2456678899999999999999999999887
Q ss_pred HH
Q 038168 736 LM 737 (757)
Q Consensus 736 ~~ 737 (757)
+.
T Consensus 281 ~h 282 (953)
T KOG0587|consen 281 KH 282 (953)
T ss_pred cC
Confidence 63
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-25 Score=230.84 Aligned_cols=208 Identities=21% Similarity=0.259 Sum_probs=173.5
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+....|-.+|.+.+.+.||+|+--+.+....|+.||-|-+|.|...|.+. ..++..+..-++..+++|++|||.+ +
T Consensus 465 eHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k---~ 540 (732)
T KOG0614|consen 465 EHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRK---G 540 (732)
T ss_pred HHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhc---C
Confidence 45667889999999999999999999999999999999999999999764 4566666777889999999999999 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRC 671 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p 671 (757)
||.|||||+|.+||.+|.+||.|||.|+.++.... +-.++||+.|.|||++.+......+|.||||++++||++|++|
T Consensus 541 iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pP 618 (732)
T KOG0614|consen 541 IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPP 618 (732)
T ss_pred ceeccCChhheeeccCCceEEeehhhHHHhccCCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999999998876543 3357899999999999999999999999999999999999999
Q ss_pred CCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 038168 672 LDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS-----MKKVLLM 737 (757)
Q Consensus 672 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----m~eVl~~ 737 (757)
|....+-.. ...+..| +|.-.++........+++++....+|.+|.- +.+|.+.
T Consensus 619 Fs~~dpmkt-------Yn~ILkG-----id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 619 FSGVDPMKT-------YNLILKG-----IDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred CCCCchHHH-------HHHHHhh-----hhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 987654221 1222222 3333445566677889999999999999975 6666553
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=198.50 Aligned_cols=221 Identities=22% Similarity=0.242 Sum_probs=165.7
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
....+|+-+|+.++|+|||++++....+...-||+||++. +|..|...-...++-.....++.|+++||.++|++ .
T Consensus 46 ssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---n 121 (292)
T KOG0662|consen 46 SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---N 121 (292)
T ss_pred HHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---h
Confidence 5678999999999999999999999999999999999965 78888766667788889999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCC-CCccccchhhHHHHHHHHhCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP-ITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+.|||+||+|.||+.++..|++|||+++-++-.- ......+-|..|.+|.++.+.+ |+...|+||.||++.|+....+
T Consensus 122 vlhrdlkpqnllin~ngelkladfglarafgipv-rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagr 200 (292)
T KOG0662|consen 122 VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200 (292)
T ss_pred hhhccCCcceEEeccCCcEEecccchhhhcCCce-EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCC
Confidence 9999999999999999999999999999876542 2233345689999999998865 7899999999999999987666
Q ss_pred CCCCCCC-CccccHHHHHHHHHhcCCc---cccccccc---c---------CHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 038168 671 CLDPNLP-DDQVILEEWVYQCFENGNL---SQLVEDEE---V---------DEKQLERMIKVALWCILDEPSLRPSMKKV 734 (757)
Q Consensus 671 p~~~~~~-~~~~~l~~~~~~~~~~~~~---~~~~d~~~---~---------~~~~~~~l~~l~~~cl~~~p~~RPsm~eV 734 (757)
|..+..+ +++....-++.....+... ..+-|-.. + .+....+=.++....+.-+|.+|.++++.
T Consensus 201 plfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaa 280 (292)
T KOG0662|consen 201 PLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAA 280 (292)
T ss_pred CCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHH
Confidence 6554433 2222211111111111111 11222111 1 11122233566667777799999999987
Q ss_pred HHH
Q 038168 735 LLM 737 (757)
Q Consensus 735 l~~ 737 (757)
++.
T Consensus 281 lqh 283 (292)
T KOG0662|consen 281 LQH 283 (292)
T ss_pred hcC
Confidence 763
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-25 Score=218.82 Aligned_cols=231 Identities=26% Similarity=0.316 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEE------eceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSL------EVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~------~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.-.+|..++..++|+|+++++.++. +..+.|+|||+|.. +|...+. ..++=.+...|..|++.|++||
T Consensus 59 akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~l 134 (369)
T KOG0665|consen 59 AKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHL 134 (369)
T ss_pred chhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHH
Confidence 355678999999999999999999885 23468999999964 7887774 3455567778999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~e 664 (757)
|+. +|+||||||+||++..+...||.|||+|+.-..+ ...+..+.|.-|.|||++.+..+.+.+||||.||++.|
T Consensus 135 hs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gE 209 (369)
T KOG0665|consen 135 HSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 209 (369)
T ss_pred Hhc---ceeecccCcccceecchhheeeccchhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHH
Confidence 998 9999999999999999999999999999865544 45667888999999999999899999999999999999
Q ss_pred HHhCCCCCCCCCCCccc----------------cHHHHHHHHHhc------CCccccccccc------cCHHHHHHHHHH
Q 038168 665 IICRRRCLDPNLPDDQV----------------ILEEWVYQCFEN------GNLSQLVEDEE------VDEKQLERMIKV 716 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~----------------~l~~~~~~~~~~------~~~~~~~d~~~------~~~~~~~~l~~l 716 (757)
|++|+--|.+...-++. .+...+....+. -.+.+.+-... .+.........+
T Consensus 210 li~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardl 289 (369)
T KOG0665|consen 210 LILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDL 289 (369)
T ss_pred HhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHH
Confidence 99999877643321110 011111111110 00111111111 122334567889
Q ss_pred HHHccccCCCCCCCHHHHHHH--hh---cCcCCCCCCCC
Q 038168 717 ALWCILDEPSLRPSMKKVLLM--LE---GTVEIPIPPNP 750 (757)
Q Consensus 717 ~~~cl~~~p~~RPsm~eVl~~--Le---~~~~~~~p~~p 750 (757)
+.+||..+|++|.+.+++++. ++ ...+++.|+.|
T Consensus 290 l~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe 328 (369)
T KOG0665|consen 290 LSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPE 328 (369)
T ss_pred HHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCc
Confidence 999999999999999999984 33 33445555544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-24 Score=207.53 Aligned_cols=166 Identities=24% Similarity=0.209 Sum_probs=127.6
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecc
Q 038168 552 GSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG 631 (757)
Q Consensus 552 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~ 631 (757)
|+|.+++.+.+..+++.++..|+.|+++||+|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 689999977667799999999999999999999997 4 999999999999999 99998765432
Q ss_pred cccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHH
Q 038168 632 IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLE 711 (757)
Q Consensus 632 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 711 (757)
..|+..|+|||++.+..++.++|||||||++|||++|+.|+........ .+ ....... ................
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~----~~~~~~~-~~~~~~~~~~~~~~~~ 137 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-IL----EILLNGM-PADDPRDRSNLESVSA 137 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HH----HHHHHHh-ccCCccccccHHHHHh
Confidence 2578999999999999999999999999999999999999864322111 11 1111111 1100000011122222
Q ss_pred --HHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 712 --RMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 712 --~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
++.+++.+|++.+|++||++.|+++.+..
T Consensus 138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 138 ARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred hhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 69999999999999999999999998864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-24 Score=225.97 Aligned_cols=163 Identities=24% Similarity=0.343 Sum_probs=139.6
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 038168 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQI 592 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 592 (757)
..+.|-+||+.-..+=||+|+-.|++.+.+|+||||+++|++-.+|.+. ..+......-++.++..|+++.|+. |+
T Consensus 675 HVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkm---GF 750 (1034)
T KOG0608|consen 675 HVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKM---GF 750 (1034)
T ss_pred hhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhc---cc
Confidence 3567889999999999999999999999999999999999999998653 3455566666888999999999998 99
Q ss_pred eeCCCCcceEEECCCCcEEEeecCCccccCC---------CC-----c---------------------------ceecc
Q 038168 593 IHCDIKPQNILMDENRCAKISDFGLAKLMKP---------DQ-----T---------------------------RTFTG 631 (757)
Q Consensus 593 iH~Dik~~Nill~~~~~~ki~DfGla~~~~~---------~~-----~---------------------------~~~~~ 631 (757)
|||||||.|||||.+|.+||.||||+.-+.- .. . .....
T Consensus 751 IHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahs 830 (1034)
T KOG0608|consen 751 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHS 830 (1034)
T ss_pred eecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhh
Confidence 9999999999999999999999999964420 00 0 01123
Q ss_pred cccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCc
Q 038168 632 IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDD 679 (757)
Q Consensus 632 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~ 679 (757)
.+||..|+|||++....++..+|.||.||||+||+-|+.||-...+.+
T Consensus 831 lvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 831 LVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred hcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 579999999999999999999999999999999999999998776654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-24 Score=201.40 Aligned_cols=161 Identities=25% Similarity=0.346 Sum_probs=134.0
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF---NPEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
.+...+|+.+..+- ..|.+|+++|........++.||.|+. ||+.+-. +.+...+....-+|+..+++||.|||+
T Consensus 88 q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~ 166 (282)
T KOG0984|consen 88 QKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS 166 (282)
T ss_pred HHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH
Confidence 46778888877665 799999999999889999999999976 7766543 345667788888999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC----CCCCccccchhhHHHH
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN----LPITVKADVYSFGVVL 662 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~Dv~S~G~~l 662 (757)
+ ..+||||+||+||||+.+|.+||+|||.+-.+.+.-... --.|-..|||||.+.. ..|+.|+||||||+++
T Consensus 167 k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt--~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItm 242 (282)
T KOG0984|consen 167 K--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT--MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITM 242 (282)
T ss_pred H--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH--HhcCCCccCChhhcCcccCcccceeehhhhhhhhhh
Confidence 8 589999999999999999999999999998765432211 1235678999998753 3689999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 038168 663 LEIICRRRCLDPNL 676 (757)
Q Consensus 663 ~elltG~~p~~~~~ 676 (757)
.||.+++.|++...
T Consensus 243 iElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 243 IEMAILRFPYESWG 256 (282)
T ss_pred hhhhhccccccccC
Confidence 99999999987543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=240.05 Aligned_cols=197 Identities=24% Similarity=0.215 Sum_probs=131.6
Q ss_pred EeceeeeEEEEeccCCChhhhhcCCCCCC-------------------CHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCC
Q 038168 537 LEVSKKILVYEYMSNGSLADILFNPEKQP-------------------NWVERMGIARDIARGILYLHDECETQIIHCDI 597 (757)
Q Consensus 537 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~l-------------------~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Di 597 (757)
.++.+.++||||+++++|.+++....... ....+..++.|++.||+|||+. +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 45668899999999999999886432111 1233457999999999999998 9999999
Q ss_pred CcceEEECC-CCcEEEeecCCccccCCCCcceecccccCccccCcccccCC----------------------CCCcccc
Q 038168 598 KPQNILMDE-NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL----------------------PITVKAD 654 (757)
Q Consensus 598 k~~Nill~~-~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k~D 654 (757)
||+|||+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 57999999999987655444444456789999999965322 2345679
Q ss_pred chhhHHHHHHHHhCCCCCCCCCCC-------ccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCC
Q 038168 655 VYSFGVVLLEIICRRRCLDPNLPD-------DQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSL 727 (757)
Q Consensus 655 v~S~G~~l~elltG~~p~~~~~~~-------~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~ 727 (757)
||||||++|||+++..+.+..... ....+..|.... ......+................+++.+||+.||++
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLV-EPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhh-ccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999999999876553321000 000111110000 000000000000000011223558999999999999
Q ss_pred CCCHHHHHHH
Q 038168 728 RPSMKKVLLM 737 (757)
Q Consensus 728 RPsm~eVl~~ 737 (757)
|||+.|+++.
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999984
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-23 Score=203.60 Aligned_cols=179 Identities=36% Similarity=0.559 Sum_probs=159.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++.+++++|++++++++++......++++|++++++|.+++......+++..+..++.+++++|++||+.
T Consensus 35 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--- 111 (215)
T cd00180 35 LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN--- 111 (215)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 56799999999999999999999999999999999999999999999976545688999999999999999999998
Q ss_pred CeeeCCCCcceEEECC-CCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhC
Q 038168 591 QIIHCDIKPQNILMDE-NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~-~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG 668 (757)
+++|+||+|.||+++. ++.++|+|||.+........ ......+...|++||..... ..+.+.|+|++|+++++|
T Consensus 112 ~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--- 187 (215)
T cd00180 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--- 187 (215)
T ss_pred CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---
Confidence 9999999999999999 89999999999987654321 12234567899999998887 889999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~L 738 (757)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 ------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4678899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=205.97 Aligned_cols=201 Identities=22% Similarity=0.300 Sum_probs=159.0
Q ss_pred HHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeC
Q 038168 517 EMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHC 595 (757)
Q Consensus 517 E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~ 595 (757)
|-.+..+- +||-+|.|+.+++.+...++|.||.++|+|--+++.. +.++.....-+..+|..||.|||+. +||.|
T Consensus 300 ek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~r---giiyr 375 (593)
T KOG0695|consen 300 EKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHER---GIIYR 375 (593)
T ss_pred hHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhc---Ceeee
Confidence 33444443 7999999999999999999999999999998777653 4556666666888999999999999 99999
Q ss_pred CCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 038168 596 DIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPN 675 (757)
Q Consensus 596 Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~ 675 (757)
|||..|||||..+.+||.|+|+++.--.+.. .+..++||+.|+|||++.+..|....|.|++||+++||+.|+.||+.-
T Consensus 376 dlkldnvlldaeghikltdygmcke~l~~gd-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 376 DLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred eccccceEEccCCceeecccchhhcCCCCCc-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 9999999999999999999999986443332 344589999999999999999999999999999999999999999853
Q ss_pred C-CCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC
Q 038168 676 L-PDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP 729 (757)
Q Consensus 676 ~-~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP 729 (757)
- ...+.+-.+++.+.+.+..+. ++.....+...+.+.-|..||.+|.
T Consensus 455 gm~n~d~ntedylfqvilekqir-------iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 455 GMDNPDMNTEDYLFQVILEKQIR-------IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cCCCcccchhHHHHHHHhhhccc-------ccceeehhhHHHHHHhhcCCcHHhc
Confidence 2 223444445555554443322 1233345566777788889999884
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-24 Score=210.81 Aligned_cols=225 Identities=23% Similarity=0.272 Sum_probs=168.6
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEec-----eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEV-----SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
..+.+.+|+++|..++|.|++..++..+-. ++.|+|+|.|. .+|..++-. ...++-....-+.+||++||+||
T Consensus 95 s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYL 172 (449)
T KOG0664|consen 95 SCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVS-PQALTPDHVKVFVYQILRGLKYL 172 (449)
T ss_pred HHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheecc-CCCCCcchhhhhHHHHHhhhHHH
Confidence 357788999999999999999999876533 36788899885 477777643 34556666777899999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLL 663 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~ 663 (757)
|+. +|.||||||.|.|++.|-..||+||||+|....++...++..+-|..|.|||.+++. .|+...||||.||++.
T Consensus 173 HsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFa 249 (449)
T KOG0664|consen 173 HTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFA 249 (449)
T ss_pred hhc---chhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHH
Confidence 998 999999999999999999999999999999888888888877789999999999986 6899999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHH----------------HHHHhcCCcccccccccc----CHHHHHHHHHHHHHcccc
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWV----------------YQCFENGNLSQLVEDEEV----DEKQLERMIKVALWCILD 723 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~----------------~~~~~~~~~~~~~d~~~~----~~~~~~~l~~l~~~cl~~ 723 (757)
||+..+-.|....+-++..+...+ +..+.++.....--+..+ +...-.+...+...+++.
T Consensus 250 ELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~ 329 (449)
T KOG0664|consen 250 ELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHF 329 (449)
T ss_pred HHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCC
Confidence 999988888765554433322111 111111111110000000 112223445666778999
Q ss_pred CCCCCCCHHHHHHHhh
Q 038168 724 EPSLRPSMKKVLLMLE 739 (757)
Q Consensus 724 ~p~~RPsm~eVl~~Le 739 (757)
+|++|.+..+.+..+.
T Consensus 330 d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 330 DPDKRISVEEALQHRY 345 (449)
T ss_pred CCcccccHhhhccccc
Confidence 9999999998887663
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-23 Score=229.34 Aligned_cols=216 Identities=21% Similarity=0.189 Sum_probs=151.7
Q ss_pred HHHHHHHHHHhhcCCCce-----eeeeeEEEe--------ceeeeEEEEeccCCChhhhhcCCC----------------
Q 038168 512 REFQTEMKVIGRTHHRNL-----VRLLGYSLE--------VSKKILVYEYMSNGSLADILFNPE---------------- 562 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~---------------- 562 (757)
+.+..|+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++...
T Consensus 217 e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~ 296 (507)
T PLN03224 217 ETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKK 296 (507)
T ss_pred chhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCc
Confidence 345568888888877665 678888753 346899999999999999986421
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccC
Q 038168 563 -------KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGT 635 (757)
Q Consensus 563 -------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt 635 (757)
..++|..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+............++
T Consensus 297 l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~t 373 (507)
T PLN03224 297 IPDNMPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLD 373 (507)
T ss_pred hhhhcccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCC
Confidence 1246778889999999999999998 999999999999999999999999999976544322222223347
Q ss_pred ccccCcccccCCC----------------------CCccccchhhHHHHHHHHhCCC-CCCCCCCCc------cccHHHH
Q 038168 636 RGYVAPEWHRNLP----------------------ITVKADVYSFGVVLLEIICRRR-CLDPNLPDD------QVILEEW 686 (757)
Q Consensus 636 ~~y~aPE~~~~~~----------------------~~~k~Dv~S~G~~l~elltG~~-p~~~~~~~~------~~~l~~~ 686 (757)
+.|+|||.+.... ...+.||||+||+++||++|.. |+....... ...+.
T Consensus 374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~-- 451 (507)
T PLN03224 374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLN-- 451 (507)
T ss_pred cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHH--
Confidence 8999999875432 1235799999999999999875 543211110 01111
Q ss_pred HHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 038168 687 VYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEP---SLRPSMKKVLLM 737 (757)
Q Consensus 687 ~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p---~~RPsm~eVl~~ 737 (757)
.|+..+....... ..........+++.++|..+| .+|+|++|+++.
T Consensus 452 ~~r~~~~~~~~~~-----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 452 RWRMYKGQKYDFS-----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HHHhhcccCCCcc-----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1222222222111 112234667888888888765 789999999864
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.5e-23 Score=183.87 Aligned_cols=107 Identities=31% Similarity=0.579 Sum_probs=91.2
Q ss_pred CCCeeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCEEEecCCCCceeEEec
Q 038168 43 GNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIAD 122 (757)
Q Consensus 43 ~~~~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~Lvl~~~~~~~~~~~~~ 122 (757)
.+++|+|++|.|++|||.+.. ..++.+|||++.+ +++||+|||+.|..+ ++.|.+++||+|+|.+.++ ..+|+++
T Consensus 6 ~~~~l~s~~~~f~~G~~~~~~--q~dgnlV~~~~~~-~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g-~~vW~S~ 80 (114)
T smart00108 6 SGQTLVSGNSLFELGFFTLIM--QNDYNLILYKSSS-RTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDG-RVVWSSN 80 (114)
T ss_pred CCCEEecCCCcEeeeccccCC--CCCEEEEEEECCC-CcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCC-CEEEEec
Confidence 456889999999999999865 4689999999887 899999999998654 4899999999999998874 4456555
Q ss_pred CC--CcceeEEEecCCCEEEEecCCceeeeccCC
Q 038168 123 DS--QSASSASMLDSGNFVLYDSNGKTLWQTFEH 154 (757)
Q Consensus 123 ~~--~~~~~a~LldsGNlVl~~~~~~~lWQSFD~ 154 (757)
+. ....+|+|+|+|||||++..+++|||||||
T Consensus 81 t~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 81 TTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred ccCCCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 43 445789999999999999999999999997
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=208.84 Aligned_cols=220 Identities=23% Similarity=0.302 Sum_probs=162.3
Q ss_pred hHHHHHHHHHHHhhcC--------CCceeeeeeEEEe----ceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTH--------HRNLVRLLGYSLE----VSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARD 576 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~--------h~niv~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ 576 (757)
-.+....||++|++++ ..+||+|+++|.. +.+.+||+|++ +.+|..+|... .+.++...+.+|++|
T Consensus 117 YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~q 195 (590)
T KOG1290|consen 117 YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQ 195 (590)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHH
Confidence 3466778999999984 2369999999874 56899999999 45777777654 467899999999999
Q ss_pred HHHHHHHhhhCCCCCeeeCCCCcceEEECCCC------------------------------------------------
Q 038168 577 IARGILYLHDECETQIIHCDIKPQNILMDENR------------------------------------------------ 608 (757)
Q Consensus 577 ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~------------------------------------------------ 608 (757)
|+.||.|||.+| +|||.||||+||||-.+.
T Consensus 196 vL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~ 273 (590)
T KOG1290|consen 196 VLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKM 273 (590)
T ss_pred HHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHH
Confidence 999999999997 999999999999992110
Q ss_pred --------------------------------------------------------------------------------
Q 038168 609 -------------------------------------------------------------------------------- 608 (757)
Q Consensus 609 -------------------------------------------------------------------------------- 608 (757)
T Consensus 274 ~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~ 353 (590)
T KOG1290|consen 274 KKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQ 353 (590)
T ss_pred HHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchh
Confidence
Q ss_pred --------------------------------------cEEEeecCCccccCCCCcceecccccCccccCcccccCCCCC
Q 038168 609 --------------------------------------CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPIT 650 (757)
Q Consensus 609 --------------------------------------~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 650 (757)
.+||+|||-|....... +.-.-|..|.|||++.+..|+
T Consensus 354 ~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khF----T~DIQTRQYRapEVllGsgY~ 429 (590)
T KOG1290|consen 354 LRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHF----TEDIQTRQYRAPEVLLGSGYS 429 (590)
T ss_pred cccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhhh----chhhhhhhccCcceeecCCCC
Confidence 02333333333222111 112247789999999999999
Q ss_pred ccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH-----------HHHhcCCcc-cccc-----------------
Q 038168 651 VKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVY-----------QCFENGNLS-QLVE----------------- 701 (757)
Q Consensus 651 ~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~-----------~~~~~~~~~-~~~d----------------- 701 (757)
+.+||||++|+++||+||...|++...+....-.+++. .....|+.. ++++
T Consensus 430 ~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~ 509 (590)
T KOG1290|consen 430 TSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLY 509 (590)
T ss_pred CchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHH
Confidence 99999999999999999999999877654222222222 222223211 1111
Q ss_pred -----ccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 702 -----DEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 702 -----~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
.-.++.+++.++.++..-||+.+|++|||+.+.++
T Consensus 510 ~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 510 EVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 12357888999999999999999999999999885
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-22 Score=195.27 Aligned_cols=213 Identities=15% Similarity=0.219 Sum_probs=158.3
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeE-EEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGY-SLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~-~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.++|.+|...--.| .|.||+.-++. ++..+.+++++||+|.|+|.+-+.. ..+......+++.|++.||.|||++
T Consensus 64 ~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsk- 140 (378)
T KOG1345|consen 64 QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSK- 140 (378)
T ss_pred HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhcc-
Confidence 47888888776566 69999988764 5556678899999999999998854 4456667778999999999999999
Q ss_pred CCCeeeCCCCcceEEEC--CCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-----CCCccccchhhHHH
Q 038168 589 ETQIIHCDIKPQNILMD--ENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-----PITVKADVYSFGVV 661 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~--~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~Dv~S~G~~ 661 (757)
.+||||||.+||||- +...+||+|||+.+..+..- ....-+..|.+||..... ...+.+|||+||++
T Consensus 141 --nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi 214 (378)
T KOG1345|consen 141 --NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGII 214 (378)
T ss_pred --chhhcccccceEEEecCCccEEEeeecccccccCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeee
Confidence 999999999999993 33689999999998654322 223346679999976432 35788999999999
Q ss_pred HHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 038168 662 LLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 662 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~L 738 (757)
++..+||+.||+.....++ . -|-+..|..++...+-+. -....+++.++.++-+.++|++|--+.++.++.
T Consensus 215 ~f~cltG~~PWQka~~~d~-~--Y~~~~~w~~rk~~~~P~~---F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 215 FFYCLTGKFPWQKASIMDK-P--YWEWEQWLKRKNPALPKK---FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred eeeeecCCCcchhhhccCc-h--HHHHHHHhcccCccCchh---hcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 9999999999985443332 2 233444555544432111 122345677788888999999997666666654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.85 E-value=5e-21 Score=194.00 Aligned_cols=162 Identities=30% Similarity=0.469 Sum_probs=142.8
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|++.+++++|+|++++++++......++++|++++++|.+++......+++.....++.+++++|.+||+.
T Consensus 40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-- 117 (225)
T smart00221 40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL-- 117 (225)
T ss_pred HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 356788999999999999999999999999999999999999999999865443388999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccc-cCCCCCccccchhhHHHHHHHHhC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWH-RNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
+++|+||+|+||+++.++.++|+|||.+...............++..|++||.. ....++.++|||+||++++||++|
T Consensus 118 -~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g 196 (225)
T smart00221 118 -GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWG 196 (225)
T ss_pred -CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHC
Confidence 999999999999999999999999999988765431122334577889999998 667788899999999999999999
Q ss_pred CCCCCC
Q 038168 669 RRCLDP 674 (757)
Q Consensus 669 ~~p~~~ 674 (757)
+.||..
T Consensus 197 ~~pf~~ 202 (225)
T smart00221 197 PEPFSG 202 (225)
T ss_pred CCCccc
Confidence 999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.1e-22 Score=210.64 Aligned_cols=151 Identities=26% Similarity=0.378 Sum_probs=134.3
Q ss_pred HHHHHHhhcC---CCceeeeeeEEEeceeeeEEEEec-cCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 516 TEMKVIGRTH---HRNLVRLLGYSLEVSKKILVYEYM-SNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 516 ~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~-~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
.|++||+.|+ |+||+|+++|+++.+.+||+||-. ++.+|.+++.- +..++..+..-|++|++.|+++||+. +
T Consensus 615 ~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~---~ 690 (772)
T KOG1152|consen 615 SEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQ---G 690 (772)
T ss_pred hhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhcccccccc---C
Confidence 6999999997 999999999999999999999975 45689999853 56778888999999999999999999 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCC-CccccchhhHHHHHHHHhCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~G~~l~elltG~~ 670 (757)
|||||||-+||.++.+|.+||+|||.+.......- ..++||.+|.|||++.+.+| ...-|||++|++||-++....
T Consensus 691 ivhrdikdenvivd~~g~~klidfgsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyken 767 (772)
T KOG1152|consen 691 IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKEN 767 (772)
T ss_pred ceecccccccEEEecCCeEEEeeccchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccC
Confidence 99999999999999999999999999987654432 34789999999999999887 566899999999999998877
Q ss_pred CCC
Q 038168 671 CLD 673 (757)
Q Consensus 671 p~~ 673 (757)
|+.
T Consensus 768 pyy 770 (772)
T KOG1152|consen 768 PYY 770 (772)
T ss_pred CCc
Confidence 765
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=180.02 Aligned_cols=216 Identities=17% Similarity=0.303 Sum_probs=159.2
Q ss_pred HHHHHHHHHHHhhcC-CCceeeeeeEEEece--eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 511 EREFQTEMKVIGRTH-HRNLVRLLGYSLEVS--KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
.+.+.+|+++|..|. |+||++|++...+.. ...||+||+.+.+...+. ..+....+.-.+.++++||.|+|+.
T Consensus 76 kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~ 151 (338)
T KOG0668|consen 76 KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSM 151 (338)
T ss_pred HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhc
Confidence 478999999999997 999999999988765 457999999998776654 2355566777899999999999999
Q ss_pred CCCCeeeCCCCcceEEECCC-CcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMDEN-RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~-~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~el 665 (757)
||.|||+||.|++||.. ...+|+|.|||..+........ .+.+.-|--||.+.. ..+.-.-|+|||||++.+|
T Consensus 152 ---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~m 226 (338)
T KOG0668|consen 152 ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 226 (338)
T ss_pred ---CcccccCCcceeeechhhceeeeeecchHhhcCCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHH
Confidence 99999999999999965 6799999999999887665432 244667788998765 4578889999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHH--------HHHhc------CCccccccccc----------cCHH-HHHHHHHHHHHc
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVY--------QCFEN------GNLSQLVEDEE----------VDEK-QLERMIKVALWC 720 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~--------~~~~~------~~~~~~~d~~~----------~~~~-~~~~l~~l~~~c 720 (757)
+-.+.||....+..+ .++..+. ..+.. .++..++.... .... ...+.++++...
T Consensus 227 iFrkepFFhG~dN~D-QLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldkl 305 (338)
T KOG0668|consen 227 IFRKEPFFHGHDNYD-QLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKL 305 (338)
T ss_pred HhccCcccCCCCCHH-HHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHH
Confidence 999999876544321 1111110 00110 11111111100 0011 135678888889
Q ss_pred cccCCCCCCCHHHHHH
Q 038168 721 ILDEPSLRPSMKKVLL 736 (757)
Q Consensus 721 l~~~p~~RPsm~eVl~ 736 (757)
|..|-.+|||+.|...
T Consensus 306 LrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 306 LRYDHQERLTAKEAMA 321 (338)
T ss_pred HhhccccccchHHHhc
Confidence 9999999999999764
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-20 Score=165.98 Aligned_cols=69 Identities=38% Similarity=0.899 Sum_probs=62.1
Q ss_pred CCceEEEEEEccCccEEEEEEeccCCCCceEEEeecCCCCCCCCCCCCCCCccccCCCCCCCCCCCCccccc
Q 038168 252 TKGMIYLMKIDSDGIFRLYSYNLRRQNSTWQVVWESTSDRCDPIGFCGFNSFCVLNDQIPDCPCLPGFVQIS 323 (757)
Q Consensus 252 ~~~~~~~~~l~~dG~lr~y~~~~~~~~~~W~~~~~~p~d~Cd~yg~CG~~g~C~~~~~~p~C~C~~GF~~~~ 323 (757)
+.+.++|++||++|++++|.|+. .+++|.+.|++|.|+||+|+.||+||+|+.+ ..|.|+|++||+|++
T Consensus 42 ~~s~~~r~~ld~~G~l~~~~w~~--~~~~W~~~~~~p~d~Cd~y~~CG~~g~C~~~-~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 42 NSSVLSRLVLDSDGQLQRYIWNE--STQSWSVFWSAPKDQCDVYGFCGPNGICNSN-NSPKCSCLPGFEPKN 110 (110)
T ss_pred CCceEEEEEEeeeeEEEEEEEec--CCCcEEEEEEecccCCCCccccCCccEeCCC-CCCceECCCCcCCCc
Confidence 56778999999999999999975 4678999999999999999999999999865 468999999999864
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.8e-21 Score=200.78 Aligned_cols=219 Identities=20% Similarity=0.263 Sum_probs=167.3
Q ss_pred HHHHHHHHHHhhcC------CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHH
Q 038168 512 REFQTEMKVIGRTH------HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE--KQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 512 ~~~~~E~~~l~~l~------h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~y 583 (757)
+.=+.|+++|++|+ .-|.++|+-.|...+++|||+|-+. -+|.++|.+-+ -.|....+..++.|+.-||..
T Consensus 473 KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALkl 551 (752)
T KOG0670|consen 473 KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKL 551 (752)
T ss_pred hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHH
Confidence 34468999999995 4589999999999999999999874 48999997654 346778888999999999999
Q ss_pred hhhCCCCCeeeCCCCcceEEECCC-CcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHH
Q 038168 584 LHDECETQIIHCDIKPQNILMDEN-RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662 (757)
Q Consensus 584 LH~~~~~~iiH~Dik~~Nill~~~-~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l 662 (757)
|... +|+|.||||.|||+++. ...||||||.|......+.. ...-+.-|.|||++.+.+|.-..|+||.||+|
T Consensus 552 LK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit---PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctL 625 (752)
T KOG0670|consen 552 LKKC---GVLHADIKPDNILVNESKNILKLCDFGSASFASENEIT---PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTL 625 (752)
T ss_pred HHhc---CeeecccCccceEeccCcceeeeccCcccccccccccc---HHHHHHhccCcceeecCcccCCccceeeceee
Confidence 9998 99999999999999876 67899999999877655432 22336689999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHH-----HHHHhcCCccc---------------------------ccccc-------
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWV-----YQCFENGNLSQ---------------------------LVEDE------- 703 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~-----~~~~~~~~~~~---------------------------~~d~~------- 703 (757)
|||.||+..|.+........+.-.+ ..+++.|.+.+ .+.|.
T Consensus 626 YElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l 705 (752)
T KOG0670|consen 626 YELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSEL 705 (752)
T ss_pred EEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHH
Confidence 9999999988776554322211110 11222221110 01110
Q ss_pred -------ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 704 -------EVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 704 -------~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
.........+..|...|+..||++|.|..|.++.
T Consensus 706 ~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 706 IAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred hccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 0123345678889999999999999999998763
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.8e-20 Score=198.90 Aligned_cols=217 Identities=28% Similarity=0.441 Sum_probs=168.8
Q ss_pred HhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcc
Q 038168 521 IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQ 600 (757)
Q Consensus 521 l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~ 600 (757)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+......++|.-...+++++++||+|||.- +...|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccc
Confidence 4678999999999999999999999999999999999998888899999999999999999999986 23399999999
Q ss_pred eEEECCCCcEEEeecCCccccCCCC-cceecccccCccccCcccccCC-------CCCccccchhhHHHHHHHHhCCCCC
Q 038168 601 NILMDENRCAKISDFGLAKLMKPDQ-TRTFTGIRGTRGYVAPEWHRNL-------PITVKADVYSFGVVLLEIICRRRCL 672 (757)
Q Consensus 601 Nill~~~~~~ki~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-------~~~~k~Dv~S~G~~l~elltG~~p~ 672 (757)
|+++|....+||+|||+........ ........-..-|.|||.+... ..+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999998775311 1111222345679999988763 2578899999999999999999999
Q ss_pred CCCCCCccccHHHHHHHHHhcCCccccccccccCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcC
Q 038168 673 DPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDE-KQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 673 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~ 743 (757)
......... .+.+.. ++.+ -.....|..... +..+++..++..||.++|++||++++|-..++....
T Consensus 159 ~~~~~~~~~--~eii~~-~~~~-~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 159 DLRNLVEDP--DEIILR-VKKG-GSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccCCh--HHHHHH-HHhc-CCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 864433321 222222 2221 111222222222 444579999999999999999999999999886543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-20 Score=213.98 Aligned_cols=213 Identities=21% Similarity=0.279 Sum_probs=172.0
Q ss_pred HHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCee
Q 038168 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQII 593 (757)
Q Consensus 514 ~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii 593 (757)
+..|+-+-.+++|+|++..+..+.+....+-+|||++. +|..++... ..+...++..++.|+..|+.|||+. +|.
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~---Gia 442 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSM---GLA 442 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhc---Cce
Confidence 45677777889999999988888877777777999999 999998653 4677778889999999999999999 999
Q ss_pred eCCCCcceEEECCCCcEEEeecCCccccCCCCc---ceecccccCccccCcccccCCCCCcc-ccchhhHHHHHHHHhCC
Q 038168 594 HCDIKPQNILMDENRCAKISDFGLAKLMKPDQT---RTFTGIRGTRGYVAPEWHRNLPITVK-ADVYSFGVVLLEIICRR 669 (757)
Q Consensus 594 H~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k-~Dv~S~G~~l~elltG~ 669 (757)
|||+|++|+++..++.+||+|||.+..+..... ....+++|+.+|+|||.+.+.++.+. .||||.|+++..|++|+
T Consensus 443 hrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~ 522 (601)
T KOG0590|consen 443 HRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR 522 (601)
T ss_pred eccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence 999999999999999999999999998765544 34557899999999999999999766 89999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
.||.....+++... .....+.......+.......+.+...++.++|+.+|.+|.||++|++
T Consensus 523 ~~Wk~a~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 523 FPWKVAKKSDNSFK-----TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred Cccccccccccchh-----hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 99987665544320 000111111111122234566778899999999999999999999986
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=185.65 Aligned_cols=218 Identities=25% Similarity=0.321 Sum_probs=162.7
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
..+.+|++.|..+ -|.||+++.++...++...+|+||++.....++..+ ++......+++.+.+||+++|+.
T Consensus 79 ~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~--- 151 (418)
T KOG1167|consen 79 SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKN--- 151 (418)
T ss_pred hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhcc---
Confidence 5678999999999 599999999999999999999999999998888754 56788889999999999999999
Q ss_pred CeeeCCCCcceEEECCC-CcEEEeecCCccccCCCC-------------cc-----------------------------
Q 038168 591 QIIHCDIKPQNILMDEN-RCAKISDFGLAKLMKPDQ-------------TR----------------------------- 627 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~-~~~ki~DfGla~~~~~~~-------------~~----------------------------- 627 (757)
+||||||||+|+|.+.. +.-.|.|||||......+ ..
T Consensus 152 GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~ 231 (418)
T KOG1167|consen 152 GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRP 231 (418)
T ss_pred CccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCcc
Confidence 99999999999999865 678999999997221000 00
Q ss_pred -eecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHH--------H-HHhcCC-
Q 038168 628 -TFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVY--------Q-CFENGN- 695 (757)
Q Consensus 628 -~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~--------~-~~~~~~- 695 (757)
...+..||+||.|||++... .-++++||||.||+++.+++++.||.....+-.. +.+.+- + ....|.
T Consensus 232 ~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~a-l~ei~tifG~~~mrk~A~l~g~~ 310 (418)
T KOG1167|consen 232 SERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADA-LAEIATIFGSAEMRKCAALPGRI 310 (418)
T ss_pred ceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccch-HHHHHHHhChHHHHHHhhcCCce
Confidence 01124599999999998764 5689999999999999999999999765543321 111110 0 000111
Q ss_pred -ccc----------------c----ccc--------cccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 696 -LSQ----------------L----VED--------EEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 696 -~~~----------------~----~d~--------~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+.+ + .-+ ..........+.++..+|++.||.+|.|+++.++.
T Consensus 311 ~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 311 LLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 100 0 000 00011123468899999999999999999998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.1e-20 Score=200.04 Aligned_cols=234 Identities=24% Similarity=0.307 Sum_probs=173.0
Q ss_pred cccHHHHHHhhcccccccc-------CCCchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhc
Q 038168 487 SFSYAELEKMTDGFKEEVG-------RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF 559 (757)
Q Consensus 487 ~~~~~~l~~~t~~f~~~lg-------~g~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 559 (757)
.-+|.|+.+|.+.-+.++- +-+..-+-..+|+-+++..+|+|||.++|.+...+..+++|||+.+|+|.+.-+
T Consensus 25 sgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~ 104 (829)
T KOG0576|consen 25 SGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYH 104 (829)
T ss_pred CCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceee
Confidence 3456666666654332211 111223456789999999999999999999999999999999999999999765
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCcccc
Q 038168 560 NPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYV 639 (757)
Q Consensus 560 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~ 639 (757)
. ...++..++-...++..+||+|||+. +-+|||||=.|||+++.+.+|++|||.+..+... ......+.||+.||
T Consensus 105 ~-TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~KrksfiGtpywm 179 (829)
T KOG0576|consen 105 V-TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAKRKSFIGTPYWM 179 (829)
T ss_pred e-cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh-hhhhhcccCCcccc
Confidence 4 45677778888899999999999998 9899999999999999999999999998765432 22334578999999
Q ss_pred Cccccc---CCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcC--CccccccccccCHHHHHHHH
Q 038168 640 APEWHR---NLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENG--NLSQLVEDEEVDEKQLERMI 714 (757)
Q Consensus 640 aPE~~~---~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~d~~~~~~~~~~~l~ 714 (757)
|||+.. .+.|..++|||+.|+...|+---..|.....+.. +..++... +-..+-|+ ..-.+.+.
T Consensus 180 apEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~l~LmTkS~~qpp~lkDk----~kws~~fh 248 (829)
T KOG0576|consen 180 APEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------ALFLMTKSGFQPPTLKDK----TKWSEFFH 248 (829)
T ss_pred chhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------HHHHhhccCCCCCcccCC----ccchHHHH
Confidence 999763 5579999999999999999976555543222111 11111111 11112222 23345678
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 038168 715 KVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 715 ~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
++++.|+-.+|++||+.+..++
T Consensus 249 ~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHhcCCCccCCChhhhee
Confidence 8888999999999999987654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.2e-19 Score=173.84 Aligned_cols=212 Identities=24% Similarity=0.379 Sum_probs=162.3
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEK-QPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
++|..|.-.|+-+.||||+.++|.|....+..++..||+.|+|...|++... ..+-.+..+++.++|+|++|||+. ++
T Consensus 232 rdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep 310 (448)
T KOG0195|consen 232 RDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EP 310 (448)
T ss_pred chhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-ch
Confidence 4677888888888999999999999999999999999999999999987543 357788999999999999999986 45
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCC---CccccchhhHHHHHHHHh
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI---TVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~k~Dv~S~G~~l~ellt 667 (757)
-|..--+....|++|++.+++|+- +-+++ .....+..-.+.||+||.++..+- -..+|+|||.+++|||.|
T Consensus 311 ~ipr~~lns~hvmidedltarism-ad~kf-----sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~t 384 (448)
T KOG0195|consen 311 MIPRFYLNSKHVMIDEDLTARISM-ADTKF-----SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNT 384 (448)
T ss_pred hhhhhhcccceEEecchhhhheec-cccee-----eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhc
Confidence 555557899999999999988852 11111 111122344678999999987654 356899999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
...||....+-+--. +.-.+| +. ..+++.....+.+++.-|+.+||.+||.+..|+-+||+.+
T Consensus 385 revpfadlspmecgm------kialeg-lr-----v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 385 REVPFADLSPMECGM------KIALEG-LR-----VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccccccCCchhhhh------hhhhcc-cc-----ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 999998655432111 000111 11 1234445567888888999999999999999999999754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-16 Score=169.02 Aligned_cols=221 Identities=26% Similarity=0.338 Sum_probs=170.4
Q ss_pred hHHHHHHHHHHHhhcCCC-ceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 510 GEREFQTEMKVIGRTHHR-NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE--KQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
....+.+|+.+++++.|+ +++++.+++......+++++++.+++|.+++.... ..+.......++.|++.++.|+|.
T Consensus 40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~ 119 (384)
T COG0515 40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119 (384)
T ss_pred HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 457789999999999988 79999999977777899999999999997775543 267888999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCC-cEEEeecCCccccCCCCcc-----eecccccCccccCcccccC---CCCCccccchh
Q 038168 587 ECETQIIHCDIKPQNILMDENR-CAKISDFGLAKLMKPDQTR-----TFTGIRGTRGYVAPEWHRN---LPITVKADVYS 657 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~-~~ki~DfGla~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S 657 (757)
. +++|||+||+||+++... .++++|||+++.+...... ......|+..|++||.+.+ .......|+||
T Consensus 120 ~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s 196 (384)
T COG0515 120 K---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWS 196 (384)
T ss_pred C---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHH
Confidence 8 899999999999999998 7999999999866544332 2355789999999999988 57899999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCcc---ccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 038168 658 FGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLS---QLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKV 734 (757)
Q Consensus 658 ~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eV 734 (757)
+|++++++++|..|+...... ................ ...... ........+.+++..|+..+|..|.++.+.
T Consensus 197 ~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~ 272 (384)
T COG0515 197 LGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTPSLASPLSPS-NPELISKAASDLLKKLLAKDPKNRLSSSSD 272 (384)
T ss_pred HHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCcccccccCcc-ccchhhHHHHHHHHHHHhcCchhcCCHHHH
Confidence 999999999999996544321 0011112222222211 000000 002223567888889999999999999887
Q ss_pred HHH
Q 038168 735 LLM 737 (757)
Q Consensus 735 l~~ 737 (757)
...
T Consensus 273 ~~~ 275 (384)
T COG0515 273 LSH 275 (384)
T ss_pred hhc
Confidence 764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.5e-16 Score=171.11 Aligned_cols=216 Identities=20% Similarity=0.203 Sum_probs=161.7
Q ss_pred HHHHHHHHHhhcCC----CceeeeeeEE-EeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 513 EFQTEMKVIGRTHH----RNLVRLLGYS-LEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 513 ~~~~E~~~l~~l~h----~niv~l~g~~-~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
.+..|+.++..+.+ +++.++++.. ..+...++||+.+ +-+|.++..... +.++..+.++|+.|++.+|++||+
T Consensus 62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~ 140 (322)
T KOG1164|consen 62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS 140 (322)
T ss_pred cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh
Confidence 67889999998873 6888999888 4777889999987 779999875544 789999999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCC-----CcEEEeecCCcc--ccCCCCc------ce-ecccccCccccCcccccCCCCCcc
Q 038168 587 ECETQIIHCDIKPQNILMDEN-----RCAKISDFGLAK--LMKPDQT------RT-FTGIRGTRGYVAPEWHRNLPITVK 652 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~-----~~~ki~DfGla~--~~~~~~~------~~-~~~~~gt~~y~aPE~~~~~~~~~k 652 (757)
. +++||||||.|+++... ..+.|.|||+++ .+..... .. ....+||..|.+++...+.+.+.+
T Consensus 141 ~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~ 217 (322)
T KOG1164|consen 141 K---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR 217 (322)
T ss_pred c---CcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc
Confidence 8 99999999999999865 469999999999 3322221 11 234679999999999999999999
Q ss_pred ccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 653 ADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 653 ~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
.|+||++.++.|++.|..||......... ..+.+......... .....+.++.++...+-..+..++|...
T Consensus 218 DDles~~Y~l~el~~g~LPW~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~ 288 (322)
T KOG1164|consen 218 DDLESLFYMLLELLKGSLPWEALEMTDLK---SKFEKDPRKLLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYE 288 (322)
T ss_pred hhhhhHHHHHHHHhcCCCCCccccccchH---HHHHHHhhhhcccc------ccCCChHHHHHHHHHhhccCCcCCCCHH
Confidence 99999999999999999999654432221 11111111111110 1111223444555545558999999999
Q ss_pred HHHHHhhcC
Q 038168 733 KVLLMLEGT 741 (757)
Q Consensus 733 eVl~~Le~~ 741 (757)
.+...|+..
T Consensus 289 ~~~~~l~~~ 297 (322)
T KOG1164|consen 289 KLAELLKDV 297 (322)
T ss_pred HHHHHHHHH
Confidence 999888653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.1e-16 Score=157.66 Aligned_cols=163 Identities=21% Similarity=0.299 Sum_probs=142.8
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
-+++.|....+.| ..++|..++-|..++.+-.||+|++ +-||+|+..=.++.++.++...||.|++.-++|+|++
T Consensus 68 PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k--- 143 (449)
T KOG1165|consen 68 PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK--- 143 (449)
T ss_pred chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---
Confidence 4688899888888 5789999999999999999999998 6688887766688999999999999999999999999
Q ss_pred CeeeCCCCcceEEECC-----CCcEEEeecCCccccCCCCcc------eecccccCccccCcccccCCCCCccccchhhH
Q 038168 591 QIIHCDIKPQNILMDE-----NRCAKISDFGLAKLMKPDQTR------TFTGIRGTRGYVAPEWHRNLPITVKADVYSFG 659 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~-----~~~~ki~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G 659 (757)
.+|.|||||+|+||.. ...+.|+|||+|+.+.+..+. ......||.+||+-....+.+-+.+.|+-|+|
T Consensus 144 ~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLG 223 (449)
T KOG1165|consen 144 DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALG 223 (449)
T ss_pred ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhh
Confidence 9999999999999963 346899999999988765442 23457799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCC
Q 038168 660 VVLLEIICRRRCLDPNLPD 678 (757)
Q Consensus 660 ~~l~elltG~~p~~~~~~~ 678 (757)
-+++..+.|..||.+.-..
T Consensus 224 HvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 224 HVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred hhhhhhccCCCccccccCc
Confidence 9999999999999875443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.3e-16 Score=168.25 Aligned_cols=123 Identities=23% Similarity=0.236 Sum_probs=98.4
Q ss_pred hHHHHHHHHHHHhhcCCCceee-eeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVR-LLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~-l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+.|.+|+++|++++|+|+++ +++ .+..+|||||+++++|... .. .. ...++.+++++|.|||+.
T Consensus 64 ~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~-~~-~~------~~~~~~~i~~aL~~lH~~- 130 (365)
T PRK09188 64 ARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLA-RP-HG------DPAWFRSAHRALRDLHRA- 130 (365)
T ss_pred HHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHh-Cc-cc------hHHHHHHHHHHHHHHHHC-
Confidence 3567999999999999999985 443 2467999999999999732 11 11 146789999999999998
Q ss_pred CCCeeeCCC-CcceEEECCCCcEEEeecCCccccCCCCcc-------eecccccCccccCcccccCC
Q 038168 589 ETQIIHCDI-KPQNILMDENRCAKISDFGLAKLMKPDQTR-------TFTGIRGTRGYVAPEWHRNL 647 (757)
Q Consensus 589 ~~~iiH~Di-k~~Nill~~~~~~ki~DfGla~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 647 (757)
+|+|||| ||+|||++.++.+||+|||+++.+...... ..++..+++.|+|||++...
T Consensus 131 --gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 131 --GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred --CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999999 999999999999999999999987654321 12456788899999988643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.6e-15 Score=154.08 Aligned_cols=196 Identities=20% Similarity=0.281 Sum_probs=138.2
Q ss_pred CCCceeeeeeEEEe---------------------------ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHH
Q 038168 525 HHRNLVRLLGYSLE---------------------------VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDI 577 (757)
Q Consensus 525 ~h~niv~l~g~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 577 (757)
+|||||++++++.+ ....|+||.-++. +|.+++.. ..++...+.-|+.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~--~~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT--RHRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc--CCCchHHHHHHHHHH
Confidence 69999999987642 2246888887754 89888854 345566777799999
Q ss_pred HHHHHHhhhCCCCCeeeCCCCcceEEE--CCCC--cEEEeecCCccccCCCC-----cceecccccCccccCcccccCCC
Q 038168 578 ARGILYLHDECETQIIHCDIKPQNILM--DENR--CAKISDFGLAKLMKPDQ-----TRTFTGIRGTRGYVAPEWHRNLP 648 (757)
Q Consensus 578 a~gL~yLH~~~~~~iiH~Dik~~Nill--~~~~--~~ki~DfGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~ 648 (757)
++|+.|||++ +|.|||+|.+|||| |+|. ...|+|||.+---.... .......-|...-||||+....+
T Consensus 351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999999 99999999999999 4443 56889999875322211 11112345777899999886543
Q ss_pred ------CCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccc
Q 038168 649 ------ITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCIL 722 (757)
Q Consensus 649 ------~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~ 722 (757)
--.|+|.|+.|-+.||+++...||...- +-.... ..+.+..++.+ +...+..+.+++...++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~-----r~Yqe~qLPal------p~~vpp~~rqlV~~lL~ 495 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDT-----RTYQESQLPAL------PSRVPPVARQLVFDLLK 495 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccc-hheech-----hhhhhhhCCCC------cccCChHHHHHHHHHhc
Confidence 2368999999999999999999998621 111111 11222223222 33445567889999999
Q ss_pred cCCCCCCCHHHHHHHh
Q 038168 723 DEPSLRPSMKKVLLML 738 (757)
Q Consensus 723 ~~p~~RPsm~eVl~~L 738 (757)
.||.+|++..-....|
T Consensus 496 r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 496 RDPSKRVSPNIAANVL 511 (598)
T ss_pred CCccccCCccHHHhHH
Confidence 9999999865444433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.1e-15 Score=145.35 Aligned_cols=164 Identities=24% Similarity=0.269 Sum_probs=140.8
Q ss_pred HHHHHHHHHHhhcCC-CceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRTHH-RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
-++.-|..+...|+| ..|..+..|..+...-.||||.+ +-+|.++..-..+.++-.+.+-++-|++.-++|+|.+
T Consensus 55 pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r--- 130 (341)
T KOG1163|consen 55 PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR--- 130 (341)
T ss_pred cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---
Confidence 467788999988865 57888888889999999999988 6799988866678889999999999999999999999
Q ss_pred CeeeCCCCcceEEECCC---CcEEEeecCCccccCCCCc------ceecccccCccccCcccccCCCCCccccchhhHHH
Q 038168 591 QIIHCDIKPQNILMDEN---RCAKISDFGLAKLMKPDQT------RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVV 661 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~---~~~ki~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~ 661 (757)
++|||||||+|+|..-+ ..+.++|||||+.+.+..+ ....+..||..|.+-....+..-+.+.|+-|+|.+
T Consensus 131 ~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYv 210 (341)
T KOG1163|consen 131 NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYV 210 (341)
T ss_pred ccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcce
Confidence 99999999999999754 4688999999998765433 23345779999999999888889999999999999
Q ss_pred HHHHHhCCCCCCCCCCCc
Q 038168 662 LLEIICRRRCLDPNLPDD 679 (757)
Q Consensus 662 l~elltG~~p~~~~~~~~ 679 (757)
|..+-.|..||++-....
T Consensus 211 LmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 211 LMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred eeeeecCCCcccccchhh
Confidence 999999999999766544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.3e-16 Score=166.07 Aligned_cols=170 Identities=23% Similarity=0.334 Sum_probs=130.4
Q ss_pred eeeEEEEeccCCChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCc
Q 038168 541 KKILVYEYMSNGSLADILFNP--EKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLA 618 (757)
Q Consensus 541 ~~~lV~e~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla 618 (757)
..|+.|+++...+|.++|... ....++.....++.|++.|+.| + +.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 467899999999999999643 3567899999999999999999 4 8999999999999999999999999999
Q ss_pred cccCCCC-----cceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHh
Q 038168 619 KLMKPDQ-----TRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFE 692 (757)
Q Consensus 619 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 692 (757)
....... ....+...||..||+||.+.+..|+.|+||||||++|+||+. -...++ ......-++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------r~~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------RIATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------HHHhhhhhh
Confidence 8776554 233455789999999999999999999999999999999986 222111 011223334
Q ss_pred cCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 693 NGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 693 ~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
.|.++...- .....=..+..+++.++|.+||+..
T Consensus 474 ~g~ip~~~~------~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 474 DGIIPPEFL------QDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred cCCCChHHh------hcCcHHHHHHHHhcCCCcccCchHH
Confidence 444441110 0112234678889999999999433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.3e-15 Score=145.29 Aligned_cols=147 Identities=18% Similarity=0.175 Sum_probs=114.2
Q ss_pred HHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 513 EFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 513 ~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
.|.+|+++|++|+ |+++++++++ +..+++|||+++.+|.+.+.. ....++.|++++|+++|.. +
T Consensus 47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~---G 111 (218)
T PRK12274 47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRC---G 111 (218)
T ss_pred HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHC---c
Confidence 5789999999995 5889999886 456999999999998764311 1235788999999999999 9
Q ss_pred eeeCCC-CcceEEECCCCcEEEeecCCccccCCCCcc----e--------ecccccCccccCcccccCC-CCC-ccccch
Q 038168 592 IIHCDI-KPQNILMDENRCAKISDFGLAKLMKPDQTR----T--------FTGIRGTRGYVAPEWHRNL-PIT-VKADVY 656 (757)
Q Consensus 592 iiH~Di-k~~Nill~~~~~~ki~DfGla~~~~~~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~k~Dv~ 656 (757)
|+|||| ||+|||++.++.++|+|||++......... . ..-...++.|++|+...-. ..+ ...+.+
T Consensus 112 IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~ 191 (218)
T PRK12274 112 VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWF 191 (218)
T ss_pred CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHH
Confidence 999999 799999999999999999999865543310 0 0112367788888755432 333 677889
Q ss_pred hhHHHHHHHHhCCCCCCC
Q 038168 657 SFGVVLLEIICRRRCLDP 674 (757)
Q Consensus 657 S~G~~l~elltG~~p~~~ 674 (757)
+-|.-+|.++|++.+.-.
T Consensus 192 ~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 192 ATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HhcchHHHHHhccCCccc
Confidence 999999999999987654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-15 Score=165.81 Aligned_cols=190 Identities=21% Similarity=0.195 Sum_probs=150.3
Q ss_pred HHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 513 EFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 513 ~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
....|..++..++ |+.+|+++-.++.....++++++..+|.|...+.+. ..+...........+|-+++++|+. +
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l---~ 117 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKL---G 117 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchh---H
Confidence 3456778888886 999999999999999999999999999999888653 3344444555777889999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRC 671 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p 671 (757)
|+|||+|++||+++.+|.+|+.|||+++..-..... +||..|||||++. ......|-||||++++||++|..|
T Consensus 118 iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~p 190 (612)
T KOG0603|consen 118 IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLP 190 (612)
T ss_pred HHHhcccccceeecccCccccCCchhhhHhHhhhhc-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCC
Confidence 999999999999999999999999999876544332 7899999999998 578899999999999999999999
Q ss_pred CCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 672 LDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 672 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
|.. +.....++.. ..++.+......+++..+...+|.+|--.
T Consensus 191 f~~----------~~~~~Il~~~--------~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 191 FGG----------DTMKRILKAE--------LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred Cch----------HHHHHHhhhc--------cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 886 1122222211 12234555566677777777788888644
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.4e-15 Score=173.37 Aligned_cols=211 Identities=23% Similarity=0.309 Sum_probs=145.8
Q ss_pred HHHHHHHHH--HhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 512 REFQTEMKV--IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 512 ~~~~~E~~~--l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
+.|.++++- .+.++|||.+++.-.-......|||-+|..+ +|.|.|.. +..+...+..-|+-|++.||..+|+.
T Consensus 64 ~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~-- 139 (1431)
T KOG1240|consen 64 RPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKL-- 139 (1431)
T ss_pred hHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHc--
Confidence 455554444 4445899999987775556667888888755 78887732 44567778888999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCcccc--CCCCcce----ecccccCccccCcccccC----------CC-CCcc
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLM--KPDQTRT----FTGIRGTRGYVAPEWHRN----------LP-ITVK 652 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~--~~~~~~~----~~~~~gt~~y~aPE~~~~----------~~-~~~k 652 (757)
+|+|+|||.+||||+.-..+.|+||.--+.. +.+.... ....+.-.+|+|||.+.. .. .+++
T Consensus 140 -gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~pa 218 (1431)
T KOG1240|consen 140 -GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPA 218 (1431)
T ss_pred -CccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChh
Confidence 9999999999999999999999999877633 2221111 111223347999997643 12 6789
Q ss_pred ccchhhHHHHHHHHhC-CCCCCCCCCCccccHHHHHHHHHhcCCcccccccc-ccCHHHHHHHHHHHHHccccCCCCCCC
Q 038168 653 ADVYSFGVVLLEIICR-RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDE-EVDEKQLERMIKVALWCILDEPSLRPS 730 (757)
Q Consensus 653 ~Dv~S~G~~l~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs 730 (757)
-||||+||++.||++- +++|+- .+.. .++.+. -.+++ ....-+-..+.++++.|++.||++|.+
T Consensus 219 MDIFS~GCViaELf~Eg~PlF~L---------SQL~--aYr~~~---~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlS 284 (1431)
T KOG1240|consen 219 MDIFSAGCVIAELFLEGRPLFTL---------SQLL--AYRSGN---ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLS 284 (1431)
T ss_pred hhhhhhhHHHHHHHhcCCCcccH---------HHHH--hHhccC---ccCHHHHHHhCcCccHHHHHHHHHccCchhccC
Confidence 9999999999999886 555541 1111 112221 00000 000011136889999999999999999
Q ss_pred HHHHHHHhhcC
Q 038168 731 MKKVLLMLEGT 741 (757)
Q Consensus 731 m~eVl~~Le~~ 741 (757)
+++.++.-.+.
T Consensus 285 AedyL~~yrG~ 295 (1431)
T KOG1240|consen 285 AEDYLQKYRGL 295 (1431)
T ss_pred HHHHHHhhhcc
Confidence 99999885543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=6e-15 Score=147.51 Aligned_cols=129 Identities=17% Similarity=0.232 Sum_probs=102.6
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEec--------eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEV--------SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y 583 (757)
+.+.+|+..+.+++|++|..+..++... ...+|||||+++.+|.++.. ++ .....+++.+|..
T Consensus 80 ~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~----~~~~~~i~~~l~~ 150 (232)
T PRK10359 80 DYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----IS----EDVKAKIKASIES 150 (232)
T ss_pred HHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-----cc----HHHHHHHHHHHHH
Confidence 3478999999999999999999886643 35789999999999988742 11 1346699999999
Q ss_pred hhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHH
Q 038168 584 LHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663 (757)
Q Consensus 584 LH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ 663 (757)
+|.. +++|||+||+||+++.++ ++|+|||..+....+... ..+.....+..++|+|+||+++.
T Consensus 151 lH~~---gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~ 213 (232)
T PRK10359 151 LHQH---GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLL 213 (232)
T ss_pred HHHc---CCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeeh
Confidence 9998 999999999999999988 999999998765332211 11344556778999999999987
Q ss_pred HHH
Q 038168 664 EII 666 (757)
Q Consensus 664 ell 666 (757)
.+.
T Consensus 214 ~~~ 216 (232)
T PRK10359 214 IYK 216 (232)
T ss_pred HHH
Confidence 664
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.7e-13 Score=136.56 Aligned_cols=103 Identities=18% Similarity=0.248 Sum_probs=82.9
Q ss_pred hHHHHHHHHHHHhhc-----CCCceeeeeeEEEece---e-eeEEEEe--ccCCChhhhhcCCCCCCCHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRT-----HHRNLVRLLGYSLEVS---K-KILVYEY--MSNGSLADILFNPEKQPNWVERMGIARDIA 578 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~~---~-~~lV~e~--~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia 578 (757)
..+++.+|+.+++++ .||||++++|++.+.. . ..+|+|| +++++|.+++.+. .++.. ..++.+++
T Consensus 39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L 114 (210)
T PRK10345 39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLL 114 (210)
T ss_pred hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHH
Confidence 457899999999999 5799999999998763 3 3378999 6689999999552 34444 35678888
Q ss_pred HHH-HHhhhCCCCCeeeCCCCcceEEECC----CCcEEEeecCCcc
Q 038168 579 RGI-LYLHDECETQIIHCDIKPQNILMDE----NRCAKISDFGLAK 619 (757)
Q Consensus 579 ~gL-~yLH~~~~~~iiH~Dik~~Nill~~----~~~~ki~DfGla~ 619 (757)
.++ +|||++ +|+||||||+|||++. +..++|+||+.+.
T Consensus 115 ~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 115 KKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred HHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 888 999999 9999999999999974 3489999954443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.4e-14 Score=143.85 Aligned_cols=161 Identities=19% Similarity=0.300 Sum_probs=108.8
Q ss_pred eeEEEEeccCCChhhhhc---CCC---CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeec
Q 038168 542 KILVYEYMSNGSLADILF---NPE---KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDF 615 (757)
Q Consensus 542 ~~lV~e~~~~gsL~~~l~---~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~Df 615 (757)
.+++|+-+ .++|.+++. ... ..+....++.+..|+++.+++||+. +++|+||||+|++++.+|.++|+||
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~~~nfll~~~G~v~Lg~F 189 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIKPENFLLDQDGGVFLGDF 189 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEE-TTS-EEE--G
T ss_pred hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccceeeEEEcCCCCEEEcCh
Confidence 36777777 458877753 221 2244566778889999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCcceecccccCccccCcccccC--------CCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHH
Q 038168 616 GLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN--------LPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWV 687 (757)
Q Consensus 616 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~ 687 (757)
+.....+..... ...+..|.+||.... ..++.+.|.|++|+++|.|.+++.|++...++.....
T Consensus 190 ~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---- 261 (288)
T PF14531_consen 190 SSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---- 261 (288)
T ss_dssp GGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----
T ss_pred HHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----
Confidence 887754432111 234578999997643 3578999999999999999999999986544322110
Q ss_pred HHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCC
Q 038168 688 YQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLR 728 (757)
Q Consensus 688 ~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~R 728 (757)
+-..+. +.++.+..|+..+|+.||++|
T Consensus 262 -------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 -------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred -------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 112234 677889999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.2e-13 Score=132.48 Aligned_cols=102 Identities=15% Similarity=0.171 Sum_probs=81.0
Q ss_pred HHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh-hhCCCCCe
Q 038168 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL-HDECETQI 592 (757)
Q Consensus 514 ~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~i 592 (757)
..+|++++.++.|+++.....+. ....+|||||+++++|.....+ ...++..+..+++.|++.+|.|| |+. +|
T Consensus 66 ~~~E~~~l~~l~~~~v~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~---gi 139 (190)
T cd05147 66 AEKEMRNLKRLVTAGIPCPEPIL--LKSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDC---RL 139 (190)
T ss_pred HHHHHHHHHHHHHCCCCCCcEEE--ecCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 45799999999887764433222 2234899999999877655322 35678889999999999999999 677 99
Q ss_pred eeCCCCcceEEECCCCcEEEeecCCccccC
Q 038168 593 IHCDIKPQNILMDENRCAKISDFGLAKLMK 622 (757)
Q Consensus 593 iH~Dik~~Nill~~~~~~ki~DfGla~~~~ 622 (757)
+||||||+|||++ ++.++|+|||++....
T Consensus 140 iHrDlkP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 140 VHADLSEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred ccCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence 9999999999998 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.4e-13 Score=131.47 Aligned_cols=104 Identities=16% Similarity=0.163 Sum_probs=83.2
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCC
Q 038168 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD-ECETQ 591 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ 591 (757)
.+..|.+.+.++.|+++.....+... ..+|||||++++++...... ...++..+...++.+++.++.+||+ . +
T Consensus 65 ~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~---g 138 (190)
T cd05145 65 WAEKEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEA---G 138 (190)
T ss_pred HHHHHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhC---C
Confidence 34689999999999987544433322 35899999998865443222 3456777889999999999999999 7 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~ 623 (757)
|+||||||+|||++ ++.++|+|||++.....
T Consensus 139 ivHrDlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 139 LVHGDLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EecCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence 99999999999999 88999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.8e-13 Score=156.74 Aligned_cols=211 Identities=25% Similarity=0.338 Sum_probs=161.3
Q ss_pred HHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHhh-hCCCC
Q 038168 514 FQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL-FNPEKQPNWVERMGIARDIARGILYLH-DECET 590 (757)
Q Consensus 514 ~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l-~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~ 590 (757)
...|..+-+++. |+|++++++...+.+..+++.||.+++++.+.+ +......+-...-.+..|+..++.|+| ..
T Consensus 67 i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~--- 143 (601)
T KOG0590|consen 67 IDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN--- 143 (601)
T ss_pred cCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---
Confidence 344666667775 999999999999999999999999999999988 443324455566678999999999999 76
Q ss_pred CeeeCCCCcceEEECCCC-cEEEeecCCccccCC-C-Ccceeccccc-CccccCcccccCC-CCCccccchhhHHHHHHH
Q 038168 591 QIIHCDIKPQNILMDENR-CAKISDFGLAKLMKP-D-QTRTFTGIRG-TRGYVAPEWHRNL-PITVKADVYSFGVVLLEI 665 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~-~~ki~DfGla~~~~~-~-~~~~~~~~~g-t~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~el 665 (757)
++.|+||||+|.+++..+ ..|++|||+|..+.. . .........| ++.|+|||...+. ...+..|+||.|+++.-+
T Consensus 144 ~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~ 223 (601)
T KOG0590|consen 144 GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAM 223 (601)
T ss_pred ccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccccc
Confidence 999999999999999999 999999999998876 3 3344455778 9999999999885 557889999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
++|..|++......... ..|.... +... ............++...++..+|+.|.+.+++..
T Consensus 224 ~~g~~p~~~~~~~~~~~-~~~~~~~---~~~~-----~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 224 LTGELPWDFPSRKDGRY-SSWKSNK---GRFT-----QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccCCCCccccccccccc-eeecccc---cccc-----cCccccCChhhhhcccccccCCchhccccccccc
Confidence 99999998765544211 1111110 0000 0111223345667777788899999999888754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.9e-12 Score=130.48 Aligned_cols=202 Identities=24% Similarity=0.339 Sum_probs=138.3
Q ss_pred HHHHhhcCCCceeeeeeEEEec-----eeeeEEEEeccCCChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 518 MKVIGRTHHRNLVRLLGYSLEV-----SKKILVYEYMSNGSLADILFNP---EKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 518 ~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..-|-++-|.|||+++.|+.+. .+..++.|||..|+|.++|++. .+.+....-.+++-||..||.|||+ |.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 3445666799999999998643 3578999999999999999653 3455666667899999999999998 68
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCC----CcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD----QTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
|+|+|+++..+.|++..++-+||.-- ........ .........+-++|-+||+-.....+..+|||+||+..+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 99999999999999999998888421 11111100 00111123467899999998888899999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
.-+..-... .+......+-.... +..+.+ ..=...+..|++.+|..||+|.+++..
T Consensus 276 ailEiq~tn--seS~~~~ee~ia~~-----i~~len---------~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTN--SESKVEVEENIANV-----IIGLEN---------GLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCC--Ccceeehhhhhhhh-----eeeccC---------ccccCcCcccccCCCCCCcchhhhhcC
Confidence 877642111 11111100000000 000000 111345667999999999999987653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.30 E-value=6.9e-12 Score=126.30 Aligned_cols=101 Identities=25% Similarity=0.432 Sum_probs=89.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
...+.+|+.++.+++|+++.....++...+..++||||+++++|.+++.... + ++..++.+++.+|.+||..
T Consensus 43 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~--- 114 (211)
T PRK14879 43 RERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSA--- 114 (211)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhC---
Confidence 3567899999999999998887777777788899999999999999985422 2 7889999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccc
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKL 620 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~ 620 (757)
+++|+|++|.|||++ ++.++|+|||++..
T Consensus 115 ~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 115 GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999999999 78899999999875
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.30 E-value=6.3e-12 Score=144.52 Aligned_cols=97 Identities=22% Similarity=0.408 Sum_probs=87.7
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|++++++++|++++....++...+..++||||+++++|.+++. .+..++.+++++|.|||+. +
T Consensus 381 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~---g 448 (535)
T PRK09605 381 ERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKA---G 448 (535)
T ss_pred HHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhC---C
Confidence 457899999999999999988888887778899999999999999874 4678999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCcccc
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLM 621 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~ 621 (757)
++||||||+|||+ +++.++|+|||+++..
T Consensus 449 iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 449 IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999999 6788999999999764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.1e-12 Score=150.34 Aligned_cols=140 Identities=24% Similarity=0.313 Sum_probs=106.6
Q ss_pred HHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCC--------------cceecccccCccccCcc
Q 038168 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ--------------TRTFTGIRGTRGYVAPE 642 (757)
Q Consensus 577 ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~--------------~~~~~~~~gt~~y~aPE 642 (757)
++.+++|||+. +|+|||+||+|.+|..-+.+|+.|||+.+.....- ......++||+.|+|||
T Consensus 152 mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 152 MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 37899999998 99999999999999999999999999997542111 01223468999999999
Q ss_pred cccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccc
Q 038168 643 WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCIL 722 (757)
Q Consensus 643 ~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~ 722 (757)
++....|...+|.|++|+++||.+-|..||.+..+++-. .+.+.. .+.. .+.+.....+...++...|+
T Consensus 229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf------g~visd-~i~w----pE~dea~p~Ea~dli~~LL~ 297 (1205)
T KOG0606|consen 229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF------GQVISD-DIEW----PEEDEALPPEAQDLIEQLLR 297 (1205)
T ss_pred hhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH------hhhhhh-hccc----cccCcCCCHHHHHHHHHHHH
Confidence 999999999999999999999999999999987665311 111111 0000 11123334567788888999
Q ss_pred cCCCCCCC
Q 038168 723 DEPSLRPS 730 (757)
Q Consensus 723 ~~p~~RPs 730 (757)
++|..|--
T Consensus 298 qnp~~Rlg 305 (1205)
T KOG0606|consen 298 QNPLCRLG 305 (1205)
T ss_pred hChHhhcc
Confidence 99999963
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.2e-11 Score=123.46 Aligned_cols=98 Identities=24% Similarity=0.450 Sum_probs=83.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++.+++|+++.....++...+..++||||+++++|.+++..... .++.+++.+|.+||..
T Consensus 41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~--- 109 (199)
T TIGR03724 41 RERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKA--- 109 (199)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHC---
Confidence 35678999999999988766555566666778999999999999998744211 7899999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccc
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKL 620 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~ 620 (757)
+++|+|++|+||+++ ++.+++.|||+++.
T Consensus 110 gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 110 GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.4e-12 Score=102.97 Aligned_cols=58 Identities=26% Similarity=0.488 Sum_probs=49.6
Q ss_pred CCcceeeeccCCCCCcceeec-ccchhhhHHHHhhcCCccccccccC----Cccccccccccc
Q 038168 341 GNKAIRELKNTKWEDVSYYVL-SETTEEKCKQACLEDCNCEAALFKE----EECKMQRLPLRF 398 (757)
Q Consensus 341 ~~~~f~~l~~~~~p~~~~~~~-~~~s~~~C~~~Cl~nCsC~a~~~~~----~~C~~~~~~l~~ 398 (757)
++++|+++++|++|++..... ...++++|++.|++||||+||+|.+ ++|++|...|.|
T Consensus 3 ~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 3 SGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred CCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 356999999999999865443 5689999999999999999999974 579999998875
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.3e-11 Score=141.03 Aligned_cols=168 Identities=24% Similarity=0.328 Sum_probs=134.1
Q ss_pred ccccccCCCchH----------------------HHHHHHHHHHhhcC---CCceeeeeeEEEeceeeeEEEEeccCCCh
Q 038168 500 FKEEVGRGSSGE----------------------REFQTEMKVIGRTH---HRNLVRLLGYSLEVSKKILVYEYMSNGSL 554 (757)
Q Consensus 500 f~~~lg~g~~~~----------------------~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~~~gsL 554 (757)
.+..+|+|++|. =+|.-=.+++.||+ -+-|..+.....-.+.-+||+||.+.|+|
T Consensus 702 I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtl 781 (974)
T KOG1166|consen 702 ISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTL 781 (974)
T ss_pred EEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccH
Confidence 446789998861 13444555666666 12333344444556678899999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEEC-------CCCcEEEeecCCccccCCCC-c
Q 038168 555 ADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMD-------ENRCAKISDFGLAKLMKPDQ-T 626 (757)
Q Consensus 555 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~-------~~~~~ki~DfGla~~~~~~~-~ 626 (757)
.+++. ..+.++|...+.++.||++-+++||.. +|||+||||+|.||. ++..++|+|||.+--+.--. .
T Consensus 782 ld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~ 857 (974)
T KOG1166|consen 782 LDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDG 857 (974)
T ss_pred HHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCC
Confidence 99996 567889999999999999999999998 999999999999993 34679999999997554222 2
Q ss_pred ceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCC
Q 038168 627 RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRC 671 (757)
Q Consensus 627 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p 671 (757)
.......+|-++-.+|...+.+.+-..|.|.++-+++-||-|+..
T Consensus 858 ~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 858 TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 355667889999999999999999999999999999999999853
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.3e-11 Score=121.61 Aligned_cols=102 Identities=19% Similarity=0.294 Sum_probs=80.7
Q ss_pred HHHHHHHHHhhcCCC--ceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 513 EFQTEMKVIGRTHHR--NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~--niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+..|+.+++++.+. .+.+++++ ...++||||+++++|...... ...+...+...++.|++.+|++||+.
T Consensus 96 ~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~--- 167 (237)
T smart00090 96 WAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKE--- 167 (237)
T ss_pred HHHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhc---
Confidence 467899999999753 34444443 245899999999988776532 23345556678999999999999998
Q ss_pred C-eeeCCCCcceEEECCCCcEEEeecCCccccCC
Q 038168 591 Q-IIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623 (757)
Q Consensus 591 ~-iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~ 623 (757)
+ ++||||||+||+++ ++.++|+|||++.....
T Consensus 168 g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 168 GELVHGDLSEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CCEEeCCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence 8 99999999999999 88999999999876443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.7e-11 Score=121.13 Aligned_cols=103 Identities=18% Similarity=0.241 Sum_probs=83.0
Q ss_pred hHHHHHHHHHHHhhcCCCce--eeeeeEEEece----eeeEEEEeccC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNL--VRLLGYSLEVS----KKILVYEYMSN-GSLADILFNPEKQPNWVERMGIARDIARGIL 582 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~ni--v~l~g~~~~~~----~~~lV~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~ 582 (757)
....+.+|+.++.+|+|+++ ++.+++..... ..++|+|++++ .+|.+++... .++. ..+.+++.+|.
T Consensus 83 ~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~----~~~~~i~~~l~ 156 (239)
T PRK01723 83 ERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA--PLSE----EQWQAIGQLIA 156 (239)
T ss_pred hhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC--CCCH----HHHHHHHHHHH
Confidence 44678899999999998885 77777754432 23599999997 6899887542 2333 23678999999
Q ss_pred HhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCcccc
Q 038168 583 YLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM 621 (757)
Q Consensus 583 yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~ 621 (757)
+||+. +|+|+||||+|||++.++.++|+|||.++..
T Consensus 157 ~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 157 RFHDA---GVYHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred HHHHC---CCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 99998 9999999999999999889999999998764
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=3e-11 Score=102.42 Aligned_cols=71 Identities=20% Similarity=0.419 Sum_probs=60.1
Q ss_pred cceeeeccCCCCCcceeecccchhhhHHHHhhcCCccccccccC--CcccccccccccccccccCCCceEEeec
Q 038168 343 KAIRELKNTKWEDVSYYVLSETTEEKCKQACLEDCNCEAALFKE--EECKMQRLPLRFGRRNLRDSSIAFVKVD 414 (757)
Q Consensus 343 ~~f~~l~~~~~p~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~--~~C~~~~~~l~~~~~~~~~~~~~ylkv~ 414 (757)
..|..++++++|+..+.. ...++++|++.|++||+|.||+|.+ ++|++|..++.+.+.....+..+||||+
T Consensus 12 ~~f~~~~~~~~~~~~~~~-~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 12 DGFLKLPDVKLPDNASAI-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred CEEEEeCCeeCCCchhhh-ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence 489999999999876654 6678999999999999999999974 7899999999887765555678999984
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.5e-10 Score=109.01 Aligned_cols=102 Identities=21% Similarity=0.283 Sum_probs=89.6
Q ss_pred HHHHHHHHHHHhhcCC--CceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHH--RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
...+.+|+.++.+++| .++++++++....+..++++||++++.+..+ +......++.+++++|++||...
T Consensus 35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~ 106 (155)
T cd05120 35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLP 106 (155)
T ss_pred hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCC
Confidence 4578899999999976 5899999988888889999999999877654 55677889999999999999875
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccc
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~ 620 (757)
..+++|+|++|+||++++.+.+++.|||.++.
T Consensus 107 ~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 107 LLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 56899999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.6e-10 Score=115.18 Aligned_cols=98 Identities=18% Similarity=0.213 Sum_probs=79.5
Q ss_pred HHHHHHHHHHhhcCCCc--eeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 512 REFQTEMKVIGRTHHRN--LVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+..|+.++.++.|++ +.+.++ ....++||||+++++|.+.... .....++.+++.++.++|+.
T Consensus 78 ~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~-- 144 (198)
T cd05144 78 LAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKH-- 144 (198)
T ss_pred HHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHC--
Confidence 34678999999998874 444443 2355899999999999876431 23457889999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~ 623 (757)
+++|+||||+||++++++.++|+|||++.....
T Consensus 145 -gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 145 -GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred -CCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.6e-10 Score=95.51 Aligned_cols=67 Identities=13% Similarity=0.205 Sum_probs=57.9
Q ss_pred CcceeeeccCCCCCcceeecccchhhhHHHHhhc---CCcccccccc--CCccccccccc-ccccccccCCCceEEee
Q 038168 342 NKAIRELKNTKWEDVSYYVLSETTEEKCKQACLE---DCNCEAALFK--EEECKMQRLPL-RFGRRNLRDSSIAFVKV 413 (757)
Q Consensus 342 ~~~f~~l~~~~~p~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~--~~~C~~~~~~l-~~~~~~~~~~~~~ylkv 413 (757)
.++|+++.++++|++.. .+.++|++.|++ ||||+||+|. +.+|..|...| .+.++..+.+.++|+|.
T Consensus 8 ~g~fl~~~~~klpd~~~-----~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r~ 80 (80)
T cd00129 8 AGTTLIKIALKIKTTKA-----NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYENK 80 (80)
T ss_pred CCeEEEeecccCCcccc-----cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeEC
Confidence 45799999999998765 578999999999 9999999995 35799999999 88888777788899873
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.1e-09 Score=116.85 Aligned_cols=203 Identities=22% Similarity=0.208 Sum_probs=149.5
Q ss_pred HHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHH----HHHHhhhCCCC
Q 038168 516 TEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIAR----GILYLHDECET 590 (757)
Q Consensus 516 ~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~ 590 (757)
+|+...+++ .|+|.++....+.+.+..++-+|++. .+|.++.+.....++......+..+..+ ||.++|..
T Consensus 166 ~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~--- 241 (524)
T KOG0601|consen 166 REFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN--- 241 (524)
T ss_pred chhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---
Confidence 445555556 59999998889999999999999986 7888888766665666666677777777 99999998
Q ss_pred CeeeCCCCcceEEECCC-CcEEEeecCCccccCCCCcc----eecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 591 QIIHCDIKPQNILMDEN-RCAKISDFGLAKLMKPDQTR----TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~-~~~ki~DfGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
.++|-|+||.||++..+ ...++.|||+...+...... ......|...|++||...+ -++..+|+|++|.++++.
T Consensus 242 ~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~ 320 (524)
T KOG0601|consen 242 NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEA 320 (524)
T ss_pred cccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhh
Confidence 99999999999999999 89999999999988765421 1122357788999998665 578899999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
.++-......... .|...+.+ ..+.++...-..++..+...|++++|..|++.+.+..
T Consensus 321 ~l~~~~~~~g~~~--------~W~~~r~~-----~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 321 ILGSHLPSVGKNS--------SWSQLRQG-----YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred HhhcccccCCCCC--------Cccccccc-----cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 9987655433111 11111111 1222222222344555888899999999998765543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.85 E-value=5.9e-09 Score=102.73 Aligned_cols=99 Identities=16% Similarity=0.223 Sum_probs=71.3
Q ss_pred HHHHHHHhhcCCCc--eeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCC
Q 038168 515 QTEMKVIGRTHHRN--LVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD-ECETQ 591 (757)
Q Consensus 515 ~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ 591 (757)
..|...+.++.+.. +.+.+++ ...++||||++++.+....-.... .. .+...++.+++.++.++|. . +
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~---~ 135 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREA---G 135 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhcc---C
Confidence 45666676665443 4444443 246899999999544321111000 01 5567899999999999998 6 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~ 623 (757)
|+|+||||+||+++ ++.++|+|||.+.....
T Consensus 136 ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 136 LVHGDLSEYNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred cCcCCCChhhEEEE-CCcEEEEECcccccccC
Confidence 99999999999999 89999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.1e-07 Score=105.69 Aligned_cols=147 Identities=16% Similarity=0.197 Sum_probs=106.7
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
....+-++-|+.++||||++++....+....|||+|-+. -|..++.+.. -...--.+.||+.||.+||++| .
T Consensus 54 ~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~~Gl~qIl~AL~FL~~d~--~ 125 (690)
T KOG1243|consen 54 ELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVCLGLFQILAALSFLNDDC--N 125 (690)
T ss_pred HHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHHHHHHHHHHHHHHHhccC--C
Confidence 345677888999999999999999999999999999764 3444443211 2333446789999999999764 8
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
++|++|....|+++..|..||++|-++........ ......--..|..|+.+.... -..|.|-||++++|++.|.
T Consensus 126 lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 126 LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 99999999999999999999999988764322111 011111122455565433221 3469999999999999993
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.2e-08 Score=109.36 Aligned_cols=107 Identities=21% Similarity=0.273 Sum_probs=78.4
Q ss_pred HHHHHHHHHHHhhcC----CCceeeeeeEEE-eceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHH-HHHHh
Q 038168 511 EREFQTEMKVIGRTH----HRNLVRLLGYSL-EVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIAR-GILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~----h~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~-gL~yL 584 (757)
+-+|.+|+..+.+++ |.+-+.+-..+. .....+|||||+++++|.++........ .+.+++..+++ .+..+
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQV 273 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHH
Confidence 446788888877773 333344433333 2346799999999999998764322222 24557777766 46788
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCC
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~ 623 (757)
|.. +++|+|+||.||+++.++.++++|||++..+..
T Consensus 274 ~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 274 LRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 887 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.63 E-value=6.6e-08 Score=93.51 Aligned_cols=96 Identities=18% Similarity=0.206 Sum_probs=71.3
Q ss_pred HHHHHHHHHhhcCCCcee-eeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--C
Q 038168 513 EFQTEMKVIGRTHHRNLV-RLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC--E 589 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~ 589 (757)
.+.+|+.+++.+.+.+++ +++.+. .+..++||||+++.++.+.. .....++.+++++|+.||... .
T Consensus 38 ~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~ 106 (170)
T cd05151 38 NRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTED---------FSDPENLEKIAKLLKKLHSSPLPD 106 (170)
T ss_pred CHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccccc---------ccCHHHHHHHHHHHHHHhCCCCCC
Confidence 457888999888665544 454443 33468999999998886531 112345788999999999872 2
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccc
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKL 620 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~ 620 (757)
..++|+|++|.||+++ ++.++++|||.+..
T Consensus 107 ~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 107 LVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 2369999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.9e-07 Score=91.64 Aligned_cols=99 Identities=15% Similarity=0.173 Sum_probs=73.7
Q ss_pred HHHHHHHhhcCC--CceeeeeeEEEeceeeeEEEEeccCCChhh-hhcCCCCCCCHHHHHHHHHHHHHHHHHh-hhCCCC
Q 038168 515 QTEMKVIGRTHH--RNLVRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNPEKQPNWVERMGIARDIARGILYL-HDECET 590 (757)
Q Consensus 515 ~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~ 590 (757)
.+|+..|+++.. -++.+++++ ...+|||||+.+..+.. .+.. ..++..+...+..+++.+|..| |+.
T Consensus 74 ~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~--- 144 (197)
T cd05146 74 EKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKEC--- 144 (197)
T ss_pred HHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhC---
Confidence 379999999853 456666654 56789999998754422 2221 1233445567889999999999 777
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~ 623 (757)
+++|+||++.|||+++ +.+.|+|||.+....+
T Consensus 145 glVHGDLs~~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 145 NLVHADLSEYNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred CeecCCCCHHHEEEEC-CcEEEEECCCceeCCC
Confidence 9999999999999974 6799999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.9e-08 Score=114.62 Aligned_cols=191 Identities=23% Similarity=0.231 Sum_probs=134.9
Q ss_pred CceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECC
Q 038168 527 RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDE 606 (757)
Q Consensus 527 ~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~ 606 (757)
|-+++..--+.-....+||++|+.+++|...|++.... +-.-....+..+...++|||.. .+.|+|++|.|.++..
T Consensus 864 P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~-saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~ 939 (1205)
T KOG0606|consen 864 PAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCL-SAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAY 939 (1205)
T ss_pred CceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCc-ccccccchhHHHHhhhhccccc---hhhcccccccchhhcc
Confidence 33443333333456789999999999999998765422 2222333555677889999996 6999999999999999
Q ss_pred CCcEEEeecCCccccCC---------------------C----Cc-----ceecccccCccccCcccccCCCCCccccch
Q 038168 607 NRCAKISDFGLAKLMKP---------------------D----QT-----RTFTGIRGTRGYVAPEWHRNLPITVKADVY 656 (757)
Q Consensus 607 ~~~~ki~DfGla~~~~~---------------------~----~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~ 656 (757)
++..+++|||.....+. . +. .......+|..|++||...+......+|.|
T Consensus 940 ~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~ 1019 (1205)
T KOG0606|consen 940 DGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWW 1019 (1205)
T ss_pred cCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhh
Confidence 99999999984432210 0 00 112236689999999999999999999999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 657 SFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 657 S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
+.|++++|.++|..|+....++... +.+..+.+... ....+...+...++...+..+|.+|-.|.
T Consensus 1020 ~~g~~l~e~l~g~pp~na~tpq~~f-------~ni~~~~~~~p----~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1020 SSGVCLFEVLTGIPPFNAETPQQIF-------ENILNRDIPWP----EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhhhhcCCCCCCCcchhhhh-------hccccCCCCCC----CCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999999999999876554321 11222222221 22334445667777778888999998766
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.8e-07 Score=88.71 Aligned_cols=98 Identities=23% Similarity=0.447 Sum_probs=80.5
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.-.+|+.+|.+++--.|.--.=+..+.+...|+|||+++-.|.+.+... +..++..+-+-+.-||.. +
T Consensus 44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~---g 112 (204)
T COG3642 44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKA---G 112 (204)
T ss_pred HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhc---C
Confidence 45678999999987555554455566777888999999999999988653 356777888888899998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCcccc
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLM 621 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~ 621 (757)
|+|+||.++||++..+. +.++||||+...
T Consensus 113 ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 113 IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 99999999999998776 899999999753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.48 E-value=5.1e-08 Score=107.37 Aligned_cols=201 Identities=19% Similarity=0.195 Sum_probs=143.2
Q ss_pred HHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeee
Q 038168 516 TEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIH 594 (757)
Q Consensus 516 ~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 594 (757)
.|+.+...+ .|.+.++....+....+.|+--||++++++...+ .-...++...++++..|++.++.++|+. .++|
T Consensus 314 ~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~ 389 (524)
T KOG0601|consen 314 GEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVH 389 (524)
T ss_pred hhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccch---hhhc
Confidence 455555555 5888999888888888888999999999887665 2234456677888999999999999987 9999
Q ss_pred CCCCcceEEECCC-CcEEEeecCCccccCCCCcceecccccCccc-cCcccccCCCCCccccchhhHHHHHHHHhCCCCC
Q 038168 595 CDIKPQNILMDEN-RCAKISDFGLAKLMKPDQTRTFTGIRGTRGY-VAPEWHRNLPITVKADVYSFGVVLLEIICRRRCL 672 (757)
Q Consensus 595 ~Dik~~Nill~~~-~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~ 672 (757)
+|+||+||++..+ +.-++.|||.+..+.-... .....+..| .+++......+..+.|++|||.-+.|.+++..-.
T Consensus 390 ~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~---~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls 466 (524)
T KOG0601|consen 390 LDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG---VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS 466 (524)
T ss_pred ccccccceeeccchhhhhccccccccccceecc---cccccccccccchhhccccccccccccccccccccccccCcccC
Confidence 9999999999886 8889999999864321111 111123334 3566666778999999999999999999987533
Q ss_pred CCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 673 DPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 673 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
..... +..+..+.+... ......+..++..++.+++..||...+...+.+.
T Consensus 467 ~~~~~----------~~~i~~~~~p~~-------~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 467 ESGVQ----------SLTIRSGDTPNL-------PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ccccc----------ceeeecccccCC-------CchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 32111 111222322221 1122556667777999999999999888776654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=8.6e-07 Score=91.95 Aligned_cols=107 Identities=16% Similarity=0.149 Sum_probs=82.6
Q ss_pred HHHHHHHHHHHhhcCCCc--eeeeeeEEEe-----ceeeeEEEEeccCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRN--LVRLLGYSLE-----VSKKILVYEYMSNG-SLADILFNP-EKQPNWVERMGIARDIARGI 581 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~n--iv~l~g~~~~-----~~~~~lV~e~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~ia~gL 581 (757)
...+.+|...+.++...+ ..+++++... ....+||+|++++- +|.+++... ....+...+..++.+++..+
T Consensus 72 ~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i 151 (268)
T PRK15123 72 VLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMV 151 (268)
T ss_pred cHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHH
Confidence 345778999888885333 3445666543 23578999999986 899887432 23345567778999999999
Q ss_pred HHhhhCCCCCeeeCCCCcceEEECC-------CCcEEEeecCCccc
Q 038168 582 LYLHDECETQIIHCDIKPQNILMDE-------NRCAKISDFGLAKL 620 (757)
Q Consensus 582 ~yLH~~~~~~iiH~Dik~~Nill~~-------~~~~ki~DfGla~~ 620 (757)
.-||.. +|+|+|++++|||++. +..+.++||+.++.
T Consensus 152 ~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 152 RDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999999 9999999999999975 46899999998864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.1e-06 Score=91.42 Aligned_cols=134 Identities=17% Similarity=0.266 Sum_probs=107.3
Q ss_pred HHHHHHhhcCCCceeeeeeEEE----eceeeeEEEEeccC-CChhhhhcCCC--------------CCCCHHHHHHHHHH
Q 038168 516 TEMKVIGRTHHRNLVRLLGYSL----EVSKKILVYEYMSN-GSLADILFNPE--------------KQPNWVERMGIARD 576 (757)
Q Consensus 516 ~E~~~l~~l~h~niv~l~g~~~----~~~~~~lV~e~~~~-gsL~~~l~~~~--------------~~l~~~~~~~i~~~ 576 (757)
.-++..+++.|.|+|++.+.+. .....++||+|+|+ ++|.++-+... ...+......++.|
T Consensus 322 ~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~Q 401 (655)
T KOG3741|consen 322 SLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQ 401 (655)
T ss_pred HHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHH
Confidence 4577889999999999998876 34578999999997 57877665321 22356778899999
Q ss_pred HHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccch
Q 038168 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVY 656 (757)
Q Consensus 577 ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~ 656 (757)
+..||.++|+. |+.-+-|.+++||++.+..++|+..|...+...+.... + .--.+-|.-
T Consensus 402 LtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~~~---------------l---e~~Qq~D~~ 460 (655)
T KOG3741|consen 402 LTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPTEP---------------L---ESQQQNDLR 460 (655)
T ss_pred HHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCCCCcc---------------h---hHHhhhhHH
Confidence 99999999998 99999999999999999999999999887766554111 1 123467899
Q ss_pred hhHHHHHHHHhCCC
Q 038168 657 SFGVVLLEIICRRR 670 (757)
Q Consensus 657 S~G~~l~elltG~~ 670 (757)
-||.+++.|.||..
T Consensus 461 ~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 461 DLGLLLLALATGTE 474 (655)
T ss_pred HHHHHHHHHhhccc
Confidence 99999999999964
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1e-07 Score=106.35 Aligned_cols=151 Identities=17% Similarity=0.258 Sum_probs=103.8
Q ss_pred HHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-------e-cccccCccccCccccc
Q 038168 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-------F-TGIRGTRGYVAPEWHR 645 (757)
Q Consensus 574 ~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-------~-~~~~gt~~y~aPE~~~ 645 (757)
+.+++.|+.|+|.. +++||++|.|++|.++.++..||+.|+.+.......... . .-......|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 45566999999986 799999999999999999999999999886544311110 0 0123456899999999
Q ss_pred CCCCCccccchhhHHHHHHHHhCCCC-CCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccC
Q 038168 646 NLPITVKADVYSFGVVLLEIICRRRC-LDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDE 724 (757)
Q Consensus 646 ~~~~~~k~Dv~S~G~~l~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~ 724 (757)
+...+.++|+||+|++++-+..|+.+ +........-.+. ....... ...+..+.+.++.+=+.+++..+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~------~~~~~~~----~~~~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS------RNLLNAG----AFGYSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh------hcccccc----cccccccCcHHHHHHHHHHhcCC
Confidence 98899999999999999999955543 3322111100000 0000000 11233555677778888889999
Q ss_pred CCCCCCHHHHHH
Q 038168 725 PSLRPSMKKVLL 736 (757)
Q Consensus 725 p~~RPsm~eVl~ 736 (757)
+.-||++.++..
T Consensus 253 ~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 253 SAVRPTLDLLLS 264 (700)
T ss_pred cccCcchhhhhc
Confidence 999998877654
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.7e-06 Score=78.03 Aligned_cols=85 Identities=25% Similarity=0.537 Sum_probs=61.8
Q ss_pred ecc-CCCEEEecCCCCceeEEecCCC---cceeEEEecCCCEEEEecCCceeeeccCCCccccCCCCcccCCCcccccCC
Q 038168 101 FNS-EGSIVLRSSQQSQDSLIADDSQ---SASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGIS 176 (757)
Q Consensus 101 ~~~-~G~Lvl~~~~~~~~~~~~~~~~---~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg~kl~~~~~L~S~~s 176 (757)
... +|+||+........+|++++.. ....+.|.++|||||.|.++.++|||=-.
T Consensus 26 ~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~---------------------- 83 (116)
T cd00028 26 MQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTT---------------------- 83 (116)
T ss_pred CCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEeccc----------------------
Confidence 344 8999998654335667766543 34678899999999999999999998210
Q ss_pred CCCCCCCceEEEecCCCCceeeeccCCCCccceEeeccc
Q 038168 177 ETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNT 215 (757)
Q Consensus 177 ~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~~ 215 (757)
.+.|.+.+.|+.||++++|...+ .+.|.+..
T Consensus 84 ---~~~~~~~~~L~ddGnlvl~~~~~-----~~~W~Sf~ 114 (116)
T cd00028 84 ---RVNGNYVLVLLDDGNLVLYDSDG-----NFLWQSFD 114 (116)
T ss_pred ---CCCCceEEEEeCCCCEEEECCCC-----CEEEcCCC
Confidence 02567899999999999886432 46787653
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.3e-06 Score=82.45 Aligned_cols=108 Identities=20% Similarity=0.330 Sum_probs=80.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccC-CChhhhhcCCCCCCCHHHH-HHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN-GSLADILFNPEKQPNWVER-MGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~l~~~~~-~~i~~~ia~gL~yLH~~~ 588 (757)
.+.-++|+++|.+++--.|.--.=++.+...-.|+|||+++ .++.+++...-........ ..++..|-+.+.-||..
T Consensus 54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n- 132 (229)
T KOG3087|consen 54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN- 132 (229)
T ss_pred HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC-
Confidence 46678899999998644444333345566667799999987 4788888654322222333 67888899999999999
Q ss_pred CCCeeeCCCCcceEEECCCC---cEEEeecCCcccc
Q 038168 589 ETQIIHCDIKPQNILMDENR---CAKISDFGLAKLM 621 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~---~~ki~DfGla~~~ 621 (757)
.|+|+||..+||+|..++ .+.++|||++...
T Consensus 133 --diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 133 --DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred --CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999999999999996553 4689999998754
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.3e-06 Score=76.92 Aligned_cols=85 Identities=26% Similarity=0.587 Sum_probs=61.0
Q ss_pred EeccCCCEEEecCCCCceeEEecCCCc---ceeEEEecCCCEEEEecCCceeeeccCCCccccCCCCcccCCCcccccCC
Q 038168 100 LFNSEGSIVLRSSQQSQDSLIADDSQS---ASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGIS 176 (757)
Q Consensus 100 ~~~~~G~Lvl~~~~~~~~~~~~~~~~~---~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg~kl~~~~~L~S~~s 176 (757)
....||++|+........+|++++... ...+.|.++|||||++.++.++|+| .|.
T Consensus 25 ~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S---~t~------------------- 82 (114)
T smart00108 25 IMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSS---NTT------------------- 82 (114)
T ss_pred CCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEe---ccc-------------------
Confidence 344789999987643345676665322 2678899999999999989999998 111
Q ss_pred CCCCCCCceEEEecCCCCceeeeccCCCCccceEeecc
Q 038168 177 ETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASN 214 (757)
Q Consensus 177 ~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~ 214 (757)
...|.+.+.|+.+|+++++...+ .+.|.+.
T Consensus 83 ---~~~~~~~~~L~ddGnlvl~~~~~-----~~~W~Sf 112 (114)
T smart00108 83 ---GANGNYVLVLLDDGNLVIYDSDG-----NFLWQSF 112 (114)
T ss_pred ---CCCCceEEEEeCCCCEEEECCCC-----CEEeCCC
Confidence 12567899999999999875322 4778764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.1e-06 Score=84.76 Aligned_cols=109 Identities=24% Similarity=0.300 Sum_probs=85.6
Q ss_pred hHHHHHHHHHHHhhcC--CCceeeeeeEEEece----eeeEEEEeccCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTH--HRNLVRLLGYSLEVS----KKILVYEYMSNG-SLADILFNPEKQPNWVERMGIARDIARGIL 582 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~ 582 (757)
+.....+|...+.+|+ .-...+.+++..... ..+||+|++++. +|.+++..... ++-..+..++.++++.+.
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIA 132 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHH
Confidence 3445778888887774 334556677766532 458999999984 79998865322 555677889999999999
Q ss_pred HhhhCCCCCeeeCCCCcceEEECCCC---cEEEeecCCccccC
Q 038168 583 YLHDECETQIIHCDIKPQNILMDENR---CAKISDFGLAKLMK 622 (757)
Q Consensus 583 yLH~~~~~~iiH~Dik~~Nill~~~~---~~ki~DfGla~~~~ 622 (757)
-||.. +|+|+|+++.|||++.+. .+.++||+.++...
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999 999999999999999887 89999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.30 E-value=2.7e-06 Score=86.00 Aligned_cols=108 Identities=23% Similarity=0.317 Sum_probs=84.7
Q ss_pred HHHHHHHHHHHhhcCCC--ceeeeeeEEEece---eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRTHHR--NLVRLLGYSLEVS---KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~--niv~l~g~~~~~~---~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
...+.+|+++++.+++. ++.+++.+..+.. ..++||||+++.+|.+.+.. ..++...+..++.++++.|.+||
T Consensus 39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH 116 (223)
T cd05154 39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALH 116 (223)
T ss_pred cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHh
Confidence 44678999999999763 4577777776543 56899999999988876532 34677778888999999999998
Q ss_pred hCC-----------------------------------------------------CCCeeeCCCCcceEEECC--CCcE
Q 038168 586 DEC-----------------------------------------------------ETQIIHCDIKPQNILMDE--NRCA 610 (757)
Q Consensus 586 ~~~-----------------------------------------------------~~~iiH~Dik~~Nill~~--~~~~ 610 (757)
+.. ...++|+|+++.||+++. ++.+
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~ 196 (223)
T cd05154 117 SVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVV 196 (223)
T ss_pred CCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEE
Confidence 521 246799999999999998 6678
Q ss_pred EEeecCCccc
Q 038168 611 KISDFGLAKL 620 (757)
Q Consensus 611 ki~DfGla~~ 620 (757)
.|+||+.+..
T Consensus 197 ~iID~e~~~~ 206 (223)
T cd05154 197 AVLDWELATL 206 (223)
T ss_pred EEEecccccc
Confidence 9999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.27 E-value=7.3e-06 Score=92.74 Aligned_cols=107 Identities=15% Similarity=0.190 Sum_probs=68.2
Q ss_pred HHHHHHHHHHHhhcC----CCceeeeeeEEEe-ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHH-HHHHh
Q 038168 511 EREFQTEMKVIGRTH----HRNLVRLLGYSLE-VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIAR-GILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~----h~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~-gL~yL 584 (757)
|-+|.+|+..+.+++ +.+.+.+=..+.+ ..+.+|||||++++.|.++-.-.....+ +..++...++ -+..+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d---~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD---MKLLAERGVEVFFTQV 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC---HHHHHHHHHHHHHHHH
Confidence 345777777776663 5555554444433 4568899999999999875211111111 1122222222 12223
Q ss_pred hhCCCCCeeeCCCCcceEEECCCC----cEEEeecCCccccCC
Q 038168 585 HDECETQIIHCDIKPQNILMDENR----CAKISDFGLAKLMKP 623 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~----~~ki~DfGla~~~~~ 623 (757)
+.. +++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 277 f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 344 999999999999999888 999999999976543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.17 E-value=5e-06 Score=81.34 Aligned_cols=101 Identities=23% Similarity=0.311 Sum_probs=66.7
Q ss_pred HHHHHHHHHHHhhcCCC--ceeeeeeEEEeceeeeEEEEecc--CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh-h
Q 038168 511 EREFQTEMKVIGRTHHR--NLVRLLGYSLEVSKKILVYEYMS--NGSLADILFNPEKQPNWVERMGIARDIARGILYL-H 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~--niv~l~g~~~~~~~~~lV~e~~~--~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL-H 585 (757)
.....+|.+.|.++..- ++.+++.+ +...|||||++ +..+..+.... ++......++.+++..+..+ |
T Consensus 52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~----~~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~ 124 (188)
T PF01163_consen 52 REWAKKEFRNLKRLYEAGVPVPKPYDY----NRNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH 124 (188)
T ss_dssp HHHHHHHHHHHHHCCCTT-SS--EEEE----ETTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCccCCcEEEE----eCCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH
Confidence 34567899999999765 56666644 34579999999 55554433221 11223455777777766664 6
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccC
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK 622 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~ 622 (757)
.. +|+|+|+.+.|||++++ .+.|+|||.+....
T Consensus 125 ~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 125 KA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp CT---TEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred hc---CceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 76 99999999999999988 99999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.9e-05 Score=83.36 Aligned_cols=168 Identities=14% Similarity=0.197 Sum_probs=114.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccc
Q 038168 564 QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEW 643 (757)
Q Consensus 564 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~ 643 (757)
..+|.-.++.++.+|.+.+-||.. +.+-+|+.++|+|+.++..+.|.|-..-.+-.. .......+|...|.+||.
T Consensus 113 ~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n--g~~~~cpVg~~eftPPEl 187 (637)
T COG4248 113 HCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN--GTLHLCPVGVSEFTPPEL 187 (637)
T ss_pred ccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeeccC--CceEecccCccccCCHHH
Confidence 458999999999999999999998 999999999999999999999987543332211 122233568889999996
Q ss_pred cc-----CCCCCccccchhhHHHHHHHHhC-CCCCCCCCCCc--cccHHHHHHHHHhcCCcccccc--------ccccC-
Q 038168 644 HR-----NLPITVKADVYSFGVVLLEIICR-RRCLDPNLPDD--QVILEEWVYQCFENGNLSQLVE--------DEEVD- 706 (757)
Q Consensus 644 ~~-----~~~~~~k~Dv~S~G~~l~elltG-~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d--------~~~~~- 706 (757)
-. +-.-+...|.|.+|+++++++-| ++|+.+..... .-.+. ..+..|.+...-+ +...+
T Consensus 188 Q~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E----~~Ia~g~f~ya~~~~~g~~p~P~~~P~ 263 (637)
T COG4248 188 QTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE----TDIAHGRFAYASDQRRGLKPPPRSIPL 263 (637)
T ss_pred hccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch----hhhhcceeeechhccCCCCCCCCCCCh
Confidence 43 44567899999999999999887 88887543211 10110 0111122111111 11111
Q ss_pred HHHHHHHHHHHHHcccc--CCCCCCCHHHHHHHhhc
Q 038168 707 EKQLERMIKVALWCILD--EPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 707 ~~~~~~l~~l~~~cl~~--~p~~RPsm~eVl~~Le~ 740 (757)
.-....+..+..+|... ++.-|||.+-.+..|..
T Consensus 264 ~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 264 SMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred hhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 12234566777788765 46789999988887764
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.3e-06 Score=69.98 Aligned_cols=69 Identities=23% Similarity=0.394 Sum_probs=51.7
Q ss_pred cceeeeccCCCCCcceeecccchhhhHHHHhhc-CCcccccccc--CCcccccc-cccccccccccCCCceEE
Q 038168 343 KAIRELKNTKWEDVSYYVLSETTEEKCKQACLE-DCNCEAALFK--EEECKMQR-LPLRFGRRNLRDSSIAFV 411 (757)
Q Consensus 343 ~~f~~l~~~~~p~~~~~~~~~~s~~~C~~~Cl~-nCsC~a~~~~--~~~C~~~~-~~l~~~~~~~~~~~~~yl 411 (757)
..|..++++.+++.........+.++|++.|++ +|+|.|+.|. ++.|.+|. .++.+.......+.+.|.
T Consensus 4 ~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~~~~~~~~~~y~ 76 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDARLFPSGGVDLYE 76 (78)
T ss_pred ceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccceecccCCceeEE
Confidence 468889999998765544455689999999999 9999999997 56799998 666666533334444444
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.3e-05 Score=78.77 Aligned_cols=104 Identities=22% Similarity=0.274 Sum_probs=84.6
Q ss_pred HHHHHHHhhcCC-CceeeeeeEEEeceeeeEEEEeccCCChhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 515 QTEMKVIGRTHH-RNLVRLLGYSLEVSKKILVYEYMSNGSLADILF--NPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 515 ~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
.+|.-+++.+++ +++.+++|+|- .++|.||.+.+++...-. ..-...+|.+|.+||.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888999976 69999999993 478999999876653210 01134689999999999999999999865557
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMK 622 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~ 622 (757)
+.-+|++++|+-+++++.+|+.|...+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8899999999999999999999998876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.93 E-value=6.4e-05 Score=74.11 Aligned_cols=109 Identities=17% Similarity=0.131 Sum_probs=84.8
Q ss_pred CchHHHHHHHHHHHhhcCCC--ceeeeeeEEE-ec----eeeeEEEEeccC-CChhhhhcCCC-CCCCHHHHHHHHHHHH
Q 038168 508 SSGEREFQTEMKVIGRTHHR--NLVRLLGYSL-EV----SKKILVYEYMSN-GSLADILFNPE-KQPNWVERMGIARDIA 578 (757)
Q Consensus 508 ~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~-~~----~~~~lV~e~~~~-gsL~~~l~~~~-~~l~~~~~~~i~~~ia 578 (757)
.+|+..|.+|+..|.+|... .+.+.. ++. .. -..+||+|-+++ -+|.+++.+.. ..++...+..++.+++
T Consensus 60 P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va 138 (216)
T PRK09902 60 PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVA 138 (216)
T ss_pred CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHH
Confidence 45788899999999999533 355555 333 21 246899997764 58998885432 4567778889999999
Q ss_pred HHHHHhhhCCCCCeeeCCCCcceEEECCCCc--EEEeecCCccc
Q 038168 579 RGILYLHDECETQIIHCDIKPQNILMDENRC--AKISDFGLAKL 620 (757)
Q Consensus 579 ~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~--~ki~DfGla~~ 620 (757)
+.|.-||.. ++.|+|+.+.||+++.++. ++++||--++.
T Consensus 139 ~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 139 LAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 999999999 9999999999999986666 99999977664
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00025 Score=70.31 Aligned_cols=68 Identities=29% Similarity=0.376 Sum_probs=54.2
Q ss_pred eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCcc
Q 038168 540 SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK 619 (757)
Q Consensus 540 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~ 619 (757)
...+|||||++|..|.++.. ++. .++..+++++.-||+. |+.|+|++|+|+++++++ +++.||+..+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred eEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 35579999999988877541 111 2556677889999998 999999999999999665 8999998776
Q ss_pred c
Q 038168 620 L 620 (757)
Q Consensus 620 ~ 620 (757)
.
T Consensus 183 ~ 183 (229)
T PF06176_consen 183 M 183 (229)
T ss_pred c
Confidence 4
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0011 Score=59.29 Aligned_cols=98 Identities=19% Similarity=0.335 Sum_probs=66.3
Q ss_pred eeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecC-CCCCCCCCceeEeccCCCEEEecCCCCceeEEecCC
Q 038168 46 SWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANR-DDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDS 124 (757)
Q Consensus 46 ~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr-~~P~~~~~~~l~~~~~G~Lvl~~~~~~~~~~~~~~~ 124 (757)
.+.+.+|.+.|-|-..|+ |-|.. ...+++|..+. ...- .....+.|..+|||||.+.. +...|.+...
T Consensus 13 p~~~~s~~~~L~l~~dGn------Lvl~~---~~~~~iWss~~t~~~~-~~~~~~~L~~~GNlvl~d~~-~~~lW~Sf~~ 81 (114)
T PF01453_consen 13 PLTSSSGNYTLILQSDGN------LVLYD---SNGSVIWSSNNTSGRG-NSGCYLVLQDDGNLVLYDSS-GNVLWQSFDY 81 (114)
T ss_dssp EEEECETTEEEEEETTSE------EEEEE---TTTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETT-SEEEEESTTS
T ss_pred ccccccccccceECCCCe------EEEEc---CCCCEEEEecccCCcc-ccCeEEEEeCCCCEEEEeec-ceEEEeecCC
Confidence 454555889999987765 55543 33678999943 2221 15688999999999999865 6667777655
Q ss_pred CcceeEEEec--CCCEEEEecCCceeeeccCCC
Q 038168 125 QSASSASMLD--SGNFVLYDSNGKTLWQTFEHP 155 (757)
Q Consensus 125 ~~~~~a~Lld--sGNlVl~~~~~~~lWQSFD~P 155 (757)
.+.+....++ .||++ ......+.|.|=+.|
T Consensus 82 ptdt~L~~q~l~~~~~~-~~~~~~~sw~s~~dp 113 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GKNDSLTSWSSNTDP 113 (114)
T ss_dssp SS-EEEEEET--TSEEE-EESTSSEEEESS---
T ss_pred CccEEEeccCcccCCCc-cccceEEeECCCCCC
Confidence 5667777777 89998 666678999986665
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.53 E-value=4e-05 Score=85.11 Aligned_cols=152 Identities=20% Similarity=0.116 Sum_probs=116.1
Q ss_pred HHHHHHHHHHhhcCCCc-eeeeeeEEEeceeeeEEEEeccCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 512 REFQTEMKVIGRTHHRN-LVRLLGYSLEVSKKILVYEYMSNG-SLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+-++++|.+++||| .++.++-+..++..+++++++..+ +-..-.......+...+...+.+.-+++|++||+.
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~-- 355 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS-- 355 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccc--
Confidence 45567899999999999 777788788888889999999887 33222222223344455556777788999999986
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
.-+|+| ||+..+ ...|..||+....+.+.. ......++..++|||+..+..+..+.|+|+.+.-..++--|-
T Consensus 356 -~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~ 427 (829)
T KOG0576|consen 356 -YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGL 427 (829)
T ss_pred -cccCcc----cccccc-cccccccccCCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCC
Confidence 568998 776665 678999999988765543 233467899999999999999999999999998777777776
Q ss_pred CCCC
Q 038168 670 RCLD 673 (757)
Q Consensus 670 ~p~~ 673 (757)
+|..
T Consensus 428 pPr~ 431 (829)
T KOG0576|consen 428 PPRS 431 (829)
T ss_pred CCCC
Confidence 6654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0023 Score=64.97 Aligned_cols=104 Identities=15% Similarity=0.150 Sum_probs=65.7
Q ss_pred HHHHHHHHHHHhhcCCCc--eeeeeeEEEeceeeeEEEEeccCCC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh--
Q 038168 511 EREFQTEMKVIGRTHHRN--LVRLLGYSLEVSKKILVYEYMSNGS-LADILFNPEKQPNWVERMGIARDIARGILYLH-- 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~e~~~~gs-L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH-- 585 (757)
.....+|.++++.+..-. +.+.+++....+...+|||+++|.. +...+.. +......++..+++.+.-||
T Consensus 36 ~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~-----~~~~~~~l~~~la~~l~~lH~~ 110 (226)
T TIGR02172 36 KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISD-----NPSRLEEIAKIFAEMAKKLHST 110 (226)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcC-----CHHHHHHHHHHHHHHHHHHhCC
Confidence 345688999999986444 4677888877777889999999963 2222110 00111112222222222222
Q ss_pred -------------------------------------hC-CCCCeeeCCCCcceEEECCCCcEEEeecCCccc
Q 038168 586 -------------------------------------DE-CETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620 (757)
Q Consensus 586 -------------------------------------~~-~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~ 620 (757)
.. ..+.++|+|+.|.||++++++ +.|+||+.+..
T Consensus 111 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 111 KCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 11 134678999999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0021 Score=66.10 Aligned_cols=109 Identities=15% Similarity=0.140 Sum_probs=66.3
Q ss_pred HHHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhhc-------------------CCC--C-CCC--
Q 038168 512 REFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF-------------------NPE--K-QPN-- 566 (757)
Q Consensus 512 ~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~-------------------~~~--~-~l~-- 566 (757)
.++.+|+++++.+. +--+.+++++....+..++|||++++.+|..... .-. . ...
T Consensus 36 ~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~ 115 (244)
T cd05150 36 YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRR 115 (244)
T ss_pred cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchh
Confidence 35677888888883 4446677887776667899999999987764421 000 0 000
Q ss_pred HHHHHHHHHH--------------------HHHHHHHhhhC----CCCCeeeCCCCcceEEECCCCcEEEeecCCccc
Q 038168 567 WVERMGIARD--------------------IARGILYLHDE----CETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620 (757)
Q Consensus 567 ~~~~~~i~~~--------------------ia~gL~yLH~~----~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~ 620 (757)
...++..... +...+..|-.. ..+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus 116 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 116 LDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred HHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 0011100000 11111222111 135689999999999999988889999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0021 Score=65.17 Aligned_cols=99 Identities=18% Similarity=0.207 Sum_probs=68.8
Q ss_pred HHHHHHHHHHHhhcCCC--ceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHHR--NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~--niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.....+|.++|.+|... .+.+.++ .+...+||||+++--|...-- ...+.. .|+..|++-+.-+-..
T Consensus 153 Rl~A~rEf~~L~~L~~~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~r~---~~en~~---~il~~il~~~~~~~~~- 221 (304)
T COG0478 153 RLAAEREFEALQRLYPEGVKVPKPIA----WNRHAVVMEYIEGVELYRLRL---DVENPD---EILDKILEEVRKAYRR- 221 (304)
T ss_pred HHHHHHHHHHHHHhhhcCCCCCCccc----cccceeeeehcccceeecccC---cccCHH---HHHHHHHHHHHHHHHc-
Confidence 45567899999999655 6666654 345679999999976654321 122222 3334444444433344
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccC
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK 622 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~ 622 (757)
+|||+|+.+-||++++|+.+.++||-.+....
T Consensus 222 --GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 222 --GIVHGDLSEFNILVTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred --CccccCCchheEEEecCCCEEEEeCcccccCC
Confidence 99999999999999999999999998776543
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.00075 Score=55.17 Aligned_cols=47 Identities=19% Similarity=0.427 Sum_probs=35.5
Q ss_pred eccCCCCCcceeecccchhhhHHHHhhcCCcccccccc--CCccccccc
Q 038168 348 LKNTKWEDVSYYVLSETTEEKCKQACLEDCNCEAALFK--EEECKMQRL 394 (757)
Q Consensus 348 l~~~~~p~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~--~~~C~~~~~ 394 (757)
++++.+++.+.......+.++|++.|+.||+|.|+.|. .+.|+++..
T Consensus 9 ~~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~ 57 (73)
T cd01100 9 GSNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS 57 (73)
T ss_pred cCCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence 35666666555444455889999999999999999986 467987665
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0037 Score=70.62 Aligned_cols=109 Identities=20% Similarity=0.291 Sum_probs=71.9
Q ss_pred hHHHHHHHHHHHhhcC----CCceeeeeeEE-EeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHH-HHH
Q 038168 510 GEREFQTEMKVIGRTH----HRNLVRLLGYS-LEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARG-ILY 583 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~----h~niv~l~g~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~g-L~y 583 (757)
.|-++.+|..-+.+++ ...-+++=..+ .-..+..|+|||++|-.+.+.........+ +..++..++++ +..
T Consensus 204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f~~q 280 (517)
T COG0661 204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAFLRQ 280 (517)
T ss_pred HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHHHHH
Confidence 3446777777777663 22223332333 334678999999999999988533333444 22334333332 222
Q ss_pred hhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCC
Q 038168 584 LHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624 (757)
Q Consensus 584 LH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~ 624 (757)
+-.. ++.|.|.+|.||+++.++.+.+.|||+...+...
T Consensus 281 ~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 281 LLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHhc---CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 2223 9999999999999999999999999999876543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0062 Score=62.28 Aligned_cols=31 Identities=29% Similarity=0.573 Sum_probs=26.8
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccc
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKL 620 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~ 620 (757)
+.++|+|+.+.||+++++...-|.||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 4589999999999999877678999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0028 Score=71.35 Aligned_cols=108 Identities=21% Similarity=0.276 Sum_probs=67.3
Q ss_pred hHHHHHHHHHHHhhc----CCCc------eeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRT----HHRN------LVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIAR 579 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l----~h~n------iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~ 579 (757)
.|-+|.+|.+-..+. +|-+ |.+++- .-...+.|+|||++|..+.+...-....++-. .|+..+.+
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~---~i~~~l~~ 311 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPH---DILNKLVE 311 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHH---HHHHHHHH
Confidence 344566666554443 4555 333322 22347899999999998877643233334433 33333333
Q ss_pred HHHHhhhCCCCCeeeCCCCcceEEECC----CCcEEEeecCCccccCCC
Q 038168 580 GILYLHDECETQIIHCDIKPQNILMDE----NRCAKISDFGLAKLMKPD 624 (757)
Q Consensus 580 gL~yLH~~~~~~iiH~Dik~~Nill~~----~~~~ki~DfGla~~~~~~ 624 (757)
+ |++.....|++|+|-+|.||++.. ++.+.+.|||+...+...
T Consensus 312 ~--~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 312 A--YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred H--HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2 222222238999999999999984 678999999999876543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0039 Score=74.39 Aligned_cols=197 Identities=17% Similarity=0.168 Sum_probs=132.2
Q ss_pred HHHHHHHHhhcCCCceeeeeeEEEeceee----eEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKK----ILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 514 ~~~E~~~l~~l~h~niv~l~g~~~~~~~~----~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..-|+..+.++.|+|+++++++..+.... .+..|++..-++.+.+.. ....+..+.+.+..++.+||.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~-- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSL-- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHh--
Confidence 34577788899999999999998765433 244667777777777754 34556777788899999999999997
Q ss_pred CCeeeCCCCcc---eEEECCCCcEEEe--ecCCccccCCCCcceecccccCccccCcccccCCCCCc--cccchhhHHHH
Q 038168 590 TQIIHCDIKPQ---NILMDENRCAKIS--DFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITV--KADVYSFGVVL 662 (757)
Q Consensus 590 ~~iiH~Dik~~---Nill~~~~~~ki~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--k~Dv~S~G~~l 662 (757)
...|.-+..+ +.-.+.++.+.++ ||+..+......... ....+..+.+||......... +.|+|.+|...
T Consensus 306 -~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 -SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred -ccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 4444444444 4445666777777 888887665433211 122345677788776665544 47999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
..+..|..+...... ...+++. .....+......|+..++++|++..+++...-
T Consensus 383 ~~~~~~~~i~~~~~~------------------~~~~l~~-----~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAV------------------PVSLLDV-----LSTSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred hhhhhcCcccccccc------------------hhhhhcc-----ccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 999988754332110 0011111 00114566777899999999999999998653
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.012 Score=71.62 Aligned_cols=111 Identities=18% Similarity=0.340 Sum_probs=68.5
Q ss_pred HHHHHHHHHHHhhcC-CCce--eeeeeEEEec---eeeeEEEEeccCCChhhh-----------------------hcCC
Q 038168 511 EREFQTEMKVIGRTH-HRNL--VRLLGYSLEV---SKKILVYEYMSNGSLADI-----------------------LFNP 561 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lV~e~~~~gsL~~~-----------------------l~~~ 561 (757)
...+.+|+++++.+. |.++ .+++++|.+. +..++||||+++..+.+- |+.-
T Consensus 82 ~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~v 161 (822)
T PLN02876 82 AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSA 161 (822)
T ss_pred HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCC
Confidence 356789999999995 6665 7888888764 367899999998654321 1110
Q ss_pred C----------CCCCH--------HHHHHH---------HHHHHHHHHHhhhCCC--------CCeeeCCCCcceEEECC
Q 038168 562 E----------KQPNW--------VERMGI---------ARDIARGILYLHDECE--------TQIIHCDIKPQNILMDE 606 (757)
Q Consensus 562 ~----------~~l~~--------~~~~~i---------~~~ia~gL~yLH~~~~--------~~iiH~Dik~~Nill~~ 606 (757)
. ....+ .....- ...+.+.+.+|..+.. +.++|+|+++.||+++.
T Consensus 162 d~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~ 241 (822)
T PLN02876 162 DVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHP 241 (822)
T ss_pred CchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcC
Confidence 0 00011 111000 1123334566644322 35999999999999985
Q ss_pred C--CcEEEeecCCcccc
Q 038168 607 N--RCAKISDFGLAKLM 621 (757)
Q Consensus 607 ~--~~~ki~DfGla~~~ 621 (757)
+ ...-|.||.++..-
T Consensus 242 ~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 242 TEDRVIGILDWELSTLG 258 (822)
T ss_pred CCCeEEEEEeeeccccC
Confidence 3 34579999988653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.026 Score=56.91 Aligned_cols=100 Identities=21% Similarity=0.306 Sum_probs=66.6
Q ss_pred HHHHHHHhhcC--CCceeeeeeEEEeceeeeEEEEeccCCCh-hhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 515 QTEMKVIGRTH--HRNLVRLLGYSLEVSKKILVYEYMSNGSL-ADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 515 ~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
.+|+.-|+++. +-.+.+-+++. +-.|||||+....+ .-.|.. -.+...+...+..++++.+.-|-.. .+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~--a~ 187 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKE--AG 187 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHh--cC
Confidence 35777777763 44444444443 34799999876421 111211 1122224566777788888877763 39
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~ 623 (757)
+||+||+.=|||+. ++.+.|+|+|-|....+
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECccccccCC
Confidence 99999999999999 88999999999976553
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.032 Score=56.38 Aligned_cols=111 Identities=21% Similarity=0.236 Sum_probs=60.1
Q ss_pred hHHHHHHHHHHHhhcCCC--ceeeeeeEEEece---eeeEEEEeccCCChhh----------------hh---cCC---C
Q 038168 510 GEREFQTEMKVIGRTHHR--NLVRLLGYSLEVS---KKILVYEYMSNGSLAD----------------IL---FNP---E 562 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~--niv~l~g~~~~~~---~~~lV~e~~~~gsL~~----------------~l---~~~---~ 562 (757)
....+.+|+.++..+... .+.+++.+..... ..+++|+++++..+.. .+ +.. .
T Consensus 33 ~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~ 112 (239)
T PF01636_consen 33 AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPF 112 (239)
T ss_dssp HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTC
T ss_pred CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccchhhhhhcccccccc
Confidence 346778899998888533 3566776554332 4689999999988877 11 011 1
Q ss_pred CCCCHHH---------HHHH------------HHHHHH-HHHHhhh----CCCCCeeeCCCCcceEEEC-CCCcEEEeec
Q 038168 563 KQPNWVE---------RMGI------------ARDIAR-GILYLHD----ECETQIIHCDIKPQNILMD-ENRCAKISDF 615 (757)
Q Consensus 563 ~~l~~~~---------~~~i------------~~~ia~-gL~yLH~----~~~~~iiH~Dik~~Nill~-~~~~~ki~Df 615 (757)
..+.+.. .... ...+.+ .+..+++ .....++|+|+.|.|||++ +++.+-|.||
T Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~ 192 (239)
T PF01636_consen 113 SPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDF 192 (239)
T ss_dssp CCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--G
T ss_pred cccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEec
Confidence 1111110 0000 111222 2333332 1345799999999999999 5565679999
Q ss_pred CCccc
Q 038168 616 GLAKL 620 (757)
Q Consensus 616 Gla~~ 620 (757)
+.+..
T Consensus 193 e~a~~ 197 (239)
T PF01636_consen 193 EDAGW 197 (239)
T ss_dssp TT-EE
T ss_pred ccceE
Confidence 88754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.086 Score=52.12 Aligned_cols=96 Identities=21% Similarity=0.264 Sum_probs=66.1
Q ss_pred hHHHHHHHHHHHhhcC------CCceeeeeeEEEeceeeeEEEEeccC------CChhhhhcCCCCCCCHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTH------HRNLVRLLGYSLEVSKKILVYEYMSN------GSLADILFNPEKQPNWVERMGIARDI 577 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~------h~niv~l~g~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~l~~~~~~~i~~~i 577 (757)
+.+++.+|+....++. +.+|.+++|+.+.....-+|+|.+.+ -+|.+++.+. .++. . +...+
T Consensus 54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~---~~~~L 127 (199)
T PF10707_consen 54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-E---LRQAL 127 (199)
T ss_pred hhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-H---HHHHH
Confidence 3455666666555554 88999999999998888999998765 2577777432 3333 2 33333
Q ss_pred HHHHHHhhhCCCCCeeeCCCCcceEEECCCC----cEEEee
Q 038168 578 ARGILYLHDECETQIIHCDIKPQNILMDENR----CAKISD 614 (757)
Q Consensus 578 a~gL~yLH~~~~~~iiH~Dik~~Nill~~~~----~~ki~D 614 (757)
-+-..||-+. .|+.+|++|.||++..+. .+.|+|
T Consensus 128 ~~f~~~l~~~---~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 128 DEFKRYLLDH---HIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHHHHHc---CCeecCCCcccEEEEecCCCceEEEEEe
Confidence 3445667666 899999999999995432 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.084 Score=56.00 Aligned_cols=44 Identities=14% Similarity=0.090 Sum_probs=34.4
Q ss_pred HHHHHHHHHHHhhcCC---CceeeeeeEEEec---eeeeEEEEeccCCCh
Q 038168 511 EREFQTEMKVIGRTHH---RNLVRLLGYSLEV---SKKILVYEYMSNGSL 554 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h---~niv~l~g~~~~~---~~~~lV~e~~~~gsL 554 (757)
...|..|...|+.|.. -.+.++++.|..+ +..+||||+++++++
T Consensus 51 ~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 51 PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 3578899999998853 3678888887643 568999999998765
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.079 Score=56.15 Aligned_cols=106 Identities=22% Similarity=0.253 Sum_probs=68.1
Q ss_pred HHHHHHHHHHHhhcCC--CceeeeeeEEEece--eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHH-HHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRTHH--RNLVRLLGYSLEVS--KKILVYEYMSNGSLADILFNPEKQPNWVERMGIA-RDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~-~~ia~gL~yLH 585 (757)
.....+|..+|+.+.- --..+.++.|.++. ..+.||+|.++..+.+.+..... . .+++ ..+++.|.-||
T Consensus 65 ~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~----~--~~~~~~~l~~~La~LH 138 (321)
T COG3173 65 AHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESL----G--RQFALDALADFLAELH 138 (321)
T ss_pred hhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccc----h--HHHHHHHHHHHHHHHh
Confidence 3455678888877743 23445677777666 66999999998544333321100 0 1111 24444444444
Q ss_pred --------------------------------------------------hCC-----CCCeeeCCCCcceEEECCCCcE
Q 038168 586 --------------------------------------------------DEC-----ETQIIHCDIKPQNILMDENRCA 610 (757)
Q Consensus 586 --------------------------------------------------~~~-----~~~iiH~Dik~~Nill~~~~~~ 610 (757)
... .+.++|+|+++.|++++.+.-+
T Consensus 139 ~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~ 218 (321)
T COG3173 139 SIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPT 218 (321)
T ss_pred CCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCee
Confidence 221 3579999999999999999889
Q ss_pred EEeecCCccccC
Q 038168 611 KISDFGLAKLMK 622 (757)
Q Consensus 611 ki~DfGla~~~~ 622 (757)
-|.||+++.+-.
T Consensus 219 gVlDwe~~~lGD 230 (321)
T COG3173 219 GVLDWELATLGD 230 (321)
T ss_pred EEEeccccccCC
Confidence 999999997643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.074 Score=55.04 Aligned_cols=30 Identities=20% Similarity=0.324 Sum_probs=26.3
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccc
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKL 620 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~ 620 (757)
..++|+|+.|.||++++++ +.|+||..+..
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 4689999999999999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.092 Score=53.47 Aligned_cols=31 Identities=26% Similarity=0.399 Sum_probs=27.3
Q ss_pred CCeeeCCCCcceEEECC-CCcEEEeecCCccc
Q 038168 590 TQIIHCDIKPQNILMDE-NRCAKISDFGLAKL 620 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~-~~~~ki~DfGla~~ 620 (757)
..++|+|+.+.|||+++ +..+.|+||..|..
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 47999999999999998 57899999988754
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.0038 Score=76.05 Aligned_cols=158 Identities=13% Similarity=0.052 Sum_probs=108.6
Q ss_pred HHHHHHHHhhcCCCceeeeeeEEE--eceeeeEEEEeccCCChhhhhcCCCCCC-CHH-HHHHHHHHH-HHHHHHhhhC-
Q 038168 514 FQTEMKVIGRTHHRNLVRLLGYSL--EVSKKILVYEYMSNGSLADILFNPEKQP-NWV-ERMGIARDI-ARGILYLHDE- 587 (757)
Q Consensus 514 ~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV~e~~~~gsL~~~l~~~~~~l-~~~-~~~~i~~~i-a~gL~yLH~~- 587 (757)
...|...+++..|+++.+...-.. +..+.+.+++|+..|.+.+.+.+..+.. +.. .-.....++ .....-+|..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344555566678888877554332 3346688999999999999987653322 111 111122222 3344444433
Q ss_pred -CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 588 -CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 588 -~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
...-.+|+++|+-|.+|..+..+|+.++|+.++..+.. .......+++-|+.|+......++.++|+|..|+-+++.-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchH-hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 23457899999999999999999999999998433222 2222355777899999999889999999999999999988
Q ss_pred hCCCCC
Q 038168 667 CRRRCL 672 (757)
Q Consensus 667 tG~~p~ 672 (757)
-|..++
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 776654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.66 E-value=0.084 Score=55.88 Aligned_cols=109 Identities=18% Similarity=0.270 Sum_probs=64.0
Q ss_pred HHHHHHHHHHhhcCCCc--eeeeeeE------EEeceeeeEEEEeccCCChhh----hh----------cC------CC-
Q 038168 512 REFQTEMKVIGRTHHRN--LVRLLGY------SLEVSKKILVYEYMSNGSLAD----IL----------FN------PE- 562 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~n--iv~l~g~------~~~~~~~~lV~e~~~~gsL~~----~l----------~~------~~- 562 (757)
++...|++++..+++.+ +.+++.. ....+..++|++++++..+.. .. +. ..
T Consensus 51 ~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~ 130 (296)
T cd05153 51 EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGER 130 (296)
T ss_pred HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccC
Confidence 45566777777774332 4444432 123345689999999877543 01 00 00
Q ss_pred ---CCCCHHHHHH----------HHHHHHHHHHHhhh----CCCCCeeeCCCCcceEEECCCCcEEEeecCCccc
Q 038168 563 ---KQPNWVERMG----------IARDIARGILYLHD----ECETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620 (757)
Q Consensus 563 ---~~l~~~~~~~----------i~~~ia~gL~yLH~----~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~ 620 (757)
....|..... ....+...+.++.. .....++|+|+.|.||+++++..+.|.||+.+..
T Consensus 131 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 131 NNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 1123332210 11223344555543 2245799999999999999987789999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.47 E-value=0.058 Score=59.48 Aligned_cols=48 Identities=27% Similarity=0.329 Sum_probs=36.4
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEece-eeeEEEEeccCCChhhhhcC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVS-KKILVYEYMSNGSLADILFN 560 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~e~~~~gsL~~~l~~ 560 (757)
.++....++++.+.|+|+...+.+..... ...+|+|++ +-||.+++..
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 34455678889999999999999887544 456788888 4588888744
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.37 E-value=0.29 Score=48.43 Aligned_cols=124 Identities=20% Similarity=0.201 Sum_probs=76.9
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
.-|+++.+++++++ .|++|..- +.-.+-++.|+|-.. .. ...-.|..+ ++.|.-.|+. ..+
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~-----------~i--~~~N~i~ag-i~~L~~fH~~-~~~ 163 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI-----------KI--NFSNFITAG-IKDLMDFHSE-NQH 163 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc-----------cc--chhHHHHHh-HHHHHHhhcc-CCC
Confidence 34667788888765 35666521 223455788877321 10 011112222 4677788865 568
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
.+|+|..|+||+-|..|.+||.|=+.... . +.-|.-- .....++++.+-+|=.-+++++...+
T Consensus 164 ~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~-----------~V~~vN~---~Y~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 164 CLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N-----------QVNMVNI---EYESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred eecCCCChhheeecCCCCEEecChhhhhh--h-----------eeeEEee---eccccChHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999654321 1 1112221 12346778888888888888876544
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.94 E-value=0.12 Score=54.90 Aligned_cols=72 Identities=18% Similarity=0.182 Sum_probs=56.4
Q ss_pred eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccc
Q 038168 541 KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620 (757)
Q Consensus 541 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~ 620 (757)
..|++|++. ++.|.. -+.-.|.+...|+.+.+.-+.-+..+ .+.-|||+.-.||||+ +|++-|+||-++|.
T Consensus 300 y~yl~~kdh-gt~is~-----ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 300 YLYLHFKDH-GTPISI-----IKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred EEEEEEecC-Cceeee-----eecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeeec
Confidence 345666654 333322 13347899999999999888888776 5889999999999999 99999999999995
Q ss_pred c
Q 038168 621 M 621 (757)
Q Consensus 621 ~ 621 (757)
-
T Consensus 371 ~ 371 (488)
T COG5072 371 S 371 (488)
T ss_pred c
Confidence 4
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=92.88 E-value=0.39 Score=52.10 Aligned_cols=32 Identities=34% Similarity=0.533 Sum_probs=27.4
Q ss_pred CCCeeeCCCCcceEEECC-CCcEEEeecCCccc
Q 038168 589 ETQIIHCDIKPQNILMDE-NRCAKISDFGLAKL 620 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~-~~~~ki~DfGla~~ 620 (757)
...++|+|+++.|||+++ ++.+.++||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 347899999999999986 47899999988864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=92.75 E-value=0.34 Score=50.78 Aligned_cols=31 Identities=35% Similarity=0.617 Sum_probs=26.0
Q ss_pred CCeeeCCCCcceEEECCCCc-EEEeecCCccc
Q 038168 590 TQIIHCDIKPQNILMDENRC-AKISDFGLAKL 620 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~-~ki~DfGla~~ 620 (757)
+.++|+|+++.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997554 56999998865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=90.50 E-value=0.19 Score=52.62 Aligned_cols=94 Identities=15% Similarity=0.169 Sum_probs=61.6
Q ss_pred HHHHHHHHhhcCC-C-ceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 514 FQTEMKVIGRTHH-R-NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 514 ~~~E~~~l~~l~h-~-niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
..+|+..|+.|.. . -+.+.++ .+..++|||++.+..|...-+ ..+..+.. ..+..-+.-|... |
T Consensus 157 a~kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~----v~d~~~ly---~~lm~~Iv~la~~---G 222 (465)
T KOG2268|consen 157 ATKEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH----VEDPPTLY---DDLMGLIVRLANH---G 222 (465)
T ss_pred HHHHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeee----cCChHHHH---HHHHHHHHHHHHc---C
Confidence 4568888888843 2 2344443 346689999998877765432 12222222 2222223334444 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCcccc
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLM 621 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~ 621 (757)
+||+|..-=||+++++..++++||--....
T Consensus 223 lIHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 223 LIHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred ceecccchheeEEecCCCEEEeechHhhcc
Confidence 999999999999999999999999765543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=90.01 E-value=0.91 Score=47.75 Aligned_cols=106 Identities=19% Similarity=0.315 Sum_probs=52.2
Q ss_pred hHHHHHHHHHHHhhcC---CCceeeeeeEEEeceeeeEEEEeccCC------------Chhhhhc-CCCCC---------
Q 038168 510 GEREFQTEMKVIGRTH---HRNLVRLLGYSLEVSKKILVYEYMSNG------------SLADILF-NPEKQ--------- 564 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~~~g------------sL~~~l~-~~~~~--------- 564 (757)
+...|..|.+-|+.|. --.+.+++++....+..+||+||++.+ .|..+-. .....
T Consensus 52 ~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~ 131 (288)
T PF03881_consen 52 GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYI 131 (288)
T ss_dssp GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEE
T ss_pred hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcc
Confidence 3456888888888883 455778899888777789999999876 1111111 11111
Q ss_pred ----------CCHHH-----HHHHHHHHH--------------HHHH-Hhhh-CCCCCeeeCCCCcceEEECCCCcEEEe
Q 038168 565 ----------PNWVE-----RMGIARDIA--------------RGIL-YLHD-ECETQIIHCDIKPQNILMDENRCAKIS 613 (757)
Q Consensus 565 ----------l~~~~-----~~~i~~~ia--------------~gL~-yLH~-~~~~~iiH~Dik~~Nill~~~~~~ki~ 613 (757)
-+|.+ |+.-..+.+ +.+. .|+. ...|-++|+||-+.|++.+.++.+.|.
T Consensus 132 G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~ 211 (288)
T PF03881_consen 132 GSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLF 211 (288)
T ss_dssp TTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-
T ss_pred cCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHHHHHHhcCCCCCceeeEcCccccceeecCCCCceee
Confidence 13432 222211111 1111 1222 125789999999999999999889988
Q ss_pred ec
Q 038168 614 DF 615 (757)
Q Consensus 614 Df 615 (757)
|=
T Consensus 212 DP 213 (288)
T PF03881_consen 212 DP 213 (288)
T ss_dssp S-
T ss_pred cc
Confidence 74
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=89.49 E-value=2.4 Score=42.49 Aligned_cols=102 Identities=21% Similarity=0.323 Sum_probs=65.5
Q ss_pred HHHHHHHHHHhhcC---CCceeeeeeEEEeceeeeEEEEeccCCChhhh-----------hcCC--CC------------
Q 038168 512 REFQTEMKVIGRTH---HRNLVRLLGYSLEVSKKILVYEYMSNGSLADI-----------LFNP--EK------------ 563 (757)
Q Consensus 512 ~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~-----------l~~~--~~------------ 563 (757)
..|..|+.-|..|. .-++.+++....+....|||+||++.+.++.. |+.. ..
T Consensus 53 ~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d~~~~~~~GqqLA~LH~~~~~~~fG~d~dn~iG~ 132 (286)
T COG3001 53 SMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLDAHSAFILGQQLARLHQWGGQAQFGLDFDNYIGT 132 (286)
T ss_pred HHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCCchhHHHHHHHHHHHHhhcCccccCcccccccCC
Confidence 56778887776663 45677888888899999999999999777611 1110 00
Q ss_pred -------CCCHH-----HHHHHHHHHH--------------HHHHHhhhCC--CCCeeeCCCCcceEEECCCCcEEEee
Q 038168 564 -------QPNWV-----ERMGIARDIA--------------RGILYLHDEC--ETQIIHCDIKPQNILMDENRCAKISD 614 (757)
Q Consensus 564 -------~l~~~-----~~~~i~~~ia--------------~gL~yLH~~~--~~~iiH~Dik~~Nill~~~~~~ki~D 614 (757)
..+|. +|+-.-.|+| ..+.-+-.+. .|..+|+||-..|++...++ +.|.|
T Consensus 133 t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg~~f~did~~~~~v~elL~~hqpqPsLlHGDLW~gN~a~~~~G-Pv~fD 210 (286)
T COG3001 133 TPQPNTWQRRWATFFAEQRIGWQLQLARERGLTFGDIDAIVEKIQELLADHQPQPSLLHGDLWSGNCAFGKDG-PVIFD 210 (286)
T ss_pred CCCCCCCcchHHHHHHHhhhhHHHHHHHHhCCCccCHHHHHHHHHHHHhcCCCCcceeecccccccccccCCC-Ceeec
Confidence 11333 3333333333 2333332222 37899999999999999998 66655
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=89.30 E-value=0.54 Score=50.11 Aligned_cols=33 Identities=30% Similarity=0.499 Sum_probs=28.7
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccc
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~ 620 (757)
...+++|+|+++.||++++++...|.||+.+..
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 356899999999999999988778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=89.18 E-value=0.78 Score=48.65 Aligned_cols=33 Identities=24% Similarity=0.322 Sum_probs=28.8
Q ss_pred CCCCeeeCCCCcceEEECCC----CcEEEeecCCccc
Q 038168 588 CETQIIHCDIKPQNILMDEN----RCAKISDFGLAKL 620 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~----~~~ki~DfGla~~ 620 (757)
....++|+|+.+.|||++++ +.++++||..+..
T Consensus 177 ~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 177 SPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred CCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 45689999999999999985 8899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=89.14 E-value=1.4 Score=47.60 Aligned_cols=31 Identities=19% Similarity=0.326 Sum_probs=26.5
Q ss_pred CCeeeCCCCcceEEECC-CCcEEEeecCCccc
Q 038168 590 TQIIHCDIKPQNILMDE-NRCAKISDFGLAKL 620 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~-~~~~ki~DfGla~~ 620 (757)
....|+|+.+.|||+++ ++.++++||..|..
T Consensus 182 ~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 182 VVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred eEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 35799999999999975 57899999998864
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=88.63 E-value=1.9 Score=42.56 Aligned_cols=84 Identities=25% Similarity=0.430 Sum_probs=59.4
Q ss_pred HHHHHHHHHhhcC---CCce--eeeeeEEEec------------------eeeeEEEEeccCCChhhhhcCCCCCCCHHH
Q 038168 513 EFQTEMKVIGRTH---HRNL--VRLLGYSLEV------------------SKKILVYEYMSNGSLADILFNPEKQPNWVE 569 (757)
Q Consensus 513 ~~~~E~~~l~~l~---h~ni--v~l~g~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~ 569 (757)
-|..|....++|+ +.++ |+.+||..-. ..+-||.||.+... ..
T Consensus 100 PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~ 165 (207)
T PF13095_consen 100 PFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PL 165 (207)
T ss_pred hHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------cc
Confidence 5777888777774 4455 8888876321 12357888776533 11
Q ss_pred HHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCc
Q 038168 570 RMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLA 618 (757)
Q Consensus 570 ~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla 618 (757)
..+-+.+|.+-|..+|.. +|+-+|+|+.|.. .-||+|||.+
T Consensus 166 ~~~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 166 QIRDIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred chhHHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 233467788888999998 9999999999985 4689999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.33 E-value=0.8 Score=49.00 Aligned_cols=33 Identities=27% Similarity=0.404 Sum_probs=28.1
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccc
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~ 620 (757)
...+++|+|++|.||+++++...-|+||+.+..
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 345899999999999999776678999998853
|
|
| >smart00223 APPLE APPLE domain | Back alignment and domain information |
|---|
Probab=87.54 E-value=0.48 Score=39.19 Aligned_cols=46 Identities=17% Similarity=0.422 Sum_probs=36.2
Q ss_pred eccCCCCCcceeecccchhhhHHHHhhcCCcccccccc--CC---cccccc
Q 038168 348 LKNTKWEDVSYYVLSETTEEKCKQACLEDCNCEAALFK--EE---ECKMQR 393 (757)
Q Consensus 348 l~~~~~p~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~--~~---~C~~~~ 393 (757)
.+++++++.+.......+.++|++.|..+=.|.++.|. +. .|+++.
T Consensus 6 ~~~~df~G~Dl~~~~~~~~~~Cq~~Ct~~~~C~~FTf~~~~~~~~~C~LK~ 56 (79)
T smart00223 6 YKNVDFRGSDINTVYVPSAQVCQKRCTSHPRCLFFTFSTNEPPEEKCLLKD 56 (79)
T ss_pred ccCccccCceeeeeecCCHHHHHHhhcCCCCccEEEeeCCCCCCCEeEeCc
Confidence 35677887777666677899999999999999999985 33 576554
|
Four-fold repeat in plasma kallikrein and coagulation factor XI. Factor XI apple 3 mediates binding to platelets. Factor XI apple 1 binds high-molecular-mass kininogen. Apple 4 in factor XI mediates dimer formation and binds to factor XIIa. Mutations in apple 4 cause factor XI deficiency, an inherited bleeding disorder. |
| >PF14295 PAN_4: PAN domain; PDB: 2YIL_E 2YIP_C 2YIO_A | Back alignment and domain information |
|---|
Probab=86.78 E-value=0.37 Score=35.76 Aligned_cols=25 Identities=32% Similarity=0.741 Sum_probs=17.4
Q ss_pred ccchhhhHHHHhhcCCccccccccC
Q 038168 362 SETTEEKCKQACLEDCNCEAALFKE 386 (757)
Q Consensus 362 ~~~s~~~C~~~Cl~nCsC~a~~~~~ 386 (757)
...+.++|++.|..+=.|.++.|..
T Consensus 14 ~~~s~~~C~~~C~~~~~C~~~~~~~ 38 (51)
T PF14295_consen 14 TASSPEECQAACAADPGCQAFTFNP 38 (51)
T ss_dssp ----HHHHHHHHHTSTT--EEEEET
T ss_pred cCCCHHHHHHHccCCCCCCEEEEEC
Confidence 4558899999999999999998864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 757 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-40 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-40 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-31 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-29 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-29 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-29 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-05 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 331 bits (852), Expect = e-108
Identities = 108/290 (37%), Positives = 157/290 (54%), Gaps = 36/290 (12%)
Query: 487 SFSYAELEKMTDGFKEE--VGRG--------------------------SSGEREFQTEM 518
FS EL+ +D F + +GRG GE +FQTE+
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78
Query: 519 KVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP---NWVERMGIAR 575
++I HRNL+RL G+ + ++++LVY YM+NGS+A L + +W +R IA
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 576 DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGT 635
ARG+ YLHD C+ +IIH D+K NIL+DE A + DFGLAKLM T T +RGT
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 198
Query: 636 RGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLP--DDQVILEEWVYQCFEN 693
G++APE+ + K DV+ +GV+LLE+I +R D DD V+L +WV +
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 694 GNLSQLVE---DEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740
L LV+ ++++E++I+VAL C P RP M +V+ MLEG
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = 1e-99
Identities = 102/312 (32%), Positives = 156/312 (50%), Gaps = 37/312 (11%)
Query: 467 SYRRIPGNGSARYCEDIAPLSFSYAELEKMTDGFKEE--VGRG----------------- 507
+ I S+ Y +LE+ T+ F + +G G
Sbjct: 8 ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVA 67
Query: 508 ------SS--GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF 559
S G EF+TE++ + H +LV L+G+ E ++ IL+Y+YM NG+L L+
Sbjct: 68 LKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY 127
Query: 560 NPEKQP---NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFG 616
+ +W +R+ I ARG+ YLH IIH D+K NIL+DEN KI+DFG
Sbjct: 128 GSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184
Query: 617 LAKLM-KPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPN 675
++K + DQT T ++GT GY+ PE+ +T K+DVYSFGVVL E++C R + +
Sbjct: 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244
Query: 676 LPDDQVILEEWVYQCFENGNLSQLVE---DEEVDEKQLERMIKVALWCILDEPSLRPSMK 732
LP + V L EW + NG L Q+V+ +++ + L + A+ C+ RPSM
Sbjct: 245 LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMG 304
Query: 733 KVLLMLEGTVEI 744
VL LE + +
Sbjct: 305 DVLWKLEYALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 297 bits (764), Expect = 2e-95
Identities = 104/297 (35%), Positives = 144/297 (48%), Gaps = 50/297 (16%)
Query: 487 SFSYAELEKMTDGFKEE--------VGRG----------------------------SSG 510
SFS+ EL+ +T+ F E +G G
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEEL 73
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP--NWV 568
+++F E+KV+ + H NLV LLG+S + LVY YM NGSL D L + P +W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 569 ERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM-KPDQTR 627
R IA+ A GI +LH+ IH DIK NIL+DE AKISDFGLA+ K QT
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 628 TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWV 687
+ I GT Y+APE R IT K+D+YSFGVVLLEII +D + +L +
Sbjct: 191 MTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLLDIK 247
Query: 688 YQCF-ENGNLSQLVED---EEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740
+ E + + D + D +E M VA C+ ++ + RP +KKV +L+
Sbjct: 248 EEIEDEEKTIEDYI-DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 7e-66
Identities = 65/305 (21%), Positives = 115/305 (37%), Gaps = 53/305 (17%)
Query: 486 LSFSYAELEKMTDGFK--EEVGRGSSGE-----------------------REFQTEMKV 520
+ L + + E RG G + + E+
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYS 71
Query: 521 IGRTHHRNLVRLLGYSLEVSK----KILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
+ H N+++ +G + L+ + GSL+D L +W E IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAET 129
Query: 577 IARGILYLHDECETQ-------IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
+ARG+ YLH++ I H DIK +N+L+ N A I+DFGLA + ++
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 630 T-GIRGTRGYVAPE-----WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVIL 683
T G GTR Y+APE + ++ D+Y+ G+VL E+ R D + + +
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 684 EEWVYQCFENGNLSQLVEDEEVD---------EKQLERMIKVALWCILDEPSLRPSMKKV 734
EE + Q ++ ++V ++ + + + C + R S V
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309
Query: 735 LLMLE 739
+
Sbjct: 310 GERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 4e-55
Identities = 79/317 (24%), Positives = 135/317 (42%), Gaps = 48/317 (15%)
Query: 464 HVGSYRRIPGNGSARYCEDIAPLSFSYAELE-KMTD-GFKEEVGRGSSGE---------- 511
H + + + +++ D KE++G GS G
Sbjct: 3 HHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSD 62
Query: 512 ----------------REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLA 555
EF E+ ++ R H N+V +G + +V EY+S GSL
Sbjct: 63 VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 556 DILFNPE--KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKIS 613
+L +Q + R+ +A D+A+G+ YLH I+H ++K N+L+D+ K+
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVC 181
Query: 614 DFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLD 673
DFGL++L K + GT ++APE R+ P K+DVYSFGV+L E+ +
Sbjct: 182 DFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ---Q 237
Query: 674 P--NLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731
P NL QV+ +L ++ + + +I+ C +EP RPS
Sbjct: 238 PWGNLNPAQVV-----AAVGFKC--KRLEIPRNLNPQ-VAAIIE---GCWTNEPWKRPSF 286
Query: 732 KKVLLMLEGTVEIPIPP 748
++ +L ++ +PP
Sbjct: 287 ATIMDLLRPLIKSAVPP 303
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-53
Identities = 68/332 (20%), Positives = 118/332 (35%), Gaps = 67/332 (20%)
Query: 486 LSFSYAELEKMTDGFK--EEVGRGSSGE---------------------REFQTEMKV-- 520
+ + +E D K E +GRG G + F E +
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYR 60
Query: 521 IGRTHHRNLVRLLGYSLEVS-----KKILVYEYMSNGSLADILFNPEKQPNWVERMGIAR 575
+ H N+ R + V+ + +LV EY NGSL L +WV +A
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAH 118
Query: 576 DIARGILYLHDE------CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD----- 624
+ RG+ YLH E + I H D+ +N+L+ + ISDFGL+ + +
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 625 --QTRTFTGIRGTRGYVAPE-------WHRNLPITVKADVYSFGVVLLEIICRRRCLDP- 674
+ GT Y+APE + D+Y+ G++ EI R L P
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 675 -NLPDDQVILEEWVYQCFENGNLSQLV----------EDEEVDEKQLERMIKVALWCILD 723
++P+ Q+ + V ++ LV E + + + + + C
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 724 EPSLRPSMKKVLLMLEG---TVEIPIPPNPTS 752
+ R + + + E +PT+
Sbjct: 299 DAEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-53
Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 47/275 (17%)
Query: 490 YAELEKMTDGFKEEVGRGSSGE----------------------REFQTEMKVIGRTHHR 527
Y E+E +E VGRG+ G + F E++ + R +H
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHP 61
Query: 528 NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP--NWVERMGIARDIARGILYLH 585
N+V+L G L LV EY GSL ++L E P M ++G+ YLH
Sbjct: 62 NIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 586 DECETQIIHCDIKPQNILMDEN-RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWH 644
+IH D+KP N+L+ KI DFG A D T +G+ ++APE
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVF 175
Query: 645 RNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEE 704
+ K DV+S+G++L E+I RR+ D + + V+ ++ +
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFD-EIGGPAFRIMWAVHNG------TRPPLIKN 228
Query: 705 VDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
+ + +E ++ C +PS RPSM++++ ++
Sbjct: 229 LPKP-IESLMT---RCWSKDPSQRPSMEEIVKIMT 259
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-50
Identities = 60/261 (22%), Positives = 103/261 (39%), Gaps = 42/261 (16%)
Query: 495 KMTDGFKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL 554
+ G E +EFQ E+ ++ +H N+V+L G +V E++ G L
Sbjct: 51 SLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDL 108
Query: 555 ADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDE-----NRC 609
L + W ++ + DIA GI Y+ + I+H D++ NI + C
Sbjct: 109 YHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVC 167
Query: 610 AKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPE--WHRNLPITVKADVYSFGVVLLEIIC 667
AK++DFGL++ + +G+ G ++APE T KAD YSF ++L I+
Sbjct: 168 AKVADFGLSQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT 223
Query: 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQL---------ERMIKVAL 718
P F+ + ++ + E+ L R+ V
Sbjct: 224 GE------GP-------------FDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIE 264
Query: 719 WCILDEPSLRPSMKKVLLMLE 739
C +P RP ++ L
Sbjct: 265 LCWSGDPKKRPHFSYIVKELS 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-50
Identities = 54/280 (19%), Positives = 107/280 (38%), Gaps = 58/280 (20%)
Query: 500 FKEEVGRGSSGE-------------------------REFQTEMKVIGRTHHRNLVRLLG 534
E +G+G G+ + F+ E+ +T H N+V +G
Sbjct: 37 IGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 535 YSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIH 594
+ ++ +L ++ + + + + IA++I +G+ YLH + I+H
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILH 153
Query: 595 CDIKPQNILMDENRCAKISDFGLAKLMK----PDQTRTFTGIRGTRGYVAPE-------- 642
D+K +N+ D + I+DFGL + + G ++APE
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 643 -WHRNLPITVKADVYSFGVVLLEIICRRRCLDP--NLPDDQVILEEWVYQCFENGNLSQL 699
LP + +DV++ G + E+ R P P + +I W +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREW---PFKTQPAEAII---WQMGT----GMKPN 262
Query: 700 VEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
+ + K++ ++ +C E RP+ K++ MLE
Sbjct: 263 LSQIGMG-KEISDILL---FCWAFEQEERPTFTKLMDMLE 298
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-50
Identities = 71/276 (25%), Positives = 114/276 (41%), Gaps = 50/276 (18%)
Query: 501 KEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN 560
KE + +R F E+KV+ H N+++ +G + + + EY+ G+L I+ +
Sbjct: 41 KELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS 100
Query: 561 PEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620
+ Q W +R+ A+DIA G+ YLH IIH D+ N L+ EN+ ++DFGLA+L
Sbjct: 101 MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARL 157
Query: 621 M-------------KPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
M K + + G ++APE K DV+SFG+VL EII
Sbjct: 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG 217
Query: 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERM----------IKVA 717
R DP+ + D ++ + +
Sbjct: 218 RVN-ADPDYLPRTM--------------------DFGLNVRGFLDRYCPPNCPPSFFPIT 256
Query: 718 LWCILDEPSLRPSMKKVLLMLEG---TVEIPIPPNP 750
+ C +P RPS K+ LE + +P P
Sbjct: 257 VRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGP 292
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-49
Identities = 72/269 (26%), Positives = 120/269 (44%), Gaps = 41/269 (15%)
Query: 500 FKEEVGRGSSGE-------------------------REFQTEMKVIGRTHHRNLVRLLG 534
+ +G GS G + F+ E+ V+ +T H N++ +G
Sbjct: 28 VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 535 YSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIH 594
YS I V ++ SL L E + + + IAR ARG+ YLH + IIH
Sbjct: 88 YSTAPQLAI-VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIH 143
Query: 595 CDIKPQNILMDENRCAKISDFGLAKLMKPDQ-TRTFTGIRGTRGYVAPEWHRN---LPIT 650
D+K NI + E+ KI DFGLA + F + G+ ++APE R P +
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 651 VKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQL 710
++DVY+FG+VL E++ + LP + + + + G+LS + +V
Sbjct: 204 FQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMVGRGSLSP--DLSKVRSNCP 255
Query: 711 ERMIKVALWCILDEPSLRPSMKKVLLMLE 739
+RM ++ C+ + RPS ++L +E
Sbjct: 256 KRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 2e-49
Identities = 69/285 (24%), Positives = 105/285 (36%), Gaps = 71/285 (24%)
Query: 500 FKEEVGRGSSGE----------------------------REFQTEMKVIGRTHHRNLVR 531
+E +G G G+ + E K+ H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 532 LLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591
L G L+ LV E+ G L +L K+ + A IARG+ YLHDE
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 592 IIHCDIKPQNILMDE--------NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEW 643
IIH D+K NIL+ + N+ KI+DFGLA+ + G ++APE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA---GAYAWMAPEV 185
Query: 644 HRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDE 703
R + +DV+S+GV+L E++ +P F + +
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGE------VP-------------FRGIDGLAVAYG- 225
Query: 704 EVDEKQL---------ERMIKVALWCILDEPSLRPSMKKVLLMLE 739
V +L E K+ C +P RPS +L L
Sbjct: 226 -VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 7e-47
Identities = 57/295 (19%), Positives = 110/295 (37%), Gaps = 82/295 (27%)
Query: 490 YAELEKMTDGFKEEVGRGSSGE--------------------------REFQTEMKVIGR 523
+ +L F ++ SGE R+F E +
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRI 63
Query: 524 THHRNLVRLLGYSLE--VSKKILVYEYMSNGSLADILFNPEKQP-NWVERMGIARDIARG 580
H N++ +LG L+ +M GSL ++L + + + A D+ARG
Sbjct: 64 FSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARG 123
Query: 581 ILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVA 640
+ +LH E I + +++++DE+ A+IS + + G +VA
Sbjct: 124 MAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVA 176
Query: 641 PEWHRNLP---ITVKADVYSFGVVLLEIICRRRCLDP--NLPDDQVILEEWVYQCFENG- 694
PE + P AD++SF V+L E++ R P +L + ++ + G
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTRE---VPFADLSNMEIG-----MKVALEGL 228
Query: 695 ----------NLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
++S+L++ C+ ++P+ RP ++ +LE
Sbjct: 229 RPTIPPGISPHVSKLMKI-----------------CMNEDPAKRPKFDMIVPILE 266
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 5e-45
Identities = 60/290 (20%), Positives = 111/290 (38%), Gaps = 53/290 (18%)
Query: 500 FKEEVGRGSSGE---------------------REFQTEMKV--IGRTHHRNLVRLLGYS 536
+++G+G GE + E ++ H N++ +
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 537 LEVSKKI----LVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ- 591
++ + L+ +Y NGSL D L + + + +A G+ +LH E +
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 592 ----IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF---TGIRGTRGYVAPE-- 642
I H D+K +NIL+ +N I+D GLA D GT+ Y+ PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 643 ----WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQ 698
+ + AD+YSFG++L E + RR + + Q+ + V ++ +
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWE-VARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277
Query: 699 LV---------EDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
+V + ++ L +M K+ C P+ R + +V L
Sbjct: 278 IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 61/290 (21%), Positives = 105/290 (36%), Gaps = 53/290 (18%)
Query: 500 FKEEVGRGSSGE---------------------REFQTEMKV--IGRTHHRNLVRLLGYS 536
E VG+G GE + + E ++ H N++ +
Sbjct: 12 LLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 537 LEVSKKI----LVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ- 591
+ L+ Y GSL D L + V + I IA G+ +LH E
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 592 ----IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR---TFTGIRGTRGYVAPEWH 644
I H D+K +NIL+ +N I+D GLA + + GT+ Y+APE
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 645 RNLPITV------KADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQ 698
+ D+++FG+VL E + RR + + D + + V ++ +
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWE-VARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248
Query: 699 LV---------EDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
+V + + L + K+ C PS R + ++ L
Sbjct: 249 VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-43
Identities = 61/290 (21%), Positives = 104/290 (35%), Gaps = 53/290 (18%)
Query: 500 FKEEVGRGSSGE---------------------REFQTEMKV--IGRTHHRNLVRLLGYS 536
+E +G+G GE R + E ++ H N++ +
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 537 LEVSKKI----LVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ- 591
+ + LV +Y +GSL D L + +A A G+ +LH E
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 592 ----IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF---TGIRGTRGYVAPE-- 642
I H D+K +NIL+ +N I+D GLA GT+ Y+APE
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 643 ----WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQ 698
++ +AD+Y+ G+V E I RR + D Q+ + V + +
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282
Query: 699 LV---------EDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
+V + + L M K+ C + R + ++ L
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-33
Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 4/177 (2%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP- 565
+ EF E V+ H NLV+LLG ++ E+M+ G+L D L +Q
Sbjct: 256 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 315
Query: 566 NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ 625
+ V + +A I+ + YL + IH ++ +N L+ EN K++DFGL++LM D
Sbjct: 316 SAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
Query: 626 TRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
G + + APE ++K+DV++FGV+L EI P + QV
Sbjct: 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 429
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-31
Identities = 56/179 (31%), Positives = 93/179 (51%), Gaps = 9/179 (5%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK--ILVYEYMSNGSLADILFNPE-K 563
G+ F E +V+ + H LV+L VS++ +V EYMS GSL D L K
Sbjct: 219 GTMSPEAFLQEAQVMKKLRHEKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGETGK 275
Query: 564 QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623
+ + +A IA G+ Y+ +H D++ NIL+ EN K++DFGLA+L++
Sbjct: 276 YLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332
Query: 624 DQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
++ G + + APE T+K+DV+SFG++L E+ + R P + + +V+
Sbjct: 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 391
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-31
Identities = 56/179 (31%), Positives = 93/179 (51%), Gaps = 9/179 (5%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK--ILVYEYMSNGSLADILFNPE-K 563
G+ F E +V+ + H LV+L VS++ +V EYMS GSL D L K
Sbjct: 302 GTMSPEAFLQEAQVMKKLRHEKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGETGK 358
Query: 564 QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623
+ + +A IA G+ Y+ +H D++ NIL+ EN K++DFGLA+L++
Sbjct: 359 YLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415
Query: 624 DQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
++ G + + APE T+K+DV+SFG++L E+ + R P + + +V+
Sbjct: 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 474
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 53/180 (29%), Positives = 91/180 (50%), Gaps = 11/180 (6%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPN 566
G+ E +F E +V+ + H LV+L G LE + LV E+M +G L+D L
Sbjct: 43 GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFA 102
Query: 567 WVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626
+G+ D+ G+ YL + +IH D+ +N L+ EN+ K+SDFG+ + + DQ
Sbjct: 103 AETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159
Query: 627 RTFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
+ TG ++ +PE + K+DV+SFGV++ E+ + N + +V+
Sbjct: 160 TSSTGTKFPVKWA----SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 215
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 46/180 (25%), Positives = 85/180 (47%), Gaps = 11/180 (6%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPN 566
GS E EF E KV+ H LV+L G + ++ EYM+NG L + L +
Sbjct: 59 GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ 118
Query: 567 WVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626
+ + + +D+ + YL + Q +H D+ +N L+++ K+SDFGL++ + D+
Sbjct: 119 TQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175
Query: 627 RTFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
+ G +R + PE + K+D+++FGV++ EI + + +
Sbjct: 176 TSSVGSKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 231
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 58/284 (20%), Positives = 109/284 (38%), Gaps = 60/284 (21%)
Query: 491 AELEKMTDGFKEEV-------GRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK- 542
+ D E+V G + + + E++++ +H N+V+ G E
Sbjct: 40 CRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99
Query: 543 -ILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQN 601
L+ E++ +GSL + L + + N +++ A I +G+ YL Q +H D+ +N
Sbjct: 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARN 156
Query: 602 ILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI------------ 649
+L++ KI DFGL K ++ D+ Y + R+ P+
Sbjct: 157 VLVESEHQVKIGDFGLTKAIETDKE----------YYTVKD-DRDSPVFWYAPECLMQSK 205
Query: 650 -TVKADVYSFGVVLLEII--CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVD 706
+ +DV+SFGV L E++ C L + + L +++ +
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT---HGQMTVTRLVNTLKEGKR- 261
Query: 707 EKQLER-----------MIKVALWCILDEPSLRPSMKKVLLMLE 739
L M K C +PS R S + ++ E
Sbjct: 262 ---LPCPPNCPDEVYQLMRK----CWEFQPSNRTSFQNLIEGFE 298
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 2e-30
Identities = 48/180 (26%), Positives = 87/180 (48%), Gaps = 11/180 (6%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPN 566
GS E EF E + + + H LV+ G + +V EY+SNG L + L + K
Sbjct: 43 GSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLE 102
Query: 567 WVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626
+ + + D+ G+ +L Q IH D+ +N L+D + C K+SDFG+ + + DQ
Sbjct: 103 PSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159
Query: 627 RTFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
+ G ++ + APE + K+DV++FG+++ E+ + + +V+
Sbjct: 160 VSSVGTKFPVKWS----APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV 215
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-30
Identities = 55/183 (30%), Positives = 93/183 (50%), Gaps = 17/183 (9%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK--ILVYEYMSNGSLADILFNPEKQ 564
GS F E V+ H LV+L V+K+ ++ E+M+ GSL D L + E
Sbjct: 223 GSMSVEAFLAEANVMKTLQHDKLVKLHAV---VTKEPIYIITEFMAKGSLLDFLKSDEGS 279
Query: 565 P-NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623
+ + + IA G+ ++ + IH D++ NIL+ + KI+DFGLA++++
Sbjct: 280 KQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336
Query: 624 DQTRTFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDD 679
++ G I+ T APE T+K+DV+SFG++L+EI+ R P + +
Sbjct: 337 NEYTAREGAKFPIKWT----APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392
Query: 680 QVI 682
+VI
Sbjct: 393 EVI 395
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 57/256 (22%), Positives = 94/256 (36%), Gaps = 44/256 (17%)
Query: 505 GRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQ 564
+ +F E +++ + H N+VRL+G + +V E + G L +
Sbjct: 150 TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR 209
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+ + D A G+ YL IH D+ +N L+ E KISDFG+++
Sbjct: 210 LRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266
Query: 625 QTRTFTG-----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDD 679
G ++ T APE + ++DV+SFG++L E PNL +
Sbjct: 267 VYAASGGLRQVPVKWT----APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ 322
Query: 680 QVILEEWVYQCFENGNLSQLVEDEEVDEKQLERM----------IKVALWCILDEPSLRP 729
Q E+V E G R+ ++ C EP RP
Sbjct: 323 QTR--EFV----EKG----------------GRLPCPELCPDAVFRLMEQCWAYEPGQRP 360
Query: 730 SMKKVLLMLEGTVEIP 745
S + L+ +
Sbjct: 361 SFSTIYQELQSIRKRH 376
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-29
Identities = 64/292 (21%), Positives = 111/292 (38%), Gaps = 55/292 (18%)
Query: 481 EDIAPLSFSYAELEKMTDGFKEEVGRGSSGEREFQTE-------MKVIGRT--------- 524
+D S + K++ K+ +G G+ G ++ +K I
Sbjct: 9 QDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREV 68
Query: 525 -------HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDI 577
H N++R + + + E + +L + + + +E + + +
Sbjct: 69 QLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQT 127
Query: 578 ARGILYLHDECETQIIHCDIKPQNILMDE-----NRCAKISDFGLAKLMKPDQ--TRTFT 630
G+ +LH I+H D+KP NIL+ A ISDFGL K + + +
Sbjct: 128 TSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184
Query: 631 GIRGTRGYVAPE---WHRNLPITVKADVYSFGVVLLEIICR-RRCLDPNLPDDQVILEEW 686
G+ GT G++APE T D++S G V +I +L IL
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL-- 242
Query: 687 VYQCFENGNLSQLVEDEEVDE--KQL-ERMIKVALWCILDEPSLRPSMKKVL 735
+L L ++ D ++L E+MI + +P RPS K VL
Sbjct: 243 -----GACSLDCLHPEKHEDVIARELIEKMIAM-------DPQKRPSAKHVL 282
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 56/259 (21%), Positives = 106/259 (40%), Gaps = 48/259 (18%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK--ILVYEYMSNGSLADILFNPEKQ 564
R+F+ E++++ H N+V+ G ++ L+ EY+ GSL D L +++
Sbjct: 51 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 110
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+ ++ + I +G+ YL + IH D+ +NIL++ KI DFGL K++ D
Sbjct: 111 IDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167
Query: 625 QTRTFTGIRGTRGYVAPEWHRNLPI-------------TVKADVYSFGVVLLEIICRRRC 671
+ + E PI +V +DV+SFGVVL E+
Sbjct: 168 KE----------FFKVKE-PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 216
Query: 672 LDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLER-----------MIKVALWC 720
+ ++ +L +L+++ +L R M + C
Sbjct: 217 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG----RLPRPDGCPDEIYMIMTE----C 268
Query: 721 ILDEPSLRPSMKKVLLMLE 739
+ + RPS + + L ++
Sbjct: 269 WNNNVNQRPSFRDLALRVD 287
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-29
Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 17/183 (9%)
Query: 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQ 564
+ + + F E V+ + H NLV+LLG +E + +V EYM+ GSL D L + +
Sbjct: 225 KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 284
Query: 565 P-NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623
+ + D+ + YL +H D+ +N+L+ E+ AK+SDFGL K
Sbjct: 285 VLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---- 337
Query: 624 DQTRTFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDD 679
+ + T ++ T APE R + K+DV+SFG++L EI R P +P
Sbjct: 338 EASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 393
Query: 680 QVI 682
V+
Sbjct: 394 DVV 396
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 57/259 (22%), Positives = 106/259 (40%), Gaps = 48/259 (18%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK--ILVYEYMSNGSLADILFNPEKQ 564
R+F+ E++++ H N+V+ G ++ L+ EY+ GSL D L +++
Sbjct: 82 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 141
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+ ++ + I +G+ YL + IH D+ +NIL++ KI DFGL K++ D
Sbjct: 142 IDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198
Query: 625 QTRTFTGIRGTRGYVAPEWHRNLPI-------------TVKADVYSFGVVLLEIICRRRC 671
+ Y E PI +V +DV+SFGVVL E+
Sbjct: 199 KE----------YYKVKE-PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 247
Query: 672 LDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLER-----------MIKVALWC 720
+ ++ +L +L+++ +L R M + C
Sbjct: 248 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG----RLPRPDGCPDEIYMIMTE----C 299
Query: 721 ILDEPSLRPSMKKVLLMLE 739
+ + RPS + + L ++
Sbjct: 300 WNNNVNQRPSFRDLALRVD 318
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 56/181 (30%), Positives = 86/181 (47%), Gaps = 12/181 (6%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP- 565
+ EF E V+ H NLV+LLG ++ E+M+ G+L D L +Q
Sbjct: 49 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 108
Query: 566 NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ 625
+ V + +A I+ + YL + IH D+ +N L+ EN K++DFGL++LM D
Sbjct: 109 SAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
Query: 626 TRTFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQV 681
G I+ T APE ++K+DV++FGV+L EI P + QV
Sbjct: 166 YTAHAGAKFPIKWT----APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 221
Query: 682 I 682
Sbjct: 222 Y 222
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 65/284 (22%), Positives = 107/284 (37%), Gaps = 62/284 (21%)
Query: 491 AELEKMTDGFKEEV-------GRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK- 542
+ DG E V G ++ E+ ++ +H ++++ G +
Sbjct: 50 YCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109
Query: 543 -ILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQN 601
LV EY+ GSL D L P + + A+ I G+ YLH IH D+ +N
Sbjct: 110 LQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARN 164
Query: 602 ILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI------------ 649
+L+D +R KI DFGLAK + Y E + P+
Sbjct: 165 VLLDNDRLVKIGDFGLAKAVPEGHE----------YYRVRE-DGDSPVFWYAPECLKEYK 213
Query: 650 -TVKADVYSFGVVLLEII--CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVD 706
+DV+SFGV L E++ C P + + + L++L+E E
Sbjct: 214 FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA---QGQMTVLRLTELLERGE-- 268
Query: 707 EKQLER-----------MIKVALWCILDEPSLRPSMKKVLLMLE 739
+L R M C E S RP+ + ++ +L+
Sbjct: 269 --RLPRPDKCPAEVYHLMKN----CWETEASFRPTFENLIPILK 306
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 64/261 (24%), Positives = 105/261 (40%), Gaps = 53/261 (20%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK--ILVYEYMSNGSLADILFNPEKQ 564
G +R+FQ E++++ H +V+ G S ++ LV EY+ +G L D L +
Sbjct: 64 GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR 123
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+ + + I +G+ YL + +H D+ +NIL++ KI+DFGLAKL+ D
Sbjct: 124 LDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180
Query: 625 QTRTFTGIRGTRGYVAPEWHRNLPI-------------TVKADVYSFGVVLLEII--CRR 669
+ YV E PI + ++DV+SFGVVL E+ C +
Sbjct: 181 KD----------YYVVRE-PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK 229
Query: 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLER-----------MIKVAL 718
C + E L +L+E+ + +L M
Sbjct: 230 SCSPSAEFLRMMGCER---DVPALSRLLELLEEGQ----RLPAPPACPAEVHELMKL--- 279
Query: 719 WCILDEPSLRPSMKKVLLMLE 739
C P RPS + L+
Sbjct: 280 -CWAPSPQDRPSFSALGPQLD 299
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 58/183 (31%), Positives = 95/183 (51%), Gaps = 17/183 (9%)
Query: 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK--ILVYEYMSNGSLADILFNPE-K 563
GS F E ++ + H+ LVRL V+++ ++ EYM NGSL D L P
Sbjct: 48 GSMSPDAFLAEANLMKQLQHQRLVRLYA---VVTQEPIYIITEYMENGSLVDFLKTPSGI 104
Query: 564 QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623
+ + + +A IA G+ ++ + IH D++ NIL+ + KI+DFGLA+L++
Sbjct: 105 KLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161
Query: 624 DQTRTFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDD 679
++ G I+ T APE T+K+DV+SFG++L EI+ R P + +
Sbjct: 162 NEYTAREGAKFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217
Query: 680 QVI 682
+VI
Sbjct: 218 EVI 220
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 63/269 (23%), Positives = 101/269 (37%), Gaps = 50/269 (18%)
Query: 500 FKEEVGRGSSG----------------------------EREFQTEMKVIGRTHHRNLVR 531
F E+GRGS + F+ E +++ H N+VR
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 532 LLGYSLEVSKK----ILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587
K +LV E M++G+L L K R I +G+ +LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH-T 147
Query: 588 CETQIIHCDIKPQNILMD-ENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN 646
IIH D+K NI + KI D GLA L + + GT ++APE +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV---IGTPEFMAPEMYEE 204
Query: 647 LPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVD 706
DVY+FG+ +LE+ P + +Y+ +G ++V
Sbjct: 205 -KYDESVDVYAFGMCMLEMATSEY------PYSECQNAAQIYRRVTSGVKPASF--DKVA 255
Query: 707 EKQLERMIKVALWCILDEPSLRPSMKKVL 735
+++ +I+ CI R S+K +L
Sbjct: 256 IPEVKEIIE---GCIRQNKDERYSIKDLL 281
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 60/186 (32%), Positives = 96/186 (51%), Gaps = 17/186 (9%)
Query: 505 GRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQ 564
G R+F +E ++G+ H N++RL G ++V EYM NGSL L + Q
Sbjct: 88 GYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ 147
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK-- 622
++ +G+ R + G+ YL + +H D+ +N+L+D N K+SDFGL+++++
Sbjct: 148 FTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
Query: 623 PDQTRTFTG----IRGTRGYVAPE--WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNL 676
PD T TG IR T APE R + +DV+SFGVV+ E++ N+
Sbjct: 205 PDAAYTTTGGKIPIRWT----APEAIAFRT--FSSASDVWSFGVVMWEVLAYGERPYWNM 258
Query: 677 PDDQVI 682
+ VI
Sbjct: 259 TNRDVI 264
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 41/167 (24%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 505 GRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQ 564
+E E V+ + ++ RLLG L + ++ + + M G L D + +
Sbjct: 55 ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN 113
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP- 623
+ IA+G+ YL + +++H D+ +N+L+ + KI+DFGLAKL+
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 624 DQTRTFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
++ G I+ A E + T ++DV+S+GV + E++
Sbjct: 171 EKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELM 213
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 50/245 (20%), Positives = 101/245 (41%), Gaps = 40/245 (16%)
Query: 508 SSGEREF-QTEMKVIGRTHHRNLVRLLGYSLEVSKKIL--VYEYMSNGSLAD-ILFNPEK 563
+ E++ +E+ ++ H N+VR ++ + L V EY G LA I ++
Sbjct: 45 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE 104
Query: 564 QPNWVER--MGIARDIARGILYLHDECET--QIIHCDIKPQNILMDENRCAKISDFGLAK 619
+ E + + + + H + ++H D+KP N+ +D + K+ DFGLA+
Sbjct: 105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164
Query: 620 LMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDD 679
++ D + T + GT Y++PE + K+D++S G +L E+ P
Sbjct: 165 ILNHDTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP---P----- 215
Query: 680 QVILEEWVYQCFENGNLSQLVE---DEEVDE------KQLERMIKVALWCILDEPSLRPS 730
F + +L + + +L +I + + RPS
Sbjct: 216 -----------FTAFSQKELAGKIREGKFRRIPYRYSDELNEIIT---RMLNLKDYHRPS 261
Query: 731 MKKVL 735
++++L
Sbjct: 262 VEEIL 266
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 59/185 (31%), Positives = 94/185 (50%), Gaps = 13/185 (7%)
Query: 504 VGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEK 563
VG R+F E ++G+ H N++RL G + ++V EYM NGSL L +
Sbjct: 83 VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA 142
Query: 564 QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK- 622
Q ++ +G+ R IA G+ YL D +H D+ +NIL++ N K+SDFGL ++++
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199
Query: 623 -PDQTRTFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLP 677
P+ T G IR T +PE T +DV+S+G+VL E++ +
Sbjct: 200 DPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 678 DDQVI 682
+ VI
Sbjct: 256 NQDVI 260
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 13/167 (7%)
Query: 505 GRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQ 564
G + M IG H ++VRLLG S LV +Y+ GSL D +
Sbjct: 53 KSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGA 111
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+ IA+G+ YL E ++H ++ +N+L+ +++DFG+A L+ PD
Sbjct: 112 LGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168
Query: 625 QTRTFTG-----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
+ I+ A E T ++DV+S+GV + E++
Sbjct: 169 DKQLLYSEAKTPIKWM----ALESIHFGKYTHQSDVWSYGVTVWELM 211
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 34/168 (20%), Positives = 61/168 (36%), Gaps = 21/168 (12%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNW-----VERM 571
M+ + + ++ L + +LV E S G+L + + N K +
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI-NLYKNTPEKVMPQGLVI 175
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILM-----------DENRCAKISDFGLAKL 620
A + I +H + +IIH DIKP N ++ D + + D G +
Sbjct: 176 SFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 621 MKP-DQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
MK + FT T G+ E N P + D + + ++
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 46/172 (26%), Positives = 67/172 (38%), Gaps = 14/172 (8%)
Query: 501 KEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN 560
K +V +F E+ + HRNL+RL G L K+ V E GSL D L
Sbjct: 55 KPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK 113
Query: 561 PEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620
+ A +A G+ YL + IH D+ +N+L+ KI DFGL +
Sbjct: 114 HQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170
Query: 621 MK--PDQTRTFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
+ D APE + + +D + FGV L E+
Sbjct: 171 LPQNDDHYVMQEHRKVPFAWC----APESLKTRTFSHASDTWMFGVTLWEMF 218
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 51/243 (20%), Positives = 97/243 (39%), Gaps = 25/243 (10%)
Query: 514 FQTEMKVIGRTHHRNLVRLLG-YSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERM 571
E +V+ + +H+N+V+L ++ L+ E+ GSL +L P E
Sbjct: 54 QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 572 G--IARDIARGILYLHDECETQIIHCDIKPQNILM----DENRCAKISDFGLAKLMKPDQ 625
+ RD+ G+ +L + I+H +IKP NI+ D K++DFG A+ ++ D+
Sbjct: 114 FLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
Query: 626 TRTFTGIRGTRGYVAPE--------WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLP 677
F + GT Y+ P+ D++S GV P
Sbjct: 171 --QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228
Query: 678 DDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL-L 736
+ +E +Y+ + ++ + ++ + + C L L+ + VL
Sbjct: 229 PRR--NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSL-SRGLQVLLTPVLAN 285
Query: 737 MLE 739
+LE
Sbjct: 286 ILE 288
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 55/186 (29%), Positives = 96/186 (51%), Gaps = 17/186 (9%)
Query: 505 GRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQ 564
G +F E ++G+ H N++RL G + +++ EYM NG+L L + +
Sbjct: 84 GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE 143
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+ ++ +G+ R IA G+ YL +H D+ +NIL++ N K+SDFGL+++++ D
Sbjct: 144 FSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200
Query: 625 QTRTFTG------IRGTRGYVAPE--WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNL 676
T+T IR T APE +R T +DV+SFG+V+ E++ L
Sbjct: 201 PEATYTTSGGKIPIRWT----APEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWEL 254
Query: 677 PDDQVI 682
+ +V+
Sbjct: 255 SNHEVM 260
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 51/251 (20%), Positives = 90/251 (35%), Gaps = 45/251 (17%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE---------VSKKILVY---EYMSNGSLADIL 558
+ E+K + + H +VR LE S K+ +Y + +L D +
Sbjct: 47 REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM 106
Query: 559 F--NPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFG 616
++ + I IA + +LH + ++H D+KP NI + K+ DFG
Sbjct: 107 NGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFG 163
Query: 617 LAKLMKPDQTR-----------TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
L M D+ TG GT+ Y++PE + K D++S G++L E+
Sbjct: 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
Query: 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQL-ERMIKVALWCILDE 724
+ P + N L + E + + M+
Sbjct: 224 LY---------PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSP-------S 267
Query: 725 PSLRPSMKKVL 735
P RP ++
Sbjct: 268 PMERPEAINII 278
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 56/254 (22%), Positives = 99/254 (38%), Gaps = 48/254 (18%)
Query: 493 LEKMTDGFKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 552
+ +M+ +EE + E+ V+ H N+V+ E +V +Y G
Sbjct: 59 ISRMSSKEREES----------RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG 108
Query: 553 SLADILFNPEKQPNWVER--MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA 610
L + N +K + E + I + ++HD +I+H DIK QNI + ++
Sbjct: 109 DLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTV 164
Query: 611 KISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670
++ DFG+A+++ I GT Y++PE N P K+D+++ G VL E+ +
Sbjct: 165 QLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
Query: 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVE---DEEVDE------KQLERMIKVALWCI 721
FE G++ LV L ++
Sbjct: 224 ---A----------------FEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS---QLF 261
Query: 722 LDEPSLRPSMKKVL 735
P RPS+ +L
Sbjct: 262 KRNPRDRPSVNSIL 275
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 17/183 (9%)
Query: 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQ 564
+ + + F E V+ + H NLV+LLG +E + +V EYM+ GSL D L + +
Sbjct: 53 KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 112
Query: 565 P-NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623
+ + D+ + YL +H D+ +N+L+ E+ AK+SDFGL K
Sbjct: 113 VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---- 165
Query: 624 DQTRTFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDD 679
+ + T ++ T APE R + K+DV+SFG++L EI R P +P
Sbjct: 166 EASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 221
Query: 680 QVI 682
V+
Sbjct: 222 DVV 224
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 48/240 (20%), Positives = 98/240 (40%), Gaps = 28/240 (11%)
Query: 505 GRGSSGEREF-QTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEK 563
+ R E+ ++ + +H N+++ +E ++ +V E G L+ ++ + +K
Sbjct: 69 DLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKK 128
Query: 564 QPNWV-ER--MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620
Q + ER + + ++H +++H DIKP N+ + K+ D GL +
Sbjct: 129 QKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF 185
Query: 621 M--KPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR---CLDPN 675
K + GT Y++PE K+D++S G +L E+ + N
Sbjct: 186 FSSKTTAAHSLV---GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 242
Query: 676 LPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
L +E+ Y + + S+ +L +++ CI +P RP + V
Sbjct: 243 LYSLCKKIEQCDYPPLPSDHYSE----------ELRQLVN---MCINPDPEKRPDVTYVY 289
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 41/181 (22%), Positives = 78/181 (43%), Gaps = 16/181 (8%)
Query: 508 SSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK--ILVYEYMSNGSLADILFNPEKQP 565
S +F E + + H ++V+L+G +++ ++ E + G L L +
Sbjct: 57 DSVREKFLQEALTMRQFDHPHIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSL 113
Query: 566 NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ 625
+ + A ++ + YL + +H DI +N+L+ N C K+ DFGL++ M+
Sbjct: 114 DLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170
Query: 626 TRTFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQV 681
+ I+ APE T +DV+ FGV + EI+ + ++ V
Sbjct: 171 YYKASKGKLPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226
Query: 682 I 682
I
Sbjct: 227 I 227
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 525 HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584
H ++RL Y + +V E N L L + W + +++ + +
Sbjct: 86 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTI 143
Query: 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF-TGIRGTRGYVAPE- 642
H I+H D+KP N L+ + K+ DFG+A M+PD T GT Y+ PE
Sbjct: 144 HQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 643 ----------WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFE 692
I+ K+DV+S G +L + + P Q + + +
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQ--IINQISKLHA 251
Query: 693 NGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+ + +E ++ EK L+ ++K C+ +P R S+ ++L
Sbjct: 252 IIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELL 291
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-27
Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 29/223 (13%)
Query: 525 HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584
H ++RL Y + +V E N L L + W + +++ + +
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTI 171
Query: 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF-TGIRGTRGYVAPE- 642
H I+H D+KP N L+ + K+ DFG+A M+PD T G Y+ PE
Sbjct: 172 HQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 643 ----------WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFE 692
I+ K+DV+S G +L + + P Q + + +
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQ--IINQISKLHA 279
Query: 693 NGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+ + +E ++ EK L+ ++K C+ +P R S+ ++L
Sbjct: 280 IIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELL 319
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 27/170 (15%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKIL-VYEYMSNGSLADILFNPEKQPNWVE 569
+F TE ++ H N++ LLG L L V YM +G L + + N P +
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 129
Query: 570 RMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
+G +A+G+ YL + +H D+ +N ++DE K++DFGLA+ M + +
Sbjct: 130 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 186
Query: 630 TGIRGTRGYVAPEWHRNLPI-------------TVKADVYSFGVVLLEII 666
G + LP+ T K+DV+SFGV+L E++
Sbjct: 187 HNKTGAK----------LPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 226
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 525 HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584
H ++RL Y + +V E N L L + W + +++ + +
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTI 124
Query: 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF-TGIRGTRGYVAPE- 642
H I+H D+KP N L+ + K+ DFG+A M+PD T GT Y+ PE
Sbjct: 125 HQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 643 ----------WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFE 692
I+ K+DV+S G +L + + P Q + + +
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQ--IINQISKLHA 232
Query: 693 NGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+ + +E ++ EK L+ ++K C+ +P R S+ ++L
Sbjct: 233 IIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELL 272
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 55/239 (23%), Positives = 83/239 (34%), Gaps = 39/239 (16%)
Query: 506 RGSSGEREFQTEMKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN---- 560
RG E+ + H VRL E L E SL
Sbjct: 95 RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGAS 153
Query: 561 -PEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK 619
PE Q G RD + +LH + ++H D+KP NI + K+ DFGL
Sbjct: 154 LPEAQ-----VWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLV 205
Query: 620 LM-KPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPD 678
+ G Y+APE + ADV+S G+ +LE+ C LP
Sbjct: 206 ELGTAGAGEVQE---GDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNME-----LPH 256
Query: 679 DQVILEEW--VYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
E W + Q + + + E L ++ + +P LR + + +L
Sbjct: 257 G---GEGWQQLRQGYLPPEFTAGLSSE------LRSVLV---MMLEPDPKLRATAEALL 303
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-27
Identities = 51/180 (28%), Positives = 76/180 (42%), Gaps = 19/180 (10%)
Query: 515 QTEMKVIGRTHHRNLVRLL------GYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWV 568
E++++ + +H N+V +L EY G L L E
Sbjct: 60 CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 119
Query: 569 ERM--GIARDIARGILYLHDECETQIIHCDIKPQNILMD---ENRCAKISDFGLAKLMKP 623
E + DI+ + YLH+ +IIH D+KP+NI++ + KI D G AK +
Sbjct: 120 EGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 624 DQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVIL 683
+ T GT Y+APE TV D +SFG + E I R P LP+ Q +
Sbjct: 177 GEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR---PFLPNWQPVQ 231
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 43/167 (25%), Positives = 77/167 (46%), Gaps = 13/167 (7%)
Query: 505 GRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQ 564
+E E V+ + ++ RLLG L S L+ + M G L D + +
Sbjct: 55 ATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN 113
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+ IA+G+ YL + +++H D+ +N+L+ + KI+DFGLAKL+ +
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 625 Q-TRTFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
+ G I+ A E + T ++DV+S+GV + E++
Sbjct: 171 EKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELM 213
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 50/239 (20%), Positives = 99/239 (41%), Gaps = 46/239 (19%)
Query: 517 EMKVIGRTHHRNLVRLLGY-------------SLEVSKKILVY---EYMSNGSLADILFN 560
E+K + + H N+V G + SK ++ E+ G+L +
Sbjct: 54 EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 561 PEKQP-NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK 619
+ + V + + I +G+ Y+H + ++I+ D+KP NI + + + KI DFGL
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 620 LMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDD 679
+K D RT GT Y++PE + + D+Y+ G++L E++
Sbjct: 171 SLKNDGKRT-RSK-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD--------- 219
Query: 680 QVILEEWVYQCFENGNLSQLVEDEEVDE---KQLERMIKVALWCILDEPSLRPSMKKVL 735
FE + D + + K+ + +++ + +P RP+ ++L
Sbjct: 220 ---------TAFETSKFFTDLRDGIISDIFDKKEKTLLQ---KLLSKKPEDRPNTSEIL 266
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKIL-VYEYMSNGSLADILFNPEKQPNWVE 569
+F TE ++ H N++ LLG L L V YM +G L + + N P +
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 193
Query: 570 RMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK---PDQT 626
+G +A+G+ +L + +H D+ +N ++DE K++DFGLA+ M D
Sbjct: 194 LIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 250
Query: 627 RTFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
TG ++ A E + T K+DV+SFGV+L E++
Sbjct: 251 HNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELM 290
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 45/178 (25%), Positives = 85/178 (47%), Gaps = 13/178 (7%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKIL-VYEYMSNGSLADILFNPEKQPNWVER 570
F E ++ +H N++ L+G L + YM +G L + +P++ P +
Sbjct: 67 EAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL 126
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
+ +ARG+ YL E + +H D+ +N ++DE+ K++DFGLA+ + R +
Sbjct: 127 ISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDI---LDREYY 180
Query: 631 GIRGTRG------YVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
++ R + A E + T K+DV+SFGV+L E++ R ++ +
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT 238
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 38/168 (22%), Positives = 69/168 (41%), Gaps = 17/168 (10%)
Query: 508 SSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNW 567
+ F ++ + H++LV G + + ILV E++ GSL L + N
Sbjct: 53 RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINI 112
Query: 568 VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMD--------ENRCAKISDFGLAK 619
+ ++ +A+ +A + +L + +IH ++ +NIL+ K+SD G++
Sbjct: 113 LWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
Query: 620 LMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEII 666
+ P I PE N + D +SFG L EI
Sbjct: 170 TVLPKDILQER-IPWV----PPECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 55/259 (21%), Positives = 101/259 (38%), Gaps = 56/259 (21%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLG------------YSLEVSKKI-LVYEYMSNGSLADI 557
+E+ ++ +H+ +VR +++ + + EY NG+L D+
Sbjct: 46 LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDL 105
Query: 558 LFNPEKQPNWVERMGIA---RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISD 614
+ + +R R I + Y+H + IIH D+KP NI +DE+R KI D
Sbjct: 106 I---HSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159
Query: 615 FGLAKLMKPDQTRTFTGIR-------------GTRGYVAPEWHRNLPI-TVKADVYSFGV 660
FGLAK + + GT YVA E K D+YS G+
Sbjct: 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGI 219
Query: 661 VLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNL---SQLVEDEEVDEKQL-ERMIKV 716
+ E+I P + + + + + ++ +++ EK++ +I
Sbjct: 220 IFFEMIY------PFSTGMERVN---ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDH 270
Query: 717 ALWCILDEPSLRPSMKKVL 735
+P+ RP + +L
Sbjct: 271 -------DPNKRPGARTLL 282
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 48/154 (31%), Positives = 79/154 (51%), Gaps = 6/154 (3%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGI 573
F+ E+ + H+N+V ++ E LV EY+ +L++ + + +
Sbjct: 58 FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINF 116
Query: 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG-I 632
I GI + H + +I+H DIKPQNIL+D N+ KI DFG+AK + + + T T +
Sbjct: 117 TNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHV 172
Query: 633 RGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
GT Y +PE + D+YS G+VL E++
Sbjct: 173 LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 53/242 (21%), Positives = 90/242 (37%), Gaps = 25/242 (10%)
Query: 515 QTEMKVIGRTHHRNLVRLLGY--SLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMG 572
E +V+ + +H+N+V+L K+L+ E+ GSL +L P E
Sbjct: 55 MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114
Query: 573 --IARDIARGILYLHDECETQIIHCDIKPQNILM----DENRCAKISDFGLAKLMKPDQT 626
+ RD+ G+ +L + I+H +IKP NI+ D K++DFG A+ ++ D+
Sbjct: 115 LIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE- 170
Query: 627 RTFTGIRGTRGYVAPE--------WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPD 678
F + GT Y+ P+ D++S GV P P
Sbjct: 171 -QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL---PFRPF 226
Query: 679 DQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL-LM 737
+ + V G S + + E L+ + VL +
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286
Query: 738 LE 739
LE
Sbjct: 287 LE 288
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 37/160 (23%), Positives = 69/160 (43%), Gaps = 12/160 (7%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVER 570
+ +F +E ++ H ++V+L+G E I + E G L L + +
Sbjct: 57 KEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLERNKNSLKVLTL 115
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
+ + I + + YL +H DI +NIL+ C K+ DFGL++ ++ + +
Sbjct: 116 VLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS 172
Query: 631 G----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
I+ +PE T +DV+ F V + EI+
Sbjct: 173 VTRLPIKWM----SPESINFRRFTTASDVWMFAVCMWEIL 208
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 51/254 (20%), Positives = 91/254 (35%), Gaps = 48/254 (18%)
Query: 506 RGSSGEREFQTEMKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQ 564
GS E+ E+ H ++VR E ++ EY + GSLAD + +
Sbjct: 49 AGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRI 108
Query: 565 PNWV---ERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN-------------- 607
++ E + + RG+ Y+H ++H DIKP NI +
Sbjct: 109 MSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165
Query: 608 -----RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPE-WHRNLPITVKADVYSFGVV 661
KI D G + Q G ++A E N KAD+++ +
Sbjct: 166 WASNKVMFKIGDLGHVTRISSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALT 220
Query: 662 LLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCI 721
++ LP + ++W G L ++ +V ++ ++K I
Sbjct: 221 VVCAAGAEP-----LPRN---GDQW--HEIRQGRLPRI---PQVLSQEFTELLK---VMI 264
Query: 722 LDEPSLRPSMKKVL 735
+P RPS ++
Sbjct: 265 HPDPERRPSAMALV 278
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 39/178 (21%), Positives = 76/178 (42%), Gaps = 14/178 (7%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVER 570
E E +++ + + +VRL+G + + V E G L L ++
Sbjct: 54 TEEMMREAQIMHQLDNPYIVRLIGVCQAEALML-VMEMAGGGPLHKFLVGKREEIPVSNV 112
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT--RT 628
+ ++ G+ YL E +H D+ +N+L+ AKISDFGL+K + D +
Sbjct: 113 AELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 169
Query: 629 FTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
+ ++ APE + ++DV+S+GV + E + + + +V+
Sbjct: 170 RSAGKWPLKWY----APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 223
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 42/169 (24%), Positives = 74/169 (43%), Gaps = 10/169 (5%)
Query: 500 FKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADIL 558
FK ++ + + + E+++ H N++RL GY + ++ L+ EY G++ L
Sbjct: 43 FKAQLEKAGVEHQ-LRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL 100
Query: 559 FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLA 618
K ++A + Y H ++IH DIKP+N+L+ KI+DFG +
Sbjct: 101 QKLSKFDEQRTAT-YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156
Query: 619 KLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
+ GT Y+ PE K D++S GV+ E +
Sbjct: 157 VHAPSSRRTDLC---GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 35/240 (14%), Positives = 83/240 (34%), Gaps = 44/240 (18%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGY--SLEVSKKILVYEYM--SNGSLADILFN---PEKQPN 566
F ++ + ++R+ + V + +Y M + + ++L + K
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 204
Query: 567 WVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626
R+ + + R + LH ++H ++P +I++D+ ++ F +
Sbjct: 205 HHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGAR 259
Query: 627 RTFTGIRGTRGYVAPEW-----------HRNLPITVKADVYSFGVVLLEIICRRRCLDPN 675
+ +RG+ PE R +T D ++ G+V+ I C P
Sbjct: 260 VVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL---PI 313
Query: 676 LPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
D + EW+++ N+ Q V +++ + R + +
Sbjct: 314 TKDAALGGSEWIFRS--CKNIPQPVRA----------LLE---GFLRYPKEDRLLPLQAM 358
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 22/168 (13%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADIL--------FNP 561
+ E Q + I + + G + ++ ++YEYM N S+
Sbjct: 91 KNELQI-ITDI---KNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 562 EKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM 621
P V + I + + Y+H+E I H D+KP NILMD+N K+SDFG ++ M
Sbjct: 146 CFIPIQVIK-CIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202
Query: 622 KPDQTRTFTGIRGTRGYVAPE--WHRNLPITVKADVYSFGVVLLEIIC 667
+ + RGT ++ PE + + K D++S G+ L +
Sbjct: 203 VDKKIKGS---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 42/217 (19%), Positives = 78/217 (35%), Gaps = 34/217 (15%)
Query: 535 YSLEVSKKILVY---EYMSNGSLADIL--FNPEKQPNWVERMGIARDIARGILYLHDECE 589
S K+ +Y + +L D + + + I IA + +LH +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-- 183
Query: 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMK-----------PDQTRTFTGIRGTRGY 638
++H D+KP NI + K+ DFGL M T TG GT+ Y
Sbjct: 184 -GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 639 VAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQ 698
++PE + K D++S G++L E++ + + + N
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLY------SFSTQMERVR---IITDVRNLKFPL 293
Query: 699 LVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
L + E + ++ + P+ RP ++
Sbjct: 294 LFTQKYPQEHMM---VQ---DMLSPSPTERPEATDII 324
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 70/294 (23%), Positives = 110/294 (37%), Gaps = 76/294 (25%)
Query: 500 FKEEVGRGSSGEREFQTE-------MKVIGR----------------THHRNLVRLLGYS 536
++ +G GSSG FQ +K + H N++R Y
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY--YC 76
Query: 537 LEVSKK--ILVYEYMSNGSLADIL----FNPEKQPNWVER--MGIARDIARGILYLHDEC 588
E + + + E N +L D++ + E E + + R IA G+ +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 132
Query: 589 ETQIIHCDIKPQNILMD-------------ENRCAKISDFGLAKLMKPDQ---TRTFTGI 632
+IIH D+KPQNIL+ EN ISDFGL K + Q
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 633 RGTRGYVAPE-------WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLP-DDQVILE 684
GT G+ APE +T D++S G V I+ + + P D+ E
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK-----HPFGDKYSRE 247
Query: 685 EWVYQCFENGNLSQLVEDEEVDE--KQL-ERMIKVALWCILDEPSLRPSMKKVL 735
+ + + + + + D + L +MI +P RP+ KVL
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH-------DPLKRPTAMKVL 294
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 48/212 (22%), Positives = 76/212 (35%), Gaps = 35/212 (16%)
Query: 481 EDIAPLSFSYAELEKMTDGFKEEVGRGSSG---------------------EREFQTEMK 519
E + P+ + Y E + VGRGS G E E+
Sbjct: 44 EKLKPVDYEYREEVHWMTH-QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV 102
Query: 520 VIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL--FNPEKQPNWVERMGIARDI 577
+V L G E + E + GSL ++ + +
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED---RALYYLGQA 159
Query: 578 ARGILYLHDECETQIIHCDIKPQNILMDEN-RCAKISDFGLAKLMKPDQTRTFTG----I 632
G+ YLH +I+H D+K N+L+ + A + DFG A ++PD I
Sbjct: 160 LEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 633 RGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664
GT ++APE P K D++S ++L
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 248
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 10/169 (5%)
Query: 500 FKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADIL 558
FK ++ + + + E+++ H N++R+ Y K+I L+ E+ G L L
Sbjct: 48 FKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL 105
Query: 559 FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLA 618
+ ++A + Y H E ++IH DIKP+N+LM KI+DFG +
Sbjct: 106 QKHGRFDEQRSAT-FMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS 161
Query: 619 KLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
+ RT GT Y+ PE K D++ GV+ E +
Sbjct: 162 VHAPSLRRRTMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-25
Identities = 40/163 (24%), Positives = 72/163 (44%), Gaps = 12/163 (7%)
Query: 508 SSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNW 567
S +F E + + H ++V+L+G E + ++ E + G L L + +
Sbjct: 432 DSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDL 490
Query: 568 VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR 627
+ A ++ + YL + +H DI +N+L+ N C K+ DFGL++ M+
Sbjct: 491 ASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 547
Query: 628 TFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
+ I+ APE T +DV+ FGV + EI+
Sbjct: 548 KASKGKLPIKWM----APESINFRRFTSASDVWMFGVCMWEIL 586
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-25
Identities = 39/184 (21%), Positives = 78/184 (42%), Gaps = 14/184 (7%)
Query: 505 GRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQ 564
G + E E +++ + + +VRL+G + + V E G L L ++
Sbjct: 374 GTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML-VMEMAGGGPLHKFLVGKREE 432
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+ ++ G+ YL E +H ++ +N+L+ AKISDFGL+K + D
Sbjct: 433 IPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489
Query: 625 QT--RTFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPD 678
+ + ++ APE + ++DV+S+GV + E + + +
Sbjct: 490 DSYYTARSAGKWPLKWY----APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545
Query: 679 DQVI 682
+V+
Sbjct: 546 PEVM 549
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 6e-25
Identities = 46/208 (22%), Positives = 91/208 (43%), Gaps = 42/208 (20%)
Query: 487 SFSYAELEKMTDGFKEEVGRGSSGE---------------------------REFQTEMK 519
+ EK+ E+G G+ G + E++
Sbjct: 29 ELKDDDFEKI-----SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ 83
Query: 520 VIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERM--GIARDI 577
V+ + +V G + + E+M GSL +L + P E++ ++ +
Sbjct: 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVSIAV 140
Query: 578 ARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRG 637
+G+ YL ++ +I+H D+KP NIL++ K+ DFG++ + +F GTR
Sbjct: 141 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRS 195
Query: 638 YVAPEWHRNLPITVKADVYSFGVVLLEI 665
Y++PE + +V++D++S G+ L+E+
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEM 223
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 36/162 (22%), Positives = 65/162 (40%), Gaps = 18/162 (11%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-----LVYEYMSNGSLADILFNPEKQPNWV 568
E + + H ++V++ + + +V EY+ SL
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVA 182
Query: 569 ERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT 628
E + +I + YLH +++ D+KP+NI++ E + K+ D G + +
Sbjct: 183 EAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI--NSFGY 236
Query: 629 FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670
+ GT G+ APE R P TV D+Y+ G L +
Sbjct: 237 ---LYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLP 274
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 9/158 (5%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVER- 570
+ E+ + H+N+V+ LG E + E + GSL+ +L + E+
Sbjct: 64 QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT 123
Query: 571 -MGIARDIARGILYLHDECETQIIHCDIKPQNILMD-ENRCAKISDFGLAKLMKPDQTRT 628
+ I G+ YLHD QI+H DIK N+L++ + KISDFG +K + T
Sbjct: 124 IGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180
Query: 629 FTGIRGTRGYVAPE--WHRNLPITVKADVYSFGVVLLE 664
T GT Y+APE AD++S G ++E
Sbjct: 181 ET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE 217
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 55/263 (20%), Positives = 94/263 (35%), Gaps = 35/263 (13%)
Query: 509 SGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK----ILVYEYMSNGSLADILFNPEKQ 564
E Q E + +H N++RL+ Y L L+ + G+L + + K
Sbjct: 68 QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKD 126
Query: 565 PNW----VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620
+ + + I RG+ +H H D+KP NIL+ + + D G
Sbjct: 127 KGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183
Query: 621 MK--PDQTRTFTGI------RGTRGYVAPE-WH--RNLPITVKADVYSFGVVLLEIICRR 669
+ +R + R T Y APE + + I + DV+S G VL ++
Sbjct: 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
Query: 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP 729
P D V + LS L +++ + +P RP
Sbjct: 244 ------GPYDMVFQKGDSVALAVQNQLSIPQSPRHSSA--LWQLLN---SMMTVDPHQRP 292
Query: 730 SMKKVLLMLEGTVEIPIPPNPTS 752
+ +L LE ++ P P T+
Sbjct: 293 HIPLLLSQLE-ALQPPAPGQHTT 314
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 43/156 (27%), Positives = 67/156 (42%), Gaps = 9/156 (5%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVER 570
R Q E + GR ++V + + + + ++ LA +L + P R
Sbjct: 79 TR-MQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPR 135
Query: 571 -MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
+ I R I + H H D+KP+NIL+ + A + DFG+A D+ T
Sbjct: 136 AVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQ 191
Query: 630 TG-IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664
G GT Y+APE T +AD+Y+ VL E
Sbjct: 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYE 227
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 53/300 (17%), Positives = 103/300 (34%), Gaps = 58/300 (19%)
Query: 487 SFSYAEL-EKMTDG----FKEEVGRGSSGEREFQTEMKVIGR-THHRNLVRLLGYSLEVS 540
F++ + + G K + R E+ + + + H N+V+ +
Sbjct: 40 GFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99
Query: 541 KK-------ILVYEYMSNGSLADILFNPEKQPNWVER--MGIARDIARGILYLHDECETQ 591
++ L+ + G L + L E + + I R + ++H +
Sbjct: 100 EESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPP 158
Query: 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMK--PDQTRTFTGI---------RGTRGYVA 640
IIH D+K +N+L+ K+ DFG A + PD + + T Y
Sbjct: 159 IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRT 218
Query: 641 PE---WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLS 697
PE + N PI K D+++ G +L + R+ P FE+G
Sbjct: 219 PEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ------HP-------------FEDGAKL 259
Query: 698 QLVE------DEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPIPPNPT 751
++V + +I+ + P R S+ +V+ L+ +
Sbjct: 260 RIVNGKYSIPPHDTQYTVFHSLIR---AMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 53/171 (30%), Positives = 80/171 (46%), Gaps = 23/171 (13%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL------FNPEKQ 564
E +F E +I + +H+N+VR +G SL+ + ++ E M+ G L L +
Sbjct: 77 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMD---ENRCAKISDFGLAK-L 620
++ + +ARDIA G YL E IH DI +N L+ R AKI DFG+A+ +
Sbjct: 137 LAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193
Query: 621 MKPDQTRTFTGIRGTRGYV-----APEWHRNLPITVKADVYSFGVVLLEII 666
+ R +G + PE T K D +SFGV+L EI
Sbjct: 194 YRASYYR-----KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 17/165 (10%)
Query: 509 SGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWV 568
+ + E E V+ + + +VR++G +LV E G L L +
Sbjct: 60 ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ-NRHVKDK 117
Query: 569 ERMGIARDIARGILYLHDECETQ-IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT- 626
+ + ++ G+ YL E +H D+ +N+L+ AKISDFGL+K ++ D+
Sbjct: 118 NIIELVHQVSMGMKYL----EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
Query: 627 -RTFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
+ T ++ APE + K+DV+SFGV++ E
Sbjct: 174 YKAQTHGKWPVKWY----APECINYYKFSSKSDVWSFGVLMWEAF 214
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKI----LVYEYMSNGSLADILFNPEKQPNWVE 569
F+ E + +H +V + + +V EY+ +L DI+ + E
Sbjct: 59 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKR 117
Query: 570 RMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD-QTRT 628
+ + D + + + H + IIH D+KP NI++ K+ DFG+A+ + + T
Sbjct: 118 AIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 629 FTG-IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
T + GT Y++PE R + ++DVYS G VL E++
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 41/193 (21%), Positives = 80/193 (41%), Gaps = 38/193 (19%)
Query: 500 FKEEVGRG-----------SSGER--------------EFQTEMKVIGRTHHRNLVRLLG 534
E++GRG SS + + E+ ++ HRN++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 535 YSLEVSKKILVYEYMSNGSLAD-ILFNPEKQPNWVER--MGIARDIARGILYLHDECETQ 591
+ + ++++E++S + + I ER + + + +LH
Sbjct: 69 SFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---N 122
Query: 592 IIHCDIKPQNILM--DENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI 649
I H DI+P+NI+ + KI +FG A+ +KP F + Y APE H++ +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVV 180
Query: 650 TVKADVYSFGVVL 662
+ D++S G ++
Sbjct: 181 STATDMWSLGTLV 193
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 41/170 (24%), Positives = 71/170 (41%), Gaps = 22/170 (12%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLE-----VSKKILVYEYMSNGSLADIL-----FNP 561
EF +E + H N++RLLG +E + K +++ +M G L L
Sbjct: 81 EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG 140
Query: 562 EKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM 621
K + DIA G+ YL +H D+ +N ++ ++ ++DFGL+K +
Sbjct: 141 PKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI 197
Query: 622 KPDQTRTFTG-----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
++ A E + T K+DV++FGV + EI
Sbjct: 198 YSGDYYRQGRIAKMPVKWI----AIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 27/176 (15%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL------------ 558
EF+ E + R H N+V LLG + +++ Y S+G L + L
Sbjct: 56 REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 559 ---FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDF 615
+ + + + IA G+ YL ++H D+ +N+L+ + KISD
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDL 172
Query: 616 GLA-KLMKPDQTRTFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
GL ++ D + IR APE ++ +D++S+GVVL E+
Sbjct: 173 GLFREVYAADYYKLLGNSLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL--------FNPE 562
EF E V+ + ++VRLLG + +++ E M+ G L L NP
Sbjct: 72 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 131
Query: 563 KQPNWVERM-GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLA-KL 620
P + +M +A +IA G+ YL+ + +H D+ +N ++ E+ KI DFG+ +
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 188
Query: 621 MKPDQTRTFTGIRGTRGYV-----APEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPN 675
+ D R +G +G + +PE ++ T +DV+SFGVVL EI
Sbjct: 189 YETDYYR-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 243
Query: 676 LPDDQVI 682
L ++QV+
Sbjct: 244 LSNEQVL 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 27/176 (15%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL------------ 558
++FQ E +++ H ++V+ G + I+V+EYM +G L L
Sbjct: 61 RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 559 ---FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDF 615
+ + + + IA IA G++YL +H D+ +N L+ N KI DF
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDF 177
Query: 616 GLAK-LMKPDQTRTFTG----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
G+++ + D R IR PE T ++DV+SFGV+L EI
Sbjct: 178 GMSRDVYSTDYYRVGGHTMLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIF 229
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 47/184 (25%), Positives = 77/184 (41%), Gaps = 44/184 (23%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL------------ 558
++FQ E +++ H+++VR G E ++V+EYM +G L L
Sbjct: 87 RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAG 146
Query: 559 --FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFG 616
+ + +A +A G++YL +H D+ +N L+ + KI DFG
Sbjct: 147 GEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFG 203
Query: 617 LAK-LMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-------------TVKADVYSFGVVL 662
+++ + D R G R LPI T ++DV+SFGVVL
Sbjct: 204 MSRDIYSTDYYR-----VGGRTM--------LPIRWMPPESILYRKFTTESDVWSFGVVL 250
Query: 663 LEII 666
EI
Sbjct: 251 WEIF 254
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 63/270 (23%), Positives = 110/270 (40%), Gaps = 80/270 (29%)
Query: 511 EREFQTE---MKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL--------- 558
+ +E MK+IG+ H+N++ LLG + ++ EY S G+L + L
Sbjct: 130 LSDLVSEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187
Query: 559 ------FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKI 612
PE+Q + + + +ARG+ YL + IH D+ +N+L+ EN KI
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKI 244
Query: 613 SDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-------------TVKADVYSFG 659
+DFGLA+ + Y + LP+ T ++DV+SFG
Sbjct: 245 ADFGLARDINNIDY-----------YKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFG 292
Query: 660 VVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIK---- 715
V++ EI P +P ++ +++ + G+ RM K
Sbjct: 293 VLMWEIFTLGGSPYPGIPVEE------LFKLLKEGH----------------RMDKPANC 330
Query: 716 ------VALWCILDEPSLRPSMKKVLLMLE 739
+ C PS RP+ K+++ L+
Sbjct: 331 TNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 53/171 (30%), Positives = 80/171 (46%), Gaps = 23/171 (13%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL------FNPEKQ 564
E +F E +I + +H+N+VR +G SL+ + ++ E M+ G L L +
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMD---ENRCAKISDFGLAK-L 620
++ + +ARDIA G YL E IH DI +N L+ R AKI DFG+A+ +
Sbjct: 178 LAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234
Query: 621 MKPDQTRTFTGIRGTRGYV-----APEWHRNLPITVKADVYSFGVVLLEII 666
+ R +G + PE T K D +SFGV+L EI
Sbjct: 235 YRAGYYR-----KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 45/188 (23%), Positives = 74/188 (39%), Gaps = 50/188 (26%)
Query: 512 REFQTE---MKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL---------- 558
+E + +G H N+V LLG +++ EY G L + L
Sbjct: 71 EALMSELKVLSYLGN--HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 559 -------FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 611
+ E + + + + +A+G+ +L IH D+ +NIL+ R K
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITK 185
Query: 612 ISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-------------TVKADVYSF 658
I DFGLA+ +K D YV R LP+ T ++DV+S+
Sbjct: 186 ICDFGLARDIKNDSN-----------YVVKGNAR-LPVKWMAPESIFNCVYTFESDVWSY 233
Query: 659 GVVLLEII 666
G+ L E+
Sbjct: 234 GIFLWELF 241
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 8/169 (4%)
Query: 500 FKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADIL 558
K + + E+ E+ + H+++V G+ E + + +V E SL ++
Sbjct: 75 PKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH 132
Query: 559 FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLA 618
+ R R I G YLH ++IH D+K N+ ++E+ KI DFGLA
Sbjct: 133 KRRKALTEPEARY-YLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
Query: 619 KLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
++ D R + GT Y+APE + + DV+S G ++ ++
Sbjct: 189 TKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 236
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 44/216 (20%), Positives = 80/216 (37%), Gaps = 47/216 (21%)
Query: 486 LSFSYAELEKMTDGFKEEVGRGSSGE---------------------------REFQTEM 518
+ +LE + E+GRG+ G + ++
Sbjct: 2 MEVKADDLEPI-----MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL 56
Query: 519 KVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWV-ERM--GIA 574
+ RT V G + E M + SL + + E + IA
Sbjct: 57 DISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIA 115
Query: 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL-AKLMKPDQTRTFTGIR 633
I + + +LH + +IH D+KP N+L++ K+ DFG+ L+
Sbjct: 116 VSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--- 170
Query: 634 GTRGYVAPE----WHRNLPITVKADVYSFGVVLLEI 665
G + Y+APE +VK+D++S G+ ++E+
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 3e-23
Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 7/169 (4%)
Query: 500 FKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADIL 558
K+ + + +R Q E+K+ + H +++ L Y E S + LV E NG + L
Sbjct: 45 DKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYL 102
Query: 559 FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLA 618
N K + E I G+LYLH I+H D+ N+L+ N KI+DFGLA
Sbjct: 103 KNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA 159
Query: 619 KLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
+K + +T + GT Y++PE +++DV+S G + ++
Sbjct: 160 TQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLI 207
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 8/169 (4%)
Query: 500 FKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADIL 558
K + + E+ E+ + H+++V G+ E + + +V E SL ++
Sbjct: 49 PKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH 106
Query: 559 FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLA 618
+ R R I G YLH ++IH D+K N+ ++E+ KI DFGLA
Sbjct: 107 KRRKALTEPEARY-YLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
Query: 619 KLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
++ D R + GT Y+APE + + DV+S G ++ ++
Sbjct: 163 TKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 210
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 41/162 (25%), Positives = 72/162 (44%), Gaps = 13/162 (8%)
Query: 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNPEKQ 564
+ + E+ ++ + HH L+ L + + +L+ E++S G L D I +
Sbjct: 87 PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA---AED 143
Query: 565 PNWVER--MGIARDIARGILYLHDECETQIIHCDIKPQNILM--DENRCAKISDFGLAKL 620
E + R G+ ++H+ I+H DIKP+NI+ + KI DFGLA
Sbjct: 144 YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK 200
Query: 621 MKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662
+ PD+ T + APE P+ D+++ GV+
Sbjct: 201 LNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 14/174 (8%)
Query: 495 KMTDGFKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL 554
K + R E + E+ ++ H N++ L + +L+ E +S G L
Sbjct: 36 KFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGEL 95
Query: 555 ADILFNPEKQPNWVER--MGIARDIARGILYLHDECETQIIHCDIKPQNILM----DENR 608
D L ++ + E + I G+ YLH + +I H D+KP+NI++ N
Sbjct: 96 FDFL---AEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNP 149
Query: 609 CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662
K+ DFG+A ++ F I GT +VAPE P+ ++AD++S GV+
Sbjct: 150 RIKLIDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 64/258 (24%), Positives = 105/258 (40%), Gaps = 60/258 (23%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV---SKKI-LVYEYMSNGSLADILFN----PE 562
RE + MK++ +H N+V+L EV K + L+ EY S G + D L E
Sbjct: 62 FREVRI-MKIL---NHPNIVKLF----EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE 113
Query: 563 KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK 622
K E R I + Y H + I+H D+K +N+L+D + KI+DFG +
Sbjct: 114 K-----EARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 165
Query: 623 PDQT-RTFTGIRGTRGYVAPEWHRNLPIT-VKADVYSFGVVLLEIICRRRCLDPNLP-DD 679
F G Y APE + + DV+S GV+L ++ LP D
Sbjct: 166 VGGKLDAFC---GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS------LPFDG 216
Query: 680 QVILEEWVYQCFENGN------LSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKK 733
Q + E + + G +S E+ L+R + + P R ++++
Sbjct: 217 QNLKE--LRERVLRGKYRIPFYMSTDCEN------LLKRFLVL-------NPIKRGTLEQ 261
Query: 734 VLL---MLEGTVEIPIPP 748
++ + G E + P
Sbjct: 262 IMKDRWINAGHEEDELKP 279
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 53/184 (28%), Positives = 82/184 (44%), Gaps = 47/184 (25%)
Query: 512 REFQTEMKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL------------ 558
R+F E++V+ + HH N++ LLG L EY +G+L D L
Sbjct: 70 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 129
Query: 559 ---FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDF 615
+ + + + A D+ARG+ YL + Q IH D+ +NIL+ EN AKI+DF
Sbjct: 130 AIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADF 186
Query: 616 GLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-------------TVKADVYSFGVVL 662
GL++ + T R LP+ T +DV+S+GV+L
Sbjct: 187 GLSR--GQEVYVKKTMGR-------------LPVRWMAIESLNYSVYTTNSDVWSYGVLL 231
Query: 663 LEII 666
EI+
Sbjct: 232 WEIV 235
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 47/164 (28%), Positives = 73/164 (44%), Gaps = 14/164 (8%)
Query: 506 RGSSGEREFQTEMKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNPEK 563
RG E E+ V+ ++ L S+ IL+ EY + G + L PE
Sbjct: 67 RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL--PEL 124
Query: 564 QPNWVER--MGIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKISDFGLA 618
E + + + I G+ YLH + I+H D+KPQNIL+ KI DFG++
Sbjct: 125 AEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181
Query: 619 KLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662
+ + I GT Y+APE PIT D+++ G++
Sbjct: 182 RKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 51/179 (28%), Positives = 85/179 (47%), Gaps = 32/179 (17%)
Query: 511 EREFQTE---MKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL--------- 558
+ +E MK+IG+ H+N++ LLG + ++ EY S G+L + L
Sbjct: 84 LSDLVSEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 141
Query: 559 ------FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKI 612
PE+Q + + + +ARG+ YL + IH D+ +N+L+ EN KI
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKI 198
Query: 613 SDFGLAKLMKPDQTRTFTG-----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
+DFGLA+ + T ++ APE + T ++DV+SFGV++ EI
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 32/179 (17%)
Query: 511 EREFQTE---MKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL--------- 558
+ +E MK+IG+ H+N++ LLG + ++ EY S G+L + L
Sbjct: 118 LSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 175
Query: 559 ------FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKI 612
NPE+Q + + + A +ARG+ YL + IH D+ +N+L+ E+ KI
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKI 232
Query: 613 SDFGLAKLMKPDQTRTFTG-----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
+DFGLA+ + T ++ APE + T ++DV+SFGV+L EI
Sbjct: 233 ADFGLARDIHHIDYYKKTTNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 38/171 (22%), Positives = 69/171 (40%), Gaps = 23/171 (13%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLE------VSKKILVYEYMSNGSLADIL-----FN 560
EF E + H ++ +L+G SL + +++ +M +G L L
Sbjct: 70 EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129
Query: 561 PEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620
+ DIA G+ YL IH D+ +N ++ E+ ++DFGL++
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRK 186
Query: 621 MKPDQTRTFTG-----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
+ ++ A E + TV +DV++FGV + EI+
Sbjct: 187 IYSGDYYRQGCASKLPVKWL----ALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 30/177 (16%)
Query: 511 EREFQTE---MKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL--------- 558
+ +E M +G H N+V LLG +++ EY G L + L
Sbjct: 93 KEALMSELKIMSHLG--QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLET 150
Query: 559 ----FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISD 614
+ + + + +A+G+ +L IH D+ +N+L+ AKI D
Sbjct: 151 DPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGD 207
Query: 615 FGLAKLMKPDQTRTFTG-----IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666
FGLA+ + D G ++ APE + TV++DV+S+G++L EI
Sbjct: 208 FGLARDIMNDSNYIVKGNARLPVKWM----APESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 14/174 (8%)
Query: 495 KMTDGFKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL 554
K + R E + E+ ++ + H N++ L + +L+ E +S G L
Sbjct: 43 KFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL 102
Query: 555 ADILFNPEKQPNWVER--MGIARDIARGILYLHDECETQIIHCDIKPQNILM----DENR 608
D L ++ + E + I G+ YLH + +I H D+KP+NI++
Sbjct: 103 FDFLA---QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156
Query: 609 CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662
K+ DFGLA ++ F I GT +VAPE P+ ++AD++S GV+
Sbjct: 157 HIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 30/204 (14%), Positives = 68/204 (33%), Gaps = 20/204 (9%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLL--GYSLEVSKKILVYEYM--SNGSLADILFNPEKQ-- 564
F ++ + ++R+ + V + +Y M + + ++L +
Sbjct: 147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 206
Query: 565 -PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623
R+ + + R + LH ++H ++P +I++D+ ++ F
Sbjct: 207 SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263
Query: 624 DQTRTFTGIRGTRGYVAPEW-----HRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPD 678
A H +T D ++ G+ + I C PN D
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL---PNTDD 320
Query: 679 DQVILEEWVYQCFENGNLSQLVED 702
+ EW+++ N+ Q V
Sbjct: 321 AALGGSEWIFR--SCKNIPQPVRA 342
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNPEKQ 564
RG + E + E+ V+ + H NL++L + +LV EY+ G L D I+ ++
Sbjct: 125 RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII---DES 181
Query: 565 PNWVER--MGIARDIARGILYLHDECETQIIHCDIKPQNILM--DENRCAKISDFGLAKL 620
N E + + I GI ++H I+H D+KP+NIL + + KI DFGLA+
Sbjct: 182 YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARR 238
Query: 621 MKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662
KP + GT ++APE ++ D++S GV+
Sbjct: 239 YKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 51/188 (27%), Positives = 79/188 (42%), Gaps = 49/188 (26%)
Query: 511 EREFQTE---MKVIGRTHHRNLVRLLGYSLEVSKKILV-YEYMSNGSLADILFN--PEKQ 564
R +E + IG H N+V LLG + ++V E+ G+L+ L + E
Sbjct: 74 HRALMSELKILIHIGH--HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 131
Query: 565 PNWVER-------------MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 611
P V + + +A+G+ +L + IH D+ +NIL+ E K
Sbjct: 132 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVK 188
Query: 612 ISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-------------TVKADVYSF 658
I DFGLA+ + D YV R LP+ T+++DV+SF
Sbjct: 189 ICDFGLARDIYKDPD-----------YVRKGDAR-LPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 659 GVVLLEII 666
GV+L EI
Sbjct: 237 GVLLWEIF 244
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 1e-22
Identities = 18/165 (10%), Positives = 42/165 (25%), Gaps = 16/165 (9%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGY--SLEVSKKILVYEYMS-----NGSLADILFNPEKQPN 566
+ +L V+ +L+ S S D ++
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192
Query: 567 WVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626
+ + + R L + ++H P N+ + + + D K
Sbjct: 193 ILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTR 247
Query: 627 RTFTGIRGTRGYVAPEW--HRNLPITVKADVYSFGVVLLEIICRR 669
+ Y E+ T + + G+ + + C
Sbjct: 248 GPASS--VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 43/197 (21%), Positives = 83/197 (42%), Gaps = 44/197 (22%)
Query: 502 EEVGRGSSG--------------------------EREFQTEMKVIGRTHHRNLVRLLGY 535
++G GS+G E+ ++ H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 536 SLEVSKKILVYEYMSNGSLADILFN---PEKQPNWVERMGIA---RDIARGILYLHDECE 589
L + ++ E++ G+L DI+ E+Q IA + + + YLH +
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ--------IATVCEAVLQALAYLHAQ-- 160
Query: 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI 649
+IH DIK +IL+ + K+SDFG + D + + + GT ++APE
Sbjct: 161 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLY 218
Query: 650 TVKADVYSFGVVLLEII 666
+ D++S G++++E++
Sbjct: 219 ATEVDIWSLGIMVIEMV 235
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 52/197 (26%), Positives = 89/197 (45%), Gaps = 44/197 (22%)
Query: 502 EEVGRGSSG--------------------------EREFQTEMKVIGRTHHRNLVRLLGY 535
E++G+G+SG + E+ V+ + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 536 SLEVSKKILVYEYMSNGSLADILFN---PEKQPNWVERMGIA---RDIARGILYLHDECE 589
L + +V EY++ GSL D++ E Q IA R+ + + +LH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ--------IAAVCRECLQALEFLHSN-- 135
Query: 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI 649
Q+IH DIK NIL+ + K++DFG + P+Q++ T + GT ++APE
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 193
Query: 650 TVKADVYSFGVVLLEII 666
K D++S G++ +E+I
Sbjct: 194 GPKVDIWSLGIMAIEMI 210
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 43/163 (26%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 511 EREFQTEMKVIGR-THHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLAD-ILFNPEKQPNW 567
E+ ++ + + H N+++L E + LV++ M G L D + EK
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDT-YETNTFFFLVFDLMKKGELFDYLT---EKV-TL 121
Query: 568 VERM--GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ 625
E+ I R + I LH I+H D+KP+NIL+D++ K++DFG + + P +
Sbjct: 122 SEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
Query: 626 TRTFTGIRGTRGYVAPE------WHRNLPITVKADVYSFGVVL 662
+ GT Y+APE + + D++S GV++
Sbjct: 179 --KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 43/198 (21%)
Query: 500 FKEEVGRGSSG---------------------------EREFQTEMKVIGRTHHRNLVRL 532
FK ++G G+ G + + E++V+ H N++++
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 533 LGYSLEVSKKI-LVYEYMSNGSLAD-ILFNPEKQPNWVERM--GIARDIARGILYLHDEC 588
E + +V E G L + I+ + E + + + + Y H +
Sbjct: 86 FEV-FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ- 143
Query: 589 ETQIIHCDIKPQNILM---DENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPE-WH 644
++H D+KP+NIL + KI DFGLA+L K D+ T GT Y+APE +
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFK 199
Query: 645 RNLPITVKADVYSFGVVL 662
R++ T K D++S GVV+
Sbjct: 200 RDV--TFKCDIWSAGVVM 215
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 508 SSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNPEKQPN 566
+ ++ +TE+ V+ R H N+++L ++ LV E ++ G L D I+ ++
Sbjct: 89 TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV----EKGY 144
Query: 567 WVERM--GIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKISDFGLAKLM 621
+ ER + I + YLH+ I+H D+KP+N+L + KI+DFGL+K++
Sbjct: 145 YSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201
Query: 622 KPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662
+ + GT GY APE R + D++S G++
Sbjct: 202 EHQVL--MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 46/175 (26%), Positives = 79/175 (45%), Gaps = 16/175 (9%)
Query: 495 KMTDGFKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL 554
K + R E + E+ ++ + H N++ L + +L+ E +S G L
Sbjct: 43 KFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL 102
Query: 555 AD-ILFNPEKQPNWVER--MGIARDIARGILYLHDECETQIIHCDIKPQNILM----DEN 607
D + ++ + E + I G+ YLH +I H D+KP+NI++
Sbjct: 103 FDFLA----QKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPI 155
Query: 608 RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662
K+ DFGLA ++ F I GT +VAPE P+ ++AD++S GV+
Sbjct: 156 PHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 16/164 (9%)
Query: 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNPEKQ 564
R + + E+ ++ H N++ L + IL+ E ++ G L D + ++
Sbjct: 53 RRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EK 108
Query: 565 PNWVER--MGIARDIARGILYLHDECETQIIHCDIKPQNILM----DENRCAKISDFGLA 618
+ E + I G+ YLH QI H D+KP+NI++ KI DFGLA
Sbjct: 109 ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
Query: 619 KLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662
+ F I GT +VAPE P+ ++AD++S GV+
Sbjct: 166 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 15/155 (9%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNPEKQPNWVERM- 571
+ E ++ + H N+VRL E S LV++ ++ G L + I+ ++ + E
Sbjct: 52 LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---ARE-FYSEADA 107
Query: 572 -GIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKISDFGLAKLMKPDQTR 627
+ I I Y H I+H ++KP+N+L+ + K++DFGLA + +
Sbjct: 108 SHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 162
Query: 628 TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662
+ G GT GY++PE + P + D+++ GV+L
Sbjct: 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.9 bits (237), Expect = 5e-22
Identities = 49/274 (17%), Positives = 89/274 (32%), Gaps = 29/274 (10%)
Query: 31 SNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSN-VSGRYYVGVFLAGIPEKTVVWTANRD 89
S + +LS SP+ + N V V++A + R+
Sbjct: 15 SVLPAYQTLSA--GQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFSSTIPLRN 72
Query: 90 DPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSAS------MLDSGNFVLYDS 143
A L F + L + + L + + +++ + D GN VL DS
Sbjct: 73 KK-----APLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDS 127
Query: 144 NGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINP 203
+ + L+ G++L G+ G L+ QGDGNLV Y
Sbjct: 128 LALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGA---GASKLVFQGDGNLVAY----- 179
Query: 204 YGTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGVNIF-NLTGGENPTKGMIYLMKID 262
A W + T KG V +G+L + ++ + TGG ++++
Sbjct: 180 GPNGAATWNAGTQGKG-AVRAVFQGDGNLVVYGAGNAVLWHSHTGGHAS-----AVLRLQ 233
Query: 263 SDGIFRLYSYNLRRQNSTWQVVWESTSDRCDPIG 296
++G + +Q +
Sbjct: 234 ANGSIAILDEKPVWARFGFQPTYRHIRKINPDQK 267
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.4 bits (132), Expect = 2e-08
Identities = 24/108 (22%), Positives = 37/108 (34%), Gaps = 13/108 (12%)
Query: 145 GKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPY 204
G+T T L Q LS G L +P+ +F L++QGDGNLV N
Sbjct: 3 GRTRIPFNGVGTSVLPAYQTLSAGQYL------LSPN-QRFKLLLQGDGNLVIQDN---- 51
Query: 205 GTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGVNIFNLTGGENPT 252
W +N + ++ L G + + +
Sbjct: 52 --GATVWVANEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWL 97
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.9 bits (115), Expect = 3e-06
Identities = 25/199 (12%), Positives = 52/199 (26%), Gaps = 39/199 (19%)
Query: 18 SSGCLTATAKQRRSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGI 77
LT + ++ + L + + L + P + + L
Sbjct: 93 RRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDSLALWNGTPAIPLVPGAIDSLLL--- 149
Query: 78 PEKTVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDSGN 137
+ + + L+F +G++V + + A A GN
Sbjct: 150 ---APGSELVQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGKGAVRAVFQGDGN 206
Query: 138 FVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQ 197
V+Y + LW S T +L +Q +G++
Sbjct: 207 LVVYGAGNAVLWH-------------------------SHTG-GHASAVLRLQANGSIAI 240
Query: 198 YANINPYGTQHAYWASNTY 216
+ WA +
Sbjct: 241 L-------DEKPVWARFGF 252
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 6e-22
Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 16/163 (9%)
Query: 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNPEKQ 564
+ + + E+ V+ + H N+V L + LV + +S G L D IL E+
Sbjct: 45 SPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL---ERG 101
Query: 565 PNWVERM--GIARDIARGILYLHDECETQIIHCDIKPQNIL---MDENRCAKISDFGLAK 619
+ E+ + + + + YLH+ I+H D+KP+N+L +EN I+DFGL+K
Sbjct: 102 -VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157
Query: 620 LMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662
+ + T GT GYVAPE P + D +S GV+
Sbjct: 158 MEQNGIMSTAC---GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 6e-22
Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 7/159 (4%)
Query: 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP 565
S + + E++ + H LV L + ++ +++YE+MS G L + + + +
Sbjct: 193 PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM 252
Query: 566 NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA--KISDFGLAKLMKP 623
+ E + R + +G+ ++H+ +H D+KP+NI+ R K+ DFGL + P
Sbjct: 253 SEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309
Query: 624 DQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662
Q+ GT + APE P+ D++S GV+
Sbjct: 310 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 47/216 (21%), Positives = 83/216 (38%), Gaps = 46/216 (21%)
Query: 486 LSFSYAELEKMTDGFKEEVGRGSSGE---------------------------REFQTEM 518
F+ +L+ + E+GRG+ G ++ ++
Sbjct: 17 WDFTAEDLKDL-----GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL 71
Query: 519 KVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWV--ERM--GI 573
V+ R+ +V+ G + E M + S + V E + I
Sbjct: 72 DVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKI 130
Query: 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIR 633
+ + +L + +IIH DIKP NIL+D + K+ DFG++ + +T
Sbjct: 131 TLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA-- 186
Query: 634 GTRGYVAPE----WHRNLPITVKADVYSFGVVLLEI 665
G R Y+APE V++DV+S G+ L E+
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 47/187 (25%), Positives = 80/187 (42%), Gaps = 36/187 (19%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV-----SKKI-LVYEYMSNGSLADILFN---P 561
+E +K + H N+V+L+ EV + +V+E ++ G + ++
Sbjct: 84 YQEIAI-LKKL---DHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLS 135
Query: 562 EKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM 621
E + +D+ +GI YLH +IIH DIKP N+L+ E+ KI+DFG++
Sbjct: 136 ED-----QARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 622 KPDQTRTFTGIRGTRGYVAPEWHRNLPITV---KADVYSFGVVLLEIICRRRCLDPNLP- 677
K GT ++APE DV++ GV L + + P
Sbjct: 188 KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ------CPF 240
Query: 678 DDQVILE 684
D+ I+
Sbjct: 241 MDERIMC 247
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 63/249 (25%), Positives = 100/249 (40%), Gaps = 43/249 (17%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGS-LADILFNPEKQPNWV 568
E KV H ++RLL + E + LV E L D + ++
Sbjct: 82 PLEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYI---TEKGPLG 137
Query: 569 ERMG--IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA-KISDFGLAKLMKPDQ 625
E + I + H ++H DIK +NIL+D R K+ DFG L+ +
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP 194
Query: 626 TRTFTGIRGTRGYVAPEWHRNLPIT-VKADVYSFGVVLLEIICRRRCLDPNLP--DDQVI 682
F GTR Y PEW + A V+S G++L +++C +P DQ I
Sbjct: 195 YTDFD---GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD------IPFERDQEI 245
Query: 683 LEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL---MLE 739
L E ++S +I+ C+ +PS RPS++++LL M
Sbjct: 246 L-EAELHF--PAHVS----------PDCCALIR---RCLAPKPSSRPSLEEILLDPWMQT 289
Query: 740 GTVEIPIPP 748
++P+ P
Sbjct: 290 PAEDVPLNP 298
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 45/193 (23%), Positives = 73/193 (37%), Gaps = 55/193 (28%)
Query: 512 REFQTE---MKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL---------- 558
+E M +G H N+V LLG L++EY G L + L
Sbjct: 93 EALMSELKMMTQLGS--HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 150
Query: 559 ------------FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDE 606
+ + + A +A+G+ +L +H D+ +N+L+
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTH 207
Query: 607 NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-------------TVKA 653
+ KI DFGLA+ + D YV R LP+ T+K+
Sbjct: 208 GKVVKICDFGLARDIMSDSN-----------YVVRGNAR-LPVKWMAPESLFEGIYTIKS 255
Query: 654 DVYSFGVVLLEII 666
DV+S+G++L EI
Sbjct: 256 DVWSYGILLWEIF 268
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 45/216 (20%), Positives = 82/216 (37%), Gaps = 49/216 (22%)
Query: 486 LSFSYAELEKMTDGFKEEVGRGSSGE---------------------------REFQTEM 518
+LE + E+G G+ G+ + ++
Sbjct: 20 YQAEINDLENL-----GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDL 74
Query: 519 KVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERM--GIAR 575
V+ ++H +V+ G + + + E M + P ER+ +
Sbjct: 75 DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIP---ERILGKMTV 131
Query: 576 DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL-AKLMKPDQTRTFTGIRG 634
I + + YL ++ +IH D+KP NIL+DE K+ DFG+ +L+ G
Sbjct: 132 AIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA---G 186
Query: 635 TRGYVAPE-----WHRNLPITVKADVYSFGVVLLEI 665
Y+APE ++ADV+S G+ L+E+
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 51/192 (26%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL------------ 558
R+ +E V+ + +H ++++L G + +L+ EY GSL L
Sbjct: 70 LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 559 -----------FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN 607
E+ + + A I++G+ YL E +++H D+ +NIL+ E
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEG 186
Query: 608 RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-------------TVKAD 654
R KISDFGL++ + + + YV R +P+ T ++D
Sbjct: 187 RKMKISDFGLSRDVYEEDS-----------YVKRSQGR-IPVKWMAIESLFDHIYTTQSD 234
Query: 655 VYSFGVVLLEII 666
V+SFGV+L EI+
Sbjct: 235 VWSFGVLLWEIV 246
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 39/165 (23%), Positives = 65/165 (39%), Gaps = 10/165 (6%)
Query: 504 VGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNPE 562
+ + E + H ++V LL +V+E+M L I+ +
Sbjct: 63 TSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRAD 122
Query: 563 KQPNWVERM--GIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKISDFGL 617
+ E + R I + Y HD IIH D+KP +L+ + + K+ FG+
Sbjct: 123 AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179
Query: 618 AKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662
A + G GT ++APE + P DV+ GV+L
Sbjct: 180 AIQLGESGLV-AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 3e-21
Identities = 44/163 (26%), Positives = 79/163 (48%), Gaps = 21/163 (12%)
Query: 511 EREFQTEMKVIGR-THHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLAD-ILFNPEKQPNW 567
+ E ++ + H +++ L+ E S + LV++ M G L D + EK
Sbjct: 143 REATRRETHILRQVAGHPHIITLIDS-YESSSFMFLVFDLMRKGELFDYLT---EKV-AL 197
Query: 568 VERM--GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ 625
E+ I R + + +LH I+H D+KP+NIL+D+N ++SDFG + ++P +
Sbjct: 198 SEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254
Query: 626 TRTFTGIRGTRGYVAPE------WHRNLPITVKADVYSFGVVL 662
+ GT GY+APE + + D+++ GV+L
Sbjct: 255 --KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 28/189 (14%)
Query: 502 EEVGRGSSGE------------------------REFQTEMKVIGRTHHRNLVRLLGYSL 537
E++G GS G +E E+ ++ + ++V+ G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 538 EVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDI 597
+ + +V EY GS++DI+ K E I + +G+ YLH + IH DI
Sbjct: 95 KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDI 151
Query: 598 KPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYS 657
K NIL++ AK++DFG+A + + T I GT ++APE + + AD++S
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADIWS 210
Query: 658 FGVVLLEII 666
G+ +E+
Sbjct: 211 LGITAIEMA 219
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-21
Identities = 51/182 (28%), Positives = 78/182 (42%), Gaps = 21/182 (11%)
Query: 495 KMTDGFKEEVGRGSSGERE-FQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNG 552
+ G + + E E+ ++ H N+++L E K LV E+ G
Sbjct: 73 QFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-FEDKKYFYLVTEFYEGG 131
Query: 553 SLAD-ILFNPEKQPNWVERM--GIARDIARGILYLHDECETQIIHCDIKPQNILM---DE 606
L + I+ + + E I + I GI YLH I+H DIKP+NIL+ +
Sbjct: 132 ELFEQII----NRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNS 184
Query: 607 NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPE-WHRNLPITVKADVYSFGVVLLEI 665
KI DFGL+ D GT Y+APE + K DV+S GV++ +
Sbjct: 185 LLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKKK--YNEKCDVWSCGVIMYIL 240
Query: 666 IC 667
+C
Sbjct: 241 LC 242
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 15/155 (9%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNPEKQPNWVERM- 571
+ E ++ + H N+VRL E S LV++ ++ G L + I+ ++ + E
Sbjct: 75 LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---ARE-FYSEADA 130
Query: 572 -GIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKISDFGLAKLMKPDQTR 627
+ I I Y H I+H ++KP+N+L+ + K++DFGLA + +
Sbjct: 131 SHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 185
Query: 628 TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662
+ G GT GY++PE + P + D+++ GV+L
Sbjct: 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 60/277 (21%), Positives = 100/277 (36%), Gaps = 87/277 (31%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL------------ 558
+ +FQ E ++ + N+V+LLG L++EYM+ G L + L
Sbjct: 94 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 559 -----------FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN 607
+ E++ IAR +A G+ YL E + +H D+ +N L+ EN
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGEN 210
Query: 608 RCAKISDFGLA-KLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-------------TVKA 653
KI+DFGL+ + D + +PI T ++
Sbjct: 211 MVVKIADFGLSRNIYSADYYK-----ADGNDA--------IPIRWMPPESIFYNRYTTES 257
Query: 654 DVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLER- 712
DV+++GVVL EI + ++VI +GN+ L
Sbjct: 258 DVWAYGVVLWEIFSYGLQPYYGMAHEEVI------YYVRDGNI-------------LACP 298
Query: 713 ----------MIKVALWCILDEPSLRPSMKKVLLMLE 739
M C P+ RPS + +L+
Sbjct: 299 ENCPLELYNLM----RLCWSKLPADRPSFCSIHRILQ 331
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 39/195 (20%)
Query: 502 EEVGRGSSGE---------------------------REFQTEMKVIGRTHHRNLVRLLG 534
E++G+GS GE + Q E+ V+ + + + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 535 YSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIA---RDIARGILYLHDECETQ 591
L+ +K ++ EY+ GS D+L +P ++ IA R+I +G+ YLH E +
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSE---K 139
Query: 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITV 651
IH DIK N+L+ E+ K++DFG+A + Q + T + GT ++APE +
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 198
Query: 652 KADVYSFGVVLLEII 666
KAD++S G+ +E+
Sbjct: 199 KADIWSLGITAIELA 213
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 41/172 (23%), Positives = 76/172 (44%), Gaps = 19/172 (11%)
Query: 500 FKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-IL 558
F R + +TE++++ + +H ++++ + + +V E M G L D ++
Sbjct: 48 FAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV 106
Query: 559 FNPEKQPNWVERM--GIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKIS 613
+ E + + YLH+ IIH D+KP+N+L+ +E+ KI+
Sbjct: 107 ---GNK-RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159
Query: 614 DFGLAKLMKPDQTRTFTGIRGTRGYVAPE---WHRNLPITVKADVYSFGVVL 662
DFG +K++ + GT Y+APE D +S GV+L
Sbjct: 160 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 7e-21
Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 16/168 (9%)
Query: 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNPEKQ 564
+ + + E++++ + H N+++L + + LV E + G L D I+ +
Sbjct: 65 KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII----SR 120
Query: 565 PNWVERM--GIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKISDFGLAK 619
+ E I R + GI Y+H +I+H D+KP+N+L+ ++ +I DFGL+
Sbjct: 121 KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177
Query: 620 LMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
+ + GT Y+APE K DV+S GV+L ++
Sbjct: 178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLS 222
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 8e-21
Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 21/173 (12%)
Query: 500 FKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-IL 558
F R + +TE++++ + +H ++++ + + +V E M G L D ++
Sbjct: 173 FAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV 231
Query: 559 FN---PEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKI 612
N E + + YLH+ IIH D+KP+N+L+ +E+ KI
Sbjct: 232 GNKRLKEA-----TCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283
Query: 613 SDFGLAKLMKPDQTRTFTGIRGTRGYVAPE---WHRNLPITVKADVYSFGVVL 662
+DFG +K++ + GT Y+APE D +S GV+L
Sbjct: 284 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 16/166 (9%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNPEKQPNWVE 569
+ E+ V+ H N+++L + + LV E G L D I+ + + E
Sbjct: 80 NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII----HRMKFNE 135
Query: 570 RM--GIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKISDFGLAKLMKPD 624
I + + G+ YLH I+H D+KP+N+L+ +++ KI DFGL+ + +
Sbjct: 136 VDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192
Query: 625 QTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670
+ GT Y+APE R K DV+S GV+L ++
Sbjct: 193 K--KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYP 235
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-20
Identities = 30/137 (21%), Positives = 53/137 (38%), Gaps = 26/137 (18%)
Query: 156 TDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNT 215
+D L +L G L + G +L I+Q D NLV Y N A WAS T
Sbjct: 1 SDRLNSGHQLDTGGSL---------AEGGYLFIIQNDCNLVLYDN------NRAVWASGT 45
Query: 216 YNKGDNVSLNLDENGHLFLMNTTGVNIFNLTGGENPTKGMIYLMKIDSDGIFRLYSYNLR 275
K L + +G+L + + + + T +N Y + + D +Y
Sbjct: 46 NGKASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGN----YYLILQRDRNVVIY----- 96
Query: 276 RQNSTWQVVWESTSDRC 292
+++ +W + ++
Sbjct: 97 --DNSNNAIWATHTNVG 111
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 1e-08
Identities = 16/95 (16%), Positives = 34/95 (35%), Gaps = 6/95 (6%)
Query: 61 QSNVSGRYYVGVF----LAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQ 116
S G Y + L VW + ++ L ++G++V+ S ++
Sbjct: 14 GSLAEGGYLFIIQNDCNLVLYDNNRAVWASGT--NGKASGCVLKMQNDGNLVIYSGSRAI 71
Query: 117 DSLIADDSQSASSASMLDSGNFVLYDSNGKTLWQT 151
+ + + N V+YD++ +W T
Sbjct: 72 WASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWAT 106
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 48/196 (24%), Positives = 79/196 (40%), Gaps = 40/196 (20%)
Query: 498 DGFKEEVGRGSSG------EREFQTE--MKVIGR----------------THHRNLVRLL 533
D + +G GS ++ +K+I + H N+V+L
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 534 GYSLEVSKKI-LVYEYMSNGSLAD-ILFNPEKQPNWVERM--GIARDIARGILYLHDECE 589
LV E ++ G L + I K+ ++ E I R + + ++HD
Sbjct: 73 EV-FHDQLHTFLVMELLNGGELFERIK----KKKHFSETEASYIMRKLVSAVSHMHDV-- 125
Query: 590 TQIIHCDIKPQNILM---DENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN 646
++H D+KP+N+L ++N KI DFG A+L PD + T Y APE
Sbjct: 126 -GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCFTLHYAAPELLNQ 183
Query: 647 LPITVKADVYSFGVVL 662
D++S GV+L
Sbjct: 184 NGYDESCDLWSLGVIL 199
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 18/161 (11%)
Query: 509 SGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLAD-ILFNPEKQPN 566
F+ E++++ H N++RL E + I LV E + G L + ++ +
Sbjct: 48 EDVDRFKQEIEIMKSLDHPNIIRLYET-FEDNTDIYLVMELCTGGELFERVV----HKRV 102
Query: 567 WVERM--GIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKISDFGLAKLM 621
+ E I +D+ + Y H + H D+KP+N L + K+ DFGLA
Sbjct: 103 FRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159
Query: 622 KPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662
KP + GT YV+P+ + D +S GV++
Sbjct: 160 KPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMM 197
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 42/196 (21%), Positives = 86/196 (43%), Gaps = 35/196 (17%)
Query: 502 EEVGRGSSGE--------------------------REFQTEMKVIGRTHHRNLVRLLGY 535
E+G G+ G+ ++ E++++ H +V+LLG
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 536 SLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHC 595
K ++ E+ G++ I+ ++ + + R + + +LH + +IIH
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHR 141
Query: 596 DIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPE-----WHRNLPIT 650
D+K N+LM +++DFG++ + + I GT ++APE ++ P
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPYD 200
Query: 651 VKADVYSFGVVLLEII 666
KAD++S G+ L+E+
Sbjct: 201 YKADIWSLGITLIEMA 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-20
Identities = 40/155 (25%), Positives = 77/155 (49%), Gaps = 14/155 (9%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNPEKQPNWVERM- 571
+ E ++ H N+VRL E L+++ ++ G L + I+ + + E
Sbjct: 57 LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV----AREYYSEADA 112
Query: 572 -GIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKISDFGLAKLMKPDQTR 627
+ I +L+ H ++H ++KP+N+L+ + K++DFGLA ++ +Q +
Sbjct: 113 SHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-Q 168
Query: 628 TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662
+ G GT GY++PE R P D+++ GV+L
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 18/156 (11%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLAD-ILFNPEKQPNWVERM 571
E++++ + H N+++L LE S +V E + G L D I+ K+ + E
Sbjct: 68 ILREVELLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGELFDEII----KRKRFSEHD 122
Query: 572 --GIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKISDFGLAKLMKPDQT 626
I + + GI Y+H I+H D+KP+NIL+ +++ KI DFGL+ + +
Sbjct: 123 AARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178
Query: 627 RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662
GT Y+APE R K DV+S GV+L
Sbjct: 179 -KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-20
Identities = 47/163 (28%), Positives = 78/163 (47%), Gaps = 20/163 (12%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLAD-ILFNPEKQPNWVER 570
E++++ + H N+++L LE S +V E + G L D I+ K+ + E
Sbjct: 67 TILREVELLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGELFDEII----KRKRFSEH 121
Query: 571 M--GIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKISDFGLAKLMKPDQ 625
I + + GI Y+H I+H D+KP+NIL+ +++ KI DFGL+ + +
Sbjct: 122 DAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
Query: 626 TRTFTGIRGTRGYVAPE-WHRNLPITVKADVYSFGVVLLEIIC 667
GT Y+APE K DV+S GV+L ++
Sbjct: 179 --KMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLS 217
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 50/194 (25%), Positives = 79/194 (40%), Gaps = 40/194 (20%)
Query: 500 FKEEVGRGSSG------EREFQTE--MKVIGRT---------------HHRNLVRLLGYS 536
KE++G GS + E +K+I ++ H N++ L
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDV- 84
Query: 537 LEVSKKI-LVYEYMSNGSLAD-ILFNPEKQPNWVERM--GIARDIARGILYLHDECETQI 592
+ K + +V E M G L D IL +Q + ER + I + + YLH + +
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ---GV 137
Query: 593 IHCDIKPQNILM----DENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP 648
+H D+KP NIL +I DFG AK ++ + T +VAPE
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTPCYTANFVAPEVLERQG 196
Query: 649 ITVKADVYSFGVVL 662
D++S GV+L
Sbjct: 197 YDAACDIWSLGVLL 210
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 42/204 (20%)
Query: 502 EEVGRGSSGE---------------------------REFQTEMKVIGRTHHRNLVRLLG 534
E +G G++ E E++ + + HH N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 535 YSLEVSKKILVYEYMSNGSLADIL----FNPEKQPNWVERMGIA---RDIARGILYLHDE 587
+ + LV + +S GS+ DI+ E + ++ IA R++ G+ YLH
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIR----GTRGYVAPE- 642
IH D+K NIL+ E+ +I+DFG++ + T +R GT ++APE
Sbjct: 141 ---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 643 WHRNLPITVKADVYSFGVVLLEII 666
+ KAD++SFG+ +E+
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELA 221
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 54/233 (23%), Positives = 94/233 (40%), Gaps = 42/233 (18%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSN-GSLADILFNPEKQPNWV 568
E +K + + ++RLL + E L+ E L D + ++
Sbjct: 94 PMEVVL-LKKV-SSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFI---TERGALQ 147
Query: 569 ERM--GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC-AKISDFGLAKLMKPDQ 625
E + + + + H+ ++H DIK +NIL+D NR K+ DFG L+K
Sbjct: 148 EELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 204
Query: 626 TRTFTGIRGTRGYVAPEWHRNLPIT-VKADVYSFGVVLLEIICRRRCLDPNLP--DDQVI 682
F GTR Y PEW R A V+S G++L +++C +P D+ I
Sbjct: 205 YTDFD---GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------IPFEHDEEI 255
Query: 683 LEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+ +S + + +I+ WC+ PS RP+ +++
Sbjct: 256 I-RGQVFF--RQRVS----------SECQHLIR---WCLALRPSDRPTFEEIQ 292
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 43/163 (26%), Positives = 68/163 (41%), Gaps = 23/163 (14%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGY---SLEVSKKI-LVYEYMSNGSLAD-ILFNPEKQP 565
+E + G ++V +L + + ++ E M G L I E+
Sbjct: 69 RQEVDHHWQASG---GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ---ERGD 122
Query: 566 NW-VERM--GIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKISDFGLAK 619
ER I RDI I +LH I H D+KP+N+L +++ K++DFG AK
Sbjct: 123 QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 620 LMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662
+ +T T YVAPE D++S GV++
Sbjct: 180 ETTQNALQTPC---YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 3e-19
Identities = 31/165 (18%), Positives = 62/165 (37%), Gaps = 16/165 (9%)
Query: 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMG 572
Q E+ V +H N+V + ++ +V +M+ GS D++ + + +
Sbjct: 72 FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELA 129
Query: 573 IA---RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
IA + + + + Y+H +H +K +IL+ + +S M R
Sbjct: 130 IAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR 186
Query: 630 TGIRGTRGYV------APE--WHRNLPITVKADVYSFGVVLLEII 666
+ V +PE K+D+YS G+ E+
Sbjct: 187 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 47/193 (24%), Positives = 78/193 (40%), Gaps = 50/193 (25%)
Query: 501 KEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLG-YSLEVSKKI-LVYEYMSNGSLADIL 558
K+++ R +GE + E++++ R H+N+++L+ E +K+ +V EY G +
Sbjct: 40 KKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--M 97
Query: 559 FN-------PEKQPNWVERMGIARD----IARGILYLHDECETQIIHCDIKPQNILMDEN 607
+ P Q A + G+ YLH + I+H DIKP N+L+
Sbjct: 98 LDSVPEKRFPVCQ---------AHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTG 145
Query: 608 RCAKISDFGLAKLMKPDQT----RTFTG---------IRGTRGYVAPEWHRNLPITVKAD 654
KIS G+A+ + P RT G G + K D
Sbjct: 146 GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGF----------KVD 195
Query: 655 VYSFGVVLLEIIC 667
++S GV L I
Sbjct: 196 IWSAGVTLYNITT 208
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 49/174 (28%), Positives = 84/174 (48%), Gaps = 22/174 (12%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYS-LEVSKKI-LVYEYMSNGSLADILFNPEKQPNWV 568
+RE Q +K+ H ++++L Y + +V EY+S G L D + +
Sbjct: 59 KREIQN-LKLF---RHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEME 112
Query: 569 ERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-R 627
R + + I + Y H ++H D+KP+N+L+D + AKI+DFGL+ +M + R
Sbjct: 113 ARR-LFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 168
Query: 628 TFTGIRGTRGYVAPEWHRNLPIT-VKADVYSFGVVLLEIICRRRCL---DPNLP 677
T G+ Y APE + D++S GV+L ++C L D ++P
Sbjct: 169 TSC---GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT--LPFDDEHVP 217
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 6e-19
Identities = 51/215 (23%), Positives = 81/215 (37%), Gaps = 52/215 (24%)
Query: 501 KEEVGRGSSGERE-FQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLAD-I 557
K ++ + + + E +TE++++ + HH N+ RL E + I LV E G L D +
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKL 119
Query: 558 LFNPEKQPNWVERMG--------------------------------------IARDIAR 579
+ I R I
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179
Query: 580 GILYLHDECETQIIHCDIKPQNILM--DENRCAKISDFGLAKLM---KPDQTRTFTGIRG 634
+ YLH++ I H DIKP+N L +++ K+ DFGL+K + T G
Sbjct: 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 635 TRGYVAPE--WHRNLPITVKADVYSFGVVLLEIIC 667
T +VAPE N K D +S GV+L ++
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 46/205 (22%)
Query: 502 EEVGRGSSG-------------------------EREFQTEMKVIGRT-HHRNLVRLLGY 535
E VG G+ G E E + E+ ++ + HHRN+ G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 536 SLEVSKKI------LVYEYMSNGSLADILFNPEKQPNWVERMGIA---RDIARGILYLHD 586
++ + LV E+ GS+ D++ N + ++ IA R+I RG+ +LH
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT--LKEEWIAYICREILRGLSHLHQ 147
Query: 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPE---- 642
++IH DIK QN+L+ EN K+ DFG++ + R T I GT ++APE
Sbjct: 148 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIAC 203
Query: 643 -WHRNLPITVKADVYSFGVVLLEII 666
+ + K+D++S G+ +E+
Sbjct: 204 DENPDATYDFKSDLWSLGITAIEMA 228
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-19
Identities = 54/211 (25%), Positives = 81/211 (38%), Gaps = 42/211 (19%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVE 569
++E K++ +H N+V+ G+ L EY S G L D +
Sbjct: 53 KKEICI-NKML---NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---------EP 98
Query: 570 RMGIARDIAR--------GILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM 621
+G+ A+ G++YLH I H DIKP+N+L+DE KISDFGLA +
Sbjct: 99 DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 155
Query: 622 KPDQTRTFTGIR-GTRGYVAPEWHRNLPIT-VKADVYSFGVVLLEIICRRRCLDPNLP-D 678
+ + GT YVAPE + DV+S G+VL ++ LP D
Sbjct: 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE------LPWD 209
Query: 679 DQ----VILEEWV---YQCFENGNLSQLVED 702
+W +
Sbjct: 210 QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 9e-19
Identities = 38/149 (25%), Positives = 67/149 (44%), Gaps = 10/149 (6%)
Query: 521 IGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGIARDIAR 579
+ +V + Y+ K+ + + M+ G L L R A +I
Sbjct: 246 VSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIIL 303
Query: 580 GILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYV 639
G+ ++H+ +++ D+KP NIL+DE+ +ISD GLA + GT GY+
Sbjct: 304 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 357
Query: 640 APE-WHRNLPITVKADVYSFGVVLLEIIC 667
APE + + AD +S G +L +++
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLR 386
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 43/162 (26%), Positives = 64/162 (39%), Gaps = 20/162 (12%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGY---SLEVSKKI-LVYEYMSNGSLAD-ILFNPEKQP 565
RE + + ++VR++ K + +V E + G L I
Sbjct: 102 RREVELHWRASQ---CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQ 156
Query: 566 NWVERM--GIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKISDFGLAKL 620
+ ER I + I I YLH I H D+KP+N+L N K++DFG AK
Sbjct: 157 AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213
Query: 621 MKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662
+ T T YVAPE D++S GV++
Sbjct: 214 TTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 2e-18
Identities = 33/140 (23%), Positives = 53/140 (37%), Gaps = 30/140 (21%)
Query: 157 DTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTY 216
+ LL Q L L G + L +Q NLV+Y N WASNT
Sbjct: 3 NVLLSGQTLHADHSL---------QAGAYTLTIQNKCNLVKYQN------GRQIWASNTD 47
Query: 217 NKGDNVSLNLDENGHLFLMNTTGVNIF-NLTGGENPTKGMIYLMKIDSDGIFRLYSYNLR 275
+G L L +G+L + + +++ + G+N Y + + DG F +Y
Sbjct: 48 RRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGK----YALVLQKDGRFVIYG---- 99
Query: 276 RQNSTWQVVWESTSDRCDPI 295
V+W + C +
Sbjct: 100 ------PVLWSLGPNGCRRV 113
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-09
Identities = 24/132 (18%), Positives = 41/132 (31%), Gaps = 33/132 (25%)
Query: 87 NRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDSGNFVLYDSNGK 146
+ D + TL ++ ++V + + + D S ++L GN V+YD N
Sbjct: 12 HADHSLQAGAYTLTIQNKCNLVKYQNGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNN 71
Query: 147 TLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGT 206
+W S GK+ L++Q DG V Y
Sbjct: 72 DVWG-------------------------SACWGDNGKYALVLQKDGRFVIYGP------ 100
Query: 207 QHAYWASNTYNK 218
W+
Sbjct: 101 --VLWSLGPNGC 110
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-18
Identities = 51/157 (32%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSL-ADILFNPEKQPNWVERMG 572
E K++ + H R +V L Y+ E + LV M+ G + I E P + E
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 573 I--ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
I I G+ +LH II+ D+KP+N+L+D++ +ISD GLA +K QT+T
Sbjct: 292 IFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348
Query: 631 GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
GT G++APE D ++ GV L E+I
Sbjct: 349 YA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 54/211 (25%), Positives = 81/211 (38%), Gaps = 42/211 (19%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVE 569
++E K++ +H N+V+ G+ L EY S G L D +
Sbjct: 53 KKEICI-NKML---NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---------EP 98
Query: 570 RMGIARDIAR--------GILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM 621
+G+ A+ G++YLH I H DIKP+N+L+DE KISDFGLA +
Sbjct: 99 DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 155
Query: 622 KPDQTRTFTGIR-GTRGYVAPEWHRNLPIT-VKADVYSFGVVLLEIICRRRCLDPNLP-D 678
+ + GT YVAPE + DV+S G+VL ++ LP D
Sbjct: 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE------LPWD 209
Query: 679 DQ----VILEEWV---YQCFENGNLSQLVED 702
+W +
Sbjct: 210 QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGIA 574
E +++ + + R +V L Y+ E + LV M+ G D+ F+ A
Sbjct: 233 NEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGG---DLKFHIYHMGQAGFPEARA 288
Query: 575 R----DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ-TRTF 629
+I G+ LH E +I++ D+KP+NIL+D++ +ISD GLA + Q +
Sbjct: 289 VFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 345
Query: 630 TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
GT GY+APE +N T D ++ G +L E+I
Sbjct: 346 V---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 40/183 (21%), Positives = 70/183 (38%), Gaps = 43/183 (23%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKK-------ILVYEYMSNGSLADIL--FNPE 562
RE Q M+ + HH N+V+L Y + ++ +V EY+ + +L +
Sbjct: 65 RELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR 122
Query: 563 KQPNWVERMGIARD--------IARGILYLHDECETQIIHCDIKPQNILMDENRCA-KIS 613
+ + R I LH + H DIKP N+L++E K+
Sbjct: 123 QVA-------PPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLC 174
Query: 614 DFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-------TVKADVYSFGVVLLEII 666
DFG AK + P + Y+ ++R + T D++S G + E++
Sbjct: 175 DFGSAKKLSPSEPNV--------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226
Query: 667 CRR 669
Sbjct: 227 LGE 229
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 64/261 (24%), Positives = 114/261 (43%), Gaps = 48/261 (18%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYS-LEVSKKI-LVYEYMSNGSLADILFNPEKQPNWV 568
RE Q +K+ H ++++L Y + I +V EY+S G L D + +
Sbjct: 64 RREIQN-LKLF---RHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE 117
Query: 569 ERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-R 627
R + + I G+ Y H ++H D+KP+N+L+D + AKI+DFGL+ +M + R
Sbjct: 118 SRR-LFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 173
Query: 628 TFTGIRGTRGYVAPEWHRNLP-ITVKADVYSFGVVLLEIICRRRCLDPNLP-DDQVILEE 685
T G+ Y APE + D++S GV+L ++C LP DD +
Sbjct: 174 TSC---GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT------LPFDDDHVPT- 223
Query: 686 WVYQCFENGN------LSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL---L 736
+++ +G L+ V L+ M++V +P R ++K +
Sbjct: 224 -LFKKICDGIFYTPQYLNPSVIS------LLKHMLQV-------DPMKRATIKDIREHEW 269
Query: 737 MLEGTVEIPIPPNPTSFLSAI 757
+ + P +P+ + I
Sbjct: 270 FKQDLPKYLFPEDPSYSSTMI 290
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 52/215 (24%), Positives = 79/215 (36%), Gaps = 48/215 (22%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV---SKKI-LVYEYMSNGSLADILFNPEKQPN 566
+RE + + H N+VR EV + ++ EY S G L + +
Sbjct: 64 QREIIN-HRSL---RHPNIVRFK----EVILTPTHLAIIMEYASGGELYERI-------- 107
Query: 567 WVERMGIARDIAR--------GILYLHDECETQIIHCDIKPQNILMDENRCA--KISDFG 616
+ D AR G+ Y H QI H D+K +N L+D + KI DFG
Sbjct: 108 -CNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG 163
Query: 617 LAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPIT-VKADVYSFGVVLLEIICRRRCL-- 672
+K ++ GT Y+APE ADV+S GV L ++
Sbjct: 164 YSKSSVLHSQPKSTV---GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA--YPF 218
Query: 673 -DPNLPDDQVILEEWV----YQCFENGNLSQLVED 702
DP P D + + Y ++ +S
Sbjct: 219 EDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH 253
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 23/174 (13%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYS-LEVSKKI-LVYEYMSNGSLADILFNPEKQPNWV 568
ERE +K++ H ++++L Y + I +V EY + G L D + ++
Sbjct: 57 EREISY-LKLL---RHPHIIKL--YDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDE 109
Query: 569 ERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-R 627
R + I I Y H I+H D+KP+N+L+D+N KI+DFGL+ +M +
Sbjct: 110 GRR-FFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK 165
Query: 628 TFTGIRGTRGYVAPEWHRNLPIT-VKADVYSFGVVLLEIICRRRCL---DPNLP 677
T G+ Y APE + DV+S G+VL ++ R L D +P
Sbjct: 166 TSC---GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR--LPFDDEFIP 214
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 29/170 (17%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLAD-ILFNPEKQPNWV 568
RE + + G HRN++ L+ + E + LV+E M GS+ I K+ ++
Sbjct: 58 FREVEMLYQCQG---HRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIH----KRRHFN 109
Query: 569 ERM--GIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKISDFGLAKLMKP 623
E + +D+A + +LH++ I H D+KP+NIL ++ KI DF L +K
Sbjct: 110 ELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166
Query: 624 DQTRTFTGIR------GTRGYVAPE-----WHRNLPITVKADVYSFGVVL 662
+ + G+ Y+APE + D++S GV+L
Sbjct: 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 46/180 (25%), Positives = 77/180 (42%), Gaps = 20/180 (11%)
Query: 494 EKMTDGFKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNG 552
EK+ + E + E + + H N++++L E LV E +G
Sbjct: 60 EKVLEDCWIEDPKLGKVTLEIAI-LSRV---EHANIIKVLDI-FENQGFFQLVMEKHGSG 114
Query: 553 S-LADILFNPEKQPNWVERMG--IARDIARGILYLHDECETQIIHCDIKPQNILMDENRC 609
L + ++ P E + I R + + YL + IIH DIK +NI++ E+
Sbjct: 115 LDLFAFI---DRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFT 168
Query: 610 AKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLP-ITVKADVYSFGVVLLEIIC 667
K+ DFG A ++ + TF GT Y APE P + +++S GV L ++
Sbjct: 169 IKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 8e-18
Identities = 51/197 (25%), Positives = 78/197 (39%), Gaps = 41/197 (20%)
Query: 502 EEVGRGSSGE-----------------------------REFQTEMKVIGRTHHRNLVRL 532
E+G GS G ++ E++ + + H N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 533 LGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQI 592
G L LV EY GS +D+L +K VE + +G+ YLH +
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 175
Query: 593 IHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPE---WHRNLPI 649
IH D+K NIL+ E K+ DFG A +M +F GT ++APE
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIM--APANSFV---GTPYWMAPEVILAMDEGQY 230
Query: 650 TVKADVYSFGVVLLEII 666
K DV+S G+ +E+
Sbjct: 231 DGKVDVWSLGITCIELA 247
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 1e-17
Identities = 25/132 (18%), Positives = 42/132 (31%), Gaps = 26/132 (19%)
Query: 158 TLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTYN 217
LL + +L S +MQGD NLV Y + SNT+
Sbjct: 4 VLLTGDVIHTDNQL---------SYESAAFVMQGDCNLVLYNEA-------GGFQSNTHG 47
Query: 218 KGDNVSLNLDENGHLFLMNTTGVNIFNLTGGENPTKGMIYLMKIDSDGIFRLYSYNLRRQ 277
+G + +L L+ G L + + + T Y + D +Y
Sbjct: 48 RGVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG------ 101
Query: 278 NSTWQVVWESTS 289
+W + +
Sbjct: 102 ----PAIWSTPA 109
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-06
Identities = 10/87 (11%), Positives = 22/87 (25%), Gaps = 32/87 (36%)
Query: 130 ASMLDSGNFVLYDSNGKT-LWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLI 188
+ + G ++ +N T +W N G +
Sbjct: 54 LRLNNRGQLEIHSANSNTPVWVY-----------------------PRSVNTVRGNYAAT 90
Query: 189 MQGDGNLVQYANINPYGTQHAYWASNT 215
+ D ++ Y A W++
Sbjct: 91 LGPDQHVTIYG--------PAIWSTPA 109
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-06
Identities = 19/123 (15%), Positives = 35/123 (28%), Gaps = 31/123 (25%)
Query: 114 QSQDSLIADDSQSASS--ASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKL 171
+ D + D+ S S M N VLY+ +Q
Sbjct: 6 LTGDVIHTDNQLSYESAAFVMQGDCNLVLYN--EAGGFQ--------------------- 42
Query: 172 FPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTYNKGDNVSLNLDENGH 231
S T+ L + G L ++ + T + + N + L + H
Sbjct: 43 ----SNTHGRGVDCTLRLNNRGQLEIHSANS--NTPVWVYPRSVNTVRGNYAATLGPDQH 96
Query: 232 LFL 234
+ +
Sbjct: 97 VTI 99
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 3e-17
Identities = 25/136 (18%), Positives = 49/136 (36%), Gaps = 28/136 (20%)
Query: 155 PTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASN 214
+ L +Q + +L +T + L+M+ D NLV + W S
Sbjct: 5 VRNVLFSSQVMYDNAQL---------ATRDYSLVMRDDCNLVLTKG----SKTNIVWESG 51
Query: 215 TYNKGDNVSLNLDENGHLFLMNTTGVNIFNL-TGGENPTKGMIYLMKIDSDGIFRLYSYN 273
T +G + + L +G L + + +F T G+ Y++ + +G +Y
Sbjct: 52 TSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGD----YVLILQINGQAVVYG-- 105
Query: 274 LRRQNSTWQVVWESTS 289
VW + +
Sbjct: 106 --------PAVWSTAA 113
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 7e-09
Identities = 18/131 (13%), Positives = 38/131 (29%), Gaps = 35/131 (26%)
Query: 87 NRDDPPVSTNATLLFNSEGSIVLRSSQQSQD--SLIADDSQSASSASMLDSGNFVLYDSN 144
+ + + +L+ + ++VL ++ + SG + D
Sbjct: 16 YDNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR 75
Query: 145 GKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPY 204
T++ S T G ++LI+Q +G V Y
Sbjct: 76 LNTVFV-------------------------SNTVGQEGDYVLILQINGQAVVY------ 104
Query: 205 GTQHAYWASNT 215
A W++
Sbjct: 105 --GPAVWSTAA 113
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 5e-17
Identities = 32/156 (20%), Positives = 55/156 (35%), Gaps = 38/156 (24%)
Query: 137 NFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLV 196
N +++ Q ++ L + L E T + IMQ D NLV
Sbjct: 1 NNIIFSK------QPDDNHPQILHATESL-----------EILFGTHVYRFIMQTDCNLV 43
Query: 197 QYANINPYGTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGVNIF-NLTGGENPTKGM 255
Y N NP WA+NT G+ L +G L ++ V ++ + G+
Sbjct: 44 LYDNNNPI------WATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGH--- 94
Query: 256 IYLMKIDSDGIFRLYSYNLRRQNSTWQVVWESTSDR 291
Y++ + D +Y +W + + R
Sbjct: 95 -YVLVLQPDRNVVIYG----------DALWATQTVR 119
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 2e-12
Identities = 21/136 (15%), Positives = 44/136 (32%), Gaps = 34/136 (25%)
Query: 82 VVWTANRDDPPVSTNA-TLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDSGNFVL 140
++ + T+ + ++ ++VL + + + A + G V+
Sbjct: 16 ILHATESLEILFGTHVYRFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVV 75
Query: 141 YDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYAN 200
+ T+WQ S G ++L++Q D N+V Y +
Sbjct: 76 ITNENVTVWQ-------------------------SPVAGKAGHYVLVLQPDRNVVIYGD 110
Query: 201 INPYGTQHAYWASNTY 216
A WA+ T
Sbjct: 111 --------ALWATQTV 118
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 1e-09
Identities = 27/139 (19%), Positives = 40/139 (28%), Gaps = 40/139 (28%)
Query: 108 VLRSSQQSQDS---LIADDSQSASSAS------MLDSGNFVLYDSNGKTLWQTFEHPTDT 158
++ S Q + L A +S + M N VLYD N +W T
Sbjct: 3 IIFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYD-NNNPIWATNTG---- 57
Query: 159 LLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTYNK 218
G ++Q DG LV N N W S K
Sbjct: 58 --------------------GLGNGCR-AVLQPDGVLVVITNEN-----VTVWQSPVAGK 91
Query: 219 GDNVSLNLDENGHLFLMNT 237
+ L L + ++ +
Sbjct: 92 AGHYVLVLQPDRNVVIYGD 110
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 6e-17
Identities = 31/132 (23%), Positives = 49/132 (37%), Gaps = 30/132 (22%)
Query: 157 DTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTY 216
+ L + LS G L + G+++ IMQ D NLV Y WA+NT
Sbjct: 2 NILYSGETLSPGEFL---------NNGRYVFIMQEDCNLVLYDV------DKPIWATNTG 46
Query: 217 NKGDNVSLNLDENGHLFLMNTTGVNIFNL-TGGENPTKGMIYLMKIDSDGIFRLYSYNLR 275
L++ +G+L + + I+ TGGEN Y+ + D +Y
Sbjct: 47 GLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGN----YVCVLQKDRNVVIYG---- 98
Query: 276 RQNSTWQVVWES 287
W +
Sbjct: 99 ------TARWAT 104
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 2e-11
Identities = 21/121 (17%), Positives = 35/121 (28%), Gaps = 33/121 (27%)
Query: 96 NATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDSGNFVLYDSNGKTLWQTFEHP 155
+ + ++VL + + SM GN V+Y +W
Sbjct: 20 RYVFIMQEDCNLVLYDVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWA----- 74
Query: 156 TDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNT 215
S T G ++ ++Q D N+V Y A WA+ T
Sbjct: 75 --------------------SNTGGENGNYVCVLQKDRNVVIYGT--------ARWATGT 106
Query: 216 Y 216
Sbjct: 107 N 107
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGIA 574
E V+ R H V+L ++ + +K+ Y NG L + R A
Sbjct: 79 RERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137
Query: 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP--DQTRTFTGI 632
+I + YLH + IIH D+KP+NIL++E+ +I+DFG AK++ P Q R +
Sbjct: 138 -EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-F 192
Query: 633 RGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
GT YV+PE +D+++ G ++ +++
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 5e-16
Identities = 27/118 (22%), Positives = 45/118 (38%), Gaps = 21/118 (17%)
Query: 155 PTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASN 214
+ L Q L +L + L+MQGD NLV Y W SN
Sbjct: 5 TNNLLFSGQVLYGDGRL---------TAKNHQLVMQGDCNLVLYG-------GKYGWQSN 48
Query: 215 TYNKGDNVSLNLDENGHLFLMNTTGVNIFNL-TGGENPTKGMIYLMKIDSDGIFRLYS 271
T+ G++ L L+ G L + + I++ + + Y++ + DG +Y
Sbjct: 49 THGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGE----YVLILQDDGFGVIYG 102
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 5e-12
Identities = 21/129 (16%), Positives = 44/129 (34%), Gaps = 34/129 (26%)
Query: 87 NRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDSGNFVLYDSNGK 146
D + N L+ + ++VL + S + + + G ++ D + K
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVLYGGKYGWQSNTHGNGEHCF-LRLNHKGELIIKDDDFK 74
Query: 147 TLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGT 206
T+W S ++ G+++LI+Q DG V Y
Sbjct: 75 TIWS-------------------------SRSSSKQGEYVLILQDDGFGVIYG------- 102
Query: 207 QHAYWASNT 215
A + +++
Sbjct: 103 -PAIFETSS 110
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 6e-16
Identities = 32/128 (25%), Positives = 45/128 (35%), Gaps = 29/128 (22%)
Query: 156 TDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNT 215
T+ LL Q L L G F L+MQ D NLV Y + W SNT
Sbjct: 3 TNYLLSGQTLDTEGHL---------KNGDFDLVMQDDCNLVLY---------NGNWQSNT 44
Query: 216 YNKGDNVSLNLDENGHLFLMNTTGVNIFNL-TGGENPTKGMIYLMKIDSDGIFRLYSYNL 274
N G + L L + G L + N G ++ Y + DG ++
Sbjct: 45 ANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGN----YAAVVHPDGRLVVFG--- 97
Query: 275 RRQNSTWQ 282
S ++
Sbjct: 98 ---PSVFK 102
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-11
Identities = 16/127 (12%), Positives = 41/127 (32%), Gaps = 36/127 (28%)
Query: 93 VSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDSGNFVLYDSNGKTLWQTF 152
+ + L+ + ++VL + ++ ++ D G V+ + +G T+W+
Sbjct: 19 KNGDFDLVMQDDCNLVLYNGNWQSNTANNG---RDCKLTLTDYGELVIKNGDGSTVWK-- 73
Query: 153 EHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWA 212
S G + ++ DG LV + + +
Sbjct: 74 -----------------------SGAQSVKGNYAAVVHPDGRLVVF--------GPSVFK 102
Query: 213 SNTYNKG 219
+ + +G
Sbjct: 103 IDPWVRG 109
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 6e-16
Identities = 27/138 (19%), Positives = 48/138 (34%), Gaps = 33/138 (23%)
Query: 157 DTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTY 216
+ L + L G L + IMQ D NLV Y + + WASNT
Sbjct: 2 NLLTNGEGLYAGQSL---------DVEPYHFIMQEDCNLVLYDH------STSVWASNTG 46
Query: 217 NKG-DNVSLNLDENGHLFLMNTTGVNIF--NLTGGENPTKGMIYLMKIDSDGIFRLYSYN 273
G L +G+ + + G +++ + G Y++ + DG +Y
Sbjct: 47 ILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGN-----YVLVLQEDGNVVIYG-- 99
Query: 274 LRRQNSTWQVVWESTSDR 291
+W + + +
Sbjct: 100 --------SDIWSTGTYK 109
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-13
Identities = 26/131 (19%), Positives = 45/131 (34%), Gaps = 34/131 (25%)
Query: 87 NRDDPPVSTNATLLFNSEGSIVL-RSSQQSQDSLIADDSQSASSASMLDSGNFVLYDSNG 145
+ + ++VL S S + A + GNFV+YD+ G
Sbjct: 11 YAGQSLDVEPYHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEG 70
Query: 146 KTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYG 205
++LW S + G ++L++Q DGN+V Y +
Sbjct: 71 RSLWA-------------------------SHSVRGNGNYVLVLQEDGNVVIYGS----- 100
Query: 206 TQHAYWASNTY 216
W++ TY
Sbjct: 101 ---DIWSTGTY 108
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 2e-09
Identities = 25/133 (18%), Positives = 43/133 (32%), Gaps = 36/133 (27%)
Query: 108 VLRSSQQSQDSLIADDSQSASSAS--MLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRL 165
+L + + L A S M + N VLYD + ++W +
Sbjct: 3 LLTNGE----GLYAGQSLDVEPYHFIMQEDCNLVLYD-HSTSVWASNTG----------- 46
Query: 166 SVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTYNKGDNVSLN 225
++Q DGN V Y + WAS++ N L
Sbjct: 47 -------------ILGKKGCKAVLQSDGNFVVYDAEG-----RSLWASHSVRGNGNYVLV 88
Query: 226 LDENGHLFLMNTT 238
L E+G++ + +
Sbjct: 89 LQEDGNVVIYGSD 101
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-15
Identities = 35/135 (25%), Positives = 50/135 (37%), Gaps = 31/135 (22%)
Query: 157 DTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTY 216
++L L G L G + LIMQGD N V Y + WASNT
Sbjct: 2 NSLSSPNSLFTGHSLEVG--------PSYRLIMQGDCNFVLYDS------GKPVWASNTG 47
Query: 217 NKGDNVSLNLDENGHLFLMNTTGVNIF--NLTGGENPTKGMIYLMKIDSDGIFRLYSYNL 274
G L L NG+L + + + I+ G E+ Y++ + D +Y
Sbjct: 48 GLGSGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDH-----YVLVLQQDRNVVIYG--- 99
Query: 275 RRQNSTWQVVWESTS 289
VVW + S
Sbjct: 100 -------PVVWATGS 107
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 7e-13
Identities = 23/124 (18%), Positives = 46/124 (37%), Gaps = 33/124 (26%)
Query: 92 PVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDSGNFVLYDSNGKTLWQT 151
V + L+ + + VL S + + S ++ ++GN V+YD + + +WQ
Sbjct: 17 EVGPSYRLIMQGDCNFVLYDSGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQ- 75
Query: 152 FEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYW 211
++TN ++L++Q D N+V Y W
Sbjct: 76 ------------------------TKTNGKEDHYVLVLQQDRNVVIYGP--------VVW 103
Query: 212 ASNT 215
A+ +
Sbjct: 104 ATGS 107
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 13/160 (8%)
Query: 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGIA 574
E++++ H LV L YS + + + +V + + G L L ++ I
Sbjct: 64 KELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC 122
Query: 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ-TRTFTGIR 633
++ + YL +IIH D+KP NIL+DE+ I+DF +A ++ + T
Sbjct: 123 -ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--- 175
Query: 634 GTRGYVAPE---WHRNLPITVKADVYSFGVVLLEIICRRR 670
GT+ Y+APE + + D +S GV E++ RR
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 17/160 (10%)
Query: 517 EMKVIGRTHHRNLVRLL-----GYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVER 570
E+ ++ +H+N++ LL SLE + + +V E M +L ++ + ER
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDHER 128
Query: 571 MG-IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
M + + GI +LH IIH D+KP NI++ + KI DFGLA+
Sbjct: 129 MSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MM 183
Query: 630 TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669
T TR Y APE + D++S G ++ E+I
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 20/153 (13%), Positives = 43/153 (28%), Gaps = 34/153 (22%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERM 571
+E + + R + R+L + ++V E++ GSL ++ + P+ V +
Sbjct: 76 QETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAI 132
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG 631
+ +A H + P + +S G L
Sbjct: 133 RAMQSLAAAADAAH---RAGVALSIDHPSRVR--------VSIDGDVVL----------- 170
Query: 632 IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664
+ + D+ G L
Sbjct: 171 --AYPATMPDANPQ-------DDIRGIGASLYA 194
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 19/160 (11%)
Query: 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGI 573
TE +V+ T H L L Y+ + ++ V EY + G ++ F+ ++ + E
Sbjct: 53 VTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGG---ELFFHLSRERVFTEER-- 106
Query: 574 AR----DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL-MKP-DQTR 627
AR +I + YLH +++ DIK +N+++D++ KI+DFGL K + +
Sbjct: 107 ARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163
Query: 628 TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
TF GT Y+APE + D + GVV+ E++C
Sbjct: 164 TFC---GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 18/160 (11%)
Query: 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGI 573
TE +V+ + H L L YS + ++ V EY + G ++ F+ ++ + E
Sbjct: 196 LTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDR-- 249
Query: 574 AR----DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK--LMKPDQTR 627
AR +I + YLH E +++ D+K +N+++D++ KI+DFGL K + +
Sbjct: 250 ARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 307
Query: 628 TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
TF GT Y+APE + D + GVV+ E++C
Sbjct: 308 TFC---GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 344
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 74.2 bits (181), Expect = 5e-15
Identities = 30/215 (13%), Positives = 63/215 (29%), Gaps = 32/215 (14%)
Query: 81 TVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQ-DSLIADDSQSASSASMLDSGNFV 139
VW +N + S+G +V+ ++Q + S S +
Sbjct: 45 VRVWASNTAGATGCR---AVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVT 101
Query: 140 LYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISET-----NPSTGKFLLIMQGDGN 194
+Y + + + T+ +T + + L M+ D N
Sbjct: 102 IYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCN 161
Query: 195 LVQYANINPYGTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGVNIF--NLTGGENPT 252
LV + W++NT KG L NG + ++ + ++ +
Sbjct: 162 LVLF------DRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGR- 214
Query: 253 KGMIYLMKIDSDGIFRLYSYNLRRQNSTWQVVWES 287
Y+ + D +Y +W +
Sbjct: 215 ----YVFVLQPDRNLAIYG----------GALWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 58.4 bits (140), Expect = 1e-09
Identities = 25/168 (14%), Positives = 45/168 (26%), Gaps = 17/168 (10%)
Query: 161 PNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTYNKGD 220
+ S L S F MQ D NLV + + WASNT
Sbjct: 7 LSHEGSHPQTLHAAQSLEL---SSFRFTMQSDCNLVLFDS------DVRVWASNTAGAT- 56
Query: 221 NVSLNLDENGHLFLMNTTGVNIF--NLTGGENPTKGMIYLMKIDSDGIFRLYSYNLRRQN 278
L +G L ++ + G Y++ + D +Y L
Sbjct: 57 GCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGN-----YVLVLQPDRTVTIYGPGLWDSG 111
Query: 279 STWQVVWESTSDRCDPIGFCGFNSFCVLNDQIPDCPCLPGFVQISQGN 326
++ + ++ + N L + + +
Sbjct: 112 TSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETD 159
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 3e-04
Identities = 31/211 (14%), Positives = 56/211 (26%), Gaps = 49/211 (23%)
Query: 129 SASMLDSGNFVLYDSNGKTLWQTFEHPTD----TLLPNQRLSVGTKLFPGI--SETNPST 182
+M N VL+D + +W + L + L + T S T S
Sbjct: 29 RFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSI 87
Query: 183 GKFLLIMQGDGNLVQYANI-------------------------NPYGTQHAYWASNTYN 217
G ++L++Q D + Y +
Sbjct: 88 GNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSL 147
Query: 218 KGDNVSLNLDENGHLFLMNTTGVNIFNLTGGENPTKGMIYLMKIDSDGIFRLYSYNLRRQ 277
+ L+++ + +L L + T G KG + +G +
Sbjct: 148 QLSPYRLSMETDCNLVLFDRDDRVWSTNTAG----KGTGCRAVLQPNGRMDVL------- 196
Query: 278 NSTWQVVWESTSDRCDPIGFCGFNSFCVLND 308
+ VW S + R VL
Sbjct: 197 TNQNIAVWTSGNSRSAG------RYVFVLQP 221
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 9e-15
Identities = 37/161 (22%), Positives = 68/161 (42%), Gaps = 14/161 (8%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E+ ++ H+N+VRL K LV+E+ L + +
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
+ +G+ + H ++H D+KPQN+L++ N K+++FGLA+ R ++ T
Sbjct: 110 LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVVTL 165
Query: 637 GYVAPE-----WHRNLPITVKADVYSFGVVLLEIICRRRCL 672
Y P+ + I D++S G + E+ R L
Sbjct: 166 WYRPPDVLFGAKLYSTSI----DMWSAGCIFAELANAGRPL 202
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 39/152 (25%), Positives = 69/152 (45%), Gaps = 8/152 (5%)
Query: 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIAR 575
E +++ + LV+L + S +V EY++ G + L + R A
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA- 148
Query: 576 DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGT 635
I YLH +I+ D+KP+N+L+D+ +++DFG AK + +T T GT
Sbjct: 149 QIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWTL---CGT 201
Query: 636 RGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
+APE + D ++ GV++ E+
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 40/158 (25%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E+ ++ HH N+V L+ LV+E+M L +L + +
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
+ RG+ + H +I+H D+KPQN+L++ + K++DFGLA+ R++T T
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVVTL 183
Query: 637 GYVAPE-----WHRNLPITVKADVYSFGVVLLEIICRR 669
Y AP+ + + D++S G + E+I +
Sbjct: 184 WYRAPDVLMGSKKYSTSV----DIWSIGCIFAEMITGK 217
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 18/164 (10%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQ-PNWVERM 571
F+ E V+ + + L Y+ + + LV +Y G L +L E + P + R
Sbjct: 121 FREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF 179
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD---QTRT 628
+A ++ I +H + +H DIKP NILMD N +++DFG + D Q+
Sbjct: 180 YLA-EMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 235
Query: 629 FTGIRGTRGYVAPE-----WHRNLPITVKADVYSFGVVLLEIIC 667
GT Y++PE + D +S GV + E++
Sbjct: 236 AV---GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 40/149 (26%), Positives = 67/149 (44%), Gaps = 15/149 (10%)
Query: 501 KEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLL----GYSLEVSKKI-LVYEYMSN--GS 553
E G S RE ++ + H N+VRL + K+ LV+E++ +
Sbjct: 49 TGEEGMPLSTIREVAV-LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT 107
Query: 554 LADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKIS 613
D + P ++ + + RG+ +LH ++H D+KPQNIL+ + K++
Sbjct: 108 YLDKVPEPGVPTETIKD--MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162
Query: 614 DFGLAKLMKPDQTRTFTGIRGTRGYVAPE 642
DFGLA++ T + T Y APE
Sbjct: 163 DFGLARIYSFQ--MALTSVVVTLWYRAPE 189
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 40/162 (24%), Positives = 73/162 (45%), Gaps = 22/162 (13%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEV---SKKI-LVYEYMSNGSLADILFNPEKQPNWVERMG 572
E++++ + H NLV LL EV +++ LV+EY + ++ L ++
Sbjct: 52 EIRMLKQLKHPNLVNLL----EVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKS 106
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGI 632
I + + + H IH D+KP+NIL+ ++ K+ DFG A+ + + +
Sbjct: 107 ITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFAR-LLTGPSDYYDDE 162
Query: 633 RGTRGYVAPE-----WHRNLPITVKADVYSFGVVLLEIICRR 669
TR Y +PE P+ DV++ G V E++
Sbjct: 163 VATRWYRSPELLVGDTQYGPPV----DVWAIGCVFAELLSGV 200
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E+ ++ H N+V+L + +LV+E++ L +L E V
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
+ GI Y HD +++H D+KPQN+L++ KI+DFGLA+ R +T T
Sbjct: 109 LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIVTL 164
Query: 637 GYVAPE-----WHRNLPITVKADVYSFGVVLLEIICRR 669
Y AP+ + I D++S G + E++
Sbjct: 165 WYRAPDVLMGSKKYSTTI----DIWSVGCIFAEMVNGT 198
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 41/164 (25%), Positives = 71/164 (43%), Gaps = 16/164 (9%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQ-PNWVERM 571
F+ E V+ R + +L ++ + + LV EY G L +L ++ P + R
Sbjct: 108 FREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF 166
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD-QTRTFT 630
+A +I I +H +H DIKP NIL+D +++DFG ++ D R+
Sbjct: 167 YLA-EIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV 222
Query: 631 GIRGTRGYVAPE-------WHRNLPITVKADVYSFGVVLLEIIC 667
+ GT Y++PE + D ++ GV E+
Sbjct: 223 AV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 42/164 (25%), Positives = 72/164 (43%), Gaps = 26/164 (15%)
Query: 517 EMKVIGRTHHRNLVRLL-----GYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVER 570
E+ ++ H N++ LL SL LV +M L I+ E+
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM----GLKFSEEK 127
Query: 571 MG-IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
+ + + +G+ Y+H ++H D+KP N+ ++E+ KI DFGLA+ +
Sbjct: 128 IQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----M 180
Query: 630 TGIRGTRGYVAPE----WHRNLPITVKADVYSFGVVLLEIICRR 669
TG TR Y APE W D++S G ++ E++ +
Sbjct: 181 TGYVVTRWYRAPEVILSWMHY---NQTVDIWSVGCIMAEMLTGK 221
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 41/158 (25%), Positives = 69/158 (43%), Gaps = 14/158 (8%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E+ ++ H N+V L LV+EY+ L L + N
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
+ RG+ Y H + +++H D+KPQN+L++E K++DFGLA+ K T+T+ T
Sbjct: 109 LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYDNEVVTL 164
Query: 637 GYVAPEW-----HRNLPITVKADVYSFGVVLLEIICRR 669
Y P+ + I D++ G + E+ R
Sbjct: 165 WYRPPDILLGSTDYSTQI----DMWGVGCIFYEMATGR 198
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 17/160 (10%)
Query: 517 EMKVIGRTHHRNLVRLL-----GYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVER 570
E+ ++ +H+N++ LL +LE + + LV E M A+ L + ER
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----AN-LCQVIQMELDHER 165
Query: 571 MG-IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
M + + GI +LH IIH D+KP NI++ + KI DFGLA+
Sbjct: 166 MSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MM 220
Query: 630 TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669
T TR Y APE + D++S G ++ E++ +
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 15/138 (10%)
Query: 512 REFQTEMKVIGRTHHRNLVRLL----GYSLEVSKKI-LVYEYMSN--GSLADILFNPEKQ 564
RE ++ + H N+VRL+ + K+ LV+E++ + D P
Sbjct: 60 REVAL-LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLP 118
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
++ + R RG+ +LH I+H D+KP+NIL+ K++DFGLA++
Sbjct: 119 AETIKD--LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173
Query: 625 QTRTFTGIRGTRGYVAPE 642
T + T Y APE
Sbjct: 174 --MALTPVVVTLWYRAPE 189
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 44/174 (25%), Positives = 74/174 (42%), Gaps = 37/174 (21%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKI------LVYEYMSNGSLADIL--FNPEKQPNWV 568
E++++ + H N+VRL + +K LV +Y+ ++ + ++ KQ
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQT--- 152
Query: 569 ERMGIARD--------IARGILYLHDECETQIIHCDIKPQNILMDENRCA-KISDFGLAK 619
+ + R + Y+H I H DIKPQN+L+D + K+ DFG AK
Sbjct: 153 ----LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205
Query: 620 LMKPDQTRTFTGIRGTRGYVAPE----WHRNLPITVKADVYSFGVVLLEIICRR 669
+ + +R Y APE T DV+S G VL E++ +
Sbjct: 206 QLVRGE--PNVSYICSRYYRAPELIFGATD---YTSSIDVWSAGCVLAELLLGQ 254
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 45/173 (26%), Positives = 72/173 (41%), Gaps = 29/173 (16%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI------LVYEYMSNGSLADILFNPEKQP 565
RE Q M+++ H N+V L + K LV EY+ ++ + K
Sbjct: 81 RELQI-MRIV---KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLK 135
Query: 566 NWVERMGIAR---DIARGILYLHDECETQIIHCDIKPQNILMDENRCA-KISDFGLAKLM 621
+ + I + R + Y+H I H DIKPQN+L+D K+ DFG AK++
Sbjct: 136 QTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192
Query: 622 KPDQTRTFTGIRGTRGYVAPE-----WHRNLPITVKADVYSFGVVLLEIICRR 669
+R Y APE + I D++S G V+ E++ +
Sbjct: 193 IAG--EPNVSYICSRYYRAPELIFGATNYTTNI----DIWSTGCVMAELMQGQ 239
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 44/133 (33%), Positives = 66/133 (49%), Gaps = 19/133 (14%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEV---SKKI-LVYEYMSNGSLADILFNPEKQPNWVERMG 572
E+K++ + H NLV LL EV K+ LV+E++ + ++ D L E PN ++
Sbjct: 74 EIKLLKQLRHENLVNLL----EVCKKKKRWYLVFEFVDH-TILDDL---ELFPNGLDYQV 125
Query: 573 I---ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
+ I GI + H IIH DIKP+NIL+ ++ K+ DFG A+ +
Sbjct: 126 VQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVY 181
Query: 630 TGIRGTRGYVAPE 642
TR Y APE
Sbjct: 182 DDEVATRWYRAPE 194
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 36/137 (26%), Positives = 63/137 (45%), Gaps = 15/137 (10%)
Query: 517 EMKVIGRTHHRNLVRLLG--------YSLEVSKKILVYEYMSNGSLADILFNPEKQPNWV 568
E+K++ H N+V L+ Y+ LV+++ + LA +L N +
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124
Query: 569 ERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM---KPDQ 625
E + + + G+ Y+H +I+H D+K N+L+ + K++DFGLA+ K Q
Sbjct: 125 EIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 626 TRTFTGIRGTRGYVAPE 642
+T T Y PE
Sbjct: 182 PNRYTNRVVTLWYRPPE 198
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 8e-14
Identities = 41/126 (32%), Positives = 60/126 (47%), Gaps = 5/126 (3%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E+K++ H N++ LL S LV+++M L I+ +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636
+G+ YLH I+H D+KP N+L+DEN K++DFGLAK R +T TR
Sbjct: 121 TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVVTR 176
Query: 637 GYVAPE 642
Y APE
Sbjct: 177 WYRAPE 182
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 48/153 (31%), Positives = 84/153 (54%), Gaps = 10/153 (6%)
Query: 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGIA 574
E ++ H ++R+ + + +++I ++ +Y+ G L +L ++ PN V + A
Sbjct: 55 DERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA 113
Query: 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRG 634
++ + YLH + II+ D+KP+NIL+D+N KI+DFG AK + PD T T G
Sbjct: 114 -EVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTYTL---CG 165
Query: 635 TRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
T Y+APE P D +SFG+++ E++
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 27/101 (26%), Positives = 45/101 (44%), Gaps = 19/101 (18%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCA-KISDFGLAKLMKPDQTRTFTGIRGT 635
+ R + ++H I H DIKPQN+L++ K+ DFG AK + P +
Sbjct: 150 LFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV------- 199
Query: 636 RGYVAPEWHRNLPI-------TVKADVYSFGVVLLEIICRR 669
Y+ ++R + T D++S G V E+I +
Sbjct: 200 -AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 43/166 (25%), Positives = 77/166 (46%), Gaps = 25/166 (15%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARD 576
E+ ++ H N+VRL +K LV+E+M N L + + + G+ +
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYM---DSRTVGNTPRGLELN 108
Query: 577 IA--------RGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT 628
+ +G+ + H+ +I+H D+KPQN+L+++ K+ DFGLA+ T
Sbjct: 109 LVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA-FGIPVNT 164
Query: 629 FTGIRGTRGYVAPE-----WHRNLPITVKADVYSFGVVLLEIICRR 669
F+ T Y AP+ + I D++S G +L E+I +
Sbjct: 165 FSSEVVTLWYRAPDVLMGSRTYSTSI----DIWSCGCILAEMITGK 206
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 37/132 (28%), Positives = 63/132 (47%), Gaps = 18/132 (13%)
Query: 544 LVYEYMSNGSLADILFNPEKQP---NWVERMGIARDIARGILYLHDECETQIIHCDIKPQ 600
+V+E + +L ++ E + +V++ I++ + G+ Y+H C IIH DIKP+
Sbjct: 107 MVFEVLGE-NLLALIKKYEHRGIPLIYVKQ--ISKQLLLGLDYMHRRC--GIIHTDIKPE 161
Query: 601 NILMDENRCA------KISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKAD 654
N+LM+ KI+D G A +T TR Y +PE P AD
Sbjct: 162 NVLMEIVDSPENLIQIKIADLGNAC----WYDEHYTNSIQTREYRSPEVLLGAPWGCGAD 217
Query: 655 VYSFGVVLLEII 666
++S ++ E+I
Sbjct: 218 IWSTACLIFELI 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 40/168 (23%), Positives = 72/168 (42%), Gaps = 29/168 (17%)
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMG 572
F E ++ + +V+L Y+ + + + +V EYM G L +++
Sbjct: 116 FWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM----------SNYD 164
Query: 573 IARDIAR--------GILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+ AR + +H IH D+KP N+L+D++ K++DFG M +
Sbjct: 165 VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221
Query: 625 -QTRTFTGIRGTRGYVAPEWHRNLPITVK----ADVYSFGVVLLEIIC 667
R T + GT Y++PE ++ D +S GV L E++
Sbjct: 222 GMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 12/101 (11%)
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
+ + +A+G+ +L + IH D+ +NIL+ E KI DFGLA+ + D
Sbjct: 196 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV-- 250
Query: 631 GIRGTRGYV-----APEWHRNLPITVKADVYSFGVVLLEII 666
R + APE + T+++DV+SFGV+L EI
Sbjct: 251 --RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 24/112 (21%), Positives = 45/112 (40%), Gaps = 10/112 (8%)
Query: 512 REFQTEMKV-IGRTHHRNLVRLLGYSLEVSKKILV-YEYMSNGSLADILFNPEKQPNWVE 569
R +E+K+ I HH N+V LLG + ++V E+ G+L+ L +
Sbjct: 70 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--------RSK 121
Query: 570 RMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM 621
R +G + + I D+K + + ++ + S F K +
Sbjct: 122 RNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 25/164 (15%)
Query: 517 EMKVIGRTHHRNLVRLL-----GYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVER 570
E++++ H N++ LL +L+ LV +M L ++ + + +R
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KHEKLGEDR 129
Query: 571 MG-IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
+ + + +G+ Y+H IIH D+KP N+ ++E+ KI DFGLA+ +
Sbjct: 130 IQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----M 182
Query: 630 TGIRGTRGYVAPE----WHRNLPITVKADVYSFGVVLLEIICRR 669
TG TR Y APE W R T D++S G ++ E+I +
Sbjct: 183 TGYVVTRWYRAPEVILNWMRY---TQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 517 EMKVIGRTHHRNLVRLL-----GYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVER 570
E++++ H N++ LL SLE + LV M L +I+ + Q +
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTDDH 133
Query: 571 MG-IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
+ + I RG+ Y+H IIH D+KP N+ ++E+ KI DFGLA+ +
Sbjct: 134 VQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----M 186
Query: 630 TGIRGTRGYVAPE----WHRNLPITVKADVYSFGVVLLEIICRR 669
TG TR Y APE W D++S G ++ E++ R
Sbjct: 187 TGYVATRWYRAPEIMLNWMHY---NQTVDIWSVGCIMAELLTGR 227
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 3e-13
Identities = 42/160 (26%), Positives = 79/160 (49%), Gaps = 19/160 (11%)
Query: 515 QTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGI 573
+ E ++ H +V L+ Y+ + K+ L+ EY+S G ++ E++ ++E
Sbjct: 69 KAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGG---ELFMQLEREGIFMEDT-- 122
Query: 574 AR----DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL-MKPDQ-TR 627
A +I+ + +LH + II+ D+KP+NI+++ K++DFGL K + T
Sbjct: 123 ACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179
Query: 628 TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
TF GT Y+APE D +S G ++ +++
Sbjct: 180 TFC---GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLT 216
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 45/164 (27%), Positives = 82/164 (50%), Gaps = 19/164 (11%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVE 569
+ E ++ +H +V+L Y+ + K+ L+ +++ G L K+ + E
Sbjct: 70 RVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTE 125
Query: 570 RMGIAR----DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL-MKPD 624
+ ++A + +LH II+ D+KP+NIL+DE K++DFGL+K + +
Sbjct: 126 ED--VKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180
Query: 625 Q-TRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
+ +F GT Y+APE T AD +SFGV++ E++
Sbjct: 181 KKAYSFC---GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 18/162 (11%)
Query: 517 EMKVIGRTHHRNLVRLLG----YSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERM 571
E++++ HH N++ L + K+ LV E M LA ++ + +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQ 137
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG 631
I G+ LH+ ++H D+ P NIL+ +N I DF LA+ D T
Sbjct: 138 YFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADA--NKTH 192
Query: 632 IRGTRGYVAPE----WHRNLPITVKADVYSFGVVLLEIICRR 669
R Y APE + T D++S G V+ E+ R+
Sbjct: 193 YVTHRWYRAPELVMQFKGF---TKLVDMWSAGCVMAEMFNRK 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 35/99 (35%), Positives = 50/99 (50%), Gaps = 12/99 (12%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF--TGIRG 634
I RG+ Y+H ++H D+KP N+L++ KI DFGLA++ PD T T
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 635 TRGYVAPE----WHRNLPITVKADVYSFGVVLLEIICRR 669
TR Y APE T D++S G +L E++ R
Sbjct: 194 TRWYRAPEIMLNSKG---YTKSIDIWSVGCILAEMLSNR 229
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 39/130 (30%), Positives = 67/130 (51%), Gaps = 17/130 (13%)
Query: 544 LVYEYMSNGSLADILFNPEKQPNWVERMGIAR----DIARGILYLHDECETQIIHCDIKP 599
V EY++ G D++++ ++ + E A +IA G+ +L + II+ D+K
Sbjct: 98 FVMEYVNGG---DLMYHIQQVGRFKEPH--AVFYAAEIAIGLFFLQSK---GIIYRDLKL 149
Query: 600 QNILMDENRCAKISDFGLAKL-MKP-DQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYS 657
N+++D KI+DFG+ K + T+TF GT Y+APE P D ++
Sbjct: 150 DNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---GTPDYIAPEIIAYQPYGKSVDWWA 206
Query: 658 FGVVLLEIIC 667
FGV+L E++
Sbjct: 207 FGVLLYEMLA 216
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 1e-12
Identities = 39/128 (30%), Positives = 68/128 (53%), Gaps = 13/128 (10%)
Query: 544 LVYEYMSNGSLADILFNPEKQPNWVERMGI--ARDIARGILYLHDECETQIIHCDIKPQN 601
V EY++ G D++++ ++ + E + A +IA G+ +L + II+ D+K N
Sbjct: 419 FVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDN 472
Query: 602 ILMDENRCAKISDFGLAKL-MKP-DQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFG 659
+++D KI+DFG+ K + T+TF GT Y+APE P D ++FG
Sbjct: 473 VMLDSEGHIKIADFGMCKENIWDGVTTKTFC---GTPDYIAPEIIAYQPYGKSVDWWAFG 529
Query: 660 VVLLEIIC 667
V+L E++
Sbjct: 530 VLLYEMLA 537
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 20/161 (12%)
Query: 515 QTEMKVIGR-THHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMG 572
QTE V + ++H LV L + ++ V EY++ G D++F+ ++Q E
Sbjct: 57 QTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEH- 111
Query: 573 IAR----DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL-MKP-DQT 626
AR +I+ + YLH E II+ D+K N+L+D K++D+G+ K ++P D T
Sbjct: 112 -ARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 167
Query: 627 RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
TF GT Y+APE R D ++ GV++ E++
Sbjct: 168 STFC---GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 205
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 25/100 (25%), Positives = 48/100 (48%), Gaps = 13/100 (13%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCA-KISDFGLAKLMKPDQTRT--FTGIR 633
+ RG+ Y+H ++H D+KP N+ ++ KI DFGLA++M P + +
Sbjct: 129 LLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 634 GTRGYVAPE----WHRNLPITVKADVYSFGVVLLEIICRR 669
T+ Y +P + T D+++ G + E++ +
Sbjct: 186 VTKWYRSPRLLLSPNN---YTKAIDMWAAGCIFAEMLTGK 222
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 40/165 (24%), Positives = 71/165 (43%), Gaps = 24/165 (14%)
Query: 517 EMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERM--GIA 574
E+ ++ HRN++ L + L++EY N L + +K P+ R+
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFL 138
Query: 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCA-----KISDFGLAKLMKPDQTRTF 629
+ G+ + H + +H D+KPQN+L+ + + KI DFGLA+ R F
Sbjct: 139 YQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIRQF 194
Query: 630 TGIRGTRGYVAPE-----WHRNLPITVKADVYSFGVVLLEIICRR 669
T T Y PE H + + D++S + E++ +
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSV----DIWSIACIWAEMLMKT 235
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL-MKPDQ-TRTFTGIRG 634
IA + YLH I++ D+KP+NIL+D ++DFGL K ++ + T TF G
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC---G 201
Query: 635 TRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
T Y+APE P D + G VL E++
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 234
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 41/130 (31%), Positives = 69/130 (53%), Gaps = 17/130 (13%)
Query: 544 LVYEYMSNGSLADILFNPEKQPNWVERMGIAR----DIARGILYLHDECETQIIHCDIKP 599
V EY++ G D++F+ ++Q E AR +I+ + YLH+ II+ D+K
Sbjct: 130 FVIEYVNGG---DLMFHMQRQRKLPEEH--ARFYSAEISLALNYLHER---GIIYRDLKL 181
Query: 600 QNILMDENRCAKISDFGLAKL-MKP-DQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYS 657
N+L+D K++D+G+ K ++P D T TF GT Y+APE R D ++
Sbjct: 182 DNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEILRGEDYGFSVDWWA 238
Query: 658 FGVVLLEIIC 667
GV++ E++
Sbjct: 239 LGVLMFEMMA 248
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL-MKPDQ-TRTFTGIRG 634
I G+ +LH I++ D+K NIL+D++ KI+DFG+ K M D T TF G
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC---G 180
Query: 635 TRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
T Y+APE D +SFGV+L E++
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL-MKPDQ-TRTFTGIRG 634
I +++LH + II+ D+K N+L+D K++DFG+ K + T TF G
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC---G 186
Query: 635 TRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
T Y+APE + + D ++ GV+L E++C
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 40/167 (23%), Positives = 66/167 (39%), Gaps = 31/167 (18%)
Query: 525 HHRNLVRLLGYSLE-VSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGIARD------ 576
H N++ L L +K+ L+++Y + L I+ + + + R
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 577 --IARGILYLHDECETQIIHCDIKPQNILM----DENRCAKISDFGLAKLMKPDQTRTFT 630
I GI YLH ++H D+KP NIL+ E KI+D G A+L +
Sbjct: 135 YQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLKPLA 190
Query: 631 GIRG---TRGYVAPEW-----HRNLPITVKADVYSFGVVLLEIICRR 669
+ T Y APE H I D+++ G + E++
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE 233
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 23/104 (22%), Positives = 43/104 (41%), Gaps = 27/104 (25%)
Query: 579 RGILYLHDECETQIIHCDIKPQNILMDENRCA-KISDFGLAKLMKPDQTRTFTGIRGTRG 637
+ + Y H I+H D+KP N+++D ++ D+GLA+ P Q
Sbjct: 141 KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN--------V 189
Query: 638 YVAPEWHR-----------NLPITVKADVYSFGVVLLEIICRRR 670
VA + + + + D++S G +L +I R+
Sbjct: 190 RVASRYFKGPELLVDYQMYDYSL----DMWSLGCMLASMIFRKE 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 31/106 (29%), Positives = 47/106 (44%), Gaps = 19/106 (17%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRG-- 634
R + LH + +IH D+KP N+L++ N K+ DFGLA+++
Sbjct: 121 TLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 635 -------TRGYVAPE----WHRNLPITVKADVYSFGVVLLEIICRR 669
TR Y APE + + DV+S G +L E+ RR
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAK---YSRAMDVWSCGCILAELFLRR 220
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKL-MKPDQTRTFTGIRGT 635
I + +LH + II+ DIK +NIL+D N ++DFGL+K + + R + GT
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGT 223
Query: 636 RGYVAPE--WHRNLPITVKADVYSFGVVLLEIIC 667
Y+AP+ + D +S GV++ E++
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 9/95 (9%)
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILM-DENRCA-KISDFGLAKLMKPDQTRTFT 630
A I + + LH +IIHCD+KP+NIL+ + R K+ DFG + + +
Sbjct: 205 FAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC----YEHQRVY 257
Query: 631 GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665
+R Y APE + D++S G +L E+
Sbjct: 258 TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILM-DENRCA-KISDFGLAKLMKPDQTRTFT 630
A+ + +L+L E IIHCD+KP+NIL+ + R A KI DFG + +
Sbjct: 162 FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC----QLGQRIY 216
Query: 631 GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664
+R Y +PE +P + D++S G +L+E
Sbjct: 217 QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 35/153 (22%), Positives = 59/153 (38%), Gaps = 39/153 (25%)
Query: 500 FKEEVGRGSSG------EREFQTE--MKVIGR--------------THHRNLVRLLGY-- 535
+ +G G +G + Q + +K++ + ++VR++
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYE 81
Query: 536 -SLEVSKKI-LVYEYMSNGSLAD-ILFNPEKQPNW-VERM--GIARDIARGILYLHDECE 589
K + +V E + G L I ++ ER I + I I YLH
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMKSIGEAIQYLHSI-- 136
Query: 590 TQIIHCDIKPQNILM---DENRCAKISDFGLAK 619
I H D+KP+N+L N K++DFG AK
Sbjct: 137 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 46/273 (16%), Positives = 83/273 (30%), Gaps = 85/273 (31%)
Query: 544 LVYEYMSNGSLADIL--FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQN 601
+V+E + + L + N + P + I + + +G+ YLH +C +IIH DIKP+N
Sbjct: 122 MVFEVLGH-HLLKWIIKSNYQGLPLPCVK-KIIQQVLQGLDYLHTKC--RIIHTDIKPEN 177
Query: 602 ILMDENRCAKISDFGLAKLMKPDQT----------------------------------- 626
IL+ N A +
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237
Query: 627 ----------RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNL 676
+ FT TR Y + E AD++S + E+ +P+
Sbjct: 238 ADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297
Query: 677 PDDQV-------------------ILEEWVY--QCF-ENGNL------------SQLVED 702
++ ++ Y + F + G+L LVE
Sbjct: 298 GEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEK 357
Query: 703 EEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
E +++ L + P R + + L
Sbjct: 358 YEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 27/121 (22%), Positives = 53/121 (43%), Gaps = 38/121 (31%)
Query: 517 EMKVIGRTHHRNLVRLL----GYSLEVSKKI-LVYEYM---------SNGSLAD-----I 557
E+ ++ R +H ++V++L +E ++ +V E + L + +
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTL 161
Query: 558 LFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL 617
L+N + G+ Y+H I+H D+KP N L++++ K+ DFGL
Sbjct: 162 LYN----------------LLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGL 202
Query: 618 A 618
A
Sbjct: 203 A 203
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 31/117 (26%), Positives = 49/117 (41%), Gaps = 30/117 (25%)
Query: 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRG-- 634
+ + I YLH ++H D+KP NIL++ K++DFGL++ + T
Sbjct: 118 LIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 635 ------------------TRGYVAPE----WHRNLPITVKADVYSFGVVLLEIICRR 669
TR Y APE + T D++S G +L EI+C +
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTK---YTKGIDMWSLGCILGEILCGK 228
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 44/245 (17%), Positives = 84/245 (34%), Gaps = 69/245 (28%)
Query: 517 EMKVIGRTHHRNLVRLLG----YSLEVSKKI-LVYEYM---------SNGSLAD-----I 557
E+ ++ R ++RL L ++ +V E + L + I
Sbjct: 75 EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTI 134
Query: 558 LFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL 617
L+N + G ++H E+ IIH D+KP N L++++ K+ DFGL
Sbjct: 135 LYN----------------LLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGL 175
Query: 618 AKLMKPDQTRTFTGIRG---------------------TRGYVAPE----WHRNLPITVK 652
A+ + ++ TR Y APE T
Sbjct: 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN---YTKS 232
Query: 653 ADVYSFGVVLLEIICRRRCLDPNLPDDQVILE-EWVYQCFENGNLSQLVEDEEVDEKQLE 711
D++S G + E++ + + + + + + N ++ E D QL
Sbjct: 233 IDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRD--QLN 290
Query: 712 RMIKV 716
+ +
Sbjct: 291 IIFNI 295
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 32/113 (28%), Positives = 44/113 (38%), Gaps = 24/113 (21%)
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF--- 629
+I + + YL + H D+KP+NIL+D+ K
Sbjct: 142 YCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
Query: 630 TGIR----G--------------TRGYVAPEWHRNLPITVKADVYSFGVVLLE 664
TGI+ G TR Y APE NL V +D++SFG VL E
Sbjct: 199 TGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 29/111 (26%), Positives = 43/111 (38%), Gaps = 26/111 (23%)
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA-------------------KIS 613
+A + + +LH+ Q+ H D+KP+NIL + +++
Sbjct: 128 MAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 614 DFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664
DFG A T I TR Y PE L DV+S G +L E
Sbjct: 185 DFGSAT----FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 28/110 (25%), Positives = 49/110 (44%), Gaps = 24/110 (21%)
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGI 632
+A I + + +LH ++ H D+KP+NIL ++ + + K+ + ++T I
Sbjct: 123 MAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYN---PKIKRDERTLINPDI 176
Query: 633 R----G--------------TRGYVAPEWHRNLPITVKADVYSFGVVLLE 664
+ G TR Y APE L + DV+S G +L+E
Sbjct: 177 KVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 19/93 (20%), Positives = 40/93 (43%), Gaps = 11/93 (11%)
Query: 583 YLHDECETQIIHCDIKPQNILMDENRCAKI--SDFGLAKLMKPDQT------RTFTGIRG 634
Y+H E + +H DIK N+L++ ++ D+GLA P+ G
Sbjct: 167 YIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDG 223
Query: 635 TRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
T + + + H + + + D+ G +++ +
Sbjct: 224 TIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT 256
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 50.7 bits (120), Expect = 1e-06
Identities = 12/83 (14%), Positives = 25/83 (30%), Gaps = 4/83 (4%)
Query: 540 SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKP 599
+ +V E+ G D+ K + I + + + H D+
Sbjct: 135 DQLFIVLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHW 190
Query: 600 QNILMDENRCAKISDFGLAKLMK 622
N+L+ + K+ K
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSST 213
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 30/101 (29%), Positives = 44/101 (43%), Gaps = 12/101 (11%)
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK---ISDFGLAKLMKPDQT--- 626
+A + I Y+H IH D+KP N LM + I DFGLAK + +T
Sbjct: 110 LADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166
Query: 627 ---RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664
R + GT Y + H + + + D+ S G VL+
Sbjct: 167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMY 207
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 22/103 (21%), Positives = 47/103 (45%), Gaps = 11/103 (10%)
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKI--SDFGLAKLMKPDQT---- 626
+ + + Y+H E + +H DIK N+L+ ++ +D+GL+ P+
Sbjct: 156 LGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212
Query: 627 --RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
G GT + + + H+ + ++ ++DV G +L +C
Sbjct: 213 QENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLC 255
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 12/101 (11%)
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK---ISDFGLAKLMKPDQT--- 626
+A + + ++H + +H DIKP N LM R A I DFGLAK + T
Sbjct: 108 LADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164
Query: 627 ---RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664
R + GT Y + H + + + D+ S G VL+
Sbjct: 165 IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMY 205
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 22/104 (21%), Positives = 44/104 (42%), Gaps = 16/104 (15%)
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILM------DENRCAKISDFGLAKLMKPDQT 626
A+ + + +H++ +++ DIKP N L+ + N + DFG+ K + T
Sbjct: 111 AAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVV-DFGMVKFYRDPVT 166
Query: 627 ------RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664
R + GT Y++ H + + D+ + G V +
Sbjct: 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMY 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 17/103 (16%), Positives = 46/103 (44%), Gaps = 11/103 (10%)
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKI--SDFGLAKLMKPDQT---- 626
+A + + +LH E + +H ++ +NI +D +++ + +G A P
Sbjct: 164 VACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220
Query: 627 --RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
+ + G +++ + H+ + ++D+ S G +L+ +
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY 263
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 14/103 (13%)
Query: 573 IARDIARGILYLHDECETQIIHCDIKPQNILM-----DENRCAKISDFGLAKLMKPDQT- 626
IA + + Y+H + +I+ D+KP+N L+ + I DF LAK +T
Sbjct: 110 IAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
Query: 627 -----RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664
R + GT Y++ H + + D+ + G + +
Sbjct: 167 KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMY 209
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 757 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.98 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.98 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.98 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.98 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.98 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.98 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.98 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.98 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.98 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.98 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.98 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.98 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.98 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.98 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.98 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.98 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.98 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.98 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.98 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.98 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.98 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.98 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.98 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.98 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.98 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.98 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.98 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.98 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.98 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.98 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.98 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.98 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.98 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.96 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.96 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.96 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.96 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.96 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.96 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.96 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.94 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.83 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.76 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.75 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.73 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.72 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.69 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.61 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.6 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.54 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.52 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.52 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.48 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.46 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.42 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.37 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.31 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.27 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.2 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.12 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.03 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.0 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.96 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.94 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.86 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.86 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.56 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.45 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.4 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.31 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.68 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.59 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.56 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.22 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.02 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.05 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.95 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.83 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.57 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 94.64 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 94.32 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 93.94 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 93.58 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 93.15 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.31 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 88.13 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 86.4 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 85.15 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 84.91 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 84.13 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.87 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.32 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=391.32 Aligned_cols=220 Identities=27% Similarity=0.386 Sum_probs=176.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.++|.+|++++++++|||||+++|++.+ +..+|||||+++|+|.++|+.....++|.++++|+.|||+||+|||++
T Consensus 76 ~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~--- 151 (307)
T 3omv_A 76 FQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK--- 151 (307)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 3689999999999999999999999865 568999999999999999988778899999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCC-cceecccccCccccCcccccC---CCCCccccchhhHHHHHHHH
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ-TRTFTGIRGTRGYVAPEWHRN---LPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~G~~l~ell 666 (757)
+||||||||+||||++++.+||+|||+|+...... ........||+.|||||++.+ .+++.++|||||||++|||+
T Consensus 152 ~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ell 231 (307)
T 3omv_A 152 NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELM 231 (307)
T ss_dssp TCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHH
T ss_pred CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHH
Confidence 99999999999999999999999999999765433 233445789999999999864 46899999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
||+.||....... .+......+..... ........+..+.+++.+||+.||++||||.||+++|+.+.
T Consensus 232 tg~~Pf~~~~~~~------~~~~~~~~~~~~p~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 232 TGELPYSHINNRD------QIIFMVGRGYASPD--LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp HSSCTTTTCCCHH------HHHHHHHTTCCCCC--STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred HCCCCCCCCChHH------HHHHHHhcCCCCCC--cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 9999997543221 12222333321111 11223344567899999999999999999999999998643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=397.54 Aligned_cols=215 Identities=23% Similarity=0.324 Sum_probs=182.3
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------------CCCCHHHHHHHHHH
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------------KQPNWVERMGIARD 576 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ 576 (757)
++|.+|+.++++++|||||+++|+|.+.+..+|||||+++|+|.++|.... ..++|.++++|+.|
T Consensus 74 ~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 153 (308)
T 4gt4_A 74 EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153 (308)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHH
Confidence 689999999999999999999999999999999999999999999996432 35899999999999
Q ss_pred HHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccc
Q 038168 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADV 655 (757)
Q Consensus 577 ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv 655 (757)
||+||+|||++ +||||||||+||||++++.+||+|||+++....... .......||+.|||||++.+..++.++||
T Consensus 154 ia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDV 230 (308)
T 4gt4_A 154 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDI 230 (308)
T ss_dssp HHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHhC---CCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchh
Confidence 99999999998 999999999999999999999999999987654332 23345679999999999999999999999
Q ss_pred hhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 038168 656 YSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKV 734 (757)
Q Consensus 656 ~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eV 734 (757)
|||||++|||+| |+.||...... + +...+..+..... +...+..+.+++.+||+.||++||||.||
T Consensus 231 wSfGvvl~El~t~g~~Pf~~~~~~------~-~~~~i~~~~~~~~------p~~~~~~~~~li~~C~~~dP~~RPs~~ei 297 (308)
T 4gt4_A 231 WSYGVVLWEVFSYGLQPYCGYSNQ------D-VVEMIRNRQVLPC------PDDCPAWVYALMIECWNEFPSRRPRFKDI 297 (308)
T ss_dssp HHHHHHHHHHHTTTCCTTTTCCHH------H-HHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hhHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCCCC------cccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 999999999999 88898754321 1 2233444433221 22345678999999999999999999999
Q ss_pred HHHhhcCc
Q 038168 735 LLMLEGTV 742 (757)
Q Consensus 735 l~~Le~~~ 742 (757)
+++|+...
T Consensus 298 ~~~L~a~~ 305 (308)
T 4gt4_A 298 HSRLRAWG 305 (308)
T ss_dssp HHHHHTSC
T ss_pred HHHHHhcc
Confidence 99998643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=396.05 Aligned_cols=218 Identities=25% Similarity=0.379 Sum_probs=176.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC--------------CCCCHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE--------------KQPNWVERMGIARD 576 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ 576 (757)
.++|.+|+++|++++|||||+++|+|.+.+..+|||||+++|+|.+++++.. ..++|.++++|+.|
T Consensus 87 ~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 166 (329)
T 4aoj_A 87 RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166 (329)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHH
Confidence 4789999999999999999999999999999999999999999999997542 35899999999999
Q ss_pred HHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccc
Q 038168 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADV 655 (757)
Q Consensus 577 ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv 655 (757)
||+||+|||++ +||||||||+||||++++.+||+|||+++....... .......||+.|||||++.+..++.++||
T Consensus 167 ia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDv 243 (329)
T 4aoj_A 167 VAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDV 243 (329)
T ss_dssp HHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHH
T ss_pred HHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccc
Confidence 99999999998 999999999999999999999999999997755433 23345679999999999999999999999
Q ss_pred hhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 038168 656 YSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKV 734 (757)
Q Consensus 656 ~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eV 734 (757)
|||||++|||+| |+.||...... + +...+..+.... .+...+.++.+|+.+||+.||++||||.||
T Consensus 244 wS~Gvvl~Ellt~G~~Pf~~~~~~------~-~~~~i~~g~~~~------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei 310 (329)
T 4aoj_A 244 WSFGVVLWEIFTYGKQPWYQLSNT------E-AIDCITQGRELE------RPRACPPEVYAIMRGCWQREPQQRHSIKDV 310 (329)
T ss_dssp HHHHHHHHHHHTTSCCTTCSSCHH------H-HHHHHHHTCCCC------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred cchHHHHHHHHcCCCCCCCCCCHH------H-HHHHHHcCCCCC------CcccccHHHHHHHHHHcCcChhHCcCHHHH
Confidence 999999999999 89998754221 1 223333332111 122334678999999999999999999999
Q ss_pred HHHhhcCcCC
Q 038168 735 LLMLEGTVEI 744 (757)
Q Consensus 735 l~~Le~~~~~ 744 (757)
+++|+.+.+.
T Consensus 311 ~~~L~~l~~~ 320 (329)
T 4aoj_A 311 HARLQALAQA 320 (329)
T ss_dssp HHHHHHHHHS
T ss_pred HHHHHHHhhC
Confidence 9999987654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=390.96 Aligned_cols=218 Identities=26% Similarity=0.424 Sum_probs=184.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC------------CCCCCHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP------------EKQPNWVERMGIARDI 577 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~------------~~~l~~~~~~~i~~~i 577 (757)
..++|.+|+++|++++|||||+++|+|.+.+..+|||||+++|+|.++|++. ...++|.++++|+.||
T Consensus 58 ~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 137 (299)
T 4asz_A 58 ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137 (299)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHH
Confidence 3578999999999999999999999999999999999999999999999643 2568999999999999
Q ss_pred HHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-ecccccCccccCcccccCCCCCccccch
Q 038168 578 ARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-FTGIRGTRGYVAPEWHRNLPITVKADVY 656 (757)
Q Consensus 578 a~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~ 656 (757)
|+||+|||++ +|+||||||+||||++++.+||+|||+|+......... .....||+.|||||++.+..++.++|||
T Consensus 138 a~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVw 214 (299)
T 4asz_A 138 AAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 214 (299)
T ss_dssp HHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHH
Confidence 9999999998 99999999999999999999999999999765544332 2345789999999999999999999999
Q ss_pred hhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 038168 657 SFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735 (757)
Q Consensus 657 S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl 735 (757)
||||++|||+| |+.||..... .+ +...+..+..... +...+.++.+++.+||+.||++||||+||+
T Consensus 215 S~Gvvl~Ellt~G~~Pf~~~~~------~~-~~~~i~~~~~~~~------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 215 SLGVVLWEIFTYGKQPWYQLSN------NE-VIECITQGRVLQR------PRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCH------HH-HHHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHcCCCCCCCCCCH------HH-HHHHHHcCCCCCC------CccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 99999999999 8999875432 11 2233344433211 223346789999999999999999999999
Q ss_pred HHhhcCcC
Q 038168 736 LMLEGTVE 743 (757)
Q Consensus 736 ~~Le~~~~ 743 (757)
+.|+.+.+
T Consensus 282 ~~L~~~~~ 289 (299)
T 4asz_A 282 TLLQNLAK 289 (299)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99997543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=375.51 Aligned_cols=226 Identities=23% Similarity=0.243 Sum_probs=174.2
Q ss_pred HHHHHHHHhhcCCCceeeeeeEEEece----eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-
Q 038168 514 FQTEMKVIGRTHHRNLVRLLGYSLEVS----KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC- 588 (757)
Q Consensus 514 ~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~- 588 (757)
+..|+..+.+++|||||+++|+|.+.+ ..+|||||+++|+|.++|+. ..++|.++++|+.|+|+||+|||+++
T Consensus 44 ~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~ 121 (303)
T 3hmm_A 44 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIV 121 (303)
T ss_dssp HHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBC
T ss_pred HHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhh
Confidence 345666678899999999999998764 67999999999999999964 46899999999999999999999863
Q ss_pred ----CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc---eecccccCccccCcccccCC------CCCccccc
Q 038168 589 ----ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR---TFTGIRGTRGYVAPEWHRNL------PITVKADV 655 (757)
Q Consensus 589 ----~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv 655 (757)
.++|+||||||+||||+.++.+||+|||+|+........ ......||+.|||||++.+. .++.++||
T Consensus 122 ~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DV 201 (303)
T 3hmm_A 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 201 (303)
T ss_dssp STTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHH
T ss_pred hccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhh
Confidence 468999999999999999999999999999977554332 22346799999999998764 47889999
Q ss_pred hhhHHHHHHHHhCCCCCCCCCCCc---------cccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCC
Q 038168 656 YSFGVVLLEIICRRRCLDPNLPDD---------QVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPS 726 (757)
Q Consensus 656 ~S~G~~l~elltG~~p~~~~~~~~---------~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~ 726 (757)
|||||++|||+||+.|+....... .... +.+......+.+...+.......+....+.+++.+||+.||+
T Consensus 202 wS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~ 280 (303)
T 3hmm_A 202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV-EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 280 (303)
T ss_dssp HHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH-HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGG
T ss_pred hhHHHHHHHHHHCCCCCCccccccccchhcccccchH-HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHh
Confidence 999999999999988765332211 1112 222233333333222222223446678899999999999999
Q ss_pred CCCCHHHHHHHhhcCc
Q 038168 727 LRPSMKKVLLMLEGTV 742 (757)
Q Consensus 727 ~RPsm~eVl~~Le~~~ 742 (757)
+||||.||+++|+.+.
T Consensus 281 ~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 281 ARLTALRIKKTLSQLS 296 (303)
T ss_dssp GSCCHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHH
Confidence 9999999999998754
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=362.08 Aligned_cols=227 Identities=22% Similarity=0.345 Sum_probs=180.2
Q ss_pred ccCcccCCCceeccCCCeeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCC----CceeEeccC
Q 038168 29 RRSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVST----NATLLFNSE 104 (757)
Q Consensus 29 ~~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~----~~~l~~~~~ 104 (757)
+.|+|++|++|++ +++||||+|+|+||||+++ ++|| |+ |++ ||||||||+|+.++ +++|+|+.|
T Consensus 13 ~~~~l~~g~~l~~--~~~l~S~~g~F~lgf~~~~----~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~ 80 (276)
T 3m7h_A 13 GTSVLPAYQTLSA--GQYLLSPNQRFKLLLQGDG----NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFY 80 (276)
T ss_dssp TSSEECTTEEBCT--TCEEECTTSSEEEEECTTS----CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEE
T ss_pred cCCEecCCCEecC--CCEEEcCCCcEEEEEECCC----CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCC
Confidence 4699999999985 6799999999999999432 5677 77 788 99999999999875 889999999
Q ss_pred CCEEE--ecCCCCceeEEecCCC-------cceeEEEecCCCEEEEecCCceeeeccCCCccccCCCCc----ccCCCcc
Q 038168 105 GSIVL--RSSQQSQDSLIADDSQ-------SASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQR----LSVGTKL 171 (757)
Q Consensus 105 G~Lvl--~~~~~~~~~~~~~~~~-------~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg~k----l~~~~~L 171 (757)
|+||| .+++ +..+|+++++. .+++|+|+|+|||||+| +.+|||| |||||+||||| |..+++|
T Consensus 81 G~Lvl~~~~~~-~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~~L 155 (276)
T 3m7h_A 81 VQYGAFLDDYS-RRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGSEL 155 (276)
T ss_dssp ESSSEEEEEGG-GTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSEEE
T ss_pred CcEEEEEeCCC-CCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCccc
Confidence 99999 6665 44566666543 34789999999999998 7899999 99999999999 6677888
Q ss_pred cccCCCCCCCCCceEEEecCCCCceeeeccCCCCccceEeeccccCCCCccccccCCCccEEEecccceeeeeecCCCCC
Q 038168 172 FPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGVNIFNLTGGENP 251 (757)
Q Consensus 172 ~S~~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (757)
++.+||++|.|++++|++|+++++.. ...+||+++++++.. ..+.++.+|.+++++..+..+...... .
T Consensus 156 ---~S~~dps~G~fsl~l~~dGnlvLy~~-----~~~~yW~Sgt~~~~~-~~l~l~~dGnLvl~d~~~~~vWsS~t~--~ 224 (276)
T 3m7h_A 156 ---VQGVVYGAGASKLVFQGDGNLVAYGP-----NGAATWNAGTQGKGA-VRAVFQGDGNLVVYGAGNAVLWHSHTG--G 224 (276)
T ss_dssp ---CTTCEEEETTEEEEECTTSCEEEECT-----TSSEEEECCCTTTTC-CEEEECTTSCEEEECTTSCEEEECSCT--T
T ss_pred ---ccCCCCCCceEEEeecCCceEEEEeC-----CCeEEEECCCCCCcc-EEEEEcCCCeEEEEeCCCcEEEEecCC--C
Confidence 46789999999999999998777532 146999999997654 667788899988887654332222211 1
Q ss_pred CCceEEEEEEccCccEEEEEEeccCCCCceEEEeecCCC
Q 038168 252 TKGMIYLMKIDSDGIFRLYSYNLRRQNSTWQVVWESTSD 290 (757)
Q Consensus 252 ~~~~~~~~~l~~dG~lr~y~~~~~~~~~~W~~~~~~p~d 290 (757)
...+|++|+.||+|++|.|. ..|..++.+|..
T Consensus 225 --~~~~rl~Ld~dGnLvly~~~-----~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 225 --HASAVLRLQANGSIAILDEK-----PVWARFGFQPTY 256 (276)
T ss_dssp --CTTCEEEECTTSCEEEEEEE-----EEEESSSCCTTS
T ss_pred --CCCEEEEEcCCccEEEEcCC-----CeEEccCccCCc
Confidence 12479999999999999872 247776666554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=379.05 Aligned_cols=217 Identities=26% Similarity=0.370 Sum_probs=180.9
Q ss_pred HHHHHHHHHHhhcCC-CceeeeeeEEEec-eeeeEEEEeccCCChhhhhcCC---------------CCCCCHHHHHHHH
Q 038168 512 REFQTEMKVIGRTHH-RNLVRLLGYSLEV-SKKILVYEYMSNGSLADILFNP---------------EKQPNWVERMGIA 574 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h-~niv~l~g~~~~~-~~~~lV~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~ 574 (757)
++|.+|+++|++++| ||||+++|+|.+. +..+||||||++|+|.++|++. ...++|.+++.|+
T Consensus 112 ~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 191 (353)
T 4ase_A 112 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191 (353)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHH
Confidence 579999999999965 8999999999764 5789999999999999999643 2347999999999
Q ss_pred HHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccc
Q 038168 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKA 653 (757)
Q Consensus 575 ~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~ 653 (757)
.|||+||+|||++ +||||||||+||||++++.+||+|||+|+.+..+... ......||+.|||||++.+..++.++
T Consensus 192 ~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ks 268 (353)
T 4ase_A 192 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 268 (353)
T ss_dssp HHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred HHHHHHHHhHhhC---CeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcc
Confidence 9999999999998 9999999999999999999999999999987655443 33457799999999999999999999
Q ss_pred cchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 654 DVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 654 Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
|||||||++|||+| |+.||....... .+...+..+..... +.....++.+++.+||+.||++|||+.
T Consensus 269 DVwS~Gv~l~El~t~G~~Pf~~~~~~~------~~~~~i~~g~~~~~------p~~~~~~~~~li~~c~~~dP~~RPt~~ 336 (353)
T 4ase_A 269 DVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA------PDYTTPEMYQTMLDCWHGEPSQRPTFS 336 (353)
T ss_dssp HHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cEeehHHHHHHHHhCCCCCCCCCCHHH------HHHHHHHcCCCCCC------CccCCHHHHHHHHHHcCcChhHCcCHH
Confidence 99999999999998 899987543322 12333444432211 122345788999999999999999999
Q ss_pred HHHHHhhcCcC
Q 038168 733 KVLLMLEGTVE 743 (757)
Q Consensus 733 eVl~~Le~~~~ 743 (757)
||+++|+.+++
T Consensus 337 eil~~L~~llq 347 (353)
T 4ase_A 337 ELVEHLGNLLQ 347 (353)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999987654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=361.62 Aligned_cols=208 Identities=25% Similarity=0.369 Sum_probs=168.7
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEe----ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLE----VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
+.|.+|++++++++|||||++++++.+ .+..+|||||+++|+|.+++.+ ...+++..+..|+.||++||+|||++
T Consensus 70 ~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~ 148 (290)
T 3fpq_A 70 QRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR 148 (290)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 679999999999999999999999875 3567999999999999999965 45689999999999999999999997
Q ss_pred CCCCeeeCCCCcceEEECC-CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMDE-NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~-~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
.++|+||||||+||||+. ++.+||+|||+|+..... .....+||+.|||||.+.+ +++.++|||||||++|||+
T Consensus 149 -~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyell 223 (290)
T 3fpq_A 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMA 223 (290)
T ss_dssp -SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHH
T ss_pred -CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHH
Confidence 123999999999999984 789999999999865432 2335689999999998865 6999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||+.||...... ..+......+......+ .....++.+++.+||+.||++|||++|+++
T Consensus 224 tg~~Pf~~~~~~------~~~~~~i~~~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 224 TSEYPYSECQNA------AQIYRRVTSGVKPASFD-----KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HSSCTTTTCSSH------HHHHHHHTTTCCCGGGG-----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HCCCCCCCCCcH------HHHHHHHHcCCCCCCCC-----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 999999643221 11223333332221111 122346889999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=371.70 Aligned_cols=212 Identities=20% Similarity=0.207 Sum_probs=174.1
Q ss_pred HHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCee
Q 038168 514 FQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQII 593 (757)
Q Consensus 514 ~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii 593 (757)
..+|+.++++++|||||++++++.+.+..||||||+++|+|.++|.+ ...+++.+...++.||+.||+|||++ +||
T Consensus 97 ~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~---~Ii 172 (336)
T 4g3f_A 97 RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTR---RIL 172 (336)
T ss_dssp CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTT---TEE
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---Cce
Confidence 35899999999999999999999999999999999999999999965 35689999999999999999999998 999
Q ss_pred eCCCCcceEEECCCC-cEEEeecCCccccCCCCcc----eecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 594 HCDIKPQNILMDENR-CAKISDFGLAKLMKPDQTR----TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 594 H~Dik~~Nill~~~~-~~ki~DfGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
||||||+||||+.++ .+||+|||+|+.+..+... ....++||+.|||||++.+..++.++|||||||++|||++|
T Consensus 173 HRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG 252 (336)
T 4g3f_A 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252 (336)
T ss_dssp CSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 999999999999987 5999999999987654321 12336799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
+.||........ + ... ..+.... ...+......+.+++.+||+.||++|||+.|+++.|+.
T Consensus 253 ~~Pf~~~~~~~~--~----~~i-~~~~~~~----~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 253 CHPWTQYFRGPL--C----LKI-ASEPPPI----REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp SCSSTTTCCSCC--H----HHH-HHSCCGG----GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCCCCCHHHH--H----HHH-HcCCCCc----hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 999976544321 1 111 1222111 11223445678899999999999999999999988764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=372.65 Aligned_cols=209 Identities=22% Similarity=0.338 Sum_probs=176.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.|.+|+++|++|+|||||++++++.+.+..||||||+++|+|.++|.... ..+++.+...|+.||+.||+|||++
T Consensus 67 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~-- 144 (350)
T 4b9d_A 67 REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR-- 144 (350)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4679999999999999999999999999999999999999999999996543 4578899999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+||||+.++.+||+|||+|+.+.... ......+||+.|||||++.+..++.++|||||||++|||++|+
T Consensus 145 -~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~ 222 (350)
T 4b9d_A 145 -KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222 (350)
T ss_dssp -TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred -CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999998764322 1233467999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
.||..... .+.+.. ...+..... +.....++.+++.+||+.||++|||++|+++
T Consensus 223 ~PF~~~~~------~~~~~~-i~~~~~~~~------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 223 HAFEAGSM------KNLVLK-IISGSFPPV------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CSCCCSSH------HHHHHH-HHHTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCcCH------HHHHHH-HHcCCCCCC------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99975422 122222 233333221 2233457889999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=368.22 Aligned_cols=208 Identities=21% Similarity=0.331 Sum_probs=175.6
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|+++|++++|||||++++++.+.+..||||||+++|+|.+++.+ ..+++.+...++.||+.||+|||++ +
T Consensus 116 ~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~ 190 (346)
T 4fih_A 116 ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQ---G 190 (346)
T ss_dssp GGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 5688999999999999999999999999999999999999999999964 4689999999999999999999999 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRC 671 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p 671 (757)
|+||||||+||||+.++.+||+|||+|+.+..... .....+||+.|||||++.+..++.++|||||||++|||++|+.|
T Consensus 191 IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~P 269 (346)
T 4fih_A 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269 (346)
T ss_dssp EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999999998755432 23457899999999999999999999999999999999999999
Q ss_pred CCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 672 LDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 672 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|...... + +...+..+....+... .....++.+++.+||+.||++|||++|+++
T Consensus 270 F~~~~~~------~-~~~~i~~~~~~~~~~~----~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 270 YFNEPPL------K-AMKMIRDNLPPRLKNL----HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp TTTSCHH------H-HHHHHHHSSCCCCSCG----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCcCHH------H-HHHHHHcCCCCCCCcc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 9753221 1 1222233222222111 223456889999999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=360.30 Aligned_cols=205 Identities=21% Similarity=0.304 Sum_probs=174.9
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|+++|++++|||||++++++++.+..||||||+++|+|.+++.+ ...++..+...++.||+.||+|||++ +
T Consensus 77 ~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~ 152 (311)
T 4aw0_A 77 PYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGK---G 152 (311)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 6789999999999999999999999999999999999999999999965 35688999999999999999999999 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
|+||||||+||||+.++.+||+|||+|+.+..... ......+||+.|||||++.+..++.++||||+||++|||++|+.
T Consensus 153 IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 232 (311)
T 4aw0_A 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 232 (311)
T ss_dssp EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSC
T ss_pred CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999998765433 33445789999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKV 734 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eV 734 (757)
||..... .+ +...+..+.+. ++.....++.+++.+||+.||++|||++|+
T Consensus 233 PF~~~~~------~~-~~~~i~~~~~~-------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 233 PFRAGNE------GL-IFAKIIKLEYD-------FPEKFFPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp SSCCSSH------HH-HHHHHHHTCCC-------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred CCCCCCH------HH-HHHHHHcCCCC-------CCcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence 9975321 11 22223333322 112234568899999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=369.03 Aligned_cols=209 Identities=21% Similarity=0.330 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.+|++++|||||++++++.+.+..||||||+++|+|.+++.. ..+++.++..|+.||+.||+|||++
T Consensus 192 ~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~--- 266 (423)
T 4fie_A 192 RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQ--- 266 (423)
T ss_dssp GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 35689999999999999999999999999999999999999999999954 4589999999999999999999999
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+||||||||+||||+.++.+||+|||+|+.+..... .....+||+.|||||++.+..++.++|||||||++|||++|+.
T Consensus 267 ~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 345 (423)
T 4fie_A 267 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 345 (423)
T ss_dssp TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999999999999999999999999999998755432 2345789999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||...... + +...+..+....+... .....++.+++.+||+.||++|||+.|+++
T Consensus 346 PF~~~~~~------~-~~~~i~~~~~~~~~~~----~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 346 PYFNEPPL------K-AMKMIRDNLPPRLKNL----HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TTTTSCHH------H-HHHHHHHSCCCCCSCT----TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCcCHH------H-HHHHHHcCCCCCCccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99753221 1 1222233322222221 123456889999999999999999999987
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=347.71 Aligned_cols=205 Identities=24% Similarity=0.386 Sum_probs=163.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|||||++++++.+.+..|+||||+ +|+|.+++.+ ...++..+...++.||+.||+|||++
T Consensus 57 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~--- 131 (275)
T 3hyh_A 57 QGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRH--- 131 (275)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 467999999999999999999999999999999999999 6899999865 45689999999999999999999999
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCC-CccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+||||++++.+||+|||+|+...... .....+||+.|||||.+.+..+ +.++||||+||++|||++|+
T Consensus 132 ~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~ 209 (275)
T 3hyh_A 132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 209 (275)
T ss_dssp TCCCCCCCTTTEEECTTCCEEECCSSCC-----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CcccccCChHHeEECCCCCEEEeecCCCeecCCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCC
Confidence 99999999999999999999999999998765432 2334689999999999998876 58999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
.||..... .+ +.+....+.... +.....++.+++.+||+.||++|||++|+++
T Consensus 210 ~PF~~~~~------~~-~~~~i~~~~~~~-------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 210 LPFDDESI------PV-LFKNISNGVYTL-------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CSSCCSSH------HH-HHHHHHHTCCCC-------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCH------HH-HHHHHHcCCCCC-------CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 99975321 11 222333333221 1123456889999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=355.57 Aligned_cols=206 Identities=23% Similarity=0.252 Sum_probs=165.6
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
..+.+|+++|++++|||||++++++.+.+..||||||+++|+|.+++.+ ...++..+...++.||+.||+|||++ +
T Consensus 71 ~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~---~ 146 (304)
T 3ubd_A 71 VRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSL---G 146 (304)
T ss_dssp C------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 4688999999999999999999999999999999999999999999965 45689999999999999999999999 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRC 671 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p 671 (757)
|+||||||+|||++.++.+||+|||+|+....... .....+||+.|||||.+.+..++.++||||+||++|||++|+.|
T Consensus 147 IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~P 225 (304)
T 3ubd_A 147 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225 (304)
T ss_dssp CCCSSCCGGGEEECTTSCEEEESSEEEEC-----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CcCCCCCHHHeEEcCCCCEEecccccceeccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCC
Confidence 99999999999999999999999999986543322 23457899999999999999999999999999999999999999
Q ss_pred CCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 038168 672 LDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS-----MKKVLL 736 (757)
Q Consensus 672 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----m~eVl~ 736 (757)
|..... .+ +......+... .+.....++.+++.+||+.||++||| ++|+++
T Consensus 226 F~~~~~------~~-~~~~i~~~~~~-------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 226 FQGKDR------KE-TMTMILKAKLG-------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp SCCSSH------HH-HHHHHHHCCCC-------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCcCH------HH-HHHHHHcCCCC-------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 975322 11 12222233222 11223456889999999999999998 467764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=341.56 Aligned_cols=208 Identities=22% Similarity=0.337 Sum_probs=159.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEece------------eeeEEEEeccCCChhhhhcCCC--CCCCHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVS------------KKILVYEYMSNGSLADILFNPE--KQPNWVERMGIARD 576 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------------~~~lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ 576 (757)
.+.+.+|+++|++++|||||++++++.+.+ ..|+||||+++|+|.+++.+.. ...++...+.|+.|
T Consensus 47 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~q 126 (299)
T 4g31_A 47 REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126 (299)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHH
Confidence 467899999999999999999999987654 3689999999999999997654 23567778899999
Q ss_pred HHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-----------eecccccCccccCccccc
Q 038168 577 IARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-----------TFTGIRGTRGYVAPEWHR 645 (757)
Q Consensus 577 ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~ 645 (757)
|+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+...... ..+..+||+.|||||.+.
T Consensus 127 i~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~ 203 (299)
T 4g31_A 127 IAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH 203 (299)
T ss_dssp HHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHT
T ss_pred HHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHc
Confidence 99999999999 9999999999999999999999999999987654321 123467999999999999
Q ss_pred CCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCC
Q 038168 646 NLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEP 725 (757)
Q Consensus 646 ~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p 725 (757)
+..++.++|||||||++|||++ ||... ..... ..........+.. ..+....+.+++.+||+.||
T Consensus 204 ~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~~~-~~~~~~~~~~p~~------~~~~~~~~~~li~~~L~~dP 268 (299)
T 4g31_A 204 GNSYSHKVDIFSLGLILFELLY---PFSTQ-----MERVR-TLTDVRNLKFPPL------FTQKYPCEYVMVQDMLSPSP 268 (299)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHHHH-HHHHHHTTCCCHH------HHHHCHHHHHHHHHHTCSSG
T ss_pred CCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHHHH-HHHHHhcCCCCCC------CcccCHHHHHHHHHHcCCCh
Confidence 9999999999999999999996 55321 11111 1122233332211 12333456789999999999
Q ss_pred CCCCCHHHHHH
Q 038168 726 SLRPSMKKVLL 736 (757)
Q Consensus 726 ~~RPsm~eVl~ 736 (757)
++|||+.|+++
T Consensus 269 ~~Rps~~eil~ 279 (299)
T 4g31_A 269 MERPEAINIIE 279 (299)
T ss_dssp GGSCCHHHHHT
T ss_pred hHCcCHHHHhc
Confidence 99999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=334.99 Aligned_cols=258 Identities=42% Similarity=0.698 Sum_probs=221.5
Q ss_pred CccccHHHHHHhhcccc--ccccCCCch--------------------------HHHHHHHHHHHhhcCCCceeeeeeEE
Q 038168 485 PLSFSYAELEKMTDGFK--EEVGRGSSG--------------------------EREFQTEMKVIGRTHHRNLVRLLGYS 536 (757)
Q Consensus 485 ~~~~~~~~l~~~t~~f~--~~lg~g~~~--------------------------~~~~~~E~~~l~~l~h~niv~l~g~~ 536 (757)
...|++.++..++++|. +.+|+|++| ...+.+|++++++++|+||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 45688999999999886 579999884 13689999999999999999999999
Q ss_pred EeceeeeEEEEeccCCChhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEe
Q 038168 537 LEVSKKILVYEYMSNGSLADILFNPE---KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKIS 613 (757)
Q Consensus 537 ~~~~~~~lV~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~ 613 (757)
.+.+..++||||+++|+|.+++.... ..+++..+..|+.|++.||+|||+.+.++|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997643 348999999999999999999999877899999999999999999999999
Q ss_pred ecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCC--CCCccccHHHHHHHHH
Q 038168 614 DFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPN--LPDDQVILEEWVYQCF 691 (757)
Q Consensus 614 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~--~~~~~~~l~~~~~~~~ 691 (757)
|||+++..............||+.|+|||.+.+..++.++||||||++++||++|+.||... .........+++....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 99999987665555555677999999999999999999999999999999999999999632 1223445556665555
Q ss_pred hcCCcccccccc---ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 692 ENGNLSQLVEDE---EVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 692 ~~~~~~~~~d~~---~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
.........+.. ....++...+.+++.+||+.||++|||+.||+++|++..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 555555555543 356788899999999999999999999999999999744
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=334.18 Aligned_cols=234 Identities=38% Similarity=0.654 Sum_probs=203.9
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---KQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.... ..+++.++..++.|+++||+|||+
T Consensus 78 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 157 (321)
T 2qkw_B 78 GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT 157 (321)
T ss_dssp HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC
Confidence 35789999999999999999999999999999999999999999999997643 358999999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+ +|+||||||+|||++.++.+||+|||+++....... .......||..|+|||.+.+..++.++||||||++++||
T Consensus 158 ~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 234 (321)
T 2qkw_B 158 R---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234 (321)
T ss_dssp T---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHH
T ss_pred C---CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHH
Confidence 8 999999999999999999999999999987543322 223345689999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCcccccccc---ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDE---EVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~---~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
++|+.|+....+.+......|.......+.+...+++. ....+....+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 235 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp HHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 99999998877776667777766666777777666654 346788899999999999999999999999999999866
Q ss_pred CCCC
Q 038168 743 EIPI 746 (757)
Q Consensus 743 ~~~~ 746 (757)
.+..
T Consensus 315 ~~~~ 318 (321)
T 2qkw_B 315 RLQE 318 (321)
T ss_dssp HSSC
T ss_pred hccc
Confidence 5543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=333.20 Aligned_cols=159 Identities=21% Similarity=0.319 Sum_probs=139.2
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
...+.+|+++|+++ +|||||++++++.+.+..++||||+++|+|.+++. .++..+...++.||+.||+|||++
T Consensus 63 ~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~-- 136 (361)
T 4f9c_A 63 PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQF-- 136 (361)
T ss_dssp HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 35788999999998 69999999999999999999999999999999983 488999999999999999999999
Q ss_pred CCeeeCCCCcceEEECCC-CcEEEeecCCccccCCCCc---------------------------ceecccccCccccCc
Q 038168 590 TQIIHCDIKPQNILMDEN-RCAKISDFGLAKLMKPDQT---------------------------RTFTGIRGTRGYVAP 641 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~-~~~ki~DfGla~~~~~~~~---------------------------~~~~~~~gt~~y~aP 641 (757)
+|+||||||+|||++.+ +.+||+|||+|+....... ...+..+||+.|+||
T Consensus 137 -gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 215 (361)
T 4f9c_A 137 -GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAP 215 (361)
T ss_dssp -TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCH
T ss_pred -CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCH
Confidence 99999999999999877 7999999999986543321 112345799999999
Q ss_pred ccccCC-CCCccccchhhHHHHHHHHhCCCCCCCCC
Q 038168 642 EWHRNL-PITVKADVYSFGVVLLEIICRRRCLDPNL 676 (757)
Q Consensus 642 E~~~~~-~~~~k~Dv~S~G~~l~elltG~~p~~~~~ 676 (757)
|++.+. .++.++||||+||+++||++|+.||....
T Consensus 216 E~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 216 EVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp HHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred HHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 999876 48999999999999999999999997544
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=337.27 Aligned_cols=218 Identities=24% Similarity=0.320 Sum_probs=167.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe------ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE------VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.+.+|+++|++++|||||++++++.. .+..||||||++ |+|.+++.+ ...+++.++..++.||+.||+||
T Consensus 97 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~yl 174 (398)
T 4b99_A 97 AKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYM 174 (398)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH
Confidence 3678899999999999999999998763 357899999996 689999965 45789999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCC---cceecccccCccccCcccccCC-CCCccccchhhHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ---TRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGV 660 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~ 660 (757)
|++ +|+||||||+|||++.++.+||+|||+|+.+.... .......+||+.|||||++.+. .++.++||||+||
T Consensus 175 H~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~ 251 (398)
T 4b99_A 175 HSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGC 251 (398)
T ss_dssp HHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred HHC---cCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHH
Confidence 998 99999999999999999999999999999765432 2234457899999999998875 4699999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccc---------------cccccccC-----HHHHHHHHHHHHHc
Q 038168 661 VLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQ---------------LVEDEEVD-----EKQLERMIKVALWC 720 (757)
Q Consensus 661 ~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~---------------~~d~~~~~-----~~~~~~l~~l~~~c 720 (757)
+++||++|+.||......+.. ..+........... +......+ .....++.+++.+|
T Consensus 252 il~ell~G~~pF~g~~~~~~l---~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~m 328 (398)
T 4b99_A 252 IFGEMLARRQLFPGKNYVHQL---QLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRM 328 (398)
T ss_dssp HHHHHHHTSCSSCCSSHHHHH---HHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHH
T ss_pred HHHHHHHCCCCCCCCCHHHHH---HHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHH
Confidence 999999999999764322211 11111110000000 00000001 11235688999999
Q ss_pred cccCCCCCCCHHHHHH
Q 038168 721 ILDEPSLRPSMKKVLL 736 (757)
Q Consensus 721 l~~~p~~RPsm~eVl~ 736 (757)
|+.||++|||+.|+++
T Consensus 329 L~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 329 LRFEPSARISAAAALR 344 (398)
T ss_dssp SCSSTTTSCCHHHHTT
T ss_pred CcCChhHCcCHHHHhc
Confidence 9999999999999987
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=348.04 Aligned_cols=211 Identities=21% Similarity=0.353 Sum_probs=176.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+++|++++|||||++++++.+.+..+|||||+++|+|.++|.+....+++.+...++.||+.||+|||++
T Consensus 198 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~--- 274 (573)
T 3uto_A 198 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN--- 274 (573)
T ss_dssp HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46788999999999999999999999999999999999999999999977667899999999999999999999999
Q ss_pred CeeeCCCCcceEEECCC--CcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 591 QIIHCDIKPQNILMDEN--RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~--~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+|||++.+ +.+||+|||+|+.+..... ....+||+.|||||++.+..++.++||||+||++|||++|
T Consensus 275 ~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G 352 (573)
T 3uto_A 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352 (573)
T ss_dssp TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 99999999999999864 8999999999998765432 3446799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+.||...... + ....+..+..... ..........+.+++.+||+.||++|||+.|+++
T Consensus 353 ~~Pf~~~~~~------~-~~~~i~~~~~~~~---~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 353 LSPFGGENDD------E-TLRNVKSCDWNMD---DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCSSCCSSHH------H-HHHHHHTTCCCCC---SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCCcCHH------H-HHHHHHhCCCCCC---cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999754321 1 1222233322111 0111122456789999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.65 Aligned_cols=253 Identities=39% Similarity=0.594 Sum_probs=206.7
Q ss_pred CCccccHHHHHHhhccccc--------cccCCCch----------------------------HHHHHHHHHHHhhcCCC
Q 038168 484 APLSFSYAELEKMTDGFKE--------EVGRGSSG----------------------------EREFQTEMKVIGRTHHR 527 (757)
Q Consensus 484 ~~~~~~~~~l~~~t~~f~~--------~lg~g~~~----------------------------~~~~~~E~~~l~~l~h~ 527 (757)
....|++.++.+++++|.+ .+|+|++| .+.+.+|+.++++++||
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4567999999999999974 49999883 36789999999999999
Q ss_pred ceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEEC
Q 038168 528 NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP--EKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMD 605 (757)
Q Consensus 528 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~ 605 (757)
||+++++++.+.+..++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 9999999999999999999999999999998643 34689999999999999999999998 999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHH
Q 038168 606 ENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILE 684 (757)
Q Consensus 606 ~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~ 684 (757)
.++.+||+|||+++........ ......||..|+|||.+.+ .++.++||||||++++||++|+.|+..........
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-- 244 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL-- 244 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT--
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH--
Confidence 9999999999999876554332 2334678999999998765 58999999999999999999999998654433211
Q ss_pred HHHHHHHh-cCCcccccccc--ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 685 EWVYQCFE-NGNLSQLVEDE--EVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 685 ~~~~~~~~-~~~~~~~~d~~--~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
.+...... ...+...+++. .......+.+.+++.+||+.+|++|||+.+|+++|+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11111111 11122222221 245677889999999999999999999999999998754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=345.13 Aligned_cols=203 Identities=20% Similarity=0.231 Sum_probs=166.7
Q ss_pred HHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeC
Q 038168 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHC 595 (757)
Q Consensus 516 ~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~ 595 (757)
.++.+++.++|||||++++++.+.+..||||||+++|+|.++|.+ ...++......++.||+.||+|||++ +||||
T Consensus 241 ~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHR 316 (689)
T 3v5w_A 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNR---FVVYR 316 (689)
T ss_dssp HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECC
T ss_pred HHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---Ccccc
Confidence 446777788999999999999999999999999999999999965 35688999999999999999999998 99999
Q ss_pred CCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHHHhCCCCCCC
Q 038168 596 DIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICRRRCLDP 674 (757)
Q Consensus 596 Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~elltG~~p~~~ 674 (757)
||||+||||+.++.+||+|||+|+.+.... ....+||+.|||||++.. ..++.++||||+||++|||++|+.||..
T Consensus 317 DLKPeNILld~~G~vKL~DFGlA~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 317 DLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred CCchHHeEEeCCCCEEecccceeeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999775443 234689999999999974 5799999999999999999999999975
Q ss_pred CCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 038168 675 NLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS-----MKKVLL 736 (757)
Q Consensus 675 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----m~eVl~ 736 (757)
....+.. + +.......... ++.....++.+++.+||+.||++|++ ++||++
T Consensus 394 ~~~~~~~---~-i~~~i~~~~~~-------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 394 HKTKDKH---E-IDRMTLTMAVE-------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp GGCCCHH---H-HHHHHHHCCCC-------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CChHHHH---H-HHHhhcCCCCC-------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 4333221 1 11222222211 12223456889999999999999998 577764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=318.89 Aligned_cols=216 Identities=31% Similarity=0.493 Sum_probs=179.6
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.|.+|++++++++||||+++++++.+.+..++||||+++|+|.+++......+++.++..++.|+++||+|||+.
T Consensus 50 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~-- 127 (310)
T 3s95_A 50 TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM-- 127 (310)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 357899999999999999999999999999999999999999999999987777899999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-------------ecccccCccccCcccccCCCCCccccch
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-------------FTGIRGTRGYVAPEWHRNLPITVKADVY 656 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~k~Dv~ 656 (757)
+|+||||||+|||++.++.+||+|||+++......... .....||+.|+|||.+.+..++.++|||
T Consensus 128 -~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 206 (310)
T 3s95_A 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVF 206 (310)
T ss_dssp -TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHH
T ss_pred -CccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHH
Confidence 99999999999999999999999999998765433211 1145799999999999999999999999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCCcc---ccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 038168 657 SFGVVLLEIICRRRCLDPNLPDDQ---VILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKK 733 (757)
Q Consensus 657 S~G~~l~elltG~~p~~~~~~~~~---~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~e 733 (757)
|||++++||++|..|+........ ...... .... .+......+.+++.+||+.||++|||+.|
T Consensus 207 slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~----~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 272 (310)
T 3s95_A 207 SFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF----LDRY----------CPPNCPPSFFPITVRCCDLDPEKRPSFVK 272 (310)
T ss_dssp HHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH----HHHT----------CCTTCCTTHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc----cccc----------CCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 999999999999998876443321 111111 0100 11122346889999999999999999999
Q ss_pred HHHHhhcCc
Q 038168 734 VLLMLEGTV 742 (757)
Q Consensus 734 Vl~~Le~~~ 742 (757)
+++.|+.+.
T Consensus 273 l~~~L~~l~ 281 (310)
T 3s95_A 273 LEHWLETLR 281 (310)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=320.42 Aligned_cols=222 Identities=30% Similarity=0.471 Sum_probs=170.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE--KQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.++|.+|++++++++||||+++++++.+.+..++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+.
T Consensus 78 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~- 156 (309)
T 3p86_A 78 VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR- 156 (309)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS-
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-
Confidence 3678999999999999999999999999999999999999999999997644 2389999999999999999999998
Q ss_pred CCC--eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 589 ETQ--IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 589 ~~~--iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+ |+||||||+|||++.++.+||+|||+++...... .......||..|+|||.+.+..++.++||||||++++||+
T Consensus 157 --~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 233 (309)
T 3p86_A 157 --NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233 (309)
T ss_dssp --SSCCCCTTCCGGGEEECTTCCEEECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred --CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHH
Confidence 7 9999999999999999999999999998654332 2233467899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcCCCC
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPI 746 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~~~~ 746 (757)
+|+.||...... +............ ..+......+.+++.+||+.+|++|||+.||++.|+.+.+-..
T Consensus 234 tg~~Pf~~~~~~------~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 234 TLQQPWGNLNPA------QVVAAVGFKCKRL------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp HCCCTTTTSCHH------HHHHHHHHSCCCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred hCCCCCCCCCHH------HHHHHHHhcCCCC------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 999998754321 1111111111111 1122334568899999999999999999999999998665443
Q ss_pred CC
Q 038168 747 PP 748 (757)
Q Consensus 747 p~ 748 (757)
||
T Consensus 302 p~ 303 (309)
T 3p86_A 302 PP 303 (309)
T ss_dssp --
T ss_pred CC
Confidence 33
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=320.83 Aligned_cols=219 Identities=28% Similarity=0.449 Sum_probs=180.5
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.|.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++......+++.++..++.|++.||+|||+. +
T Consensus 95 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ 171 (325)
T 3kul_A 95 RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---G 171 (325)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 5789999999999999999999999999999999999999999999987777899999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc--eecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-C
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR--TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-R 668 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G 668 (757)
|+||||||+|||++.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||++++||++ |
T Consensus 172 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g 251 (325)
T 3kul_A 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYG 251 (325)
T ss_dssp EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999987654322 2233456788999999999999999999999999999999 9
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcCCCC
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEIPI 746 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~~~~ 746 (757)
+.||...... + +......+... ..+......+.+++.+||+.||++|||+.||+++|+.+...+.
T Consensus 252 ~~p~~~~~~~------~-~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 252 ERPYWNMTNR------D-VISSVEEGYRL------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp CCTTTTSCHH------H-HHHHHHTTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred CCCcccCCHH------H-HHHHHHcCCCC------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 9998653221 1 12222222111 1122334678999999999999999999999999998765443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=315.54 Aligned_cols=230 Identities=25% Similarity=0.354 Sum_probs=180.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEece----eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVS----KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
...+.+|+.++++++||||+++++++.+.. ..++||||+++|+|.+++.. ..+++.++..++.|+++||+|||+
T Consensus 62 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~ 139 (322)
T 3soc_A 62 SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHE 139 (322)
T ss_dssp HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHh
Confidence 355677999999999999999999998754 46999999999999999964 458999999999999999999998
Q ss_pred CC-------CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccC-----CCCCccc
Q 038168 587 EC-------ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRN-----LPITVKA 653 (757)
Q Consensus 587 ~~-------~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~k~ 653 (757)
.+ .++|+||||||+|||++.++.+||+|||+++........ ......||..|+|||.+.+ ..++.++
T Consensus 140 ~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 219 (322)
T 3soc_A 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRI 219 (322)
T ss_dssp CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHH
T ss_pred hccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccc
Confidence 52 348999999999999999999999999999877654332 2334679999999999886 3567789
Q ss_pred cchhhHHHHHHHHhCCCCCCCCCCCccccHHH---------HHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccC
Q 038168 654 DVYSFGVVLLEIICRRRCLDPNLPDDQVILEE---------WVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDE 724 (757)
Q Consensus 654 Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~---------~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~ 724 (757)
||||||+++|||++|+.||..........+.. ..........................++.+++.+||+.|
T Consensus 220 DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (322)
T 3soc_A 220 DMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD 299 (322)
T ss_dssp HHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSS
T ss_pred hhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCC
Confidence 99999999999999999998755433222111 111222222222222222223456678999999999999
Q ss_pred CCCCCCHHHHHHHhhcCc
Q 038168 725 PSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 725 p~~RPsm~eVl~~Le~~~ 742 (757)
|++|||+.||++.|+.+.
T Consensus 300 P~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 300 AEARLSAGCVGERITQMQ 317 (322)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHH
Confidence 999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=320.62 Aligned_cols=217 Identities=25% Similarity=0.393 Sum_probs=180.6
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------------CCCCHHHHHHHH
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------------KQPNWVERMGIA 574 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~ 574 (757)
.+.+.+|+.+++++ +||||+++++++.+.+..++||||+++|+|.+++.... ..+++.+++.++
T Consensus 130 ~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 209 (370)
T 2psq_A 130 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209 (370)
T ss_dssp HHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHH
Confidence 46789999999999 89999999999999999999999999999999996532 357899999999
Q ss_pred HHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccc
Q 038168 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKA 653 (757)
Q Consensus 575 ~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~ 653 (757)
.||++||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++
T Consensus 210 ~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 286 (370)
T 2psq_A 210 YQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 286 (370)
T ss_dssp HHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHH
T ss_pred HHHHHHHHHHHhC---CeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHH
Confidence 9999999999998 999999999999999999999999999987654332 223345678899999999999999999
Q ss_pred cchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 654 DVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 654 Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
||||||+++|||++ |+.||......+ +...+..+.... .+......+.+++.+||+.+|++||++.
T Consensus 287 DvwslG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ 353 (370)
T 2psq_A 287 DVWSFGVLMWEIFTLGGSPYPGIPVEE-------LFKLLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQRPTFK 353 (370)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHTTCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhcCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 99999999999999 999887543221 112233332211 1223346789999999999999999999
Q ss_pred HHHHHhhcCcC
Q 038168 733 KVLLMLEGTVE 743 (757)
Q Consensus 733 eVl~~Le~~~~ 743 (757)
|+++.|+.+..
T Consensus 354 ell~~L~~il~ 364 (370)
T 2psq_A 354 QLVEDLDRILT 364 (370)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999997653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.61 Aligned_cols=222 Identities=27% Similarity=0.445 Sum_probs=185.3
Q ss_pred cCCCchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 505 GRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 505 g~g~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.......+++.+|++++++++||||+++++++.+.+..++||||+++++|.+++......+++.++..++.|+++||+||
T Consensus 43 ~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l 122 (269)
T 4hcu_A 43 REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 122 (269)
T ss_dssp CTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHH
Confidence 33444568899999999999999999999999999999999999999999999987777899999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~e 664 (757)
|+. +|+||||||+||+++.++.+||+|||+++..............++..|+|||.+.+..++.++||||||++++|
T Consensus 123 H~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 199 (269)
T 4hcu_A 123 EEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 199 (269)
T ss_dssp HHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHH
Confidence 998 99999999999999999999999999998776544444445667889999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 665 IIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 665 llt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
|++ |+.||...... + .......+.. ...+ ......+.+++.+||+.||++||++.|++++|+.+.
T Consensus 200 ll~~g~~p~~~~~~~------~-~~~~~~~~~~--~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 200 VFSEGKIPYENRSNS------E-VVEDISTGFR--LYKP----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp HHTTSCCTTTTCCHH------H-HHHHHHTTCC--CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCCCCCCCCCCHH------H-HHHHHhcCcc--CCCC----CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 999 89888653221 1 1122222211 1111 122456889999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=318.99 Aligned_cols=216 Identities=22% Similarity=0.350 Sum_probs=178.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..++|.+|+.++++++||||+++++++.+.. .++|+||+++|+|.+++......+++..++.++.|+++||+|||+.
T Consensus 60 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-- 136 (327)
T 3poz_A 60 ANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136 (327)
T ss_dssp CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC--
Confidence 4578999999999999999999999998754 7899999999999999987777899999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+|+||||||+|||++.++.+||+|||+++....... .......+|..|+|||.+.+..++.++||||||++++||++
T Consensus 137 -~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 215 (327)
T 3poz_A 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 215 (327)
T ss_dssp -TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred -CeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhc
Confidence 999999999999999999999999999998765433 22334567889999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
|+.||....... + ......+.... .+......+.+++.+||+.+|++||++.||+++|+.+.
T Consensus 216 g~~p~~~~~~~~---~----~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 216 GSKPYDGIPASE---I----SSILEKGERLP------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp SCCTTTTCCGGG---H----HHHHHTTCCCC------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccCCCHHH---H----HHHHHcCCCCC------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 999987543322 1 12222222111 12223457889999999999999999999999997643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=306.85 Aligned_cols=236 Identities=19% Similarity=0.310 Sum_probs=192.5
Q ss_pred CccccHHHHHHhhccc------------cccccCCCch--------------------------HHHHHHHHHHHhhcCC
Q 038168 485 PLSFSYAELEKMTDGF------------KEEVGRGSSG--------------------------EREFQTEMKVIGRTHH 526 (757)
Q Consensus 485 ~~~~~~~~l~~~t~~f------------~~~lg~g~~~--------------------------~~~~~~E~~~l~~l~h 526 (757)
...+++++++.+++.. .+.+|+|++| .+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 3558899999888752 2468999873 3678999999999999
Q ss_pred CceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECC
Q 038168 527 RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDE 606 (757)
Q Consensus 527 ~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~ 606 (757)
+||+++++++...+..++||||+++++|.+++.. ..+++.++..++.|+++||+|||+. +|+||||||+|||++.
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL 176 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC
Confidence 9999999999999999999999999999999854 4689999999999999999999998 9999999999999999
Q ss_pred CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHH
Q 038168 607 NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEW 686 (757)
Q Consensus 607 ~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~ 686 (757)
++.+||+|||+++....... ......||+.|+|||.+.+..++.++||||||++++||++|+.||...... +
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------~- 248 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------Q- 248 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------H-
T ss_pred CCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-
Confidence 99999999999987654332 223467999999999999999999999999999999999999998753221 1
Q ss_pred HHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 687 VYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 687 ~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
....+........... ......+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 249 AMKRLRDSPPPKLKNS----HKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHSSCCCCTTG----GGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHhcCCCCCcCcc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122222222222111 1223568899999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.54 Aligned_cols=224 Identities=24% Similarity=0.357 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHhh--cCCCceeeeeeEEEec----eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGR--THHRNLVRLLGYSLEV----SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~--l~h~niv~l~g~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.+..|.+++.. ++||||+++++++.+. ...++||||+++|+|.+++. ...+++..+.+++.|++.||+||
T Consensus 44 ~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~l 121 (301)
T 3q4u_A 44 EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHL 121 (301)
T ss_dssp HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHH
Confidence 4567777777776 7999999999987653 46899999999999999994 35689999999999999999999
Q ss_pred h--------hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce---ecccccCccccCcccccCC------
Q 038168 585 H--------DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT---FTGIRGTRGYVAPEWHRNL------ 647 (757)
Q Consensus 585 H--------~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------ 647 (757)
| +. +|+||||||+|||++.++.+||+|||+++......... .....||+.|+|||.+.+.
T Consensus 122 H~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 198 (301)
T 3q4u_A 122 HIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCF 198 (301)
T ss_dssp HSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCH
T ss_pred HHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcc
Confidence 9 66 99999999999999999999999999998765543322 2235799999999999876
Q ss_pred CCCccccchhhHHHHHHHHhC----------CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHH
Q 038168 648 PITVKADVYSFGVVLLEIICR----------RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVA 717 (757)
Q Consensus 648 ~~~~k~Dv~S~G~~l~elltG----------~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~ 717 (757)
.++.++||||||++++||++| +.||......... ... ..........................+.+++
T Consensus 199 ~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 276 (301)
T 3q4u_A 199 DSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS-FED-MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLM 276 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-HHH-HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHH
T ss_pred cCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc-hhh-hhHHHhccCCCCCCChhhccCccHHHHHHHH
Confidence 556899999999999999999 7777654443322 111 1222222222212222223446778899999
Q ss_pred HHccccCCCCCCCHHHHHHHhhcC
Q 038168 718 LWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 718 ~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
.+||+.||++|||+.||+++|+.+
T Consensus 277 ~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 277 KECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhhcChhhCCCHHHHHHHHhcc
Confidence 999999999999999999999863
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=321.23 Aligned_cols=217 Identities=27% Similarity=0.450 Sum_probs=169.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..++|.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.+....+++.++..++.||++||+|||++
T Consensus 89 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-- 166 (373)
T 2qol_A 89 QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM-- 166 (373)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 346799999999999999999999999999999999999999999999987777899999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce--ecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT--FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+|||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++
T Consensus 167 -~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt 245 (373)
T 2qol_A 167 -GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245 (373)
T ss_dssp -TCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred -CeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHh
Confidence 99999999999999999999999999998776543222 222345778999999999999999999999999999998
Q ss_pred -CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 668 -RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 668 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
|+.|+...... + +......+... ..+......+.+++.+||+.+|++||++.||+++|+.+.
T Consensus 246 ~g~~P~~~~~~~------~-~~~~i~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 246 YGERPYWEMSNQ------D-VIKAVDEGYRL------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp TC-CTTTTCCHH------H-HHHHHHTTEEC------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHH------H-HHHHHHcCCCC------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 99998653221 1 12222222111 112234567899999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=308.15 Aligned_cols=227 Identities=23% Similarity=0.344 Sum_probs=179.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.|.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. ...+++.++..++.|++.||+|||+.
T Consensus 55 ~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--- 130 (294)
T 4eqm_A 55 LKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDM--- 130 (294)
T ss_dssp HHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46789999999999999999999999999999999999999999999964 34689999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++..............||+.|+|||.+.+..++.++||||||++++||++|+.
T Consensus 131 ~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~ 210 (294)
T 4eqm_A 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210 (294)
T ss_dssp TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred CcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999998776544444445679999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcCcCCCCCCC
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-SMKKVLLMLEGTVEIPIPPN 749 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-sm~eVl~~Le~~~~~~~p~~ 749 (757)
||...... ......... ..... +.......+..+.+++.+|++.||++|| +++++.+.|+....-.....
T Consensus 211 pf~~~~~~------~~~~~~~~~-~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~ 281 (294)
T 4eqm_A 211 PFNGETAV------SIAIKHIQD-SVPNV--TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281 (294)
T ss_dssp SSCSSCHH------HHHHHHHSS-CCCCH--HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred CCCCCChH------HHHHHHhhc-cCCCc--chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence 99754321 111122221 11111 0112223456789999999999999998 99999999998765544443
Q ss_pred C
Q 038168 750 P 750 (757)
Q Consensus 750 p 750 (757)
+
T Consensus 282 ~ 282 (294)
T 4eqm_A 282 D 282 (294)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=331.76 Aligned_cols=221 Identities=28% Similarity=0.385 Sum_probs=184.5
Q ss_pred CCchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 507 g~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.....++|.+|+.++++++|||||++++++.+.+..++||||+++|+|.+++... ...+++..++.|+.||++||+|||
T Consensus 256 ~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH 335 (495)
T 1opk_A 256 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335 (495)
T ss_dssp SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3345688999999999999999999999999999999999999999999999753 356899999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
++ +|+||||||+|||++.++.+||+|||+++..............++..|+|||.+.+..++.++||||||++++||
T Consensus 336 ~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el 412 (495)
T 1opk_A 336 KK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412 (495)
T ss_dssp HT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred hC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHH
Confidence 98 999999999999999999999999999998765444444455678899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcC
Q 038168 666 IC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 666 lt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~ 743 (757)
++ |+.|+....... +.+.+..+... ..+......+.+++.+||+.||++|||+.+|+++|+.+.+
T Consensus 413 ~t~g~~p~~~~~~~~-------~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 413 ATYGMSPYPGIDLSQ-------VYELLEKDYRM------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HTTSCCSSTTCCGGG-------HHHHHHTTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HhCCCCCCCCCCHHH-------HHHHHHcCCCC------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 99 888887543221 12222222111 1122334678899999999999999999999999998653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=309.19 Aligned_cols=219 Identities=15% Similarity=0.152 Sum_probs=178.8
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+.+.+|+.+++++ +|+||+++++++.+.+..++||||+ +++|.+++......+++.++..++.|++.||+|||+.
T Consensus 49 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--- 124 (330)
T 2izr_A 49 PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK--- 124 (330)
T ss_dssp CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 4688999999999 9999999999999999999999999 9999999976667899999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCc-----EEEeecCCccccCCCCcc------eecccccCccccCcccccCCCCCccccchhhH
Q 038168 591 QIIHCDIKPQNILMDENRC-----AKISDFGLAKLMKPDQTR------TFTGIRGTRGYVAPEWHRNLPITVKADVYSFG 659 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~-----~ki~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G 659 (757)
+|+||||||+|||++.++. +||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||
T Consensus 125 ~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 204 (330)
T 2izr_A 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALG 204 (330)
T ss_dssp TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHH
Confidence 9999999999999998887 999999999976543321 12356799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 660 VVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 660 ~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
++++||++|+.||..............+.......... ......+ ++.+++..|++.+|.+||++++|++.|+
T Consensus 205 ~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 205 HMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp HHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred HHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 99999999999998764443222111111110000000 0001122 8999999999999999999999999997
Q ss_pred cC
Q 038168 740 GT 741 (757)
Q Consensus 740 ~~ 741 (757)
.+
T Consensus 278 ~~ 279 (330)
T 2izr_A 278 DL 279 (330)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.97 Aligned_cols=220 Identities=26% Similarity=0.424 Sum_probs=184.9
Q ss_pred CchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 508 SSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 508 ~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
....+++.+|++++++++||||+++++++.+.+..++||||+++++|.+++......+++.++..++.|++.||+|||+.
T Consensus 44 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 123 (268)
T 3sxs_A 44 SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123 (268)
T ss_dssp TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34567899999999999999999999999999999999999999999999977666789999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+||+++.++.+||+|||+++..............+|..|+|||.+.+..++.++||||||++++||++
T Consensus 124 ---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 200 (268)
T 3sxs_A 124 ---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200 (268)
T ss_dssp ---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHT
T ss_pred ---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHc
Confidence 99999999999999999999999999999876665555555667888999999999899999999999999999999
Q ss_pred -CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcC
Q 038168 668 -RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 668 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~ 743 (757)
|+.||...... + .......+.. ...+. .....+.+++.+||+.+|++|||+.|+++.|+.+.+
T Consensus 201 ~g~~p~~~~~~~------~-~~~~~~~~~~--~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 201 LGKMPYDLYTNS------E-VVLKVSQGHR--LYRPH----LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TTCCTTTTSCHH------H-HHHHHHTTCC--CCCCT----TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCCCccccChH------H-HHHHHHcCCC--CCCCC----cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 99988644321 1 1111222211 11111 123568899999999999999999999999998765
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=302.49 Aligned_cols=211 Identities=26% Similarity=0.368 Sum_probs=175.4
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++||||+++++++...+..++||||+++|+|.+++.+ ..+++.++..++.|++.||+|||+.
T Consensus 60 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~-- 135 (297)
T 3fxz_A 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN-- 135 (297)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 356789999999999999999999999999999999999999999999964 3588999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+..++.++||||||++++||++|+
T Consensus 136 -~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 213 (297)
T 3fxz_A 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213 (297)
T ss_dssp -TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999987654433 233467899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
.||...... .........+. .....+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 214 ~pf~~~~~~------~~~~~~~~~~~-~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 214 PPYLNENPL------RALYLIATNGT-PELQNP----EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CTTTTSCHH------HHHHHHHHHCS-CCCSCG----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCHH------HHHHHHHhCCC-CCCCCc----cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 998654221 11112222221 111112 2234568899999999999999999999873
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=305.04 Aligned_cols=223 Identities=24% Similarity=0.385 Sum_probs=185.0
Q ss_pred ccCCCchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038168 504 VGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 504 lg~g~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y 583 (757)
+-......+++.+|++++++++|+||+++++++.+.+..++||||+++++|.+++......+++.++..++.|++.||+|
T Consensus 56 ~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~ 135 (283)
T 3gen_A 56 IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135 (283)
T ss_dssp ECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHH
Confidence 33444457889999999999999999999999999999999999999999999998766779999999999999999999
Q ss_pred hhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHH
Q 038168 584 LHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663 (757)
Q Consensus 584 LH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ 663 (757)
||++ +|+||||||+|||++.++.+||+|||+++..............+|..|+|||.+.+..++.++||||||++++
T Consensus 136 lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 212 (283)
T 3gen_A 136 LESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMW 212 (283)
T ss_dssp HHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHH
T ss_pred HHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHH
Confidence 9998 9999999999999999999999999999877654433344456788899999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 664 EIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 664 ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
||++ |+.||...... + .......+... ..+ ......+.+++.+||+.+|++|||+.|+++.|+.+.
T Consensus 213 ~l~t~g~~p~~~~~~~------~-~~~~~~~~~~~--~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 213 EIYSLGKMPYERFTNS------E-TAEHIAQGLRL--YRP----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp HHHTTTCCTTTTSCHH------H-HHHHHHTTCCC--CCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhCCCCCccccChh------H-HHHHHhcccCC--CCC----CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 9998 99998754321 1 11222222111 111 122357889999999999999999999999998654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=327.52 Aligned_cols=220 Identities=27% Similarity=0.430 Sum_probs=180.7
Q ss_pred CCchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhh
Q 038168 507 GSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 507 g~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
+....++|.+|+.++++++|||||++++++. .+..++||||+++|+|.+++.... ..+++.+++.++.||++||+|||
T Consensus 223 ~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH 301 (454)
T 1qcf_A 223 GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301 (454)
T ss_dssp TSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH
T ss_pred CCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3445789999999999999999999999986 567899999999999999997543 46789999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
++ +|+||||||+|||++.++.+||+|||+++..............++..|+|||.+....++.++||||||++++||
T Consensus 302 ~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el 378 (454)
T 1qcf_A 302 QR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 378 (454)
T ss_dssp HT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred hC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHH
Confidence 98 999999999999999999999999999997754332223345567899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcC
Q 038168 666 IC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 666 lt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~ 743 (757)
++ |+.|+...... + +...+..+... .. +...+..+.+++.+||+.||++|||+++|+++|+.+..
T Consensus 379 ~t~g~~P~~~~~~~------~-~~~~i~~~~~~--~~----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 379 VTYGRIPYPGMSNP------E-VIRALERGYRM--PR----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HTTSCCSSTTCCHH------H-HHHHHHHTCCC--CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred HhCCCCCCCCCCHH------H-HHHHHHcCCCC--CC----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 99 99998653221 1 12222222111 11 12334678999999999999999999999999998654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.20 Aligned_cols=215 Identities=22% Similarity=0.339 Sum_probs=166.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++||||+++++++. .+..++||||+++++|.+++......+++.++..++.|++.||+|||+.
T Consensus 60 ~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--- 135 (281)
T 1mp8_A 60 REKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 135 (281)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 467899999999999999999999984 4678999999999999999977666799999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-CC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-RR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G~ 669 (757)
+|+||||||+|||++.++.+||+|||+++..............+++.|+|||.+.+..++.++||||||++++||++ |+
T Consensus 136 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~ 215 (281)
T 1mp8_A 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 215 (281)
T ss_dssp TCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC
T ss_pred CeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCC
Confidence 99999999999999999999999999998776544333334557789999999999999999999999999999997 88
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
.||......+ . ...+..+.... .+......+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 216 ~pf~~~~~~~---~----~~~i~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 216 KPFQGVKNND---V----IGRIENGERLP------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp CTTTTCCGGG---H----HHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcCCHHH---H----HHHHHcCCCCC------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 8887543322 1 11222222111 12233467889999999999999999999999998753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.70 Aligned_cols=221 Identities=29% Similarity=0.420 Sum_probs=175.2
Q ss_pred CCCchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHh
Q 038168 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 506 ~g~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+....++|.+|++++++++||||+++++++.+ +..++||||+++|+|.+++... ...+++.+++.++.|+++||+||
T Consensus 218 ~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~L 296 (452)
T 1fmk_A 218 PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296 (452)
T ss_dssp TTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334456889999999999999999999999876 6789999999999999999653 35689999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~e 664 (757)
|++ +|+||||||+|||++.++.+||+|||+++..............++..|+|||.+.+..++.++||||||++++|
T Consensus 297 H~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~e 373 (452)
T 1fmk_A 297 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE 373 (452)
T ss_dssp HHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHH
Confidence 998 99999999999999999999999999998776544333344567889999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcC
Q 038168 665 IIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 665 llt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~ 743 (757)
|++ |+.|+...... + +...+..+... ..+....+.+.+++.+||+.||++|||+++|+++|+.+..
T Consensus 374 l~t~g~~P~~~~~~~------~-~~~~i~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 374 LTTKGRVPYPGMVNR------E-VLDQVERGYRM------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp HHTTTCCSSTTCCHH------H-HHHHHHTTCCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHhCCCCCCCCCCHH------H-HHHHHHcCCCC------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 999 88888643221 1 22222333111 1122345678899999999999999999999999998654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=307.12 Aligned_cols=223 Identities=23% Similarity=0.377 Sum_probs=174.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.+.|.+|++++++++||||+++++++... ...++||||+++|+|.+++......+++.++..++.|++.||+|||+.
T Consensus 55 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~- 133 (295)
T 3ugc_A 55 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 133 (295)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC-
Confidence 46789999999999999999999998654 458999999999999999987666799999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc--eecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR--TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+|+||||||+|||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||+
T Consensus 134 --~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 211 (295)
T 3ugc_A 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211 (295)
T ss_dssp --TCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred --CcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999977544321 222345777899999999999999999999999999999
Q ss_pred hCCCCCCCCCCC---------ccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 667 CRRRCLDPNLPD---------DQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 667 tG~~p~~~~~~~---------~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+|..|+.....+ ...............+.... .+.....++.+++.+||+.||++|||+.||+++
T Consensus 212 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 212 TYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCC------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCC------CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999887643110 01111111222222222111 122334678999999999999999999999999
Q ss_pred hhcCc
Q 038168 738 LEGTV 742 (757)
Q Consensus 738 Le~~~ 742 (757)
|+.+.
T Consensus 286 L~~l~ 290 (295)
T 3ugc_A 286 VDQIR 290 (295)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=322.02 Aligned_cols=215 Identities=23% Similarity=0.303 Sum_probs=177.3
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
++|.+|++++++++||||+++++++.+.+..++||||+++|+|.+++......+++.++..++.|+++||+|||++ +
T Consensus 157 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ 233 (377)
T 3cbl_A 157 AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---C 233 (377)
T ss_dssp TTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 4688999999999999999999999999999999999999999999976666789999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceec-ccccCccccCcccccCCCCCccccchhhHHHHHHHHh-CC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT-GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-RR 669 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G~ 669 (757)
|+||||||+|||++.++.+||+|||+++........... ...++..|+|||.+.+..++.++||||||++++||++ |+
T Consensus 234 ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~ 313 (377)
T 3cbl_A 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGA 313 (377)
T ss_dssp EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999875443222111 1235778999999999999999999999999999998 88
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
.|+...... .+......+.... .+...+..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 314 ~p~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 314 SPYPNLSNQ-------QTREFVEKGGRLP------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp CSSTTSCHH-------HHHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHH-------HHHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 888653221 1222233332111 11223457889999999999999999999999998753
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=288.71 Aligned_cols=211 Identities=17% Similarity=0.291 Sum_probs=157.2
Q ss_pred cccCcccCCCceeccCCCeeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCE
Q 038168 28 QRRSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSI 107 (757)
Q Consensus 28 ~~~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~L 107 (757)
++.|+|++|++|++ +++| ++|.|+|||+.+++ +.+ |.. +|+||+|||+.| ..+.|.+..||+|
T Consensus 6 ~~~~~i~~g~~L~~--g~~l--~~g~f~l~f~~~gn------l~l-y~~---~~~vW~an~~~~---~~~~l~l~~dGnL 68 (236)
T 1dlp_A 6 GLSHEGSHPQTLHA--AQSL--ELSSFRFTMQSDCN------LVL-FDS---DVRVWASNTAGA---TGCRAVLQSDGLL 68 (236)
T ss_dssp CSSSSSCSCSCCCT--TCEE--CSTTEEEEECTTSC------EEE-EES---SSEEECCCCCSC---SCCBCCBCSSSCB
T ss_pred eccceeCCCCEECC--CCEE--EcCCEEEEECCCCc------EEE-EEC---CEEEEECCCCCC---CCeEEEEcCCCcE
Confidence 34699999999986 4577 59999999987665 334 432 799999999988 6789999999999
Q ss_pred EEecCCCCceeEEecCCC--cceeEEEecCCCEEEEecCCceeeeccCCCcccc----------CCCCcccCC-Cccccc
Q 038168 108 VLRSSQQSQDSLIADDSQ--SASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTL----------LPNQRLSVG-TKLFPG 174 (757)
Q Consensus 108 vl~~~~~~~~~~~~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTl----------Lpg~kl~~~-~~L~S~ 174 (757)
||.+.++. .+|++++.. ....|+|+|+|||||++. ++||||||||||+ +||||++.+ ++|++
T Consensus 69 vl~d~~~~-~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s- 143 (236)
T 1dlp_A 69 VILTAQNT-IRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHA- 143 (236)
T ss_dssp CCBCTTTC-CSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECS-
T ss_pred EEEcCCCc-EEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEEc-
Confidence 99987644 456655432 235899999999999954 8999999998554 777777654 46774
Q ss_pred CCCCCCCCCceEEEecCCCCceeeeccCCCCccceEeeccccCCCCccccccCCCccEEEecccceeeeeecCCCCCCCc
Q 038168 175 ISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGVNIFNLTGGENPTKG 254 (757)
Q Consensus 175 ~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (757)
.+||++|.|++.+|++|+++++.. ...||++++|++.......++.+|.+++++.++..+...+... ..
T Consensus 144 --~~d~s~G~~~l~l~~dG~LvL~~~------~~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~--~~- 212 (236)
T 1dlp_A 144 --TQSLQLSPYRLSMETDCNLVLFDR------DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSR--SA- 212 (236)
T ss_dssp --SCCCBCSSCEEEEETTTEEEEEBT------TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEECCCCC--SS-
T ss_pred --CcEeecCcEEEEECCCCcEEEEcC------CEeEEeCCCcCCCCceEEEECCCCcEEEEeCCCcEEEEeCCCC--CC-
Confidence 689999999999999998776532 2589999998654334456778888766654444333333221 12
Q ss_pred eEEEEEEccCccEEEEE
Q 038168 255 MIYLMKIDSDGIFRLYS 271 (757)
Q Consensus 255 ~~~~~~l~~dG~lr~y~ 271 (757)
..+|++||+||++++|.
T Consensus 213 ~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 213 GRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp SCCEEEECSSSCEEEEC
T ss_pred CCEEEEEcCCCcEEEeC
Confidence 35789999999999984
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=302.68 Aligned_cols=222 Identities=15% Similarity=0.163 Sum_probs=181.7
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|+.+++++ +|+|++++++++.+....++||||+ +++|.+++......+++.++..++.|++.||+|||+.
T Consensus 49 ~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-- 125 (298)
T 1csn_A 49 APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK-- 125 (298)
T ss_dssp SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 35688999999999 8999999999999999999999999 9999999987667799999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCc-----EEEeecCCccccCCCCcc------eecccccCccccCcccccCCCCCccccchhh
Q 038168 590 TQIIHCDIKPQNILMDENRC-----AKISDFGLAKLMKPDQTR------TFTGIRGTRGYVAPEWHRNLPITVKADVYSF 658 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~-----~ki~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~ 658 (757)
+|+||||||+|||++.++. +||+|||+++........ ......||..|+|||.+.+..++.++|||||
T Consensus 126 -~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 204 (298)
T 1csn_A 126 -SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEAL 204 (298)
T ss_dssp -TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred -CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHH
Confidence 9999999999999987765 999999999877544321 2344679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 038168 659 GVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 659 G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~L 738 (757)
|++++||++|+.||..............+........... ........+.+++.+||+.||++||++++|++.|
T Consensus 205 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l 278 (298)
T 1csn_A 205 GHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 278 (298)
T ss_dssp HHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred HHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 9999999999999987554433222221111111111111 1112346789999999999999999999999999
Q ss_pred hcCc
Q 038168 739 EGTV 742 (757)
Q Consensus 739 e~~~ 742 (757)
+.+.
T Consensus 279 ~~~~ 282 (298)
T 1csn_A 279 SKVL 282 (298)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=306.04 Aligned_cols=220 Identities=30% Similarity=0.480 Sum_probs=168.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.|.+|+.++++++|+||+++++++ ..+..++||||+++++|.+++......+++.++..++.|++.||+|||+.
T Consensus 64 ~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--- 139 (289)
T 3og7_A 64 LQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK--- 139 (289)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 36789999999999999999999965 45568999999999999999987778899999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCC-cceecccccCccccCccccc---CCCCCccccchhhHHHHHHHH
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ-TRTFTGIRGTRGYVAPEWHR---NLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~G~~l~ell 666 (757)
+|+||||||+|||++.++.+||+|||+++...... ........||..|+|||.+. +..++.++||||||++++||+
T Consensus 140 ~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 219 (289)
T 3og7_A 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219 (289)
T ss_dssp TCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHH
T ss_pred CcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHH
Confidence 99999999999999999999999999998665322 22233467899999999986 567889999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
+|+.||....... .+......+...... .........++.+++.+||+.+|++|||+.|++++|+.+.
T Consensus 220 ~g~~p~~~~~~~~------~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 220 TGQLPYSNINNRD------QIIEMVGRGSLSPDL--SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HSSCTTSSCCCHH------HHHHHHHHTSCCCCT--TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HCCCCccccchHH------HHHHHhcccccCcch--hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 9999997543321 122333333332211 1122334567999999999999999999999999999865
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.52 Aligned_cols=219 Identities=27% Similarity=0.390 Sum_probs=182.2
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------------CCCCHHHHHHHH
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------------KQPNWVERMGIA 574 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~ 574 (757)
.+++.+|+++++++ +||||+++++++.+.+..++||||+++|+|.+++.... ..+++.++..|+
T Consensus 118 ~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 197 (382)
T 3tt0_A 118 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197 (382)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHH
Confidence 46789999999999 99999999999999999999999999999999996543 458999999999
Q ss_pred HHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccc
Q 038168 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKA 653 (757)
Q Consensus 575 ~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~ 653 (757)
.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....... .......+|..|+|||.+.+..++.++
T Consensus 198 ~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 274 (382)
T 3tt0_A 198 YQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 274 (382)
T ss_dssp HHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHH
T ss_pred HHHHHHHHHHHhC---CEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchh
Confidence 9999999999998 999999999999999999999999999987754332 233345678899999999999999999
Q ss_pred cchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 654 DVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 654 Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
||||||++++||++ |+.|+..... .+ +...+..+..... +.....++.+++.+||+.+|++|||+.
T Consensus 275 DiwslG~il~ellt~g~~p~~~~~~------~~-~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rps~~ 341 (382)
T 3tt0_A 275 DVWSFGVLLWEIFTLGGSPYPGVPV------EE-LFKLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFK 341 (382)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCH------HH-HHHHHHTTCCCCC------CSSCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHHcCCCCCC------CccCCHHHHHHHHHHcCCChhhCcCHH
Confidence 99999999999999 9988864322 11 2233333322111 122345788999999999999999999
Q ss_pred HHHHHhhcCcCCC
Q 038168 733 KVLLMLEGTVEIP 745 (757)
Q Consensus 733 eVl~~Le~~~~~~ 745 (757)
||++.|+.+....
T Consensus 342 ell~~L~~~~~~~ 354 (382)
T 3tt0_A 342 QLVEDLDRIVALT 354 (382)
T ss_dssp HHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHH
Confidence 9999999866443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.05 Aligned_cols=215 Identities=23% Similarity=0.338 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+||+++++++. .+..++||||+++|+|.+++......+++..+..++.|++.||+|||+.
T Consensus 59 ~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--- 134 (325)
T 3kex_A 59 FQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH--- 134 (325)
T ss_dssp BCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 356788999999999999999999886 5668899999999999999987667789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-C
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-R 668 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G 668 (757)
+|+||||||+|||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |
T Consensus 135 ~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g 214 (325)
T 3kex_A 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFG 214 (325)
T ss_dssp TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCC
Confidence 9999999999999999999999999999987654432 2344667889999999999999999999999999999999 9
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
+.||....... +......+..... + ......+.+++.+||+.||++||++.||++.|+.+.
T Consensus 215 ~~p~~~~~~~~-------~~~~~~~~~~~~~--~----~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 215 AEPYAGLRLAE-------VPDLLEKGERLAQ--P----QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CCTTTTSCTTH-------HHHHHHTTCBCCC--C----TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCCccccCHHH-------HHHHHHcCCCCCC--C----CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 99997644322 1222232221111 1 112345788999999999999999999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.50 Aligned_cols=212 Identities=18% Similarity=0.308 Sum_probs=176.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++......+++.++..++.|++.||+|||+.
T Consensus 44 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~-- 121 (321)
T 1tki_A 44 DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH-- 121 (321)
T ss_dssp HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 456788999999999999999999999999999999999999999999977667799999999999999999999998
Q ss_pred CCeeeCCCCcceEEECC--CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 590 TQIIHCDIKPQNILMDE--NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~--~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+|||++. ++.+||+|||+++....... .....||+.|+|||.+.+..++.++||||||++++||++
T Consensus 122 -givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 198 (321)
T 1tki_A 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198 (321)
T ss_dssp -TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH
T ss_pred -CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999999987 78999999999988765432 334568999999999999889999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|+.||...... + ....+..+...... ........++.+++.+||+.||++|||+.|+++
T Consensus 199 g~~pf~~~~~~------~-~~~~i~~~~~~~~~---~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 199 GINPFLAETNQ------Q-IIENIMNAEYTFDE---EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp SSCTTCCSSHH------H-HHHHHHHTCCCCCH---HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCcCCCHH------H-HHHHHHcCCCCCCh---hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99999753321 1 11222222221110 000122467889999999999999999999998
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.59 Aligned_cols=217 Identities=26% Similarity=0.387 Sum_probs=177.7
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEece-eeeEEEEeccCCChhhhhcCCCC-------------------------
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVS-KKILVYEYMSNGSLADILFNPEK------------------------- 563 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~------------------------- 563 (757)
.+.+.+|+++++++ +||||+++++++.+.+ ..++||||+++|+|.+++.....
T Consensus 69 ~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (359)
T 3vhe_A 69 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148 (359)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------
T ss_pred HHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchh
Confidence 36799999999999 8999999999998755 48999999999999999976432
Q ss_pred ----------------------------------------CCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEE
Q 038168 564 ----------------------------------------QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNIL 603 (757)
Q Consensus 564 ----------------------------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nil 603 (757)
.+++..+..++.|+++||+|||++ +|+||||||+|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIl 225 (359)
T 3vhe_A 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 225 (359)
T ss_dssp -----------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred hhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEE
Confidence 178999999999999999999998 9999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCccc
Q 038168 604 MDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-RRRCLDPNLPDDQV 681 (757)
Q Consensus 604 l~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~ 681 (757)
++.++.+||+|||+++....... .......||..|+|||.+.+..++.++||||||++++||++ |+.||........
T Consensus 226 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 304 (359)
T 3vhe_A 226 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 304 (359)
T ss_dssp ECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-
T ss_pred EcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-
Confidence 99999999999999987654433 23344678999999999999999999999999999999998 9999876443321
Q ss_pred cHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 682 ILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 682 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
+......+..... +.....++.+++..||+.||++|||+.||+++|+.+.
T Consensus 305 -----~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 305 -----FCRRLKEGTRMRA------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp -----HHHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHHHcCCCCCC------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 2222333322111 1123356889999999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=320.74 Aligned_cols=213 Identities=29% Similarity=0.375 Sum_probs=175.8
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEece-eeeEEEEeccCCChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVS-KKILVYEYMSNGSLADILFNPEK-QPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..+.|.+|+.++++++||||+++++++.+.+ ..++||||+++|+|.+++.+... .+++..++.++.||++||+|||++
T Consensus 229 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 308 (450)
T 1k9a_A 229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308 (450)
T ss_dssp TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4578999999999999999999999987765 78999999999999999976543 479999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+|||++.++.+||+|||+++...... ....++..|+|||.+.+..++.++||||||++++||++
T Consensus 309 ---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t 381 (450)
T 1k9a_A 309 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381 (450)
T ss_dssp ---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHT
T ss_pred ---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999998653321 12356889999999999999999999999999999998
Q ss_pred -CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 668 -RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 668 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
|+.|+......+ +...+..+.... .+......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 382 ~g~~P~~~~~~~~-------~~~~i~~~~~~~------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 382 FGRVPYPRIPLKD-------VVPRVEKGYKMD------APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp TTCCSSTTSCTTT-------HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHH-------HHHHHHcCCCCC------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 999987554332 112223332111 12233467889999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=306.77 Aligned_cols=207 Identities=22% Similarity=0.329 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++||||+++++++...+..++||||+++|+|.+++... ..++..++..++.|+++||+|||+.
T Consensus 58 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~--- 133 (328)
T 3fe3_A 58 LQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQK--- 133 (328)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 467889999999999999999999999999999999999999999998653 5688999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCC-ccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPIT-VKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++...... ......||+.|+|||.+.+..+. .++||||+|++++||++|+
T Consensus 134 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 211 (328)
T 3fe3_A 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211 (328)
T ss_dssp TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSS
T ss_pred CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCC
Confidence 99999999999999999999999999998765433 23446799999999999988765 8999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
.||..... .+ .......+.... +......+.+++.+||+.||++|||++|+++.
T Consensus 212 ~pf~~~~~------~~-~~~~i~~~~~~~-------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 212 LPFDGQNL------KE-LRERVLRGKYRI-------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CSSCCSSH------HH-HHHHHHHCCCCC-------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCH------HH-HHHHHHhCCCCC-------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 99975421 11 222333333221 11234568899999999999999999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=302.84 Aligned_cols=216 Identities=29% Similarity=0.475 Sum_probs=168.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCC--CCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEK--QPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..+.|.+|++++++++||||+++++++.+ ..++||||+++|+|.+++..... .+++..++.++.|+++||+|||+.
T Consensus 44 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 121 (307)
T 2eva_A 44 ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121 (307)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhC
Confidence 45789999999999999999999998874 48999999999999999976543 478899999999999999999994
Q ss_pred CCCCeeeCCCCcceEEECCCCc-EEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMDENRC-AKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~-~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
...+|+||||||+|||++.++. +||+|||++...... .....||..|+|||.+.+..++.++||||||++++||+
T Consensus 122 ~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 197 (307)
T 2eva_A 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVI 197 (307)
T ss_dssp SSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHH
Confidence 3339999999999999998876 799999999765432 22346899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
+|+.||........ ...+. ...+..... .......+.+++.+||+.||++|||+.||+++|+.+.
T Consensus 198 ~g~~p~~~~~~~~~----~~~~~-~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 198 TRRKPFDEIGGPAF----RIMWA-VHNGTRPPL------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp HTCCTTTTTCSSHH----HHHHH-HHTTCCCCC------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred HCCCCchhhCccHH----HHHHH-HhcCCCCCc------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 99999875433211 11111 122222111 1123456889999999999999999999999998744
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=318.95 Aligned_cols=237 Identities=20% Similarity=0.218 Sum_probs=190.0
Q ss_pred cHHHHHHhhcccc--ccccCCCchH-----------------------------HHHHHHHHHHhhcCCCceeeeeeEEE
Q 038168 489 SYAELEKMTDGFK--EEVGRGSSGE-----------------------------REFQTEMKVIGRTHHRNLVRLLGYSL 537 (757)
Q Consensus 489 ~~~~l~~~t~~f~--~~lg~g~~~~-----------------------------~~~~~E~~~l~~l~h~niv~l~g~~~ 537 (757)
.+.++...+++|. ++||+|++|. +.+.+|+.++++++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 3445555566665 6899999851 22889999999999999999999999
Q ss_pred eceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCC
Q 038168 538 EVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGL 617 (757)
Q Consensus 538 ~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGl 617 (757)
+.+..+|||||+++|+|.+++.+....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhh
Confidence 99999999999999999999987677899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCcceecccccCccccCccccc-----CCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHh
Q 038168 618 AKLMKPDQTRTFTGIRGTRGYVAPEWHR-----NLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFE 692 (757)
Q Consensus 618 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 692 (757)
++..............||+.|+|||++. ...++.++|||||||+++||++|+.||......+ ....+.....
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~---~~~~i~~~~~ 298 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGKIMNHKE 298 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTHHH
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH---HHHhhhhccc
Confidence 9887665555555578999999999987 5678999999999999999999999997542211 1111111001
Q ss_pred cCCccccccccccCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 038168 693 NGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSL--RPSMKKVLLM 737 (757)
Q Consensus 693 ~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~--RPsm~eVl~~ 737 (757)
.-.++.. .......+.+++.+||+.+|++ ||+++|+++.
T Consensus 299 ~~~~p~~------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 299 RFQFPTQ------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HCCCCSS------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccCCcc------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1111111 0112356888999999888877 9999999873
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=317.19 Aligned_cols=217 Identities=27% Similarity=0.380 Sum_probs=176.3
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC------CCCCHHHHHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE------KQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~y 583 (757)
...++.+|+.++++++||||+++++++.+....++||||+++|+|.+++.... ..+++.+++.++.||++||+|
T Consensus 117 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 196 (367)
T 3l9p_A 117 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196 (367)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHH
Confidence 34678999999999999999999999999999999999999999999996432 458999999999999999999
Q ss_pred hhhCCCCCeeeCCCCcceEEECCCC---cEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccchhhH
Q 038168 584 LHDECETQIIHCDIKPQNILMDENR---CAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFG 659 (757)
Q Consensus 584 LH~~~~~~iiH~Dik~~Nill~~~~---~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G 659 (757)
||++ +|+||||||+|||++.++ .+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||
T Consensus 197 LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG 273 (367)
T 3l9p_A 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 273 (367)
T ss_dssp HHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHhC---CeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHH
Confidence 9999 999999999999999554 599999999986532221 222335678999999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 038168 660 VVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 660 ~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~L 738 (757)
|+++||++ |+.||...... + +......+..... +......+.+++.+||+.+|++|||+.||++.|
T Consensus 274 ~il~ellt~g~~pf~~~~~~------~-~~~~i~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l 340 (367)
T 3l9p_A 274 VLLWEIFSLGYMPYPSKSNQ------E-VLEFVTSGGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340 (367)
T ss_dssp HHHHHHHTTSCCSSTTCCHH------H-HHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCCCC------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 99999998 98888654221 1 2222233221111 122345688999999999999999999999999
Q ss_pred hcCc
Q 038168 739 EGTV 742 (757)
Q Consensus 739 e~~~ 742 (757)
+.+.
T Consensus 341 ~~~~ 344 (367)
T 3l9p_A 341 EYCT 344 (367)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 8644
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.27 Aligned_cols=211 Identities=27% Similarity=0.451 Sum_probs=173.0
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|+.++++++|+||+++++++.+.. ++||||+++|+|.+++......+++..+..++.|++.||+|||+. +
T Consensus 68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~ 142 (287)
T 4f0f_A 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---N 142 (287)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---S
T ss_pred HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 67999999999999999999999986654 699999999999999988778899999999999999999999998 7
Q ss_pred --eeeCCCCcceEEECCCCc-----EEEeecCCccccCCCCcceecccccCccccCcccc--cCCCCCccccchhhHHHH
Q 038168 592 --IIHCDIKPQNILMDENRC-----AKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWH--RNLPITVKADVYSFGVVL 662 (757)
Q Consensus 592 --iiH~Dik~~Nill~~~~~-----~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~k~Dv~S~G~~l 662 (757)
|+||||||+|||++.++. +||+|||+++.... ......||..|+|||.+ ....++.++||||||+++
T Consensus 143 ~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l 218 (287)
T 4f0f_A 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218 (287)
T ss_dssp SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHH
T ss_pred CCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHH
Confidence 999999999999988776 99999999985433 23346789999999998 445678999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
+||++|+.||......... .... ......... .+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 219 ~~l~~g~~pf~~~~~~~~~----~~~~-~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 219 YTILTGEGPFDEYSYGKIK----FINM-IREEGLRPT-----IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHSSCTTTTCCCCHHH----HHHH-HHHSCCCCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHcCCCCCccccccHHH----HHHH-HhccCCCCC-----CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 9999999999765433211 1111 122211111 1223346789999999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=311.86 Aligned_cols=217 Identities=25% Similarity=0.409 Sum_probs=167.8
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEe-ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLE-VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..++|.+|+.++++++||||+++++++.+ .+..++||||+++|+|.+++......+++.++..++.|+++||+|||++
T Consensus 133 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~- 211 (373)
T 3c1x_A 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK- 211 (373)
T ss_dssp HHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 35789999999999999999999998765 4578999999999999999988777889999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc---eecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR---TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||
T Consensus 212 --~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 289 (373)
T 3c1x_A 212 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 289 (373)
T ss_dssp --TCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred --CEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999876443221 22345678899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 666 IC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 666 lt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
++ |..|+......+ .. .....+... ..+ ......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 290 lt~~~~p~~~~~~~~---~~----~~~~~~~~~--~~p----~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 290 MTRGAPPYPDVNTFD---IT----VYLLQGRRL--LQP----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp HTTSCCSCTTSCSSC---HH----HHHHTTCCC--CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhCcCCCCCCCCHHH---HH----HHHHcCCCC--CCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 99 556665433222 11 112222211 112 223456889999999999999999999999998744
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=301.16 Aligned_cols=216 Identities=29% Similarity=0.392 Sum_probs=182.3
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+.+.+|++++++++|+||+++++++.+.+..++||||+++++|.+++... ...+++..+..++.|++.||+|||+.
T Consensus 52 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~- 130 (288)
T 3kfa_A 52 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK- 130 (288)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH-
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC-
Confidence 4578999999999999999999999999999999999999999999999754 35689999999999999999999999
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+|+|+||||+||+++.++.+||+|||++...............++..|+|||.+.+..++.++||||||++++||++
T Consensus 131 --~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~ 208 (288)
T 3kfa_A 131 --NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 208 (288)
T ss_dssp --TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999877665555555677889999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
|+.|+....... . .......... ..+......+.+++.+|++.||++|||+.||+++|+.+
T Consensus 209 g~~p~~~~~~~~---~----~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 209 GMSPYPGIDLSQ---V----YELLEKDYRM------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp SCCSSTTCCGGG---H----HHHHHTTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHH---H----HHHHhccCCC------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 888886543221 1 1122222111 11123346789999999999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=312.05 Aligned_cols=224 Identities=16% Similarity=0.187 Sum_probs=177.6
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEec----eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEV----SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..+..|+..+++++|+||+++++++... ...+|||||+ +++|.+++......+++.+++.|+.||+.||+|||+.
T Consensus 93 ~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~ 171 (364)
T 3op5_A 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH 171 (364)
T ss_dssp HHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4566788889999999999999998875 4589999999 9999999987667899999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEEC--CCCcEEEeecCCccccCCCCcc------eecccccCccccCcccccCCCCCccccchhhH
Q 038168 588 CETQIIHCDIKPQNILMD--ENRCAKISDFGLAKLMKPDQTR------TFTGIRGTRGYVAPEWHRNLPITVKADVYSFG 659 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~--~~~~~ki~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G 659 (757)
+|+||||||+|||++ .++.+||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||
T Consensus 172 ---~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 248 (364)
T 3op5_A 172 ---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILG 248 (364)
T ss_dssp ---TEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred ---CeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHH
Confidence 999999999999999 8899999999999876543221 11335699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 660 VVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 660 ~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
++++||++|+.||......... ......... ..+..++++.......+.++.+++..|++.+|++||++.+|+++|+
T Consensus 249 ~~l~el~~g~~Pf~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~ 325 (364)
T 3op5_A 249 YCMIQWLTGHLPWEDNLKDPKY--VRDSKIRYR-ENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325 (364)
T ss_dssp HHHHHHHHSCCTTGGGTTCHHH--HHHHHHHHH-HCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred HHHHHHHhCCCCccccccCHHH--HHHHHHHhh-hhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence 9999999999999854333211 111111111 1122222221111223467889999999999999999999999998
Q ss_pred cCc
Q 038168 740 GTV 742 (757)
Q Consensus 740 ~~~ 742 (757)
.+.
T Consensus 326 ~~~ 328 (364)
T 3op5_A 326 QGL 328 (364)
T ss_dssp HHH
T ss_pred HHH
Confidence 643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=306.78 Aligned_cols=217 Identities=22% Similarity=0.343 Sum_probs=173.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+++.+|+.++++++||||+++++++.... .++|+||+++|+|.+++......+++..+..++.|++.||+|||+.
T Consensus 60 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-- 136 (327)
T 3lzb_A 60 ANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136 (327)
T ss_dssp CHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC--
Confidence 5688999999999999999999999998765 7899999999999999987777899999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+|+||||||+|||++.++.+||+|||+++....... .......+|..|+|||.+.+..++.++||||||++++||++
T Consensus 137 -~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~ 215 (327)
T 3lzb_A 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 215 (327)
T ss_dssp -TCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred -CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHC
Confidence 999999999999999999999999999987754332 22334557889999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcC
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~ 743 (757)
|+.||....... + ......+.... .+......+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 216 g~~p~~~~~~~~---~----~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 216 GSKPYDGIPASE---I----SSILEKGERLP------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp SCCTTTTCCGGG---H----HHHHHTTCCCC------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCCCCCCHHH---H----HHHHHcCCCCC------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 999987643322 1 12222222111 112234568899999999999999999999999987653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=297.91 Aligned_cols=225 Identities=21% Similarity=0.313 Sum_probs=181.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEece--eeeEEEEeccCCChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVS--KKILVYEYMSNGSLADILFNPE--KQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
.+.+.+|++++++++||||+++++++.+.+ ..++||||+++++|.+++.... ..+++.++..++.|++.||+|||+
T Consensus 51 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 130 (319)
T 4euu_A 51 VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130 (319)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 477889999999999999999999998765 7799999999999999997643 338999999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEE----CCCCcEEEeecCCccccCCCCcceecccccCccccCccccc--------CCCCCcccc
Q 038168 587 ECETQIIHCDIKPQNILM----DENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR--------NLPITVKAD 654 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill----~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~k~D 654 (757)
. +|+||||||+|||+ +.++.+||+|||+++....... .....||..|+|||.+. +..++.++|
T Consensus 131 ~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~D 205 (319)
T 4euu_A 131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVD 205 (319)
T ss_dssp T---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHH
T ss_pred C---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHH
Confidence 8 99999999999999 7888899999999987755432 23456899999999886 578899999
Q ss_pred chhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCc---c--------------ccccccccCHHHHHHHHHHH
Q 038168 655 VYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNL---S--------------QLVEDEEVDEKQLERMIKVA 717 (757)
Q Consensus 655 v~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~--------------~~~d~~~~~~~~~~~l~~l~ 717 (757)
|||||++++||++|+.||......... .+.+......... . .+.............+.+++
T Consensus 206 iwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll 283 (319)
T 4euu_A 206 LWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL 283 (319)
T ss_dssp HHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHH
Confidence 999999999999999999764433221 1222222221110 0 00111134567788899999
Q ss_pred HHccccCCCCCCCHHHHHHHhhcCc
Q 038168 718 LWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 718 ~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
.+||+.||++|||++|+++...+..
T Consensus 284 ~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 284 ANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HHhccCChhhhccHHHhhhccHHHh
Confidence 9999999999999999999987644
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=296.34 Aligned_cols=214 Identities=29% Similarity=0.381 Sum_probs=166.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++. ...+++.++..++.|+++||+|||++...
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~ 127 (271)
T 3dtc_A 50 IENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIV 127 (271)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSS
T ss_pred HHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 4678999999999999999999999999999999999999999999984 45789999999999999999999998222
Q ss_pred CeeeCCCCcceEEECC--------CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHH
Q 038168 591 QIIHCDIKPQNILMDE--------NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~--------~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l 662 (757)
+|+||||||+|||++. ++.+||+|||+++....... ....|+..|+|||.+.+..++.++||||||+++
T Consensus 128 ~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 204 (271)
T 3dtc_A 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLL 204 (271)
T ss_dssp CCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHH
T ss_pred ceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHH
Confidence 2999999999999986 67899999999986654322 234689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
+||++|+.||...... ...... ........ .+......+.+++.+||+.||++|||+.|++++|+.+
T Consensus 205 ~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 205 WELLTGEVPFRGIDGL------AVAYGV-AMNKLALP-----IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHHCCCTTTTSCHH------HHHHHH-HTSCCCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHHHhCCCCCCCCCHH------HHHHhh-hcCCCCCC-----CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 9999999998753221 111111 11211111 1223346789999999999999999999999999853
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=328.41 Aligned_cols=215 Identities=20% Similarity=0.323 Sum_probs=176.6
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..++|.+|++++++++|||||++++++.. +..++||||+++|+|.+++......+++.++..++.||++||+|||++
T Consensus 379 ~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-- 455 (613)
T 2ozo_A 379 DTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-- 455 (613)
T ss_dssp THHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 56889999999999999999999999976 568999999999999999987777899999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce--ecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT--FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+||||+.++.+||+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++
T Consensus 456 -~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt 534 (613)
T 2ozo_A 456 -NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534 (613)
T ss_dssp -TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred -CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999775443221 122345689999999999999999999999999999998
Q ss_pred -CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 668 -RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 668 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
|+.||......+ +...+..+.... .+.....++.+++..||+.+|++||++.+|++.|+..
T Consensus 535 ~G~~Pf~~~~~~~-------~~~~i~~~~~~~------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 535 YGQKPYKKMKGPE-------VMAFIEQGKRME------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp TSCCTTTTCCSHH-------HHHHHHTTCCCC------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHH-------HHHHHHcCCCCC------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 999987643321 223333332211 1223456789999999999999999999999999873
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=297.20 Aligned_cols=217 Identities=24% Similarity=0.393 Sum_probs=178.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceee-eEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK-ILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~-~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|+.++++++||||+++++++.+.+.. ++|+||+.+|+|.+++......+++.++..++.|++.||+|||+.
T Consensus 66 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-- 143 (298)
T 3pls_A 66 VEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ-- 143 (298)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 46789999999999999999999999876655 999999999999999988778899999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc---ceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT---RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+|+||||||+|||++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||++++||+
T Consensus 144 -~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 222 (298)
T 3pls_A 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222 (298)
T ss_dssp -TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred -CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHh
Confidence 999999999999999999999999999987654322 1223356788999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
+|+.|+....... .. ......+.... .+......+.+++.+||+.||++|||+.+++++|+.+.
T Consensus 223 ~g~~~~~~~~~~~--~~----~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 223 TRGAPPYRHIDPF--DL----THFLAQGRRLP------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp HTSCCTTTTSCGG--GH----HHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hCCCCCCccCCHH--HH----HHHhhcCCCCC------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9776654433222 11 12222222111 11223457889999999999999999999999998743
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=307.57 Aligned_cols=217 Identities=27% Similarity=0.394 Sum_probs=180.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-----------------------CCCCH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-----------------------KQPNW 567 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~l~~ 567 (757)
.+.|.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.... ..+++
T Consensus 94 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 173 (343)
T 1luf_A 94 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173 (343)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCH
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCH
Confidence 4678999999999999999999999999999999999999999999996532 56899
Q ss_pred HHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccC
Q 038168 568 VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRN 646 (757)
Q Consensus 568 ~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 646 (757)
.+++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......+|..|+|||.+.+
T Consensus 174 ~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 250 (343)
T 1luf_A 174 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 250 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc
Confidence 99999999999999999998 999999999999999999999999999987654322 22234567899999999999
Q ss_pred CCCCccccchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCC
Q 038168 647 LPITVKADVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEP 725 (757)
Q Consensus 647 ~~~~~k~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p 725 (757)
..++.++||||||++++||++ |+.||..... .+ .......+..... +......+.+++.+||+.||
T Consensus 251 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~~-~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p 317 (343)
T 1luf_A 251 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH------EE-VIYYVRDGNILAC------PENCPLELYNLMRLCWSKLP 317 (343)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HH-HHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSG
T ss_pred CCcCcccccHHHHHHHHHHHhcCCCcCCCCCh------HH-HHHHHhCCCcCCC------CCCCCHHHHHHHHHHcccCc
Confidence 999999999999999999999 9988865322 11 2223333433221 12334578999999999999
Q ss_pred CCCCCHHHHHHHhhcCcC
Q 038168 726 SLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 726 ~~RPsm~eVl~~Le~~~~ 743 (757)
++||++.+|+++|+.+.+
T Consensus 318 ~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 318 ADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp GGSCCHHHHHHHHHHTTC
T ss_pred ccCCCHHHHHHHHHHHHh
Confidence 999999999999998764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=298.23 Aligned_cols=216 Identities=21% Similarity=0.318 Sum_probs=175.0
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++||||+++++++.+ +..++||||+++++|.+++......+++..+..++.|+++||+|||+.
T Consensus 56 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-- 132 (281)
T 3cc6_A 56 NKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI-- 132 (281)
T ss_dssp HHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 45789999999999999999999999865 456899999999999999977667789999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-C
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-R 668 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G 668 (757)
+|+||||||+||+++.++.+||+|||+++..............++..|+|||.+.+..++.++||||||++++||++ |
T Consensus 133 -~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g 211 (281)
T 3cc6_A 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFG 211 (281)
T ss_dssp -TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred -CcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCC
Confidence 99999999999999999999999999998776544333444567889999999998999999999999999999998 9
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
+.||....... .. .....+.... .+......+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 212 ~~p~~~~~~~~---~~----~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 212 KQPFFWLENKD---VI----GVLEKGDRLP------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp CCTTTTSCGGG---HH----HHHHHTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcccCChHH---HH----HHHhcCCCCC------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 99987543322 11 1222221111 11123456889999999999999999999999998754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.11 Aligned_cols=217 Identities=26% Similarity=0.437 Sum_probs=174.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe-ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE-VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|+.++++++||||+++++++.+ .+..++||||+++|+|.+++......+++.++..++.|+++||+|||+.
T Consensus 70 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-- 147 (298)
T 3f66_A 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-- 147 (298)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 4678999999999999999999998654 5578999999999999999987777889999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc---ceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT---RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+|+||||||+|||++.++.+||+|||+++....... .......+|..|+|||.+.+..++.++||||||++++||+
T Consensus 148 -~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 226 (298)
T 3f66_A 148 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 226 (298)
T ss_dssp -TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred -CccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999987654332 2223456788999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
+|..|+........ .. .....+... ..+ ......+.+++.+||+.+|++|||+.|++++|+.+.
T Consensus 227 ~~~~~~~~~~~~~~--~~----~~~~~~~~~--~~~----~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 227 TRGAPPYPDVNTFD--IT----VYLLQGRRL--LQP----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp TTSCCSSTTSCTTT--HH----HHHHTTCCC--CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hCCCCCCccCCHHH--HH----HHHhcCCCC--CCC----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 95554433222211 11 111222111 111 122356889999999999999999999999999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=299.91 Aligned_cols=218 Identities=22% Similarity=0.305 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++||||+++++++.+.+..++||||+++ +|.+++......+++.++..++.|++.||+|||+.
T Consensus 63 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--- 138 (311)
T 3niz_A 63 PSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH--- 138 (311)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred hHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46788999999999999999999999999999999999985 88888877777799999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++....... ......||..|+|||.+.+ ..++.++||||||++++||++|+
T Consensus 139 ~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 217 (311)
T 3niz_A 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217 (311)
T ss_dssp TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCC
Confidence 999999999999999999999999999987653322 2334568999999999876 56899999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccc----------------ccccc---ccCHHHHHHHHHHHHHccccCCCCCCC
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQ----------------LVEDE---EVDEKQLERMIKVALWCILDEPSLRPS 730 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~----------------~~d~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs 730 (757)
.||......+... .+........... ..+.. ........++.+++.+||+.||++|||
T Consensus 218 ~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 294 (311)
T 3niz_A 218 PLFPGVTDDDQLP---KIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS 294 (311)
T ss_dssp CSCCCSSTTTHHH---HHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC
T ss_pred CCCCCCChHHHHH---HHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC
Confidence 9998655443221 1111111111000 00000 001122357889999999999999999
Q ss_pred HHHHHH
Q 038168 731 MKKVLL 736 (757)
Q Consensus 731 m~eVl~ 736 (757)
++|+++
T Consensus 295 ~~ell~ 300 (311)
T 3niz_A 295 ARDAMN 300 (311)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=302.19 Aligned_cols=217 Identities=26% Similarity=0.419 Sum_probs=180.3
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCC-----------------CCCHHHHHH
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEK-----------------QPNWVERMG 572 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------------~l~~~~~~~ 572 (757)
.+.+.+|+.+++++ +||||+++++++.+.+..++||||+++|+|.+++..... .+++.++..
T Consensus 70 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (313)
T 1t46_A 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149 (313)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHH
T ss_pred HHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHH
Confidence 47799999999999 999999999999999999999999999999999965432 489999999
Q ss_pred HHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-ecccccCccccCcccccCCCCCc
Q 038168 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-FTGIRGTRGYVAPEWHRNLPITV 651 (757)
Q Consensus 573 i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ 651 (757)
++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++......... .....+|..|+|||.+.+..++.
T Consensus 150 ~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 226 (313)
T 1t46_A 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 226 (313)
T ss_dssp HHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHC---CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCCh
Confidence 999999999999998 99999999999999999999999999998876554332 23356788999999999999999
Q ss_pred cccchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC
Q 038168 652 KADVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS 730 (757)
Q Consensus 652 k~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 730 (757)
++||||||++++||++ |+.|+........ .......+... . .+......+.+++.+||+.||++|||
T Consensus 227 ~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~~--~----~~~~~~~~l~~li~~~l~~dp~~Rps 294 (313)
T 1t46_A 227 ESDVWSYGIFLWELFSLGSSPYPGMPVDSK------FYKMIKEGFRM--L----SPEHAPAEMYDIMKTCWDADPLKRPT 294 (313)
T ss_dssp HHHHHHHHHHHHHHHTTTCCSSTTCCSSHH------HHHHHHHTCCC--C----CCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcccchhH------HHHHhccCCCC--C----CcccCCHHHHHHHHHHcCCCchhCcC
Confidence 9999999999999999 9998875443221 12222222111 1 11223467899999999999999999
Q ss_pred HHHHHHHhhcCc
Q 038168 731 MKKVLLMLEGTV 742 (757)
Q Consensus 731 m~eVl~~Le~~~ 742 (757)
+.||+++|+.+.
T Consensus 295 ~~ell~~L~~~~ 306 (313)
T 1t46_A 295 FKQIVQLIEKQI 306 (313)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=296.24 Aligned_cols=216 Identities=21% Similarity=0.329 Sum_probs=180.3
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|++++++++||||+++++++ +.+..++||||+++++|.+++......+++.++..++.|+++||+|||+.
T Consensus 53 ~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-- 129 (287)
T 1u59_A 53 DTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-- 129 (287)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 457799999999999999999999999 55678999999999999999987677799999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce--ecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT--FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+||+++.++.+||+|||+++......... .....+|..|+|||.+.+..++.++||||||++++||++
T Consensus 130 -~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 208 (287)
T 1u59_A 130 -NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208 (287)
T ss_dssp -TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred -CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHc
Confidence 99999999999999999999999999999876544322 223456889999999998899999999999999999998
Q ss_pred -CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 668 -RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 668 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
|+.||......+ .......+.... .+......+.+++..||+.+|++||++.+|++.|+.+.
T Consensus 209 ~g~~p~~~~~~~~-------~~~~i~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 209 YGQKPYKKMKGPE-------VMAFIEQGKRME------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp TSCCTTTTCCTHH-------HHHHHHTTCCCC------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcccCCHHH-------HHHHHhcCCcCC------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 999987543321 122233332211 12234567899999999999999999999999998743
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=301.06 Aligned_cols=212 Identities=25% Similarity=0.363 Sum_probs=174.1
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. ...+++.++..++.|++.||+|||+.
T Consensus 57 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~-- 133 (326)
T 2y0a_A 57 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSL-- 133 (326)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHC--
Confidence 457899999999999999999999999999999999999999999999964 45689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCC----cEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENR----CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~----~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|||++.++ .+||+|||+++....... .....||+.|+|||.+.+..++.++||||||++++||
T Consensus 134 -~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 210 (326)
T 2y0a_A 134 -QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210 (326)
T ss_dssp -TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred -CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999887 899999999987754322 2345789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++|+.||...... +.. ........... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 211 l~g~~pf~~~~~~------~~~-~~~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 211 LSGASPFLGDTKQ------ETL-ANVSAVNYEFE---DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHSCCSSCCSSHH------HHH-HHHHHTCCCCC---HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHCcCCCCCCCHH------HHH-HHHHhcCCCcC---ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 9999998753221 111 11121111100 00011223568899999999999999999999873
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.89 Aligned_cols=216 Identities=26% Similarity=0.443 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++......+++.++..++.|+++||+|||+.
T Consensus 90 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--- 166 (333)
T 1mqb_A 90 RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM--- 166 (333)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 46789999999999999999999999999999999999999999999987667899999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc--eecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR--TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+|+||||||+|||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++
T Consensus 167 ~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 246 (333)
T 1mqb_A 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY 246 (333)
T ss_dssp TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcC
Confidence 9999999999999999999999999999877544322 2223456788999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
|+.||...... + +...+..+.... .+......+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 247 g~~pf~~~~~~------~-~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 247 GERPYWELSNH------E-VMKAINDGFRLP------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp SCCTTTTCCHH------H-HHHHHHTTCCCC------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCcccCCHH------H-HHHHHHCCCcCC------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 99998643221 1 222223321111 11233467899999999999999999999999998643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.83 Aligned_cols=212 Identities=26% Similarity=0.352 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+||+++++++.+.+..++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+.
T Consensus 49 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~--- 124 (323)
T 3tki_A 49 PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI--- 124 (323)
T ss_dssp --CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 36788999999999999999999999999999999999999999999965 45689999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCC-CccccchhhHHHHHHHHhC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+|||++.++.+||+|||+++.+..... .......||+.|+|||.+.+..+ +.++||||||++++||++|
T Consensus 125 givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 204 (323)
T 3tki_A 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204 (323)
T ss_dssp TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999987643322 22335679999999999988775 7899999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+.||......... . ..+...... ..+ .......+.+++.+||+.||++|||+.|+++.
T Consensus 205 ~~pf~~~~~~~~~-~-----~~~~~~~~~--~~~---~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 205 ELPWDQPSDSCQE-Y-----SDWKEKKTY--LNP---WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp SCSCSSSCTTSHH-H-----HHHHTTCTT--STT---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCchHHHH-H-----HHHhccccc--CCc---cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 9999765443221 1 111111111 010 11234567899999999999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=301.28 Aligned_cols=208 Identities=24% Similarity=0.282 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++||||+++++++...+..++||||+++|+|.+++.. ...++..++..++.||+.||+|||++
T Consensus 49 ~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--- 124 (337)
T 1o6l_A 49 VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR--- 124 (337)
T ss_dssp HHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 45688999999999999999999999999999999999999999999864 35688999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||++++||++|+.
T Consensus 125 ~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 203 (337)
T 1o6l_A 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203 (337)
T ss_dssp TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCC
Confidence 99999999999999999999999999998643322 22344679999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLLM 737 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~~ 737 (757)
||..... .+ ..+....+... .+.....++.+++.+||+.||++|| +++||++.
T Consensus 204 Pf~~~~~------~~-~~~~i~~~~~~-------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 204 PFYNQDH------ER-LFELILMEEIR-------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp SSCCSSH------HH-HHHHHHHCCCC-------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCH------HH-HHHHHHcCCCC-------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 9975321 11 11222222221 1122345788999999999999999 89999763
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.88 Aligned_cols=211 Identities=24% Similarity=0.362 Sum_probs=174.2
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.
T Consensus 58 ~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~-- 134 (361)
T 2yab_A 58 CREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTK-- 134 (361)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 357899999999999999999999999999999999999999999999965 45689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCC----cEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENR----CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~----~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||
T Consensus 135 -givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~l 211 (361)
T 2yab_A 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211 (361)
T ss_dssp -TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred -CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHH
Confidence 999999999999998876 79999999998765432 23346799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
++|..||...... + ....+..+..... + .........+.+++.+||+.||++|||+.|+++
T Consensus 212 l~g~~Pf~~~~~~------~-~~~~i~~~~~~~~--~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 212 LSGASPFLGDTKQ------E-TLANITAVSYDFD--E-EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHSCCSSCCSSHH------H-HHHHHHTTCCCCC--H-HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCCCCCCCCCHH------H-HHHHHHhcCCCCC--c-hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9999999754221 1 1122222222110 0 001122456889999999999999999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=308.53 Aligned_cols=212 Identities=22% Similarity=0.322 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
...+.+|+.++++++|+||+++++++.+.+..++||||+++|+|.+++......+++.++..++.||+.||+|||+.
T Consensus 92 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 168 (387)
T 1kob_A 92 KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH--- 168 (387)
T ss_dssp HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 45789999999999999999999999999999999999999999999977666789999999999999999999998
Q ss_pred CeeeCCCCcceEEECC--CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 591 QIIHCDIKPQNILMDE--NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~--~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+|||++. ++.+||+|||+++....... .....||+.|+|||++.+..++.++||||||++++||++|
T Consensus 169 givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 246 (387)
T 1kob_A 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246 (387)
T ss_dssp TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred CeeecccchHHeEEecCCCCceEEEecccceecCCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhC
Confidence 9999999999999974 47799999999998765432 2234689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+.||...... +.. ........... .........++.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~Pf~~~~~~------~~~-~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 247 LSPFAGEDDL------ETL-QNVKRCDWEFD---EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCSSCCSSHH------HHH-HHHHHCCCCCC---SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCHH------HHH-HHHHhCCCCCC---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 9999753221 111 12222222111 11112234678899999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=296.53 Aligned_cols=217 Identities=27% Similarity=0.426 Sum_probs=181.3
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+++.+|++++++++||||+++++++.+.+..++||||+++++|.+++......+++.++..++.|+++||+|||+.
T Consensus 46 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-- 123 (267)
T 3t9t_A 46 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-- 123 (267)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 457899999999999999999999999999999999999999999999987667789999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-C
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-R 668 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G 668 (757)
+++|+||||+||+++.++.+||+|||+++..............++..|+|||.+.+..++.++||||||++++||++ |
T Consensus 124 -~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g 202 (267)
T 3t9t_A 124 -CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 202 (267)
T ss_dssp -TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -CcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccC
Confidence 99999999999999999999999999998765433333344567889999999998899999999999999999999 8
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
+.|+..... .+ ....+..+... ..+ ......+.+++.+|++.||++||++.|++++|+.+.
T Consensus 203 ~~p~~~~~~------~~-~~~~i~~~~~~--~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 203 KIPYENRSN------SE-VVEDISTGFRL--YKP----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CCTTTTCCH------HH-HHHHHHTTCCC--CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCH------HH-HHHHHhcCCcC--CCC----ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 888865322 11 11222222111 111 123456889999999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=307.29 Aligned_cols=215 Identities=24% Similarity=0.410 Sum_probs=176.7
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-------------CCCCCHHHHHHHHHHH
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-------------EKQPNWVERMGIARDI 577 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~i 577 (757)
+.+.+|+.+++++ +||||+++++++.+.+..++||||+++|+|.+++... ...+++..+..++.|+
T Consensus 94 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi 173 (333)
T 2i1m_A 94 EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173 (333)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHH
Confidence 5688999999999 8999999999999999999999999999999998642 2457899999999999
Q ss_pred HHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccccch
Q 038168 578 ARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKADVY 656 (757)
Q Consensus 578 a~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~ 656 (757)
+.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ......+|..|+|||.+.+..++.++|||
T Consensus 174 ~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 250 (333)
T 2i1m_A 174 AQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 250 (333)
T ss_dssp HHHHHHHHHT---TEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHhcC---CcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHH
Confidence 9999999998 9999999999999999999999999999876543332 22335678899999999999999999999
Q ss_pred hhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 038168 657 SFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735 (757)
Q Consensus 657 S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl 735 (757)
|||++++||++ |..|+........ .......+... ..+ ......+.+++.+||+.||++|||+.||+
T Consensus 251 slG~il~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~--~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 318 (333)
T 2i1m_A 251 SYGILLWEIFSLGLNPYPGILVNSK------FYKLVKDGYQM--AQP----AFAPKNIYSIMQACWALEPTHRPTFQQIC 318 (333)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCSSHH------HHHHHHHTCCC--CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHcCCCCCCcccchhHH------HHHHHhcCCCC--CCC----CCCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 99999999999 8888875433221 12222222111 111 12245788999999999999999999999
Q ss_pred HHhhcC
Q 038168 736 LMLEGT 741 (757)
Q Consensus 736 ~~Le~~ 741 (757)
+.|+.+
T Consensus 319 ~~L~~~ 324 (333)
T 2i1m_A 319 SFLQEQ 324 (333)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=296.38 Aligned_cols=221 Identities=19% Similarity=0.213 Sum_probs=177.6
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEE-EeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYS-LEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+++.+|+.++++++|++++..++.+ .+.+..++||||+ +++|.+++......+++.++..++.|++.||+|||+.
T Consensus 49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--- 124 (296)
T 4hgt_A 49 PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--- 124 (296)
T ss_dssp CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 4688999999999988877777665 5667889999999 9999999976667799999999999999999999998
Q ss_pred CeeeCCCCcceEEE---CCCCcEEEeecCCccccCCCCc------ceecccccCccccCcccccCCCCCccccchhhHHH
Q 038168 591 QIIHCDIKPQNILM---DENRCAKISDFGLAKLMKPDQT------RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVV 661 (757)
Q Consensus 591 ~iiH~Dik~~Nill---~~~~~~ki~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~ 661 (757)
+|+||||||+|||+ +.++.+||+|||+++....... .......||..|+|||.+.+..++.++||||||++
T Consensus 125 ~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 204 (296)
T 4hgt_A 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYV 204 (296)
T ss_dssp TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHH
Confidence 99999999999999 7889999999999987755432 12234678999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 662 LLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 662 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
++||++|+.||.......................... ........+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 205 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 205 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred HHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 9999999999987554443332222221111111100 0112246789999999999999999999999999874
Q ss_pred c
Q 038168 742 V 742 (757)
Q Consensus 742 ~ 742 (757)
.
T Consensus 279 ~ 279 (296)
T 4hgt_A 279 F 279 (296)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=303.91 Aligned_cols=212 Identities=25% Similarity=0.334 Sum_probs=175.1
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+++.+|++++++++||||+++++++.+.+..+|||||+++++|.+++......+++..+..++.||++||+|||+.
T Consensus 129 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 206 (373)
T 2x4f_A 129 DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM-- 206 (373)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 457899999999999999999999999999999999999999999999976666789999999999999999999998
Q ss_pred CCeeeCCCCcceEEE--CCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 590 TQIIHCDIKPQNILM--DENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill--~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+|||+ +.++.+||+|||+++....... .....||+.|+|||++.+..++.++||||||++++||++
T Consensus 207 -~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 283 (373)
T 2x4f_A 207 -YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS 283 (373)
T ss_dssp -TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHH
T ss_pred -CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHh
Confidence 99999999999999 6678999999999997754432 223468999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|+.||...... +....... ...... . ........++.+++.+||+.||++|||+.|+++
T Consensus 284 g~~pf~~~~~~------~~~~~i~~-~~~~~~--~-~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 284 GLSPFLGDNDA------ETLNNILA-CRWDLE--D-EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SSCTTCCSSHH------HHHHHHHH-TCCCSC--S-GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHH------HHHHHHHh-ccCCCC--h-hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999754321 11122222 211100 0 001123467899999999999999999999987
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.84 Aligned_cols=219 Identities=22% Similarity=0.286 Sum_probs=157.5
Q ss_pred HHHHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
...+.+|+.++++++ ||||+++++++.+....++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+.
T Consensus 49 ~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-- 125 (325)
T 3kn6_A 49 EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDV-- 125 (325)
T ss_dssp HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 467889999999997 99999999999999999999999999999999965 45689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCC---cEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENR---CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~---~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+|+||||||+|||++.++ .+||+|||+++....... ......||..|+|||.+.+..++.++||||||++++||+
T Consensus 126 -~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 203 (325)
T 3kn6_A 126 -GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTML 203 (325)
T ss_dssp -TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------------------CCCCHHHHHHHHHHHHHHHH
T ss_pred -CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHH
Confidence 999999999999997665 899999999987654322 233456899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+|+.||..................+..+...... ........++.+++.+||+.||++|||++|+++.
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 204 SGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG---EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HSSCTTC-------CCCHHHHHHHHTTTCCCCCS---HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred hCCCCCCCCccccccccHHHHHHHHHcCCCCCCc---ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 9999998654332211112233334444332111 1112234678999999999999999999999854
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=312.11 Aligned_cols=212 Identities=21% Similarity=0.322 Sum_probs=175.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++
T Consensus 54 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~--- 129 (444)
T 3soa_A 54 HQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQM--- 129 (444)
T ss_dssp HHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 35788999999999999999999999999999999999999999998865 35688999999999999999999998
Q ss_pred CeeeCCCCcceEEEC---CCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 591 QIIHCDIKPQNILMD---ENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~---~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+|||++ .++.+||+|||+++....... ......||+.|+|||.+.+..++.++||||+|+++|+|++
T Consensus 130 givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~ 208 (444)
T 3soa_A 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV 208 (444)
T ss_dssp TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHh
Confidence 999999999999998 467899999999987654432 2345679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|+.||..... . .....+..+....... ........+.+++.+||+.||++|||+.|+++.
T Consensus 209 G~~Pf~~~~~---~----~~~~~i~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 209 GYPPFWDEDQ---H----RLYQQIKAGAYDFPSP---EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp SSCSCCCSSH---H----HHHHHHHHTCCCCCTT---TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCCccH---H----HHHHHHHhCCCCCCcc---ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 9999864321 1 1223333343321111 111234568899999999999999999999873
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=327.68 Aligned_cols=217 Identities=29% Similarity=0.419 Sum_probs=179.3
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..++|.+|+++|++++|+||+++++++.+ +..+|||||+++|+|.+++... ...+++.+++.|+.||++||+|||++
T Consensus 305 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~- 382 (535)
T 2h8h_A 305 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 382 (535)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 45789999999999999999999999876 6789999999999999999643 35689999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+|+||||||+|||++.++.+||+|||+++..............++..|+|||.+.+..++.++||||||+++|||++
T Consensus 383 --~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~ 460 (535)
T 2h8h_A 383 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 460 (535)
T ss_dssp --TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred --CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999998765433222334557889999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcC
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~ 743 (757)
|+.||...... + +...+..+.... .+......+.+++.+||+.||++|||+++|+++|+.+..
T Consensus 461 g~~P~~~~~~~------~-~~~~i~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 461 GRVPYPGMVNR------E-VLDQVERGYRMP------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp TCCSSTTCCHH------H-HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCCCCHH------H-HHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 88888643221 1 222233332111 112334678899999999999999999999999998654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.96 Aligned_cols=216 Identities=26% Similarity=0.415 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-----------------------CCCCH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-----------------------KQPNW 567 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~l~~ 567 (757)
.+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.... ..+++
T Consensus 70 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (314)
T 2ivs_A 70 LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149 (314)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECH
T ss_pred HHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCH
Confidence 4678899999999999999999999999999999999999999999996532 23789
Q ss_pred HHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccC
Q 038168 568 VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRN 646 (757)
Q Consensus 568 ~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~ 646 (757)
.++..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++........ ......++..|+|||.+.+
T Consensus 150 ~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 226 (314)
T 2ivs_A 150 GDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD 226 (314)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHC---CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC
Confidence 99999999999999999998 9999999999999999999999999999877554332 2233557889999999999
Q ss_pred CCCCccccchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCC
Q 038168 647 LPITVKADVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEP 725 (757)
Q Consensus 647 ~~~~~k~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p 725 (757)
..++.++||||||++++||++ |+.|+....... +......+.... .+......+.+++.+||+.||
T Consensus 227 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dp 293 (314)
T 2ivs_A 227 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER-------LFNLLKTGHRME------RPDNCSEEMYRLMLQCWKQEP 293 (314)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSG
T ss_pred CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHhhcCCcCC------CCccCCHHHHHHHHHHccCCh
Confidence 999999999999999999999 999987544322 122233332111 122334678999999999999
Q ss_pred CCCCCHHHHHHHhhcCc
Q 038168 726 SLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 726 ~~RPsm~eVl~~Le~~~ 742 (757)
++||++.||++.|+.+.
T Consensus 294 ~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 294 DKRPVFADISKDLEKMM 310 (314)
T ss_dssp GGSCCHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHH
Confidence 99999999999998754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=310.82 Aligned_cols=210 Identities=19% Similarity=0.226 Sum_probs=172.2
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 038168 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQI 592 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 592 (757)
.+.+|+.++++++|||||++++++.+.+..++||||+++|+|.+++.+ ..+++..+..++.||+.||+|||+. +|
T Consensus 115 ~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~---gi 189 (410)
T 3v8s_A 115 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSM---GF 189 (410)
T ss_dssp THHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred HHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 377999999999999999999999999999999999999999999964 4588899999999999999999998 99
Q ss_pred eeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCC----CCccccchhhHHHHHHHHhC
Q 038168 593 IHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP----ITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 593 iH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~Dv~S~G~~l~elltG 668 (757)
+||||||+||||+.++.+||+|||+++..............||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 190 vHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G 269 (410)
T 3v8s_A 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269 (410)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHS
T ss_pred EeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhC
Confidence 99999999999999999999999999887665544445678999999999998765 78999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSL--RPSMKKVLLM 737 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~--RPsm~eVl~~ 737 (757)
+.||...... +..............-+. .....++.+++.+||+.+|++ ||+++||++.
T Consensus 270 ~~Pf~~~~~~------~~~~~i~~~~~~~~~p~~----~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 270 DTPFYADSLV------GTYSKIMNHKNSLTFPDD----NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp SCTTCCSSHH------HHHHHHHTHHHHCCCCTT----CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred CCCCCCCChh------hHHHHHHhccccccCCCc----ccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 9999753221 111111111000001011 122356889999999999988 9999999974
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=303.90 Aligned_cols=223 Identities=16% Similarity=0.217 Sum_probs=176.2
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEe----ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLE----VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
+.+.+|+.+++.++|+||+++++++.. ....++||||+ +++|.+++.... .+++.++..++.||+.||+|||+.
T Consensus 93 ~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~ 170 (345)
T 2v62_A 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHEN 170 (345)
T ss_dssp HHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Confidence 567889999999999999999999988 67899999999 999999997544 789999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCC--cEEEeecCCccccCCCCc------ceecccccCccccCcccccCCCCCccccchhhH
Q 038168 588 CETQIIHCDIKPQNILMDENR--CAKISDFGLAKLMKPDQT------RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFG 659 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~--~~ki~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G 659 (757)
+|+||||||+|||++.++ .+||+|||+++.+..... .......||..|+|||.+.+..++.++||||||
T Consensus 171 ---~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 247 (345)
T 2v62_A 171 ---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILG 247 (345)
T ss_dssp ---TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHH
T ss_pred ---CeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHH
Confidence 999999999999998887 999999999987643321 112346799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 660 VVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 660 ~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
++++||++|+.||.......... .. ....... .+...............++.+++.+||+.||++||++.+|++.|+
T Consensus 248 ~il~ell~g~~pf~~~~~~~~~~-~~-~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 324 (345)
T 2v62_A 248 YCMLRWLCGKLPWEQNLKDPVAV-QT-AKTNLLD-ELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILN 324 (345)
T ss_dssp HHHHHHHHSSCTTGGGTTCHHHH-HH-HHHHHHH-TTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHC
T ss_pred HHHHHHHhCCCCccccccccHHH-HH-HHHhhcc-cccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 99999999999996433222111 11 1111111 111111000001123457999999999999999999999999998
Q ss_pred cCc
Q 038168 740 GTV 742 (757)
Q Consensus 740 ~~~ 742 (757)
...
T Consensus 325 ~~~ 327 (345)
T 2v62_A 325 PHG 327 (345)
T ss_dssp TTC
T ss_pred ccC
Confidence 744
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=305.30 Aligned_cols=211 Identities=21% Similarity=0.340 Sum_probs=173.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+.
T Consensus 72 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~--- 147 (362)
T 2bdw_A 72 FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSN--- 147 (362)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 36788999999999999999999999999999999999999999999865 45689999999999999999999998
Q ss_pred CeeeCCCCcceEEECCC---CcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 591 QIIHCDIKPQNILMDEN---RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~---~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++
T Consensus 148 ~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 225 (362)
T 2bdw_A 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225 (362)
T ss_dssp TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHH
Confidence 99999999999999865 459999999998765432 2334679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|+.||..... . + ....+..+...... .........+.+++.+||+.||++||++.|+++.
T Consensus 226 g~~Pf~~~~~---~---~-~~~~i~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 226 GYPPFWDEDQ---H---R-LYAQIKAGAYDYPS---PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp SSCSSCCSSH---H---H-HHHHHHHTCCCCCT---TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCCH---H---H-HHHHHHhCCCCCCc---ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9999865321 1 1 22233333322111 0111234568899999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=298.28 Aligned_cols=229 Identities=25% Similarity=0.335 Sum_probs=173.9
Q ss_pred HHHHHHHHHHhhc--CCCceeeeeeEEEec----eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 512 REFQTEMKVIGRT--HHRNLVRLLGYSLEV----SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 512 ~~~~~E~~~l~~l--~h~niv~l~g~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
..+..|.+++..+ +|+||+++++++.+. ...++||||+++|+|.+++.. ..+++.++..++.|++.||+|||
T Consensus 74 ~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH 151 (337)
T 3mdy_A 74 ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLH 151 (337)
T ss_dssp HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHH
T ss_pred chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH
Confidence 4556666666555 999999999999877 688999999999999999954 46899999999999999999999
Q ss_pred hCC-----CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce---ecccccCccccCcccccCCCCCcc-----
Q 038168 586 DEC-----ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT---FTGIRGTRGYVAPEWHRNLPITVK----- 652 (757)
Q Consensus 586 ~~~-----~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k----- 652 (757)
+++ .++|+||||||+|||++.++.+||+|||+++.+....... .....||..|+|||.+.+.....+
T Consensus 152 ~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 231 (337)
T 3mdy_A 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYI 231 (337)
T ss_dssp SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHH
T ss_pred HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCcc
Confidence 752 3489999999999999999999999999998765443321 124578999999999988766665
Q ss_pred -ccchhhHHHHHHHHhC----------CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHcc
Q 038168 653 -ADVYSFGVVLLEIICR----------RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCI 721 (757)
Q Consensus 653 -~Dv~S~G~~l~elltG----------~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl 721 (757)
+||||||+++|||++| +.|+......... ... .....................+...++.+++.+||
T Consensus 232 ~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 309 (337)
T 3mdy_A 232 MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS-YED-MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECW 309 (337)
T ss_dssp HHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-HHH-HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHS
T ss_pred ccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc-hhh-hHHHHhhhccCccccccchhhHHHHHHHHHHHHhh
Confidence 9999999999999999 5555543332221 111 22222222222222211223467788999999999
Q ss_pred ccCCCCCCCHHHHHHHhhcCcCC
Q 038168 722 LDEPSLRPSMKKVLLMLEGTVEI 744 (757)
Q Consensus 722 ~~~p~~RPsm~eVl~~Le~~~~~ 744 (757)
+.||++|||+.||++.|+.+.+-
T Consensus 310 ~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 310 AHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hhChhhCCCHHHHHHHHHHHHhh
Confidence 99999999999999999986543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=305.47 Aligned_cols=212 Identities=20% Similarity=0.273 Sum_probs=172.7
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP---EKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.+. ...+++..+..++.||+.||+|||+
T Consensus 69 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~ 148 (351)
T 3c0i_A 69 STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148 (351)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3577999999999999999999999999999999999999999998887542 3458999999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCc---EEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHH
Q 038168 587 ECETQIIHCDIKPQNILMDENRC---AKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~---~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ 663 (757)
+ +|+||||||+|||++.++. +||+|||+++....... ......||+.|+|||.+.+..++.++||||||++++
T Consensus 149 ~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 224 (351)
T 3c0i_A 149 N---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILF 224 (351)
T ss_dssp T---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHH
T ss_pred C---CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHH
Confidence 8 9999999999999986654 99999999987765332 233467999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||++|+.||.... . + .......+..... +. ........+.+++.+||+.||++|||+.|+++
T Consensus 225 ~ll~g~~pf~~~~---~----~-~~~~i~~~~~~~~--~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 225 ILLSGCLPFYGTK---E----R-LFEGIIKGKYKMN--PR-QWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHSSCSSCSSH---H----H-HHHHHHHTCCCCC--HH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHCCCCCCCcH---H----H-HHHHHHcCCCCCC--cc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9999999997531 1 1 1222222322111 00 00122467889999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=312.16 Aligned_cols=209 Identities=22% Similarity=0.205 Sum_probs=171.9
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 038168 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQI 592 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 592 (757)
.+.+|..++.+++|+||+++++++.+.+..+|||||+++|+|.+++.+....+++..+..++.||+.||+|||+. +|
T Consensus 107 ~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---gi 183 (412)
T 2vd5_A 107 CFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GY 183 (412)
T ss_dssp CHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred HHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 378899999999999999999999999999999999999999999976556789999999999999999999998 99
Q ss_pred eeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc-------CCCCCccccchhhHHHHHHH
Q 038168 593 IHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR-------NLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 593 iH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~k~Dv~S~G~~l~el 665 (757)
+||||||+||||+.++.+||+|||+++..............||+.|+|||++. ...++.++|||||||++|||
T Consensus 184 iHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyel 263 (412)
T 2vd5_A 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263 (412)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHH
T ss_pred eecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHH
Confidence 99999999999999999999999999987665544444568999999999987 45789999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHh---cCCccccccccccCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFE---NGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLR---PSMKKVLLM 737 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~R---Psm~eVl~~ 737 (757)
++|+.||......+ ....... .-.+.. .......++.+++.+||+ +|++| |+++||++.
T Consensus 264 ltG~~Pf~~~~~~~------~~~~i~~~~~~~~~p~------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 264 FYGQTPFYADSTAE------TYGKIVHYKEHLSLPL------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHSSCTTCCSSHHH------HHHHHHTHHHHCCCC----------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HhCCCCCCCCCHHH------HHHHHHhcccCcCCCc------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 99999997543211 1111111 011110 112234678899999999 99998 589998763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=306.35 Aligned_cols=208 Identities=24% Similarity=0.311 Sum_probs=169.1
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+.+.+|..++.++ +|||||++++++.+.+..++||||+++|+|.+++.+ ...+++..+..++.||+.||+|||++
T Consensus 97 ~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~--- 172 (396)
T 4dc2_A 97 DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHER--- 172 (396)
T ss_dssp CHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 4578899999887 899999999999999999999999999999999865 35689999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||+++||++|+.
T Consensus 173 givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~ 251 (396)
T 4dc2_A 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251 (396)
T ss_dssp TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CEEeccCCHHHEEECCCCCEEEeecceeeecccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999998643222 22345689999999999999999999999999999999999999
Q ss_pred CCCCCCCCc--cccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 671 CLDPNLPDD--QVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 671 p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
||......+ .....+...+....+... .+.....++.+++.+||+.||++||+.
T Consensus 252 Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-------~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 252 PFDIVGSSDNPDQNTEDYLFQVILEKQIR-------IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp SSTTTTC------CCHHHHHHHHHHCCCC-------CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCcccccccccchhhHHHHHHHHhccccC-------CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 997543221 111112233333333222 122234568899999999999999985
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=297.85 Aligned_cols=224 Identities=22% Similarity=0.355 Sum_probs=180.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..+.+.+|++++++++|+||+++++++.+. +..++||||+++++|.+++......+++.++..++.|++.||+|||+.
T Consensus 66 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 145 (302)
T 4e5w_A 66 HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145 (302)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC
Confidence 457789999999999999999999999876 568999999999999999976667799999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc--eecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR--TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|||++.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||++++||
T Consensus 146 ---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 222 (302)
T 4e5w_A 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222 (302)
T ss_dssp ---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred ---CcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHH
Confidence 9999999999999999999999999999987655432 23346688889999999999999999999999999999
Q ss_pred HhCCCCCCCCC--------CCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 666 ICRRRCLDPNL--------PDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 666 ltG~~p~~~~~--------~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++|+.|+.... +................+.... .+......+.+++.+||+.||++|||+.|++++
T Consensus 223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 296 (302)
T 4e5w_A 223 LTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296 (302)
T ss_dssp HTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCC------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCC------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 99998754321 1111111111222222222111 122334678999999999999999999999999
Q ss_pred hhcCc
Q 038168 738 LEGTV 742 (757)
Q Consensus 738 Le~~~ 742 (757)
|+.+.
T Consensus 297 L~~ll 301 (302)
T 4e5w_A 297 FEALL 301 (302)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 98753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=303.29 Aligned_cols=218 Identities=24% Similarity=0.357 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCC----------------------CCCH
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEK----------------------QPNW 567 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~----------------------~l~~ 567 (757)
.+.+.+|+.+++++ +||||+++++++...+..++||||+++|+|.+++..... .+++
T Consensus 92 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 171 (344)
T 1rjb_A 92 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171 (344)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCH
T ss_pred HHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCH
Confidence 46789999999999 899999999999999999999999999999999976542 3789
Q ss_pred HHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccC
Q 038168 568 VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRN 646 (757)
Q Consensus 568 ~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~ 646 (757)
..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+
T Consensus 172 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 248 (344)
T 1rjb_A 172 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 248 (344)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc
Confidence 99999999999999999998 9999999999999999999999999999876544332 2334567889999999999
Q ss_pred CCCCccccchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCC
Q 038168 647 LPITVKADVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEP 725 (757)
Q Consensus 647 ~~~~~k~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p 725 (757)
..++.++||||||++++||++ |+.||........ .......+.... .+......+.+++.+||+.||
T Consensus 249 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp 316 (344)
T 1rjb_A 249 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN------FYKLIQNGFKMD------QPFYATEEIYIIMQSCWAFDS 316 (344)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSG
T ss_pred CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH------HHHHHhcCCCCC------CCCCCCHHHHHHHHHHcCCCc
Confidence 999999999999999999998 9999876543221 122223221111 112234678999999999999
Q ss_pred CCCCCHHHHHHHhhcCcC
Q 038168 726 SLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 726 ~~RPsm~eVl~~Le~~~~ 743 (757)
++|||+.||++.|+.+..
T Consensus 317 ~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 317 RKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp GGSCCHHHHHHHHHHHC-
T ss_pred hhCcCHHHHHHHHHHHHH
Confidence 999999999999997543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=294.58 Aligned_cols=221 Identities=18% Similarity=0.207 Sum_probs=176.9
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEE-EeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYS-LEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+++.+|+.++++++|++++..+.++ .+.+..++||||+ +++|.+++......+++.++..++.|++.||+|||++
T Consensus 49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--- 124 (296)
T 3uzp_A 49 PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--- 124 (296)
T ss_dssp CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 5789999999999988877666665 5566789999999 9999999976667899999999999999999999998
Q ss_pred CeeeCCCCcceEEE---CCCCcEEEeecCCccccCCCCcc------eecccccCccccCcccccCCCCCccccchhhHHH
Q 038168 591 QIIHCDIKPQNILM---DENRCAKISDFGLAKLMKPDQTR------TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVV 661 (757)
Q Consensus 591 ~iiH~Dik~~Nill---~~~~~~ki~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~ 661 (757)
+|+||||||+|||+ +.++.+||+|||+++........ ......||..|+|||.+.+..++.++||||||++
T Consensus 125 ~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 204 (296)
T 3uzp_A 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYV 204 (296)
T ss_dssp TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHH
Confidence 99999999999999 48899999999999877554331 1234679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 662 LLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 662 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
++||++|+.||..............+.......... .........+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 205 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 205 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 999999999998754443322222222111111110 01112246789999999999999999999999999875
Q ss_pred c
Q 038168 742 V 742 (757)
Q Consensus 742 ~ 742 (757)
.
T Consensus 279 ~ 279 (296)
T 3uzp_A 279 F 279 (296)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-33 Score=302.38 Aligned_cols=209 Identities=23% Similarity=0.318 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|||||++++++.+.+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.
T Consensus 59 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~--- 134 (384)
T 4fr4_A 59 VRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQ--- 134 (384)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 36788999999999999999999999999999999999999999999975 45689999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC---CCCCccccchhhHHHHHHHHh
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN---LPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 135 givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ellt 212 (384)
T 4fr4_A 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212 (384)
T ss_dssp TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHH
T ss_pred CceeccCcHHHeEECCCCCEEEeccceeeeccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHh
Confidence 99999999999999999999999999998765432 2345679999999999874 458999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS-MKKVLL 736 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-m~eVl~ 736 (757)
|+.||..........+ .......... .+......+.+++.+||+.||++||+ +++|++
T Consensus 213 G~~Pf~~~~~~~~~~~----~~~~~~~~~~-------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 213 GRRPYHIRSSTSSKEI----VHTFETTVVT-------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp SSCSSCCCTTSCHHHH----HHHHHHCCCC-------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCCCCCCCccHHHH----HHHHhhcccC-------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 9999976544332211 1112222111 12223467899999999999999998 777764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=297.68 Aligned_cols=223 Identities=18% Similarity=0.205 Sum_probs=169.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. ...+++.++..++.|+++||+|||+.
T Consensus 78 ~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~--- 153 (309)
T 2h34_A 78 RTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAA--- 153 (309)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 47789999999999999999999999999999999999999999999964 34689999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||++...............|+..|+|||.+.+..++.++||||||++++||++|+.
T Consensus 154 ~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 233 (309)
T 2h34_A 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233 (309)
T ss_dssp TCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSC
T ss_pred cCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999998776544334445678999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcCcCCCCCC
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-SMKKVLLMLEGTVEIPIPP 748 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-sm~eVl~~Le~~~~~~~p~ 748 (757)
||..... ............. +..........+.+++.+||+.||++|| +++++++.|+...+...+.
T Consensus 234 pf~~~~~-------~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 234 PYQGDQL-------SVMGAHINQAIPR----PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp SSCSCHH-------HHHHHHHHSCCCC----GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred CCCCchH-------HHHHHHhccCCCC----ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 9874321 1122222221111 1112223345788999999999999999 9999999999866554433
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=298.87 Aligned_cols=229 Identities=22% Similarity=0.337 Sum_probs=170.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEecee----eeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSK----KILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
.+.+.+|+.++++++||||+++++++..... .++||||+++++|.+++.. ...+++.++..++.|++.||+|||+
T Consensus 56 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~ 134 (311)
T 3ork_A 56 YLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQ 134 (311)
T ss_dssp HHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3578999999999999999999999886654 4999999999999999964 3468999999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc--ceecccccCccccCcccccCCCCCccccchhhHHHHHH
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT--RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~e 664 (757)
+ +|+||||||+|||++.++.+||+|||+++....... .......||..|+|||.+.+..++.++||||||++++|
T Consensus 135 ~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 211 (311)
T 3ork_A 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211 (311)
T ss_dssp T---TCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHH
T ss_pred C---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHH
Confidence 8 999999999999999999999999999987654332 22234668999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHH-HHHHhhcCcC
Q 038168 665 IICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKK-VLLMLEGTVE 743 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~e-Vl~~Le~~~~ 743 (757)
|++|+.||..... .+.............. .........+.+++.+||+.||++||+..+ +...|.....
T Consensus 212 ll~g~~pf~~~~~------~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 212 VLTGEPPFTGDSP------VSVAYQHVREDPIPPS----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHSSCSCCCSSH------HHHHHHHHHCCCCCHH----HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred HHhCCCCCCCCCh------HHHHHHHhcCCCCCcc----cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 9999999865332 1222222232222111 111123467889999999999999996555 4456655444
Q ss_pred CCCCCCCCCc
Q 038168 744 IPIPPNPTSF 753 (757)
Q Consensus 744 ~~~p~~p~~~ 753 (757)
...|+.|...
T Consensus 282 ~~~~~~~~~~ 291 (311)
T 3ork_A 282 GEPPEAPKVL 291 (311)
T ss_dssp TCCCSSCCCC
T ss_pred CCCCCCCccc
Confidence 4444444443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=299.47 Aligned_cols=203 Identities=24% Similarity=0.276 Sum_probs=163.6
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.++..|+..+.++ +|+||+++++++.+++..++||||+ +++|.+++......+++.++..++.|++.||+|||+.
T Consensus 101 ~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 176 (311)
T 3p1a_A 101 ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ--- 176 (311)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 3455666666666 8999999999999999999999999 6799999877677799999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++....... .....||++|+|||++.+ .++.++||||||++++||++|..
T Consensus 177 ~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~ 253 (311)
T 3p1a_A 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNME 253 (311)
T ss_dssp TEECCCCSGGGEEECGGGCEEECCCTTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCC
T ss_pred CEecCCCCHHHEEECCCCCEEEccceeeeecccCCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999987654322 233568999999999876 79999999999999999999987
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
++.... .+..+..+.... ........++.+++.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~----------~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 254 LPHGGE----------GWQQLRQGYLPP-----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCSSHH----------HHHHHTTTCCCH-----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCcc----------HHHHHhccCCCc-----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 654311 122223222211 111223467899999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=300.98 Aligned_cols=223 Identities=24% Similarity=0.377 Sum_probs=178.1
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..+.+.+|++++++++||||+++++++.+. ...++||||+++|+|.+++... .+++.++..++.|++.||+|||+.
T Consensus 76 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~ 153 (318)
T 3lxp_A 76 HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQ 153 (318)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhC
Confidence 356799999999999999999999999874 5789999999999999999653 489999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc--eecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR--TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||
T Consensus 154 ---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 230 (318)
T 3lxp_A 154 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230 (318)
T ss_dssp ---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred ---CccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999987654332 22345678889999999999999999999999999999
Q ss_pred HhCCCCCCCCCCC--------ccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 666 ICRRRCLDPNLPD--------DQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 666 ltG~~p~~~~~~~--------~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++|+.|+...... ...............+... ..+......+.+++.+||+.||++|||+.|+++.
T Consensus 231 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 304 (318)
T 3lxp_A 231 LTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPI 304 (318)
T ss_dssp HTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCC------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999988643211 0000001112222222111 1122344679999999999999999999999999
Q ss_pred hhcCcC
Q 038168 738 LEGTVE 743 (757)
Q Consensus 738 Le~~~~ 743 (757)
|+.+.+
T Consensus 305 L~~l~~ 310 (318)
T 3lxp_A 305 LKTVHE 310 (318)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 997543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-33 Score=298.88 Aligned_cols=225 Identities=25% Similarity=0.311 Sum_probs=178.2
Q ss_pred HHHHHHHHHHHhh--cCCCceeeeeeEEEece----eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGR--THHRNLVRLLGYSLEVS----KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.+.+|++++.. ++||||+++++++...+ ..++||||+++|+|.+++.+ ..+++.++..++.|++.||+||
T Consensus 78 ~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~l 155 (342)
T 1b6c_B 78 ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHL 155 (342)
T ss_dssp HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHH
Confidence 4678889999888 79999999999998776 78999999999999999964 4689999999999999999999
Q ss_pred h--------hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc---eecccccCccccCcccccCC------
Q 038168 585 H--------DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR---TFTGIRGTRGYVAPEWHRNL------ 647 (757)
Q Consensus 585 H--------~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------ 647 (757)
| +. +|+||||||+|||++.++.+||+|||+++........ ......||..|+|||.+.+.
T Consensus 156 H~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 232 (342)
T 1b6c_B 156 HMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 232 (342)
T ss_dssp HCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCH
T ss_pred HHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhccccccccc
Confidence 9 66 9999999999999999999999999999876554432 22345789999999998775
Q ss_pred CCCccccchhhHHHHHHHHhC----------CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHH
Q 038168 648 PITVKADVYSFGVVLLEIICR----------RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVA 717 (757)
Q Consensus 648 ~~~~k~Dv~S~G~~l~elltG----------~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~ 717 (757)
.++.++||||||++++||++| ..||........ .... .....................+....+.+++
T Consensus 233 ~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 310 (342)
T 1b6c_B 233 ESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP-SVEE-MRKVVCEQKLRPNIPNRWQSCEALRVMAKIM 310 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-CHHH-HHHHHTTSCCCCCCCGGGGTSHHHHHHHHHH
T ss_pred ccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc-cHHH-HHHHHHHHHhCCCCcccccchhHHHHHHHHH
Confidence 344789999999999999999 667665433221 1222 2222222222222211122446778899999
Q ss_pred HHccccCCCCCCCHHHHHHHhhcCc
Q 038168 718 LWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 718 ~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
.+||+.||++|||+.||+++|+.+.
T Consensus 311 ~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 311 RECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp HHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhccChhhCCCHHHHHHHHHHHH
Confidence 9999999999999999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=290.73 Aligned_cols=211 Identities=23% Similarity=0.348 Sum_probs=173.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNPEK-QPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
.+.|.+|+.++++++||||+++++++.+. +..++||||+++|+|.+++..... .+++.++..++.|+++||+|||+.
T Consensus 51 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 130 (271)
T 3kmu_A 51 SRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130 (271)
T ss_dssp HHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS
T ss_pred HHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 46799999999999999999999999877 778999999999999999977543 589999999999999999999997
Q ss_pred CCCC--eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCc---cccchhhHHHH
Q 038168 588 CETQ--IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITV---KADVYSFGVVL 662 (757)
Q Consensus 588 ~~~~--iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---k~Dv~S~G~~l 662 (757)
+ |+||||||+|||++.++.+||+|||++..... ....||+.|+|||.+.+...+. ++||||||+++
T Consensus 131 ---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il 201 (271)
T 3kmu_A 131 ---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201 (271)
T ss_dssp ---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHH
T ss_pred ---CCceecCCCccceEEEcCCcceeEEeccceeeecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHH
Confidence 7 99999999999999999999999988765332 2346799999999998765544 79999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
+||++|+.||..... .+........+.... .+......+.+++..||+.||++|||++|+++.|+.+.
T Consensus 202 ~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 202 WELVTREVPFADLSN------MEIGMKVALEGLRPT------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHHHCSCTTTTSCH------HHHHHHHHHSCCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHhCCCCccccCh------HHHHHHHHhcCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 999999999874322 111222222222111 12233456899999999999999999999999998754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=293.58 Aligned_cols=217 Identities=29% Similarity=0.454 Sum_probs=178.3
Q ss_pred chHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 509 SGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 509 ~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
...+.+.+|++++++++|+||+++++++.+ +..++||||+++++|.+++.... ..+++.++..++.|++.||+|||+.
T Consensus 50 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 128 (279)
T 1qpc_A 50 MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128 (279)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 346789999999999999999999999864 56899999999999999996532 3689999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+||++++++.+||+|||+++..............++..|+|||.+.+..++.++||||||++++||++
T Consensus 129 ---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 205 (279)
T 1qpc_A 129 ---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205 (279)
T ss_dssp ---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred ---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHh
Confidence 99999999999999999999999999999876554444444567889999999998899999999999999999999
Q ss_pred -CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 668 -RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 668 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
|+.|+...... + .......+... .. +......+.+++.+|++.+|++|||+.++++.|+.+.
T Consensus 206 ~g~~p~~~~~~~------~-~~~~~~~~~~~--~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 206 HGRIPYPGMTNP------E-VIQNLERGYRM--VR----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp TTCCSSTTCCHH------H-HHHHHHTTCCC--CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCcccCHH------H-HHHHHhcccCC--CC----cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 88888643221 1 12222222111 11 1233467889999999999999999999999998743
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-33 Score=304.82 Aligned_cols=217 Identities=18% Similarity=0.209 Sum_probs=170.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|+.++++++|||||++++++.+.+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.
T Consensus 70 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-- 147 (389)
T 3gni_B 70 VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM-- 147 (389)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 467888999999999999999999999999999999999999999999654 35689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc------ceecccccCccccCcccccC--CCCCccccchhhHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT------RTFTGIRGTRGYVAPEWHRN--LPITVKADVYSFGVV 661 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~G~~ 661 (757)
+|+||||||+|||++.++.+||+|||++........ .......||..|+|||.+.+ ..++.++|||||||+
T Consensus 148 -~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 226 (389)
T 3gni_B 148 -GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT 226 (389)
T ss_dssp -TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHH
T ss_pred -CeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHH
Confidence 999999999999999999999999999875432211 11123468999999999987 679999999999999
Q ss_pred HHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccc---------------------------------------
Q 038168 662 LLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVED--------------------------------------- 702 (757)
Q Consensus 662 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~--------------------------------------- 702 (757)
++||++|+.||.......... .. ..+....+.+.
T Consensus 227 l~el~~g~~pf~~~~~~~~~~--~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (389)
T 3gni_B 227 ACELANGHVPFKDMPATQMLL--EK-----LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPS 299 (389)
T ss_dssp HHHHHHSSCTTTTCCSTTHHH--HC-------------------------------------------------------
T ss_pred HHHHHHCCCCCCCCCHHHHHH--HH-----hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCC
Confidence 999999999997644332110 00 00000000000
Q ss_pred cccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 703 EEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 703 ~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
..........+.+++.+||+.||++|||+.|+++.
T Consensus 300 ~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 300 HPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00122234678999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=290.36 Aligned_cols=208 Identities=25% Similarity=0.356 Sum_probs=153.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++......+++.++..++.|+++||+|||+.
T Consensus 55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--- 131 (278)
T 3cok_A 55 VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH--- 131 (278)
T ss_dssp HHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 36789999999999999999999999999999999999999999999987767899999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+||+++.++.+||+|||++......... .....||+.|+|||.+.+..++.++||||||++++||++|+.
T Consensus 132 ~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 210 (278)
T 3cok_A 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRP 210 (278)
T ss_dssp TEECSSCCGGGEEECTTCCEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSC
T ss_pred CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999999876533221 223568999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|+......... .... .... ..+......+.+++.+||+.||++|||++++++
T Consensus 211 p~~~~~~~~~~-------~~~~---~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 211 PFDTDTVKNTL-------NKVV---LADY----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SSCCCSCC------------CC---SSCC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCChhHHHHH-------HHHh---hccc----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 99754432210 0000 0111 112223457889999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=299.30 Aligned_cols=211 Identities=23% Similarity=0.354 Sum_probs=173.6
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++......+++..+..++.|++.||+|||++
T Consensus 55 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-- 132 (289)
T 4fvq_A 55 YSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN-- 132 (289)
T ss_dssp GHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC--
Confidence 346789999999999999999999999999999999999999999999987666689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCc--------EEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHH
Q 038168 590 TQIIHCDIKPQNILMDENRC--------AKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGV 660 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~--------~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~ 660 (757)
+|+||||||+|||++.++. +||+|||++...... ....++..|+|||.+.+ ..++.++||||||+
T Consensus 133 -~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 206 (289)
T 4fvq_A 133 -TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGT 206 (289)
T ss_dssp -TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHH
T ss_pred -CeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHH
Confidence 9999999999999998887 999999999765332 22457889999999987 67999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccccHHHHHHHHHhc-CCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 661 VLLEIICRRRCLDPNLPDDQVILEEWVYQCFEN-GNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 661 ~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
+++||++|..|+....... . ....... ..... ....++.+++.+||+.||++|||+.|+++.|+
T Consensus 207 il~el~~g~~~~~~~~~~~-----~-~~~~~~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 271 (289)
T 4fvq_A 207 TLWEICSGGDKPLSALDSQ-----R-KLQFYEDRHQLPA---------PKAAELANLINNCMDYEPDHRPSFRAIIRDLN 271 (289)
T ss_dssp HHHHHHTTTCCTTTTSCHH-----H-HHHHHHTTCCCCC---------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHcCCCCCccccchH-----H-HHHHhhccCCCCC---------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 9999999766554332211 1 1111111 11111 11345889999999999999999999999999
Q ss_pred cCcC
Q 038168 740 GTVE 743 (757)
Q Consensus 740 ~~~~ 743 (757)
.+..
T Consensus 272 ~l~~ 275 (289)
T 4fvq_A 272 SLFT 275 (289)
T ss_dssp TCC-
T ss_pred HhcC
Confidence 8765
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-33 Score=297.48 Aligned_cols=210 Identities=21% Similarity=0.323 Sum_probs=167.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEece-------------------------------------------------
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVS------------------------------------------------- 540 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------------------------------------------------- 540 (757)
..+.+.+|++++++++||||+++++++.+..
T Consensus 47 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 126 (332)
T 3qd2_B 47 AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126 (332)
T ss_dssp HHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---------------------------------------
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccccc
Confidence 4578999999999999999999999986543
Q ss_pred --------eeeEEEEeccCCChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcE
Q 038168 541 --------KKILVYEYMSNGSLADILFNPE--KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA 610 (757)
Q Consensus 541 --------~~~lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ 610 (757)
..++||||+++++|.+++.... ....+..+.+++.||+.||+|||++ +|+||||||+|||++.++.+
T Consensus 127 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 203 (332)
T 3qd2_B 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVV 203 (332)
T ss_dssp -----CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred ccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCE
Confidence 2789999999999999997654 3356778899999999999999998 99999999999999999999
Q ss_pred EEeecCCccccCCCCc-----------ceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCc
Q 038168 611 KISDFGLAKLMKPDQT-----------RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDD 679 (757)
Q Consensus 611 ki~DfGla~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~ 679 (757)
||+|||+++....... .......||+.|+|||.+.+..++.++||||||++++||++|..|+..
T Consensus 204 kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----- 278 (332)
T 3qd2_B 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----- 278 (332)
T ss_dssp EECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----
T ss_pred EEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----
Confidence 9999999998765432 122345799999999999999999999999999999999998654310
Q ss_pred cccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 680 QVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 680 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
. .............. ........+.+++.+||+.||++|||+.|+++.
T Consensus 279 ---~-~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 279 ---R-VRIITDVRNLKFPL------LFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp ---H-HHHHHHHHTTCCCH------HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred ---H-HHHHHHhhccCCCc------ccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 0 11112222222211 122344667899999999999999999999873
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=301.54 Aligned_cols=218 Identities=26% Similarity=0.391 Sum_probs=180.3
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------------CCCCHHHHHHHH
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------------KQPNWVERMGIA 574 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~ 574 (757)
.+.+.+|+++++++ +||||+++++++.+.+..++||||+++|+|.+++.... ..+++.++..++
T Consensus 84 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 163 (334)
T 2pvf_A 84 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163 (334)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHH
Confidence 46788999999999 89999999999999999999999999999999997643 247899999999
Q ss_pred HHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccc
Q 038168 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKA 653 (757)
Q Consensus 575 ~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~ 653 (757)
.||++||+|||+. +|+||||||+|||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++
T Consensus 164 ~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 240 (334)
T 2pvf_A 164 YQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 240 (334)
T ss_dssp HHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHH
T ss_pred HHHHHHHHHHHhC---CeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHH
Confidence 9999999999998 9999999999999999999999999999877654332 23345678899999999988999999
Q ss_pred cchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 654 DVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 654 Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
||||||++++||++ |+.|+..... .+ +...+..+.... .+......+.+++.+||+.+|++|||+.
T Consensus 241 Di~slG~il~ellt~g~~p~~~~~~------~~-~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ 307 (334)
T 2pvf_A 241 DVWSFGVLMWEIFTLGGSPYPGIPV------EE-LFKLLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQRPTFK 307 (334)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCH------HH-HHHHHHHTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHHHHhCCCCCcCcCCH------HH-HHHHHhcCCCCC------CCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999999999999 9998865322 11 222233332111 1122345788999999999999999999
Q ss_pred HHHHHhhcCcCC
Q 038168 733 KVLLMLEGTVEI 744 (757)
Q Consensus 733 eVl~~Le~~~~~ 744 (757)
||++.|+.+...
T Consensus 308 ell~~L~~l~~~ 319 (334)
T 2pvf_A 308 QLVEDLDRILTL 319 (334)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHhc
Confidence 999999986644
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=326.83 Aligned_cols=212 Identities=24% Similarity=0.357 Sum_probs=173.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.++|.+|++++++++|+|||++++++.. +..++||||+++|+|.+++.. ...+++.++..|+.||+.||+|||++
T Consensus 414 ~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~--- 488 (635)
T 4fl3_A 414 KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEES--- 488 (635)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 4789999999999999999999999964 557899999999999999964 45689999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc--ceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT--RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+|+||||||+||||+.++.+||+|||+++.+..... .......+|..|+|||++.+..++.++||||||++++||++
T Consensus 489 ~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~ 568 (635)
T 4fl3_A 489 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 568 (635)
T ss_dssp TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999999998765432 22233456889999999999999999999999999999998
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
|+.||...... .+...+..+.... .+.....++.+++..||+.||++||++.+|+++|+.
T Consensus 569 G~~Pf~~~~~~-------~~~~~i~~~~~~~------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 569 GQKPYRGMKGS-------EVTAMLEKGERMG------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp TCCSSTTCCHH-------HHHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCCCCHH-------HHHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 99998754321 1233333333221 122334678999999999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=301.31 Aligned_cols=212 Identities=23% Similarity=0.350 Sum_probs=159.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.. ...+++.++..++.|+++||+|||+.
T Consensus 92 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~--- 167 (349)
T 2w4o_A 92 KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHEN--- 167 (349)
T ss_dssp -------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46788999999999999999999999999999999999999999999965 45689999999999999999999998
Q ss_pred CeeeCCCCcceEEECC---CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 591 QIIHCDIKPQNILMDE---NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~---~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+|||++. ++.+||+|||+++...... ......||+.|+|||.+.+..++.++||||||++++||++
T Consensus 168 ~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 245 (349)
T 2w4o_A 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC 245 (349)
T ss_dssp TCCCCCCCGGGEEESSSSTTCCEEECCCC------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHh
Confidence 9999999999999975 8899999999998764432 2234578999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|+.||....... .....+..+..... .....+....+.+++.+||+.||++|||+.|+++.
T Consensus 246 g~~pf~~~~~~~------~~~~~i~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 246 GFEPFYDERGDQ------FMFRRILNCEYYFI---SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp SSCTTCCTTCHH------HHHHHHHTTCCCCC---TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCCCCCcccH------HHHHHHHhCCCccC---CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999987543221 11222222222111 11112334678899999999999999999999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=290.07 Aligned_cols=220 Identities=20% Similarity=0.226 Sum_probs=170.8
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++ +|.+++......+++.++..++.|++.||+|||++
T Consensus 44 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~-- 120 (292)
T 3o0g_A 44 VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR-- 120 (292)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred cchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 347789999999999999999999999999999999999986 66666655567799999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCC-CCccccchhhHHHHHHHHhC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP-ITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+|||++.++.+||+|||+++....... ......||..|+|||.+.+.. ++.++||||||++++||++|
T Consensus 121 -~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~ 198 (292)
T 3o0g_A 121 -NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198 (292)
T ss_dssp -TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTT
T ss_pred -CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHc
Confidence 999999999999999999999999999987653322 223457899999999998766 79999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCC---ccccc---cc------------cccCHHHHHHHHHHHHHccccCCCCCCC
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGN---LSQLV---ED------------EEVDEKQLERMIKVALWCILDEPSLRPS 730 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~---d~------------~~~~~~~~~~l~~l~~~cl~~~p~~RPs 730 (757)
+.|+....... .....+.+...... ..... +. ..........+.+++.+||+.||++|||
T Consensus 199 ~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 276 (292)
T 3o0g_A 199 GRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276 (292)
T ss_dssp SCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCC
Confidence 98865432211 11111111111100 00000 00 0011234567889999999999999999
Q ss_pred HHHHHH
Q 038168 731 MKKVLL 736 (757)
Q Consensus 731 m~eVl~ 736 (757)
++|+++
T Consensus 277 ~~e~l~ 282 (292)
T 3o0g_A 277 AEEALQ 282 (292)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999987
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=294.40 Aligned_cols=204 Identities=24% Similarity=0.309 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.+ ...+++..+..++.||+.||+|||++
T Consensus 50 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--- 125 (318)
T 1fot_A 50 VEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSK--- 125 (318)
T ss_dssp HHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 45678899999999999999999999999999999999999999999965 35688999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||++++||++|+.
T Consensus 126 ~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 201 (318)
T 1fot_A 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201 (318)
T ss_dssp TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred CccccCCChheEEEcCCCCEEEeecCcceecCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCC
Confidence 9999999999999999999999999999875432 234678999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~ 736 (757)
||..... .+.... ...+... .+.....++.+++.+||+.||++|| +++||++
T Consensus 202 pf~~~~~------~~~~~~-i~~~~~~-------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 202 PFYDSNT------MKTYEK-ILNAELR-------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp TTCCSSH------HHHHHH-HHHCCCC-------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCH------HHHHHH-HHhCCCC-------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 9975321 111122 2222221 1122345688999999999999999 8899885
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-33 Score=289.97 Aligned_cols=214 Identities=22% Similarity=0.340 Sum_probs=174.2
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEe----------------ceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHH
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLE----------------VSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIA 574 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~----------------~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~ 574 (757)
+.+.+|++++++++||||+++++++.. ....++||||+++++|.+++... ...+++..+..++
T Consensus 49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~ 128 (284)
T 2a19_B 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128 (284)
T ss_dssp GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHH
Confidence 467899999999999999999998864 45579999999999999999653 3578999999999
Q ss_pred HHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCcccc
Q 038168 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKAD 654 (757)
Q Consensus 575 ~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~D 654 (757)
.|++.||+|||+. +|+|+||||+|||++.++.+||+|||+++....... .....|+..|+|||.+.+..++.++|
T Consensus 129 ~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~D 203 (284)
T 2a19_B 129 EQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVD 203 (284)
T ss_dssp HHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHH
T ss_pred HHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhh
Confidence 9999999999998 999999999999999999999999999987755432 23356899999999999999999999
Q ss_pred chhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 038168 655 VYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKV 734 (757)
Q Consensus 655 v~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eV 734 (757)
|||||++++||++|..|+... .........+.+.. .....+.+++.+||+.||++|||+.|+
T Consensus 204 i~slG~il~~l~~~~~~~~~~---------~~~~~~~~~~~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~e~ 265 (284)
T 2a19_B 204 LYALGLILAELLHVCDTAFET---------SKFFTDLRDGIISD---------IFDKKEKTLLQKLLSKKPEDRPNTSEI 265 (284)
T ss_dssp HHHHHHHHHHHHSCCSSHHHH---------HHHHHHHHTTCCCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hHHHHHHHHHHHhcCCcchhH---------HHHHHHhhcccccc---------cCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999999999999998775311 11122233332221 123457899999999999999999999
Q ss_pred HHHhhcCcCCCCCC
Q 038168 735 LLMLEGTVEIPIPP 748 (757)
Q Consensus 735 l~~Le~~~~~~~p~ 748 (757)
++.|+....-+..+
T Consensus 266 l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 266 LRTLTVWKKSPEKN 279 (284)
T ss_dssp HHHHHHHTC-----
T ss_pred HHHHHHHhhCCCcc
Confidence 99999876555443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=300.62 Aligned_cols=224 Identities=25% Similarity=0.335 Sum_probs=179.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEE--eceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSL--EVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.+.+.+|++++++++|+||+++++++. +.+..++||||+++++|.+++......+++.++..++.|++.||+|||+.
T Consensus 68 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~- 146 (327)
T 3lxl_A 68 QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR- 146 (327)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 466899999999999999999999887 45678999999999999999976556789999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc--eecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR--TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+|+||||||+|||++.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||++++||+
T Consensus 147 --~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll 224 (327)
T 3lxl_A 147 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224 (327)
T ss_dssp --TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred --CccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHH
Confidence 9999999999999999999999999999987654432 223356788899999999999999999999999999999
Q ss_pred hCCCCCCCCCCC--------ccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 038168 667 CRRRCLDPNLPD--------DQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 667 tG~~p~~~~~~~--------~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~L 738 (757)
+|+.|+.....+ ...............+... ..+......+.+++.+||+.||++|||+.||+++|
T Consensus 225 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 298 (327)
T 3lxl_A 225 TYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRL------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298 (327)
T ss_dssp TTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hCCCCCccccchhhhhcccccccccHHHHHHHhhcccCC------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 999987643211 0011111122222222211 11223456789999999999999999999999999
Q ss_pred hcCcC
Q 038168 739 EGTVE 743 (757)
Q Consensus 739 e~~~~ 743 (757)
+.+..
T Consensus 299 ~~~~~ 303 (327)
T 3lxl_A 299 DMLWS 303 (327)
T ss_dssp HHC--
T ss_pred HHHHh
Confidence 97653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-33 Score=298.58 Aligned_cols=228 Identities=23% Similarity=0.347 Sum_probs=169.1
Q ss_pred HHHHHHHHH--HhhcCCCceeeeeeEEEe-----ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 512 REFQTEMKV--IGRTHHRNLVRLLGYSLE-----VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 512 ~~~~~E~~~--l~~l~h~niv~l~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
..+..|.++ +..++|+||+++++.+.. ....++||||+++|+|.+++.. ...++..+..++.|+++||+||
T Consensus 50 ~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~L 127 (336)
T 3g2f_A 50 QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYL 127 (336)
T ss_dssp HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHH
Confidence 445555554 456899999999986543 3367899999999999999954 3458999999999999999999
Q ss_pred hhCC------CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-------ceecccccCccccCcccccC-----
Q 038168 585 HDEC------ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-------RTFTGIRGTRGYVAPEWHRN----- 646 (757)
Q Consensus 585 H~~~------~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~----- 646 (757)
|+.+ .++|+||||||+|||++.++.+||+|||+++.+..... .......||..|+|||.+.+
T Consensus 128 H~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 207 (336)
T 3g2f_A 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR 207 (336)
T ss_dssp HCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGG
T ss_pred HhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccc
Confidence 9863 33899999999999999999999999999987654321 22234579999999999887
Q ss_pred --CCCCccccchhhHHHHHHHHhCCCCCCCCCCCccc------------cHHHHHHHHHhcC-CccccccccccCHHHHH
Q 038168 647 --LPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQV------------ILEEWVYQCFENG-NLSQLVEDEEVDEKQLE 711 (757)
Q Consensus 647 --~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~------------~l~~~~~~~~~~~-~~~~~~d~~~~~~~~~~ 711 (757)
..++.++||||||++++||++|+.|+......... .... ........ ....+-+..........
T Consensus 208 ~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
T 3g2f_A 208 DXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFED-MQVLVSREKQRPKFPEAWKENSLAVR 286 (336)
T ss_dssp GHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHH-HHHHHTTSCCCCCCCTTCCCCSHHHH
T ss_pred cccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHH-HHhhhcccccCCCCCcccccccchHH
Confidence 45678999999999999999998877544332110 1111 11111111 11111111122345667
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 712 RMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 712 ~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
.+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 287 ~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 287 SLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 8999999999999999999999999999855
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=294.09 Aligned_cols=216 Identities=25% Similarity=0.383 Sum_probs=167.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEecee-----eeEEEEeccCCChhhhhc-----CCCCCCCHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSK-----KILVYEYMSNGSLADILF-----NPEKQPNWVERMGIARDIARG 580 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~lV~e~~~~gsL~~~l~-----~~~~~l~~~~~~~i~~~ia~g 580 (757)
.+.+.+|+.++++++||||+++++++.+.+. .++||||+++++|.+++. .....+++.++..++.|+++|
T Consensus 80 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~a 159 (313)
T 3brb_A 80 IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159 (313)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHH
Confidence 4678999999999999999999999987653 499999999999999984 234568999999999999999
Q ss_pred HHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccchhhH
Q 038168 581 ILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFG 659 (757)
Q Consensus 581 L~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G 659 (757)
|.|||+. +|+||||||+|||++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||
T Consensus 160 L~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 236 (313)
T 3brb_A 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 236 (313)
T ss_dssp HHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHH
T ss_pred HHHHHhC---CcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHH
Confidence 9999998 999999999999999999999999999987654332 222334578899999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 038168 660 VVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 660 ~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~L 738 (757)
++++||++ |+.|+....... . ......+.... .+......+.+++.+||+.||++|||+.++++.|
T Consensus 237 ~il~el~~~g~~p~~~~~~~~---~----~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 303 (313)
T 3brb_A 237 VTMWEIATRGMTPYPGVQNHE---M----YDYLLHGHRLK------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQL 303 (313)
T ss_dssp HHHHHHHTTSCCSSTTCCGGG---H----HHHHHTTCCCC------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHhcCCCCCccCCHHH---H----HHHHHcCCCCC------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999 888876543321 1 11222222111 1122346789999999999999999999999999
Q ss_pred hcCc
Q 038168 739 EGTV 742 (757)
Q Consensus 739 e~~~ 742 (757)
+.+.
T Consensus 304 ~~l~ 307 (313)
T 3brb_A 304 EKLL 307 (313)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=298.78 Aligned_cols=219 Identities=22% Similarity=0.329 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-----EKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.+.+.+|++++++++||||+++++++.+.+..++||||++ |+|.+++... ...+++..+..++.||++||+|||
T Consensus 47 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH 125 (317)
T 2pmi_A 47 PSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125 (317)
T ss_dssp CHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 4678999999999999999999999999999999999998 5999988532 245889999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLE 664 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~e 664 (757)
+. +|+||||||+|||++.++.+||+|||+++....... ......||..|+|||.+.+. .++.++||||||++++|
T Consensus 126 ~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 201 (317)
T 2pmi_A 126 EN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAE 201 (317)
T ss_dssp HT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred HC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHH
Confidence 98 999999999999999999999999999987653322 22345689999999998764 68999999999999999
Q ss_pred HHhCCCCCCCCCCCccccHHHHHHHHHhcCC---c------ccc---cc---c--------cccCHHHHHHHHHHHHHcc
Q 038168 665 IICRRRCLDPNLPDDQVILEEWVYQCFENGN---L------SQL---VE---D--------EEVDEKQLERMIKVALWCI 721 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~------~~~---~d---~--------~~~~~~~~~~l~~l~~~cl 721 (757)
|++|+.||......+. ...+........ . ... +. + ..........+.+++.+||
T Consensus 202 l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 278 (317)
T 2pmi_A 202 MITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLL 278 (317)
T ss_dssp HHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHS
T ss_pred HHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHC
Confidence 9999999975432211 111111111000 0 000 00 0 0001122357899999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 038168 722 LDEPSLRPSMKKVLLM 737 (757)
Q Consensus 722 ~~~p~~RPsm~eVl~~ 737 (757)
+.||++|||+.|+++.
T Consensus 279 ~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 279 QLNPDMRLSAKQALHH 294 (317)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred CCCcccCCCHHHHhCC
Confidence 9999999999999863
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=300.71 Aligned_cols=205 Identities=23% Similarity=0.335 Sum_probs=169.8
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|+.++++++||||+++++++...+..++||||+ +|+|.+++.. ...+++.++..++.|++.||+|||+. +
T Consensus 54 ~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---g 128 (336)
T 3h4j_B 54 MRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRH---K 128 (336)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 57889999999999999999999999999999999999 7899988854 35689999999999999999999999 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCC-CccccchhhHHHHHHHHhCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~G~~l~elltG~~ 670 (757)
|+||||||+|||+++++.+||+|||++........ .....||+.|+|||.+.+..+ ++++||||||++++||++|+.
T Consensus 129 ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 206 (336)
T 3h4j_B 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRL 206 (336)
T ss_dssp CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSC
T ss_pred eEecCCchhhEEEcCCCCEEEEEeccceeccCCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCC
Confidence 99999999999999999999999999987654332 234578999999999988776 789999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
||.......... ....+. ...+......+.+++.+||+.||++|||++|+++.
T Consensus 207 Pf~~~~~~~~~~-------~i~~~~-------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 207 PFDDEFIPNLFK-------KVNSCV-------YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp SSBCSSSTTCBC-------CCCSSC-------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCCccHHHHHH-------HHHcCC-------CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 997543322100 000000 01122234568899999999999999999999873
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=303.87 Aligned_cols=215 Identities=22% Similarity=0.253 Sum_probs=166.3
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEe----ceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhh
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLE----VSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
..+.+|+.++.++ +|+||+++++++.. ....+|||||+++|+|.+++.... ..+++.++..|+.||+.||+|||
T Consensus 99 ~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH 178 (400)
T 1nxk_A 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178 (400)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 5788999988555 89999999999875 667899999999999999997654 46899999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECC---CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDE---NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~---~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l 662 (757)
+. +|+||||||+|||++. ++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++
T Consensus 179 ~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 253 (400)
T 1nxk_A 179 SI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253 (400)
T ss_dssp HT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHH
T ss_pred HC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHH
Confidence 98 9999999999999998 7899999999998765332 22346789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|||++|+.||........... ....+..+..... .........++.+++.+||+.||++|||+.||++.
T Consensus 254 ~ell~g~~pf~~~~~~~~~~~---~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 254 YILLCGYPPFYSNHGLAISPG---MKTRIRMGQYEFP---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HHHHHSSCSCCCCTTCSSCCS---HHHHHHHTCCCCC---TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHhCCCCCCCCccccccHH---HHHHHHcCcccCC---CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 999999999976543321100 1122223322211 01112234678899999999999999999999984
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=9.6e-33 Score=299.07 Aligned_cols=203 Identities=20% Similarity=0.237 Sum_probs=172.1
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.+. ..++..++..++.||+.||+|||++ +
T Consensus 86 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ 161 (350)
T 1rdq_E 86 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSL---D 161 (350)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 57889999999999999999999999999999999999999999999653 4688999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRC 671 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p 671 (757)
|+||||||+|||++.++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||++++||++|+.|
T Consensus 162 ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 237 (350)
T 1rdq_E 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237 (350)
T ss_dssp EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccCccceEEECCCCCEEEcccccceeccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCC
Confidence 999999999999999999999999999876433 2345789999999999999999999999999999999999999
Q ss_pred CCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 038168 672 LDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS-----MKKVLL 736 (757)
Q Consensus 672 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----m~eVl~ 736 (757)
|..... .+ ....+..+... .+......+.+++.+||+.||++||+ ++||++
T Consensus 238 f~~~~~------~~-~~~~i~~~~~~-------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 238 FFADQP------IQ-IYEKIVSGKVR-------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SCCSSH------HH-HHHHHHHCCCC-------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCH------HH-HHHHHHcCCCC-------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 975321 11 22223333322 11223456889999999999999998 888875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.4e-33 Score=302.88 Aligned_cols=206 Identities=22% Similarity=0.341 Sum_probs=167.2
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+.+.+|..+++++ +||||+++++++.+.+..++||||+++|+|.+++.+ ...+++.++..++.||+.||+|||++
T Consensus 68 ~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--- 143 (353)
T 3txo_A 68 ECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDK--- 143 (353)
T ss_dssp HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 5678899999998 799999999999999999999999999999999965 35688999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.
T Consensus 144 givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 222 (353)
T 3txo_A 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222 (353)
T ss_dssp TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCcccCCCHHHEEECCCCCEEEccccceeecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCC
Confidence 99999999999999999999999999998643322 22344679999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM------KKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm------~eVl~ 736 (757)
||...... + ....+..+... ++......+.+++.+||+.||++||++ .||++
T Consensus 223 Pf~~~~~~------~-~~~~i~~~~~~-------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 223 PFEAENED------D-LFEAILNDEVV-------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp SSCCSSHH------H-HHHHHHHCCCC-------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCCHH------H-HHHHHHcCCCC-------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 99754221 1 12222223221 112234568899999999999999998 66765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=297.13 Aligned_cols=214 Identities=23% Similarity=0.294 Sum_probs=171.9
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|+.+++++ +||||+++++++.+.+..++||||+++|+|.+++.+ ...+++..+..++.||+.||+|||++
T Consensus 53 ~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~-- 129 (345)
T 3a8x_A 53 IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHER-- 129 (345)
T ss_dssp HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 35688999999988 899999999999999999999999999999999864 34688999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||+++||++|+
T Consensus 130 -~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 207 (345)
T 3a8x_A 130 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207 (345)
T ss_dssp -TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -CceecCCCHHHEEECCCCCEEEEeccccccccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999998643322 2234467999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcc--ccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 038168 670 RCLDPNLPDDQ--VILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM------KKVLL 736 (757)
Q Consensus 670 ~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm------~eVl~ 736 (757)
.||........ ........+....+... .+......+.+++.+||+.||++||++ .|+++
T Consensus 208 ~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 208 SPFDIVGSSDNPDQNTEDYLFQVILEKQIR-------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp CTTTTTTC-------CHHHHHHHHHHCCCC-------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred CCcCCcccccccccccHHHHHHHHHcCCCC-------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 99975322110 01112222333333221 112234568899999999999999995 56654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-33 Score=301.44 Aligned_cols=205 Identities=28% Similarity=0.380 Sum_probs=169.9
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+++.+|++++++++||||+++++++.+.+..++||||++ |+|.+++......+++.++..++.|+++||+|||+. +
T Consensus 99 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 174 (348)
T 1u5q_A 99 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---N 174 (348)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 578999999999999999999999999999999999997 688888865567789999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc---CCCCCccccchhhHHHHHHHHhC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR---NLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~G~~l~elltG 668 (757)
|+||||||+|||++.++.+||+|||+++..... ....||+.|+|||.+. ...++.++||||||++++||++|
T Consensus 175 ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g 249 (348)
T 1u5q_A 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249 (348)
T ss_dssp CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999999876432 2356899999999984 56789999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+.|+..... ........... ..... .......+.+++.+||+.||++|||++++++.
T Consensus 250 ~~p~~~~~~------~~~~~~~~~~~-~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 250 KPPLFNMNA------MSALYHIAQNE-SPALQ-----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp SCTTTTSCH------HHHHHHHHHSC-CCCCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCCh------HHHHHHHHhcC-CCCCC-----CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 999864321 11122222221 11111 11234568899999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-32 Score=288.82 Aligned_cols=208 Identities=22% Similarity=0.313 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe--ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE--VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.+.+.+|++++++++||||+++++++.+ .+..++||||+++++|.+++. ...+++.++..++.|+++||+|||+.
T Consensus 80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~- 156 (298)
T 2zv2_A 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQ- 156 (298)
T ss_dssp -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4578999999999999999999999986 568899999999999998763 35789999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCC---CCccccchhhHHHHHHH
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP---ITVKADVYSFGVVLLEI 665 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. .+.++||||||++++||
T Consensus 157 --~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l 233 (298)
T 2zv2_A 157 --KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233 (298)
T ss_dssp --TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred --CeeccCCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence 999999999999999999999999999987654332 233467899999999998765 47889999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
++|+.||..... .. .......+..... +. ......+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~g~~pf~~~~~------~~-~~~~~~~~~~~~~-~~----~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 234 VFGQCPFMDERI------MC-LHSKIKSQALEFP-DQ----PDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHSSCSSCCSSH------HH-HHHHHHHCCCCCC-SS----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHCCCCCCCccH------HH-HHHHHhcccCCCC-Cc----cccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 999999864321 11 1222222222111 11 123356889999999999999999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=299.72 Aligned_cols=214 Identities=23% Similarity=0.271 Sum_probs=162.8
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+.
T Consensus 59 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~-- 135 (361)
T 3uc3_A 59 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSM-- 135 (361)
T ss_dssp SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 457789999999999999999999999999999999999999999999864 34689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCc--EEEeecCCccccCCCCcceecccccCccccCcccccCCCCCcc-ccchhhHHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENRC--AKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVK-ADVYSFGVVLLEII 666 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~--~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-~Dv~S~G~~l~ell 666 (757)
+|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||.+.+..+..+ +||||||++++||+
T Consensus 136 -~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 212 (361)
T 3uc3_A 136 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVML 212 (361)
T ss_dssp -TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHH
T ss_pred -CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHH
Confidence 9999999999999987765 9999999998543222 2233568999999999988887655 89999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+|+.||........ ......... ....... +. ......+.+++.+||+.||++|||+.|+++.
T Consensus 213 ~g~~Pf~~~~~~~~--~~~~~~~~~-~~~~~~~-~~----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 213 VGAYPFEDPEEPRD--YRKTIQRIL-SVKYSIP-DD----IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HSSCSCC----CCC--HHHHHHHHH-TTCCCCC-TT----SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hCCCCCCCCccHHH--HHHHHHHHh-cCCCCCC-Cc----CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 99999976543322 222222221 1111111 11 1123568899999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.2e-33 Score=298.44 Aligned_cols=214 Identities=29% Similarity=0.396 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------------CCCCHHHHHHHH
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------------KQPNWVERMGIA 574 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~ 574 (757)
.+.+.+|+++++++ +||||+++++++.+.+..++||||+++++|.+++.... ..+++.++..++
T Consensus 69 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 148 (327)
T 1fvr_A 69 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148 (327)
T ss_dssp -CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHH
Confidence 45789999999999 99999999999999999999999999999999997643 468999999999
Q ss_pred HHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCcccc
Q 038168 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKAD 654 (757)
Q Consensus 575 ~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~D 654 (757)
.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ......++..|+|||.+.+..++.++|
T Consensus 149 ~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~D 223 (327)
T 1fvr_A 149 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSD 223 (327)
T ss_dssp HHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHH
T ss_pred HHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhc
Confidence 9999999999998 99999999999999999999999999997433211 122245688999999999888999999
Q ss_pred chhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 038168 655 VYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKK 733 (757)
Q Consensus 655 v~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~e 733 (757)
|||||++++||++ |+.||...... + ....+..+.... .+......+.+++.+||+.+|++|||+.|
T Consensus 224 i~slG~il~ellt~g~~pf~~~~~~------~-~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~e 290 (327)
T 1fvr_A 224 VWSYGVLLWEIVSLGGTPYCGMTCA------E-LYEKLPQGYRLE------KPLNCDDEVYDLMRQCWREKPYERPSFAQ 290 (327)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHGGGTCCCC------CCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred chHHHHHHHHHHcCCCCCCCCCcHH------H-HHHHhhcCCCCC------CCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999998 99998654321 1 222233321111 11223467889999999999999999999
Q ss_pred HHHHhhcCc
Q 038168 734 VLLMLEGTV 742 (757)
Q Consensus 734 Vl~~Le~~~ 742 (757)
+++.|+.+.
T Consensus 291 ll~~L~~~~ 299 (327)
T 1fvr_A 291 ILVSLNRML 299 (327)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998744
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.9e-33 Score=297.33 Aligned_cols=217 Identities=24% Similarity=0.369 Sum_probs=167.9
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceee------eEEEEeccCCChhhhhcCC-----CCCCCHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK------ILVYEYMSNGSLADILFNP-----EKQPNWVERMGIARDIA 578 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~------~lV~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia 578 (757)
..+.+.+|++++++++||||+++++++...+.. ++||||+++|+|.+++... ...+++.++..++.|++
T Consensus 68 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~ 147 (323)
T 3qup_A 68 DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147 (323)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHH
Confidence 357799999999999999999999999877655 9999999999999998532 23589999999999999
Q ss_pred HHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccchh
Q 038168 579 RGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYS 657 (757)
Q Consensus 579 ~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S 657 (757)
+||+|||+. +|+||||||+|||++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||
T Consensus 148 ~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 224 (323)
T 3qup_A 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWA 224 (323)
T ss_dssp HHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhh
Confidence 999999998 999999999999999999999999999987654332 2223355688999999999999999999999
Q ss_pred hHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 658 FGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 658 ~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||++++||++ |+.||......+ . ......+.... .+......+.+++.+||+.||++|||+.++++
T Consensus 225 lG~il~ell~~g~~p~~~~~~~~---~----~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 291 (323)
T 3qup_A 225 FGVTMWEIMTRGQTPYAGIENAE---I----YNYLIGGNRLK------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291 (323)
T ss_dssp HHHHHHHHHTTSCCTTTTCCGGG---H----HHHHHTTCCCC------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCCCCCccccChHH---H----HHHHhcCCCCC------CCCccCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999 888887543322 1 11222222111 12233467899999999999999999999999
Q ss_pred HhhcCc
Q 038168 737 MLEGTV 742 (757)
Q Consensus 737 ~Le~~~ 742 (757)
.|+.+.
T Consensus 292 ~l~~~l 297 (323)
T 3qup_A 292 ELENIL 297 (323)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=294.38 Aligned_cols=212 Identities=24% Similarity=0.219 Sum_probs=165.3
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC------------------------------
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP------------------------------ 561 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~------------------------------ 561 (757)
+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.+++...
T Consensus 73 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (345)
T 3hko_A 73 ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152 (345)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHS
T ss_pred HHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccc
Confidence 67889999999999999999999999999999999999999999998521
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCC--cEEEeecCCccccCCCC---cc
Q 038168 562 ---------EKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR--CAKISDFGLAKLMKPDQ---TR 627 (757)
Q Consensus 562 ---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~--~~ki~DfGla~~~~~~~---~~ 627 (757)
...+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.+.... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 229 (345)
T 3hko_A 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY 229 (345)
T ss_dssp CC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---
T ss_pred ccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccc
Confidence 11124667788999999999999998 999999999999998776 89999999998764322 12
Q ss_pred eecccccCccccCcccccC--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCcccccccccc
Q 038168 628 TFTGIRGTRGYVAPEWHRN--LPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEV 705 (757)
Q Consensus 628 ~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 705 (757)
......||+.|+|||.+.+ ..++.++||||||++++||++|+.||...... +.............. ..
T Consensus 230 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~~----~~ 299 (345)
T 3hko_A 230 GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCFEN----PN 299 (345)
T ss_dssp -----CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCTTS----GG
T ss_pred cccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccccCC----cc
Confidence 2345678999999999875 67899999999999999999999998754321 112222222211111 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 706 DEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 706 ~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
.......+.+++.+||+.||++||++.|+++
T Consensus 300 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 300 YNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1123456889999999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-33 Score=297.22 Aligned_cols=217 Identities=24% Similarity=0.376 Sum_probs=178.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------CCCCHHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------KQPNWVERMGIARDIARGI 581 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL 581 (757)
...+.+|+.++++++|+||+++++++.+.+..++||||+++|+|.+++.... ..+++..+++++.|++.||
T Consensus 72 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 151 (322)
T 1p4o_A 72 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151 (322)
T ss_dssp HHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHH
Confidence 4568899999999999999999999999999999999999999999986421 4568999999999999999
Q ss_pred HHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccccchhhHH
Q 038168 582 LYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGV 660 (757)
Q Consensus 582 ~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~ 660 (757)
+|||++ +|+||||||+|||++.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+
T Consensus 152 ~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 228 (322)
T 1p4o_A 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 228 (322)
T ss_dssp HHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHHC---CCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHH
Confidence 999998 9999999999999999999999999999866443322 122345688999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 661 VLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 661 ~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
+++||++ |+.|+..... .+ .......+..... +......+.+++.+||+.||++|||+.|+++.|+
T Consensus 229 il~el~~~g~~p~~~~~~------~~-~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~ 295 (322)
T 1p4o_A 229 VLWEIATLAEQPYQGLSN------EQ-VLRFVMEGGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295 (322)
T ss_dssp HHHHHHHTSCCTTTTSCH------HH-HHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred HHHHHHhcCCCccccCCH------HH-HHHHHHcCCcCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 9999999 7888764321 11 2222333322211 1233466889999999999999999999999998
Q ss_pred cCcC
Q 038168 740 GTVE 743 (757)
Q Consensus 740 ~~~~ 743 (757)
...+
T Consensus 296 ~~~~ 299 (322)
T 1p4o_A 296 EEME 299 (322)
T ss_dssp GGSC
T ss_pred Hhhc
Confidence 7643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.8e-33 Score=294.19 Aligned_cols=221 Identities=19% Similarity=0.321 Sum_probs=170.9
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN---PEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
..+.+.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++.. ....+++..+..++.|+++||+|||+
T Consensus 75 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 154 (310)
T 2wqm_A 75 ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154 (310)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh
Confidence 456789999999999999999999999999999999999999999999854 34668999999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
. +++|+||||+||+++.++.+||+|||+++....... ......|+..|+|||.+.+..++.++||||||++++||+
T Consensus 155 ~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~ 230 (310)
T 2wqm_A 155 R---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 230 (310)
T ss_dssp T---TCCCCCCCGGGEEECTTSCEEECCC-------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred C---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHH
Confidence 8 999999999999999999999999999987654322 223356899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcCC
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEI 744 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~~ 744 (757)
+|+.||...... ... .......+...... ......++.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 231 ~g~~p~~~~~~~----~~~-~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 231 ALQSPFYGDKMN----LYS-LCKKIEQCDYPPLP-----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp HSSCTTC---CC----HHH-HHHHHHTTCSCCCC-----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hCCCCCcccchh----HHH-HHHHhhcccCCCCc-----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 999998753322 111 12223333322211 122345788999999999999999999999999986543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.9e-33 Score=295.46 Aligned_cols=220 Identities=22% Similarity=0.299 Sum_probs=173.6
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEe----ceeeeEEEEeccCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLE----VSKKILVYEYMSNGSLADILFN---PEKQPNWVERMGIARDIARGIL 582 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~ 582 (757)
..+.+.+|++++++++||||+++++++.. ....++||||+++|+|.+++.. ....+++.++..++.|+++||+
T Consensus 69 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~ 148 (317)
T 2buj_A 69 DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148 (317)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 45778999999999999999999999873 4578999999999999999864 3567899999999999999999
Q ss_pred HhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc--------eecccccCccccCcccccCCC---CCc
Q 038168 583 YLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR--------TFTGIRGTRGYVAPEWHRNLP---ITV 651 (757)
Q Consensus 583 yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~ 651 (757)
|||+. +|+||||||+|||++.++.+||+|||+++........ ......||..|+|||.+.+.. ++.
T Consensus 149 ~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 225 (317)
T 2buj_A 149 AIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDE 225 (317)
T ss_dssp HHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECT
T ss_pred HHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCc
Confidence 99998 9999999999999999999999999998865422110 112345799999999987654 689
Q ss_pred cccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 652 KADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 652 k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
++||||||++++||++|+.||......... .. ..... ... .. ........+.+++.+||+.||++|||+
T Consensus 226 ~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~----~~~~~-~~~-~~----~~~~~~~~l~~li~~~l~~dp~~Rps~ 294 (317)
T 2buj_A 226 RTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VA----LAVQN-QLS-IP----QSPRHSSALWQLLNSMMTVDPHQRPHI 294 (317)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HH----HHHHC-C---CC----CCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hhhHHHHHHHHHHHHhCCCChhhhhcccch-hh----HHhhc-cCC-CC----ccccCCHHHHHHHHHHhhcChhhCCCH
Confidence 999999999999999999998532111111 11 11111 110 00 112234578999999999999999999
Q ss_pred HHHHHHhhcCcC
Q 038168 732 KKVLLMLEGTVE 743 (757)
Q Consensus 732 ~eVl~~Le~~~~ 743 (757)
.||++.|+.+..
T Consensus 295 ~~ll~~L~~~~~ 306 (317)
T 2buj_A 295 PLLLSQLEALQP 306 (317)
T ss_dssp HHHHHHHHHTCC
T ss_pred HHHHHHhhhcCC
Confidence 999999997653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-32 Score=304.66 Aligned_cols=206 Identities=23% Similarity=0.386 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++||||+++++++...+..++||||+++|+|.+++.+ ...+++.++..++.||+.||+|||+.
T Consensus 60 ~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~--- 135 (476)
T 2y94_A 60 VGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRH--- 135 (476)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 35788999999999999999999999999999999999999999999965 45689999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCC-CccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++....... .....||+.|+|||.+.+..+ +.++||||||++++||++|+
T Consensus 136 givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~ 213 (476)
T 2y94_A 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213 (476)
T ss_dssp TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSS
T ss_pred CCCcccccHHHEEEecCCCeEEEeccchhhcccccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCC
Confidence 999999999999999999999999999998754332 234578999999999988765 78999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
.||...... . ....+..+.... + ......+.+++.+||+.||++|||+.||++
T Consensus 214 ~Pf~~~~~~------~-~~~~i~~~~~~~---p----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 214 LPFDDDHVP------T-LFKKICDGIFYT---P----QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CSSCCSSSH------H-HHHHHHTTCCCC---C----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCHH------H-HHHHHhcCCcCC---C----ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 999753221 1 122233332211 1 122356889999999999999999999997
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=287.77 Aligned_cols=210 Identities=25% Similarity=0.369 Sum_probs=165.6
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP---EKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
..+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.+++... ...+++..+..++.|+++||+|||+
T Consensus 63 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 142 (285)
T 3is5_A 63 PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142 (285)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4578999999999999999999999999999999999999999999988542 3678999999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEE---CCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHH
Q 038168 587 ECETQIIHCDIKPQNILM---DENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill---~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ 663 (757)
. +|+||||||+|||+ +.++.+||+|||+++....... .....||..|+|||.+. ..++.++||||||++++
T Consensus 143 ~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~ 216 (285)
T 3is5_A 143 Q---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMY 216 (285)
T ss_dssp T---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHH
T ss_pred C---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHH
Confidence 8 99999999999999 4567899999999987654322 23456899999999876 56899999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||++|+.||...... + .................. ....+.+++.+||+.||++|||+.||++
T Consensus 217 ~ll~g~~pf~~~~~~------~-~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 217 FLLTGCLPFTGTSLE------E-VQQKATYKEPNYAVECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHSSCSSCCSSHH------H-HHHHHHHCCCCCCC--CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHhCCCCCCCCCHH------H-HHhhhccCCcccccccCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999998754221 1 111111111111111111 2356789999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.9e-33 Score=297.92 Aligned_cols=224 Identities=23% Similarity=0.370 Sum_probs=178.4
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEece--eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVS--KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..+.+.+|++++++++|+||+++++++...+ ..++||||+++++|.+++......+++.++..++.|+++||+|||+.
T Consensus 85 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 164 (326)
T 2w1i_A 85 HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164 (326)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4568999999999999999999999987654 67999999999999999987667799999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce--ecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT--FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||
T Consensus 165 ---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 241 (326)
T 2w1i_A 165 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 241 (326)
T ss_dssp ---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred ---CEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999999999999876544322 2234567789999999998999999999999999999
Q ss_pred HhCCCCCCCCCC---------CccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 666 ICRRRCLDPNLP---------DDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 666 ltG~~p~~~~~~---------~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
++|+.|+..... .........+.+.+..+.... .+.....++.+++.+||+.||++|||+.||++
T Consensus 242 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 242 FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCC------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCC------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999988763210 000111111222222221111 12233467899999999999999999999999
Q ss_pred HhhcCc
Q 038168 737 MLEGTV 742 (757)
Q Consensus 737 ~Le~~~ 742 (757)
.|+.+.
T Consensus 316 ~L~~l~ 321 (326)
T 2w1i_A 316 RVDQIR 321 (326)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.98 E-value=8.2e-33 Score=291.38 Aligned_cols=218 Identities=23% Similarity=0.305 Sum_probs=168.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++||||+++++++.+.+..++||||+++ +|.+++......+++.++..++.|+++||+|||++
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--- 119 (288)
T 1ob3_A 44 PSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--- 119 (288)
T ss_dssp CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred chhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 36788999999999999999999999999999999999986 99999987667889999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++....... ......||..|+|||.+.+. .++.++||||||++++||++|+
T Consensus 120 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 198 (288)
T 1ob3_A 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198 (288)
T ss_dssp TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999987653322 22345689999999998764 5899999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCC---cccc-----ccc----------cccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGN---LSQL-----VED----------EEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~-----~d~----------~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
.||......+ .+ ..+.+...... .... .++ .........++.+++.+||+.||++|||+
T Consensus 199 ~pf~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 275 (288)
T 1ob3_A 199 PLFPGVSEAD--QL-MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275 (288)
T ss_dssp CSCCCSSHHH--HH-HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred CCCCCCCHHH--HH-HHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCH
Confidence 9987543211 11 11111111100 0000 000 00112234678899999999999999999
Q ss_pred HHHHH
Q 038168 732 KKVLL 736 (757)
Q Consensus 732 ~eVl~ 736 (757)
.|+++
T Consensus 276 ~e~l~ 280 (288)
T 1ob3_A 276 KQALE 280 (288)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.98 E-value=8.3e-33 Score=295.15 Aligned_cols=234 Identities=22% Similarity=0.300 Sum_probs=170.1
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..+.+.+|++++.++ +||||+++++++.+.+..++||||+++++|.+++.. ...+++.++..++.|++.||+|||+.
T Consensus 53 ~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~- 130 (316)
T 2ac3_A 53 IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNK- 130 (316)
T ss_dssp CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 457899999999995 799999999999999999999999999999999965 35688999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCc---EEEeecCCccccCCCCc------ceecccccCccccCcccccC-----CCCCcccc
Q 038168 589 ETQIIHCDIKPQNILMDENRC---AKISDFGLAKLMKPDQT------RTFTGIRGTRGYVAPEWHRN-----LPITVKAD 654 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~---~ki~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~k~D 654 (757)
+|+||||||+|||++.++. +||+|||+++....... .......||..|+|||.+.+ ..++.++|
T Consensus 131 --~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D 208 (316)
T 2ac3_A 131 --GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCD 208 (316)
T ss_dssp --TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHH
T ss_pred --CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccc
Confidence 9999999999999998765 99999999986643221 11223568999999999875 56889999
Q ss_pred chhhHHHHHHHHhCCCCCCCCCCCccc--------cHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCC
Q 038168 655 VYSFGVVLLEIICRRRCLDPNLPDDQV--------ILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPS 726 (757)
Q Consensus 655 v~S~G~~l~elltG~~p~~~~~~~~~~--------~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~ 726 (757)
|||||++++||++|+.||......+.. ............+...... .........+.+++.+||+.||+
T Consensus 209 iwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~ 285 (316)
T 2ac3_A 209 LWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPD---KDWAHISCAAKDLISKLLVRDAK 285 (316)
T ss_dssp HHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCH---HHHTTSCHHHHHHHHHHSCSSTT
T ss_pred cHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCc---hhcccCCHHHHHHHHHHhhCChh
Confidence 999999999999999999865433210 0011122333333322110 00011245789999999999999
Q ss_pred CCCCHHHHHHH--hhcCcCCCCCCCC
Q 038168 727 LRPSMKKVLLM--LEGTVEIPIPPNP 750 (757)
Q Consensus 727 ~RPsm~eVl~~--Le~~~~~~~p~~p 750 (757)
+|||+.|+++. +++.......|.|
T Consensus 286 ~Rps~~e~l~hp~~~~~~~~~~~~~~ 311 (316)
T 2ac3_A 286 QRLSAAQVLQHPWVQGCAPENTLPTP 311 (316)
T ss_dssp TSCCHHHHHHSTTCC-----------
T ss_pred hCCCHHHHhcChhhcCCCCcccCCCc
Confidence 99999999984 4443333333333
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-33 Score=301.18 Aligned_cols=225 Identities=23% Similarity=0.352 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++......+++.++..++.|++.||+|||++
T Consensus 73 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--- 149 (319)
T 2y4i_B 73 LKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK--- 149 (319)
T ss_dssp CCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 35678899999999999999999999999999999999999999999987667789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc----ceecccccCccccCcccccC---------CCCCccccchh
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT----RTFTGIRGTRGYVAPEWHRN---------LPITVKADVYS 657 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~---------~~~~~k~Dv~S 657 (757)
+|+||||||+|||++ ++.+||+|||+++....... .......|+..|+|||.+.+ ..++.++||||
T Consensus 150 ~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~s 228 (319)
T 2y4i_B 150 GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228 (319)
T ss_dssp TCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHH
T ss_pred CccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHH
Confidence 999999999999998 67999999999886542211 12223568999999999874 45789999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 658 FGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 658 ~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
||++++||++|+.||.....+ . .......+....... .....++.+++.+||+.||++|||+.+|+++
T Consensus 229 lG~il~el~~g~~p~~~~~~~------~-~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 229 LGTIWYELHAREWPFKTQPAE------A-IIWQMGTGMKPNLSQ-----IGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp HHHHHHHHHHSSCSSSSCCHH------H-HHHHHHTTCCCCCCC-----SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHH------H-HHHHhccCCCCCCCc-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999999998753321 1 112222232222111 1223468899999999999999999999999
Q ss_pred hhcCcCC-CCCCCCC
Q 038168 738 LEGTVEI-PIPPNPT 751 (757)
Q Consensus 738 Le~~~~~-~~p~~p~ 751 (757)
|+.+..- ...+.|.
T Consensus 297 l~~l~~~~~~~~~~~ 311 (319)
T 2y4i_B 297 LEKLPKRNRRLSHPG 311 (319)
T ss_dssp HTTC-----------
T ss_pred HHHHHHhhccCCCCc
Confidence 9986643 3334443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.2e-33 Score=310.46 Aligned_cols=206 Identities=22% Similarity=0.278 Sum_probs=164.1
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD-ECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~ 590 (757)
+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .
T Consensus 193 ~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--- 268 (446)
T 4ejn_A 193 AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEK--- 268 (446)
T ss_dssp --------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcC---
Confidence 5677899999999999999999999999999999999999999999864 3568999999999999999999998 7
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||++++||++|+.
T Consensus 269 giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 347 (446)
T 4ejn_A 269 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347 (446)
T ss_dssp CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCC
Confidence 99999999999999999999999999998644332 22344679999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~ 736 (757)
||...... . .......+... .+......+.+++.+||+.||++|| +++|+++
T Consensus 348 Pf~~~~~~------~-~~~~i~~~~~~-------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 348 PFYNQDHE------K-LFELILMEEIR-------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp SSCCSSHH------H-HHHHHHHCCCC-------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCHH------H-HHHHHHhCCCC-------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 99653221 1 11222222211 1122345688999999999999999 9999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=302.93 Aligned_cols=225 Identities=22% Similarity=0.317 Sum_probs=181.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEece--eeeEEEEeccCCChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVS--KKILVYEYMSNGSLADILFNPE--KQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
.+.+.+|++++++++||||+++++++.+.+ ..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+
T Consensus 51 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 130 (396)
T 4eut_A 51 VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130 (396)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999999999998765 6799999999999999997643 338999999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEE----CCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC--------CCCCcccc
Q 038168 587 ECETQIIHCDIKPQNILM----DENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN--------LPITVKAD 654 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill----~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~D 654 (757)
. +|+||||||+|||+ +.++.+||+|||+++....... .....||..|+|||.+.+ ..++.++|
T Consensus 131 ~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~D 205 (396)
T 4eut_A 131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVD 205 (396)
T ss_dssp T---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHH
T ss_pred C---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHH
Confidence 8 99999999999999 7788899999999987654332 234578999999998865 56788999
Q ss_pred chhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCcccc------------------ccccccCHHHHHHHHHH
Q 038168 655 VYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQL------------------VEDEEVDEKQLERMIKV 716 (757)
Q Consensus 655 v~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~------------------~d~~~~~~~~~~~l~~l 716 (757)
|||||+++|||++|+.||......... .+.+..... +..... -............+.++
T Consensus 206 iwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~l 282 (396)
T 4eut_A 206 LWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIIT-GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPV 282 (396)
T ss_dssp HHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHHH-SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHhc-CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHH
Confidence 999999999999999999764432211 122222222 211100 00112356778889999
Q ss_pred HHHccccCCCCCCCHHHHHHHhhcCcC
Q 038168 717 ALWCILDEPSLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 717 ~~~cl~~~p~~RPsm~eVl~~Le~~~~ 743 (757)
+.+||+.||++||++.|+++.|+.+.+
T Consensus 283 l~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 283 LANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HHHhhccChhhhccHHHHHHHHHHHhh
Confidence 999999999999999999999987654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-33 Score=299.67 Aligned_cols=205 Identities=22% Similarity=0.296 Sum_probs=170.1
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+.+..|..+++++ +||||+++++++.+.+..++||||+++|+|.+++.+ ...+++.++..++.||+.||+|||++
T Consensus 62 ~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--- 137 (345)
T 1xjd_A 62 ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSK--- 137 (345)
T ss_dssp HHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 5678899999887 999999999999999999999999999999999964 35688999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+..++.++||||||++++||++|+.
T Consensus 138 ~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 216 (345)
T 1xjd_A 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216 (345)
T ss_dssp TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCC
Confidence 999999999999999999999999999986533222 2345679999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK-KVL 735 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~-eVl 735 (757)
||...... + ..+.+..+... .+......+.+++.+||+.||++||++. ||+
T Consensus 217 Pf~~~~~~------~-~~~~i~~~~~~-------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 217 PFHGQDEE------E-LFHSIRMDNPF-------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp SSCCSSHH------H-HHHHHHHCCCC-------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCCCHH------H-HHHHHHhCCCC-------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 99753221 1 12222222211 1122345688999999999999999997 665
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=296.98 Aligned_cols=220 Identities=20% Similarity=0.291 Sum_probs=169.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe--------ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE--------VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGIL 582 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~ 582 (757)
...+.+|+.++++++|+||+++++++.. .+..++||||+++ +|.+.+......+++.++..++.|++.||+
T Consensus 60 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~ 138 (351)
T 3mi9_A 60 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 138 (351)
T ss_dssp CHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence 4678899999999999999999999987 3468999999985 788888776677999999999999999999
Q ss_pred HhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc---ceecccccCccccCcccccC-CCCCccccchhh
Q 038168 583 YLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT---RTFTGIRGTRGYVAPEWHRN-LPITVKADVYSF 658 (757)
Q Consensus 583 yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~ 658 (757)
|||+. +|+||||||+|||++.++.+||+|||+++.+..... .......||+.|+|||.+.+ ..++.++|||||
T Consensus 139 ~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 215 (351)
T 3mi9_A 139 YIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 215 (351)
T ss_dssp HHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHH
T ss_pred HHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHH
Confidence 99998 999999999999999999999999999987653322 22344678999999999876 458999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCC---cccc-----------ccccccC-HH------HHHHHHHHH
Q 038168 659 GVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGN---LSQL-----------VEDEEVD-EK------QLERMIKVA 717 (757)
Q Consensus 659 G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~-----------~d~~~~~-~~------~~~~l~~l~ 717 (757)
|++++||++|+.||......... ..+......-. .... ....... .+ ....+.+++
T Consensus 216 G~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (351)
T 3mi9_A 216 GCIMAEMWTRSPIMQGNTEQHQL---ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI 292 (351)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHH
Confidence 99999999999998764322211 11111111100 0000 0000000 01 134588999
Q ss_pred HHccccCCCCCCCHHHHHHH
Q 038168 718 LWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 718 ~~cl~~~p~~RPsm~eVl~~ 737 (757)
.+||+.||++|||++|+++.
T Consensus 293 ~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 293 DKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhcCChhhCCCHHHHhCC
Confidence 99999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=292.34 Aligned_cols=212 Identities=25% Similarity=0.375 Sum_probs=174.4
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+++.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.
T Consensus 58 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~-- 134 (321)
T 2a2a_A 58 SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTK-- 134 (321)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 467899999999999999999999999999999999999999999999965 45678999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCC----cEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENR----CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~----~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|||++.++ .+||+|||+++....... .....||+.|+|||.+.+..++.++||||||++++||
T Consensus 135 -~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 211 (321)
T 2a2a_A 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211 (321)
T ss_dssp -TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred -CeecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHH
Confidence 999999999999999887 799999999987654322 2345689999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++|+.||...... + ....+....... + ..........+.+++.+||+.||++|||+.|+++.
T Consensus 212 ~~g~~pf~~~~~~------~-~~~~i~~~~~~~--~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 212 LSGASPFLGDTKQ------E-TLANITSVSYDF--D-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHSCCSSCCSSHH------H-HHHHHHTTCCCC--C-HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCCCCCHH------H-HHHHHHhccccc--C-hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9999998753221 1 111222221110 0 00011223568899999999999999999999873
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=6.5e-32 Score=282.15 Aligned_cols=213 Identities=26% Similarity=0.347 Sum_probs=173.8
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++.. ...+++.++..++.|+++||+|||+.
T Consensus 48 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-- 124 (276)
T 2yex_A 48 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI-- 124 (276)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 457899999999999999999999999999999999999999999999964 45688999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCC-CccccchhhHHHHHHHHh
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~G~~l~ellt 667 (757)
+|+|+||||+||+++.++.+||+|||++........ .......|+..|+|||.+.+..+ +.++||||||++++||++
T Consensus 125 -~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 203 (276)
T 2yex_A 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203 (276)
T ss_dssp -TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred -CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHh
Confidence 999999999999999999999999999987643322 22334678999999999988765 789999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|+.||......... . ..+...... ... .......+.+++.+||+.||++|||+.|+++.
T Consensus 204 g~~p~~~~~~~~~~-~-----~~~~~~~~~-~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 204 GELPWDQPSDSCQE-Y-----SDWKEKKTY-LNP----WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp SSCCCSCSCTTSHH-H-----HHHHTTCTT-STT----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCCchHHHH-H-----HHhhhcccc-cCc----hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 99999765433211 1 111211111 100 11234568899999999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=298.15 Aligned_cols=211 Identities=20% Similarity=0.193 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHhhcC---CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTH---HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN----PEKQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~gL~y 583 (757)
..++..|++++++++ |+||+++++++...+..++||||+++|+|.+++.. ....+++.++..|+.||++||+|
T Consensus 108 ~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~ 187 (365)
T 3e7e_A 108 PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187 (365)
T ss_dssp HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHH
Confidence 467889999998887 99999999999999999999999999999999964 35678999999999999999999
Q ss_pred hhhCCCCCeeeCCCCcceEEECC-----------CCcEEEeecCCccccCCC-CcceecccccCccccCcccccCCCCCc
Q 038168 584 LHDECETQIIHCDIKPQNILMDE-----------NRCAKISDFGLAKLMKPD-QTRTFTGIRGTRGYVAPEWHRNLPITV 651 (757)
Q Consensus 584 LH~~~~~~iiH~Dik~~Nill~~-----------~~~~ki~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ 651 (757)
||+. +|+||||||+||||+. ++.+||+|||+++.+... .........||..|+|||++.+..++.
T Consensus 188 lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 264 (365)
T 3e7e_A 188 VHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNY 264 (365)
T ss_dssp HHTT---TEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBST
T ss_pred HhhC---CeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCc
Confidence 9998 9999999999999998 899999999999765422 233445578999999999999999999
Q ss_pred cccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCC-CC
Q 038168 652 KADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLR-PS 730 (757)
Q Consensus 652 k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~R-Ps 730 (757)
++||||||++++||++|+.||......... ....+.. . ...+.+.+++..|++.+|.+| |+
T Consensus 265 ~~DiwslG~il~elltg~~pf~~~~~~~~~--------------~~~~~~~-~---~~~~~~~~~~~~~l~~~p~~r~~~ 326 (365)
T 3e7e_A 265 QIDYFGVAATVYCMLFGTYMKVKNEGGECK--------------PEGLFRR-L---PHLDMWNEFFHVMLNIPDCHHLPS 326 (365)
T ss_dssp HHHHHHHHHHHHHHHHSSCCCEEEETTEEE--------------ECSCCTT-C---SSHHHHHHHHHHHHCCCCTTCCCC
T ss_pred cccHHHHHHHHHHHHhCCCccccCCCCcee--------------echhccc-c---CcHHHHHHHHHHHcCCCCCCcchH
Confidence 999999999999999999998643322110 0011111 0 123456778888999999999 58
Q ss_pred HHHHHHHhhcCc
Q 038168 731 MKKVLLMLEGTV 742 (757)
Q Consensus 731 m~eVl~~Le~~~ 742 (757)
+.++.+.|+...
T Consensus 327 ~~~l~~~l~~~l 338 (365)
T 3e7e_A 327 LDLLRQKLKKVF 338 (365)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 888888887643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=8.9e-33 Score=294.69 Aligned_cols=217 Identities=26% Similarity=0.394 Sum_probs=178.1
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEece-eeeEEEEeccCCChhhhhcCCCCC---------------CCHHHHHHH
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVS-KKILVYEYMSNGSLADILFNPEKQ---------------PNWVERMGI 573 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~---------------l~~~~~~~i 573 (757)
.+.+.+|+.+++++ +||||+++++++.+.+ ..++||||+++++|.+++...... +++.++..+
T Consensus 74 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (316)
T 2xir_A 74 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153 (316)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHH
T ss_pred HHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHH
Confidence 45788999999999 7999999999988754 589999999999999999765432 789999999
Q ss_pred HHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCcc
Q 038168 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVK 652 (757)
Q Consensus 574 ~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k 652 (757)
+.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....... .......+|..|+|||.+.+..++.+
T Consensus 154 ~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 230 (316)
T 2xir_A 154 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 230 (316)
T ss_dssp HHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccch
Confidence 99999999999998 999999999999999999999999999987755433 22334667899999999999999999
Q ss_pred ccchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 653 ADVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 653 ~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
+||||||++++||++ |+.|+........ .......+..... +......+.+++.+||+.||++|||+
T Consensus 231 ~Di~slG~il~~l~t~g~~p~~~~~~~~~------~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~ 298 (316)
T 2xir_A 231 SDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMRA------PDYTTPEMYQTMLDCWHGEPSQRPTF 298 (316)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCCSHH------HHHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hHHHHHHHHHHHHHhCCCCCCcccchhHH------HHHHhccCccCCC------CCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 999999999999998 9999875443221 2222333322111 11234568899999999999999999
Q ss_pred HHHHHHhhcCc
Q 038168 732 KKVLLMLEGTV 742 (757)
Q Consensus 732 ~eVl~~Le~~~ 742 (757)
.||++.|+.+.
T Consensus 299 ~ell~~L~~~~ 309 (316)
T 2xir_A 299 SELVEHLGNLL 309 (316)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999998754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-32 Score=306.06 Aligned_cols=220 Identities=18% Similarity=0.211 Sum_probs=176.9
Q ss_pred HHHHHHHHHHhhcCC-CceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRTHH-RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+++.+|+++++.++| +++..+..++.+.+..+|||||+ +++|.+++......+++.+++.|+.||+.||+|||++
T Consensus 47 ~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--- 122 (483)
T 3sv0_A 47 PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--- 122 (483)
T ss_dssp CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 468899999999976 56666666777888899999999 9999999976677899999999999999999999998
Q ss_pred CeeeCCCCcceEEE---CCCCcEEEeecCCccccCCCCcc------eecccccCccccCcccccCCCCCccccchhhHHH
Q 038168 591 QIIHCDIKPQNILM---DENRCAKISDFGLAKLMKPDQTR------TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVV 661 (757)
Q Consensus 591 ~iiH~Dik~~Nill---~~~~~~ki~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~ 661 (757)
+|+||||||+|||| +.++.+||+|||+++.+...... ......||..|+|||.+.+..++.++||||||++
T Consensus 123 gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvi 202 (483)
T 3sv0_A 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYV 202 (483)
T ss_dssp TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHH
Confidence 99999999999999 68899999999999977554321 1235679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 662 LLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 662 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
+|||++|+.||..............+...........+ ......++.+++..||+.+|++||++.+|+++|+.+
T Consensus 203 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 203 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 99999999999876554332222222111111111111 012246789999999999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.6e-33 Score=323.65 Aligned_cols=214 Identities=22% Similarity=0.338 Sum_probs=173.8
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.|.+|+.++++++||||+++++++. .+..++||||+++|+|.+++......+++..++.++.|+++||+|||++ +
T Consensus 436 ~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---g 511 (656)
T 2j0j_A 436 EKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---R 511 (656)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 67899999999999999999999985 4568999999999999999987666789999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-CCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-RRR 670 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G~~ 670 (757)
|+||||||+|||++.++.+||+|||+++..............+++.|+|||.+.+..++.++||||||++++||++ |..
T Consensus 512 ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~ 591 (656)
T 2j0j_A 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 591 (656)
T ss_dssp CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999999876544433344567889999999999999999999999999999997 888
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
||...... + +...+..+.... .+......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 592 Pf~~~~~~------~-~~~~i~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 592 PFQGVKNN------D-VIGRIENGERLP------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp TTTTCCHH------H-HHHHHHHTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHH------H-HHHHHHcCCCCC------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 88653221 1 112222222111 12233467889999999999999999999999998753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=292.38 Aligned_cols=218 Identities=24% Similarity=0.282 Sum_probs=169.1
Q ss_pred HHHHHHHHHHHhhcC---CCceeeeeeEEEece-----eeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTH---HRNLVRLLGYSLEVS-----KKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGI 581 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL 581 (757)
...+.+|+.++++++ ||||+++++++.... ..++||||++ ++|.+++.... ..+++.++..++.|++.||
T Consensus 55 ~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al 133 (308)
T 3g33_A 55 PISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133 (308)
T ss_dssp CHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHH
Confidence 356778888887775 999999999998654 5789999997 59999997654 3489999999999999999
Q ss_pred HHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHH
Q 038168 582 LYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVV 661 (757)
Q Consensus 582 ~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~ 661 (757)
+|||++ +|+||||||+|||++.++.+||+|||+++...... ......||+.|+|||.+.+..++.++||||||++
T Consensus 134 ~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 208 (308)
T 3g33_A 134 DFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCI 208 (308)
T ss_dssp HHHHHT---TCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHH
T ss_pred HHHHHC---CcccCCCCHHHEEEcCCCCEEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHH
Confidence 999999 99999999999999999999999999998765432 2344678999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCC---ccccc-------c-cc-----ccCHHHHHHHHHHHHHccccCC
Q 038168 662 LLEIICRRRCLDPNLPDDQVILEEWVYQCFENGN---LSQLV-------E-DE-----EVDEKQLERMIKVALWCILDEP 725 (757)
Q Consensus 662 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~-------d-~~-----~~~~~~~~~l~~l~~~cl~~~p 725 (757)
++||++|+.||......+ ....+........ ..... . .. ....+..+.+.+++.+||+.||
T Consensus 209 l~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 285 (308)
T 3g33_A 209 FAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNP 285 (308)
T ss_dssp HHHTTTSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSST
T ss_pred HHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCC
Confidence 999999999987543221 1111111111100 00000 0 00 0111234678899999999999
Q ss_pred CCCCCHHHHHHH
Q 038168 726 SLRPSMKKVLLM 737 (757)
Q Consensus 726 ~~RPsm~eVl~~ 737 (757)
++|||+.|+++.
T Consensus 286 ~~R~t~~e~l~h 297 (308)
T 3g33_A 286 HKRISAFRALQH 297 (308)
T ss_dssp TTSCCHHHHHTS
T ss_pred ccCCCHHHHhcC
Confidence 999999999863
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=286.72 Aligned_cols=209 Identities=22% Similarity=0.321 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.. ...+++.++..++.|++.||+|||+.
T Consensus 50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~--- 125 (277)
T 3f3z_A 50 VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKL--- 125 (277)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 57899999999999999999999999999999999999999999998864 35589999999999999999999998
Q ss_pred CeeeCCCCcceEEE---CCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 591 QIIHCDIKPQNILM---DENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill---~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+|||+ +.++.+||+|||++........ .....||+.|+|||.+.+. ++.++||||||++++||++
T Consensus 126 ~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~ 202 (277)
T 3f3z_A 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLC 202 (277)
T ss_dssp TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHH
T ss_pred CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHH
Confidence 99999999999999 7889999999999987654332 2335689999999988764 8999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|+.||...... + .......+....... ........+.+++.+||+.||++|||+.|+++
T Consensus 203 g~~p~~~~~~~------~-~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 203 GYPPFSAPTDS------E-VMLKIREGTFTFPEK---DWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp SSCSSCCSSHH------H-HHHHHHHCCCCCCHH---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCCHH------H-HHHHHHhCCCCCCch---hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99998753321 1 122223332221100 00022467889999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=310.75 Aligned_cols=211 Identities=27% Similarity=0.310 Sum_probs=175.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|+.+|++++|||||++++++.+.+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++
T Consensus 228 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~-- 305 (576)
T 2acx_A 228 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE-- 305 (576)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 3568899999999999999999999999999999999999999999997654 4589999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+||||+.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 306 -gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~ 382 (576)
T 2acx_A 306 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382 (576)
T ss_dssp -TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSS
T ss_pred -CEeccCCchheEEEeCCCCeEEEecccceecccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999987754432 23457999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLL 736 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~ 736 (757)
.||........ ... +......... .++......+.+++.+||+.||++|| +++||++
T Consensus 383 ~PF~~~~~~~~--~~~-i~~~i~~~~~-------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 383 SPFQQRKKKIK--REE-VERLVKEVPE-------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CSSSCSSSCCC--HHH-HHHHHHHCCC-------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred CCCcccccchh--HHH-HHHHhhcccc-------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 99986543221 111 2222222211 11223346788999999999999999 7788875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.4e-32 Score=286.75 Aligned_cols=207 Identities=26% Similarity=0.386 Sum_probs=167.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe----ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE----VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
.+.+.+|+.++++++||||+++++++.. ....++||||+++++|.+++.. ...+++..+..++.|++.||+|||+
T Consensus 69 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~ 147 (290)
T 1t4h_A 69 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT 147 (290)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHc
Confidence 4678999999999999999999999875 4568999999999999999964 3568899999999999999999999
Q ss_pred CCCCC--eeeCCCCcceEEEC-CCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHH
Q 038168 587 ECETQ--IIHCDIKPQNILMD-ENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663 (757)
Q Consensus 587 ~~~~~--iiH~Dik~~Nill~-~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ 663 (757)
. + |+||||||+|||++ .++.+||+|||++........ ....||+.|+|||.+.+ .++.++||||||++++
T Consensus 148 ~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~ 220 (290)
T 1t4h_A 148 R---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCML 220 (290)
T ss_dssp S---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB---EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHH
T ss_pred C---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccccc---ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHH
Confidence 8 7 99999999999998 789999999999976544322 23568999999998774 5899999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||++|+.||....... . .......+...... +......+.+++.+||+.||++|||+.||++
T Consensus 221 ~l~~g~~pf~~~~~~~-----~-~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 221 EMATSEYPYSECQNAA-----Q-IYRRVTSGVKPASF-----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHSSCTTTTCSSHH-----H-HHHHHTTTCCCGGG-----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCCCCCcCcHH-----H-HHHHHhccCCcccc-----CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 9999999987543211 1 12222222221111 1122356889999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=297.72 Aligned_cols=212 Identities=23% Similarity=0.305 Sum_probs=171.4
Q ss_pred HHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 513 EFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 513 ~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +
T Consensus 61 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~---g 136 (342)
T 2qr7_A 61 DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQ---G 136 (342)
T ss_dssp CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 456799999888 799999999999999999999999999999999965 35689999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCC----CcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 592 IIHCDIKPQNILMDEN----RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 592 iiH~Dik~~Nill~~~----~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
|+||||||+|||+.++ +.+||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++
T Consensus 137 ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 215 (342)
T 2qr7_A 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT 215 (342)
T ss_dssp EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhc
Confidence 9999999999998543 3599999999987654332 2234578999999999998889999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|+.||......... + +...+..+..... ..........+.+++.+||+.||++||++.|+++
T Consensus 216 g~~Pf~~~~~~~~~---~-~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 216 GYTPFANGPDDTPE---E-ILARIGSGKFSLS---GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp SSCSSCSSTTSCHH---H-HHHHHHHCCCCCC---STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCCcCCHH---H-HHHHHccCCcccC---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 99999754332221 1 2233344433211 1111233467889999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=297.03 Aligned_cols=210 Identities=23% Similarity=0.366 Sum_probs=163.0
Q ss_pred HHHHHHHHHHHhhcCC--CceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHH--RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.+.+.+|+.++++++| +||+++++++.+.+..++||| +.+++|.+++.. ...+++.++..++.||+.||+|||+.
T Consensus 51 ~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~- 127 (343)
T 3dbq_A 51 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH- 127 (343)
T ss_dssp HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 4778999999999976 999999999999999999999 568899999975 45688999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccC-----------CCCCccccch
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRN-----------LPITVKADVY 656 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~ 656 (757)
+|+||||||+|||++ ++.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||
T Consensus 128 --~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diw 204 (343)
T 3dbq_A 128 --GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204 (343)
T ss_dssp --TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHH
T ss_pred --CeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHH
Confidence 999999999999997 578999999999877554332 2334679999999999865 6789999999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 657 SFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 657 S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|||++++||++|+.||...... .............. ..+......+.+++.+||+.||++|||+.|+++
T Consensus 205 slG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 205 SLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPNHEI------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHCTTSCC------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHhCCCcchhhhhH-----HHHHHHHhcCCccc------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 9999999999999999753221 11111111111111 111122356889999999999999999999987
Q ss_pred H
Q 038168 737 M 737 (757)
Q Consensus 737 ~ 737 (757)
.
T Consensus 274 h 274 (343)
T 3dbq_A 274 H 274 (343)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=286.61 Aligned_cols=210 Identities=21% Similarity=0.338 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.
T Consensus 49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--- 124 (284)
T 3kk8_A 49 FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSN--- 124 (284)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 36788999999999999999999999999999999999999999988864 35688999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCc---EEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 591 QIIHCDIKPQNILMDENRC---AKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~---~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+||+++.++. +||+|||++........ .....||+.|+|||.+.+..++.++||||||++++||++
T Consensus 125 ~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 202 (284)
T 3kk8_A 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 202 (284)
T ss_dssp TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHH
Confidence 9999999999999986654 99999999987654332 234678999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|+.||...... . .......+...... .........+.+++.+||+.||++|||+.|+++
T Consensus 203 g~~pf~~~~~~------~-~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 203 GYPPFWDEDQH------R-LYAQIKAGAYDYPS---PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp SSCSSCCSSHH------H-HHHHHHHTCCCCCT---TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCchh------H-HHHHHHhccccCCc---hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 99998653221 1 12222333222111 111123456889999999999999999999988
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=295.77 Aligned_cols=206 Identities=22% Similarity=0.305 Sum_probs=170.3
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+.+.+|..+++++ +||||+++++++.+.+..++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+.
T Consensus 65 ~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--- 140 (353)
T 2i0e_A 65 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSK--- 140 (353)
T ss_dssp HHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 5678899999988 899999999999999999999999999999999964 34688999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||++++||++|+.
T Consensus 141 givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 219 (353)
T 2i0e_A 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219 (353)
T ss_dssp TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCC
Confidence 99999999999999999999999999998643322 22344679999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS-----MKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----m~eVl~ 736 (757)
||..... .+ ..+.+..+... ++.....++.+++.+||+.||++||+ ++||++
T Consensus 220 Pf~~~~~------~~-~~~~i~~~~~~-------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 220 PFEGEDE------DE-LFQSIMEHNVA-------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp SSCCSSH------HH-HHHHHHHCCCC-------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCCCH------HH-HHHHHHhCCCC-------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 9975321 11 12222222221 11233467889999999999999995 467664
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=295.95 Aligned_cols=217 Identities=28% Similarity=0.392 Sum_probs=175.6
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC------CCCCHHHHHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE------KQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~y 583 (757)
..+++.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.... ..+++.+++.++.|++.||+|
T Consensus 76 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~ 155 (327)
T 2yfx_A 76 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155 (327)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHH
Confidence 45679999999999999999999999999999999999999999999997543 458899999999999999999
Q ss_pred hhhCCCCCeeeCCCCcceEEECC---CCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccchhhH
Q 038168 584 LHDECETQIIHCDIKPQNILMDE---NRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFG 659 (757)
Q Consensus 584 LH~~~~~~iiH~Dik~~Nill~~---~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G 659 (757)
||+. +|+||||||+|||++. +..+||+|||+++....... .......++..|+|||.+.+..++.++||||||
T Consensus 156 LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 232 (327)
T 2yfx_A 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 232 (327)
T ss_dssp HHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HhhC---CeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHH
Confidence 9998 9999999999999984 45699999999986543322 222335678999999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 038168 660 VVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738 (757)
Q Consensus 660 ~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~L 738 (757)
++++||++ |+.|+...... + .......+..... +......+.+++.+||+.||++||++.+|++.|
T Consensus 233 ~il~ellt~g~~p~~~~~~~------~-~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 299 (327)
T 2yfx_A 233 VLLWEIFSLGYMPYPSKSNQ------E-VLEFVTSGGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299 (327)
T ss_dssp HHHHHHHTTSCCSSTTCCHH------H-HHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCcCHH------H-HHHHHhcCCCCCC------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 99999998 88888653221 1 1222233222111 122345788999999999999999999999999
Q ss_pred hcCc
Q 038168 739 EGTV 742 (757)
Q Consensus 739 e~~~ 742 (757)
+.+.
T Consensus 300 ~~~~ 303 (327)
T 2yfx_A 300 EYCT 303 (327)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 8644
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=287.28 Aligned_cols=206 Identities=25% Similarity=0.398 Sum_probs=169.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.
T Consensus 53 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~--- 128 (279)
T 3fdn_A 53 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSK--- 128 (279)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 46788999999999999999999999999999999999999999999864 35688999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||++....... .....|+..|+|||.+.+..++.++||||||++++||++|+.
T Consensus 129 ~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 205 (279)
T 3fdn_A 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205 (279)
T ss_dssp TCEECCCCGGGEEECTTSCEEECSCCEESCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred CEecccCChHhEEEcCCCCEEEEeccccccCCccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCC
Confidence 99999999999999999999999999986544332 234568999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
||...... + ........... .+......+.+++.+||+.||++|||+.||++.
T Consensus 206 p~~~~~~~------~-~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 206 PFEANTYQ------E-TYKRISRVEFT-------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp TTCCSSHH------H-HHHHHHHTCCC-------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCCcHH------H-HHHHHHhCCCC-------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 98743221 1 11222222111 112234568899999999999999999999974
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=288.26 Aligned_cols=213 Identities=24% Similarity=0.351 Sum_probs=176.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+++.+|++++++++||||+++++++ +.+..++||||+++++|.+++.. ...+++.++..++.|++.||+|||+.
T Consensus 62 ~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~--- 136 (291)
T 1xbb_A 62 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEES--- 136 (291)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 56799999999999999999999999 56678999999999999999965 35688999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce--ecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT--FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+|+||||||+|||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++
T Consensus 137 ~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 216 (291)
T 1xbb_A 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 216 (291)
T ss_dssp TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhc
Confidence 99999999999999999999999999998876544322 223456789999999998889999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
|+.||...... .+......+.... .+......+.+++.+||+.||++||++.+|++.|+.+
T Consensus 217 g~~p~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 217 GQKPYRGMKGS-------EVTAMLEKGERMG------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp TCCSSTTCCHH-------HHHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHH-------HHHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99998754321 1222333332211 1223456789999999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-33 Score=291.66 Aligned_cols=214 Identities=20% Similarity=0.327 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe--ceeeeEEEEeccCCChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE--VSKKILVYEYMSNGSLADILFNP---EKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.+.+.+|++++++++||||+++++++.+ ....++||||+++++|.+++... ...+++..+..++.|++.||+|||
T Consensus 49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH 128 (279)
T 2w5a_A 49 KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128 (279)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 4678999999999999999999998854 56789999999999999999643 345899999999999999999999
Q ss_pred hCCCCC-----eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHH
Q 038168 586 DECETQ-----IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGV 660 (757)
Q Consensus 586 ~~~~~~-----iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~ 660 (757)
+. + |+||||||+|||++.++.+||+|||+++........ .....|+..|+|||.+.+..++.++||||||+
T Consensus 129 ~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 204 (279)
T 2w5a_A 129 RR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGC 204 (279)
T ss_dssp HH---C------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHH
T ss_pred cc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHH
Confidence 98 6 999999999999999999999999999876543221 22356899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 661 VLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 661 ~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
+++||++|+.|+..... . + ....+..+....+ +.....++.+++.+||+.||++||++.||++.+..
T Consensus 205 il~~l~~g~~p~~~~~~---~---~-~~~~i~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 205 LLYELCALMPPFTAFSQ---K---E-LAGKIREGKFRRI------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp HHHHHHHSSCSSCCSSH---H---H-HHHHHHHTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHCCCCCcccCH---H---H-HHHHHhhcccccC------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 99999999999875421 1 1 2233344433221 12334678999999999999999999999998754
Q ss_pred C
Q 038168 741 T 741 (757)
Q Consensus 741 ~ 741 (757)
.
T Consensus 272 ~ 272 (279)
T 2w5a_A 272 L 272 (279)
T ss_dssp C
T ss_pred h
Confidence 3
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=288.60 Aligned_cols=222 Identities=22% Similarity=0.300 Sum_probs=167.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.
T Consensus 46 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~--- 121 (311)
T 4agu_A 46 KKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKH--- 121 (311)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46788999999999999999999999999999999999999999998864 45689999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+||+++.++.+||+|||+++....... ......||..|+|||.+.+ ..++.++||||||++++||++|+
T Consensus 122 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 200 (311)
T 4agu_A 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200 (311)
T ss_dssp TEECCCCSGGGEEECTTSCEEECCCTTCEECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCC
Confidence 999999999999999999999999999987654322 2234568999999999876 67899999999999999999999
Q ss_pred CCCCCCCCCccccHHHHH--------HHHHhcCCcc---cccccccc------CHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 670 RCLDPNLPDDQVILEEWV--------YQCFENGNLS---QLVEDEEV------DEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~--------~~~~~~~~~~---~~~d~~~~------~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
.||......+........ ...+...... ...++... .......+.+++.+||+.||++|||++
T Consensus 201 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 280 (311)
T 4agu_A 201 PLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCE 280 (311)
T ss_dssp CSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHH
T ss_pred CCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHH
Confidence 999765432211110000 0001111000 00111100 122345688999999999999999999
Q ss_pred HHHHH
Q 038168 733 KVLLM 737 (757)
Q Consensus 733 eVl~~ 737 (757)
|+++.
T Consensus 281 ell~h 285 (311)
T 4agu_A 281 QLLHH 285 (311)
T ss_dssp HHHTS
T ss_pred HHhcC
Confidence 99864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=297.64 Aligned_cols=241 Identities=25% Similarity=0.361 Sum_probs=184.2
Q ss_pred CccccHHHHHHhhcccc--ccccCCCch-------------------------HHHHHHHHHHHhhcC-----CCceeee
Q 038168 485 PLSFSYAELEKMTDGFK--EEVGRGSSG-------------------------EREFQTEMKVIGRTH-----HRNLVRL 532 (757)
Q Consensus 485 ~~~~~~~~l~~~t~~f~--~~lg~g~~~-------------------------~~~~~~E~~~l~~l~-----h~niv~l 532 (757)
...+++.+.....++|. ++||+|++| .+.+..|+.++++++ |+||+++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34455555555555554 678888873 356788999999996 9999999
Q ss_pred eeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECC-----
Q 038168 533 LGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDE----- 606 (757)
Q Consensus 533 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~----- 606 (757)
++++...+..++||||+ +++|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccc
Confidence 99999999999999999 999999997543 4589999999999999999999998 9999999999999976
Q ss_pred --------------------CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 607 --------------------NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 607 --------------------~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
++.+||+|||+++...... ....||+.|+|||.+.+..++.++||||||++++||+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 7899999999998654322 3457899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHh-----------cCCccccccc--------cc-cC---------------HHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFE-----------NGNLSQLVED--------EE-VD---------------EKQLE 711 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~-----------~~~~~~~~d~--------~~-~~---------------~~~~~ 711 (757)
+|+.||......+.. ..+..... .......++. .. .. ....+
T Consensus 254 ~g~~pf~~~~~~~~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 254 TGSLLFRTHEHMEHL---AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HSSCSCCCSSHHHHH---HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HCCCCCCCCcHHHHH---HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 999999754322111 11111000 0000000000 00 00 00125
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 038168 712 RMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 712 ~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
.+.+++.+||+.||++|||+.|+++
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhc
Confidence 6789999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-33 Score=289.80 Aligned_cols=213 Identities=29% Similarity=0.381 Sum_probs=167.4
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEec-eeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEV-SKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..+.+.+|++++++++|+||+++++++.+. +..++||||+++++|.+++.... ..+++..+..++.|+++||+|||+.
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 136 (278)
T 1byg_A 57 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136 (278)
T ss_dssp --HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 457899999999999999999999997654 47899999999999999996543 2378899999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+++||||||+||+++.++.+||+|||+++...... ....++..|+|||.+.+..++.++||||||++++||++
T Consensus 137 ---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t 209 (278)
T 1byg_A 137 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209 (278)
T ss_dssp ---TCCCSCCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ---CccccCCCcceEEEeCCCcEEEeeccccccccccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHh
Confidence 99999999999999999999999999998654322 12356889999999999999999999999999999998
Q ss_pred -CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 668 -RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 668 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
|+.|+......+ . ......+... ..+......+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 210 ~g~~p~~~~~~~~---~----~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 210 FGRVPYPRIPLKD---V----VPRVEKGYKM------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp TSCCSCTTSCGGG---H----HHHHTTTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHH---H----HHHHhcCCCC------CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 999887543221 1 1222222111 112233467889999999999999999999999998753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=301.45 Aligned_cols=209 Identities=22% Similarity=0.341 Sum_probs=161.6
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 038168 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQI 592 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 592 (757)
.+.+|+.++++++||||+++++++.. +..++||||+++|+|.+++.. ...+++.++..++.|++.||+|||++ +|
T Consensus 186 ~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i 260 (419)
T 3i6u_A 186 NVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHEN---GI 260 (419)
T ss_dssp CHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 58899999999999999999999754 457999999999999999865 45689999999999999999999998 99
Q ss_pred eeCCCCcceEEECCC---CcEEEeecCCccccCCCCcceecccccCccccCcccccC---CCCCccccchhhHHHHHHHH
Q 038168 593 IHCDIKPQNILMDEN---RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN---LPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 593 iH~Dik~~Nill~~~---~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~G~~l~ell 666 (757)
+||||||+|||++.+ ..+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||++++||+
T Consensus 261 vHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~ll 338 (419)
T 3i6u_A 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338 (419)
T ss_dssp CCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHH
T ss_pred cccCCChHhEEEecCCCcceEEEeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHH
Confidence 999999999999654 459999999998765432 2334678999999999863 57889999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+|+.||........ + ......+....... ........+.+++.+||+.||++|||+.|+++.
T Consensus 339 tg~~pf~~~~~~~~--~----~~~i~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 339 SGYPPFSEHRTQVS--L----KDQITSGKYNFIPE---VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HSSCSSCCCSSSCC--H----HHHHHTTCCCCCHH---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HCCCCCCCCcchHH--H----HHHHhcCCCCCCch---hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 99999975433222 1 12223333221100 011234678999999999999999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=290.28 Aligned_cols=218 Identities=23% Similarity=0.294 Sum_probs=176.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|++++++++|+||+++++++.+.. .++|+||+++++|.+++......+++.++..++.|+++||+|||++
T Consensus 64 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-- 140 (291)
T 1u46_A 64 AMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK-- 140 (291)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC--
Confidence 4577899999999999999999999998765 8899999999999999976656789999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce--ecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT--FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+|+||||+||+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++
T Consensus 141 -~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 219 (291)
T 1u46_A 141 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219 (291)
T ss_dssp -TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred -CcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999998876543322 223557889999999998889999999999999999999
Q ss_pred -CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcC
Q 038168 668 -RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 668 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~ 743 (757)
|+.||..... .+........+... .........+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 220 ~g~~p~~~~~~------~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 220 YGQEPWIGLNG------SQILHKIDKEGERL------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp TSCCTTTTCCH------HHHHHHHHTSCCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCCCcccCCH------HHHHHHHHccCCCC------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 9999875422 11122222221111 1112334678999999999999999999999999987553
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-33 Score=299.66 Aligned_cols=224 Identities=16% Similarity=0.199 Sum_probs=176.3
Q ss_pred HHHHHHHHHHhhcCCCceee---------------eeeEEEe-ceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHH
Q 038168 512 REFQTEMKVIGRTHHRNLVR---------------LLGYSLE-VSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIA 574 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~---------------l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~ 574 (757)
+.+.+|++++++++|+||++ +++++.. .+..++||||+ +++|.+++... ...+++.++..++
T Consensus 87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~ 165 (352)
T 2jii_A 87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVA 165 (352)
T ss_dssp STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHH
T ss_pred chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHH
Confidence 35889999999999999988 6677766 67889999999 99999999764 3678999999999
Q ss_pred HHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCC--cEEEeecCCccccCCCCcc------eecccccCccccCcccccC
Q 038168 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENR--CAKISDFGLAKLMKPDQTR------TFTGIRGTRGYVAPEWHRN 646 (757)
Q Consensus 575 ~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~--~~ki~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~ 646 (757)
.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.+...... ......||+.|+|||.+.+
T Consensus 166 ~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 166 CRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp HHHHHHHHHHHHT---TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHhC---CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence 9999999999998 999999999999999998 9999999999876543221 1233578999999999999
Q ss_pred CCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCC
Q 038168 647 LPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPS 726 (757)
Q Consensus 647 ~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~ 726 (757)
..++.++||||||++++||++|+.||......... +.... ..+.. ....+.+...........+.+++.+||+.||+
T Consensus 243 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 319 (352)
T 2jii_A 243 CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED-IMKQK-QKFVD-KPGPFVGPCGHWIRPSETLQKYLKVVMALTYE 319 (352)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH-HHHHH-HHHHH-SCCCEECTTSCEECCCHHHHHHHHHHHTCCTT
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHH-HHHHH-HhccC-ChhhhhhhccccCCCcHHHHHHHHHHHhCChh
Confidence 99999999999999999999999999865433221 11111 11111 11112111111112246789999999999999
Q ss_pred CCCCHHHHHHHhhcCc
Q 038168 727 LRPSMKKVLLMLEGTV 742 (757)
Q Consensus 727 ~RPsm~eVl~~Le~~~ 742 (757)
+||++++|+++|+.+.
T Consensus 320 ~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 320 EKPPYAMLRNNLEALL 335 (352)
T ss_dssp CCCCHHHHHHHHHHHH
T ss_pred hCCCHHHHHHHHHHHH
Confidence 9999999999998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-33 Score=298.38 Aligned_cols=216 Identities=20% Similarity=0.280 Sum_probs=165.5
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 038168 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQI 592 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 592 (757)
.+.+|+.++++++|+||+++++++.+.+..++||||++ |+|.+++......+++.++..++.|++.||+|||+. +|
T Consensus 46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i 121 (324)
T 3mtl_A 46 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KV 121 (324)
T ss_dssp CCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 34579999999999999999999999999999999998 599999887777899999999999999999999998 99
Q ss_pred eeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHHHhCCCC
Q 038168 593 IHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICRRRC 671 (757)
Q Consensus 593 iH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~elltG~~p 671 (757)
+||||||+|||++.++.+||+|||+++...... .......||..|+|||.+.+ ..++.++||||||++++||++|+.|
T Consensus 122 vH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 200 (324)
T 3mtl_A 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPL 200 (324)
T ss_dssp EESSCCGGGEEECTTCCEEECSSSEEECC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCcCHHHEEECCCCCEEEccCcccccccCCc-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999998654332 22234568999999999876 5689999999999999999999999
Q ss_pred CCCCCCCccccHHHHHHHHHhcC---Ccccccccc----------------ccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 038168 672 LDPNLPDDQVILEEWVYQCFENG---NLSQLVEDE----------------EVDEKQLERMIKVALWCILDEPSLRPSMK 732 (757)
Q Consensus 672 ~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d~~----------------~~~~~~~~~l~~l~~~cl~~~p~~RPsm~ 732 (757)
|......+. ...+.+..... ......... .........+.+++.+||+.||++|||++
T Consensus 201 f~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 277 (324)
T 3mtl_A 201 FPGSTVEEQ---LHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAE 277 (324)
T ss_dssp CCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCHHHH---HHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHH
Confidence 976432221 11111111110 011110000 00112245688999999999999999999
Q ss_pred HHHH
Q 038168 733 KVLL 736 (757)
Q Consensus 733 eVl~ 736 (757)
|+++
T Consensus 278 e~l~ 281 (324)
T 3mtl_A 278 DAMK 281 (324)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9988
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-32 Score=295.78 Aligned_cols=210 Identities=22% Similarity=0.351 Sum_probs=164.1
Q ss_pred HHHHHHHHHHHhhcC--CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTH--HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.+.+.+|+.++++++ |+||+++++++...+..++||| +.+++|.+++... ..+++.++..++.||+.||+|||+.
T Consensus 98 ~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~- 174 (390)
T 2zmd_A 98 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQH- 174 (390)
T ss_dssp HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 477899999999996 5999999999999999999999 6788999999753 4678889999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccC-----------CCCCccccch
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRN-----------LPITVKADVY 656 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~ 656 (757)
+|+||||||+|||++ ++.+||+|||+++.+...... ......||+.|+|||++.+ ..++.++|||
T Consensus 175 --~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diw 251 (390)
T 2zmd_A 175 --GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251 (390)
T ss_dssp --TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHH
T ss_pred --CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHH
Confidence 999999999999995 578999999999877544332 2334679999999999875 4689999999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 657 SFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 657 S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||||++|||++|+.||...... ......... ...... .+......+.+++.+||+.||++|||+.||++
T Consensus 252 SlGvil~ell~G~~Pf~~~~~~-----~~~~~~~~~-~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 252 SLGCILYYMTYGKTPFQQIINQ-----ISKLHAIID-PNHEIE-----FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHHC-TTSCCC-----CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHHCCCcchhhhHH-----HHHHHHHhC-ccccCC-----CCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 9999999999999999754321 111122221 111100 11111356889999999999999999999986
Q ss_pred H
Q 038168 737 M 737 (757)
Q Consensus 737 ~ 737 (757)
.
T Consensus 321 h 321 (390)
T 2zmd_A 321 H 321 (390)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=285.21 Aligned_cols=211 Identities=23% Similarity=0.347 Sum_probs=174.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+++.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++......+++.++..++.|++.||.|||+.
T Consensus 68 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--- 144 (314)
T 3com_A 68 LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM--- 144 (314)
T ss_dssp CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 47899999999999999999999999999999999999999999999975567789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+++|+||||+||+++.++.+||+|||++........ ......|+..|+|||.+.+..++.++||||||++++||++|+.
T Consensus 145 ~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 223 (314)
T 3com_A 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP 223 (314)
T ss_dssp TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999987654322 2234568999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||...... .... ............+. .....+.+++.+||+.||++|||+.++++
T Consensus 224 p~~~~~~~------~~~~-~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 224 PYADIHPM------RAIF-MIPTNPPPTFRKPE----LWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp TTTTSCHH------HHHH-HHHHSCCCCCSSGG----GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCChH------HHHH-HHhcCCCcccCCcc----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 98743221 1111 11122111111121 22356889999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-32 Score=284.19 Aligned_cols=211 Identities=25% Similarity=0.392 Sum_probs=170.7
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. ...+++.++..++.|++.||+|||+.
T Consensus 51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-- 127 (283)
T 3bhy_A 51 SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSK-- 127 (283)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 468899999999999999999999999999999999999999999999964 35689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCC----cEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENR----CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~----~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+||+++.++ .+||+|||++........ .....|+..|+|||.+.+..++.++||||||++++||
T Consensus 128 -~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 204 (283)
T 3bhy_A 128 -RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 204 (283)
T ss_dssp -TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred -CccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHH
Confidence 999999999999998877 899999999987654322 2345689999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
++|+.||...... + ....+....... +..........+.+++.+||+.||++||++.|+++
T Consensus 205 ~~g~~p~~~~~~~------~-~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 205 LSGASPFLGETKQ------E-TLTNISAVNYDF---DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHSSCTTCCSSHH------H-HHHHHHTTCCCC---CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHCCCCCCCcchH------H-HHHHhHhcccCC---cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 9999998754221 1 111222221110 00001122456889999999999999999999987
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=283.76 Aligned_cols=205 Identities=22% Similarity=0.312 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|+||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.|+++||+|||+.
T Consensus 58 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~--- 133 (284)
T 2vgo_A 58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHER--- 133 (284)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 467899999999999999999999999999999999999999999998653 4688999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+||+++.++.+||+|||++....... .....|+..|+|||.+.+..++.++||||||++++||++|+.
T Consensus 134 ~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 210 (284)
T 2vgo_A 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP 210 (284)
T ss_dssp TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred CceecCCCHHHEEEcCCCCEEEecccccccCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCC
Confidence 99999999999999999999999999997654322 223568999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||...... + ........... .+......+.+++.+|++.||++||++.|+++
T Consensus 211 pf~~~~~~------~-~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 211 PFDSPSHT------E-THRRIVNVDLK-------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TTCCSSHH------H-HHHHHHTTCCC-------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCHh------H-HHHHHhccccC-------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 98753221 1 11122222211 11223456889999999999999999999987
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=297.98 Aligned_cols=203 Identities=25% Similarity=0.289 Sum_probs=160.1
Q ss_pred HHHHHHHHH-HhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKV-IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+.+.+|..+ ++.++||||+++++++.+.+..++||||+++|+|.+++.+ ...++...+..++.||+.||+|||++
T Consensus 83 ~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--- 158 (373)
T 2r5t_A 83 KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSL--- 158 (373)
T ss_dssp --------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 456677776 5778999999999999999999999999999999999865 34678888999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.
T Consensus 159 givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 237 (373)
T 2r5t_A 159 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237 (373)
T ss_dssp TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CceecCCCHHHEEECCCCCEEEeeCccccccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999998643222 22344679999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKK 733 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~e 733 (757)
||..... .+ ..+.+..+... .+......+.+++.+||+.||++||++.+
T Consensus 238 Pf~~~~~------~~-~~~~i~~~~~~-------~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 238 PFYSRNT------AE-MYDNILNKPLQ-------LKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp TTCCSBH------HH-HHHHHHHSCCC-------CCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred CCCCCCH------HH-HHHHHHhcccC-------CCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 9975321 11 12222222221 11123356889999999999999999853
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-32 Score=287.00 Aligned_cols=209 Identities=22% Similarity=0.333 Sum_probs=173.8
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++.. ...+++.++..++.|+++||+|||+.
T Consensus 58 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-- 134 (294)
T 2rku_A 58 QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRN-- 134 (294)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 456789999999999999999999999999999999999999999998854 35688999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++....... ......|+..|+|||.+.+..++.++||||||++++||++|+
T Consensus 135 -~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 212 (294)
T 2rku_A 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212 (294)
T ss_dssp -TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -CccccCCChHhEEEcCCCCEEEEeccCceecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999987653322 223356899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
.||...... +. ......+... .+......+.+++.+||+.||++|||++|+++.
T Consensus 213 ~p~~~~~~~------~~-~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 213 PPFETSCLK------ET-YLRIKKNEYS-------IPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CTTCCSSHH------HH-HHHHHTTCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCCCCCHH------HH-HHHHhhccCC-------CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 998753221 11 1122222211 111223568899999999999999999999973
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=292.63 Aligned_cols=218 Identities=22% Similarity=0.319 Sum_probs=170.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEece------eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVS------KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.+.+|++++++++|+||+++++++...+ ..++||||+ +++|.+++.. ..+++..+..++.||++||+||
T Consensus 68 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~L 144 (367)
T 1cm8_A 68 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYI 144 (367)
T ss_dssp HHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999999999997653 469999999 8899999864 4688999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLL 663 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~ 663 (757)
|+. +|+||||||+|||++.++.+||+|||+++..... .....+|..|+|||.+.+ ..++.++||||+||+++
T Consensus 145 H~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 217 (367)
T 1cm8_A 145 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 217 (367)
T ss_dssp HHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHH
T ss_pred HHC---CccccCcCHHHEEEcCCCCEEEEeeecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHH
Confidence 998 9999999999999999999999999999876432 234578999999999887 68999999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHhcCCc--------------------cccc--cccccCHHHHHHHHHHHHHcc
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENGNL--------------------SQLV--EDEEVDEKQLERMIKVALWCI 721 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--------------------~~~~--d~~~~~~~~~~~l~~l~~~cl 721 (757)
||++|+.||......+.. ..+.... +.. .... +-..........+.+++.+||
T Consensus 218 ell~g~~pf~~~~~~~~l---~~i~~~~--g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL 292 (367)
T 1cm8_A 218 EMITGKTLFKGSDHLDQL---KEIMKVT--GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 292 (367)
T ss_dssp HHHHSSCSSCCSSHHHHH---HHHHHHH--CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHS
T ss_pred HHHhCCCCCCCCCHHHHH---HHHHHhc--CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHc
Confidence 999999999754322111 0010000 000 0000 000111223467889999999
Q ss_pred ccCCCCCCCHHHHHH--HhhcCcC
Q 038168 722 LDEPSLRPSMKKVLL--MLEGTVE 743 (757)
Q Consensus 722 ~~~p~~RPsm~eVl~--~Le~~~~ 743 (757)
+.||++|||+.|+++ .++...+
T Consensus 293 ~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 293 VLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp CSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred cCChhHCCCHHHHhcChHHHhhcC
Confidence 999999999999998 3555443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=304.17 Aligned_cols=211 Identities=24% Similarity=0.299 Sum_probs=173.5
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP---EKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||++
T Consensus 230 ~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~- 308 (543)
T 3c4z_A 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR- 308 (543)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc-
Confidence 56889999999999999999999999999999999999999999998754 24689999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+||||+.++.+||+|||+++.+...... .....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 309 --gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG 385 (543)
T 3c4z_A 309 --NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385 (543)
T ss_dssp --TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred --CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhC
Confidence 9999999999999999999999999999876544322 2345799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM-----KKVLL 736 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm-----~eVl~ 736 (757)
+.||....... ...+. .+....+... .+......+.+++.+||+.||++||++ ++|++
T Consensus 386 ~~PF~~~~~~~--~~~~~-~~~i~~~~~~-------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 386 RGPFRARGEKV--ENKEL-KQRVLEQAVT-------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp SCSSCCTTCCC--CHHHH-HHHHHHCCCC-------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CCCCCCCccch--hHHHH-HHHHhhcccC-------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 99997653321 11121 2222222211 122334678899999999999999976 56653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=291.75 Aligned_cols=218 Identities=26% Similarity=0.398 Sum_probs=161.2
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcC-------CCCCCCHHHHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN-------PEKQPNWVERMGIARDIARGIL 582 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~ia~gL~ 582 (757)
..+++.+|+.++++++||||+++++++...+..++||||+++++|.+++.. ....+++..+..++.|+++||+
T Consensus 56 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 135 (303)
T 2vwi_A 56 SMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135 (303)
T ss_dssp ----------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHH
Confidence 346788999999999999999999999999999999999999999999863 2456899999999999999999
Q ss_pred HhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc----ceecccccCccccCcccccC-CCCCccccchh
Q 038168 583 YLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT----RTFTGIRGTRGYVAPEWHRN-LPITVKADVYS 657 (757)
Q Consensus 583 yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S 657 (757)
|||+. +|+||||||+||+++.++.+||+|||++........ .......||..|+|||.+.+ ..++.++||||
T Consensus 136 ~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 212 (303)
T 2vwi_A 136 YLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWS 212 (303)
T ss_dssp HHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHH
T ss_pred HHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHH
Confidence 99998 999999999999999999999999999987654321 11234568999999999876 56899999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCC--ccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 038168 658 FGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGN--LSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735 (757)
Q Consensus 658 ~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl 735 (757)
||++++||++|+.||......... ........ .................+.+++.+||+.||++||++.|++
T Consensus 213 lG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 286 (303)
T 2vwi_A 213 FGITAIELATGAAPYHKYPPMKVL------MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286 (303)
T ss_dssp HHHHHHHHHHSSCTTTTSCGGGHH------HHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHhCCCCCccCchhhHH------HHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHh
Confidence 999999999999998764332211 11111110 1100111111122345788999999999999999999998
Q ss_pred H
Q 038168 736 L 736 (757)
Q Consensus 736 ~ 736 (757)
+
T Consensus 287 ~ 287 (303)
T 2vwi_A 287 R 287 (303)
T ss_dssp T
T ss_pred h
Confidence 7
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=304.05 Aligned_cols=219 Identities=24% Similarity=0.266 Sum_probs=162.0
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEec------eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEV------SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y 583 (757)
..+.+.+|+.++++++|||||++++++... ...++||||++++ |.+.+.. .+++.++..++.||+.||+|
T Consensus 104 ~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~-l~~~~~~---~l~~~~~~~~~~qil~aL~~ 179 (464)
T 3ttj_A 104 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKH 179 (464)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCC-HHHHHhh---cCCHHHHHHHHHHHHHHHHH
Confidence 356788999999999999999999998654 4679999999865 6666632 48899999999999999999
Q ss_pred hhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHH
Q 038168 584 LHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663 (757)
Q Consensus 584 LH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ 663 (757)
||+. +|+||||||+|||++.++.+||+|||+++...... ..+...||+.|+|||++.+..++.++|||||||+++
T Consensus 180 lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 254 (464)
T 3ttj_A 180 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254 (464)
T ss_dssp HHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred HHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHH
Confidence 9998 99999999999999999999999999998765432 234467899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHH----------------HHHHHHhcC-Cccc-----ccccc------ccCHHHHHHHHH
Q 038168 664 EIICRRRCLDPNLPDDQVILEE----------------WVYQCFENG-NLSQ-----LVEDE------EVDEKQLERMIK 715 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~----------------~~~~~~~~~-~~~~-----~~d~~------~~~~~~~~~l~~ 715 (757)
||++|+.||......++..... .+....... .... ..... .........+.+
T Consensus 255 ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 334 (464)
T 3ttj_A 255 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 334 (464)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHH
Confidence 9999999997543211110000 000000000 0000 00000 011223567899
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 038168 716 VALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 716 l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++.+||+.||++|||++|+++.
T Consensus 335 Ll~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 335 LLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHcCCChhhCCCHHHHhcC
Confidence 9999999999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=300.33 Aligned_cols=219 Identities=23% Similarity=0.316 Sum_probs=166.0
Q ss_pred hHHHHHHHHHHHhhcC-CCceeeeeeEEEece--eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 510 GEREFQTEMKVIGRTH-HRNLVRLLGYSLEVS--KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
..+.+.+|+.+++++. |+||+++++++...+ ..++||||++ ++|.+++.. ..+++..+..++.||++||+|||+
T Consensus 51 ~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~ 127 (388)
T 3oz6_A 51 DAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHS 127 (388)
T ss_dssp HHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3467889999999997 999999999997544 6899999998 589998864 468899999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCC--------------------cceecccccCccccCcccccC
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ--------------------TRTFTGIRGTRGYVAPEWHRN 646 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~ 646 (757)
. +|+||||||+|||++.++.+||+|||+++.+.... ....+...||+.|+|||++.+
T Consensus 128 ~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (388)
T 3oz6_A 128 G---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204 (388)
T ss_dssp T---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred C---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence 8 99999999999999999999999999998764311 122344679999999999886
Q ss_pred -CCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCC-----------------------------c
Q 038168 647 -LPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGN-----------------------------L 696 (757)
Q Consensus 647 -~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-----------------------------~ 696 (757)
..++.++|||||||+++||++|+.||......+.. ..+........ .
T Consensus 205 ~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (388)
T 3oz6_A 205 STKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL---ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNK 281 (388)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----C
T ss_pred CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCH
Confidence 67899999999999999999999999754322111 10111100000 0
Q ss_pred cccccc-------cccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 697 SQLVED-------EEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 697 ~~~~d~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
...... ..........+.+++.+||+.||++|||++|+++.
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 282 RDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp CCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 000000 00000123568899999999999999999999886
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-32 Score=292.89 Aligned_cols=208 Identities=23% Similarity=0.339 Sum_probs=173.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++.. ...+++.++..++.|+++||+|||++
T Consensus 84 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~-- 160 (335)
T 2owb_A 84 QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRN-- 160 (335)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 456789999999999999999999999999999999999999999998854 35689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++....... ......|+..|+|||.+.+..++.++||||||++++||++|+
T Consensus 161 -~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 238 (335)
T 2owb_A 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238 (335)
T ss_dssp -TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCc
Confidence 999999999999999999999999999987653322 223456899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
.||...... +. ......+... .+......+.+++.+||+.||++|||+.|+++
T Consensus 239 ~pf~~~~~~------~~-~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 239 PPFETSCLK------ET-YLRIKKNEYS-------IPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CTTCCSSHH------HH-HHHHHHTCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCCCCCHH------HH-HHHHhcCCCC-------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 998753211 11 1112222211 11122356888999999999999999999997
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=285.68 Aligned_cols=209 Identities=27% Similarity=0.399 Sum_probs=174.2
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++.. ..+++.++..++.|++.||+|||+.
T Consensus 63 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~-- 138 (303)
T 3a7i_A 63 EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSE-- 138 (303)
T ss_dssp THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 457899999999999999999999999999999999999999999999954 5689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+|+||||+||+++.++.+||+|||++........ ......|+..|+|||.+.+..++.++||||||++++||++|+
T Consensus 139 -~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 216 (303)
T 3a7i_A 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216 (303)
T ss_dssp -TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -CCccCCCChheEEECCCCCEEEeecccceecCcccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCC
Confidence 999999999999999999999999999987654332 223456899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
.|+...... . .......+.... ........+.+++..||+.||++|||+.|+++.
T Consensus 217 ~p~~~~~~~------~-~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 217 PPHSELHPM------K-VLFLIPKNNPPT------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CTTTTSCHH------H-HHHHHHHSCCCC------CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCCCCcCHH------H-HHHHhhcCCCCC------CccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 998643221 1 111122222111 112234568899999999999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=288.55 Aligned_cols=212 Identities=23% Similarity=0.339 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.+++.+|+.+++++ +||||+++++++.+.+..++||||+++|+|.+++... ...+++.++..++.|++.||+|||+.
T Consensus 72 ~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~- 150 (327)
T 3lm5_A 72 RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN- 150 (327)
T ss_dssp HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 47899999999999 5699999999999999999999999999999998654 46789999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECC---CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 589 ETQIIHCDIKPQNILMDE---NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~---~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|||++. ++.+||+|||+++....... .....||+.|+|||.+.+..++.++||||||++++||
T Consensus 151 --givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 226 (327)
T 3lm5_A 151 --NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYML 226 (327)
T ss_dssp --TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred --CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHH
Confidence 9999999999999998 78999999999987654322 2345789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++|+.||....... .. ........... ..........+.+++.+||+.||++|||++|+++.
T Consensus 227 l~g~~pf~~~~~~~------~~-~~i~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 227 LTHTSPFVGEDNQE------TY-LNISQVNVDYS---EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHSSCSSCCSSHHH------HH-HHHHHTCCCCC---TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HhCCCCCCCCCchH------HH-HHHHhcccccC---chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 99999986543211 11 11111111111 11112334668899999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-32 Score=303.33 Aligned_cols=153 Identities=25% Similarity=0.407 Sum_probs=129.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec-----eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV-----SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.+.+.+|+.+|++++|+|||++++++... ...|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||
T Consensus 96 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH 173 (458)
T 3rp9_A 96 CKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVH 173 (458)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 46789999999999999999999998533 56899999984 789998865 456899999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc--------------------------ceecccccCcccc
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT--------------------------RTFTGIRGTRGYV 639 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~--------------------------~~~~~~~gt~~y~ 639 (757)
+. +|+||||||+||||+.++.+||+|||+++....... ...+..+||+.|+
T Consensus 174 ~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 250 (458)
T 3rp9_A 174 SA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYR 250 (458)
T ss_dssp HT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTC
T ss_pred hC---CcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCccccccc
Confidence 98 999999999999999999999999999997653221 1234567899999
Q ss_pred Ccccc-cCCCCCccccchhhHHHHHHHHhC
Q 038168 640 APEWH-RNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 640 aPE~~-~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
|||++ .+..++.++|||||||+++||++|
T Consensus 251 aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 251 APELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 99976 566799999999999999999994
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-32 Score=286.05 Aligned_cols=216 Identities=24% Similarity=0.397 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. ...+++.++..++.|++.||+|||+.
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--- 125 (304)
T 2jam_A 50 DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHEN--- 125 (304)
T ss_dssp --HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 45788999999999999999999999999999999999999999998854 34688999999999999999999998
Q ss_pred CeeeCCCCcceEEE---CCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 591 QIIHCDIKPQNILM---DENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill---~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+||++ +.++.+||+|||+++...... .....|+..|+|||.+.+..++.++||||||++++||++
T Consensus 126 ~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 202 (304)
T 2jam_A 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC 202 (304)
T ss_dssp TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHH
T ss_pred CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHH
Confidence 99999999999999 788999999999997654321 223468999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcCcC
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL--MLEGTVE 743 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~--~Le~~~~ 743 (757)
|+.||...... + ....+..+.... +..........+.+++.+||+.||++|||+.|+++ .+++...
T Consensus 203 g~~pf~~~~~~------~-~~~~i~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 203 GYPPFYEETES------K-LFEKIKEGYYEF---ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp SSCTTTTSCHH------H-HHHHHHHCCCCC---CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred CCCCCCCCCHH------H-HHHHHHcCCCCC---CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 99998753221 1 122233332211 11111233467899999999999999999999987 4554433
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=292.12 Aligned_cols=212 Identities=22% Similarity=0.290 Sum_probs=153.8
Q ss_pred HHHHHHHHHHHhhcC-CCceeeeeeEEE--------eceeeeEEEEeccCCChhhhhcC--CCCCCCHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTH-HRNLVRLLGYSL--------EVSKKILVYEYMSNGSLADILFN--PEKQPNWVERMGIARDIAR 579 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-h~niv~l~g~~~--------~~~~~~lV~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~ 579 (757)
.+.+.+|+.+++++. ||||+++++++. .....++|+||+. |+|.+++.. ....+++.++..++.||+.
T Consensus 69 ~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~ 147 (337)
T 3ll6_A 69 NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147 (337)
T ss_dssp HHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHH
Confidence 467899999999996 999999999984 3456899999996 799998854 3456899999999999999
Q ss_pred HHHHhhhCCCCC--eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-----------ecccccCccccCcccc--
Q 038168 580 GILYLHDECETQ--IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-----------FTGIRGTRGYVAPEWH-- 644 (757)
Q Consensus 580 gL~yLH~~~~~~--iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~-- 644 (757)
||+|||+. + |+||||||+|||++.++.+||+|||+++......... .....||..|+|||.+
T Consensus 148 ~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 224 (337)
T 3ll6_A 148 AVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDL 224 (337)
T ss_dssp HHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------C
T ss_pred HHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhc
Confidence 99999998 7 9999999999999999999999999998775433211 1134589999999998
Q ss_pred -cCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHcccc
Q 038168 645 -RNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILD 723 (757)
Q Consensus 645 -~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~ 723 (757)
.+..++.++||||||++++||++|+.||........ ..+...... .......+.+++.+||+.
T Consensus 225 ~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----------~~~~~~~~~-----~~~~~~~~~~li~~~l~~ 288 (337)
T 3ll6_A 225 YSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-----------VNGKYSIPP-----HDTQYTVFHSLIRAMLQV 288 (337)
T ss_dssp CTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------------CCCCT-----TCCSSGGGHHHHHHHSCS
T ss_pred cccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-----------hcCcccCCc-----ccccchHHHHHHHHHccC
Confidence 566789999999999999999999999864322110 011111000 011123478899999999
Q ss_pred CCCCCCCHHHHHHHhhcCc
Q 038168 724 EPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 724 ~p~~RPsm~eVl~~Le~~~ 742 (757)
||++|||+.|+++.|+.+.
T Consensus 289 ~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 289 NPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp SGGGSCCHHHHHHHHHHHH
T ss_pred ChhhCcCHHHHHHHHHHHH
Confidence 9999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-32 Score=290.06 Aligned_cols=199 Identities=22% Similarity=0.289 Sum_probs=168.1
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG-SLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
.+.+|+.++++++||||+++++++.+.+..++||||+..| +|.+++.. ...+++..+..|+.|++.||+|||+. +
T Consensus 75 ~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ 150 (335)
T 3dls_A 75 KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLK---D 150 (335)
T ss_dssp EEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4668999999999999999999999999999999999877 99999865 44689999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCC-CccccchhhHHHHHHHHhCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~G~~l~elltG~~ 670 (757)
|+||||||+|||++.++.+||+|||+++....... .....||+.|+|||.+.+..+ +.++||||||++++||++|+.
T Consensus 151 ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 228 (335)
T 3dls_A 151 IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEEN 228 (335)
T ss_dssp EECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSC
T ss_pred eEEeccCHHHEEEcCCCcEEEeecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCC
Confidence 99999999999999999999999999987755432 233568999999999988876 889999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
||...... ....... +......+.+++.+||+.||++|||+.|+++.
T Consensus 229 pf~~~~~~-----------------~~~~~~~---~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 229 PFCELEET-----------------VEAAIHP---PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SCSSGGGG-----------------TTTCCCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred chhhHHHH-----------------HhhccCC---CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 98642110 0000011 11123568899999999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=293.26 Aligned_cols=217 Identities=19% Similarity=0.258 Sum_probs=160.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++||||+++++++.+.+..++||||++ |+|.+++... ..+++.++..|+.||+.||+|||++
T Consensus 77 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~--- 151 (329)
T 3gbz_A 77 PGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSR--- 151 (329)
T ss_dssp ---CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred chhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 3567899999999999999999999999999999999998 4999998653 4588999999999999999999998
Q ss_pred CeeeCCCCcceEEE-----CCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHH
Q 038168 591 QIIHCDIKPQNILM-----DENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLE 664 (757)
Q Consensus 591 ~iiH~Dik~~Nill-----~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~e 664 (757)
+|+||||||+|||+ +.++.+||+|||+++....... ......||..|+|||.+.+. .++.++||||||++++|
T Consensus 152 ~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 230 (329)
T 3gbz_A 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAE 230 (329)
T ss_dssp TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHH
Confidence 99999999999999 4556699999999987654322 22345679999999999875 48999999999999999
Q ss_pred HHhCCCCCCCCCCCccccHHHHHHHHHhcCC---cc-------------cccccc---ccCHHHHHHHHHHHHHccccCC
Q 038168 665 IICRRRCLDPNLPDDQVILEEWVYQCFENGN---LS-------------QLVEDE---EVDEKQLERMIKVALWCILDEP 725 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~-------------~~~d~~---~~~~~~~~~l~~l~~~cl~~~p 725 (757)
|++|+.||......+ .+.. +........ .. ...... ........++.+++.+||+.||
T Consensus 231 ll~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 307 (329)
T 3gbz_A 231 MLMKTPLFPGDSEID--QLFK-IFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDP 307 (329)
T ss_dssp HHHSSCSSCCSSHHH--HHHH-HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSG
T ss_pred HHHCCCCcCCCCHHH--HHHH-HHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCCh
Confidence 999999987543211 1111 111110000 00 000000 0011123678899999999999
Q ss_pred CCCCCHHHHHH
Q 038168 726 SLRPSMKKVLL 736 (757)
Q Consensus 726 ~~RPsm~eVl~ 736 (757)
++|||+.|+++
T Consensus 308 ~~R~t~~e~l~ 318 (329)
T 3gbz_A 308 VKRISAKNALE 318 (329)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHhC
Confidence 99999999987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-32 Score=282.90 Aligned_cols=204 Identities=21% Similarity=0.299 Sum_probs=168.0
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP---EKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
...++.+|+..+.++ +||||+++++++.+.+..++||||+++++|.+++... ...+++.++..++.||++||+|||
T Consensus 53 ~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH 132 (289)
T 1x8b_A 53 DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132 (289)
T ss_dssp HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 467889999999999 9999999999999999999999999999999999653 256899999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECC-------------------CCcEEEeecCCccccCCCCcceecccccCccccCcccccC
Q 038168 586 DECETQIIHCDIKPQNILMDE-------------------NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN 646 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~-------------------~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 646 (757)
++ +|+||||||+|||++. ...+||+|||++........ ..||..|+|||.+.+
T Consensus 133 ~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~ 204 (289)
T 1x8b_A 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQE 204 (289)
T ss_dssp HT---TEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTT
T ss_pred hC---CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCccc-----cCCCccccChhHhcC
Confidence 98 9999999999999984 44799999999987654332 358999999999987
Q ss_pred C-CCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCC
Q 038168 647 L-PITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEP 725 (757)
Q Consensus 647 ~-~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p 725 (757)
. .+++++||||||++++||++|..++... . ....+..+....+ +......+.+++.+||+.||
T Consensus 205 ~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~-----~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dp 268 (289)
T 1x8b_A 205 NYTHLPKADIFALALTVVCAAGAEPLPRNG-----D-----QWHEIRQGRLPRI------PQVLSQEFTELLKVMIHPDP 268 (289)
T ss_dssp CCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----H-----HHHHHHTTCCCCC------SSCCCHHHHHHHHHHTCSSG
T ss_pred CCCCCchhhHHHHHHHHHHHhcCCCCCcch-----h-----HHHHHHcCCCCCC------CcccCHHHHHHHHHHhCCCc
Confidence 6 6678999999999999999998765321 1 1222333333222 11234568899999999999
Q ss_pred CCCCCHHHHHHH
Q 038168 726 SLRPSMKKVLLM 737 (757)
Q Consensus 726 ~~RPsm~eVl~~ 737 (757)
++|||+.|+++.
T Consensus 269 ~~Rps~~~ll~h 280 (289)
T 1x8b_A 269 ERRPSAMALVKH 280 (289)
T ss_dssp GGSCCHHHHHTC
T ss_pred ccCCCHHHHhhC
Confidence 999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-32 Score=293.89 Aligned_cols=214 Identities=21% Similarity=0.356 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. .
T Consensus 75 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~--~ 151 (360)
T 3eqc_A 75 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREK--H 151 (360)
T ss_dssp HHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHH--H
T ss_pred HHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHh--C
Confidence 46789999999999999999999999999999999999999999999965 34688999999999999999999983 1
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++..... ......||..|+|||.+.+..++.++||||||++++||++|+.
T Consensus 152 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 228 (360)
T 3eqc_A 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 228 (360)
T ss_dssp CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSC
T ss_pred CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 7999999999999999999999999999755321 1233578999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccH------------------------------------HHHHHHHHhcCCccccccccccCHHHHHHHH
Q 038168 671 CLDPNLPDDQVIL------------------------------------EEWVYQCFENGNLSQLVEDEEVDEKQLERMI 714 (757)
Q Consensus 671 p~~~~~~~~~~~l------------------------------------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~ 714 (757)
||........... .+.. +....+.... .........+.
T Consensus 229 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~ 302 (360)
T 3eqc_A 229 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL-DYIVNEPPPK-----LPSGVFSLEFQ 302 (360)
T ss_dssp CSSCCCHHHHHHHHC------------------------------CCCHHHHH-HHHHHSCCCC-----CCTTTSCHHHH
T ss_pred CCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhh-hHHhccCCCC-----CCcccccHHHH
Confidence 9975432110000 0000 0000010000 01112345689
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 038168 715 KVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 715 ~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+++.+||+.||++|||++|+++
T Consensus 303 ~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 303 DFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhcChhhCCCHHHHhh
Confidence 9999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-32 Score=286.30 Aligned_cols=212 Identities=21% Similarity=0.341 Sum_probs=169.2
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++......+++.++..++.|++.||+|||+.
T Consensus 59 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-- 136 (302)
T 2j7t_A 59 ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK-- 136 (302)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC--
Confidence 357899999999999999999999999999999999999999999999876667799999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccc-----cCCCCCccccchhhHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWH-----RNLPITVKADVYSFGVVLLE 664 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~k~Dv~S~G~~l~e 664 (757)
+++||||||+||+++.++.+||+|||++....... .......|+..|+|||.+ .+..++.++||||||++++|
T Consensus 137 -~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 214 (302)
T 2j7t_A 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214 (302)
T ss_dssp -TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHH
T ss_pred -CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHH
Confidence 99999999999999999999999999976432111 112234689999999988 36678999999999999999
Q ss_pred HHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 665 IICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|++|+.|+...... ...... ..+.......+. .....+.+++.+||+.||++|||+.|+++
T Consensus 215 l~~g~~p~~~~~~~------~~~~~~-~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 215 MAQIEPPHHELNPM------RVLLKI-AKSDPPTLLTPS----KWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHSSCTTTTSCHH------HHHHHH-HHSCCCCCSSGG----GSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HhcCCCCCccCCHH------HHHHHH-hccCCcccCCcc----ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 99999998754221 111122 222222222222 22456889999999999999999999976
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=283.84 Aligned_cols=212 Identities=25% Similarity=0.321 Sum_probs=168.5
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE--KQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..+.+.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++.... ..+++..+..++.|+++||+|||+.
T Consensus 62 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 141 (295)
T 2clq_A 62 YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141 (295)
T ss_dssp --HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC
Confidence 35779999999999999999999999999999999999999999999997543 3457888999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECC-CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCC--CCccccchhhHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMDE-NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP--ITVKADVYSFGVVLLE 664 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~-~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~G~~l~e 664 (757)
+|+|+||||+||+++. ++.+||+|||+++....... ......|+..|+|||.+.+.. ++.++||||||++++|
T Consensus 142 ---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~ 217 (295)
T 2clq_A 142 ---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE 217 (295)
T ss_dssp ---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHH
T ss_pred ---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHH
Confidence 9999999999999987 89999999999987654321 223456899999999987654 8899999999999999
Q ss_pred HHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 665 IICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|++|+.||........ . .......... ...+.....++.+++.+||+.||++||++.|+++
T Consensus 218 l~~g~~pf~~~~~~~~----~-~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 218 MATGKPPFYELGEPQA----A-MFKVGMFKVH------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHTSCTTGGGSSHHH----H-HHHHHHHCCC------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHCCCCccCCCchhH----H-HHhhcccccc------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9999999864322111 0 1111111111 1112233467889999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=293.33 Aligned_cols=220 Identities=22% Similarity=0.281 Sum_probs=171.1
Q ss_pred hHHHHHHHHHHHhhcC--------CCceeeeeeEEE----eceeeeEEEEeccCCChhhhh-cCCCCCCCHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTH--------HRNLVRLLGYSL----EVSKKILVYEYMSNGSLADIL-FNPEKQPNWVERMGIARD 576 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~--------h~niv~l~g~~~----~~~~~~lV~e~~~~gsL~~~l-~~~~~~l~~~~~~~i~~~ 576 (757)
..+.+.+|+.++++++ |+||+++++++. +....++||||+. ++|.+++ ......+++.++..++.|
T Consensus 76 ~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~q 154 (397)
T 1wak_A 76 YTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQ 154 (397)
T ss_dssp HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHH
Confidence 3577889999999996 788999999987 5668899999995 5555555 444467899999999999
Q ss_pred HHHHHHHhhhCCCCCeeeCCCCcceEEECCCC------------------------------------------------
Q 038168 577 IARGILYLHDECETQIIHCDIKPQNILMDENR------------------------------------------------ 608 (757)
Q Consensus 577 ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~------------------------------------------------ 608 (757)
|+.||+|||+++ +|+||||||+|||++.++
T Consensus 155 i~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (397)
T 1wak_A 155 VLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEK 232 (397)
T ss_dssp HHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGG
T ss_pred HHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccc
Confidence 999999999852 899999999999999775
Q ss_pred -cEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHH
Q 038168 609 -CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWV 687 (757)
Q Consensus 609 -~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~ 687 (757)
.+||+|||+++..... .....||..|+|||.+.+..++.++|||||||+++||++|+.||...............
T Consensus 233 ~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 308 (397)
T 1wak_A 233 LKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308 (397)
T ss_dssp CCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHH
T ss_pred cceEecccccccccccc----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHH
Confidence 7999999999876533 23356899999999999999999999999999999999999999876544322111111
Q ss_pred HHHHh-----------cCCc-----------cccc------------cccccCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 038168 688 YQCFE-----------NGNL-----------SQLV------------EDEEVDEKQLERMIKVALWCILDEPSLRPSMKK 733 (757)
Q Consensus 688 ~~~~~-----------~~~~-----------~~~~------------d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~e 733 (757)
..... .+.. ..+. .....+.+....+.+++.+||+.||++|||+.|
T Consensus 309 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 388 (397)
T 1wak_A 309 ALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 388 (397)
T ss_dssp HHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHH
T ss_pred HHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHH
Confidence 11110 0110 0000 011235677788999999999999999999999
Q ss_pred HHH
Q 038168 734 VLL 736 (757)
Q Consensus 734 Vl~ 736 (757)
|++
T Consensus 389 ~l~ 391 (397)
T 1wak_A 389 CLR 391 (397)
T ss_dssp HHT
T ss_pred Hhh
Confidence 986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=280.10 Aligned_cols=210 Identities=25% Similarity=0.392 Sum_probs=167.4
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEE--eceeeeEEEEeccCCChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSL--EVSKKILVYEYMSNGSLADILFN-PEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
..+.+.+|++++++++|+||+++++++. +.+..++||||++++ |.+++.. ....+++.++..++.|+++||+|||+
T Consensus 49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~ 127 (305)
T 2wtk_C 49 GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS 127 (305)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH
Confidence 4578999999999999999999999984 455789999999987 6666643 34678999999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCC-cceecccccCccccCcccccCCC--CCccccchhhHHHHH
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ-TRTFTGIRGTRGYVAPEWHRNLP--ITVKADVYSFGVVLL 663 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~G~~l~ 663 (757)
+ +|+||||||+|||++.++.+||+|||++....... ........|+..|+|||.+.+.. .+.++||||||++++
T Consensus 128 ~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~ 204 (305)
T 2wtk_C 128 Q---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLY 204 (305)
T ss_dssp T---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHH
T ss_pred C---CeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHH
Confidence 8 99999999999999999999999999998765432 22333466899999999987654 478999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
||++|+.|+..... .+ ....+..+.... +......+.+++.+||+.||++|||+.|+++.
T Consensus 205 ~l~~g~~p~~~~~~------~~-~~~~i~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 205 NITTGLYPFEGDNI------YK-LFENIGKGSYAI-------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHSSCSCCCSSH------HH-HHHHHHHCCCCC-------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHhCCCCCCCchH------HH-HHHHHhcCCCCC-------CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 99999999875321 11 122233332211 11234568899999999999999999999974
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=297.25 Aligned_cols=212 Identities=25% Similarity=0.338 Sum_probs=159.9
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCC------CHHHHHHHHHHHHHHHHHh
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP------NWVERMGIARDIARGILYL 584 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l------~~~~~~~i~~~ia~gL~yL 584 (757)
+.+.+|+++++++ +|||||++++++.+.+..++||||++ |+|.+++....... .+..+..++.||+.||+||
T Consensus 53 ~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 131 (434)
T 2rio_A 53 DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131 (434)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHH
Confidence 5678999999987 89999999999999999999999996 69999997643221 2334578999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCC-------------CcEEEeecCCccccCCCCcc---eecccccCccccCcccccC--
Q 038168 585 HDECETQIIHCDIKPQNILMDEN-------------RCAKISDFGLAKLMKPDQTR---TFTGIRGTRGYVAPEWHRN-- 646 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~-------------~~~ki~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-- 646 (757)
|+. +|+||||||+|||++.+ ..+||+|||+++........ ......||+.|+|||++.+
T Consensus 132 H~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 208 (434)
T 2rio_A 132 HSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESN 208 (434)
T ss_dssp HHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCC
T ss_pred HHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccc
Confidence 998 99999999999999654 58999999999987654322 2234679999999999876
Q ss_pred -----CCCCccccchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHc
Q 038168 647 -----LPITVKADVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWC 720 (757)
Q Consensus 647 -----~~~~~k~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~c 720 (757)
..++.++|||||||+++||++ |+.||....... . . +..+.......+.........++.+++.+|
T Consensus 209 ~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----~----~-i~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 279 (434)
T 2rio_A 209 NLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE----S----N-IIRGIFSLDEMKCLHDRSLIAEATDLISQM 279 (434)
T ss_dssp TTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----H----H-HHHTCCCCCCCTTCCCHHHHHHHHHHHHHH
T ss_pred ccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----H----H-HhcCCCCcccccccccccchHHHHHHHHHH
Confidence 678999999999999999999 899986443211 0 1 111111111111123456678899999999
Q ss_pred cccCCCCCCCHHHHHH
Q 038168 721 ILDEPSLRPSMKKVLL 736 (757)
Q Consensus 721 l~~~p~~RPsm~eVl~ 736 (757)
|+.||++|||+.||++
T Consensus 280 L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 280 IDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TCSSGGGSCCHHHHHT
T ss_pred hhCChhhCCCHHHHHh
Confidence 9999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=301.79 Aligned_cols=210 Identities=24% Similarity=0.350 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++||||+++++++.+....++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+.
T Consensus 65 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~--- 140 (486)
T 3mwu_A 65 TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKH--- 140 (486)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 56789999999999999999999999999999999999999999998864 35689999999999999999999998
Q ss_pred CeeeCCCCcceEEEC---CCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 591 QIIHCDIKPQNILMD---ENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~---~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+ .++.++||||+|+++++|++
T Consensus 141 ~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~ 217 (486)
T 3mwu_A 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS 217 (486)
T ss_dssp TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHH
T ss_pred CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHh
Confidence 999999999999995 45679999999998765432 2334578999999999876 59999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|+.||...... + ....+..+........ .......+.+++.+||+.||++|||+.|+++.
T Consensus 218 g~~pf~~~~~~------~-~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 218 GTPPFYGKNEY------D-ILKRVETGKYAFDLPQ---WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SSCSSCCSSHH------H-HHHHHHHTCCCSCSGG---GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCCCCCCHH------H-HHHHHHhCCCCCCCcc---cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 99999754221 1 2223333333221111 11234568899999999999999999999984
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=299.42 Aligned_cols=157 Identities=23% Similarity=0.354 Sum_probs=133.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec-----eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV-----SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.+.+.+|+.++++++|+||+++++++... +..++||||++ ++|.+++.. ...+++..+..++.||++||+|||
T Consensus 69 ~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH 146 (432)
T 3n9x_A 69 CKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIH 146 (432)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 46889999999999999999999999766 57899999987 599999865 456899999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc---------------------ceecccccCccccCcccc
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT---------------------RTFTGIRGTRGYVAPEWH 644 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~ 644 (757)
+. +|+||||||+|||++.++.+||+|||+++....... ...+..+||+.|+|||.+
T Consensus 147 ~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 223 (432)
T 3n9x_A 147 ES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI 223 (432)
T ss_dssp HT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHH
T ss_pred HC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHH
Confidence 98 999999999999999999999999999997754322 123557899999999986
Q ss_pred -cCCCCCccccchhhHHHHHHHHhCCCCC
Q 038168 645 -RNLPITVKADVYSFGVVLLEIICRRRCL 672 (757)
Q Consensus 645 -~~~~~~~k~Dv~S~G~~l~elltG~~p~ 672 (757)
....++.++||||+||+++||++|..|+
T Consensus 224 ~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 224 LLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp TTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred hcCCCCCcccccchHHHHHHHHHhccccc
Confidence 5667999999999999999999865444
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-32 Score=291.44 Aligned_cols=219 Identities=26% Similarity=0.373 Sum_probs=167.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.
T Consensus 68 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~--- 143 (331)
T 4aaa_A 68 KKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSH--- 143 (331)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46688999999999999999999999999999999999999999988654 45689999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+++....... ......|+..|+|||.+.+. .++.++||||||++++||++|+
T Consensus 144 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 222 (331)
T 4aaa_A 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222 (331)
T ss_dssp TCCCCCCCGGGEEECTTSCEEECCCTTC-------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSS
T ss_pred CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999987654322 22335689999999998875 7899999999999999999999
Q ss_pred CCCCCCCCCccccHHHHH----------HHHHhcC------Cccccccccc---cCHHHHHHHHHHHHHccccCCCCCCC
Q 038168 670 RCLDPNLPDDQVILEEWV----------YQCFENG------NLSQLVEDEE---VDEKQLERMIKVALWCILDEPSLRPS 730 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~----------~~~~~~~------~~~~~~d~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs 730 (757)
.||......+.. .... ...+... .......... ......+.+.+++.+||+.||++|||
T Consensus 223 ~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 300 (331)
T 4aaa_A 223 PLFPGDSDIDQL--YHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF 300 (331)
T ss_dssp CSCCCSSHHHHH--HHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCCcHHHH--HHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCC
Confidence 998754332111 1100 0001111 1111111110 11123567999999999999999999
Q ss_pred HHHHHH
Q 038168 731 MKKVLL 736 (757)
Q Consensus 731 m~eVl~ 736 (757)
+.|+++
T Consensus 301 ~~ell~ 306 (331)
T 4aaa_A 301 CAELLH 306 (331)
T ss_dssp GGGGGG
T ss_pred HHHHhc
Confidence 999886
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=302.12 Aligned_cols=200 Identities=12% Similarity=0.157 Sum_probs=156.4
Q ss_pred hHHHHHHHH---HHHhhcCCCceeeee-------eEEEece-----------------eeeEEEEeccCCChhhhhcCCC
Q 038168 510 GEREFQTEM---KVIGRTHHRNLVRLL-------GYSLEVS-----------------KKILVYEYMSNGSLADILFNPE 562 (757)
Q Consensus 510 ~~~~~~~E~---~~l~~l~h~niv~l~-------g~~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~ 562 (757)
..+.|.+|+ +++++++|||||+++ +++.+.+ ..++||||+ +|+|.+++....
T Consensus 116 ~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~ 194 (377)
T 3byv_A 116 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL 194 (377)
T ss_dssp HHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc
Confidence 457899999 556666899999998 5555442 278999999 689999996532
Q ss_pred C------CCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCc
Q 038168 563 K------QPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTR 636 (757)
Q Consensus 563 ~------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~ 636 (757)
. .+++..+..|+.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.... ......| .
T Consensus 195 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~ 266 (377)
T 3byv_A 195 SHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-R 266 (377)
T ss_dssp HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-T
T ss_pred ccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-c
Confidence 2 233688889999999999999998 999999999999999999999999999986432 2334567 9
Q ss_pred cccCcccccCC-----------CCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCcccccccccc
Q 038168 637 GYVAPEWHRNL-----------PITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEV 705 (757)
Q Consensus 637 ~y~aPE~~~~~-----------~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 705 (757)
.|+|||.+.+. .++.++||||||++++||++|+.||.......... .+...
T Consensus 267 ~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~---------------~~~~~--- 328 (377)
T 3byv_A 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE---------------WIFRS--- 328 (377)
T ss_dssp TCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG---------------GGGSS---
T ss_pred CccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh---------------hhhhh---
Confidence 99999999887 89999999999999999999999986543322110 11110
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 706 DEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 706 ~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
.......+.+++.+||+.||++|||+.|+++
T Consensus 329 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 329 CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 0122356889999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=285.74 Aligned_cols=214 Identities=22% Similarity=0.357 Sum_probs=174.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhh------hcCC-CCCCCHHHHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADI------LFNP-EKQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~ia~gL~y 583 (757)
.+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.++ +... ...+++..+..++.|++.||+|
T Consensus 87 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~ 166 (348)
T 2pml_X 87 YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSY 166 (348)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHH
Confidence 37899999999999999999999999999999999999999999998 6543 4678999999999999999999
Q ss_pred hhh-CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCc-cccchhhHH
Q 038168 584 LHD-ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITV-KADVYSFGV 660 (757)
Q Consensus 584 LH~-~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-k~Dv~S~G~ 660 (757)
||+ . +|+|+||||+||+++.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+
T Consensus 167 lH~~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 240 (348)
T 2pml_X 167 IHNEK---NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240 (348)
T ss_dssp HHHTS---CEECCCCCGGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHH
T ss_pred HhccC---CEeecCCChHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHH
Confidence 998 7 9999999999999999999999999999876443 33446789999999999887 6666 999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccc------------cCHHHHHHHHHHHHHccccCCCCC
Q 038168 661 VLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEE------------VDEKQLERMIKVALWCILDEPSLR 728 (757)
Q Consensus 661 ~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~------------~~~~~~~~l~~l~~~cl~~~p~~R 728 (757)
+++||++|+.||........ ....+..+......+... ........+.+++.+||+.||++|
T Consensus 241 il~~l~~g~~pf~~~~~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 314 (348)
T 2pml_X 241 CLYVMFYNVVPFSLKISLVE------LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314 (348)
T ss_dssp HHHHHHHSSCSSCCSSCSHH------HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHHhCCCCCCCCCcHHH------HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhC
Confidence 99999999999976543211 122233332221111000 012334678999999999999999
Q ss_pred CCHHHHHH
Q 038168 729 PSMKKVLL 736 (757)
Q Consensus 729 Psm~eVl~ 736 (757)
||+.|+++
T Consensus 315 ps~~e~l~ 322 (348)
T 2pml_X 315 ITSEDALK 322 (348)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhc
Confidence 99999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=283.68 Aligned_cols=212 Identities=27% Similarity=0.422 Sum_probs=163.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe-------------ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE-------------VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDI 577 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 577 (757)
.+.+.+|+.++++++||||+++++++.+ .+..++||||+++++|.+++......+++.++..++.|+
T Consensus 46 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi 125 (303)
T 1zy4_A 46 LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125 (303)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHH
Confidence 4678999999999999999999998865 467899999999999999997666677889999999999
Q ss_pred HHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCC-------------cceecccccCccccCcccc
Q 038168 578 ARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ-------------TRTFTGIRGTRGYVAPEWH 644 (757)
Q Consensus 578 a~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~ 644 (757)
++||+|||++ +|+||||||+|||++.++.+||+|||+++...... ........|+..|+|||.+
T Consensus 126 ~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 202 (303)
T 1zy4_A 126 LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVL 202 (303)
T ss_dssp HHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHH
T ss_pred HHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccc
Confidence 9999999998 99999999999999999999999999998765321 1122345689999999998
Q ss_pred cCC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHcccc
Q 038168 645 RNL-PITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILD 723 (757)
Q Consensus 645 ~~~-~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~ 723 (757)
.+. .++.++||||||++++||++ |+... ....+ ....+...... -+..........+.+++.+||+.
T Consensus 203 ~~~~~~~~~~Di~slG~il~~l~~---p~~~~-----~~~~~-~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~ 270 (303)
T 1zy4_A 203 DGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-----MERVN-ILKKLRSVSIE---FPPDFDDNKMKVEKKIIRLLIDH 270 (303)
T ss_dssp TSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHHHH-HHHHHHSTTCC---CCTTCCTTTSHHHHHHHHHHTCS
T ss_pred cCCCCCcchhhHHHHHHHHHHHHh---ccCCc-----hhHHH-HHHhccccccc---cCccccccchHHHHHHHHHHHhc
Confidence 865 78999999999999999998 33211 01111 12222222111 11223344456788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 038168 724 EPSLRPSMKKVLLM 737 (757)
Q Consensus 724 ~p~~RPsm~eVl~~ 737 (757)
||++|||+.|+++.
T Consensus 271 dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 271 DPNKRPGARTLLNS 284 (303)
T ss_dssp SGGGSCCHHHHHHS
T ss_pred CcccCcCHHHHhCC
Confidence 99999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=288.37 Aligned_cols=207 Identities=21% Similarity=0.207 Sum_probs=162.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
...+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. ...++..++..++.||+.||+|||++
T Consensus 65 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~--- 140 (327)
T 3a62_A 65 TAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQK--- 140 (327)
T ss_dssp ------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 45678899999999999999999999999999999999999999999864 34678889999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+..++.++||||||++++||++|+.
T Consensus 141 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 219 (327)
T 3a62_A 141 GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219 (327)
T ss_dssp TCCCCCCCTTTEEECTTSCEEECCCSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CEEcccCCHHHeEECCCCcEEEEeCCcccccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCC
Confidence 999999999999999999999999999986443222 2234678999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~ 736 (757)
||...... +.... +..+... .+......+.+++.+||+.||++|| ++.|+++
T Consensus 220 pf~~~~~~------~~~~~-i~~~~~~-------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 220 PFTGENRK------KTIDK-ILKCKLN-------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp SCCCSSHH------HHHHH-HHHTCCC-------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCCCCHH------HHHHH-HHhCCCC-------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 99753221 11112 2222211 1122346788999999999999999 7778876
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=294.69 Aligned_cols=223 Identities=20% Similarity=0.247 Sum_probs=158.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe--ceeeeEEEEeccCCChhhhhcCC--------CCCCCHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE--VSKKILVYEYMSNGSLADILFNP--------EKQPNWVERMGIARDIARG 580 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~g 580 (757)
.+.+.+|+.+|++++||||+++++++.. ....++||||+++ +|.+++... ...+++..+..|+.||+.|
T Consensus 62 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 140 (405)
T 3rgf_A 62 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140 (405)
T ss_dssp CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHH
Confidence 3578899999999999999999999954 6688999999974 787777421 2348999999999999999
Q ss_pred HHHhhhCCCCCeeeCCCCcceEEE----CCCCcEEEeecCCccccCCCCc--ceecccccCccccCcccccCC-CCCccc
Q 038168 581 ILYLHDECETQIIHCDIKPQNILM----DENRCAKISDFGLAKLMKPDQT--RTFTGIRGTRGYVAPEWHRNL-PITVKA 653 (757)
Q Consensus 581 L~yLH~~~~~~iiH~Dik~~Nill----~~~~~~ki~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~ 653 (757)
|+|||+. +|+||||||+|||| +.++.+||+|||+++.+..... .......||+.|+|||++.+. .++.++
T Consensus 141 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 217 (405)
T 3rgf_A 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI 217 (405)
T ss_dssp HHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHH
T ss_pred HHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchh
Confidence 9999998 99999999999999 6778999999999987754322 223446789999999999874 589999
Q ss_pred cchhhHHHHHHHHhCCCCCCCCCCCc------cccHHHHHHHHHhcCC---cccccc------------ccc---cC---
Q 038168 654 DVYSFGVVLLEIICRRRCLDPNLPDD------QVILEEWVYQCFENGN---LSQLVE------------DEE---VD--- 706 (757)
Q Consensus 654 Dv~S~G~~l~elltG~~p~~~~~~~~------~~~l~~~~~~~~~~~~---~~~~~d------------~~~---~~--- 706 (757)
|||||||+++||++|+.||.....+. .......+...+.... ...+.. ... ..
T Consensus 218 DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (405)
T 3rgf_A 218 DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIK 297 (405)
T ss_dssp HHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHH
T ss_pred hhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhh
Confidence 99999999999999999997654321 0011111111111000 000000 000 00
Q ss_pred ------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 707 ------EKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 707 ------~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
......+.+++.+||+.||++|||++|+++.
T Consensus 298 ~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 298 YMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0013567899999999999999999999984
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=277.67 Aligned_cols=207 Identities=22% Similarity=0.383 Sum_probs=164.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++... ..+++.++..++.|++.||+|||+.
T Consensus 55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~--- 130 (276)
T 2h6d_A 55 VGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRH--- 130 (276)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 457889999999999999999999999999999999999999999999643 4588999999999999999999999
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCC-CccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+|+||||+||+++.++.+||+|||++........ .....++..|+|||.+.+... +.++||||||++++||++|+
T Consensus 131 ~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 208 (276)
T 2h6d_A 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208 (276)
T ss_dssp CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSS
T ss_pred CCccCCCChhhEEECCCCCEEEeecccccccCCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999987654322 223468999999999988765 68999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
.||..... .. ..+....+... .+......+.+++.+||+.||++|||+.||++.
T Consensus 209 ~p~~~~~~------~~-~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 209 LPFDDEHV------PT-LFKKIRGGVFY-------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CSSCCSSH------HH-HHHHHHHCCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCCCCcH------HH-HHHHhhcCccc-------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 99864321 11 12222322211 111223568899999999999999999999984
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=292.19 Aligned_cols=217 Identities=23% Similarity=0.259 Sum_probs=161.9
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEec-----eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEV-----SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
+.+.+|+.++++++||||+++++++... ...++||||++ |+|.+++......+++..+..++.||+.||+|||+
T Consensus 74 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 152 (362)
T 3pg1_A 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE 152 (362)
T ss_dssp HHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 7899999999999999999999998543 36799999998 68988888777789999999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHH
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~el 665 (757)
. +|+||||||+|||++.++.+||+|||+++....... .....||..|+|||.+.+ ..++.++||||||++++||
T Consensus 153 ~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 227 (362)
T 3pg1_A 153 A---GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227 (362)
T ss_dssp T---TCCCCCCCGGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHH
T ss_pred C---cCEecCCChHHEEEcCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHH
Confidence 8 999999999999999999999999999985543322 234568999999999877 6789999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCC-------------------ccccccc--cccCHHHHHHHHHHHHHccccC
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGN-------------------LSQLVED--EEVDEKQLERMIKVALWCILDE 724 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-------------------~~~~~d~--~~~~~~~~~~l~~l~~~cl~~~ 724 (757)
++|+.||......+. ...+........ ....... ..........+.+++.+||+.|
T Consensus 228 ~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 304 (362)
T 3pg1_A 228 FNRKALFRGSTFYNQ---LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFN 304 (362)
T ss_dssp HHSSCSCCCSSHHHH---HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSS
T ss_pred HhCCCCCCCCCHHHH---HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCC
Confidence 999999975432111 111111110000 0000000 0011223456889999999999
Q ss_pred CCCCCCHHHHHHH
Q 038168 725 PSLRPSMKKVLLM 737 (757)
Q Consensus 725 p~~RPsm~eVl~~ 737 (757)
|++|||+.|+++.
T Consensus 305 P~~Rpt~~ell~h 317 (362)
T 3pg1_A 305 PQRRISTEQALRH 317 (362)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhhCCCHHHHHcC
Confidence 9999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=303.98 Aligned_cols=210 Identities=25% Similarity=0.374 Sum_probs=174.0
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.. ...+++.++..++.||+.||+|||++
T Consensus 69 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-- 145 (484)
T 3nyv_A 69 DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKN-- 145 (484)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 467899999999999999999999999999999999999999999999865 45689999999999999999999998
Q ss_pred CCeeeCCCCcceEEE---CCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 590 TQIIHCDIKPQNILM---DENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 590 ~~iiH~Dik~~Nill---~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+|+||||||+|||+ +.++.+||+|||+++.+..... .....||+.|+|||.+.+ .++.++||||+|+++|||+
T Consensus 146 -~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll 221 (484)
T 3nyv_A 146 -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILL 221 (484)
T ss_dssp -TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHH
T ss_pred -CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHH
Confidence 99999999999999 5678999999999987754432 234568999999999876 6899999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+|+.||...... + ....+..+........ .......+.+++.+||+.+|++|||+.|+++
T Consensus 222 ~g~~pf~~~~~~------~-~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 222 SGCPPFNGANEY------D-ILKKVEKGKYTFELPQ---WKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HSSCSSCCSSHH------H-HHHHHHHCCCCCCSGG---GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HCCCCCCCCCHH------H-HHHHHHcCCCCCCCcc---cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 999999754321 1 2223333433211111 1123456889999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=302.58 Aligned_cols=209 Identities=25% Similarity=0.362 Sum_probs=170.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|||||++++++.+....++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.
T Consensus 80 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~--- 155 (494)
T 3lij_A 80 NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKH--- 155 (494)
T ss_dssp THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46789999999999999999999999999999999999999999998854 35688999999999999999999998
Q ss_pred CeeeCCCCcceEEECCC---CcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 591 QIIHCDIKPQNILMDEN---RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~---~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++
T Consensus 156 ~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~ 232 (494)
T 3lij_A 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA 232 (494)
T ss_dssp TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH
T ss_pred CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHh
Confidence 99999999999999764 559999999998765432 233467999999999876 469999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|+.||...... + +...+..+....... ........+.+++.+||+.+|++|||+.|+++
T Consensus 233 g~~pf~~~~~~------~-~~~~i~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 233 GYPPFGGQTDQ------E-ILRKVEKGKYTFDSP---EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SSCSSCCSSHH------H-HHHHHHHTCCCCCSG---GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCCHH------H-HHHHHHhCCCCCCch---hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 99999754321 1 223333333221110 01123456889999999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-32 Score=292.65 Aligned_cols=213 Identities=23% Similarity=0.249 Sum_probs=172.4
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+.+.+|+++++++ +|+||+++++++.+.+..++||||+++|+|.+++.. ...+++.++..++.||++||+|||+.
T Consensus 103 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--- 178 (355)
T 1vzo_A 103 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKL--- 178 (355)
T ss_dssp GGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 4466799999999 699999999999999999999999999999999964 34688999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC--CCCCccccchhhHHHHHHHHhC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN--LPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+|||++.++.+||+|||+++.+............||+.|+|||.+.+ ..++.++||||||++++||++|
T Consensus 179 ~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g 258 (355)
T 1vzo_A 179 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258 (355)
T ss_dssp TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHS
T ss_pred CcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHC
Confidence 99999999999999999999999999998776544444455679999999999986 3578999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHh
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLLML 738 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~~L 738 (757)
+.||........ .......... ... ..+.+....+.+++.+||+.||++|| ++.|+++..
T Consensus 259 ~~pf~~~~~~~~--~~~~~~~~~~-~~~-------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 259 ASPFTVDGEKNS--QAEISRRILK-SEP-------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp SCTTSCTTSCCC--HHHHHHHHHH-CCC-------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CCCCccCCccch--HHHHHHHHhc-cCC-------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 999975433221 1222222221 111 11223346688999999999999999 999998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=290.67 Aligned_cols=219 Identities=26% Similarity=0.346 Sum_probs=172.1
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|++++++++|+||+++++++.+.+..++||||+++ +|.+++......+++.++..++.|+++||+|||+. +
T Consensus 57 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ 132 (346)
T 1ua2_A 57 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---W 132 (346)
T ss_dssp THHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 4678999999999999999999999999999999999986 89999877667788999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+. .++.++||||||++++||++|..
T Consensus 133 ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 211 (346)
T 1ua2_A 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211 (346)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EECCCCCHHHEEEcCCCCEEEEecccceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 9999999999999999999999999998765432 223345789999999998764 58999999999999999999998
Q ss_pred CCCCCCCCccccHHHHHHHHHhcC---Ccccc------ccc---cccC-----HHHHHHHHHHHHHccccCCCCCCCHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENG---NLSQL------VED---EEVD-----EKQLERMIKVALWCILDEPSLRPSMKK 733 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~------~d~---~~~~-----~~~~~~l~~l~~~cl~~~p~~RPsm~e 733 (757)
|+......+ .+.. +....... ..... ... ...+ ......+.+++.+||+.||++|||+.|
T Consensus 212 ~~~~~~~~~--~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 288 (346)
T 1ua2_A 212 FLPGDSDLD--QLTR-IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 288 (346)
T ss_dssp SSCCSSHHH--HHHH-HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred CCCCCCHHH--HHHH-HHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHH
Confidence 886543211 1111 11111110 00000 000 0001 223467899999999999999999999
Q ss_pred HHHHh
Q 038168 734 VLLML 738 (757)
Q Consensus 734 Vl~~L 738 (757)
+++.-
T Consensus 289 ll~h~ 293 (346)
T 1ua2_A 289 ALKMK 293 (346)
T ss_dssp HHTSG
T ss_pred HhcCh
Confidence 99853
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=312.24 Aligned_cols=206 Identities=22% Similarity=0.310 Sum_probs=171.9
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+.+..|..++.++ +|+||+++++++.+.+..||||||+++|+|.+++... ..+++.++..++.||+.||+|||++
T Consensus 386 ~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~--- 461 (674)
T 3pfq_A 386 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK--- 461 (674)
T ss_dssp HHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 4578899999988 7999999999999999999999999999999999653 4689999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+||||+.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.
T Consensus 462 gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~ 540 (674)
T 3pfq_A 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540 (674)
T ss_dssp SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred CeEeccCChhhEEEcCCCcEEEeecceeeccccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCC
Confidence 999999999999999999999999999986443322 2345789999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM-----KKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm-----~eVl~ 736 (757)
||..... .+ +.+.+..+... ++.....++.+++..||+.||++||++ +||++
T Consensus 541 Pf~~~~~------~~-~~~~i~~~~~~-------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 541 PFEGEDE------DE-LFQSIMEHNVA-------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SSCCSSH------HH-HHHHHHSSCCC-------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCCCCCH------HH-HHHHHHhCCCC-------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 9975322 11 22222333221 122344678999999999999999998 67764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=296.68 Aligned_cols=210 Identities=10% Similarity=0.014 Sum_probs=150.3
Q ss_pred HHHHHHHHHHHhhc--CCCceeeee-------eEEEec-----------------eeeeEEEEeccCCChhhhhcCCCCC
Q 038168 511 EREFQTEMKVIGRT--HHRNLVRLL-------GYSLEV-----------------SKKILVYEYMSNGSLADILFNPEKQ 564 (757)
Q Consensus 511 ~~~~~~E~~~l~~l--~h~niv~l~-------g~~~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~ 564 (757)
.+.+++|+.+++.+ +||||++++ +++... ...++||||++ |+|.+++......
T Consensus 106 ~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~ 184 (371)
T 3q60_A 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV 184 (371)
T ss_dssp HHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc
Confidence 45677886555555 699988755 333322 45799999999 8999999765444
Q ss_pred CCHHHH------HHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccc
Q 038168 565 PNWVER------MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGY 638 (757)
Q Consensus 565 l~~~~~------~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y 638 (757)
+.+..+ ..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++..... .....+|+.|
T Consensus 185 ~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y 257 (371)
T 3q60_A 185 YVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTY 257 (371)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGG
T ss_pred cchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCC
Confidence 566666 78889999999999998 9999999999999999999999999999876432 1134567999
Q ss_pred cCcccccC--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCcccccccc---ccCHHHHHHH
Q 038168 639 VAPEWHRN--LPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDE---EVDEKQLERM 713 (757)
Q Consensus 639 ~aPE~~~~--~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~---~~~~~~~~~l 713 (757)
+|||.+.+ ..++.++||||||++++||++|+.||....+...... ............ .........+
T Consensus 258 ~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (371)
T 3q60_A 258 APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFV 329 (371)
T ss_dssp CCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHH
T ss_pred cChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHH
Confidence 99999987 6899999999999999999999999986644321100 000000000000 0011335678
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 038168 714 IKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 714 ~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
.+++.+||+.||++|||+.|+++
T Consensus 330 ~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 330 KTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHHHHcCCChhhCCCHHHHhc
Confidence 89999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=285.45 Aligned_cols=215 Identities=18% Similarity=0.294 Sum_probs=168.4
Q ss_pred HHHHHHHHHHHhhcC-CCceeeeeeEEEe--ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 511 EREFQTEMKVIGRTH-HRNLVRLLGYSLE--VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
.+.+.+|+.++++++ |+||+++++++.+ ....++||||+++++|.+++. .++..++..++.|++.||+|||+.
T Consensus 74 ~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~ 149 (330)
T 3nsz_A 74 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSM 149 (330)
T ss_dssp HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhC
Confidence 578999999999997 9999999999987 667899999999999999884 378899999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCC-cEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMDENR-CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~-~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|||++.++ .+||+|||+++....... .....++..|+|||.+.+ ..++.++||||||++++||
T Consensus 150 ---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 224 (330)
T 3nsz_A 150 ---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 224 (330)
T ss_dssp ---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred ---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHH
Confidence 999999999999999776 899999999987654432 233568999999999877 6789999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHH--------HHHHHhcCCcc------------------ccccccccCHHHHHHHHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEW--------VYQCFENGNLS------------------QLVEDEEVDEKQLERMIKVALW 719 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~~~~------------------~~~d~~~~~~~~~~~l~~l~~~ 719 (757)
++|+.||......... +... ....+...... .... ..........+.+++.+
T Consensus 225 l~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 302 (330)
T 3nsz_A 225 IFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH-SENQHLVSPEALDFLDK 302 (330)
T ss_dssp HHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCC-TTTGGGCCHHHHHHHHT
T ss_pred HhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhcc-ccccccCCHHHHHHHHH
Confidence 9999999654332111 1110 00111111100 0000 00111135678999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 038168 720 CILDEPSLRPSMKKVLL 736 (757)
Q Consensus 720 cl~~~p~~RPsm~eVl~ 736 (757)
||+.||++|||++|+++
T Consensus 303 ~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 303 LLRYDHQSRLTAREAME 319 (330)
T ss_dssp TSCSSGGGSCCHHHHHT
T ss_pred HhcCCcccCCCHHHHhc
Confidence 99999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-32 Score=289.40 Aligned_cols=211 Identities=26% Similarity=0.386 Sum_probs=163.4
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEe------ceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLE------VSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGI 581 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL 581 (757)
..+.+.+|+.+++++ +|+||+++++++.. .+..++||||+++++|.+++.... ..++...+..++.||+.||
T Consensus 63 ~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l 142 (326)
T 2x7f_A 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142 (326)
T ss_dssp TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHH
Confidence 357899999999999 89999999999986 467899999999999999997543 5688999999999999999
Q ss_pred HHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc-----CCCCCccccch
Q 038168 582 LYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR-----NLPITVKADVY 656 (757)
Q Consensus 582 ~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~ 656 (757)
+|||+. +|+|+||||+|||++.++.+||+|||++........ ......|+..|+|||.+. +..++.++|||
T Consensus 143 ~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~ 218 (326)
T 2x7f_A 143 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW 218 (326)
T ss_dssp HHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHH
T ss_pred HHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHH
Confidence 999998 999999999999999999999999999987643321 123356899999999987 56789999999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 657 SFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 657 S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|||++++||++|+.|+...... ...... ......... .......+.+++.+||+.||++||++.|+++
T Consensus 219 slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 219 SLGITAIEMAEGAPPLCDMHPM------RALFLI-PRNPAPRLK-----SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHHHHHHSSCTTTTSCHH------HHHHHH-HHSCCCCCS-----CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCCCcHH------HHHHHh-hcCccccCC-----ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 9999999999999998643221 111111 122111111 1122357889999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=287.84 Aligned_cols=218 Identities=23% Similarity=0.318 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec-----eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV-----SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.+.+.+|++++++++||||+++++++... ...++|+||++ |+|.+++.. ..+++.++..++.|++.||+|||
T Consensus 69 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH 145 (364)
T 3qyz_A 69 CQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIH 145 (364)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH
Confidence 36788999999999999999999998754 36899999998 599998854 45899999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce--ecccccCccccCcccccC-CCCCccccchhhHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT--FTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVL 662 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l 662 (757)
+. +|+||||||+|||++.++.+||+|||+++......... .....||+.|+|||.+.+ ..++.++||||||+++
T Consensus 146 ~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 222 (364)
T 3qyz_A 146 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCIL 222 (364)
T ss_dssp HT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHH
T ss_pred HC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHH
Confidence 98 99999999999999999999999999998765433221 234678999999998765 4589999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCc---------------cccccccc-----cCHHHHHHHHHHHHHccc
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVYQCFENGNL---------------SQLVEDEE-----VDEKQLERMIKVALWCIL 722 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---------------~~~~d~~~-----~~~~~~~~l~~l~~~cl~ 722 (757)
+||++|+.||......+.. ..+......... .....+.. ........+.+++.+||+
T Consensus 223 ~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 299 (364)
T 3qyz_A 223 AEMLSNRPIFPGKHYLDQL---NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLT 299 (364)
T ss_dssp HHHHHSSCSSCCSSGGGHH---HHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTC
T ss_pred HHHHHCCCCCCCCChHHHH---HHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcC
Confidence 9999999999765433221 111111100000 00000000 111224568999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 038168 723 DEPSLRPSMKKVLLM 737 (757)
Q Consensus 723 ~~p~~RPsm~eVl~~ 737 (757)
.||++|||+.|+++.
T Consensus 300 ~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 300 FNPHKRIEVEQALAH 314 (364)
T ss_dssp SSTTTSCCHHHHHTS
T ss_pred CChhhCCCHHHHhcC
Confidence 999999999999973
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=289.39 Aligned_cols=215 Identities=23% Similarity=0.323 Sum_probs=154.3
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEec------eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEV------SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y 583 (757)
..+.+.+|+.++++++|+||+++++++... ...++|+|++ +++|.+++.. ..+++..+..++.||++||+|
T Consensus 71 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~ 147 (367)
T 2fst_X 71 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKY 147 (367)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHH
Confidence 356788999999999999999999998653 5679999999 6899998854 568999999999999999999
Q ss_pred hhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHH
Q 038168 584 LHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVL 662 (757)
Q Consensus 584 LH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l 662 (757)
||+. +|+||||||+|||++.++.+||+|||+++..... .....||..|+|||.+.+ ..++.++|||||||++
T Consensus 148 LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 220 (367)
T 2fst_X 148 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 220 (367)
T ss_dssp HHHT---TCCCCCCCGGGEEECTTCCEEECC-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHH
T ss_pred HHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHH
Confidence 9998 9999999999999999999999999999875432 334678999999999887 6789999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHHHHHhcCC------c---------cccccccccC-----HHHHHHHHHHHHHccc
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVYQCFENGN------L---------SQLVEDEEVD-----EKQLERMIKVALWCIL 722 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~---------~~~~d~~~~~-----~~~~~~l~~l~~~cl~ 722 (757)
+||++|+.||......+.. ..+.+...... + ..+....... ......+.+++.+||+
T Consensus 221 ~ell~g~~pf~~~~~~~~l---~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~ 297 (367)
T 2fst_X 221 AELLTGRTLFPGTDHIDQL---KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 297 (367)
T ss_dssp HHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSC
T ss_pred HHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCC
Confidence 9999999999754322111 11111110000 0 0000000001 1123568899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 038168 723 DEPSLRPSMKKVLLM 737 (757)
Q Consensus 723 ~~p~~RPsm~eVl~~ 737 (757)
.||++|||+.|+++.
T Consensus 298 ~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 298 LDSDKRITAAQALAH 312 (367)
T ss_dssp SSGGGSCCHHHHHTS
T ss_pred CCcccCcCHHHHhcC
Confidence 999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=296.73 Aligned_cols=209 Identities=23% Similarity=0.332 Sum_probs=159.2
Q ss_pred HHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 513 EFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 513 ~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
.+.+|+++++++ +|||||++++++.+.+..++||||++ |+|.+++..........++..++.||++||+|||+. +
T Consensus 63 ~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ 138 (432)
T 3p23_A 63 FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---N 138 (432)
T ss_dssp ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---c
Confidence 356899999999 89999999999999999999999997 599999987665555556778999999999999998 9
Q ss_pred eeeCCCCcceEEECC-----CCcEEEeecCCccccCCCCc--ceecccccCccccCccccc---CCCCCccccchhhHHH
Q 038168 592 IIHCDIKPQNILMDE-----NRCAKISDFGLAKLMKPDQT--RTFTGIRGTRGYVAPEWHR---NLPITVKADVYSFGVV 661 (757)
Q Consensus 592 iiH~Dik~~Nill~~-----~~~~ki~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~G~~ 661 (757)
|+||||||+|||++. ...+||+|||+++....... .......||+.|+|||.+. ...++.++|||||||+
T Consensus 139 ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~i 218 (432)
T 3p23_A 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCV 218 (432)
T ss_dssp CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHH
T ss_pred CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHH
Confidence 999999999999953 34688999999987754332 2234567999999999997 4567889999999999
Q ss_pred HHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 662 LLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 662 l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
++||++ |..|+....... ........... .. .........+.+++.+||+.||++|||+.||++
T Consensus 219 l~ellt~g~~pf~~~~~~~-------~~~~~~~~~~~-~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 219 FYYVISEGSHPFGKSLQRQ-------ANILLGACSLD-CL---HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHHHTTSCBTTBSTTTHH-------HHHHTTCCCCT-TS---CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCCCCcchhhHHH-------HHHHhccCCcc-cc---CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 999999 888885432211 11111111111 11 112344566889999999999999999999984
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-31 Score=293.13 Aligned_cols=158 Identities=23% Similarity=0.324 Sum_probs=139.6
Q ss_pred HHHHHHHHHHHhhc------CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRT------HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 511 ~~~~~~E~~~l~~l------~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~y 583 (757)
.+++.+|+.+++.+ +|+||+++++++...+..++||||+. ++|.+++.... ..+++..+..|+.||+.||+|
T Consensus 137 ~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~ 215 (429)
T 3kvw_A 137 HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215 (429)
T ss_dssp HHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 36778899998888 57799999999999999999999996 68999886544 458999999999999999999
Q ss_pred hhhCCCCCeeeCCCCcceEEECCCCc--EEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHH
Q 038168 584 LHDECETQIIHCDIKPQNILMDENRC--AKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVV 661 (757)
Q Consensus 584 LH~~~~~~iiH~Dik~~Nill~~~~~--~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~ 661 (757)
||+. +|+||||||+|||++.++. +||+|||+++..... .....||+.|+|||++.+..++.++|||||||+
T Consensus 216 LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 288 (429)
T 3kvw_A 216 LHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCI 288 (429)
T ss_dssp HHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHH
T ss_pred HHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHH
Confidence 9999 9999999999999999887 999999999765432 223578999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCC
Q 038168 662 LLEIICRRRCLDPNL 676 (757)
Q Consensus 662 l~elltG~~p~~~~~ 676 (757)
++||++|+.||....
T Consensus 289 l~elltG~~pf~~~~ 303 (429)
T 3kvw_A 289 LAELLTGYPLLPGED 303 (429)
T ss_dssp HHHHHHSSCSSCCSS
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999987543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=284.59 Aligned_cols=218 Identities=23% Similarity=0.246 Sum_probs=159.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEece------eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVS------KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.+.+|+.++++++||||+++++++...+ ..++||||+++ +|.+++. ..+++..+..++.||+.||+||
T Consensus 68 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~l 143 (371)
T 2xrw_A 68 AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHL 143 (371)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999999999997654 78999999975 7888874 3588999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~e 664 (757)
|+. +|+||||||+|||++.++.+||+|||+++...... ......||+.|+|||.+.+..++.++||||||++++|
T Consensus 144 H~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 218 (371)
T 2xrw_A 144 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218 (371)
T ss_dssp HHT---TCCCSCCCGGGEEECTTSCEEECCCCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred HHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHH
Confidence 998 99999999999999999999999999998764332 2234578999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCccccHH----------------HHHHHHHhcC-Ccc---------cccccc--ccCHHHHHHHHHH
Q 038168 665 IICRRRCLDPNLPDDQVILE----------------EWVYQCFENG-NLS---------QLVEDE--EVDEKQLERMIKV 716 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~----------------~~~~~~~~~~-~~~---------~~~d~~--~~~~~~~~~l~~l 716 (757)
|++|+.||......+..... .......... ... ....+. .........+.++
T Consensus 219 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (371)
T 2xrw_A 219 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 298 (371)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHH
Confidence 99999999754321100000 0000000000 000 000000 0112335789999
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 038168 717 ALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 717 ~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+.+||+.||++|||++|+++.
T Consensus 299 i~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 299 LSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHCcCChhhCCCHHHHhCC
Confidence 999999999999999999873
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-31 Score=282.05 Aligned_cols=217 Identities=21% Similarity=0.276 Sum_probs=171.3
Q ss_pred hHHHHHHHHHHHhhcCCCc------eeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRN------LVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGIL 582 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~ 582 (757)
..+.+.+|++++++++|+| ++++++++.+.+..++||||+ +++|.+++.... ..+++.++..++.|+++||+
T Consensus 54 ~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~ 132 (339)
T 1z57_A 54 YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN 132 (339)
T ss_dssp HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 3567889999999997665 999999999999999999999 889999986544 46889999999999999999
Q ss_pred HhhhCCCCCeeeCCCCcceEEECC-------------------CCcEEEeecCCccccCCCCcceecccccCccccCccc
Q 038168 583 YLHDECETQIIHCDIKPQNILMDE-------------------NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEW 643 (757)
Q Consensus 583 yLH~~~~~~iiH~Dik~~Nill~~-------------------~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~ 643 (757)
|||++ +|+||||||+|||++. ++.+||+|||+++..... .....||..|+|||.
T Consensus 133 ~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~ 205 (339)
T 1z57_A 133 FLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEV 205 (339)
T ss_dssp HHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHH
T ss_pred HHHHC---CCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHH
Confidence 99998 9999999999999987 668999999999875432 233568999999999
Q ss_pred ccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHh--------cCCcc------------------
Q 038168 644 HRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFE--------NGNLS------------------ 697 (757)
Q Consensus 644 ~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~--------~~~~~------------------ 697 (757)
+.+..++.++||||||++++||++|+.||......+.. ..+..... .....
T Consensus 206 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
T 1z57_A 206 ILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL---AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGR 282 (339)
T ss_dssp HTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH---HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHH
T ss_pred hhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccc
Confidence 99999999999999999999999999999754322211 11111100 00000
Q ss_pred -------ccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 698 -------QLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 698 -------~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
.............+.+.+++.+||+.||++|||+.||++.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 283 YVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 0000011233556789999999999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-31 Score=284.84 Aligned_cols=217 Identities=21% Similarity=0.294 Sum_probs=165.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec-----eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV-----SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
...+.+|+.++++++|+||+++++++... ...++||||++ ++|.+++.. ..+++..+..++.|++.||+|||
T Consensus 53 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH 129 (353)
T 2b9h_A 53 ALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLH 129 (353)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH
Confidence 46788999999999999999999988754 67899999997 689998854 46899999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc---------eecccccCccccCcccccC-CCCCccccc
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR---------TFTGIRGTRGYVAPEWHRN-LPITVKADV 655 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv 655 (757)
+. +|+||||||+|||++.++.+||+|||+++........ ......||..|+|||.+.+ ..++.++||
T Consensus 130 ~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 206 (353)
T 2b9h_A 130 GS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDV 206 (353)
T ss_dssp HT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHH
T ss_pred HC---CeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhH
Confidence 98 9999999999999999999999999999877543221 1223578999999998765 678999999
Q ss_pred hhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCC-------------------ccccccc--cccCHHHHHHHH
Q 038168 656 YSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGN-------------------LSQLVED--EEVDEKQLERMI 714 (757)
Q Consensus 656 ~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-------------------~~~~~d~--~~~~~~~~~~l~ 714 (757)
||||++++||++|+.||......... ..+........ +...... ..........+.
T Consensus 207 ~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
T 2b9h_A 207 WSCGCILAELFLRRPIFPGRDYRHQL---LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGI 283 (353)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHH
Confidence 99999999999999998754321110 00111100000 0000000 000112346788
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 038168 715 KVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 715 ~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+++.+||+.||++|||+.|+++
T Consensus 284 ~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 284 DLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCcCcccCCCHHHHhc
Confidence 9999999999999999999997
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=278.39 Aligned_cols=208 Identities=20% Similarity=0.242 Sum_probs=155.1
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 513 EFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN---PEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.++...++.++||||+++++++.+.+..++||||++ |+|.+++.. ....+++..+..++.|++.||+|||++
T Consensus 52 ~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-- 128 (290)
T 3fme_A 52 LLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK-- 128 (290)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--
Confidence 34455556888899999999999999999999999998 588777643 456789999999999999999999984
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccc----cCCCCCccccchhhHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWH----RNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~Dv~S~G~~l~el 665 (757)
.+|+||||||+|||++.++.+||+|||+++....... .....||+.|+|||.+ .+..++.++||||||++++||
T Consensus 129 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l 206 (290)
T 3fme_A 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206 (290)
T ss_dssp SCCCCCCCSGGGCEECTTCCEEBCCC-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHH
T ss_pred CCeecCCCCHHHEEECCCCCEEEeecCCccccccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHH
Confidence 3899999999999999999999999999987654332 2224689999999996 566789999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
++|+.|+....... .............. ........+.+++.+||+.||++|||+.|+++
T Consensus 207 ~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 207 AILRFPYDSWGTPF-----QQLKQVVEEPSPQL------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHTSCSSCCCSCHH-----HHHHHHHHSCCCCC------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHCCCCccccCchH-----HHHHHHhccCCCCc------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 99999987532211 11222222221111 11123456889999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-31 Score=286.64 Aligned_cols=213 Identities=22% Similarity=0.295 Sum_probs=162.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceee------eEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK------ILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~------~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.+.+|+.++++++||||+++++++...+.. ++||||++ ++|.+++. ..+++.++..++.|++.||+||
T Consensus 85 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~L 160 (371)
T 4exu_A 85 AKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYI 160 (371)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHH
Confidence 46788999999999999999999999877654 99999998 68888873 3489999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLL 663 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~ 663 (757)
|+. +|+||||||+|||++.++.+||+|||+++..... .....||+.|+|||.+.+ ..++.++||||||++++
T Consensus 161 H~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (371)
T 4exu_A 161 HSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 233 (371)
T ss_dssp HHT---TCCCSCCCGGGEEECTTCCEEECSTTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHH
T ss_pred HHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHH
Confidence 998 9999999999999999999999999999865432 234578999999999887 68999999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHhcCC------c---------ccccccc-----ccCHHHHHHHHHHHHHcccc
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENGN------L---------SQLVEDE-----EVDEKQLERMIKVALWCILD 723 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~---------~~~~d~~-----~~~~~~~~~l~~l~~~cl~~ 723 (757)
||++|+.||......+. +.. +........ + ..+.... .........+.+++.+||+.
T Consensus 234 el~~g~~pf~~~~~~~~--~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 310 (371)
T 4exu_A 234 EMLTGKTLFKGKDYLDQ--LTQ-ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLEL 310 (371)
T ss_dssp HHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCS
T ss_pred HHHhCCCCCCCCChHHH--HHH-HHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCC
Confidence 99999999975432111 101 100000000 0 0000000 01112346789999999999
Q ss_pred CCCCCCCHHHHHHH
Q 038168 724 EPSLRPSMKKVLLM 737 (757)
Q Consensus 724 ~p~~RPsm~eVl~~ 737 (757)
||++|||+.|+++.
T Consensus 311 dP~~Rpt~~ell~h 324 (371)
T 4exu_A 311 DVDKRLTAAQALTH 324 (371)
T ss_dssp CTTTSCCHHHHHTS
T ss_pred ChhhcCCHHHHhcC
Confidence 99999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=281.44 Aligned_cols=218 Identities=22% Similarity=0.257 Sum_probs=163.7
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEecee-------eeEEEEeccCCChhhhhc---CCCCCCCHHHHHHHHHHHHHHH
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSK-------KILVYEYMSNGSLADILF---NPEKQPNWVERMGIARDIARGI 581 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-------~~lV~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~gL 581 (757)
..+.+|++.+++++||||+++++++...+. .++||||++++ |.+.+. .....+++..+..++.|++.||
T Consensus 64 ~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 142 (360)
T 3e3p_A 64 NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSI 142 (360)
T ss_dssp CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHH
Confidence 467788899999999999999999976443 78999999874 444332 3456788999999999999999
Q ss_pred HHhh--hCCCCCeeeCCCCcceEEECC-CCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchh
Q 038168 582 LYLH--DECETQIIHCDIKPQNILMDE-NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYS 657 (757)
Q Consensus 582 ~yLH--~~~~~~iiH~Dik~~Nill~~-~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S 657 (757)
.||| +. +|+||||||+|||++. ++.+||+|||+++....... .....||..|+|||.+.+. .++.++||||
T Consensus 143 ~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~s 217 (360)
T 3e3p_A 143 GCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWS 217 (360)
T ss_dssp HHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHH
T ss_pred HHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHH
Confidence 9999 77 9999999999999997 89999999999987654432 2345689999999998765 4899999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCccccHHHHHH----------HHHhcC-Cccccccccc---------cCHHHHHHHHHHH
Q 038168 658 FGVVLLEIICRRRCLDPNLPDDQVILEEWVY----------QCFENG-NLSQLVEDEE---------VDEKQLERMIKVA 717 (757)
Q Consensus 658 ~G~~l~elltG~~p~~~~~~~~~~~l~~~~~----------~~~~~~-~~~~~~d~~~---------~~~~~~~~l~~l~ 717 (757)
||++++||++|+.||....... .+..... ..+... ......+... ........+.+++
T Consensus 218 lG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 295 (360)
T 3e3p_A 218 VGCIFAEMMLGEPIFRGDNSAG--QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLL 295 (360)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHH
T ss_pred HHHHHHHHHhCCCCcCCCChHH--HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHH
Confidence 9999999999999997643221 1111110 000000 0000000000 1112457899999
Q ss_pred HHccccCCCCCCCHHHHHHH
Q 038168 718 LWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 718 ~~cl~~~p~~RPsm~eVl~~ 737 (757)
.+||+.||++|||+.|+++.
T Consensus 296 ~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 296 SALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHTCSSGGGSCCHHHHTTS
T ss_pred HHHhccCccccCCHHHHhcC
Confidence 99999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-31 Score=282.61 Aligned_cols=218 Identities=20% Similarity=0.263 Sum_probs=145.7
Q ss_pred HHHH-HHHhhcCCCceeeeeeEEEe----ceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 515 QTEM-KVIGRTHHRNLVRLLGYSLE----VSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 515 ~~E~-~~l~~l~h~niv~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.+|+ ..++.++|+||+++++++.. ....++||||+++|+|.+++.... ..+++.++..++.|++.||+|||++
T Consensus 69 ~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~- 147 (336)
T 3fhr_A 69 RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH- 147 (336)
T ss_dssp HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3344 34566799999999999876 456899999999999999997654 4689999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECC---CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 589 ETQIIHCDIKPQNILMDE---NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~---~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|||++. ++.+||+|||+++...... .....+|+.|+|||.+.+..++.++||||||++++||
T Consensus 148 --~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l 222 (336)
T 3fhr_A 148 --NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 222 (336)
T ss_dssp --TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHH
T ss_pred --CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHH
Confidence 9999999999999976 4569999999998665332 2235679999999999988999999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcCcC
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL--MLEGTVE 743 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~--~Le~~~~ 743 (757)
++|+.||.......... . .......+... .+..........+.+++.+||+.||++|||+.|+++ .+.....
T Consensus 223 ~~g~~pf~~~~~~~~~~--~-~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 223 LCGFPPFYSNTGQAISP--G-MKRRIRLGQYG---FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296 (336)
T ss_dssp HHSSCCC------------------------C---CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred HHCCCCCCCccchhhhh--h-HHHhhhccccc---cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence 99999997544322100 0 01111111111 011111233467889999999999999999999998 4554333
Q ss_pred C
Q 038168 744 I 744 (757)
Q Consensus 744 ~ 744 (757)
.
T Consensus 297 ~ 297 (336)
T 3fhr_A 297 V 297 (336)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=284.71 Aligned_cols=225 Identities=22% Similarity=0.351 Sum_probs=170.5
Q ss_pred HHHHHHHHHHHhhcC-----------CCceeeeeeEEEece----eeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTH-----------HRNLVRLLGYSLEVS----KKILVYEYMSNGSLADILFNP-EKQPNWVERMGIA 574 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~~~----~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~ 574 (757)
.+.+.+|+.++++++ |+||+++++++...+ ..++||||+ +++|.+++... ...+++..+..++
T Consensus 59 ~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~ 137 (373)
T 1q8y_A 59 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQIS 137 (373)
T ss_dssp HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHH
T ss_pred hhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHH
Confidence 467889999999986 899999999998654 789999999 89999998654 3558999999999
Q ss_pred HHHHHHHHHhhhCCCCCeeeCCCCcceEEEC------CCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCC
Q 038168 575 RDIARGILYLHDECETQIIHCDIKPQNILMD------ENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP 648 (757)
Q Consensus 575 ~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~------~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 648 (757)
.||+.||+|||+++ +|+||||||+|||++ ..+.+||+|||+++..... .....||+.|+|||.+.+..
T Consensus 138 ~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~ 211 (373)
T 1q8y_A 138 KQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAP 211 (373)
T ss_dssp HHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCC
T ss_pred HHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCC
Confidence 99999999999842 899999999999994 4458999999999876532 23356899999999999999
Q ss_pred CCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHh-cCCccc---------------------c-------
Q 038168 649 ITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFE-NGNLSQ---------------------L------- 699 (757)
Q Consensus 649 ~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~-~~~~~~---------------------~------- 699 (757)
++.++||||||++++||++|+.||............+.+..... .+..+. +
T Consensus 212 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (373)
T 1q8y_A 212 WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 291 (373)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC
T ss_pred CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccc
Confidence 99999999999999999999999986543221111111111110 011000 0
Q ss_pred -----ccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcCc
Q 038168 700 -----VEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL--MLEGTV 742 (757)
Q Consensus 700 -----~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~--~Le~~~ 742 (757)
......+......+.+++.+||+.||++|||+.||++ .+.+..
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 292 LEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp HHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred hhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence 0011235677889999999999999999999999998 455443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=297.57 Aligned_cols=210 Identities=25% Similarity=0.380 Sum_probs=172.6
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++||||+++++++.+....++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.
T Consensus 89 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-- 165 (504)
T 3q5i_A 89 FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKH-- 165 (504)
T ss_dssp THHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 356789999999999999999999999999999999999999999998864 35689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCC---cEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENR---CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~---~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+|+||||||+|||++.++ .+||+|||+++....... .....||+.|+|||.+. ..++.++||||+|+++++|+
T Consensus 166 -~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll 241 (504)
T 3q5i_A 166 -NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILL 241 (504)
T ss_dssp -TEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHH
T ss_pred -CeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHH
Confidence 999999999999998775 699999999987755432 33457899999999987 46899999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+|+.||...... + +......+........ ......++.+++.+||+.||++|||+.|+++
T Consensus 242 ~g~~pf~~~~~~------~-~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 242 CGYPPFGGQNDQ------D-IIKKVEKGKYYFDFND---WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HSSCSSCCSSHH------H-HHHHHHHCCCCCCHHH---HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCCCCCCCHH------H-HHHHHHcCCCCCCccc---cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999999754321 1 2233333332211100 0112356889999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=278.86 Aligned_cols=209 Identities=22% Similarity=0.343 Sum_probs=166.9
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
..+.+|++++++++||||+++++++...+ .++||||+++++|.+++.. ...+++.++..++.||+.||+|||++ +
T Consensus 60 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ 134 (322)
T 2ycf_A 60 LNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHEN---G 134 (322)
T ss_dssp -CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 45889999999999999999999987655 8999999999999999864 45688999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCc---EEEeecCCccccCCCCcceecccccCccccCccccc---CCCCCccccchhhHHHHHHH
Q 038168 592 IIHCDIKPQNILMDENRC---AKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR---NLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~---~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~G~~l~el 665 (757)
|+||||||+|||++.++. +||+|||+++...... ......||..|+|||.+. ...++.++||||||++++||
T Consensus 135 ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l 212 (322)
T 2ycf_A 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 212 (322)
T ss_dssp EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHH
T ss_pred eeccCCCHHHEEEecCCCCCeEEEccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHH
Confidence 999999999999987654 9999999998765432 123356899999999874 56789999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
++|+.||........ +. .....+.....- .........+.+++.+||+.||++||++.|+++
T Consensus 213 ~~g~~pf~~~~~~~~--~~----~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 213 LSGYPPFSEHRTQVS--LK----DQITSGKYNFIP---EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHSSCSSCSTTCSSC--HH----HHHHHTCCCCCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCCCCCcccchHHH--HH----HHHHhCccccCc---hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 999999975543322 11 222223222110 001122467899999999999999999999884
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-30 Score=279.42 Aligned_cols=210 Identities=22% Similarity=0.369 Sum_probs=170.6
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|+.+++++ +||||+++++++......++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.
T Consensus 143 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~-- 219 (365)
T 2y7j_A 143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHAN-- 219 (365)
T ss_dssp HHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 35678999999999 799999999999999999999999999999999864 35689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC------CCCCccccchhhHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN------LPITVKADVYSFGVVLL 663 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~S~G~~l~ 663 (757)
+|+|+||||+|||++.++.+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||++++
T Consensus 220 -gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ 296 (365)
T 2y7j_A 220 -NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296 (365)
T ss_dssp -TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHH
T ss_pred -CeecCCCCHHHEEECCCCCEEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHH
Confidence 999999999999999999999999999987754332 234678999999998863 35889999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||++|+.||..... . . .......+...... + ........+.+++.+||+.||++|||+.|+++
T Consensus 297 ell~g~~pf~~~~~---~---~-~~~~i~~~~~~~~~-~--~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 297 TLLAGSPPFWHRRQ---I---L-MLRMIMEGQYQFSS-P--EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHSSCSSCCSSH---H---H-HHHHHHHTCCCCCH-H--HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHCCCCCCCCCH---H---H-HHHHHHhCCCCCCC-c--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99999999865321 1 1 11222223221110 0 00112356889999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=289.45 Aligned_cols=215 Identities=23% Similarity=0.294 Sum_probs=163.6
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEEec--------------------------------------eeeeEEEEeccCCCh
Q 038168 513 EFQTEMKVIGRTHHRNLVRLLGYSLEV--------------------------------------SKKILVYEYMSNGSL 554 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~g~~~~~--------------------------------------~~~~lV~e~~~~gsL 554 (757)
...+|++++++++|+||+++++++... ...++||||++ |+|
T Consensus 46 ~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L 124 (383)
T 3eb0_A 46 YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTL 124 (383)
T ss_dssp SCCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEH
T ss_pred hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccH
Confidence 345799999999999999999998442 23789999998 587
Q ss_pred hhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEEC-CCCcEEEeecCCccccCCCCcceec
Q 038168 555 ADILFN---PEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMD-ENRCAKISDFGLAKLMKPDQTRTFT 630 (757)
Q Consensus 555 ~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~-~~~~~ki~DfGla~~~~~~~~~~~~ 630 (757)
.+.+.. ....+++..+..++.||++||+|||+. +|+||||||+|||++ .++.+||+|||+++....... ..
T Consensus 125 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~ 199 (383)
T 3eb0_A 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SV 199 (383)
T ss_dssp HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CC
T ss_pred HHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--Cc
Confidence 777642 356789999999999999999999998 999999999999998 688999999999987654332 23
Q ss_pred ccccCccccCcccccCC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhc----------C-----
Q 038168 631 GIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFEN----------G----- 694 (757)
Q Consensus 631 ~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----------~----- 694 (757)
...+|..|+|||.+.+. .++.++||||+|++++||++|+.||......+. +... .+.... .
T Consensus 200 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i-~~~~g~p~~~~~~~~~~~~~~~ 276 (383)
T 3eb0_A 200 AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQ--LVRI-IQIMGTPTKEQMIRMNPHYTEV 276 (383)
T ss_dssp CCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH-HHHHCCCCHHHHHHHCTTC--C
T ss_pred CcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHH--HHHH-HHHhCCCCHHHHHHhCcccccc
Confidence 45679999999998775 489999999999999999999999976432221 1111 110000 0
Q ss_pred Cccccccc---cccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 695 NLSQLVED---EEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 695 ~~~~~~d~---~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
.+...... ...+......+.+++.+||+.||++|||+.|+++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 277 RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000 0112234467899999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=281.48 Aligned_cols=216 Identities=19% Similarity=0.261 Sum_probs=168.2
Q ss_pred hHHHHHHHHHHHhhcCCCc------eeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRN------LVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGIL 582 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~ 582 (757)
..+.+.+|+.++++++|++ ++.+++++...+..++||||+ +++|.+++... ...+++.++..++.||+.||+
T Consensus 59 ~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~ 137 (355)
T 2eu9_A 59 YREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Confidence 4567889999999998776 999999999999999999999 55666666543 357899999999999999999
Q ss_pred HhhhCCCCCeeeCCCCcceEEE-------------------CCCCcEEEeecCCccccCCCCcceecccccCccccCccc
Q 038168 583 YLHDECETQIIHCDIKPQNILM-------------------DENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEW 643 (757)
Q Consensus 583 yLH~~~~~~iiH~Dik~~Nill-------------------~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~ 643 (757)
|||+. +|+||||||+|||+ +.++.+||+|||+++...... ....||..|+|||.
T Consensus 138 ~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~ 210 (355)
T 2eu9_A 138 FLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEV 210 (355)
T ss_dssp HHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHH
T ss_pred HHHHC---CcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCee
Confidence 99998 99999999999999 567899999999998754322 34578999999999
Q ss_pred ccCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHh--------cCCcccc----------------
Q 038168 644 HRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFE--------NGNLSQL---------------- 699 (757)
Q Consensus 644 ~~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~--------~~~~~~~---------------- 699 (757)
+.+..++.++||||||++++||++|+.||......+.. ..+..... .......
T Consensus 211 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (355)
T 2eu9_A 211 ILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL---VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGR 287 (355)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHH
T ss_pred eecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhc
Confidence 99999999999999999999999999999754322111 11111100 0000000
Q ss_pred ---------ccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 700 ---------VEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 700 ---------~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
.........+...+.+++.+||+.||++|||+.|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 288 YVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000112344568999999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=289.58 Aligned_cols=215 Identities=23% Similarity=0.264 Sum_probs=161.7
Q ss_pred HHHHHHHHhhcCCCceeeeeeEEEec------eeeeEEEEeccCCChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 514 FQTEMKVIGRTHHRNLVRLLGYSLEV------SKKILVYEYMSNGSLADILF---NPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 514 ~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lV~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
+.+|++++++++|+|||++++++... ...++||||+++ +|.+.+. .....+++..+..++.||++||+||
T Consensus 94 ~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 172 (420)
T 1j1b_A 94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172 (420)
T ss_dssp CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 45799999999999999999988542 236799999986 5655553 2356789999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCC-CcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDEN-RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVL 662 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~-~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l 662 (757)
|+. +|+||||||+|||++.+ +.+||+|||+++.+..... .....||+.|+|||++.+. .++.++|||||||++
T Consensus 173 H~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il 247 (420)
T 1j1b_A 173 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247 (420)
T ss_dssp HTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHH
Confidence 998 99999999999999965 6789999999997654332 2345789999999998765 789999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHHH-------HHh--cCCcccccccc--------ccCHHHHHHHHHHHHHccccCC
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVYQ-------CFE--NGNLSQLVEDE--------EVDEKQLERMIKVALWCILDEP 725 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~~-------~~~--~~~~~~~~d~~--------~~~~~~~~~l~~l~~~cl~~~p 725 (757)
+||++|+.||......+ .+.+.+.. .+. .........+. .+......++.+++.+||+.||
T Consensus 248 ~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP 325 (420)
T 1j1b_A 248 AELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325 (420)
T ss_dssp HHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSG
T ss_pred HHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCCh
Confidence 99999999997643221 11111110 000 01111111010 0112234678999999999999
Q ss_pred CCCCCHHHHHH
Q 038168 726 SLRPSMKKVLL 736 (757)
Q Consensus 726 ~~RPsm~eVl~ 736 (757)
++|||+.|+++
T Consensus 326 ~~R~t~~e~l~ 336 (420)
T 1j1b_A 326 TARLTPLEACA 336 (420)
T ss_dssp GGSCCHHHHHT
T ss_pred hHCCCHHHHhC
Confidence 99999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=274.27 Aligned_cols=210 Identities=22% Similarity=0.320 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.+.+.+|++++++++ ||||+++++++.+.+..++||||+++++|.+++.. ...+++.++..++.|++.||+|||+.
T Consensus 67 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-- 143 (298)
T 1phk_A 67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKL-- 143 (298)
T ss_dssp HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 356789999999995 99999999999999999999999999999999964 35688999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc------CCCCCccccchhhHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR------NLPITVKADVYSFGVVLL 663 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~Dv~S~G~~l~ 663 (757)
+++|+||||+||+++.++.+||+|||++........ .....|+..|+|||.+. ...++.++||||||++++
T Consensus 144 -~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~ 220 (298)
T 1phk_A 144 -NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 220 (298)
T ss_dssp -TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHH
T ss_pred -CcccCCCCcceEEEcCCCcEEEecccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHH
Confidence 999999999999999999999999999987654332 23456899999999885 456889999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||++|+.|+...... . .......+...... .........+.+++.+||+.||++|||+.|+++
T Consensus 221 ~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 221 TLLAGSPPFWHRKQM------L-MLRMIMSGNYQFGS---PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHSSCSSCCSSHH------H-HHHHHHHTCCCCCT---TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCcCccHH------H-HHHHHhcCCcccCc---ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 999999998643211 1 12222233222111 111233467899999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=278.70 Aligned_cols=215 Identities=22% Similarity=0.312 Sum_probs=164.2
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEE--------------eceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSL--------------EVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIAR 575 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~ 575 (757)
..+++.+|++++++++||||+++++++. +....++||||++ |+|.+++.. ..+++..+..++.
T Consensus 51 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~ 127 (320)
T 2i6l_A 51 SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMY 127 (320)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHH
Confidence 3577899999999999999999999873 4467899999998 699999854 4688999999999
Q ss_pred HHHHHHHHhhhCCCCCeeeCCCCcceEEEC-CCCcEEEeecCCccccCCCCc--ceecccccCccccCcccccC-CCCCc
Q 038168 576 DIARGILYLHDECETQIIHCDIKPQNILMD-ENRCAKISDFGLAKLMKPDQT--RTFTGIRGTRGYVAPEWHRN-LPITV 651 (757)
Q Consensus 576 ~ia~gL~yLH~~~~~~iiH~Dik~~Nill~-~~~~~ki~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ 651 (757)
|+++||+|||+. +|+||||||+|||++ +++.+||+|||+++....... .......++..|+|||.+.+ ..++.
T Consensus 128 qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 204 (320)
T 2i6l_A 128 QLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTK 204 (320)
T ss_dssp HHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCH
T ss_pred HHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCc
Confidence 999999999998 999999999999997 567999999999987654322 12233567899999998865 67899
Q ss_pred cccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCc-------------cccc-----ccc----ccCHHH
Q 038168 652 KADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNL-------------SQLV-----EDE----EVDEKQ 709 (757)
Q Consensus 652 k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-------------~~~~-----d~~----~~~~~~ 709 (757)
++||||||++++||++|+.||......+. .......... .... .+. ......
T Consensus 205 ~~Di~slG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (320)
T 2i6l_A 205 AIDMWAAGCIFAEMLTGKTLFAGAHELEQ------MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGI 278 (320)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTC
T ss_pred hhhhHhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchh
Confidence 99999999999999999999975432111 1111111000 0000 000 011123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 710 LERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 710 ~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
..++.+++.+||+.||++|||+.|+++
T Consensus 279 ~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 279 SREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 467899999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=280.47 Aligned_cols=213 Identities=22% Similarity=0.284 Sum_probs=163.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEecee------eeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSK------KILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.+.+|+.++++++||||+++++++...+. .++||||++ ++|.+++. ..+++.++..++.||+.||+||
T Consensus 67 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~L 142 (353)
T 3coi_A 67 AKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYI 142 (353)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHH
Confidence 4678899999999999999999999987653 499999998 68988874 3489999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLL 663 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~ 663 (757)
|++ +|+||||||+|||++.++.+||+|||+++..... .....+|..|+|||.+.+ ..++.++||||||++++
T Consensus 143 H~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~ 215 (353)
T 3coi_A 143 HSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215 (353)
T ss_dssp HHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHH
T ss_pred HHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHH
Confidence 998 9999999999999999999999999999865432 234568999999999877 67899999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHhcC------------------Cccccc--cccccCHHHHHHHHHHHHHcccc
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENG------------------NLSQLV--EDEEVDEKQLERMIKVALWCILD 723 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------------------~~~~~~--d~~~~~~~~~~~l~~l~~~cl~~ 723 (757)
||++|+.||......+. +.. +....... .+.... +-..........+.+++.+||+.
T Consensus 216 el~~g~~pf~~~~~~~~--~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 292 (353)
T 3coi_A 216 EMLTGKTLFKGKDYLDQ--LTQ-ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLEL 292 (353)
T ss_dssp HHHHSSCSSBSSCHHHH--HHH-HHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCS
T ss_pred HHHhCCCCCCCCCHHHH--HHH-HHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCC
Confidence 99999999975432111 100 11100000 000000 00011223456789999999999
Q ss_pred CCCCCCCHHHHHHH
Q 038168 724 EPSLRPSMKKVLLM 737 (757)
Q Consensus 724 ~p~~RPsm~eVl~~ 737 (757)
||++|||+.|+++.
T Consensus 293 dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 293 DVDKRLTAAQALTH 306 (353)
T ss_dssp CTTTSCCHHHHHTS
T ss_pred CcccCCCHHHHhcC
Confidence 99999999999873
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=273.48 Aligned_cols=210 Identities=24% Similarity=0.348 Sum_probs=170.7
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|++++++++||||+++++++.+.+..++|+||+++++|.+++.. ...+++.++..++.|++.||+|||+.
T Consensus 64 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-- 140 (287)
T 2wei_A 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKH-- 140 (287)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 467899999999999999999999999999999999999999999998864 34688999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCC---CcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDEN---RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~---~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+++|+||||+||+++.+ ..+||+|||++........ .....++..|+|||.+.+ .++.++||||||++++||+
T Consensus 141 -~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~ 216 (287)
T 2wei_A 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILL 216 (287)
T ss_dssp -TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHH
T ss_pred -CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHH
Confidence 99999999999999764 4799999999987654332 223457899999998876 4899999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+|+.||...... + ....+..+........ .......+.+++.+||+.||++|||+.|+++
T Consensus 217 ~g~~p~~~~~~~------~-~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 217 SGTPPFYGKNEY------D-ILKRVETGKYAFDLPQ---WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HSSCSSCCSSHH------H-HHHHHHHCCCCCCSGG---GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCHH------H-HHHHHHcCCCCCCchh---hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 999998753221 1 2223333333211111 1122456889999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=276.07 Aligned_cols=211 Identities=22% Similarity=0.356 Sum_probs=162.4
Q ss_pred hHHHHHHHHHHHhhcC--CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 510 GEREFQTEMKVIGRTH--HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
..+.+.+|++++++++ |+||+++++++.+.+..++||| +.+++|.+++.. ...+++.++..++.|+++||+|||+.
T Consensus 69 ~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~ 146 (313)
T 3cek_A 69 TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH 146 (313)
T ss_dssp HHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3477899999999997 5999999999999999999999 678899999965 35678999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccC-----------CCCCccccc
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRN-----------LPITVKADV 655 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv 655 (757)
+|+||||||+|||+++ +.+||+|||+++........ ......|+..|+|||.+.+ ..++.++||
T Consensus 147 ---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di 222 (313)
T 3cek_A 147 ---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 222 (313)
T ss_dssp ---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHH
T ss_pred ---CceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHH
Confidence 9999999999999965 89999999999876544322 2234568999999999875 478899999
Q ss_pred hhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 038168 656 YSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735 (757)
Q Consensus 656 ~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl 735 (757)
||||++++||++|+.||....... .............. .+......+.+++.+||+.||++||++.|++
T Consensus 223 ~slG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 291 (313)
T 3cek_A 223 WSLGCILYYMTYGKTPFQQIINQI-----SKLHAIIDPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291 (313)
T ss_dssp HHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHCTTSCCC------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHHHhCCCchhhHHHHH-----HHHHHHHhcccccC------CcccchHHHHHHHHHHccCCcccCcCHHHHh
Confidence 999999999999999987543211 11112221111111 1111235688999999999999999999998
Q ss_pred HH
Q 038168 736 LM 737 (757)
Q Consensus 736 ~~ 737 (757)
+.
T Consensus 292 ~h 293 (313)
T 3cek_A 292 AH 293 (313)
T ss_dssp TS
T ss_pred cC
Confidence 74
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=277.22 Aligned_cols=215 Identities=24% Similarity=0.281 Sum_probs=166.1
Q ss_pred HHHHHHHHHhhc---CCCceeeeeeEEE-----eceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHH
Q 038168 513 EFQTEMKVIGRT---HHRNLVRLLGYSL-----EVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 513 ~~~~E~~~l~~l---~h~niv~l~g~~~-----~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~y 583 (757)
.+.+|+.+++++ +||||+++++++. .....++||||++ |+|.+++.... ..+++.++..++.|++.||+|
T Consensus 57 ~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~ 135 (326)
T 1blx_A 57 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135 (326)
T ss_dssp THHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHH
Confidence 355677776666 8999999999987 5678899999998 69999986543 458999999999999999999
Q ss_pred hhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHH
Q 038168 584 LHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663 (757)
Q Consensus 584 LH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ 663 (757)
||+. +|+||||||+|||++.++.+||+|||+++...... ......|+..|+|||.+.+..++.++||||||++++
T Consensus 136 lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 210 (326)
T 1blx_A 136 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 210 (326)
T ss_dssp HHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred HHHC---CceeccCCHHHeEEcCCCCEEEecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHH
Confidence 9998 99999999999999999999999999998764322 233457899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHhcC---Ccccc-------cc------ccccCHHHHHHHHHHHHHccccCCCC
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENG---NLSQL-------VE------DEEVDEKQLERMIKVALWCILDEPSL 727 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~-------~d------~~~~~~~~~~~l~~l~~~cl~~~p~~ 727 (757)
||++|+.||....... ....+....... ..... .. ...........+.+++.+||+.||++
T Consensus 211 ~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 287 (326)
T 1blx_A 211 EMFRRKPLFRGSSDVD---QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 287 (326)
T ss_dssp HHHHSSCSCCCSSHHH---HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTT
T ss_pred HHHcCCCCCCCCCHHH---HHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCccc
Confidence 9999999987543211 111111111100 00000 00 00111233467889999999999999
Q ss_pred CCCHHHHHH
Q 038168 728 RPSMKKVLL 736 (757)
Q Consensus 728 RPsm~eVl~ 736 (757)
|||+.|+++
T Consensus 288 Rpt~~e~l~ 296 (326)
T 1blx_A 288 RISAYSALS 296 (326)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999995
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-30 Score=280.85 Aligned_cols=160 Identities=26% Similarity=0.388 Sum_probs=138.0
Q ss_pred HHHHHHHHHHHhhcC-CC-----ceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTH-HR-----NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-h~-----niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~y 583 (757)
.+++..|+.+++.++ |+ +++++++++...+..++||||++ ++|.+++.... ..+++..+..++.|++.||.|
T Consensus 94 ~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 172 (382)
T 2vx3_A 94 LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172 (382)
T ss_dssp HHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHH
Confidence 366778999998885 55 49999999999999999999996 59999987654 568999999999999999999
Q ss_pred hhhCCCCCeeeCCCCcceEEEC--CCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHH
Q 038168 584 LHDECETQIIHCDIKPQNILMD--ENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVV 661 (757)
Q Consensus 584 LH~~~~~~iiH~Dik~~Nill~--~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~ 661 (757)
||.+ ..+|+||||||+|||++ .++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+
T Consensus 173 lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 247 (382)
T 2vx3_A 173 LATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCI 247 (382)
T ss_dssp HTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHH
T ss_pred hccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHH
Confidence 9952 23899999999999995 4788999999999876532 234578999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCC
Q 038168 662 LLEIICRRRCLDPNL 676 (757)
Q Consensus 662 l~elltG~~p~~~~~ 676 (757)
++||++|+.||....
T Consensus 248 l~elltg~~pf~~~~ 262 (382)
T 2vx3_A 248 LVEMHTGEPLFSGAN 262 (382)
T ss_dssp HHHHHHSSCSSCCSS
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999998543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-30 Score=271.98 Aligned_cols=209 Identities=21% Similarity=0.274 Sum_probs=154.0
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD-ECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~ 590 (757)
+.+.++..+++.++||||+++++++.+.+..++||||+ ++.+..+.......+++..+..++.|+++||+|||+ .
T Consensus 69 ~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--- 144 (318)
T 2dyl_A 69 RILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH--- 144 (318)
T ss_dssp HHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---
Confidence 34445556788889999999999999999999999999 455555554445678999999999999999999998 5
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc-----CCCCCccccchhhHHHHHHH
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR-----NLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~G~~l~el 665 (757)
+|+|+||||+|||++.++.+||+|||++........ .....|+..|+|||.+. ...++.++||||||++++||
T Consensus 145 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l 222 (318)
T 2dyl_A 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222 (318)
T ss_dssp CCCCCCCCGGGEEECTTSCEEECCCTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHH
T ss_pred CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHH
Confidence 899999999999999999999999999986654322 22356899999999984 55788999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
++|+.||....... +....... +......... .....+.+++.+||+.||++||++.|+++
T Consensus 223 ~~g~~pf~~~~~~~-----~~~~~~~~-~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 223 ATGQFPYKNCKTDF-----EVLTKVLQ-EEPPLLPGHM----GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHSSCTTTTCCSHH-----HHHHHHHH-SCCCCCCSSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HhCCCCCCCCCccH-----HHHHHHhc-cCCCCCCccC----CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 99999987532211 11122222 2221111111 12356889999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-30 Score=281.46 Aligned_cols=214 Identities=23% Similarity=0.277 Sum_probs=162.1
Q ss_pred HHHHHHhhcCCCceeeeeeEEEece------eeeEEEEeccCCChhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 516 TEMKVIGRTHHRNLVRLLGYSLEVS------KKILVYEYMSNGSLADILF--NPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 516 ~E~~~l~~l~h~niv~l~g~~~~~~------~~~lV~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
+|++++++++|+||+++++++.... ..++||||++++.+..... .....+++..+..++.||++||+|||+.
T Consensus 81 ~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 160 (394)
T 4e7w_A 81 RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160 (394)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 6999999999999999999986543 3789999998765444331 2346788999999999999999999998
Q ss_pred CCCCeeeCCCCcceEEEC-CCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMD-ENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEI 665 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~-~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++|||||||+++||
T Consensus 161 ---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 235 (394)
T 4e7w_A 161 ---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAEL 235 (394)
T ss_dssp ---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred ---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999 789999999999987654332 2345689999999998765 589999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHh---------------cCCccccccc---cccCHHHHHHHHHHHHHccccCCCC
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFE---------------NGNLSQLVED---EEVDEKQLERMIKVALWCILDEPSL 727 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~---------------~~~~~~~~d~---~~~~~~~~~~l~~l~~~cl~~~p~~ 727 (757)
++|+.||......+. +...+ .... ...+...... ..+......++.+++.+||+.||++
T Consensus 236 l~g~~pf~~~~~~~~--l~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (394)
T 4e7w_A 236 MQGQPLFPGESGIDQ--LVEII-KVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSA 312 (394)
T ss_dssp HHSSCSSCCSSHHHH--HHHHH-HHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HhCCCCCCCCCHHHH--HHHHH-HHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhh
Confidence 999999976432211 11111 1000 0011110000 0012223467999999999999999
Q ss_pred CCCHHHHHHH
Q 038168 728 RPSMKKVLLM 737 (757)
Q Consensus 728 RPsm~eVl~~ 737 (757)
|||+.|+++.
T Consensus 313 R~t~~e~l~h 322 (394)
T 4e7w_A 313 RLTAIEALCH 322 (394)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhcC
Confidence 9999999974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=278.64 Aligned_cols=199 Identities=23% Similarity=0.382 Sum_probs=165.5
Q ss_pred HHHHHHHHHHhhcC--CCceeeeeeEEEeceeeeEEEEeccC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 512 REFQTEMKVIGRTH--HRNLVRLLGYSLEVSKKILVYEYMSN-GSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 512 ~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
+.+.+|+.++++++ |+||+++++++.+.+..++|+|++.. ++|.+++.. ...+++..+..++.|+++||+|||+.
T Consensus 91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~- 168 (320)
T 3a99_A 91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNC- 168 (320)
T ss_dssp CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 45678999999996 59999999999999999999999986 899999865 35688999999999999999999998
Q ss_pred CCCeeeCCCCcceEEEC-CCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCC-CccccchhhHHHHHHHH
Q 038168 589 ETQIIHCDIKPQNILMD-ENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEII 666 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~-~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~G~~l~ell 666 (757)
+|+||||||+|||++ +++.+||+|||+++...... .....||..|+|||.+.+..+ +.++||||||++++||+
T Consensus 169 --~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~ 243 (320)
T 3a99_A 169 --GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243 (320)
T ss_dssp --TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred --CcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHH
Confidence 999999999999999 77999999999998765432 233568999999999887765 78899999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+|+.||.... .. ..+... .+ .....++.+++.+||+.||++|||++||++.
T Consensus 244 ~g~~pf~~~~------------~~-~~~~~~---~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 244 CGDIPFEHDE------------EI-IRGQVF---FR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HSSCSCCSHH------------HH-HHCCCC---CS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HCCCCCCChh------------hh-hccccc---cc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999986321 11 111111 11 1223568899999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-30 Score=275.16 Aligned_cols=213 Identities=23% Similarity=0.304 Sum_probs=146.2
Q ss_pred HHHHHHHHH-HHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMK-VIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN----PEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.+++..|+. +++.++||||+++++++.+.+..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||
T Consensus 64 ~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH 142 (327)
T 3aln_A 64 QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142 (327)
T ss_dssp HHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh
Confidence 345666666 77778999999999999999999999999985 78777642 2467899999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccc----cCCCCCccccchhhHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWH----RNLPITVKADVYSFGVV 661 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~Dv~S~G~~ 661 (757)
+. .+|+||||||+|||++.++.+||+|||+++....... .....||..|+|||.+ .+..++.++||||||++
T Consensus 143 ~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 218 (327)
T 3aln_A 143 EN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGIT 218 (327)
T ss_dssp HH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--------------------------------CCSHHHHHHHHHH
T ss_pred cc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHH
Confidence 84 3899999999999999999999999999987654322 2234689999999998 45678999999999999
Q ss_pred HHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 662 LLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 662 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
++||++|+.||......... . .....+....+.. .........+.+++.+||+.||++|||+.||++
T Consensus 219 l~~l~~g~~pf~~~~~~~~~-----~-~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 219 LYELATGRFPYPKWNSVFDQ-----L-TQVVKGDPPQLSN--SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp HHHHHHSCCCSSCC-------------CCCCCSCCCCCCC--CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchHHHH-----H-HHHhcCCCCCCCC--cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 99999999998753221100 0 0001111111111 011123467899999999999999999999965
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=290.25 Aligned_cols=219 Identities=24% Similarity=0.297 Sum_probs=166.7
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEe------ceeeeEEEEeccCCChhhhhcCCC--CCCCHHHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLE------VSKKILVYEYMSNGSLADILFNPE--KQPNWVERMGIARDIARGI 581 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~~lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL 581 (757)
..+.+.+|+.++++++||||+++++++.. .+..++||||+++|+|.+++.... ..+++..+..++.|++.||
T Consensus 55 ~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL 134 (676)
T 3qa8_A 55 NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134 (676)
T ss_dssp HHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHH
Confidence 35679999999999999999999998765 667899999999999999997643 3588889999999999999
Q ss_pred HHhhhCCCCCeeeCCCCcceEEECCCCc---EEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhh
Q 038168 582 LYLHDECETQIIHCDIKPQNILMDENRC---AKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSF 658 (757)
Q Consensus 582 ~yLH~~~~~~iiH~Dik~~Nill~~~~~---~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~ 658 (757)
+|||+. +|+||||||+||+++.++. +||+|||+++....... .....||..|+|||.+.+..++.++|||||
T Consensus 135 ~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSL 209 (676)
T 3qa8_A 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSF 209 (676)
T ss_dssp HHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHH
T ss_pred HHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHH
Confidence 999998 9999999999999997654 99999999987654332 234678999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCccc---cHHHHHHHHH----hcCCcc--c-cccccccCHHHHHHHHHHHHHccccCCCCC
Q 038168 659 GVVLLEIICRRRCLDPNLPDDQV---ILEEWVYQCF----ENGNLS--Q-LVEDEEVDEKQLERMIKVALWCILDEPSLR 728 (757)
Q Consensus 659 G~~l~elltG~~p~~~~~~~~~~---~l~~~~~~~~----~~~~~~--~-~~d~~~~~~~~~~~l~~l~~~cl~~~p~~R 728 (757)
|++++||++|+.||......... .......... ..+... . ...+..........+.+++.+||+.||++|
T Consensus 210 GviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kR 289 (676)
T 3qa8_A 210 GTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQR 289 (676)
T ss_dssp HHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC--
T ss_pred HHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhC
Confidence 99999999999999753210000 0000000000 000000 0 011122344567889999999999999999
Q ss_pred CCHHH
Q 038168 729 PSMKK 733 (757)
Q Consensus 729 Psm~e 733 (757)
||+.|
T Consensus 290 PTa~e 294 (676)
T 3qa8_A 290 GTDPQ 294 (676)
T ss_dssp -CCTT
T ss_pred cCHHH
Confidence 99976
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-29 Score=294.71 Aligned_cols=197 Identities=22% Similarity=0.321 Sum_probs=160.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEecee-----eeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSK-----KILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.+.+.+|+.++++++||||+++++++.+.+. .+|||||+++++|.+++.. .+++.+++.|+.||++||+|||
T Consensus 123 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH 199 (681)
T 2pzi_A 123 QAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH 199 (681)
T ss_dssp HHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH
Confidence 4578899999999999999999999987665 6999999999999998743 7899999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
++ +|+||||||+|||++.+ .+||+|||+++..... ....||++|+|||++.+.. +.++||||||++++||
T Consensus 200 ~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l 269 (681)
T 2pzi_A 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAAL 269 (681)
T ss_dssp HT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHH
T ss_pred HC---CCeecccChHHeEEeCC-cEEEEecccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHH
Confidence 98 99999999999999986 8999999999876543 3456899999999987654 8999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhc
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-SMKKVLLMLEG 740 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-sm~eVl~~Le~ 740 (757)
++|..|+........ . ...........+.+++.+||+.||++|| +++++.+.|.+
T Consensus 270 ~~g~~~~~~~~~~~~----------------~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 270 TLDLPTRNGRYVDGL----------------P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HSCCCEETTEECSSC----------------C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HhCCCCCcccccccc----------------c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 999888764221110 0 0001112346788999999999999999 56666666654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=269.25 Aligned_cols=198 Identities=25% Similarity=0.435 Sum_probs=160.3
Q ss_pred HHHHHHHHHhhc----CCCceeeeeeEEEeceeeeEEEEe-ccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 513 EFQTEMKVIGRT----HHRNLVRLLGYSLEVSKKILVYEY-MSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 513 ~~~~E~~~l~~l----~h~niv~l~g~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
.+.+|+.++.++ +|+||+++++++.+.+..++|+|+ +++++|.+++.. ...+++.++..++.|+++||+|||+.
T Consensus 80 ~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~ 158 (312)
T 2iwi_A 80 TCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSR 158 (312)
T ss_dssp CCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 356789999888 899999999999999999999999 789999999965 34689999999999999999999999
Q ss_pred CCCCeeeCCCCcceEEEC-CCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCC-CccccchhhHHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMD-ENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEI 665 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~-~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+||+++ .++.+||+|||+++...... .....|+..|+|||.+.+..+ +.++||||||++++||
T Consensus 159 ---~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l 232 (312)
T 2iwi_A 159 ---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDM 232 (312)
T ss_dssp ---TEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred ---CeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHH
Confidence 999999999999999 88999999999998775432 234568999999999887666 4589999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++|+.||.... .. ...... .+......+.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~g~~pf~~~~------------~~-~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 233 VCGDIPFERDQ------------EI-LEAELH-------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHSSCSCCSHH------------HH-HHTCCC-------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCCChH------------HH-hhhccC-------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999986320 01 111111 112234568899999999999999999999983
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=264.51 Aligned_cols=200 Identities=21% Similarity=0.295 Sum_probs=154.5
Q ss_pred HHHHHHHHHHH-hhcCCCceeeeeeEEEe----ceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVI-GRTHHRNLVRLLGYSLE----VSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l-~~l~h~niv~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yL 584 (757)
...+.+|+.++ +.++||||+++++++.. ....++||||+++|+|.+++.... ..+++.++..++.|++.||+||
T Consensus 54 ~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 133 (299)
T 3m2w_A 54 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133 (299)
T ss_dssp SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 36788999988 55599999999999887 678899999999999999997643 4689999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECC---CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDE---NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVV 661 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~---~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~ 661 (757)
|+. +|+||||||+|||++. ++.+||+|||++.... +..++.++||||||++
T Consensus 134 H~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-----------------------~~~~~~~~DiwslG~i 187 (299)
T 3m2w_A 134 HSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-----------------------GEKYDKSCDMWSLGVI 187 (299)
T ss_dssp HHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-----------------------TCGGGGHHHHHHHHHH
T ss_pred HhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc-----------------------cccCCchhhHHHHHHH
Confidence 998 9999999999999998 7899999999987543 2346789999999999
Q ss_pred HHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCcccccc-ccccC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 662 LLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVE-DEEVD----EKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 662 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-~~~~~----~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
++||++|+.||........ .......... ....+ ......+.+++.+||+.||++|||+.|+++
T Consensus 188 l~el~tg~~pf~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 188 MYILLCGYPPFYSNHGLAI-----------SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HHHHHHSSCSCCC------------------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHCCCCCCCCcchhh-----------hHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 9999999999965432210 0000000000 00111 123467899999999999999999999998
Q ss_pred --HhhcCcCCCCC
Q 038168 737 --MLEGTVEIPIP 747 (757)
Q Consensus 737 --~Le~~~~~~~p 747 (757)
.+......+.+
T Consensus 257 hp~~~~~~~~~~~ 269 (299)
T 3m2w_A 257 HPWIMQSTKVPQT 269 (299)
T ss_dssp SHHHHTGGGSCCC
T ss_pred ChhhcccccCCCC
Confidence 34444444433
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-29 Score=260.71 Aligned_cols=190 Identities=14% Similarity=0.170 Sum_probs=151.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.|.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++.. .....+..+|+.|++.||+|||++
T Consensus 75 ~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~--- 148 (286)
T 3uqc_A 75 LQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRA--- 148 (286)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHC---
Confidence 47899999999999999999999999999999999999999999999953 245567889999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+++| |++ +++.++||||||+++|||++|+.
T Consensus 149 givH~Dikp~NIll~~~g~~kl~~~~---------------------~~~-------~~~~~~Di~slG~il~elltg~~ 200 (286)
T 3uqc_A 149 GVALSIDHPSRVRVSIDGDVVLAYPA---------------------TMP-------DANPQDDIRGIGASLYALLVNRW 200 (286)
T ss_dssp TCCCCCCSGGGEEEETTSCEEECSCC---------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEE
T ss_pred CCccCCCCcccEEEcCCCCEEEEecc---------------------ccC-------CCCchhHHHHHHHHHHHHHHCCC
Confidence 99999999999999999999998543 333 36889999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
||............ ... ..+. ...+..........+.+++.+||+.||++| |+.|+++.|+...
T Consensus 201 Pf~~~~~~~~~~~~---~~~-~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 201 PLPEAGVRSGLAPA---ERD-TAGQ---PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp CSCCCSBCCCSEEC---CBC-TTSC---BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred CCCcCCcchhhHHH---HHH-hccC---CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 99865443211000 000 0000 000111122334678999999999999999 9999999998744
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-28 Score=268.15 Aligned_cols=198 Identities=14% Similarity=0.160 Sum_probs=147.3
Q ss_pred HHHHHHHHHHHhhcCC-Ccee---------------eee------eEEEe-----ceeeeEEEEeccCCChhhhhc----
Q 038168 511 EREFQTEMKVIGRTHH-RNLV---------------RLL------GYSLE-----VSKKILVYEYMSNGSLADILF---- 559 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h-~niv---------------~l~------g~~~~-----~~~~~lV~e~~~~gsL~~~l~---- 559 (757)
.+.|++|+.+++.++| +|.. ++. .+... ....+++|+++ .++|.+++.
T Consensus 122 ~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~ 200 (413)
T 3dzo_A 122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS 200 (413)
T ss_dssp CHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhc
Confidence 5789999999999987 3221 111 11111 11345666654 689999883
Q ss_pred --CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCcc
Q 038168 560 --NPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRG 637 (757)
Q Consensus 560 --~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~ 637 (757)
.....+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++..... .....| +.
T Consensus 201 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~ 272 (413)
T 3dzo_A 201 HSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RG 272 (413)
T ss_dssp HTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TT
T ss_pred ccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-Cc
Confidence 3345578889999999999999999998 9999999999999999999999999999865432 344567 99
Q ss_pred ccCcccc----------cCCCCCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCH
Q 038168 638 YVAPEWH----------RNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDE 707 (757)
Q Consensus 638 y~aPE~~----------~~~~~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 707 (757)
|+|||.+ .+..++.++|||||||++|||++|+.||......... ...+... .
T Consensus 273 y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~---------------~~~~~~~---~ 334 (413)
T 3dzo_A 273 FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS---------------EWIFRSC---K 334 (413)
T ss_dssp TCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS---------------GGGGSSC---C
T ss_pred eeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH---------------HHHHhhc---c
Confidence 9999998 5566889999999999999999999999754322211 0111100 0
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHH
Q 038168 708 KQLERMIKVALWCILDEPSLRPSMKKVL 735 (757)
Q Consensus 708 ~~~~~l~~l~~~cl~~~p~~RPsm~eVl 735 (757)
..++.+.+++.+||+.||++||++.|++
T Consensus 335 ~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 335 NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 1236689999999999999999976664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=254.83 Aligned_cols=202 Identities=10% Similarity=0.040 Sum_probs=150.9
Q ss_pred HHHHHHHHHHHhhcC---------CCceeeeeeEE-----------------Ee-------------ceeeeEEEEeccC
Q 038168 511 EREFQTEMKVIGRTH---------HRNLVRLLGYS-----------------LE-------------VSKKILVYEYMSN 551 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~---------h~niv~l~g~~-----------------~~-------------~~~~~lV~e~~~~ 551 (757)
.+.+.+|+.++++++ |+|||++.+.+ .+ .+..+|||||+++
T Consensus 67 ~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~ 146 (336)
T 2vuw_A 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146 (336)
T ss_dssp HHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECC
T ss_pred HHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCC
Confidence 467888999888886 66666666653 22 6789999999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh-hCCCCCeeeCCCCcceEEECCCC--------------------cE
Q 038168 552 GSLADILFNPEKQPNWVERMGIARDIARGILYLH-DECETQIIHCDIKPQNILMDENR--------------------CA 610 (757)
Q Consensus 552 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiH~Dik~~Nill~~~~--------------------~~ 610 (757)
|+|.+.+.+ ..+++.++..++.||+.||+||| +. +|+||||||+|||++.++ .+
T Consensus 147 g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~v 221 (336)
T 2vuw_A 147 GIDLEQMRT--KLSSLATAKSILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQV 221 (336)
T ss_dssp CEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEE
T ss_pred CccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceE
Confidence 987776643 56799999999999999999999 88 999999999999999887 89
Q ss_pred EEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHH-HHHHHhCCCCCCCCCCCccccHHHHHHH
Q 038168 611 KISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVV-LLEIICRRRCLDPNLPDDQVILEEWVYQ 689 (757)
Q Consensus 611 ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~-l~elltG~~p~~~~~~~~~~~l~~~~~~ 689 (757)
||+|||+++..... ...||+.|+|||.+.+.. +.++||||++++ .+++++|..|+... ........
T Consensus 222 kL~DFG~a~~~~~~------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~ 288 (336)
T 2vuw_A 222 SIIDYTLSRLERDG------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTD 288 (336)
T ss_dssp EECCCTTCBEEETT------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHH
T ss_pred EEeeccccEecCCC------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHH
Confidence 99999999876532 246899999999998776 899999998777 77788888776310 00001111
Q ss_pred HHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 038168 690 CFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735 (757)
Q Consensus 690 ~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl 735 (757)
.+....................++.+++.+||+.| |++|++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 289 KMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 11111111111112223456788999999999966 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.8e-27 Score=267.93 Aligned_cols=150 Identities=18% Similarity=0.167 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.++|.+|+++|+++ +|+||+++++++++++..||||||++|++|.++|... ..++.. +|+.||+.||+|||++
T Consensus 285 ~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~-- 358 (569)
T 4azs_A 285 KYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQ-- 358 (569)
T ss_dssp HHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHC--
Confidence 46799999999999 7999999999999999999999999999999999764 344543 5899999999999999
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+||||||||+||||++++.+||+|||+|+....+.. .....+||++|||||.+.+ .+..++|+||+|++++++.++.
T Consensus 359 -GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 359 -GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp -TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C-CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred -CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 999999999999999999999999999997755432 2344789999999999876 4677899999999988876554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.7e-21 Score=222.41 Aligned_cols=147 Identities=18% Similarity=0.254 Sum_probs=128.1
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.|.+|++++++++||||+++..++...++.+|||||+++++|.+++.. +..++.|+++||+|||++ +
T Consensus 384 ~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~---g 451 (540)
T 3en9_A 384 SRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKN---D 451 (540)
T ss_dssp HHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHC---c
Confidence 4589999999999999999777777788888999999999999999965 568999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce------ecccccCccccCcccccC--CCCCccccchhhHHHHH
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT------FTGIRGTRGYVAPEWHRN--LPITVKADVYSFGVVLL 663 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~G~~l~ 663 (757)
|+||||||+|||++. .+||+|||+++......... .....||+.|||||++.. ..|+..+|+||..+-.+
T Consensus 452 IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l 529 (540)
T 3en9_A 452 VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELM 529 (540)
T ss_dssp EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHH
T ss_pred CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHH
Confidence 999999999999999 99999999999876543322 235679999999999987 56888999999999998
Q ss_pred HHHhCCCCC
Q 038168 664 EIICRRRCL 672 (757)
Q Consensus 664 elltG~~p~ 672 (757)
+-+.++.++
T Consensus 530 ~~v~~r~rY 538 (540)
T 3en9_A 530 KDVERRARY 538 (540)
T ss_dssp HHHHTCSCC
T ss_pred HHHHhcccc
Confidence 888777654
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.76 E-value=4e-18 Score=152.83 Aligned_cols=105 Identities=15% Similarity=0.297 Sum_probs=86.4
Q ss_pred ccCcccCCCceeccCCCeee--eCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCC
Q 038168 29 RRSNISIGSSLSPIGNSSWR--SPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGS 106 (757)
Q Consensus 29 ~~~~i~~g~~l~~~~~~~lv--S~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~ 106 (757)
..++|.+|++|.+ +++|+ |++|.|+|+|+++|+ + +||++ +++||+|||+.| +.++.+.+..||+
T Consensus 7 ~~~~l~~g~~L~~--g~~l~~~S~~g~~~L~~~~dgn----l---vly~~---~~~vW~sn~~~~--~~~~~l~l~~dGN 72 (119)
T 1b2p_A 7 KQPDDNHPQILHA--TESLEILFGTHVYRFIMQTDCN----L---VLYDN---NNPIWATNTGGL--GNGCRAVLQPDGV 72 (119)
T ss_dssp SCSSSCCCCEEET--TCEEEEEETTEEEEEEECTTSC----E---EEEET---TEEEEECCCTTS--CSSCEEEECTTSC
T ss_pred cCcccCCCCEEcC--CCEEEEeCCCCCEEEEEecCCC----E---EEEEC---CEEEEeCCCccC--CCceEEEEccCCE
Confidence 3589999999986 55899 999999999998765 2 58875 799999999876 4568899999999
Q ss_pred EEEecCCCCceeEEecCCC--cceeEEEecCCCEEEEecCCceeeec
Q 038168 107 IVLRSSQQSQDSLIADDSQ--SASSASMLDSGNFVLYDSNGKTLWQT 151 (757)
Q Consensus 107 Lvl~~~~~~~~~~~~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQS 151 (757)
|||.+.+ +..+|++.+.. +...++|+|+|||||++ .++|||
T Consensus 73 LVl~d~~-~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~S 115 (119)
T 1b2p_A 73 LVVITNE-NVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWAT 115 (119)
T ss_dssp EEEECTT-CCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEEC
T ss_pred EEEEeCC-CcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCC
Confidence 9999876 44566665432 24679999999999998 389998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=8.6e-18 Score=148.74 Aligned_cols=107 Identities=18% Similarity=0.289 Sum_probs=86.9
Q ss_pred CcccCCCceeccCCCeeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCEEEe
Q 038168 31 SNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVLR 110 (757)
Q Consensus 31 ~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~Lvl~ 110 (757)
|+|.+||+|.+ +++|+ ++|.|+|+|+..|+ | |||+ ..++||.||++.| +.++.+.+..||||||.
T Consensus 2 d~l~~g~~L~~--g~~l~-~~~~~~l~~~~dGn------l-vl~~---~~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~ 66 (110)
T 3a0c_A 2 NSLSSPNSLFT--GHSLE-VGPSYRLIMQGDCN------F-VLYD---SGKPVWASNTGGL--GSGCRLTLHNNGNLVIY 66 (110)
T ss_dssp CEEETTCEECT--TCEEE-ETTTEEEEECTTSC------E-EEEE---TTEEEEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred CEeCCCCEECC--CCEEE-ECCCEEEEEcCCCc------E-EEEE---CCEEEEECCCCCC--CCcEEEEEeCCCCEEEE
Confidence 78999999985 55899 99999999988776 2 6776 3799999999876 34678999999999999
Q ss_pred cCCCCceeEEecCCCc--ceeEEEecCCCEEEEecCCceeeeccCCCc
Q 038168 111 SSQQSQDSLIADDSQS--ASSASMLDSGNFVLYDSNGKTLWQTFEHPT 156 (757)
Q Consensus 111 ~~~~~~~~~~~~~~~~--~~~a~LldsGNlVl~~~~~~~lWQSFD~PT 156 (757)
+.+ +..+|++.+..+ ...++|+|+|||||++. .+||||+||.
T Consensus 67 ~~~-~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 67 DQS-NRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp CTT-CCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred CCC-CcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 876 445666554432 35799999999999975 8999999984
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.73 E-value=3.2e-17 Score=143.46 Aligned_cols=103 Identities=19% Similarity=0.363 Sum_probs=82.8
Q ss_pred cCcccCCCceeccCCCeeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCEEE
Q 038168 30 RSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVL 109 (757)
Q Consensus 30 ~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~Lvl 109 (757)
+++|.+||.|.+ +++|+| |.|.|.|...++ |.++. ..++||+|||+.|. ...+.|.+..||+|||
T Consensus 1 kn~L~~g~~L~~--g~~L~s--g~y~l~~q~DgN------Lvly~----~~~~vW~ant~~~~-~~~~~L~l~~dGnLvL 65 (105)
T 4h3o_A 1 RNILDNNEGLYA--GQSLDV--EPYHFIMQDDCN------LVLYD----HSTSTWASNTEIGG-KSGCSAVLQSDGNFVV 65 (105)
T ss_dssp CCEECTTEEECT--TCEEEE--TTEEEEECTTSC------EEEEE----TTEEEEECCCCCTT-CCSCEEEECTTSCEEE
T ss_pred CCCcCCCCEEcC--CCEEEE--CCEEEEECCCCe------EEEEE----CCEEEEEecCCCCC-CccEEEEEeCCccEEE
Confidence 478999999985 558888 889999988776 77764 36899999999995 4467899999999999
Q ss_pred ecCCCCceeEEecCCC--cceeEEEecCCCEEEEecCCceeeec
Q 038168 110 RSSQQSQDSLIADDSQ--SASSASMLDSGNFVLYDSNGKTLWQT 151 (757)
Q Consensus 110 ~~~~~~~~~~~~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQS 151 (757)
.|.++ ..+|++++.. ...+|+|+|+|||||++. .||||
T Consensus 66 ~d~~~-~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 66 YDSSG-RSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp ECTTC-CEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred ECCCc-EEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 99874 4556555432 336899999999999964 69998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=3.9e-17 Score=145.91 Aligned_cols=108 Identities=19% Similarity=0.341 Sum_probs=86.3
Q ss_pred cCcccCCCceeccCCCeeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCEEE
Q 038168 30 RSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVL 109 (757)
Q Consensus 30 ~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~Lvl 109 (757)
.|||.+||+|.+ +++|+ +|.|+|+|+.+++ +. +|+ ..++||+||++.| +.++.|.|..+|+|||
T Consensus 2 ~dtl~~gq~L~~--g~~L~--~g~~~L~~~~dgn----lv---ly~---~~~~vW~sn~~~~--~~~~~l~l~~~GnLvl 65 (115)
T 2dpf_A 2 DNVLLSGQTLHA--DHSLQ--AGAYTLTIQNKCN----LV---KYQ---NGRQIWASNTDRR--GSGCRLTLLSDGNLVI 65 (115)
T ss_dssp CCEEETTCEEET--TEEEE--ETTEEEEECTTSC----EE---EEE---TTEEEEECSCTTS--CSSCEEEECTTSCEEE
T ss_pred CCEeCCCCEECC--CCEEE--CCCEEEEEcCCCc----EE---EEe---CCEEEEeCCCCCC--CCceEEEECCCCcEEE
Confidence 489999999985 55888 8999999987665 32 365 4799999999988 3567999999999999
Q ss_pred ecCCCCceeEEecCCC--cceeEEEecCCCEEEEecCCceeeeccCCCcc
Q 038168 110 RSSQQSQDSLIADDSQ--SASSASMLDSGNFVLYDSNGKTLWQTFEHPTD 157 (757)
Q Consensus 110 ~~~~~~~~~~~~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTD 157 (757)
.+.+ +..+|++.... ...+++|+|+|||||++. ++||||.+++.
T Consensus 66 ~d~~-~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 66 YDHN-NNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp ECTT-CCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred ECCC-ceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 9875 44566665432 236799999999999964 89999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.69 E-value=8.9e-17 Score=142.90 Aligned_cols=108 Identities=19% Similarity=0.407 Sum_probs=86.7
Q ss_pred cCcccCCCceeccCCCeeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCEEE
Q 038168 30 RSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVL 109 (757)
Q Consensus 30 ~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~Lvl 109 (757)
+|||.+||+|.+ +++| ++|.|+|+|+++++ | +||++ .++||+||++.+ +.++.+.+..+|+|||
T Consensus 1 tdtl~~gq~L~~--g~~L--~~~~~~L~~~~dgn------l-vl~~~---~~~vW~sn~~~~--~~~~~l~l~~~GNLvl 64 (112)
T 1xd5_A 1 SDRLNSGHQLDT--GGSL--AEGGYLFIIQNDCN------L-VLYDN---NRAVWASGTNGK--ASGCVLKMQNDGNLVI 64 (112)
T ss_dssp CCEEETTEEECT--TCEE--EETTEEEEECTTSC------E-EEEET---TEEEEECCCTTS--CSSEEEEECTTSCEEE
T ss_pred CCCCCCCCEECC--CCEE--eCCCEEEEEcCCCc------E-EEEEC---CEEEEeCCCcCC--CCCEEEEEeCCCCEEE
Confidence 389999999985 5577 58999999998876 2 35764 689999999763 4567899999999999
Q ss_pred ecCCCCceeEEecCCC--cceeEEEecCCCEEEEecCCceeeeccCCC
Q 038168 110 RSSQQSQDSLIADDSQ--SASSASMLDSGNFVLYDSNGKTLWQTFEHP 155 (757)
Q Consensus 110 ~~~~~~~~~~~~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFD~P 155 (757)
.+ + +..+|++.+.. ...+++|+++|||||++.++.++||||+|.
T Consensus 65 ~d-~-~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 65 YS-G-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp EE-T-TEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred Ec-C-CEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 98 4 45667665432 236799999999999987788999999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=2.4e-15 Score=132.80 Aligned_cols=101 Identities=20% Similarity=0.375 Sum_probs=79.6
Q ss_pred CcccCCCceeccCCCeeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCEEEe
Q 038168 31 SNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVLR 110 (757)
Q Consensus 31 ~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~Lvl~ 110 (757)
.||.+||+|.+ +++|+ +|.|+|+|+..|+ .+| |.. .++||+||++.+ +.++.|.+..||+|||.
T Consensus 2 ntL~~gq~L~~--g~~L~--~g~~~L~~q~dGn----Lvl---y~~---~~~vW~snt~~~--~~~~~l~l~~dGNLvl~ 65 (109)
T 3dzw_A 2 NILYSGETLSP--GEFLN--NGRYVFIMQEDCN----LVL---YDV---DKPIWATNTGGL--DRRCHLSMQSDGNLVVY 65 (109)
T ss_dssp CEEETTEEECT--TCEEE--ETTEEEEECTTSC----EEE---EET---TEEEEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred CCcCCCCEeCC--CCEEE--CCCEEEEEcCCCc----EEE---EeC---CEEEEECCcccC--CCCEEEEEeCCCCEEEE
Confidence 68999999975 55786 7999999987765 333 654 589999999876 45678999999999999
Q ss_pred cCCCCceeEEecCCC-c-ceeEEEecCCCEEEEecCCceeeec
Q 038168 111 SSQQSQDSLIADDSQ-S-ASSASMLDSGNFVLYDSNGKTLWQT 151 (757)
Q Consensus 111 ~~~~~~~~~~~~~~~-~-~~~a~LldsGNlVl~~~~~~~lWQS 151 (757)
+.++ ..+|++++.. . ..+|+|+|+|||||++. .+|||
T Consensus 66 ~~~~-~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s 104 (109)
T 3dzw_A 66 SPRN-NPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWAT 104 (109)
T ss_dssp CTTS-CEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCC
T ss_pred CCCC-CEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeC
Confidence 8764 4566655432 2 36799999999999984 89998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=3.8e-16 Score=163.25 Aligned_cols=106 Identities=13% Similarity=0.092 Sum_probs=88.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
...+.+|+.++++++ | +++.+++. .+..++||||+++++|.+ +.. .....++.|+++||+|||+.
T Consensus 148 ~~~~~~E~~~l~~l~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~--- 212 (282)
T 1zar_A 148 IRSARNEFRALQKLQ--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHR--- 212 (282)
T ss_dssp HHHHHHHHHHHHHTT--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhcc--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHC---
Confidence 467899999999999 5 77777553 466799999999999998 522 12446999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN 646 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 646 (757)
+|+||||||+|||++ ++.+||+|||+++. +..++|||++..
T Consensus 213 giiHrDlkp~NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 213 GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp TEECSCCSTTSEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred CCEeCCCCHHHEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 999999999999999 99999999999974 345788888753
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.54 E-value=2.7e-14 Score=126.86 Aligned_cols=96 Identities=24% Similarity=0.472 Sum_probs=76.3
Q ss_pred CCCCCCCceeEeccCCCEEEecCCCCceeEEecCCC--cceeEEEecCCCEEEEecCCceeeeccCCCccccCCCCcccC
Q 038168 90 DPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQ--SASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSV 167 (757)
Q Consensus 90 ~P~~~~~~~l~~~~~G~Lvl~~~~~~~~~~~~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg~kl~~ 167 (757)
.|+.+...+|.|..||+|+|.+. +..+|++++.. ....|+|+|+|||||+| ++.++||||+
T Consensus 14 ~~L~~~~~~L~~~~dgnlvl~~~--~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~-------------- 76 (112)
T 1xd5_A 14 GSLAEGGYLFIIQNDCNLVLYDN--NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNT-------------- 76 (112)
T ss_dssp CEEEETTEEEEECTTSCEEEEET--TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCC--------------
T ss_pred CEEeCCCEEEEEcCCCcEEEEEC--CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCc--------------
Confidence 34445668999999999999876 35667766543 23789999999999999 7889999994
Q ss_pred CCcccccCCCCCCCCCceEEEecCCCCceeeeccCCCCccceEeeccccCC
Q 038168 168 GTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTYNK 218 (757)
Q Consensus 168 ~~~L~S~~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~ 218 (757)
||++|.|++.++++|++++|... ..+||++++|++
T Consensus 77 -----------~~~~g~~~l~l~~dGnlvl~~~~-----~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 -----------NRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNVG 111 (112)
T ss_dssp -----------CCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCCC
T ss_pred -----------cCCCCCEEEEEeCCCcEEEECCC-----CceEEECCCccC
Confidence 45678999999999998876421 358999999864
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=2.8e-14 Score=126.12 Aligned_cols=88 Identities=25% Similarity=0.510 Sum_probs=71.4
Q ss_pred CCCceeEeccCCCEEEecCCCCceeEEecCCCc--ceeEEEecCCCEEEEecCCceeeeccCCCccccCCCCcccCCCcc
Q 038168 94 STNATLLFNSEGSIVLRSSQQSQDSLIADDSQS--ASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKL 171 (757)
Q Consensus 94 ~~~~~l~~~~~G~Lvl~~~~~~~~~~~~~~~~~--~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg~kl~~~~~L 171 (757)
+...+|.+..||+|||.+. +..+|++++... ...++|+|+|||||+|.++.++||||
T Consensus 19 ~~~~~l~~~~dGnlvl~~~--~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~------------------- 77 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYDS--GKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTK------------------- 77 (110)
T ss_dssp TTTEEEEECTTSCEEEEET--TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECC-------------------
T ss_pred CCCEEEEEcCCCcEEEEEC--CEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecC-------------------
Confidence 4467899999999999984 456677665432 36899999999999999899999999
Q ss_pred cccCCCCCCCCCceEEEecCCCCceeeeccCCCCccceEeecccc
Q 038168 172 FPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTY 216 (757)
Q Consensus 172 ~S~~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~ 216 (757)
+++++|.|++.++++|++++|. ..||+++++
T Consensus 78 ------t~~~~g~~~l~l~~dGnlvl~~--------~~~W~S~~~ 108 (110)
T 3a0c_A 78 ------TNGKEDHYVLVLQQDRNVVIYG--------PVVWATGSG 108 (110)
T ss_dssp ------CCCSSSCCEEEECTTSCEEEEC--------SEEEECSCC
T ss_pred ------CCCCCCCEEEEEeCCccEEEEC--------CCEecCCCc
Confidence 3466899999999999988763 179998765
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.52 E-value=5e-14 Score=124.29 Aligned_cols=102 Identities=15% Similarity=0.239 Sum_probs=78.0
Q ss_pred ccCcccCCCceeccCCCeeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCEE
Q 038168 29 RRSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIV 108 (757)
Q Consensus 29 ~~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~Lv 108 (757)
++|||.+||+|.+ +++|+| |.|.|-|...|+ |.+ |.. ++||.+|++.. +.++.|.+..+|+||
T Consensus 5 ~~dtL~~gq~L~~--g~~L~s--g~~~L~~q~dGn------Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~dGNLv 67 (110)
T 3r0e_B 5 TNNLLFSGQVLYG--DGRLTA--KNHQLVMQGDCN------LVL-YGG----KYGWQSNTHGN--GEHCFLRLNHKGELI 67 (110)
T ss_dssp BTTEEETTCEEET--TEEEEC--SSCEEEECTTSC------EEE-ECS----SSCEECCCTTS--SSSCEEEECTTSCEE
T ss_pred ccCEECCCCEecC--CCEEEe--CCEEEEEcCCCe------EEE-ECC----eEEEECCCcCC--CcCEEEEEeCCCcEE
Confidence 4699999999985 558987 569997755544 444 654 48999999762 445789999999999
Q ss_pred EecCCCCceeEEecCCC--cceeEEEecCCCEEEEecCCceeeec
Q 038168 109 LRSSQQSQDSLIADDSQ--SASSASMLDSGNFVLYDSNGKTLWQT 151 (757)
Q Consensus 109 l~~~~~~~~~~~~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQS 151 (757)
|.+.++ ..+|++++.. ...+|+|+|+|||||++ ..+|+|
T Consensus 68 l~d~~~-~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 68 IKDDDF-KTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp EECTTC-CEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred EEeCCC-CEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 998764 4566665432 23689999999999998 489997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.48 E-value=3.8e-13 Score=119.31 Aligned_cols=105 Identities=11% Similarity=0.256 Sum_probs=81.7
Q ss_pred ccCcccCCCceeccCCCeeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCEE
Q 038168 29 RRSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIV 108 (757)
Q Consensus 29 ~~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~Lv 108 (757)
..++|.+||.|.+ ++.|. +|.|.|-|...|+ |.++..+ ..++||.+|+..+ +.++.|.+..+|+||
T Consensus 5 ~~~tL~~gq~L~~--g~~L~--~g~~~L~~q~dGN------LvL~~~~--~~~~vWssnt~~~--~~~~~l~l~~dGNLV 70 (113)
T 3mez_B 5 VRNVLFSSQVMYD--NAQLA--TRDYSLVMRDDCN------LVLTKGS--KTNIVWESGTSGR--GQHCFMRLGHSGELD 70 (113)
T ss_dssp CSSEEETTCEEET--TCEEE--ETTEEEEECTTSC------EEEEETT--TTEEEEECCCTTS--CSSCEEEECTTSCEE
T ss_pred cCCEeCCCCEECC--CCEeE--cCCEEEEEcCCCE------EEEEECC--CCEEEEECCcccC--CcCEEEEEeCCCcEE
Confidence 3689999999985 44676 4889999987665 6665431 4789999999865 346789999999999
Q ss_pred EecCCCCceeEEecCCC--cceeEEEecCCCEEEEecCCceeeec
Q 038168 109 LRSSQQSQDSLIADDSQ--SASSASMLDSGNFVLYDSNGKTLWQT 151 (757)
Q Consensus 109 l~~~~~~~~~~~~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQS 151 (757)
|.+.++ ..+|++++.. ...+|+|+|+|||||++ ..+|+|
T Consensus 71 l~d~~~-~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 71 ITDDRL-NTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp EECTTS-CEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred EECCCC-CEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 998764 4566665532 23689999999999997 689997
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.46 E-value=2.5e-13 Score=121.53 Aligned_cols=85 Identities=22% Similarity=0.445 Sum_probs=69.6
Q ss_pred CceeEeccCCCEEEecCCCCceeEEecCCCc--ceeEEEecCCCEEEEecCCceeeeccCCCccccCCCCcccCCCcccc
Q 038168 96 NATLLFNSEGSIVLRSSQQSQDSLIADDSQS--ASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFP 173 (757)
Q Consensus 96 ~~~l~~~~~G~Lvl~~~~~~~~~~~~~~~~~--~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg~kl~~~~~L~S 173 (757)
...|.|..||+|+|.+. +..+|+++.... ...++|+|+|||||+|.++.++||||
T Consensus 31 ~~~L~~~~dgnlvly~~--~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~--------------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN--NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP--------------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET--TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS---------------------
T ss_pred CEEEEEecCCCEEEEEC--CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCC---------------------
Confidence 35788889999999986 456677665432 36899999999999999899999999
Q ss_pred cCCCCCCCCCceEEEecCCCCceeeeccCCCCccceEeeccc
Q 038168 174 GISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNT 215 (757)
Q Consensus 174 ~~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~~ 215 (757)
+||++|.|++.++++|+++++. ..||++++
T Consensus 88 ----~~~~~g~~~l~l~~~Gnlvl~~--------~~~W~Sg~ 117 (119)
T 1b2p_A 88 ----VAGKAGHYVLVLQPDRNVVIYG--------DALWATQT 117 (119)
T ss_dssp ----CCCCSSCEEEEECTTSCEEEEE--------SEEEECCC
T ss_pred ----CCCCCCCEEEEEECCCcEEEEC--------ccEeCCCC
Confidence 3567899999999999988763 27999876
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=7e-13 Score=118.19 Aligned_cols=89 Identities=24% Similarity=0.474 Sum_probs=72.3
Q ss_pred CCceeEeccCCCEEEecCCCCceeEEecCCC--cceeEEEecCCCEEEEecCCceeeeccCCCccccCCCCcccCCCccc
Q 038168 95 TNATLLFNSEGSIVLRSSQQSQDSLIADDSQ--SASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLF 172 (757)
Q Consensus 95 ~~~~l~~~~~G~Lvl~~~~~~~~~~~~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg~kl~~~~~L~ 172 (757)
....|.|..||+|+|.+. ...+|++++.. ....++|+|+|||||+|.++.++|||||+
T Consensus 20 g~~~L~~~~dgnlvly~~--~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~------------------ 79 (115)
T 2dpf_A 20 GAYTLTIQNKCNLVKYQN--GRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACW------------------ 79 (115)
T ss_dssp TTEEEEECTTSCEEEEET--TEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCC------------------
T ss_pred CCEEEEEcCCCcEEEEeC--CEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCC------------------
Confidence 456788889999999873 45677766543 23689999999999999888999999998
Q ss_pred ccCCCCCCCCCceEEEecCCCCceeeeccCCCCccceEeeccccCC
Q 038168 173 PGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTYNK 218 (757)
Q Consensus 173 S~~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~ 218 (757)
+++|.|++.++++|+++++. ..||++++|..
T Consensus 80 -------~~~g~~~l~l~~dGnlvl~~--------~~~W~S~~~~~ 110 (115)
T 2dpf_A 80 -------GDNGKYALVLQKDGRFVIYG--------PVLWSLGPNGC 110 (115)
T ss_dssp -------CSSSCCEEEECTTSCEEEEC--------SEEECSSTTCB
T ss_pred -------CCCCCEEEEEeCCCeEEEEC--------CCEEECCCCCC
Confidence 34688999999999988762 17999999964
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.37 E-value=2.1e-12 Score=113.65 Aligned_cols=106 Identities=13% Similarity=0.318 Sum_probs=80.0
Q ss_pred ccCcccCCCceeccCCCeeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCEE
Q 038168 29 RRSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIV 108 (757)
Q Consensus 29 ~~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~Lv 108 (757)
+.|||.+||.|.+ +++| .+|.|.|.|...|+ |-+ |.. +|.+|+..+ +.+..|.+..||+||
T Consensus 2 ~~dtL~~gq~L~~--g~~L--~~g~~~L~~q~dGN------Lvl-~~~------~Wssnt~~~--~~~~~l~l~~dGnLv 62 (109)
T 3r0e_A 2 GTNYLLSGQTLDT--EGHL--KNGDFDLVMQDDCN------LVL-YNG------NWQSNTANN--GRDCKLTLTDYGELV 62 (109)
T ss_dssp CCSEEETTCEECT--TCEE--EETTEEEEECTTSC------EEE-ETT------TEECCCTTS--CSSCEEEECTTSCEE
T ss_pred ccCCcCCCCCcCC--CCEe--ECCCEEEEEecCCe------EEE-EeC------eEEcCCCCC--CCcEEEEEcCCCeEE
Confidence 3699999999985 4567 57999999987665 323 442 699998764 456899999999999
Q ss_pred EecCCCCceeEEecCCC--cceeEEEecCCCEEEEecCCceeeeccCCCccccCCC
Q 038168 109 LRSSQQSQDSLIADDSQ--SASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPN 162 (757)
Q Consensus 109 l~~~~~~~~~~~~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg 162 (757)
|.+.++ ..+|++++.. ...+|+|+|+|||||++ ..+|+| +|.+||
T Consensus 63 l~d~~~-~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 63 IKNGDG-STVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI-----DPWVRG 109 (109)
T ss_dssp EECTTS-CEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE-----CTTSCC
T ss_pred EEeCCC-CEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC-----CCccCC
Confidence 998764 4556655432 23689999999999997 689998 555554
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=7.9e-13 Score=136.16 Aligned_cols=98 Identities=18% Similarity=0.325 Sum_probs=77.5
Q ss_pred HHHHHHHHHHhhcCCCce--eeeeeEEEeceeeeEEEEeccC-C----ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 512 REFQTEMKVIGRTHHRNL--VRLLGYSLEVSKKILVYEYMSN-G----SLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~ni--v~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
..+.+|+.+|++++|+++ .+++++ +..+|||||+.+ | +|.++... .++.....++.|++.+|.||
T Consensus 115 ~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~l 186 (258)
T 1zth_A 115 IWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRL 186 (258)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHH
Confidence 468899999999988864 333332 467899999952 4 66665432 12345678999999999999
Q ss_pred h-hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccC
Q 038168 585 H-DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK 622 (757)
Q Consensus 585 H-~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~ 622 (757)
| +. +|+||||||+|||++. .++|+|||+|....
T Consensus 187 H~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 187 YQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp HHTS---CEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred HHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 9 87 9999999999999998 99999999997653
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.27 E-value=2.1e-11 Score=107.65 Aligned_cols=102 Identities=15% Similarity=0.261 Sum_probs=77.3
Q ss_pred cCcccCCCceeccCCCeeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCEEE
Q 038168 30 RSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVL 109 (757)
Q Consensus 30 ~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~Lvl 109 (757)
+++|.+||.|.+ ++.| .+|.|.|-|...|+ |-+ |.. .. ||.+|+..+ +.+..|.+..+|+|||
T Consensus 2 ~~~l~~gq~L~~--g~~L--~~g~~~L~~q~dGn------Lvl-~~~---~~-vW~snt~~~--~~~~~l~l~~dGNLVl 64 (111)
T 3mez_A 2 NNVLLTGDVIHT--DNQL--SYESAAFVMQGDCN------LVL-YNE---AG-GFQSNTHGR--GVDCTLRLNNRGQLEI 64 (111)
T ss_dssp TTEEETTCEECT--TCEE--EETTEEEEECTTSC------EEE-ECS---SC-CEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred cCEeCCCCEeCC--CCEE--ecCCEEEEEccCCe------EEE-ECC---CC-EEECCcccC--CcCEEEEEcCCCcEEE
Confidence 588999999985 4467 37999999987665 433 543 23 999999776 4457899999999999
Q ss_pred ecCCCCceeEEecCC----CcceeEEEecCCCEEEEecCCceeeec
Q 038168 110 RSSQQSQDSLIADDS----QSASSASMLDSGNFVLYDSNGKTLWQT 151 (757)
Q Consensus 110 ~~~~~~~~~~~~~~~----~~~~~a~LldsGNlVl~~~~~~~lWQS 151 (757)
.+.++...+|++++. ....+++|+|+|||||++ ..+|+|
T Consensus 65 ~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 65 HSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp ECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred EeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 988654435555431 123679999999999997 789998
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.20 E-value=6.7e-11 Score=104.79 Aligned_cols=95 Identities=18% Similarity=0.305 Sum_probs=72.5
Q ss_pred CCCCCCCCCceeEeccCCCEEEecCCCCceeEEecCCC--cceeEEEecCCCEEEEecCCceeeeccCCCccccCCCCcc
Q 038168 88 RDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQ--SASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRL 165 (757)
Q Consensus 88 r~~P~~~~~~~l~~~~~G~Lvl~~~~~~~~~~~~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg~kl 165 (757)
.+.|+.+...+|.+..||+|||.+.+.+..+|++++.. ....++|+|+|||||+|.++.++|||-.+
T Consensus 17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~----------- 85 (113)
T 3mez_B 17 DNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTV----------- 85 (113)
T ss_dssp TTCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCC-----------
T ss_pred CCCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCc-----------
Confidence 45666677789999999999999874345667766543 23689999999999999988999998221
Q ss_pred cCCCcccccCCCCCCCCCceEEEecCCCCceeeeccCCCCccceEeeccc
Q 038168 166 SVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNT 215 (757)
Q Consensus 166 ~~~~~L~S~~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~~ 215 (757)
-..|.|.+.++.||++++|. .+.|.+++
T Consensus 86 --------------~~~~~~~~~L~~dGnlvly~--------~~~W~s~~ 113 (113)
T 3mez_B 86 --------------GQEGDYVLILQINGQAVVYG--------PAVWSTAA 113 (113)
T ss_dssp --------------CSSSCCEEEECTTSCEEEEC--------SEEEESCC
T ss_pred --------------CCCCCEEEEEcCCceEEEec--------CCEecCCC
Confidence 01356899999999999883 37888753
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.12 E-value=1.6e-10 Score=101.85 Aligned_cols=92 Identities=13% Similarity=0.320 Sum_probs=69.6
Q ss_pred CCCCCCCceeEeccCCCEEEecCCCCceeEEecCCC-c-ceeEEEecCCCEEEEecCCc-eeeeccCCCccccCCCCccc
Q 038168 90 DPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQ-S-ASSASMLDSGNFVLYDSNGK-TLWQTFEHPTDTLLPNQRLS 166 (757)
Q Consensus 90 ~P~~~~~~~l~~~~~G~Lvl~~~~~~~~~~~~~~~~-~-~~~a~LldsGNlVl~~~~~~-~lWQSFD~PTDTlLpg~kl~ 166 (757)
.++.+....|.+..||+|||.+.++ .|++++.. . ...++|+|+|||||+|.++. ++|||.-+
T Consensus 15 ~~L~~g~~~L~~q~dGnLvl~~~~~---vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~------------ 79 (111)
T 3mez_A 15 NQLSYESAAFVMQGDCNLVLYNEAG---GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS------------ 79 (111)
T ss_dssp CEEEETTEEEEECTTSCEEEECSSC---CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS------------
T ss_pred CEEecCCEEEEEccCCeEEEECCCC---EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc------------
Confidence 4445566789999999999998764 55555432 2 36899999999999998776 59999621
Q ss_pred CCCcccccCCCCCCCCCceEEEecCCCCceeeeccCCCCccceEeeccc
Q 038168 167 VGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNT 215 (757)
Q Consensus 167 ~~~~L~S~~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~~ 215 (757)
.....|.|.+.++.||++++|. .++|.+++
T Consensus 80 -----------~~~~~~~~~l~Lq~dGNlvly~--------~~~W~s~t 109 (111)
T 3mez_A 80 -----------VNTVRGNYAATLGPDQHVTIYG--------PAIWSTPA 109 (111)
T ss_dssp -----------CCCCSSCCEEEECTTSCEEEEC--------SEEEECCC
T ss_pred -----------cCCCCcCEEEEECCCCeEEEec--------cCEEccCC
Confidence 1123578999999999999984 37898765
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.03 E-value=8.8e-10 Score=96.97 Aligned_cols=87 Identities=21% Similarity=0.386 Sum_probs=65.8
Q ss_pred CCCCCceeEeccCCCEEEecCCCCceeEEecCCCc--ceeEEEecCCCEEEEecCCceeeeccCCCccccCCCCcccCCC
Q 038168 92 PVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQS--ASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGT 169 (757)
Q Consensus 92 ~~~~~~~l~~~~~G~Lvl~~~~~~~~~~~~~~~~~--~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg~kl~~~~ 169 (757)
+.+....|.+..||+|||.+. . ..|++++... ...++|+|+|||||+|.++.++|||-.+-
T Consensus 21 L~sg~~~L~~q~dGnLvl~~~--~-~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~-------------- 83 (110)
T 3r0e_B 21 LTAKNHQLVMQGDCNLVLYGG--K-YGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSS-------------- 83 (110)
T ss_dssp EECSSCEEEECTTSCEEEECS--S-SCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCCC--------------
T ss_pred EEeCCEEEEEcCCCeEEEECC--e-EEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCcC--------------
Confidence 334557899999999999876 2 4566554332 36899999999999999889999994311
Q ss_pred cccccCCCCCCCCCceEEEecCCCCceeeeccCCCCccceEeecc
Q 038168 170 KLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASN 214 (757)
Q Consensus 170 ~L~S~~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~ 214 (757)
..|.|.+.++.||++++|. .+.|.++
T Consensus 84 -----------~~~~~~~~L~~dGNlvly~--------~~~W~t~ 109 (110)
T 3r0e_B 84 -----------KQGEYVLILQDDGFGVIYG--------PAIFETS 109 (110)
T ss_dssp -----------SSSCCEEEECTTSCEEEEC--------SEEEESC
T ss_pred -----------CCCCEEEEEcCCccEEEec--------CCEecCC
Confidence 1356899999999999884 2678775
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=1.6e-09 Score=111.51 Aligned_cols=112 Identities=14% Similarity=0.302 Sum_probs=80.3
Q ss_pred ccCcccCCCc----eeccCCCeeeeCCCeEEEEEEeCC-CCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEecc
Q 038168 29 RRSNISIGSS----LSPIGNSSWRSPSGLYAFGFYPQS-NVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNS 103 (757)
Q Consensus 29 ~~~~i~~g~~----l~~~~~~~lvS~~g~F~lGFf~~~-~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~ 103 (757)
.+||+.+|+. |. .+++|+| +..++.|+|... ...+.++| | .+ ..+++|.+++..+ +. ..|.+..
T Consensus 135 ptdtlLpg~~~~~~l~--~g~~L~S-~~dps~G~fsl~l~~dGnlvL--y-~~--~~~~yW~Sgt~~~--~~-~~l~l~~ 203 (276)
T 3m7h_A 135 PAIPLVPGAIDSLLLA--PGSELVQ-GVVYGAGASKLVFQGDGNLVA--Y-GP--NGAATWNAGTQGK--GA-VRAVFQG 203 (276)
T ss_dssp TTSCCCCSCTTCEEEC--SSEEECT-TCEEEETTEEEEECTTSCEEE--E-CT--TSSEEEECCCTTT--TC-CEEEECT
T ss_pred cccccccccccccccc--cCccccc-CCCCCCceEEEeecCCceEEE--E-eC--CCeEEEECCCCCC--cc-EEEEEcC
Confidence 4589999998 65 3456765 457777776542 11234443 3 32 2579999999876 22 7899999
Q ss_pred CCCEEEecCCCCceeEEecCC-CcceeEEEecCCCEEEEecCCceeeeccCC
Q 038168 104 EGSIVLRSSQQSQDSLIADDS-QSASSASMLDSGNFVLYDSNGKTLWQTFEH 154 (757)
Q Consensus 104 ~G~Lvl~~~~~~~~~~~~~~~-~~~~~a~LldsGNlVl~~~~~~~lWQSFD~ 154 (757)
+|+|++.+.++ ...|.+.+. ....+|+|+|+|||||++. +.+||||||
T Consensus 204 dGnLvl~d~~~-~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 204 DGNLVVYGAGN-AVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp TSCEEEECTTS-CEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred CCeEEEEeCCC-cEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 99999998864 455655543 3347899999999999986 689999997
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.96 E-value=2.7e-09 Score=93.83 Aligned_cols=87 Identities=22% Similarity=0.461 Sum_probs=66.2
Q ss_pred CCCceeEeccCCCEEEecCCCCceeEEecCCC--cceeEEEecCCCEEEEecCCceeeeccCCCccccCCCCcccCCCcc
Q 038168 94 STNATLLFNSEGSIVLRSSQQSQDSLIADDSQ--SASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKL 171 (757)
Q Consensus 94 ~~~~~l~~~~~G~Lvl~~~~~~~~~~~~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg~kl~~~~~L 171 (757)
+....|.+..||+|||.+. +..+|++++.. ....++|+|+|||||+|.++.++|||....
T Consensus 18 ~g~~~L~~q~dGnLvly~~--~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~---------------- 79 (109)
T 3dzw_A 18 NGRYVFIMQEDCNLVLYDV--DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG---------------- 79 (109)
T ss_dssp ETTEEEEECTTSCEEEEET--TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCC----------------
T ss_pred CCCEEEEEcCCCcEEEEeC--CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCC----------------
Confidence 3457899999999999887 35567666543 236899999999999998889999984321
Q ss_pred cccCCCCCCCCCceEEEecCCCCceeeeccCCCCccceEeeccc
Q 038168 172 FPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNT 215 (757)
Q Consensus 172 ~S~~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~~ 215 (757)
..+.|.+.++.||++++|. .+.|.+++
T Consensus 80 ---------~~~~~~~~L~ddGNlvly~--------~~~W~s~t 106 (109)
T 3dzw_A 80 ---------ENGNYVCVLQKDRNVVIYG--------TARWATGT 106 (109)
T ss_dssp ---------SSSCEEEEECTTSCEEEEE--------SCCCCCCC
T ss_pred ---------CCCCEEEEEeCCCEEEEEC--------CCEEeCCC
Confidence 1356899999999999874 15677664
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.94 E-value=2.6e-09 Score=93.80 Aligned_cols=91 Identities=15% Similarity=0.401 Sum_probs=69.1
Q ss_pred CCCCCCCCceeEeccCCCEEEecCCCCceeEEecCCC--cceeEEEecCCCEEEEecCCceeeeccCCCccccCCCCccc
Q 038168 89 DDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQ--SASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLS 166 (757)
Q Consensus 89 ~~P~~~~~~~l~~~~~G~Lvl~~~~~~~~~~~~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg~kl~ 166 (757)
+.|+.+....|.+..||+|||.+. .|++++.. ....++|+++|||||+|.++.++|+|-..
T Consensus 15 g~~L~~g~~~L~~q~dGNLvl~~~-----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~t~------------ 77 (109)
T 3r0e_A 15 EGHLKNGDFDLVMQDDCNLVLYNG-----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQ------------ 77 (109)
T ss_dssp TCEEEETTEEEEECTTSCEEEETT-----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECCCC------------
T ss_pred CCEeECCCEEEEEecCCeEEEEeC-----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCCCc------------
Confidence 445555677899999999999874 35555433 23688999999999999988999987210
Q ss_pred CCCcccccCCCCCCCCCceEEEecCCCCceeeeccCCCCccceEeeccccC
Q 038168 167 VGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTYN 217 (757)
Q Consensus 167 ~~~~L~S~~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~ 217 (757)
...+.|.+.++.||++++|. .+.|.+++|-
T Consensus 78 -------------~~~~~~~~~L~~dGNlvly~--------~~~W~s~t~~ 107 (109)
T 3r0e_A 78 -------------SVKGNYAAVVHPDGRLVVFG--------PSVFKIDPWV 107 (109)
T ss_dssp -------------CSSSCCEEEEETTTEEEEEC--------SEEEEECTTS
T ss_pred -------------CCCcCEEEEEcCCCeEEEEe--------cCEECCCCcc
Confidence 12357889999999999883 3789998874
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.86 E-value=5.4e-10 Score=120.08 Aligned_cols=95 Identities=18% Similarity=0.182 Sum_probs=68.8
Q ss_pred HHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeC
Q 038168 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHC 595 (757)
Q Consensus 516 ~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~ 595 (757)
+|...|.++.+.++.-..-+ .....+|||||++++.|.++... .....++.|++.+|.|||+. +||||
T Consensus 162 kE~~nL~rL~~~gv~vp~p~--~~~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~---gIVHr 229 (397)
T 4gyi_A 162 KEFAFMKALYEEGFPVPEPI--AQSRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKH---GLIHG 229 (397)
T ss_dssp HHHHHHHHHHHTTCSCCCEE--EEETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred HHHHHHHHHHhcCCCCCeee--eccCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHC---CCcCC
Confidence 46666666644433211111 12234799999999998776422 12346889999999999998 99999
Q ss_pred CCCcceEEECCCC----------cEEEeecCCccccC
Q 038168 596 DIKPQNILMDENR----------CAKISDFGLAKLMK 622 (757)
Q Consensus 596 Dik~~Nill~~~~----------~~ki~DfGla~~~~ 622 (757)
||||.|||+++++ .+.|+||+-+....
T Consensus 230 DLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 230 DFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9999999998776 38999999887544
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.86 E-value=8.7e-09 Score=104.11 Aligned_cols=86 Identities=20% Similarity=0.379 Sum_probs=64.5
Q ss_pred CceeEeccCCCEEEecCCCCceeEEecCC-CcceeEEEecCCCEEEEecCCceeeeccCCCccccCCCCcccCCCccccc
Q 038168 96 NATLLFNSEGSIVLRSSQQSQDSLIADDS-QSASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPG 174 (757)
Q Consensus 96 ~~~l~~~~~G~Lvl~~~~~~~~~~~~~~~-~~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg~kl~~~~~L~S~ 174 (757)
...|.|..+|+|+|.+. ..++|+++.. .....++|.++|||||+|.++.++|+|+++
T Consensus 27 ~f~l~f~~~gnl~ly~~--~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~-------------------- 84 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS--DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTK-------------------- 84 (236)
T ss_dssp TEEEEECTTSCEEEEES--SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCC--------------------
T ss_pred CEEEEECCCCcEEEEEC--CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCcc--------------------
Confidence 34566667888888876 3456666543 234688999999999999999999999875
Q ss_pred CCCCCCCCCceEEEecCCCCceeeeccCCCCccceEeecccc
Q 038168 175 ISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTY 216 (757)
Q Consensus 175 ~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~ 216 (757)
.+.|.|.+.++.+|+++++. ..||.+..+
T Consensus 85 -----~~~~~~~~~l~d~Gnlvl~~--------~~~W~S~~~ 113 (236)
T 1dlp_A 85 -----GSIGNYVLVLQPDRTVTIYG--------PGLWDSGTS 113 (236)
T ss_dssp -----CCSSCCEEEECSSSCEEEEC--------SEEEECSCC
T ss_pred -----ccCCcEEEEEeCCCCEEEec--------CCEEECCCC
Confidence 12467889999999999862 168877654
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.69 E-value=6.3e-08 Score=84.23 Aligned_cols=76 Identities=30% Similarity=0.660 Sum_probs=59.2
Q ss_pred CceeEeccCCCEEEecCCCCceeEEecCCC---cceeEEEecCCCEEEEecCCceeeeccCCCccccCCCCcccCCCccc
Q 038168 96 NATLLFNSEGSIVLRSSQQSQDSLIADDSQ---SASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLF 172 (757)
Q Consensus 96 ~~~l~~~~~G~Lvl~~~~~~~~~~~~~~~~---~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg~kl~~~~~L~ 172 (757)
.-+|.+..||+|||.+.+ ..+|++++.. .+..++|.++|||||.|.++.++|+|-.
T Consensus 20 ~y~l~~q~DgNLvly~~~--~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~t------------------- 78 (105)
T 4h3o_A 20 PYHFIMQDDCNLVLYDHS--TSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHS------------------- 78 (105)
T ss_dssp TEEEEECTTSCEEEEETT--EEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECCC-------------------
T ss_pred CEEEEECCCCeEEEEECC--EEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEecC-------------------
Confidence 357888899999999864 4556665432 2367899999999999999999998721
Q ss_pred ccCCCCCCCCCceEEEecCCCCceee
Q 038168 173 PGISETNPSTGKFLLIMQGDGNLVQY 198 (757)
Q Consensus 173 S~~s~~dps~G~fs~~~~~~g~~~~~ 198 (757)
....|.+.+.++.+|++++|
T Consensus 79 ------~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 79 ------TRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp ------CCCSSCEEEEECTTSCEEEE
T ss_pred ------CCCCCCEEEEEeCCCeEEEE
Confidence 12346789999999999987
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=8.7e-08 Score=98.28 Aligned_cols=102 Identities=14% Similarity=0.099 Sum_probs=82.9
Q ss_pred HHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC---
Q 038168 513 EFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC--- 588 (757)
Q Consensus 513 ~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--- 588 (757)
.+.+|+.+++.+. |..+.++++++.+.+..++||||+++.+|.+.+.. ......++.+++++|..||+..
T Consensus 55 ~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~ 128 (263)
T 3tm0_A 55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISD 128 (263)
T ss_dssp CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCccc
Confidence 4788999999984 67788999999888899999999999999876421 1223478899999999999810
Q ss_pred -----------------------------------------------------CCCeeeCCCCcceEEECCCCcEEEeec
Q 038168 589 -----------------------------------------------------ETQIIHCDIKPQNILMDENRCAKISDF 615 (757)
Q Consensus 589 -----------------------------------------------------~~~iiH~Dik~~Nill~~~~~~ki~Df 615 (757)
.+.++|+|++|.|||++++..+.|+||
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDw 208 (263)
T 3tm0_A 129 CPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDL 208 (263)
T ss_dssp CSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCC
T ss_pred CCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEc
Confidence 145899999999999987766789999
Q ss_pred CCccc
Q 038168 616 GLAKL 620 (757)
Q Consensus 616 Gla~~ 620 (757)
+.+..
T Consensus 209 e~a~~ 213 (263)
T 3tm0_A 209 GRSGR 213 (263)
T ss_dssp TTCEE
T ss_pred hhccc
Confidence 98753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.45 E-value=3.6e-07 Score=93.21 Aligned_cols=99 Identities=17% Similarity=0.158 Sum_probs=76.8
Q ss_pred HHHHHHHHHhhcCCCc--eeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--
Q 038168 513 EFQTEMKVIGRTHHRN--LVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC-- 588 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-- 588 (757)
.+.+|+.+++.+++.+ +.+++++....+..++||||+++.+|. ... .+ ...++.++++.|..||+..
T Consensus 59 ~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~ 129 (264)
T 1nd4_A 59 ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPA 129 (264)
T ss_dssp CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGG
T ss_pred hhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCC
Confidence 4778999999986545 456888888777889999999999884 211 11 2367788888888888742
Q ss_pred -----------------------------------------------------CCCeeeCCCCcceEEECCCCcEEEeec
Q 038168 589 -----------------------------------------------------ETQIIHCDIKPQNILMDENRCAKISDF 615 (757)
Q Consensus 589 -----------------------------------------------------~~~iiH~Dik~~Nill~~~~~~ki~Df 615 (757)
...++|+|++|.|||++++..++|+||
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~ 209 (264)
T 1nd4_A 130 TCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDC 209 (264)
T ss_dssp GCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCC
T ss_pred CCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcc
Confidence 123999999999999988777789999
Q ss_pred CCccc
Q 038168 616 GLAKL 620 (757)
Q Consensus 616 Gla~~ 620 (757)
+.+..
T Consensus 210 ~~a~~ 214 (264)
T 1nd4_A 210 GRLGV 214 (264)
T ss_dssp TTCEE
T ss_pred hhccc
Confidence 99764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.40 E-value=7.9e-07 Score=95.70 Aligned_cols=107 Identities=19% Similarity=0.256 Sum_probs=85.4
Q ss_pred HHHHHHHHHHhhcC--CCceeeeeeEEEec---eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 512 REFQTEMKVIGRTH--HRNLVRLLGYSLEV---SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 512 ~~~~~E~~~l~~l~--h~niv~l~g~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
..+.+|+.+++.++ +..+.+++.++.+. +..++||||+++..|.+.. -..++..++..++.++++.|..||.
T Consensus 81 ~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 81 HAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp -CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhC
Confidence 45778999999996 45688899988776 3579999999998885422 2346778888999999999999997
Q ss_pred CC-------------------------------------------------------CCCeeeCCCCcceEEECCCCc--
Q 038168 587 EC-------------------------------------------------------ETQIIHCDIKPQNILMDENRC-- 609 (757)
Q Consensus 587 ~~-------------------------------------------------------~~~iiH~Dik~~Nill~~~~~-- 609 (757)
.. ...++|+|+++.|||++.++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v 237 (359)
T 3dxp_A 158 VDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRV 237 (359)
T ss_dssp SCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCE
T ss_pred CCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcE
Confidence 31 257999999999999997753
Q ss_pred EEEeecCCcccc
Q 038168 610 AKISDFGLAKLM 621 (757)
Q Consensus 610 ~ki~DfGla~~~ 621 (757)
+.|.||+.+..-
T Consensus 238 ~~viDwe~a~~g 249 (359)
T 3dxp_A 238 LAVLDWELSTLG 249 (359)
T ss_dssp EEECCCTTCEEE
T ss_pred EEEECccccccC
Confidence 689999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.31 E-value=3e-07 Score=96.62 Aligned_cols=157 Identities=20% Similarity=0.225 Sum_probs=101.9
Q ss_pred hHHHHHHHHHHHhhcC-CCc--eeeeeeEEEece---eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038168 510 GEREFQTEMKVIGRTH-HRN--LVRLLGYSLEVS---KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~-h~n--iv~l~g~~~~~~---~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y 583 (757)
....+.+|+.+|+.+. +.. +.+++......+ ..|+|||++++..|.+... ..++..++..++.++++.|..
T Consensus 53 ~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~ 129 (304)
T 3sg8_A 53 GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSE 129 (304)
T ss_dssp HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHH
Confidence 3567889999999884 332 344555443333 3489999999988875432 235667778888999998888
Q ss_pred hhhC-------------------------------------------------------CCCCeeeCCCCcceEEECC--
Q 038168 584 LHDE-------------------------------------------------------CETQIIHCDIKPQNILMDE-- 606 (757)
Q Consensus 584 LH~~-------------------------------------------------------~~~~iiH~Dik~~Nill~~-- 606 (757)
||.. ..+.++|+|++|.||++++
T Consensus 130 LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~ 209 (304)
T 3sg8_A 130 LHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK 209 (304)
T ss_dssp HHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT
T ss_pred HHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC
Confidence 8861 1246899999999999998
Q ss_pred CCcEEEeecCCccccCCCCcceecc-------------cccCccccC-cccccCCCCCccccchhhHHHHHHHHhCCCC
Q 038168 607 NRCAKISDFGLAKLMKPDQTRTFTG-------------IRGTRGYVA-PEWHRNLPITVKADVYSFGVVLLEIICRRRC 671 (757)
Q Consensus 607 ~~~~ki~DfGla~~~~~~~~~~~~~-------------~~gt~~y~a-PE~~~~~~~~~k~Dv~S~G~~l~elltG~~p 671 (757)
+..+.|+||+.+............. .....+... |+.... .....+.|+++.+++++.+|..+
T Consensus 210 ~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~ 286 (304)
T 3sg8_A 210 NTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMD 286 (304)
T ss_dssp TEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHH
T ss_pred CCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHH
Confidence 5668899999987643221110000 000011112 222111 12235789999999999999864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00024 Score=74.33 Aligned_cols=107 Identities=17% Similarity=0.158 Sum_probs=75.5
Q ss_pred HHHHHHHHHHHhhcCCC---ceeeeeeEEE-eceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 511 EREFQTEMKVIGRTHHR---NLVRLLGYSL-EVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~---niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
...+.+|+.+|+.|.+. .+.+.+.++. ..+..++|||++++..|.+.... .++..++..++.++++.|..||.
T Consensus 53 ~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~ 129 (306)
T 3tdw_A 53 ADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSA 129 (306)
T ss_dssp HHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhc
Confidence 46788999999999753 3556666664 34457899999999888763211 23445555666666666666664
Q ss_pred C---------------------------------------------------------CCCCeeeCCCCcceEEECC---
Q 038168 587 E---------------------------------------------------------CETQIIHCDIKPQNILMDE--- 606 (757)
Q Consensus 587 ~---------------------------------------------------------~~~~iiH~Dik~~Nill~~--- 606 (757)
. ..+.++|+|+++.||+++.
T Consensus 130 ~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~ 209 (306)
T 3tdw_A 130 FPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSR 209 (306)
T ss_dssp SCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCS
T ss_pred CCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCC
Confidence 2 2235799999999999987
Q ss_pred CCc-EEEeecCCccc
Q 038168 607 NRC-AKISDFGLAKL 620 (757)
Q Consensus 607 ~~~-~ki~DfGla~~ 620 (757)
++. ..|+||+.+..
T Consensus 210 ~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 210 QTPLTGIIDFGDAAI 224 (306)
T ss_dssp SCCEEEECCCTTCEE
T ss_pred CCceEEEEehhhcCC
Confidence 344 58999998865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00012 Score=74.87 Aligned_cols=105 Identities=15% Similarity=0.139 Sum_probs=78.5
Q ss_pred HHHHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-
Q 038168 511 EREFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC- 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~- 588 (757)
..++.+|...|+.+. +--+.++++++.+.+..++|||++++.++.+..... ...+..+..++++.|..||...
T Consensus 63 ~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~ 137 (272)
T 4gkh_A 63 ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPV 137 (272)
T ss_dssp HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCG
T ss_pred HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCc
Confidence 356788999998884 334778899999889999999999998887654221 1223456667777777777421
Q ss_pred ------------------------------------------------------CCCeeeCCCCcceEEECCCCcEEEee
Q 038168 589 ------------------------------------------------------ETQIIHCDIKPQNILMDENRCAKISD 614 (757)
Q Consensus 589 ------------------------------------------------------~~~iiH~Dik~~Nill~~~~~~ki~D 614 (757)
.+.++|+|+.+.|||+++++.+-|+|
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viD 217 (272)
T 4gkh_A 138 CNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCID 217 (272)
T ss_dssp GGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECC
T ss_pred ccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEE
Confidence 12379999999999999887778999
Q ss_pred cCCccc
Q 038168 615 FGLAKL 620 (757)
Q Consensus 615 fGla~~ 620 (757)
|+.+..
T Consensus 218 we~a~~ 223 (272)
T 4gkh_A 218 VGRVGI 223 (272)
T ss_dssp CTTCEE
T ss_pred Cccccc
Confidence 998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00041 Score=74.13 Aligned_cols=108 Identities=11% Similarity=0.157 Sum_probs=66.6
Q ss_pred HHHHHHHHHhhcC-C--CceeeeeeEEEec---eeeeEEEEeccCCChhhhhc---CC--CCCCCHHHHHHHHHHHHHHH
Q 038168 513 EFQTEMKVIGRTH-H--RNLVRLLGYSLEV---SKKILVYEYMSNGSLADILF---NP--EKQPNWVERMGIARDIARGI 581 (757)
Q Consensus 513 ~~~~E~~~l~~l~-h--~niv~l~g~~~~~---~~~~lV~e~~~~gsL~~~l~---~~--~~~l~~~~~~~i~~~ia~gL 581 (757)
.+.+|+.+++.++ + -.+.+++.++.+. ...++|||++++..|.+.+. .. ...++..++..++.++++.|
T Consensus 73 ~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~L 152 (357)
T 3ats_A 73 RLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAAL 152 (357)
T ss_dssp CHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHH
Confidence 4667888888874 2 3567788877655 35689999999877764320 00 00112222222223333322
Q ss_pred ------------------------------------------------------HHhhhCC-------CCCeeeCCCCcc
Q 038168 582 ------------------------------------------------------LYLHDEC-------ETQIIHCDIKPQ 600 (757)
Q Consensus 582 ------------------------------------------------------~yLH~~~-------~~~iiH~Dik~~ 600 (757)
.+|.+.. .+.++|+|+++.
T Consensus 153 a~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~ 232 (357)
T 3ats_A 153 ATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNWVRSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVG 232 (357)
T ss_dssp HHHTTCSSHHHHTGGGC-----CCHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGG
T ss_pred HHHhCCCCccCChhhccCCCCCCchHHHHHHHHHHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCC
Confidence 3332211 357999999999
Q ss_pred eEEECCCCcEEEeecCCccc
Q 038168 601 NILMDENRCAKISDFGLAKL 620 (757)
Q Consensus 601 Nill~~~~~~ki~DfGla~~ 620 (757)
|||++++..+.|+||+.+..
T Consensus 233 Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 233 NVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp GEEEETTEEEEECCGGGCEE
T ss_pred eEEEeCCcEEEEEccccccc
Confidence 99999655679999998864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.05 E-value=0.0093 Score=62.73 Aligned_cols=32 Identities=22% Similarity=0.299 Sum_probs=28.6
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccc
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~ 620 (757)
...++|+|+++.|||++.++.+.|+||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 46899999999999998888999999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.95 E-value=0.019 Score=55.81 Aligned_cols=100 Identities=13% Similarity=0.031 Sum_probs=67.4
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecc
Q 038168 552 GSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG 631 (757)
Q Consensus 552 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~ 631 (757)
-+|.++|...+..++..+...++.|.++.|.-+-... .-..+=+-|..|+|..+|.+...+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc------------
Confidence 3799999888889999999999999999988762210 111333457999999999988764 1110
Q ss_pred cccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 632 IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 632 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
.....+.+||... ...+.+.-|||+|+++|.-+--
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 0123456787653 4557888999999999998843
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.57 E-value=0.032 Score=58.12 Aligned_cols=105 Identities=14% Similarity=0.178 Sum_probs=68.5
Q ss_pred HHHHHHHHHHHhhcC---CCceeeeeeEEEeceeeeEEEEeccCCChhh-----------hhcCCCC-------------
Q 038168 511 EREFQTEMKVIGRTH---HRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-----------ILFNPEK------------- 563 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~-----------~l~~~~~------------- 563 (757)
...|..|+..|+.|. ...+.+++.++...+..++|||++++..+.. .|+....
T Consensus 72 ~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G 151 (312)
T 3jr1_A 72 RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLG 151 (312)
T ss_dssp HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEET
T ss_pred HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Confidence 456888999998884 3568889988887788999999999976531 1111100
Q ss_pred --------CCCHHHHH---HHHH----------------HHHHH-HHHhhh-CCCCCeeeCCCCcceEEECCCCcEEEee
Q 038168 564 --------QPNWVERM---GIAR----------------DIARG-ILYLHD-ECETQIIHCDIKPQNILMDENRCAKISD 614 (757)
Q Consensus 564 --------~l~~~~~~---~i~~----------------~ia~g-L~yLH~-~~~~~iiH~Dik~~Nill~~~~~~ki~D 614 (757)
.-+|.... ++.. .++.- ...|.. ...+.++|+|+.+.|++++.++ +.|.|
T Consensus 152 ~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD 230 (312)
T 3jr1_A 152 PIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCN 230 (312)
T ss_dssp TEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECS
T ss_pred CcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEc
Confidence 12565322 1111 11111 123321 2357899999999999999887 88999
Q ss_pred cC
Q 038168 615 FG 616 (757)
Q Consensus 615 fG 616 (757)
+.
T Consensus 231 ~~ 232 (312)
T 3jr1_A 231 PA 232 (312)
T ss_dssp CC
T ss_pred Cc
Confidence 73
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=94.64 E-value=0.06 Score=57.65 Aligned_cols=106 Identities=17% Similarity=0.170 Sum_probs=64.5
Q ss_pred HHHHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhh-----------------hcCC----CCCCC--
Q 038168 511 EREFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADI-----------------LFNP----EKQPN-- 566 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~-----------------l~~~----~~~l~-- 566 (757)
.....+|..+++.|. +.-..++++++.++ +||||+++..|..- |+.. .+...
T Consensus 97 ~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l 172 (379)
T 3feg_A 97 VDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWL 172 (379)
T ss_dssp HHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccH
Confidence 445668888888884 32235677666542 89999998665421 1111 12233
Q ss_pred HHHHHHHHHHHH-------------------HHHHHhhh-----CCCCCeeeCCCCcceEEECCC----CcEEEeecCCc
Q 038168 567 WVERMGIARDIA-------------------RGILYLHD-----ECETQIIHCDIKPQNILMDEN----RCAKISDFGLA 618 (757)
Q Consensus 567 ~~~~~~i~~~ia-------------------~gL~yLH~-----~~~~~iiH~Dik~~Nill~~~----~~~ki~DfGla 618 (757)
|.+..++..++. +.+..|.+ .....++|+|+.+.|||++.+ +.+.|+||..+
T Consensus 173 ~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a 252 (379)
T 3feg_A 173 FGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS 252 (379)
T ss_dssp HHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred HHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence 334444443332 12233321 123478999999999999876 78999999988
Q ss_pred cc
Q 038168 619 KL 620 (757)
Q Consensus 619 ~~ 620 (757)
..
T Consensus 253 ~~ 254 (379)
T 3feg_A 253 SY 254 (379)
T ss_dssp EE
T ss_pred Cc
Confidence 54
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=94.32 E-value=0.067 Score=57.65 Aligned_cols=32 Identities=25% Similarity=0.306 Sum_probs=26.9
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCcccc
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLM 621 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~ 621 (757)
...++|+|+.+.|||++.+ .++|.||..+..-
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G 257 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFYG 257 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCcccccC
Confidence 3589999999999999876 4899999887653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=93.94 E-value=0.04 Score=60.27 Aligned_cols=39 Identities=21% Similarity=0.237 Sum_probs=25.8
Q ss_pred HHHHHHHHHHhhcCCCce-eeeeeEEEeceeeeEEEEeccCCCh
Q 038168 512 REFQTEMKVIGRTHHRNL-VRLLGYSLEVSKKILVYEYMSNGSL 554 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~gsL 554 (757)
+.+.+|..+++.|...++ .++++.+.+ .+|+||+++..|
T Consensus 120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence 445578888888853333 566765543 289999986444
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=93.58 E-value=0.084 Score=54.46 Aligned_cols=31 Identities=26% Similarity=0.341 Sum_probs=25.8
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCcccc
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLM 621 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~ 621 (757)
..++|+|+.+.||+ ..++.+.|+||..+..-
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 45899999999999 55667899999988653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=93.15 E-value=0.18 Score=55.37 Aligned_cols=36 Identities=17% Similarity=0.205 Sum_probs=24.8
Q ss_pred HHHHHHHhhcCCCce-eeeeeEEEeceeeeEEEEeccCCCh
Q 038168 515 QTEMKVIGRTHHRNL-VRLLGYSLEVSKKILVYEYMSNGSL 554 (757)
Q Consensus 515 ~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~gsL 554 (757)
.+|..+++.|...++ .++++.+.. .+||||+++..|
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 478888888865444 467776632 259999998555
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=88.13 E-value=0.47 Score=51.38 Aligned_cols=80 Identities=10% Similarity=0.029 Sum_probs=49.4
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC---CCCccccchhhHHHHHHH
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL---PITVKADVYSFGVVLLEI 665 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~S~G~~l~el 665 (757)
...++|+|+++.|||++.++ ++|+||+.+..-.....-...-..-...|.+|+..... .-....++......+++.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 35899999999999999876 99999999875432211110000011345666654321 112335566778888887
Q ss_pred HhCC
Q 038168 666 ICRR 669 (757)
Q Consensus 666 ltG~ 669 (757)
+++.
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=86.40 E-value=0.84 Score=47.47 Aligned_cols=34 Identities=29% Similarity=0.342 Sum_probs=28.9
Q ss_pred CCCeeeCCCCcceEEECCC----CcEEEeecCCccccC
Q 038168 589 ETQIIHCDIKPQNILMDEN----RCAKISDFGLAKLMK 622 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~----~~~ki~DfGla~~~~ 622 (757)
...++|+|+.+.|||++.+ ..+.|+||+.+..-.
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 4589999999999999875 679999999987543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=85.15 E-value=0.43 Score=49.40 Aligned_cols=32 Identities=22% Similarity=0.332 Sum_probs=27.3
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccc
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~ 620 (757)
...++|+|+++.|||++++..+.|+||+.+..
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 45799999999999999876668999998753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=84.91 E-value=0.58 Score=50.37 Aligned_cols=30 Identities=27% Similarity=0.389 Sum_probs=25.2
Q ss_pred CeeeCCCCcceEEE------CCCCcEEEeecCCccc
Q 038168 591 QIIHCDIKPQNILM------DENRCAKISDFGLAKL 620 (757)
Q Consensus 591 ~iiH~Dik~~Nill------~~~~~~ki~DfGla~~ 620 (757)
.++|+|+.+.|||+ +++..++++||-.|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567899999988854
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=84.13 E-value=1.1 Score=46.34 Aligned_cols=30 Identities=23% Similarity=0.232 Sum_probs=26.1
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccc
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKL 620 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~ 620 (757)
...++|+|+++.|||++ + .+.|+||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 35789999999999999 4 899999998764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.87 E-value=2.4 Score=40.95 Aligned_cols=115 Identities=10% Similarity=0.160 Sum_probs=80.0
Q ss_pred CCCceeeeeeEEEeceeeeEEEEeccCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEE
Q 038168 525 HHRNLVRLLGYSLEVSKKILVYEYMSNG-SLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNIL 603 (757)
Q Consensus 525 ~h~niv~l~g~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nil 603 (757)
.||+++.. .+-.+.+...+.|+.-+.+ ++.. + +..+...+++++..|+....+++.. +|--+.|+|++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEE
Confidence 68888866 4556666766666654422 2222 2 3467889999999999988777654 78899999999
Q ss_pred ECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCC
Q 038168 604 MDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLD 673 (757)
Q Consensus 604 l~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~ 673 (757)
++.++.++|.-.|+-..+.+. ..++..=.-.+=+++..+++++..|+
T Consensus 112 f~~~~~p~i~~RGik~~l~P~-----------------------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVVDPL-----------------------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp ECTTSCEEESCCEETTTBSCC-----------------------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EcCCCCEEEEEccCccCCCCC-----------------------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999887765433221 11222234467788899999887654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.32 E-value=3.7 Score=39.80 Aligned_cols=115 Identities=9% Similarity=0.064 Sum_probs=76.5
Q ss_pred CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHH-HhhhCCCCCeeeCCCCcceEE
Q 038168 525 HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGIL-YLHDECETQIIHCDIKPQNIL 603 (757)
Q Consensus 525 ~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~iiH~Dik~~Nil 603 (757)
.||++ -...-.+++...+.|+.-+++.=...+ +.++...+++++..|+.... +++. -+|--+.|+|++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 57777 333446667777777765443222223 34677889999999988777 6664 478899999999
Q ss_pred ECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCCCC
Q 038168 604 MDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLD 673 (757)
Q Consensus 604 l~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p~~ 673 (757)
+|.++.++|.-.|+-..+ +|.- .++..=.-++=+++..++.++..|+
T Consensus 117 f~~~~~p~i~hRGi~~~l------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 117 FNRALEPFFLHVGVKESL------------------PPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp ECTTCCEEESCCEETTTB------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EeCCCcEEEEEcCCcccC------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999988775433 2221 1112223366778888888776543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 757 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-52 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-50 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-47 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-44 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-38 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-36 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-33 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-33 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-32 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-32 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-29 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-28 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-19 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 3e-18 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-09 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 1e-04 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-18 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 5e-18 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-17 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 3e-17 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 1e-08 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 3e-17 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 5e-12 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 2e-05 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-14 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 1e-13 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 1e-06 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 4e-12 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 7e-12 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 2e-08 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 4e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-57
Identities = 63/235 (26%), Positives = 113/235 (48%), Gaps = 16/235 (6%)
Query: 509 SGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWV 568
+ F+ E+ V+ +T H N++ +GYS + +V ++ SL L E + +
Sbjct: 46 QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMI 104
Query: 569 ERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM-KPDQTR 627
+ + IAR A+G+ YLH + IIH D+K NI + E+ KI DFGLA + + +
Sbjct: 105 KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161
Query: 628 TFTGIRGTRGYVAPEWHRNL---PITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILE 684
F + G+ ++APE R P + ++DVY+FG+VL E++ + P +
Sbjct: 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL------PYSNINNR 215
Query: 685 EWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
+ + G LS + +V + M ++ C+ + RP ++L +E
Sbjct: 216 DQIIFMVGRGYLSP--DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 3e-54
Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 17/235 (7%)
Query: 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP 565
+GS F E ++ + H+ LVRL + ++ EYM NGSL D L P
Sbjct: 47 QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK 105
Query: 566 -NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+ + +A IA G+ ++ + IH D++ NIL+ + KI+DFGLA+L++ +
Sbjct: 106 LTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162
Query: 625 QTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILE 684
+ G + + APE T+K+DV+SFG++L EI+ R P + + +VI
Sbjct: 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-- 220
Query: 685 EWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
Q E G + E + ++ C + P RP+ + +LE
Sbjct: 221 ----QNLERG------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 3e-52
Identities = 63/238 (26%), Positives = 110/238 (46%), Gaps = 15/238 (6%)
Query: 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP 565
G+ E +F E +V+ + H LV+L G LE + LV+E+M +G L+D L
Sbjct: 39 EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF 98
Query: 566 NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ 625
+G+ D+ G+ YL + C +IH D+ +N L+ EN+ K+SDFG+ + + DQ
Sbjct: 99 AAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155
Query: 626 TRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEE 685
+ TG + + +PE + K+DV+SFGV++ E+ + N + +V+ E
Sbjct: 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV--E 213
Query: 686 WVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVE 743
+ F + ++ C + P RP+ ++L L E
Sbjct: 214 DISTGFR----------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 3e-52
Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 15/234 (6%)
Query: 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP 565
GS E EF E KV+ H LV+L G + ++ EYM+NG L + L +
Sbjct: 38 EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRF 97
Query: 566 NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ 625
+ + + +D+ + YL + +H D+ +N L+++ K+SDFGL++ + D+
Sbjct: 98 QTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154
Query: 626 TRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEE 685
+ G + + PE + K+D+++FGV++ EI + + + E
Sbjct: 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--E 212
Query: 686 WVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
+ Q E++ + C ++ RP+ K +L +
Sbjct: 213 HIAQGLR----------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (458), Expect = 5e-52
Identities = 64/303 (21%), Positives = 126/303 (41%), Gaps = 60/303 (19%)
Query: 488 FSYAELEKMTDGFKEEV-----------GRGSSGE------------------------- 511
F++ + + F +E+ G G GE
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 512 -----REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPN 566
R+F +E ++G+ H N++ L G + + +++ E+M NGSL L + Q
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 567 WVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626
++ +G+ R IA G+ YL D +H D+ +NIL++ N K+SDFGL++ ++ D +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 627 ----RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
+ G + + APE + T +DV+S+G+V+ E++ ++ + VI
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
Query: 683 LEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742
+ Q + + ++ L C + + RP +++ L+ +
Sbjct: 244 --NAIEQDYR----------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291
Query: 743 EIP 745
P
Sbjct: 292 RNP 294
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-50
Identities = 66/264 (25%), Positives = 107/264 (40%), Gaps = 43/264 (16%)
Query: 500 FKEEVGRGSSGE----------------------REFQTEMKVIGRTHHRNLVRLLGYSL 537
+ +G+G G+ + F E V+ + H NLV+LLG +
Sbjct: 11 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 538 EVSKKI-LVYEYMSNGSLADILFNPEKQP-NWVERMGIARDIARGILYLHDECETQIIHC 595
E + +V EYM+ GSL D L + + + + D+ + YL +H
Sbjct: 71 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 127
Query: 596 DIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADV 655
D+ +N+L+ E+ AK+SDFGL K Q + APE R + K+DV
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALREKKFSTKSDV 183
Query: 656 YSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIK 715
+SFG++L EI R P +P V E G + + + +
Sbjct: 184 WSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKG------YKMDAPDGCPPAVYE 231
Query: 716 VALWCILDEPSLRPSMKKVLLMLE 739
V C + ++RPS ++ LE
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (442), Expect = 7e-50
Identities = 74/285 (25%), Positives = 116/285 (40%), Gaps = 43/285 (15%)
Query: 483 IAPLSFSYAELEKMTDGFK--EEVGRGSSGE-------------------------REFQ 515
+ P S +Y + E ++G G GE EF
Sbjct: 2 MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL 61
Query: 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP-NWVERMGIA 574
E V+ H NLV+LLG ++ E+M+ G+L D L +Q + V + +A
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121
Query: 575 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRG 634
I+ + YL + IH D+ +N L+ EN K++DFGL++LM D G +
Sbjct: 122 TQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 635 TRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENG 694
+ APE ++K+DV++FGV+L EI P + Q VY+ E
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKD 232
Query: 695 NLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
E E E++ ++ C PS RPS ++ E
Sbjct: 233 ------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-49
Identities = 65/244 (26%), Positives = 106/244 (43%), Gaps = 17/244 (6%)
Query: 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN-PEKQ 564
G+ F E +V+ + H LV+L + +V EYMS GSL D L K
Sbjct: 51 PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKY 109
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+ + +A IA G+ Y+ +H D++ NIL+ EN K++DFGLA+L++ +
Sbjct: 110 LRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 166
Query: 625 QTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILE 684
+ G + + APE T+K+DV+SFG++L E+ + R P + + +
Sbjct: 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---- 222
Query: 685 EWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEI 744
V E G + E + + C EP RP+ + + LE
Sbjct: 223 --VLDQVERG------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
Query: 745 PIPP 748
P
Sbjct: 275 TEPQ 278
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-49
Identities = 63/280 (22%), Positives = 109/280 (38%), Gaps = 49/280 (17%)
Query: 494 EKMTDGFKEEVGRGSSGE------------------------------REFQTEMKVIGR 523
+ F E +GRG G +F TE ++
Sbjct: 25 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84
Query: 524 THHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGIL 582
H N++ LLG L +V YM +G L + + N P + +G +A+G
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-- 142
Query: 583 YLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ---TRTFTGIRGTRGYV 639
+ + +H D+ +N ++DE K++DFGLA+ M + TG + ++
Sbjct: 143 -MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 640 APEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQL 699
A E + T K+DV+SFGV+L E++ R P V + + L Q
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQGRRLLQ- 255
Query: 700 VEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
E + + +V L C + +RPS +++ +
Sbjct: 256 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-48
Identities = 59/243 (24%), Positives = 114/243 (46%), Gaps = 17/243 (6%)
Query: 505 GRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQ 564
G +F E ++G+ H N++RL G + +++ EYM NG+L L + +
Sbjct: 47 GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE 106
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+ ++ +G+ R IA G+ YL + +H D+ +NIL++ N K+SDFGL+++++ D
Sbjct: 107 FSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163
Query: 625 Q--TRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
T T +G + + APE T +DV+SFG+V+ E++ L + +V+
Sbjct: 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM 223
Query: 683 LEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742
+ + F + ++ + C E + RP ++ +L+ +
Sbjct: 224 --KAINDGFR----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
Query: 743 EIP 745
P
Sbjct: 272 RAP 274
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 3e-48
Identities = 47/237 (19%), Positives = 94/237 (39%), Gaps = 18/237 (7%)
Query: 505 GRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQ 564
G + E E +++ + + +VRL+G + +LV E G L L ++
Sbjct: 47 GTEKADTEEMMREAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREE 105
Query: 565 PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD 624
+ ++ G+ YL ++ +H D+ +N+L+ AKISDFGL+K + D
Sbjct: 106 IPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162
Query: 625 QT--RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
+ + + + APE + ++DV+S+GV + E + + + +V+
Sbjct: 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 222
Query: 683 LEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
E G + E + + + C + + RP V +
Sbjct: 223 ------AFIEQG------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 1e-47
Identities = 63/269 (23%), Positives = 100/269 (37%), Gaps = 50/269 (18%)
Query: 500 FKEEVGRGSSGE----------------------------REFQTEMKVIGRTHHRNLVR 531
F E+GRGS + F+ E +++ H N+VR
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 532 LLGYSLEVSKK----ILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587
K +LV E M++G+L L K R I +G+ +LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 588 CETQIIHCDIKPQNILM-DENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN 646
IIH D+K NI + KI D GLA L + + GT ++APE +
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV---IGTPEFMAPEMYEE 187
Query: 647 LPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVD 706
DVY+FG+ +LE+ P + +Y+ +G V+ D
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEY------PYSECQNAAQIYRRVTSG-----VKPASFD 235
Query: 707 EKQLERMIKVALWCILDEPSLRPSMKKVL 735
+ + + ++ CI R S+K +L
Sbjct: 236 KVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 1e-47
Identities = 66/316 (20%), Positives = 118/316 (37%), Gaps = 73/316 (23%)
Query: 486 LSFSYAELEKMTDGFK--EEVGRGSSG--------------------------------E 511
L+ LE + + ++G G+ G +
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP------ 565
+FQ E ++ + N+V+LLG L++EYM+ G L + L +
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 566 -----------------NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR 608
+ E++ IAR +A G+ YL E + +H D+ +N L+ EN
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENM 177
Query: 609 CAKISDFGLAKLMKP-DQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667
KI+DFGL++ + D + ++ PE T ++DV+++GVVL EI
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSL 727
+ ++VI +GN+ E+ + + C P+
Sbjct: 238 YGLQPYYGMAHEEVI------YYVRDGNILACPENCP------LELYNLMRLCWSKLPAD 285
Query: 728 RPSMKKVLLMLEGTVE 743
RPS + +L+ E
Sbjct: 286 RPSFCSIHRILQRMCE 301
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 8e-47
Identities = 58/290 (20%), Positives = 104/290 (35%), Gaps = 53/290 (18%)
Query: 500 FKEEVGRGSSG-----------------------EREFQTEMKVIGRTHHRNLVRLLGYS 536
+E +G+G G + E+ H N++ +
Sbjct: 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 537 LEVSKKI----LVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC---- 588
+ + LV +Y +GSL D L + +A A G+ +LH E
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 589 -ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF---TGIRGTRGYVAPEW- 643
+ I H D+K +NIL+ +N I+D GLA GT+ Y+APE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 644 -----HRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQ 698
++ +AD+Y+ G+V EI R + D Q+ + V + +
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCS-IGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 699 LVEDEEVD---------EKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
+V ++++ + L M K+ C + R + ++ L
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 9e-47
Identities = 54/270 (20%), Positives = 110/270 (40%), Gaps = 36/270 (13%)
Query: 493 LEKMTDGFK--EEVGRGSSGE---------------------------REFQTEMKVIGR 523
+E D F+ E+G G+ G + E++V+
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 524 THHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILY 583
+ +V G + + E+M GSL +L + P ++ + +G+ Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP-EQILGKVSIAVIKGLTY 119
Query: 584 LHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEW 643
L ++ +I+H D+KP NIL++ K+ DFG++ + +F GTR Y++PE
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPER 174
Query: 644 HRNLPITVKADVYSFGVVLLEIICRRRCLDP-NLPDDQVILEEWVYQCFENGNLSQLVED 702
+ +V++D++S G+ L+E+ R + P + + +++ V
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 703 EEVDEKQLERMIKVALWCILDEPSLRPSMK 732
+ ++ +A++ +LD P K
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPK 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-46
Identities = 60/252 (23%), Positives = 104/252 (41%), Gaps = 33/252 (13%)
Query: 511 EREFQTEMKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF---------- 559
+E+KV+ +H N+V LLG +++ EY G L + L
Sbjct: 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 560 -------NPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKI 612
+ E + + + + +A+G+ +L + IH D+ +NIL+ R KI
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKI 186
Query: 613 SDFGLAKLMKPDQTRTFTG-IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRC 671
DFGLA+ +K D G R ++APE N T ++DV+S+G+ L E+
Sbjct: 187 CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 672 LDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731
P +P D Y+ + G E M + C +P RP+
Sbjct: 247 PYPGMPVD-----SKFYKMIKEG------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTF 295
Query: 732 KKVLLMLEGTVE 743
K+++ ++E +
Sbjct: 296 KQIVQLIEKQIS 307
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-46
Identities = 53/231 (22%), Positives = 89/231 (38%), Gaps = 19/231 (8%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVER 570
+ E E V+ + + +VR++G E +LV E G L L
Sbjct: 52 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVK-DKNI 109
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT--RT 628
+ + ++ G+ YL + +H D+ +N+L+ AKISDFGL+K ++ D+ +
Sbjct: 110 IELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166
Query: 629 FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVY 688
T + + APE + K+DV+SFGV++ E + + + V
Sbjct: 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VT 220
Query: 689 QCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
E G E M + C + RP V L L
Sbjct: 221 AMLEKG------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-45
Identities = 57/256 (22%), Positives = 102/256 (39%), Gaps = 38/256 (14%)
Query: 508 SSGEREFQTEMKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPN 566
SS +E+K++ + H N+V LLG L++EY G L + L + ++ +
Sbjct: 81 SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFS 140
Query: 567 ----------------------WVERMGIARDIARGILYLHDECETQIIHCDIKPQNILM 604
+ + + A +A+G+ +L + +H D+ +N+L+
Sbjct: 141 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLV 197
Query: 605 DENRCAKISDFGLAKLMKPDQTRTF-TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663
+ KI DFGLA+ + D R ++APE T+K+DV+S+G++L
Sbjct: 198 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 257
Query: 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILD 723
EI P +P D Y+ +NG + E + + C
Sbjct: 258 EIFSLGVNPYPGIPVDANF-----YKLIQNG------FKMDQPFYATEEIYIIMQSCWAF 306
Query: 724 EPSLRPSMKKVLLMLE 739
+ RPS + L
Sbjct: 307 DSRKRPSFPNLTSFLG 322
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 4e-45
Identities = 43/232 (18%), Positives = 96/232 (41%), Gaps = 21/232 (9%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKIL--VYEYMSNGSLADILFNPEKQP--- 565
++ +E+ ++ H N+VR ++ + L V EY G LA ++ K+
Sbjct: 47 KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 106
Query: 566 NWVERMGIARDIARGILYLHD--ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKP 623
+ + + + + H + ++H D+KP N+ +D + K+ DFGLA+++
Sbjct: 107 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166
Query: 624 DQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVIL 683
D + GT Y++PE + K+D++S G +L E+ +
Sbjct: 167 DTSFA-KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---- 221
Query: 684 EEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+ G ++ + + + ++ + + RPS++++L
Sbjct: 222 ---LAGKIREGKFRRI------PYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-44
Identities = 50/231 (21%), Positives = 98/231 (42%), Gaps = 17/231 (7%)
Query: 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVE 569
+E E V+ + ++ RLLG L S L+ + M G L D + +
Sbjct: 54 ANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQY 112
Query: 570 RMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-T 628
+ IA+G+ YL D +++H D+ +N+L+ + KI+DFGLAKL+ ++
Sbjct: 113 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169
Query: 629 FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVY 688
G + ++A E + T ++DV+S+GV + E++ +P + +
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------IS 223
Query: 689 QCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
E G E + + + C + + RP +++++
Sbjct: 224 SILEKG------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 6e-44
Identities = 51/240 (21%), Positives = 93/240 (38%), Gaps = 26/240 (10%)
Query: 500 FKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF 559
+ + ++ E++ + + H N ++ G L LV EY + +
Sbjct: 48 MSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV 107
Query: 560 NPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK 619
+ +K VE + +G+ YLH +IH D+K NIL+ E K+ DFG A
Sbjct: 108 H-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS 163
Query: 620 LMKPDQTRTFTGIRGTRGYVAPEW---HRNLPITVKADVYSFGVVLLEIICRRRCLDPNL 676
+M P + GT ++APE K DV+S G+ +E+ R+ L
Sbjct: 164 IMAPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218
Query: 677 PDDQVI-LEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+ + + ++G+ S+ + C+ P RP+ + +L
Sbjct: 219 AMSALYHIAQNESPALQSGHWSEYFRN-------------FVDSCLQKIPQDRPTSEVLL 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 8e-44
Identities = 46/229 (20%), Positives = 91/229 (39%), Gaps = 20/229 (8%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERM 571
++ E+ ++ H N+V+LL + ++ E+ + G++ ++ E+ +
Sbjct: 54 EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQ 113
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG 631
+ + + YLH + +IIH D+K NIL + K++DFG++ R +
Sbjct: 114 VVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS- 169
Query: 632 IRGTRGYVAPEW-----HRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEW 686
GT ++APE ++ P KADV+S G+ L+E+ P
Sbjct: 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------- 222
Query: 687 VYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
V L + + +K C+ R + ++L
Sbjct: 223 VLLKIAKSEPPTLAQPSRWSS-NFKDFLK---KCLEKNVDARWTTSQLL 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-43
Identities = 65/250 (26%), Positives = 107/250 (42%), Gaps = 33/250 (13%)
Query: 510 GEREFQTEMKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP--- 565
R+F E++V+ + HH N++ LLG L EY +G+L D L
Sbjct: 53 DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 112
Query: 566 ------------NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKIS 613
+ + + A D+ARG+ YL + Q IH D+ +NIL+ EN AKI+
Sbjct: 113 AFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIA 169
Query: 614 DFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLD 673
DFGL++ + +T R ++A E T +DV+S+GV+L EI+
Sbjct: 170 DFGLSRGQEVYVKKTMG--RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--- 224
Query: 674 PNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKK 733
P + E + + L E + + + C ++P RPS +
Sbjct: 225 --TPYCGMTCAELYEKLPQGYRL-------EKPLNCDDEVYDLMRQCWREKPYERPSFAQ 275
Query: 734 VLLMLEGTVE 743
+L+ L +E
Sbjct: 276 ILVSLNRMLE 285
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 4e-43
Identities = 54/242 (22%), Positives = 89/242 (36%), Gaps = 17/242 (7%)
Query: 500 FKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF 559
K +V +F E+ + HRNL+RL G L +V E GSL D L
Sbjct: 44 LKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLR 102
Query: 560 NPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK 619
+ A +A G+ YL + IH D+ +N+L+ KI DFGL +
Sbjct: 103 KHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 159
Query: 620 LMKPDQTRTF--TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLP 677
+ + + + APE + + +D + FGV L E+ + L
Sbjct: 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219
Query: 678 DDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737
Q++ + + E E + + V + C +P RP+ +
Sbjct: 220 GSQILH-----------KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
Query: 738 LE 739
L
Sbjct: 269 LL 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 4e-43
Identities = 51/225 (22%), Positives = 94/225 (41%), Gaps = 21/225 (9%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVER 570
E + + E+++ H N++RL GY + ++ L+ EY G++ L K
Sbjct: 50 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-EQRT 108
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
++A + Y H + ++IH DIKP+N+L+ KI+DFG + + T
Sbjct: 109 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL- 164
Query: 631 GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQC 690
GT Y+ PE K D++S GV+ E + + + N +
Sbjct: 165 --CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---------- 212
Query: 691 FENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
++ + + + V E + + PS RP +++VL
Sbjct: 213 YKRISRVEFTFPDFVT----EGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-42
Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 17/232 (7%)
Query: 506 RGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQP 565
R + E+ + +H N+V+ G+ E + + L EY S G L D + P
Sbjct: 42 RAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP 101
Query: 566 NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPD- 624
+ + G++YLH I H DIKP+N+L+DE KISDFGLA + + +
Sbjct: 102 -EPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157
Query: 625 QTRTFTGIRGTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEIICRRRCLDPNLPDDQVIL 683
+ R + GT YVAPE + DV+S G+VL ++ D Q
Sbjct: 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217
Query: 684 EEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+ + + N +++D ++ +++ PS R ++ +
Sbjct: 218 DWKEKKTYLN-------PWKKIDS-APLALLH---KILVENPSARITIPDIK 258
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 50/229 (21%), Positives = 91/229 (39%), Gaps = 16/229 (6%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVER 570
+F E + + H ++V+L+G E + ++ E + G L L + +
Sbjct: 52 REKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASL 110
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
+ A ++ + YL + +H DI +N+L+ N C K+ DFGL++ M+ +
Sbjct: 111 ILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 167
Query: 631 GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQC 690
+ ++APE T +DV+ FGV + EI+ Q + V
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV------KPFQGVKNNDVIGR 221
Query: 691 FENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739
ENG E + + + C +PS RP ++ L
Sbjct: 222 IENG------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-41
Identities = 53/229 (23%), Positives = 97/229 (42%), Gaps = 21/229 (9%)
Query: 509 SGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWV 568
+ E+ V+ + N+V L L + +V EY++ GSL D++ E +
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEG 116
Query: 569 ERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT 628
+ + R+ + + +LH Q+IH DIK NIL+ + K++DFG + P+Q++
Sbjct: 117 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 629 FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQV--ILEEW 686
+ + GT ++APE K D++S G++ +E+I P + I
Sbjct: 174 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232
Query: 687 VYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+ LS + D C+ + R S K++L
Sbjct: 233 TPELQNPEKLSAIFRD-------------FLNRCLDMDVEKRGSAKELL 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-40
Identities = 58/255 (22%), Positives = 111/255 (43%), Gaps = 26/255 (10%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQ------ 564
EF E V+ + ++VRLLG + +++ E M+ G L L +
Sbjct: 67 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 126
Query: 565 ---PNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLM 621
P+ + + +A +IA G+ YL+ + +H D+ +N ++ E+ KI DFG+ + +
Sbjct: 127 LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 183
Query: 622 KP-DQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQ 680
D R +++PE ++ T +DV+SFGVVL EI L ++Q
Sbjct: 184 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243
Query: 681 VILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740
V+ + G L ++ + + ++ C P +RPS +++ ++
Sbjct: 244 VL------RFVMEGGLLDKPDNC------PDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291
Query: 741 TVEIPIPPNPTSFLS 755
+E P + + S
Sbjct: 292 EME-PGFREVSFYYS 305
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-40
Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 32/254 (12%)
Query: 508 SSGEREFQTEMKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF------- 559
+ +EM+++ H+N++ LLG + ++ EY S G+L + L
Sbjct: 59 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118
Query: 560 --------NPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 611
NPE+Q + + + A +ARG+ YL + + IH D+ +N+L+ E+ K
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 175
Query: 612 ISDFGLAKLMKPDQTRTFT-GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670
I+DFGLA+ + T R ++APE + T ++DV+SFGV+L EI
Sbjct: 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
Query: 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS 730
P +P E +++ + G + + + C PS RP+
Sbjct: 236 SPYPGVP------VEELFKLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPT 283
Query: 731 MKKVLLMLEGTVEI 744
K+++ L+ V +
Sbjct: 284 FKQLVEDLDRIVAL 297
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 61/254 (24%), Positives = 107/254 (42%), Gaps = 32/254 (12%)
Query: 508 SSGEREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNPEKQP 565
S R +E+K++ HH N+V LLG + + ++ E+ G+L+ L + +
Sbjct: 57 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 116
Query: 566 ---------------NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA 610
+ + +A+G+ +L + IH D+ +NIL+ E
Sbjct: 117 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVV 173
Query: 611 KISDFGLAKLMKPDQTRTFTG-IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669
KI DFGLA+ + D G R ++APE + T+++DV+SFGV+L EI
Sbjct: 174 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 233
Query: 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP 729
P V ++E + + G + M + L C EPS RP
Sbjct: 234 AS-----PYPGVKIDEEFCRRLKEGT------RMRAPDYTTPEMYQTMLDCWHGEPSQRP 282
Query: 730 SMKKVLLMLEGTVE 743
+ +++ L ++
Sbjct: 283 TFSELVEHLGNLLQ 296
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 144 bits (365), Expect = 1e-38
Identities = 46/229 (20%), Positives = 100/229 (43%), Gaps = 17/229 (7%)
Query: 509 SGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWV 568
S + + E++ + H LV L + ++ +++YE+MS G L + + + + +
Sbjct: 65 SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED 124
Query: 569 ERMGIARDIARGILYLHDECETQIIHCDIKPQNILM--DENRCAKISDFGLAKLMKPDQT 626
E + R + +G+ ++H+ +H D+KP+NI+ + K+ DFGL + P Q+
Sbjct: 125 EAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181
Query: 627 RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEW 686
T GT + APE P+ D++S GV+ ++ D+
Sbjct: 182 VKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------ 233
Query: 687 VYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+ ++ + + + + I+ +L +P+ R ++ + L
Sbjct: 234 -LRNVKSCDWNMDDSAFSGISEDGKDFIR---KLLLADPNTRMTIHQAL 278
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 42/228 (18%), Positives = 80/228 (35%), Gaps = 19/228 (8%)
Query: 509 SGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWV 568
+ E V+ R H V+L + K Y NG L +
Sbjct: 50 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC 109
Query: 569 ERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT 628
A + L IIH D+KP+NIL++E+ +I+DFG AK++ P+ +
Sbjct: 110 ----TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165
Query: 629 FTG-IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWV 687
GT YV+PE +D+++ G ++ +++
Sbjct: 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI------- 218
Query: 688 YQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+Q + EK + + ++ + + R +++
Sbjct: 219 FQKIIKLEY-------DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 138 bits (348), Expect = 2e-36
Identities = 48/230 (20%), Positives = 95/230 (41%), Gaps = 17/230 (7%)
Query: 508 SSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNW 567
+ + E+ ++ + HH L+ L + + +L+ E++S G L D + + + +
Sbjct: 67 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE 126
Query: 568 VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA--KISDFGLAKLMKPDQ 625
E + R G+ ++H+ I+H DIKP+NI+ + + + KI DFGLA + PD+
Sbjct: 127 AEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183
Query: 626 TRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEE 685
T T + APE P+ D+++ GV+ ++ +
Sbjct: 184 IVKVT--TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET----- 236
Query: 686 WVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
Q + + + + + IK + EP R ++ L
Sbjct: 237 --LQNVKRCDWEFDEDAFSSVSPEAKDFIK---NLLQKEPRKRLTVHDAL 281
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-36
Identities = 39/230 (16%), Positives = 90/230 (39%), Gaps = 17/230 (7%)
Query: 508 SSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNW 567
+ + + E+ ++ HRN++ L + + ++++E++S + + + + N
Sbjct: 42 GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNE 101
Query: 568 VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA--KISDFGLAKLMKPDQ 625
E + + + +LH I H DI+P+NI+ R + KI +FG A+ +KP
Sbjct: 102 REIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158
Query: 626 TRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEE 685
Y APE H++ ++ D++S G ++ ++
Sbjct: 159 NFRLL--FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------ 210
Query: 686 WVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+ + N + E + + + ++ E R + + L
Sbjct: 211 -IIENIMNAEYTFDEEAFKEISIEAMDFVD---RLLVKERKSRMTASEAL 256
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (324), Expect = 1e-33
Identities = 51/228 (22%), Positives = 89/228 (39%), Gaps = 19/228 (8%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVER 570
E + E+ V+ + H N+V L L+ + +S G L D + + +
Sbjct: 51 EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDA 109
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNIL---MDENRCAKISDFGLAKLMKPDQTR 627
+ + + YLHD I+H D+KP+N+L +DE+ ISDFGL+K+ P
Sbjct: 110 SRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-- 164
Query: 628 TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWV 687
+ GT GYVAPE P + D +S GV+ ++C
Sbjct: 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL------- 217
Query: 688 YQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
++ + + I+ + +P R + ++ L
Sbjct: 218 FEQILKAEYEFDSPYWDDISDSAKDFIR---HLMEKDPEKRFTCEQAL 262
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 127 bits (321), Expect = 2e-33
Identities = 50/250 (20%), Positives = 95/250 (38%), Gaps = 27/250 (10%)
Query: 500 FKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI----LVYEYMSNGSLA 555
+ ++ R S F+ E + +H +V + + +V EY+ +L
Sbjct: 40 LRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLR 99
Query: 556 DILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDF 615
DI+ + + D + + + + IIH D+KP NI++ K+ DF
Sbjct: 100 DIVHTEGPMT-PKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDF 155
Query: 616 GLAKLMKPDQTR--TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLD 673
G+A+ + + GT Y++PE R + ++DVYS G VL E++
Sbjct: 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215
Query: 674 PNLPDD---QVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP- 729
+ P Q + E+ + + LS ++ V L + P R
Sbjct: 216 GDSPVSVAYQHVREDPIPPSARHEGLSADLDA-------------VVLKALAKNPENRYQ 262
Query: 730 SMKKVLLMLE 739
+ ++ L
Sbjct: 263 TAAEMRADLV 272
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 127 bits (319), Expect = 3e-33
Identities = 46/232 (19%), Positives = 92/232 (39%), Gaps = 23/232 (9%)
Query: 511 EREFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVE 569
E+ ++ + H N+++L + LV++ M G L D L E
Sbjct: 53 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS-EKE 111
Query: 570 RMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTF 629
I R + I LH I+H D+KP+NIL+D++ K++DFG + + P +
Sbjct: 112 TRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-- 166
Query: 630 TGIRGTRGYVAPEWHR------NLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVIL 683
+ GT Y+APE + + D++S GV++ ++
Sbjct: 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--- 223
Query: 684 EEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+ +GN + + ++ ++ ++ +P R + ++ L
Sbjct: 224 ----LRMIMSGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEAL 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 8e-33
Identities = 55/266 (20%), Positives = 94/266 (35%), Gaps = 32/266 (12%)
Query: 500 FKEEVGRGSSGEREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL 558
K++V E +V+ H L + V EY++ G L +
Sbjct: 35 LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI 94
Query: 559 FNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLA 618
+ K A +I G+ +L I++ D+K NIL+D++ KI+DFG+
Sbjct: 95 QSCHKFD-LSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMC 150
Query: 619 KLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPD 678
K + GT Y+APE D +SFGV+L E++ +
Sbjct: 151 KENMLGDAK-TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS-----PFH 204
Query: 679 DQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL-- 736
Q E + +N + +E E D L ++ EP R ++ +
Sbjct: 205 GQDEEELFHSIRMDNPFYPRWLEKEAKD--LLVKLFVR-------EPEKRLGVRGDIRQH 255
Query: 737 ----------MLEGTVEIPIPPNPTS 752
+ ++ P P S
Sbjct: 256 PLFREINWEELERKEIDPPFRPKVKS 281
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (317), Expect = 8e-33
Identities = 37/241 (15%), Positives = 77/241 (31%), Gaps = 18/241 (7%)
Query: 508 SSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNW 567
+ + E K+ + + + ++ + SL D+ ++ +
Sbjct: 43 KTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSL 102
Query: 568 VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKI---SDFGLAKLMKPD 624
+ +A + I Y+H + IH D+KP N LM + + DFGLAK +
Sbjct: 103 KTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159
Query: 625 QTRTF------TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPD 678
+T + GT Y + H + + + D+ S G VL+
Sbjct: 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219
Query: 679 DQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLML 738
+ E + + + + L + +C +P + +
Sbjct: 220 TKRQKYERISEKKMSTPIEVLCKGYP------SEFATYLNFCRSLRFDDKPDYSYLRQLF 273
Query: 739 E 739
Sbjct: 274 R 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 48/233 (20%), Positives = 90/233 (38%), Gaps = 22/233 (9%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK----ILVYEYMSNGSLADILFNPEKQP- 565
RE + + ++VR++ + ++V E + G L + + Q
Sbjct: 52 RREVELHWRAS---QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 108
Query: 566 NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC---AKISDFGLAKLMK 622
E I + I I YLH I H D+KP+N+L R K++DFG AK
Sbjct: 109 TEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165
Query: 623 PDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI 682
+ T T YVAPE D++S GV++ ++C P + +
Sbjct: 166 SHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLA 220
Query: 683 LEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
+ + G + ++++ +I+ + EP+ R ++ + +
Sbjct: 221 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFM 270
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 126 bits (316), Expect = 5e-32
Identities = 42/238 (17%), Positives = 92/238 (38%), Gaps = 19/238 (7%)
Query: 495 KMTDGFKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL 554
K D + ++ +G + + + ++ +V + K + + M+ G L
Sbjct: 35 KCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL 94
Query: 555 ADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISD 614
L + + A +I G+ ++H+ +++ D+KP NIL+DE+ +ISD
Sbjct: 95 HYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD 150
Query: 615 FGLAKLMKPDQTRTFTGIRGTRGYVAPE-WHRNLPITVKADVYSFGVVLLEIICRRRCLD 673
GLA + GT GY+APE + + AD +S G +L +++
Sbjct: 151 LGLACDFSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207
Query: 674 PNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731
+ D+ ++ + + +L +++ + + + R
Sbjct: 208 QHKTKDKHEIDRMTLTM-------AVELPDSFSP-ELRSLLE---GLLQRDVNRRLGC 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 123 bits (309), Expect = 8e-32
Identities = 33/243 (13%), Positives = 77/243 (31%), Gaps = 20/243 (8%)
Query: 508 SSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNW 567
S + + E + + + Y + ++ + SL D+L ++ +
Sbjct: 41 RSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSV 100
Query: 568 VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDE-----NRCAKISDFGLAKLMK 622
A+ + + +H++ +++ DIKP N L+ + DFG+ K +
Sbjct: 101 KTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157
Query: 623 PDQTRTF------TGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNL 676
T+ + GT Y++ H + + D+ + G V + +
Sbjct: 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217
Query: 677 PDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736
E + + ++ L +L E K + P +
Sbjct: 218 AATNKQKYERIGEKKQSTPLRELCAGFP------EEFYKYMHYARNLAFDATPDYDYLQG 271
Query: 737 MLE 739
+
Sbjct: 272 LFS 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 5e-31
Identities = 53/240 (22%), Positives = 91/240 (37%), Gaps = 20/240 (8%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVER 570
R E+K++ H N++ LL S LV+++M I+ +
Sbjct: 44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHI 102
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
+G+ YLH I+H D+KP N+L+DEN K++DFGLAK R +T
Sbjct: 103 KAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYT 158
Query: 631 GIRGTRGYVAPE-WHRNLPITVKADVYSFGVVLLEIICRRRCLDPN-------------- 675
TR Y APE V D+++ G +L E++ R L +
Sbjct: 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 218
Query: 676 LPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
P ++ + + + + + ++ + L P R + + L
Sbjct: 219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 51/243 (20%), Positives = 84/243 (34%), Gaps = 24/243 (9%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK-----ILVYEYMSNGSLADILFNPEKQP 565
RE ++ + H N+VRL LV+E++ + PE
Sbjct: 55 IREVA-VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 113
Query: 566 NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ 625
+ + RG+ +LH ++H D+KPQNIL+ + K++DFGLA++
Sbjct: 114 PTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 170
Query: 626 TRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEE 685
T + T Y APE D++S G + E+ R+ + DQ+
Sbjct: 171 A--LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228
Query: 686 WVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDE-------------PSLRPSMK 732
V + + V +DE P+ R S
Sbjct: 229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288
Query: 733 KVL 735
L
Sbjct: 289 SAL 291
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-30
Identities = 48/229 (20%), Positives = 86/229 (37%), Gaps = 30/229 (13%)
Query: 511 EREFQTEMKVIGR--THHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWV 568
E+ ++ + + ++RLL + +L+ E
Sbjct: 51 GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE 110
Query: 569 ERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR-CAKISDFGLAKLMKPDQTR 627
+ + + ++H DIK +NIL+D NR K+ DFG L+K
Sbjct: 111 LARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT 167
Query: 628 TFTGIRGTRGYVAPEWHRNLP-ITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEW 686
F GTR Y PEW R A V+S G++L +++C D+ I+
Sbjct: 168 DFD---GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD----IPFEHDEEIIR-- 218
Query: 687 VYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735
Q+ + V + + +I+ WC+ PS RP+ +++
Sbjct: 219 ----------GQVFFRQRVSS-ECQHLIR---WCLALRPSDRPTFEEIQ 253
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (293), Expect = 2e-29
Identities = 46/171 (26%), Positives = 82/171 (47%), Gaps = 8/171 (4%)
Query: 500 FKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF 559
K+E+ E ++ H ++R+ G + + ++ +Y+ G L +L
Sbjct: 37 LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR 96
Query: 560 NPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK 619
++ PN V + A ++ + YLH + II+ D+KP+NIL+D+N KI+DFG AK
Sbjct: 97 KSQRFPNPVAKF-YAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK 152
Query: 620 LMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670
+ + GT Y+APE P D +SFG+++ E++
Sbjct: 153 YVPDVTYT----LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 115 bits (288), Expect = 4e-29
Identities = 45/240 (18%), Positives = 85/240 (35%), Gaps = 19/240 (7%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVER 570
E+ ++ H N+V+L + +LV+E++ + E V
Sbjct: 44 PSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC-EGGLESVTA 102
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
+ GI Y HD ++H D+KPQN+L++ KI+DFGLA+ +
Sbjct: 103 KSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
Query: 631 GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQC 690
I + + D++S G + E++ DQ++ +
Sbjct: 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219
Query: 691 FENGNLSQLVEDEEVDEKQL---------------ERMIKVALWCILDEPSLRPSMKKVL 735
+ N + E + D E I + + +P+ R + K+ L
Sbjct: 220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 5e-29
Identities = 50/245 (20%), Positives = 93/245 (37%), Gaps = 20/245 (8%)
Query: 495 KMTDGFKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL 554
K + + R + + E+ ++ H N++ L + IL+ E ++ G L
Sbjct: 41 KFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL 100
Query: 555 ADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA---- 610
D L ++ E + I G ++ QI H D+KP+NI++ +
Sbjct: 101 FDFLAE-KESLTEEEATEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRI 156
Query: 611 KISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670
KI DFGLA + I GT +VAPE P+ ++AD++S GV+ ++
Sbjct: 157 KIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 214
Query: 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS 730
+ + N E + I+ ++ +P R +
Sbjct: 215 PFLGDTKQE-------TLANVSAVNYEFEDEYFSNTSALAKDFIR---RLLVKDPKKRMT 264
Query: 731 MKKVL 735
++ L
Sbjct: 265 IQDSL 269
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-28
Identities = 57/311 (18%), Positives = 100/311 (32%), Gaps = 64/311 (20%)
Query: 471 IPGNGSARYCEDIAPLSFSYAELEKMTDGFKEEVGRGSSG-------------------- 510
PG G R P SY + + +G GS G
Sbjct: 9 TPGQGPDR------PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVL 54
Query: 511 --EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKK------ILVYEYMSNGSLADILFNPE 562
+R E++++ + H N+VRL + +K LV +Y+
Sbjct: 55 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 563 KQP--NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNI-LMDENRCAKISDFGLAK 619
+ + + R + Y+H I H DIKPQN+ L + K+ DFG AK
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171
Query: 620 LMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDD 679
+ + + I T DV+S G VL E++ + + D
Sbjct: 172 QLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230
Query: 680 QV---------ILEEWVYQCFENGNLSQLVEDEEVDEKQLER------MIKVALWCILDE 724
Q+ E + + N + + + ++ R I + +
Sbjct: 231 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 290
Query: 725 PSLRPSMKKVL 735
P+ R + +
Sbjct: 291 PTARLTPLEAC 301
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 3e-28
Identities = 52/248 (20%), Positives = 96/248 (38%), Gaps = 29/248 (11%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGY----SLEVSKKILVYEYMSNGSLADILFNPEKQPNW 567
+ E+K++ R H N++ + ++E K + + ++ L +L + +
Sbjct: 51 QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSN 108
Query: 568 VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR 627
I RG+ Y+H ++H D+KP N+L++ KI DFGLA++ PD
Sbjct: 109 DHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165
Query: 628 --TFTGIRGTRGYVAPE-WHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQV--- 681
T TR Y APE + T D++S G +L E++ R DQ+
Sbjct: 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225
Query: 682 ------ILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVA--------LWCILDEPSL 727
+E + + L+ ++ R+ A + P
Sbjct: 226 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 285
Query: 728 RPSMKKVL 735
R +++ L
Sbjct: 286 RIEVEQAL 293
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-27
Identities = 41/240 (17%), Positives = 82/240 (34%), Gaps = 18/240 (7%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVER 570
E+ ++ +H N+V+LL +K LV+E++ + +
Sbjct: 45 PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLI 104
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
+ +G+ + H ++H D+KPQN+L++ K++DFGLA+
Sbjct: 105 KSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
Query: 631 GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVIL------- 683
+ + D++S G + E++ RR + DQ+
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 221
Query: 684 ---EEWVYQCFENGNLSQLVEDEEVDEKQL-----ERMIKVALWCILDEPSLRPSMKKVL 735
W + D ++ E + + +P+ R S K L
Sbjct: 222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 8e-27
Identities = 45/171 (26%), Positives = 68/171 (39%), Gaps = 5/171 (2%)
Query: 500 FKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF 559
++EV TE +V+ T H L L + V EY + G L L
Sbjct: 38 LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 97
Query: 560 NPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK 619
R +I L +++ DIK +N+++D++ KI+DFGL K
Sbjct: 98 RERVFTEERARF-YGAEIVSA---LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153
Query: 620 LMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670
D T GT Y+APE + D + GVV+ E++C R
Sbjct: 154 EGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 5e-26
Identities = 42/242 (17%), Positives = 85/242 (35%), Gaps = 17/242 (7%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKI--------LVYEYMSNGSLADILFNPE 562
E+K++ H N+V L+ + LV+++ + +
Sbjct: 53 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV 112
Query: 563 KQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMK 622
K E + + + G L+ +I+H D+K N+L+ + K++DFGLA+
Sbjct: 113 KFT-LSEIKRVMQMLLNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168
Query: 623 PDQT---RTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICRRRCLDPNLPD 678
+ +T T Y PE D++ G ++ E+ R + N
Sbjct: 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 228
Query: 679 DQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL-M 737
Q+ L + + E ++ +L + K + L P ++ +
Sbjct: 229 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 288
Query: 738 LE 739
L
Sbjct: 289 LV 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-24
Identities = 39/241 (16%), Positives = 76/241 (31%), Gaps = 20/241 (8%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVER 570
E+ ++ H+N+VRL K LV+E+ + +
Sbjct: 45 PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIV 103
Query: 571 MGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFT 630
+ +G+ + H ++H D+KPQN+L++ N K+++FGLA+
Sbjct: 104 KSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
Query: 631 GIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVI-------- 682
+ + D++S G + E+ R L P D +
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220
Query: 683 ---LEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVAL-----WCILDEPSLRPSMKKV 734
E+W + + + + P R S ++
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
Query: 735 L 735
L
Sbjct: 281 L 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 100 bits (249), Expect = 2e-23
Identities = 43/254 (16%), Positives = 98/254 (38%), Gaps = 38/254 (14%)
Query: 511 EREFQTEMKVIGR-THHRNLVRLLGYSLEVSKK--ILVYEYMSNGSLADILFNPEKQPNW 567
+++ + E+K++ N++ L + + LV+E+++N + +
Sbjct: 73 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTD 128
Query: 568 VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMD-ENRCAKISDFGLAKLMKPDQT 626
+ +I + + Y H I+H D+KP N+++D E+R ++ D+GLA+ P Q
Sbjct: 129 YDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185
Query: 627 RTFTGIRGTRGYVAPEWHRNLP-ITVKADVYSFGVVLLEIICRRRCLDPNLPDD------ 679
+R + PE + D++S G +L +I R+ +
Sbjct: 186 YNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243
Query: 680 -QVILEEWVYQCFENGNLSQLVEDEEV----DEKQLERMIKVALWCILDE---------- 724
+V+ E +Y + N+ ++ K+ ER + ++
Sbjct: 244 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303
Query: 725 ---PSLRPSMKKVL 735
R + ++ +
Sbjct: 304 RYDHQSRLTAREAM 317
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 98.3 bits (244), Expect = 8e-23
Identities = 48/254 (18%), Positives = 95/254 (37%), Gaps = 32/254 (12%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERM 571
E +++ + LV+L + S +V EY++ G + L + +
Sbjct: 86 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHAR 144
Query: 572 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTG 631
A I YLH +I+ D+KP+N+L+D+ +++DFG AK +K
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWT 197
Query: 632 IRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCF 691
+ GT +APE + D ++ GV++ E+ P D + + E +
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP---PFFADQPIQIYEKIVSG- 253
Query: 692 ENGNLSQLVEDEEVDEKQLERMIKVALWCILDE--PSLRPSMKKVL-----------LML 738
++ L+ +++ L L + +L+ + + +
Sbjct: 254 ------KVRFPSHFSS-DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 739 EGTVEIPIPPNPTS 752
+ VE P P
Sbjct: 307 QRKVEAPFIPKFKG 320
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 9e-23
Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 7/183 (3%)
Query: 501 KEEVGRGSSGEREFQTEMKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF 559
K + + + +TE +V+ LV L +K L+ +Y++ G L L
Sbjct: 62 KATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS 121
Query: 560 NPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAK 619
E+ + + +L L + II+ DIK +NIL+D N ++DFGL+K
Sbjct: 122 QRERFTEHE----VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177
Query: 620 LMKPDQTRTFTGIRGTRGYVAPEWHR--NLPITVKADVYSFGVVLLEIICRRRCLDPNLP 677
D+T GT Y+AP+ R + D +S GV++ E++ +
Sbjct: 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237
Query: 678 DDQ 680
+
Sbjct: 238 KNS 240
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 2e-21
Identities = 43/175 (24%), Positives = 70/175 (40%), Gaps = 15/175 (8%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGYSL------EVSKKILVYEYMSNGSLADILFNPEKQP 565
+ E+ ++ +H+N++ LL E LV E M I + +
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI----QMEL 116
Query: 566 NWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQ 625
+ + + GI +LH IIH D+KP NI++ + KI DFGLA+
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173
Query: 626 TRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQ 680
T TR Y APE + D++S G ++ E++ + DQ
Sbjct: 174 MMTPY--VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 3e-21
Identities = 63/306 (20%), Positives = 109/306 (35%), Gaps = 68/306 (22%)
Query: 488 FSYAELEKMTDGFK------EEVGRGSSGE----------------------------RE 513
F E+ K + + VG G+ G +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 514 FQTEMKVIGRTHHRNLVRLLGYSLE------VSKKILVYEYMSNGSLADILFNPEKQPNW 567
E++++ H N++ LL + LV +M G+ L EK
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLG-E 120
Query: 568 VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR 627
+ + +G+ Y+H IIH D+KP N+ ++E+ KI DFGLA+
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS---- 173
Query: 628 TFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEW 686
TG TR Y APE N + T D++S G ++ E+I + + DQ+
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 687 VYQCFENGNLSQLVEDE---------EVDEKQLERMIKVA--------LWCILDEPSLRP 729
V + +L DE E+++K ++ A ++ + R
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
Query: 730 SMKKVL 735
+ + L
Sbjct: 294 TAGEAL 299
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.9 bits (214), Expect = 5e-19
Identities = 50/247 (20%), Positives = 91/247 (36%), Gaps = 32/247 (12%)
Query: 512 REFQTEMKVIGRTHHRNLVRLLGY-----SLEVSKKILVYEYMSNGSLADILFNPEKQPN 566
+ E++++ H N++ LL SLE + + ++ L +I ++
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI--VKCQKLT 119
Query: 567 WVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT 626
+ I RG+ Y+H IIH D+KP N+ ++E+ KI DFGLA+
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD--- 173
Query: 627 RTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICRRR--------------- 670
TG TR Y APE N + D++S G ++ E++ R
Sbjct: 174 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232
Query: 671 --CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLR 728
P + I E ++ + V + + ++ + R
Sbjct: 233 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 292
Query: 729 PSMKKVL 735
+ + L
Sbjct: 293 ITAAQAL 299
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 78.8 bits (194), Expect = 3e-18
Identities = 23/141 (16%), Positives = 40/141 (28%), Gaps = 34/141 (24%)
Query: 78 PEKTVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDSGN 137
E + T + ++ S+ ++VL S + + A + G
Sbjct: 9 HEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWA-SNTAGATGCRAVLQSDGL 67
Query: 138 FVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQ 197
V+ + W S T S G ++L++Q D +
Sbjct: 68 LVILTAQNTIRWS-------------------------SGTKGSIGNYVLVLQPDRTVTI 102
Query: 198 YANINPYGTQHAYWASNTYNK 218
Y W S T NK
Sbjct: 103 YG--------PGLWDSGTSNK 115
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 53.4 bits (128), Expect = 2e-09
Identities = 24/113 (21%), Positives = 39/113 (34%), Gaps = 23/113 (20%)
Query: 181 STGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGV 240
F MQ D NLV + + WASNT L +G L ++
Sbjct: 24 ELSSFRFTMQSDCNLVLFDS------DVRVWASNTAGAT-GCRAVLQSDGLLVILTAQNT 76
Query: 241 NIFNL-TGGENPTKGMIYLMKIDSDGIFRLYSYNLRRQNSTWQVVWES-TSDR 291
++ T G Y++ + D +Y +W+S TS++
Sbjct: 77 IRWSSGTKGSIGN----YVLVLQPDRTVTIY----------GPGLWDSGTSNK 115
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 39.9 bits (93), Expect = 1e-04
Identities = 23/118 (19%), Positives = 33/118 (27%), Gaps = 34/118 (28%)
Query: 117 DSLIADDSQSASSA--SMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPG 174
+L A S SS +M N VL+DS+
Sbjct: 15 QTLHAAQSLELSSFRFTMQSDCNLVLFDSDV---------------------------RV 47
Query: 175 ISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTYNKGDNVSLNLDENGHL 232
+ ++Q DG LV N W+S T N L L + +
Sbjct: 48 WASNTAGATGCRAVLQSDGLLVILTAQN-----TIRWSSGTKGSIGNYVLVLQPDRTV 100
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 84.7 bits (208), Expect = 3e-18
Identities = 41/199 (20%), Positives = 76/199 (38%), Gaps = 19/199 (9%)
Query: 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVY---------------EYMSNGSLA 555
+ E+K++ R + + + K+L + E + LA
Sbjct: 53 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA 112
Query: 556 DILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMD-ENRCAKISD 614
I + + I++ + G+ Y+H C IIH DIKP+N+LM+ + +
Sbjct: 113 LIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ 170
Query: 615 FGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRCLD 673
+A L +T TR Y +PE P AD++S ++ E+I +
Sbjct: 171 IKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
Query: 674 PNLPDDQVILEEWVYQCFE 692
P+ ++ + Q E
Sbjct: 231 PDEGHSYTKDDDHIAQIIE 249
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 78.4 bits (193), Expect = 5e-18
Identities = 27/143 (18%), Positives = 50/143 (34%), Gaps = 30/143 (20%)
Query: 129 SASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLI 188
S + ++GN +LY + G ++ TL Q L + L
Sbjct: 2 SVVVANNGNSILYSTQG------NDNHPQTLHATQSLQ---------------LSPYRLS 40
Query: 189 MQGDGNLVQYANINPYGTQHAYWASNTYNKGDNVSLNLDENGHLFLMNTTGVNIFNLTGG 248
M+ D NLV + W++NT KG L NG + ++ + ++
Sbjct: 41 METDCNLVLFDR------DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNS 94
Query: 249 ENPTKGMIYLMKIDSDGIFRLYS 271
+ + Y+ + D +Y
Sbjct: 95 RSAGR---YVFVLQPDRNLAIYG 114
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 76.9 bits (189), Expect = 1e-17
Identities = 17/138 (12%), Positives = 37/138 (26%), Gaps = 33/138 (23%)
Query: 76 GIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDS 135
T + + L ++ ++VL S + A + +
Sbjct: 16 TQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPN 75
Query: 136 GNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNL 195
G + + +W + + S G+++ ++Q D NL
Sbjct: 76 GRMDVLTNQNIAVWTSG-------------------------NSRSAGRYVFVLQPDRNL 110
Query: 196 VQYANINPYGTQHAYWAS 213
Y A W +
Sbjct: 111 AIYG--------GALWTT 120
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 76.2 bits (187), Expect = 3e-17
Identities = 29/143 (20%), Positives = 48/143 (33%), Gaps = 30/143 (20%)
Query: 149 WQTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQH 208
Q ++ L + L E T + IMQ D NLV Y N +
Sbjct: 7 KQPDDNHPQILHATESL-----------EILFGTHVYRFIMQTDCNLVLYDN------NN 49
Query: 209 AYWASNTYNKGDNVSLNLDENGHLFLMNTTGVNIFNLTGGENPTKGMIYLMKIDSDGIFR 268
WA+NT G+ L +G L ++ V ++ K Y++ + D
Sbjct: 50 PIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQ---SPVAGKAGHYVLVLQPDRNVV 106
Query: 269 LYSYNLRRQNSTWQVVWESTSDR 291
+Y +W + + R
Sbjct: 107 IYG----------DALWATQTVR 119
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 51.6 bits (123), Expect = 1e-08
Identities = 20/123 (16%), Positives = 40/123 (32%), Gaps = 33/123 (26%)
Query: 94 STNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDSGNFVLYDSNGKTLWQTFE 153
+ + ++ ++VL + + + A + G V+ + T+WQ
Sbjct: 29 THVYRFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQ--- 85
Query: 154 HPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWAS 213
S G ++L++Q D N+V Y + A WA+
Sbjct: 86 ----------------------SPVAGKAGHYVLVLQPDRNVVIYGD--------ALWAT 115
Query: 214 NTY 216
T
Sbjct: 116 QTV 118
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 75.6 bits (185), Expect = 3e-17
Identities = 28/138 (20%), Positives = 52/138 (37%), Gaps = 26/138 (18%)
Query: 156 TDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNT 215
+D L +L G L + G +L I+Q D NLV Y N A WAS T
Sbjct: 1 SDRLNSGHQLDTGGSL---------AEGGYLFIIQNDCNLVLYDN------NRAVWASGT 45
Query: 216 YNKGDNVSLNLDENGHLFLMNTTGVNIFNLTGGENPTKGMIYLMKIDSDGIFRLYSYNLR 275
K L + +G+L + + + + + Y + + D +Y
Sbjct: 46 NGKASGCVLKMQNDGNLVIYSGSRAIWAS----NTNRQNGNYYLILQRDRNVVIY----- 96
Query: 276 RQNSTWQVVWESTSDRCD 293
+++ +W + ++ +
Sbjct: 97 --DNSNNAIWATHTNVGN 112
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 61.0 bits (147), Expect = 5e-12
Identities = 16/107 (14%), Positives = 37/107 (34%), Gaps = 12/107 (11%)
Query: 51 SGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVLR 110
G Y F N+ VW + + ++ L ++G++V+
Sbjct: 18 EGGYLFIIQNDCNLVLYDN----------NRAVWASGTNGK--ASGCVLKMQNDGNLVIY 65
Query: 111 SSQQSQDSLIADDSQSASSASMLDSGNFVLYDSNGKTLWQTFEHPTD 157
S ++ + + + N V+YD++ +W T + +
Sbjct: 66 SGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 42.5 bits (99), Expect = 2e-05
Identities = 23/124 (18%), Positives = 41/124 (33%), Gaps = 31/124 (25%)
Query: 93 VSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDSGNFVLYDSNGKTLWQTF 152
+ ++ ++VL + ++ + + S M + GN V+Y +
Sbjct: 17 AEGGYLFIIQNDCNLVLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAIWASNT 76
Query: 153 EHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWA 212
N G + LI+Q D N+V Y N N A WA
Sbjct: 77 --------------------------NRQNGNYYLILQRDRNVVIYDNSNN-----AIWA 105
Query: 213 SNTY 216
++T
Sbjct: 106 THTN 109
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 68.7 bits (167), Expect = 6e-14
Identities = 20/131 (15%), Positives = 37/131 (28%), Gaps = 16/131 (12%)
Query: 493 LEKMTDGFKEEVGRGSSGEREFQTEMKVIGRTHHRNLVRLLG----YSLEVSKKILVYEY 548
+ FK+ + G+ F R R L +L G ++ E
Sbjct: 32 HKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMEL 91
Query: 549 MSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR 608
+ + + I + + I+H D+ N+L+ E
Sbjct: 92 IDAK--------ELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG 140
Query: 609 CAKISDFGLAK 619
I DF +
Sbjct: 141 I-WIIDFPQSV 150
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 65.4 bits (159), Expect = 1e-13
Identities = 26/118 (22%), Positives = 44/118 (37%), Gaps = 18/118 (15%)
Query: 157 DTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTY 216
+ L + LS G L + G F+ IMQ D NLV Y WA+NT
Sbjct: 2 NILYSGETLSTGEFL---------NYGSFVFIMQEDCNLVLYDV------DKPIWATNTG 46
Query: 217 NKGDNVSLNLDENGHLFLMNTTGVNIFNLTGGENPTKGMIYLMKIDSDGIFRLYSYNL 274
+ L++ +G+L + N + + + Y+ + D +Y +
Sbjct: 47 GLSRSCFLSMQTDGNLVVYN---PSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTDR 101
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 45.8 bits (108), Expect = 1e-06
Identities = 22/124 (17%), Positives = 40/124 (32%), Gaps = 33/124 (26%)
Query: 93 VSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQSASSASMLDSGNFVLYDSNGKTLWQTF 152
+ + + ++VL + + + SM GN V+Y+ + K +W
Sbjct: 17 NYGSFVFIMQEDCNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWA-- 74
Query: 153 EHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWA 212
S T G ++ I+Q D N+V Y WA
Sbjct: 75 -----------------------SNTGGQNGNYVCILQKDRNVVIYGT--------DRWA 103
Query: 213 SNTY 216
+ T+
Sbjct: 104 TGTH 107
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 61.1 bits (148), Expect = 4e-12
Identities = 18/99 (18%), Positives = 35/99 (35%), Gaps = 9/99 (9%)
Query: 61 QSNVSGRYYVGVF----LAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQ 116
QS Y+ + L T VW +N + S+G+ V+ ++
Sbjct: 14 QSLDVEPYHFIMQEDCNLVLYDHSTSVWASNTGIL-GKKGCKAVLQSDGNFVVYDAEGRS 72
Query: 117 D-SLIADDSQSASSASMLDSGNFVLYDSNGKTLWQTFEH 154
+ + + + GN V+Y S+ +W T +
Sbjct: 73 LWASHSVRGNGNYVLVLQEDGNVVIYGSD---IWSTGTY 108
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 60.4 bits (146), Expect = 7e-12
Identities = 26/136 (19%), Positives = 46/136 (33%), Gaps = 29/136 (21%)
Query: 157 DTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTY 216
+ L + L G L + IMQ D NLV Y + + WASNT
Sbjct: 2 NLLTNGEGLYAGQSL---------DVEPYHFIMQEDCNLVLYDH------STSVWASNTG 46
Query: 217 NKGDNVS-LNLDENGHLFLMNTTGVNIFNLTGGENPTKGMIYLMKIDSDGIFRLYSYNLR 275
G L +G+ + + G +++ Y++ + DG +Y
Sbjct: 47 ILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGN---YVLVLQEDGNVVIYG---- 99
Query: 276 RQNSTWQVVWESTSDR 291
+W + + +
Sbjct: 100 ------SDIWSTGTYK 109
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 50.7 bits (121), Expect = 2e-08
Identities = 25/125 (20%), Positives = 45/125 (36%), Gaps = 34/125 (27%)
Query: 93 VSTNATLLFNSEGSIVLRSSQQSQ-DSLIADDSQSASSASMLDSGNFVLYDSNGKTLWQT 151
+ + ++VL S S + A + GNFV+YD+ G++LW +
Sbjct: 17 DVEPYHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWAS 76
Query: 152 FEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYW 211
+ G ++L++Q DGN+V Y + W
Sbjct: 77 H-------------------------SVRGNGNYVLVLQEDGNVVIYGS--------DIW 103
Query: 212 ASNTY 216
++ TY
Sbjct: 104 STGTY 108
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 44.2 bits (104), Expect = 4e-06
Identities = 25/133 (18%), Positives = 43/133 (32%), Gaps = 36/133 (27%)
Query: 108 VLRSSQQSQDSLIADDS--QSASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRL 165
+L + + L A S M + N VLYD + ++W +
Sbjct: 3 LLTNGE----GLYAGQSLDVEPYHFIMQEDCNLVLYD-HSTSVWASNTG----------- 46
Query: 166 SVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTYNKGDNVSLN 225
++Q DGN V Y + WAS++ N L
Sbjct: 47 -------------ILGKKGCKAVLQSDGNFVVY-----DAEGRSLWASHSVRGNGNYVLV 88
Query: 226 LDENGHLFLMNTT 238
L E+G++ + +
Sbjct: 89 LQEDGNVVIYGSD 101
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 757 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.98 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.97 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.95 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.8 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.71 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.69 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.69 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.57 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.55 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.4 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.17 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.08 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.02 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.94 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.8 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.78 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.13 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.93 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 93.96 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 92.39 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 92.08 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 88.77 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 88.45 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 87.05 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 86.64 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 85.09 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.83 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 80.18 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.9e-45 Score=382.09 Aligned_cols=240 Identities=25% Similarity=0.450 Sum_probs=189.7
Q ss_pred ccHHHHHHhhcccc-----------ccccCCCch------------------------------HHHHHHHHHHHhhcCC
Q 038168 488 FSYAELEKMTDGFK-----------EEVGRGSSG------------------------------EREFQTEMKVIGRTHH 526 (757)
Q Consensus 488 ~~~~~l~~~t~~f~-----------~~lg~g~~~------------------------------~~~~~~E~~~l~~l~h 526 (757)
++|+++.+++++|. +.||+|+|| .++|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 57778888887764 368999984 2679999999999999
Q ss_pred CceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECC
Q 038168 527 RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDE 606 (757)
Q Consensus 527 ~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~ 606 (757)
||||+++|++.+.+..++||||+++|+|.+++......++|.+++.|+.|||+||+|||++ +|+||||||+||||+.
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~ 163 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNS 163 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECC
Confidence 9999999999999999999999999999999988777899999999999999999999998 9999999999999999
Q ss_pred CCcEEEeecCCccccCCCCcc----eecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCccc
Q 038168 607 NRCAKISDFGLAKLMKPDQTR----TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-RRRCLDPNLPDDQV 681 (757)
Q Consensus 607 ~~~~ki~DfGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~ 681 (757)
++.+||+|||+++.+...... ......||+.|||||.+.+..++.++|||||||++|||+| |+.||......
T Consensus 164 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--- 240 (299)
T d1jpaa_ 164 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--- 240 (299)
T ss_dssp TCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---
T ss_pred CCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---
Confidence 999999999999987654332 1223567999999999999999999999999999999998 88888654321
Q ss_pred cHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcC
Q 038168 682 ILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 682 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~ 743 (757)
+ +...+..+.... .+.+.+.++.+++.+||+.||++||||.||++.|+.+++
T Consensus 241 ---~-~~~~i~~~~~~~------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 241 ---D-VINAIEQDYRLP------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ---H-HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---H-HHHHHHcCCCCC------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1 122223322111 122345678899999999999999999999999987654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-44 Score=368.87 Aligned_cols=224 Identities=28% Similarity=0.451 Sum_probs=174.8
Q ss_pred ccCCCchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038168 504 VGRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 504 lg~g~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y 583 (757)
+-.+....++|.+|++++++++|||||+++|+|.+.+..++||||+++|+|.+++......+++.+++.|+.|+|+||+|
T Consensus 37 i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~ 116 (263)
T d1sm2a_ 37 IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 116 (263)
T ss_dssp CCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred ECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHh
Confidence 33344457899999999999999999999999999999999999999999999998877889999999999999999999
Q ss_pred hhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHH
Q 038168 584 LHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663 (757)
Q Consensus 584 LH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ 663 (757)
||++ +|+||||||+|||+++++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|
T Consensus 117 lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~ 193 (263)
T d1sm2a_ 117 LEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMW 193 (263)
T ss_dssp HHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred hhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHH
Confidence 9998 9999999999999999999999999999987665555555577899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
||+|++.|+...... .+ +.+.+..+.. ...+. ...+++.+++.+||+.||++||||+||+++|++++
T Consensus 194 el~t~~~~~~~~~~~-----~~-~~~~i~~~~~--~~~p~----~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 194 EVFSEGKIPYENRSN-----SE-VVEDISTGFR--LYKPR----LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp HHHTTSCCTTCSCCH-----HH-HHHHHHHTCC--CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHCCCCCCCCCCH-----HH-HHHHHHhcCC--CCCcc----ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 999976555433221 11 1222233211 11122 23457889999999999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=364.25 Aligned_cols=221 Identities=29% Similarity=0.432 Sum_probs=177.4
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..++|.+|++++++++|||||+++|++.+ +..++||||+++|+|.+++......+++.+++.|+.|||+||+|||++
T Consensus 47 ~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~-- 123 (276)
T d1uwha_ 47 QLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK-- 123 (276)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC--
Confidence 45789999999999999999999998765 568999999999999999987777899999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccC---CCCCccccchhhHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRN---LPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+||||+.++.+||+|||+|+....... .......||+.|||||.+.+ ..++.++|||||||++|||
T Consensus 124 -~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el 202 (276)
T d1uwha_ 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 202 (276)
T ss_dssp -TCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHH
T ss_pred -CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHH
Confidence 999999999999999999999999999987754333 33445789999999999864 3589999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
+||+.||....... .+......+...... .......++++.+++.+||+.||++||||+||+++|+.+.
T Consensus 203 ~tg~~Pf~~~~~~~------~~~~~~~~~~~~p~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 203 MTGQLPYSNINNRD------QIIFMVGRGYLSPDL--SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp HHSSCTTTTCCCHH------HHHHHHHHTSCCCCG--GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHCCCCCCCCChHH------HHHHHHhcCCCCCcc--hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 99999997543321 122233333222111 1123334567899999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-43 Score=366.68 Aligned_cols=217 Identities=29% Similarity=0.407 Sum_probs=185.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.++|.+|+++|++++|||||+++|++.+++..++||||+++|+|.+++... ...+++..++.|+.|||+||+|||++
T Consensus 57 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-- 134 (287)
T d1opja_ 57 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-- 134 (287)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC--
Confidence 478999999999999999999999999999999999999999999999653 46789999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+||||++++.+||+|||+++..............|++.|+|||++.+..++.++|||||||++|||++|+
T Consensus 135 -~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~ 213 (287)
T d1opja_ 135 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 213 (287)
T ss_dssp -TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTS
T ss_pred -CcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCC
Confidence 9999999999999999999999999999988766666666677899999999999999999999999999999999988
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
.|+....... .+.+.+..+.... .+...++++.+++.+||+.||++||||+||++.|+.+.
T Consensus 214 ~p~~~~~~~~------~~~~~i~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 214 MSPYPGIDLS------QVYELLEKDYRME------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCSSTTCCHH------HHHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCcchHH------HHHHHHhcCCCCC------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 7765433221 1223333332111 12233467899999999999999999999999998754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-42 Score=358.31 Aligned_cols=213 Identities=22% Similarity=0.330 Sum_probs=180.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.++|.+|+++|++++|||||+++|++.. +..+|||||+++|+|.+++......+++.++..++.|||+||+|||++
T Consensus 53 ~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~--- 128 (285)
T d1u59a_ 53 TEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--- 128 (285)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 4789999999999999999999999865 568999999999999999877777899999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce--ecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT--FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+|+||||||+||||+.++.+||+|||+++.+....... .....||+.|+|||++.+..++.++|||||||++|||+|
T Consensus 129 ~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~ 208 (285)
T d1u59a_ 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY 208 (285)
T ss_dssp TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred CeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhC
Confidence 99999999999999999999999999999876544322 234568999999999999999999999999999999998
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
|+.||...... + +...+..+..... +...+.++.+++.+||+.||++||||.+|++.|+.
T Consensus 209 G~~Pf~~~~~~------~-~~~~i~~~~~~~~------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 209 GQKPYKKMKGP------E-VMAFIEQGKRMEC------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp SCCTTTTCCTH------H-HHHHHHTTCCCCC------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCCCHH------H-HHHHHHcCCCCCC------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 89998754321 1 2233444433221 22334678899999999999999999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=358.87 Aligned_cols=217 Identities=30% Similarity=0.491 Sum_probs=180.0
Q ss_pred CchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 508 SSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 508 ~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
....++|.+|++++++++|||||+++|++.+ +..++||||+++|+|.+++.... ..++|.++++|+.|||+||+|||+
T Consensus 49 ~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~ 127 (272)
T d1qpca_ 49 SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127 (272)
T ss_dssp SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3346889999999999999999999998865 56799999999999999886543 468999999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+ +|+||||||+||||++++.+||+|||+|+..............||+.|+|||++.+..++.++|||||||++|||+
T Consensus 128 ~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ell 204 (272)
T d1qpca_ 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204 (272)
T ss_dssp T---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred C---CcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHH
Confidence 8 9999999999999999999999999999988766555556678999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
||+.|+....... + +.+.+..+... ..+ ...++++.+++.+||+.||++||||+||+++|+.
T Consensus 205 t~~~~~~~~~~~~-----~-~~~~i~~~~~~--~~p----~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 205 THGRIPYPGMTNP-----E-VIQNLERGYRM--VRP----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp TTTCCSSTTCCHH-----H-HHHHHHTTCCC--CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hCCCCCCCCCCHH-----H-HHHHHHhcCCC--CCc----ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 9776655432211 1 22223333211 112 2234568899999999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=359.72 Aligned_cols=219 Identities=26% Similarity=0.440 Sum_probs=176.6
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.++|.+|++++++++|||||+++|++.+.+..++||||+.+++|.+++......++|.++++++.|+++||+|||++
T Consensus 53 ~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~--- 129 (283)
T d1mqba_ 53 RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM--- 129 (283)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---
Confidence 46799999999999999999999999999999999999999999999887778899999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc--ceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT--RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+||||+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 130 ~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~ 209 (283)
T d1mqba_ 130 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY 209 (283)
T ss_dssp TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhC
Confidence 999999999999999999999999999998755433 223346789999999999999999999999999999999998
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcCC
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEI 744 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~~ 744 (757)
+.|+....... + +...+..+.... .+...+.++.+++.+||+.||++||||.||+++|+.+++.
T Consensus 210 ~~~~~~~~~~~-----~-~~~~i~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 210 GERPYWELSNH-----E-VMKAINDGFRLP------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp SCCTTTTCCHH-----H-HHHHHHTTCCCC------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCccccCCHH-----H-HHHHHhccCCCC------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 77665433221 1 223333332211 1223446789999999999999999999999999986654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-42 Score=356.15 Aligned_cols=212 Identities=25% Similarity=0.358 Sum_probs=176.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.++|.+|++++++++|||||+++|+|.. +..+|||||+++|+|.+++.. ...+++.++++|+.|||+||+|||++
T Consensus 52 ~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~--- 126 (277)
T d1xbba_ 52 KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEES--- 126 (277)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhC---
Confidence 4689999999999999999999999864 467899999999999999864 45689999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce--ecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT--FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+|+||||||+||||+.++.+||+|||+++.+....... .....||+.|+|||.+.+..++.++|||||||++|||+|
T Consensus 127 ~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~ 206 (277)
T d1xbba_ 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 206 (277)
T ss_dssp TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred CcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhC
Confidence 99999999999999999999999999999876554432 234678999999999999999999999999999999998
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
|+.||...... + +...+..+.... .+...+.++.+++.+||+.||++||||++|+++|+.
T Consensus 207 g~~Pf~~~~~~------~-~~~~i~~~~~~~------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 207 GQKPYRGMKGS------E-VTAMLEKGERMG------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TCCSSTTCCHH------H-HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCCCCHH------H-HHHHHHcCCCCC------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 89998753221 1 223334443221 122334678899999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-42 Score=350.98 Aligned_cols=221 Identities=24% Similarity=0.391 Sum_probs=187.9
Q ss_pred cCCCchHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 505 GRGSSGEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 505 g~g~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
-.+...+++|.+|+.++++++|||||+++|+|.+.+..++||||+++|+|.+++......+++..+.+++.|+|+||+||
T Consensus 37 ~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~L 116 (258)
T d1k2pa_ 37 KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116 (258)
T ss_dssp ESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH
T ss_pred CcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHH
Confidence 34444678999999999999999999999999999999999999999999999888778899999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~e 664 (757)
|++ +|+||||||+|||++.++.+||+|||+++..............||+.|+|||.+.+..++.++||||||+++||
T Consensus 117 H~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~e 193 (258)
T d1k2pa_ 117 ESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWE 193 (258)
T ss_dssp HHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHh
Confidence 998 99999999999999999999999999998876655555556779999999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 665 IIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 665 llt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
|+| |+.||...... + +...+..+.. ...+. ...+++.+++.+||+.||++|||++||++.|.++
T Consensus 194 l~t~g~~Pf~~~~~~------~-~~~~i~~~~~--~~~p~----~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 194 IYSLGKMPYERFTNS------E-TAEHIAQGLR--LYRPH----LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHTTSCCTTTTSCHH------H-HHHHHHTTCC--CCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHhcCCCCCCCCCHH------H-HHHHHHhCCC--CCCcc----cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 998 78888654321 1 2223333321 11222 2336789999999999999999999999998653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=362.14 Aligned_cols=214 Identities=25% Similarity=0.366 Sum_probs=178.8
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC----------------------CCCCH
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE----------------------KQPNW 567 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------------~~l~~ 567 (757)
.+.|.+|+.+++++ +|||||++++++.+.+..++||||+++|+|.++|+... ..+++
T Consensus 84 ~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 163 (325)
T d1rjba_ 84 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163 (325)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCH
T ss_pred HHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCH
Confidence 36789999999999 89999999999999999999999999999999997643 24789
Q ss_pred HHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccC
Q 038168 568 VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRN 646 (757)
Q Consensus 568 ~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~ 646 (757)
.+++.|+.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+........ ......||+.|||||.+.+
T Consensus 164 ~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (325)
T d1rjba_ 164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 240 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC
Confidence 99999999999999999998 9999999999999999999999999999876554433 3345678999999999999
Q ss_pred CCCCccccchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCC
Q 038168 647 LPITVKADVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEP 725 (757)
Q Consensus 647 ~~~~~k~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p 725 (757)
..++.++|||||||++|||+| |+.||........ +.+..+.+... ..+....+++.+++.+||+.||
T Consensus 241 ~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~------~~~~~~~~~~~------~~p~~~~~~l~~li~~cl~~dP 308 (325)
T d1rjba_ 241 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN------FYKLIQNGFKM------DQPFYATEEIYIIMQSCWAFDS 308 (325)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHTTCCC------CCCTTCCHHHHHHHHHHTCSSG
T ss_pred CCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH------HHHHHhcCCCC------CCCCcCCHHHHHHHHHHcCCCh
Confidence 999999999999999999998 8999875433221 22333333211 1122234678999999999999
Q ss_pred CCCCCHHHHHHHhh
Q 038168 726 SLRPSMKKVLLMLE 739 (757)
Q Consensus 726 ~~RPsm~eVl~~Le 739 (757)
++||||+||+++|.
T Consensus 309 ~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 309 RKRPSFPNLTSFLG 322 (325)
T ss_dssp GGSCCHHHHHHHHH
T ss_pred hHCcCHHHHHHHHh
Confidence 99999999999995
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=350.08 Aligned_cols=211 Identities=26% Similarity=0.352 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|||||++++++.+.+..+|||||+++|+|.+++.+ ...+++.++..++.||++||+|||++
T Consensus 47 ~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~--- 122 (271)
T d1nvra_ 47 PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI--- 122 (271)
T ss_dssp --CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc---
Confidence 35689999999999999999999999999999999999999999999965 45789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCC-CccccchhhHHHHHHHHhC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+|||+++++.+||+|||+|+....... ......+||+.|||||++.+..+ +.++||||+||++|||++|
T Consensus 123 ~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G 202 (271)
T d1nvra_ 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202 (271)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhC
Confidence 999999999999999999999999999997754432 33445789999999999988876 6789999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+.||.......... .......... .+ ......++.+++.+||+.||++|||++|+++
T Consensus 203 ~~pf~~~~~~~~~~------~~~~~~~~~~--~~---~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 203 ELPWDQPSDSCQEY------SDWKEKKTYL--NP---WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp SCSCSSSSTTSHHH------HHHHTTCTTS--TT---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCChHHHHH------HHHhcCCCCC--Cc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99997654332111 1111111110 00 1122356788999999999999999999865
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=353.49 Aligned_cols=219 Identities=30% Similarity=0.439 Sum_probs=173.4
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP-EKQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
..++|.+|+.++++++|+|||+++|++.+ ++.++||||+++|+|.+++... ...++|.+++.|+.|||.||+|||++
T Consensus 55 ~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~- 132 (285)
T d1fmka3 55 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 132 (285)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh-
Confidence 45889999999999999999999999854 5679999999999999998654 35689999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+||||+.++.+||+|||+++..............||..|+|||++....++.++||||||+++|||++|
T Consensus 133 --~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~ 210 (285)
T d1fmka3 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 210 (285)
T ss_dssp --TCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --heecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhC
Confidence 999999999999999999999999999998765555555557789999999999999999999999999999999998
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcCC
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTVEI 744 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~~~ 744 (757)
+.|+....... + +...+..+.... .+....+++.+++.+||+.||++||+|++|+++|+....-
T Consensus 211 ~~p~~~~~~~~-----~-~~~~i~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 211 GRVPYPGMVNR-----E-VLDQVERGYRMP------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TCCSSTTCCHH-----H-HHHHHHTTCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCCCCHH-----H-HHHHHHhcCCCC------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 77765543321 1 122223222111 1223346789999999999999999999999999985543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=347.83 Aligned_cols=205 Identities=25% Similarity=0.401 Sum_probs=174.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|||||++++++.+.+..++||||+++|+|.+++.+ ...+++.++..++.||++||+|||++
T Consensus 50 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~--- 125 (263)
T d2j4za1 50 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSK--- 125 (263)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46789999999999999999999999999999999999999999999964 35689999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 126 ~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~ 202 (263)
T d2j4za1 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 202 (263)
T ss_dssp TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred CeeeeeeccccceecCCCCEeecccceeeecCCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCC
Confidence 99999999999999999999999999998765432 234679999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||...... + .......+... .+....+++.+++.+||+.||++|||++||++
T Consensus 203 Pf~~~~~~------~-~~~~i~~~~~~-------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 203 PFEANTYQ------E-TYKRISRVEFT-------FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TTCCSSHH------H-HHHHHHTTCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCHH------H-HHHHHHcCCCC-------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 99653221 1 22223333221 11223456889999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=344.54 Aligned_cols=209 Identities=26% Similarity=0.370 Sum_probs=168.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe----ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE----VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
.+.|.+|+++|++++|||||++++++.+ ....++||||+++|+|.+++.+ ...+++.++..++.||++||+|||+
T Consensus 52 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~ 130 (270)
T d1t4ha_ 52 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT 130 (270)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHH
Confidence 3678999999999999999999999865 3567999999999999999964 3568899999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEEC-CCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 587 ECETQIIHCDIKPQNILMD-ENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~-~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+ .++|+||||||+||||+ +++.+||+|||+++...... .....||+.|||||.+.+ +++.++|||||||++|||
T Consensus 131 ~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel 205 (270)
T d1t4ha_ 131 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEM 205 (270)
T ss_dssp S-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHH
T ss_pred C-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHH
Confidence 7 12399999999999996 57899999999998654332 234679999999998875 699999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
++|+.||....... .+.+....+...... +.....++.+++.+||+.||++|||++|+++
T Consensus 206 ~~g~~Pf~~~~~~~------~~~~~i~~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 206 ATSEYPYSECQNAA------QIYRRVTSGVKPASF-----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHSSCTTTTCSSHH------HHHHHHTTTCCCGGG-----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHCCCCCCCcccHH------HHHHHHHcCCCCccc-----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 99999996433211 122333333222111 1122345889999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-40 Score=344.39 Aligned_cols=209 Identities=26% Similarity=0.369 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|||||++++++.+.+..++||||+++|+|.+++.+ ..++..++..++.||+.||+|||++
T Consensus 61 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~--- 135 (293)
T d1yhwa1 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN--- 135 (293)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46799999999999999999999999999999999999999999998854 4689999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 136 ~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 214 (293)
T d1yhwa1 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (293)
T ss_dssp TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCC
Confidence 999999999999999999999999999998754432 2344679999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||...... +........+.. .+..+ ......+.+++.+||+.||++|||+.|+++
T Consensus 215 Pf~~~~~~------~~~~~~~~~~~~-~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 215 PYLNENPL------RALYLIATNGTP-ELQNP----EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp TTTTSCHH------HHHHHHHHHCSC-CCSSG----GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCCHH------HHHHHHHhCCCC-CCCCc----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99643221 112222222221 12122 223466889999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-41 Score=349.17 Aligned_cols=215 Identities=22% Similarity=0.342 Sum_probs=168.7
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.|.+|++++++++|||||+++|++. .+..++||||+++|+|.+++......+++.+++.++.||++||+|||+.
T Consensus 52 ~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~--- 127 (273)
T d1mp8a_ 52 REKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 127 (273)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---
Confidence 467999999999999999999999986 4678999999999999999877777899999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-CC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC-RR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt-G~ 669 (757)
+|+||||||+||+++.++.+||+|||+++..............||+.|+|||.+.+..++.++|||||||++|||++ |.
T Consensus 128 ~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~ 207 (273)
T d1mp8a_ 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 207 (273)
T ss_dssp TCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC
T ss_pred CeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCC
Confidence 99999999999999999999999999999876655555555678999999999999999999999999999999998 78
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
.|+......+ +...+..+.... .+...+.++.+++.+||+.||++|||+.||++.|+.+.
T Consensus 208 ~P~~~~~~~~-------~~~~i~~~~~~~------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 208 KPFQGVKNND-------VIGRIENGERLP------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp CTTTTCCGGG-------HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHH-------HHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 8876543322 122233333221 12233467899999999999999999999999998643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-41 Score=349.11 Aligned_cols=211 Identities=21% Similarity=0.322 Sum_probs=174.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.|.+|+++|++++|||||++++++.+.+..++||||+++|+|.+++.+....+++.++..++.||++||+|||++
T Consensus 53 ~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~--- 129 (288)
T d2jfla1 53 LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN--- 129 (288)
T ss_dssp GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46789999999999999999999999999999999999999999999876667799999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCccccc-----CCCCCccccchhhHHHHHHH
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHR-----NLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|||++.++.+||+|||+|+...... .......||+.|+|||++. +..++.++|||||||++|||
T Consensus 130 ~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyem 208 (288)
T d2jfla1 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 208 (288)
T ss_dssp TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHH
T ss_pred CEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHH
Confidence 99999999999999999999999999997653221 1223467999999999984 45689999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
++|+.||......+. +.. ...+....+..+. ....++.+++.+||+.||++|||++|+++
T Consensus 209 ltg~~Pf~~~~~~~~------~~~-i~~~~~~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 209 AEIEPPHHELNPMRV------LLK-IAKSEPPTLAQPS----RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHSSCTTTTSCGGGH------HHH-HHHSCCCCCSSGG----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhCCCCCCCCCHHHH------HHH-HHcCCCCCCCccc----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 999999976433221 112 2223222222222 23456889999999999999999999976
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=347.88 Aligned_cols=212 Identities=20% Similarity=0.356 Sum_probs=162.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe--ceeeeEEEEeccCCChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE--VSKKILVYEYMSNGSLADILFNP---EKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.+.|.+|++++++++|||||++++++.+ .+..|+||||+++|+|.+++.+. ...+++.++..++.||+.||+|||
T Consensus 47 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH 126 (269)
T d2java1 47 KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126 (269)
T ss_dssp HHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3568999999999999999999999865 44679999999999999998642 467899999999999999999999
Q ss_pred hCC--CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHH
Q 038168 586 DEC--ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663 (757)
Q Consensus 586 ~~~--~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ 663 (757)
++. ..+|+||||||+||||+.++.+||+|||+++.+..... ......||+.|||||.+.+..++.++|||||||++|
T Consensus 127 ~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvily 205 (269)
T d2java1 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 205 (269)
T ss_dssp HHCC---------CCGGGEEECTTSCEEECCHHHHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred HhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHH
Confidence 862 12499999999999999999999999999998764432 234467999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
||++|+.||...... + +...+..+....+ +....+++.+++.+||+.||++|||++|+++
T Consensus 206 el~tg~~Pf~~~~~~------~-~~~~i~~~~~~~~------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 206 ELCALMPPFTAFSQK------E-LAGKIREGKFRRI------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHSSCSCCCSSHH------H-HHHHHHHTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhhCCCCCCCCCHH------H-HHHHHHcCCCCCC------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 999999999753221 1 2233344444322 1223457889999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-41 Score=349.69 Aligned_cols=206 Identities=21% Similarity=0.300 Sum_probs=170.8
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|++++++++|||||++++++.+.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +
T Consensus 53 ~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~ 128 (288)
T d1uu3a_ 53 PYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGK---G 128 (288)
T ss_dssp HHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccc---c
Confidence 5789999999999999999999999999999999999999999998864 45688999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
|+||||||+|||+++++.+||+|||+|+.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 129 iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~ 208 (288)
T d1uu3a_ 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 208 (288)
T ss_dssp EECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCC
Confidence 99999999999999999999999999998765433 23345679999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl 735 (757)
||...... + +.+....+... ++.....++.+++.+||+.||++|||++|++
T Consensus 209 Pf~~~~~~------~-~~~~i~~~~~~-------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 209 PFRAGNEY------L-IFQKIIKLEYD-------FPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp SSCCSSHH------H-HHHHHHTTCCC-------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CCCCcCHH------H-HHHHHHcCCCC-------CCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 99753211 1 12222333321 1122345688999999999999999999863
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=350.68 Aligned_cols=217 Identities=26% Similarity=0.430 Sum_probs=180.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec-eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV-SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
.++|.+|++++++++|||||+++|++.+. ...++||||+++|+|.+++......+++..+++++.|+|+||.|||+.
T Consensus 72 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~-- 149 (311)
T d1r0pa_ 72 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-- 149 (311)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc--
Confidence 36799999999999999999999998764 588999999999999999988888889999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc---eecccccCccccCcccccCCCCCccccchhhHHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR---TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEII 666 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ell 666 (757)
+|+||||||+||||++++.+||+|||+++........ ......||..|+|||.+....++.++||||||+++|||+
T Consensus 150 -~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~ 228 (311)
T d1r0pa_ 150 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 228 (311)
T ss_dssp -TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred -CcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHH
Confidence 9999999999999999999999999999987654332 233467899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 667 CRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 667 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
+|+.|+.......+ +...+..+... ..+. ....++.+++.+||+.||++||+|.||++.|+.+.
T Consensus 229 t~~~p~~~~~~~~~------~~~~i~~g~~~--~~p~----~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 229 TRGAPPYPDVNTFD------ITVYLLQGRRL--LQPE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp TTSCCSCC------------CHHHHHTTCCC--CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HCCCCCCCCCCHHH------HHHHHHcCCCC--CCcc----cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 98888765433221 11223333321 1222 23356889999999999999999999999998754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-40 Score=347.31 Aligned_cols=217 Identities=27% Similarity=0.389 Sum_probs=179.2
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-----------------------CCCCH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-----------------------KQPNW 567 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~l~~ 567 (757)
.++|.+|++++++++||||+++++++.+.+..++||||+++|+|.++++... ..+++
T Consensus 60 ~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 139 (301)
T d1lufa_ 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139 (301)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCH
T ss_pred HHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCH
Confidence 4679999999999999999999999999999999999999999999996321 34789
Q ss_pred HHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccC
Q 038168 568 VERMGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRN 646 (757)
Q Consensus 568 ~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 646 (757)
.+++.|+.|+|.||+|||++ +|+||||||+|||||.++.+||+|||+++.+..... .......|++.|+|||.+.+
T Consensus 140 ~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 216 (301)
T d1lufa_ 140 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHhhhcccC---CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc
Confidence 99999999999999999998 999999999999999999999999999987654433 22334678899999999999
Q ss_pred CCCCccccchhhHHHHHHHHhCCC-CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCC
Q 038168 647 LPITVKADVYSFGVVLLEIICRRR-CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEP 725 (757)
Q Consensus 647 ~~~~~k~Dv~S~G~~l~elltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p 725 (757)
..++.++|||||||++|||++|.. |+..... .+ +...+.++..... +...+.++.+|+.+||+.+|
T Consensus 217 ~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~------~e-~~~~v~~~~~~~~------p~~~~~~~~~li~~cl~~~P 283 (301)
T d1lufa_ 217 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH------EE-VIYYVRDGNILAC------PENCPLELYNLMRLCWSKLP 283 (301)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HH-HHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSG
T ss_pred CCCChhhhhccchhhHHHHHccCCCCCCCCCH------HH-HHHHHHcCCCCCC------CccchHHHHHHHHHHcCCCh
Confidence 999999999999999999999975 4443211 11 2233444543322 22334578999999999999
Q ss_pred CCCCCHHHHHHHhhcCcC
Q 038168 726 SLRPSMKKVLLMLEGTVE 743 (757)
Q Consensus 726 ~~RPsm~eVl~~Le~~~~ 743 (757)
++||||.||+++|+.+.+
T Consensus 284 ~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 284 ADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp GGSCCHHHHHHHHHHTTC
T ss_pred hHCcCHHHHHHHHHHhcC
Confidence 999999999999998754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=351.37 Aligned_cols=219 Identities=21% Similarity=0.334 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD-ECE 589 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~ 589 (757)
.+.+.+|+.+|++++|||||++++++.+.++.++||||+++|+|.+++.+ ...+++.++..++.|+++||+|||+ +
T Consensus 48 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~-- 124 (322)
T d1s9ja_ 48 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKH-- 124 (322)
T ss_dssp HHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhC--
Confidence 46899999999999999999999999999999999999999999999965 3468999999999999999999996 5
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+||||++++.+||+|||+|+..... .....+||+.|+|||++.+.+++.++||||+||+++||++|+
T Consensus 125 -~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~ 200 (322)
T d1s9ja_ 125 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200 (322)
T ss_dssp -CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred -CEEccccCHHHeeECCCCCEEEeeCCCccccCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 8999999999999999999999999999866432 223468999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccHHH-HHH--------HHHhcCC--cccccc-------------------ccccCHHHHHHHHHHHHH
Q 038168 670 RCLDPNLPDDQVILEE-WVY--------QCFENGN--LSQLVE-------------------DEEVDEKQLERMIKVALW 719 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~-~~~--------~~~~~~~--~~~~~d-------------------~~~~~~~~~~~l~~l~~~ 719 (757)
.||............. ... .....+. .....+ +.........++.+++.+
T Consensus 201 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 280 (322)
T d1s9ja_ 201 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 280 (322)
T ss_dssp CCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHH
Confidence 9997654322100000 000 0000000 000000 000001123568899999
Q ss_pred ccccCCCCCCCHHHHHH
Q 038168 720 CILDEPSLRPSMKKVLL 736 (757)
Q Consensus 720 cl~~~p~~RPsm~eVl~ 736 (757)
||+.||++|||++|+++
T Consensus 281 ~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 281 CLIKNPAERADLKQLMV 297 (322)
T ss_dssp HTCSSTTTSCCHHHHHT
T ss_pred HcCCChhHCcCHHHHhh
Confidence 99999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-40 Score=346.49 Aligned_cols=215 Identities=22% Similarity=0.353 Sum_probs=176.7
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..++|.+|++++++++|||||+++|+|.++ ..++|+||+.+|+|.+++......+++..+++++.|||+||+|||++
T Consensus 54 ~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~-- 130 (317)
T d1xkka_ 54 ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 130 (317)
T ss_dssp THHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc--
Confidence 467899999999999999999999999875 56788999999999999988788899999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+|+||||||+||||+.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+|
T Consensus 131 -~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~ 209 (317)
T d1xkka_ 131 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 209 (317)
T ss_dssp -TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred -CcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHC
Confidence 9999999999999999999999999999987654433 2344678999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
|..|+......+ +...+..+.... .+.....++.+++.+||+.||++|||+.||++.|+.+
T Consensus 210 g~~p~~~~~~~~-------~~~~i~~~~~~~------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 210 GSKPYDGIPASE-------ISSILEKGERLP------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp SCCTTTTSCGGG-------HHHHHHHTCCCC------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHH-------HHHHHHcCCCCC------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 677776543221 122233332111 1223346788999999999999999999999988754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-40 Score=339.61 Aligned_cols=216 Identities=23% Similarity=0.302 Sum_probs=177.1
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..++|.+|+.+|++++|||||+++|++.+ +..++||||+++|+|.+++......+++..++.++.|||+||+|||++
T Consensus 54 ~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~-- 130 (273)
T d1u46a_ 54 AMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK-- 130 (273)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC--
Confidence 45789999999999999999999999975 467899999999999999877667799999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce--ecccccCccccCcccccCCCCCccccchhhHHHHHHHHh
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT--FTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+||||+.++.+||+|||+++......... .....|+..|+|||.+.+..++.++||||||+++|||+|
T Consensus 131 -~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt 209 (273)
T d1u46a_ 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209 (273)
T ss_dssp -TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred -CEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHh
Confidence 99999999999999999999999999999876554432 234567889999999999999999999999999999998
Q ss_pred -CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 668 -RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 668 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
|+.||..... .+......+.+..... +...+..+.+++.+||+.||++||||.||+++|+..
T Consensus 210 ~G~~Pf~~~~~------~~~~~~i~~~~~~~~~------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 210 YGQEPWIGLNG------SQILHKIDKEGERLPR------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TSCCTTTTCCH------HHHHHHHHTSCCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCcCH------HHHHHHHHhCCCCCCC------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 8988864322 1222333333322111 122335688999999999999999999999999753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-39 Score=342.77 Aligned_cols=210 Identities=23% Similarity=0.331 Sum_probs=160.8
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|+.+|++++|||||++++++.+++..||||||+++|+|.+++.. ...+++.+...++.||+.||+|||++ +
T Consensus 52 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~ 127 (307)
T d1a06a_ 52 GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDL---G 127 (307)
T ss_dssp ---CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhc---e
Confidence 5678999999999999999999999999999999999999999999965 45689999999999999999999998 9
Q ss_pred eeeCCCCcceEEEC---CCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 592 IIHCDIKPQNILMD---ENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 592 iiH~Dik~~Nill~---~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
|+||||||+|||+. +++.+||+|||+++...... ......||+.|||||.+.+..++.++|||||||++|||++|
T Consensus 128 iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g 205 (307)
T d1a06a_ 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 205 (307)
T ss_dssp CCCSCCCGGGEEESSSSTTCCEEECCC--------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred eeeEEecccceeecccCCCceEEEeccceeEEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhC
Confidence 99999999999994 57899999999998765432 22346799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+.||...... + .......+..... ........+++.+++.+||+.||++|||++|+++.
T Consensus 206 ~~Pf~~~~~~------~-~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 206 YPPFYDENDA------K-LFEQILKAEYEFD---SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp SCSCCCSSHH------H-HHHHHHTTCCCCC---TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCCCCCHH------H-HHHHHhccCCCCC---CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 9999753221 1 1222222322111 11122334678999999999999999999999983
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=339.44 Aligned_cols=212 Identities=28% Similarity=0.366 Sum_probs=168.1
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEec-eeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhhCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEV-SKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLHDEC 588 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~ 588 (757)
.++|.+|++++++++|||||+++|+|.+. +..++||||+++|+|.+++.+.. ..++|.++++|+.||++||+|||+.
T Consensus 44 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~- 122 (262)
T d1byga_ 44 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 122 (262)
T ss_dssp -HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC-
Confidence 57899999999999999999999999654 56899999999999999997543 4589999999999999999999998
Q ss_pred CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHh-
Q 038168 589 ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIIC- 667 (757)
Q Consensus 589 ~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ellt- 667 (757)
+|+||||||+|||++.++.+||+|||+++...... ....++..|+|||++.+..+++++||||||+++|||+|
T Consensus 123 --~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~ 196 (262)
T d1byga_ 123 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 196 (262)
T ss_dssp --TCCCSCCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --ceeccccchHhheecCCCCEeecccccceecCCCC----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHC
Confidence 99999999999999999999999999998754332 23457899999999999999999999999999999998
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTV 742 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~~ 742 (757)
|+.|+...... .+ ...+..+..... +.....++.+++.+||+.||++||||.||+++|+.++
T Consensus 197 ~~~p~~~~~~~---~~----~~~i~~~~~~~~------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 197 GRVPYPRIPLK---DV----VPRVEKGYKMDA------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp SCCSCTTSCGG---GH----HHHHTTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHH---HH----HHHHHcCCCCCC------CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 56666543222 11 122233322222 2233467889999999999999999999999998653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=343.70 Aligned_cols=215 Identities=30% Similarity=0.407 Sum_probs=175.9
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC---------------CCCCCHHHHHHHHH
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP---------------EKQPNWVERMGIAR 575 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~ 575 (757)
++|.+|+++|+++ +|||||+++|++.+++..++||||+++|+|.++|++. ...+++.++.+++.
T Consensus 55 ~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 134 (309)
T d1fvra_ 55 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134 (309)
T ss_dssp CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHH
Confidence 5799999999999 7999999999999999999999999999999999754 35789999999999
Q ss_pred HHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccc
Q 038168 576 DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADV 655 (757)
Q Consensus 576 ~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv 655 (757)
|||+||+|||+. +|+||||||+|||++.++.+||+|||+++....... .....||..|+|||.+.+..++.++||
T Consensus 135 qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDv 209 (309)
T d1fvra_ 135 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDV 209 (309)
T ss_dssp HHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHH
T ss_pred HHHHHHHhhhcC---CccccccccceEEEcCCCceEEcccccccccccccc--ccceecCCcccchHHhccCCCCcccee
Confidence 999999999998 999999999999999999999999999986543222 223568999999999999999999999
Q ss_pred hhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 038168 656 YSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVL 735 (757)
Q Consensus 656 ~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl 735 (757)
|||||++|||++|..|+..... ..+ +...+.++.... .+....+++.+++.+||+.||++||||+||+
T Consensus 210 wSfGvil~ell~~~~~p~~~~~-----~~~-~~~~i~~~~~~~------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil 277 (309)
T d1fvra_ 210 WSYGVLLWEIVSLGGTPYCGMT-----CAE-LYEKLPQGYRLE------KPLNCDDEVYDLMRQCWREKPYERPSFAQIL 277 (309)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCC-----HHH-HHHHGGGTCCCC------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ehhHHHHHHHHhcCCCCCCCCC-----HHH-HHHHHHhcCCCC------CCccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9999999999998764332221 111 223333332111 1223346789999999999999999999999
Q ss_pred HHhhcCcC
Q 038168 736 LMLEGTVE 743 (757)
Q Consensus 736 ~~Le~~~~ 743 (757)
+.|+++.+
T Consensus 278 ~~L~~i~~ 285 (309)
T d1fvra_ 278 VSLNRMLE 285 (309)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99987553
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-39 Score=342.69 Aligned_cols=204 Identities=25% Similarity=0.352 Sum_probs=169.6
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|+++|++++|||||++++++.+.+..++||||+++|+|..++.. ...+++.++..++.||+.||+|||++ +
T Consensus 60 ~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~---~ 135 (309)
T d1u5ra_ 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---N 135 (309)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 5789999999999999999999999999999999999999999876643 45789999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC---CCCCccccchhhHHHHHHHHhC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN---LPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~G~~l~elltG 668 (757)
|+||||||+||||+.++.+||+|||+++..... ....||+.|||||++.+ ..++.++|||||||++|||++|
T Consensus 136 iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g 210 (309)
T d1u5ra_ 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (309)
T ss_dssp CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred EeccCCCcceEEECCCCCEEEeecccccccCCC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHC
Confidence 999999999999999999999999999865432 33579999999999864 4689999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+.||..... .+....... +....+. +....+.+.+++.+||+.||++|||++|+++
T Consensus 211 ~~Pf~~~~~------~~~~~~i~~-~~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 211 KPPLFNMNA------MSALYHIAQ-NESPALQ-----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SCTTTTSCH------HHHHHHHHH-SCCCCCS-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCH------HHHHHHHHh-CCCCCCC-----CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 999874322 111222222 2222211 1223457889999999999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.1e-39 Score=345.35 Aligned_cols=212 Identities=22% Similarity=0.327 Sum_probs=177.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+++|++++|||||++++++.+++..+|||||+++|+|.+++......++..+...|+.||+.||+|||++
T Consensus 70 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~--- 146 (352)
T d1koba_ 70 KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH--- 146 (352)
T ss_dssp HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46788999999999999999999999999999999999999999998877677899999999999999999999998
Q ss_pred CeeeCCCCcceEEEC--CCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 591 QIIHCDIKPQNILMD--ENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 591 ~iiH~Dik~~Nill~--~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+||||+ .++.+||+|||+|+.+..... .....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 147 ~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG 224 (352)
T d1koba_ 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224 (352)
T ss_dssp TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred CeeecccccccccccccCCCeEEEeecccceecCCCCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhC
Confidence 999999999999998 568999999999998765433 2345789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+.||...... + .......+..... .........++.+++.+||+.||++|||+.|+++.
T Consensus 225 ~~Pf~~~~~~------~-~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 225 LSPFAGEDDL------E-TLQNVKRCDWEFD---EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCSSCCSSHH------H-HHHHHHHCCCCCC---SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCHH------H-HHHHHHhCCCCCC---cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999753321 1 1222233322211 11112334678899999999999999999999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-39 Score=338.79 Aligned_cols=224 Identities=23% Similarity=0.248 Sum_probs=172.4
Q ss_pred HHHHHHhhcCCCceeeeeeEEEece----eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC---
Q 038168 516 TEMKVIGRTHHRNLVRLLGYSLEVS----KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC--- 588 (757)
Q Consensus 516 ~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--- 588 (757)
.|+..+++++|||||+++|+|.+.+ ..++||||+++|+|.+++++ ..++|.++++++.|+|.||+|||+..
T Consensus 46 ~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~ 123 (303)
T d1vjya_ 46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGT 123 (303)
T ss_dssp HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCST
T ss_pred HHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhh
Confidence 4555667889999999999998654 67999999999999999964 46899999999999999999999742
Q ss_pred --CCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc---eecccccCccccCcccccCC------CCCccccchh
Q 038168 589 --ETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR---TFTGIRGTRGYVAPEWHRNL------PITVKADVYS 657 (757)
Q Consensus 589 --~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~S 657 (757)
.++|+||||||+||||+.++.+||+|||+++........ ......||+.|+|||++.+. .++.++||||
T Consensus 124 ~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S 203 (303)
T d1vjya_ 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 203 (303)
T ss_dssp TCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHH
T ss_pred ccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhh
Confidence 359999999999999999999999999999987554332 23357799999999998764 3678999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCc---------cccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCC
Q 038168 658 FGVVLLEIICRRRCLDPNLPDD---------QVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLR 728 (757)
Q Consensus 658 ~G~~l~elltG~~p~~~~~~~~---------~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~R 728 (757)
|||++|||+||..|+....... .... .........+....-+.......+....+.+++.+||+.||++|
T Consensus 204 ~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 282 (303)
T d1vjya_ 204 MGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV-EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 282 (303)
T ss_dssp HHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH-HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGS
T ss_pred hHHHHHHHhhCCCCCCcccccccchhhcccccchH-HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHC
Confidence 9999999999998875432211 1111 22233333333322221222234566789999999999999999
Q ss_pred CCHHHHHHHhhcCc
Q 038168 729 PSMKKVLLMLEGTV 742 (757)
Q Consensus 729 Psm~eVl~~Le~~~ 742 (757)
|||.||+++|+.+.
T Consensus 283 ps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 283 LTALRIKKTLSQLS 296 (303)
T ss_dssp CCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHH
Confidence 99999999998643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.9e-39 Score=345.29 Aligned_cols=212 Identities=21% Similarity=0.343 Sum_probs=176.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.+|++++|||||++++++.+.+..+|||||+++|+|.+++.+....+++.++..|+.||+.||+|||++
T Consensus 67 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~--- 143 (350)
T d1koaa2 67 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN--- 143 (350)
T ss_dssp HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---
Confidence 46789999999999999999999999999999999999999999999977667799999999999999999999998
Q ss_pred CeeeCCCCcceEEECC--CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 591 QIIHCDIKPQNILMDE--NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~--~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+|||++. ++.+||+|||+++.+..... .....||+.|||||++.+..++.++|||||||++|||++|
T Consensus 144 ~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G 221 (350)
T d1koaa2 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221 (350)
T ss_dssp TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred CCeeeeechhHeeeccCCCCeEEEeecchheecccccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhC
Confidence 9999999999999964 57899999999998765433 2346789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+.||..... .+.. .....+..... ........+++.+++.+||+.||++|||++|+++.
T Consensus 222 ~~Pf~~~~~------~~~~-~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 222 LSPFGGEND------DETL-RNVKSCDWNMD---DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp SCSSCCSSH------HHHH-HHHHHTCCCSC---CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCCCCCCH------HHHH-HHHHhCCCCCC---cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 999975422 1112 22222222111 11111234568899999999999999999999884
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=341.63 Aligned_cols=217 Identities=26% Similarity=0.376 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEec-eeeeEEEEeccCCChhhhhcCC---------------CCCCCHHHHHHH
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEV-SKKILVYEYMSNGSLADILFNP---------------EKQPNWVERMGI 573 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~~~lV~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i 573 (757)
.+++.+|+.++.++ +|+|||++++++.+. +..++||||+++|+|.++++.. ...+++.++..+
T Consensus 60 ~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 139 (299)
T d1ywna1 60 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139 (299)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHH
Confidence 46788898888887 789999999998765 4689999999999999999643 234789999999
Q ss_pred HHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCcc
Q 038168 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVK 652 (757)
Q Consensus 574 ~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k 652 (757)
+.||++||+|||++ +|+||||||+||||++++.+||+|||+|+........ ......||+.|+|||.+.+..++.+
T Consensus 140 ~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~ 216 (299)
T d1ywna1 140 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 216 (299)
T ss_dssp HHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHhC---CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcc
Confidence 99999999999998 9999999999999999999999999999876554433 3345679999999999999999999
Q ss_pred ccchhhHHHHHHHHhCCC-CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 653 ADVYSFGVVLLEIICRRR-CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 653 ~Dv~S~G~~l~elltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
+|||||||++|||++|.. |+....... .+...+..+..... +.....++.+++.+||+.||++|||+
T Consensus 217 sDiwS~Gvil~ellt~~~~p~~~~~~~~------~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rpt~ 284 (299)
T d1ywna1 217 SDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA------PDYTTPEMYQTMLDCWHGEPSQRPTF 284 (299)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCCSH------HHHHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred cceeehHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCCCCC------CccCCHHHHHHHHHHcCCChhHCcCH
Confidence 999999999999999765 554332221 12333444432222 12234568899999999999999999
Q ss_pred HHHHHHhhcCc
Q 038168 732 KKVLLMLEGTV 742 (757)
Q Consensus 732 ~eVl~~Le~~~ 742 (757)
+||+++|+.++
T Consensus 285 ~eil~~L~~il 295 (299)
T d1ywna1 285 SELVEHLGNLL 295 (299)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999998764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-39 Score=339.14 Aligned_cols=218 Identities=27% Similarity=0.369 Sum_probs=181.8
Q ss_pred hHHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC---------------CCCCHHHHHHH
Q 038168 510 GEREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE---------------KQPNWVERMGI 573 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i 573 (757)
..+++.+|+..+.++ +|||||+++++|.+.+..++||||+++|+|.+++.... ..+++.+++++
T Consensus 61 ~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 140 (299)
T d1fgka_ 61 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 140 (299)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHH
Confidence 347889999999999 89999999999999999999999999999999996543 45899999999
Q ss_pred HHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc-eecccccCccccCcccccCCCCCcc
Q 038168 574 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR-TFTGIRGTRGYVAPEWHRNLPITVK 652 (757)
Q Consensus 574 ~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k 652 (757)
+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ......+++.|+|||.+.+..++++
T Consensus 141 ~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k 217 (299)
T d1fgka_ 141 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ 217 (299)
T ss_dssp HHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHhhhC---CEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch
Confidence 99999999999999 9999999999999999999999999999977554332 3344678999999999999999999
Q ss_pred ccchhhHHHHHHHHh-CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 653 ADVYSFGVVLLEIIC-RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 653 ~Dv~S~G~~l~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
+||||||+++|||++ |..|+..... ..+...+..+..... + .....++.+++.+||+.||++|||+
T Consensus 218 ~DiwS~Gvvl~ell~~g~~p~~~~~~-------~~~~~~i~~~~~~~~--p----~~~~~~l~~li~~cl~~dP~~Rps~ 284 (299)
T d1fgka_ 218 SDVWSFGVLLWEIFTLGGSPYPGVPV-------EELFKLLKEGHRMDK--P----SNCTNELYMMMRDCWHAVPSQRPTF 284 (299)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHTTCCCCC--C----SSCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hhhHHhHHHHHHhccCCCCCCCCCCH-------HHHHHHHHcCCCCCC--C----ccchHHHHHHHHHHccCCHhHCcCH
Confidence 999999999999998 5666653221 113334444432221 1 2234568999999999999999999
Q ss_pred HHHHHHhhcCcC
Q 038168 732 KKVLLMLEGTVE 743 (757)
Q Consensus 732 ~eVl~~Le~~~~ 743 (757)
.||+++|+++.+
T Consensus 285 ~eil~~L~~i~a 296 (299)
T d1fgka_ 285 KQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHhh
Confidence 999999998653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-39 Score=337.59 Aligned_cols=218 Identities=25% Similarity=0.370 Sum_probs=179.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCC---------CCCCCHHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNP---------EKQPNWVERMGIARDIARGI 581 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~---------~~~l~~~~~~~i~~~ia~gL 581 (757)
...|.+|++++++++|||||+++|++...+..++||||+++|+|.+++... ...+++..+.+++.|+|+||
T Consensus 67 ~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl 146 (308)
T d1p4oa_ 67 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146 (308)
T ss_dssp HHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHH
Confidence 356899999999999999999999999999999999999999999998632 23468999999999999999
Q ss_pred HHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcce-ecccccCccccCcccccCCCCCccccchhhHH
Q 038168 582 LYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRT-FTGIRGTRGYVAPEWHRNLPITVKADVYSFGV 660 (757)
Q Consensus 582 ~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~ 660 (757)
.|||++ +|+||||||+|||+++++.+||+|||+++.+....... .....||+.|+|||.+.+..++.++||||||+
T Consensus 147 ~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~ 223 (308)
T d1p4oa_ 147 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 223 (308)
T ss_dssp HHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHhhC---CeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHH
Confidence 999998 99999999999999999999999999998775443322 23456899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 038168 661 VLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 740 (757)
Q Consensus 661 ~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~ 740 (757)
++|||+||+.++..... ..+ +...+..+..... +......+.+++.+||+.+|++||||+||+++|+.
T Consensus 224 il~El~t~~~~p~~~~~-----~~~-~~~~i~~~~~~~~------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ 291 (308)
T d1p4oa_ 224 VLWEIATLAEQPYQGLS-----NEQ-VLRFVMEGGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291 (308)
T ss_dssp HHHHHHHTSCCTTTTSC-----HHH-HHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred HHHHHHhCCCCCCCCCC-----HHH-HHHHHHhCCCCCC------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 99999999644332221 112 2223334433221 12234679999999999999999999999999998
Q ss_pred CcC
Q 038168 741 TVE 743 (757)
Q Consensus 741 ~~~ 743 (757)
.++
T Consensus 292 ~~~ 294 (308)
T d1p4oa_ 292 EME 294 (308)
T ss_dssp GSC
T ss_pred hcC
Confidence 765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-38 Score=334.11 Aligned_cols=207 Identities=24% Similarity=0.286 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.+|++++|||||++++++.+.+..|+||||+++|+|.+++.+ ...++......++.||+.||+|||++
T Consensus 49 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~--- 124 (337)
T d1o6la_ 49 VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR--- 124 (337)
T ss_dssp HHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhc---
Confidence 36788999999999999999999999999999999999999999999865 45678888899999999999999999
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||++.++.+||+|||+|+....... .....+||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus 125 ~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~ 203 (337)
T d1o6la_ 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203 (337)
T ss_dssp TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred CccccccCHHHeEecCCCCEEEeecccccccccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCC
Confidence 999999999999999999999999999987654332 2345789999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS-----MKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----m~eVl~ 736 (757)
||...... + +.+....+.+. ++.....++.+++.+||+.||++||+ ++|+++
T Consensus 204 pf~~~~~~------~-~~~~i~~~~~~-------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 204 PFYNQDHE------R-LFELILMEEIR-------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SSCCSSHH------H-HHHHHHHCCCC-------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCcCHH------H-HHHHHhcCCCC-------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 99754321 1 22233333322 11223456889999999999999995 778876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=336.55 Aligned_cols=217 Identities=27% Similarity=0.430 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHhhc-CCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCC-----------------CCCCHHHHHH
Q 038168 511 EREFQTEMKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPE-----------------KQPNWVERMG 572 (757)
Q Consensus 511 ~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------~~l~~~~~~~ 572 (757)
..+|.+|+.+++++ +|||||+++|+|.+.+..++||||+++|+|.++++... ..+++..+.+
T Consensus 70 ~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 149 (311)
T d1t46a_ 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149 (311)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHH
Confidence 45799999999999 69999999999999999999999999999999986432 3578999999
Q ss_pred HHHHHHHHHHHhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc-ceecccccCccccCcccccCCCCCc
Q 038168 573 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT-RTFTGIRGTRGYVAPEWHRNLPITV 651 (757)
Q Consensus 573 i~~~ia~gL~yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 651 (757)
++.|||+||+|||++ +++||||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.
T Consensus 150 ~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 226 (311)
T d1t46a_ 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 226 (311)
T ss_dssp HHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHhC---CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCC
Confidence 999999999999999 999999999999999999999999999998765443 3334578999999999999999999
Q ss_pred cccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 652 KADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 652 k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
++||||||+++|||+|++.|+......... +.+.++.+.... .+.....++.+|+.+||+.||++||||
T Consensus 227 ~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-----~~~~i~~~~~~~------~~~~~~~~l~~Li~~cl~~dP~~RPs~ 295 (311)
T d1t46a_ 227 ESDVWSYGIFLWELFSLGSSPYPGMPVDSK-----FYKMIKEGFRML------SPEHAPAEMYDIMKTCWDADPLKRPTF 295 (311)
T ss_dssp HHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-----HHHHHHHTCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred cccccchHHHHHHHHhCCCCCCCCCCHHHH-----HHHHHhcCCCCC------CcccccHHHHHHHHHHcCCChhHCcCH
Confidence 999999999999999966555433332211 223333332211 112234678999999999999999999
Q ss_pred HHHHHHhhcC
Q 038168 732 KKVLLMLEGT 741 (757)
Q Consensus 732 ~eVl~~Le~~ 741 (757)
+||+++|++.
T Consensus 296 ~~il~~L~~~ 305 (311)
T d1t46a_ 296 KQIVQLIEKQ 305 (311)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHh
Confidence 9999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=333.85 Aligned_cols=211 Identities=25% Similarity=0.369 Sum_probs=174.3
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.|.+|+++|++++|||||++++++.+.+..+|||||+++|+|.+++.. ...+++.++..++.|++.||+|||+.
T Consensus 56 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~-- 132 (293)
T d1jksa_ 56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSL-- 132 (293)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhc--
Confidence 357899999999999999999999999999999999999999999999965 34689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCC----cEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHH
Q 038168 590 TQIIHCDIKPQNILMDENR----CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEI 665 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~----~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|||++.++ .+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 133 -~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyel 209 (293)
T d1jksa_ 133 -QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 209 (293)
T ss_dssp -TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred -ceeecccccceEEEecCCCcccceEecchhhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHH
Confidence 999999999999998776 499999999987754332 3345789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 666 ICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
++|+.||...... + .......+..... ..........+.+++.+||+.||++|||++|+++
T Consensus 210 l~g~~Pf~~~~~~------~-~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 210 LSGASPFLGDTKQ------E-TLANVSAVNYEFE---DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHSSCSSCCSSHH------H-HHHHHHTTCCCCC---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HcCCCCCCCCCHH------H-HHHHHHhcCCCCC---chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999999754321 1 1122222222111 0111123456889999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-38 Score=335.23 Aligned_cols=214 Identities=22% Similarity=0.257 Sum_probs=170.8
Q ss_pred HHHHHHHHHHhhc-CCCceeeeeeEEEe----ceeeeEEEEeccCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhh
Q 038168 512 REFQTEMKVIGRT-HHRNLVRLLGYSLE----VSKKILVYEYMSNGSLADILFNPE-KQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 512 ~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
+.+.+|++++.++ +|||||++++++.+ ....|+||||+++|+|.+++.+.. ..+++.++..|+.||+.||+|||
T Consensus 49 ~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH 128 (335)
T d2ozaa1 49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128 (335)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 6788999997765 89999999999875 467899999999999999997653 56899999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECC---CCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDE---NRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVL 662 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~---~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l 662 (757)
+. +|+||||||+|||++. ++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++
T Consensus 129 ~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvil 203 (335)
T d2ozaa1 129 SI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 203 (335)
T ss_dssp HT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHH
T ss_pred Hc---CCccccccccccccccccccccccccccceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhH
Confidence 98 9999999999999985 46799999999987765432 3346799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
|||++|+.||.......... ........+... -+........+++.+++.+||+.||++|||+.|+++
T Consensus 204 y~lltg~~Pf~~~~~~~~~~---~~~~~i~~~~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 204 YILLCGYPPFYSNHGLAISP---GMKTRIRMGQYE---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp HHHTTSSCSCEETTCC-----------CCCSCSSS---CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhCCCCCCCCCHHHHHH---HHHHHHhcCCCC---CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 99999999997554322111 011111111111 111112234567899999999999999999999988
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.1e-38 Score=330.60 Aligned_cols=204 Identities=24% Similarity=0.330 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.++++++|||||++++++.+.+..++||||+++|+|..++.. ...++......++.||+.||+|||++
T Consensus 48 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~--- 123 (316)
T d1fota_ 48 VEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSK--- 123 (316)
T ss_dssp HHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccC---
Confidence 46788999999999999999999999999999999999999999998864 45677888889999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+||||+.++.+||+|||+|+..... .....||+.|||||++.+..++.++|||||||++|||++|+.
T Consensus 124 ~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~ 199 (316)
T d1fota_ 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199 (316)
T ss_dssp TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred cEEccccCchheeEcCCCCEEEecCccceEeccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCC
Confidence 9999999999999999999999999999876543 234679999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~ 736 (757)
||..... .+ .......+... .+.....++.+++.+||+.||++|| |++|+++
T Consensus 200 Pf~~~~~------~~-~~~~i~~~~~~-------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 200 PFYDSNT------MK-TYEKILNAELR-------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp TTCCSSH------HH-HHHHHHHCCCC-------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCcCH------HH-HHHHHHcCCCC-------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 9975322 11 12222233221 1122335688999999999999996 8999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.6e-37 Score=321.41 Aligned_cols=217 Identities=23% Similarity=0.351 Sum_probs=170.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEece----eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVS----KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
.+.|.+|++++++++|||||++++++...+ ..||||||+++++|.+++.. ...+++.++..++.||+.||+|||+
T Consensus 51 ~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~ 129 (277)
T d1o6ya_ 51 YLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQ 129 (277)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 467899999999999999999999987654 47899999999999998864 3568999999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCc--ceecccccCccccCcccccCCCCCccccchhhHHHHHH
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQT--RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~e 664 (757)
. +|+||||||+|||++.++..+|+|||.+........ .......||+.|+|||.+.+..+++++|||||||++||
T Consensus 130 ~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilye 206 (277)
T d1o6ya_ 130 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 206 (277)
T ss_dssp T---TEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred C---CccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHH
Confidence 8 999999999999999999999999999986644332 23345679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcC
Q 038168 665 IICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-SMKKVLLMLEGT 741 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-sm~eVl~~Le~~ 741 (757)
|+||+.||..... .+........+....... ....++++.+++.+||+.||++|| |++++++.|.++
T Consensus 207 lltG~~Pf~~~~~------~~~~~~~~~~~~~~~~~~----~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 207 VLTGEPPFTGDSP------VSVAYQHVREDPIPPSAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HHHSSCSCCCSSH------HHHHHHHHHCCCCCGGGT----SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHhCCCCCCCcCH------HHHHHHHHhcCCCCCchh----ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 9999999975322 122333444433322111 122346788999999999999999 899999988754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-37 Score=321.83 Aligned_cols=210 Identities=22% Similarity=0.314 Sum_probs=173.3
Q ss_pred HHHHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+.+.+|+.++++++ |||||++++++.+.+..||||||+++|+|.+++.. ...+++.++..++.||++||+|||++
T Consensus 54 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~--- 129 (277)
T d1phka_ 54 EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKL--- 129 (277)
T ss_dssp HHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc---
Confidence 46889999999997 99999999999999999999999999999999965 45689999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC------CCCCccccchhhHHHHHH
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN------LPITVKADVYSFGVVLLE 664 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~S~G~~l~e 664 (757)
+|+||||||+|||++.++.+||+|||+++.+..... .....||..|+|||++.+ ..++.++||||+||+++|
T Consensus 130 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilye 207 (277)
T d1phka_ 130 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 207 (277)
T ss_dssp TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHH
T ss_pred CCcccccccceEEEcCCCCeEEccchheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhh
Confidence 999999999999999999999999999998765332 344679999999998863 357889999999999999
Q ss_pred HHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 665 IICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|++|+.||...... + .......+..... ........+++.+++.+||+.||++|||++||++.
T Consensus 208 ml~g~~Pf~~~~~~------~-~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 208 LLAGSPPFWHRKQM------L-MLRMIMSGNYQFG---SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHSSCSSCCSSHH------H-HHHHHHHTCCCCC---TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hccCCCCCCCCCHH------H-HHHHHHhCCCCCC---CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 99999999754321 1 2222333332211 11112334678899999999999999999999763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.4e-37 Score=331.27 Aligned_cols=203 Identities=20% Similarity=0.226 Sum_probs=165.5
Q ss_pred HHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeC
Q 038168 516 TEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQIIHC 595 (757)
Q Consensus 516 ~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~ 595 (757)
+|+++++.++|||||++++++.+.+..|+||||+++|+|.+++.+ ...+++.++..++.||+.||+|||++ +|+||
T Consensus 56 ~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHr 131 (364)
T d1omwa3 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNR---FVVYR 131 (364)
T ss_dssp HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred HHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHC---Cccce
Confidence 446777888899999999999999999999999999999999965 35678889999999999999999998 99999
Q ss_pred CCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHHHHHHhCCCCCCC
Q 038168 596 DIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLLEIICRRRCLDP 674 (757)
Q Consensus 596 Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~elltG~~p~~~ 674 (757)
||||+||||+.++.+||+|||+|+.+.... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 132 DlKP~NILl~~~g~iKl~DFGla~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 132 DLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp CCSGGGEEECSSSCEEECCCTTCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred eeccceeEEcCCCcEEEeeeceeeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999775443 234579999999999875 5689999999999999999999999986
Q ss_pred CCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 038168 675 NLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS-----MKKVLL 736 (757)
Q Consensus 675 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----m~eVl~ 736 (757)
........ +........ . ..+.....++.+++.+||+.||++||| ++|+++
T Consensus 209 ~~~~~~~~----~~~~~~~~~---~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 209 HKTKDKHE----IDRMTLTMA---V----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SCSSCHHH----HHHHSSSCC---C----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCHHHHHH----HHHhcccCC---C----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 54433211 111111111 1 111223456889999999999999999 578865
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-37 Score=328.55 Aligned_cols=203 Identities=20% Similarity=0.232 Sum_probs=172.1
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|+++|++++|||||++++++.+.+..++||||+.+|+|.+++.+ ...++..+...++.||+.||.|||++ +
T Consensus 86 ~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~---~ 161 (350)
T d1rdqe_ 86 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSL---D 161 (350)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 5688999999999999999999999999999999999999999999865 34688999999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRRC 671 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~p 671 (757)
|+||||||+||||+.++.+||+|||+|+.+... .....||+.|||||++.+..++.++|||||||++|||++|+.|
T Consensus 162 iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~P 237 (350)
T d1rdqe_ 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237 (350)
T ss_dssp EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EecCcCCHHHcccCCCCCEEeeeceeeeecccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCC
Confidence 999999999999999999999999999976533 2346799999999999999999999999999999999999999
Q ss_pred CCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 038168 672 LDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRP-----SMKKVLL 736 (757)
Q Consensus 672 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----sm~eVl~ 736 (757)
|..... .. ....+..+.... +.....++.+++.+||+.||++|+ |++|+++
T Consensus 238 f~~~~~------~~-~~~~i~~~~~~~-------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 238 FFADQP------IQ-IYEKIVSGKVRF-------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SCCSSH------HH-HHHHHHHCCCCC-------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCcCH------HH-HHHHHhcCCCCC-------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 975321 11 122223332211 122345688999999999999994 8999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-37 Score=328.06 Aligned_cols=211 Identities=19% Similarity=0.317 Sum_probs=174.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
...+.+|+++|++++|||||++++++.+.+..||||||+++|+|.+++......++..+...|+.||+.||+|||++
T Consensus 45 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~--- 121 (321)
T d1tkia_ 45 QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH--- 121 (321)
T ss_dssp HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---
Confidence 45688999999999999999999999999999999999999999999987666799999999999999999999998
Q ss_pred CeeeCCCCcceEEECCC--CcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhC
Q 038168 591 QIIHCDIKPQNILMDEN--RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~--~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+|||++.+ ..+||+|||+++....... .....+|+.|+|||...+..++.++||||+||++|||++|
T Consensus 122 ~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G 199 (321)
T d1tkia_ 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199 (321)
T ss_dssp TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHS
T ss_pred CCCcccccccceeecCCCceEEEEcccchhhccccCCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhC
Confidence 99999999999999854 5899999999987654332 2335689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLL 736 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~ 736 (757)
+.||...... + +...+..+..... .........++.+++.+||+.||++|||+.|+++
T Consensus 200 ~~Pf~~~~~~------~-~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 200 INPFLAETNQ------Q-IIENIMNAEYTFD---EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp SCTTCCSSHH------H-HHHHHHHTCCCCC---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHH------H-HHHHHHhCCCCCC---hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999754321 1 1222222222110 0000112356889999999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-38 Score=328.47 Aligned_cols=218 Identities=25% Similarity=0.316 Sum_probs=170.1
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
+.+.+|+.++++++|||||++++++.+.+..++||||++++++..+. .....++..++..++.||+.||+|||++ +
T Consensus 45 ~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~---~ 120 (299)
T d1ua2a_ 45 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQH---W 120 (299)
T ss_dssp THHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcc---c
Confidence 46889999999999999999999999999999999999988777665 4456688889999999999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhCCC
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+. .++.++|||||||+++||++|+.
T Consensus 121 iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~ 199 (299)
T d1ua2a_ 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 199 (299)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred eecccCCcceEEecCCCccccccCccccccCCCcc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcC
Confidence 99999999999999999999999999987654432 22345789999999988654 57999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCcccccc------------ccccC-----HHHHHHHHHHHHHccccCCCCCCCHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVE------------DEEVD-----EKQLERMIKVALWCILDEPSLRPSMKK 733 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d------------~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPsm~e 733 (757)
||......+.. ..+.+...........+ ....+ ....+.+.+++.+||+.||++|||++|
T Consensus 200 pf~~~~~~~~l---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e 276 (299)
T d1ua2a_ 200 FLPGDSDLDQL---TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 276 (299)
T ss_dssp SSCCSSHHHHH---HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred CCCCCCHHHHH---HHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 98754332211 11111111000000000 00011 122467899999999999999999999
Q ss_pred HHHH
Q 038168 734 VLLM 737 (757)
Q Consensus 734 Vl~~ 737 (757)
+++.
T Consensus 277 ~L~H 280 (299)
T d1ua2a_ 277 ALKM 280 (299)
T ss_dssp HHTS
T ss_pred HhCC
Confidence 9873
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-37 Score=322.67 Aligned_cols=217 Identities=23% Similarity=0.289 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|++++++++|||||++++++.+.+..++||||+.++.+..........+++.++..++.||+.||+|||++
T Consensus 45 ~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~--- 121 (298)
T d1gz8a_ 45 PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 121 (298)
T ss_dssp CHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---
Confidence 46789999999999999999999999999999999999987655555455567799999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCC-CCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP-ITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||+|+....... ......||+.|+|||.+.... .+.++||||+||++|||++|+
T Consensus 122 ~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~ 200 (298)
T d1gz8a_ 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200 (298)
T ss_dssp TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CEEccccCchheeecccCcceeccCCcceeccCCcc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCC
Confidence 999999999999999999999999999987654332 233457999999999877665 588999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHh-cCCccccccc---------------cc-----cCHHHHHHHHHHHHHccccCCCCC
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFE-NGNLSQLVED---------------EE-----VDEKQLERMIKVALWCILDEPSLR 728 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~d~---------------~~-----~~~~~~~~l~~l~~~cl~~~p~~R 728 (757)
.||......+ . .....+ .+...+...+ .. .......++.+++.+||+.||++|
T Consensus 201 ~Pf~~~~~~~--~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R 274 (298)
T d1gz8a_ 201 ALFPGDSEID--Q----LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKR 274 (298)
T ss_dssp CSCCCSSHHH--H----HHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTS
T ss_pred CCCCCCCHHH--H----HHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHC
Confidence 9997542211 1 111111 0110000000 00 011223678899999999999999
Q ss_pred CCHHHHHHH
Q 038168 729 PSMKKVLLM 737 (757)
Q Consensus 729 Psm~eVl~~ 737 (757)
||++|+++.
T Consensus 275 ~t~~ell~H 283 (298)
T d1gz8a_ 275 ISAKAALAH 283 (298)
T ss_dssp CCHHHHHTS
T ss_pred cCHHHHhCC
Confidence 999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-37 Score=324.64 Aligned_cols=206 Identities=21% Similarity=0.276 Sum_probs=170.3
Q ss_pred HHHHHHHHHHh-hcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIG-RTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+.+..|+.++. .++|||||++++++.+++..|+||||+++|+|.+++.. ...++..++..++.||+.||+|||++
T Consensus 47 ~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~--- 122 (320)
T d1xjda_ 47 ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSK--- 122 (320)
T ss_dssp HHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 45677777765 68999999999999999999999999999999999964 45678889999999999999999999
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHHHHhCCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLEIICRRR 670 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~elltG~~ 670 (757)
+|+||||||+|||+++++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 123 ~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 201 (320)
T d1xjda_ 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 201 (320)
T ss_dssp TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CeeeccCcccceeecCCCceeccccchhhhcccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCC
Confidence 999999999999999999999999999986654332 2344679999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 038168 671 CLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMK-KVLL 736 (757)
Q Consensus 671 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~-eVl~ 736 (757)
||...... .+......+... .+.....++.+++.+||+.||++||++. |+++
T Consensus 202 PF~~~~~~-------~~~~~i~~~~~~-------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 202 PFHGQDEE-------ELFHSIRMDNPF-------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp SSCCSSHH-------HHHHHHHHCCCC-------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCCCHH-------HHHHHHHcCCCC-------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 99754321 122223333221 1122345688999999999999999996 6753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-36 Score=315.43 Aligned_cols=218 Identities=24% Similarity=0.290 Sum_probs=167.7
Q ss_pred HHHHHHHHHHhhc---CCCceeeeeeEEEe-----ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038168 512 REFQTEMKVIGRT---HHRNLVRLLGYSLE-----VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILY 583 (757)
Q Consensus 512 ~~~~~E~~~l~~l---~h~niv~l~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y 583 (757)
..+.+|+.+++.| +||||+++++++.. ....++++||++++.+..........+++.....++.|++.||+|
T Consensus 52 ~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~y 131 (305)
T d1blxa_ 52 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131 (305)
T ss_dssp CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 3466777777666 79999999999863 346899999999988877766667788999999999999999999
Q ss_pred hhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHH
Q 038168 584 LHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663 (757)
Q Consensus 584 LH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ 663 (757)
||++ +|+||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+.+++.++||||+||+++
T Consensus 132 LH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ 206 (305)
T d1blxa_ 132 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 206 (305)
T ss_dssp HHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred HHhC---CEEecCCCccEEEEcCCCCeeecchhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHH
Confidence 9998 9999999999999999999999999999865433 2334567999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHhcCC---ccc-------cc-c-----ccccCHHHHHHHHHHHHHccccCCCC
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENGN---LSQ-------LV-E-----DEEVDEKQLERMIKVALWCILDEPSL 727 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~-------~~-d-----~~~~~~~~~~~l~~l~~~cl~~~p~~ 727 (757)
||++|+.||......+. +.. +.+...... ... .. . .........+.+.+++.+||+.||++
T Consensus 207 ell~g~~pf~~~~~~~~--~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~ 283 (305)
T d1blxa_ 207 EMFRRKPLFRGSSDVDQ--LGK-ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 283 (305)
T ss_dssp HHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTT
T ss_pred HHHHCCCCCCCCCHHHH--HHH-HHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhH
Confidence 99999999975432211 111 111110000 000 00 0 00111223456788999999999999
Q ss_pred CCCHHHHHHH
Q 038168 728 RPSMKKVLLM 737 (757)
Q Consensus 728 RPsm~eVl~~ 737 (757)
|||+.|+++.
T Consensus 284 R~sa~e~L~H 293 (305)
T d1blxa_ 284 RISAYSALSH 293 (305)
T ss_dssp SCCHHHHHTS
T ss_pred CcCHHHHhcC
Confidence 9999999873
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=314.34 Aligned_cols=198 Identities=23% Similarity=0.387 Sum_probs=163.5
Q ss_pred HHHHHHHHHhhcC--CCceeeeeeEEEeceeeeEEEEeccC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 513 EFQTEMKVIGRTH--HRNLVRLLGYSLEVSKKILVYEYMSN-GSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 513 ~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
++.+|+.++++++ |||||++++++.+.+..++||||+.+ ++|.+++.+ ...+++.++..++.||++||+|||+.
T Consensus 53 ~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~-- 129 (273)
T d1xwsa_ 53 RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNC-- 129 (273)
T ss_dssp EEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4678999999996 89999999999999999999999976 577777754 45689999999999999999999998
Q ss_pred CCeeeCCCCcceEEECCC-CcEEEeecCCccccCCCCcceecccccCccccCcccccCCCC-CccccchhhHHHHHHHHh
Q 038168 590 TQIIHCDIKPQNILMDEN-RCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPI-TVKADVYSFGVVLLEIIC 667 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~-~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~G~~l~ellt 667 (757)
+|+||||||+|||++.+ +.+||+|||+++...... .+...||+.|+|||++.+..+ +.++||||+||++|||++
T Consensus 130 -~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~ 205 (273)
T d1xwsa_ 130 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205 (273)
T ss_dssp -TEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred -CCccccCcccceEEecCCCeEEECccccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhh
Confidence 99999999999999855 799999999998764332 334679999999999987765 677999999999999999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038168 668 RRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 668 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
|+.||.... + ...+... -+ .....++.+++.+||+.||++|||++|+++.
T Consensus 206 g~~Pf~~~~------------~-i~~~~~~---~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 206 GDIPFEHDE------------E-IIRGQVF---FR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp SSCSCCSHH------------H-HHHCCCC---CS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCch------------H-HhhcccC---CC----CCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 999986421 1 1112111 11 1223568899999999999999999999873
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.8e-35 Score=306.63 Aligned_cols=220 Identities=19% Similarity=0.188 Sum_probs=168.1
Q ss_pred HHHHHHHHHHhhcCCCceeee-eeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRL-LGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l-~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+++..|++++++++|+|+|.. .++..+.+..++||||+ +++|.+.+......+++.++..++.|++.||+|||++
T Consensus 47 ~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--- 122 (299)
T d1ckia_ 47 PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--- 122 (299)
T ss_dssp CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---
Confidence 568899999999987765555 55556777889999998 5577777666677899999999999999999999998
Q ss_pred CeeeCCCCcceEEECC---CCcEEEeecCCccccCCCCc------ceecccccCccccCcccccCCCCCccccchhhHHH
Q 038168 591 QIIHCDIKPQNILMDE---NRCAKISDFGLAKLMKPDQT------RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVV 661 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~---~~~~ki~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~ 661 (757)
+|+||||||+|||++. +..+||+|||+|+.+..... .......||+.|+|||.+.+..++.++|||||||+
T Consensus 123 ~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~ 202 (299)
T d1ckia_ 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYV 202 (299)
T ss_dssp TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHH
T ss_pred CeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHH
Confidence 9999999999999863 56799999999998754332 12345679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 038168 662 LLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 741 (757)
Q Consensus 662 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le~~ 741 (757)
++||++|+.||......................... ......+.++.+++..|++.+|++||+++++.+.|+..
T Consensus 203 l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 203 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 999999999998655443222111111110111110 11112346788999999999999999999999888763
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.9e-35 Score=304.83 Aligned_cols=220 Identities=16% Similarity=0.168 Sum_probs=177.2
Q ss_pred HHHHHHHHHHhhcCC-CceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRTHH-RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+.+++|++++++++| +|++++++++.+....++||||+ +++|.+++......++..++..++.|++.||+|||+.
T Consensus 45 ~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~--- 120 (293)
T d1csna_ 45 PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK--- 120 (293)
T ss_dssp CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---
Confidence 457889999999965 89999999999999999999998 6899999977777899999999999999999999998
Q ss_pred CeeeCCCCcceEEECC-----CCcEEEeecCCccccCCCCc------ceecccccCccccCcccccCCCCCccccchhhH
Q 038168 591 QIIHCDIKPQNILMDE-----NRCAKISDFGLAKLMKPDQT------RTFTGIRGTRGYVAPEWHRNLPITVKADVYSFG 659 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~-----~~~~ki~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G 659 (757)
+|+||||||+|||++. ++.+||+|||+|+.+..... .......||+.|||||.+.+..++.++||||||
T Consensus 121 giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG 200 (293)
T d1csna_ 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALG 200 (293)
T ss_dssp TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred CceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhh
Confidence 9999999999999974 57899999999998754322 123346799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 038168 660 VVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 739 (757)
Q Consensus 660 ~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~Le 739 (757)
++++||++|+.||..............+..........++ ....++++.+++..|+..+|++||+++.+.+.|+
T Consensus 201 ~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 201 HVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp HHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred HHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 9999999999999865554432222211111111111111 1122356888999999999999999999988887
Q ss_pred cC
Q 038168 740 GT 741 (757)
Q Consensus 740 ~~ 741 (757)
.+
T Consensus 275 ~~ 276 (293)
T d1csna_ 275 KV 276 (293)
T ss_dssp HH
T ss_pred HH
Confidence 63
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-35 Score=308.22 Aligned_cols=218 Identities=23% Similarity=0.298 Sum_probs=166.5
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
.+.+.+|+.+|++++|||||++++++.+.+..++|+||+.++.+..+. .....++..++..++.||+.||+|||+.
T Consensus 44 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~--- 119 (286)
T d1ob3a_ 44 PSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDR--- 119 (286)
T ss_dssp CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccC---
Confidence 478999999999999999999999999999999999999887776665 4457789999999999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHHHhCC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEIICRR 669 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~elltG~ 669 (757)
+|+||||||+|||++.++.+||+|||++........ ......+++.|+|||.+.+. .++.++|||||||+++||++|+
T Consensus 120 ~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~ 198 (286)
T d1ob3a_ 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198 (286)
T ss_dssp TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred cEEecCCCCceeeEcCCCCEEecccccceecccCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCC
Confidence 999999999999999999999999999987754332 23345689999999998764 5689999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHHhcCC---cc---cc------c---cc---cccCHHHHHHHHHHHHHccccCCCCCCCH
Q 038168 670 RCLDPNLPDDQVILEEWVYQCFENGN---LS---QL------V---ED---EEVDEKQLERMIKVALWCILDEPSLRPSM 731 (757)
Q Consensus 670 ~p~~~~~~~~~~~l~~~~~~~~~~~~---~~---~~------~---d~---~~~~~~~~~~l~~l~~~cl~~~p~~RPsm 731 (757)
.||......+. +.. +........ .. .. . .+ ..........+.+++.+||+.||++|||+
T Consensus 199 ~pf~~~~~~~~--~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~ 275 (286)
T d1ob3a_ 199 PLFPGVSEADQ--LMR-IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275 (286)
T ss_dssp CSCCCSSHHHH--HHH-HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred CCCCCCCHHHH--HHH-HHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH
Confidence 99975432111 111 111110000 00 00 0 00 00112224578899999999999999999
Q ss_pred HHHHH
Q 038168 732 KKVLL 736 (757)
Q Consensus 732 ~eVl~ 736 (757)
+|+++
T Consensus 276 ~ell~ 280 (286)
T d1ob3a_ 276 KQALE 280 (286)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-34 Score=307.34 Aligned_cols=224 Identities=22% Similarity=0.293 Sum_probs=168.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEece------eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVS------KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.+.+|+++|++++|||||++++++...+ +.++||||+ +.+|..++. ...+++..+..++.||+.||+||
T Consensus 61 ~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~L 137 (346)
T d1cm8a_ 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYI 137 (346)
T ss_dssp HHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999999999997654 569999999 557777764 34689999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLL 663 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~ 663 (757)
|++ +|+||||||+|||++.++.+||+|||+++..... .+...||+.|+|||.+.+. .++.++||||+||+++
T Consensus 138 H~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 210 (346)
T d1cm8a_ 138 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 210 (346)
T ss_dssp HHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHH
T ss_pred HhC---CCcccccCcchhhcccccccccccccceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHH
Confidence 998 9999999999999999999999999999876543 2346789999999998764 5689999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHH-------HHhcC----------Cccccc--cccccCHHHHHHHHHHHHHccccC
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQ-------CFENG----------NLSQLV--EDEEVDEKQLERMIKVALWCILDE 724 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~-------~~~~~----------~~~~~~--d~~~~~~~~~~~l~~l~~~cl~~~ 724 (757)
||++|+.||......... ...... .+... ...... +...........+.+++.+||+.|
T Consensus 211 ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d 288 (346)
T d1cm8a_ 211 EMITGKTLFKGSDHLDQL--KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLD 288 (346)
T ss_dssp HHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSS
T ss_pred HHHHCcCCCCCCChHHHH--HHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCC
Confidence 999999999754321111 000000 00000 000000 000111222356789999999999
Q ss_pred CCCCCCHHHHHHH--hhcCcCCCC
Q 038168 725 PSLRPSMKKVLLM--LEGTVEIPI 746 (757)
Q Consensus 725 p~~RPsm~eVl~~--Le~~~~~~~ 746 (757)
|++|||+.|+++. ++.+.+...
T Consensus 289 P~~R~ta~eiL~Hp~f~~~~~~~~ 312 (346)
T d1cm8a_ 289 AEQRVTAGEALAHPYFESLHDTED 312 (346)
T ss_dssp TTTSCCHHHHHHSGGGTTTC----
T ss_pred hhHCcCHHHHhcChhhCcCCCccc
Confidence 9999999999985 666554433
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-34 Score=303.24 Aligned_cols=218 Identities=19% Similarity=0.276 Sum_probs=164.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe--------ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE--------VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGIL 582 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~ 582 (757)
.+.+.+|+++|++++|+|++++++.+.. ....++||||+.++.+..+. .....++......++.|++.||+
T Consensus 53 ~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~ 131 (318)
T d3blha1 53 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLY 131 (318)
T ss_dssp CHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHH
Confidence 4678899999999999999999998865 34578999999887776554 44567788889999999999999
Q ss_pred HhhhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc---eecccccCccccCcccccCC-CCCccccchhh
Q 038168 583 YLHDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR---TFTGIRGTRGYVAPEWHRNL-PITVKADVYSF 658 (757)
Q Consensus 583 yLH~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~ 658 (757)
|||++ +|+||||||+|||++.++.+||+|||+++.+...... ......||+.|+|||.+.+. .++.++||||+
T Consensus 132 ~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSl 208 (318)
T d3blha1 132 YIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 208 (318)
T ss_dssp HHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred HhccC---CEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccC
Confidence 99998 9999999999999999999999999999877643321 22335799999999998765 68999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCccccHHHHHHHHHhcCCccccc----c------------ccccCH-------HHHHHHHH
Q 038168 659 GVVLLEIICRRRCLDPNLPDDQVILEEWVYQCFENGNLSQLV----E------------DEEVDE-------KQLERMIK 715 (757)
Q Consensus 659 G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~----d------------~~~~~~-------~~~~~l~~ 715 (757)
||+++||++|+.||......... ....+.. +...... + ...... .....+.+
T Consensus 209 Gvil~el~~g~~pf~~~~~~~~~---~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 283 (318)
T d3blha1 209 GCIMAEMWTRSPIMQGNTEQHQL---ALISQLC--GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 283 (318)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHH---HHHHHHH--CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHH
T ss_pred CceeeeHhhCCCCCCCCCHHHHH---HHHHHhc--CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHH
Confidence 99999999999999754322111 1111111 1100000 0 000011 11245678
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 038168 716 VALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 716 l~~~cl~~~p~~RPsm~eVl~~ 737 (757)
++.+||+.||++|||++|+++.
T Consensus 284 Ll~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 284 LIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHCcCChhHCcCHHHHHcC
Confidence 9999999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-34 Score=304.34 Aligned_cols=222 Identities=23% Similarity=0.314 Sum_probs=167.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEece----eeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLEVS----KKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD 586 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 586 (757)
.+.+.+|+.+|++++||||+++++++.... ..+++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||+
T Consensus 50 ~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~ 127 (345)
T d1pmea_ 50 CQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS 127 (345)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 467899999999999999999999987543 34556677789999999964 368999999999999999999999
Q ss_pred CCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcc--eecccccCccccCcccccC-CCCCccccchhhHHHHH
Q 038168 587 ECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTR--TFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVLL 663 (757)
Q Consensus 587 ~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l~ 663 (757)
+ +|+||||||+||||++++.+||+|||+++........ ......||+.|+|||.+.. ..++.++||||+||+++
T Consensus 128 ~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ 204 (345)
T d1pmea_ 128 A---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA 204 (345)
T ss_dssp T---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHH
T ss_pred C---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceeh
Confidence 8 9999999999999999999999999999876543322 2334679999999999854 46789999999999999
Q ss_pred HHHhCCCCCCCCCCCccccHHHHHHHHHhcCCcc---------------cccccccc-----CHHHHHHHHHHHHHcccc
Q 038168 664 EIICRRRCLDPNLPDDQVILEEWVYQCFENGNLS---------------QLVEDEEV-----DEKQLERMIKVALWCILD 723 (757)
Q Consensus 664 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---------------~~~d~~~~-----~~~~~~~l~~l~~~cl~~ 723 (757)
||++|+.||......+.... ........... ........ ......++.+++.+||+.
T Consensus 205 eml~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 281 (345)
T d1pmea_ 205 EMLSNRPIFPGKHYLDQLNH---ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF 281 (345)
T ss_dssp HHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCS
T ss_pred HHhhCCCCCCCCCHHHHHHH---HhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccC
Confidence 99999999975432211111 00000000000 00000000 111224688999999999
Q ss_pred CCCCCCCHHHHHHH--hhc
Q 038168 724 EPSLRPSMKKVLLM--LEG 740 (757)
Q Consensus 724 ~p~~RPsm~eVl~~--Le~ 740 (757)
||++|||++|+++. |+.
T Consensus 282 dP~~R~ta~e~L~hpf~~~ 300 (345)
T d1pmea_ 282 NPHKRIEVEQALAHPYLEQ 300 (345)
T ss_dssp STTTSCCHHHHHTSGGGTT
T ss_pred ChhHCcCHHHHhcCHhhcc
Confidence 99999999999985 553
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-34 Score=306.06 Aligned_cols=211 Identities=22% Similarity=0.245 Sum_probs=171.3
Q ss_pred HHHHHHHHHHhhcCC-CceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 038168 512 REFQTEMKVIGRTHH-RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECET 590 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 590 (757)
+.+.+|++++++++| |||+++++++.+....++||||+.+|+|.+++... ..+.......++.||+.||+|||+.
T Consensus 73 ~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~--- 148 (322)
T d1vzoa_ 73 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKL--- 148 (322)
T ss_dssp GGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcC---
Confidence 567899999999966 89999999999999999999999999999998654 3456678888999999999999998
Q ss_pred CeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC--CCCccccchhhHHHHHHHHhC
Q 038168 591 QIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL--PITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 591 ~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+||||+.++.+||+|||+++.+............|++.|+|||.+.+. .++.++|||||||++|||++|
T Consensus 149 ~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG 228 (322)
T d1vzoa_ 149 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228 (322)
T ss_dssp TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHS
T ss_pred CEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhC
Confidence 999999999999999999999999999988765555445557899999999998765 478899999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcCCccccccccccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENGNLSQLVEDEEVDEKQLERMIKVALWCILDEPSLRPS-----MKKVLL 736 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----m~eVl~ 736 (757)
+.||......+.. .. +.......... .+.....++.+++.+||+.||++||| ++|+++
T Consensus 229 ~~PF~~~~~~~~~--~~-i~~~~~~~~~~-------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 229 ASPFTVDGEKNSQ--AE-ISRRILKSEPP-------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp SCTTSCTTSCCCH--HH-HHHHHHHCCCC-------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCCCCCCHHHHH--HH-HHHhcccCCCC-------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 9999765443321 11 22222222111 12234567899999999999999994 788876
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-34 Score=308.78 Aligned_cols=217 Identities=23% Similarity=0.253 Sum_probs=162.3
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEEec------eeeeEEEEeccCCChhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 513 EFQTEMKVIGRTHHRNLVRLLGYSLEV------SKKILVYEYMSNGSLADILF--NPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lV~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.+|+++|++++|+|||++++++... ...+|||||++++.+..+.. .....+++.++..++.||+.||+||
T Consensus 59 ~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL 138 (350)
T d1q5ka_ 59 FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138 (350)
T ss_dssp SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 345899999999999999999998543 24689999998765444332 2356789999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCC-cEEEeecCCccccCCCCcceecccccCccccCcccccC-CCCCccccchhhHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENR-CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRN-LPITVKADVYSFGVVL 662 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~-~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~G~~l 662 (757)
|++ +|+||||||+||||+.++ .+||+|||+++.+..... .....||..|+|||.+.+ ..++.++||||+||++
T Consensus 139 H~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il 213 (350)
T d1q5ka_ 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213 (350)
T ss_dssp HTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred Hhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEE
Confidence 998 999999999999999775 899999999987755432 233578999999998765 5789999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccHHHHHH----------HHHh----cCCccccccc---cccCHHHHHHHHHHHHHccccCC
Q 038168 663 LEIICRRRCLDPNLPDDQVILEEWVY----------QCFE----NGNLSQLVED---EEVDEKQLERMIKVALWCILDEP 725 (757)
Q Consensus 663 ~elltG~~p~~~~~~~~~~~l~~~~~----------~~~~----~~~~~~~~d~---~~~~~~~~~~l~~l~~~cl~~~p 725 (757)
+||++|+.||......+. +..... .... ...+...... .........++.+++.+||+.||
T Consensus 214 ~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 291 (350)
T d1q5ka_ 214 AELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291 (350)
T ss_dssp HHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSG
T ss_pred EehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCCh
Confidence 999999999975432211 111100 0000 0011110000 01112234568899999999999
Q ss_pred CCCCCHHHHHH
Q 038168 726 SLRPSMKKVLL 736 (757)
Q Consensus 726 ~~RPsm~eVl~ 736 (757)
++|||+.|+++
T Consensus 292 ~~R~ta~e~L~ 302 (350)
T d1q5ka_ 292 TARLTPLEACA 302 (350)
T ss_dssp GGSCCHHHHHT
T ss_pred hHCcCHHHHhc
Confidence 99999999996
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-33 Score=290.51 Aligned_cols=220 Identities=20% Similarity=0.212 Sum_probs=171.3
Q ss_pred hHHHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 038168 510 GEREFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECE 589 (757)
Q Consensus 510 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 589 (757)
..+.+.+|+.++++++|+|||++++++.+.+..++|+|++.+++|..++.. ...+++..+..++.|++.||+|||++
T Consensus 44 ~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~-- 120 (292)
T d1unla_ 44 VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR-- 120 (292)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcC--
Confidence 357899999999999999999999999999999999999999999888754 56678899999999999999999998
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCC-CCccccchhhHHHHHHHHhC
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP-ITVKADVYSFGVVLLEIICR 668 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~G~~l~elltG 668 (757)
+|+||||||+|||++.++.+||+|||.++....... ......++..|+|||.+.... ++.++||||+||+++||++|
T Consensus 121 -~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g 198 (292)
T d1unla_ 121 -NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198 (292)
T ss_dssp -TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTT
T ss_pred -CEeeecccCcccccccCCceeeeecchhhcccCCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhC
Confidence 999999999999999999999999999998754432 223345788899999887665 68999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHhcC---Ccc---cccc------------ccccCHHHHHHHHHHHHHccccCCCCCCC
Q 038168 669 RRCLDPNLPDDQVILEEWVYQCFENG---NLS---QLVE------------DEEVDEKQLERMIKVALWCILDEPSLRPS 730 (757)
Q Consensus 669 ~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~---~~~d------------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 730 (757)
+.|+.......+ ....+....... ... ...+ ...........+.+++.+||+.||++|||
T Consensus 199 ~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s 276 (292)
T d1unla_ 199 GRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276 (292)
T ss_dssp SCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcC
Confidence 999754332211 111111111110 000 0000 00112233456888999999999999999
Q ss_pred HHHHHH
Q 038168 731 MKKVLL 736 (757)
Q Consensus 731 m~eVl~ 736 (757)
++||++
T Consensus 277 a~e~L~ 282 (292)
T d1unla_ 277 AEEALQ 282 (292)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.98 E-value=1.4e-32 Score=292.69 Aligned_cols=217 Identities=17% Similarity=0.295 Sum_probs=164.9
Q ss_pred HHHHHHHHHHHhhcC-CCceeeeeeEEEec--eeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 038168 511 EREFQTEMKVIGRTH-HRNLVRLLGYSLEV--SKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDE 587 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 587 (757)
.+++.+|+++|++++ ||||+++++++... ...++||||+++++|..+. +.++..++..++.||+.||+|||++
T Consensus 73 ~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~ 148 (328)
T d3bqca1 73 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSM 148 (328)
T ss_dssp HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 478999999999995 99999999998743 4689999999999998764 3588999999999999999999999
Q ss_pred CCCCeeeCCCCcceEEECCCC-cEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHHH
Q 038168 588 CETQIIHCDIKPQNILMDENR-CAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLEI 665 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~-~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~el 665 (757)
+|+||||||+|||++.++ .+||+|||+++....... .....+|..|+|||.+.+. .++.++||||+||+++||
T Consensus 149 ---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~ 223 (328)
T d3bqca1 149 ---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 223 (328)
T ss_dssp ---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred ---ccccccccccceEEcCCCCeeeecccccceeccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHh
Confidence 999999999999998654 699999999987765432 2345789999999998765 479999999999999999
Q ss_pred HhCCCCCCCCCCCccccHH--H-----HHHHHHhcCCcc------ccccc-----------cccCHHHHHHHHHHHHHcc
Q 038168 666 ICRRRCLDPNLPDDQVILE--E-----WVYQCFENGNLS------QLVED-----------EEVDEKQLERMIKVALWCI 721 (757)
Q Consensus 666 ltG~~p~~~~~~~~~~~l~--~-----~~~~~~~~~~~~------~~~d~-----------~~~~~~~~~~l~~l~~~cl 721 (757)
++|+.||............ . ............ ..... .........++.+++.+||
T Consensus 224 ~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL 303 (328)
T d3bqca1 224 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303 (328)
T ss_dssp HHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHS
T ss_pred ccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHc
Confidence 9999998765432211000 0 000001100000 00000 0001122356889999999
Q ss_pred ccCCCCCCCHHHHHH
Q 038168 722 LDEPSLRPSMKKVLL 736 (757)
Q Consensus 722 ~~~p~~RPsm~eVl~ 736 (757)
+.||++|||++|+++
T Consensus 304 ~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 304 RYDHQSRLTAREAME 318 (328)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred cCChhHCcCHHHHhc
Confidence 999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-32 Score=293.09 Aligned_cols=220 Identities=20% Similarity=0.263 Sum_probs=163.3
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe-----ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE-----VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLH 585 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 585 (757)
.+.+.+|+++|++++|+|+|++++++.. ....++|+||+.+|+|.+++.. +.++..++..++.||+.||+|||
T Consensus 61 ~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH 138 (348)
T d2gfsa1 61 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH 138 (348)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHH
Confidence 4678899999999999999999999863 3345777888899999999954 46899999999999999999999
Q ss_pred hCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCC-CCCccccchhhHHHHHH
Q 038168 586 DECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNL-PITVKADVYSFGVVLLE 664 (757)
Q Consensus 586 ~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~G~~l~e 664 (757)
++ +|+||||||+|||++.++.+|++|||++..... ......|+..|+|||...+. .++.++||||+||+++|
T Consensus 139 ~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ 211 (348)
T d2gfsa1 139 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211 (348)
T ss_dssp HT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHH
T ss_pred hC---CCcccccCCccccccccccccccccchhcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHH
Confidence 98 999999999999999999999999999976432 23346789999999987765 46899999999999999
Q ss_pred HHhCCCCCCCCCCCccccHHHHHHHHHhcCCc---------------ccccccccc-----CHHHHHHHHHHHHHccccC
Q 038168 665 IICRRRCLDPNLPDDQVILEEWVYQCFENGNL---------------SQLVEDEEV-----DEKQLERMIKVALWCILDE 724 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---------------~~~~d~~~~-----~~~~~~~l~~l~~~cl~~~ 724 (757)
|++|+.||....... ....+......... ......... .......+.+++.+||+.|
T Consensus 212 ll~g~~pF~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d 288 (348)
T d2gfsa1 212 LLTGRTLFPGTDHID---QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 288 (348)
T ss_dssp HHHSSCSCCCSSHHH---HHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSS
T ss_pred HHhCCCCCCCCCHHH---HHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCC
Confidence 999999997543211 11111111000000 000000000 0112356789999999999
Q ss_pred CCCCCCHHHHHH--HhhcCc
Q 038168 725 PSLRPSMKKVLL--MLEGTV 742 (757)
Q Consensus 725 p~~RPsm~eVl~--~Le~~~ 742 (757)
|++|||+.|+++ .+....
T Consensus 289 P~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 289 SDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp GGGSCCHHHHHTSGGGTTTC
T ss_pred hhhCcCHHHHhcCHhhCCCC
Confidence 999999999998 455443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.1e-32 Score=292.13 Aligned_cols=218 Identities=23% Similarity=0.255 Sum_probs=158.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeeEEEe------ceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038168 511 EREFQTEMKVIGRTHHRNLVRLLGYSLE------VSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYL 584 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 584 (757)
.+.+.+|+.++++++|||||++++++.. ....|+||||+.++.+. .+. ..+++..+..++.||+.||+||
T Consensus 60 ~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~-~~~---~~~~~~~i~~~~~qil~gl~~L 135 (355)
T d2b1pa1 60 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ-VIQ---MELDHERMSYLLYQMLCGIKHL 135 (355)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHH-HHT---SCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHH-hhh---cCCCHHHHHHHHHHHHHHHHHh
Confidence 3568899999999999999999999863 36789999999765554 442 3578999999999999999999
Q ss_pred hhCCCCCeeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHHH
Q 038168 585 HDECETQIIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLLE 664 (757)
Q Consensus 585 H~~~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~e 664 (757)
|+. +|+||||||+|||++.++.+|++|||+++...... ......+|+.|+|||++.+..+++++||||+||+++|
T Consensus 136 H~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~e 210 (355)
T d2b1pa1 136 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210 (355)
T ss_dssp HHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred hhc---ccccccCCccccccccccceeeechhhhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHH
Confidence 999 99999999999999999999999999998765432 2334578999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCccccHH----------------HHHHHHHhcCC-cc-----cccc----c--cccCHHHHHHHHHH
Q 038168 665 IICRRRCLDPNLPDDQVILE----------------EWVYQCFENGN-LS-----QLVE----D--EEVDEKQLERMIKV 716 (757)
Q Consensus 665 lltG~~p~~~~~~~~~~~l~----------------~~~~~~~~~~~-~~-----~~~d----~--~~~~~~~~~~l~~l 716 (757)
|++|+.||............ ........... .. .... + ..........+.++
T Consensus 211 ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl 290 (355)
T d2b1pa1 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290 (355)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred HhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHH
Confidence 99999998654221100000 00000011100 00 0000 0 01123446778999
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 038168 717 ALWCILDEPSLRPSMKKVLLM 737 (757)
Q Consensus 717 ~~~cl~~~p~~RPsm~eVl~~ 737 (757)
+.+||+.||++|||++||++.
T Consensus 291 l~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 291 LSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHCcCChhHCcCHHHHhcC
Confidence 999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.95 E-value=1.4e-28 Score=265.31 Aligned_cols=235 Identities=21% Similarity=0.271 Sum_probs=165.3
Q ss_pred HHHHHHHHHHHhhcC-----------CCceeeeeeEEEece--eeeEEEEeccCCChhh--hhcCCCCCCCHHHHHHHHH
Q 038168 511 EREFQTEMKVIGRTH-----------HRNLVRLLGYSLEVS--KKILVYEYMSNGSLAD--ILFNPEKQPNWVERMGIAR 575 (757)
Q Consensus 511 ~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~--~l~~~~~~l~~~~~~~i~~ 575 (757)
.+.+.+|++++++++ |+|||++++++.... ..+++++++..+.... ........+....+..++.
T Consensus 53 ~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~ 132 (362)
T d1q8ya_ 53 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132 (362)
T ss_dssp HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHH
Confidence 366788999998885 578999999886543 4566666665544322 2233456778889999999
Q ss_pred HHHHHHHHhhh-CCCCCeeeCCCCcceEEECCCCc------EEEeecCCccccCCCCcceecccccCccccCcccccCCC
Q 038168 576 DIARGILYLHD-ECETQIIHCDIKPQNILMDENRC------AKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLP 648 (757)
Q Consensus 576 ~ia~gL~yLH~-~~~~~iiH~Dik~~Nill~~~~~------~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 648 (757)
||+.||+|||+ . +|+||||||+||||+.++. +|++|||.+...... .....||+.|+|||.+.+..
T Consensus 133 qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~ 205 (362)
T d1q8ya_ 133 QLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAP 205 (362)
T ss_dssp HHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCC
T ss_pred HHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccceeeEeecccccccccc----cccccccccccChhhccccC
Confidence 99999999998 5 8999999999999986653 999999999865432 23456899999999999999
Q ss_pred CCccccchhhHHHHHHHHhCCCCCCCCCCCccccHHHHHHHHH-hcCC--------------------ccccc-------
Q 038168 649 ITVKADVYSFGVVLLEIICRRRCLDPNLPDDQVILEEWVYQCF-ENGN--------------------LSQLV------- 700 (757)
Q Consensus 649 ~~~k~Dv~S~G~~l~elltG~~p~~~~~~~~~~~l~~~~~~~~-~~~~--------------------~~~~~------- 700 (757)
++.++||||+||+++||++|+.||................... .-|. .....
T Consensus 206 ~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
T d1q8ya_ 206 WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 285 (362)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC
T ss_pred CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCc
Confidence 9999999999999999999999987644322111111111100 0000 00000
Q ss_pred ------cccccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhc---CcCCCCCCCCCC
Q 038168 701 ------EDEEVDEKQLERMIKVALWCILDEPSLRPSMKKVLLM--LEG---TVEIPIPPNPTS 752 (757)
Q Consensus 701 ------d~~~~~~~~~~~l~~l~~~cl~~~p~~RPsm~eVl~~--Le~---~~~~~~p~~p~~ 752 (757)
...........++.+++.+||+.||++|||++|+++. +++ ..+++.|+.|.+
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 286 LEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 348 (362)
T ss_dssp HHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTTCCCTTSCTT
T ss_pred hhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCCcccCCCCCcccC
Confidence 0011245667889999999999999999999999984 543 345566665543
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.80 E-value=1.1e-19 Score=159.58 Aligned_cols=111 Identities=18% Similarity=0.348 Sum_probs=90.9
Q ss_pred cCcccCCCceeccCCCeeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCEEE
Q 038168 30 RSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVL 109 (757)
Q Consensus 30 ~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~Lvl 109 (757)
+|||.+||.|.+ +++|+ +|.|+|+|+..|+ |.+++. .++||.||++.| ..++.|.|..||+|+|
T Consensus 1 tDtL~~gq~L~~--g~~l~--~g~~~l~~q~DGN------Lvly~~----~~~vW~s~~~~~--~~~~~l~l~~dGnLvl 64 (112)
T d1xd5a_ 1 SDRLNSGHQLDT--GGSLA--EGGYLFIIQNDCN------LVLYDN----NRAVWASGTNGK--ASGCVLKMQNDGNLVI 64 (112)
T ss_dssp CCEEETTEEECT--TCEEE--ETTEEEEECTTSC------EEEEET----TEEEEECCCTTS--CSSEEEEECTTSCEEE
T ss_pred CCEecCCCEecC--CCEEE--ECCEEEEEcCCCC------EEEEcC----CcEEEEccCccC--CCCcEEEEeccccEEE
Confidence 489999999986 55787 4999999998876 667653 589999999887 4457899999999999
Q ss_pred ecCCCCceeEEecCCC-cceeEEEecCCCEEEEecCCceeeeccCCCcc
Q 038168 110 RSSQQSQDSLIADDSQ-SASSASMLDSGNFVLYDSNGKTLWQTFEHPTD 157 (757)
Q Consensus 110 ~~~~~~~~~~~~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTD 157 (757)
.+.+ ..+||+.+... +..+|+|+|+|||||++.+++++|||+.+|+|
T Consensus 65 ~~~~-~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 65 YSGS-RAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp EETT-EEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred EecC-CeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 9875 55555554443 34689999999999999999999999999986
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.71 E-value=7e-18 Score=148.86 Aligned_cols=102 Identities=14% Similarity=0.245 Sum_probs=84.6
Q ss_pred EEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCEEEecCCCCceeEEecCCC-cceeEEEecCCCEEEEecCCceee
Q 038168 71 GVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADDSQ-SASSASMLDSGNFVLYDSNGKTLW 149 (757)
Q Consensus 71 gIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~Lvl~~~~~~~~~~~~~~~~-~~~~a~LldsGNlVl~~~~~~~lW 149 (757)
-|||.++++++.+|++|++.|+.....+|.+..||+|||.+.+ ...|++.+... ....|+|+|+|||||+|.++.++|
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~~-~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRD-DRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBTT-BCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecCC-cEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 4999999999999999999999888889999999999999876 33343333332 347899999999999999999999
Q ss_pred eccCCCccccCCCCcccCCCcccccCCCCCCCCCceEEEecCCCCceee
Q 038168 150 QTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQY 198 (757)
Q Consensus 150 QSFD~PTDTlLpg~kl~~~~~L~S~~s~~dps~G~fs~~~~~~g~~~~~ 198 (757)
|||. +.++|.|.+.+|+||++++|
T Consensus 90 ~S~t-------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 90 TSGN-------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp ECCC-------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EeCC-------------------------CCCCCcEEEEECCCCcEEEe
Confidence 9973 34578899999999999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.69 E-value=7.9e-17 Score=139.68 Aligned_cols=106 Identities=20% Similarity=0.334 Sum_probs=83.1
Q ss_pred cCcccCCCceeccCCCeeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCEEE
Q 038168 30 RSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVL 109 (757)
Q Consensus 30 ~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~Lvl 109 (757)
+|+|.+||.|.+ +++|+ +|.|.|+|...++ |.++. ..++||+||++.|. ...+.|.|++||+|||
T Consensus 1 ~~~L~~g~~L~~--g~~l~--~g~~~l~~q~dgn------Lvl~~----~~~~vW~ant~~~~-~~~~~l~l~~dGnLvl 65 (109)
T d1kj1a_ 1 RNLLTNGEGLYA--GQSLD--VEPYHFIMQEDCN------LVLYD----HSTSVWASNTGILG-KKGCKAVLQSDGNFVV 65 (109)
T ss_dssp CCEEETTCEEET--TCEEE--ETTEEEEECTTSC------EEEEE----TTEEEEECCCCCTT-CCCCEEEECTTSCEEE
T ss_pred CCCccCCCEEeC--CCEEE--eCCEEEEecCCCe------EEEEe----CCEEEEEeCCCCCC-ceeEEEEEcCCceEEE
Confidence 378999999986 44675 5899999987766 55654 35899999999985 4567899999999999
Q ss_pred ecCCCCceeEEecCC--CcceeEEEecCCCEEEEecCCceeeeccCC
Q 038168 110 RSSQQSQDSLIADDS--QSASSASMLDSGNFVLYDSNGKTLWQTFEH 154 (757)
Q Consensus 110 ~~~~~~~~~~~~~~~--~~~~~a~LldsGNlVl~~~~~~~lWQSFD~ 154 (757)
.+.++ ..+|+++++ ....+|+|+|+|||||+++ .+|||+-|
T Consensus 66 ~~~~g-~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~ 108 (109)
T d1kj1a_ 66 YDAEG-RSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY 108 (109)
T ss_dssp ECSSS-CEEEECCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred EeCCC-cEEEEEeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence 99874 445655443 2346799999999999964 69999865
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.69 E-value=6.2e-17 Score=140.31 Aligned_cols=104 Identities=17% Similarity=0.321 Sum_probs=82.9
Q ss_pred CcccCCCceeccCCCeeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCEEEe
Q 038168 31 SNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVLR 110 (757)
Q Consensus 31 ~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~Lvl~ 110 (757)
|+|.+||+|.+ +++|+ +|.|.|+|+..|+ |.||.. .++||.||++.| +..+.|.+..+|+|+|.
T Consensus 2 ~~L~~g~~L~~--G~~l~--ng~~~l~~q~DGN------Lvly~~----~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~ 65 (108)
T d1jpca_ 2 NILYSGETLST--GEFLN--YGSFVFIMQEDCN------LVLYDV----DKPIWATNTGGL--SRSCFLSMQTDGNLVVY 65 (108)
T ss_dssp CEEETTEEECT--TCEEE--ETTEEEEECTTSC------EEEEET----TEEEEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred CCccCCCEecC--CCEEE--cCCEEEEECCCCe------EEEEeC----CceeeEeCCCCC--CCccEEEEeccceEEEE
Confidence 78899999975 44674 6999999998887 777753 578999999887 55678999999999999
Q ss_pred cCCCCceeEEecCCCc--ceeEEEecCCCEEEEecCCceeeeccCC
Q 038168 111 SSQQSQDSLIADDSQS--ASSASMLDSGNFVLYDSNGKTLWQTFEH 154 (757)
Q Consensus 111 ~~~~~~~~~~~~~~~~--~~~a~LldsGNlVl~~~~~~~lWQSFD~ 154 (757)
++++. .+|++++... ..+|+|+|+|||||++. .+||||+|
T Consensus 66 ~~~g~-~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 66 NPSNK-PIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp CTTCC-EEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred CCCcc-ceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 98844 5555543322 35789999999999964 59999987
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.57 E-value=7.1e-16 Score=134.34 Aligned_cols=110 Identities=17% Similarity=0.284 Sum_probs=92.0
Q ss_pred EEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCEEEecCCCCceeEEecC-CCcceeEEEecCCCEEEEecCCceeee
Q 038168 72 VFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVLRSSQQSQDSLIADD-SQSASSASMLDSGNFVLYDSNGKTLWQ 150 (757)
Q Consensus 72 Iw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~Lvl~~~~~~~~~~~~~~-~~~~~~a~LldsGNlVl~~~~~~~lWQ 150 (757)
|||.-.++.+..|..+.+.++.+...+|.+..||+|||.+++ ...|++++ ...+..+.|+|+|||||+|.++.++||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~~--~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWs 80 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSD--VRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWS 80 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEESS--SEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcCC--eeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEE
Confidence 788877888999999999999888889999999999999864 34455543 345688999999999999999999999
Q ss_pred ccCCCccccCCCCcccCCCcccccCCCCCCCCCceEEEecCCCCceeeeccCCCCccceEeecccc
Q 038168 151 TFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTY 216 (757)
Q Consensus 151 SFD~PTDTlLpg~kl~~~~~L~S~~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~ 216 (757)
|+- +.++|.|.+.||+||++++|- .++|.+++-
T Consensus 81 S~t-------------------------~~~~g~y~l~Lq~DGNlvlY~--------~~~Wssgt~ 113 (115)
T d1dlpa1 81 SGT-------------------------KGSIGNYVLVLQPDRTVTIYG--------PGLWDSGTS 113 (115)
T ss_dssp CCC-------------------------CCCSSCCEEEECSSSCEEEEC--------SEEEECSCC
T ss_pred cCC-------------------------CCCCCCEEEEECCCCcEEEeC--------CCeecCCCC
Confidence 863 356899999999999999872 379988764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.55 E-value=1.5e-15 Score=146.71 Aligned_cols=132 Identities=14% Similarity=0.143 Sum_probs=93.6
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 038168 512 REFQTEMKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDECETQ 591 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 591 (757)
....+|...+.++.|.++++.+++. ..++||||+++..+.++. ......++.|++++|+|||++ +
T Consensus 59 ~~~~~e~~~l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~l~--------~~~~~~i~~ql~~~l~~lH~~---g 123 (191)
T d1zara2 59 RSARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYRVR--------VENPDEVLDMILEEVAKFYHR---G 123 (191)
T ss_dssp HHHHHHHHHHHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGGCC--------CSCHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHHccCCCcceEEEec----CCEEEEEeeccccccchh--------hHHHHHHHHHHHHHHHHHhhC---C
Confidence 4556789999999999999887653 347999999987665432 233457899999999999998 9
Q ss_pred eeeCCCCcceEEECCCCcEEEeecCCccccCCCCcceecccccCccccCcccccCCCCCccccchhhHHHHH
Q 038168 592 IIHCDIKPQNILMDENRCAKISDFGLAKLMKPDQTRTFTGIRGTRGYVAPEWHRNLPITVKADVYSFGVVLL 663 (757)
Q Consensus 592 iiH~Dik~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G~~l~ 663 (757)
|+||||||+|||++++ .++|+|||+|............. ..... -.|. ....++.++|+||..--++
T Consensus 124 iiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~--rd~~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 124 IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILE--RDVRN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp EECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHH--HHHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred EEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHHH--HHHHH-HHHH-HcCCCCCcccHHHHHHHHh
Confidence 9999999999999965 48999999998765332211000 00000 0011 1356788999999865443
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.40 E-value=7.5e-13 Score=115.74 Aligned_cols=102 Identities=15% Similarity=0.284 Sum_probs=78.6
Q ss_pred cCcccCCCceeccCCCeeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCEEE
Q 038168 30 RSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVL 109 (757)
Q Consensus 30 ~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~Lvl 109 (757)
.++|.+||+|. ..+.+|.|.|.|...|+ |-++ . ..++||.||+..| +....|.|..||+|+|
T Consensus 14 ~~~l~~~q~l~------~~~~~~~y~l~mQ~DGN------LVLy-~---~~~~vWssnt~~~--~~~~~l~l~~dGnLvL 75 (119)
T d1b2pa_ 14 PQILHATESLE------ILFGTHVYRFIMQTDCN------LVLY-D---NNNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp CCEEETTCEEE------EEETTEEEEEEECTTSC------EEEE-E---TTEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred CCEEeCCCeEE------EecCCceEEEEECCCCc------EEEE-E---CCeEEEEecCCCC--CcceEEEEEeCCCEEE
Confidence 36788888774 56889999999998887 5554 2 3679999999776 4457899999999999
Q ss_pred ecCCCCceeEEecCCC-c-ceeEEEecCCCEEEEecCCceeeeccC
Q 038168 110 RSSQQSQDSLIADDSQ-S-ASSASMLDSGNFVLYDSNGKTLWQTFE 153 (757)
Q Consensus 110 ~~~~~~~~~~~~~~~~-~-~~~a~LldsGNlVl~~~~~~~lWQSFD 153 (757)
.+.++. .+|++++.. . ..+++|+|+|||||++ ..+|||-.
T Consensus 76 ~d~~g~-~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 76 ITNENV-TVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp ECTTCC-EEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred ECCCCc-EEEECCCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence 998854 455554432 2 3578999999999985 47999954
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.17 E-value=2.3e-11 Score=106.48 Aligned_cols=111 Identities=23% Similarity=0.416 Sum_probs=79.3
Q ss_pred CCEEEEecCCceee--eccCCCccccCCCCcccCCCcccccCCCCCCCCCceEEEecCCCCceeeeccCCCCccceEeec
Q 038168 136 GNFVLYDSNGKTLW--QTFEHPTDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWAS 213 (757)
Q Consensus 136 GNlVl~~~~~~~lW--QSFD~PTDTlLpg~kl~~~~~L~S~~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~ 213 (757)
||+|+++..+.++| +|+|.|++||.++|.|. .|.|.|.++.||+++++.. ...||.+
T Consensus 1 g~~v~~~~~n~il~~~~~~~~~~~~l~~~q~l~---------------~g~y~L~~q~DGNLvL~~~------~~~vW~s 59 (120)
T d1dlpa2 1 GSVVVANNGNSILYSTQGNDNHPQTLHATQSLQ---------------LSPYRLSMETDCNLVLFDR------DDRVWST 59 (120)
T ss_dssp SCCCCSSCCCEECCCC--CCCCCCEECSSCCCB---------------CSSCEEEEETTTEEEEEBT------TBCCSCC
T ss_pred CcEEEEeCCCeEEEcCCCCCCcccEEcCCCeeE---------------cCCEEEEEcCCCcEEEecC------CcEEEEE
Confidence 44444444444555 68899999999999984 5789999999999998743 2478888
Q ss_pred cccCCCCccccccCCCccEEEecccceeeeeecCCCCCCCceEEEEEEccCccEEEE
Q 038168 214 NTYNKGDNVSLNLDENGHLFLMNTTGVNIFNLTGGENPTKGMIYLMKIDSDGIFRLY 270 (757)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~lr~y 270 (757)
.....+....+.++.+|.+.+.+..+......... .....++++|++||+|++|
T Consensus 60 ~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~---~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 60 NTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNS---RSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp CCCSSCSSCEEEEETTTEEEEEETTTEEEEECCCC---CSSSCCEEEECSSSCEEEE
T ss_pred ccccCCCcEEEEEeCCeeEEEEcCCCCEEEEeCCC---CCCCcEEEEECCCCcEEEe
Confidence 76655555667888999998887766554433221 1222468999999999998
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.08 E-value=1.9e-10 Score=99.57 Aligned_cols=111 Identities=25% Similarity=0.449 Sum_probs=83.2
Q ss_pred ccccCCCCcccCCCcccccCCCCCCCCCceEEEecCCCCceeeeccCCCCccceEeeccccCCCCccccccCCCccEEEe
Q 038168 156 TDTLLPNQRLSVGTKLFPGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTYNKGDNVSLNLDENGHLFLM 235 (757)
Q Consensus 156 TDTlLpg~kl~~~~~L~S~~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~ 235 (757)
||||+|||.|..+..|+ .|+|.|.+|.||++++|.. ..++|.++.........+.++.+|.+++.
T Consensus 1 tDtL~~gq~L~~g~~l~---------~g~~~l~~q~DGNLvly~~------~~~vW~s~~~~~~~~~~l~l~~dGnLvl~ 65 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLA---------EGGYLFIIQNDCNLVLYDN------NRAVWASGTNGKASGCVLKMQNDGNLVIY 65 (112)
T ss_dssp CCEEETTEEECTTCEEE---------ETTEEEEECTTSCEEEEET------TEEEEECCCTTSCSSEEEEECTTSCEEEE
T ss_pred CCEecCCCEecCCCEEE---------ECCEEEEEcCCCCEEEEcC------CcEEEEccCccCCCCcEEEEeccccEEEE
Confidence 89999999999999996 4999999999999998753 25899888776555667889999999887
Q ss_pred cccceeeeeecCCCCCCCceEEEEEEccCccEEEEEEeccCCCCceEEEeecCCCCC
Q 038168 236 NTTGVNIFNLTGGENPTKGMIYLMKIDSDGIFRLYSYNLRRQNSTWQVVWESTSDRC 292 (757)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~lr~y~~~~~~~~~~W~~~~~~p~d~C 292 (757)
+.....+... .......++++|+.||+|++|.- .....|+...+.|
T Consensus 66 ~~~~~~w~s~----t~~~~~~~~l~L~ddGNlvly~~-------~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 66 SGSRAIWASN----TNRQNGNYYLILQRDRNVVIYDN-------SNNAIWATHTNVG 111 (112)
T ss_dssp ETTEEEEECC----CCCSCCCCEEEECTTSCEEEECT-------TSCEEEECCCCCC
T ss_pred ecCCeEEEEe----eccCCCceEEEEcCCCCEEEECC-------CCcEEecCCCccC
Confidence 6544332211 12223356899999999999841 2346788777655
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.02 E-value=2.9e-10 Score=98.23 Aligned_cols=96 Identities=17% Similarity=0.318 Sum_probs=71.6
Q ss_pred cCcccCCCceeccCCCeeeeCCCeEEEEEEeCCCCCCcEEEEEEecCCCCCeEEEEecCCCCCCCCCceeEeccCCCEEE
Q 038168 30 RSNISIGSSLSPIGNSSWRSPSGLYAFGFYPQSNVSGRYYVGVFLAGIPEKTVVWTANRDDPPVSTNATLLFNSEGSIVL 109 (757)
Q Consensus 30 ~~~i~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~~ylgIw~~~i~~~tvVWvANr~~P~~~~~~~l~~~~~G~Lvl 109 (757)
.+||.+||+|. +|.|.|.|...|+ |.++. ..++||.+|... ...+.+.+..+|+|||
T Consensus 14 ~~tl~~~~~l~----------~g~~~l~~q~DGN------LvL~~----~~~~vW~s~t~~---~~~~~l~l~~dGNLvl 70 (115)
T d1dlpa1 14 PQTLHAAQSLE----------LSSFRFTMQSDCN------LVLFD----SDVRVWASNTAG---ATGCRAVLQSDGLLVI 70 (115)
T ss_dssp CSCCCTTCEEC----------STTEEEEECTTSC------EEEEE----SSSEEECCCCCS---CSCCBCCBCSSSCBCC
T ss_pred cceecCCCcEE----------cCCEEEEECCCCe------EEEEc----CCeeEEEcccCC---CCceEEEEeccCCEEE
Confidence 36677777763 5789999998887 66764 246899998643 3467899999999999
Q ss_pred ecCCCCceeEEecCC--CcceeEEEecCCCEEEEecCCceeeecc
Q 038168 110 RSSQQSQDSLIADDS--QSASSASMLDSGNFVLYDSNGKTLWQTF 152 (757)
Q Consensus 110 ~~~~~~~~~~~~~~~--~~~~~a~LldsGNlVl~~~~~~~lWQSF 152 (757)
.+..+.. +|++.+. ....+++|+++|||||++ ..+|+|-
T Consensus 71 ~d~~~~~-vWsS~t~~~~g~y~l~Lq~DGNlvlY~---~~~Wssg 111 (115)
T d1dlpa1 71 LTAQNTI-RWSSGTKGSIGNYVLVLQPDRTVTIYG---PGLWDSG 111 (115)
T ss_dssp BCTTTCC-SCCCCCCCCSSCCEEEECSSSCEEEEC---SEEEECS
T ss_pred EccCCCE-EEEcCCCCCCCCEEEEECCCCcEEEeC---CCeecCC
Confidence 9887544 4544433 233579999999999995 4799984
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.94 E-value=1.5e-09 Score=94.41 Aligned_cols=84 Identities=23% Similarity=0.476 Sum_probs=64.0
Q ss_pred eeEeccCCCEEEecCCCCceeEEecCCC--cceeEEEecCCCEEEEecCCceeeeccCCCccccCCCCcccCCCcccccC
Q 038168 98 TLLFNSEGSIVLRSSQQSQDSLIADDSQ--SASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFPGI 175 (757)
Q Consensus 98 ~l~~~~~G~Lvl~~~~~~~~~~~~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg~kl~~~~~L~S~~ 175 (757)
.|.+..||||||.+++ . ..|++++.. ..+.++|.++|||||.|.++.++|+|. |
T Consensus 33 ~l~mQ~DGNLVLy~~~-~-~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~---t------------------- 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDNN-N-PIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP---V------------------- 88 (119)
T ss_dssp EEEECTTSCEEEEETT-E-EEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS---C-------------------
T ss_pred EEEECCCCcEEEEECC-e-EEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECC---C-------------------
Confidence 5778899999999875 3 344444332 247899999999999999999999872 1
Q ss_pred CCCCCCCCceEEEecCCCCceeeeccCCCCccceEeecccc
Q 038168 176 SETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTY 216 (757)
Q Consensus 176 s~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~ 216 (757)
.-+.|.|.+.||+||++++|- .+.|.+++.
T Consensus 89 ---~~~~~~~~l~Lq~DGNlvlYg--------~~~W~S~T~ 118 (119)
T d1b2pa_ 89 ---AGKAGHYVLVLQPDRNVVIYG--------DALWATQTV 118 (119)
T ss_dssp ---CCCSSCEEEEECTTSCEEEEE--------SEEEECCCC
T ss_pred ---cCCCCceEEEEcCCCCEEEEC--------CCEeccCCc
Confidence 123578899999999999872 368988764
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.80 E-value=7e-09 Score=88.72 Aligned_cols=85 Identities=25% Similarity=0.500 Sum_probs=63.8
Q ss_pred CceeEeccCCCEEEecCCCCceeEEecCCCc--ceeEEEecCCCEEEEecCCceeeeccCCCccccCCCCcccCCCcccc
Q 038168 96 NATLLFNSEGSIVLRSSQQSQDSLIADDSQS--ASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLFP 173 (757)
Q Consensus 96 ~~~l~~~~~G~Lvl~~~~~~~~~~~~~~~~~--~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg~kl~~~~~L~S 173 (757)
.-+|.+..||||||.+.+ ..+|+++.... .+.++|.++|||||.+.++.++|+| .
T Consensus 20 ~~~l~~q~DGNLvly~~~--~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS---~------------------ 76 (108)
T d1jpca_ 20 SFVFIMQEDCNLVLYDVD--KPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS---N------------------ 76 (108)
T ss_dssp TEEEEECTTSCEEEEETT--EEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC---C------------------
T ss_pred CEEEEECCCCeEEEEeCC--ceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc---c------------------
Confidence 357888899999999865 34555554332 3689999999999999999999987 1
Q ss_pred cCCCCCCCCCceEEEecCCCCceeeeccCCCCccceEeeccc
Q 038168 174 GISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNT 215 (757)
Q Consensus 174 ~~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~~ 215 (757)
+..+.+.|.+.|+.||++++|- .+.|.+++
T Consensus 77 ----t~~~~~~~~l~L~ddGNlVly~--------~~~W~S~t 106 (108)
T d1jpca_ 77 ----TGGQNGNYVCILQKDRNVVIYG--------TDRWATGT 106 (108)
T ss_dssp ----CCCSCSCEEEEECTTSCEEEEE--------CCCCCCCC
T ss_pred ----ccCCCCcEEEEEcCCCCEEEeC--------CCcccCCC
Confidence 1124578899999999999872 24676654
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.78 E-value=1.5e-08 Score=86.63 Aligned_cols=86 Identities=27% Similarity=0.637 Sum_probs=64.8
Q ss_pred CceeEeccCCCEEEecCCCCceeEEecCCC---cceeEEEecCCCEEEEecCCceeeeccCCCccccCCCCcccCCCccc
Q 038168 96 NATLLFNSEGSIVLRSSQQSQDSLIADDSQ---SASSASMLDSGNFVLYDSNGKTLWQTFEHPTDTLLPNQRLSVGTKLF 172 (757)
Q Consensus 96 ~~~l~~~~~G~Lvl~~~~~~~~~~~~~~~~---~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg~kl~~~~~L~ 172 (757)
.-.|.+..||+|||...+ ..+|++++.. .+..+.|.++|||||+|+++.++|+|-
T Consensus 20 ~~~l~~q~dgnLvl~~~~--~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s~-------------------- 77 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYDHS--TSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASH-------------------- 77 (109)
T ss_dssp TEEEEECTTSCEEEEETT--EEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEECC--------------------
T ss_pred CEEEEecCCCeEEEEeCC--EEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEEe--------------------
Confidence 356778899999999764 3455555432 246789999999999999999999981
Q ss_pred ccCCCCCCCCCceEEEecCCCCceeeeccCCCCccceEeecccc
Q 038168 173 PGISETNPSTGKFLLIMQGDGNLVQYANINPYGTQHAYWASNTY 216 (757)
Q Consensus 173 S~~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~ 216 (757)
+..+.|.|.+.|++||++++|- ...|.++++
T Consensus 78 -----t~~~~~~~~l~L~ddGNlvly~--------~~~W~S~t~ 108 (109)
T d1kj1a_ 78 -----SVRGNGNYVLVLQEDGNVVIYG--------SDIWSTGTY 108 (109)
T ss_dssp -----CCCCSSCCEEEECTTSCEEEEC--------CEEEECCCC
T ss_pred -----eECCCCCEEEEEeCCCcEEEEC--------CCEecCCCc
Confidence 1123577899999999999872 368988765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.13 E-value=0.00048 Score=67.51 Aligned_cols=101 Identities=14% Similarity=0.108 Sum_probs=72.8
Q ss_pred HHHHHHHHhhcC-CCceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhhCC----
Q 038168 514 FQTEMKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHDEC---- 588 (757)
Q Consensus 514 ~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---- 588 (757)
+.+|+..+..+. +--+.+++.+..+++..++||+++++..+.+..... . ...+++.++++.|..||+..
T Consensus 56 ~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~---~---~~~~~~~~l~~~l~~lH~~~~~~~ 129 (263)
T d1j7la_ 56 VEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE---Q---SPEKIIELYAECIRLFHSIDISDC 129 (263)
T ss_dssp HHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC---S---CHHHHHHHHHHHHHHHHTSCCTTC
T ss_pred HHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc---c---cHHHHHHHHHHHHHHHhccCcccc
Confidence 567788777763 434677888888888899999999998887654221 1 12335666666677776421
Q ss_pred ----------------------------------------------------CCCeeeCCCCcceEEECCCCcEEEeecC
Q 038168 589 ----------------------------------------------------ETQIIHCDIKPQNILMDENRCAKISDFG 616 (757)
Q Consensus 589 ----------------------------------------------------~~~iiH~Dik~~Nill~~~~~~ki~DfG 616 (757)
...++|+|+.|.|||++++...-|.||+
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe 209 (263)
T d1j7la_ 130 PYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLG 209 (263)
T ss_dssp SCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCT
T ss_pred ccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeech
Confidence 1237899999999999987777899999
Q ss_pred Cccc
Q 038168 617 LAKL 620 (757)
Q Consensus 617 la~~ 620 (757)
.+..
T Consensus 210 ~a~~ 213 (263)
T d1j7la_ 210 RSGR 213 (263)
T ss_dssp TCEE
T ss_pred hccc
Confidence 8764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.93 E-value=0.00092 Score=65.02 Aligned_cols=98 Identities=16% Similarity=0.171 Sum_probs=65.3
Q ss_pred HHHHHHHHhhcCC--CceeeeeeEEEeceeeeEEEEeccCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhh-----
Q 038168 514 FQTEMKVIGRTHH--RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNPEKQPNWVERMGIARDIARGILYLHD----- 586 (757)
Q Consensus 514 ~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~----- 586 (757)
+..|+..++.+.. -.+.+++++..+.+..++|||++++..+.+... . ...++.++++.|.-||.
T Consensus 51 l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~~------~---~~~~~~~l~~~la~LH~~~~~~ 121 (255)
T d1nd4a_ 51 LQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHL------A---PAEKVSIMADAMRRLHTLDPAT 121 (255)
T ss_dssp HHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSCC------C---HHHHHHHHHHHHHHHTTSCGGG
T ss_pred HHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccccc------c---HHHHHHHHHHHHHHHccCChhh
Confidence 5667777777643 335677888888888899999999876654211 1 11122333344444442
Q ss_pred ----------------------------------------------CC----CCCeeeCCCCcceEEECCCCcEEEeecC
Q 038168 587 ----------------------------------------------EC----ETQIIHCDIKPQNILMDENRCAKISDFG 616 (757)
Q Consensus 587 ----------------------------------------------~~----~~~iiH~Dik~~Nill~~~~~~ki~DfG 616 (757)
.. .+.++|+|+.|.|||++++..+-|+||+
T Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~ 201 (255)
T d1nd4a_ 122 CPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCG 201 (255)
T ss_dssp CCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCT
T ss_pred CCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEch
Confidence 11 1247999999999999988778899999
Q ss_pred Cccc
Q 038168 617 LAKL 620 (757)
Q Consensus 617 la~~ 620 (757)
.+..
T Consensus 202 ~~~~ 205 (255)
T d1nd4a_ 202 RLGV 205 (255)
T ss_dssp TCEE
T ss_pred hccc
Confidence 8754
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.96 E-value=0.0083 Score=37.36 Aligned_cols=34 Identities=29% Similarity=0.495 Sum_probs=26.6
Q ss_pred CCCCCCCCCCCCCCccccCCCCCCCCCCCCccccc
Q 038168 289 SDRCDPIGFCGFNSFCVLNDQIPDCPCLPGFVQIS 323 (757)
Q Consensus 289 ~d~Cd~yg~CG~~g~C~~~~~~p~C~C~~GF~~~~ 323 (757)
.|.|.+-..|| +|.|..--..-.|.|-+||+|..
T Consensus 1 tdECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 1 TDECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CCGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CCccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 37899999998 89997533346699999998643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=92.39 E-value=0.094 Score=53.90 Aligned_cols=31 Identities=26% Similarity=0.352 Sum_probs=26.5
Q ss_pred CCeeeCCCCcceEEECCCCcEEEeecCCcccc
Q 038168 590 TQIIHCDIKPQNILMDENRCAKISDFGLAKLM 621 (757)
Q Consensus 590 ~~iiH~Dik~~Nill~~~~~~ki~DfGla~~~ 621 (757)
..++|+|+++.|||++++. ++|.||-.+..-
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G 253 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFYG 253 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence 3689999999999998775 899999888653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=92.08 E-value=0.072 Score=54.82 Aligned_cols=40 Identities=20% Similarity=0.240 Sum_probs=26.9
Q ss_pred HHHHHHHHHHhhcCCCce-eeeeeEEEeceeeeEEEEeccCCChh
Q 038168 512 REFQTEMKVIGRTHHRNL-VRLLGYSLEVSKKILVYEYMSNGSLA 555 (757)
Q Consensus 512 ~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~ 555 (757)
....+|..+++.+.-.++ .++++++.+ .+|+||+++..|.
T Consensus 89 idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 89 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPLS 129 (395)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEECC
T ss_pred hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccCC
Confidence 345578888888843344 477777643 5799999875553
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.77 E-value=0.053 Score=36.11 Aligned_cols=31 Identities=26% Similarity=0.651 Sum_probs=25.1
Q ss_pred CCCCC-CCCCCCCCccccCCCCCCCCCCCCcc
Q 038168 290 DRCDP-IGFCGFNSFCVLNDQIPDCPCLPGFV 320 (757)
Q Consensus 290 d~Cd~-yg~CG~~g~C~~~~~~p~C~C~~GF~ 320 (757)
|.|.. ...|..+|.|........|.|++||+
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 56775 46799999998655568899999996
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.45 E-value=0.18 Score=33.55 Aligned_cols=32 Identities=22% Similarity=0.439 Sum_probs=25.1
Q ss_pred CCCCCCCCCCCCCCccccCCCCCCCCCCCCccc
Q 038168 289 SDRCDPIGFCGFNSFCVLNDQIPDCPCLPGFVQ 321 (757)
Q Consensus 289 ~d~Cd~yg~CG~~g~C~~~~~~p~C~C~~GF~~ 321 (757)
.|+|... .|+..+.|.....+..|.|++||+.
T Consensus 5 idEC~~~-~~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEP-DVCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSST-TSCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCc-CCCCCCEeECCCCCeEeECCCCccc
Confidence 4788754 4557899987666789999999974
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=87.05 E-value=0.19 Score=49.61 Aligned_cols=32 Identities=22% Similarity=0.347 Sum_probs=28.5
Q ss_pred CCCCeeeCCCCcceEEECCCCcEEEeecCCcc
Q 038168 588 CETQIIHCDIKPQNILMDENRCAKISDFGLAK 619 (757)
Q Consensus 588 ~~~~iiH~Dik~~Nill~~~~~~ki~DfGla~ 619 (757)
...++||+|+.+.||+++++...-|.||+.+.
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccccCCcchhhhhcccccceeEecccccc
Confidence 45689999999999999998878899999885
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.64 E-value=0.14 Score=33.31 Aligned_cols=30 Identities=30% Similarity=0.615 Sum_probs=23.0
Q ss_pred CCCCCCCCCCCCCccccCCCCCCCCCCCCcc
Q 038168 290 DRCDPIGFCGFNSFCVLNDQIPDCPCLPGFV 320 (757)
Q Consensus 290 d~Cd~yg~CG~~g~C~~~~~~p~C~C~~GF~ 320 (757)
|.|. ..-|-..|.|........|.|++||+
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~ 30 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFE 30 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEE
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCC
Confidence 4565 46788888897655568999999995
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.09 E-value=0.23 Score=32.69 Aligned_cols=31 Identities=29% Similarity=0.607 Sum_probs=24.0
Q ss_pred CCCCCCCCCCCCCccccCCCCCCCCCCCCcccc
Q 038168 290 DRCDPIGFCGFNSFCVLNDQIPDCPCLPGFVQI 322 (757)
Q Consensus 290 d~Cd~yg~CG~~g~C~~~~~~p~C~C~~GF~~~ 322 (757)
|+|...+.| ..+|.....+..|.|++||...
T Consensus 2 dEC~~~~~C--~~~C~n~~Gsy~C~C~~Gy~L~ 32 (41)
T d1i0ua2 2 DECQDPDTC--SQLCVNLEGGYKCQCEEGFQLD 32 (41)
T ss_dssp CTTTTTTSC--SSCEECSSSCCEECCCTTEEEC
T ss_pred ccCCCCCCC--CCEeECCCCCEEeECCCCCeEC
Confidence 678777777 4689866667889999999753
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.83 E-value=0.19 Score=33.64 Aligned_cols=31 Identities=26% Similarity=0.552 Sum_probs=23.2
Q ss_pred CCCCC-CCCCCCCCccccCCCCCCCCCCCCccc
Q 038168 290 DRCDP-IGFCGFNSFCVLNDQIPDCPCLPGFVQ 321 (757)
Q Consensus 290 d~Cd~-yg~CG~~g~C~~~~~~p~C~C~~GF~~ 321 (757)
|+|.. ...| .++.|.....+..|.|++||+.
T Consensus 4 dEC~~~~~~C-~~~~C~Nt~Gsy~C~C~~Gy~~ 35 (44)
T d1lmja1 4 DECRISPDLC-GRGQCVNTPGDFECKCDEGYES 35 (44)
T ss_dssp CTTTTCSSTT-TTSCEEEETTEEEECCCSSEEE
T ss_pred cccCCCCCCC-CCCEeEcCCCCeEEeCCCCCcc
Confidence 67875 3455 4789986666788999999973
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.18 E-value=0.21 Score=32.44 Aligned_cols=30 Identities=23% Similarity=0.608 Sum_probs=22.8
Q ss_pred CCCCCCCCCCCCCccccCCCCCCCCCCCCcc
Q 038168 290 DRCDPIGFCGFNSFCVLNDQIPDCPCLPGFV 320 (757)
Q Consensus 290 d~Cd~yg~CG~~g~C~~~~~~p~C~C~~GF~ 320 (757)
|.|. ..-|...|.|........|.|++||.
T Consensus 2 d~C~-~~PC~n~g~C~~~~~~y~C~C~~G~~ 31 (39)
T d2vj3a2 2 NECV-SNPCQNDATCLDQIGEFQCICMPGYE 31 (39)
T ss_dssp CTTT-TCCCCSSCEEEECSSCEEEECCTTEE
T ss_pred cCCc-CCCCCCCCEEECCCCCEEEeCCCCCc
Confidence 4564 35688889997655568899999995
|